data_2kdo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kdo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.863 0.364 . . . . 1.5800000000000001 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -155.24 171.15 20.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.881 -0.785 . . . . 0.97999999999999998 108.881 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -78.9 -56.65 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.578 0.227 . . . . 2.0 111.518 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.26 90.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 1.24 111.099 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.2 mmt-85 -148.1 149.77 32.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.474 -0.33 . . . . 2.0899999999999999 110.213 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.69 -6.32 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.984 0.421 . . . . 1.73 111.371 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -11.14 45.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.81999999999999995 110.716 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -119.15 25.57 10.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.012 -0.54 . . . . 0.20000000000000001 111.354 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -90.63 151.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.167 0.508 . . . . 0.29999999999999999 111.843 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.88 139.15 42.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.323 -0.853 . . . . 0.17999999999999999 109.342 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 46.0 t -80.13 120.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.906 0.384 . . . . 0.63 111.306 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 HG12 HG13 ' A' ' 31' ' ' ILE . 2.4 p -149.75 131.08 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 0.97999999999999998 109.572 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -148.67 148.58 30.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.835 0.35 . . . . 0.45000000000000001 111.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.4 ttp -108.1 129.85 55.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.128 -0.487 . . . . 0.34000000000000002 110.095 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.06 114.16 25.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.062 -0.517 . . . . 1.97 110.148 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.6 175.37 6.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 1.6599999999999999 109.541 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.67 92.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.704 0.288 . . . . 0.5 111.002 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.68 42.95 1.28 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.68 -0.772 . . . . 0.22 112.911 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 162.24 4.11 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.79 0.295 . . . . 2.3399999999999999 110.769 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 39.4 mmt180 -126.57 147.58 49.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 2.25 109.576 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -139.9 94.14 2.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.982 -0.377 . . . . 0.37 109.982 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -104.46 129.6 52.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.539 -0.3 . . . . 1.25 110.343 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.444 HG13 HG12 ' A' ' 20' ' ' VAL . 29.9 pt -131.48 -179.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.05 111.12 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.6 114.38 9.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.98999999999999999 111.015 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.63 179.45 3.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 0.42999999999999999 110.344 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.69 139.82 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.39000000000000001 110.77 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.75 -5.08 52.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 1.0600000000000001 112.241 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.43 78.2 4.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.573 0.225 . . . . 0.34999999999999998 110.861 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 tttp 50.97 60.43 3.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.656 -0.702 . . . . 2.23 110.389 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.4 p -57.15 -32.92 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.412 -0.813 . . . . 0.38 112.529 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -83.47 5.02 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.182 0.515 . . . . 0.19 111.409 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.352 0 CA-C-N 116.056 -0.52 . . . . 0.23000000000000001 113.607 -179.015 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.225 0.536 . . . . 1.3600000000000001 110.114 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -175.49 -177.54 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.304 -0.862 . . . . 0.54000000000000004 108.675 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.96 30.05 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 2.6200000000000001 110.773 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -120.63 -54.78 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 1.3200000000000001 110.502 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.55 -17.29 63.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 1.2 110.644 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.84 -18.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.47 0.652 . . . . 0.58999999999999997 109.728 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.78 99.48 12.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.25 109.733 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -68.36 -48.92 63.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.31 111.159 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -127.0 151.1 49.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.549 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -106.56 16.55 24.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.338 0.59 . . . . 0.78000000000000003 109.715 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.6 127.39 53.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.731 . . . . 0.63 110.204 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 68' ' ' ALA . 7.1 p -108.41 138.41 35.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.067 0.46 . . . . 0.12 110.444 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -95.69 130.49 42.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.266 -0.424 . . . . 0.37 110.538 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 10.3 t -86.13 -17.98 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.347 0.594 . . . . 0.20000000000000001 109.752 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -177.94 105.13 0.05 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.201 -0.909 . . . . 1.1599999999999999 109.717 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.52 -19.94 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.428 0.529 . . . . 0.12 112.428 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -36.66 73.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.975 0.417 . . . . 1.1399999999999999 110.812 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -91.25 -36.53 13.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.87 110.223 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.04 38.87 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.885 -0.674 . . . . 0.35999999999999999 111.801 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.47 104.49 16.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.72 0.295 . . . . 2.3900000000000001 110.553 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.0 t -92.85 116.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.548 -0.538 . . . . 0.47999999999999998 109.548 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HG13 ' A' ' 58' ' ' VAL . . . -82.7 124.44 30.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.111 0.482 . . . . 0.23000000000000001 111.52 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 6.8 ptpp? -87.85 -175.64 5.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 1.1200000000000001 109.294 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HG3' ' OE2' ' A' ' 71' ' ' GLU . 11.7 pttm -60.61 -27.15 67.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.991 0.367 . . . . 1.3 111.991 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' OE2' ' HG3' ' A' ' 70' ' ' LYS . 8.3 mp0 -78.86 -32.43 46.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.222 0.534 . . . . 1.47 110.245 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 51.0 m-20 -68.72 -50.09 53.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.26000000000000001 110.74 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.89 -29.27 70.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.956 -0.298 . . . . 0.13 111.205 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.423 HG21 ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -71.26 -22.97 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.089 0.471 . . . . 1.7 109.969 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 m -95.33 -44.98 7.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.045 0.45 . . . . 0.40000000000000002 110.917 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.26 58.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.72 -51.59 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.078 -0.341 . . . . 1.55 110.078 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.21 16.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.722 -0.751 . . . . 0.28000000000000003 112.054 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 81' ' ' ASP . 5.2 m -125.09 137.85 54.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.163 -0.31 . . . . 1.9099999999999999 110.163 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.15 -11.54 57.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.503 -0.317 . . . . 0.40999999999999998 111.525 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' H ' HG21 ' A' ' 79' ' ' THR . 21.6 t70 -85.42 117.82 24.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.68000000000000005 110.705 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.96 -31.08 68.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.22 111.256 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.36 -47.63 75.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.625 0.25 . . . . 1.47 111.471 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.12 -51.07 71.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.998 0.428 . . . . 1.7 110.788 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mt -61.0 -51.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.648 -0.706 . . . . 0.23000000000000001 111.169 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 99.9 m -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.20999999999999999 111.152 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -62.22 -42.08 98.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.491 -0.322 . . . . 0.82999999999999996 110.432 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.69 -43.33 89.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.33000000000000002 110.134 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.85 -32.57 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.305 0.574 . . . . 0.19 110.82 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.95 -32.05 61.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.818 -0.628 . . . . 0.27000000000000002 112.61 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -100.57 -13.54 18.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.789 0.662 . . . . 0.31 112.789 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.27 25.38 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.375 -0.203 . . . . 1.21 111.015 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -132.72 -175.98 14.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.032 -1.08 . . . . 0.17000000000000001 113.64 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -83.4 76.52 9.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.234 0.54 . . . . 1.74 109.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.99 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.624 -0.717 . . . . 0.77000000000000002 110.91 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.9 mm-40 -72.78 105.72 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.738 -0.467 . . . . 0.72999999999999998 109.738 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 1.1599999999999999 111.077 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.879 0.371 . . . . 1.73 110.667 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -129.22 98.97 5.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.69999999999999996 110.449 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -67.62 147.24 52.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 2.0499999999999998 109.81 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.409 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 31.5 m 58.78 61.65 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.523 0.678 . . . . 2.1099999999999999 110.625 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -4.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 1.3500000000000001 111.138 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -95.15 -30.64 13.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 1.6200000000000001 109.816 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 145' ' ' SER . 1.4 m -66.3 123.75 20.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 1.1299999999999999 110.93 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.04 42.02 3.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.905 0.882 . . . . 0.46000000000000002 112.229 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -67.69 111.28 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.72 -0.673 . . . . 1.95 110.761 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -82.73 101.88 11.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 1.5900000000000001 110.046 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.7 p -58.6 -76.9 0.04 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 112.358 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -82.35 62.27 5.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.93 0.395 . . . . 1.54 111.296 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -166.07 -48.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.167 -0.47 . . . . 0.78000000000000003 110.459 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.8 22.38 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.65000000000000002 110.964 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.59 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 0.16 111.938 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 4.1 mm? -74.51 -34.84 63.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.552 -0.295 . . . . 0.88 111.033 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.6 -48.86 70.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.17 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.76 -48.27 81.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.23999999999999999 111.951 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.78 -28.66 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.761 0.315 . . . . 0.38 111.594 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.0 mmtp -80.74 -33.81 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 1.0700000000000001 110.359 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.7 -39.19 93.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 2.7200000000000002 110.199 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.97 -46.89 73.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 110.162 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -62.04 -30.23 70.83 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.8 -0.636 . . . . 1.5900000000000001 111.429 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -53.76 -44.57 70.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.56999999999999995 110.409 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 -69.81 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 1.1699999999999999 110.15 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 62.2 ttp -102.37 123.93 47.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.007 -0.542 . . . . 0.41999999999999998 111.079 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.99 99.52 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.02 -0.536 . . . . 1.3700000000000001 110.401 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.34 -0.846 . . . . 1.8799999999999999 110.895 179.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.628 0.252 . . . . 1.46 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -128.42 134.67 48.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.441 -0.345 . . . . 3.0499999999999998 111.172 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 211' ' ' VAL . 2.7 mp -129.49 145.76 51.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 0.5 110.108 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.455 ' HB3' HG22 ' A' ' 211' ' ' VAL . 9.8 ptm180 -126.72 132.12 51.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.384 -0.371 . . . . 0.28999999999999998 110.413 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 22.0 m-85 -92.95 140.37 29.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 0.52000000000000002 110.533 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.403 ' C ' HD12 ' A' ' 180' ' ' LEU . 14.3 mt -120.85 118.37 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.527 -0.306 . . . . 0.28999999999999998 111.309 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 179' ' ' ILE . 0.0 OUTLIER -152.12 156.43 33.91 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.95 -0.568 . . . . 0.14999999999999999 109.906 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.31 172.4 12.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.66 2.24 . . . . 0.14999999999999999 112.516 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.8 -44.95 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.387 -0.37 . . . . 0.91000000000000003 111.652 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -52.92 -55.84 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.981 -0.554 . . . . 1.24 111.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.55 -27.24 61.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.424 -0.353 . . . . 0.25 111.403 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.57 -34.78 90.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.216 -0.516 . . . . 0.19 111.893 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -77.75 52.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.36 0.6 . . . . 0.68999999999999995 109.813 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -152.59 -46.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.258 -0.883 . . . . 1.99 109.477 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.53 -26.21 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 1.1399999999999999 110.693 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 12.0 ttpt -67.31 -21.73 65.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.47 . . . . 1.3400000000000001 110.603 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.9 OUTLIER -100.19 8.76 43.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.481 . . . . 0.85999999999999999 110.921 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -124.85 -45.49 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.568 -0.287 . . . . 0.64000000000000001 111.08 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.4 mt -78.29 -35.39 47.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.715 0.265 . . . . 1.1399999999999999 111.715 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 23.7 mmtt -62.4 -52.71 64.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.271 0.471 . . . . 1.6499999999999999 112.271 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.7 Cg_endo -58.98 -24.6 74.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.153 1.902 . . . . 0.29999999999999999 113.073 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.55 -22.05 54.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 1.01 110.765 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.3 mm 59.3 66.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.41999999999999998 110.518 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -134.19 15.11 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.765 -0.652 . . . . 1.3600000000000001 109.91 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.14 163.69 2.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.328 0.585 . . . . 0.54000000000000004 112.07 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.85 160.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.41 64.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 2.2400000000000002 111.095 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.503 ' O ' HG21 ' A' ' 211' ' ' VAL . 2.3 t -161.65 90.36 0.78 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.34 -0.615 . . . . 0.80000000000000004 109.34 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.79 163.86 29.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 1.6699999999999999 110.423 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -119.18 131.47 55.85 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.939 -0.763 . . . . 0.28000000000000003 108.939 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.45 31.56 6.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.55000000000000004 111.29 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -96.11 -115.76 3.11 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.832 -0.699 . . . . 0.35999999999999999 112.275 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -91.63 -22.6 20.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.83999999999999997 110.148 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.46 123.15 40.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 2.04 109.345 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.94 77.89 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.032 0.444 . . . . 1.24 110.932 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 29.7 mt-10 -75.45 118.65 18.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.052 -0.522 . . . . 1.04 109.884 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 34.1 mt -122.84 126.81 74.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.877 0.37 . . . . 0.56999999999999995 110.847 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 201' ' ' SER . 39.4 t -94.09 104.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.91000000000000003 109.731 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.6 t -130.91 115.56 16.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.15 -0.477 . . . . 0.20999999999999999 110.121 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.7 125.3 2.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.439 ' CG1' ' H ' ' A' ' 215' ' ' ASP . 3.3 tt -104.84 -170.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.566 -0.288 . . . . 0.69999999999999996 110.319 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.439 ' H ' ' CG1' ' A' ' 214' ' ' ILE . 37.4 m-20 -62.27 141.14 96.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.512 0.196 . . . . 1.3 110.572 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.77 -26.73 83.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.051 2.5 . . . . 0.98999999999999999 113.362 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.71 78.85 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.761 -0.733 . . . . 0.65000000000000002 111.945 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 62.6 m -110.68 25.44 11.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 2.04 110.558 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -60.11 -32.42 70.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.65000000000000002 111.277 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -18.52 59.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.93000000000000005 110.893 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.5 -24.68 24.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.40000000000000002 111.096 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.6 tp -96.13 -42.43 12.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.691 -0.404 . . . . 1.5 111.459 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.404 ' N ' HG21 ' A' ' 222' ' ' ILE . 18.5 t70 -67.17 -22.4 65.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.881 0.326 . . . . 0.33000000000000002 111.881 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.27 -28.28 64.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.65 0.262 . . . . 1.1399999999999999 111.352 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.38 -37.35 6.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.609 -0.269 . . . . 1.1499999999999999 110.365 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -59.09 -34.31 52.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 1.1899999999999999 111.27 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 16.6 ptpt -53.91 -31.5 50.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.707 0.632 . . . . 1.73 112.707 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -113.52 -25.29 8.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 2.6800000000000002 112.063 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 228' ' ' LYS . 0.4 OUTLIER -69.79 -41.97 74.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.174 0.435 . . . . 1.3300000000000001 112.174 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.0 t -135.8 -37.48 0.74 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.373 -0.531 . . . . 0.34999999999999998 112.376 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 42.0 mtpt -59.67 -41.52 90.82 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 1.0700000000000001 110.731 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.41 38.03 3.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.17000000000000001 111.535 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -151.97 -53.36 0.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.645 0.26 . . . . 0.68000000000000005 110.649 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -114.97 -168.16 15.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.074 -0.584 . . . . 0.13 111.995 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.9 m -101.81 144.5 30.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.956 -0.387 . . . . 0.81000000000000005 109.956 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.32 119.19 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 1.0600000000000001 110.612 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -113.22 151.68 30.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.731 -0.668 . . . . 0.39000000000000001 109.904 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.79 145.1 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.639 0.256 . . . . 1.04 110.705 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 0.39000000000000001 109.497 179.385 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.781 0.324 . . . . 1.03 110.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.22 177.09 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.448 -0.575 . . . . 0.67000000000000004 109.448 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.88 -77.04 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.713 0.292 . . . . 1.6399999999999999 111.01 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.12 76.05 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.338 0.59 . . . . 2.0699999999999998 110.603 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -147.91 159.21 44.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.43 -0.805 . . . . 2.1200000000000001 109.258 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.53 42.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.62 110.337 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 p -110.82 -66.01 1.12 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.001 -0.545 . . . . 0.23999999999999999 110.427 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -92.34 60.18 3.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.48 0.657 . . . . 1.29 109.464 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 HG12 ' OE1' ' A' ' 54' ' ' GLN . 17.0 m -100.08 148.44 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.354 -0.839 . . . . 0.20000000000000001 111.453 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.471 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -113.6 114.6 26.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.831 -0.622 . . . . 0.22 109.904 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.46 121.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.95999999999999996 110.838 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.9 p -133.43 122.3 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.966 -0.561 . . . . 0.25 110.316 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -110.36 128.4 55.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.518 . . . . 0.47999999999999998 110.733 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.8 ttp -89.35 141.75 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.28000000000000003 110.963 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.89 122.35 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.9199999999999999 110.316 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -125.22 32.62 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.846 -0.161 . . . . 0.85999999999999999 110.988 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.14 70.84 0.49 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.757 0.661 . . . . 0.56999999999999995 111.805 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 -35.62 4.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.876 -0.678 . . . . 0.67000000000000004 111.654 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -106.07 148.48 27.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.154 -0.684 . . . . 2.2999999999999998 109.154 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.21 153.62 51.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.636 0.255 . . . . 2.5499999999999998 110.434 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -144.82 116.6 8.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.274 -0.639 . . . . 0.53000000000000003 109.274 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 59' ' ' PHE . 3.3 pm0 -112.0 132.94 54.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.16 111.661 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -128.94 145.75 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.571 -0.74 . . . . 1.1599999999999999 109.905 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.85 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.503 -0.317 . . . . 0.94999999999999996 110.263 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.03 171.17 7.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.365 -0.379 . . . . 0.16 110.347 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.23 119.68 13.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.28000000000000003 109.908 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -75.32 69.61 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 1.0800000000000001 111.135 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.03 64.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.63 109.321 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.51 50.96 13.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.808 -0.633 . . . . 1.6100000000000001 110.326 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.86 10.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.359 -0.837 . . . . 1.1299999999999999 112.901 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.6 12.39 7.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.734 0.778 . . . . 1.0600000000000001 109.463 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.41999999999999998 113.055 -178.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.035 -0.728 . . . . 1.97 109.035 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' OD1' ' HB2' ' A' ' 50' ' ' ASP . 9.5 t0 -65.61 124.01 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.75 110.483 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 tp -70.48 -17.31 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 1.4199999999999999 111.951 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -59.84 -35.86 75.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.07 0.462 . . . . 1.6699999999999999 110.503 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.83 -33.41 21.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 1.49 110.465 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.62 -38.39 82.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.884 -0.598 . . . . 0.40999999999999998 111.246 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.83 84.05 6.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.051 -0.351 . . . . 0.26000000000000001 110.051 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' OE1' HG12 ' A' ' 17' ' ' VAL . 37.4 mt-30 -66.26 -77.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.40000000000000002 111.098 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -74.96 129.21 37.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.32000000000000001 110.23 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -93.82 12.28 26.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.368 0.604 . . . . 0.66000000000000003 110.034 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.495 -0.775 . . . . 0.17999999999999999 109.962 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.65 146.3 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.692 -0.485 . . . . 1.0700000000000001 109.692 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 19.0 m-85 -104.94 140.16 38.58 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.885 -0.413 . . . . 0.83999999999999997 109.885 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 2.4 t -92.58 -16.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 1.03 110.339 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -178.97 95.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.536 -0.757 . . . . 0.45000000000000001 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.67 -27.45 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.432 . . . . 0.37 111.53 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 m -68.35 -20.63 64.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.785 0.326 . . . . 0.46999999999999997 111.461 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.71 3.95 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 2.0899999999999999 110.419 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 28.14 73.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.14000000000000001 112.109 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.08 102.43 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.73999999999999999 110.711 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 128.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.029 -0.532 . . . . 0.25 110.516 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.24 116.62 32.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.94999999999999996 110.15 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -87.09 178.89 6.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.985 -0.552 . . . . 2.98 110.253 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -23.93 67.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.258 -0.177 . . . . 0.41999999999999998 111.438 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -87.22 0.94 54.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.782 0.325 . . . . 0.45000000000000001 110.593 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.5 -42.22 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.25 -0.432 . . . . 1.21 110.738 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.5 -28.19 68.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.784 0.326 . . . . 0.25 110.765 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -68.85 -28.7 40.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.199 0.523 . . . . 1.8799999999999999 110.067 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.74 20.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.932 -0.576 . . . . 1.45 110.296 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 -56.76 9.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.793 -0.64 . . . . 0.53000000000000003 111.736 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -102.86 -55.15 2.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.652 0.263 . . . . 1.1200000000000001 111.003 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.85 -32.28 1.58 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.671 . . . . 0.26000000000000001 111.954 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.41 133.38 33.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.608 0.242 . . . . 0.93999999999999995 110.758 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.08 2.86 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.973 0.416 . . . . 0.68000000000000005 110.595 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 85' ' ' ILE . 6.8 t70 -91.39 126.43 36.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.934 -0.575 . . . . 1.1399999999999999 110.234 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.29 -27.3 63.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.569 . . . . 1.0800000000000001 111.13 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -62.66 -49.1 76.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.359 -0.382 . . . . 1.6399999999999999 110.409 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 87' ' ' LYS . 6.4 mm-40 -61.02 -43.25 99.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.58999999999999997 110.899 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 81' ' ' ASP . 50.1 mm -60.61 -49.29 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.31 110.114 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.443 ' HG ' HD23 ' A' ' 90' ' ' LEU . 52.8 t -64.7 -34.3 77.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.12 110.949 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 29.4 ttpt -61.31 -43.99 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.57999999999999996 110.403 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -68.85 -38.64 79.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.84999999999999998 110.472 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -67.34 -33.44 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.39000000000000001 110.799 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD23 ' HG ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -77.91 -12.11 59.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.97 -0.559 . . . . 1.0900000000000001 112.504 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 92' ' ' LYS . 14.6 t -116.1 -21.37 9.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 1.23 112.046 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HG2' HG23 ' A' ' 91' ' ' THR . 33.0 mmmt -124.8 25.91 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.025 0.44 . . . . 0.69999999999999996 110.249 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.6 176.63 19.08 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.669 -0.777 . . . . 0.40999999999999998 112.322 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -85.31 82.81 8.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 2.48 111.365 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.18 124.93 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.119 -0.492 . . . . 1.52 110.268 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 18' ' ' ALA . 3.4 pt20 -75.79 109.29 9.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.172 0.511 . . . . 0.79000000000000004 110.011 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.254 0.55 . . . . 0.28999999999999998 111.095 -179.747 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.22 110.108 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -78.18 56.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.337 -0.847 . . . . 0.80000000000000004 110.909 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.05 169.57 17.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.973 -0.558 . . . . 3.1600000000000001 110.694 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.03 107.08 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 1.04 110.059 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.3 69.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.004 0.431 . . . . 0.58999999999999997 109.973 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 61.72 85.27 0.12 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.406 -0.815 . . . . 1.5700000000000001 110.383 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.1 m -80.42 44.79 0.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.859 -0.609 . . . . 0.40999999999999998 111.354 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.46 -21.11 28.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.907 -0.588 . . . . 0.33000000000000002 109.79 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 80.9 1.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.448 -0.796 . . . . 1.1100000000000001 109.58 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -86.14 16.33 4.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.47999999999999998 112.039 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 131.82 51.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.553 -0.294 . . . . 1.3400000000000001 111.424 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 58.24 48.56 12.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.715 -0.675 . . . . 1.78 111.299 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 59.41 53.11 5.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.537 -0.756 . . . . 0.98999999999999999 111.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.1 30.29 19.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.306 -0.861 . . . . 0.28999999999999998 112.071 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.58 85.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.23999999999999999 110.521 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.55 -7.85 50.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.713 -0.676 . . . . 1.1000000000000001 111.234 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -99.56 -47.04 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.537 -0.542 . . . . 0.93999999999999995 109.537 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.47999999999999998 111.426 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.62 -15.14 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.053 0.454 . . . . 0.71999999999999997 111.457 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -109.06 0.04 19.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.319 0.581 . . . . 2.3500000000000001 110.355 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -84.55 -54.26 4.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.617 -0.719 . . . . 0.64000000000000001 109.787 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -69.25 -18.9 63.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.23000000000000001 110.435 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.532 ' N ' HD12 ' A' ' 163' ' ' LEU . 46.6 tttm -69.35 -22.01 63.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.91000000000000003 110.11 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -81.66 -12.82 58.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.835 -0.62 . . . . 0.63 110.391 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.82 -39.65 5.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.178 -0.465 . . . . 1.04 110.731 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.3 tpp -141.79 143.98 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.5 110.722 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -96.4 119.59 35.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.281 -0.418 . . . . 0.98999999999999999 110.282 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.285 -0.416 . . . . 1.2 110.78 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 40.5 mtm . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.012 -0.366 . . . . 1.95 110.012 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -102.02 131.54 48.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.369 -0.604 . . . . 1.74 109.369 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.7 mp -116.5 157.22 25.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.203 0.525 . . . . 0.58999999999999997 111.325 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.59 ' HB2' ' OE2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -127.77 160.58 31.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.143 -0.935 . . . . 1.8600000000000001 108.9 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -129.3 128.61 43.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.695 0.283 . . . . 0.68999999999999995 110.463 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -114.52 121.69 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.466 0.651 . . . . 1.3700000000000001 111.386 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.433 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -150.1 157.31 37.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.421 -0.808 . . . . 0.13 109.902 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.21 163.85 11.47 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.688 2.259 . . . . 0.11 112.501 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.23 -39.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.256 -0.429 . . . . 0.31 112.05 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -57.95 -60.79 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.726 0.298 . . . . 0.53000000000000003 111.638 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.87 -19.46 61.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 1.4399999999999999 111.509 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.86 72.87 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.943 -0.646 . . . . 0.22 111.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -61.82 -32.65 72.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.614 0.245 . . . . 2.1899999999999999 110.712 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -55.75 -43.97 77.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.014 -0.539 . . . . 1.55 111.668 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 -35.27 12.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.416 -0.356 . . . . 0.55000000000000004 111.63 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.77 -34.25 75.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.688 0.28 . . . . 2.52 111.171 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -95.88 20.73 9.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.807 0.299 . . . . 1.23 111.807 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -146.35 -45.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.447 0.536 . . . . 1.6899999999999999 112.447 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -75.89 -39.71 55.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.662 0.268 . . . . 0.60999999999999999 111.494 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.587 ' HZ3' ' CD ' ' A' ' 202' ' ' GLU . 5.2 mtpt -58.6 -52.79 72.19 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.191 -0.459 . . . . 1.6699999999999999 112.002 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 34.1 Cg_endo -65.12 -12.5 35.03 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.056 1.837 . . . . 0.11 112.961 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.8 mt -88.64 -7.52 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.359 . . . . 0.22 110.304 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 6.8 mm 59.64 40.26 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.519 -0.764 . . . . 0.40000000000000002 110.815 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -112.21 19.96 17.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 1.4299999999999999 109.947 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.68 139.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.813 -0.631 . . . . 0.40000000000000002 111.053 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.93 164.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.812 -0.631 . . . . 1.8999999999999999 110.039 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -71.14 56.29 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 1.6699999999999999 111.092 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.2 m -156.17 88.21 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.907 -0.775 . . . . 0.77000000000000002 108.907 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.587 ' CD ' ' HZ3' ' A' ' 193' ' ' LYS . 2.4 pt-20 -134.94 140.03 45.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.533 -0.758 . . . . 1.1499999999999999 110.396 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.37 137.41 53.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.629 -0.508 . . . . 0.47999999999999998 109.629 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.29 30.38 7.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 1.28 111.501 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -79.72 -140.28 2.16 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.729 -0.748 . . . . 1.3100000000000001 112.847 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.63 -20.96 66.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.93 0.395 . . . . 1.26 111.529 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -136.09 143.2 44.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.923 -0.399 . . . . 1.26 109.923 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.99 85.53 6.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.46999999999999997 110.75 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.59 ' OE2' ' HB2' ' A' ' 177' ' ' ARG . 10.3 tp10 -90.28 106.21 18.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.137 -0.69 . . . . 1.5 109.137 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.79 134.62 58.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.957 0.408 . . . . 0.23000000000000001 111.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.5 t -84.53 108.01 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.17999999999999999 110.21 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.0 m -126.59 90.35 3.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.135 -0.484 . . . . 0.35999999999999999 110.406 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.411 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -155.78 132.01 10.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.28000000000000003 109.837 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.82 173.21 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.521 -0.309 . . . . 1.5600000000000001 110.276 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 4.1 m-20 -69.51 169.35 12.54 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.456 -0.338 . . . . 1.22 110.417 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.49 -161.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.642 2.228 . . . . 0.81999999999999995 112.794 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.62 -98.52 1.55 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.34000000000000002 111.718 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 68.9 m -75.98 0.88 16.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 1.9299999999999999 111.563 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 44.3 t80 -61.46 -32.3 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 0.28999999999999998 111.033 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -9.1 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 1.6200000000000001 111.701 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -92.7 -32.69 14.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.794 0.331 . . . . 1.1000000000000001 110.567 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' ' 226' ' ' ILE . 4.8 tp -94.51 -31.37 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.384 0.513 . . . . 2.0499999999999998 112.384 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.491 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -60.24 -28.12 67.77 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.33 -0.231 . . . . 0.94999999999999996 111.42 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -56.43 -35.37 67.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.81 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.2 pp -95.81 -24.89 16.26 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 1.29 110.492 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -61.59 -38.1 79.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.367 -0.379 . . . . 0.55000000000000004 110.693 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 223' ' ' ASP . 13.7 ptpt -64.31 -16.48 62.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.656 0.613 . . . . 0.28999999999999998 112.656 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.57 -23.47 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.613 -0.435 . . . . 0.80000000000000004 111.838 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -81.93 -43.23 18.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.588 0.588 . . . . 0.92000000000000004 112.588 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -128.18 -38.87 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.364 -0.535 . . . . 0.34999999999999998 111.914 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 14.7 tttt -63.76 -28.06 69.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.941 0.401 . . . . 2.8500000000000001 110.563 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -102.13 16.98 55.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.912 -0.661 . . . . 0.32000000000000001 112.123 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.7 -36.09 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.339 . . . . 0.39000000000000001 111.044 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.51 -156.04 6.65 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.515 -0.85 . . . . 0.28000000000000003 112.725 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 m -101.98 137.7 39.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.875 0.369 . . . . 0.20000000000000001 110.425 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.13 149.11 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 1.01 111.013 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.35 161.04 39.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.678 . . . . 0.33000000000000002 109.168 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.2 m -99.04 148.45 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.762 0.315 . . . . 0.27000000000000002 111.066 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 109.576 -0.527 . . . . 0.64000000000000001 109.576 179.406 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.912 0.387 . . . . 0.25 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HB2' ' H ' ' A' ' 11' ' ' GLN . 5.0 m120 -107.88 -89.57 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.37 110.293 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' H ' ' HB2' ' A' ' 10' ' ' ASN . 24.8 mm-40 -137.51 -88.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.675 -0.491 . . . . 0.33000000000000002 109.675 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.01 107.64 23.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.316 -0.624 . . . . 1.3899999999999999 109.316 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -158.31 152.44 24.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.1 -0.5 . . . . 1.5800000000000001 110.373 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -78.77 49.06 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.62 110.968 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.3 p -129.04 -45.61 1.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.128 0.49 . . . . 0.25 110.606 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -106.69 39.54 1.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.28000000000000003 109.672 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.38 135.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.29999999999999999 111.581 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.06 116.08 31.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.966 -0.561 . . . . 0.14999999999999999 109.844 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.6 114.73 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.845 -0.616 . . . . 1.04 111.387 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 136.29 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 1.04 108.986 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.434 ' HD3' ' CD ' ' A' ' 30' ' ' GLU . 12.4 ttp180 -142.18 140.98 32.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.089 0.471 . . . . 1.72 111.939 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 tpt -135.55 119.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.89000000000000001 108.877 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -122.62 114.95 21.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.902 0.382 . . . . 1.9199999999999999 111.734 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -112.42 -164.41 0.91 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.36 6.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.702 0.287 . . . . 0.40999999999999998 111.375 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.74 4.77 24.4 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.357 -0.925 . . . . 1.0900000000000001 113.229 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -126.76 119.02 25.86 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.488 -0.419 . . . . 1.0800000000000001 110.34 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -140.98 122.54 15.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.295 -0.411 . . . . 2.4500000000000002 110.478 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -149.96 146.87 27.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.285 0.365 . . . . 0.46000000000000002 110.923 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.434 ' CD ' ' HD3' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -143.9 136.77 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.90000000000000002 110.714 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -139.98 -173.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.885 0.374 . . . . 0.96999999999999997 110.59 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.46 116.65 13.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.46999999999999997 110.185 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' H ' ' A' ' 34' ' ' TYR . 7.8 p -112.67 -158.35 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.334 -0.394 . . . . 0.13 111.172 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -74.65 -169.1 0.8 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 1.1200000000000001 110.673 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -74.43 -157.88 0.06 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.894 0.378 . . . . 1.3899999999999999 111.295 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -56.71 -19.95 19.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.109 0.781 . . . . 0.56000000000000005 113.109 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -63.55 -19.03 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.40000000000000002 111.203 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.05 -24.92 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.1 0.476 . . . . 0.23000000000000001 110.767 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.2 -13.29 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.323 -0.398 . . . . 0.34999999999999998 110.403 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.934 -0.575 . . . . 0.33000000000000002 112.416 179.804 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.52 0.2 . . . . 1.53 110.98 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.49 ' O ' HG21 ' A' ' 52' ' ' VAL . 1.2 m-20 -52.88 114.26 1.37 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.258 -0.428 . . . . 1.4399999999999999 111.303 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.54 -28.28 68.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 1.7 111.662 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.05 -36.76 82.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.265 0.555 . . . . 0.94999999999999996 110.403 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.67 -30.21 56.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 1.0900000000000001 109.951 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 48' ' ' ASP . 21.9 t -75.48 -27.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.95999999999999996 110.847 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.09 84.85 7.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.172 0.51 . . . . 1.0700000000000001 111.148 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -57.34 -64.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.378 -0.828 . . . . 0.17999999999999999 110.528 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -91.23 80.47 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.004 -0.544 . . . . 0.34999999999999998 109.968 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -80.06 63.79 4.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.63 0.728 . . . . 1.27 110.942 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -148.35 96.04 2.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.796 -1.093 . . . . 0.29999999999999999 108.074 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG21 HG12 ' A' ' 31' ' ' ILE . 12.1 p -78.82 146.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.664 -0.698 . . . . 0.91000000000000003 112.194 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -116.23 147.35 41.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.57 -0.741 . . . . 0.38 109.263 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t -84.43 -33.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.568 0.699 . . . . 0.93999999999999995 109.387 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -166.05 104.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.127 -0.942 . . . . 1.29 109.889 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.71 -27.73 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.48999999999999999 111.609 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 m -60.84 -45.99 92.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.735 0.302 . . . . 0.48999999999999999 111.062 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -27.0 25.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.015 0.436 . . . . 1.54 110.615 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.72 29.79 8.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.805 -0.712 . . . . 0.14999999999999999 111.469 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -83.33 109.36 17.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 2.0499999999999998 110.431 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.63 133.11 36.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.41999999999999998 109.726 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.06 105.17 14.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.029 0.442 . . . . 0.92000000000000004 110.856 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 34.2 pttt -85.86 -175.81 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.384 -0.599 . . . . 2.1499999999999999 109.384 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.8 pttp -58.81 -23.48 60.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.643 0.259 . . . . 1.6599999999999999 111.419 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.26 -22.03 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.501 -0.318 . . . . 2.2200000000000002 111.316 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 21.8 m-20 -86.41 -52.28 5.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.39 -0.368 . . . . 0.33000000000000002 110.748 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.63 -28.84 70.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.23999999999999999 111.599 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -68.15 -26.55 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.797 0.332 . . . . 1.05 111.018 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 p -102.66 -25.08 13.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 1.75 111.327 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.61 -41.76 16.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.31 111.445 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -97.36 -41.43 8.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 0.63 110.324 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.72 -29.14 5.72 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.758 -0.734 . . . . 0.26000000000000001 112.345 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.96 145.81 43.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.696 0.284 . . . . 0.26000000000000001 110.782 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.39 3.01 53.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.242 0.544 . . . . 0.72999999999999998 110.336 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 85' ' ' ILE . 26.6 t0 -74.25 108.78 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 1.45 110.551 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -60.46 -30.58 69.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.20999999999999999 110.978 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -60.65 -40.77 93.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.278 -0.419 . . . . 1.46 111.097 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -71.34 -38.78 71.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.6499999999999999 110.881 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 81' ' ' ASP . 30.0 mm -60.24 -55.11 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.25 110.936 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 7.4 p -67.74 -34.66 77.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.11 111.397 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 83' ' ' THR . 33.3 ttpt -58.82 -45.17 90.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.605 0.241 . . . . 0.37 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -60.62 -45.8 92.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 1.02 110.868 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.5 mt -72.43 -25.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 0.93999999999999995 111.439 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.43 -40.52 23.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.053 0.39 . . . . 1.02 112.053 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -91.18 -21.16 21.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.07 0.767 . . . . 0.82999999999999996 113.07 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -110.99 -24.68 10.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.632 -0.427 . . . . 0.81999999999999995 111.296 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.77 -166.07 31.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.757 . . . . 0.47999999999999998 111.931 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -120.97 131.59 54.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.168 0.509 . . . . 2.0600000000000001 111.278 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 97' ' ' VAL . 14.7 p -118.28 160.36 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.75 109.05 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -73.27 85.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.238 0.542 . . . . 0.26000000000000001 111.044 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 95' ' ' VAL . 3.8 m . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.20999999999999999 111.306 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.95999999999999996 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.6 p80 40.82 50.65 3.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.085 0.954 . . . . 0.26000000000000001 112.68 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.46 111.85 21.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 1.8999999999999999 110.397 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -77.92 45.45 0.52 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.233 0.539 . . . . 0.67000000000000004 111.135 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.6 -24.49 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.65000000000000002 110.553 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -82.38 22.6 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.85999999999999999 111.162 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.73 14.5 5.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.349 0.595 . . . . 1.6100000000000001 110.326 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -79.31 -46.3 17.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.63 110.408 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -154.74 -161.81 1.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 1.1699999999999999 109.7 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.4 m -55.98 118.07 4.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.98999999999999999 111.152 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -23.93 65.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 1.23 111.392 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.79 1.05 28.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.901 0.382 . . . . 1.5800000000000001 110.654 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -115.59 -45.53 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.423 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.0 pt20 -94.06 19.46 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.20999999999999999 111.579 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.78 72.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.28999999999999998 111.282 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.1 mm? -68.43 -18.36 64.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.37 111.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -92.4 -36.97 12.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.85 0.357 . . . . 2.4900000000000002 110.63 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 155' ' ' GLN . 24.7 t -64.79 -43.18 96.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.874 -0.603 . . . . 0.23999999999999999 111.017 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.6 tt -61.36 -32.55 53.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 1.21 111.133 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 41.1 mttp -67.29 -48.62 67.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.711 0.291 . . . . 1.8799999999999999 110.364 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -39.72 89.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.59999999999999998 110.719 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -42.99 99.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 2.0600000000000001 110.443 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -65.75 -20.72 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 1.8100000000000001 111.283 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 161' ' ' LYS . 32.4 mt-10 -72.72 -32.54 65.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.694 0.283 . . . . 0.68999999999999995 110.822 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -82.21 -44.09 16.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.065 0.46 . . . . 1.8600000000000001 110.137 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 21.2 ptp -144.45 134.38 23.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.872 -0.604 . . . . 2.0699999999999998 109.737 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.45 120.91 19.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.202 0.525 . . . . 1.3799999999999999 111.493 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.525 -0.761 . . . . 1.46 109.641 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 C--O 1.227 -0.095 0 N-CA-C 110.193 -0.299 . . . . 2.0600000000000001 110.193 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -119.48 144.09 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 2.2799999999999998 110.491 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.69 154.74 41.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 1.05 110.976 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -124.44 152.61 43.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.12 109.426 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 95.6 m-85 -116.09 124.64 50.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.854 0.359 . . . . 0.14999999999999999 110.611 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.469 HG12 ' OE2' ' A' ' 209' ' ' GLU . 4.4 mt -102.07 114.5 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 1.23 111.47 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.3 OUTLIER -159.11 150.15 16.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 1.21 110.262 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.93 165.47 27.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.79 2.327 . . . . 0.29999999999999999 112.064 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.95 -30.44 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.762 0.315 . . . . 0.23999999999999999 110.928 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.11 -50.03 62.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.72999999999999998 110.497 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -91.94 -21.95 20.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.73999999999999999 110.272 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.16 -30.23 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.483 -0.781 . . . . 0.26000000000000001 113.635 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -68.21 -16.44 63.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.072 0.436 . . . . 1.79 111.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.99 -15.65 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 1.96 109.665 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.38 -45.08 5.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.267 -0.878 . . . . 2.98 110.537 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -57.69 -53.49 57.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 1.5700000000000001 111.093 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.66 31.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.088 -0.505 . . . . 0.59999999999999998 111.12 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -144.16 -51.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.839 0.311 . . . . 1.8999999999999999 111.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.97 -37.58 22.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.176 0.435 . . . . 0.72999999999999998 112.176 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 6.1 mtpt -60.25 -48.54 93.85 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.234 0.457 . . . . 1.1799999999999999 112.234 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.4 Cg_endo -60.0 -13.89 25.37 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.063 1.842 . . . . 0.17999999999999999 113.043 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.49 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 66.9 mt -85.48 -2.58 58.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.472 -0.195 . . . . 1.22 110.472 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 39.2 pt 41.78 40.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.543 1.137 . . . . 0.82999999999999996 113.736 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 195' ' ' LEU . 78.9 mttt -123.32 24.41 8.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 1.99 109.665 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.27 169.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 0.40999999999999998 110.353 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 88.6 mt -110.94 144.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.021 -0.536 . . . . 0.96999999999999997 110.118 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -70.57 70.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.48 0.488 . . . . 0.66000000000000003 111.334 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.1 m -157.39 38.72 0.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.28999999999999998 109.287 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 193' ' ' LYS . 45.9 mt-10 -82.5 145.07 29.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 111.608 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -117.62 123.69 46.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.14000000000000001 110.089 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.61 159.78 18.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.284 -0.416 . . . . 0.62 110.193 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 139.34 -116.61 1.25 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.045 -0.598 . . . . 0.28000000000000003 111.912 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.25 -18.05 37.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.518 0.675 . . . . 1.75 109.554 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.05 177.21 7.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.114 -0.948 . . . . 0.17000000000000001 109.5 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tp -138.37 77.51 1.63 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.404 . . . . 0.93999999999999995 110.61 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 15.9 mt-10 -82.93 99.73 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.174 -0.467 . . . . 0.23000000000000001 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 28.7 mt -102.88 132.91 48.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.74 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.06 122.41 50.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.892 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.9 t -147.39 120.24 8.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.274 -0.421 . . . . 1.3799999999999999 110.128 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.07 125.08 1.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.305 -0.628 . . . . 1.05 109.305 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.3 tt -117.1 157.61 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.922 -0.399 . . . . 1.3799999999999999 109.922 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.08 150.59 10.39 Favored Pre-proline 0 C--O 1.236 0.344 0 O-C-N 123.295 0.372 . . . . 0.62 111.536 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.1 158.35 3.41 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.654 2.903 . . . . 1.5700000000000001 113.569 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.15 -82.87 0.41 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.631 -0.988 . . . . 0.64000000000000001 110.631 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.1 m -72.92 -16.32 61.56 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.31 -0.626 . . . . 1.5700000000000001 109.31 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.41 -42.71 98.76 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.564 -0.744 . . . . 1.54 110.762 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.494 ' HD2' ' OD1' ' A' ' 223' ' ' ASP . 17.9 tpt180 -62.2 -27.33 68.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.151 0.5 . . . . 0.44 110.874 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.37 -34.92 70.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.181 -0.463 . . . . 2.5 111.358 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.628 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.3 tt -96.24 -29.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.529 -0.305 . . . . 2.52 111.76 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -62.52 -23.83 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 0.92000000000000004 110.746 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.12 -25.63 65.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.867 -0.606 . . . . 1.26 111.4 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.0 OUTLIER -106.4 -32.55 8.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.928 -0.309 . . . . 0.62 110.872 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 222' ' ' ILE . 47.2 mm -58.26 -35.28 52.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.954 0.407 . . . . 1.04 110.705 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 231' ' ' LYS . 16.4 ptmt -54.32 -34.29 60.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.458 -0.792 . . . . 2.2999999999999998 112.609 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -106.09 -24.29 12.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.689 0.281 . . . . 0.84999999999999998 111.344 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.12 -59.67 3.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.068 -0.514 . . . . 0.34000000000000002 111.848 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -125.52 -24.26 3.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.294 0.479 . . . . 0.26000000000000001 112.294 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 227' ' ' LYS . 75.6 tttt -66.94 -28.79 68.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.81000000000000005 110.66 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.83 -14.28 37.53 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.883 -0.675 . . . . 0.68000000000000005 112.25 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -84.99 -22.31 29.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.381 . . . . 0.85999999999999999 110.69 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -147.15 -168.98 14.27 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.536 -0.84 . . . . 0.27000000000000002 112.342 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 m -96.77 131.73 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.891 -0.411 . . . . 0.28000000000000003 109.891 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.31 142.66 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.004 0.43 . . . . 1.1499999999999999 111.323 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -144.0 155.14 43.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.09 -0.504 . . . . 0.85999999999999999 109.937 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -81.28 152.2 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 0.23000000000000001 110.748 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.944 -0.391 . . . . 1.55 109.944 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 113.433 0.901 . . . . 0.58999999999999997 113.433 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.83 -77.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.60999999999999999 110.195 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.5 -98.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.051 -0.522 . . . . 0.39000000000000001 109.632 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.7 mt -87.15 89.26 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.25 0.548 . . . . 0.47999999999999998 109.886 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -143.47 134.83 26.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.599 -0.728 . . . . 1.76 109.754 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.78 61.09 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 111.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -9.74 3.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 1.4099999999999999 110.87 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 35' ' ' LYS . 6.6 t-20 -153.59 63.88 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.191 -1.04 . . . . 1.49 108.191 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 32' ' ' ALA . 3.5 m -106.31 128.04 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.012 -0.995 . . . . 1.0900000000000001 111.542 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.16 113.08 18.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.806 . . . . 0.23000000000000001 109.626 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.15 117.24 19.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.19 110.872 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.28 128.84 73.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.82 -0.807 . . . . 1.0800000000000001 108.82 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD2' ' OE1' ' A' ' 30' ' ' GLU . 30.5 ttt180 -137.01 131.48 32.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.595 0.591 . . . . 1.54 112.595 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.468 ' HB2' HG21 ' A' ' 89' ' ' ILE . 19.2 ttt -83.77 140.7 31.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.674 . . . . 1.1100000000000001 109.556 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.55 99.18 6.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 1.1200000000000001 111.036 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -111.6 -179.69 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 1.0800000000000001 110.331 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.09 -54.47 45.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.477 0.486 . . . . 0.10000000000000001 112.072 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.94 28.73 3.64 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.23000000000000001 111.845 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -148.17 146.84 28.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.775 0.321 . . . . 1.8 110.359 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.82 142.54 20.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.228 -0.656 . . . . 1.26 109.228 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 24.6 m-85 -145.85 129.32 16.92 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.376 0.423 . . . . 0.77000000000000002 110.497 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.574 ' OE1' ' HD2' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -119.95 137.57 53.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.873 0.368 . . . . 0.34000000000000002 110.711 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.89 -171.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 1.55 110.455 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -141.51 133.97 28.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.81999999999999995 111.954 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.36 158.66 19.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.064 -0.516 . . . . 0.53000000000000003 110.755 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -82.41 120.79 25.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.704 0.631 . . . . 0.48999999999999999 112.704 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 84.3 mttt 44.38 39.32 3.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.131 1.16 . . . . 1.5900000000000001 114.131 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.92 18.85 4.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.405 0.52 . . . . 1.73 112.405 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -73.01 1.16 9.44 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.002 0.43 . . . . 0.68999999999999995 111.424 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.81 -19.58 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.365 0.603 . . . . 0.28999999999999998 110.241 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.05 3.33 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.435 0.636 . . . . 0.22 109.87 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-N 115.241 -0.89 . . . . 0.12 113.204 -179.467 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.503 -0.925 . . . . 1.01 108.503 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.47 140.27 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.352 0.596 . . . . 0.64000000000000001 111.016 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -85.44 4.52 35.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.803 -0.635 . . . . 1.27 110.632 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.44 -24.29 42.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.597 -0.729 . . . . 0.67000000000000004 110.645 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -108.42 -30.52 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.40999999999999998 111.05 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -24.82 29.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.484 -0.326 . . . . 0.77000000000000002 111.299 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.47 116.25 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.676 -0.49 . . . . 1.1100000000000001 109.676 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -88.12 -43.22 11.82 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 1.1499999999999999 111.015 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -119.86 118.11 29.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.42999999999999999 111.08 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -81.38 4.62 20.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.219 0.533 . . . . 1.05 110.272 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -115.62 134.59 54.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.19 -0.67 . . . . 0.32000000000000001 109.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.13 150.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 110.087 -0.338 . . . . 1.0600000000000001 110.087 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 70.7 m-85 -103.66 139.64 38.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.648 0.261 . . . . 0.48999999999999999 110.551 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 2.1 t -87.05 -16.43 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.475 -0.565 . . . . 0.40999999999999998 109.475 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 3.2 t-20 175.76 97.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.284 -0.871 . . . . 0.75 109.854 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.52 -25.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.25 110.827 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -21.08 66.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.193 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -119.11 0.48 11.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 1.0900000000000001 111.016 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.88 29.79 62.51 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.594 -0.812 . . . . 0.31 112.072 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -83.88 101.85 11.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.634 0.254 . . . . 1.7 110.666 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.3 130.88 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.73 114.78 28.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.16 0.505 . . . . 1.03 110.776 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 24.4 pttt -73.82 177.17 5.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 2.2799999999999998 109.529 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -61.27 -28.53 69.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.3200000000000001 110.2 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.35 -27.97 56.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.866 -0.606 . . . . 1.0700000000000001 110.189 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 7.7 m-20 -72.88 -51.9 16.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.52000000000000002 110.251 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.94 -33.71 76.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.17999999999999999 111.198 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -69.61 -23.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.234 0.54 . . . . 0.14999999999999999 109.954 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -95.65 -21.82 17.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.41999999999999998 110.715 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.78 -53.09 4.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.399 -0.364 . . . . 0.37 111.706 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -90.17 -34.2 15.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.931 0.396 . . . . 0.46000000000000002 110.239 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.08 -14.66 44.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.729 -0.748 . . . . 0.46000000000000002 112.548 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p -115.61 141.8 47.58 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.778 -0.248 . . . . 1.95 110.989 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.12 -10.77 51.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.159 -0.682 . . . . 0.57999999999999996 109.159 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.43 120.78 25.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.096 -0.956 . . . . 1.03 109.898 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.98 -22.56 61.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.947 -0.57 . . . . 0.66000000000000003 112.419 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -58.93 -49.67 76.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.274 -0.17 . . . . 0.16 111.091 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 87' ' ' LYS . 33.2 mm-40 -62.37 -43.36 99.01 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.047 0.451 . . . . 0.81999999999999995 111.008 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.48 -52.32 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 0.20999999999999999 110.769 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.81 -35.56 76.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.20999999999999999 110.778 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 30.1 ttpt -62.34 -46.58 88.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.379 . . . . 1.3300000000000001 110.366 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 1.03 110.764 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 22' ' ' MET . 77.9 mt -69.18 -28.31 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 1.0600000000000001 109.967 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -38.09 36.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.718 -0.674 . . . . 1.0900000000000001 111.922 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 92' ' ' LYS . 12.1 t -93.36 -10.11 36.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.544 0.572 . . . . 0.47999999999999998 112.544 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 91' ' ' THR . 34.6 mmtm -137.55 35.35 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.023 -0.423 . . . . 1.6599999999999999 111.206 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.18 -147.37 4.53 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.581 -0.819 . . . . 0.19 112.237 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -136.06 128.79 30.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.649 -0.501 . . . . 1.1599999999999999 109.649 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.99 142.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.559 -0.292 . . . . 1.1599999999999999 110.892 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.61 84.29 1.57 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.201 0.524 . . . . 0.38 109.883 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.44 0.638 . . . . 1.1299999999999999 112.584 -178.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 122.896 1.331 . . . . 1.1599999999999999 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -85.04 16.47 3.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.703 -1.135 . . . . 0.64000000000000001 110.842 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.19 151.7 35.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.681 -0.691 . . . . 1.6200000000000001 110.109 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.2 m -64.18 116.72 6.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 1.0900000000000001 110.708 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.2 t -103.32 -51.08 9.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.45000000000000001 110.872 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -136.35 -171.72 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.98999999999999999 110.614 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.46 -34.15 76.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 0.5 110.11 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.57 101.29 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.437 -0.802 . . . . 0.91000000000000003 109.674 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -85.25 71.21 10.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.8200000000000001 109.477 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 m -133.2 129.0 37.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.883 -0.599 . . . . 0.38 111.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -7.41 46.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.28999999999999998 110.958 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.03 9.55 6.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.783 -0.644 . . . . 0.28000000000000003 110.611 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -162.31 -58.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.34000000000000002 110.049 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -87.33 41.27 0.97 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.976 -0.556 . . . . 0.26000000000000001 110.362 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.68 -32.65 71.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 0.20999999999999999 111.663 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.5 mm? -81.01 -2.7 49.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.355 -0.384 . . . . 2.25 111.378 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -111.11 -44.7 3.54 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.963 -0.295 . . . . 2.27 111.091 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -58.48 -42.82 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.5 110.969 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.07 -28.38 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.20999999999999999 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 16.4 mttp -68.57 -42.78 77.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.853 0.359 . . . . 1.6899999999999999 110.392 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -35.82 61.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.63 110.659 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.78 -35.15 79.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.31 110.069 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 167' ' ' MET . 2.1 ttpm? -60.28 -20.8 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.112 -0.949 . . . . 1.95 111.662 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -70.72 -20.38 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 1.0600000000000001 111.191 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -115.11 -47.05 2.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.869 0.366 . . . . 1.26 110.652 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 13.5 tpt -117.59 122.74 44.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 0.27000000000000002 110.914 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -93.79 110.34 21.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.098 -0.501 . . . . 0.95999999999999996 110.157 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 0.97999999999999998 111.083 -179.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 120.804 0.335 . . . . 2.0600000000000001 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -114.39 140.04 48.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 3.02 110.085 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.485 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 1.7 mt -127.98 150.95 49.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.039 0.447 . . . . 1.02 110.657 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -129.51 174.31 9.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.351 -0.84 . . . . 0.88 109.231 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.462 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 3.6 p90 -133.58 145.58 50.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.153 -0.314 . . . . 0.58999999999999997 110.153 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.25 106.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 1.2 111.439 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 157.23 46.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.055 -0.52 . . . . 0.26000000000000001 110.943 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.31 178.44 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.808 2.339 . . . . 0.16 113.123 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.39 -45.81 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.627 0.603 . . . . 0.5 112.627 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.91 -45.9 85.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.083 0.468 . . . . 1.9399999999999999 111.607 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.61 -39.74 67.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.69999999999999996 110.68 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -62.69 -38.33 96.26 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.68 -0.691 . . . . 0.16 113.104 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.08 -34.28 68.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.776 0.287 . . . . 0.78000000000000003 111.776 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.475 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 31.7 mmmt -71.91 -33.32 68.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.566 0.21 . . . . 1.77 111.566 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -85.36 -26.3 26.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.58999999999999997 109.99 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 80.5 tttt -60.94 -31.55 71.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.23000000000000001 110.62 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.42 12.68 28.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 3.1499999999999999 111.197 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 9.2 mtmt -126.5 -58.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.222 0.453 . . . . 1.3899999999999999 112.222 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.3 -42.01 26.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.641 . . . . 0.19 112.729 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 189' ' ' LYS . 1.6 mtpt -58.16 -50.95 85.22 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.07 0.767 . . . . 0.75 113.07 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 20.5 Cg_endo -60.91 -14.76 34.39 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.456 2.104 . . . . 0.20999999999999999 113.404 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.405 ' O ' ' HD2' ' A' ' 197' ' ' LYS . 72.4 mt -82.19 -11.51 58.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 1.01 110.15 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mm 56.64 35.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.732 -0.667 . . . . 0.58999999999999997 110.569 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -109.64 18.16 20.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 2.3799999999999999 110.042 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 m -113.6 137.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.259 -0.882 . . . . 0.45000000000000001 110.384 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.63 148.28 5.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.954 -0.566 . . . . 1.5900000000000001 109.52 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.7 75.13 0.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.749 0.785 . . . . 0.93999999999999995 111.559 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.2 m -149.83 33.62 0.68 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.146 -1.057 . . . . 0.46000000000000002 108.146 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.4 pt-20 -79.72 129.96 34.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.768 -1.106 . . . . 0.80000000000000004 111.792 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -97.13 105.73 17.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.361 -0.977 . . . . 0.29999999999999999 108.361 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.44 131.31 45.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.80000000000000004 110.434 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 163.57 -104.77 0.24 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.848 -0.691 . . . . 1.02 112.127 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.4 -17.27 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.4 0.619 . . . . 2.2799999999999998 110.016 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -140.67 176.91 8.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.231 -0.895 . . . . 0.59999999999999998 109.35 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.4 tp -128.27 84.73 2.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.372 -0.603 . . . . 0.90000000000000002 109.372 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 19.3 tt0 -96.56 109.39 21.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.603 -0.726 . . . . 1.24 110.815 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.462 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 5.9 mt -130.97 152.04 36.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.739 0.304 . . . . 1.1399999999999999 110.314 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.4 t -98.7 117.59 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.19 109.808 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 21.0 p -122.92 56.02 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.40000000000000002 111.411 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.485 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -126.56 125.29 41.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.034 0.445 . . . . 0.12 111.05 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 pt -114.8 -159.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.412 -0.813 . . . . 1.02 109.751 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.65 162.3 60.95 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 110.127 -0.323 . . . . 0.33000000000000002 110.127 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.92 -177.42 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.67 2.247 . . . . 0.23999999999999999 113.157 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.69 1.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.066 -0.814 . . . . 0.14999999999999999 111.066 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.14 -24.22 65.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.297 0.57 . . . . 1.03 110.039 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.13 -32.35 73.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.40000000000000002 109.947 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -23.51 63.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 1.1299999999999999 110.497 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.4 -38.79 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 1.48 110.72 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.6 tt -85.11 -24.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 1.72 111.356 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.12 -30.23 61.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.84 0.352 . . . . 0.65000000000000002 110.957 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -56.14 -33.07 64.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.714 -0.675 . . . . 1.5800000000000001 111.447 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.85 -23.99 14.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.769 -0.372 . . . . 0.54000000000000004 110.927 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 222' ' ' ILE . 46.3 mm -64.51 -37.92 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.41999999999999998 110.508 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -62.87 -29.19 70.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.0600000000000001 111.388 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -105.54 11.29 32.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.619 . . . . 1.6699999999999999 110.035 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -96.83 -126.55 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.022 -1.103 . . . . 0.51000000000000001 108.022 178.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.418 HG21 ' CD2' ' A' ' 178' ' ' PHE . 9.5 t -65.2 -27.91 69.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.868 0.365 . . . . 1.0900000000000001 110.999 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.27 -12.13 61.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 1.0600000000000001 111.083 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -108.37 18.37 33.05 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.964 -0.636 . . . . 0.23999999999999999 112.591 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -149.13 -44.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.62 0.247 . . . . 1.47 111.042 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -105.74 -171.56 23.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.682 -0.771 . . . . 0.33000000000000002 112.191 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -107.9 143.32 36.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.724 0.297 . . . . 1.05 110.217 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.48 165.7 13.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 1.6100000000000001 110.902 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -154.13 151.94 29.84 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.52 -0.918 . . . . 2.0899999999999999 108.52 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.11 155.07 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.232 0.539 . . . . 0.65000000000000002 111.576 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 1.55 108.279 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.247 0.546 . . . . 0.47999999999999998 110.839 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -87.7 155.05 20.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.51000000000000001 110.464 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -63.33 -39.45 94.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.2 112.256 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.415 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 17.5 mt -145.7 82.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.628 0.252 . . . . 1.3 111.237 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -164.18 172.83 13.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 1.9199999999999999 110.771 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.61 48.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.60999999999999999 112.27 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.99 3.18 3.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.215 0.531 . . . . 0.46000000000000002 110.66 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.77 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.704 -0.85 . . . . 0.40000000000000002 108.704 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 32' ' ' ALA . 22.8 m -100.46 150.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.981 -1.009 . . . . 0.46999999999999997 112.527 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.37 111.77 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.378 -0.971 . . . . 0.81000000000000005 108.378 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.41 110.89 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 1.6499999999999999 111.991 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.0 p -103.54 135.93 38.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 1.1699999999999999 109.005 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.93 127.92 47.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.92000000000000004 111.996 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 57.8 ttp -101.16 115.39 30.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.312 -0.625 . . . . 1.0600000000000001 109.312 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 115.86 24.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.433 . . . . 1.73 110.604 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 25.4 mmm-85 -123.93 163.72 20.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.989 -0.551 . . . . 1.23 110.365 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.84 76.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 1.23 110.872 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.83 -57.7 4.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.799 . . . . 0.38 112.242 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -159.47 152.17 21.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.13 -0.322 . . . . 1.1499999999999999 110.13 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 2.2 ptt180 -91.41 149.03 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.564 -0.532 . . . . 2.3900000000000001 109.564 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -129.46 120.29 25.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.415 -0.357 . . . . 0.55000000000000004 110.654 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 4.8 mt-10 -116.82 123.9 48.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.52000000000000002 110.9 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mt -128.29 146.82 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.067 -0.346 . . . . 0.37 110.067 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -102.9 103.22 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 0.83999999999999997 110.303 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 p -100.96 -162.44 0.94 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.12 -0.491 . . . . 0.54000000000000004 110.749 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.69 -174.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.049 0.452 . . . . 0.52000000000000002 111.17 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -75.01 -139.83 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.567 -0.742 . . . . 1.8200000000000001 110.491 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.48 -10.79 37.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.947 0.403 . . . . 0.23999999999999999 111.546 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -62.85 -30.85 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.69999999999999996 111.16 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.8 -23.99 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.029 0.442 . . . . 1.0600000000000001 111.067 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.95 -30.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.439 0.638 . . . . 0.98999999999999999 110.2 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 CA-C-N 115.606 -0.724 . . . . 0.46000000000000002 112.126 179.665 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 pttt . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.68 0.276 . . . . 1.51 110.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.2 140.04 56.32 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.004 -0.544 . . . . 1.21 110.493 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -80.9 -18.02 48.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.115 0.783 . . . . 0.70999999999999996 113.115 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' N ' HD12 ' A' ' 49' ' ' LEU . 5.8 t70 -67.3 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.555 -0.535 . . . . 1.3999999999999999 109.555 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.56 -19.83 62.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.191 0.519 . . . . 1.02 110.001 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 69.2 t -78.83 -23.47 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.612 -0.722 . . . . 1.0600000000000001 109.287 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.65 92.62 4.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.255 -0.884 . . . . 1.9299999999999999 110.432 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 12' ' ' ILE . 33.7 mm-40 -60.36 -44.47 95.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 1.6100000000000001 109.939 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.4 p -115.05 121.57 43.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.753 -0.658 . . . . 1.1399999999999999 109.992 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -87.76 23.26 2.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.309 0.576 . . . . 0.48999999999999999 110.204 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.8 157.78 27.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.401 -0.818 . . . . 0.46000000000000002 109.5 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.16 135.32 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.92000000000000004 111.128 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . 61.8 m-85 -91.03 138.62 31.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.415 -0.357 . . . . 0.85999999999999999 110.422 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 2.1 t -94.93 -33.32 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.571 . . . . 0.80000000000000004 110.037 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -164.68 93.48 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.92000000000000004 109.539 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 p -66.09 -20.47 27.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.42999999999999999 111.509 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.07 -4.53 55.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.5 110.85 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -126.95 -16.03 5.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.897 -0.592 . . . . 1.9299999999999999 110.588 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.95 17.78 57.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.927 -0.654 . . . . 0.35999999999999999 111.496 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.58 113.08 22.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.846 0.355 . . . . 0.97999999999999998 110.563 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.61 141.26 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 1.3700000000000001 109.969 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.54 126.21 48.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.221 -0.445 . . . . 0.39000000000000001 110.653 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' HG3' ' H ' ' A' ' 71' ' ' GLU . 10.9 ptpt -98.97 -171.7 2.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.944 -0.571 . . . . 1.5 109.661 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -59.73 -30.08 68.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.97 111.353 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 6.4 tt0 -80.67 -1.11 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.119 0.485 . . . . 1.8100000000000001 110.768 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.56 -52.4 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.455 -0.339 . . . . 1.5800000000000001 110.979 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -31.61 71.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 1.01 111.611 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -29.95 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.64000000000000001 110.919 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -98.65 -29.31 13.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.971 0.415 . . . . 0.76000000000000001 111.074 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.58 45.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.507 . . . . 0.48999999999999999 111.43 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -105.24 -41.54 5.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.487 -0.324 . . . . 0.5 110.79 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.96 -23.83 5.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.176 -1.011 . . . . 0.22 112.221 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -97.98 133.95 41.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.68 0.276 . . . . 0.46000000000000002 110.682 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.16 10.93 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.307 0.575 . . . . 0.56999999999999995 110.429 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -106.86 128.31 54.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.79 -0.641 . . . . 0.65000000000000002 109.69 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -69.98 -19.24 63.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.62 -0.264 . . . . 0.42999999999999999 111.289 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 7.9 m -60.54 -45.85 92.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.365 -0.38 . . . . 0.59999999999999998 111.002 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -71.13 -23.36 62.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 1.4199999999999999 111.309 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mm -77.81 -52.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.379 . . . . 0.28999999999999998 110.158 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.95 -41.75 99.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.1899999999999999 111.131 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 83' ' ' THR . 8.0 tttt -58.65 -31.84 68.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 1.7 110.91 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 91' ' ' THR . 1.6 tt0 -76.09 -46.36 29.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.909 -0.587 . . . . 0.91000000000000003 110.332 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -65.82 -31.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 1.2 111.211 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -8.21 59.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 0.41999999999999998 111.449 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -102.31 -28.44 12.26 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.778 -0.369 . . . . 1.1200000000000001 111.554 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -144.05 43.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.234 0.54 . . . . 2.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.18 172.78 20.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.651 -0.785 . . . . 0.32000000000000001 112.117 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.38 89.92 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.862 0.363 . . . . 1.3899999999999999 110.539 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 p -104.77 149.29 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.34999999999999998 110.248 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.07 98.13 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.19 0.519 . . . . 2.5699999999999998 111.048 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 1.02 110.598 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 122.209 1.004 . . . . 2.6800000000000002 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.58 37.37 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.93000000000000005 111.201 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -82.91 110.63 18.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.926 -0.579 . . . . 1.04 110.162 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.4 m -73.08 116.82 14.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.051 -0.522 . . . . 1.75 110.061 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.8 -43.4 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.558 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -132.04 152.57 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 1.6599999999999999 110.226 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.25 1.44 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 1.1699999999999999 110.808 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.39 -37.48 85.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.97999999999999998 110.341 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt 50.99 57.38 6.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.56 -0.746 . . . . 1.3400000000000001 110.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.8 m -118.91 118.31 31.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.119 -0.491 . . . . 0.96999999999999997 110.954 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -52.53 -61.64 2.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.2 0.815 . . . . 0.76000000000000001 113.2 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 5.21 3.29 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.962 0.727 . . . . 0.55000000000000004 112.962 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -44.55 3.81 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.816 -0.354 . . . . 0.95999999999999996 110.583 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.21 10.73 36.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.806 0.336 . . . . 0.52000000000000002 110.548 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.05 83.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.25 111.604 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -67.29 -21.6 65.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 2.0299999999999998 111.257 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.28 -49.54 9.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.88 109.835 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.33 -40.14 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.535 . . . . 0.20999999999999999 111.148 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.23 -8.17 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.201 0.524 . . . . 1.1699999999999999 111.765 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -37.16 4.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.503 -0.555 . . . . 0.40000000000000002 109.503 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.39 -45.83 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.725 . . . . 1.5800000000000001 110.338 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.43 -29.62 69.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.956 -0.565 . . . . 0.41999999999999998 110.358 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.91 -20.98 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 1.5600000000000001 110.414 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.04 -10.75 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 2.4500000000000002 110.595 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -108.04 -26.31 10.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.957 -0.565 . . . . 1.7 110.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.9 ttp -150.03 125.85 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.885 -0.598 . . . . 3.0800000000000001 110.042 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -72.19 121.45 19.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 2.75 110.538 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.38 110.475 -179.72 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.721 0.296 . . . . 1.2 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.07 140.21 35.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 2.0699999999999998 111.275 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.56 146.13 49.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.51000000000000001 110.347 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.487 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 22.0 ptt85 -113.54 139.74 48.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.824 -0.625 . . . . 0.33000000000000002 110.451 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 48.7 t80 -105.94 125.87 51.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.253 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 pt -114.09 135.59 53.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.672 0.272 . . . . 0.72999999999999998 111.407 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.511 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -178.53 163.03 1.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.90000000000000002 109.568 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.27 165.76 31.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.151 1.901 . . . . 0.29999999999999999 112.151 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 t -63.96 -21.93 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.342 -0.39 . . . . 0.14000000000000001 111.574 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -47.89 -60.78 2.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.146 -0.479 . . . . 0.48999999999999999 111.784 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -93.82 -20.84 19.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.917 0.389 . . . . 0.38 109.985 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.23 93.68 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.793 -0.639 . . . . 0.11 113.485 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -60.33 -33.98 73.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.835 0.317 . . . . 1.1499999999999999 110.943 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.03 -48.56 78.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.951 -0.568 . . . . 1.5700000000000001 111.602 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -21.95 47.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.991 -0.284 . . . . 0.95999999999999996 111.184 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -60.67 -47.82 84.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 2.2999999999999998 110.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.59 16.64 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.78000000000000003 111.222 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -119.93 -50.53 2.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.758 0.313 . . . . 2.2200000000000002 111.346 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.49 -39.79 27.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.603 0.594 . . . . 0.73999999999999999 112.603 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 12.2 mtpp -61.66 -52.98 65.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.791 0.663 . . . . 0.85999999999999999 112.791 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.7 Cg_endo -65.51 -19.8 60.69 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.99 1.793 . . . . 0.31 112.974 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.53 -2.24 58.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.66 -0.245 . . . . 0.56999999999999995 110.797 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.5 mt 54.44 59.52 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.422 0.63 . . . . 0.5 111.399 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -139.55 35.83 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.516 0.674 . . . . 2.3199999999999998 109.673 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.69 167.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.46000000000000002 109.964 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.1 mt -119.99 150.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.52 109.315 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -73.04 71.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.353 0.597 . . . . 2.54 111.701 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 m -151.71 35.71 0.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.3 -1.0 . . . . 0.60999999999999999 108.3 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.0 mt-10 -94.84 152.65 18.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.919 -1.037 . . . . 1.8600000000000001 111.585 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -105.99 148.49 27.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.63 109.206 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -138.22 94.92 2.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.873 0.368 . . . . 1.4299999999999999 110.56 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -162.96 -108.45 0.22 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.156 -0.778 . . . . 0.28000000000000003 111.156 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -25.46 19.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.694 0.759 . . . . 1.8500000000000001 108.981 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -119.78 165.18 14.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.717 -1.129 . . . . 0.71999999999999997 109.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.63 78.17 1.77 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.798 0.333 . . . . 1.55 110.599 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 33.8 tt0 -75.12 107.44 7.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.873 -0.788 . . . . 0.53000000000000003 108.873 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 74.2 mt -121.19 135.82 60.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.027 0.441 . . . . 0.48999999999999999 111.941 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.98 107.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.16 -0.682 . . . . 0.33000000000000002 109.16 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.17 26.66 9.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.241 0.46 . . . . 1.29 112.241 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 121.08 43.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.849 0.356 . . . . 0.81000000000000005 110.481 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.409 ' HB ' ' H ' ' A' ' 215' ' ' ASP . 21.6 pt -108.38 -165.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.84999999999999998 111.231 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.593 ' OD2' ' HD2' ' A' ' 216' ' ' PRO . 0.1 OUTLIER -64.86 160.38 55.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.791 -0.641 . . . . 1.1299999999999999 111.111 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.593 ' HD2' ' OD2' ' A' ' 215' ' ' ASP . 59.7 Cg_endo -70.52 -154.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.817 2.344 . . . . 0.38 113.05 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.62 -91.42 0.77 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.403 -0.679 . . . . 0.20999999999999999 111.403 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.91 -0.38 21.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.26000000000000001 110.732 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 222' ' ' ILE . 2.5 p90 -62.42 -24.65 67.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.12 110.557 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -68.44 -29.81 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.354 0.597 . . . . 1.0700000000000001 110.003 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.11 -34.29 38.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.325 -0.852 . . . . 1.51 110.988 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.549 ' O ' HG12 ' A' ' 226' ' ' ILE . 5.2 tt -77.58 -32.65 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.19 110.559 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.38 -28.34 65.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 0.12 111.05 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -54.28 -40.72 68.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.805 -0.634 . . . . 1.3100000000000001 111.174 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 229' ' ' GLU . 0.9 OUTLIER -94.34 -38.43 10.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.553 -0.294 . . . . 0.23999999999999999 110.541 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 222' ' ' ILE . 48.5 mm -54.08 -37.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.44 111.384 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 7.1 ptpp? -59.79 -23.33 63.2 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.789 0.663 . . . . 2.1400000000000001 112.789 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.13 -25.15 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.443 . . . . 1.2 111.507 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -72.99 -44.15 61.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.12 -0.491 . . . . 0.59999999999999998 111.944 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -135.06 -42.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.355 0.502 . . . . 0.53000000000000003 112.355 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 226' ' ' ILE . 24.8 mtpt -60.08 -25.75 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.801 0.297 . . . . 1.1799999999999999 111.801 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -100.28 12.8 60.22 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.907 -0.663 . . . . 0.40000000000000002 112.984 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -101.2 -15.0 17.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.39000000000000001 110.574 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.4 -131.55 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.862 -0.685 . . . . 0.32000000000000001 112.14 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 m -129.31 141.61 51.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 0.66000000000000003 110.726 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -116.65 158.62 23.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.125 -0.489 . . . . 1.73 110.646 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.76 164.88 28.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.3 -0.409 . . . . 1.1000000000000001 110.038 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.41 154.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.963 0.411 . . . . 0.67000000000000004 111.267 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.60999999999999999 110.572 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.668 0.618 . . . . 2.0299999999999998 112.668 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.28 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 1.9199999999999999 110.779 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -123.41 -81.01 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.535 -0.542 . . . . 2.4900000000000002 109.535 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.44 98.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.445 -0.576 . . . . 1.8799999999999999 109.445 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -141.82 145.1 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.863 -0.608 . . . . 0.59999999999999998 110.331 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.01 13.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.244 -0.435 . . . . 0.66000000000000003 111.709 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 p -96.02 -6.03 39.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.897 0.38 . . . . 1.47 111.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -151.02 52.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.154 0.502 . . . . 1.45 110.087 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.77 132.43 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.925 -0.58 . . . . 0.87 110.846 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.25 123.17 36.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.741 -0.466 . . . . 0.92000000000000004 109.741 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 t -81.6 114.82 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.332 0.587 . . . . 0.20999999999999999 111.147 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.0 133.04 70.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.939 -0.763 . . . . 1.02 108.939 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 147.18 37.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.14999999999999999 111.726 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.48 ' SD ' ' HD3' ' A' ' 24' ' ' ARG . 43.1 ttp -120.7 117.48 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.40000000000000002 110.187 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -99.5 114.7 27.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.291 -0.413 . . . . 0.94999999999999996 109.932 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HD3' ' SD ' ' A' ' 22' ' ' MET . 14.7 mmm-85 -100.55 -172.73 2.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.266 -0.425 . . . . 0.5 109.883 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.46 -24.24 46.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.844 0.313 . . . . 0.66000000000000003 111.844 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.17 -58.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.418 -0.896 . . . . 1.0900000000000001 113.135 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -123.26 175.91 6.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.079 0.466 . . . . 2.4399999999999999 110.934 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.13 142.76 48.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 1.3700000000000001 108.979 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -130.94 119.21 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.787 0.327 . . . . 1.0600000000000001 111.147 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 130.8 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 1.1100000000000001 109.915 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.71 172.27 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.84 0.352 . . . . 1.1000000000000001 110.661 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 122.31 22.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.262 -0.426 . . . . 0.28999999999999998 110.387 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 m -118.63 -163.35 0.95 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 2.3599999999999999 110.848 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.437 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 t80 -72.94 -171.15 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.29999999999999999 110.715 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -71.59 -157.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.279 -0.419 . . . . 0.71999999999999997 111.828 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -48.67 -22.64 0.82 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.303 0.853 . . . . 1.6699999999999999 113.303 -178.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -60.69 -18.81 56.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.255 0.465 . . . . 0.83999999999999997 112.255 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.28 -22.81 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 111.842 0.312 . . . . 0.14999999999999999 111.842 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' ASN . 4.0 p -76.02 -10.83 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.016 0.436 . . . . 0.34999999999999998 110.838 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 C-N-CA 120.986 -0.626 . . . . 0.12 112.073 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 6.8 ptmt . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 111.582 0.216 . . . . 1.96 111.582 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 5.5 t70 -169.32 123.15 0.79 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.629 -0.508 . . . . 0.93000000000000005 109.629 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.83 -35.57 76.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.197 0.443 . . . . 0.26000000000000001 112.197 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.11 -39.52 89.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.523 . . . . 0.75 110.375 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -91.57 16.93 9.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.682 -0.69 . . . . 1.3100000000000001 110.603 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.1 -38.03 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 0.46999999999999997 110.132 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 81.42 6.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.144 -0.48 . . . . 1.1599999999999999 110.708 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.437 ' NE2' ' HA ' ' A' ' 34' ' ' TYR . 39.2 mt-30 -61.66 -71.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.28000000000000003 110.473 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -85.71 86.53 7.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.078 0.466 . . . . 0.65000000000000002 109.987 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.72 66.6 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 1.72 110.381 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.0 m -154.76 131.42 10.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.21 -0.905 . . . . 0.39000000000000001 108.782 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 p -103.49 136.08 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.283 0.564 . . . . 0.37 110.977 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -106.45 135.59 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.951 -0.568 . . . . 0.65000000000000002 110.006 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t -89.79 -30.88 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.464 0.65 . . . . 0.22 110.207 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -151.66 103.42 2.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.716 -0.675 . . . . 0.57999999999999996 110.313 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.65 -23.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.847 0.356 . . . . 0.96999999999999997 111.465 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -35.62 44.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.037 0.446 . . . . 0.29999999999999999 110.856 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -89.11 -40.68 12.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.045 -0.525 . . . . 1.22 110.909 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.17 33.57 2.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.899 -0.667 . . . . 0.34000000000000002 111.504 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.54 106.5 18.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.55000000000000004 110.764 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.31 129.52 47.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.014 -0.539 . . . . 0.33000000000000002 109.736 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.07 112.43 24.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.148 0.499 . . . . 0.89000000000000001 110.759 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -82.35 -176.06 6.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.885 -0.598 . . . . 0.95999999999999996 109.614 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -60.33 -34.34 73.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.597 0.221 . . . . 1.9199999999999999 111.597 -178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.9 pm0 -72.86 -13.47 61.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.97999999999999998 111.447 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.47 -48.52 5.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.839 -0.344 . . . . 0.44 110.574 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.58 -31.27 71.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.695 0.283 . . . . 0.39000000000000001 111.081 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -23.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.27 0.557 . . . . 1.0900000000000001 110.314 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.565 . . . . 0.28000000000000003 110.535 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.82 -50.27 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.37 111.287 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -49.56 6.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.379 . . . . 0.59999999999999998 110.47 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.42 6.03 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.262 -0.735 . . . . 0.28000000000000003 111.262 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.35 143.36 27.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.279 -0.461 . . . . 1.6299999999999999 110.407 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.75 -5.19 48.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 0.84999999999999998 110.846 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -91.55 123.99 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.8 -0.444 . . . . 1.1200000000000001 109.8 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.87 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.70999999999999996 112.019 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -73.21 -32.61 64.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.38 . . . . 0.45000000000000001 110.958 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 17.7 mm-40 -67.56 -36.93 81.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.221 -0.445 . . . . 0.23999999999999999 111.125 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.57 -49.28 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 1.3999999999999999 110.209 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.1 m -66.11 -26.07 67.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.23999999999999999 111.523 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 84' ' ' GLU . 37.5 ttpt -57.14 -44.91 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 1.3 111.033 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.62 -40.83 61.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.417 -0.356 . . . . 0.76000000000000001 110.98 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.01 -36.55 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.883 0.373 . . . . 0.22 111.728 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.777 0.658 . . . . 0.13 112.777 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -105.8 -26.71 11.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.325 0.861 . . . . 1.1200000000000001 113.325 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -108.06 3.17 23.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.62 111.113 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.04 178.42 16.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.737 -0.744 . . . . 0.41999999999999998 111.873 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 122.52 38.37 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.958 -0.386 . . . . 0.23999999999999999 109.958 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.18 137.21 53.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.022 -0.535 . . . . 0.29999999999999999 109.973 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -77.23 84.0 3.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.084 0.468 . . . . 0.35999999999999999 111.151 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 1.0900000000000001 110.473 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.428 ' CG1' ' HG3' ' A' ' 166' ' ' LYS . 6.3 mt . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.836 0.35 . . . . 0.23000000000000001 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t60 51.34 47.53 24.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.435 -0.802 . . . . 1.3 110.368 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.85 119.47 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.604 -0.726 . . . . 1.0 110.322 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 97.47 11.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.001 -0.545 . . . . 1.6000000000000001 111.295 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.78 -169.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.76 -0.654 . . . . 2.0899999999999999 109.708 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -78.4 89.37 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.621 -0.511 . . . . 1.8700000000000001 109.621 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -41.85 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 1.0700000000000001 112.845 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.16 -12.84 62.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 3.0800000000000001 111.968 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 154' ' ' GLN . 95.0 mttt -121.36 9.82 10.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 1.5900000000000001 111.215 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -87.51 3.78 46.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 1.51 110.715 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -37.93 87.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.63 111.525 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -155.79 -26.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.915 0.339 . . . . 0.94999999999999996 111.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 150' ' ' LYS . 43.3 tt0 -68.43 -60.46 2.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 1.02 110.778 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.409 ' O ' HG21 ' A' ' 159' ' ' VAL . 0.7 OUTLIER -94.33 14.29 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 1.8100000000000001 111.155 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.080000000000000002 111.548 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.75 -21.55 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.353 -0.385 . . . . 1.3 111.075 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.55 -39.14 20.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.311 -0.404 . . . . 1.04 110.451 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 155' ' ' GLN . 61.8 t -62.81 -49.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.083 -0.508 . . . . 0.97999999999999998 111.083 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.7 tp -64.78 -33.56 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.25 110.536 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 1.6 mmmt -69.25 -43.01 74.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 2.3100000000000001 110.174 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -61.26 -36.06 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.41999999999999998 110.474 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.6 tp -69.06 -40.4 78.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.906 -0.588 . . . . 0.17999999999999999 110.558 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -70.93 -11.11 60.78 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.881 -0.599 . . . . 1.6200000000000001 111.177 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 36.3 mm-40 -73.48 -27.92 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.049 0.452 . . . . 0.97999999999999998 110.074 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.428 ' HG3' ' CG1' ' A' ' 142' ' ' ILE . 16.2 mmtt -93.14 -39.01 11.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.17999999999999999 111.323 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 52.9 mtt -130.32 136.64 49.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.974 0.416 . . . . 1.01 110.896 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -79.77 81.61 6.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 2.23 110.421 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.4 pt . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 1.51 111.691 -179.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.266 -0.272 . . . . 2.2200000000000002 110.266 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HA ' ' CB ' ' A' ' 213' ' ' LEU . 90.3 mtt180 -115.88 143.62 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 1.0800000000000001 110.994 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.51 172.15 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.144 -0.48 . . . . 0.26000000000000001 110.522 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 177' ' ' ARG . 8.6 ptm180 -141.35 140.17 33.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 2.1000000000000001 110.388 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.65 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 9.1 p90 -94.72 150.21 20.45 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.531 -0.468 . . . . 0.31 110.077 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.84 118.54 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.545 . . . . 0.56000000000000005 111.214 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.22 156.87 34.02 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.746 -0.661 . . . . 1.1799999999999999 110.245 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.22 173.09 10.04 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.397 2.064 . . . . 0.23999999999999999 112.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.42 -42.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.298 0.481 . . . . 0.66000000000000003 112.298 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.17 -38.71 87.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.751 0.31 . . . . 0.44 111.571 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.18 -34.81 28.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.043 0.449 . . . . 1.5800000000000001 110.542 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.15 -29.75 71.97 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.23999999999999999 112.569 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -65.97 -13.47 59.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.3 . . . . 1.3500000000000001 111.513 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.92 -18.52 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.706 0.289 . . . . 1.5900000000000001 110.89 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -17.85 6.6 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.788 0.292 . . . . 1.98 111.788 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 85.4 tttt -55.57 -52.3 64.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 1.73 110.872 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -98.74 27.58 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.1799999999999999 111.744 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -137.77 -40.95 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.857 0.317 . . . . 2.25 111.857 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.97 -40.94 11.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.845 0.355 . . . . 1.28 110.6 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.548 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpp -60.29 -48.37 94.2 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.566 . . . . 1.29 112.527 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.1 Cg_endo -58.53 -12.82 15.05 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.529 2.153 . . . . 0.17000000000000001 113.464 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.93 -9.84 58.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.006 -0.368 . . . . 0.54000000000000004 110.006 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.7 mt 59.3 31.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.517 -0.765 . . . . 0.56000000000000005 111.14 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -113.51 30.44 7.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.105 -0.498 . . . . 1.1899999999999999 109.793 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.16 155.43 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.555 -0.748 . . . . 0.42999999999999999 111.072 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.41 147.76 9.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.434 -0.803 . . . . 0.32000000000000001 109.453 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -70.39 67.46 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.146 0.498 . . . . 1.1499999999999999 111.781 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.1 m -156.33 33.4 0.33 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.42 -0.585 . . . . 0.92000000000000004 109.42 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.444 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.1 OUTLIER -90.9 160.96 15.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.4 -0.818 . . . . 1.1200000000000001 110.77 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.41 141.47 52.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.229 -0.656 . . . . 0.38 109.229 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -116.11 31.42 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.389 . . . . 0.85999999999999999 110.933 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.81 -125.11 2.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.713 -0.755 . . . . 0.45000000000000001 112.536 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.89 -31.61 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.195 0.521 . . . . 2.5899999999999999 109.893 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -110.43 111.81 23.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.664 -0.865 . . . . 0.37 108.664 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.13 73.91 4.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.022 0.439 . . . . 0.68000000000000005 111.121 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 42.5 mt-10 -83.47 111.6 19.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 1.23 110.523 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.65 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 22.5 mt -125.3 142.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.526 . . . . 1.1499999999999999 110.908 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.39 123.9 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.855 -0.794 . . . . 0.34000000000000002 108.855 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 13.2 p -137.1 52.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.54000000000000004 112.0 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 175' ' ' ARG . 4.1 mm? -122.25 114.74 21.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.19 -0.3 . . . . 0.87 110.19 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.417 HG23 ' H ' ' A' ' 215' ' ' ASP . 0.6 OUTLIER -104.99 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.381 -0.372 . . . . 1.0900000000000001 110.339 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.417 ' H ' HG23 ' A' ' 214' ' ' ILE . 2.8 m-20 -80.5 164.27 52.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 1.24 110.624 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.75 -178.04 2.51 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.16 1.907 . . . . 0.48999999999999999 112.176 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.2 -79.99 1.43 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.517 -0.849 . . . . 0.32000000000000001 111.567 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -16.73 64.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.084 0.469 . . . . 0.42999999999999999 110.878 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 1.3 p90 -62.41 -20.61 64.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.19 110.932 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -65.43 -21.98 66.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.18 0.514 . . . . 0.27000000000000002 110.303 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -76.29 -33.15 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.546 -0.752 . . . . 1.8999999999999999 110.878 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 9.3 tt -95.15 -26.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 1.72 110.836 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -34.95 71.55 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.061 -0.518 . . . . 0.19 111.527 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -29.37 70.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.73999999999999999 111.834 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -97.9 -30.89 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.518 -0.473 . . . . 0.54000000000000004 111.825 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 222' ' ' ILE . 19.8 mm -57.33 -40.42 73.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 0.28999999999999998 111.152 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.0 ptpp? -69.23 -8.39 45.42 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.28 0.845 . . . . 1.55 113.28 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -124.7 -31.1 3.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.563 -0.455 . . . . 0.34999999999999998 111.842 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -54.21 7.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.296 0.48 . . . . 1.1000000000000001 112.296 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.0 t -108.02 -42.86 4.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.733 0.642 . . . . 0.37 112.733 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 79.4 tttt -61.42 -34.69 75.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 2.6299999999999999 111.234 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.12 10.41 73.66 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.473 -0.87 . . . . 0.62 112.684 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -140.69 20.32 2.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 1.97 111.141 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 173.67 -145.71 8.4 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.582 -0.818 . . . . 0.65000000000000002 112.357 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.4 m -138.62 147.31 42.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.374 -0.232 . . . . 0.42999999999999999 110.374 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 1.1 pt? -121.5 135.45 55.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.849 0.357 . . . . 0.48999999999999999 110.333 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -129.1 173.28 10.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 1.54 110.422 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -79.4 164.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.56 -0.291 . . . . 0.89000000000000001 110.696 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 175' ' ' ARG . 1.2 pt? . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 2.1600000000000001 110.179 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.741 0.305 . . . . 0.84999999999999998 110.651 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.759 -0.459 . . . . 0.82999999999999996 109.759 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -71.73 -40.34 69.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 0.82999999999999996 109.464 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -129.4 98.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.674 -0.861 . . . . 1.1499999999999999 108.674 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -144.97 135.77 24.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.408 -0.36 . . . . 2.5899999999999999 110.868 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.431 ' O ' HG21 ' A' ' 17' ' ' VAL . 98.5 mt -66.16 -16.61 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 2.2200000000000002 112.02 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -89.65 -2.97 58.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.756 0.313 . . . . 0.85999999999999999 111.382 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -114.75 14.61 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.83999999999999997 110.544 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 14' ' ' LEU . 23.2 m -86.93 151.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.008 -0.542 . . . . 0.37 111.39 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.72 53.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.653 -0.703 . . . . 0.29999999999999999 109.626 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.59 117.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.959 0.409 . . . . 0.75 111.139 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.59 125.43 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.932 -0.576 . . . . 0.27000000000000002 110.291 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 143.38 50.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.042 0.448 . . . . 2.8799999999999999 111.598 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.3 ttt -109.15 129.12 55.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.607 -0.724 . . . . 1.02 110.047 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -100.09 116.62 32.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.662 0.267 . . . . 1.8400000000000001 110.746 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -112.0 41.18 2.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 3.02 110.165 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 63.35 90.42 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.522 -0.763 . . . . 1.49 111.061 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.52 -48.29 3.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 0.28999999999999998 112.017 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -98.63 108.56 21.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.052 0.453 . . . . 1.97 110.659 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HD3' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.39 143.95 48.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 2.6400000000000001 109.979 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 97.0 m-85 -132.59 150.01 52.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.59999999999999998 110.441 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -138.87 154.06 48.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.662 0.268 . . . . 1.26 110.594 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.55 169.66 18.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.892 -0.594 . . . . 0.64000000000000001 110.153 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.46 21.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.369 . . . . 1.1699999999999999 111.384 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -121.54 165.61 15.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.917 -0.583 . . . . 0.5 110.333 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -75.0 129.7 38.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.067 0.46 . . . . 0.31 111.373 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 37' ' ' LYS . 67.8 tttt -67.85 147.51 52.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.636 -0.711 . . . . 1.8899999999999999 111.057 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.14 -21.47 0.25 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.86 0.864 . . . . 0.69999999999999996 111.816 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 35' ' ' LYS . 28.7 mmtm -94.91 -45.08 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.051 0.453 . . . . 0.96999999999999997 110.467 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 p -68.67 -18.27 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.955 -0.566 . . . . 0.39000000000000001 111.864 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 HG11 ' A' ' 97' ' ' VAL . 7.6 p -67.71 -16.37 20.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.171 0.51 . . . . 0.58999999999999997 110.641 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-N 115.762 -0.654 . . . . 0.17999999999999999 112.701 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 109.953 -0.388 . . . . 0.62 109.953 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -52.29 117.88 3.14 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.469 0.481 . . . . 1.28 110.19 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.509 ' H ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.26 -4.03 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.603 0.594 . . . . 0.89000000000000001 112.603 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.94 -35.47 8.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.074 0.464 . . . . 1.5600000000000001 109.838 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.65 -36.45 73.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 1.8300000000000001 109.734 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.06 -24.25 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 1.03 110.779 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.33 87.14 6.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.19 110.008 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -64.11 -53.53 48.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.20000000000000001 111.286 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -128.53 107.44 9.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.142 -0.481 . . . . 1.8300000000000001 110.895 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.8 71.1 5.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.512 0.673 . . . . 1.03 110.277 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.4 m -153.15 130.66 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.303 -0.862 . . . . 0.33000000000000002 109.329 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' A' ' 29' ' ' PHE . 7.2 p -107.25 140.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 1.0 110.606 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 149.94 24.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.482 . . . . 0.47999999999999998 111.568 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.422 ' CG2' ' HB1' ' A' ' 68' ' ' ALA . 39.4 t -112.76 -40.43 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.66 -0.7 . . . . 0.54000000000000004 109.584 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -154.55 116.41 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 1.2 109.038 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.36 -25.18 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.949 0.352 . . . . 0.70999999999999996 111.949 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -49.41 77.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 1.0900000000000001 111.515 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -101.36 10.89 40.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 1.1299999999999999 111.251 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.02 56.45 25.12 Favored Glycine 0 C--O 1.229 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.54000000000000004 112.931 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -102.34 114.46 28.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.668 0.271 . . . . 0.66000000000000003 110.328 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.9 t -112.43 131.66 63.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.31 109.676 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB1' ' CG2' ' A' ' 60' ' ' VAL . . . -84.71 120.3 26.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.977 0.417 . . . . 0.26000000000000001 111.384 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 3.1 tppt? -78.27 171.82 14.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.851 -0.796 . . . . 2.3700000000000001 108.851 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 19.2 pttp -59.9 -18.29 43.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 2.2200000000000002 111.284 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -87.1 -7.24 58.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.58999999999999997 111.644 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -114.87 -44.44 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 1.95 111.563 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 69' ' ' LYS . 2.7 pp -61.83 -23.22 66.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.879 0.371 . . . . 0.32000000000000001 110.96 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 73' ' ' LEU . 16.6 tt -66.92 -35.99 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.23 -0.441 . . . . 0.96999999999999997 110.363 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -8.86 51.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 1.0900000000000001 111.152 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.67 -14.77 19.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.218 -0.446 . . . . 1.0700000000000001 111.044 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -121.32 -43.41 2.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.60999999999999999 111.008 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . 124.61 -14.25 7.68 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.632 -0.587 . . . . 0.14999999999999999 111.632 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 6.0 m -151.48 150.71 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.407 -0.59 . . . . 0.19 109.407 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.38 -4.77 59.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.683 0.277 . . . . 0.22 111.148 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.48 109.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.495 . . . . 1.1499999999999999 110.469 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.03 -38.96 93.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 1.5 111.532 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -43.77 98.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 1.54 111.793 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 87' ' ' LYS . 24.7 mm-40 -62.3 -45.69 92.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.622 0.248 . . . . 0.82999999999999996 111.536 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -64.18 -48.17 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.34999999999999998 109.982 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 43.2 t -61.95 -42.65 99.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.647 -0.706 . . . . 1.3999999999999999 110.471 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 84' ' ' GLU . 31.0 ttpt -56.75 -47.23 80.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 1.8899999999999999 111.214 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -46.6 88.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 1.01 110.812 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.12 -32.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.961 -0.563 . . . . 0.40000000000000002 110.512 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -81.46 -4.51 56.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.93000000000000005 111.428 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.401 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 88.3 m -105.35 -46.98 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.082 -0.247 . . . . 0.39000000000000001 111.374 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 91' ' ' THR . 7.8 mmmm -122.53 40.06 3.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.137 0.494 . . . . 3.5299999999999998 110.817 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.75 21.66 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.664 -0.698 . . . . 0.19 111.521 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.77 94.09 8.09 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.921 -0.4 . . . . 2.3199999999999998 109.921 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -102.69 143.26 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.35999999999999999 111.308 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.04 89.18 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.867 -0.606 . . . . 1.02 110.911 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG11 HG23 ' A' ' 39' ' ' VAL . 10.5 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.095 -0.502 . . . . 0.46000000000000002 110.759 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.808 -0.441 . . . . 0.44 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 46.09 58.43 4.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.666 -0.697 . . . . 1.8799999999999999 111.923 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -124.1 143.04 50.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.994 -0.548 . . . . 1.02 110.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 m -129.67 158.98 37.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.176 -0.676 . . . . 0.34999999999999998 109.176 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 t -76.67 -55.12 11.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.776 0.322 . . . . 0.52000000000000002 110.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 135.04 8.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 1.8899999999999999 110.27 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -8.16 55.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.985 0.421 . . . . 0.97999999999999998 111.346 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -85.14 -2.17 57.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.201 0.524 . . . . 0.64000000000000001 110.343 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -114.35 145.7 41.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.599 -0.728 . . . . 0.65000000000000002 109.229 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 86.5 p -76.0 169.45 18.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.934 0.397 . . . . 0.28999999999999998 110.716 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -36.07 74.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 1.5900000000000001 111.536 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.65 -11.94 58.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 2.1099999999999999 111.451 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.01 -11.44 44.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.382 -0.372 . . . . 1.3500000000000001 111.767 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 151' ' ' SER . 19.0 pt20 -137.88 13.89 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.40999999999999998 110.763 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.42 68.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.14000000000000001 111.475 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.72 -23.56 64.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.75 111.054 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -99.19 -42.65 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.425 -0.352 . . . . 1.77 111.011 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 155' ' ' GLN . 89.1 t -57.5 -36.03 52.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.23000000000000001 111.352 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.6 tt -73.79 -10.23 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.173 0.511 . . . . 1.4299999999999999 110.749 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -109.06 -9.2 15.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 1.5700000000000001 109.964 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -53.69 38.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.14000000000000001 110.542 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -71.02 -16.61 62.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.48 -0.327 . . . . 0.17000000000000001 110.63 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -67.81 -23.35 65.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.013 -0.539 . . . . 1.1399999999999999 109.846 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -76.46 -29.14 56.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.345 -0.613 . . . . 0.38 109.345 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.59 -54.29 5.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.237 -0.892 . . . . 1.79 109.446 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.3 mmt -125.36 109.13 12.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.88 109.349 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -77.19 108.67 10.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.093 0.473 . . . . 1.0 111.213 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.769 -0.651 . . . . 0.39000000000000001 110.334 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.533 0.206 . . . . 0.73999999999999999 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -117.33 130.66 56.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.566 0.222 . . . . 1.26 110.525 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.16 153.82 39.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.45 -0.341 . . . . 0.68999999999999995 111.311 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -119.63 169.83 9.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.723 -0.671 . . . . 1.3799999999999999 109.305 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.41 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 2.9 p90 -138.69 138.26 37.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.963 0.411 . . . . 0.93000000000000005 110.792 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.31 118.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.418 ' CD1' ' HD2' ' A' ' 181' ' ' PRO . 43.6 tp -156.4 126.57 3.34 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.685 -0.234 . . . . 0.56999999999999995 110.59 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 180' ' ' LEU . 14.9 Cg_endo -58.48 156.36 31.7 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.963 2.442 . . . . 0.31 112.549 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.43 -40.24 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.817 0.673 . . . . 0.20000000000000001 112.817 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.46 -42.98 61.96 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.386 0.513 . . . . 0.59999999999999998 112.386 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.08 -26.6 14.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.267 -0.424 . . . . 0.40999999999999998 110.986 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.08 -29.68 71.64 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.104 -0.498 . . . . 0.28000000000000003 113.113 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 74.4 tttt -62.13 -23.13 66.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.775 0.288 . . . . 1.3100000000000001 111.366 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -68.55 -36.72 79.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.37 110.658 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -89.87 -27.05 20.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 1.3799999999999999 110.949 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -54.83 -52.51 62.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 1.79 111.791 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 5.4 pt-20 -86.46 24.54 1.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.147 0.425 . . . . 1.76 112.147 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.39 -41.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.807 -0.357 . . . . 1.1599999999999999 111.593 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.6 mt -85.98 -47.56 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.974 0.361 . . . . 1.1799999999999999 111.974 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 22.7 mtpp -59.89 -51.78 78.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.648 0.61 . . . . 1.52 112.648 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.6 Cg_endo -61.59 -20.06 67.27 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.383 2.055 . . . . 0.51000000000000001 113.24 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.5 8.01 33.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.543 0.211 . . . . 0.66000000000000003 110.742 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.8 pt 35.97 60.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.255 1.022 . . . . 1.1399999999999999 113.67 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -136.51 26.62 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.634 0.731 . . . . 1.8300000000000001 109.65 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.77 151.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 114.844 -1.071 . . . . 0.32000000000000001 109.831 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.37 149.03 4.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.115 -0.493 . . . . 0.29999999999999999 110.573 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 67.88 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.314 0.578 . . . . 1.8 111.562 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -149.66 38.75 0.77 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.302 -0.629 . . . . 0.56000000000000005 109.302 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 193' ' ' LYS . 18.9 mt-10 -86.92 172.34 10.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.561 -0.745 . . . . 0.62 111.104 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.5 118.62 4.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.784 -0.821 . . . . 0.98999999999999999 108.784 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.22 114.9 28.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 110.925 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -163.05 -104.67 0.19 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.884 -0.674 . . . . 0.88 111.541 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -16.37 32.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.539 0.685 . . . . 2.48 109.367 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 209' ' ' GLU . 2.8 pm0 -142.22 172.68 12.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.109 -0.95 . . . . 1.4099999999999999 108.749 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.28 84.4 2.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.682 -0.488 . . . . 0.20000000000000001 109.682 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 2.9 tp10 -85.99 112.82 21.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.622 -0.717 . . . . 1.74 109.758 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.41 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 51.0 mt -132.16 146.02 33.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.614 0.245 . . . . 0.59999999999999998 110.574 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.03 113.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.58999999999999997 109.691 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 20.3 t -132.73 97.64 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.38 110.699 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.9 106.25 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 1.0600000000000001 109.875 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 215' ' ' ASP . 8.1 tp -90.72 168.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.367 -0.379 . . . . 1.3400000000000001 110.685 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.442 ' H ' HG13 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -68.03 164.4 41.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.443 -0.344 . . . . 1.1799999999999999 110.449 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.58 170.73 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.996 2.464 . . . . 0.44 113.392 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 92.24 -87.28 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.773 -0.931 . . . . 0.39000000000000001 110.773 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.71 -1.92 27.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 2.0600000000000001 110.861 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.48 -33.46 69.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.26000000000000001 111.542 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -81.15 -16.76 52.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.133 0.492 . . . . 1.3100000000000001 110.78 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.5 -44.33 24.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.71999999999999997 109.521 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 226' ' ' ILE . 11.6 tt -78.07 -38.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.672 -0.695 . . . . 0.38 110.3 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -28.71 68.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.997 0.427 . . . . 0.42999999999999999 110.413 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.596 ' O ' ' HE2' ' A' ' 228' ' ' LYS . 14.5 tp10 -51.02 -46.12 61.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.283 -0.871 . . . . 1.95 111.008 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -90.7 -29.28 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.395 -0.366 . . . . 0.23999999999999999 111.277 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 222' ' ' ILE . 32.2 mm -58.23 -38.89 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.915 0.339 . . . . 0.34000000000000002 111.915 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.9 ptpt -64.6 -10.15 24.32 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.147 0.795 . . . . 1.3 113.147 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.596 ' HE2' ' O ' ' A' ' 224' ' ' GLU . 5.7 pttt -124.72 -32.78 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.655 -0.418 . . . . 2.0600000000000001 111.132 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -47.17 73.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 1.4299999999999999 111.997 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.0 t -130.11 -41.55 1.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.129 0.418 . . . . 0.41999999999999998 112.129 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 0.3 OUTLIER -67.3 -21.7 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.951 0.405 . . . . 2.7799999999999998 110.805 -179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.73 14.41 64.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.889 -0.672 . . . . 0.5 111.978 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -135.51 -45.82 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 1.7 110.835 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -109.22 -154.97 16.15 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.799 -0.715 . . . . 0.53000000000000003 112.225 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -120.94 152.81 38.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.275 -0.269 . . . . 0.44 110.275 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 236' ' ' LEU . 2.0 pt? -95.44 150.0 20.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 1.2 110.496 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.24 160.03 43.99 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.341 -0.614 . . . . 0.88 109.341 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.17 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.88 0.372 . . . . 0.46000000000000002 111.013 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.238 0.457 0 N-CA-C 109.412 -0.588 . . . . 1.1299999999999999 109.412 179.609 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.646 -0.501 . . . . 0.81999999999999995 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -172.03 168.73 5.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -91.27 -57.84 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 0.80000000000000004 109.889 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.1 mt -129.69 105.16 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 1.03 110.024 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -177.71 149.1 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.141 -0.688 . . . . 1.8100000000000001 109.141 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.45 61.09 0.66 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.124 0.487 . . . . 0.96999999999999997 112.04 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -42.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 0.34999999999999998 109.327 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -105.1 37.14 2.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.45000000000000001 109.941 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.47 155.66 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.20999999999999999 111.589 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -118.46 125.45 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.503 -0.771 . . . . 0.92000000000000004 109.29 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.27 133.58 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.448 . . . . 0.71999999999999997 111.676 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 4.1 p -133.78 129.9 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.66 -0.7 . . . . 1.05 109.504 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.22 140.42 52.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 2.3599999999999999 111.906 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 59.0 ttp -123.26 125.71 45.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.92000000000000004 109.691 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -100.04 118.8 37.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.656 0.265 . . . . 1.45 110.757 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -113.21 -159.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.89000000000000001 110.791 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.56 -73.73 0.07 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.152 -0.477 . . . . 0.37 111.684 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.27 29.78 5.62 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.468 -0.872 . . . . 0.33000000000000002 112.335 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.03 146.56 21.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.238 -0.282 . . . . 1.0800000000000001 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ptt-85 -141.0 93.16 2.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.046 0.45 . . . . 2.6800000000000002 110.308 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -76.93 152.41 35.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 2.0 111.671 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 15.0 pt-20 -146.86 133.02 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.23999999999999999 109.583 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -132.11 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.97 0.414 . . . . 0.81999999999999995 110.957 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 18' ' ' ALA . . . -137.18 110.77 8.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.14000000000000001 110.516 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.4 m -106.89 -175.81 2.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.909 -0.587 . . . . 0.58999999999999997 110.559 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.529 ' HA ' HE21 ' A' ' 54' ' ' GLN . 3.0 t80 -66.69 122.77 18.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.006 0.431 . . . . 0.39000000000000001 110.544 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.29 124.83 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.533 -0.758 . . . . 0.58999999999999997 112.745 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.0 t30 66.28 3.73 2.88 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.832 -1.076 . . . . 0.83999999999999997 113.414 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 44.2 tptt -107.51 -33.79 7.23 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.673 -0.642 . . . . 1.8899999999999999 110.242 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.57 -22.05 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.078 -0.51 . . . . 0.79000000000000004 110.837 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.27 -18.11 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.75 109.86 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.624 0 CA-C-N 115.75 -0.659 . . . . 0.14999999999999999 112.219 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 19.9 ptmt . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.445 0.165 . . . . 1.8300000000000001 111.445 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -178.0 126.5 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.238 -0.282 . . . . 0.52000000000000002 110.238 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 52' ' ' VAL . 48.3 mt -61.6 -29.01 69.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 2.4700000000000002 112.048 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.21 -35.69 55.42 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.707 -0.397 . . . . 0.92000000000000004 110.698 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.54 -29.14 41.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 1.6499999999999999 110.945 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 49' ' ' LEU . 1.5 p -72.17 -12.57 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.052 0.453 . . . . 0.40000000000000002 110.792 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.619 HD21 ' SG ' ' A' ' 86' ' ' CYS . 2.1 mm? -94.19 97.53 10.33 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.566 -0.531 . . . . 1.3700000000000001 109.566 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.529 HE21 ' HA ' ' A' ' 34' ' ' TYR . 73.2 mt-30 -66.03 -39.55 90.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.42999999999999999 110.83 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 t -117.3 136.63 52.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.798 0.332 . . . . 0.48999999999999999 110.539 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -100.32 16.06 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.03 110.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 m -110.28 112.28 24.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.713 -0.676 . . . . 0.91000000000000003 110.024 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 31' ' ' ILE . 7.2 p -92.12 139.22 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.27000000000000002 110.221 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.407 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 11.7 m-85 -100.89 160.71 14.14 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.023 -0.362 . . . . 0.66000000000000003 110.023 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.94 -61.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.063 0.459 . . . . 1.24 110.834 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.13 92.42 3.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.71 110.41 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -65.68 -24.69 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.174 0.511 . . . . 1.05 110.43 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -29.56 67.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.7 -0.682 . . . . 1.51 111.387 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.12 -34.58 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 2.3399999999999999 110.74 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.88 41.35 2.31 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.261 -0.736 . . . . 0.47999999999999998 111.261 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -105.19 121.07 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.785 0.326 . . . . 1.21 111.179 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.03 141.55 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.47999999999999998 109.93 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.78 104.09 13.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.132 0.491 . . . . 0.31 109.84 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -82.29 -174.9 5.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 1.1599999999999999 110.842 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -34.17 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.762 0.652 . . . . 1.9099999999999999 112.762 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 pm0 -80.84 -4.07 53.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.822 0.344 . . . . 0.92000000000000004 111.302 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.65 -52.23 3.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 0.17999999999999999 110.502 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.331 . . . . 0.35999999999999999 111.706 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.02 -22.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.93999999999999995 110.949 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -103.06 -32.47 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.81999999999999995 111.46 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.31 -36.63 46.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.37 111.5 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.68 -51.5 2.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 2.5299999999999998 110.109 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.93 -37.75 2.41 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.47999999999999998 111.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.35 147.4 26.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.623 0.249 . . . . 2.3199999999999998 110.38 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -100.3 -7.56 24.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.448 -0.342 . . . . 1.1000000000000001 111.628 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.18 126.24 38.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.722 0.296 . . . . 1.21 110.719 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -27.47 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 0.5 111.815 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -63.58 -39.92 95.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.878 0.371 . . . . 0.75 110.468 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.37 -40.66 85.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.25 110.747 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.99 -48.19 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.32000000000000001 109.885 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.619 ' SG ' HD21 ' A' ' 53' ' ' LEU . 36.8 t -65.12 -29.61 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.725 . . . . 0.26000000000000001 111.39 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -58.67 -49.53 77.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.397 . . . . 1.0600000000000001 110.827 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -68.95 -37.42 78.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.798 -0.637 . . . . 1.76 110.551 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.22 -31.02 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.168 -0.469 . . . . 1.1100000000000001 111.497 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.66 -18.86 56.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.976 0.361 . . . . 1.0600000000000001 111.976 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 t -108.31 -34.78 6.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.652 -0.419 . . . . 1.1799999999999999 112.066 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -101.51 7.12 42.52 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.917 0.389 . . . . 1.3799999999999999 110.564 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.22 175.34 17.34 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.523 -0.846 . . . . 0.17999999999999999 112.778 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -102.14 119.04 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.935 -0.394 . . . . 1.3400000000000001 109.935 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.65 146.63 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.704 -0.68 . . . . 1.1799999999999999 110.252 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.69 101.62 1.07 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.77000000000000002 110.122 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.989 -0.55 . . . . 0.54000000000000004 111.358 -179.091 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.8 mt . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.465 -0.198 . . . . 1.4399999999999999 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 58.5 49.94 9.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.177 -0.465 . . . . 1.8600000000000001 110.601 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.28 87.26 6.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 1.6299999999999999 110.136 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -81.92 121.91 27.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.728 -0.669 . . . . 1.0800000000000001 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.6 -76.01 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.171 -0.468 . . . . 0.33000000000000002 110.416 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.631 -0.507 . . . . 0.75 109.631 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 123.1 15.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.279 0.362 . . . . 0.63 110.671 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.0 p30 43.38 46.35 5.55 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.134 0.896 . . . . 0.20000000000000001 112.406 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.466 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -59.09 -53.96 52.41 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.108 -0.701 . . . . 1.6499999999999999 109.108 178.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 155' ' ' GLN . 2.7 p -103.31 179.95 4.12 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.668 -0.697 . . . . 0.22 109.439 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 150.02 49.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.753 0.279 . . . . 0.76000000000000001 111.753 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tttm 64.11 46.44 3.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.791 -0.641 . . . . 1.01 111.774 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 59.23 71.39 0.59 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.658 -0.701 . . . . 0.34999999999999998 111.369 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.482 ' HA ' ' OG ' ' A' ' 151' ' ' SER . 1.9 pm0 44.36 39.26 2.98 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.871 0.868 . . . . 0.089999999999999997 112.782 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.84 -35.77 75.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.13 112.02 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 4.1 mm? -67.2 -27.54 67.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.878 0.371 . . . . 1.01 110.765 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.466 ' OE1' ' HB3' ' A' ' 150' ' ' LYS . 3.5 mp0 -82.42 -44.81 15.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 0.46000000000000002 109.949 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.46 ' O ' HD11 ' A' ' 163' ' ' LEU . 98.9 t -61.79 -43.52 97.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.17999999999999999 111.238 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.9 tt -66.61 -10.77 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.284 -0.416 . . . . 0.34999999999999998 112.063 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -115.17 -10.54 12.14 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.173 -0.329 . . . . 1.8700000000000001 110.883 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -87.18 -36.96 17.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.395 . . . . 0.77000000000000002 111.547 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -74.89 -13.67 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.22 110.91 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.544 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.4 tmmt? -62.83 -25.03 68.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.971 -0.559 . . . . 0.44 110.659 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.34 -24.74 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.005 -0.543 . . . . 0.69999999999999996 110.666 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -93.48 -48.65 6.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.384 -0.598 . . . . 2.25 109.384 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 19.7 mmt -127.34 104.89 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.098 -0.705 . . . . 2.29 109.098 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -87.96 127.81 35.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.03 0.443 . . . . 1.5700000000000001 111.232 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.612 -0.722 . . . . 0.95999999999999996 110.399 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.685 0.278 . . . . 2.27 110.66 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.94 130.92 41.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.263 -0.426 . . . . 1.5800000000000001 110.73 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 213' ' ' LEU . 16.9 tp -116.91 130.84 56.96 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.53 -0.544 . . . . 2.1000000000000001 109.53 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -126.28 164.13 21.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.88 0.371 . . . . 0.75 110.236 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 94.5 m-85 -122.51 145.04 48.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.635 -0.505 . . . . 0.41999999999999998 109.635 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -127.69 114.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.501 0.667 . . . . 0.40000000000000002 111.526 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.412 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -147.45 158.96 42.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.38 109.626 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.66 173.92 6.12 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.333 2.022 . . . . 0.19 112.417 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 t -54.01 -31.4 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.54000000000000004 112.009 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -53.54 -59.5 4.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.974 0.416 . . . . 0.28000000000000003 110.579 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -77.31 -24.43 50.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.73999999999999999 110.264 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 188' ' ' LEU . . . -59.92 -35.64 87.6 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.865 -0.607 . . . . 0.23000000000000001 112.239 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -77.73 2.72 16.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.7 0.285 . . . . 1.8799999999999999 110.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 190' ' ' GLU . 69.9 mmtt -104.09 -48.43 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.581 -0.281 . . . . 1.8700000000000001 111.412 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.418 ' CD2' ' HA2' ' A' ' 185' ' ' GLY . 1.3 pt? -79.44 -26.22 41.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.91000000000000003 111.549 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 17.5 ttpt -66.38 -26.53 67.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 0.98999999999999999 111.307 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 187' ' ' LYS . 0.4 OUTLIER -95.47 1.36 53.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.457 -0.338 . . . . 0.56999999999999995 111.465 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 27.8 mttp -122.97 -43.07 2.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.362 0.504 . . . . 1.6599999999999999 112.362 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.16 -44.3 47.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.192 0.442 . . . . 0.32000000000000001 112.192 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.5 mtpt -58.95 -51.36 82.41 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.841 0.682 . . . . 0.63 112.841 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.1 Cg_endo -61.91 -9.1 13.21 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.307 2.005 . . . . 0.20999999999999999 113.513 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 73.8 mt -81.69 -6.97 59.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.23000000000000001 110.477 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.2 mm 52.36 53.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.695 -0.684 . . . . 0.19 111.036 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -146.62 27.03 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.717 -0.674 . . . . 1.8899999999999999 110.181 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.68 147.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.993 -0.549 . . . . 0.13 111.073 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.41 144.62 12.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.058 -0.519 . . . . 1.1599999999999999 109.926 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -68.78 80.55 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.289 0.566 . . . . 2.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.6 t -160.21 17.3 0.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.92000000000000004 109.376 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.3 mp0 -75.29 134.03 41.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.22 110.547 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -100.71 136.73 40.12 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.837 -0.619 . . . . 0.79000000000000004 109.673 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 144.24 44.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.712 0.291 . . . . 0.82999999999999996 110.348 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 152.69 -121.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.719 -0.753 . . . . 0.62 111.58 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -82.01 -24.33 35.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.194 0.521 . . . . 0.48999999999999999 110.074 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -124.82 158.7 32.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.472 -0.786 . . . . 2.1499999999999999 109.543 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.68 91.7 3.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.041 -0.355 . . . . 0.98999999999999999 110.041 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 45.6 mt-10 -94.6 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.301 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.9 mt -119.01 142.38 34.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.715 -0.221 . . . . 1.1100000000000001 110.863 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.74 134.63 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.963 -0.384 . . . . 1.1499999999999999 109.963 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 14.6 t -119.55 -32.75 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.744 0.646 . . . . 1.3300000000000001 112.744 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -74.56 121.56 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.825 0.345 . . . . 1.3100000000000001 111.477 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 4.0 tt -125.47 -54.63 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.676 . . . . 1.26 111.185 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 219' ' ' PHE . 0.4 OUTLIER -140.09 161.3 56.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.877 -0.416 . . . . 0.32000000000000001 109.877 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.52 -173.37 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.437 2.092 . . . . 0.28999999999999998 113.117 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.01 -88.39 0.77 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.91 -0.586 . . . . 0.45000000000000001 112.439 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.62 -18.69 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.659 0.384 . . . . 1.21 111.173 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.434 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 2.3 p90 -63.69 -25.22 68.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.94999999999999996 110.597 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 220' ' ' ARG . 2.1 tpp180 -76.72 -32.11 57.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.90000000000000002 110.139 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.46 -43.21 70.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.492 . . . . 1.1200000000000001 110.64 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 6.3 tt -73.71 -23.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.054 0.455 . . . . 1.1299999999999999 110.789 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.7 -29.58 68.2 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.16 111.486 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.6 -30.32 65.21 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.585 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.4 pp -105.0 -35.32 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.997 -0.281 . . . . 1.23 111.317 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.9 mm -55.23 -36.39 39.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 120.788 0.327 . . . . 0.25 111.721 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HB3' ' HZ1' ' A' ' 227' ' ' LYS . 1.0 OUTLIER -62.38 -17.22 58.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.669 0.618 . . . . 1.6599999999999999 112.669 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.68 -23.98 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 1.1399999999999999 111.07 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -68.2 -47.54 67.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 1.9199999999999999 111.713 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.4 t -129.98 -32.45 1.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.674 -0.41 . . . . 0.60999999999999999 111.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 76.8 tttt -66.56 -30.42 70.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.181 0.515 . . . . 1.0700000000000001 110.132 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -97.7 23.77 34.53 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.73 -0.668 . . . . 0.22 111.696 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -133.9 -36.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.34000000000000002 110.31 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.38 -176.89 16.93 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.848 -0.691 . . . . 0.28000000000000003 111.753 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.3 t -87.36 159.76 18.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 0.78000000000000003 110.333 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 153.65 25.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.198 -0.455 . . . . 0.46000000000000002 110.947 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.16 143.29 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.781 -0.645 . . . . 1.8899999999999999 109.705 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.09 124.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.523 . . . . 0.40999999999999998 111.367 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 109.299 -0.63 . . . . 0.97999999999999998 109.299 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 121.052 0.453 . . . . 1.6200000000000001 111.087 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.52 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 27.3 t-20 -144.2 149.12 35.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.549 . . . . 1.9299999999999999 109.831 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -54.96 40.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.742 0.306 . . . . 0.52000000000000002 111.701 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mt -91.17 63.54 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.104 0.478 . . . . 1.47 111.242 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 2.4 mmp_? -136.43 148.98 48.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.1200000000000001 110.479 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.45 -0.92 56.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.63 110.333 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -77.62 -41.34 38.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.263 0.554 . . . . 1.02 110.456 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -108.48 78.52 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.818 -0.628 . . . . 0.66000000000000003 109.936 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.447 HG11 ' OE1' ' A' ' 54' ' ' GLN . 19.2 m -120.54 140.81 43.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.017 -0.538 . . . . 0.22 111.128 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -110.64 116.3 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.087 -0.708 . . . . 0.19 109.087 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.64 110.52 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 0.23999999999999999 111.591 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.13 137.79 28.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.997 -1.112 . . . . 0.81999999999999995 107.997 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 136.82 49.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.326 0.584 . . . . 0.40999999999999998 112.453 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 36.7 ttp -121.38 120.62 35.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.032 -0.986 . . . . 0.34999999999999998 109.488 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.28 129.96 55.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.909 -0.404 . . . . 1.53 109.909 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -108.7 35.92 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.409 -0.36 . . . . 0.76000000000000001 110.771 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.19 63.75 1.81 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.648 0.737 . . . . 0.35999999999999999 109.942 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.94 -70.43 0.48 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.211 -1.155 . . . . 0.20000000000000001 110.211 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -87.23 135.82 33.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 1.8600000000000001 109.217 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -128.23 151.63 49.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.92000000000000004 111.322 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -141.08 126.23 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.41999999999999998 110.347 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 132.34 56.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.11 -0.495 . . . . 0.26000000000000001 110.08 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -129.52 149.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 1.1499999999999999 110.688 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.23 115.98 31.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.93999999999999995 110.909 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 2.1 p -149.08 141.01 23.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.57999999999999996 109.983 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -114.58 -84.42 0.61 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.227 -0.189 . . . . 0.68999999999999995 111.091 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 65.16 -179.94 0.19 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.808 0.692 . . . . 1.5800000000000001 111.559 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.62 78.16 9.9 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.279 -1.008 . . . . 2.3199999999999998 108.279 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt 67.88 78.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.372 -0.831 . . . . 1.0800000000000001 109.422 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.42 -26.56 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.489 -0.778 . . . . 0.46000000000000002 111.782 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.48 -28.83 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.58999999999999997 110.687 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.17999999999999999 111.814 179.559 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HZ2' ' CD ' ' A' ' 51' ' ' GLU . 17.1 ptmt . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 109.979 -0.378 . . . . 1.27 109.979 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 164.51 4.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.023 0.439 . . . . 1.22 111.932 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.595 ' O ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -84.22 -8.74 58.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.566 . . . . 0.95999999999999996 111.311 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -27.33 66.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.311 -0.404 . . . . 0.84999999999999998 110.808 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CD ' ' HZ2' ' A' ' 47' ' ' LYS . 12.3 tt0 -104.18 16.85 25.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.46999999999999997 111.813 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 49' ' ' LEU . 3.0 p -108.3 -27.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.465 -0.494 . . . . 1.05 110.991 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.35 91.36 5.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.397 -0.365 . . . . 0.28000000000000003 110.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.447 ' OE1' HG11 ' A' ' 17' ' ' VAL . 69.2 mt-30 -69.31 -31.06 69.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.47 0.652 . . . . 0.33000000000000002 109.717 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -140.82 126.5 19.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.239 -0.891 . . . . 1.04 109.264 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -86.77 42.74 1.03 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.28999999999999998 110.629 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.7 113.76 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.833 -0.621 . . . . 1.0900000000000001 110.267 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.4 p -91.5 138.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.741 -0.466 . . . . 0.46000000000000002 109.741 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.02 150.18 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.306 -0.406 . . . . 0.22 111.116 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.42 -47.38 7.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 1.1499999999999999 109.429 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -130.57 103.28 6.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 0.39000000000000001 109.349 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.0 -28.09 23.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 113.044 0.757 . . . . 0.26000000000000001 113.044 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 p -82.12 -27.57 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.525 -0.47 . . . . 0.93999999999999995 111.81 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -100.54 -2.04 34.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 1.8799999999999999 111.093 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.55 45.29 78.7 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.29999999999999999 113.1 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.33 112.3 25.06 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.921 -0.399 . . . . 0.73999999999999999 109.921 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.09 144.38 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 0.46000000000000002 110.752 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.98 109.56 20.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.635 -0.506 . . . . 0.93000000000000005 109.635 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.626 ' HB3' ' OE2' ' A' ' 71' ' ' GLU . 7.5 mtpt -78.88 176.62 9.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.886 -0.597 . . . . 1.8300000000000001 110.878 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.77 -32.11 67.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 1.24 112.176 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.626 ' OE2' ' HB3' ' A' ' 69' ' ' LYS . 1.7 pm0 -93.25 4.0 54.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.756 0.312 . . . . 1.02 111.166 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -105.69 -46.49 4.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 2.1600000000000001 110.206 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.77 -33.56 75.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.31 111.048 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 tt -68.54 -21.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.231 0.538 . . . . 1.49 110.432 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -99.38 1.09 44.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.68999999999999995 110.635 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.93 -51.35 2.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.66000000000000003 110.931 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.61 -15.35 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 2.1200000000000001 110.864 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.03 -25.35 20.31 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.749 -0.738 . . . . 0.32000000000000001 112.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 138.26 31.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.68 0.276 . . . . 0.48999999999999999 110.805 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.9 -5.52 55.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.424 0.631 . . . . 0.64000000000000001 109.6 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.37 117.01 28.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.162 -0.926 . . . . 0.42999999999999999 110.511 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -68.75 -22.17 64.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 1.0800000000000001 111.062 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -47.0 77.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.357 -0.383 . . . . 1.0900000000000001 111.064 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -56.43 -39.63 73.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.224 0.535 . . . . 1.3400000000000001 110.382 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 89' ' ' ILE . 66.9 mt -70.22 -48.2 62.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.683 -0.69 . . . . 0.17000000000000001 110.106 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 31' ' ' ILE . 51.6 t -58.61 -40.24 82.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 0.16 110.243 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 91' ' ' THR . 5.3 tttp -58.64 -47.19 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 1.52 109.88 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.05 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 2.2200000000000002 110.937 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 85' ' ' ILE . 69.0 mt -67.54 -29.9 47.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.046 0.45 . . . . 0.93999999999999995 110.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -35.19 35.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.031 -0.531 . . . . 0.94999999999999996 111.976 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 87' ' ' LYS . 6.9 t -96.38 -18.05 20.2 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.998 0.74 . . . . 0.28000000000000003 112.998 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -124.42 17.35 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.8300000000000001 111.283 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.91 178.44 18.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.59 -0.814 . . . . 0.23000000000000001 112.459 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.09 112.23 24.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 2.6800000000000002 110.615 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.21 155.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.56000000000000005 109.756 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -71.34 99.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.026 0.441 . . . . 0.72999999999999998 110.487 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.47999999999999998 110.481 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 122.053 0.93 . . . . 1.2 110.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -122.33 -2.25 9.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.536 -0.756 . . . . 1.0900000000000001 110.734 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -78.65 124.24 27.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.319 -0.4 . . . . 1.75 111.029 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.4 m 55.39 34.47 22.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.574 -0.739 . . . . 0.84999999999999998 112.261 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.92 -53.3 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.57999999999999996 110.679 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -134.7 14.41 3.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 2.0800000000000001 110.208 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 116.94 10.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.84 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 67.8 66.16 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.097 0.559 . . . . 0.68000000000000005 110.797 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -164.48 159.46 19.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.154 -0.684 . . . . 1.01 109.154 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.52 154.38 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 1.5800000000000001 110.297 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.67 -49.55 76.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.857 0.688 . . . . 1.1399999999999999 112.857 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -82.22 -16.07 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.628 0.251 . . . . 1.3899999999999999 111.673 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.76 -59.19 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.45000000000000001 111.826 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -105.2 23.29 13.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.528 -0.305 . . . . 0.37 111.552 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.976 0.362 . . . . 0.25 111.976 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.45 -16.75 57.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.269 -0.423 . . . . 0.70999999999999996 111.908 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.21 -42.38 10.45 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.906 -0.317 . . . . 0.78000000000000003 110.988 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -39.05 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.402 -0.363 . . . . 0.28999999999999998 111.273 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.61 -19.74 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.336 -0.393 . . . . 0.66000000000000003 111.283 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -99.34 -16.94 18.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 1.8400000000000001 110.595 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -62.55 1.46 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.93000000000000005 111.035 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -71.71 -17.7 62.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.37 111.467 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.441 ' N ' HD12 ' A' ' 163' ' ' LEU . 6.4 tmtt? -70.26 -34.28 72.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.888 0.375 . . . . 1.8200000000000001 110.628 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -77.76 -34.47 52.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 1.76 110.579 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -35.95 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.3 0.572 . . . . 1.0800000000000001 109.972 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 tpt -124.24 91.16 3.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.703 -0.851 . . . . 0.39000000000000001 108.703 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.42 101.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.391 0.615 . . . . 2.1000000000000001 111.674 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.1 pt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.129 -0.941 . . . . 1.0600000000000001 109.775 178.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 53.5 mtt . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.633 0.254 . . . . 1.4399999999999999 110.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 54.7 mtt180 -135.13 117.51 15.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 1.3799999999999999 111.116 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.424 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 13.7 mt -108.22 152.51 24.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.867 -0.606 . . . . 2.8300000000000001 110.213 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -140.82 159.97 41.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.222 -0.445 . . . . 0.37 110.176 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 0.8 OUTLIER -134.17 132.82 40.26 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.181 -0.674 . . . . 0.13 109.181 178.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.2 tt -126.73 123.16 62.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.114 0.483 . . . . 0.10000000000000001 111.476 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.457 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.9 OUTLIER -159.76 156.01 23.69 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 0.28999999999999998 110.028 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.87 143.36 30.45 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.861 2.374 . . . . 0.16 112.428 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.82 -31.54 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.51000000000000001 112.427 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -54.89 -46.45 74.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.583 0.23 . . . . 1.3799999999999999 111.534 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.25 -30.79 17.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.92000000000000004 109.841 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.645 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.39 -29.78 72.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.467 -0.788 . . . . 0.25 113.08 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -59.34 -26.41 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 1.0600000000000001 111.087 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -44.52 73.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 1.3899999999999999 110.523 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 3.0 pp -76.76 -22.91 53.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.32000000000000001 110.053 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 71.3 tttt -63.0 -35.34 79.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 1.3300000000000001 110.189 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -101.07 18.31 20.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.783 -0.644 . . . . 1.6499999999999999 110.981 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -131.28 -52.79 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.064 0.394 . . . . 1.5600000000000001 112.064 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.509 HD13 ' SG ' ' A' ' 212' ' ' CYS . 1.1 tm? -86.35 -44.18 12.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.19 111.722 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpt -57.13 -48.42 97.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.809 0.67 . . . . 1.01 112.809 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.9 Cg_endo -59.04 -16.64 33.87 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.298 1.998 . . . . 0.26000000000000001 113.282 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 56.0 mt -74.2 -15.82 61.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 0.41999999999999998 110.162 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 16.7 mt 56.45 60.63 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.645 -0.707 . . . . 0.83999999999999997 111.586 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -135.3 10.06 3.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.691 -0.686 . . . . 2.2000000000000002 109.737 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.2 167.48 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.582 -0.735 . . . . 0.40000000000000002 111.672 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.72 148.48 10.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.42 -0.809 . . . . 0.32000000000000001 108.945 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.12 57.99 0.36 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.263 0.554 . . . . 1.3400000000000001 111.711 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -146.35 55.84 1.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.568 -0.742 . . . . 1.0700000000000001 109.275 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.1 pt-20 -106.13 167.7 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.46000000000000002 111.516 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.9 t70 -131.51 123.53 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.624 -0.88 . . . . 0.78000000000000003 108.624 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.78 31.49 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.91000000000000003 110.802 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.09 -102.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.596 -0.811 . . . . 0.46000000000000002 112.067 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -95.78 -31.09 13.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.439 0.638 . . . . 0.34000000000000002 109.577 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.18 136.96 54.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.384 -0.825 . . . . 0.72999999999999998 109.44 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 203' ' ' ASP . 36.1 tp -88.82 99.65 12.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.077 0.465 . . . . 0.20000000000000001 110.265 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 50.2 tt0 -109.38 114.78 28.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.20000000000000001 109.712 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 178' ' ' PHE . 21.3 mt -127.39 141.13 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 0.96999999999999997 110.891 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.8 125.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.089 -0.708 . . . . 0.25 109.089 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.509 ' SG ' HD13 ' A' ' 192' ' ' LEU . 50.8 t -139.83 99.97 3.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.578 0.227 . . . . 0.96999999999999997 111.454 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER 177.73 121.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.966 -0.753 . . . . 1.1699999999999999 108.966 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -116.0 -40.41 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 111.832 0.308 . . . . 1.7 111.832 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.45 143.69 36.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.879 0.326 . . . . 0.68999999999999995 111.879 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.68 -30.16 35.03 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.875 2.383 . . . . 0.27000000000000002 112.077 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.5 -23.37 75.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.915 -0.66 . . . . 0.46000000000000002 111.761 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.7 6.75 44.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.215 0.531 . . . . 1.9199999999999999 110.572 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.34 -47.68 81.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.716 -0.674 . . . . 1.3700000000000001 110.526 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -66.17 -23.68 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.627 . . . . 2.73 111.087 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.54 -42.82 28.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.778 -0.646 . . . . 2.1899999999999999 111.507 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 0.6 OUTLIER -82.1 -33.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.07 0.396 . . . . 2.0699999999999998 112.07 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.79 -24.49 67.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.881 0.372 . . . . 0.46999999999999997 111.045 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 12.9 mm-40 -61.76 -31.41 71.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 0.5 111.408 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.7 OUTLIER -102.6 -36.79 8.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.117 -0.233 . . . . 0.35999999999999999 110.82 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.8 mm -53.88 -34.35 25.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.61 -0.268 . . . . 0.96999999999999997 111.72 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 17.2 ptpt -55.99 -32.06 63.58 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.126 0.417 . . . . 1.79 112.126 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -108.72 -27.15 9.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.007 0.432 . . . . 1.02 110.881 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.57 . . . . 0.62 112.091 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -149.73 -30.89 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.008 0.744 . . . . 0.81000000000000005 113.008 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 33.3 ttmt -58.9 -37.56 76.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.95 0.341 . . . . 2.9100000000000001 111.84 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.25 18.6 51.13 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.678 -0.772 . . . . 0.20000000000000001 112.629 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -129.99 -47.84 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.87 110.501 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -119.65 -158.01 10.48 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.815 -0.707 . . . . 0.34000000000000002 112.209 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.3 m -108.09 138.64 44.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.346 . . . . 0.85999999999999999 110.532 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 150.09 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 1.77 109.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.43 167.77 23.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.053 0.454 . . . . 1.9199999999999999 110.764 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.13 150.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.76000000000000001 109.742 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.046 0.451 . . . . 0.51000000000000001 110.503 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.53000000000000003 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -153.71 156.83 38.54 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.259 -0.645 . . . . 0.37 109.259 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.1 -19.23 28.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.083 0.401 . . . . 0.82999999999999996 112.083 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.32 70.94 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.299 0.571 . . . . 1.74 110.803 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -146.35 149.49 33.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.749 -0.66 . . . . 1.45 109.998 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.13 -9.32 38.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.443 0.535 . . . . 0.66000000000000003 112.443 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -90.86 2.67 55.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 0.40999999999999998 111.48 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -135.35 32.43 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.213 0.53 . . . . 1.8700000000000001 110.532 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.32 152.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.69 -0.686 . . . . 0.31 111.514 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.43 140.76 48.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.843 -0.617 . . . . 0.22 110.053 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.48 117.7 32.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.204 0.526 . . . . 1.3300000000000001 110.948 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.62 117.47 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.28000000000000003 109.993 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 149.29 50.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.6499999999999999 111.11 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 55.9 ttp -122.14 139.37 53.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.336 -0.847 . . . . 1.1200000000000001 110.472 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -116.11 120.99 40.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.714 -0.476 . . . . 0.40000000000000002 109.714 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -122.37 89.47 3.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.549 -0.296 . . . . 0.84999999999999998 110.52 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.15 46.75 23.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.693 -0.685 . . . . 0.70999999999999996 111.734 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.91 -48.78 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.448 -0.882 . . . . 0.64000000000000001 112.815 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -69.38 129.22 39.14 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.199 -0.297 . . . . 1.1599999999999999 110.199 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -119.11 143.64 47.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.763 0.316 . . . . 0.85999999999999999 111.336 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -132.87 142.42 48.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.29999999999999999 109.82 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 24.9 tt0 -146.54 133.02 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.62 -0.511 . . . . 1.75 109.62 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -136.49 130.38 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.326 -0.397 . . . . 0.95999999999999996 110.01 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 113.09 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.16 111.686 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 31.2 m -107.55 175.91 5.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.786 -0.643 . . . . 0.17999999999999999 110.219 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.564 ' CD1' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.77 150.42 37.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.098 0.475 . . . . 0.34999999999999998 111.084 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -87.5 -7.85 57.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.457 0.539 . . . . 1.98 112.457 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -78.63 78.33 5.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.64000000000000001 111.76 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 52.27 63.24 2.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.89 -0.596 . . . . 2.1499999999999999 111.852 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 7.9 p -70.45 -24.2 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.954 -0.566 . . . . 0.63 110.714 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.14 -5.35 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.049 -0.523 . . . . 0.42999999999999999 111.276 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.391 0 C-N-CA 121.239 -0.505 . . . . 0.17999999999999999 112.852 -179.723 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.753 0.311 . . . . 1.75 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -167.69 160.43 12.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.974 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tp -109.92 -14.63 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 1.1799999999999999 110.886 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.28 -40.54 6.71 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.611 -0.514 . . . . 0.41999999999999998 109.611 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.48 -24.91 61.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.913 -0.585 . . . . 1.8799999999999999 110.345 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.564 HG22 ' CD1' ' A' ' 34' ' ' TYR . 12.0 p -70.88 -26.55 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.415 -0.587 . . . . 0.32000000000000001 109.415 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.55 97.71 7.96 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 1.0900000000000001 110.189 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -67.23 -37.03 82.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.22 108.904 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 t -157.52 126.09 5.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.773 -1.103 . . . . 1.03 108.98 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 10.5 p80 -77.7 67.17 3.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.556 0.693 . . . . 0.71999999999999997 110.556 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -138.59 111.84 8.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.292 -0.867 . . . . 1.3799999999999999 110.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -100.68 135.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.55000000000000004 110.103 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -91.66 163.84 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.92 0.39 . . . . 2.7400000000000002 111.238 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.44 -49.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.019 -0.734 . . . . 1.1699999999999999 109.019 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -142.46 103.63 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.722 . . . . 0.34000000000000002 109.173 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.9 -26.9 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.19 -0.459 . . . . 0.56000000000000005 112.132 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 m -72.42 -36.06 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.9 0.381 . . . . 0.31 110.971 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.68 5.85 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.193 -0.458 . . . . 0.47999999999999998 110.845 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.0 44.19 96.4 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.207 -0.52 . . . . 0.17000000000000001 112.79 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -112.63 121.96 46.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.863 0.363 . . . . 1.1899999999999999 110.736 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.78 170.4 7.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.98 -0.554 . . . . 1.9399999999999999 109.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.45 120.96 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.082 0.467 . . . . 0.97999999999999998 111.049 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -87.74 -178.28 6.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.078 -0.712 . . . . 1.8999999999999999 109.078 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HG3' ' OE1' ' A' ' 71' ' ' GLU . 3.1 pttp -56.56 -39.39 73.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.842 0.353 . . . . 2.1099999999999999 111.333 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.537 ' OE1' ' HG3' ' A' ' 70' ' ' LYS . 7.1 pm0 -75.75 -11.25 59.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 1.79 111.847 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -98.03 -48.69 5.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.655 -0.248 . . . . 0.97999999999999998 110.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.72 -32.81 73.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.737 -0.211 . . . . 0.51000000000000001 111.514 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 79' ' ' THR . 6.9 tt -64.51 -26.78 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.085 0.469 . . . . 1.24 110.455 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 m -95.55 -10.46 29.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 1.95 110.276 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.22 -54.69 4.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.736 -0.666 . . . . 1.22 111.252 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -100.72 -37.87 8.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.75 111.33 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.66 -18.17 8.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.293 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.73 141.57 30.58 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.165 -0.309 . . . . 0.58999999999999997 110.165 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -14.26 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.31 111.09 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' OD1' HG23 ' A' ' 83' ' ' THR . 17.0 t0 -90.09 125.14 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.58999999999999997 110.178 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.424 ' HG3' ' HB2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.95 -21.76 54.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.07 -0.514 . . . . 0.87 112.171 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.416 HG23 ' OD1' ' A' ' 81' ' ' ASP . 2.5 t -68.0 -31.51 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.224 -0.591 . . . . 1.95 110.034 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 74.3 mm-40 -70.22 -36.78 74.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.092 -0.707 . . . . 1.0800000000000001 109.092 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 89' ' ' ILE . 32.6 mm -64.34 -45.73 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.206 -0.906 . . . . 0.28000000000000003 109.172 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.49 -42.3 91.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.64000000000000001 110.575 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.86 -38.32 90.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 2.48 110.189 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 7.5 mm100 -64.28 -39.95 94.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.4399999999999999 109.76 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 85' ' ' ILE . 45.1 mt -67.66 -26.75 36.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.46999999999999997 110.391 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.75 -27.4 31.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.144 -0.48 . . . . 1.26 111.731 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.36 -30.86 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.62 0.6 . . . . 0.52000000000000002 112.62 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -111.45 -3.73 15.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.029 0.442 . . . . 1.46 110.939 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.5 178.77 22.61 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.673 -0.775 . . . . 0.34000000000000002 112.516 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.2 112.02 24.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.41 . . . . 1.3100000000000001 110.573 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.03 148.09 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.605 -0.725 . . . . 0.45000000000000001 110.219 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -62.36 100.17 0.17 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.386 0.612 . . . . 0.68000000000000005 111.058 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 1.1799999999999999 111.142 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 7.0 tp . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.234 -0.284 . . . . 0.35999999999999999 110.234 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 35.5 t60 50.57 57.91 6.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.932 -0.576 . . . . 1.54 110.914 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.503 ' CD2' ' HG2' ' A' ' 162' ' ' GLN . 44.0 t80 -97.16 136.34 37.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.731 . . . . 1.4199999999999999 110.059 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.9 124.05 22.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.721 0.296 . . . . 0.54000000000000004 110.305 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.25 39.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.195 0.522 . . . . 0.38 111.012 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 55.02 83.96 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 1.95 111.989 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -14.51 62.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.982 -0.554 . . . . 0.58999999999999997 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -102.0 14.88 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.514 0.673 . . . . 0.82999999999999996 109.188 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -147.65 -149.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.584 -0.734 . . . . 1.3700000000000001 109.832 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.1 t -152.99 175.94 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.918 -0.401 . . . . 0.19 109.918 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -65.8 -36.18 82.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 1.27 111.941 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -76.73 -9.46 58.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.419 -0.355 . . . . 0.44 111.487 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -47.57 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.70999999999999996 110.113 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -161.77 73.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.97999999999999998 110.987 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -75.26 -24.74 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.58999999999999997 110.745 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.18 -51.16 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.607 . . . . 0.75 110.878 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.84 -35.27 79.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.40999999999999998 110.625 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.6 -52.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.25 110.981 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.2 tp -66.01 -31.98 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.349 -0.387 . . . . 0.25 111.125 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -72.41 -31.66 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 1.1299999999999999 110.479 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.503 ' HG2' ' CD2' ' A' ' 144' ' ' TYR . 7.4 tp-100 -68.93 -37.78 79.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.96999999999999997 109.928 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.59 -40.61 97.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.29999999999999999 109.994 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -66.29 -21.27 66.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.366 -0.834 . . . . 1.22 111.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -71.08 -28.6 64.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.829 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.462 ' HG3' ' HB ' ' A' ' 142' ' ' ILE . 7.1 mmtt -93.09 -41.62 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.53000000000000003 110.036 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.9 mmm -130.53 99.53 5.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 2.5899999999999999 109.498 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.35 93.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.165 0.507 . . . . 1.4099999999999999 110.973 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.49 -0.777 . . . . 0.20999999999999999 109.859 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 109.518 -0.549 . . . . 0.72999999999999998 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.99 126.93 22.28 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.921 0.391 . . . . 1.1499999999999999 110.74 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.432 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 5.7 mp -113.16 144.59 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.31 110.199 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.56 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 16.0 ptt180 -123.67 138.66 54.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.926 -0.579 . . . . 0.14999999999999999 110.125 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 71.9 m-85 -106.3 124.58 49.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.035 -0.357 . . . . 0.10000000000000001 110.035 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.18 112.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.42999999999999999 111.291 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.83 152.81 27.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.829 -0.623 . . . . 0.28999999999999998 110.137 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.98 153.36 74.03 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.124 1.883 . . . . 0.14000000000000001 111.06 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.74 -30.96 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.91000000000000003 111.329 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.99 -41.94 62.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.584 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -97.56 -31.9 12.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.64000000000000001 110.781 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.33 -31.05 68.89 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.86 -0.609 . . . . 0.42999999999999999 112.597 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -64.36 -16.27 61.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.56 0.219 . . . . 3.2000000000000002 111.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -82.89 -44.5 15.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 1.55 111.004 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 -23.29 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 0.56999999999999995 111.311 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -54.54 -55.32 30.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.72999999999999998 111.325 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -82.89 29.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.366 -0.379 . . . . 0.53000000000000003 111.629 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -134.8 -48.9 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.68999999999999995 110.45 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.4 mt -78.83 -39.83 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 1.49 111.705 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 39.7 mtpt -64.68 -50.51 64.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.529 0.566 . . . . 2.3599999999999999 112.529 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.7 Cg_endo -62.28 -15.79 46.96 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.978 1.786 . . . . 0.19 112.879 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.44 2.96 49.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.549 -0.296 . . . . 0.98999999999999999 110.223 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 23.7 pt 41.2 41.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.252 1.021 . . . . 0.94999999999999996 112.746 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -117.8 18.76 14.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.548 0.69 . . . . 2.2400000000000002 109.798 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.6 m -111.82 164.06 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.27 -0.877 . . . . 0.60999999999999999 110.565 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.91 138.48 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.793 -0.817 . . . . 0.39000000000000001 108.793 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.49 70.96 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.422 0.629 . . . . 1.75 111.374 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.5 m -144.73 28.15 1.3 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.46 109.742 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 9.1 pt-20 -85.73 168.78 14.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 1.8999999999999999 110.62 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -131.34 126.83 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.22 110.681 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.54 79.14 4.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 2.4300000000000002 110.915 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -125.7 2.68 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.247 -0.741 . . . . 0.33000000000000002 111.247 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.83 -36.55 17.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.453 0.645 . . . . 2.7599999999999998 109.726 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -113.35 114.64 26.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.146 -0.933 . . . . 3.0499999999999998 108.99 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.51 80.72 4.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.141 0.496 . . . . 0.55000000000000004 110.38 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 28.0 tt0 -80.19 105.68 11.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.66000000000000003 110.115 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.12 138.27 37.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 1.2 110.473 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.19 113.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.20999999999999999 109.826 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.81 105.5 5.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.028 0.442 . . . . 0.19 111.168 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.432 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -148.86 144.96 27.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.275 -0.639 . . . . 1.55 109.275 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.1 tt -137.26 163.17 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.588 -0.278 . . . . 1.04 110.45 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 165.7 4.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.828 0.451 . . . . 0.73999999999999999 110.808 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.53 -172.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.457 2.105 . . . . 0.28000000000000003 112.855 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 81.12 -92.6 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.699 -0.762 . . . . 0.23000000000000001 111.537 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.19 -12.36 50.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 2.1099999999999999 110.957 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.454 ' HA ' HG23 ' A' ' 222' ' ' ILE . 79.7 t80 -58.2 -30.68 66.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.396 . . . . 0.19 110.617 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -69.4 -18.63 63.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 2.2400000000000002 110.732 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -90.3 -35.24 15.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.469 -0.332 . . . . 1.77 111.24 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.583 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 5.3 tt -82.35 -34.88 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.552 0.215 . . . . 0.19 111.266 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.64 -25.74 66.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.183 0.516 . . . . 0.80000000000000004 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.21 -32.35 66.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.421 -0.808 . . . . 0.64000000000000001 111.45 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.48 -36.13 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.784 -0.367 . . . . 1.74 110.433 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.1 mm -53.86 -41.09 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 116.556 -0.293 . . . . 0.51000000000000001 111.367 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -55.94 -31.1 62.63 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.887 -0.597 . . . . 0.59999999999999998 112.603 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.54 ' HE3' ' C ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.63 2.62 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.852 0.316 . . . . 3.1699999999999999 111.852 -178.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 6.5 tp10 -94.25 -56.39 2.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.36 . . . . 0.89000000000000001 110.865 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t -126.66 -21.85 4.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.083 -0.508 . . . . 0.81000000000000005 111.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -61.88 -50.51 71.92 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.842 -0.429 . . . . 0.44 109.842 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.74 34.65 4.52 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.25 111.77 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -129.9 -30.4 2.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.747 0.308 . . . . 2.2599999999999998 110.538 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -151.3 -151.37 5.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.712 -0.756 . . . . 0.40000000000000002 112.368 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.2 m -110.81 145.85 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.125 -0.324 . . . . 0.33000000000000002 110.125 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.58 145.37 42.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 0.76000000000000001 110.659 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.61 170.63 15.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.497 -0.774 . . . . 1.1599999999999999 109.173 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.17 153.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.404 -0.591 . . . . 0.29999999999999999 109.404 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.20999999999999999 109.921 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.81000000000000005 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -153.62 -171.77 4.01 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.845 -0.428 . . . . 0.95999999999999996 109.845 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -84.62 -85.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.911 0.386 . . . . 1.24 111.021 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.443 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 mp -93.74 83.49 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.195 0.522 . . . . 1.01 110.721 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.4 mmt85 -141.55 148.59 39.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.667 -0.697 . . . . 2.52 109.972 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.41 -9.75 58.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.066 0.46 . . . . 2.1699999999999999 111.258 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.29 9.11 30.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 0.78000000000000003 111.336 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -145.03 37.65 1.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.69999999999999996 109.743 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.84 -168.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.32 -0.855 . . . . 0.25 111.916 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.29 152.94 36.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.553 -0.748 . . . . 0.28000000000000003 109.496 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.07 119.4 47.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.864 0.364 . . . . 0.22 110.749 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 2.4 p -155.47 110.32 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.34999999999999998 109.784 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.61 142.16 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.83999999999999997 111.665 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.485 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 37.7 ttp -112.73 129.57 56.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.56000000000000005 110.033 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 124.76 47.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 2.2999999999999998 110.028 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -104.19 -166.49 1.25 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.688 -0.687 . . . . 1.3300000000000001 110.3 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.23 90.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.427 -0.351 . . . . 0.83999999999999997 111.037 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.06 46.17 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.594 -0.813 . . . . 0.33000000000000002 112.442 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -172.82 156.83 3.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.977 -0.379 . . . . 2.5600000000000001 109.977 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 145.13 48.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.76000000000000001 109.779 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -134.23 138.61 45.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.378 -0.373 . . . . 0.65000000000000002 110.639 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 34.6 tt0 -144.19 142.53 30.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.58 0.229 . . . . 1.28 110.664 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.93 -164.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.559 . . . . 0.14000000000000001 110.107 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.4 153.35 51.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.391 -0.225 . . . . 0.32000000000000001 110.391 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 42.5 m -133.39 127.3 33.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.852 0.358 . . . . 0.32000000000000001 111.297 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.432 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 2.1 t80 -62.89 122.28 15.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.45000000000000001 112.375 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 55.72 17.49 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.066 -0.97 . . . . 1.3799999999999999 112.81 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER 62.19 23.35 13.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.0 0.429 . . . . 0.84999999999999998 110.35 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -74.52 -1.13 20.01 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.246 0.462 . . . . 1.8100000000000001 112.246 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.98 -23.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.53 . . . . 0.20000000000000001 110.423 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.15 -7.46 9.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.82 -0.627 . . . . 0.22 109.798 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.331 0 CA-C-N 115.62 -0.718 . . . . 0.20999999999999999 111.95 179.538 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tptp . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.682 0.277 . . . . 1.1699999999999999 111.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.71 127.55 28.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.444 -0.798 . . . . 0.46999999999999997 110.941 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.45 -10.17 59.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.023 -0.535 . . . . 1.5 111.088 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -105.15 -9.7 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 0.67000000000000004 111.072 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -102.08 -39.34 7.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 1.27 110.21 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 6.6 p -72.94 -20.13 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.187 -0.461 . . . . 1.1000000000000001 111.077 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.17 102.79 14.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.393 -0.367 . . . . 0.10000000000000001 110.391 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 12' ' ' ILE . 57.6 mt-30 -82.89 -73.54 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.165 -0.471 . . . . 0.39000000000000001 110.428 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 m -67.2 106.48 2.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.81 -0.632 . . . . 0.089999999999999997 110.3 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -87.97 49.63 1.84 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.461 0.648 . . . . 0.56999999999999995 110.427 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 p -161.11 141.97 11.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.064 -0.971 . . . . 0.17000000000000001 108.872 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.98 145.47 16.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.262 -0.273 . . . . 0.23000000000000001 110.262 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -89.67 160.66 16.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.634 0.254 . . . . 0.10000000000000001 111.057 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.9 t -123.35 -50.98 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 1.1100000000000001 109.945 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 65.8 m-20 -129.23 112.46 13.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.81000000000000005 109.427 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 7.3 p -79.63 -34.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.83 0.348 . . . . 1.1100000000000001 111.42 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -78.18 -28.1 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 1.6299999999999999 110.926 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -94.35 -6.85 43.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.167 -0.469 . . . . 1.3600000000000001 110.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.03 53.92 36.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.017 -0.611 . . . . 0.59999999999999998 112.045 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 12.2 mm100 -121.96 121.39 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.40999999999999998 111.015 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.0 t -110.68 146.0 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.493 -0.776 . . . . 0.29999999999999999 109.632 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.99 121.94 42.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 1.01 110.27 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 -171.87 2.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.068 -0.716 . . . . 1.48 109.068 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.484 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -56.86 -39.68 74.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.835 0.309 . . . . 1.21 111.835 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -72.74 -16.74 61.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.624 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.86 -53.48 4.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.061 0.457 . . . . 0.20000000000000001 110.654 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.99 -23.81 66.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.12 111.754 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -64.16 -30.37 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.863 0.363 . . . . 1.1000000000000001 110.64 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -97.2 -23.27 16.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.841 0.353 . . . . 0.97999999999999998 110.599 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.13 -47.72 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 1.0700000000000001 110.974 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 -59.03 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.79000000000000004 110.401 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.72 -37.43 1.03 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.544 -0.836 . . . . 0.16 112.506 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.56 135.1 44.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.452 0.168 . . . . 1.3 111.054 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.77 43.63 1.0 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 0.53000000000000003 111.02 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.7 130.89 46.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.193 -0.458 . . . . 0.35999999999999999 110.128 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -27.26 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 1.1699999999999999 111.368 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.565 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 1.1 m -65.65 -35.7 81.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.189 0.518 . . . . 0.28000000000000003 111.074 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.86 -24.94 60.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.098 -0.501 . . . . 1.3400000000000001 110.567 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 89' ' ' ILE . 29.6 mm -84.17 -51.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.16 110.822 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 30.0 p -60.63 -37.12 80.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.23999999999999999 111.917 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -64.08 -30.12 71.21 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.898 0.38 . . . . 2.5 110.613 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -77.9 -38.99 44.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.931 -0.396 . . . . 2.6000000000000001 109.931 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 56.5 mt -67.1 -25.3 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.34999999999999998 110.5 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -81.55 -35.65 30.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.747 -0.66 . . . . 0.96999999999999997 112.061 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 -20.56 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.733 0.642 . . . . 0.98999999999999999 112.733 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 22' ' ' MET . 5.2 mmtm -127.78 23.09 6.25 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.879 -0.329 . . . . 1.3300000000000001 111.632 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.14 -176.02 14.22 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.228 -0.987 . . . . 0.20999999999999999 113.501 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 mm-40 -101.88 105.07 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.287 -0.457 . . . . 1.6200000000000001 109.924 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.05 146.0 15.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.33000000000000002 110.444 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -66.69 97.96 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.381 . . . . 1.8600000000000001 110.221 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 121.058 0.456 . . . . 2.0699999999999998 110.908 -179.748 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.88 0.371 . . . . 0.33000000000000002 110.134 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 60.74 28.12 17.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.348 -0.842 . . . . 1.45 112.01 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -124.19 129.37 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.74 -0.467 . . . . 0.60999999999999999 109.74 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.73 141.13 37.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.0 -0.545 . . . . 0.32000000000000001 110.826 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.75 -63.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.346 -0.388 . . . . 0.23000000000000001 110.564 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -151.32 129.09 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.131 -0.322 . . . . 2.4300000000000002 110.131 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 145.82 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 0.60999999999999999 111.65 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.8 t30 66.39 9.87 6.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.73 112.196 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -84.66 140.35 31.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.249 -0.648 . . . . 1.24 109.249 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.3 m -59.02 132.68 54.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.96 -0.385 . . . . 0.40999999999999998 109.96 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -45.13 73.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.541 0.571 . . . . 1.3100000000000001 112.541 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -64.07 -25.18 67.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.389 0.514 . . . . 2.6299999999999999 112.389 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.52 -25.72 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.871 0.323 . . . . 2.1699999999999999 111.871 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 159' ' ' VAL . 25.6 pt20 -109.32 12.81 24.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.922 0.391 . . . . 0.40000000000000002 111.114 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.16 87.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.1200000000000001 111.142 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.3 -31.5 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.40999999999999998 110.645 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -76.04 -36.22 59.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.58999999999999997 110.399 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 155' ' ' GLN . 94.5 t -65.12 -48.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.22 110.758 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.22 -33.78 64.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.826 0.346 . . . . 1.0600000000000001 110.711 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.4 mtmt -67.86 -46.29 72.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.326 . . . . 1.6799999999999999 110.121 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -65.86 -36.32 83.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.81000000000000005 110.72 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.19 -42.85 99.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 1.22 110.317 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 167' ' ' MET . 1.4 tmmt? -60.57 -28.72 68.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.492 -0.777 . . . . 0.56999999999999995 111.306 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.3 mm-40 -70.47 -25.62 63.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.474 . . . . 1.3600000000000001 110.887 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -99.9 -39.1 8.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 1.52 111.052 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 36.2 ttm -135.25 129.16 33.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.843 -0.428 . . . . 1.99 109.843 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -80.97 97.79 7.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.95 0.405 . . . . 0.93999999999999995 111.182 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.546 . . . . 1.0900000000000001 110.299 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.222 -0.659 . . . . 2.75 109.222 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 83.7 mtm180 -133.59 129.58 37.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.968 0.413 . . . . 1.1699999999999999 111.181 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mt -116.65 151.59 35.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 109.915 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.414 ' HE ' ' CD ' ' A' ' 209' ' ' GLU . 6.8 ptm180 -134.69 135.21 41.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.322 -0.399 . . . . 0.28000000000000003 110.446 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 49.1 m-85 -102.17 128.04 48.84 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.991 -0.374 . . . . 0.32000000000000001 109.991 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.59 123.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 0.53000000000000003 111.196 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.46 160.61 32.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.562 -0.744 . . . . 0.94999999999999996 110.052 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.03 165.64 11.95 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.779 2.319 . . . . 0.16 112.567 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.24 -41.42 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.399 -0.364 . . . . 0.51000000000000001 111.76 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -59.3 -47.49 85.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 1.4399999999999999 111.078 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.58 53.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 0.63 111.581 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.3 71.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.177 -0.535 . . . . 0.27000000000000002 113.13 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -71.44 -8.17 52.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.828 0.307 . . . . 0.77000000000000002 111.828 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -87.66 -6.04 58.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.64 0.257 . . . . 1.48 111.066 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -26.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.675 -0.238 . . . . 0.58999999999999997 111.342 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -56.78 16.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.838 0.351 . . . . 2.3199999999999998 111.235 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.64 10.5 3.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 229' ' ' GLU . 20.9 mtpt -118.14 -41.68 2.86 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.684 0.253 . . . . 1.51 111.684 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.33 -38.46 18.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.981 0.363 . . . . 0.53000000000000003 111.981 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 11.0 mtpt -59.52 -47.54 97.6 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.597 0.591 . . . . 0.44 112.597 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.9 Cg_endo -64.6 -8.95 18.79 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.468 2.112 . . . . 0.20000000000000001 113.474 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.1 mt -90.46 -5.15 56.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.858 0.361 . . . . 0.14999999999999999 110.203 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.2 mm 58.09 54.18 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.666 0.746 . . . . 0.11 110.309 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.97 16.99 7.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.454 -0.794 . . . . 0.32000000000000001 110.556 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.95 142.37 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.58999999999999997 111.608 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.94 159.03 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.527 -0.761 . . . . 0.59999999999999998 109.547 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -70.77 53.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.25 0.463 . . . . 1.8700000000000001 112.25 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.7 m -167.18 100.58 0.52 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.496 0.719 . . . . 0.72999999999999998 109.797 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.465 ' CD ' ' HZ1' ' A' ' 193' ' ' LYS . 47.6 mt-10 -128.05 145.78 50.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.40999999999999998 111.361 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.27 119.3 38.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.874 -0.417 . . . . 0.25 109.874 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.16 101.39 6.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 109.909 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -156.98 -109.4 0.29 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.954 -0.641 . . . . 0.26000000000000001 111.741 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -88.69 -13.35 39.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.631 0.729 . . . . 1.6599999999999999 109.037 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.58 -177.32 4.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.612 -1.176 . . . . 1.1299999999999999 108.536 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 40.9 tp -134.1 117.22 16.36 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.813 -0.439 . . . . 0.42999999999999999 109.813 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 48.3 tt0 -128.77 117.6 21.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.053 -0.522 . . . . 0.34000000000000002 109.632 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.79 141.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.825 0.345 . . . . 2.1899999999999999 111.125 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.46 111.23 24.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.471 -0.566 . . . . 1.0700000000000001 109.471 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 60.29 0.71 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.992 0.425 . . . . 1.1299999999999999 111.706 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -138.59 113.94 9.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.768 -0.456 . . . . 0.45000000000000001 109.768 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.79 -78.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.17000000000000001 111.567 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -138.92 160.83 61.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.521 -0.309 . . . . 0.20999999999999999 110.766 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.53 176.19 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.55 2.166 . . . . 0.23000000000000001 111.712 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.24 -75.4 1.77 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.499 -0.858 . . . . 0.14999999999999999 111.883 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -5.25 32.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.69 0.281 . . . . 2.6699999999999999 110.843 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 7.7 p90 -59.71 -23.53 63.24 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.22 110.991 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.43 ' HA ' ' OD1' ' A' ' 223' ' ' ASP . 1.2 tpm_? -60.32 -27.89 67.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.875 0.369 . . . . 3.1299999999999999 110.884 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -50.23 65.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.33000000000000002 110.499 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 8.3 tt -81.33 -34.9 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 1.97 111.854 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 219' ' ' PHE . 0.0 OUTLIER -64.34 -28.07 69.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.722 0.296 . . . . 1.71 111.299 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -66.49 -36.13 81.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.6899999999999999 110.382 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -90.89 -39.71 12.15 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.678 -0.409 . . . . 0.14000000000000001 110.92 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.3 mm -55.7 -36.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.463 -0.335 . . . . 0.37 111.604 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -56.49 -23.72 41.31 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.739 0.644 . . . . 1.3400000000000001 112.739 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.5 pttm -121.26 -19.19 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.798 0.296 . . . . 1.5900000000000001 111.798 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 191' ' ' LYS . 2.2 tp10 -78.64 -32.27 47.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.28999999999999998 112.34 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -143.26 -33.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.446 -0.502 . . . . 0.81000000000000005 111.364 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -66.12 -18.66 65.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.177 0.513 . . . . 0.34000000000000002 110.529 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.82 15.47 28.85 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.14000000000000001 111.512 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -128.49 -35.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.725 0.297 . . . . 1.0900000000000001 110.73 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.95 -150.29 6.55 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.91 -0.662 . . . . 0.29999999999999999 112.742 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.2 m -116.71 145.84 43.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.318 . . . . 1.29 110.812 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 1.5 pt? -106.4 137.45 44.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.943 0.401 . . . . 0.41999999999999998 110.688 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -129.31 163.75 25.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.66000000000000003 110.444 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.14 169.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.797 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.877 0.37 . . . . 2.0499999999999998 111.138 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 16' ' ' ASN . 7.9 p . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.642 0.258 . . . . 0.52000000000000002 110.729 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -131.58 -82.63 0.51 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.615 0.245 . . . . 1.6299999999999999 110.683 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -129.34 -122.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.601 -0.272 . . . . 1.3899999999999999 110.598 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.95 94.42 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.28999999999999998 110.636 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 13' ' ' ARG . 10.3 mmt85 -134.4 -171.47 2.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.686 -0.688 . . . . 2.0 109.759 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.54 12.65 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.275 0.559 . . . . 2.2400000000000002 110.379 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.65 -32.75 7.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 0.75 111.833 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.407 ' HB3' HG23 ' A' ' 9' ' ' THR . 26.0 p-10 -97.63 18.62 15.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 1.1000000000000001 111.443 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.1 m -85.8 157.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.599 0.714 . . . . 0.42999999999999999 112.786 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.11 140.05 53.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.625 -1.17 . . . . 0.5 108.96 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -89.08 98.57 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 1.0800000000000001 111.311 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.36 120.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.847 -0.615 . . . . 0.31 109.696 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -122.75 132.56 54.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.35999999999999999 112.146 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 39.0 ttp -107.01 122.66 46.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.93999999999999995 110.337 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -97.63 123.62 41.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 1.99 109.99 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -107.39 -154.9 0.53 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.449 -0.341 . . . . 0.55000000000000004 110.096 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.43 -59.55 2.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.84 0.311 . . . . 0.58999999999999997 111.84 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.84 21.56 5.88 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.638 -0.791 . . . . 0.84999999999999998 112.634 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -155.86 161.01 40.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.692 -0.484 . . . . 1.4099999999999999 109.692 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 142.83 28.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.341 -0.615 . . . . 0.46999999999999997 109.341 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.89 141.26 47.3 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.343 0.402 . . . . 0.27000000000000002 110.523 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.663 ' HG2' ' CD1' ' A' ' 59' ' ' PHE . 14.1 pt-20 -139.68 149.22 43.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.052 -0.351 . . . . 0.38 110.052 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.3 pt -136.75 -176.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.771 -0.65 . . . . 0.40999999999999998 110.591 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.36 109.88 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.308 0.575 . . . . 1.1499999999999999 111.282 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 11.3 p -117.77 -179.63 3.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.698 -0.853 . . . . 0.31 108.698 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.437 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -70.32 143.12 52.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.479 -0.489 . . . . 0.47999999999999998 110.212 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -85.4 -41.87 15.05 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.383 0.512 . . . . 1.6100000000000001 112.383 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -64.63 127.45 31.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.642 -0.254 . . . . 1.75 111.643 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.5 pttp 43.64 37.34 1.5 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.31 1.044 . . . . 2.27 113.021 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.7 p -64.47 -21.73 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.52 0.676 . . . . 0.46000000000000002 111.178 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 -4.2 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.65000000000000002 110.802 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.47999999999999998 112.693 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.78 0.324 . . . . 2.1099999999999999 111.194 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.06 149.02 48.42 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.98999999999999999 110.94 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.76 -20.97 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.46000000000000002 111.392 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -30.24 71.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 1.01 110.473 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.26 -24.46 24.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.98999999999999999 109.823 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.29 -41.18 80.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.537 -0.756 . . . . 0.13 110.121 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.473 HD13 HE21 ' A' ' 82' ' ' GLN . 0.7 OUTLIER -75.8 92.28 3.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.426 -0.806 . . . . 0.37 109.899 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -74.64 -61.52 1.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.28999999999999998 111.834 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.84 108.02 19.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.894 0.378 . . . . 1.1200000000000001 110.944 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.4 69.32 9.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.224 0.535 . . . . 1.1100000000000001 111.438 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -154.4 105.06 2.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.822 -0.626 . . . . 0.56000000000000005 110.13 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -94.7 141.55 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.394 -0.595 . . . . 0.98999999999999999 109.394 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.663 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -93.73 157.76 16.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.064 0.459 . . . . 0.27000000000000002 111.678 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.29 -56.47 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.47 -0.937 . . . . 0.28999999999999998 108.47 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -150.02 116.79 5.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.76000000000000001 109.406 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.97 -17.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 111.252 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.9 t -64.81 -26.26 68.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 1.4199999999999999 110.689 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -122.64 -0.91 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.431 . . . . 1.51 110.987 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.96 37.48 64.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.936 -0.649 . . . . 0.42999999999999999 112.039 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -86.37 118.73 26.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 1.8899999999999999 110.772 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.79 144.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.70999999999999996 109.732 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.29 133.06 52.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.15 0.5 . . . . 0.31 110.631 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 7.3 mtmt -107.64 -171.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.736 -0.666 . . . . 1.5600000000000001 109.884 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.54 68.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.683 0.277 . . . . 0.35999999999999999 111.263 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.542 ' OE1' ' HB3' ' A' ' 69' ' ' LYS . 5.0 pm0 -80.32 -5.67 56.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.529 -0.305 . . . . 0.46000000000000002 111.482 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.33 -44.15 4.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.84 -0.344 . . . . 0.42999999999999999 110.966 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.35 -26.91 68.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.93 0.395 . . . . 0.26000000000000001 110.454 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -27.83 33.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 116.077 -0.511 . . . . 0.5 109.908 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -17.66 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.448 0.642 . . . . 0.23000000000000001 109.63 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.28 -59.19 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.748 . . . . 0.32000000000000001 110.664 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -95.19 -52.0 4.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.284 -0.417 . . . . 0.32000000000000001 110.464 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.06 -26.68 2.71 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.472 -0.651 . . . . 0.20000000000000001 111.472 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.36 143.49 28.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.564 -0.318 . . . . 0.22 110.617 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.85 10.08 32.57 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 1.4399999999999999 110.817 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.5 120.25 36.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.602 -0.726 . . . . 0.76000000000000001 110.454 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.473 HE21 HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.18 -29.78 71.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.28999999999999998 111.091 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.651 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -60.11 -37.87 81.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.93999999999999995 110.795 179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.92 -24.9 62.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.65000000000000002 110.637 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.6 mm -79.49 -49.05 20.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.17999999999999999 109.47 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 25.7 p -67.51 -29.33 68.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 1.03 110.706 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 83' ' ' THR . 18.5 ttpt -66.07 -16.59 64.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.211 0.529 . . . . 0.70999999999999996 110.419 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.89 -52.59 4.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 1.02 109.692 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 19.6 mt -61.44 -35.31 65.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.748 -0.66 . . . . 0.51000000000000001 112.365 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 2.1 mm? -73.95 2.37 8.78 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.422 0.897 . . . . 0.34000000000000002 113.422 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -145.4 -32.92 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.611 -0.436 . . . . 1.27 112.135 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.03 10.21 38.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.001 -0.37 . . . . 2.1000000000000001 110.001 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.92 -173.79 13.31 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.784 -0.722 . . . . 0.5 112.093 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -95.6 101.73 13.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.842 0.353 . . . . 2.1899999999999999 110.398 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 p -100.35 133.35 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.992 -0.549 . . . . 0.56999999999999995 109.688 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -74.19 84.71 1.86 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.272 0.558 . . . . 1.55 110.326 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 1.3300000000000001 111.455 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.848 -0.427 . . . . 1.1899999999999999 109.848 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 63.72 32.67 13.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.544 -0.753 . . . . 1.3600000000000001 111.162 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -100.12 104.04 15.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.87 -0.604 . . . . 0.75 109.781 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 m -74.13 134.79 42.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.44 110.529 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.32 75.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.04 -0.527 . . . . 0.5 110.397 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.66 -168.82 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.189 -0.914 . . . . 1.6299999999999999 110.985 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.0 t -125.92 15.96 7.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.739 0.781 . . . . 0.54000000000000004 109.573 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -100.06 -0.26 39.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.161 -0.927 . . . . 1.22 111.078 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.79 20.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.157 0.503 . . . . 1.3600000000000001 110.004 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 1.5 m -77.21 51.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.34999999999999998 112.279 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -28.53 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.98999999999999999 111.902 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 11.88 35.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.123 -0.49 . . . . 0.26000000000000001 111.068 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 2.0 tp-100 -113.5 -49.25 2.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 1.3600000000000001 110.524 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.45 ' O ' HG22 ' A' ' 159' ' ' VAL . 40.5 mt-30 -105.94 34.05 3.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 0.81000000000000005 111.204 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.42 -35.97 77.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.942 -0.572 . . . . 0.91000000000000003 110.845 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.91 -25.04 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.015 -0.539 . . . . 1.74 111.068 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -79.58 -42.42 25.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.828 -0.434 . . . . 0.57999999999999996 109.828 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HD11 ' A' ' 163' ' ' LEU . 21.8 t -64.53 -41.72 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.934 -0.575 . . . . 0.23999999999999999 111.002 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -26.08 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.457 . . . . 1.23 111.598 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -93.69 -21.67 19.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.12 0.486 . . . . 0.60999999999999999 110.134 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.46 -53.0 32.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.64 -0.709 . . . . 0.54000000000000004 111.533 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -79.59 -10.79 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.678 -0.409 . . . . 0.29999999999999999 110.942 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.439 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.7 ttpt -65.05 -26.57 68.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.373 0.606 . . . . 1.6100000000000001 110.035 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.09 -8.3 58.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 2.0699999999999998 110.612 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -110.56 -35.23 6.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.189 -0.46 . . . . 1.3100000000000001 110.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.49 130.7 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 1.28 110.237 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.13 82.29 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.361 0.601 . . . . 1.6399999999999999 110.783 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.9 pt . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.523 -0.762 . . . . 1.51 111.585 -179.522 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.713 -0.477 . . . . 0.54000000000000004 109.713 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 mtm180 -92.74 135.73 33.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.035 -0.358 . . . . 0.56000000000000005 110.035 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.1 150.26 43.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.012 0.434 . . . . 1.03 111.081 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 -176.15 3.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.89000000000000001 109.371 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.1 p90 -150.16 127.91 11.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.777 -0.453 . . . . 0.53000000000000003 109.777 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.8 126.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.70999999999999996 111.26 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.406 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 2.6 pt? -167.34 147.24 4.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.38 -0.827 . . . . 1.75 109.472 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.44 162.3 34.41 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.858 2.372 . . . . 0.69999999999999996 112.914 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.6 -35.44 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.60999999999999999 111.44 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -47.86 -47.51 31.58 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.795 -0.638 . . . . 0.67000000000000004 111.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.24 -26.42 14.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.7 0.286 . . . . 0.78000000000000003 110.973 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.86 -33.19 77.33 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.22 113.041 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -64.04 -14.29 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.088 0.403 . . . . 2.6099999999999999 112.088 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -44.81 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.559 0.219 . . . . 0.82999999999999996 111.252 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.7 pp -86.12 -20.69 28.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.48999999999999999 110.483 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.91 -41.95 62.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.421 -0.809 . . . . 2.1499999999999999 111.969 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.487 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -103.94 15.49 28.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.235 0.457 . . . . 1.1599999999999999 112.235 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.559 ' HZ3' ' CD ' ' A' ' 229' ' ' GLU . 1.1 ttpm? -124.22 -30.49 3.44 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.452 -0.499 . . . . 3.0499999999999998 111.692 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.19 -42.83 9.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.593 0.235 . . . . 0.89000000000000001 111.468 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.529 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 13.5 mtpt -58.05 -47.35 99.03 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.051 0.76 . . . . 1.02 113.051 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.3 Cg_endo -60.72 -16.26 42.53 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.199 1.933 . . . . 0.19 113.401 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.76 -21.0 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.336 -0.246 . . . . 0.17999999999999999 110.336 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 78.86 -10.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.466 -0.788 . . . . 0.20999999999999999 111.526 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -86.74 54.36 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.248 0.547 . . . . 1.1699999999999999 110.771 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.85 138.41 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.258 -0.883 . . . . 0.28999999999999998 109.613 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.6 142.26 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.658 -0.497 . . . . 1.53 109.658 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -68.76 81.94 0.29 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.133 0.492 . . . . 1.99 110.465 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 68.8 m -157.53 31.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.333 -0.849 . . . . 0.20000000000000001 109.745 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.96 154.41 28.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.35999999999999999 110.66 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -108.58 111.86 23.91 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.159 -0.682 . . . . 0.56999999999999995 109.159 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.39 80.43 3.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.217 0.532 . . . . 1.26 110.356 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -148.36 -130.56 1.96 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.685 -0.689 . . . . 0.51000000000000001 112.197 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -78.84 -26.76 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.478 . . . . 0.81000000000000005 110.601 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.67 145.19 49.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.91 -0.774 . . . . 1.8100000000000001 108.91 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 28.1 tp -105.03 85.9 2.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.936 0.398 . . . . 0.42999999999999999 110.972 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 5.0 tt0 -93.11 118.69 31.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.96999999999999997 109.748 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 19.8 mt -128.68 159.13 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.569 -0.287 . . . . 0.96999999999999997 111.026 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.9 t -116.6 121.13 66.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.656 -0.498 . . . . 1.02 109.656 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.435 ' SG ' ' HE2' ' A' ' 178' ' ' PHE . 4.6 p -118.51 -30.52 5.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.113 0.412 . . . . 0.57999999999999996 112.113 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.62 108.47 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.692 0.282 . . . . 0.58999999999999997 111.013 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.6 tt -110.28 -54.87 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.56 162.2 54.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.04 0.385 . . . . 0.33000000000000002 112.04 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.33 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.013 2.475 . . . . 0.37 111.334 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 65.35 -81.15 0.08 OUTLIER Glycine 0 C--N 1.339 0.703 0 O-C-N 123.463 0.477 . . . . 0.20000000000000001 111.963 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 2.1 p -75.6 17.97 0.26 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.179 0.592 . . . . 0.67000000000000004 111.117 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 217' ' ' GLY . 8.6 p90 -87.76 -16.94 32.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.45000000000000001 109.859 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -69.28 -48.11 62.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 1.8700000000000001 110.549 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.57 -31.02 71.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 1.3600000000000001 110.758 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 46.1 mm -82.8 -42.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.023 -0.535 . . . . 2.25 110.491 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.79 -37.07 68.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.55000000000000004 111.05 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -56.1 -35.21 66.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 1.28 111.758 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.7 pp -94.41 -33.05 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.475 -0.49 . . . . 2.0800000000000001 110.834 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.4 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-N 116.395 -0.366 . . . . 0.52000000000000002 111.418 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -63.53 -22.11 66.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.127 0.417 . . . . 1.55 112.127 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.45 8.65 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 0.46000000000000002 111.167 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.559 ' CD ' ' HZ3' ' A' ' 191' ' ' LYS . 70.1 tt0 -108.96 -83.52 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.126 -0.488 . . . . 1.6699999999999999 110.697 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.1 t -84.38 -30.01 25.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.305 -0.407 . . . . 0.29999999999999999 111.184 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -64.64 -30.89 71.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.992 0.425 . . . . 1.6000000000000001 111.05 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.19 12.56 66.69 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.528 -0.844 . . . . 0.37 112.235 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -123.79 -46.85 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.919 0.39 . . . . 1.46 110.593 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -125.55 -162.25 11.25 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.773 -0.727 . . . . 0.38 112.562 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.94 132.23 56.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.21 -0.292 . . . . 1.5 110.21 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.04 157.29 26.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.057 0.456 . . . . 1.9199999999999999 111.097 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.71 153.39 38.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.597 -0.729 . . . . 0.84999999999999998 109.485 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.77 156.96 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.237 -0.282 . . . . 0.35999999999999999 110.237 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.014 0.435 . . . . 1.1399999999999999 110.695 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.397 0.618 . . . . 1.29 112.567 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -69.79 157.67 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.884 -0.598 . . . . 1.8400000000000001 110.042 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 2.3199999999999998 111.594 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.99 81.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 1.29 111.251 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -153.7 143.67 22.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 1.8700000000000001 109.981 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 17' ' ' VAL . 82.0 mt -67.25 -13.15 61.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.1400000000000001 111.147 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -87.35 4.11 44.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.48999999999999999 110.849 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -139.29 35.91 2.08 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.463 0.649 . . . . 0.39000000000000001 110.321 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 14' ' ' LEU . 20.3 m -106.41 156.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.20999999999999999 111.633 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.85 137.67 46.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.5 109.958 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 t -78.98 108.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.932 0.396 . . . . 0.55000000000000004 110.722 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.11 129.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.922 -0.581 . . . . 0.93000000000000005 109.925 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.0 144.11 30.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.953 0.406 . . . . 1.3400000000000001 111.34 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.93 127.29 43.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.671 -0.695 . . . . 0.94999999999999996 109.819 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.97 118.51 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.014 0.435 . . . . 1.0600000000000001 110.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 9.8 mmm180 -92.72 -155.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.906 -0.588 . . . . 2.3599999999999999 109.99 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.96 -54.08 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.60999999999999999 110.986 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.53 -34.4 1.09 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.431 -0.89 . . . . 0.20999999999999999 112.48 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 29.1 tptt -97.77 158.94 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.933 0.397 . . . . 1.72 110.496 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 152.76 38.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.168 -0.678 . . . . 0.91000000000000003 109.168 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.02 140.35 38.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.034 0.445 . . . . 0.34000000000000002 111.213 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -130.4 130.19 44.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 1.1000000000000001 109.717 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -174.49 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.136 0.493 . . . . 1.0800000000000001 111.361 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.54 103.04 4.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.27000000000000002 109.791 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -102.88 -173.22 2.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.96999999999999997 110.11 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.7 150.06 37.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.73 -0.47 . . . . 0.39000000000000001 109.73 178.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -108.61 28.5 8.33 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.428 -0.509 . . . . 1.8700000000000001 110.966 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -103.11 81.78 2.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.54000000000000004 109.919 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt 57.86 49.4 12.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.984 -0.553 . . . . 1.45 110.948 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.23 -23.73 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.762 -0.654 . . . . 0.28000000000000003 111.802 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.98 -4.43 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.207 0.527 . . . . 0.27000000000000002 110.626 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.10000000000000001 112.642 -179.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 110.561 -0.162 . . . . 0.84999999999999998 110.561 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.25 148.6 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.644 0.259 . . . . 0.71999999999999997 110.528 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.24 -31.01 72.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.482 . . . . 0.83999999999999997 111.654 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.95 -32.49 72.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.53000000000000003 110.628 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.99 -19.76 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.083 0.468 . . . . 1.8 110.407 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.497 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 66.9 t -74.34 -43.74 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.731 -0.668 . . . . 1.03 109.57 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.05 99.25 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.435 -0.802 . . . . 1.8700000000000001 111.138 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 34' ' ' TYR . 14.6 mt-30 -84.13 -65.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.5 109.975 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 t -97.16 130.64 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.192 -0.458 . . . . 1.1200000000000001 110.183 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.37 -5.66 59.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.132 -0.485 . . . . 1.47 110.668 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -96.39 116.13 28.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.523 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.44 146.4 9.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.925 -0.58 . . . . 0.17000000000000001 109.624 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -102.0 154.38 19.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.32000000000000001 111.126 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.78 -31.4 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.20000000000000001 109.485 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.2 91.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.069 -0.969 . . . . 0.70999999999999996 109.218 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.05 -28.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.465 -0.334 . . . . 0.28000000000000003 111.826 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -34.43 77.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.876 0.37 . . . . 0.63 111.158 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -106.52 10.9 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 3.0800000000000001 111.031 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.36 28.62 71.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.876 -0.678 . . . . 0.47999999999999998 112.468 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.33 110.83 14.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.571 0.224 . . . . 2.2799999999999998 110.44 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.81 133.81 52.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.999 -0.546 . . . . 1.02 110.444 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 116.33 32.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.023 0.439 . . . . 0.84999999999999998 109.951 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -87.53 -179.52 6.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.87 -0.605 . . . . 2.2400000000000002 110.105 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -57.57 -32.95 67.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 1.47 111.271 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -87.57 7.88 27.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.182 -0.463 . . . . 0.67000000000000004 111.29 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.81 -48.77 3.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.81999999999999995 110.081 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.93 -31.92 73.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.999 -0.546 . . . . 0.48999999999999999 110.212 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -28.14 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.28999999999999998 110.348 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -92.46 -8.43 44.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.235 0.541 . . . . 1.4099999999999999 110.965 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.65 -58.83 2.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.27000000000000002 110.97 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -89.69 -34.88 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.396 -0.365 . . . . 0.98999999999999999 110.833 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.09 30.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.524 -0.846 . . . . 0.35999999999999999 112.283 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -134.23 136.4 43.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.005 -0.369 . . . . 0.85999999999999999 110.005 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.74 -12.93 57.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.64000000000000001 110.748 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.16 102.66 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.54000000000000004 110.396 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.48 -23.65 66.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.89 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.4 88.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.864 -0.607 . . . . 0.53000000000000003 110.734 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.45 -34.93 79.45 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.854 0.359 . . . . 0.33000000000000002 110.234 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.3 -51.68 69.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.392 -0.596 . . . . 0.28999999999999998 109.392 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 54.0 t -64.63 -32.55 74.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.457 -0.792 . . . . 0.17000000000000001 110.374 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -57.63 -51.98 67.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.931 -0.577 . . . . 1.6299999999999999 110.838 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -63.59 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.549 . . . . 0.34999999999999998 111.177 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.8 mt -66.98 -24.69 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.107 0.48 . . . . 1.02 111.48 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -80.21 -33.26 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.735 0.303 . . . . 0.29999999999999999 111.582 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.425 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.2 t -97.83 -22.65 16.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.789 0.663 . . . . 1.1000000000000001 112.789 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HG2' HG23 ' A' ' 91' ' ' THR . 14.3 mmmm -115.22 -2.97 12.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.579 -0.448 . . . . 0.73999999999999999 111.761 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.42 -176.69 21.32 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.517 -0.849 . . . . 0.52000000000000002 112.291 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -108.15 107.84 18.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 1.3200000000000001 110.409 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.61 142.14 24.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.431 -0.804 . . . . 0.23000000000000001 110.186 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 99.82 0.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.239 0.542 . . . . 0.88 110.596 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.747 -0.66 . . . . 0.51000000000000001 111.691 -178.906 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 143' ' ' HIS . 18.1 tt . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.864 0.364 . . . . 0.47999999999999998 110.23 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 142' ' ' ILE . 60.5 m-70 72.68 90.7 0.09 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.379 -0.828 . . . . 0.41999999999999998 111.488 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -75.72 95.79 3.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.863 -1.062 . . . . 1.04 110.239 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -155.36 74.69 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.902 -0.59 . . . . 0.71999999999999997 109.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.8 67.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.69999999999999996 110.776 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 149' ' ' ASN . 16.3 mtpt 55.0 79.27 0.15 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.698 -0.683 . . . . 0.46000000000000002 111.244 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.64 17.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 1.3799999999999999 111.999 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 147' ' ' LYS . 4.5 t-20 -68.8 -62.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.211 -0.449 . . . . 0.64000000000000001 109.824 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.52 138.55 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.746 -0.661 . . . . 0.91000000000000003 109.847 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -163.42 -158.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.668 -0.493 . . . . 1.6000000000000001 109.668 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.91 95.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.535 0.334 . . . . 0.44 111.853 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 53.72 42.99 31.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.752 -0.658 . . . . 0.83999999999999997 110.553 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 60.72 66.95 0.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.163 -0.926 . . . . 0.90000000000000002 111.46 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.602 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 0.4 OUTLIER 55.9 31.03 17.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.151 -0.931 . . . . 0.87 113.13 178.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.02 63.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.179 0.514 . . . . 0.34999999999999998 110.613 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -29.66 42.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.363 0.601 . . . . 1.28 110.237 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.602 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.4 mp0 -68.54 -41.75 79.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.97999999999999998 111.379 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.26 -30.29 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.48 111.48 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.69 -39.66 86.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.021 0.439 . . . . 0.44 110.704 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.16 -5.5 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 1.49 111.033 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.58 -70.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 1.8200000000000001 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.494 HD11 ' H ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -70.88 -11.08 60.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.28 -0.418 . . . . 2.4199999999999999 111.397 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -61.55 -34.64 75.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.164 0.507 . . . . 1.6000000000000001 110.255 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -87.79 23.7 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.759 -0.655 . . . . 0.59999999999999998 110.815 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -138.73 -52.98 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.937 -0.574 . . . . 1.0700000000000001 110.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.1 ttm -139.7 151.16 45.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.019 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -71.59 131.91 43.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 1.3999999999999999 110.467 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.76000000000000001 110.344 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.904 0.383 . . . . 1.3500000000000001 111.136 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -83.49 143.64 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 2.1000000000000001 110.533 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.8 mp -126.55 161.94 26.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.208 -0.451 . . . . 1.0800000000000001 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.519 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 15.8 ptt180 -127.09 154.93 44.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.2 -0.454 . . . . 0.34999999999999998 110.156 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 63.2 t80 -120.98 131.26 54.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.439 -0.346 . . . . 0.34999999999999998 110.217 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.91 133.36 66.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.463 0.173 . . . . 0.73999999999999999 111.358 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 178' ' ' PHE . 1.0 OUTLIER -171.37 161.1 5.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.688 -0.233 . . . . 0.33000000000000002 110.518 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.22 155.77 66.7 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.23 . . . . 0.17000000000000001 112.476 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.05 -33.94 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.995 -0.548 . . . . 0.80000000000000004 111.749 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -48.79 -48.81 40.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.221 -0.445 . . . . 2.4900000000000002 111.725 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -95.77 -28.15 14.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.857 0.36 . . . . 0.53000000000000003 110.946 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.11 -32.06 81.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.012 -0.613 . . . . 0.27000000000000002 112.779 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.5 71.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.73 0.3 . . . . 1.55 111.405 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.11 -46.47 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.94999999999999996 111.189 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -17.53 39.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.68000000000000005 111.175 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -57.24 -44.59 83.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.5600000000000001 110.588 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.72 17.12 5.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.46000000000000002 111.485 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -129.08 -39.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 1.1100000000000001 111.662 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.62 -42.57 24.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 1.2 111.758 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 30.0 mtpp -62.63 -48.0 87.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.743 0.646 . . . . 1.46 112.743 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.2 Cg_endo -59.47 -8.61 7.26 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.583 2.189 . . . . 0.059999999999999998 113.837 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.37 -14.83 60.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.34999999999999998 110.121 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.6 mm 59.56 32.88 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.835 0.826 . . . . 0.20000000000000001 110.273 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -125.89 23.01 7.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.656 -0.702 . . . . 0.91000000000000003 110.322 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.5 m -103.26 134.63 43.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.17999999999999999 110.439 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -84.68 147.93 5.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.279 -0.419 . . . . 1.6399999999999999 109.979 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 63.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 1.5900000000000001 111.42 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 m -140.22 21.53 2.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.277 -0.638 . . . . 1.51 109.277 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.53 140.77 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.648 -0.706 . . . . 1.78 111.263 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.42 105.2 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.42 -0.585 . . . . 0.65000000000000002 109.42 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.61 102.04 13.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.022 -0.536 . . . . 1.73 110.723 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -169.11 -150.06 6.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.983 -0.627 . . . . 0.63 111.826 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.09 -31.31 72.45 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.028 0.442 . . . . 1.8899999999999999 110.604 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.411 ' NE2' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -117.45 109.42 16.75 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.759 . . . . 1.29 108.952 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.3 99.78 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.074 -0.512 . . . . 1.1100000000000001 110.599 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.2 tt0 -100.98 109.41 21.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.34999999999999998 109.614 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 210' ' ' ILE . 66.3 mt -117.26 134.83 59.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.306 -0.407 . . . . 1.21 110.576 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.61 105.9 18.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.23999999999999999 109.925 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 8.4 t -130.78 96.58 4.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.35999999999999999 110.368 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 132.87 11.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.306 -0.628 . . . . 1.1699999999999999 109.306 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -122.88 171.16 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.517 -0.31 . . . . 0.39000000000000001 110.28 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.59 171.0 3.15 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.005 0.522 . . . . 0.56000000000000005 111.091 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.33 -163.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.394 2.062 . . . . 0.81000000000000005 113.105 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 82.81 -95.68 1.83 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.507 -0.854 . . . . 0.40999999999999998 111.092 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.8 m -80.77 17.94 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.537 . . . . 0.67000000000000004 110.445 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 217' ' ' GLY . 15.7 p90 -68.84 -23.1 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.592 . . . . 0.28999999999999998 111.599 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.1 -45.48 63.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.026 0.441 . . . . 1.6200000000000001 110.201 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -62.49 -20.7 64.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.418 -0.81 . . . . 1.96 112.356 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.4 tt -98.57 -43.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.454 -0.499 . . . . 1.24 111.11 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.07 -32.76 74.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.74 0.274 . . . . 0.37 111.74 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.46 -25.06 61.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.428 -0.351 . . . . 0.97999999999999998 111.553 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.3 pp -101.27 -28.79 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.005 0.431 . . . . 0.51000000000000001 110.109 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.4 mm -64.51 -33.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.23999999999999999 111.0 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 11.4 ptmt -60.48 -26.25 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.84 0.682 . . . . 1.9399999999999999 112.84 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -111.45 -20.57 12.17 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.48 -0.488 . . . . 0.94999999999999996 112.094 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.25 -46.67 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.39000000000000001 111.55 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -113.42 -56.14 2.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.173 0.434 . . . . 0.77000000000000002 112.173 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 49.4 mtmt -64.69 -7.7 11.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.89000000000000001 111.825 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.33 16.66 32.01 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.975 -0.631 . . . . 0.28000000000000003 111.648 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -128.51 -56.12 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.643 0.258 . . . . 1.4399999999999999 111.527 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -123.02 -139.21 5.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.326 -0.94 . . . . 0.57999999999999996 113.369 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 73.3 m -121.51 141.62 50.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.54000000000000004 111.431 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 150.21 29.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.398 -0.819 . . . . 0.29999999999999999 109.997 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.95 161.57 39.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 0.26000000000000001 109.916 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.17 153.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.317 . . . . 1.1299999999999999 110.647 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.8 tp . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.44 109.861 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.428 HG22 ' OH ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.783 -0.451 . . . . 0.93999999999999995 109.783 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -161.49 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.233 -0.187 . . . . 1.3400000000000001 111.115 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -124.55 -59.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.993 0.425 . . . . 1.9099999999999999 110.351 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.407 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 5.0 mt -128.51 102.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.95999999999999996 109.73 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -134.16 127.21 31.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.154 -0.475 . . . . 1.8 110.802 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.98 -10.02 59.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.361 0.601 . . . . 0.65000000000000002 110.437 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.3 -15.47 50.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.89000000000000001 111.275 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -125.72 40.36 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.17000000000000001 111.679 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.12 147.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.97 0.414 . . . . 0.23000000000000001 110.636 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.82 144.46 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.14999999999999999 110.536 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.32 126.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 0.27000000000000002 110.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.63 115.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.666 -0.697 . . . . 0.41999999999999998 109.58 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -119.27 132.83 55.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.311 -0.404 . . . . 1.29 111.432 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.7 ttp -87.58 132.31 34.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.938 -0.574 . . . . 1.1699999999999999 110.201 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 118.57 37.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.315 -0.402 . . . . 1.0700000000000001 110.618 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 32.9 mmt180 -120.57 -177.5 3.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.39000000000000001 110.323 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.14 81.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.366 0.506 . . . . 0.32000000000000001 112.366 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.3 29.72 2.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.391 -0.909 . . . . 0.38 112.339 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 31.3 tptt -150.35 148.82 29.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.59 -0.522 . . . . 1.6899999999999999 109.59 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.41 30.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.527 -0.546 . . . . 1.1399999999999999 109.527 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -134.29 144.55 48.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.38 110.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -142.94 137.3 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.32 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.85 167.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.682 -0.488 . . . . 0.38 109.682 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 110.61 20.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.81000000000000005 111.824 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -108.74 164.6 12.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.914 -0.585 . . . . 0.19 109.943 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.428 ' OH ' HG22 ' A' ' 9' ' ' THR . 0.1 OUTLIER -66.94 138.05 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.639 -0.255 . . . . 0.25 110.361 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -0.68 23.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 1.26 111.442 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.41 71.38 1.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.63 111.162 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.66 66.07 1.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.356 0.662 . . . . 2.4199999999999999 111.368 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -69.49 -30.25 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.96999999999999997 110.876 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -87.31 5.62 3.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.514 0.673 . . . . 0.39000000000000001 110.327 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.458 -0.792 . . . . 0.28999999999999998 112.523 -179.53 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.394 0.616 . . . . 1.1599999999999999 112.647 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' OD2' HD21 ' A' ' 49' ' ' LEU . 17.2 t70 -75.72 160.78 29.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.069 -0.969 . . . . 0.25 110.513 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.535 ' H ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.71 -19.83 60.09 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.78 0.289 . . . . 0.37 111.78 -179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.69 -38.4 64.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.172 0.511 . . . . 0.27000000000000002 109.974 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.57 -32.78 62.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.47 -0.786 . . . . 1.21 111.049 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.96 -17.13 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.312 . . . . 1.05 111.413 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.79 111.15 13.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 1.47 110.168 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 12' ' ' ILE . 11.5 mm-40 -85.29 -78.65 0.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.938 -0.574 . . . . 0.91000000000000003 110.449 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -75.4 117.97 17.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.948 -0.569 . . . . 1.72 110.783 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -86.86 31.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.813 -0.63 . . . . 0.82999999999999996 111.167 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 m -125.67 140.83 52.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.67 -0.493 . . . . 0.79000000000000004 109.67 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.11 142.36 31.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 1.05 110.29 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.3 161.21 16.49 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.013 0.375 . . . . 0.35999999999999999 112.013 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.483 ' CG2' ' HB1' ' A' ' 68' ' ' ALA . 61.1 t -123.96 -55.07 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.792 -0.64 . . . . 0.39000000000000001 109.329 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.08 101.89 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 1.8400000000000001 109.662 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.33 -37.19 79.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.67000000000000004 111.827 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.16 6.45 6.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.37 0.507 . . . . 0.55000000000000004 112.37 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -135.15 -5.37 2.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.849 0.357 . . . . 1.4399999999999999 110.848 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.97 61.63 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.893 -0.67 . . . . 0.35999999999999999 111.819 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.39 113.1 24.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.03 0.443 . . . . 0.66000000000000003 110.929 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.46 128.87 76.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.649 -0.705 . . . . 0.55000000000000004 109.245 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.483 ' HB1' ' CG2' ' A' ' 60' ' ' VAL . . . -84.67 117.63 23.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 111.267 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.87 -174.52 4.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.16 -0.473 . . . . 1.4299999999999999 110.017 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -55.76 -33.04 63.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.46 0.541 . . . . 2.75 112.46 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -82.13 -7.59 59.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.814 0.34 . . . . 1.8100000000000001 111.792 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.38 -49.51 3.55 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.805 -0.358 . . . . 1.78 111.217 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.44 -29.28 68.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.929 0.395 . . . . 0.27000000000000002 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.99 -25.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.898 -0.592 . . . . 1.3999999999999999 110.463 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -97.33 -26.59 14.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.31 111.001 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.77 -39.46 30.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.122 -0.49 . . . . 0.52000000000000002 112.093 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.54 -16.49 13.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.004 -0.278 . . . . 1.4099999999999999 111.45 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.37 79.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.48999999999999999 112.29 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.42 136.97 47.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.568 0.223 . . . . 1.45 110.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -90.55 -23.47 20.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.401 0.619 . . . . 0.58999999999999997 109.899 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.83 103.44 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.81999999999999995 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.87 -31.28 71.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.162 0.506 . . . . 0.40000000000000002 109.951 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -61.02 -29.06 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.59999999999999998 110.282 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.81 -39.33 24.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.805 -0.442 . . . . 0.34000000000000002 109.805 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.12 -50.19 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.23999999999999999 109.441 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.7 t -61.53 -38.72 88.44 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.20999999999999999 110.61 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.73 -41.96 96.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 3.3500000000000001 110.292 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -65.49 -40.67 93.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.78000000000000003 110.786 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.485 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 70.9 mt -71.19 -21.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.47999999999999998 110.907 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -45.88 10.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.451 -0.341 . . . . 0.98999999999999999 111.575 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -83.0 -21.35 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.362 0.505 . . . . 1.8899999999999999 112.362 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.65 31.89 4.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 2.2799999999999998 110.723 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 89' ' ' ILE . . . -128.34 179.76 16.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.498 -0.858 . . . . 0.14999999999999999 112.442 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.85 93.31 5.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.703 0.287 . . . . 0.81000000000000005 110.644 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 p -98.3 134.76 35.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.83999999999999997 109.909 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.62 75.62 2.01 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.206 0.527 . . . . 0.98999999999999999 112.261 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.68999999999999995 110.437 179.523 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 122.632 1.206 . . . . 0.48999999999999999 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -110.84 -5.63 14.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.595 -1.184 . . . . 0.31 110.53 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.73 115.34 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.507 0.558 . . . . 1.3300000000000001 112.507 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 63.9 m 56.11 39.96 30.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.475 -0.784 . . . . 1.1699999999999999 112.796 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.36 -66.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 110.34 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -96.6 -55.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.098 0.475 . . . . 2.3100000000000001 109.799 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.5 25.44 14.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.523 -0.762 . . . . 0.88 111.063 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 57.12 38.08 28.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.721 -0.672 . . . . 0.66000000000000003 110.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -89.68 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 1.6899999999999999 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -149.28 161.44 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.448 . . . . 0.93999999999999995 111.264 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -106.02 -34.04 7.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 1.6499999999999999 110.862 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -88.96 -50.47 6.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 1.0800000000000001 111.418 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -69.14 -14.97 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 1.0 111.559 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.1 mt-30 -112.43 7.48 19.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.629 -0.259 . . . . 0.44 110.912 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.63 72.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.347 . . . . 0.33000000000000002 111.133 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.65 -35.67 80.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.51 . . . . 1.79 111.227 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.95 -46.93 85.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 0.60999999999999999 111.116 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 155' ' ' GLN . 59.3 t -67.04 -48.57 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.34999999999999998 112.112 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -61.23 -35.16 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 1.1399999999999999 111.729 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.39 -32.55 54.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.737 0.303 . . . . 2.9199999999999999 110.592 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.87 -37.96 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.84999999999999998 110.098 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.07 -36.92 85.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 1.98 110.036 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 167' ' ' MET . 31.0 tttm -69.31 -12.53 61.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.444 -0.798 . . . . 1.74 111.396 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.3 -32.05 55.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.51 . . . . 0.57999999999999996 109.693 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -89.26 -44.45 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 1.8600000000000001 111.097 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 38.4 mtm -128.75 139.04 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 3.21 110.655 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -89.15 85.83 6.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.538 -0.541 . . . . 1.21 109.538 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 167' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 1.27 112.138 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 39.8 mtt . . . . . 0 C--O 1.234 0.272 0 N-CA-C 110.184 -0.302 . . . . 2.2000000000000002 110.184 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 175' ' ' ARG . 4.6 mpt_? -124.43 128.24 48.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.478 -0.328 . . . . 1.9299999999999999 110.353 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -128.61 145.12 51.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.616 -0.513 . . . . 0.28999999999999998 109.616 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -126.18 147.91 49.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.783 0.325 . . . . 0.40000000000000002 110.629 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.04 143.46 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.891 -0.595 . . . . 0.56000000000000005 110.244 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.7 tt -133.4 117.72 28.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.449 0.642 . . . . 0.28000000000000003 110.508 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.416 HD21 HD22 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -149.79 156.44 38.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.385 -0.825 . . . . 0.14000000000000001 109.936 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.72 166.06 14.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 0.14000000000000001 112.546 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.5 t -50.44 -39.89 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.922 -0.581 . . . . 0.23000000000000001 111.962 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -51.33 -53.68 33.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.324 -0.398 . . . . 0.28000000000000003 111.46 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -29.9 31.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.138 -0.483 . . . . 2.0800000000000001 110.883 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.37 94.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.639 -0.71 . . . . 0.28999999999999998 113.084 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.64 -35.9 71.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.891 0.377 . . . . 1.97 111.351 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -76.6 -44.6 33.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.235 -0.439 . . . . 1.1100000000000001 111.814 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.416 HD22 HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -72.2 -32.33 66.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.772 0.32 . . . . 1.01 111.669 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -59.68 -50.55 73.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 1.28 111.435 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -80.34 18.28 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.44 112.119 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -124.29 -49.44 1.81 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.855 -0.338 . . . . 1.8100000000000001 111.648 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.1 -36.58 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.188 0.44 . . . . 2.5 112.188 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 26.5 mtpp -61.39 -52.45 70.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.558 0.577 . . . . 1.3300000000000001 112.558 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.1 Cg_endo -66.09 -14.01 42.46 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.028 1.819 . . . . 0.35999999999999999 112.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 1.0900000000000001 110.312 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mt 62.62 38.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.559 -0.746 . . . . 0.44 111.043 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -120.84 14.23 11.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 1.6899999999999999 110.465 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.86 149.46 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.978 -0.555 . . . . 0.31 111.02 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.5 mt -101.25 155.61 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.685 . . . . 0.46999999999999997 109.744 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.93 64.19 0.5 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.931 0.396 . . . . 1.6399999999999999 111.1 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.4 m -149.4 31.01 0.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 1.51 110.302 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -81.74 146.88 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.736 -0.665 . . . . 1.5 111.161 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -118.9 133.49 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.834 -0.802 . . . . 1.22 108.834 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.31 111.34 19.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.156 0.503 . . . . 1.0700000000000001 111.395 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -166.93 -131.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.255 -0.738 . . . . 0.14000000000000001 111.255 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.64 -28.32 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.619 0.723 . . . . 0.71999999999999997 109.301 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -119.31 142.87 47.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.811 -1.086 . . . . 1.3200000000000001 109.614 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.28 89.66 5.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.684 -0.487 . . . . 0.16 109.684 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.15 98.41 8.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.398 -0.593 . . . . 0.55000000000000004 109.398 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.9 mm -112.59 134.89 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.44 110.827 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.35 112.57 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.33000000000000002 109.981 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.98 94.41 3.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.943 0.401 . . . . 0.60999999999999999 110.83 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.02 95.83 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.084 -0.507 . . . . 1.0600000000000001 109.845 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.496 HG12 ' H ' ' A' ' 215' ' ' ASP . 9.8 tt -94.23 179.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 1.78 110.061 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.496 ' H ' HG12 ' A' ' 214' ' ' ILE . 4.4 m-20 -67.0 152.85 95.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 111.896 0.332 . . . . 1.0800000000000001 111.896 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.88 166.57 11.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.751 2.301 . . . . 0.26000000000000001 112.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 91.11 -75.98 1.53 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.363 -1.095 . . . . 0.34000000000000002 110.363 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -28.41 64.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.258 0.551 . . . . 0.42999999999999999 109.642 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.88 -26.12 68.19 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.521 -0.763 . . . . 0.34000000000000002 110.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -17.66 64.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.845 0.355 . . . . 1.47 111.383 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -84.17 -50.37 7.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.906 0.384 . . . . 0.69999999999999996 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.695 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 15.1 tt -72.87 -28.05 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.78000000000000003 111.395 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.457 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 4.0 t70 -55.35 -33.02 63.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.863 0.363 . . . . 1.1499999999999999 111.143 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.76 -32.69 67.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.885 -0.598 . . . . 0.46000000000000002 111.733 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 3.0 pp -92.78 -32.99 14.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.545 -0.462 . . . . 1.51 109.862 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 26.9 mm -55.64 -43.37 72.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.279 -0.419 . . . . 1.1699999999999999 111.474 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 12.7 ptpt -61.95 -17.68 57.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.173 0.805 . . . . 0.62 113.173 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -119.92 -16.83 8.61 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.874 -0.516 . . . . 0.72999999999999998 111.515 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 3.1 tp10 -79.95 -39.28 30.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.449 . . . . 1.25 111.15 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 t -136.47 -36.23 0.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.284 0.475 . . . . 1.6699999999999999 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 23.9 tptp -55.96 -46.49 78.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 111.054 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.07 28.22 13.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.65000000000000002 111.958 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -132.85 -46.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 2.54 110.839 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -130.44 -153.4 7.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.034 -0.603 . . . . 0.31 111.976 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.5 m -124.18 156.66 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.626 0.251 . . . . 0.65000000000000002 110.518 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.67 165.65 18.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.714 0.292 . . . . 1.7 111.043 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -151.64 152.85 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.6100000000000001 110.051 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.9 141.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.056 0.455 . . . . 0.20999999999999999 111.181 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.253 -0.43 . . . . 1.05 110.44 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.366 0.603 . . . . 1.28 111.464 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -80.33 161.36 25.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.807 -0.633 . . . . 1.76 109.894 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -58.53 -40.11 82.02 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.974 0.416 . . . . 0.67000000000000004 110.405 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mt -119.95 95.32 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 1.6200000000000001 109.632 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -159.27 137.99 10.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.832 -0.622 . . . . 2.8700000000000001 110.21 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.81 37.03 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.52000000000000002 111.006 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.8 p -106.67 -28.58 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.32000000000000001 110.633 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 12.6 m120 -126.26 50.41 1.9 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.78000000000000003 110.26 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 m -92.6 155.33 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.20999999999999999 111.073 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.62 134.03 55.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 0.12 109.688 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.55 127.12 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 0.12 110.889 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 2.7 p -140.59 118.98 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 0.93000000000000005 109.648 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -123.56 132.9 54.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.243 0.544 . . . . 1.1399999999999999 112.047 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.53 159.56 18.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.835 -0.62 . . . . 1.1100000000000001 110.063 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -121.06 115.85 23.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.582 -0.281 . . . . 1.8899999999999999 110.637 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 16.2 mmm180 -99.39 55.39 0.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.731 0.301 . . . . 2.3599999999999999 110.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.24 34.28 20.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.586 -0.734 . . . . 0.45000000000000001 111.778 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.78 -62.92 0.42 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.331 -0.708 . . . . 0.33000000000000002 111.331 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -74.35 145.73 43.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.69 -0.485 . . . . 1.77 109.69 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 28' ' ' ARG . 5.2 mmt180 -109.82 140.26 43.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.271 -0.27 . . . . 0.83999999999999997 110.271 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -134.34 118.61 17.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.361 -0.381 . . . . 1.24 110.158 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -135.87 146.21 47.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.757 0.313 . . . . 1.0900000000000001 110.333 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -132.24 179.26 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.778 -0.646 . . . . 0.14999999999999999 110.26 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.2 106.9 9.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.105 0.479 . . . . 0.12 110.659 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 m -103.58 171.09 7.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.696 -0.683 . . . . 1.1899999999999999 109.416 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' ASN . 11.2 t80 -88.26 154.58 20.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.873 0.368 . . . . 1.05 110.485 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -78.34 31.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 1.52 110.832 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 34' ' ' TYR . 12.9 t30 -85.92 43.34 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.057 -0.519 . . . . 2.4100000000000001 110.56 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt 61.1 46.76 7.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.636 -0.711 . . . . 0.46000000000000002 110.84 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.02 -23.94 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.008 -0.542 . . . . 0.93000000000000005 111.364 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.46 -31.38 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.477 -0.329 . . . . 0.94999999999999996 110.503 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 121.118 -0.563 . . . . 0.29999999999999999 112.571 -179.589 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 109.506 -0.553 . . . . 1.04 109.506 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.55 167.53 10.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.926 -0.398 . . . . 0.56000000000000005 109.926 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.6 tp -104.05 6.79 36.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.457 0.54 . . . . 0.62 112.457 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.77 -44.42 7.09 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.421 -0.512 . . . . 1.21 110.486 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.91 -27.94 61.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.436 -0.802 . . . . 0.69999999999999996 111.048 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.85 -13.01 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.25 110.533 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.99 107.64 18.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.036 -0.529 . . . . 1.0800000000000001 110.055 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -65.71 -44.33 86.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.642 . . . . 0.35999999999999999 111.316 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 t -142.89 136.12 28.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.058 0.456 . . . . 0.45000000000000001 110.145 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -96.68 25.91 4.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.014 -0.539 . . . . 1.3400000000000001 110.851 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -96.68 88.74 4.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.127 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.02 141.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.104 -0.498 . . . . 0.51000000000000001 109.924 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -90.91 162.42 14.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.28999999999999998 111.797 -178.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.92 -46.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.14999999999999999 109.56 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -154.15 120.11 5.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.11 -0.95 . . . . 0.29999999999999999 108.989 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.03 -27.58 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.067 0.395 . . . . 0.32000000000000001 112.067 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -38.39 87.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.062 0.458 . . . . 0.46999999999999997 110.941 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -99.35 -5.35 29.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 2.0800000000000001 110.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.23 52.23 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.914 -0.66 . . . . 0.34999999999999998 111.881 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -105.81 123.19 47.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.973 0.416 . . . . 1.0700000000000001 110.886 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 59' ' ' PHE . 35.2 t -114.97 130.76 68.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.75 -0.659 . . . . 0.34999999999999998 109.994 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.25 110.82 19.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.95999999999999996 110.459 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -84.8 -171.7 3.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.922 -0.581 . . . . 2.1600000000000001 109.803 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -56.7 -38.92 72.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.179 0.437 . . . . 1.7 112.179 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 8.5 pm0 -81.85 -1.34 47.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.34000000000000002 111.5 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -47.79 4.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.69999999999999996 110.963 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.9 -34.28 77.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.611 -0.268 . . . . 0.27000000000000002 110.966 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.08 -24.84 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.076 0.465 . . . . 2.2200000000000002 110.574 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 m -93.22 -32.53 14.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.205 -0.452 . . . . 0.28999999999999998 110.851 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.31 -54.32 7.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.5 111.716 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.44 -36.02 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.2 -0.455 . . . . 2.9300000000000002 110.948 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.87 -25.04 25.24 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.832 -0.907 . . . . 0.44 110.832 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.92 124.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.279 -0.46 . . . . 1.4199999999999999 110.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -23.8 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.172 0.51 . . . . 1.02 109.876 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.98 104.24 2.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.406 -0.815 . . . . 1.3100000000000001 110.093 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -59.86 -31.92 70.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.69999999999999996 111.643 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -38.72 92.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 1.48 110.211 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.05 -40.06 94.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.115 -0.493 . . . . 1.1299999999999999 109.712 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.98 -50.3 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.60999999999999999 109.555 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.8 m -59.66 -34.85 73.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.262 -0.881 . . . . 0.20000000000000001 110.751 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.84 -44.42 96.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.75 110.922 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -63.26 -40.46 97.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.89000000000000001 110.378 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.1 mt -69.7 -34.31 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.66 . . . . 0.64000000000000001 110.866 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.41 -21.23 49.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.365 . . . . 1.23 111.732 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -97.16 -53.59 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.334 0.494 . . . . 1.78 112.334 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -102.32 20.96 15.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 1.4099999999999999 111.373 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.27 165.41 12.8 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.677 -0.773 . . . . 0.28999999999999998 112.173 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.2 tt0 -87.58 102.69 14.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.014 -0.365 . . . . 1.8899999999999999 110.014 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 p -106.29 126.02 61.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 1.01 110.449 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -79.68 88.4 5.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.925 -0.579 . . . . 3.0899999999999999 111.139 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 1.1599999999999999 110.744 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.519 0.2 . . . . 0.26000000000000001 110.95 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 58.05 67.25 0.98 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.889 -0.596 . . . . 0.23999999999999999 110.201 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.69 120.15 31.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 1.3 110.737 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 m -86.11 153.41 22.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.57999999999999996 110.406 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 t -110.31 -80.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.64 0.257 . . . . 0.67000000000000004 110.723 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.62 160.0 30.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.763 0.316 . . . . 1.27 110.39 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 2.25 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 0.80000000000000004 111.138 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.5 -23.89 61.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.55000000000000004 111.344 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . 45.6 mttm 63.02 36.01 12.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.143 0.497 . . . . 2.54 110.995 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.9 132.35 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.39000000000000001 111.951 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.9 m 52.71 84.18 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.251 0.621 . . . . 0.66000000000000003 112.52 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp 52.47 38.24 24.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 1.8 111.58 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.668 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 6.1 tt0 58.85 59.62 2.77 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.049 -0.523 . . . . 1.21 110.703 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.668 ' HG2' ' O ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 46.32 42.09 9.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.207 1.003 . . . . 1.1499999999999999 112.07 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.66 72.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.96999999999999997 110.67 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -67.38 -31.11 71.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 1.6899999999999999 110.698 179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -71.67 -29.11 64.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.923 -0.399 . . . . 0.52000000000000002 109.923 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.54 -37.56 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.862 -0.792 . . . . 0.17999999999999999 108.862 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.2 -40.7 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.184 -0.916 . . . . 0.96999999999999997 109.567 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.1 mmtp -66.95 -39.32 87.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 1.6599999999999999 110.11 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -58.29 -40.76 82.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.737 -0.665 . . . . 2.0499999999999998 110.529 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.65 -46.65 86.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.29999999999999999 110.108 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -62.45 -36.65 83.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 1.1799999999999999 111.414 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 47.9 mm-40 -62.65 -35.53 79.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.411 -0.358 . . . . 0.44 111.431 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -92.25 -41.52 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.31 -0.405 . . . . 1.01 111.089 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.69 106.55 8.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.182 -0.463 . . . . 1.6799999999999999 109.868 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -75.1 101.74 4.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 1.9399999999999999 110.977 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.766 -0.652 . . . . 1.2 110.729 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.677 0.275 . . . . 1.5 110.569 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.44 133.65 55.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.482 . . . . 0.81999999999999995 110.282 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.44 141.38 48.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.237 -0.438 . . . . 0.33000000000000002 110.274 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.59 139.66 46.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.128 0.489 . . . . 1.3300000000000001 110.962 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 90.4 t80 -113.93 143.28 44.97 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.161 -0.681 . . . . 0.27000000000000002 109.161 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.6 131.56 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.427 0.528 . . . . 0.46000000000000002 112.427 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.433 HD21 ' HD2' ' A' ' 181' ' ' PRO . 7.0 mt -160.61 139.57 7.74 Favored Pre-proline 0 C--N 1.333 -0.112 0 CA-C-N 115.625 -0.716 . . . . 2.1099999999999999 109.649 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.433 ' HD2' HD21 ' A' ' 180' ' ' LEU . 21.3 Cg_endo -62.09 156.03 52.4 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.571 2.181 . . . . 0.20999999999999999 111.674 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.0 t -49.73 -37.05 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.744 0.418 . . . . 0.19 111.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -46.78 -47.08 20.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.27 111.451 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.31 -28.59 12.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.33000000000000002 110.588 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.87 64.89 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.009 -0.541 . . . . 0.19 113.233 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -27.73 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.656 0.243 . . . . 1.4099999999999999 111.656 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -76.18 -46.58 27.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.577 0.227 . . . . 1.6499999999999999 111.184 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -25.11 59.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.514 -0.312 . . . . 2.04 111.155 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -59.33 -34.21 72.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 1.4199999999999999 110.919 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.45 6.78 25.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.56 . . . . 1.5 112.187 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 26.6 mtpt -135.38 -28.1 1.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.067 0.766 . . . . 1.75 113.067 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 -56.96 3.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.97 0.414 . . . . 1.8100000000000001 111.349 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 27.1 mtpp -61.1 -52.65 70.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.47 0.915 . . . . 0.28000000000000003 113.47 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 56.3 Cg_endo -68.29 -5.89 16.08 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.191 1.927 . . . . 0.38 114.047 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 191' ' ' LYS . 2.0 mm? -102.52 1.73 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.771 -0.371 . . . . 0.25 110.377 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mt 53.19 45.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.693 0.759 . . . . 0.38 111.23 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -116.91 24.24 11.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 0.37 110.028 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.57 156.72 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.723 -0.671 . . . . 0.28999999999999998 111.341 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.53 145.34 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.95999999999999996 109.072 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 65.99 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.375 0.509 . . . . 0.54000000000000004 112.375 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 m -145.54 36.1 1.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.406 -0.815 . . . . 0.72999999999999998 108.858 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.3 pt-20 -89.87 166.75 13.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.738 -0.665 . . . . 0.55000000000000004 112.25 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.14 118.16 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 1.52 109.6 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.22 45.29 1.25 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.34000000000000002 111.032 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -102.71 -139.58 10.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.725 -0.75 . . . . 0.23000000000000001 112.288 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -78.87 -27.67 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.468 . . . . 1.3400000000000001 110.228 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -120.85 109.53 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.677 -0.692 . . . . 1.51 109.165 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.8 tp -69.83 92.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.89 . . . . 1.99 111.298 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.0 tt0 -94.48 117.46 30.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.028 -0.73 . . . . 0.44 109.028 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 210' ' ' ILE . 8.4 mt -128.18 147.43 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.777 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.33 115.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.507 -0.553 . . . . 0.26000000000000001 109.507 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.4 m -121.4 57.75 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.793 0.33 . . . . 1.4399999999999999 111.722 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.98 127.59 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.715 -0.476 . . . . 0.55000000000000004 109.715 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.71 -51.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.319 -0.4 . . . . 1.47 111.22 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 2.9 p30 -155.54 166.34 16.46 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.725 -0.216 . . . . 1.2 110.639 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 86.2 Cg_endo -80.34 -159.24 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.35 2.034 . . . . 0.58999999999999997 112.754 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.68 -94.14 1.29 Allowed Glycine 0 C--O 1.238 0.392 0 C-N-CA 120.871 -0.681 . . . . 0.35999999999999999 111.621 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.26 -17.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.65000000000000002 110.109 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -55.54 -35.27 65.5 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.314 -0.857 . . . . 0.52000000000000002 110.481 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -25.06 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.6299999999999999 111.563 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -86.06 -45.48 11.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 2.7200000000000002 110.276 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.551 ' O ' HG12 ' A' ' 226' ' ' ILE . 16.3 tt -69.02 -26.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 1.8999999999999999 110.686 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -31.75 72.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.249 -0.432 . . . . 0.23999999999999999 110.196 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.55 -22.96 64.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.678 -0.692 . . . . 1.1699999999999999 110.05 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.8 mt -96.02 -46.61 6.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.525 -0.761 . . . . 0.89000000000000001 109.592 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.5 mm -55.76 -37.96 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.894 -0.594 . . . . 1.1699999999999999 112.326 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -52.64 -31.56 37.47 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.353 0.501 . . . . 1.6399999999999999 112.353 -179.105 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -112.33 -23.93 10.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.82999999999999996 110.711 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 226' ' ' ILE . 1.5 tp10 -62.47 -51.23 68.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.69999999999999996 111.606 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.1 -28.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.432 0.53 . . . . 0.88 112.432 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 32.8 mttt -58.98 -43.88 91.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 1.23 110.97 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.45 39.49 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.646 -0.788 . . . . 0.28000000000000003 112.845 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -151.07 -18.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.888 0.344 . . . . 1.1000000000000001 111.5 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -147.52 -158.17 7.76 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.907 . . . . 0.28000000000000003 112.491 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.5 m -119.11 141.89 48.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.786 0.327 . . . . 0.40999999999999998 110.547 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.32 143.05 51.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 1.0700000000000001 110.639 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 238' ' ' VAL . 2.9 tt0 -134.07 171.17 14.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.638 -0.504 . . . . 1.6699999999999999 109.638 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.47 ' H ' ' HG2' ' A' ' 237' ' ' GLU . 27.6 m -86.08 149.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.795 0.331 . . . . 1.01 110.429 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 109.769 -0.456 . . . . 1.1699999999999999 109.769 179.652 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.69999999999999996 110.5 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 7.0 t-20 -105.99 -175.41 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.954 -0.566 . . . . 0.71999999999999997 109.643 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -77.75 -85.29 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.626 0.25 . . . . 2.7200000000000002 110.926 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mt -91.38 92.41 3.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.302 0.572 . . . . 1.02 110.764 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 68.2 mmt-85 -143.53 133.11 23.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.26 15.45 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.45 -0.341 . . . . 2.46 111.483 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 p -101.56 -3.11 29.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.434 -0.348 . . . . 0.93000000000000005 111.475 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 37.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.18 0.514 . . . . 1.8999999999999999 110.431 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 54' ' ' GLN . 33.9 m -95.53 150.61 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.65000000000000002 111.597 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.9 151.91 25.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.933 -0.576 . . . . 0.47999999999999998 109.582 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 126.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.781 0.324 . . . . 1.0700000000000001 111.013 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.66 116.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.825 -0.805 . . . . 0.37 108.825 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.1 ttp180 -114.89 123.24 48.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.276 -0.42 . . . . 2.1200000000000001 111.705 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.447 ' HA ' ' CA ' ' A' ' 93' ' ' GLY . 51.6 ttp -88.61 131.45 34.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.98999999999999999 110.595 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -101.87 126.32 48.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.469 . . . . 1.77 110.165 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 16.9 mmm180 -122.11 -164.62 1.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.329 -0.249 . . . . 0.69999999999999996 110.329 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.32 -53.88 14.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.16 111.175 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.1 27.58 3.14 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.517 -0.849 . . . . 0.53000000000000003 112.685 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 162.66 41.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.337 . . . . 2.0499999999999998 110.47 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 141.3 23.23 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.329 -0.619 . . . . 1.5700000000000001 109.329 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -136.05 144.44 45.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.556 -0.293 . . . . 0.34000000000000002 110.333 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 1.2 pt-20 -145.6 144.45 30.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.682 0.277 . . . . 1.6799999999999999 110.682 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.3 mt -140.13 144.67 27.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.45000000000000001 109.994 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.77 122.99 28.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.47999999999999998 110.523 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.44 -170.44 2.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.26000000000000001 110.924 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.94 -176.19 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.453 -0.339 . . . . 1.05 110.987 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -76.67 -140.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.431 -0.35 . . . . 2.21 111.858 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -60.54 -6.8 1.78 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.426 0.898 . . . . 0.81999999999999995 113.426 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.97 -2.96 58.84 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.008 -0.433 . . . . 1.51 111.387 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.15 -33.01 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.268 . . . . 0.28999999999999998 111.499 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.05 70.23 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.119 0.961 . . . . 0.38 110.431 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.738 0 CA-C-N 114.807 -1.088 . . . . 0.27000000000000002 112.596 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.495 -0.557 . . . . 2.0499999999999998 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.45 153.67 17.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.257 -0.883 . . . . 0.70999999999999996 108.966 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.03 -27.32 62.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.562 0.22 . . . . 1.03 111.334 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.40999999999999998 111.797 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -87.37 0.15 55.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.8700000000000001 111.791 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.32 -5.54 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.564 0.697 . . . . 0.72999999999999998 110.027 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.24 133.48 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.438 -0.801 . . . . 1.53 109.961 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HG3' HG12 ' A' ' 17' ' ' VAL . 29.0 mm-40 -85.77 -48.88 8.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.099 0.476 . . . . 0.33000000000000002 110.709 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.1 t -119.25 166.68 12.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.891 -0.595 . . . . 1.1299999999999999 109.727 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -121.24 32.54 5.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.272 0.558 . . . . 0.70999999999999996 110.061 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.01 126.36 50.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.79 . . . . 0.55000000000000004 109.447 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -108.86 137.65 39.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.873 0.368 . . . . 0.20000000000000001 110.367 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.95 158.27 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.372 . . . . 0.70999999999999996 111.645 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.18 -56.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.44 109.186 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -137.72 101.13 4.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.255 -0.884 . . . . 0.32000000000000001 109.56 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.71 -30.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.75 110.917 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -70.12 -12.32 61.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.987 0.422 . . . . 0.39000000000000001 111.181 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -121.37 4.71 10.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 1.4099999999999999 110.846 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.82 38.46 94.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.739 -0.743 . . . . 0.40000000000000002 111.351 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -101.77 120.81 40.95 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.14 0.495 . . . . 1.22 111.644 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.9 140.55 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.19 109.919 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.11 127.01 40.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.289 0.566 . . . . 0.83999999999999997 110.834 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -88.86 -178.06 5.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.426 -0.806 . . . . 1.95 109.661 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.67 68.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.102 0.477 . . . . 1.8999999999999999 110.735 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -80.03 -5.31 55.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 2.1899999999999999 111.116 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.27 -46.09 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.334 -0.394 . . . . 0.46999999999999997 111.125 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.82 -28.01 69.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.22 111.149 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.2 tt -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.105 0.478 . . . . 0.33000000000000002 110.596 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -35.75 17.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.54000000000000004 110.841 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.55 -52.66 12.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.701 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -89.65 -66.98 0.87 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.988 0.423 . . . . 1.01 110.927 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.72 -50.82 0.47 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.172 -0.771 . . . . 0.31 111.172 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 148.21 25.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.919 -0.4 . . . . 0.93000000000000005 109.919 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.25 3.82 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 1.23 110.664 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.58 122.92 36.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.207 -0.451 . . . . 1.45 109.962 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -60.33 -27.48 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.527 0.566 . . . . 2.1699999999999999 112.527 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.013 0.435 . . . . 0.80000000000000004 110.605 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.0 -23.16 23.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.1200000000000001 110.275 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -79.54 -55.07 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.28000000000000003 109.975 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 11.7 p -63.98 -24.87 67.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.21 110.721 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 83' ' ' THR . 40.7 ttmt -54.25 -41.75 69.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.645 . . . . 1.5 111.037 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -84.6 -38.19 20.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 1.5600000000000001 110.72 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.47 -34.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.52000000000000002 111.981 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -25.02 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.069 0.766 . . . . 1.0900000000000001 113.069 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.61 -20.74 11.59 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.362 -0.535 . . . . 1.1299999999999999 112.399 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -111.0 12.4 22.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.923 0.392 . . . . 1.3200000000000001 110.57 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 22' ' ' MET . . . -129.11 175.7 18.74 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.663 -0.78 . . . . 0.27000000000000002 112.773 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -91.83 92.84 8.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.991 0.424 . . . . 1.3999999999999999 110.602 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 p -91.66 140.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.869 -0.605 . . . . 0.35999999999999999 109.691 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -69.34 84.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.75 110.837 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.568 -0.742 . . . . 0.55000000000000004 111.544 -179.44 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 121.265 0.555 . . . . 0.67000000000000004 109.728 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -86.16 2.37 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 1.1299999999999999 111.757 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -107.46 121.42 44.58 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.751 -0.38 . . . . 1.4199999999999999 110.038 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 m -51.1 132.65 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.856 0.723 . . . . 0.53000000000000003 111.978 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.93 68.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.995 -0.548 . . . . 1.8999999999999999 110.156 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 61.52 80.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.606 -0.725 . . . . 1.8100000000000001 111.446 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -3.33 16.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.245 0.545 . . . . 1.04 111.153 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -77.82 -15.96 58.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.432 0.635 . . . . 0.32000000000000001 109.56 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -94.65 159.47 15.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.289 -0.869 . . . . 0.77000000000000002 109.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t -71.57 133.49 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.887 0.375 . . . . 0.81999999999999995 110.289 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -26.37 68.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 1.1699999999999999 110.811 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -82.65 -12.31 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 1.8 110.677 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -91.07 -34.75 14.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 2.2000000000000002 110.512 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.423 ' O ' HG23 ' A' ' 159' ' ' VAL . 14.4 mt-30 -110.07 17.13 21.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 2.02 111.564 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.79 72.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.027 0.442 . . . . 0.23999999999999999 111.383 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.34 -46.88 81.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.635 . . . . 1.6200000000000001 110.791 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -59.5 -38.57 81.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.467 . . . . 0.25 111.129 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 155' ' ' GLN . 96.2 t -67.69 -49.72 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.95999999999999996 111.701 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.6 -34.31 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.644 0.239 . . . . 0.39000000000000001 111.644 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -72.43 -40.54 67.02 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.271 -0.27 . . . . 2.3100000000000001 110.271 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -59.04 -40.01 83.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.144 0.497 . . . . 1.23 110.087 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 53.3 tp -70.24 -41.22 73.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.598 -0.728 . . . . 1.5 110.313 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 167' ' ' MET . 59.8 tttm -58.14 -33.8 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.019 -0.537 . . . . 1.6200000000000001 111.568 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.99 -30.56 71.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.765 0.317 . . . . 1.8600000000000001 111.185 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -94.98 -41.86 8.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.37 110.411 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -133.56 119.89 20.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.089 -0.505 . . . . 1.3600000000000001 109.656 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -90.53 109.01 20.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.08 0.467 . . . . 2.71 111.182 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.573 -0.74 . . . . 1.04 110.919 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 112.507 0.558 . . . . 1.9299999999999999 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -140.31 145.71 37.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.026 0.441 . . . . 1.02 111.826 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.38 150.64 50.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.28999999999999998 108.821 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.464 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 23.1 ptt180 -121.72 153.6 38.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.062 0.458 . . . . 0.28000000000000003 110.962 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 31.4 t80 -117.64 128.21 54.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.27000000000000002 109.876 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.52 128.51 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 1.8600000000000001 111.065 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.518 HD23 ' CE2' ' A' ' 178' ' ' PHE . 0.6 OUTLIER -173.18 160.29 3.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.393 -0.595 . . . . 0.93999999999999995 109.393 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.13 147.64 73.49 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.129 1.886 . . . . 0.23000000000000001 111.536 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 72.9 t -61.62 -22.07 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.908 0.385 . . . . 0.44 110.708 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -52.7 -42.55 64.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.1499999999999999 110.541 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.5 -32.78 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.54000000000000004 109.817 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.96 -20.41 64.52 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.614 -0.721 . . . . 0.13 113.347 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.63 -26.54 61.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.95 0.405 . . . . 1.78 111.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -76.68 -57.45 3.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 1.28 110.989 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -19.57 65.17 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.256 0.465 . . . . 2.0 112.256 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -54.19 -51.6 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.441 . . . . 1.46 111.442 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.88 21.68 4.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.387 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -122.7 0.02 9.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 3.0800000000000001 109.978 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.27 -54.17 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 1.9399999999999999 111.807 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.1 mtpp -53.92 -53.27 59.94 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.813 0.671 . . . . 1.28 112.813 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.8 Cg_endo -65.36 -14.15 43.49 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.219 1.946 . . . . 0.40999999999999998 112.889 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.4 -18.75 40.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.407 -0.36 . . . . 0.81999999999999995 110.442 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 31.4 mt 57.46 75.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.761 -0.654 . . . . 1.54 111.721 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.7 27.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.798 -0.637 . . . . 0.83999999999999997 109.838 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.91 -173.46 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.306 -0.861 . . . . 0.96999999999999997 109.927 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.67 137.66 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.342 -0.614 . . . . 1.46 109.342 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.06 71.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.511 0.507 . . . . 2.0899999999999999 111.185 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 34.39 0.46 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.497 -0.774 . . . . 0.93000000000000005 109.135 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.27 168.45 14.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.889 -0.596 . . . . 1.8700000000000001 111.774 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -126.1 127.32 45.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.611 -0.722 . . . . 1.1299999999999999 109.724 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -115.76 130.15 56.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.599 -0.273 . . . . 1.21 110.5 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 165.97 -114.66 0.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.74 -0.743 . . . . 1.27 112.277 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -40.16 31.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.661 0.743 . . . . 1.3100000000000001 109.092 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -117.41 157.6 25.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.93 -1.032 . . . . 1.79 108.757 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.93 95.03 5.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.101 0.477 . . . . 1.1499999999999999 110.351 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 28.4 tt0 -92.85 107.83 19.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.58999999999999997 109.819 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.47 128.47 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.379 -0.373 . . . . 0.33000000000000002 111.129 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.7 t -90.97 98.02 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.317 -0.623 . . . . 0.91000000000000003 109.317 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 37.3 t -113.51 114.18 26.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.088 -0.506 . . . . 0.31 111.33 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.84 134.46 1.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.248 -0.649 . . . . 1.1899999999999999 109.248 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.5 tt -131.79 171.82 17.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.496 -0.32 . . . . 0.46999999999999997 110.217 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 42.1 m-20 -55.72 148.98 33.56 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.009 -0.541 . . . . 1.75 111.407 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.83 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.078 2.519 . . . . 0.83999999999999997 113.081 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.36 -90.13 0.92 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.879 -0.888 . . . . 0.10000000000000001 110.879 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.7 m -73.34 -4.5 33.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 1.98 110.214 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 79.1 t80 -55.59 -38.78 69.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.23000000000000001 111.265 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 8.1 tpt180 -65.64 -31.2 72.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.565 0.222 . . . . 1.3999999999999999 111.16 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.49 -35.97 78.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.41999999999999998 110.741 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.598 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 3.6 tp -84.95 -27.48 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 1.71 109.879 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.452 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 26.1 t70 -64.44 -29.13 70.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.34999999999999998 110.688 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 220' ' ' ARG . 12.9 mm-40 -53.42 -33.32 53.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.72 -0.673 . . . . 0.47999999999999998 112.007 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -97.47 -33.43 11.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.948 -0.39 . . . . 0.28000000000000003 109.948 178.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 222' ' ' ILE . 31.4 mm -55.96 -37.75 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.20999999999999999 111.78 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 231' ' ' LYS . 8.0 ptpt -62.22 -23.67 66.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.891 0.7 . . . . 1.22 112.891 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -112.47 -28.36 7.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.531 -0.468 . . . . 1.23 111.132 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -41.28 74.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.009 -0.541 . . . . 0.87 111.843 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.28 -47.06 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.501 0.556 . . . . 0.34000000000000002 112.501 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 25.7 ttmt -53.35 -45.96 69.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.938 0.399 . . . . 0.25 111.088 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.28 48.23 2.9 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.806 -0.712 . . . . 0.22 112.017 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.82 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.727 0.299 . . . . 2.0800000000000001 110.902 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.25 -146.99 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.17000000000000001 112.379 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.0 m -108.84 131.24 55.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.82999999999999996 110.858 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -111.82 149.94 31.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.835 -0.432 . . . . 0.31 109.835 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -142.52 -178.84 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.311 -0.404 . . . . 0.26000000000000001 110.01 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.72 149.93 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.975 0.417 . . . . 0.20999999999999999 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.448 0.642 . . . . 0.28999999999999998 109.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.005 0.431 . . . . 0.47999999999999998 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.45 158.66 15.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.09 -0.505 . . . . 0.84999999999999998 110.193 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -71.08 -50.45 33.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.88 111.174 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.16 94.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.19 109.839 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -166.64 160.14 14.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.0 110.338 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.13 7.19 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.23000000000000001 111.539 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 p -96.99 -0.06 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.38 110.712 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -141.98 38.11 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.612 . . . . 0.22 109.506 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.72 150.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.19 111.799 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.54 137.06 54.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.365 -0.834 . . . . 0.23999999999999999 109.877 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -76.09 122.78 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.377 . . . . 0.39000000000000001 110.989 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -151.57 129.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.17999999999999999 110.498 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 148.0 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 1.1200000000000001 111.152 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 17.6 ttt -110.67 134.3 52.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.61 . . . . 0.28999999999999998 110.847 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -96.68 103.77 15.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.634 -0.506 . . . . 1.5600000000000001 109.634 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 10.9 mmm180 -84.07 -179.82 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.548 -0.296 . . . . 1.8100000000000001 110.62 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.6 69.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.514 . . . . 0.47999999999999998 111.918 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.11 -39.44 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.92 . . . . 0.59999999999999998 113.28 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tttt -113.91 -174.94 2.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.781 0.324 . . . . 1.8700000000000001 110.826 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 5.6 mmt180 -137.03 154.8 50.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.442 -0.948 . . . . 1.0700000000000001 108.442 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -133.48 102.75 5.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.178 -0.304 . . . . 0.32000000000000001 110.178 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' HA ' ' A' ' 61' ' ' ASN . 2.6 mt-10 -106.05 127.0 52.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.37 110.773 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -135.06 -172.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.11 110.798 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.6 110.23 3.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.391 . . . . 1.01 110.886 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 53' ' ' LEU . 62.5 m -100.18 -175.47 2.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 0.16 109.779 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' CZ ' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -72.18 167.45 20.29 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.91 0.386 . . . . 0.34999999999999998 111.338 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -99.69 7.77 44.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.088 0.47 . . . . 1.3500000000000001 111.079 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -87.61 84.94 7.04 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.874 -0.331 . . . . 0.23000000000000001 110.379 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm 58.06 57.18 4.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.733 -0.667 . . . . 1.02 110.778 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.1 p -74.65 61.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.794 1.283 . . . . 1.49 110.74 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.56 9.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.471 -1.24 . . . . 0.67000000000000004 109.308 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-N 115.595 -0.729 . . . . 0.25 112.395 -179.038 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.95999999999999996 110.583 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 3.1 p30 -166.52 -175.53 3.22 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.146 -0.687 . . . . 0.98999999999999999 109.146 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.5 33.86 4.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.453 0.644 . . . . 0.96999999999999997 110.07 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -120.86 -43.97 2.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.542 -0.754 . . . . 1.8799999999999999 109.314 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -87.0 -31.66 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.345 -0.843 . . . . 1.1100000000000001 108.829 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG22 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 t -63.25 -37.25 78.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.901 -1.045 . . . . 0.51000000000000001 110.035 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 HD21 ' SG ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -83.47 80.22 9.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.373 -0.83 . . . . 0.78000000000000003 109.243 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.6 -62.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.288 -0.869 . . . . 0.41999999999999998 111.039 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -78.66 91.98 4.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.67 -0.696 . . . . 0.20000000000000001 111.277 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -84.22 60.46 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.415 0.626 . . . . 0.84999999999999998 110.555 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.3 t -152.91 82.81 1.21 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.241 -0.891 . . . . 0.75 109.136 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.64 138.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.781 -0.645 . . . . 0.28999999999999998 110.636 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -101.14 145.88 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.41999999999999998 109.945 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 97.5 t -73.35 -40.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.033 -0.728 . . . . 0.56999999999999995 109.033 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.426 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 2.1 t-20 -176.38 127.34 0.2 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.054 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.07 -37.93 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.734 -0.666 . . . . 1.1499999999999999 111.772 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.4 m -83.44 43.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.93000000000000005 111.122 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -47.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 2.6800000000000002 110.046 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.14 -2.8 47.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.755 -0.736 . . . . 0.46999999999999997 112.269 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.3 121.95 22.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.69 0.281 . . . . 1.05 110.803 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.8 t -105.86 134.41 47.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.958 -0.386 . . . . 1.1000000000000001 109.958 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.1 98.32 10.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.158 0.504 . . . . 1.01 110.589 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -81.17 178.9 8.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.045 -0.724 . . . . 3.0899999999999999 109.045 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -51.63 -35.8 43.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.685 0.278 . . . . 1.27 111.537 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.51 -30.01 70.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 2.0899999999999999 111.805 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.67 -51.21 6.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 2.1800000000000002 111.829 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 80' ' ' ASP . 2.2 pp -60.12 -32.55 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.22 111.881 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -69.26 -16.39 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.202 0.525 . . . . 1.55 110.363 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.6 m -105.89 -39.15 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.79000000000000004 111.142 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.94 -41.06 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.387 . . . . 0.42999999999999999 111.07 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -96.63 -57.39 2.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.24 109.823 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.29 -31.93 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.902 -0.666 . . . . 0.53000000000000003 112.142 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.02 145.35 45.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.55 0.215 . . . . 1.6599999999999999 110.531 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 7.8 p-10 -92.8 11.68 26.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.059 0.456 . . . . 0.69999999999999996 110.917 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 85' ' ' ILE . 13.5 t0 -82.1 117.72 22.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.44 109.781 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.07 -31.14 70.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 1.1100000000000001 111.535 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' HB ' ' OD1' ' A' ' 81' ' ' ASP . 23.2 m -63.83 -46.97 82.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 0.81999999999999995 110.559 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 13.3 tp10 -67.8 -33.04 74.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.47999999999999998 110.949 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 81' ' ' ASP . 41.6 mm -65.38 -57.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.34000000000000002 111.05 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.64 -28.48 68.51 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.083 0.401 . . . . 0.81000000000000005 112.083 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' THR . 28.0 mtpt -55.34 -53.56 54.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.925 0.393 . . . . 1.3700000000000001 111.14 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -63.9 -40.01 95.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.74 -0.664 . . . . 0.97999999999999998 111.729 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.3 mt -69.81 -28.35 36.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.29 0.567 . . . . 0.98999999999999999 111.078 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -32.12 40.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.291 -0.413 . . . . 1.22 111.771 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 87' ' ' LYS . 11.4 t -99.06 -29.48 12.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.133 0.79 . . . . 1.01 113.133 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -119.44 12.04 12.31 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.073 -0.392 . . . . 2.3700000000000001 111.801 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.84 -177.33 18.39 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.583 -0.818 . . . . 0.44 111.551 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.49 106.62 18.66 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.119 -0.326 . . . . 1.8 110.119 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG13 HG11 ' A' ' 97' ' ' VAL . 2.1 p -117.66 148.64 20.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.622 -0.717 . . . . 0.40999999999999998 110.173 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -70.8 77.09 0.62 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.078 0.466 . . . . 0.40999999999999998 111.64 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG11 HG13 ' A' ' 95' ' ' VAL . 15.6 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 1.27 110.438 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 111.687 0.255 . . . . 0.32000000000000001 111.687 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 m80 59.96 32.17 21.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.122 0.264 . . . . 0.45000000000000001 111.366 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -134.13 133.99 41.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.889 0.376 . . . . 1.0800000000000001 110.669 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 m -155.36 170.28 22.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.687 -0.688 . . . . 0.52000000000000002 109.194 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.48 -84.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.949 -0.3 . . . . 0.22 110.351 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -143.95 104.48 4.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 1.05 110.373 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -12.08 60.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.19 111.629 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.94 5.68 50.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.22 110.925 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 151' ' ' SER . 12.0 mmmm -116.1 -159.88 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.29 -0.414 . . . . 1.6499999999999999 110.528 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 150' ' ' LYS . 3.0 m -75.41 81.66 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.364 0.602 . . . . 0.63 109.925 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.72 -25.44 18.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.71999999999999997 113.514 -178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -13.06 33.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.65 -0.656 . . . . 1.3799999999999999 111.757 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -84.69 -25.1 28.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.318 0.58 . . . . 0.5 109.592 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.94 29.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.564 -0.744 . . . . 0.17999999999999999 110.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.1 -18.36 63.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.27000000000000002 112.241 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.36 -46.38 16.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.113 0.482 . . . . 0.45000000000000001 109.873 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -62.49 -46.0 90.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 0.54000000000000004 111.023 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.37 -38.39 48.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.722 -0.672 . . . . 0.22 111.506 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.2 -34.34 66.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 2.1099999999999999 111.138 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -82.87 -9.92 59.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.135 -0.484 . . . . 1.9399999999999999 111.412 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -55.09 6.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.34000000000000002 110.127 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.41 -24.0 66.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.268 -0.424 . . . . 1.0900000000000001 110.623 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -61.57 -26.03 67.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 1.8400000000000001 110.153 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -80.59 -7.01 59.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.48999999999999999 110.845 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -107.62 -48.15 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.46000000000000002 110.281 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 mmm -145.85 148.11 32.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 1.27 110.414 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -90.95 99.9 12.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.273 -0.421 . . . . 2.48 110.005 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 116.037 -0.529 . . . . 0.31 110.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 5.1 ttt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.985 -0.376 . . . . 2.2799999999999998 109.985 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -137.69 120.83 16.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.024 -0.361 . . . . 0.62 110.024 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.8 mp -120.43 157.91 28.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.99 0.424 . . . . 0.45000000000000001 110.875 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -179.47 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.553 -0.749 . . . . 0.54000000000000004 109.862 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 1.9 p90 -141.66 139.63 33.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.721 0.296 . . . . 0.89000000000000001 110.328 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -108.68 122.17 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.198 -0.456 . . . . 0.46999999999999997 110.943 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.8 149.83 9.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.609 -0.723 . . . . 1.8999999999999999 109.814 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.11 160.57 37.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.917 2.411 . . . . 0.12 112.789 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.36 -34.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 1.3999999999999999 111.121 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -55.2 -45.93 75.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 1.1299999999999999 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -85.57 -30.25 23.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.384 -0.371 . . . . 1.45 110.57 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.04 -22.05 77.1 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.41999999999999998 113.066 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -61.15 -28.23 68.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.0 0.429 . . . . 1.97 110.88 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 4.55 51.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.262 -0.426 . . . . 1.9099999999999999 110.733 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.4 tp -111.82 -41.05 4.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 1.8799999999999999 110.987 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -55.77 -44.37 77.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.6200000000000001 111.19 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -80.61 6.24 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.178 0.436 . . . . 0.46000000000000002 112.178 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -123.06 -2.76 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.292 -0.255 . . . . 1.48 111.127 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.3 -48.69 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.48 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 60.3 tttt -59.8 -50.28 87.47 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.367 0.506 . . . . 1.71 112.367 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 48.6 Cg_endo -68.0 -2.65 9.14 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.174 1.916 . . . . 0.20999999999999999 112.913 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.25 3.02 55.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 110.053 -0.351 . . . . 1.48 110.053 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.409 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 16.9 mt 52.72 72.22 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.178 -0.919 . . . . 0.17999999999999999 110.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 0.1 OUTLIER -152.8 19.37 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.608 -0.723 . . . . 0.39000000000000001 109.932 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.442 HG13 ' SG ' ' A' ' 212' ' ' CYS . 33.2 m -108.95 145.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.499 . . . . 0.28000000000000003 111.013 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.4 mt -97.02 159.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.679 . . . . 0.34999999999999998 109.397 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.07 59.77 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.262 0.553 . . . . 1.3200000000000001 111.613 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -155.99 74.62 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.28 -0.637 . . . . 0.45000000000000001 109.28 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' A' ' 193' ' ' LYS . 7.2 pt-20 -123.52 155.01 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.48 . . . . 1.45 111.045 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.41 129.64 46.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.836 -0.62 . . . . 0.31 109.937 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.7 109.24 11.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.93 0.395 . . . . 1.77 110.117 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -168.77 -96.33 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.041 -0.599 . . . . 0.32000000000000001 111.649 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -89.01 -10.88 45.91 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.122 -0.696 . . . . 0.68999999999999995 109.122 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.19 -176.89 5.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.009 -0.996 . . . . 0.29999999999999999 109.621 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.9 tp -130.02 76.87 1.75 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.581 -0.526 . . . . 0.47999999999999998 109.581 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.69 108.58 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.792 -0.64 . . . . 0.93000000000000005 110.715 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 55.3 mt -123.13 137.39 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.34999999999999998 110.611 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.9 t -91.53 123.75 43.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.28999999999999998 110.065 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.442 ' SG ' HG13 ' A' ' 198' ' ' VAL . 57.4 m -137.21 102.34 4.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.244 -0.435 . . . . 0.89000000000000001 110.468 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.434 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -159.66 136.96 9.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.388 -0.597 . . . . 0.28000000000000003 109.388 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.565 HG13 ' H ' ' A' ' 215' ' ' ASP . 5.6 tp -134.86 179.36 4.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.525 -0.307 . . . . 0.42999999999999999 110.354 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.565 ' H ' HG13 ' A' ' 214' ' ' ILE . 16.8 m-20 -60.43 164.22 7.31 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 122.978 0.511 . . . . 0.83999999999999997 110.861 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 215' ' ' ASP . 10.2 Cg_endo -52.65 170.38 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.853 2.368 . . . . 0.089999999999999997 112.923 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.48 -80.44 1.65 Allowed Glycine 0 C--O 1.237 0.315 0 N-CA-C 110.43 -1.068 . . . . 0.11 110.43 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.24 -22.44 63.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.34000000000000002 109.107 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -59.5 -32.26 70.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.298 -0.865 . . . . 0.35999999999999999 110.767 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 220' ' ' ARG . 11.4 mmt180 -85.93 -15.79 40.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.46000000000000002 110.161 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 0.7 OUTLIER -79.69 -48.75 13.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.55000000000000004 109.134 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 tt -66.66 -34.65 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 1.1000000000000001 109.775 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 227' ' ' LYS . 1.8 t70 -59.98 -36.58 77.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.907 -0.588 . . . . 0.44 110.919 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 9.8 mm-40 -47.13 -41.14 16.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.664 -0.698 . . . . 0.90000000000000002 111.934 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -34.09 10.2 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.793 -0.363 . . . . 0.60999999999999999 111.266 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 8.9 mm -56.28 -39.11 58.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 5.8 ptmt -64.74 -11.65 38.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.976 0.732 . . . . 1.3100000000000001 112.976 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -25.74 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.552 -0.459 . . . . 2.4100000000000001 112.005 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.14 -47.83 26.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.64000000000000001 111.362 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -116.38 -38.8 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.845 -0.342 . . . . 0.35999999999999999 111.59 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -66.09 -25.05 66.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 1.97 110.24 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.95 25.35 28.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.015 -0.612 . . . . 0.41999999999999998 111.718 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -139.84 -55.18 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.583 -0.525 . . . . 0.89000000000000001 109.583 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.41 -145.53 9.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.314 -0.714 . . . . 0.28999999999999998 111.314 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.41 133.25 46.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 117.031 0.416 . . . . 1.48 110.018 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -89.55 149.65 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.953 -0.388 . . . . 1.78 109.953 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -155.56 154.61 31.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.83999999999999997 110.179 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -72.57 158.6 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.596 0.236 . . . . 0.27000000000000002 110.406 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.2 tp . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.458 0.647 . . . . 1.3600000000000001 111.015 -179.418 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.241 0.543 . . . . 0.67000000000000004 111.336 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -90.86 -76.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.93000000000000005 110.752 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -161.37 -80.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.81 0.338 . . . . 0.72999999999999998 110.822 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.18 47.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.132 0.491 . . . . 2.0099999999999998 111.728 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -121.07 151.69 39.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.001 -0.545 . . . . 2.0499999999999998 110.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.71 45.45 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.217 0.532 . . . . 1.8999999999999999 111.608 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -99.51 -33.75 10.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.092 0.472 . . . . 1.3 111.063 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.54 72.33 1.42 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.219 -0.66 . . . . 0.72999999999999998 109.219 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.12 149.01 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.669 -0.696 . . . . 1.1499999999999999 111.331 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.66 123.0 49.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.68999999999999995 109.412 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.43 120.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.114 0.483 . . . . 1.4199999999999999 111.077 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.21 116.89 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.739 . . . . 0.88 109.525 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -126.83 132.95 50.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.229 0.538 . . . . 0.92000000000000004 112.032 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 66.6 ttp -111.48 119.45 38.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.176 -0.676 . . . . 1.1100000000000001 109.176 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 124.23 50.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.782 0.325 . . . . 1.79 110.828 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -109.86 -164.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.533 . . . . 3.2599999999999998 110.055 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.61 72.89 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.3 0.375 . . . . 1.75 111.596 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.08 7.77 4.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.399 -0.905 . . . . 0.92000000000000004 112.952 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -123.13 145.26 48.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 2.5600000000000001 111.261 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -129.72 132.15 46.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.067 -0.716 . . . . 1.03 109.067 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.79 144.81 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.478 0.18 . . . . 0.32000000000000001 110.871 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 44.8 tt0 -156.8 143.11 18.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.986 -0.376 . . . . 1.21 109.986 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.07 -173.21 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.85999999999999999 110.737 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.82 119.78 26.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.58999999999999997 110.915 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.43 ' SG ' HD22 ' A' ' 90' ' ' LEU . 29.5 m -116.76 157.78 24.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 0.39000000000000001 110.641 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.531 ' HD1' ' NE2' ' A' ' 54' ' ' GLN . 1.3 t80 -74.15 145.13 44.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.829 0.347 . . . . 1.0900000000000001 110.226 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 8.97 4.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.312 -0.404 . . . . 1.3999999999999999 111.599 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.55 88.34 7.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.305 -0.247 . . . . 1.52 110.797 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.5 44.35 24.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.508 -0.769 . . . . 1.03 112.091 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.89 149.24 8.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 1.03 110.188 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 39' ' ' VAL . 3.9 t 68.81 23.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.41 0.624 . . . . 0.20000000000000001 110.459 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.404 0 CA-C-N 115.898 -0.592 . . . . 0.17000000000000001 113.292 178.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.968 -0.753 . . . . 1.3400000000000001 108.968 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.41 138.79 58.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.81 0.338 . . . . 0.52000000000000002 111.284 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 52' ' ' VAL . 6.0 mp -68.23 -24.45 64.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.981 -0.554 . . . . 0.63 110.229 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.26 -27.28 68.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.373 0.606 . . . . 1.1399999999999999 109.946 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 17.65 19.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 1.48 111.161 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.3 p -125.12 -9.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.347 . . . . 0.28000000000000003 111.087 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' HE22 ' A' ' 82' ' ' GLN . 1.9 mm? -96.24 110.07 22.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.333 -0.394 . . . . 0.52000000000000002 110.35 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' NE2' ' HD1' ' A' ' 34' ' ' TYR . 17.1 mt-30 -70.52 -35.81 73.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 2.3799999999999999 110.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -122.11 164.37 17.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.748 -0.66 . . . . 1.0800000000000001 110.458 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -125.19 18.05 8.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.947 -0.569 . . . . 1.1599999999999999 109.629 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -116.39 118.49 32.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.462 -0.79 . . . . 1.51 110.164 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.95 143.14 14.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.239 -0.437 . . . . 0.95999999999999996 110.227 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -83.97 157.5 21.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.629 0.252 . . . . 0.28000000000000003 111.087 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 68' ' ' ALA . 83.3 t -117.8 -49.48 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.482 0.658 . . . . 1.28 109.539 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -144.15 111.37 5.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.815 . . . . 0.71999999999999997 108.955 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.5 -37.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.006 0.373 . . . . 0.45000000000000001 112.006 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -31.17 72.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.933 0.397 . . . . 0.78000000000000003 111.142 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -100.96 -1.85 33.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 1.3700000000000001 111.242 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.84 48.13 83.42 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.96 -0.638 . . . . 0.38 112.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -106.6 123.65 48.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.794 0.331 . . . . 0.68999999999999995 111.231 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.76 139.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.736 -0.666 . . . . 0.089999999999999997 109.537 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 60' ' ' VAL . . . -90.93 128.13 36.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.17000000000000001 111.653 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -91.33 -172.33 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.362 -0.607 . . . . 1.24 109.362 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -63.27 -30.74 71.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.758 0.314 . . . . 0.48999999999999999 111.004 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 74' ' ' ILE . 2.1 pm0 -79.62 -24.82 41.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 1.1899999999999999 110.973 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.19 -51.95 15.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.424 -0.353 . . . . 1.8100000000000001 110.288 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.43 -32.78 74.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.34000000000000002 110.935 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -66.8 -23.53 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.961 0.41 . . . . 1.02 110.237 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -100.93 -5.81 25.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.70999999999999996 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.18 -40.27 7.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.53000000000000003 110.763 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.97 -34.51 6.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.48999999999999999 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.01 -10.02 29.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.032 -0.604 . . . . 0.31 111.926 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 147.09 44.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.476 0.179 . . . . 0.94999999999999996 110.523 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -96.69 -8.91 30.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.809 0.338 . . . . 0.85999999999999999 111.02 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.525 ' O ' HG12 ' A' ' 85' ' ' ILE . 56.0 t0 -73.84 110.78 8.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.168 -0.469 . . . . 0.98999999999999999 110.099 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.518 HE22 ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -62.07 -27.86 69.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.851 -0.613 . . . . 0.71999999999999997 110.882 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -34.39 77.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.76000000000000001 110.538 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.96 -29.27 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 81' ' ' ASP . 39.7 mm -67.28 -46.32 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.02 -0.733 . . . . 0.39000000000000001 109.02 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 p -71.1 -24.08 62.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.742 -0.663 . . . . 1.03 110.349 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -59.9 -41.83 92.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.215 0.531 . . . . 1.6399999999999999 109.718 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.04 -49.67 55.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.411 -0.813 . . . . 0.45000000000000001 110.726 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.76 -35.12 65.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 1.1299999999999999 112.245 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.43 HD22 ' SG ' ' A' ' 33' ' ' CYS . 3.7 mm? -82.77 -11.31 58.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.247 0.832 . . . . 1.01 113.247 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -122.98 -10.1 8.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.151 -0.62 . . . . 0.19 112.389 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -121.94 -5.26 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.733 0.302 . . . . 0.22 110.827 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.8 -169.33 19.26 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.547 -0.835 . . . . 0.19 113.067 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.29 107.44 18.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.702 -0.481 . . . . 1.52 109.702 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 p -106.28 138.52 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.34000000000000002 110.456 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.26 89.39 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 1.22 111.021 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.45 . . . . 1.0600000000000001 111.033 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.1 tt . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 119.841 -0.123 . . . . 1.1299999999999999 110.989 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 41.16 51.53 3.43 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.686 0.616 . . . . 1.02 111.7 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -114.01 94.59 4.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 0.94999999999999996 111.406 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 139.29 30.79 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.629 . . . . 1.1899999999999999 109.887 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.66 83.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.792 0.33 . . . . 1.3200000000000001 110.533 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 60.75 54.45 3.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.743 -0.662 . . . . 1.76 111.405 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -15.43 63.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.77000000000000002 111.818 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -101.48 15.95 27.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 1.27 111.007 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -119.23 -125.2 0.28 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.39 -0.368 . . . . 1.01 110.907 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.77 79.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 1.71 111.023 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -21.94 60.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.922 -0.581 . . . . 0.73999999999999999 112.52 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -90.89 9.7 29.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.369 . . . . 1.54 111.168 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -128.98 -44.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 1.3600000000000001 110.154 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -71.56 -6.02 37.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.814 -0.63 . . . . 1.6200000000000001 111.22 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -36.82 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.48999999999999999 110.8 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.91 -39.21 76.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.1200000000000001 110.693 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 12.2 mp0 -64.99 -46.17 82.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.049 -0.523 . . . . 0.81999999999999995 111.147 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.26 -44.18 80.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 111.971 0.36 . . . . 0.52000000000000002 111.971 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.16 -29.59 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.874 0.324 . . . . 0.92000000000000004 111.874 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -97.21 -12.84 22.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.591 0.234 . . . . 1.22 111.188 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 3.9 tp-100 -68.15 -43.61 77.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.662 -0.496 . . . . 0.32000000000000001 109.662 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.36 -32.12 73.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.38 109.903 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -67.93 -21.89 65.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.555 -0.748 . . . . 1.5800000000000001 110.391 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.6 -32.85 60.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.42999999999999999 110.271 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -52.82 7.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.82 -0.807 . . . . 2.02 108.82 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mtp -131.59 112.45 12.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.944 -0.761 . . . . 1.4399999999999999 108.944 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -73.52 81.23 1.46 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 1.5800000000000001 111.75 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.562 -0.744 . . . . 1.1499999999999999 109.76 178.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.943 0.401 . . . . 1.1100000000000001 111.33 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HA ' ' HG ' ' A' ' 213' ' ' LEU . 25.3 mtp180 -84.08 147.99 27.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 1.3700000000000001 111.153 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -129.45 175.64 8.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.32000000000000001 110.567 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.86 167.38 21.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.98999999999999999 109.826 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.3 t80 -123.67 143.08 50.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.636 -0.256 . . . . 0.35999999999999999 110.691 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.6 pt -133.28 115.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.025 0.44 . . . . 0.27000000000000002 110.548 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 180' ' ' LEU . 2.3 pt? -155.84 155.63 29.63 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.028 -0.533 . . . . 0.22 110.238 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.95 161.44 33.07 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.994 2.463 . . . . 0.23000000000000001 113.27 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.8 t -57.65 -35.53 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.607 -0.724 . . . . 0.55000000000000004 111.89 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.31 -39.78 61.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.42999999999999999 111.998 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 49.6 mm-40 -104.46 -17.74 14.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.988 0.423 . . . . 0.46000000000000002 110.529 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.31 -34.6 88.78 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.171 -0.538 . . . . 0.29999999999999999 112.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 30.6 ttpt -71.62 -7.55 48.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.928 0.394 . . . . 1.4299999999999999 111.098 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -84.15 -58.26 2.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.679 0.276 . . . . 1.23 110.704 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -25.66 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 1.1100000000000001 111.21 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.52 -37.21 85.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.837 0.351 . . . . 1.8300000000000001 110.723 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 13.7 mm-40 -90.99 11.23 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.396 -0.366 . . . . 0.76000000000000001 110.684 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -121.1 -49.24 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.09 -36.73 35.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.109 0.781 . . . . 1.0600000000000001 113.109 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 24.8 mtpp -60.93 -50.98 82.54 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 112.228 0.455 . . . . 0.40000000000000002 112.228 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 21.3 Cg_endo -61.43 -19.58 64.93 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.147 1.898 . . . . 0.26000000000000001 112.609 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.95 -13.02 58.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.349 . . . . 1.1200000000000001 110.141 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.1 mt 55.22 59.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.49 -0.777 . . . . 0.56000000000000005 110.371 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 21.37 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.33 -0.85 . . . . 0.68000000000000005 109.783 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.81 149.51 23.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 1.2 110.416 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.66 149.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.374 -0.602 . . . . 1.0800000000000001 109.374 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -73.45 70.01 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 1.3600000000000001 111.005 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.0 m -151.85 37.03 0.56 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.743 -0.662 . . . . 1.1599999999999999 109.397 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.1 pt-20 -88.08 175.25 7.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.596 . . . . 1.6399999999999999 111.798 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.96 146.81 52.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.40000000000000002 109.341 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.35 25.88 9.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.431 0.16 . . . . 1.45 111.431 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.21 -141.88 7.85 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.786 -0.721 . . . . 0.68000000000000005 112.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -74.42 -17.51 60.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.179 0.514 . . . . 2.0 110.642 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 121.38 34.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.699 -0.682 . . . . 1.6899999999999999 109.61 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.71 85.8 6.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.127 0.489 . . . . 0.70999999999999996 110.369 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 25.4 tt0 -76.72 93.61 3.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.817 -0.629 . . . . 1.71 110.048 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.2 127.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.652 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.51 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.855 0.359 . . . . 1.05 110.361 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.8 p -124.51 104.68 8.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.34999999999999998 110.898 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.401 ' HG ' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -164.35 127.37 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.313 -0.625 . . . . 0.35999999999999999 109.313 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.03 -163.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.634 -0.257 . . . . 0.29999999999999999 111.546 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -49.05 148.96 3.66 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.529 -0.76 . . . . 0.77000000000000002 112.388 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.86 -50.09 14.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.134 2.556 . . . . 0.68000000000000005 113.071 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.08 -57.3 8.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.46999999999999997 112.657 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 51.4 m -55.88 -36.6 67.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.239 0.459 . . . . 1.0900000000000001 112.239 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.93 -39.75 90.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.096 -0.642 . . . . 0.87 110.609 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -70.89 -8.14 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 2.4100000000000001 110.647 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.46 -22.67 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.755 -0.657 . . . . 1.25 110.571 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 226' ' ' ILE . 7.6 tp -108.69 -29.11 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.453 -0.34 . . . . 1.29 111.459 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 33.9 t70 -61.37 -21.09 63.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.873 0.368 . . . . 0.76000000000000001 111.104 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -26.32 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.85999999999999999 111.114 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 228' ' ' LYS . 0.7 OUTLIER -114.02 -25.53 8.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.575 -0.284 . . . . 0.94999999999999996 110.571 178.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.5 mm -66.51 -33.24 62.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.666 0.27 . . . . 1.46 110.979 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.96 -35.88 77.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.391 . . . . 1.5600000000000001 110.782 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.55 11.21 39.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.239 0.543 . . . . 1.3600000000000001 110.011 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -102.21 -65.77 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.93000000000000005 110.45 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -121.57 -30.1 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 0.75 111.803 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -61.12 -33.05 72.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.161 0.505 . . . . 1.8799999999999999 110.704 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.36 22.82 37.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.71999999999999997 110.974 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -118.66 -57.43 2.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.882 0.372 . . . . 1.9099999999999999 110.4 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.08 -136.08 5.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 0.40000000000000002 112.806 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.7 m -132.59 148.85 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.42999999999999999 110.621 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.68 160.29 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.913 0.387 . . . . 1.01 111.078 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -144.97 157.34 44.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.2 -0.667 . . . . 0.40999999999999998 109.2 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.11 148.34 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.33000000000000002 110.919 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.299 0.571 . . . . 1.8100000000000001 109.818 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.23999999999999999 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t30 65.09 18.4 11.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.624 -0.716 . . . . 0.46000000000000002 112.383 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.89 -3.0 52.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.068 -0.345 . . . . 1.4099999999999999 110.068 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mt 55.1 68.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.568 -0.742 . . . . 1.29 110.922 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -136.37 166.86 22.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.729 -0.669 . . . . 0.34999999999999998 109.5 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -75.78 53.52 0.74 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.977 0.418 . . . . 0.72999999999999998 110.634 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -123.41 -44.83 2.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.991 -0.549 . . . . 1.3799999999999999 111.554 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -112.05 23.51 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 2.6600000000000001 110.593 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -74.41 137.42 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.58999999999999997 112.256 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -91.78 140.26 29.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.614 -0.721 . . . . 0.78000000000000003 110.205 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.07 130.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.186 0.517 . . . . 0.55000000000000004 111.872 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 5.7 p -150.13 126.4 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.574 -0.739 . . . . 0.93999999999999995 109.024 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -132.86 141.7 48.55 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.655 0.613 . . . . 2.4900000000000002 112.655 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttp -113.65 108.71 17.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.166 -0.925 . . . . 0.25 108.806 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -86.94 99.34 11.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.4399999999999999 111.248 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -96.13 167.01 11.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 1.3600000000000001 109.926 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.16 73.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.362 -0.381 . . . . 0.5 111.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.87 -50.78 6.22 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.95 -0.643 . . . . 0.59999999999999998 112.521 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -161.81 147.43 13.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.777 -0.453 . . . . 1.3700000000000001 109.777 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.39 143.87 25.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.671 -0.492 . . . . 1.71 109.671 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.34 132.36 42.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.538 -0.301 . . . . 0.35999999999999999 111.024 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.536 ' OE2' ' HD2' ' A' ' 21' ' ' ARG . 22.8 tt0 -124.4 134.87 52.99 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.459 -0.571 . . . . 1.48 109.459 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.37 145.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.404 . . . . 0.38 111.151 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 18' ' ' ALA . . . -106.37 112.77 25.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.479 -0.563 . . . . 1.3400000000000001 109.479 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.1 168.05 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 1.3300000000000001 111.835 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.473 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 22.3 t80 -73.26 117.68 15.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.762 -0.654 . . . . 1.8400000000000001 109.854 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.83 82.39 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.398 0.618 . . . . 2.6899999999999999 111.707 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.67 75.5 0.78 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.098 -0.955 . . . . 0.83999999999999997 108.452 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.69 36.19 2.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.956 -1.02 . . . . 1.6399999999999999 109.837 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.18 -40.55 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.493 -0.776 . . . . 0.39000000000000001 110.908 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.58 2.27 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.8899999999999999 110.605 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 111.217 -0.753 . . . . 0.31 111.217 179.623 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 110.094 -0.336 . . . . 0.73999999999999999 110.094 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.72 143.77 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.137 -0.32 . . . . 0.28999999999999998 110.137 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.91 -24.88 67.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 1.29 111.24 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -57.83 -37.17 73.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.943 0.401 . . . . 0.38 110.772 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -83.77 -19.61 34.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.972 -0.558 . . . . 2.04 110.798 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.07 -25.47 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 1.1499999999999999 110.938 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 55' ' ' THR . 2.4 mm? -74.76 99.83 3.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.40000000000000002 110.921 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 34' ' ' TYR . 29.2 mt-30 -77.34 -24.48 50.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 1.3400000000000001 110.671 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' HD13 ' A' ' 53' ' ' LEU . 12.6 t -130.63 152.01 50.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 1.1399999999999999 109.808 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -112.53 7.87 19.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.071 0.462 . . . . 0.46999999999999997 110.4 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -110.23 145.59 37.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.016 -0.538 . . . . 0.81000000000000005 109.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 p -112.04 139.8 34.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 0.19 110.934 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -78.01 151.47 33.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 1.1100000000000001 111.547 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.48 -59.34 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.499 -0.319 . . . . 0.70999999999999996 111.636 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -123.68 126.67 46.99 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.456 -0.152 . . . . 0.63 110.825 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.17 -26.36 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 111.957 0.355 . . . . 1.5900000000000001 111.957 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.7 m -72.02 -47.06 54.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.192 0.52 . . . . 1.6200000000000001 110.207 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.47 -22.27 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 2.3100000000000001 110.2 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 44.58 36.6 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 0.46000000000000002 111.374 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -108.02 124.1 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.083 0.468 . . . . 1.6100000000000001 111.068 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.01 145.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.471 -0.786 . . . . 0.58999999999999997 109.606 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.51 126.76 42.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.93000000000000005 110.838 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -97.21 -171.53 2.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.653 -0.703 . . . . 2.04 110.112 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -51.28 -40.21 58.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.699 0.629 . . . . 1.54 112.699 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -62.15 -26.7 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.692 0.627 . . . . 0.46999999999999997 112.692 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -94.17 -44.71 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.682 -0.407 . . . . 0.25 111.751 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.31 -34.69 75.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.929 -0.309 . . . . 0.97999999999999998 111.827 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 74' ' ' ILE . 8.5 tt -67.11 -25.67 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 1.5800000000000001 110.736 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 m -94.58 -43.03 8.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.16 111.387 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.09 -46.43 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.16 112.088 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -94.07 -29.75 15.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 1.21 110.689 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 16.19 54.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.466 -0.874 . . . . 0.80000000000000004 112.184 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.5 m -145.94 124.56 12.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.19 -0.3 . . . . 2.1299999999999999 110.19 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.29 60.68 5.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.433 0.635 . . . . 1.1599999999999999 110.41 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.45 ' OD2' ' HB ' ' A' ' 83' ' ' THR . 19.6 t70 -151.97 111.84 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.728 -0.669 . . . . 2.4100000000000001 109.986 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -68.33 -24.66 64.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.511 . . . . 1.6799999999999999 111.218 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.45 ' HB ' ' OD2' ' A' ' 81' ' ' ASP . 11.6 m -66.82 -45.76 77.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.53 -0.305 . . . . 1.02 110.228 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -58.89 -46.54 87.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.67000000000000004 110.402 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.96 -48.23 87.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.553 -0.749 . . . . 0.40999999999999998 110.596 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.2 -34.6 75.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.19 110.895 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -62.01 -42.21 98.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 0.47999999999999998 110.14 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.55 -40.37 84.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.40000000000000002 110.002 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 20' ' ' VAL . 76.3 mt -68.87 -30.89 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.617 -0.719 . . . . 0.40999999999999998 111.004 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -18.79 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.398 -0.365 . . . . 1.02 111.69 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -105.7 -15.47 14.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.59 -0.444 . . . . 1.03 112.075 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -142.05 36.48 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 3.0 111.164 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.47 165.83 24.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.529 -0.843 . . . . 0.40000000000000002 112.587 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 80.1 mt-10 -82.01 93.49 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 1.52 110.246 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.01 137.24 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.338 -0.392 . . . . 0.28000000000000003 110.227 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -73.31 76.05 1.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.202 0.525 . . . . 0.80000000000000004 111.77 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 1.1200000000000001 111.298 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 144' ' ' TYR . 8.6 mt . . . . . 0 C--O 1.232 0.178 0 N-CA-C 111.422 0.156 . . . . 0.47999999999999998 111.422 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.3 t60 75.06 -24.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.865 0.728 . . . . 1.6499999999999999 111.674 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 142' ' ' ILE . 29.8 t80 -70.86 135.06 47.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.165 -0.309 . . . . 1.3500000000000001 110.165 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 170.38 10.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.426 -0.352 . . . . 0.59999999999999998 110.665 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.21 48.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.33000000000000002 110.536 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 52.41 30.23 7.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.88 111.341 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 148' ' ' THR . 14.6 t 42.33 73.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.341 1.056 . . . . 1.1499999999999999 112.497 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p30 51.37 18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.705 1.202 . . . . 0.64000000000000001 114.114 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.05 140.47 48.43 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.97 -0.456 . . . . 1.78 111.046 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.4 m 62.57 38.96 11.98 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.66000000000000003 110.915 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -63.93 -33.82 76.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.94 4.07 31.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.855 0.359 . . . . 1.75 110.95 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -105.16 -54.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.28000000000000003 110.834 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -94.91 16.75 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 0.69999999999999996 111.935 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -57.69 -42.8 84.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.894 0.378 . . . . 0.29999999999999999 111.133 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.37 3.16 32.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.76000000000000001 111.881 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -111.46 -48.64 3.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 1.1499999999999999 110.798 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.427 ' O ' HD11 ' A' ' 163' ' ' LEU . 58.5 t -64.65 -39.21 84.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 0.27000000000000002 110.863 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tt -68.22 -9.86 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.189 -0.46 . . . . 0.27000000000000002 111.356 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -102.67 -35.46 8.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.822 -0.436 . . . . 2.0499999999999998 109.822 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -57.37 -56.61 19.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.342 -0.845 . . . . 1.01 111.778 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.566 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -72.41 -21.76 61.21 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.68 -0.408 . . . . 0.57999999999999996 111.218 -178.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.02 -31.24 67.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.94999999999999996 110.008 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.05 -32.91 73.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.653 -0.703 . . . . 1.03 109.87 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.43 -44.65 14.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.701 -0.681 . . . . 2.3700000000000001 110.427 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.0 tpp -145.99 126.32 13.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.36 -0.382 . . . . 1.8100000000000001 110.655 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -80.69 122.5 27.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.815 -0.439 . . . . 1.77 109.815 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.415 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.40999999999999998 111.673 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 60.2 mtm . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 120.847 0.356 . . . . 3.1600000000000001 111.226 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -76.42 133.0 39.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.802 -0.635 . . . . 0.85999999999999999 110.466 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt -105.39 147.02 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.024 -0.535 . . . . 1.77 110.896 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.585 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 17.1 ptt180 -128.82 141.9 51.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.245 -0.65 . . . . 0.68000000000000005 109.245 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.8 128.27 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.799 0.333 . . . . 0.26000000000000001 110.754 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 30.8 pt -102.02 137.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 1.1200000000000001 110.763 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.7 123.48 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.83999999999999997 109.591 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.26 142.77 45.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.552 2.168 . . . . 0.22 112.032 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.7 t -45.56 -37.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.153 0.581 . . . . 0.34999999999999998 112.176 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -48.5 -40.61 27.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.912 -0.586 . . . . 0.45000000000000001 112.151 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -117.93 7.23 12.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.01 0.433 . . . . 0.48999999999999999 110.526 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.502 ' O ' HD21 ' A' ' 188' ' ' LEU . . . -66.57 -31.21 77.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.32000000000000001 112.777 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 82.1 tttt -63.74 -29.02 70.28 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.69 -0.3 . . . . 2.1400000000000001 111.28 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.76 -47.52 84.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.58999999999999997 111.601 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.502 HD21 ' O ' ' A' ' 185' ' ' GLY . 0.1 OUTLIER -85.77 -22.04 27.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.857 0.36 . . . . 0.65000000000000002 110.607 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -60.1 -52.15 66.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.941 -0.572 . . . . 1.72 110.971 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 11.3 pt-20 -89.27 22.25 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.90000000000000002 111.253 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.455 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -121.38 -47.08 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.511 -0.313 . . . . 0.92000000000000004 111.172 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.01 -39.14 21.66 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.493 0.553 . . . . 1.3200000000000001 112.493 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 53.2 mttm -59.89 -49.92 89.05 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.815 0.672 . . . . 1.9199999999999999 112.815 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.0 Cg_endo -60.18 -19.77 58.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.135 1.89 . . . . 0.29999999999999999 113.044 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 86.3 mt -79.09 -14.43 59.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.607 -0.269 . . . . 0.25 110.438 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.7 mm 56.22 41.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.801 0.81 . . . . 0.26000000000000001 110.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -124.91 28.81 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.343 -0.844 . . . . 0.67000000000000004 109.949 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.6 m -119.13 156.07 21.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.335 -0.848 . . . . 0.17999999999999999 110.43 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.68 147.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.531 -0.544 . . . . 1.54 109.531 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.82 76.3 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 1.23 110.945 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.0 m -155.56 26.3 0.39 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 0.20000000000000001 109.521 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 2.7 mp0 -80.37 162.61 24.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 1.79 111.641 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -109.16 143.26 38.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.903 -0.777 . . . . 1.6000000000000001 108.903 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.75 37.94 3.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 1.22 110.69 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -99.74 -97.67 2.18 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.705 -0.759 . . . . 0.66000000000000003 112.078 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -95.73 -22.32 17.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.158 0.504 . . . . 2.25 110.916 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.49 160.79 37.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.75 109.999 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.15 80.11 2.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.042 0.449 . . . . 1.1899999999999999 110.101 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.585 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 47.2 tt0 -76.62 96.78 4.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.44 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 37.9 mm -96.95 139.55 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.866 0.365 . . . . 1.1399999999999999 111.152 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.76 116.57 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.39000000000000001 110.323 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.2 p -139.28 96.13 3.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.351 . . . . 0.97999999999999998 110.676 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.44 136.66 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.495 -0.557 . . . . 0.84999999999999998 109.495 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.16 -45.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.601 0.238 . . . . 0.94999999999999996 111.191 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -168.92 158.16 7.66 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.564 -0.289 . . . . 0.90000000000000002 110.235 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.54 -16.71 54.03 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.816 2.344 . . . . 0.72999999999999998 113.197 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -71.06 -60.05 4.71 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.004 -0.617 . . . . 0.33000000000000002 112.388 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 222' ' ' ILE . 2.2 m -79.0 -8.71 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.973 0.415 . . . . 0.34999999999999998 110.847 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.19 -29.4 68.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.34000000000000002 111.873 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -60.54 -50.61 72.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 0.52000000000000002 111.065 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -77.86 2.27 17.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 1.24 111.608 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.542 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 28.2 mm -101.76 -55.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.878 0.371 . . . . 2.0099999999999998 110.382 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.81 -26.08 67.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.35999999999999999 111.813 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.5 -26.35 65.21 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.195 -0.457 . . . . 1.1000000000000001 111.795 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.0 pp -106.65 -34.01 7.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.33000000000000002 110.126 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.0 mm -55.78 -35.3 39.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.077 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 18.1 ptpt -53.32 -37.17 62.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.582 -0.735 . . . . 2.4300000000000002 112.426 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -19.69 13.7 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.594 -0.443 . . . . 3.1200000000000001 112.15 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.5 -41.07 48.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.213 0.449 . . . . 1.3799999999999999 112.213 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.1 t -142.22 -32.52 0.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.257 0.836 . . . . 0.59999999999999998 113.257 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 37.5 ttmt -57.75 -47.57 82.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.781 0.324 . . . . 1.73 111.462 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.03 10.72 71.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.965 -0.636 . . . . 0.23000000000000001 112.404 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -112.32 -59.86 1.94 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.52000000000000002 110.188 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -106.46 -119.15 4.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.29999999999999999 111.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 7.9 m -143.67 150.69 39.09 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 122.703 -0.292 . . . . 0.47999999999999998 110.574 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.83 142.98 40.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 2.1099999999999999 111.045 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.84 -173.78 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.988 -0.551 . . . . 1.04 109.718 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.93 153.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.418 . . . . 0.28999999999999998 111.772 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 1.21 109.724 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.004 0.431 . . . . 0.37 110.795 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -171.55 -59.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.93000000000000005 109.566 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB3' ' H ' ' A' ' 12' ' ' ILE . 17.7 mm-40 -128.08 -157.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.662 -0.699 . . . . 3.2200000000000002 111.031 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.458 ' H ' ' HB3' ' A' ' 11' ' ' GLN . 18.2 mm -69.42 100.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.118 0.485 . . . . 1.52 111.099 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -136.25 134.56 38.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.631 -0.713 . . . . 1.8400000000000001 109.744 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.6 mt -66.18 -4.76 8.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.167 0.432 . . . . 1.75 112.167 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -20.34 52.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.124 0.488 . . . . 0.63 111.069 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -114.36 71.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.48999999999999999 110.278 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.5 m -123.13 121.79 63.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.42999999999999999 111.762 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.76 116.16 31.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.619 . . . . 0.46000000000000002 109.327 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.56 109.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.104 0.478 . . . . 1.1299999999999999 111.685 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 p -105.92 129.44 59.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.541 -0.911 . . . . 0.47999999999999998 108.541 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -125.72 125.4 42.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.372 -0.531 . . . . 0.68000000000000005 112.095 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.27 116.18 28.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 1.0700000000000001 109.603 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 128.54 54.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 1.96 110.622 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -113.67 -156.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.617 -0.72 . . . . 1.6000000000000001 109.501 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.86 -60.33 2.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.39000000000000001 110.878 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.18 32.43 3.96 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.959 -0.639 . . . . 0.33000000000000002 111.713 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.02 142.42 31.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 2.3199999999999998 109.726 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.12 125.66 10.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.509 -0.314 . . . . 2.2200000000000002 110.572 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -144.35 132.02 21.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.333 -0.394 . . . . 0.37 110.727 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.91 138.17 43.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.444 . . . . 0.68000000000000005 110.424 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.448 HG23 ' H ' ' A' ' 32' ' ' ALA . 1.1 mt -136.76 172.22 15.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.781 0.324 . . . . 1.97 110.656 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' H ' HG23 ' A' ' 31' ' ' ILE . . . -124.84 107.91 11.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.107 -0.497 . . . . 0.28999999999999998 109.993 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 m -98.55 -161.84 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.23999999999999999 110.077 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.57 -173.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.443 0.164 . . . . 1.03 110.624 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -74.47 -133.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.943 0.401 . . . . 1.6699999999999999 111.499 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.69 6.21 0.24 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.091 0.774 . . . . 0.68000000000000005 113.091 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 -15.0 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.222 -0.299 . . . . 1.51 110.913 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.23 -27.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.328 0.492 . . . . 0.33000000000000002 112.328 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.83 101.43 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.223 0.535 . . . . 1.01 111.091 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.358 0 CA-C-N 115.291 -0.868 . . . . 0.28000000000000003 112.574 179.609 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 111.771 0.286 . . . . 1.6799999999999999 111.771 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.51 127.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.905 -0.405 . . . . 2.04 109.905 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.06 -24.35 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.225 -0.443 . . . . 1.5 111.669 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.63 -41.88 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.02 0.438 . . . . 1.98 110.587 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -78.31 -30.31 48.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 1.8700000000000001 110.169 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.28 -33.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.94999999999999996 110.143 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.28 84.88 6.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.184 -0.462 . . . . 0.34000000000000002 110.458 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.0 -61.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.747 -0.661 . . . . 0.90000000000000002 110.973 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.23 120.24 22.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.953 0.406 . . . . 0.13 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -99.03 5.96 46.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.322 -0.399 . . . . 1.0900000000000001 110.683 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.25 114.75 28.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.895 -0.593 . . . . 0.57999999999999996 110.072 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 31' ' ' ILE . 3.7 p -89.12 136.82 22.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.88 110.507 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -95.21 149.22 21.56 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.11 -0.33 . . . . 0.46999999999999997 110.11 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.17 -45.39 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.458 0.647 . . . . 1.1200000000000001 109.745 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -155.46 107.86 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.485 -0.78 . . . . 2.6000000000000001 109.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.59 -28.98 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.59 . . . . 0.59999999999999998 112.095 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.6 m -73.42 -16.7 61.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.876 0.369 . . . . 1.3700000000000001 111.299 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -13.82 14.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.814 0.34 . . . . 1.1200000000000001 110.45 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.77 75.78 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.31 111.751 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -87.24 112.04 21.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.981 0.419 . . . . 1.8 110.964 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 t -98.0 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.93999999999999995 109.621 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.93 115.11 27.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.864 -0.421 . . . . 1.03 109.864 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.088 -0.506 . . . . 1.6000000000000001 109.747 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -59.4 -30.23 68.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.098 0.475 . . . . 1.5 110.436 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.99 -19.68 54.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.623 -0.717 . . . . 2.3199999999999998 110.899 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.57 -47.58 8.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.51000000000000001 110.966 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 2.3 pp -67.02 -31.77 72.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.259 -0.428 . . . . 0.20000000000000001 111.399 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.46 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.708 0.289 . . . . 1.25 111.384 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -91.38 -9.42 44.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.728 0.299 . . . . 1.23 111.663 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.42 -43.15 5.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.20000000000000001 111.417 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -92.09 -37.5 12.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.49 -0.323 . . . . 0.31 110.75 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.03 -17.95 29.11 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.14999999999999999 112.128 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -116.53 142.22 47.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.917 -0.401 . . . . 0.91000000000000003 109.917 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.65 2.38 48.64 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.98 0.419 . . . . 0.32000000000000001 111.053 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.54 109.0 20.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.543 -0.54 . . . . 1.29 109.543 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -33.17 75.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 0.79000000000000004 111.764 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.32 78.62 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.933 0.397 . . . . 1.3999999999999999 111.114 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -36.9 83.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.746 -0.661 . . . . 1.9399999999999999 110.487 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.8 mt -72.0 -41.56 68.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 1.02 110.328 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.28 -37.79 78.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.871 -0.604 . . . . 0.14999999999999999 110.011 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -61.43 -42.6 99.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.415 -0.811 . . . . 1.8999999999999999 110.409 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.68 -49.17 64.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.923 -0.58 . . . . 1.27 110.775 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.7 mt -57.88 -34.43 48.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.041 -0.527 . . . . 1.1899999999999999 111.413 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -41.34 87.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.42 0.526 . . . . 1.01 112.42 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -96.84 -11.7 24.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.001 0.741 . . . . 1.1200000000000001 113.001 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -106.6 -31.28 8.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.173 0.434 . . . . 1.1399999999999999 112.173 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.56 -173.65 29.58 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.479 -0.867 . . . . 0.45000000000000001 113.136 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -91.74 107.26 19.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.397 . . . . 1.8799999999999999 110.978 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.02 134.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.803 -0.814 . . . . 0.73999999999999999 108.803 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 96.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 1.48 111.491 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 1.4299999999999999 110.245 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.7 mm . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.728 0.299 . . . . 0.58999999999999997 110.651 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -132.78 15.56 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.541 . . . . 1.53 110.202 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.34 164.44 17.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.604 -0.726 . . . . 0.87 109.614 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -69.56 113.97 7.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.191 -0.3 . . . . 1.6000000000000001 110.191 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.68 -49.32 81.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.998 -0.546 . . . . 0.34000000000000002 110.253 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.504 ' HB3' ' OD1' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -143.63 119.61 10.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 1.71 109.732 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -18.69 59.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.57999999999999996 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 24.1 p-10 -84.63 -16.38 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.34000000000000002 110.837 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -104.58 132.27 51.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 1.3300000000000001 110.112 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.9 m -84.12 168.86 15.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.352 -0.385 . . . . 1.02 110.775 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -57.72 -36.58 72.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.51000000000000001 111.708 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -79.48 5.58 12.49 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 2.1299999999999999 112.098 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -111.15 -56.35 2.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.801 0.334 . . . . 0.65000000000000002 111.116 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.413 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.4 pt20 -99.25 27.92 4.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.479 -0.328 . . . . 0.71999999999999997 111.55 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.13 -48.68 70.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.23000000000000001 112.092 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.79 -30.84 64.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.352 -0.385 . . . . 0.28000000000000003 111.022 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.001 -0.28 . . . . 1.6499999999999999 110.437 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 155' ' ' GLN . 52.4 t -63.33 -52.9 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.371 -0.377 . . . . 1.3300000000000001 110.595 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.9 -32.24 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.345 -0.389 . . . . 0.57999999999999996 110.984 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -70.54 -35.11 72.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 2.29 110.244 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -35.46 80.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.93999999999999995 110.221 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.18 -37.6 81.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.344 0.592 . . . . 0.38 109.514 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -69.79 -33.32 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.163 -0.926 . . . . 2.1899999999999999 111.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 -27.56 64.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.885 0.374 . . . . 1.28 110.752 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -81.12 -47.21 13.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.704 -0.48 . . . . 1.8799999999999999 109.704 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.3 tpt -134.13 99.39 4.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.403 -0.591 . . . . 1.9199999999999999 109.403 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 113.06 5.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 1.29 111.151 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.472 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.453 -0.794 . . . . 1.45 110.521 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 18.1 ptt? . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.756 0.312 . . . . 0.34999999999999998 110.592 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.97 137.81 49.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 1.3799999999999999 110.451 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 32.2 mt -118.26 149.67 40.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.614 -0.513 . . . . 1.6299999999999999 109.614 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.432 ' HG2' ' HG2' ' A' ' 209' ' ' GLU . 16.1 ttp180 -110.67 136.78 49.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.386 -0.37 . . . . 1.4099999999999999 110.27 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 52.6 m-85 -99.65 137.94 37.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.28000000000000003 110.381 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -126.31 128.05 71.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.29999999999999999 110.581 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -167.63 155.51 8.35 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 1.1100000000000001 110.614 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.97 160.02 35.64 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.853 2.369 . . . . 0.29999999999999999 112.732 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.5 t -57.94 -37.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.251 -0.431 . . . . 0.28999999999999998 111.315 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -51.4 -38.77 55.16 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.65000000000000002 111.748 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 0.7 OUTLIER -102.05 -26.79 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.68999999999999995 111.282 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.51 -34.24 87.7 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 116.054 -0.521 . . . . 0.17000000000000001 113.61 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -61.69 -25.88 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.723 -0.281 . . . . 2.0600000000000001 111.596 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.511 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 13.4 mptt -62.35 -41.85 98.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.978 0.418 . . . . 1.3999999999999999 110.874 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 1.1 pp -87.75 -30.32 20.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.433 -0.348 . . . . 0.34000000000000002 111.133 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.33 -31.96 71.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 1.0700000000000001 111.675 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -86.62 -7.57 58.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.616 0.599 . . . . 1.71 112.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.511 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 26.1 mtmt -122.7 -29.89 3.95 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.129 0.788 . . . . 1.53 113.129 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -87.18 -32.82 19.62 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.164 0.431 . . . . 1.5 112.164 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 2.1 mtpt -72.55 -43.45 9.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.142 0.793 . . . . 1.76 113.142 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 11.0 Cg_endo -54.31 -34.63 80.96 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 122.415 2.077 . . . . 0.54000000000000004 113.642 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -92.73 13.75 19.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.772 -0.371 . . . . 0.90000000000000002 111.462 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 18.6 pt 33.22 56.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.435 1.094 . . . . 1.05 113.897 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -109.98 16.71 21.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 1.0700000000000001 109.773 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.41 152.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.376 -0.829 . . . . 0.65000000000000002 110.769 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 4.6 mp -84.89 144.8 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.347 -0.612 . . . . 1.4199999999999999 109.347 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -72.43 74.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.405 0.621 . . . . 2.46 111.029 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 m -157.07 27.04 0.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.296 -0.865 . . . . 1.6799999999999999 109.146 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 137.98 34.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.768 -0.651 . . . . 1.27 111.342 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.04 117.34 33.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.457 -0.571 . . . . 0.57999999999999996 109.457 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -98.62 59.2 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.983 0.42 . . . . 0.81000000000000005 111.342 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -109.24 -127.74 5.52 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.417 -0.896 . . . . 0.34999999999999998 111.684 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.06 -28.6 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 1.5700000000000001 109.458 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -118.62 117.97 30.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.805 -1.089 . . . . 1.23 108.405 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mp -80.42 79.09 7.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.126 0.489 . . . . 0.96999999999999997 111.093 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 6.0 tt0 -86.25 106.23 17.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.561 -0.745 . . . . 1.8100000000000001 109.201 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 8.0 mt -120.62 146.9 24.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.939 -0.573 . . . . 0.54000000000000004 111.089 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER -104.22 122.27 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.804 -0.443 . . . . 1.3600000000000001 109.804 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.544 ' O ' HD21 ' A' ' 213' ' ' LEU . 12.8 t -144.39 79.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.643 -0.423 . . . . 0.16 111.717 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 212' ' ' CYS . 0.6 OUTLIER -140.39 116.08 10.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.41999999999999998 109.622 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.3 tt -94.12 172.76 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 1.3500000000000001 111.432 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.452 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -58.01 168.89 1.02 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.612 0.765 . . . . 0.57999999999999996 111.513 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 41.3 Cg_endo -66.68 -172.66 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.271 1.981 . . . . 0.70999999999999996 112.875 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.03 -75.04 1.94 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.656 -0.783 . . . . 0.27000000000000002 111.435 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.96 -1.91 55.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.063 0.459 . . . . 1.1100000000000001 110.581 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.07 -26.78 67.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.548 . . . . 0.27000000000000002 111.449 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -80.2 -32.66 38.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.412 . . . . 2.3999999999999999 110.526 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -72.51 -36.12 68.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.41999999999999998 110.594 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 13.3 tt -79.32 -26.16 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.40999999999999998 110.849 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.85 -32.22 70.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.325 -0.398 . . . . 0.75 110.88 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.63 -35.47 68.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.0800000000000001 111.778 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.9 pp -95.02 -37.3 11.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.773 -0.371 . . . . 0.69999999999999996 110.889 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 33.5 mm -58.22 -39.87 75.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.718 0.294 . . . . 1.1499999999999999 111.308 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -63.98 -20.15 65.67 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.798 0.666 . . . . 1.52 112.798 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -118.96 5.06 11.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.745 -0.382 . . . . 2.25 111.841 -179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 1.0 OUTLIER -108.38 -73.39 0.69 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.846 0.355 . . . . 1.0 111.207 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -100.81 -34.95 9.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.077 0.399 . . . . 0.56000000000000005 112.077 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 61.4 tttm -77.54 -23.88 50.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.52 110.598 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.48 -8.44 62.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.25 112.044 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -113.46 -7.01 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 2.04 111.292 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -157.99 179.19 33.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.168 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 t -91.91 162.94 14.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.784 -0.45 . . . . 0.46999999999999997 109.784 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.51 144.83 44.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.797 0.332 . . . . 1.1299999999999999 110.912 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -140.63 176.49 8.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.885 -0.598 . . . . 1.8500000000000001 109.987 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.39 145.3 11.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.044 0.45 . . . . 0.71999999999999997 111.17 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.3 tp . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.368 0.604 . . . . 1.5600000000000001 110.522 179.633 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.962 0 N-CA-C 111.83 -0.508 . . . . 0.66000000000000003 111.83 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.3 p80 42.35 44.51 3.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.746 0.818 . . . . 1.04 112.281 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.7 tpp -137.97 -61.11 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.5 110.044 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.0 t -100.05 141.9 32.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.79000000000000004 109.629 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 pt -89.27 -31.63 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.976 -0.29 . . . . 0.90000000000000002 111.151 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -73.93 100.48 3.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.932 0.396 . . . . 0.91000000000000003 110.702 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.17 81.09 32.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.82999999999999996 110.292 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.09 141.98 19.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.848 2.366 . . . . 0.89000000000000001 112.449 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.01 133.84 35.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.863 0.364 . . . . 1.5800000000000001 110.981 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -155.24 171.15 20.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.881 -0.785 . . . . 0.97999999999999998 108.881 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -78.9 -56.65 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.578 0.227 . . . . 2.0 111.518 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.26 90.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 1.24 111.099 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.2 mmt-85 -148.1 149.77 32.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.474 -0.33 . . . . 2.0899999999999999 110.213 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.69 -6.32 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.984 0.421 . . . . 1.73 111.371 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -11.14 45.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.81999999999999995 110.716 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -119.15 25.57 10.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.012 -0.54 . . . . 0.20000000000000001 111.354 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -90.63 151.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.167 0.508 . . . . 0.29999999999999999 111.843 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.88 139.15 42.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.323 -0.853 . . . . 0.17999999999999999 109.342 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 46.0 t -80.13 120.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.906 0.384 . . . . 0.63 111.306 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG12 HG13 ' A' ' 31' ' ' ILE . 2.4 p -149.75 131.08 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 0.97999999999999998 109.572 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -148.67 148.58 30.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.835 0.35 . . . . 0.45000000000000001 111.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.4 ttp -108.1 129.85 55.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.128 -0.487 . . . . 0.34000000000000002 110.095 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.06 114.16 25.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.062 -0.517 . . . . 1.97 110.148 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.6 175.37 6.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 1.6599999999999999 109.541 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.67 92.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.704 0.288 . . . . 0.5 111.002 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.68 42.95 1.28 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.68 -0.772 . . . . 0.22 112.911 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 162.24 4.11 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.79 0.295 . . . . 2.3399999999999999 110.769 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 39.4 mmt180 -126.57 147.58 49.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 2.25 109.576 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -139.9 94.14 2.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.982 -0.377 . . . . 0.37 109.982 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -104.46 129.6 52.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.539 -0.3 . . . . 1.25 110.343 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.444 HG13 HG12 ' A' ' 20' ' ' VAL . 29.9 pt -131.48 -179.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.05 111.12 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.6 114.38 9.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.98999999999999999 111.015 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.63 179.45 3.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 0.42999999999999999 110.344 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.69 139.82 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.39000000000000001 110.77 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.75 -5.08 52.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 1.0600000000000001 112.241 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.43 78.2 4.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.573 0.225 . . . . 0.34999999999999998 110.861 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 tttp 50.97 60.43 3.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.656 -0.702 . . . . 2.23 110.389 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.4 p -57.15 -32.92 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.412 -0.813 . . . . 0.38 112.529 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -83.47 5.02 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.182 0.515 . . . . 0.19 111.409 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.12 -31.84 80.31 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 116.056 -0.52 . . . . 0.23000000000000001 113.607 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' CH2' ' HG3' ' A' ' 87' ' ' LYS . 47.5 p-90 -63.88 -25.04 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.869 0.335 . . . . 0.27000000000000002 111.78 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -80.75 -2.36 46.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.718 0.294 . . . . 0.59999999999999998 111.401 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -131.57 1.56 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.623 -0.262 . . . . 1.6499999999999999 111.072 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 40.03 42.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.879 -0.677 . . . . 0.34000000000000002 112.623 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.61 13.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 1.26 110.349 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 41' ' ' TRP . 0.8 OUTLIER -93.24 179.99 5.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 1.3100000000000001 110.855 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -116.26 -19.83 10.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.225 0.536 . . . . 1.3600000000000001 110.114 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -175.49 -177.54 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.304 -0.862 . . . . 0.54000000000000004 108.675 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.96 30.05 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 2.6200000000000001 110.773 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -120.63 -54.78 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 1.3200000000000001 110.502 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.55 -17.29 63.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 1.2 110.644 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.84 -18.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.47 0.652 . . . . 0.58999999999999997 109.728 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.78 99.48 12.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.25 109.733 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -68.36 -48.92 63.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.31 111.159 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -127.0 151.1 49.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.549 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -106.56 16.55 24.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.338 0.59 . . . . 0.78000000000000003 109.715 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.6 127.39 53.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.731 . . . . 0.63 110.204 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 68' ' ' ALA . 7.1 p -108.41 138.41 35.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.067 0.46 . . . . 0.12 110.444 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -95.69 130.49 42.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.266 -0.424 . . . . 0.37 110.538 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 10.3 t -86.13 -17.98 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.347 0.594 . . . . 0.20000000000000001 109.752 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -177.94 105.13 0.05 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.201 -0.909 . . . . 1.1599999999999999 109.717 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.52 -19.94 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.428 0.529 . . . . 0.12 112.428 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -36.66 73.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.975 0.417 . . . . 1.1399999999999999 110.812 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -91.25 -36.53 13.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.87 110.223 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.04 38.87 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.885 -0.674 . . . . 0.35999999999999999 111.801 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.47 104.49 16.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.72 0.295 . . . . 2.3900000000000001 110.553 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.0 t -92.85 116.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.548 -0.538 . . . . 0.47999999999999998 109.548 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB2' HG13 ' A' ' 58' ' ' VAL . . . -82.7 124.44 30.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.111 0.482 . . . . 0.23000000000000001 111.52 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 6.8 ptpp? -87.85 -175.64 5.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 1.1200000000000001 109.294 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HG3' ' OE2' ' A' ' 71' ' ' GLU . 11.7 pttm -60.61 -27.15 67.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.991 0.367 . . . . 1.3 111.991 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' OE2' ' HG3' ' A' ' 70' ' ' LYS . 8.3 mp0 -78.86 -32.43 46.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.222 0.534 . . . . 1.47 110.245 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 51.0 m-20 -68.72 -50.09 53.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.26000000000000001 110.74 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.89 -29.27 70.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.956 -0.298 . . . . 0.13 111.205 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.423 HG21 ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -71.26 -22.97 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.089 0.471 . . . . 1.7 109.969 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 m -95.33 -44.98 7.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.045 0.45 . . . . 0.40000000000000002 110.917 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.26 58.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.72 -51.59 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.078 -0.341 . . . . 1.55 110.078 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.21 16.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.722 -0.751 . . . . 0.28000000000000003 112.054 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 81' ' ' ASP . 5.2 m -125.09 137.85 54.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.163 -0.31 . . . . 1.9099999999999999 110.163 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.15 -11.54 57.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.503 -0.317 . . . . 0.40999999999999998 111.525 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' H ' HG21 ' A' ' 79' ' ' THR . 21.6 t70 -85.42 117.82 24.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.68000000000000005 110.705 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.96 -31.08 68.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.22 111.256 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.36 -47.63 75.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.625 0.25 . . . . 1.47 111.471 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.12 -51.07 71.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.998 0.428 . . . . 1.7 110.788 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mt -61.0 -51.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.648 -0.706 . . . . 0.23000000000000001 111.169 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 99.9 m -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.20999999999999999 111.152 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 27.4 ttpp -62.22 -42.08 98.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.491 -0.322 . . . . 0.82999999999999996 110.432 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.69 -43.33 89.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.33000000000000002 110.134 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.85 -32.57 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.305 0.574 . . . . 0.19 110.82 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.95 -32.05 61.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.818 -0.628 . . . . 0.27000000000000002 112.61 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -100.57 -13.54 18.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.789 0.662 . . . . 0.31 112.789 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.27 25.38 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.375 -0.203 . . . . 1.21 111.015 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -132.72 -175.98 14.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.032 -1.08 . . . . 0.17000000000000001 113.64 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -83.4 76.52 9.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.234 0.54 . . . . 1.74 109.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.99 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.624 -0.717 . . . . 0.77000000000000002 110.91 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.9 mm-40 -72.78 105.72 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.738 -0.467 . . . . 0.72999999999999998 109.738 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.19 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 1.1599999999999999 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 101' ' ' GLU . 1.3 m -79.79 115.28 19.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.81999999999999995 110.809 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -94.71 -25.75 16.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.269 -0.423 . . . . 1.3500000000000001 111.055 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -128.24 -72.85 0.6 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.412 -0.358 . . . . 2.27 110.469 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' A' ' 98' ' ' SER . 56.0 mm-40 -75.94 127.18 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.154 -0.475 . . . . 1.3899999999999999 110.085 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.75 62.29 7.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.171 -0.468 . . . . 2.1099999999999999 110.842 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -146.39 -179.78 6.99 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.33 -0.618 . . . . 0.32000000000000001 109.33 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.56 -142.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.164 0.29 . . . . 0.70999999999999996 110.606 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 76.19 1.95 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.166 0.508 . . . . 1.23 110.333 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 107' ' ' GLU . 4.7 tp -165.01 -172.06 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.446 -0.797 . . . . 0.71999999999999997 109.301 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.424 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 19.0 mm-40 58.74 28.0 16.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.425 0.453 . . . . 0.81999999999999995 111.81 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 63.54 25.96 14.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 111.507 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.6 tpt -65.43 -22.53 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 2.4399999999999999 111.206 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -70.93 -25.0 62.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.884 0.373 . . . . 0.40999999999999998 110.476 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -80.66 -17.52 50.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 1.1100000000000001 110.305 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.55 -57.27 12.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.895 -0.593 . . . . 0.78000000000000003 110.217 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.58 -29.16 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.64000000000000001 110.145 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.34 71.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.786 -0.643 . . . . 1.01 110.567 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -71.47 -38.0 71.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.929 -0.578 . . . . 1.8100000000000001 110.07 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.73 -39.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.739 -0.664 . . . . 1.95 111.248 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.46 -22.58 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.412 -0.358 . . . . 0.28999999999999998 111.438 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -56.28 23.96 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.807 0.299 . . . . 0.56999999999999995 111.807 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 2.7 m-20 -66.94 -16.75 64.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 2.2799999999999998 111.624 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HG3' ' OD1' ' A' ' 215' ' ' ASP . 3.9 ttmm -84.26 -8.64 58.98 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.18 0.437 . . . . 1.6299999999999999 112.18 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.3 m -132.65 156.26 47.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.927 0.394 . . . . 0.93999999999999995 111.129 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 60.8 t -111.57 128.2 68.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.76 -0.459 . . . . 2.1400000000000001 109.76 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -93.53 149.67 37.61 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.396 -0.366 . . . . 0.52000000000000002 110.591 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.27 172.1 14.74 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.182 1.921 . . . . 0.19 111.138 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 126' ' ' THR . 1.7 pt-20 -49.94 116.44 1.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.929 0.395 . . . . 1.1100000000000001 111.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 1.6 t 176.23 -26.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.44 -0.8 . . . . 0.89000000000000001 109.822 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm 175.83 -176.67 0.11 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.802 -0.814 . . . . 1.77 108.802 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -91.55 155.41 43.96 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.528 -0.175 . . . . 0.48999999999999999 110.528 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.8 -7.5 7.66 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.212 2.608 . . . . 0.34999999999999998 113.75 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.13 -14.87 61.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.79000000000000004 110.382 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -74.91 81.3 2.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.20000000000000001 110.906 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.52 -38.32 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.14999999999999999 110.932 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.3 mm -57.69 -34.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.55000000000000004 111.53 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.41 -44.48 94.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.56000000000000005 111.447 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.2 tt -81.24 -30.92 11.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.902 -0.319 . . . . 0.27000000000000002 111.173 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.533 ' CD ' ' HZ2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -66.6 -37.29 84.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.353 -0.385 . . . . 0.58999999999999997 110.638 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.502 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 3.4 mmm180 -61.53 -31.12 71.12 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.28 111.59 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.23 -31.46 16.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.047 0.451 . . . . 0.35999999999999999 110.726 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 3.0 tpt -65.13 -51.92 58.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.524 -0.762 . . . . 1.6599999999999999 111.289 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' HZ2' ' CD ' ' A' ' 136' ' ' GLU . 1.9 ptpp? -78.13 -5.15 50.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.29999999999999999 111.676 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -80.23 -45.9 17.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.901 0.382 . . . . 0.51000000000000001 110.488 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.54 -49.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.73 110.667 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -129.22 98.97 5.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.69999999999999996 110.449 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -67.62 147.24 52.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 2.0499999999999998 109.81 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.409 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 31.5 m 58.78 61.65 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.523 0.678 . . . . 2.1099999999999999 110.625 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -4.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 1.3500000000000001 111.138 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -95.15 -30.64 13.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 1.6200000000000001 109.816 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 145' ' ' SER . 1.4 m -66.3 123.75 20.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 1.1299999999999999 110.93 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.04 42.02 3.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.905 0.882 . . . . 0.46000000000000002 112.229 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -67.69 111.28 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.72 -0.673 . . . . 1.95 110.761 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -82.73 101.88 11.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 1.5900000000000001 110.046 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.7 p -58.6 -76.9 0.04 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 112.358 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -82.35 62.27 5.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.93 0.395 . . . . 1.54 111.296 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -166.07 -48.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.167 -0.47 . . . . 0.78000000000000003 110.459 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.8 22.38 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.65000000000000002 110.964 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.59 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 0.16 111.938 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 4.1 mm? -74.51 -34.84 63.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.552 -0.295 . . . . 0.88 111.033 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.6 -48.86 70.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.17 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.76 -48.27 81.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.23999999999999999 111.951 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.78 -28.66 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.761 0.315 . . . . 0.38 111.594 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.0 mmtp -80.74 -33.81 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 1.0700000000000001 110.359 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.7 -39.19 93.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 2.7200000000000002 110.199 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.97 -46.89 73.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 110.162 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -62.04 -30.23 70.83 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.8 -0.636 . . . . 1.5900000000000001 111.429 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -53.76 -44.57 70.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.56999999999999995 110.409 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 -69.81 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 1.1699999999999999 110.15 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 62.2 ttp -102.37 123.93 47.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.007 -0.542 . . . . 0.41999999999999998 111.079 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.99 99.52 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.02 -0.536 . . . . 1.3700000000000001 110.401 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 pt -74.8 157.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.34 -0.846 . . . . 1.8799999999999999 110.895 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 122' ' ' VAL . 8.6 mm-40 -98.53 101.79 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.234 -0.439 . . . . 1.1799999999999999 110.311 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 63.76 -169.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.707 -0.679 . . . . 2.1299999999999999 111.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -161.12 -162.0 0.87 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.33000000000000002 109.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.491 ' HE1' ' O ' ' A' ' 213' ' ' LEU . 64.9 t60 -78.44 113.89 16.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 2.46 110.79 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.839 -0.619 . . . . 1.46 110.903 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -128.42 134.67 48.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.441 -0.345 . . . . 3.0499999999999998 111.172 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 211' ' ' VAL . 2.7 mp -129.49 145.76 51.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 0.5 110.108 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.455 ' HB3' HG22 ' A' ' 211' ' ' VAL . 9.8 ptm180 -126.72 132.12 51.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.384 -0.371 . . . . 0.28999999999999998 110.413 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 22.0 m-85 -92.95 140.37 29.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 0.52000000000000002 110.533 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.403 ' C ' HD12 ' A' ' 180' ' ' LEU . 14.3 mt -120.85 118.37 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.527 -0.306 . . . . 0.28999999999999998 111.309 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 179' ' ' ILE . 0.0 OUTLIER -152.12 156.43 33.91 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.95 -0.568 . . . . 0.14999999999999999 109.906 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.31 172.4 12.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.66 2.24 . . . . 0.14999999999999999 112.516 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.8 -44.95 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.387 -0.37 . . . . 0.91000000000000003 111.652 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -52.92 -55.84 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.981 -0.554 . . . . 1.24 111.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.55 -27.24 61.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.424 -0.353 . . . . 0.25 111.403 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.57 -34.78 90.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.216 -0.516 . . . . 0.19 111.893 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -77.75 52.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.36 0.6 . . . . 0.68999999999999995 109.813 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -152.59 -46.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.258 -0.883 . . . . 1.99 109.477 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.53 -26.21 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 1.1399999999999999 110.693 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 12.0 ttpt -67.31 -21.73 65.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.47 . . . . 1.3400000000000001 110.603 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.9 OUTLIER -100.19 8.76 43.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.481 . . . . 0.85999999999999999 110.921 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -124.85 -45.49 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.568 -0.287 . . . . 0.64000000000000001 111.08 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.4 mt -78.29 -35.39 47.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.715 0.265 . . . . 1.1399999999999999 111.715 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 23.7 mmtt -62.4 -52.71 64.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.271 0.471 . . . . 1.6499999999999999 112.271 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.7 Cg_endo -58.98 -24.6 74.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.153 1.902 . . . . 0.29999999999999999 113.073 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.55 -22.05 54.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 1.01 110.765 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.3 mm 59.3 66.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.41999999999999998 110.518 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -134.19 15.11 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.765 -0.652 . . . . 1.3600000000000001 109.91 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.14 163.69 2.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.328 0.585 . . . . 0.54000000000000004 112.07 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.85 160.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.378 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.41 64.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 2.2400000000000002 111.095 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.503 ' O ' HG21 ' A' ' 211' ' ' VAL . 2.3 t -161.65 90.36 0.78 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.34 -0.615 . . . . 0.80000000000000004 109.34 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.79 163.86 29.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 1.6699999999999999 110.423 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -119.18 131.47 55.85 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.939 -0.763 . . . . 0.28000000000000003 108.939 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.45 31.56 6.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.55000000000000004 111.29 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -96.11 -115.76 3.11 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.832 -0.699 . . . . 0.35999999999999999 112.275 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -91.63 -22.6 20.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.83999999999999997 110.148 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.46 123.15 40.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 2.04 109.345 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.94 77.89 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.032 0.444 . . . . 1.24 110.932 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 29.7 mt-10 -75.45 118.65 18.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.052 -0.522 . . . . 1.04 109.884 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 34.1 mt -122.84 126.81 74.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.877 0.37 . . . . 0.56999999999999995 110.847 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 201' ' ' SER . 39.4 t -94.09 104.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.91000000000000003 109.731 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.6 t -130.91 115.56 16.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.15 -0.477 . . . . 0.20999999999999999 110.121 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.491 ' O ' ' HE1' ' A' ' 173' ' ' HIS . 0.2 OUTLIER -164.7 125.3 2.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.918 -0.583 . . . . 1.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.439 ' CG1' ' H ' ' A' ' 215' ' ' ASP . 3.3 tt -104.84 -170.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.566 -0.288 . . . . 0.69999999999999996 110.319 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 119' ' ' ASP . 37.4 m-20 -62.27 141.14 96.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.512 0.196 . . . . 1.3 110.572 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.77 -26.73 83.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.051 2.5 . . . . 0.98999999999999999 113.362 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.71 78.85 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.761 -0.733 . . . . 0.65000000000000002 111.945 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 62.6 m -110.68 25.44 11.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 2.04 110.558 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -60.11 -32.42 70.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.65000000000000002 111.277 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -18.52 59.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.93000000000000005 110.893 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.5 -24.68 24.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.40000000000000002 111.096 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.6 tp -96.13 -42.43 12.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.691 -0.404 . . . . 1.5 111.459 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.404 ' N ' HG21 ' A' ' 222' ' ' ILE . 18.5 t70 -67.17 -22.4 65.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.881 0.326 . . . . 0.33000000000000002 111.881 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.27 -28.28 64.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.65 0.262 . . . . 1.1399999999999999 111.352 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.38 -37.35 6.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.609 -0.269 . . . . 1.1499999999999999 110.365 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -59.09 -34.31 52.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 1.1899999999999999 111.27 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 16.6 ptpt -53.91 -31.5 50.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.707 0.632 . . . . 1.73 112.707 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -113.52 -25.29 8.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 2.6800000000000002 112.063 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 228' ' ' LYS . 0.4 OUTLIER -69.79 -41.97 74.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.174 0.435 . . . . 1.3300000000000001 112.174 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.0 t -135.8 -37.48 0.74 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.373 -0.531 . . . . 0.34999999999999998 112.376 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 42.0 mtpt -59.67 -41.52 90.82 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 1.0700000000000001 110.731 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.41 38.03 3.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.17000000000000001 111.535 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -151.97 -53.36 0.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.645 0.26 . . . . 0.68000000000000005 110.649 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -114.97 -168.16 15.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.074 -0.584 . . . . 0.13 111.995 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.9 m -101.81 144.5 30.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.956 -0.387 . . . . 0.81000000000000005 109.956 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.32 119.19 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 1.0600000000000001 110.612 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -113.22 151.68 30.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.731 -0.668 . . . . 0.39000000000000001 109.904 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.79 145.1 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.639 0.256 . . . . 1.04 110.705 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.6 tp -107.21 98.64 8.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 0.39000000000000001 109.497 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -117.25 -7.83 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.328 -0.396 . . . . 0.55000000000000004 111.546 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.16 109.2 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 1.8600000000000001 111.06 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -103.29 8.66 38.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.729 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.75 10.93 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.509 0.671 . . . . 1.54 110.227 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.6 p -123.19 172.38 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.97999999999999998 109.306 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.42 ' H ' HG22 ' A' ' 244' ' ' VAL . 3.9 tp10 -67.58 115.07 6.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.999 0.428 . . . . 1.6399999999999999 110.267 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.436 ' HB3' ' OG ' ' A' ' 201' ' ' SER . 40.5 mt-10 -75.29 -38.78 60.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.044 -0.525 . . . . 1.46 111.141 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 150.34 -123.36 1.54 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.131 -0.787 . . . . 0.33000000000000002 111.131 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.83 132.21 54.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.759 0.314 . . . . 1.6699999999999999 110.388 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -114.3 -0.35 13.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.284 0.564 . . . . 0.68999999999999995 110.256 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.22 146.62 15.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 2.6000000000000001 109.825 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -85.36 -6.78 59.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.996 0.427 . . . . 0.78000000000000003 110.292 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.356 -0.831 . . . . 2.1400000000000001 110.593 179.783 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.596 -0.602 . . . . 0.33000000000000002 111.596 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -118.99 150.83 39.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.828 0.347 . . . . 2.1200000000000001 110.831 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -104.06 133.05 49.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.096 -0.502 . . . . 1.3300000000000001 110.049 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -61.24 2.65 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.263 0.352 . . . . 1.3700000000000001 110.855 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mp -104.73 -85.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.861 -0.422 . . . . 0.90000000000000002 109.861 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -126.02 -66.26 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.261 0.553 . . . . 0.56000000000000005 109.598 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.85 81.22 9.22 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.853 -0.612 . . . . 1.05 109.961 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.5 160.68 28.57 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.987 2.458 . . . . 0.81999999999999995 112.214 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.16 149.35 30.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.224 -0.444 . . . . 1.03 110.479 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.22 177.09 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.448 -0.575 . . . . 0.67000000000000004 109.448 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.88 -77.04 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.713 0.292 . . . . 1.6399999999999999 111.01 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.12 76.05 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.338 0.59 . . . . 2.0699999999999998 110.603 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -147.91 159.21 44.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.43 -0.805 . . . . 2.1200000000000001 109.258 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.53 42.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.62 110.337 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 p -110.82 -66.01 1.12 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.001 -0.545 . . . . 0.23999999999999999 110.427 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -92.34 60.18 3.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.48 0.657 . . . . 1.29 109.464 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.41 HG12 ' OE1' ' A' ' 54' ' ' GLN . 17.0 m -100.08 148.44 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.354 -0.839 . . . . 0.20000000000000001 111.453 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.471 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -113.6 114.6 26.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.831 -0.622 . . . . 0.22 109.904 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.46 121.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.95999999999999996 110.838 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.9 p -133.43 122.3 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.966 -0.561 . . . . 0.25 110.316 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -110.36 128.4 55.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.518 . . . . 0.47999999999999998 110.733 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.8 ttp -89.35 141.75 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.28000000000000003 110.963 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.89 122.35 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.9199999999999999 110.316 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -125.22 32.62 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.846 -0.161 . . . . 0.85999999999999999 110.988 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.14 70.84 0.49 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.757 0.661 . . . . 0.56999999999999995 111.805 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 -35.62 4.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.876 -0.678 . . . . 0.67000000000000004 111.654 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -106.07 148.48 27.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.154 -0.684 . . . . 2.2999999999999998 109.154 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.21 153.62 51.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.636 0.255 . . . . 2.5499999999999998 110.434 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -144.82 116.6 8.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.274 -0.639 . . . . 0.53000000000000003 109.274 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 59' ' ' PHE . 3.3 pm0 -112.0 132.94 54.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.16 111.661 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -128.94 145.75 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.571 -0.74 . . . . 1.1599999999999999 109.905 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.85 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.503 -0.317 . . . . 0.94999999999999996 110.263 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.03 171.17 7.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.365 -0.379 . . . . 0.16 110.347 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.23 119.68 13.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.28000000000000003 109.908 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -75.32 69.61 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 1.0800000000000001 111.135 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.03 64.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.63 109.321 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.51 50.96 13.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.808 -0.633 . . . . 1.6100000000000001 110.326 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.86 10.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.359 -0.837 . . . . 1.1299999999999999 112.901 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.6 12.39 7.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.734 0.778 . . . . 1.0600000000000001 109.463 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.18 -49.06 7.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.41999999999999998 113.055 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.532 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -69.27 -0.41 6.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.017 0.437 . . . . 2.1600000000000001 111.278 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH1' ' HB3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -96.09 1.13 52.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.203 0.525 . . . . 2.9300000000000002 109.71 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 m -141.77 -37.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.454 -0.794 . . . . 1.1100000000000001 110.14 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA3' ' OE1' ' A' ' 154' ' ' GLN . . . -150.75 -115.78 0.72 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.255 -0.738 . . . . 0.28000000000000003 111.255 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.36 137.99 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.087 0.443 . . . . 1.48 110.992 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 4.6 pt-20 -109.57 -73.05 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.377 -0.374 . . . . 1.05 110.025 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 20.4 ptmt -170.71 -172.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.035 -0.728 . . . . 1.97 109.035 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' OD1' ' HB2' ' A' ' 50' ' ' ASP . 9.5 t0 -65.61 124.01 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.75 110.483 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 tp -70.48 -17.31 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 1.4199999999999999 111.951 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -59.84 -35.86 75.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.07 0.462 . . . . 1.6699999999999999 110.503 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.83 -33.41 21.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 1.49 110.465 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.62 -38.39 82.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.884 -0.598 . . . . 0.40999999999999998 111.246 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.83 84.05 6.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.051 -0.351 . . . . 0.26000000000000001 110.051 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' OE1' HG12 ' A' ' 17' ' ' VAL . 37.4 mt-30 -66.26 -77.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.40000000000000002 111.098 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -74.96 129.21 37.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.32000000000000001 110.23 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -93.82 12.28 26.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.368 0.604 . . . . 0.66000000000000003 110.034 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.495 -0.775 . . . . 0.17999999999999999 109.962 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.65 146.3 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.692 -0.485 . . . . 1.0700000000000001 109.692 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 19.0 m-85 -104.94 140.16 38.58 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.885 -0.413 . . . . 0.83999999999999997 109.885 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 2.4 t -92.58 -16.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 1.03 110.339 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -178.97 95.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.536 -0.757 . . . . 0.45000000000000001 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.67 -27.45 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.432 . . . . 0.37 111.53 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 m -68.35 -20.63 64.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.785 0.326 . . . . 0.46999999999999997 111.461 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.71 3.95 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 2.0899999999999999 110.419 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 28.14 73.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.14000000000000001 112.109 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.08 102.43 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.73999999999999999 110.711 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 128.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.029 -0.532 . . . . 0.25 110.516 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.24 116.62 32.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.94999999999999996 110.15 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -87.09 178.89 6.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.985 -0.552 . . . . 2.98 110.253 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -23.93 67.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.258 -0.177 . . . . 0.41999999999999998 111.438 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -87.22 0.94 54.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.782 0.325 . . . . 0.45000000000000001 110.593 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.5 -42.22 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.25 -0.432 . . . . 1.21 110.738 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.5 -28.19 68.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.784 0.326 . . . . 0.25 110.765 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -68.85 -28.7 40.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.199 0.523 . . . . 1.8799999999999999 110.067 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.74 20.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.932 -0.576 . . . . 1.45 110.296 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 -56.76 9.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.793 -0.64 . . . . 0.53000000000000003 111.736 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -102.86 -55.15 2.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.652 0.263 . . . . 1.1200000000000001 111.003 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.85 -32.28 1.58 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.671 . . . . 0.26000000000000001 111.954 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.41 133.38 33.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.608 0.242 . . . . 0.93999999999999995 110.758 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.08 2.86 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.973 0.416 . . . . 0.68000000000000005 110.595 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 85' ' ' ILE . 6.8 t70 -91.39 126.43 36.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.934 -0.575 . . . . 1.1399999999999999 110.234 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.29 -27.3 63.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.569 . . . . 1.0800000000000001 111.13 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -62.66 -49.1 76.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.359 -0.382 . . . . 1.6399999999999999 110.409 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 87' ' ' LYS . 6.4 mm-40 -61.02 -43.25 99.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.58999999999999997 110.899 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 81' ' ' ASP . 50.1 mm -60.61 -49.29 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.31 110.114 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.443 ' HG ' HD23 ' A' ' 90' ' ' LEU . 52.8 t -64.7 -34.3 77.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.12 110.949 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 29.4 ttpt -61.31 -43.99 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.57999999999999996 110.403 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -68.85 -38.64 79.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.84999999999999998 110.472 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -67.34 -33.44 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.39000000000000001 110.799 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD23 ' HG ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -77.91 -12.11 59.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.97 -0.559 . . . . 1.0900000000000001 112.504 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 92' ' ' LYS . 14.6 t -116.1 -21.37 9.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 1.23 112.046 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HG2' HG23 ' A' ' 91' ' ' THR . 33.0 mmmt -124.8 25.91 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.025 0.44 . . . . 0.69999999999999996 110.249 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.6 176.63 19.08 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.669 -0.777 . . . . 0.40999999999999998 112.322 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -85.31 82.81 8.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 2.48 111.365 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.18 124.93 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.119 -0.492 . . . . 1.52 110.268 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 18' ' ' ALA . 3.4 pt20 -75.79 109.29 9.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.172 0.511 . . . . 0.79000000000000004 110.011 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.27 128.62 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.254 0.55 . . . . 0.28999999999999998 111.095 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.64 150.75 52.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.674 . . . . 0.65000000000000002 110.029 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.3 t70 -91.36 -154.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.518 -0.31 . . . . 0.59999999999999998 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 7.0 mmmm 74.4 52.54 0.09 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.235 0.614 . . . . 1.97 110.597 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.82 110.29 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.095 -0.957 . . . . 1.8700000000000001 110.564 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -175.05 175.73 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.451 -0.574 . . . . 1.95 109.451 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.4 ' H ' ' HG3' ' A' ' 102' ' ' ARG . 45.1 m80 72.38 50.89 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.21 0.604 . . . . 2.71 110.44 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 175.79 10.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.389 -0.823 . . . . 1.1899999999999999 111.313 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.76 154.34 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.922 -0.399 . . . . 0.79000000000000004 109.922 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.78 74.79 4.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.352 0.596 . . . . 0.90000000000000002 111.237 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -115.03 -173.2 2.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.608 -0.724 . . . . 1.28 109.775 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -79.74 61.3 3.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.528 -0.545 . . . . 1.75 109.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.46 ' O ' HG12 ' A' ' 113' ' ' ILE . 73.2 mmm -52.92 -50.18 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 1.6599999999999999 111.65 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -63.89 -22.71 67.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.274 -0.421 . . . . 0.55000000000000004 111.992 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.78 -44.85 12.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 2.1499999999999999 110.307 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -45.12 88.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.214 -0.448 . . . . 0.82999999999999996 110.82 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 109' ' ' MET . 44.5 pt -64.85 -29.87 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.875 0.369 . . . . 0.44 110.288 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.07 79.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.357 0.599 . . . . 0.26000000000000001 109.807 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -67.02 -38.36 85.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.5 -0.773 . . . . 1.8300000000000001 110.262 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.414 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 1.3 mp -69.46 -51.55 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.901 -0.59 . . . . 1.77 111.163 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.6 -30.27 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 111.811 0.3 . . . . 0.17999999999999999 111.811 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.37 69.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.32000000000000001 110.648 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.42 23.78 1.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.497 . . . . 0.93999999999999995 110.695 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -129.52 6.18 5.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.88 109.737 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.08 162.59 35.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.421 -0.809 . . . . 0.42999999999999999 109.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 125.85 53.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.087 0.47 . . . . 0.62 110.918 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -103.66 155.17 37.29 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.7 -0.682 . . . . 0.28000000000000003 109.989 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.84 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.421 2.08 . . . . 0.68000000000000005 111.666 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HB ' ' A' ' 126' ' ' THR . 1.7 pm0 -63.57 124.32 21.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 1.3700000000000001 110.881 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 6.0 t 177.83 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 1.1699999999999999 110.444 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -161.21 -77.4 0.05 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.687 0.279 . . . . 1.8899999999999999 110.38 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -161.07 158.18 23.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.065 -0.717 . . . . 1.0600000000000001 109.065 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.57 -32.71 95.09 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.263 1.976 . . . . 0.23000000000000001 111.597 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.3 90.02 3.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.08 -0.711 . . . . 0.76000000000000001 109.08 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 m -114.0 109.98 19.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.32000000000000001 111.595 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.23 -31.83 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.438 0.637 . . . . 0.93999999999999995 109.375 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.8 mm -66.3 -24.86 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.365 -0.834 . . . . 0.23000000000000001 111.032 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.7 tp -62.12 -55.48 28.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 0.51000000000000001 110.043 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.56 -31.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 1.04 110.061 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 11.6 tt0 -59.49 -44.89 92.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 1.2 110.063 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.88 68.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 1.4299999999999999 110.936 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.6 18.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.393 -0.367 . . . . 0.33000000000000002 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 39.0 tpp -65.52 -36.21 83.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.359 0.599 . . . . 1.28 109.769 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 1.3 tmtp? -65.93 -32.65 74.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 2.54 109.425 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.57 -65.74 0.86 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.221 -0.9 . . . . 0.56999999999999995 110.407 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.63 63.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.494 0.664 . . . . 0.22 110.108 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -78.18 56.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.337 -0.847 . . . . 0.80000000000000004 110.909 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.05 169.57 17.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.973 -0.558 . . . . 3.1600000000000001 110.694 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.03 107.08 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 1.04 110.059 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.3 69.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.004 0.431 . . . . 0.58999999999999997 109.973 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 61.72 85.27 0.12 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.406 -0.815 . . . . 1.5700000000000001 110.383 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.1 m -80.42 44.79 0.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.859 -0.609 . . . . 0.40999999999999998 111.354 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.46 -21.11 28.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.907 -0.588 . . . . 0.33000000000000002 109.79 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 80.9 1.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.448 -0.796 . . . . 1.1100000000000001 109.58 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -86.14 16.33 4.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.47999999999999998 112.039 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 131.82 51.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.553 -0.294 . . . . 1.3400000000000001 111.424 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 58.24 48.56 12.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.715 -0.675 . . . . 1.78 111.299 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.422 ' OE1' ' HA3' ' A' ' 44' ' ' GLY . 24.1 tt0 59.41 53.11 5.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.537 -0.756 . . . . 0.98999999999999999 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.1 30.29 19.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.306 -0.861 . . . . 0.28999999999999998 112.071 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.58 85.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.23999999999999999 110.521 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.55 -7.85 50.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.713 -0.676 . . . . 1.1000000000000001 111.234 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -99.56 -47.04 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.537 -0.542 . . . . 0.93999999999999995 109.537 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.47999999999999998 111.426 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.62 -15.14 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.053 0.454 . . . . 0.71999999999999997 111.457 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -109.06 0.04 19.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.319 0.581 . . . . 2.3500000000000001 110.355 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -84.55 -54.26 4.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.617 -0.719 . . . . 0.64000000000000001 109.787 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -69.25 -18.9 63.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.23000000000000001 110.435 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.532 ' N ' HD12 ' A' ' 163' ' ' LEU . 46.6 tttm -69.35 -22.01 63.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.91000000000000003 110.11 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -81.66 -12.82 58.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.835 -0.62 . . . . 0.63 110.391 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.82 -39.65 5.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.178 -0.465 . . . . 1.04 110.731 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.3 tpp -141.79 143.98 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.5 110.722 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -96.4 119.59 35.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.281 -0.418 . . . . 0.98999999999999999 110.282 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.97 170.05 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.285 -0.416 . . . . 1.2 110.78 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.68 141.73 29.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.727 -0.842 . . . . 2.0600000000000001 108.727 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 24.37 0.29 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.417 . . . . 2.9399999999999999 111.604 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.27 120.25 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.81999999999999995 110.267 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 154.11 32.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.324 . . . . 0.38 110.876 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 40.5 mtm -138.88 177.46 7.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.419 . . . . 1.95 110.012 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -102.02 131.54 48.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.369 -0.604 . . . . 1.74 109.369 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.7 mp -116.5 157.22 25.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.203 0.525 . . . . 0.58999999999999997 111.325 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.59 ' HB2' ' OE2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -127.77 160.58 31.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.143 -0.935 . . . . 1.8600000000000001 108.9 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -129.3 128.61 43.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.695 0.283 . . . . 0.68999999999999995 110.463 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -114.52 121.69 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.466 0.651 . . . . 1.3700000000000001 111.386 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.433 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -150.1 157.31 37.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.421 -0.808 . . . . 0.13 109.902 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.21 163.85 11.47 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.688 2.259 . . . . 0.11 112.501 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.23 -39.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.256 -0.429 . . . . 0.31 112.05 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -57.95 -60.79 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.726 0.298 . . . . 0.53000000000000003 111.638 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.87 -19.46 61.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 1.4399999999999999 111.509 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.86 72.87 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.943 -0.646 . . . . 0.22 111.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -61.82 -32.65 72.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.614 0.245 . . . . 2.1899999999999999 110.712 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -55.75 -43.97 77.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.014 -0.539 . . . . 1.55 111.668 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 -35.27 12.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.416 -0.356 . . . . 0.55000000000000004 111.63 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.77 -34.25 75.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.688 0.28 . . . . 2.52 111.171 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -95.88 20.73 9.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.807 0.299 . . . . 1.23 111.807 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -146.35 -45.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.447 0.536 . . . . 1.6899999999999999 112.447 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -75.89 -39.71 55.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.662 0.268 . . . . 0.60999999999999999 111.494 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.587 ' HZ3' ' CD ' ' A' ' 202' ' ' GLU . 5.2 mtpt -58.6 -52.79 72.19 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.191 -0.459 . . . . 1.6699999999999999 112.002 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 34.1 Cg_endo -65.12 -12.5 35.03 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.056 1.837 . . . . 0.11 112.961 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.8 mt -88.64 -7.52 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.359 . . . . 0.22 110.304 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 6.8 mm 59.64 40.26 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.519 -0.764 . . . . 0.40000000000000002 110.815 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -112.21 19.96 17.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 1.4299999999999999 109.947 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.68 139.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.813 -0.631 . . . . 0.40000000000000002 111.053 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.93 164.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.812 -0.631 . . . . 1.8999999999999999 110.039 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -71.14 56.29 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 1.6699999999999999 111.092 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.2 m -156.17 88.21 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.907 -0.775 . . . . 0.77000000000000002 108.907 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.587 ' CD ' ' HZ3' ' A' ' 193' ' ' LYS . 2.4 pt-20 -134.94 140.03 45.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.533 -0.758 . . . . 1.1499999999999999 110.396 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.37 137.41 53.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.629 -0.508 . . . . 0.47999999999999998 109.629 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.29 30.38 7.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 1.28 111.501 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -79.72 -140.28 2.16 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.729 -0.748 . . . . 1.3100000000000001 112.847 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.63 -20.96 66.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.93 0.395 . . . . 1.26 111.529 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -136.09 143.2 44.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.923 -0.399 . . . . 1.26 109.923 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.99 85.53 6.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.46999999999999997 110.75 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.59 ' OE2' ' HB2' ' A' ' 177' ' ' ARG . 10.3 tp10 -90.28 106.21 18.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.137 -0.69 . . . . 1.5 109.137 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.79 134.62 58.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.957 0.408 . . . . 0.23000000000000001 111.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.5 t -84.53 108.01 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.17999999999999999 110.21 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.0 m -126.59 90.35 3.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.135 -0.484 . . . . 0.35999999999999999 110.406 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.411 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -155.78 132.01 10.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.28000000000000003 109.837 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.82 173.21 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.521 -0.309 . . . . 1.5600000000000001 110.276 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 4.1 m-20 -69.51 169.35 12.54 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.456 -0.338 . . . . 1.22 110.417 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 27.4 Cg_exo -63.49 -161.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.642 2.228 . . . . 0.81999999999999995 112.794 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.62 -98.52 1.55 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.34000000000000002 111.718 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 68.9 m -75.98 0.88 16.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 1.9299999999999999 111.563 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 44.3 t80 -61.46 -32.3 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 0.28999999999999998 111.033 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -9.1 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 1.6200000000000001 111.701 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -92.7 -32.69 14.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.794 0.331 . . . . 1.1000000000000001 110.567 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' ' 226' ' ' ILE . 4.8 tp -94.51 -31.37 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.384 0.513 . . . . 2.0499999999999998 112.384 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.491 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -60.24 -28.12 67.77 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.33 -0.231 . . . . 0.94999999999999996 111.42 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -56.43 -35.37 67.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.81 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.2 pp -95.81 -24.89 16.26 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 1.29 110.492 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -61.59 -38.1 79.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.367 -0.379 . . . . 0.55000000000000004 110.693 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 223' ' ' ASP . 13.7 ptpt -64.31 -16.48 62.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.656 0.613 . . . . 0.28999999999999998 112.656 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.57 -23.47 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.613 -0.435 . . . . 0.80000000000000004 111.838 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -81.93 -43.23 18.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.588 0.588 . . . . 0.92000000000000004 112.588 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -128.18 -38.87 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.364 -0.535 . . . . 0.34999999999999998 111.914 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 14.7 tttt -63.76 -28.06 69.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.941 0.401 . . . . 2.8500000000000001 110.563 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -102.13 16.98 55.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.912 -0.661 . . . . 0.32000000000000001 112.123 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.7 -36.09 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.339 . . . . 0.39000000000000001 111.044 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.51 -156.04 6.65 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.515 -0.85 . . . . 0.28000000000000003 112.725 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 m -101.98 137.7 39.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.875 0.369 . . . . 0.20000000000000001 110.425 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.13 149.11 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 1.01 111.013 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.35 161.04 39.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.678 . . . . 0.33000000000000002 109.168 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.2 m -99.04 148.45 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.762 0.315 . . . . 0.27000000000000002 111.066 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -87.26 94.12 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.576 -0.527 . . . . 0.64000000000000001 109.576 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.81 9.59 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.693 -0.685 . . . . 0.78000000000000003 110.304 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 85.07 6.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.76000000000000001 110.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -108.13 -6.98 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 1.1200000000000001 110.502 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.0 -76.24 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.15 -0.477 . . . . 0.48999999999999999 110.468 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -98.49 161.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.927 -0.578 . . . . 0.52000000000000002 110.077 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -80.4 155.77 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.885 -0.413 . . . . 0.78000000000000003 109.885 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -130.43 140.51 50.56 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.502 -0.317 . . . . 1.24 110.191 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 151.79 127.34 1.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.558 -0.829 . . . . 0.56999999999999995 112.235 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -111.0 68.56 0.66 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.666 0.746 . . . . 1.24 109.134 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -76.43 -8.12 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.136 -0.938 . . . . 0.55000000000000004 111.441 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -83.38 70.78 10.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.101 0.476 . . . . 1.3700000000000001 110.68 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -79.27 -12.63 59.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.21 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 115.803 -0.635 . . . . 2.0699999999999998 110.068 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.521 -0.632 . . . . 0.97999999999999998 111.521 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -145.06 148.2 33.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.805 -0.443 . . . . 0.64000000000000001 109.805 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 mtt -116.28 98.72 6.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.153 0.501 . . . . 1.27 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.78 90.58 4.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.85999999999999999 110.829 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.2 mt -61.66 -54.89 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.46000000000000002 110.915 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -130.22 149.26 52.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.668 . . . . 0.28999999999999998 109.828 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.9 m -152.44 88.88 3.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.735 0.302 . . . . 0.26000000000000001 111.399 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.41 126.47 14.26 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.214 1.943 . . . . 0.22 111.101 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -108.54 94.22 4.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.912 0.387 . . . . 0.25 110.887 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HB2' ' H ' ' A' ' 11' ' ' GLN . 5.0 m120 -107.88 -89.57 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.37 110.293 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' H ' ' HB2' ' A' ' 10' ' ' ASN . 24.8 mm-40 -137.51 -88.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.675 -0.491 . . . . 0.33000000000000002 109.675 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.01 107.64 23.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.316 -0.624 . . . . 1.3899999999999999 109.316 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -158.31 152.44 24.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.1 -0.5 . . . . 1.5800000000000001 110.373 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -78.77 49.06 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.62 110.968 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.3 p -129.04 -45.61 1.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.128 0.49 . . . . 0.25 110.606 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -106.69 39.54 1.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.28000000000000003 109.672 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.38 135.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.29999999999999999 111.581 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.06 116.08 31.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.966 -0.561 . . . . 0.14999999999999999 109.844 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.6 114.73 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.845 -0.616 . . . . 1.04 111.387 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 136.29 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 1.04 108.986 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.434 ' HD3' ' CD ' ' A' ' 30' ' ' GLU . 12.4 ttp180 -142.18 140.98 32.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.089 0.471 . . . . 1.72 111.939 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 tpt -135.55 119.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.89000000000000001 108.877 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -122.62 114.95 21.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.902 0.382 . . . . 1.9199999999999999 111.734 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -112.42 -164.41 0.91 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.36 6.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.702 0.287 . . . . 0.40999999999999998 111.375 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.74 4.77 24.4 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.357 -0.925 . . . . 1.0900000000000001 113.229 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -126.76 119.02 25.86 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.488 -0.419 . . . . 1.0800000000000001 110.34 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -140.98 122.54 15.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.295 -0.411 . . . . 2.4500000000000002 110.478 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -149.96 146.87 27.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.285 0.365 . . . . 0.46000000000000002 110.923 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.434 ' CD ' ' HD3' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -143.9 136.77 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.90000000000000002 110.714 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -139.98 -173.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.885 0.374 . . . . 0.96999999999999997 110.59 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.46 116.65 13.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.46999999999999997 110.185 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' H ' ' A' ' 34' ' ' TYR . 7.8 p -112.67 -158.35 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.334 -0.394 . . . . 0.13 111.172 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -74.65 -169.1 0.8 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 1.1200000000000001 110.673 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -74.43 -157.88 0.06 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.894 0.378 . . . . 1.3899999999999999 111.295 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -56.71 -19.95 19.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.109 0.781 . . . . 0.56000000000000005 113.109 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -63.55 -19.03 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.40000000000000002 111.203 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.05 -24.92 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.1 0.476 . . . . 0.23000000000000001 110.767 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.2 -13.29 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.323 -0.398 . . . . 0.34999999999999998 110.403 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.72 68.68 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.934 -0.575 . . . . 0.33000000000000002 112.416 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -72.18 -35.56 69.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.875 0.369 . . . . 1.1100000000000001 110.762 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.28 2.42 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.91 0.386 . . . . 1.1899999999999999 111.168 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -134.47 28.58 3.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.3 0.572 . . . . 0.47999999999999998 109.842 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.62 -130.92 3.19 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.378 -0.828 . . . . 0.31 111.232 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -138.56 122.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.85999999999999999 110.709 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.58 -163.36 0.85 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.474 -0.565 . . . . 0.69999999999999996 109.474 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -96.89 -164.13 1.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.52 0.2 . . . . 1.53 110.98 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.49 ' O ' HG21 ' A' ' 52' ' ' VAL . 1.2 m-20 -52.88 114.26 1.37 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.258 -0.428 . . . . 1.4399999999999999 111.303 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.54 -28.28 68.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 1.7 111.662 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.05 -36.76 82.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.265 0.555 . . . . 0.94999999999999996 110.403 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.67 -30.21 56.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 1.0900000000000001 109.951 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 48' ' ' ASP . 21.9 t -75.48 -27.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.95999999999999996 110.847 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.09 84.85 7.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.172 0.51 . . . . 1.0700000000000001 111.148 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -57.34 -64.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.378 -0.828 . . . . 0.17999999999999999 110.528 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -91.23 80.47 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.004 -0.544 . . . . 0.34999999999999998 109.968 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -80.06 63.79 4.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.63 0.728 . . . . 1.27 110.942 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -148.35 96.04 2.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.796 -1.093 . . . . 0.29999999999999999 108.074 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG21 HG12 ' A' ' 31' ' ' ILE . 12.1 p -78.82 146.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.664 -0.698 . . . . 0.91000000000000003 112.194 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -116.23 147.35 41.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.57 -0.741 . . . . 0.38 109.263 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t -84.43 -33.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.568 0.699 . . . . 0.93999999999999995 109.387 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -166.05 104.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.127 -0.942 . . . . 1.29 109.889 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.71 -27.73 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.48999999999999999 111.609 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 m -60.84 -45.99 92.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.735 0.302 . . . . 0.48999999999999999 111.062 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -27.0 25.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.015 0.436 . . . . 1.54 110.615 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.72 29.79 8.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.805 -0.712 . . . . 0.14999999999999999 111.469 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -83.33 109.36 17.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 2.0499999999999998 110.431 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.63 133.11 36.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.41999999999999998 109.726 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.06 105.17 14.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.029 0.442 . . . . 0.92000000000000004 110.856 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 34.2 pttt -85.86 -175.81 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.384 -0.599 . . . . 2.1499999999999999 109.384 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.8 pttp -58.81 -23.48 60.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.643 0.259 . . . . 1.6599999999999999 111.419 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.26 -22.03 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.501 -0.318 . . . . 2.2200000000000002 111.316 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 21.8 m-20 -86.41 -52.28 5.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.39 -0.368 . . . . 0.33000000000000002 110.748 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.63 -28.84 70.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.23999999999999999 111.599 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -68.15 -26.55 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.797 0.332 . . . . 1.05 111.018 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 p -102.66 -25.08 13.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 1.75 111.327 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.61 -41.76 16.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.31 111.445 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -97.36 -41.43 8.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 0.63 110.324 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.72 -29.14 5.72 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.758 -0.734 . . . . 0.26000000000000001 112.345 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.96 145.81 43.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.696 0.284 . . . . 0.26000000000000001 110.782 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.39 3.01 53.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.242 0.544 . . . . 0.72999999999999998 110.336 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 85' ' ' ILE . 26.6 t0 -74.25 108.78 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 1.45 110.551 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -60.46 -30.58 69.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.20999999999999999 110.978 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -60.65 -40.77 93.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.278 -0.419 . . . . 1.46 111.097 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -71.34 -38.78 71.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.6499999999999999 110.881 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 81' ' ' ASP . 30.0 mm -60.24 -55.11 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.25 110.936 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 7.4 p -67.74 -34.66 77.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.11 111.397 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 83' ' ' THR . 33.3 ttpt -58.82 -45.17 90.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.605 0.241 . . . . 0.37 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -60.62 -45.8 92.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 1.02 110.868 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.5 mt -72.43 -25.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 0.93999999999999995 111.439 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.43 -40.52 23.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.053 0.39 . . . . 1.02 112.053 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -91.18 -21.16 21.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.07 0.767 . . . . 0.82999999999999996 113.07 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -110.99 -24.68 10.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.632 -0.427 . . . . 0.81999999999999995 111.296 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.77 -166.07 31.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.757 . . . . 0.47999999999999998 111.931 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -120.97 131.59 54.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.168 0.509 . . . . 2.0600000000000001 111.278 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 97' ' ' VAL . 14.7 p -118.28 160.36 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.75 109.05 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -73.27 85.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.238 0.542 . . . . 0.26000000000000001 111.044 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 95' ' ' VAL . 3.8 m -95.4 150.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.20999999999999999 111.306 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.32 178.13 4.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.824 -0.625 . . . . 1.74 110.118 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.45 -177.13 6.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.56999999999999995 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -90.29 151.23 21.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.334 -0.247 . . . . 1.49 110.334 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.29 171.35 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.52000000000000002 110.755 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -80.74 114.9 19.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.112 -0.494 . . . . 1.03 110.873 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.4 t60 56.73 75.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 0.89000000000000001 111.433 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -72.46 -62.08 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.254 -0.43 . . . . 1.4399999999999999 110.777 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -168.32 132.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.864 -0.607 . . . . 2.1299999999999999 110.222 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.05 54.29 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.056 0.455 . . . . 2.0 110.407 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 109' ' ' MET . 3.4 mm-40 -91.35 174.08 7.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.015 -0.539 . . . . 1.9299999999999999 111.142 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -76.84 29.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.523 . . . . 0.40000000000000002 111.49 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 107' ' ' GLU . 23.6 ptt? -61.41 -33.4 73.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.48999999999999999 110.889 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -74.08 -20.46 60.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.324 . . . . 0.56000000000000005 110.587 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -47.03 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 1.3 110.025 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -48.55 81.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.77 -0.65 . . . . 1.02 110.301 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 mm -83.65 52.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.78 0.8 . . . . 0.25 109.573 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.41 -31.97 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.22 110.825 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.1 t -60.2 -24.29 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.54000000000000004 111.562 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.57 -46.49 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 0.55000000000000004 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.49 -27.22 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.31 110.582 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.72 71.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.152 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.49 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.1 OUTLIER -67.59 -40.27 84.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.127 -0.488 . . . . 1.49 110.915 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -86.52 -3.64 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 1.47 111.223 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 2.8 t -86.04 84.46 7.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.148 -0.686 . . . . 1.51 109.148 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.61 175.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.904 -0.589 . . . . 0.38 112.5 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 25.6 t-20 176.97 -55.15 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.31 109.656 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 84.0 Cg_endo -77.97 166.85 24.47 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.929 1.752 . . . . 0.34000000000000002 112.104 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.92 -22.0 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 1.1200000000000001 111.588 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 7.4 t -75.2 -172.81 1.81 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.594 -0.275 . . . . 1.3300000000000001 110.601 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.31 105.08 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 4.4100000000000001 110.281 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.549 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -90.6 -50.37 0.34 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.683 -0.689 . . . . 1.8600000000000001 112.173 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 128' ' ' ARG . 20.0 Cg_endo -58.58 168.98 3.52 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.292 1.995 . . . . 0.39000000000000001 113.035 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.8 t80 74.47 -20.32 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.698 0.799 . . . . 1.1599999999999999 111.751 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 129' ' ' PRO . 1.7 m -80.12 76.18 6.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.207 0.527 . . . . 0.46000000000000002 111.218 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.24 -27.98 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.755 -0.657 . . . . 1.1399999999999999 110.76 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.25 -27.37 39.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.518 -0.765 . . . . 0.47999999999999998 111.51 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.91 -54.26 33.58 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.919 0.39 . . . . 0.31 110.512 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 tp -71.0 -28.49 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.05 110.66 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 1.3500000000000001 110.193 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -65.44 -46.59 79.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 2.1800000000000002 110.656 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.45 81.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 1.1499999999999999 111.489 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 44.9 ttp -58.36 -47.32 84.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 3.3500000000000001 111.606 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -77.67 -24.25 49.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.818 -0.353 . . . . 1.0700000000000001 111.054 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.88 -37.44 73.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.018 0.437 . . . . 0.31 110.422 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.43 -24.29 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.835 -0.431 . . . . 0.95999999999999996 109.835 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.6 p80 40.82 50.65 3.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.085 0.954 . . . . 0.26000000000000001 112.68 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.46 111.85 21.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 1.8999999999999999 110.397 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -77.92 45.45 0.52 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.233 0.539 . . . . 0.67000000000000004 111.135 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.6 -24.49 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.65000000000000002 110.553 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -82.38 22.6 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.85999999999999999 111.162 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.73 14.5 5.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.349 0.595 . . . . 1.6100000000000001 110.326 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -79.31 -46.3 17.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.63 110.408 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -154.74 -161.81 1.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 1.1699999999999999 109.7 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.4 m -55.98 118.07 4.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.98999999999999999 111.152 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -23.93 65.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 1.23 111.392 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.79 1.05 28.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.901 0.382 . . . . 1.5800000000000001 110.654 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -115.59 -45.53 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.423 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.0 pt20 -94.06 19.46 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.20999999999999999 111.579 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.78 72.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.28999999999999998 111.282 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.1 mm? -68.43 -18.36 64.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.37 111.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -92.4 -36.97 12.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.85 0.357 . . . . 2.4900000000000002 110.63 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 155' ' ' GLN . 24.7 t -64.79 -43.18 96.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.874 -0.603 . . . . 0.23999999999999999 111.017 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.6 tt -61.36 -32.55 53.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 1.21 111.133 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 41.1 mttp -67.29 -48.62 67.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.711 0.291 . . . . 1.8799999999999999 110.364 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -39.72 89.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.59999999999999998 110.719 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -42.99 99.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 2.0600000000000001 110.443 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -65.75 -20.72 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 1.8100000000000001 111.283 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 161' ' ' LYS . 32.4 mt-10 -72.72 -32.54 65.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.694 0.283 . . . . 0.68999999999999995 110.822 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -82.21 -44.09 16.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.065 0.46 . . . . 1.8600000000000001 110.137 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 21.2 ptp -144.45 134.38 23.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.872 -0.604 . . . . 2.0699999999999998 109.737 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.45 120.91 19.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.202 0.525 . . . . 1.3799999999999999 111.493 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 pp -122.83 174.59 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.525 -0.761 . . . . 1.46 109.641 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.26 118.84 31.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.24 0.543 . . . . 1.1899999999999999 110.575 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 11.8 14.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.691 -0.686 . . . . 0.77000000000000002 111.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.04 133.29 49.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.041 -0.527 . . . . 1.3 111.369 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.2 148.85 10.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 2.1600000000000001 110.013 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -159.1 -177.14 6.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.193 -0.299 . . . . 2.0600000000000001 110.193 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -119.48 144.09 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 2.2799999999999998 110.491 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.69 154.74 41.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 1.05 110.976 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -124.44 152.61 43.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.12 109.426 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 95.6 m-85 -116.09 124.64 50.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.854 0.359 . . . . 0.14999999999999999 110.611 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.469 HG12 ' OE2' ' A' ' 209' ' ' GLU . 4.4 mt -102.07 114.5 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 1.23 111.47 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.3 OUTLIER -159.11 150.15 16.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 1.21 110.262 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.93 165.47 27.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.79 2.327 . . . . 0.29999999999999999 112.064 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.95 -30.44 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.762 0.315 . . . . 0.23999999999999999 110.928 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.11 -50.03 62.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.72999999999999998 110.497 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -91.94 -21.95 20.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.73999999999999999 110.272 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.16 -30.23 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.483 -0.781 . . . . 0.26000000000000001 113.635 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -68.21 -16.44 63.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.072 0.436 . . . . 1.79 111.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.99 -15.65 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 1.96 109.665 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.38 -45.08 5.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.267 -0.878 . . . . 2.98 110.537 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -57.69 -53.49 57.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 1.5700000000000001 111.093 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.66 31.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.088 -0.505 . . . . 0.59999999999999998 111.12 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -144.16 -51.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.839 0.311 . . . . 1.8999999999999999 111.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.97 -37.58 22.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.176 0.435 . . . . 0.72999999999999998 112.176 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 6.1 mtpt -60.25 -48.54 93.85 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.234 0.457 . . . . 1.1799999999999999 112.234 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.4 Cg_endo -60.0 -13.89 25.37 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.063 1.842 . . . . 0.17999999999999999 113.043 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.49 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 66.9 mt -85.48 -2.58 58.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.472 -0.195 . . . . 1.22 110.472 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 39.2 pt 41.78 40.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.543 1.137 . . . . 0.82999999999999996 113.736 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 195' ' ' LEU . 78.9 mttt -123.32 24.41 8.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 1.99 109.665 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.27 169.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 0.40999999999999998 110.353 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 88.6 mt -110.94 144.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.021 -0.536 . . . . 0.96999999999999997 110.118 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -70.57 70.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.48 0.488 . . . . 0.66000000000000003 111.334 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.1 m -157.39 38.72 0.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.28999999999999998 109.287 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 193' ' ' LYS . 45.9 mt-10 -82.5 145.07 29.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 111.608 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -117.62 123.69 46.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.14000000000000001 110.089 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.61 159.78 18.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.284 -0.416 . . . . 0.62 110.193 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 139.34 -116.61 1.25 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.045 -0.598 . . . . 0.28000000000000003 111.912 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.25 -18.05 37.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.518 0.675 . . . . 1.75 109.554 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.05 177.21 7.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.114 -0.948 . . . . 0.17000000000000001 109.5 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 tp -138.37 77.51 1.63 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.404 . . . . 0.93999999999999995 110.61 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 15.9 mt-10 -82.93 99.73 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.174 -0.467 . . . . 0.23000000000000001 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 28.7 mt -102.88 132.91 48.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.74 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.06 122.41 50.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.892 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.9 t -147.39 120.24 8.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.274 -0.421 . . . . 1.3799999999999999 110.128 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.07 125.08 1.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.305 -0.628 . . . . 1.05 109.305 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.3 tt -117.1 157.61 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.922 -0.399 . . . . 1.3799999999999999 109.922 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.08 150.59 10.39 Favored Pre-proline 0 C--O 1.236 0.344 0 O-C-N 123.295 0.372 . . . . 0.62 111.536 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 10.2 Cg_endo -51.1 158.35 3.41 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.654 2.903 . . . . 1.5700000000000001 113.569 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 103.15 -82.87 0.41 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.631 -0.988 . . . . 0.64000000000000001 110.631 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.1 m -72.92 -16.32 61.56 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.31 -0.626 . . . . 1.5700000000000001 109.31 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -63.41 -42.71 98.76 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.564 -0.744 . . . . 1.54 110.762 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.494 ' HD2' ' OD1' ' A' ' 223' ' ' ASP . 17.9 tpt180 -62.2 -27.33 68.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.151 0.5 . . . . 0.44 110.874 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.37 -34.92 70.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.181 -0.463 . . . . 2.5 111.358 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.628 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.3 tt -96.24 -29.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.529 -0.305 . . . . 2.52 111.76 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.494 ' OD1' ' HD2' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -62.52 -23.83 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 0.92000000000000004 110.746 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.12 -25.63 65.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.867 -0.606 . . . . 1.26 111.4 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.0 OUTLIER -106.4 -32.55 8.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.928 -0.309 . . . . 0.62 110.872 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 222' ' ' ILE . 47.2 mm -58.26 -35.28 52.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.954 0.407 . . . . 1.04 110.705 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 231' ' ' LYS . 16.4 ptmt -54.32 -34.29 60.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.458 -0.792 . . . . 2.2999999999999998 112.609 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -106.09 -24.29 12.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.689 0.281 . . . . 0.84999999999999998 111.344 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.12 -59.67 3.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.068 -0.514 . . . . 0.34000000000000002 111.848 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -125.52 -24.26 3.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.294 0.479 . . . . 0.26000000000000001 112.294 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 227' ' ' LYS . 75.6 tttt -66.94 -28.79 68.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.81000000000000005 110.66 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.83 -14.28 37.53 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.883 -0.675 . . . . 0.68000000000000005 112.25 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -84.99 -22.31 29.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.381 . . . . 0.85999999999999999 110.69 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -147.15 -168.98 14.27 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.536 -0.84 . . . . 0.27000000000000002 112.342 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 m -96.77 131.73 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.891 -0.411 . . . . 0.28000000000000003 109.891 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.31 142.66 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.004 0.43 . . . . 1.1499999999999999 111.323 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -144.0 155.14 43.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.09 -0.504 . . . . 0.85999999999999999 109.937 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -81.28 152.2 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 0.23000000000000001 110.748 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 92.73 4.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.944 -0.391 . . . . 1.55 109.944 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -119.57 13.18 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.564 0.697 . . . . 1.0 109.704 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.8 100.65 11.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.416 -0.811 . . . . 1.0800000000000001 109.801 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.1 34.77 4.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.973 -0.558 . . . . 1.53 110.323 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.2 -67.11 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.381 -0.372 . . . . 1.3899999999999999 111.42 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.01 158.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.37 110.438 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -72.13 121.93 20.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.788 -0.449 . . . . 1.1399999999999999 109.788 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -130.63 147.87 52.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.477 -0.329 . . . . 0.85999999999999999 110.519 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 110.26 92.61 2.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.89 -0.671 . . . . 0.42999999999999999 112.333 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.2 137.2 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.261 -0.274 . . . . 1.1299999999999999 110.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.49 29.37 1.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.977 -0.556 . . . . 1.22 109.639 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -143.64 112.44 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 2.3700000000000001 110.455 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.58 16.13 16.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.259 0.552 . . . . 0.56000000000000005 110.551 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.327 -0.844 . . . . 1.96 109.554 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 111.529 -0.629 . . . . 0.55000000000000004 111.529 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -129.66 125.4 35.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.803 0.335 . . . . 0.29999999999999999 110.534 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -109.0 120.87 43.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 0.80000000000000004 110.241 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.93 123.41 49.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.325 -0.398 . . . . 0.40999999999999998 110.376 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt -81.04 -11.1 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.33000000000000002 111.084 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -102.69 134.27 46.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.60999999999999999 109.47 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.39 85.68 5.73 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.123 -0.231 . . . . 0.82999999999999996 111.51 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.61 -47.39 4.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.725 2.284 . . . . 0.82999999999999996 111.072 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p 48.15 35.43 5.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.156 -0.929 . . . . 0.58999999999999997 113.433 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.83 -77.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.60999999999999999 110.195 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.5 -98.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.051 -0.522 . . . . 0.39000000000000001 109.632 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.7 mt -87.15 89.26 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.25 0.548 . . . . 0.47999999999999998 109.886 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -143.47 134.83 26.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.599 -0.728 . . . . 1.76 109.754 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.78 61.09 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 111.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -9.74 3.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 1.4099999999999999 110.87 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 35' ' ' LYS . 6.6 t-20 -153.59 63.88 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.191 -1.04 . . . . 1.49 108.191 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 32' ' ' ALA . 3.5 m -106.31 128.04 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.012 -0.995 . . . . 1.0900000000000001 111.542 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.16 113.08 18.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.806 . . . . 0.23000000000000001 109.626 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.15 117.24 19.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.19 110.872 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.28 128.84 73.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.82 -0.807 . . . . 1.0800000000000001 108.82 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD2' ' OE1' ' A' ' 30' ' ' GLU . 30.5 ttt180 -137.01 131.48 32.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.595 0.591 . . . . 1.54 112.595 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.468 ' HB2' HG21 ' A' ' 89' ' ' ILE . 19.2 ttt -83.77 140.7 31.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.674 . . . . 1.1100000000000001 109.556 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.55 99.18 6.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 1.1200000000000001 111.036 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -111.6 -179.69 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 1.0800000000000001 110.331 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.09 -54.47 45.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.477 0.486 . . . . 0.10000000000000001 112.072 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.94 28.73 3.64 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.23000000000000001 111.845 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -148.17 146.84 28.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.775 0.321 . . . . 1.8 110.359 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.82 142.54 20.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.228 -0.656 . . . . 1.26 109.228 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 24.6 m-85 -145.85 129.32 16.92 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.376 0.423 . . . . 0.77000000000000002 110.497 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.574 ' OE1' ' HD2' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -119.95 137.57 53.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.873 0.368 . . . . 0.34000000000000002 110.711 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.89 -171.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 1.55 110.455 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -141.51 133.97 28.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.81999999999999995 111.954 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.36 158.66 19.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.064 -0.516 . . . . 0.53000000000000003 110.755 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -82.41 120.79 25.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.704 0.631 . . . . 0.48999999999999999 112.704 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 84.3 mttt 44.38 39.32 3.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.131 1.16 . . . . 1.5900000000000001 114.131 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.92 18.85 4.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.405 0.52 . . . . 1.73 112.405 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -73.01 1.16 9.44 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.002 0.43 . . . . 0.68999999999999995 111.424 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.81 -19.58 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.365 0.603 . . . . 0.28999999999999998 110.241 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.05 3.33 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.435 0.636 . . . . 0.22 109.87 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.1 -55.56 23.48 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.241 -0.89 . . . . 0.12 113.204 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -70.23 -6.14 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.241 0.52 . . . . 0.34999999999999998 112.118 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -2.72 58.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.888 0.375 . . . . 0.58999999999999997 110.04 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 m -144.35 -16.0 0.57 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.109 0.411 . . . . 1.26 112.109 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.13 44.03 1.95 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.984 -0.627 . . . . 0.23000000000000001 111.892 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -139.27 29.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.395 . . . . 1.3200000000000001 110.16 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -80.68 169.82 17.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 1.96 112.257 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -157.39 -168.55 2.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.086 -0.961 . . . . 1.01 108.503 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.47 140.27 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.352 0.596 . . . . 0.64000000000000001 111.016 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -85.44 4.52 35.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.803 -0.635 . . . . 1.27 110.632 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.44 -24.29 42.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.597 -0.729 . . . . 0.67000000000000004 110.645 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -108.42 -30.52 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.40999999999999998 111.05 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -24.82 29.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.484 -0.326 . . . . 0.77000000000000002 111.299 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.47 116.25 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.676 -0.49 . . . . 1.1100000000000001 109.676 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -88.12 -43.22 11.82 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 1.1499999999999999 111.015 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -119.86 118.11 29.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.42999999999999999 111.08 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -81.38 4.62 20.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.219 0.533 . . . . 1.05 110.272 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -115.62 134.59 54.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.19 -0.67 . . . . 0.32000000000000001 109.19 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.13 150.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 110.087 -0.338 . . . . 1.0600000000000001 110.087 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 70.7 m-85 -103.66 139.64 38.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.648 0.261 . . . . 0.48999999999999999 110.551 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 2.1 t -87.05 -16.43 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.475 -0.565 . . . . 0.40999999999999998 109.475 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 3.2 t-20 175.76 97.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.284 -0.871 . . . . 0.75 109.854 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.52 -25.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.25 110.827 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -21.08 66.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.193 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -119.11 0.48 11.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 1.0900000000000001 111.016 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.88 29.79 62.51 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.594 -0.812 . . . . 0.31 112.072 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -83.88 101.85 11.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.634 0.254 . . . . 1.7 110.666 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.3 130.88 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.73 114.78 28.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.16 0.505 . . . . 1.03 110.776 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 24.4 pttt -73.82 177.17 5.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 2.2799999999999998 109.529 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -61.27 -28.53 69.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.3200000000000001 110.2 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.35 -27.97 56.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.866 -0.606 . . . . 1.0700000000000001 110.189 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 7.7 m-20 -72.88 -51.9 16.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.52000000000000002 110.251 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.94 -33.71 76.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.17999999999999999 111.198 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -69.61 -23.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.234 0.54 . . . . 0.14999999999999999 109.954 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -95.65 -21.82 17.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.41999999999999998 110.715 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.78 -53.09 4.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.399 -0.364 . . . . 0.37 111.706 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -90.17 -34.2 15.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.931 0.396 . . . . 0.46000000000000002 110.239 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.08 -14.66 44.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.729 -0.748 . . . . 0.46000000000000002 112.548 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p -115.61 141.8 47.58 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.778 -0.248 . . . . 1.95 110.989 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.12 -10.77 51.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.159 -0.682 . . . . 0.57999999999999996 109.159 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.43 120.78 25.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.096 -0.956 . . . . 1.03 109.898 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.98 -22.56 61.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.947 -0.57 . . . . 0.66000000000000003 112.419 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -58.93 -49.67 76.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.274 -0.17 . . . . 0.16 111.091 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 87' ' ' LYS . 33.2 mm-40 -62.37 -43.36 99.01 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.047 0.451 . . . . 0.81999999999999995 111.008 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.48 -52.32 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 0.20999999999999999 110.769 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.81 -35.56 76.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.20999999999999999 110.778 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 30.1 ttpt -62.34 -46.58 88.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.379 . . . . 1.3300000000000001 110.366 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 1.03 110.764 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 22' ' ' MET . 77.9 mt -69.18 -28.31 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 1.0600000000000001 109.967 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -38.09 36.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.718 -0.674 . . . . 1.0900000000000001 111.922 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 92' ' ' LYS . 12.1 t -93.36 -10.11 36.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.544 0.572 . . . . 0.47999999999999998 112.544 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 91' ' ' THR . 34.6 mmtm -137.55 35.35 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.023 -0.423 . . . . 1.6599999999999999 111.206 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.18 -147.37 4.53 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.581 -0.819 . . . . 0.19 112.237 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -136.06 128.79 30.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.649 -0.501 . . . . 1.1599999999999999 109.649 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.99 142.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.559 -0.292 . . . . 1.1599999999999999 110.892 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.61 84.29 1.57 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.201 0.524 . . . . 0.38 109.883 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.95 167.04 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.44 0.638 . . . . 1.1299999999999999 112.584 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.4 m -156.0 156.9 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.851 -1.068 . . . . 1.47 108.219 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.78 149.85 43.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.996 0.426 . . . . 1.3100000000000001 110.708 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.5 -179.76 4.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.37 111.567 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.89 132.93 33.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 1.22 110.299 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.63 121.01 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.685 0.615 . . . . 1.1499999999999999 111.078 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.426 ' HB2' HG11 ' A' ' 45' ' ' VAL . 30.6 m80 -140.95 -175.79 4.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.93000000000000005 109.684 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -108.07 154.59 21.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.011 0.434 . . . . 0.94999999999999996 109.942 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.58 -33.79 0.86 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.707 -0.679 . . . . 0.39000000000000001 110.377 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt 56.57 38.13 29.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.644 -0.707 . . . . 0.56000000000000005 111.182 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -138.15 104.37 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.65000000000000002 110.464 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 57.2 54.08 7.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.154 0.502 . . . . 0.75 110.007 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.3 ttt -54.61 -36.61 64.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.445 -0.798 . . . . 2.1600000000000001 111.883 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -64.08 -40.55 96.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 1.78 110.16 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -69.28 -39.66 78.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 1.6499999999999999 110.078 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -58.73 -56.96 15.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.561 -0.745 . . . . 0.41999999999999998 111.255 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.5 tp -65.63 -28.66 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.40000000000000002 111.612 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.64 66.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.22 110.779 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.1 m -71.83 -32.42 67.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.104 0.478 . . . . 1.9299999999999999 110.699 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.16 -29.65 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.54 . . . . 0.33000000000000002 111.106 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.02 -20.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.396 -0.366 . . . . 0.20999999999999999 111.0 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.28 -56.65 14.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.542 -0.299 . . . . 0.27000000000000002 111.762 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.83 -29.52 70.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.54000000000000004 111.327 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.436 ' HG3' ' OD2' ' A' ' 215' ' ' ASP . 64.5 tttp -70.65 -30.29 66.87 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.859 -0.609 . . . . 0.71999999999999997 111.195 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 55.1 m -93.55 89.99 6.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.264 0.554 . . . . 0.26000000000000001 110.453 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.03 118.21 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.375 0.607 . . . . 1.3400000000000001 111.632 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -135.42 61.45 44.28 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.42999999999999999 109.913 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 90.3 Cg_endo -79.99 36.03 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.656 2.238 . . . . 0.56000000000000005 113.306 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -84.64 -54.79 4.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.486 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 t -132.48 0.16 3.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.378 0.609 . . . . 1.6200000000000001 110.394 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 128' ' ' ARG . 2.0 tpmt? -143.98 164.62 30.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 1.6699999999999999 109.792 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -95.32 141.57 23.41 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.111 -0.7 . . . . 0.56999999999999995 109.111 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.09 -20.17 44.6 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.85 2.367 . . . . 0.42999999999999999 113.024 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.54 40.8 0.6 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.018 0.437 . . . . 1.9199999999999999 110.981 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -125.83 84.76 2.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.375 0.607 . . . . 0.44 109.888 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.14 -25.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.178 -0.919 . . . . 0.28999999999999998 112.3 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.9 mm -50.01 -51.06 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.245 0.831 . . . . 0.59999999999999998 113.245 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.396 0.517 . . . . 0.47999999999999998 112.396 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 tp -79.99 -26.56 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.891 0.376 . . . . 0.19 111.045 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.72 -46.23 83.16 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 110.034 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.73 -44.04 93.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 1.2 110.307 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 142' ' ' ILE . . . -63.78 -41.65 97.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 0.20999999999999999 110.742 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -63.22 -38.52 91.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.71999999999999997 110.35 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -31.46 69.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.112 -0.494 . . . . 1.6799999999999999 110.462 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.18 -53.42 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.735 -0.468 . . . . 1.22 109.735 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 138' ' ' ALA . 10.4 tp -88.75 50.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 122.896 1.331 . . . . 1.1599999999999999 109.544 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -85.04 16.47 3.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.703 -1.135 . . . . 0.64000000000000001 110.842 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.19 151.7 35.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.681 -0.691 . . . . 1.6200000000000001 110.109 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.2 m -64.18 116.72 6.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 1.0900000000000001 110.708 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.2 t -103.32 -51.08 9.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.45000000000000001 110.872 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -136.35 -171.72 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.98999999999999999 110.614 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.46 -34.15 76.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 0.5 110.11 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.57 101.29 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.437 -0.802 . . . . 0.91000000000000003 109.674 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -85.25 71.21 10.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 1.8200000000000001 109.477 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 m -133.2 129.0 37.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.883 -0.599 . . . . 0.38 111.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -7.41 46.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.28999999999999998 110.958 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.449 ' HZ1' ' CG ' ' A' ' 112' ' ' ASP . 89.8 mttt -81.03 9.55 6.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.783 -0.644 . . . . 0.28000000000000003 110.611 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -162.31 -58.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.34000000000000002 110.049 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -87.33 41.27 0.97 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.976 -0.556 . . . . 0.26000000000000001 110.362 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.68 -32.65 71.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 0.20999999999999999 111.663 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.5 mm? -81.01 -2.7 49.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.355 -0.384 . . . . 2.25 111.378 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -111.11 -44.7 3.54 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.963 -0.295 . . . . 2.27 111.091 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -58.48 -42.82 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.5 110.969 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.07 -28.38 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.20999999999999999 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 16.4 mttp -68.57 -42.78 77.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.853 0.359 . . . . 1.6899999999999999 110.392 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -35.82 61.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.63 110.659 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.78 -35.15 79.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.31 110.069 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 167' ' ' MET . 2.1 ttpm? -60.28 -20.8 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.112 -0.949 . . . . 1.95 111.662 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -70.72 -20.38 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 1.0600000000000001 111.191 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -115.11 -47.05 2.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.869 0.366 . . . . 1.26 110.652 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 13.5 tpt -117.59 122.74 44.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 0.27000000000000002 110.914 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -93.79 110.34 21.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.098 -0.501 . . . . 0.95999999999999996 110.157 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp -125.87 157.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 0.97999999999999998 111.083 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 158.54 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.182 -0.463 . . . . 2.5899999999999999 110.148 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.88 32.65 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.748 0.309 . . . . 0.57999999999999996 111.546 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.96 118.65 10.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.991 0.424 . . . . 0.60999999999999999 111.726 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -165.35 134.61 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.28999999999999998 109.718 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.01 -173.09 2.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 2.0600000000000001 110.744 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -114.39 140.04 48.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 3.02 110.085 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.485 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 1.7 mt -127.98 150.95 49.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.039 0.447 . . . . 1.02 110.657 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -129.51 174.31 9.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.351 -0.84 . . . . 0.88 109.231 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.462 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 3.6 p90 -133.58 145.58 50.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.153 -0.314 . . . . 0.58999999999999997 110.153 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.25 106.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 1.2 111.439 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 157.23 46.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.055 -0.52 . . . . 0.26000000000000001 110.943 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.31 178.44 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.808 2.339 . . . . 0.16 113.123 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.39 -45.81 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.627 0.603 . . . . 0.5 112.627 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.91 -45.9 85.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.083 0.468 . . . . 1.9399999999999999 111.607 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.61 -39.74 67.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.69999999999999996 110.68 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -62.69 -38.33 96.26 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.68 -0.691 . . . . 0.16 113.104 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.08 -34.28 68.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.776 0.287 . . . . 0.78000000000000003 111.776 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.475 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 31.7 mmmt -71.91 -33.32 68.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.566 0.21 . . . . 1.77 111.566 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -85.36 -26.3 26.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.58999999999999997 109.99 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 80.5 tttt -60.94 -31.55 71.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.23000000000000001 110.62 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.42 12.68 28.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 3.1499999999999999 111.197 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 9.2 mtmt -126.5 -58.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.222 0.453 . . . . 1.3899999999999999 112.222 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.3 -42.01 26.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.641 . . . . 0.19 112.729 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 189' ' ' LYS . 1.6 mtpt -58.16 -50.95 85.22 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.07 0.767 . . . . 0.75 113.07 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 20.5 Cg_endo -60.91 -14.76 34.39 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.456 2.104 . . . . 0.20999999999999999 113.404 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.405 ' O ' ' HD2' ' A' ' 197' ' ' LYS . 72.4 mt -82.19 -11.51 58.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 1.01 110.15 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mm 56.64 35.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.732 -0.667 . . . . 0.58999999999999997 110.569 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -109.64 18.16 20.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 2.3799999999999999 110.042 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 m -113.6 137.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.259 -0.882 . . . . 0.45000000000000001 110.384 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.63 148.28 5.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.954 -0.566 . . . . 1.5900000000000001 109.52 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.7 75.13 0.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.749 0.785 . . . . 0.93999999999999995 111.559 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.2 m -149.83 33.62 0.68 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.146 -1.057 . . . . 0.46000000000000002 108.146 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.4 pt-20 -79.72 129.96 34.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.768 -1.106 . . . . 0.80000000000000004 111.792 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -97.13 105.73 17.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.361 -0.977 . . . . 0.29999999999999999 108.361 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.44 131.31 45.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.80000000000000004 110.434 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 163.57 -104.77 0.24 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.848 -0.691 . . . . 1.02 112.127 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.4 -17.27 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.4 0.619 . . . . 2.2799999999999998 110.016 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -140.67 176.91 8.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.231 -0.895 . . . . 0.59999999999999998 109.35 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.4 tp -128.27 84.73 2.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.372 -0.603 . . . . 0.90000000000000002 109.372 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 19.3 tt0 -96.56 109.39 21.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.603 -0.726 . . . . 1.24 110.815 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.462 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 5.9 mt -130.97 152.04 36.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.739 0.304 . . . . 1.1399999999999999 110.314 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.4 t -98.7 117.59 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.19 109.808 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 21.0 p -122.92 56.02 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.40000000000000002 111.411 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.485 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -126.56 125.29 41.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.034 0.445 . . . . 0.12 111.05 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 pt -114.8 -159.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.412 -0.813 . . . . 1.02 109.751 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -80.65 162.3 60.95 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 110.127 -0.323 . . . . 0.33000000000000002 110.127 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.92 -177.42 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.67 2.247 . . . . 0.23999999999999999 113.157 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.69 1.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.066 -0.814 . . . . 0.14999999999999999 111.066 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.14 -24.22 65.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.297 0.57 . . . . 1.03 110.039 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.13 -32.35 73.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.40000000000000002 109.947 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -23.51 63.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 1.1299999999999999 110.497 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.4 -38.79 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 1.48 110.72 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.6 tt -85.11 -24.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 1.72 111.356 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.12 -30.23 61.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.84 0.352 . . . . 0.65000000000000002 110.957 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -56.14 -33.07 64.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.714 -0.675 . . . . 1.5800000000000001 111.447 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.85 -23.99 14.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.769 -0.372 . . . . 0.54000000000000004 110.927 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 222' ' ' ILE . 46.3 mm -64.51 -37.92 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.41999999999999998 110.508 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -62.87 -29.19 70.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.0600000000000001 111.388 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -105.54 11.29 32.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.619 . . . . 1.6699999999999999 110.035 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -96.83 -126.55 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.022 -1.103 . . . . 0.51000000000000001 108.022 178.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.418 HG21 ' CD2' ' A' ' 178' ' ' PHE . 9.5 t -65.2 -27.91 69.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.868 0.365 . . . . 1.0900000000000001 110.999 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.27 -12.13 61.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 1.0600000000000001 111.083 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -108.37 18.37 33.05 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.964 -0.636 . . . . 0.23999999999999999 112.591 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -149.13 -44.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.62 0.247 . . . . 1.47 111.042 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -105.74 -171.56 23.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.682 -0.771 . . . . 0.33000000000000002 112.191 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -107.9 143.32 36.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.724 0.297 . . . . 1.05 110.217 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.48 165.7 13.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 1.6100000000000001 110.902 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -154.13 151.94 29.84 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.52 -0.918 . . . . 2.0899999999999999 108.52 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.11 155.07 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.232 0.539 . . . . 0.65000000000000002 111.576 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.47 77.41 2.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 1.55 108.279 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -70.96 -26.33 63.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.673 . . . . 1.71 111.243 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.435 ' H ' HD21 ' A' ' 241' ' ' LEU . 1.2 mm? -52.37 132.76 34.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 2.2200000000000002 111.093 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -132.62 -1.14 3.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.086 0.469 . . . . 1.9299999999999999 110.034 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.87 -66.12 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.397 -0.819 . . . . 1.45 110.964 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.86 150.43 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.311 -0.404 . . . . 0.81999999999999995 110.275 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.07 110.41 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.397 -0.365 . . . . 1.78 110.022 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -114.94 152.4 32.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 2.1000000000000001 110.961 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -166.44 171.46 41.43 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.941 -0.863 . . . . 0.28999999999999998 110.941 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.79 90.34 5.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.215 0.531 . . . . 1.21 110.289 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -86.18 -9.96 55.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.81000000000000005 110.316 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.5 tptp 57.42 62.4 2.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.457 -0.792 . . . . 0.94999999999999996 110.599 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -63.11 -48.27 79.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.843 -0.617 . . . . 1.0900000000000001 110.658 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.693 -0.67 . . . . 2.9700000000000002 110.406 179.629 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.706 -0.558 . . . . 0.47999999999999998 111.706 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -111.21 105.42 14.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.964 0.382 . . . . 2.1400000000000001 110.185 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 tpp -153.4 166.03 33.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.15 -0.477 . . . . 1.5 109.999 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -78.3 87.65 4.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.064 0.459 . . . . 1.53 110.295 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mt -101.57 122.94 54.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.93999999999999995 109.796 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.521 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.0 t80 -71.22 143.68 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.071 -0.344 . . . . 1.1299999999999999 110.071 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -101.51 98.2 8.94 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.229 -0.441 . . . . 0.83999999999999997 111.471 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 87.0 Cg_endo -88.99 1.7 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.472 2.115 . . . . 0.55000000000000004 111.646 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m 62.28 75.33 0.41 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.277 -0.874 . . . . 0.47999999999999998 110.839 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -87.7 155.05 20.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.51000000000000001 110.464 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -63.33 -39.45 94.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.2 112.256 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.415 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 17.5 mt -145.7 82.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.628 0.252 . . . . 1.3 111.237 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -164.18 172.83 13.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 1.9199999999999999 110.771 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.61 48.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.60999999999999999 112.27 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.99 3.18 3.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.215 0.531 . . . . 0.46000000000000002 110.66 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.77 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.704 -0.85 . . . . 0.40000000000000002 108.704 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 32' ' ' ALA . 22.8 m -100.46 150.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.981 -1.009 . . . . 0.46999999999999997 112.527 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.37 111.77 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.378 -0.971 . . . . 0.81000000000000005 108.378 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.41 110.89 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 1.6499999999999999 111.991 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.0 p -103.54 135.93 38.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 1.1699999999999999 109.005 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.93 127.92 47.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.92000000000000004 111.996 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 57.8 ttp -101.16 115.39 30.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.312 -0.625 . . . . 1.0600000000000001 109.312 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 115.86 24.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.433 . . . . 1.73 110.604 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 25.4 mmm-85 -123.93 163.72 20.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.989 -0.551 . . . . 1.23 110.365 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.84 76.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 1.23 110.872 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.83 -57.7 4.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.799 . . . . 0.38 112.242 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -159.47 152.17 21.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.13 -0.322 . . . . 1.1499999999999999 110.13 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 2.2 ptt180 -91.41 149.03 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.564 -0.532 . . . . 2.3900000000000001 109.564 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -129.46 120.29 25.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.415 -0.357 . . . . 0.55000000000000004 110.654 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 4.8 mt-10 -116.82 123.9 48.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.52000000000000002 110.9 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mt -128.29 146.82 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.067 -0.346 . . . . 0.37 110.067 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -102.9 103.22 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 0.83999999999999997 110.303 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 p -100.96 -162.44 0.94 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.12 -0.491 . . . . 0.54000000000000004 110.749 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.69 -174.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.049 0.452 . . . . 0.52000000000000002 111.17 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -75.01 -139.83 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.567 -0.742 . . . . 1.8200000000000001 110.491 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.48 -10.79 37.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.947 0.403 . . . . 0.23999999999999999 111.546 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -62.85 -30.85 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.69999999999999996 111.16 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.8 -23.99 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.029 0.442 . . . . 1.0600000000000001 111.067 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.95 -30.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.439 0.638 . . . . 0.98999999999999999 110.2 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.68 18.42 50.17 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.606 -0.724 . . . . 0.46000000000000002 112.126 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 40.3 t90 -80.13 -54.33 5.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.82 0.343 . . . . 0.51000000000000001 110.813 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -97.98 -13.7 20.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.285 0.564 . . . . 1.8899999999999999 110.233 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.4 m -101.61 14.66 31.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 0.54000000000000004 110.218 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.33 -146.4 5.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.561 -0.745 . . . . 0.35999999999999999 111.655 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.73 112.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.731 0.3 . . . . 0.5 110.59 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB3' ' H ' ' A' ' 47' ' ' LYS . 28.7 mm-40 -130.14 -159.09 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.485 -0.325 . . . . 0.46000000000000002 110.251 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 46' ' ' GLU . 58.8 pttt -112.68 -159.07 0.67 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.586 -0.279 . . . . 1.51 110.719 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.2 140.04 56.32 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.004 -0.544 . . . . 1.21 110.493 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -80.9 -18.02 48.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.115 0.783 . . . . 0.70999999999999996 113.115 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' N ' HD12 ' A' ' 49' ' ' LEU . 5.8 t70 -67.3 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.555 -0.535 . . . . 1.3999999999999999 109.555 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.56 -19.83 62.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.191 0.519 . . . . 1.02 110.001 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 69.2 t -78.83 -23.47 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.612 -0.722 . . . . 1.0600000000000001 109.287 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.65 92.62 4.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.255 -0.884 . . . . 1.9299999999999999 110.432 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 12' ' ' ILE . 33.7 mm-40 -60.36 -44.47 95.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 1.6100000000000001 109.939 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.4 p -115.05 121.57 43.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.753 -0.658 . . . . 1.1399999999999999 109.992 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -87.76 23.26 2.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.309 0.576 . . . . 0.48999999999999999 110.204 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.8 157.78 27.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.401 -0.818 . . . . 0.46000000000000002 109.5 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.16 135.32 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.92000000000000004 111.128 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . 61.8 m-85 -91.03 138.62 31.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.415 -0.357 . . . . 0.85999999999999999 110.422 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 2.1 t -94.93 -33.32 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.571 . . . . 0.80000000000000004 110.037 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -164.68 93.48 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.92000000000000004 109.539 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 p -66.09 -20.47 27.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.42999999999999999 111.509 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.07 -4.53 55.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.5 110.85 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -126.95 -16.03 5.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.897 -0.592 . . . . 1.9299999999999999 110.588 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.95 17.78 57.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.927 -0.654 . . . . 0.35999999999999999 111.496 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.58 113.08 22.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.846 0.355 . . . . 0.97999999999999998 110.563 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.61 141.26 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 1.3700000000000001 109.969 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.54 126.21 48.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.221 -0.445 . . . . 0.39000000000000001 110.653 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' HG3' ' H ' ' A' ' 71' ' ' GLU . 10.9 ptpt -98.97 -171.7 2.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.944 -0.571 . . . . 1.5 109.661 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -59.73 -30.08 68.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.97 111.353 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 6.4 tt0 -80.67 -1.11 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.119 0.485 . . . . 1.8100000000000001 110.768 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.56 -52.4 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.455 -0.339 . . . . 1.5800000000000001 110.979 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -31.61 71.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 1.01 111.611 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -29.95 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.64000000000000001 110.919 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -98.65 -29.31 13.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.971 0.415 . . . . 0.76000000000000001 111.074 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.58 45.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.507 . . . . 0.48999999999999999 111.43 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -105.24 -41.54 5.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.487 -0.324 . . . . 0.5 110.79 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.96 -23.83 5.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.176 -1.011 . . . . 0.22 112.221 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -97.98 133.95 41.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.68 0.276 . . . . 0.46000000000000002 110.682 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.16 10.93 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.307 0.575 . . . . 0.56999999999999995 110.429 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -106.86 128.31 54.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.79 -0.641 . . . . 0.65000000000000002 109.69 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -69.98 -19.24 63.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.62 -0.264 . . . . 0.42999999999999999 111.289 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 7.9 m -60.54 -45.85 92.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.365 -0.38 . . . . 0.59999999999999998 111.002 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -71.13 -23.36 62.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 1.4199999999999999 111.309 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mm -77.81 -52.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.379 . . . . 0.28999999999999998 110.158 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.95 -41.75 99.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.1899999999999999 111.131 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 83' ' ' THR . 8.0 tttt -58.65 -31.84 68.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 1.7 110.91 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 91' ' ' THR . 1.6 tt0 -76.09 -46.36 29.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.909 -0.587 . . . . 0.91000000000000003 110.332 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -65.82 -31.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 1.2 111.211 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -8.21 59.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 0.41999999999999998 111.449 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -102.31 -28.44 12.26 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.778 -0.369 . . . . 1.1200000000000001 111.554 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -144.05 43.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.234 0.54 . . . . 2.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.18 172.78 20.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.651 -0.785 . . . . 0.32000000000000001 112.117 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.38 89.92 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.862 0.363 . . . . 1.3899999999999999 110.539 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 p -104.77 149.29 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.34999999999999998 110.248 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.07 98.13 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.19 0.519 . . . . 2.5699999999999998 111.048 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.86 172.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 1.02 110.598 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -122.24 -86.62 0.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.874 -0.417 . . . . 1.6100000000000001 109.874 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.26 149.78 48.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.927 -0.397 . . . . 1.6299999999999999 109.927 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 26.36 0.38 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.954 0.406 . . . . 1.5700000000000001 110.257 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -70.2 124.35 23.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.902 -0.59 . . . . 1.01 111.732 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -121.97 -56.61 1.83 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.39000000000000001 109.657 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 26.7 m-70 60.61 98.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.906 0.754 . . . . 0.40999999999999998 112.537 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.5 m -147.76 105.93 3.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.781 -0.645 . . . . 0.29999999999999999 109.599 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -119.04 145.82 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.55000000000000004 111.438 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' MET . 1.5 mt -165.01 136.45 4.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.492 -0.776 . . . . 0.53000000000000003 109.489 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 108' ' ' GLN . 0.4 OUTLIER -74.94 152.84 38.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.261 -0.274 . . . . 1.4399999999999999 110.261 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 82.6 mt-30 75.1 -11.24 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.053 0.845 . . . . 0.39000000000000001 111.397 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -60.62 -34.26 73.99 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.988 0.423 . . . . 0.48999999999999999 110.961 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -64.88 -22.87 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.45000000000000001 111.338 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.6 -26.92 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 2.0699999999999998 109.963 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.6 -53.09 12.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.58999999999999997 109.989 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.84 -30.37 49.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.642 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.17999999999999999 110.678 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.8 m -71.17 -39.05 72.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 1.8500000000000001 110.923 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.68 -41.04 77.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.792 -0.64 . . . . 2.5899999999999999 111.255 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.95 -16.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.091 -0.504 . . . . 0.29999999999999999 112.19 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.98 82.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.83 0.348 . . . . 0.17000000000000001 111.629 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -17.93 26.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.256 0.55 . . . . 0.26000000000000001 110.37 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -81.72 -46.89 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.842 -0.617 . . . . 1.6899999999999999 111.109 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.7 m -87.72 87.01 7.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.166 0.507 . . . . 0.29999999999999999 110.555 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -100.08 -177.98 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.54 -0.755 . . . . 0.37 110.759 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -141.67 155.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.046 -0.353 . . . . 0.91000000000000003 110.046 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.92 57.28 5.67 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.993 2.462 . . . . 0.54000000000000004 113.209 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -131.81 -174.17 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.364 -0.606 . . . . 0.78000000000000003 109.364 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 t -66.76 -31.74 72.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.54000000000000004 110.552 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -106.57 83.25 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.709 -0.478 . . . . 1.6000000000000001 109.709 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HB2' ' HD3' ' A' ' 129' ' ' PRO . 18.9 mtp180 -72.97 -55.72 3.82 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.915 -0.584 . . . . 0.52000000000000002 111.254 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 128' ' ' ARG . 74.4 Cg_endo -76.13 118.46 4.98 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.271 1.314 . . . . 0.23999999999999999 111.572 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -88.04 -179.63 6.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.905 0.383 . . . . 0.46000000000000002 110.972 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -101.72 158.79 15.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.289 -0.414 . . . . 0.81000000000000005 110.633 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.4 -36.08 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.20999999999999999 109.991 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mm -64.93 -36.78 78.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.342 -0.845 . . . . 0.42999999999999999 111.279 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.18 -51.48 63.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.571 -0.286 . . . . 0.69999999999999996 110.988 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.18 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.829 -0.348 . . . . 0.52000000000000002 110.147 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.09 -40.16 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.463 . . . . 1.5800000000000001 109.87 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -32.9 71.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.683 -0.69 . . . . 0.70999999999999996 110.518 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.78 -36.89 21.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.294 -0.412 . . . . 0.28000000000000003 110.634 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -66.32 -45.45 80.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 1.05 110.96 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -72.01 -15.67 62.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 1.77 110.568 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.45 -33.61 54.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 0.52000000000000002 109.737 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.5 52.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.209 1.004 . . . . 2.6800000000000002 110.102 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.58 37.37 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.93000000000000005 111.201 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -82.91 110.63 18.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.926 -0.579 . . . . 1.04 110.162 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.4 m -73.08 116.82 14.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.051 -0.522 . . . . 1.75 110.061 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.8 -43.4 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.558 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -132.04 152.57 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 1.6599999999999999 110.226 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.25 1.44 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 1.1699999999999999 110.808 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' HIS . 27.3 t-20 -66.39 -37.48 85.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.97999999999999998 110.341 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt 50.99 57.38 6.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.56 -0.746 . . . . 1.3400000000000001 110.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.8 m -118.91 118.31 31.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.119 -0.491 . . . . 0.96999999999999997 110.954 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -52.53 -61.64 2.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.2 0.815 . . . . 0.76000000000000001 113.2 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 5.21 3.29 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.962 0.727 . . . . 0.55000000000000004 112.962 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -44.55 3.81 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.816 -0.354 . . . . 0.95999999999999996 110.583 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.21 10.73 36.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.806 0.336 . . . . 0.52000000000000002 110.548 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.05 83.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.25 111.604 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -67.29 -21.6 65.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 2.0299999999999998 111.257 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.28 -49.54 9.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.88 109.835 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.33 -40.14 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.535 . . . . 0.20999999999999999 111.148 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.23 -8.17 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.201 0.524 . . . . 1.1699999999999999 111.765 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -37.16 4.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.503 -0.555 . . . . 0.40000000000000002 109.503 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.39 -45.83 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.725 . . . . 1.5800000000000001 110.338 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.43 -29.62 69.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.956 -0.565 . . . . 0.41999999999999998 110.358 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.91 -20.98 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 1.5600000000000001 110.414 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.04 -10.75 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 2.4500000000000002 110.595 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -108.04 -26.31 10.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.957 -0.565 . . . . 1.7 110.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.9 ttp -150.03 125.85 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.885 -0.598 . . . . 3.0800000000000001 110.042 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -72.19 121.45 19.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 2.75 110.538 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.3 pt -131.51 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.38 110.475 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -104.97 172.51 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.635 -0.505 . . . . 1.04 109.635 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -79.51 166.26 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 2.6800000000000002 111.155 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.9 175.84 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.10000000000000001 111.442 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -96.69 148.72 22.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.596 . . . . 2.1099999999999999 110.151 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.6 mmm -97.45 172.49 7.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 1.2 110.928 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.07 140.21 35.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 2.0699999999999998 111.275 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.56 146.13 49.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.51000000000000001 110.347 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.487 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 22.0 ptt85 -113.54 139.74 48.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.824 -0.625 . . . . 0.33000000000000002 110.451 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 48.7 t80 -105.94 125.87 51.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.253 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 pt -114.09 135.59 53.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.672 0.272 . . . . 0.72999999999999998 111.407 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.511 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -178.53 163.03 1.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.90000000000000002 109.568 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.27 165.76 31.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.151 1.901 . . . . 0.29999999999999999 112.151 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 t -63.96 -21.93 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.342 -0.39 . . . . 0.14000000000000001 111.574 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -47.89 -60.78 2.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.146 -0.479 . . . . 0.48999999999999999 111.784 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -93.82 -20.84 19.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.917 0.389 . . . . 0.38 109.985 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.23 93.68 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.793 -0.639 . . . . 0.11 113.485 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -60.33 -33.98 73.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.835 0.317 . . . . 1.1499999999999999 110.943 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.03 -48.56 78.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.951 -0.568 . . . . 1.5700000000000001 111.602 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -21.95 47.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.991 -0.284 . . . . 0.95999999999999996 111.184 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -60.67 -47.82 84.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 2.2999999999999998 110.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.59 16.64 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.78000000000000003 111.222 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -119.93 -50.53 2.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.758 0.313 . . . . 2.2200000000000002 111.346 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.49 -39.79 27.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.603 0.594 . . . . 0.73999999999999999 112.603 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 12.2 mtpp -61.66 -52.98 65.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.791 0.663 . . . . 0.85999999999999999 112.791 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.7 Cg_endo -65.51 -19.8 60.69 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.99 1.793 . . . . 0.31 112.974 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.53 -2.24 58.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.66 -0.245 . . . . 0.56999999999999995 110.797 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.5 mt 54.44 59.52 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.422 0.63 . . . . 0.5 111.399 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -139.55 35.83 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.516 0.674 . . . . 2.3199999999999998 109.673 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.69 167.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.46000000000000002 109.964 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.1 mt -119.99 150.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.52 109.315 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -73.04 71.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.353 0.597 . . . . 2.54 111.701 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 m -151.71 35.71 0.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.3 -1.0 . . . . 0.60999999999999999 108.3 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.0 mt-10 -94.84 152.65 18.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.919 -1.037 . . . . 1.8600000000000001 111.585 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -105.99 148.49 27.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.63 109.206 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -138.22 94.92 2.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.873 0.368 . . . . 1.4299999999999999 110.56 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -162.96 -108.45 0.22 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.156 -0.778 . . . . 0.28000000000000003 111.156 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -25.46 19.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.694 0.759 . . . . 1.8500000000000001 108.981 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -119.78 165.18 14.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.717 -1.129 . . . . 0.71999999999999997 109.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.63 78.17 1.77 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.798 0.333 . . . . 1.55 110.599 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 33.8 tt0 -75.12 107.44 7.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.873 -0.788 . . . . 0.53000000000000003 108.873 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 74.2 mt -121.19 135.82 60.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.027 0.441 . . . . 0.48999999999999999 111.941 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.98 107.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.16 -0.682 . . . . 0.33000000000000002 109.16 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.17 26.66 9.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.241 0.46 . . . . 1.29 112.241 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 121.08 43.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.849 0.356 . . . . 0.81000000000000005 110.481 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.409 ' HB ' ' H ' ' A' ' 215' ' ' ASP . 21.6 pt -108.38 -165.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.84999999999999998 111.231 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.593 ' OD2' ' HD2' ' A' ' 216' ' ' PRO . 0.1 OUTLIER -64.86 160.38 55.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.791 -0.641 . . . . 1.1299999999999999 111.111 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.593 ' HD2' ' OD2' ' A' ' 215' ' ' ASP . 59.7 Cg_endo -70.52 -154.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.817 2.344 . . . . 0.38 113.05 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.62 -91.42 0.77 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.403 -0.679 . . . . 0.20999999999999999 111.403 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.91 -0.38 21.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.26000000000000001 110.732 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 222' ' ' ILE . 2.5 p90 -62.42 -24.65 67.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.12 110.557 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -68.44 -29.81 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.354 0.597 . . . . 1.0700000000000001 110.003 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.11 -34.29 38.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.325 -0.852 . . . . 1.51 110.988 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.549 ' O ' HG12 ' A' ' 226' ' ' ILE . 5.2 tt -77.58 -32.65 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.19 110.559 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.38 -28.34 65.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 0.12 111.05 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -54.28 -40.72 68.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.805 -0.634 . . . . 1.3100000000000001 111.174 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 229' ' ' GLU . 0.9 OUTLIER -94.34 -38.43 10.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.553 -0.294 . . . . 0.23999999999999999 110.541 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 222' ' ' ILE . 48.5 mm -54.08 -37.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.44 111.384 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 7.1 ptpp? -59.79 -23.33 63.2 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.789 0.663 . . . . 2.1400000000000001 112.789 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.13 -25.15 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.443 . . . . 1.2 111.507 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -72.99 -44.15 61.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.12 -0.491 . . . . 0.59999999999999998 111.944 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -135.06 -42.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.355 0.502 . . . . 0.53000000000000003 112.355 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 226' ' ' ILE . 24.8 mtpt -60.08 -25.75 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.801 0.297 . . . . 1.1799999999999999 111.801 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -100.28 12.8 60.22 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.907 -0.663 . . . . 0.40000000000000002 112.984 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -101.2 -15.0 17.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.39000000000000001 110.574 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.4 -131.55 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.862 -0.685 . . . . 0.32000000000000001 112.14 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 m -129.31 141.61 51.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 0.66000000000000003 110.726 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -116.65 158.62 23.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.125 -0.489 . . . . 1.73 110.646 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.76 164.88 28.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.3 -0.409 . . . . 1.1000000000000001 110.038 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.41 154.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.963 0.411 . . . . 0.67000000000000004 111.267 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.15 100.05 10.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.60999999999999999 110.572 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -86.42 67.18 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.607 0.717 . . . . 1.45 110.419 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.4 mt -142.56 92.04 2.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.579 -0.737 . . . . 0.90000000000000002 109.886 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.473 ' H ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -118.77 16.02 13.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.226 -0.897 . . . . 1.8999999999999999 109.33 -179.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.27 -62.73 1.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.132 -0.94 . . . . 0.82999999999999996 110.599 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.59 141.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.633 . . . . 1.21 109.993 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -102.47 112.47 25.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.987 0.422 . . . . 1.3999999999999999 110.457 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.12 153.07 33.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.651 -0.704 . . . . 0.73999999999999999 110.207 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -128.08 -153.8 8.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.665 -0.778 . . . . 0.35999999999999999 112.193 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.66 53.05 2.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.59999999999999998 110.783 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.443 ' H ' ' HG2' ' A' ' 249' ' ' GLU . 3.0 pt-20 -92.51 17.72 9.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.53000000000000003 111.008 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.454 ' HG3' ' OE1' ' A' ' 252' ' ' GLU . 6.5 tptp -148.21 133.37 18.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 1.02 109.585 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -98.83 -27.07 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 1.4399999999999999 111.174 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.454 ' OE1' ' HG3' ' A' ' 250' ' ' LYS . 2.7 pm0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.705 -0.665 . . . . 1.3100000000000001 109.985 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.013 -0.435 . . . . 1.3400000000000001 112.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -111.42 145.93 38.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.761 0.281 . . . . 0.97999999999999998 110.435 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 mmt -95.86 144.88 25.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.331 -0.395 . . . . 2.1899999999999999 110.58 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 m -156.04 166.46 33.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.697 -0.483 . . . . 1.46 109.697 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -83.17 74.06 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 110.076 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.35 147.8 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.89 -0.595 . . . . 2.1200000000000001 109.725 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -122.09 84.94 45.85 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.577 0.227 . . . . 0.42999999999999999 110.517 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HB2' ' OD1' ' A' ' 10' ' ' ASN . 36.7 Cg_endo -66.03 -36.47 29.87 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.53 2.153 . . . . 1.55 112.312 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 37.85 49.16 1.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.895 0.878 . . . . 2.0299999999999998 112.668 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.523 ' OD1' ' HB2' ' A' ' 8' ' ' PRO . 16.6 m120 -68.28 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 1.9199999999999999 110.779 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -123.41 -81.01 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.535 -0.542 . . . . 2.4900000000000002 109.535 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.44 98.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.445 -0.576 . . . . 1.8799999999999999 109.445 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -141.82 145.1 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.863 -0.608 . . . . 0.59999999999999998 110.331 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.01 13.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.244 -0.435 . . . . 0.66000000000000003 111.709 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 p -96.02 -6.03 39.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.897 0.38 . . . . 1.47 111.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -151.02 52.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.154 0.502 . . . . 1.45 110.087 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.77 132.43 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.925 -0.58 . . . . 0.87 110.846 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.25 123.17 36.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.741 -0.466 . . . . 0.92000000000000004 109.741 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 t -81.6 114.82 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.332 0.587 . . . . 0.20999999999999999 111.147 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.0 133.04 70.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.939 -0.763 . . . . 1.02 108.939 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 147.18 37.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.14999999999999999 111.726 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.48 ' SD ' ' HD3' ' A' ' 24' ' ' ARG . 43.1 ttp -120.7 117.48 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.40000000000000002 110.187 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -99.5 114.7 27.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.291 -0.413 . . . . 0.94999999999999996 109.932 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HD3' ' SD ' ' A' ' 22' ' ' MET . 14.7 mmm-85 -100.55 -172.73 2.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.266 -0.425 . . . . 0.5 109.883 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.46 -24.24 46.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.844 0.313 . . . . 0.66000000000000003 111.844 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.17 -58.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.418 -0.896 . . . . 1.0900000000000001 113.135 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -123.26 175.91 6.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.079 0.466 . . . . 2.4399999999999999 110.934 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.13 142.76 48.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 1.3700000000000001 108.979 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -130.94 119.21 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.787 0.327 . . . . 1.0600000000000001 111.147 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 130.8 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 1.1100000000000001 109.915 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.71 172.27 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.84 0.352 . . . . 1.1000000000000001 110.661 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 122.31 22.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.262 -0.426 . . . . 0.28999999999999998 110.387 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 m -118.63 -163.35 0.95 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 2.3599999999999999 110.848 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.437 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 t80 -72.94 -171.15 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.29999999999999999 110.715 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -71.59 -157.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.279 -0.419 . . . . 0.71999999999999997 111.828 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -48.67 -22.64 0.82 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.303 0.853 . . . . 1.6699999999999999 113.303 -178.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -60.69 -18.81 56.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.255 0.465 . . . . 0.83999999999999997 112.255 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.28 -22.81 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 111.842 0.312 . . . . 0.14999999999999999 111.842 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' ASN . 4.0 p -76.02 -10.83 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.016 0.436 . . . . 0.34999999999999998 110.838 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.86 -25.69 69.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.986 -0.626 . . . . 0.12 112.073 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -61.65 -45.87 92.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.647 0.26 . . . . 2.5800000000000001 111.386 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.96 17.48 9.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.68999999999999995 110.949 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m -118.43 -37.01 3.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.56999999999999995 110.627 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.03 -107.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.615 -0.594 . . . . 0.45000000000000001 111.615 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.22 123.67 68.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.221 -0.288 . . . . 1.3899999999999999 110.221 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.93 176.73 6.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 1.46 110.885 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 6.8 ptmt -69.77 -64.12 0.94 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 1.96 111.582 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 5.5 t70 -169.32 123.15 0.79 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.629 -0.508 . . . . 0.93000000000000005 109.629 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.83 -35.57 76.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.197 0.443 . . . . 0.26000000000000001 112.197 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.11 -39.52 89.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.523 . . . . 0.75 110.375 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -91.57 16.93 9.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.682 -0.69 . . . . 1.3100000000000001 110.603 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.1 -38.03 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 0.46999999999999997 110.132 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 81.42 6.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.144 -0.48 . . . . 1.1599999999999999 110.708 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.437 ' NE2' ' HA ' ' A' ' 34' ' ' TYR . 39.2 mt-30 -61.66 -71.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.28000000000000003 110.473 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -85.71 86.53 7.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.078 0.466 . . . . 0.65000000000000002 109.987 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.72 66.6 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 1.72 110.381 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.0 m -154.76 131.42 10.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.21 -0.905 . . . . 0.39000000000000001 108.782 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 p -103.49 136.08 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.283 0.564 . . . . 0.37 110.977 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -106.45 135.59 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.951 -0.568 . . . . 0.65000000000000002 110.006 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t -89.79 -30.88 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.464 0.65 . . . . 0.22 110.207 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -151.66 103.42 2.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.716 -0.675 . . . . 0.57999999999999996 110.313 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.65 -23.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.847 0.356 . . . . 0.96999999999999997 111.465 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -35.62 44.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.037 0.446 . . . . 0.29999999999999999 110.856 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -89.11 -40.68 12.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.045 -0.525 . . . . 1.22 110.909 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.17 33.57 2.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.899 -0.667 . . . . 0.34000000000000002 111.504 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.54 106.5 18.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.55000000000000004 110.764 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.31 129.52 47.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.014 -0.539 . . . . 0.33000000000000002 109.736 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.07 112.43 24.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.148 0.499 . . . . 0.89000000000000001 110.759 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -82.35 -176.06 6.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.885 -0.598 . . . . 0.95999999999999996 109.614 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -60.33 -34.34 73.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.597 0.221 . . . . 1.9199999999999999 111.597 -178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.9 pm0 -72.86 -13.47 61.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.97999999999999998 111.447 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.47 -48.52 5.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.839 -0.344 . . . . 0.44 110.574 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.58 -31.27 71.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.695 0.283 . . . . 0.39000000000000001 111.081 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -23.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.27 0.557 . . . . 1.0900000000000001 110.314 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.565 . . . . 0.28000000000000003 110.535 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.82 -50.27 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.37 111.287 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -49.56 6.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.379 . . . . 0.59999999999999998 110.47 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.42 6.03 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.262 -0.735 . . . . 0.28000000000000003 111.262 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.35 143.36 27.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.279 -0.461 . . . . 1.6299999999999999 110.407 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.75 -5.19 48.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 0.84999999999999998 110.846 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -91.55 123.99 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.8 -0.444 . . . . 1.1200000000000001 109.8 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.87 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.70999999999999996 112.019 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -73.21 -32.61 64.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.38 . . . . 0.45000000000000001 110.958 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 17.7 mm-40 -67.56 -36.93 81.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.221 -0.445 . . . . 0.23999999999999999 111.125 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.57 -49.28 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 1.3999999999999999 110.209 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.1 m -66.11 -26.07 67.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.23999999999999999 111.523 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 84' ' ' GLU . 37.5 ttpt -57.14 -44.91 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 1.3 111.033 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.62 -40.83 61.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.417 -0.356 . . . . 0.76000000000000001 110.98 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.01 -36.55 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.883 0.373 . . . . 0.22 111.728 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.777 0.658 . . . . 0.13 112.777 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -105.8 -26.71 11.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.325 0.861 . . . . 1.1200000000000001 113.325 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -108.06 3.17 23.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.62 111.113 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.04 178.42 16.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.737 -0.744 . . . . 0.41999999999999998 111.873 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 122.52 38.37 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.958 -0.386 . . . . 0.23999999999999999 109.958 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.18 137.21 53.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.022 -0.535 . . . . 0.29999999999999999 109.973 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -77.23 84.0 3.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.084 0.468 . . . . 0.35999999999999999 111.151 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.04 175.66 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 1.0900000000000001 110.473 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -124.78 84.36 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.40999999999999998 110.754 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.47 ' CG ' ' HZ3' ' A' ' 153' ' ' LYS . 5.5 t70 -147.4 142.1 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.604 -0.271 . . . . 0.38 111.036 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.35 111.9 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.438 -0.347 . . . . 0.46999999999999997 110.338 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.05 132.36 20.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 1.04 110.642 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -138.65 127.48 23.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 2.7400000000000002 110.007 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -125.67 114.92 19.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.54 0.21 . . . . 1.3200000000000001 110.503 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 t -102.29 106.05 16.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.356 0.598 . . . . 2.1200000000000001 111.111 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.27 141.66 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 2.2999999999999998 109.582 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 mp -99.61 -77.82 0.52 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.361 -0.237 . . . . 1.22 110.361 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 52.89 30.66 9.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.003 0.521 . . . . 1.8100000000000001 112.24 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 60.92 28.08 17.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.35 -0.386 . . . . 0.93999999999999995 111.408 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.8 ttm -60.73 -19.7 59.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.772 0.32 . . . . 1.96 111.295 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -58.63 -41.22 85.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.89000000000000001 110.153 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -80.48 -28.9 37.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 1.03 110.022 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.91 -53.88 53.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.27000000000000002 110.103 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.1 mt -67.52 -35.06 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.932 -0.576 . . . . 0.32000000000000001 110.102 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.96 77.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.637 -0.71 . . . . 0.26000000000000001 111.474 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -64.22 -31.31 72.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 2.1800000000000002 111.17 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -78.96 -50.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.233 -0.44 . . . . 1.0700000000000001 111.319 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.87 -26.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.085 0.402 . . . . 0.33000000000000002 112.085 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.78 -37.51 76.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.694 0.257 . . . . 0.44 111.694 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.05 -34.63 15.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.892 0.377 . . . . 1.6399999999999999 110.937 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.08 -37.62 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.94999999999999996 111.352 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 88.0 m -139.28 94.92 2.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.334 0.588 . . . . 0.73999999999999999 110.693 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.2 m -92.88 164.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.602 -0.726 . . . . 1.3 111.396 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -155.96 132.41 6.01 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.661 -0.699 . . . . 1.26 109.877 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -90.42 27.33 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.01 2.473 . . . . 1.6299999999999999 112.084 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -100.86 16.04 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 1.47 110.745 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -138.14 -65.56 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.115 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 126' ' ' THR . 12.7 tptm -148.76 -77.64 0.15 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.761 -0.375 . . . . 1.6499999999999999 111.47 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -158.19 152.19 19.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.523 0.201 . . . . 1.8799999999999999 111.103 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.74 42.46 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.075 2.517 . . . . 0.94999999999999996 113.126 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -148.26 30.18 0.86 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.007 0.432 . . . . 1.3400000000000001 110.234 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.446 ' O ' HD22 ' A' ' 134' ' ' LEU . 20.6 m -151.59 117.82 5.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.634 -0.257 . . . . 0.39000000000000001 111.624 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.01 -27.91 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.138 0.494 . . . . 0.28999999999999998 111.174 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -56.47 -25.74 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.23999999999999999 111.613 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -62.59 -42.56 99.64 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.759 0.314 . . . . 0.45000000000000001 110.524 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.403 ' N ' ' HG ' ' A' ' 134' ' ' LEU . 6.4 tp -83.76 -29.03 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.759 0.314 . . . . 2.25 110.771 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.55 -34.4 77.0 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.074 -0.713 . . . . 1.22 109.074 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.15 -44.79 92.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.339 -0.846 . . . . 1.05 109.937 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.77 73.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.884 -0.598 . . . . 0.17000000000000001 110.863 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -58.96 -47.12 86.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.713 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -4.41 51.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.17 -0.468 . . . . 1.49 111.032 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -34.55 23.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.63 109.556 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.428 ' CG1' ' HG3' ' A' ' 166' ' ' LYS . 6.3 mt -93.75 -53.26 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.441 -0.8 . . . . 0.23000000000000001 110.507 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t60 51.34 47.53 24.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.435 -0.802 . . . . 1.3 110.368 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.85 119.47 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.604 -0.726 . . . . 1.0 110.322 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 97.47 11.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.001 -0.545 . . . . 1.6000000000000001 111.295 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.78 -169.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.76 -0.654 . . . . 2.0899999999999999 109.708 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -78.4 89.37 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.621 -0.511 . . . . 1.8700000000000001 109.621 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -41.85 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 1.0700000000000001 112.845 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.16 -12.84 62.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 3.0800000000000001 111.968 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 154' ' ' GLN . 95.0 mttt -121.36 9.82 10.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 1.5900000000000001 111.215 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -87.51 3.78 46.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 1.51 110.715 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -37.93 87.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.63 111.525 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HZ3' ' CG ' ' A' ' 99' ' ' ASP . 20.4 ptmt -155.79 -26.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.915 0.339 . . . . 0.94999999999999996 111.915 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 150' ' ' LYS . 43.3 tt0 -68.43 -60.46 2.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 1.02 110.778 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.409 ' O ' HG21 ' A' ' 159' ' ' VAL . 0.7 OUTLIER -94.33 14.29 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 1.8100000000000001 111.155 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.080000000000000002 111.548 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.75 -21.55 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.353 -0.385 . . . . 1.3 111.075 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.55 -39.14 20.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.311 -0.404 . . . . 1.04 110.451 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 155' ' ' GLN . 61.8 t -62.81 -49.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.083 -0.508 . . . . 0.97999999999999998 111.083 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.7 tp -64.78 -33.56 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.25 110.536 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 1.6 mmmt -69.25 -43.01 74.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 2.3100000000000001 110.174 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -61.26 -36.06 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.41999999999999998 110.474 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.6 tp -69.06 -40.4 78.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.906 -0.588 . . . . 0.17999999999999999 110.558 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -70.93 -11.11 60.78 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.881 -0.599 . . . . 1.6200000000000001 111.177 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 36.3 mm-40 -73.48 -27.92 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.049 0.452 . . . . 0.97999999999999998 110.074 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.428 ' HG3' ' CG1' ' A' ' 142' ' ' ILE . 16.2 mmtt -93.14 -39.01 11.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.17999999999999999 111.323 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 52.9 mtt -130.32 136.64 49.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.974 0.416 . . . . 1.01 110.896 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -79.77 81.61 6.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 2.23 110.421 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.4 pt -100.21 124.82 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 1.51 111.691 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -177.72 130.76 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.523 -0.762 . . . . 1.1599999999999999 109.172 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.89 92.39 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.435 . . . . 2.1099999999999999 112.13 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.11 137.79 38.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.916 -0.772 . . . . 0.44 108.916 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -142.13 139.42 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.726 0.298 . . . . 1.3300000000000001 111.234 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.1 mtp -111.28 178.73 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.305 -0.407 . . . . 2.2200000000000002 110.266 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HA ' ' CB ' ' A' ' 213' ' ' LEU . 90.3 mtt180 -115.88 143.62 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 1.0800000000000001 110.994 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.51 172.15 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.144 -0.48 . . . . 0.26000000000000001 110.522 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 177' ' ' ARG . 8.6 ptm180 -141.35 140.17 33.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 2.1000000000000001 110.388 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.65 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 9.1 p90 -94.72 150.21 20.45 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.531 -0.468 . . . . 0.31 110.077 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.84 118.54 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.545 . . . . 0.56000000000000005 111.214 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.22 156.87 34.02 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.746 -0.661 . . . . 1.1799999999999999 110.245 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.22 173.09 10.04 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.397 2.064 . . . . 0.23999999999999999 112.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.42 -42.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.298 0.481 . . . . 0.66000000000000003 112.298 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.17 -38.71 87.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.751 0.31 . . . . 0.44 111.571 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.18 -34.81 28.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.043 0.449 . . . . 1.5800000000000001 110.542 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.15 -29.75 71.97 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.23999999999999999 112.569 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -65.97 -13.47 59.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.3 . . . . 1.3500000000000001 111.513 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.92 -18.52 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.706 0.289 . . . . 1.5900000000000001 110.89 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -17.85 6.6 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.788 0.292 . . . . 1.98 111.788 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 85.4 tttt -55.57 -52.3 64.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 1.73 110.872 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -98.74 27.58 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.1799999999999999 111.744 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -137.77 -40.95 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.857 0.317 . . . . 2.25 111.857 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.97 -40.94 11.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.845 0.355 . . . . 1.28 110.6 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.548 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpp -60.29 -48.37 94.2 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.566 . . . . 1.29 112.527 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.1 Cg_endo -58.53 -12.82 15.05 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.529 2.153 . . . . 0.17000000000000001 113.464 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.93 -9.84 58.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.006 -0.368 . . . . 0.54000000000000004 110.006 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.7 mt 59.3 31.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.517 -0.765 . . . . 0.56000000000000005 111.14 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -113.51 30.44 7.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.105 -0.498 . . . . 1.1899999999999999 109.793 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.16 155.43 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.555 -0.748 . . . . 0.42999999999999999 111.072 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.41 147.76 9.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.434 -0.803 . . . . 0.32000000000000001 109.453 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -70.39 67.46 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.146 0.498 . . . . 1.1499999999999999 111.781 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.1 m -156.33 33.4 0.33 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.42 -0.585 . . . . 0.92000000000000004 109.42 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.444 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.1 OUTLIER -90.9 160.96 15.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.4 -0.818 . . . . 1.1200000000000001 110.77 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.41 141.47 52.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.229 -0.656 . . . . 0.38 109.229 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -116.11 31.42 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.389 . . . . 0.85999999999999999 110.933 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.81 -125.11 2.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.713 -0.755 . . . . 0.45000000000000001 112.536 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.89 -31.61 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.195 0.521 . . . . 2.5899999999999999 109.893 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -110.43 111.81 23.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.664 -0.865 . . . . 0.37 108.664 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.13 73.91 4.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.022 0.439 . . . . 0.68000000000000005 111.121 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 42.5 mt-10 -83.47 111.6 19.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 1.23 110.523 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.65 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 22.5 mt -125.3 142.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.526 . . . . 1.1499999999999999 110.908 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.39 123.9 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.855 -0.794 . . . . 0.34000000000000002 108.855 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 13.2 p -137.1 52.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.54000000000000004 112.0 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 175' ' ' ARG . 4.1 mm? -122.25 114.74 21.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.19 -0.3 . . . . 0.87 110.19 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.417 HG23 ' H ' ' A' ' 215' ' ' ASP . 0.6 OUTLIER -104.99 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.381 -0.372 . . . . 1.0900000000000001 110.339 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.417 ' H ' HG23 ' A' ' 214' ' ' ILE . 2.8 m-20 -80.5 164.27 52.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 1.24 110.624 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.75 -178.04 2.51 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.16 1.907 . . . . 0.48999999999999999 112.176 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.2 -79.99 1.43 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.517 -0.849 . . . . 0.32000000000000001 111.567 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -16.73 64.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.084 0.469 . . . . 0.42999999999999999 110.878 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 1.3 p90 -62.41 -20.61 64.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.19 110.932 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -65.43 -21.98 66.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.18 0.514 . . . . 0.27000000000000002 110.303 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -76.29 -33.15 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.546 -0.752 . . . . 1.8999999999999999 110.878 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 9.3 tt -95.15 -26.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 1.72 110.836 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -34.95 71.55 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.061 -0.518 . . . . 0.19 111.527 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -29.37 70.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.73999999999999999 111.834 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -97.9 -30.89 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.518 -0.473 . . . . 0.54000000000000004 111.825 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 222' ' ' ILE . 19.8 mm -57.33 -40.42 73.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 0.28999999999999998 111.152 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.0 ptpp? -69.23 -8.39 45.42 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.28 0.845 . . . . 1.55 113.28 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -124.7 -31.1 3.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.563 -0.455 . . . . 0.34999999999999998 111.842 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -54.21 7.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.296 0.48 . . . . 1.1000000000000001 112.296 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.0 t -108.02 -42.86 4.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.733 0.642 . . . . 0.37 112.733 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 79.4 tttt -61.42 -34.69 75.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 2.6299999999999999 111.234 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.12 10.41 73.66 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.473 -0.87 . . . . 0.62 112.684 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -140.69 20.32 2.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 1.97 111.141 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 173.67 -145.71 8.4 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.582 -0.818 . . . . 0.65000000000000002 112.357 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.4 m -138.62 147.31 42.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.374 -0.232 . . . . 0.42999999999999999 110.374 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 1.1 pt? -121.5 135.45 55.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.849 0.357 . . . . 0.48999999999999999 110.333 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -129.1 173.28 10.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 1.54 110.422 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -79.4 164.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.56 -0.291 . . . . 0.89000000000000001 110.696 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 175' ' ' ARG . 1.2 pt? -88.75 14.17 10.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 2.1600000000000001 110.179 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -82.47 69.4 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.555 -0.748 . . . . 0.82999999999999996 110.284 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.413 ' HB3' ' OE1' ' A' ' 246' ' ' GLU . 34.3 tp -115.75 -78.79 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.63 -0.714 . . . . 0.75 110.327 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 51.16 36.56 16.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.041 0.537 . . . . 3.3599999999999999 111.564 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.38 -9.1 13.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.474 0.654 . . . . 1.4299999999999999 110.376 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.88 174.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.544 -0.91 . . . . 1.0600000000000001 108.544 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.96 98.63 0.03 OUTLIER 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.267 0.556 . . . . 2.5299999999999998 111.173 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.413 ' OE1' ' HB3' ' A' ' 241' ' ' LEU . 3.0 tt0 -88.76 75.84 8.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.484 -0.78 . . . . 1.9099999999999999 111.132 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 128.69 126.76 2.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.388 -0.91 . . . . 0.68999999999999995 112.721 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 250' ' ' LYS . 37.3 t0 -139.66 99.9 3.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -96.41 17.75 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 1.78 111.336 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.448 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 0.9 OUTLIER -82.27 81.1 8.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.317 0.58 . . . . 1.6899999999999999 110.209 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -74.34 -25.95 59.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 1.6100000000000001 109.64 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.406 ' C ' ' HZ1' ' A' ' 250' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.189 -0.914 . . . . 2.2999999999999998 109.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.964 0 N-CA-C 112.311 -0.316 . . . . 0.65000000000000002 112.311 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -85.37 160.03 19.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 1.48 111.148 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -116.31 154.5 30.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.139 -0.482 . . . . 1.01 110.042 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -130.42 170.44 14.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.332 . . . . 0.81999999999999995 110.851 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mt -76.17 -59.64 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.846 -0.427 . . . . 1.3100000000000001 109.846 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -83.56 159.57 21.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.676 -0.693 . . . . 1.72 110.171 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -140.78 89.63 10.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.881 0.372 . . . . 0.51000000000000001 110.452 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.86 155.38 34.45 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.059 2.506 . . . . 0.76000000000000001 112.575 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.28 123.29 49.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.84999999999999998 110.651 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.759 -0.459 . . . . 0.82999999999999996 109.759 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -71.73 -40.34 69.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 0.82999999999999996 109.464 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -129.4 98.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.674 -0.861 . . . . 1.1499999999999999 108.674 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -144.97 135.77 24.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.408 -0.36 . . . . 2.5899999999999999 110.868 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.431 ' O ' HG21 ' A' ' 17' ' ' VAL . 98.5 mt -66.16 -16.61 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 2.2200000000000002 112.02 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -89.65 -2.97 58.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.756 0.313 . . . . 0.85999999999999999 111.382 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -114.75 14.61 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.83999999999999997 110.544 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 14' ' ' LEU . 23.2 m -86.93 151.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.008 -0.542 . . . . 0.37 111.39 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.72 53.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.653 -0.703 . . . . 0.29999999999999999 109.626 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.59 117.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.959 0.409 . . . . 0.75 111.139 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.59 125.43 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.932 -0.576 . . . . 0.27000000000000002 110.291 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 143.38 50.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.042 0.448 . . . . 2.8799999999999999 111.598 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.3 ttt -109.15 129.12 55.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.607 -0.724 . . . . 1.02 110.047 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -100.09 116.62 32.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.662 0.267 . . . . 1.8400000000000001 110.746 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -112.0 41.18 2.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 3.02 110.165 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 63.35 90.42 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.522 -0.763 . . . . 1.49 111.061 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.52 -48.29 3.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 0.28999999999999998 112.017 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -98.63 108.56 21.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.052 0.453 . . . . 1.97 110.659 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HD3' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.39 143.95 48.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 2.6400000000000001 109.979 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 97.0 m-85 -132.59 150.01 52.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.59999999999999998 110.441 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -138.87 154.06 48.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.662 0.268 . . . . 1.26 110.594 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.55 169.66 18.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.892 -0.594 . . . . 0.64000000000000001 110.153 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.46 21.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.369 . . . . 1.1699999999999999 111.384 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -121.54 165.61 15.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.917 -0.583 . . . . 0.5 110.333 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -75.0 129.7 38.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.067 0.46 . . . . 0.31 111.373 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 37' ' ' LYS . 67.8 tttt -67.85 147.51 52.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.636 -0.711 . . . . 1.8899999999999999 111.057 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.14 -21.47 0.25 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.86 0.864 . . . . 0.69999999999999996 111.816 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 35' ' ' LYS . 28.7 mmtm -94.91 -45.08 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.051 0.453 . . . . 0.96999999999999997 110.467 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 p -68.67 -18.27 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.955 -0.566 . . . . 0.39000000000000001 111.864 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 HG11 ' A' ' 97' ' ' VAL . 7.6 p -67.71 -16.37 20.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.171 0.51 . . . . 0.58999999999999997 110.641 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.19 -35.17 90.46 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.762 -0.654 . . . . 0.17999999999999999 112.701 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -65.71 -17.47 64.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.975 0.417 . . . . 0.5 111.53 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.582 ' NH1' ' HA ' ' A' ' 91' ' ' THR . 10.0 mmp_? -108.42 4.86 24.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.524 -0.307 . . . . 0.37 110.751 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -131.21 13.35 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.333 . . . . 0.85999999999999999 111.548 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.89 36.48 86.72 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.66000000000000003 112.763 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.55 61.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.951 0.405 . . . . 0.64000000000000001 110.148 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -68.98 156.48 38.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.122 -0.49 . . . . 1.79 110.72 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -155.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.21 -0.45 . . . . 0.62 109.953 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -52.29 117.88 3.14 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.469 0.481 . . . . 1.28 110.19 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.509 ' H ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.26 -4.03 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.603 0.594 . . . . 0.89000000000000001 112.603 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.94 -35.47 8.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.074 0.464 . . . . 1.5600000000000001 109.838 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.65 -36.45 73.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 1.8300000000000001 109.734 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.06 -24.25 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 1.03 110.779 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.33 87.14 6.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.19 110.008 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -64.11 -53.53 48.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.20000000000000001 111.286 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -128.53 107.44 9.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.142 -0.481 . . . . 1.8300000000000001 110.895 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.8 71.1 5.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.512 0.673 . . . . 1.03 110.277 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.4 m -153.15 130.66 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.303 -0.862 . . . . 0.33000000000000002 109.329 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' A' ' 29' ' ' PHE . 7.2 p -107.25 140.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 1.0 110.606 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 149.94 24.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.482 . . . . 0.47999999999999998 111.568 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.422 ' CG2' ' HB1' ' A' ' 68' ' ' ALA . 39.4 t -112.76 -40.43 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.66 -0.7 . . . . 0.54000000000000004 109.584 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -154.55 116.41 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 1.2 109.038 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.36 -25.18 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.949 0.352 . . . . 0.70999999999999996 111.949 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -49.41 77.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 1.0900000000000001 111.515 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -101.36 10.89 40.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 1.1299999999999999 111.251 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.02 56.45 25.12 Favored Glycine 0 C--O 1.229 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.54000000000000004 112.931 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -102.34 114.46 28.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.668 0.271 . . . . 0.66000000000000003 110.328 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.9 t -112.43 131.66 63.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.31 109.676 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB1' ' CG2' ' A' ' 60' ' ' VAL . . . -84.71 120.3 26.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.977 0.417 . . . . 0.26000000000000001 111.384 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 3.1 tppt? -78.27 171.82 14.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.851 -0.796 . . . . 2.3700000000000001 108.851 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 19.2 pttp -59.9 -18.29 43.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 2.2200000000000002 111.284 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -87.1 -7.24 58.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.58999999999999997 111.644 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -114.87 -44.44 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 1.95 111.563 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 69' ' ' LYS . 2.7 pp -61.83 -23.22 66.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.879 0.371 . . . . 0.32000000000000001 110.96 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 73' ' ' LEU . 16.6 tt -66.92 -35.99 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.23 -0.441 . . . . 0.96999999999999997 110.363 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -8.86 51.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 1.0900000000000001 111.152 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.67 -14.77 19.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.218 -0.446 . . . . 1.0700000000000001 111.044 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -121.32 -43.41 2.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.60999999999999999 111.008 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . 124.61 -14.25 7.68 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.632 -0.587 . . . . 0.14999999999999999 111.632 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 6.0 m -151.48 150.71 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.407 -0.59 . . . . 0.19 109.407 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.38 -4.77 59.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.683 0.277 . . . . 0.22 111.148 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.48 109.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.495 . . . . 1.1499999999999999 110.469 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.03 -38.96 93.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 1.5 111.532 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -43.77 98.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 1.54 111.793 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 87' ' ' LYS . 24.7 mm-40 -62.3 -45.69 92.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.622 0.248 . . . . 0.82999999999999996 111.536 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -64.18 -48.17 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.34999999999999998 109.982 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 43.2 t -61.95 -42.65 99.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.647 -0.706 . . . . 1.3999999999999999 110.471 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 84' ' ' GLU . 31.0 ttpt -56.75 -47.23 80.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 1.8899999999999999 111.214 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -46.6 88.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 1.01 110.812 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.12 -32.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.961 -0.563 . . . . 0.40000000000000002 110.512 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -81.46 -4.51 56.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.93000000000000005 111.428 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.582 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 88.3 m -105.35 -46.98 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.082 -0.247 . . . . 0.39000000000000001 111.374 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 91' ' ' THR . 7.8 mmmm -122.53 40.06 3.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.137 0.494 . . . . 3.5299999999999998 110.817 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.75 21.66 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.664 -0.698 . . . . 0.19 111.521 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.77 94.09 8.09 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.921 -0.4 . . . . 2.3199999999999998 109.921 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -102.69 143.26 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.35999999999999999 111.308 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.04 89.18 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.867 -0.606 . . . . 1.02 110.911 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG11 HG23 ' A' ' 39' ' ' VAL . 10.5 m -98.26 139.73 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.095 -0.502 . . . . 0.46000000000000002 110.759 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.8 -58.82 2.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 0.56999999999999995 110.345 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.82 164.37 23.19 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.441 -0.577 . . . . 0.35999999999999999 109.441 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.641 ' NZ ' ' HA ' ' A' ' 100' ' ' LYS . 2.0 tpmp? -139.71 49.38 1.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.434 . . . . 1.05 111.486 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 9.0 tp10 -102.16 118.25 36.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.126 -0.488 . . . . 2.77 110.057 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -175.27 149.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 2.04 109.717 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -138.57 134.07 33.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.54000000000000004 110.681 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -147.73 124.1 10.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.916 -0.584 . . . . 0.63 110.263 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -124.96 116.42 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.012 0.434 . . . . 2.1800000000000002 110.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.8 tp -130.57 151.95 50.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.99 -0.55 . . . . 1.04 109.717 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.85 138.05 44.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.9099999999999999 110.801 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 60.18 21.75 11.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.921 -0.581 . . . . 2.5 111.444 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -31.5 71.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.62 111.006 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 32.7 p90 -68.51 -30.28 69.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 1.2 110.627 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.51000000000000001 110.262 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.29 -35.56 73.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.76000000000000001 110.897 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -94.25 -22.96 5.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.959 -0.564 . . . . 0.97999999999999998 110.62 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' PHE . . . -63.39 -34.35 77.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.39000000000000001 111.609 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -65.1 -14.51 60.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 2.2000000000000002 111.468 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mt -94.11 -45.0 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.94999999999999996 110.513 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 114' ' ' ALA . 14.9 p -70.77 -30.48 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.368 -0.378 . . . . 0.5 111.543 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.49 -12.51 60.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.997 0.427 . . . . 0.71999999999999997 111.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -102.94 -42.02 5.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 1.02 109.858 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.4 -26.1 64.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.442 -0.799 . . . . 2.7200000000000002 111.489 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.541 ' SG ' ' HG2' ' A' ' 171' ' ' ARG . 2.0 m -122.95 148.53 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.5 -0.318 . . . . 1.0900000000000001 110.364 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.01 148.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.082 0.467 . . . . 0.93999999999999995 111.41 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 124' ' ' PRO . 0.8 OUTLIER -83.56 156.77 65.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.356 -0.838 . . . . 0.81999999999999995 109.776 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.421 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 62.6 Cg_endo -73.26 -157.07 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.526 2.151 . . . . 0.29999999999999999 112.333 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -71.14 80.13 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.464 0.65 . . . . 1.8600000000000001 111.191 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 t -163.47 -38.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.73999999999999999 110.589 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.72 152.88 30.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.05 -0.352 . . . . 1.8300000000000001 110.05 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.34 152.59 43.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.464 -0.334 . . . . 1.22 110.127 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.24 108.55 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.565 2.177 . . . . 0.94999999999999996 112.315 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -127.22 -61.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.803 -0.635 . . . . 1.25 110.404 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.7 p -123.96 176.72 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.52000000000000002 110.366 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.4 t -63.58 -21.32 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.331 0.586 . . . . 0.56000000000000005 110.719 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.9 mm -57.89 -25.88 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.464 -0.789 . . . . 0.68999999999999995 111.676 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.0 tp -51.97 -41.81 62.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.373 -0.376 . . . . 1.26 111.568 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -99.98 -28.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.452 -0.34 . . . . 0.41999999999999998 110.822 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.844 0.354 . . . . 1.02 110.365 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -63.61 -23.81 67.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.95999999999999996 111.103 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.24 -38.53 13.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.27000000000000002 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 53.9 tpp -65.67 -47.92 73.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.545 . . . . 2.5699999999999998 110.992 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -77.1 -8.23 57.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.37 111.147 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 137' ' ' ARG . 22.3 t0 -76.26 -56.13 4.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.60999999999999999 110.085 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.0 tt -73.99 -42.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 0.44 109.808 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 46.09 58.43 4.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.666 -0.697 . . . . 1.8799999999999999 111.923 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -124.1 143.04 50.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.994 -0.548 . . . . 1.02 110.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 m -129.67 158.98 37.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.176 -0.676 . . . . 0.34999999999999998 109.176 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 t -76.67 -55.12 11.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.776 0.322 . . . . 0.52000000000000002 110.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 135.04 8.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 1.8899999999999999 110.27 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -8.16 55.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.985 0.421 . . . . 0.97999999999999998 111.346 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -85.14 -2.17 57.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.201 0.524 . . . . 0.64000000000000001 110.343 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -114.35 145.7 41.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.599 -0.728 . . . . 0.65000000000000002 109.229 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 86.5 p -76.0 169.45 18.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.934 0.397 . . . . 0.28999999999999998 110.716 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -36.07 74.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 1.5900000000000001 111.536 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.65 -11.94 58.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 2.1099999999999999 111.451 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.01 -11.44 44.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.382 -0.372 . . . . 1.3500000000000001 111.767 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 151' ' ' SER . 19.0 pt20 -137.88 13.89 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.40999999999999998 110.763 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.42 68.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.14000000000000001 111.475 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.72 -23.56 64.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.75 111.054 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -99.19 -42.65 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.425 -0.352 . . . . 1.77 111.011 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 155' ' ' GLN . 89.1 t -57.5 -36.03 52.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.23000000000000001 111.352 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.6 tt -73.79 -10.23 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.173 0.511 . . . . 1.4299999999999999 110.749 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -109.06 -9.2 15.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 1.5700000000000001 109.964 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -53.69 38.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.14000000000000001 110.542 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -71.02 -16.61 62.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.48 -0.327 . . . . 0.17000000000000001 110.63 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -67.81 -23.35 65.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.013 -0.539 . . . . 1.1399999999999999 109.846 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -76.46 -29.14 56.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.345 -0.613 . . . . 0.38 109.345 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.59 -54.29 5.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.237 -0.892 . . . . 1.79 109.446 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.3 mmt -125.36 109.13 12.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.88 109.349 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -77.19 108.67 10.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.093 0.473 . . . . 1.0 111.213 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -101.22 153.64 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.769 -0.651 . . . . 0.39000000000000001 110.334 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.68 154.09 20.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 3.2799999999999998 110.67 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.541 ' HG2' ' SG ' ' A' ' 121' ' ' CYS . 11.5 mtm180 -135.24 -7.68 2.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.729 -0.669 . . . . 2.9700000000000002 111.233 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.33 140.93 58.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.916 0.339 . . . . 0.66000000000000003 111.916 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -148.19 120.67 8.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.079 -0.509 . . . . 0.40999999999999998 110.57 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 22.5 mmt -111.86 -174.94 2.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.73999999999999999 110.667 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -117.33 130.66 56.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.566 0.222 . . . . 1.26 110.525 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.16 153.82 39.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.45 -0.341 . . . . 0.68999999999999995 111.311 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -119.63 169.83 9.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.723 -0.671 . . . . 1.3799999999999999 109.305 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.41 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 2.9 p90 -138.69 138.26 37.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.963 0.411 . . . . 0.93000000000000005 110.792 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.31 118.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.418 ' CD1' ' HD2' ' A' ' 181' ' ' PRO . 43.6 tp -156.4 126.57 3.34 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.685 -0.234 . . . . 0.56999999999999995 110.59 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 180' ' ' LEU . 14.9 Cg_endo -58.48 156.36 31.7 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.963 2.442 . . . . 0.31 112.549 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.43 -40.24 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.817 0.673 . . . . 0.20000000000000001 112.817 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.46 -42.98 61.96 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.386 0.513 . . . . 0.59999999999999998 112.386 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.08 -26.6 14.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.267 -0.424 . . . . 0.40999999999999998 110.986 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.08 -29.68 71.64 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.104 -0.498 . . . . 0.28000000000000003 113.113 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 74.4 tttt -62.13 -23.13 66.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.775 0.288 . . . . 1.3100000000000001 111.366 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -68.55 -36.72 79.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.37 110.658 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -89.87 -27.05 20.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 1.3799999999999999 110.949 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -54.83 -52.51 62.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 1.79 111.791 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 5.4 pt-20 -86.46 24.54 1.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.147 0.425 . . . . 1.76 112.147 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.39 -41.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.807 -0.357 . . . . 1.1599999999999999 111.593 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.6 mt -85.98 -47.56 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.974 0.361 . . . . 1.1799999999999999 111.974 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 22.7 mtpp -59.89 -51.78 78.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.648 0.61 . . . . 1.52 112.648 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.6 Cg_endo -61.59 -20.06 67.27 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.383 2.055 . . . . 0.51000000000000001 113.24 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.5 8.01 33.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.543 0.211 . . . . 0.66000000000000003 110.742 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.8 pt 35.97 60.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.255 1.022 . . . . 1.1399999999999999 113.67 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -136.51 26.62 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.634 0.731 . . . . 1.8300000000000001 109.65 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.77 151.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 114.844 -1.071 . . . . 0.32000000000000001 109.831 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.37 149.03 4.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.115 -0.493 . . . . 0.29999999999999999 110.573 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 67.88 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.314 0.578 . . . . 1.8 111.562 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.468 ' HA ' ' HA2' ' A' ' 247' ' ' GLY . 18.9 m -149.66 38.75 0.77 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.302 -0.629 . . . . 0.56000000000000005 109.302 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 193' ' ' LYS . 18.9 mt-10 -86.92 172.34 10.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.561 -0.745 . . . . 0.62 111.104 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.5 118.62 4.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.784 -0.821 . . . . 0.98999999999999999 108.784 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.22 114.9 28.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 110.925 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -163.05 -104.67 0.19 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.884 -0.674 . . . . 0.88 111.541 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -16.37 32.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.539 0.685 . . . . 2.48 109.367 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 209' ' ' GLU . 2.8 pm0 -142.22 172.68 12.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.109 -0.95 . . . . 1.4099999999999999 108.749 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.28 84.4 2.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.682 -0.488 . . . . 0.20000000000000001 109.682 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 2.9 tp10 -85.99 112.82 21.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.622 -0.717 . . . . 1.74 109.758 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.41 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 51.0 mt -132.16 146.02 33.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.614 0.245 . . . . 0.59999999999999998 110.574 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.03 113.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.58999999999999997 109.691 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 20.3 t -132.73 97.64 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.38 110.699 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.9 106.25 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 1.0600000000000001 109.875 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 215' ' ' ASP . 8.1 tp -90.72 168.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.367 -0.379 . . . . 1.3400000000000001 110.685 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.442 ' H ' HG13 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -68.03 164.4 41.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.443 -0.344 . . . . 1.1799999999999999 110.449 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.58 170.73 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.996 2.464 . . . . 0.44 113.392 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 92.24 -87.28 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.773 -0.931 . . . . 0.39000000000000001 110.773 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.71 -1.92 27.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 2.0600000000000001 110.861 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.48 -33.46 69.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.26000000000000001 111.542 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -81.15 -16.76 52.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.133 0.492 . . . . 1.3100000000000001 110.78 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.5 -44.33 24.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.71999999999999997 109.521 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 226' ' ' ILE . 11.6 tt -78.07 -38.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.672 -0.695 . . . . 0.38 110.3 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -28.71 68.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.997 0.427 . . . . 0.42999999999999999 110.413 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.596 ' O ' ' HE2' ' A' ' 228' ' ' LYS . 14.5 tp10 -51.02 -46.12 61.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.283 -0.871 . . . . 1.95 111.008 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -90.7 -29.28 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.395 -0.366 . . . . 0.23999999999999999 111.277 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 222' ' ' ILE . 32.2 mm -58.23 -38.89 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.915 0.339 . . . . 0.34000000000000002 111.915 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.9 ptpt -64.6 -10.15 24.32 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.147 0.795 . . . . 1.3 113.147 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.596 ' HE2' ' O ' ' A' ' 224' ' ' GLU . 5.7 pttt -124.72 -32.78 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.655 -0.418 . . . . 2.0600000000000001 111.132 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -47.17 73.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 1.4299999999999999 111.997 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.0 t -130.11 -41.55 1.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.129 0.418 . . . . 0.41999999999999998 112.129 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 0.3 OUTLIER -67.3 -21.7 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.951 0.405 . . . . 2.7799999999999998 110.805 -179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.73 14.41 64.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.889 -0.672 . . . . 0.5 111.978 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -135.51 -45.82 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 1.7 110.835 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -109.22 -154.97 16.15 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.799 -0.715 . . . . 0.53000000000000003 112.225 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -120.94 152.81 38.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.275 -0.269 . . . . 0.44 110.275 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 236' ' ' LEU . 2.0 pt? -95.44 150.0 20.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 1.2 110.496 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.24 160.03 43.99 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.341 -0.614 . . . . 0.88 109.341 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.17 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.88 0.372 . . . . 0.46000000000000002 111.013 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.29 103.49 9.26 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.412 -0.588 . . . . 1.1299999999999999 109.412 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -172.03 26.67 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.974 0.361 . . . . 0.31 111.974 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.545 ' HB2' ' CD ' ' A' ' 246' ' ' GLU . 3.4 mm? -68.0 124.84 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.071 0.462 . . . . 0.68000000000000005 110.652 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -100.53 -8.46 23.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 1.5800000000000001 111.131 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -72.52 -73.34 0.2 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.696 -0.483 . . . . 0.85999999999999999 109.696 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.84 156.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.625 -0.716 . . . . 0.58999999999999997 109.388 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.01 130.2 38.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 2.1200000000000001 111.158 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.545 ' CD ' ' HB2' ' A' ' 241' ' ' LEU . 33.5 mt-10 -96.3 143.48 27.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.75 -0.659 . . . . 1.6000000000000001 110.019 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 201' ' ' SER . . . 112.71 102.0 2.56 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.48 -0.867 . . . . 0.37 113.42 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -142.05 114.2 8.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.273 -0.64 . . . . 1.1000000000000001 109.273 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 28.68 8.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 0.78000000000000003 111.044 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -97.38 108.53 21.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.094 -0.503 . . . . 1.2 110.428 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -81.33 -22.88 38.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 1.3100000000000001 110.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.288 -0.863 . . . . 1.03 110.043 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.549 -0.62 . . . . 0.82999999999999996 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -134.58 84.78 2.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.304 . . . . 0.69999999999999996 110.27 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 30.6 tpp 60.75 48.61 6.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 1.0600000000000001 110.959 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.72 91.86 8.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.559 -0.746 . . . . 0.52000000000000002 109.851 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.5 -50.15 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.001 -0.545 . . . . 0.92000000000000004 111.006 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -114.25 99.84 7.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.308 -0.406 . . . . 3.6000000000000001 110.599 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.83 94.11 27.56 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 1.3 110.503 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.52 175.55 3.81 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.223 2.616 . . . . 0.34999999999999998 112.61 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t -88.46 153.62 21.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.53 . . . . 0.81999999999999995 109.646 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -172.03 168.73 5.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -91.27 -57.84 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 0.80000000000000004 109.889 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.1 mt -129.69 105.16 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 1.03 110.024 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -177.71 149.1 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.141 -0.688 . . . . 1.8100000000000001 109.141 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.45 61.09 0.66 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.124 0.487 . . . . 0.96999999999999997 112.04 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -42.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 0.34999999999999998 109.327 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -105.1 37.14 2.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.45000000000000001 109.941 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.47 155.66 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.20999999999999999 111.589 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -118.46 125.45 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.503 -0.771 . . . . 0.92000000000000004 109.29 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.27 133.58 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.448 . . . . 0.71999999999999997 111.676 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 4.1 p -133.78 129.9 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.66 -0.7 . . . . 1.05 109.504 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.22 140.42 52.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 2.3599999999999999 111.906 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 59.0 ttp -123.26 125.71 45.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.92000000000000004 109.691 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -100.04 118.8 37.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.656 0.265 . . . . 1.45 110.757 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -113.21 -159.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.89000000000000001 110.791 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.56 -73.73 0.07 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.152 -0.477 . . . . 0.37 111.684 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.27 29.78 5.62 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.468 -0.872 . . . . 0.33000000000000002 112.335 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.03 146.56 21.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.238 -0.282 . . . . 1.0800000000000001 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ptt-85 -141.0 93.16 2.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.046 0.45 . . . . 2.6800000000000002 110.308 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -76.93 152.41 35.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 2.0 111.671 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 15.0 pt-20 -146.86 133.02 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.23999999999999999 109.583 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -132.11 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.97 0.414 . . . . 0.81999999999999995 110.957 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 18' ' ' ALA . . . -137.18 110.77 8.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.14000000000000001 110.516 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.4 m -106.89 -175.81 2.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.909 -0.587 . . . . 0.58999999999999997 110.559 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.529 ' HA ' HE21 ' A' ' 54' ' ' GLN . 3.0 t80 -66.69 122.77 18.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.006 0.431 . . . . 0.39000000000000001 110.544 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.29 124.83 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.533 -0.758 . . . . 0.58999999999999997 112.745 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.443 ' OD1' ' HB3' ' A' ' 98' ' ' SER . 46.0 t30 66.28 3.73 2.88 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.832 -1.076 . . . . 0.83999999999999997 113.414 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 44.2 tptt -107.51 -33.79 7.23 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.673 -0.642 . . . . 1.8899999999999999 110.242 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.57 -22.05 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.078 -0.51 . . . . 0.79000000000000004 110.837 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.27 -18.11 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.75 109.86 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.11 93.47 Favored Glycine 0 C--O 1.222 -0.624 0 CA-C-N 115.75 -0.659 . . . . 0.14999999999999999 112.219 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -65.8 -18.53 65.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.318 0.58 . . . . 0.47999999999999998 110.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -90.31 -43.32 10.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.997 -0.547 . . . . 1.6699999999999999 111.817 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.09 -16.72 29.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.533 0.568 . . . . 0.54000000000000004 112.533 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.42 -107.23 0.2 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.672 -0.775 . . . . 0.78000000000000003 112.449 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.12 137.71 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.164 -0.31 . . . . 1.1699999999999999 110.164 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -103.45 -87.33 0.43 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.903 -0.406 . . . . 0.59999999999999998 109.903 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 19.9 ptmt -159.8 -43.95 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.324 -0.235 . . . . 1.8300000000000001 111.445 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -178.0 126.5 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.238 -0.282 . . . . 0.52000000000000002 110.238 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 52' ' ' VAL . 48.3 mt -61.6 -29.01 69.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 2.4700000000000002 112.048 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.21 -35.69 55.42 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.707 -0.397 . . . . 0.92000000000000004 110.698 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.54 -29.14 41.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 1.6499999999999999 110.945 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 49' ' ' LEU . 1.5 p -72.17 -12.57 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.052 0.453 . . . . 0.40000000000000002 110.792 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.619 HD21 ' SG ' ' A' ' 86' ' ' CYS . 2.1 mm? -94.19 97.53 10.33 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.566 -0.531 . . . . 1.3700000000000001 109.566 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.529 HE21 ' HA ' ' A' ' 34' ' ' TYR . 73.2 mt-30 -66.03 -39.55 90.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.42999999999999999 110.83 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 t -117.3 136.63 52.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.798 0.332 . . . . 0.48999999999999999 110.539 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -100.32 16.06 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.03 110.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 m -110.28 112.28 24.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.713 -0.676 . . . . 0.91000000000000003 110.024 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 31' ' ' ILE . 7.2 p -92.12 139.22 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.27000000000000002 110.221 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.407 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 11.7 m-85 -100.89 160.71 14.14 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.023 -0.362 . . . . 0.66000000000000003 110.023 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.94 -61.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.063 0.459 . . . . 1.24 110.834 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.13 92.42 3.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.71 110.41 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -65.68 -24.69 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.174 0.511 . . . . 1.05 110.43 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -29.56 67.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.7 -0.682 . . . . 1.51 111.387 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.12 -34.58 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 2.3399999999999999 110.74 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.88 41.35 2.31 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.261 -0.736 . . . . 0.47999999999999998 111.261 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -105.19 121.07 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.785 0.326 . . . . 1.21 111.179 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.03 141.55 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.47999999999999998 109.93 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.78 104.09 13.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.132 0.491 . . . . 0.31 109.84 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -82.29 -174.9 5.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 1.1599999999999999 110.842 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -34.17 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.762 0.652 . . . . 1.9099999999999999 112.762 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 pm0 -80.84 -4.07 53.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.822 0.344 . . . . 0.92000000000000004 111.302 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.65 -52.23 3.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 0.17999999999999999 110.502 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.331 . . . . 0.35999999999999999 111.706 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.02 -22.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.93999999999999995 110.949 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -103.06 -32.47 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.81999999999999995 111.46 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.31 -36.63 46.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.37 111.5 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.68 -51.5 2.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 2.5299999999999998 110.109 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.93 -37.75 2.41 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.47999999999999998 111.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.35 147.4 26.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.623 0.249 . . . . 2.3199999999999998 110.38 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -100.3 -7.56 24.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.448 -0.342 . . . . 1.1000000000000001 111.628 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.18 126.24 38.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.722 0.296 . . . . 1.21 110.719 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -27.47 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 0.5 111.815 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -63.58 -39.92 95.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.878 0.371 . . . . 0.75 110.468 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.37 -40.66 85.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.25 110.747 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.99 -48.19 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.32000000000000001 109.885 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.619 ' SG ' HD21 ' A' ' 53' ' ' LEU . 36.8 t -65.12 -29.61 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.725 . . . . 0.26000000000000001 111.39 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -58.67 -49.53 77.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.397 . . . . 1.0600000000000001 110.827 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -68.95 -37.42 78.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.798 -0.637 . . . . 1.76 110.551 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.22 -31.02 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.168 -0.469 . . . . 1.1100000000000001 111.497 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.66 -18.86 56.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.976 0.361 . . . . 1.0600000000000001 111.976 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 t -108.31 -34.78 6.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.652 -0.419 . . . . 1.1799999999999999 112.066 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -101.51 7.12 42.52 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.917 0.389 . . . . 1.3799999999999999 110.564 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.22 175.34 17.34 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.523 -0.846 . . . . 0.17999999999999999 112.778 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -102.14 119.04 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.935 -0.394 . . . . 1.3400000000000001 109.935 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.65 146.63 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.704 -0.68 . . . . 1.1799999999999999 110.252 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.69 101.62 1.07 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.77000000000000002 110.122 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 m -106.9 163.59 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.989 -0.55 . . . . 0.54000000000000004 111.358 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 115' ' ' THR . 10.6 t -143.23 -68.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.946 -0.57 . . . . 0.51000000000000001 109.635 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 30.3 t0 -179.07 157.03 0.82 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.533 0.52 . . . . 0.22 109.862 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 8.2 tptp -167.44 171.66 10.28 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 123.321 0.388 . . . . 2.2999999999999998 110.854 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.417 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.1 mp0 -52.32 117.77 3.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.705 -0.68 . . . . 0.62 112.293 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -73.97 125.03 27.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.818 -0.628 . . . . 1.6799999999999999 111.073 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -149.48 -40.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.411 -0.359 . . . . 2.0 111.219 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -151.97 -171.47 3.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.707 -0.224 . . . . 1.1000000000000001 110.478 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.15 148.71 52.75 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.6 -0.519 . . . . 0.90000000000000002 109.6 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -71.31 0.69 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.433 -0.349 . . . . 0.34000000000000002 111.244 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.74 -62.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.835 0.35 . . . . 1.79 110.634 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.06 79.14 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 1.3100000000000001 110.769 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.3 ptp -62.34 -32.9 73.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.32000000000000001 111.267 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.41 -3.22 32.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.148 0.499 . . . . 0.81999999999999995 110.654 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -135.85 34.1 2.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.984 -0.746 . . . . 0.67000000000000004 108.984 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.39 -49.41 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.999 -1.001 . . . . 1.3200000000000001 110.325 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.1 mt -79.67 -23.07 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.485 0.659 . . . . 0.22 110.194 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.03 2.28 9.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.393 -0.821 . . . . 0.34000000000000002 112.938 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 98' ' ' SER . 68.6 p -85.43 -53.44 5.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.808 0.337 . . . . 0.91000000000000003 111.055 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.38 -42.73 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.876 -0.602 . . . . 0.52000000000000002 111.604 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.97 -25.68 32.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.081 -0.509 . . . . 0.26000000000000001 111.081 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.7 81.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.913 0.387 . . . . 0.38 110.792 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.3 OUTLIER -84.36 -14.43 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.315 0.579 . . . . 0.57999999999999996 110.139 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.457 ' HZ1' ' CG ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -89.37 -26.51 21.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 2.0099999999999998 110.857 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.8 50.45 2.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 0.28000000000000003 111.644 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.86 154.47 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.412 -0.358 . . . . 0.40999999999999998 110.389 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -52.67 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.498 -0.319 . . . . 0.34999999999999998 111.744 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -92.94 163.19 2.65 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.262 1.974 . . . . 0.53000000000000003 113.065 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.76 -28.7 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.67000000000000004 111.436 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 t -71.3 -16.05 62.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.67000000000000004 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -161.85 87.44 0.66 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.916 -0.772 . . . . 0.84999999999999998 108.916 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' CB ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -56.37 -60.81 8.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.91 -0.586 . . . . 0.83999999999999997 111.418 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 56.8 Cg_endo -90.12 135.4 2.27 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.122 1.881 . . . . 0.62 112.503 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -89.28 162.07 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.967 -0.56 . . . . 0.46000000000000002 110.242 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.78 140.36 45.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.154 -0.475 . . . . 1.54 109.759 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 t -51.53 -32.24 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.228 -0.442 . . . . 0.92000000000000004 112.18 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.4 mm -61.2 -32.95 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.559 -0.291 . . . . 0.12 111.72 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.41 -51.11 64.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.73999999999999999 111.371 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -33.77 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.19 110.914 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -55.07 -48.03 74.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.125 0.488 . . . . 0.44 110.367 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -59.91 -47.01 87.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.264 -0.88 . . . . 1.52 111.202 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.8 -38.3 88.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.12 111.655 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.4 ttp -67.7 -46.26 72.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 0.33000000000000002 110.594 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -66.31 -32.0 73.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.885 -0.598 . . . . 2.4399999999999999 110.251 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.18 -46.7 75.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.592 -0.731 . . . . 0.34000000000000002 111.235 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.8 mt -82.95 -53.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.354 -0.384 . . . . 1.4399999999999999 110.465 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 58.5 49.94 9.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.177 -0.465 . . . . 1.8600000000000001 110.601 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.28 87.26 6.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 1.6299999999999999 110.136 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -81.92 121.91 27.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.728 -0.669 . . . . 1.0800000000000001 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.6 -76.01 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.171 -0.468 . . . . 0.33000000000000002 110.416 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.631 -0.507 . . . . 0.75 109.631 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 123.1 15.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.279 0.362 . . . . 0.63 110.671 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.0 p30 43.38 46.35 5.55 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.134 0.896 . . . . 0.20000000000000001 112.406 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.466 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -59.09 -53.96 52.41 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.108 -0.701 . . . . 1.6499999999999999 109.108 178.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 155' ' ' GLN . 2.7 p -103.31 179.95 4.12 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.668 -0.697 . . . . 0.22 109.439 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 150.02 49.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.753 0.279 . . . . 0.76000000000000001 111.753 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tttm 64.11 46.44 3.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.791 -0.641 . . . . 1.01 111.774 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 59.23 71.39 0.59 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.658 -0.701 . . . . 0.34999999999999998 111.369 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.482 ' HA ' ' OG ' ' A' ' 151' ' ' SER . 1.9 pm0 44.36 39.26 2.98 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.871 0.868 . . . . 0.089999999999999997 112.782 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.84 -35.77 75.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.13 112.02 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 4.1 mm? -67.2 -27.54 67.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.878 0.371 . . . . 1.01 110.765 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.466 ' OE1' ' HB3' ' A' ' 150' ' ' LYS . 3.5 mp0 -82.42 -44.81 15.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 0.46000000000000002 109.949 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.46 ' O ' HD11 ' A' ' 163' ' ' LEU . 98.9 t -61.79 -43.52 97.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.17999999999999999 111.238 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.9 tt -66.61 -10.77 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.284 -0.416 . . . . 0.34999999999999998 112.063 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -115.17 -10.54 12.14 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.173 -0.329 . . . . 1.8700000000000001 110.883 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -87.18 -36.96 17.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.395 . . . . 0.77000000000000002 111.547 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -74.89 -13.67 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.22 110.91 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.544 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.4 tmmt? -62.83 -25.03 68.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.971 -0.559 . . . . 0.44 110.659 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.34 -24.74 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.005 -0.543 . . . . 0.69999999999999996 110.666 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -93.48 -48.65 6.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.384 -0.598 . . . . 2.25 109.384 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 19.7 mmt -127.34 104.89 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.098 -0.705 . . . . 2.29 109.098 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -87.96 127.81 35.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.03 0.443 . . . . 1.5700000000000001 111.232 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 154.31 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.612 -0.722 . . . . 0.95999999999999996 110.399 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -145.53 88.5 1.85 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.898 0.38 . . . . 1.1000000000000001 110.57 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.72 114.93 0.28 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.072 -0.513 . . . . 0.96999999999999997 110.336 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 131.82 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 1.05 110.922 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -127.11 95.89 4.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.695 0.76 . . . . 2.1200000000000001 109.94 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.4 ttm -88.08 170.38 11.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.223 -0.899 . . . . 2.27 110.66 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.94 130.92 41.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.263 -0.426 . . . . 1.5800000000000001 110.73 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 213' ' ' LEU . 16.9 tp -116.91 130.84 56.96 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.53 -0.544 . . . . 2.1000000000000001 109.53 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -126.28 164.13 21.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.88 0.371 . . . . 0.75 110.236 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 94.5 m-85 -122.51 145.04 48.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.635 -0.505 . . . . 0.41999999999999998 109.635 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -127.69 114.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.501 0.667 . . . . 0.40000000000000002 111.526 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.412 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -147.45 158.96 42.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.38 109.626 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.66 173.92 6.12 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.333 2.022 . . . . 0.19 112.417 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.3 t -54.01 -31.4 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.54000000000000004 112.009 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -53.54 -59.5 4.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.974 0.416 . . . . 0.28000000000000003 110.579 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -77.31 -24.43 50.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.73999999999999999 110.264 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 188' ' ' LEU . . . -59.92 -35.64 87.6 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.865 -0.607 . . . . 0.23000000000000001 112.239 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -77.73 2.72 16.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.7 0.285 . . . . 1.8799999999999999 110.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 190' ' ' GLU . 69.9 mmtt -104.09 -48.43 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.581 -0.281 . . . . 1.8700000000000001 111.412 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.418 ' CD2' ' HA2' ' A' ' 185' ' ' GLY . 1.3 pt? -79.44 -26.22 41.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.91000000000000003 111.549 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 17.5 ttpt -66.38 -26.53 67.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 0.98999999999999999 111.307 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 187' ' ' LYS . 0.4 OUTLIER -95.47 1.36 53.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.457 -0.338 . . . . 0.56999999999999995 111.465 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 27.8 mttp -122.97 -43.07 2.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.362 0.504 . . . . 1.6599999999999999 112.362 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.16 -44.3 47.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.192 0.442 . . . . 0.32000000000000001 112.192 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.5 mtpt -58.95 -51.36 82.41 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.841 0.682 . . . . 0.63 112.841 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.1 Cg_endo -61.91 -9.1 13.21 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.307 2.005 . . . . 0.20999999999999999 113.513 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 73.8 mt -81.69 -6.97 59.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.23000000000000001 110.477 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.2 mm 52.36 53.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.695 -0.684 . . . . 0.19 111.036 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -146.62 27.03 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.717 -0.674 . . . . 1.8899999999999999 110.181 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.68 147.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.993 -0.549 . . . . 0.13 111.073 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.41 144.62 12.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.058 -0.519 . . . . 1.1599999999999999 109.926 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -68.78 80.55 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.289 0.566 . . . . 2.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.6 t -160.21 17.3 0.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.92000000000000004 109.376 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.3 mp0 -75.29 134.03 41.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.22 110.547 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -100.71 136.73 40.12 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.837 -0.619 . . . . 0.79000000000000004 109.673 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 144.24 44.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.712 0.291 . . . . 0.82999999999999996 110.348 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 152.69 -121.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.719 -0.753 . . . . 0.62 111.58 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -82.01 -24.33 35.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.194 0.521 . . . . 0.48999999999999999 110.074 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -124.82 158.7 32.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.472 -0.786 . . . . 2.1499999999999999 109.543 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.68 91.7 3.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.041 -0.355 . . . . 0.98999999999999999 110.041 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 45.6 mt-10 -94.6 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.301 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.9 mt -119.01 142.38 34.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.715 -0.221 . . . . 1.1100000000000001 110.863 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.74 134.63 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.963 -0.384 . . . . 1.1499999999999999 109.963 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 14.6 t -119.55 -32.75 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.744 0.646 . . . . 1.3300000000000001 112.744 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -74.56 121.56 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.825 0.345 . . . . 1.3100000000000001 111.477 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 4.0 tt -125.47 -54.63 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.676 . . . . 1.26 111.185 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 0.4 OUTLIER -140.09 161.3 56.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.877 -0.416 . . . . 0.32000000000000001 109.877 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.52 -173.37 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.437 2.092 . . . . 0.28999999999999998 113.117 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 75.01 -88.39 0.77 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.91 -0.586 . . . . 0.45000000000000001 112.439 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.62 -18.69 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.659 0.384 . . . . 1.21 111.173 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.434 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 2.3 p90 -63.69 -25.22 68.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.94999999999999996 110.597 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 220' ' ' ARG . 2.1 tpp180 -76.72 -32.11 57.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.90000000000000002 110.139 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.46 -43.21 70.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.492 . . . . 1.1200000000000001 110.64 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 6.3 tt -73.71 -23.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.054 0.455 . . . . 1.1299999999999999 110.789 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.7 -29.58 68.2 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.16 111.486 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.6 -30.32 65.21 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.585 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.4 pp -105.0 -35.32 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.997 -0.281 . . . . 1.23 111.317 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.9 mm -55.23 -36.39 39.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 120.788 0.327 . . . . 0.25 111.721 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HB3' ' HZ1' ' A' ' 227' ' ' LYS . 1.0 OUTLIER -62.38 -17.22 58.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.669 0.618 . . . . 1.6599999999999999 112.669 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.68 -23.98 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 1.1399999999999999 111.07 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -68.2 -47.54 67.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 1.9199999999999999 111.713 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.4 t -129.98 -32.45 1.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.674 -0.41 . . . . 0.60999999999999999 111.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 76.8 tttt -66.56 -30.42 70.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.181 0.515 . . . . 1.0700000000000001 110.132 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -97.7 23.77 34.53 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.73 -0.668 . . . . 0.22 111.696 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -133.9 -36.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.34000000000000002 110.31 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.38 -176.89 16.93 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.848 -0.691 . . . . 0.28000000000000003 111.753 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.3 t -87.36 159.76 18.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 0.78000000000000003 110.333 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 153.65 25.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.198 -0.455 . . . . 0.46000000000000002 110.947 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.16 143.29 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.781 -0.645 . . . . 1.8899999999999999 109.705 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.09 124.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.523 . . . . 0.40999999999999998 111.367 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.75 74.07 3.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.299 -0.63 . . . . 0.97999999999999998 109.299 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -84.03 -2.02 55.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.615 -0.721 . . . . 1.3300000000000001 112.458 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -43.68 98.34 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 1.22 110.224 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 52.4 pttt 40.79 34.35 0.26 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.182 0.993 . . . . 1.3300000000000001 112.881 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -117.25 -68.98 0.88 Allowed 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.406 -0.59 . . . . 0.90000000000000002 109.406 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.16 128.57 49.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.59 -0.893 . . . . 0.23999999999999999 108.59 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -129.39 98.29 4.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.064 0.459 . . . . 1.4399999999999999 111.324 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -147.75 169.22 20.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.279 -0.638 . . . . 2.98 109.279 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -149.51 -155.42 6.76 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.85 -0.69 . . . . 1.0 111.502 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -86.98 91.23 8.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.101 0.477 . . . . 1.1299999999999999 110.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 18.51 14.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.73 . . . . 0.73999999999999999 110.061 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 86.46 4.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.844 -0.616 . . . . 1.6100000000000001 109.677 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -98.57 -20.89 16.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.413 . . . . 0.93000000000000005 110.783 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.47 -0.776 . . . . 2.4399999999999999 109.873 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.997 0 N-CA-C 112.078 -0.409 . . . . 0.59999999999999998 112.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -157.5 133.44 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 1.46 110.344 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -110.77 61.87 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.278 0.561 . . . . 1.4199999999999999 110.234 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -94.64 27.96 2.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.68000000000000005 110.929 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 pt -132.56 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.34000000000000002 110.372 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t80 -83.86 162.62 20.49 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.544 -0.539 . . . . 1.74 109.544 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 87.66 13.34 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.768 0.318 . . . . 0.31 111.219 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.5 Cg_exo -78.04 157.76 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.781 2.321 . . . . 0.68999999999999995 111.022 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -107.37 103.23 12.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.052 0.453 . . . . 1.6200000000000001 111.087 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.52 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 27.3 t-20 -144.2 149.12 35.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.549 . . . . 1.9299999999999999 109.831 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -54.96 40.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.742 0.306 . . . . 0.52000000000000002 111.701 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mt -91.17 63.54 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.104 0.478 . . . . 1.47 111.242 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 2.4 mmp_? -136.43 148.98 48.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.1200000000000001 110.479 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.45 -0.92 56.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.63 110.333 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -77.62 -41.34 38.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.263 0.554 . . . . 1.02 110.456 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -108.48 78.52 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.818 -0.628 . . . . 0.66000000000000003 109.936 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.447 HG11 ' OE1' ' A' ' 54' ' ' GLN . 19.2 m -120.54 140.81 43.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.017 -0.538 . . . . 0.22 111.128 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 33' ' ' CYS . . . -110.64 116.3 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.087 -0.708 . . . . 0.19 109.087 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.64 110.52 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 0.23999999999999999 111.591 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.13 137.79 28.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.997 -1.112 . . . . 0.81999999999999995 107.997 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 136.82 49.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.326 0.584 . . . . 0.40999999999999998 112.453 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 36.7 ttp -121.38 120.62 35.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.032 -0.986 . . . . 0.34999999999999998 109.488 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.28 129.96 55.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.909 -0.404 . . . . 1.53 109.909 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -108.7 35.92 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.409 -0.36 . . . . 0.76000000000000001 110.771 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.19 63.75 1.81 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.648 0.737 . . . . 0.35999999999999999 109.942 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.94 -70.43 0.48 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.211 -1.155 . . . . 0.20000000000000001 110.211 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -87.23 135.82 33.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 1.8600000000000001 109.217 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -128.23 151.63 49.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.92000000000000004 111.322 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -141.08 126.23 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.41999999999999998 110.347 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 132.34 56.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.11 -0.495 . . . . 0.26000000000000001 110.08 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -129.52 149.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 1.1499999999999999 110.688 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.23 115.98 31.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.93999999999999995 110.909 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 2.1 p -149.08 141.01 23.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.57999999999999996 109.983 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -114.58 -84.42 0.61 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.227 -0.189 . . . . 0.68999999999999995 111.091 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 65.16 -179.94 0.19 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.808 0.692 . . . . 1.5800000000000001 111.559 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.62 78.16 9.9 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.279 -1.008 . . . . 2.3199999999999998 108.279 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HZ1' ' CG ' ' A' ' 99' ' ' ASP . 45.3 mtpt 67.88 78.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.372 -0.831 . . . . 1.0800000000000001 109.422 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.42 -26.56 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.489 -0.778 . . . . 0.46000000000000002 111.782 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.48 -28.83 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.58999999999999997 110.687 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.43 -32.45 84.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.17999999999999999 111.814 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -64.87 -29.87 70.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.92000000000000004 110.092 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -65.63 -33.46 75.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 2.2400000000000002 110.156 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m -87.24 -21.94 25.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.094 0.473 . . . . 0.80000000000000004 109.999 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.15 27.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.068 -0.587 . . . . 0.42999999999999999 112.288 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 t -105.52 76.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.882 0.373 . . . . 0.58999999999999997 110.113 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 47' ' ' LYS . 2.3 mm-40 -172.61 172.15 4.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.55000000000000004 109.904 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HG2' ' OE1' ' A' ' 46' ' ' GLU . 17.1 ptmt -83.55 -168.29 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.979 -0.378 . . . . 1.27 109.979 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 164.51 4.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.023 0.439 . . . . 1.22 111.932 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.595 ' O ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -84.22 -8.74 58.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.566 . . . . 0.95999999999999996 111.311 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -27.33 66.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.311 -0.404 . . . . 0.84999999999999998 110.808 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CD ' ' HZ2' ' A' ' 47' ' ' LYS . 12.3 tt0 -104.18 16.85 25.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.46999999999999997 111.813 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 49' ' ' LEU . 3.0 p -108.3 -27.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.465 -0.494 . . . . 1.05 110.991 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.35 91.36 5.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.397 -0.365 . . . . 0.28000000000000003 110.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.447 ' OE1' HG11 ' A' ' 17' ' ' VAL . 69.2 mt-30 -69.31 -31.06 69.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.47 0.652 . . . . 0.33000000000000002 109.717 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -140.82 126.5 19.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.239 -0.891 . . . . 1.04 109.264 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -86.77 42.74 1.03 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.28999999999999998 110.629 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.7 113.76 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.833 -0.621 . . . . 1.0900000000000001 110.267 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.4 p -91.5 138.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.741 -0.466 . . . . 0.46000000000000002 109.741 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.02 150.18 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.306 -0.406 . . . . 0.22 111.116 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.42 -47.38 7.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 1.1499999999999999 109.429 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -130.57 103.28 6.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 0.39000000000000001 109.349 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.0 -28.09 23.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 113.044 0.757 . . . . 0.26000000000000001 113.044 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 p -82.12 -27.57 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.525 -0.47 . . . . 0.93999999999999995 111.81 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -100.54 -2.04 34.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 1.8799999999999999 111.093 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.55 45.29 78.7 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.29999999999999999 113.1 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.33 112.3 25.06 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.921 -0.399 . . . . 0.73999999999999999 109.921 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.09 144.38 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 0.46000000000000002 110.752 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.98 109.56 20.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.635 -0.506 . . . . 0.93000000000000005 109.635 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.626 ' HB3' ' OE2' ' A' ' 71' ' ' GLU . 7.5 mtpt -78.88 176.62 9.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.886 -0.597 . . . . 1.8300000000000001 110.878 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.77 -32.11 67.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 1.24 112.176 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.626 ' OE2' ' HB3' ' A' ' 69' ' ' LYS . 1.7 pm0 -93.25 4.0 54.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.756 0.312 . . . . 1.02 111.166 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -105.69 -46.49 4.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 2.1600000000000001 110.206 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.77 -33.56 75.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.31 111.048 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 tt -68.54 -21.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.231 0.538 . . . . 1.49 110.432 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -99.38 1.09 44.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.68999999999999995 110.635 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.93 -51.35 2.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.66000000000000003 110.931 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.61 -15.35 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 2.1200000000000001 110.864 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.03 -25.35 20.31 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.749 -0.738 . . . . 0.32000000000000001 112.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 138.26 31.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.68 0.276 . . . . 0.48999999999999999 110.805 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.9 -5.52 55.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.424 0.631 . . . . 0.64000000000000001 109.6 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.37 117.01 28.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.162 -0.926 . . . . 0.42999999999999999 110.511 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -68.75 -22.17 64.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 1.0800000000000001 111.062 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -47.0 77.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.357 -0.383 . . . . 1.0900000000000001 111.064 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -56.43 -39.63 73.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.224 0.535 . . . . 1.3400000000000001 110.382 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 89' ' ' ILE . 66.9 mt -70.22 -48.2 62.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.683 -0.69 . . . . 0.17000000000000001 110.106 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 31' ' ' ILE . 51.6 t -58.61 -40.24 82.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 0.16 110.243 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 91' ' ' THR . 5.3 tttp -58.64 -47.19 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 1.52 109.88 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.05 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 2.2200000000000002 110.937 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 85' ' ' ILE . 69.0 mt -67.54 -29.9 47.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.046 0.45 . . . . 0.93999999999999995 110.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -35.19 35.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.031 -0.531 . . . . 0.94999999999999996 111.976 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 87' ' ' LYS . 6.9 t -96.38 -18.05 20.2 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.998 0.74 . . . . 0.28000000000000003 112.998 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -124.42 17.35 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.8300000000000001 111.283 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.91 178.44 18.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.59 -0.814 . . . . 0.23000000000000001 112.459 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.09 112.23 24.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 2.6800000000000002 110.615 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.21 155.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.56000000000000005 109.756 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -71.34 99.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.026 0.441 . . . . 0.72999999999999998 110.487 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.61 167.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.47999999999999998 110.481 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 m -146.11 -74.55 0.22 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.243 -0.435 . . . . 0.93000000000000005 110.064 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.495 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -94.8 169.38 10.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.875 -0.417 . . . . 0.52000000000000002 109.875 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -164.56 165.96 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.797 -0.445 . . . . 1.75 109.797 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -71.35 154.39 41.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.305 0.574 . . . . 1.1399999999999999 111.277 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.42 91.52 3.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.821 -0.627 . . . . 3.0 110.183 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -133.17 128.29 35.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.071 -0.513 . . . . 1.55 110.396 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.03 145.93 50.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.896 -0.593 . . . . 1.4399999999999999 110.018 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.32 148.53 31.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.889 0.376 . . . . 0.53000000000000003 110.395 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.79 105.26 9.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 1.52 110.429 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -158.32 175.81 13.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.17999999999999999 109.829 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -89.28 30.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.518 0.199 . . . . 0.81000000000000005 111.376 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.2 ptp -60.19 -32.13 70.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.691 0.282 . . . . 0.22 110.884 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.28 -34.89 66.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.10000000000000001 110.287 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.38 -30.88 63.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.92000000000000004 110.214 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 115' ' ' THR . 16.5 t70 -61.75 -50.97 70.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.947 -0.569 . . . . 1.53 110.595 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 tp -73.86 -27.43 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.28999999999999998 110.367 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.96 91.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.13 111.187 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 112' ' ' ASP . 2.0 t -65.35 -22.28 66.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.51000000000000001 110.779 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -83.06 -55.72 6.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.046 -0.525 . . . . 0.25 110.271 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.09 -31.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.36 0.504 . . . . 0.31 112.36 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.91 -15.3 62.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.16 111.714 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.52 -16.03 17.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.173 -0.467 . . . . 1.46 110.787 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -3.18 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.637 0.606 . . . . 1.8 112.637 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.9 p -129.23 154.57 46.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.066 0.46 . . . . 0.68000000000000005 111.125 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.76 146.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.751 -0.659 . . . . 2.0299999999999998 110.3 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.27 153.76 38.78 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.819 -0.437 . . . . 2.4399999999999999 109.819 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.31 -159.94 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.529 2.152 . . . . 0.88 112.289 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.7 91.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 0.90000000000000002 111.23 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.0 t -170.69 -42.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.726 -0.67 . . . . 0.57999999999999996 110.19 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -177.08 119.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.534 -0.543 . . . . 1.2 109.534 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -77.66 149.17 77.52 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.557 -0.292 . . . . 1.9299999999999999 110.899 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 134.4 54.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.742 2.294 . . . . 0.35999999999999999 112.425 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -157.41 -46.19 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 1.4099999999999999 109.988 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.0 p -126.56 169.24 13.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.80000000000000004 110.713 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.99 -25.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.486 . . . . 0.29999999999999999 110.66 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.01 -24.16 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.512 -0.767 . . . . 0.52000000000000002 111.311 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.9 tp -53.57 -57.41 10.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.436 . . . . 1.1899999999999999 111.193 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -30.79 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 0.42999999999999999 110.907 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -60.59 -39.41 87.97 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.314 -0.403 . . . . 0.82999999999999996 110.96 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -58.99 -36.67 75.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.206 -0.452 . . . . 1.3500000000000001 111.258 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.14 -36.3 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.503 -0.317 . . . . 0.23000000000000001 111.271 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 12.3 ttt -63.4 -40.97 98.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.249 -0.432 . . . . 0.39000000000000001 111.293 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -71.23 -25.54 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 1.78 110.883 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.33 -47.94 58.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.499 . . . . 0.41999999999999998 109.935 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.65 73.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.053 0.93 . . . . 1.2 110.06 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -122.33 -2.25 9.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.536 -0.756 . . . . 1.0900000000000001 110.734 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -78.65 124.24 27.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.319 -0.4 . . . . 1.75 111.029 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.4 m 55.39 34.47 22.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.574 -0.739 . . . . 0.84999999999999998 112.261 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.92 -53.3 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.57999999999999996 110.679 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -134.7 14.41 3.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 2.0800000000000001 110.208 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 116.94 10.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.84 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 67.8 66.16 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.097 0.559 . . . . 0.68000000000000005 110.797 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -164.48 159.46 19.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.154 -0.684 . . . . 1.01 109.154 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.52 154.38 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 1.5800000000000001 110.297 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.67 -49.55 76.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.857 0.688 . . . . 1.1399999999999999 112.857 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -82.22 -16.07 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.628 0.251 . . . . 1.3899999999999999 111.673 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.76 -59.19 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.45000000000000001 111.826 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -105.2 23.29 13.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.528 -0.305 . . . . 0.37 111.552 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.976 0.362 . . . . 0.25 111.976 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.45 -16.75 57.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.269 -0.423 . . . . 0.70999999999999996 111.908 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.21 -42.38 10.45 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.906 -0.317 . . . . 0.78000000000000003 110.988 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -39.05 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.402 -0.363 . . . . 0.28999999999999998 111.273 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.61 -19.74 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.336 -0.393 . . . . 0.66000000000000003 111.283 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -99.34 -16.94 18.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 1.8400000000000001 110.595 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -62.55 1.46 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.93000000000000005 111.035 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -71.71 -17.7 62.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.37 111.467 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.441 ' N ' HD12 ' A' ' 163' ' ' LEU . 6.4 tmtt? -70.26 -34.28 72.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.888 0.375 . . . . 1.8200000000000001 110.628 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -77.76 -34.47 52.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 1.76 110.579 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -35.95 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.3 0.572 . . . . 1.0800000000000001 109.972 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 tpt -124.24 91.16 3.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.703 -0.851 . . . . 0.39000000000000001 108.703 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.42 101.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.391 0.615 . . . . 2.1000000000000001 111.674 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.89 142.62 20.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.129 -0.941 . . . . 1.0600000000000001 109.775 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -98.54 107.42 19.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.563 -0.289 . . . . 2.3300000000000001 110.574 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -82.07 70.28 8.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.927 0.394 . . . . 3.0299999999999998 110.066 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -138.91 162.23 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.148 -0.478 . . . . 0.51000000000000001 110.561 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -109.43 123.79 49.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.2 -0.455 . . . . 2.2000000000000002 109.967 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 53.5 mtt -82.51 153.56 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.135 -0.484 . . . . 1.4399999999999999 110.655 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 54.7 mtt180 -135.13 117.51 15.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 1.3799999999999999 111.116 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.424 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 13.7 mt -108.22 152.51 24.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.867 -0.606 . . . . 2.8300000000000001 110.213 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -140.82 159.97 41.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.222 -0.445 . . . . 0.37 110.176 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 0.8 OUTLIER -134.17 132.82 40.26 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.181 -0.674 . . . . 0.13 109.181 178.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.2 tt -126.73 123.16 62.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.114 0.483 . . . . 0.10000000000000001 111.476 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.457 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.9 OUTLIER -159.76 156.01 23.69 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 0.28999999999999998 110.028 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.87 143.36 30.45 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.861 2.374 . . . . 0.16 112.428 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.82 -31.54 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.51000000000000001 112.427 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -54.89 -46.45 74.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.583 0.23 . . . . 1.3799999999999999 111.534 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.25 -30.79 17.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.92000000000000004 109.841 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.645 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.39 -29.78 72.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.467 -0.788 . . . . 0.25 113.08 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -59.34 -26.41 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 1.0600000000000001 111.087 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -44.52 73.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 1.3899999999999999 110.523 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 3.0 pp -76.76 -22.91 53.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.32000000000000001 110.053 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 71.3 tttt -63.0 -35.34 79.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 1.3300000000000001 110.189 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -101.07 18.31 20.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.783 -0.644 . . . . 1.6499999999999999 110.981 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -131.28 -52.79 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.064 0.394 . . . . 1.5600000000000001 112.064 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.509 HD13 ' SG ' ' A' ' 212' ' ' CYS . 1.1 tm? -86.35 -44.18 12.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.19 111.722 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpt -57.13 -48.42 97.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.809 0.67 . . . . 1.01 112.809 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.9 Cg_endo -59.04 -16.64 33.87 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.298 1.998 . . . . 0.26000000000000001 113.282 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 56.0 mt -74.2 -15.82 61.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 0.41999999999999998 110.162 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 16.7 mt 56.45 60.63 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.645 -0.707 . . . . 0.83999999999999997 111.586 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -135.3 10.06 3.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.691 -0.686 . . . . 2.2000000000000002 109.737 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.2 167.48 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.582 -0.735 . . . . 0.40000000000000002 111.672 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.72 148.48 10.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.42 -0.809 . . . . 0.32000000000000001 108.945 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.12 57.99 0.36 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.263 0.554 . . . . 1.3400000000000001 111.711 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -146.35 55.84 1.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.568 -0.742 . . . . 1.0700000000000001 109.275 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.1 pt-20 -106.13 167.7 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.46000000000000002 111.516 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.9 t70 -131.51 123.53 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.624 -0.88 . . . . 0.78000000000000003 108.624 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.78 31.49 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.91000000000000003 110.802 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.09 -102.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.596 -0.811 . . . . 0.46000000000000002 112.067 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -95.78 -31.09 13.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.439 0.638 . . . . 0.34000000000000002 109.577 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.18 136.96 54.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.384 -0.825 . . . . 0.72999999999999998 109.44 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 203' ' ' ASP . 36.1 tp -88.82 99.65 12.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.077 0.465 . . . . 0.20000000000000001 110.265 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 50.2 tt0 -109.38 114.78 28.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.20000000000000001 109.712 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 178' ' ' PHE . 21.3 mt -127.39 141.13 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 0.96999999999999997 110.891 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.8 125.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.089 -0.708 . . . . 0.25 109.089 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.509 ' SG ' HD13 ' A' ' 192' ' ' LEU . 50.8 t -139.83 99.97 3.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.578 0.227 . . . . 0.96999999999999997 111.454 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER 177.73 121.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.966 -0.753 . . . . 1.1699999999999999 108.966 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -116.0 -40.41 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 111.832 0.308 . . . . 1.7 111.832 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.45 143.69 36.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.879 0.326 . . . . 0.68999999999999995 111.879 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.68 -30.16 35.03 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.875 2.383 . . . . 0.27000000000000002 112.077 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.5 -23.37 75.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.915 -0.66 . . . . 0.46000000000000002 111.761 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.7 6.75 44.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.215 0.531 . . . . 1.9199999999999999 110.572 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.34 -47.68 81.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.716 -0.674 . . . . 1.3700000000000001 110.526 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -66.17 -23.68 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.627 . . . . 2.73 111.087 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.54 -42.82 28.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.778 -0.646 . . . . 2.1899999999999999 111.507 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 0.6 OUTLIER -82.1 -33.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.07 0.396 . . . . 2.0699999999999998 112.07 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.79 -24.49 67.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.881 0.372 . . . . 0.46999999999999997 111.045 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 12.9 mm-40 -61.76 -31.41 71.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 0.5 111.408 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.7 OUTLIER -102.6 -36.79 8.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.117 -0.233 . . . . 0.35999999999999999 110.82 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.8 mm -53.88 -34.35 25.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.61 -0.268 . . . . 0.96999999999999997 111.72 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 17.2 ptpt -55.99 -32.06 63.58 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.126 0.417 . . . . 1.79 112.126 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -108.72 -27.15 9.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.007 0.432 . . . . 1.02 110.881 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.57 . . . . 0.62 112.091 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -149.73 -30.89 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.008 0.744 . . . . 0.81000000000000005 113.008 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 33.3 ttmt -58.9 -37.56 76.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.95 0.341 . . . . 2.9100000000000001 111.84 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.25 18.6 51.13 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.678 -0.772 . . . . 0.20000000000000001 112.629 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -129.99 -47.84 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.87 110.501 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -119.65 -158.01 10.48 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.815 -0.707 . . . . 0.34000000000000002 112.209 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.3 m -108.09 138.64 44.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.346 . . . . 0.85999999999999999 110.532 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 150.09 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 1.77 109.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.43 167.77 23.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.053 0.454 . . . . 1.9199999999999999 110.764 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.13 150.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.76000000000000001 109.742 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.53 88.68 4.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.046 0.451 . . . . 0.51000000000000001 110.503 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -120.42 158.3 27.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.85999999999999999 109.881 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.7 tp 64.41 80.85 0.22 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.605 0.566 . . . . 0.56999999999999995 110.979 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.49 32.24 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.882 -0.599 . . . . 1.1299999999999999 110.943 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -101.4 -38.96 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.262 0.553 . . . . 0.70999999999999996 109.864 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.41 160.13 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.54 -0.755 . . . . 0.67000000000000004 109.082 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -56.02 127.15 29.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 1.3899999999999999 110.664 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -71.28 -77.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 1.54 111.086 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.28 175.94 21.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.671 -0.776 . . . . 1.1299999999999999 111.851 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -101.21 92.61 5.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.931 0.396 . . . . 0.78000000000000003 110.157 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -5.06 59.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.05 111.173 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.23 107.74 19.4 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.643 -0.503 . . . . 1.53 109.643 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -96.54 5.46 50.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.101 0.476 . . . . 0.65000000000000002 110.308 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 115.707 -0.678 . . . . 1.23 110.031 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 111.909 -0.477 . . . . 1.52 111.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -132.82 154.6 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 1.8100000000000001 110.157 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -147.18 151.16 36.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.718 0.294 . . . . 1.1799999999999999 110.239 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -156.7 119.48 4.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.425 -0.352 . . . . 0.41999999999999998 110.226 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.95 -54.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.14 -0.482 . . . . 0.34999999999999998 110.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -99.81 152.87 19.63 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.63 109.323 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -139.77 94.47 9.14 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.934 0.397 . . . . 1.3 111.226 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.52 145.88 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.936 2.424 . . . . 0.68999999999999995 112.526 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 m -78.78 124.32 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.86 -0.609 . . . . 0.53000000000000003 110.809 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -153.71 156.83 38.54 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.259 -0.645 . . . . 0.37 109.259 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.1 -19.23 28.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.083 0.401 . . . . 0.82999999999999996 112.083 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.32 70.94 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.299 0.571 . . . . 1.74 110.803 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -146.35 149.49 33.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.749 -0.66 . . . . 1.45 109.998 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.13 -9.32 38.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.443 0.535 . . . . 0.66000000000000003 112.443 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -90.86 2.67 55.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 0.40999999999999998 111.48 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -135.35 32.43 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.213 0.53 . . . . 1.8700000000000001 110.532 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.32 152.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.69 -0.686 . . . . 0.31 111.514 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.43 140.76 48.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.843 -0.617 . . . . 0.22 110.053 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.48 117.7 32.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.204 0.526 . . . . 1.3300000000000001 110.948 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.62 117.47 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.28000000000000003 109.993 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 149.29 50.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.6499999999999999 111.11 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 55.9 ttp -122.14 139.37 53.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.336 -0.847 . . . . 1.1200000000000001 110.472 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -116.11 120.99 40.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.714 -0.476 . . . . 0.40000000000000002 109.714 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -122.37 89.47 3.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.549 -0.296 . . . . 0.84999999999999998 110.52 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.15 46.75 23.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.693 -0.685 . . . . 0.70999999999999996 111.734 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.91 -48.78 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.448 -0.882 . . . . 0.64000000000000001 112.815 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -69.38 129.22 39.14 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.199 -0.297 . . . . 1.1599999999999999 110.199 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -119.11 143.64 47.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.763 0.316 . . . . 0.85999999999999999 111.336 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -132.87 142.42 48.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.29999999999999999 109.82 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 24.9 tt0 -146.54 133.02 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.62 -0.511 . . . . 1.75 109.62 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -136.49 130.38 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.326 -0.397 . . . . 0.95999999999999996 110.01 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 113.09 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.16 111.686 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 31.2 m -107.55 175.91 5.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.786 -0.643 . . . . 0.17999999999999999 110.219 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.564 ' CD1' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.77 150.42 37.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.098 0.475 . . . . 0.34999999999999998 111.084 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -87.5 -7.85 57.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.457 0.539 . . . . 1.98 112.457 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -78.63 78.33 5.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.64000000000000001 111.76 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 52.27 63.24 2.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.89 -0.596 . . . . 2.1499999999999999 111.852 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 7.9 p -70.45 -24.2 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.954 -0.566 . . . . 0.63 110.714 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.14 -5.35 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.049 -0.523 . . . . 0.42999999999999999 111.276 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.22 -28.41 58.77 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.239 -0.505 . . . . 0.17999999999999999 112.852 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' HE1' ' HB ' ' A' ' 91' ' ' THR . 21.8 t-105 -65.07 -33.84 77.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 1.8100000000000001 111.101 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -75.9 -41.41 52.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 1.3300000000000001 110.771 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.67 -39.54 61.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.304 -0.407 . . . . 1.1499999999999999 111.273 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.52 -98.3 0.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.293 -0.956 . . . . 0.45000000000000001 112.974 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG11 ' OE1' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -125.89 163.84 26.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.739 0.304 . . . . 1.6799999999999999 110.822 -179.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' OE1' HG11 ' A' ' 45' ' ' VAL . 1.1 pm0 -89.76 161.65 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.436 -0.579 . . . . 1.3899999999999999 109.436 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -34.5 16.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.875 -0.33 . . . . 1.75 110.449 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -167.69 160.43 12.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.974 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tp -109.92 -14.63 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 1.1799999999999999 110.886 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.28 -40.54 6.71 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.611 -0.514 . . . . 0.41999999999999998 109.611 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.48 -24.91 61.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.913 -0.585 . . . . 1.8799999999999999 110.345 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.564 HG22 ' CD1' ' A' ' 34' ' ' TYR . 12.0 p -70.88 -26.55 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.415 -0.587 . . . . 0.32000000000000001 109.415 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.55 97.71 7.96 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 1.0900000000000001 110.189 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -67.23 -37.03 82.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.22 108.904 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 t -157.52 126.09 5.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.773 -1.103 . . . . 1.03 108.98 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 10.5 p80 -77.7 67.17 3.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.556 0.693 . . . . 0.71999999999999997 110.556 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -138.59 111.84 8.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.292 -0.867 . . . . 1.3799999999999999 110.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -100.68 135.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.55000000000000004 110.103 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -91.66 163.84 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.92 0.39 . . . . 2.7400000000000002 111.238 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.44 -49.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.019 -0.734 . . . . 1.1699999999999999 109.019 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -142.46 103.63 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.722 . . . . 0.34000000000000002 109.173 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.9 -26.9 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.19 -0.459 . . . . 0.56000000000000005 112.132 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 m -72.42 -36.06 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.9 0.381 . . . . 0.31 110.971 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.68 5.85 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.193 -0.458 . . . . 0.47999999999999998 110.845 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.0 44.19 96.4 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.207 -0.52 . . . . 0.17000000000000001 112.79 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -112.63 121.96 46.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.863 0.363 . . . . 1.1899999999999999 110.736 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.78 170.4 7.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.98 -0.554 . . . . 1.9399999999999999 109.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.45 120.96 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.082 0.467 . . . . 0.97999999999999998 111.049 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -87.74 -178.28 6.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.078 -0.712 . . . . 1.8999999999999999 109.078 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HG3' ' OE1' ' A' ' 71' ' ' GLU . 3.1 pttp -56.56 -39.39 73.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.842 0.353 . . . . 2.1099999999999999 111.333 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.537 ' OE1' ' HG3' ' A' ' 70' ' ' LYS . 7.1 pm0 -75.75 -11.25 59.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 1.79 111.847 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -98.03 -48.69 5.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.655 -0.248 . . . . 0.97999999999999998 110.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.72 -32.81 73.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.737 -0.211 . . . . 0.51000000000000001 111.514 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 79' ' ' THR . 6.9 tt -64.51 -26.78 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.085 0.469 . . . . 1.24 110.455 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 m -95.55 -10.46 29.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 1.95 110.276 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.22 -54.69 4.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.736 -0.666 . . . . 1.22 111.252 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -100.72 -37.87 8.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.75 111.33 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.66 -18.17 8.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.293 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.73 141.57 30.58 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.165 -0.309 . . . . 0.58999999999999997 110.165 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -14.26 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.31 111.09 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' OD1' HG23 ' A' ' 83' ' ' THR . 17.0 t0 -90.09 125.14 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.58999999999999997 110.178 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.424 ' HG3' ' HB2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.95 -21.76 54.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.07 -0.514 . . . . 0.87 112.171 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.416 HG23 ' OD1' ' A' ' 81' ' ' ASP . 2.5 t -68.0 -31.51 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.224 -0.591 . . . . 1.95 110.034 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 74.3 mm-40 -70.22 -36.78 74.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.092 -0.707 . . . . 1.0800000000000001 109.092 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 89' ' ' ILE . 32.6 mm -64.34 -45.73 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.206 -0.906 . . . . 0.28000000000000003 109.172 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.49 -42.3 91.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.64000000000000001 110.575 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.86 -38.32 90.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 2.48 110.189 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 7.5 mm100 -64.28 -39.95 94.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.4399999999999999 109.76 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 85' ' ' ILE . 45.1 mt -67.66 -26.75 36.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.46999999999999997 110.391 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.75 -27.4 31.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.144 -0.48 . . . . 1.26 111.731 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.438 ' HB ' ' HE1' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -101.36 -30.86 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.62 0.6 . . . . 0.52000000000000002 112.62 -177.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -111.45 -3.73 15.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.029 0.442 . . . . 1.46 110.939 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.5 178.77 22.61 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.673 -0.775 . . . . 0.34000000000000002 112.516 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.2 112.02 24.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.41 . . . . 1.3100000000000001 110.573 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.03 148.09 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.605 -0.725 . . . . 0.45000000000000001 110.219 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -62.36 100.17 0.17 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.386 0.612 . . . . 0.68000000000000005 111.058 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.56 88.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 1.1799999999999999 111.142 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 m -91.92 27.31 2.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 0.65000000000000002 110.002 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -118.56 122.8 43.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 1.8500000000000001 109.767 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.6 148.72 52.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.325 . . . . 0.89000000000000001 110.569 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -135.04 160.48 38.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.586 -0.279 . . . . 0.67000000000000004 110.314 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -112.56 155.53 24.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.251 -0.432 . . . . 1.3200000000000001 110.551 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -146.35 140.71 26.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.939 -0.393 . . . . 0.66000000000000003 109.939 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.76 -60.81 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.763 0.283 . . . . 0.76000000000000001 111.763 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -97.36 101.74 13.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 1.23 111.461 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.8 mt -95.88 -28.61 14.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 1.2 110.115 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 17.9 mt-10 -58.88 -24.96 62.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.312 -0.858 . . . . 0.95999999999999996 112.874 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -41.05 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.683 -0.407 . . . . 1.77 111.187 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -48.48 80.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 1.77 111.172 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -87.08 1.3 53.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.46 -0.336 . . . . 0.41999999999999998 111.779 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 27.9 ttp180 -84.14 -31.26 25.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.654 -0.499 . . . . 1.01 109.654 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.63 -48.88 75.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.5 110.069 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.4 tp -68.0 -27.46 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.238 0.542 . . . . 1.0700000000000001 110.051 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.15 -33.7 75.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.40999999999999998 110.877 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.04 -23.37 65.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.029 0.443 . . . . 0.58999999999999997 110.424 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.4 mt -83.41 -41.94 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.89000000000000001 110.534 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.87 -19.62 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.34000000000000002 111.357 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.02 69.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.57999999999999996 110.926 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.99 10.85 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 1.0800000000000001 109.958 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.3 -49.49 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.927 -0.579 . . . . 1.45 111.154 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.428 ' HB2' HG23 ' A' ' 169' ' ' ILE . 26.5 p -92.65 109.45 20.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.015 0.436 . . . . 1.1399999999999999 111.227 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.34 162.35 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.272 -0.422 . . . . 0.82999999999999996 110.564 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.5 147.54 3.82 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.8200000000000001 109.965 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.87 64.39 4.96 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.711 2.274 . . . . 0.62 112.209 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.44 -171.82 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.783 -0.644 . . . . 1.3400000000000001 110.434 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.0 t -76.99 -12.58 59.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.245 0.545 . . . . 0.58999999999999997 110.184 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -118.61 131.5 56.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.745 -0.662 . . . . 1.0600000000000001 109.36 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 128' ' ' ARG . 1.0 OUTLIER -95.16 153.72 39.68 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.43 -0.35 . . . . 1.6899999999999999 110.489 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.29 48.48 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.994 2.462 . . . . 0.44 112.493 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -95.03 -7.99 38.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.57999999999999996 110.269 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 154.12 36.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.206 -0.452 . . . . 1.3400000000000001 110.531 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.06 -18.09 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.116 -0.493 . . . . 0.17999999999999999 111.339 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.1 mm -54.08 -31.18 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.118 -0.492 . . . . 0.35999999999999999 111.593 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.95 -52.34 64.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.37 111.17 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -81.37 -30.35 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.344 -0.389 . . . . 1.0600000000000001 110.87 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.87 -46.93 87.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.825 0.345 . . . . 1.51 110.219 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -61.38 -39.93 92.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 1.8300000000000001 111.148 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.94 70.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.359 -0.382 . . . . 0.31 111.281 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -42.78 91.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 2.7000000000000002 110.878 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -67.09 -30.86 71.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 1.8300000000000001 110.878 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -71.2 -45.74 62.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.80000000000000004 111.106 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 7.0 tp -73.01 -42.57 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.792 -0.363 . . . . 0.35999999999999999 110.234 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 35.5 t60 50.57 57.91 6.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.932 -0.576 . . . . 1.54 110.914 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.503 ' CD2' ' HG2' ' A' ' 162' ' ' GLN . 44.0 t80 -97.16 136.34 37.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.731 . . . . 1.4199999999999999 110.059 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.9 124.05 22.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.721 0.296 . . . . 0.54000000000000004 110.305 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.25 39.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.195 0.522 . . . . 0.38 111.012 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 55.02 83.96 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 1.95 111.989 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -14.51 62.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.982 -0.554 . . . . 0.58999999999999997 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -102.0 14.88 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.514 0.673 . . . . 0.82999999999999996 109.188 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -147.65 -149.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.584 -0.734 . . . . 1.3700000000000001 109.832 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.1 t -152.99 175.94 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.918 -0.401 . . . . 0.19 109.918 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -65.8 -36.18 82.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 1.27 111.941 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -76.73 -9.46 58.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.419 -0.355 . . . . 0.44 111.487 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -47.57 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.70999999999999996 110.113 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -161.77 73.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.97999999999999998 110.987 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -75.26 -24.74 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.58999999999999997 110.745 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.18 -51.16 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.607 . . . . 0.75 110.878 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.84 -35.27 79.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.40999999999999998 110.625 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.6 -52.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.25 110.981 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.2 tp -66.01 -31.98 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.349 -0.387 . . . . 0.25 111.125 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -72.41 -31.66 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 1.1299999999999999 110.479 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.503 ' HG2' ' CD2' ' A' ' 144' ' ' TYR . 7.4 tp-100 -68.93 -37.78 79.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.96999999999999997 109.928 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.59 -40.61 97.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.29999999999999999 109.994 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -66.29 -21.27 66.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.366 -0.834 . . . . 1.22 111.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -71.08 -28.6 64.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.829 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.462 ' HG3' ' HB ' ' A' ' 142' ' ' ILE . 7.1 mmtt -93.09 -41.62 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.53000000000000003 110.036 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.9 mmm -130.53 99.53 5.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 2.5899999999999999 109.498 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.35 93.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.165 0.507 . . . . 1.4099999999999999 110.973 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -89.33 164.67 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.49 -0.777 . . . . 0.20999999999999999 109.859 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -172.11 -144.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.021 -0.363 . . . . 0.52000000000000002 110.021 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 69.85 55.06 0.35 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.333 0.653 . . . . 0.85999999999999999 111.942 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.51 155.63 40.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.40000000000000002 109.856 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -119.28 149.06 42.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 2.0299999999999998 111.986 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 63.1 mtt -124.84 -118.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.72999999999999998 109.518 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.99 126.93 22.28 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.921 0.391 . . . . 1.1499999999999999 110.74 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.432 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 5.7 mp -113.16 144.59 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.31 110.199 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.56 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 16.0 ptt180 -123.67 138.66 54.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.926 -0.579 . . . . 0.14999999999999999 110.125 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 71.9 m-85 -106.3 124.58 49.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.035 -0.357 . . . . 0.10000000000000001 110.035 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.18 112.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.42999999999999999 111.291 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.83 152.81 27.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.829 -0.623 . . . . 0.28999999999999998 110.137 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.98 153.36 74.03 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.124 1.883 . . . . 0.14000000000000001 111.06 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.74 -30.96 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.91000000000000003 111.329 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.99 -41.94 62.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.584 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -97.56 -31.9 12.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.64000000000000001 110.781 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.33 -31.05 68.89 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.86 -0.609 . . . . 0.42999999999999999 112.597 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -64.36 -16.27 61.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.56 0.219 . . . . 3.2000000000000002 111.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -82.89 -44.5 15.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 1.55 111.004 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 -23.29 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 0.56999999999999995 111.311 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -54.54 -55.32 30.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.72999999999999998 111.325 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -82.89 29.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.366 -0.379 . . . . 0.53000000000000003 111.629 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -134.8 -48.9 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.68999999999999995 110.45 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.4 mt -78.83 -39.83 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 1.49 111.705 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 39.7 mtpt -64.68 -50.51 64.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.529 0.566 . . . . 2.3599999999999999 112.529 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.7 Cg_endo -62.28 -15.79 46.96 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.978 1.786 . . . . 0.19 112.879 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.44 2.96 49.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.549 -0.296 . . . . 0.98999999999999999 110.223 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 23.7 pt 41.2 41.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.252 1.021 . . . . 0.94999999999999996 112.746 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -117.8 18.76 14.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.548 0.69 . . . . 2.2400000000000002 109.798 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.6 m -111.82 164.06 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.27 -0.877 . . . . 0.60999999999999999 110.565 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.91 138.48 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.793 -0.817 . . . . 0.39000000000000001 108.793 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.49 70.96 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.422 0.629 . . . . 1.75 111.374 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.5 m -144.73 28.15 1.3 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 1.46 109.742 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 9.1 pt-20 -85.73 168.78 14.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 1.8999999999999999 110.62 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -131.34 126.83 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.22 110.681 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.54 79.14 4.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 2.4300000000000002 110.915 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -125.7 2.68 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.247 -0.741 . . . . 0.33000000000000002 111.247 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.83 -36.55 17.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.453 0.645 . . . . 2.7599999999999998 109.726 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -113.35 114.64 26.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.146 -0.933 . . . . 3.0499999999999998 108.99 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.51 80.72 4.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.141 0.496 . . . . 0.55000000000000004 110.38 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 28.0 tt0 -80.19 105.68 11.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.66000000000000003 110.115 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.12 138.27 37.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 1.2 110.473 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.19 113.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.20999999999999999 109.826 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.81 105.5 5.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.028 0.442 . . . . 0.19 111.168 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.432 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -148.86 144.96 27.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.275 -0.639 . . . . 1.55 109.275 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.1 tt -137.26 163.17 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.588 -0.278 . . . . 1.04 110.45 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 165.7 4.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.828 0.451 . . . . 0.73999999999999999 110.808 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.53 -172.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.457 2.105 . . . . 0.28000000000000003 112.855 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 81.12 -92.6 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.699 -0.762 . . . . 0.23000000000000001 111.537 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.19 -12.36 50.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 2.1099999999999999 110.957 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.454 ' HA ' HG23 ' A' ' 222' ' ' ILE . 79.7 t80 -58.2 -30.68 66.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.396 . . . . 0.19 110.617 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -69.4 -18.63 63.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 2.2400000000000002 110.732 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -90.3 -35.24 15.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.469 -0.332 . . . . 1.77 111.24 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.583 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 5.3 tt -82.35 -34.88 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.552 0.215 . . . . 0.19 111.266 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.64 -25.74 66.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.183 0.516 . . . . 0.80000000000000004 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.21 -32.35 66.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.421 -0.808 . . . . 0.64000000000000001 111.45 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.48 -36.13 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.784 -0.367 . . . . 1.74 110.433 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.1 mm -53.86 -41.09 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 116.556 -0.293 . . . . 0.51000000000000001 111.367 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -55.94 -31.1 62.63 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.887 -0.597 . . . . 0.59999999999999998 112.603 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.54 ' HE3' ' C ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.63 2.62 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.852 0.316 . . . . 3.1699999999999999 111.852 -178.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 6.5 tp10 -94.25 -56.39 2.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.36 . . . . 0.89000000000000001 110.865 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t -126.66 -21.85 4.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.083 -0.508 . . . . 0.81000000000000005 111.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -61.88 -50.51 71.92 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.842 -0.429 . . . . 0.44 109.842 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.74 34.65 4.52 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.25 111.77 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -129.9 -30.4 2.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.747 0.308 . . . . 2.2599999999999998 110.538 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -151.3 -151.37 5.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.712 -0.756 . . . . 0.40000000000000002 112.368 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.2 m -110.81 145.85 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.125 -0.324 . . . . 0.33000000000000002 110.125 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.58 145.37 42.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 0.76000000000000001 110.659 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.61 170.63 15.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.497 -0.774 . . . . 1.1599999999999999 109.173 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.17 153.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.404 -0.591 . . . . 0.29999999999999999 109.404 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.5 tp -78.67 70.64 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.20999999999999999 109.921 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.407 ' OD1' ' HE2' ' A' ' 242' ' ' LYS . 66.6 t30 -103.69 47.77 0.87 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.679 -0.691 . . . . 2.0299999999999998 110.426 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.45 -71.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.56000000000000005 110.65 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.407 ' HE2' ' OD1' ' A' ' 240' ' ' ASN . 0.0 OUTLIER 61.82 27.77 16.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.137 -0.483 . . . . 1.27 110.713 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.54 -51.83 2.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.571 . . . . 0.64000000000000001 110.272 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 246' ' ' GLU . 6.4 p -138.12 134.94 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.46999999999999997 109.559 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -111.11 21.5 16.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 0.70999999999999996 110.524 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 244' ' ' VAL . 36.1 tt0 -95.66 119.03 33.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.877 -0.601 . . . . 1.3899999999999999 110.739 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.33 160.69 20.59 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.41999999999999998 111.4 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -79.96 89.94 5.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.187 0.518 . . . . 0.68999999999999995 110.846 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -106.45 14.38 27.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.716 -0.674 . . . . 0.45000000000000001 110.269 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -125.45 89.58 3.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.859 -0.609 . . . . 0.71999999999999997 110.693 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -71.21 -35.28 71.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.079 0.466 . . . . 0.77000000000000002 110.646 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.698 -0.668 . . . . 1.9299999999999999 109.901 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.542 -0.623 . . . . 0.93000000000000005 111.542 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 1.1599999999999999 110.264 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -59.84 116.61 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.835 -0.62 . . . . 3.3100000000000001 110.792 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -130.22 117.71 20.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.096 -0.502 . . . . 0.57999999999999996 110.13 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.69 -56.06 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 1.0600000000000001 110.91 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -91.33 93.05 8.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.398 . . . . 2.9900000000000002 110.636 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 87.43 55.87 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.60999999999999999 110.691 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 151.75 52.26 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.559 2.173 . . . . 0.32000000000000001 112.557 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -103.24 124.44 48.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.81000000000000005 110.615 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -153.62 -171.77 4.01 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.845 -0.428 . . . . 0.95999999999999996 109.845 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -84.62 -85.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.911 0.386 . . . . 1.24 111.021 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.443 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 mp -93.74 83.49 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.195 0.522 . . . . 1.01 110.721 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.4 mmt85 -141.55 148.59 39.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.667 -0.697 . . . . 2.52 109.972 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.41 -9.75 58.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.066 0.46 . . . . 2.1699999999999999 111.258 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.29 9.11 30.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 0.78000000000000003 111.336 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -145.03 37.65 1.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.69999999999999996 109.743 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.84 -168.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.32 -0.855 . . . . 0.25 111.916 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.29 152.94 36.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.553 -0.748 . . . . 0.28000000000000003 109.496 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.07 119.4 47.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.864 0.364 . . . . 0.22 110.749 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 2.4 p -155.47 110.32 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.34999999999999998 109.784 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.61 142.16 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.83999999999999997 111.665 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.485 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 37.7 ttp -112.73 129.57 56.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.56000000000000005 110.033 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 124.76 47.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 2.2999999999999998 110.028 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -104.19 -166.49 1.25 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.688 -0.687 . . . . 1.3300000000000001 110.3 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.23 90.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.427 -0.351 . . . . 0.83999999999999997 111.037 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.06 46.17 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.594 -0.813 . . . . 0.33000000000000002 112.442 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -172.82 156.83 3.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.977 -0.379 . . . . 2.5600000000000001 109.977 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 145.13 48.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.76000000000000001 109.779 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -134.23 138.61 45.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.378 -0.373 . . . . 0.65000000000000002 110.639 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 34.6 tt0 -144.19 142.53 30.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.58 0.229 . . . . 1.28 110.664 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.93 -164.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.559 . . . . 0.14000000000000001 110.107 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.4 153.35 51.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.391 -0.225 . . . . 0.32000000000000001 110.391 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 42.5 m -133.39 127.3 33.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.852 0.358 . . . . 0.32000000000000001 111.297 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 2.1 t80 -62.89 122.28 15.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.45000000000000001 112.375 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 55.72 17.49 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.066 -0.97 . . . . 1.3799999999999999 112.81 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER 62.19 23.35 13.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.0 0.429 . . . . 0.84999999999999998 110.35 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -74.52 -1.13 20.01 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.246 0.462 . . . . 1.8100000000000001 112.246 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.98 -23.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.53 . . . . 0.20000000000000001 110.423 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.15 -7.46 9.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.82 -0.627 . . . . 0.22 109.798 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 43' ' ' SER . . . -62.48 -27.78 70.12 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.62 -0.718 . . . . 0.20999999999999999 111.95 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -73.73 2.13 8.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.67000000000000004 111.001 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -130.41 23.99 5.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.982 -0.747 . . . . 0.57999999999999996 108.982 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' OG ' ' HA2' ' A' ' 40' ' ' GLY . 1.5 p -148.96 15.75 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.46000000000000002 110.702 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.96 23.76 77.53 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.133 -0.556 . . . . 0.23000000000000001 113.901 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.36 78.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.093 0.446 . . . . 0.29999999999999999 110.474 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.46 136.21 55.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.044 -0.354 . . . . 1.27 110.044 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -125.28 159.49 31.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.584 -0.28 . . . . 1.1699999999999999 111.097 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.71 127.55 28.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.444 -0.798 . . . . 0.46999999999999997 110.941 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.45 -10.17 59.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.023 -0.535 . . . . 1.5 111.088 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -105.15 -9.7 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 0.67000000000000004 111.072 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -102.08 -39.34 7.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 1.27 110.21 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 6.6 p -72.94 -20.13 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.187 -0.461 . . . . 1.1000000000000001 111.077 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.17 102.79 14.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.393 -0.367 . . . . 0.10000000000000001 110.391 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 12' ' ' ILE . 57.6 mt-30 -82.89 -73.54 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.165 -0.471 . . . . 0.39000000000000001 110.428 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 m -67.2 106.48 2.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.81 -0.632 . . . . 0.089999999999999997 110.3 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -87.97 49.63 1.84 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.461 0.648 . . . . 0.56999999999999995 110.427 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 p -161.11 141.97 11.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.064 -0.971 . . . . 0.17000000000000001 108.872 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.98 145.47 16.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.262 -0.273 . . . . 0.23000000000000001 110.262 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -89.67 160.66 16.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.634 0.254 . . . . 0.10000000000000001 111.057 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.9 t -123.35 -50.98 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 1.1100000000000001 109.945 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 65.8 m-20 -129.23 112.46 13.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.81000000000000005 109.427 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 7.3 p -79.63 -34.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.83 0.348 . . . . 1.1100000000000001 111.42 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -78.18 -28.1 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 1.6299999999999999 110.926 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -94.35 -6.85 43.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.167 -0.469 . . . . 1.3600000000000001 110.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.03 53.92 36.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.017 -0.611 . . . . 0.59999999999999998 112.045 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 12.2 mm100 -121.96 121.39 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.40999999999999998 111.015 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.0 t -110.68 146.0 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.493 -0.776 . . . . 0.29999999999999999 109.632 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.99 121.94 42.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 1.01 110.27 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 -171.87 2.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.068 -0.716 . . . . 1.48 109.068 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.484 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -56.86 -39.68 74.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.835 0.309 . . . . 1.21 111.835 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -72.74 -16.74 61.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.624 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.86 -53.48 4.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.061 0.457 . . . . 0.20000000000000001 110.654 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.99 -23.81 66.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.12 111.754 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -64.16 -30.37 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.863 0.363 . . . . 1.1000000000000001 110.64 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -97.2 -23.27 16.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.841 0.353 . . . . 0.97999999999999998 110.599 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.13 -47.72 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 1.0700000000000001 110.974 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 -59.03 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.79000000000000004 110.401 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.72 -37.43 1.03 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.544 -0.836 . . . . 0.16 112.506 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.56 135.1 44.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.452 0.168 . . . . 1.3 111.054 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.77 43.63 1.0 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 0.53000000000000003 111.02 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.7 130.89 46.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.193 -0.458 . . . . 0.35999999999999999 110.128 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.74 -27.26 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 1.1699999999999999 111.368 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.565 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 1.1 m -65.65 -35.7 81.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.189 0.518 . . . . 0.28000000000000003 111.074 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.86 -24.94 60.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.098 -0.501 . . . . 1.3400000000000001 110.567 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 89' ' ' ILE . 29.6 mm -84.17 -51.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.16 110.822 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 30.0 p -60.63 -37.12 80.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.23999999999999999 111.917 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -64.08 -30.12 71.21 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.898 0.38 . . . . 2.5 110.613 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -77.9 -38.99 44.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.931 -0.396 . . . . 2.6000000000000001 109.931 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 56.5 mt -67.1 -25.3 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.34999999999999998 110.5 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -81.55 -35.65 30.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.747 -0.66 . . . . 0.96999999999999997 112.061 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 -20.56 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.733 0.642 . . . . 0.98999999999999999 112.733 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 22' ' ' MET . 5.2 mmtm -127.78 23.09 6.25 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.879 -0.329 . . . . 1.3300000000000001 111.632 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.14 -176.02 14.22 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.228 -0.987 . . . . 0.20999999999999999 113.501 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 mm-40 -101.88 105.07 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.287 -0.457 . . . . 1.6200000000000001 109.924 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.05 146.0 15.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.33000000000000002 110.444 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -66.69 97.96 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.381 . . . . 1.8600000000000001 110.221 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.03 131.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.058 0.456 . . . . 2.0699999999999998 110.908 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.6 m -157.15 126.1 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.55 -0.75 . . . . 0.28999999999999998 109.054 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.93 93.81 1.02 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 2.6000000000000001 110.458 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -101.74 -45.88 5.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.76000000000000001 111.496 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -127.63 161.3 29.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.136 0.493 . . . . 0.62 110.877 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -137.18 136.36 38.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.587 -0.733 . . . . 1.74 110.078 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.531 ' CG ' ' H ' ' A' ' 104' ' ' THR . 7.5 t-80 -161.11 -158.17 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.482 -0.562 . . . . 0.63 109.482 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.531 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 4.3 m -137.65 128.1 26.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.97999999999999998 109.385 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.426 ' OE1' ' HG2' ' A' ' 108' ' ' GLN . 0.4 OUTLIER -65.03 149.2 50.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.83 0.348 . . . . 0.20999999999999999 111.203 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.4 tp -97.01 -48.1 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.2 -0.454 . . . . 2.0600000000000001 110.928 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.482 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 4.9 mm-40 -71.83 -88.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.365 -0.38 . . . . 1.74 111.457 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 107' ' ' GLU . 2.1 pm0 -88.14 61.49 6.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 1.4399999999999999 110.278 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.3 ttp -52.91 -40.03 63.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.539 -0.755 . . . . 1.6100000000000001 111.762 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -67.16 -31.9 72.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.778 -0.646 . . . . 0.29999999999999999 111.481 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -77.51 -31.65 53.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.588 -0.278 . . . . 0.91000000000000003 111.13 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.518 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.1 t70 -57.36 -46.63 83.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.942 0.401 . . . . 0.58999999999999997 109.966 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -75.24 -32.64 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 1.04 109.949 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.26 93.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.23999999999999999 111.364 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -78.54 3.94 14.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.765 0.283 . . . . 0.25 111.765 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 112' ' ' ASP . 52.7 mt -112.92 -11.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.688 0.756 . . . . 1.46 109.76 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 -20.48 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.564 . . . . 0.47999999999999998 111.594 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.27 81.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.762 0.315 . . . . 0.44 111.449 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.483 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -71.08 -35.83 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.053 -0.521 . . . . 1.26 110.703 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -68.97 -32.71 72.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.62 110.939 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 28.5 m -84.79 81.56 8.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.23000000000000001 110.568 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -74.63 142.93 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.594 . . . . 0.25 111.57 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -133.75 99.2 14.18 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.711 -0.677 . . . . 0.29999999999999999 109.98 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.72 25.1 0.69 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.653 2.235 . . . . 0.62 112.586 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.35 -48.95 6.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.558 -0.292 . . . . 0.76000000000000001 110.758 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 t -170.78 -33.16 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.893 -0.323 . . . . 1.0800000000000001 111.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -95.17 108.34 20.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.034 0.445 . . . . 2.1499999999999999 110.221 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.42 154.2 93.45 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 1.3400000000000001 111.21 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.62 53.81 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.315 2.677 . . . . 0.72999999999999998 112.97 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.22 16.43 3.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.858 -0.61 . . . . 0.53000000000000003 109.692 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 m -122.86 108.66 13.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 1.1899999999999999 111.318 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -30.79 44.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.859 -0.609 . . . . 1.1399999999999999 110.737 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.02 -27.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.612 . . . . 0.29999999999999999 111.35 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.52 -45.3 89.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 1.0600000000000001 111.156 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -33.76 8.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.559 -0.292 . . . . 0.94999999999999996 110.475 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.4 -39.66 88.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 1.53 110.983 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -37.34 85.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.555 . . . . 1.5 110.404 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.49 -39.29 28.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.09 -0.505 . . . . 0.14999999999999999 111.262 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 31.9 ttp -61.23 -36.35 79.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 0.31 110.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.58 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 2.1600000000000001 110.575 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.78 -39.57 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.29999999999999999 110.216 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 8.1 mt -58.04 -53.03 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.966 -0.561 . . . . 0.33000000000000002 110.134 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 60.74 28.12 17.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.348 -0.842 . . . . 1.45 112.01 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -124.19 129.37 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.74 -0.467 . . . . 0.60999999999999999 109.74 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.73 141.13 37.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.0 -0.545 . . . . 0.32000000000000001 110.826 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.75 -63.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.346 -0.388 . . . . 0.23000000000000001 110.564 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -151.32 129.09 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.131 -0.322 . . . . 2.4300000000000002 110.131 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 145.82 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 0.60999999999999999 111.65 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.8 t30 66.39 9.87 6.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.73 112.196 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -84.66 140.35 31.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.249 -0.648 . . . . 1.24 109.249 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.494 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 2.3 m -59.02 132.68 54.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.96 -0.385 . . . . 0.40999999999999998 109.96 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -45.13 73.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.541 0.571 . . . . 1.3100000000000001 112.541 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -64.07 -25.18 67.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.389 0.514 . . . . 2.6299999999999999 112.389 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.52 -25.72 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.871 0.323 . . . . 2.1699999999999999 111.871 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 159' ' ' VAL . 25.6 pt20 -109.32 12.81 24.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.922 0.391 . . . . 0.40000000000000002 111.114 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.16 87.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.1200000000000001 111.142 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.3 -31.5 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.40999999999999998 110.645 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -76.04 -36.22 59.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.58999999999999997 110.399 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 155' ' ' GLN . 94.5 t -65.12 -48.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.22 110.758 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.22 -33.78 64.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.826 0.346 . . . . 1.0600000000000001 110.711 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.4 mtmt -67.86 -46.29 72.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.326 . . . . 1.6799999999999999 110.121 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -65.86 -36.32 83.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.81000000000000005 110.72 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.19 -42.85 99.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 1.22 110.317 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 167' ' ' MET . 1.4 tmmt? -60.57 -28.72 68.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.492 -0.777 . . . . 0.56999999999999995 111.306 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.3 mm-40 -70.47 -25.62 63.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.474 . . . . 1.3600000000000001 110.887 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -99.9 -39.1 8.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 1.52 111.052 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 36.2 ttm -135.25 129.16 33.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.843 -0.428 . . . . 1.99 109.843 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -80.97 97.79 7.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.95 0.405 . . . . 0.93999999999999995 111.182 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -101.22 166.11 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.546 . . . . 1.0900000000000001 110.299 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.42 93.53 7.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.996 0.427 . . . . 0.52000000000000002 110.751 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -102.66 13.36 34.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 1.5800000000000001 110.143 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.87 98.87 9.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.51000000000000001 110.569 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.478 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 2.0 p-80 -91.67 142.47 27.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.971 -0.559 . . . . 0.29999999999999999 110.772 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.23 167.23 11.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.222 -0.659 . . . . 2.75 109.222 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 83.7 mtm180 -133.59 129.58 37.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.968 0.413 . . . . 1.1699999999999999 111.181 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mt -116.65 151.59 35.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 109.915 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.414 ' HE ' ' CD ' ' A' ' 209' ' ' GLU . 6.8 ptm180 -134.69 135.21 41.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.322 -0.399 . . . . 0.28000000000000003 110.446 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 49.1 m-85 -102.17 128.04 48.84 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.991 -0.374 . . . . 0.32000000000000001 109.991 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.59 123.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 0.53000000000000003 111.196 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.46 160.61 32.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.562 -0.744 . . . . 0.94999999999999996 110.052 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.03 165.64 11.95 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.779 2.319 . . . . 0.16 112.567 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.24 -41.42 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.399 -0.364 . . . . 0.51000000000000001 111.76 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -59.3 -47.49 85.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 1.4399999999999999 111.078 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.58 53.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 0.63 111.581 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.3 71.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.177 -0.535 . . . . 0.27000000000000002 113.13 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -71.44 -8.17 52.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.828 0.307 . . . . 0.77000000000000002 111.828 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -87.66 -6.04 58.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.64 0.257 . . . . 1.48 111.066 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -26.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.675 -0.238 . . . . 0.58999999999999997 111.342 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -56.78 16.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.838 0.351 . . . . 2.3199999999999998 111.235 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.64 10.5 3.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 229' ' ' GLU . 20.9 mtpt -118.14 -41.68 2.86 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.684 0.253 . . . . 1.51 111.684 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.33 -38.46 18.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.981 0.363 . . . . 0.53000000000000003 111.981 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 11.0 mtpt -59.52 -47.54 97.6 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.597 0.591 . . . . 0.44 112.597 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.9 Cg_endo -64.6 -8.95 18.79 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.468 2.112 . . . . 0.20000000000000001 113.474 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.1 mt -90.46 -5.15 56.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.858 0.361 . . . . 0.14999999999999999 110.203 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.2 mm 58.09 54.18 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.666 0.746 . . . . 0.11 110.309 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.97 16.99 7.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.454 -0.794 . . . . 0.32000000000000001 110.556 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.95 142.37 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.58999999999999997 111.608 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.94 159.03 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.527 -0.761 . . . . 0.59999999999999998 109.547 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -70.77 53.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.25 0.463 . . . . 1.8700000000000001 112.25 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.7 m -167.18 100.58 0.52 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.496 0.719 . . . . 0.72999999999999998 109.797 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.465 ' CD ' ' HZ1' ' A' ' 193' ' ' LYS . 47.6 mt-10 -128.05 145.78 50.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.40999999999999998 111.361 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.27 119.3 38.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.874 -0.417 . . . . 0.25 109.874 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.16 101.39 6.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 109.909 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -156.98 -109.4 0.29 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.954 -0.641 . . . . 0.26000000000000001 111.741 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -88.69 -13.35 39.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.631 0.729 . . . . 1.6599999999999999 109.037 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.58 -177.32 4.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.612 -1.176 . . . . 1.1299999999999999 108.536 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 40.9 tp -134.1 117.22 16.36 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.813 -0.439 . . . . 0.42999999999999999 109.813 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 48.3 tt0 -128.77 117.6 21.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.053 -0.522 . . . . 0.34000000000000002 109.632 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.79 141.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.825 0.345 . . . . 2.1899999999999999 111.125 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.46 111.23 24.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.471 -0.566 . . . . 1.0700000000000001 109.471 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 60.29 0.71 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.992 0.425 . . . . 1.1299999999999999 111.706 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -138.59 113.94 9.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.768 -0.456 . . . . 0.45000000000000001 109.768 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.79 -78.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.17000000000000001 111.567 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -138.92 160.83 61.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.521 -0.309 . . . . 0.20999999999999999 110.766 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 173' ' ' HIS . 70.2 Cg_endo -74.53 176.19 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.55 2.166 . . . . 0.23000000000000001 111.712 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 77.24 -75.4 1.77 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.499 -0.858 . . . . 0.14999999999999999 111.883 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -5.25 32.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.69 0.281 . . . . 2.6699999999999999 110.843 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 7.7 p90 -59.71 -23.53 63.24 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.22 110.991 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.43 ' HA ' ' OD1' ' A' ' 223' ' ' ASP . 1.2 tpm_? -60.32 -27.89 67.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.875 0.369 . . . . 3.1299999999999999 110.884 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -50.23 65.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.33000000000000002 110.499 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 8.3 tt -81.33 -34.9 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 1.97 111.854 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 219' ' ' PHE . 0.0 OUTLIER -64.34 -28.07 69.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.722 0.296 . . . . 1.71 111.299 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -66.49 -36.13 81.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.6899999999999999 110.382 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -90.89 -39.71 12.15 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.678 -0.409 . . . . 0.14000000000000001 110.92 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.3 mm -55.7 -36.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.463 -0.335 . . . . 0.37 111.604 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -56.49 -23.72 41.31 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.739 0.644 . . . . 1.3400000000000001 112.739 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.5 pttm -121.26 -19.19 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.798 0.296 . . . . 1.5900000000000001 111.798 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 191' ' ' LYS . 2.2 tp10 -78.64 -32.27 47.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.28999999999999998 112.34 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -143.26 -33.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.446 -0.502 . . . . 0.81000000000000005 111.364 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -66.12 -18.66 65.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.177 0.513 . . . . 0.34000000000000002 110.529 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.82 15.47 28.85 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.14000000000000001 111.512 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -128.49 -35.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.725 0.297 . . . . 1.0900000000000001 110.73 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.95 -150.29 6.55 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.91 -0.662 . . . . 0.29999999999999999 112.742 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.2 m -116.71 145.84 43.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.318 . . . . 1.29 110.812 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 1.5 pt? -106.4 137.45 44.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.943 0.401 . . . . 0.41999999999999998 110.688 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -129.31 163.75 25.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.66000000000000003 110.444 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.14 169.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.797 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.72 12.3 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.877 0.37 . . . . 2.0499999999999998 111.138 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -79.0 70.42 5.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 1.4299999999999999 110.272 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.39 81.95 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.703 -0.68 . . . . 1.5700000000000001 110.26 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.06 -19.59 17.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.709 -0.678 . . . . 0.77000000000000002 109.735 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.57 -60.41 2.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.113 -0.949 . . . . 1.1899999999999999 110.627 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.17 150.97 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 0.46999999999999997 110.318 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -80.67 146.46 31.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.083 -0.34 . . . . 1.5600000000000001 110.083 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -157.97 112.15 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.992 -0.373 . . . . 1.3300000000000001 109.992 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 149.77 127.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.799 -0.637 . . . . 0.19 111.845 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -114.29 145.26 41.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.84 -0.43 . . . . 0.69999999999999996 109.84 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 -7.17 37.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.79 -0.448 . . . . 0.81000000000000005 109.79 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.77 53.46 8.26 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.988 -1.005 . . . . 1.47 111.272 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -71.78 -23.11 61.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.235 0.54 . . . . 1.1899999999999999 109.807 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.4 -0.809 . . . . 1.4199999999999999 109.718 179.102 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 111.549 -0.62 . . . . 0.5 111.549 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -69.24 127.54 33.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.902 -0.407 . . . . 0.48999999999999999 109.902 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.5 mmt -53.49 -53.47 51.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.756 0.312 . . . . 1.54 110.464 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -96.13 106.44 18.62 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.515 -0.55 . . . . 1.24 109.515 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 tp -152.6 120.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.378 0.608 . . . . 0.53000000000000003 110.667 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -84.66 110.44 18.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 1.1399999999999999 110.24 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.31 5.0 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.943 -0.571 . . . . 0.84999999999999998 110.327 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.73 109.76 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.594 2.196 . . . . 0.82999999999999996 112.1 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 16' ' ' ASN . 7.9 p -114.46 105.65 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.13 -0.486 . . . . 0.52000000000000002 110.729 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -131.58 -82.63 0.51 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.615 0.245 . . . . 1.6299999999999999 110.683 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -129.34 -122.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.601 -0.272 . . . . 1.3899999999999999 110.598 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.95 94.42 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.28999999999999998 110.636 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 13' ' ' ARG . 10.3 mmt85 -134.4 -171.47 2.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.686 -0.688 . . . . 2.0 109.759 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.54 12.65 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.275 0.559 . . . . 2.2400000000000002 110.379 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.65 -32.75 7.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 0.75 111.833 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.407 ' HB3' HG23 ' A' ' 9' ' ' THR . 26.0 p-10 -97.63 18.62 15.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 1.1000000000000001 111.443 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.1 m -85.8 157.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.599 0.714 . . . . 0.42999999999999999 112.786 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.11 140.05 53.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.625 -1.17 . . . . 0.5 108.96 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -89.08 98.57 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 1.0800000000000001 111.311 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.36 120.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.847 -0.615 . . . . 0.31 109.696 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -122.75 132.56 54.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.35999999999999999 112.146 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 39.0 ttp -107.01 122.66 46.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.93999999999999995 110.337 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -97.63 123.62 41.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 1.99 109.99 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -107.39 -154.9 0.53 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.449 -0.341 . . . . 0.55000000000000004 110.096 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.43 -59.55 2.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.84 0.311 . . . . 0.58999999999999997 111.84 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.84 21.56 5.88 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.638 -0.791 . . . . 0.84999999999999998 112.634 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -155.86 161.01 40.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.692 -0.484 . . . . 1.4099999999999999 109.692 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 142.83 28.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.341 -0.615 . . . . 0.46999999999999997 109.341 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.89 141.26 47.3 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.343 0.402 . . . . 0.27000000000000002 110.523 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.663 ' HG2' ' CD1' ' A' ' 59' ' ' PHE . 14.1 pt-20 -139.68 149.22 43.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.052 -0.351 . . . . 0.38 110.052 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.3 pt -136.75 -176.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.771 -0.65 . . . . 0.40999999999999998 110.591 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.36 109.88 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.308 0.575 . . . . 1.1499999999999999 111.282 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 11.3 p -117.77 -179.63 3.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.698 -0.853 . . . . 0.31 108.698 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.437 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -70.32 143.12 52.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.479 -0.489 . . . . 0.47999999999999998 110.212 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -85.4 -41.87 15.05 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.383 0.512 . . . . 1.6100000000000001 112.383 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -64.63 127.45 31.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.642 -0.254 . . . . 1.75 111.643 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.5 pttp 43.64 37.34 1.5 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.31 1.044 . . . . 2.27 113.021 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.7 p -64.47 -21.73 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.52 0.676 . . . . 0.46000000000000002 111.178 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 -4.2 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.65000000000000002 110.802 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 -24.05 71.21 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.47999999999999998 112.693 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.51 ' NE1' ' HB3' ' A' ' 90' ' ' LEU . 1.3 p-90 -75.22 -33.11 61.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.394 . . . . 0.26000000000000001 110.049 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 91' ' ' THR . 10.7 tpp85 -72.12 -22.21 61.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.17 0.509 . . . . 1.9199999999999999 110.272 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -101.86 -6.11 23.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.93999999999999995 110.905 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.18 44.88 90.13 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.035 -0.53 . . . . 0.34000000000000002 112.711 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 t -119.44 -18.56 5.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.969 0.414 . . . . 0.76000000000000001 110.659 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -91.38 -170.35 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 2.2599999999999998 112.059 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -170.83 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.475 -0.784 . . . . 2.1099999999999999 111.194 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.06 149.02 48.42 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.98999999999999999 110.94 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.76 -20.97 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.46000000000000002 111.392 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -30.24 71.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 1.01 110.473 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.26 -24.46 24.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.98999999999999999 109.823 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.29 -41.18 80.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.537 -0.756 . . . . 0.13 110.121 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.473 HD13 HE21 ' A' ' 82' ' ' GLN . 0.7 OUTLIER -75.8 92.28 3.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.426 -0.806 . . . . 0.37 109.899 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -74.64 -61.52 1.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.28999999999999998 111.834 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.84 108.02 19.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.894 0.378 . . . . 1.1200000000000001 110.944 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.4 69.32 9.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.224 0.535 . . . . 1.1100000000000001 111.438 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -154.4 105.06 2.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.822 -0.626 . . . . 0.56000000000000005 110.13 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -94.7 141.55 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.394 -0.595 . . . . 0.98999999999999999 109.394 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.663 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -93.73 157.76 16.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.064 0.459 . . . . 0.27000000000000002 111.678 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.29 -56.47 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.47 -0.937 . . . . 0.28999999999999998 108.47 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -150.02 116.79 5.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.76000000000000001 109.406 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.97 -17.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 111.252 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.9 t -64.81 -26.26 68.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 1.4199999999999999 110.689 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -122.64 -0.91 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.431 . . . . 1.51 110.987 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.96 37.48 64.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.936 -0.649 . . . . 0.42999999999999999 112.039 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -86.37 118.73 26.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 1.8899999999999999 110.772 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.79 144.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.70999999999999996 109.732 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.29 133.06 52.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.15 0.5 . . . . 0.31 110.631 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 7.3 mtmt -107.64 -171.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.736 -0.666 . . . . 1.5600000000000001 109.884 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.54 68.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.683 0.277 . . . . 0.35999999999999999 111.263 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.542 ' OE1' ' HB3' ' A' ' 69' ' ' LYS . 5.0 pm0 -80.32 -5.67 56.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.529 -0.305 . . . . 0.46000000000000002 111.482 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.33 -44.15 4.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.84 -0.344 . . . . 0.42999999999999999 110.966 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.35 -26.91 68.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.93 0.395 . . . . 0.26000000000000001 110.454 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -27.83 33.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 116.077 -0.511 . . . . 0.5 109.908 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -17.66 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.448 0.642 . . . . 0.23000000000000001 109.63 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.28 -59.19 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.748 . . . . 0.32000000000000001 110.664 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -95.19 -52.0 4.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.284 -0.417 . . . . 0.32000000000000001 110.464 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.06 -26.68 2.71 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.472 -0.651 . . . . 0.20000000000000001 111.472 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.36 143.49 28.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.564 -0.318 . . . . 0.22 110.617 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.85 10.08 32.57 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 1.4399999999999999 110.817 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.5 120.25 36.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.602 -0.726 . . . . 0.76000000000000001 110.454 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.473 HE21 HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.18 -29.78 71.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.28999999999999998 111.091 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.651 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -60.11 -37.87 81.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.93999999999999995 110.795 179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.92 -24.9 62.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.65000000000000002 110.637 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.6 mm -79.49 -49.05 20.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.17999999999999999 109.47 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 25.7 p -67.51 -29.33 68.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 1.03 110.706 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 83' ' ' THR . 18.5 ttpt -66.07 -16.59 64.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.211 0.529 . . . . 0.70999999999999996 110.419 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.89 -52.59 4.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 1.02 109.692 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 19.6 mt -61.44 -35.31 65.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.748 -0.66 . . . . 0.51000000000000001 112.365 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HB3' ' NE1' ' A' ' 41' ' ' TRP . 2.1 mm? -73.95 2.37 8.78 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.422 0.897 . . . . 0.34000000000000002 113.422 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 3.3 t -145.4 -32.92 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.611 -0.436 . . . . 1.27 112.135 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.03 10.21 38.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.001 -0.37 . . . . 2.1000000000000001 110.001 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.92 -173.79 13.31 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.784 -0.722 . . . . 0.5 112.093 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -95.6 101.73 13.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.842 0.353 . . . . 2.1899999999999999 110.398 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 p -100.35 133.35 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.992 -0.549 . . . . 0.56999999999999995 109.688 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -74.19 84.71 1.86 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.272 0.558 . . . . 1.55 110.326 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.03 162.97 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 1.3300000000000001 111.455 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.7 m -140.7 153.02 45.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.595 -0.73 . . . . 1.3500000000000001 109.459 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -74.69 95.02 2.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 1.22 110.518 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -159.01 131.63 6.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 2.3599999999999999 110.802 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 162.38 27.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.46999999999999997 110.272 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.82 160.3 25.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.771 -0.455 . . . . 2.4900000000000002 109.771 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -108.16 147.51 31.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.76 0.314 . . . . 1.05 110.605 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.33 137.26 52.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.048 -0.524 . . . . 0.51000000000000001 110.998 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.51 118.63 37.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.981 -0.377 . . . . 3.1899999999999999 109.981 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -141.23 150.24 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.387 -0.369 . . . . 0.59999999999999998 110.339 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 109' ' ' MET . 1.5 mp0 -81.91 -29.14 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.291 0.567 . . . . 1.97 110.097 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 16.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.714 -0.675 . . . . 1.49 111.192 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 107' ' ' GLU . 48.1 ttm -60.84 -34.37 74.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.546 -0.297 . . . . 1.8300000000000001 110.91 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -58.45 -49.57 76.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.63 110.506 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -71.72 -34.13 69.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.882 -0.599 . . . . 2.3500000000000001 110.298 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.581 ' CG ' ' HZ1' ' A' ' 150' ' ' LYS . 22.6 t70 -56.58 -49.58 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.903 -0.59 . . . . 0.29999999999999999 110.746 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.35 -39.88 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.29999999999999999 110.441 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.81 94.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.752 . . . . 0.26000000000000001 112.756 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.1 t -70.58 -15.48 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.212 0.449 . . . . 0.33000000000000002 112.212 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.85 -33.88 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 1.6299999999999999 110.766 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.2 p -86.81 -13.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.411 -0.358 . . . . 0.75 111.047 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.56 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.54000000000000004 111.984 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -13.74 62.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 1.72 111.3 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -15.82 57.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 2.1899999999999999 111.108 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.6 p -119.55 140.66 50.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.111 0.482 . . . . 0.38 111.091 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.63 161.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.248 -0.433 . . . . 0.25 109.957 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . 2.0 p30 -149.91 165.09 18.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.515 -0.55 . . . . 0.20000000000000001 109.515 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 123' ' ' ASN . 43.0 Cg_endo -67.81 -164.66 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.678 2.252 . . . . 0.14999999999999999 112.778 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.59 59.21 2.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.84999999999999998 111.488 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.41 HG22 ' OD1' ' A' ' 123' ' ' ASN . 1.4 t -129.41 -23.11 2.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.816 0.341 . . . . 0.93000000000000005 110.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 1.8 tppt? -154.57 159.04 40.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.73 -0.47 . . . . 1.3500000000000001 109.73 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 142.71 36.45 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.725 -0.472 . . . . 1.6499999999999999 109.725 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.92 -8.32 19.47 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.577 2.185 . . . . 0.27000000000000002 112.106 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.12 9.27 36.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.935 -0.575 . . . . 0.40000000000000002 110.663 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 m -82.95 89.07 6.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.411 0.624 . . . . 0.33000000000000002 110.303 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.22 -33.12 59.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.305 -0.862 . . . . 0.28000000000000003 111.401 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.06 -31.8 46.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.068 -0.514 . . . . 0.23000000000000001 111.774 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.86 -54.42 42.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.40999999999999998 110.872 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -29.38 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.57999999999999996 110.535 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -57.6 -44.31 85.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.436 -0.347 . . . . 0.41999999999999998 110.775 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -60.13 -39.22 85.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 2.6000000000000001 111.157 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.78 -39.95 56.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.332 -0.394 . . . . 0.98999999999999999 111.054 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -50.25 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.37 111.322 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.52 -17.63 64.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.531 -0.304 . . . . 1.9199999999999999 111.607 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.98 -33.42 61.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.437 -0.579 . . . . 0.82999999999999996 109.437 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.3 mt -82.05 -40.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.671 -0.695 . . . . 1.1899999999999999 109.848 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 63.72 32.67 13.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.544 -0.753 . . . . 1.3600000000000001 111.162 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -100.12 104.04 15.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.87 -0.604 . . . . 0.75 109.781 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 m -74.13 134.79 42.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.44 110.529 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.32 75.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.04 -0.527 . . . . 0.5 110.397 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.66 -168.82 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.189 -0.914 . . . . 1.6299999999999999 110.985 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.0 t -125.92 15.96 7.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.739 0.781 . . . . 0.54000000000000004 109.573 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -100.06 -0.26 39.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.161 -0.927 . . . . 1.22 111.078 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.581 ' HZ1' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 59.38 40.79 20.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.157 0.503 . . . . 1.3600000000000001 110.004 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 1.5 m -77.21 51.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.34999999999999998 112.279 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -28.53 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.98999999999999999 111.902 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 11.88 35.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.123 -0.49 . . . . 0.26000000000000001 111.068 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 2.0 tp-100 -113.5 -49.25 2.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 1.3600000000000001 110.524 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.45 ' O ' HG22 ' A' ' 159' ' ' VAL . 40.5 mt-30 -105.94 34.05 3.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 0.81000000000000005 111.204 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.42 -35.97 77.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.942 -0.572 . . . . 0.91000000000000003 110.845 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.91 -25.04 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.015 -0.539 . . . . 1.74 111.068 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -79.58 -42.42 25.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.828 -0.434 . . . . 0.57999999999999996 109.828 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HD11 ' A' ' 163' ' ' LEU . 21.8 t -64.53 -41.72 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.934 -0.575 . . . . 0.23999999999999999 111.002 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -26.08 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.457 . . . . 1.23 111.598 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -93.69 -21.67 19.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.12 0.486 . . . . 0.60999999999999999 110.134 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.46 -53.0 32.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.64 -0.709 . . . . 0.54000000000000004 111.533 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -79.59 -10.79 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.678 -0.409 . . . . 0.29999999999999999 110.942 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.439 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.7 ttpt -65.05 -26.57 68.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.373 0.606 . . . . 1.6100000000000001 110.035 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.09 -8.3 58.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 2.0699999999999998 110.612 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -110.56 -35.23 6.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.189 -0.46 . . . . 1.3100000000000001 110.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.49 130.7 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 1.28 110.237 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.13 82.29 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.361 0.601 . . . . 1.6399999999999999 110.783 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.9 pt -94.94 175.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.523 -0.762 . . . . 1.51 111.585 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -127.23 171.41 11.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.68999999999999995 110.058 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -162.87 75.88 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.153 0.501 . . . . 1.28 109.926 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.97 98.67 10.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.926 -0.579 . . . . 0.20000000000000001 110.639 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -162.02 134.16 5.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.34999999999999998 110.925 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -120.77 170.62 9.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.747 -0.66 . . . . 0.54000000000000004 109.713 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 mtm180 -92.74 135.73 33.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.035 -0.358 . . . . 0.56000000000000005 110.035 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.1 150.26 43.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.012 0.434 . . . . 1.03 111.081 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 -176.15 3.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.89000000000000001 109.371 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.1 p90 -150.16 127.91 11.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.777 -0.453 . . . . 0.53000000000000003 109.777 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.8 126.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.70999999999999996 111.26 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.406 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 2.6 pt? -167.34 147.24 4.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.38 -0.827 . . . . 1.75 109.472 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.44 162.3 34.41 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.858 2.372 . . . . 0.69999999999999996 112.914 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.6 -35.44 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.60999999999999999 111.44 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -47.86 -47.51 31.58 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.795 -0.638 . . . . 0.67000000000000004 111.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.24 -26.42 14.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.7 0.286 . . . . 0.78000000000000003 110.973 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.86 -33.19 77.33 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.22 113.041 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -64.04 -14.29 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.088 0.403 . . . . 2.6099999999999999 112.088 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -44.81 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.559 0.219 . . . . 0.82999999999999996 111.252 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.7 pp -86.12 -20.69 28.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.48999999999999999 110.483 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.91 -41.95 62.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.421 -0.809 . . . . 2.1499999999999999 111.969 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.487 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -103.94 15.49 28.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.235 0.457 . . . . 1.1599999999999999 112.235 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.559 ' HZ3' ' CD ' ' A' ' 229' ' ' GLU . 1.1 ttpm? -124.22 -30.49 3.44 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.452 -0.499 . . . . 3.0499999999999998 111.692 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.19 -42.83 9.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.593 0.235 . . . . 0.89000000000000001 111.468 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.529 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 13.5 mtpt -58.05 -47.35 99.03 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.051 0.76 . . . . 1.02 113.051 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.3 Cg_endo -60.72 -16.26 42.53 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.199 1.933 . . . . 0.19 113.401 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.76 -21.0 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.336 -0.246 . . . . 0.17999999999999999 110.336 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 78.86 -10.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.466 -0.788 . . . . 0.20999999999999999 111.526 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -86.74 54.36 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.248 0.547 . . . . 1.1699999999999999 110.771 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.85 138.41 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.258 -0.883 . . . . 0.28999999999999998 109.613 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.6 142.26 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.658 -0.497 . . . . 1.53 109.658 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -68.76 81.94 0.29 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.133 0.492 . . . . 1.99 110.465 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 247' ' ' GLY . 68.8 m -157.53 31.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.333 -0.849 . . . . 0.20000000000000001 109.745 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.96 154.41 28.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.35999999999999999 110.66 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -108.58 111.86 23.91 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.159 -0.682 . . . . 0.56999999999999995 109.159 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.39 80.43 3.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.217 0.532 . . . . 1.26 110.356 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -148.36 -130.56 1.96 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.685 -0.689 . . . . 0.51000000000000001 112.197 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -78.84 -26.76 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.478 . . . . 0.81000000000000005 110.601 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.67 145.19 49.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.91 -0.774 . . . . 1.8100000000000001 108.91 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 28.1 tp -105.03 85.9 2.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.936 0.398 . . . . 0.42999999999999999 110.972 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 5.0 tt0 -93.11 118.69 31.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.96999999999999997 109.748 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 19.8 mt -128.68 159.13 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.569 -0.287 . . . . 0.96999999999999997 111.026 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.9 t -116.6 121.13 66.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.656 -0.498 . . . . 1.02 109.656 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.435 ' SG ' ' HE2' ' A' ' 178' ' ' PHE . 4.6 p -118.51 -30.52 5.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.113 0.412 . . . . 0.57999999999999996 112.113 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.62 108.47 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.692 0.282 . . . . 0.58999999999999997 111.013 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.6 tt -110.28 -54.87 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.56 162.2 54.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.04 0.385 . . . . 0.33000000000000002 112.04 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.33 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.013 2.475 . . . . 0.37 111.334 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 65.35 -81.15 0.08 OUTLIER Glycine 0 C--N 1.339 0.703 0 O-C-N 123.463 0.477 . . . . 0.20000000000000001 111.963 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 2.1 p -75.6 17.97 0.26 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.179 0.592 . . . . 0.67000000000000004 111.117 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 217' ' ' GLY . 8.6 p90 -87.76 -16.94 32.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.45000000000000001 109.859 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -69.28 -48.11 62.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 1.8700000000000001 110.549 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.57 -31.02 71.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 1.3600000000000001 110.758 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 46.1 mm -82.8 -42.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.023 -0.535 . . . . 2.25 110.491 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.79 -37.07 68.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.55000000000000004 111.05 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -56.1 -35.21 66.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 1.28 111.758 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.7 pp -94.41 -33.05 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.475 -0.49 . . . . 2.0800000000000001 110.834 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.4 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-N 116.395 -0.366 . . . . 0.52000000000000002 111.418 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -63.53 -22.11 66.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.127 0.417 . . . . 1.55 112.127 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.45 8.65 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 0.46000000000000002 111.167 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.559 ' CD ' ' HZ3' ' A' ' 191' ' ' LYS . 70.1 tt0 -108.96 -83.52 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.126 -0.488 . . . . 1.6699999999999999 110.697 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.1 t -84.38 -30.01 25.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.305 -0.407 . . . . 0.29999999999999999 111.184 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -64.64 -30.89 71.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.992 0.425 . . . . 1.6000000000000001 111.05 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.19 12.56 66.69 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.528 -0.844 . . . . 0.37 112.235 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -123.79 -46.85 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.919 0.39 . . . . 1.46 110.593 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -125.55 -162.25 11.25 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.773 -0.727 . . . . 0.38 112.562 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.94 132.23 56.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.21 -0.292 . . . . 1.5 110.21 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.04 157.29 26.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.057 0.456 . . . . 1.9199999999999999 111.097 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.71 153.39 38.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.597 -0.729 . . . . 0.84999999999999998 109.485 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.77 156.96 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.237 -0.282 . . . . 0.35999999999999999 110.237 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.0 77.29 10.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.014 0.435 . . . . 1.1399999999999999 110.695 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.62 -2.51 58.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.814 -0.63 . . . . 1.3200000000000001 110.184 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.75 78.64 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 1.72 110.194 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -116.84 17.19 15.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.731 -0.668 . . . . 1.79 110.379 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -107.99 -58.27 2.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 2.1099999999999999 110.856 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.5 149.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.989 -0.551 . . . . 0.94999999999999996 110.089 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.58 144.0 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.784 0.326 . . . . 1.53 110.303 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -147.16 156.56 43.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 1.1000000000000001 110.221 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 201' ' ' SER . . . 106.36 110.08 3.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.757 -0.735 . . . . 0.51000000000000001 111.637 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -122.74 125.3 45.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.47999999999999998 111.217 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.76 7.12 9.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.888 -0.596 . . . . 0.94999999999999996 109.725 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.12 107.52 17.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 1.6100000000000001 110.497 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -72.06 -32.53 67.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.109 0.48 . . . . 1.3 110.035 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.436 -0.802 . . . . 1.3999999999999999 109.758 -179.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.642 -0.583 . . . . 0.35999999999999999 111.642 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -72.38 -53.3 12.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.74 0.305 . . . . 1.3500000000000001 110.205 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 mtt 60.72 30.36 19.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.607 -0.724 . . . . 1.72 111.347 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.48 -6.25 52.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.837 -0.619 . . . . 0.66000000000000003 110.968 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mt 57.7 62.59 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.497 0.665 . . . . 0.46999999999999997 110.036 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -99.08 27.14 5.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.732 -0.667 . . . . 0.33000000000000002 110.881 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -104.72 96.18 10.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.78000000000000003 110.431 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' O ' HG22 ' A' ' 9' ' ' THR . 73.8 Cg_endo -75.78 -12.47 20.02 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.513 2.142 . . . . 1.4299999999999999 112.411 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.0 t 49.66 24.44 1.19 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.341 1.056 . . . . 1.29 112.567 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -69.79 157.67 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.884 -0.598 . . . . 1.8400000000000001 110.042 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 2.3199999999999998 111.594 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.99 81.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 1.29 111.251 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -153.7 143.67 22.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 1.8700000000000001 109.981 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 17' ' ' VAL . 82.0 mt -67.25 -13.15 61.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.1400000000000001 111.147 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -87.35 4.11 44.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.48999999999999999 110.849 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -139.29 35.91 2.08 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.463 0.649 . . . . 0.39000000000000001 110.321 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 14' ' ' LEU . 20.3 m -106.41 156.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.20999999999999999 111.633 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.85 137.67 46.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.5 109.958 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 t -78.98 108.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.932 0.396 . . . . 0.55000000000000004 110.722 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.11 129.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.922 -0.581 . . . . 0.93000000000000005 109.925 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.0 144.11 30.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.953 0.406 . . . . 1.3400000000000001 111.34 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.93 127.29 43.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.671 -0.695 . . . . 0.94999999999999996 109.819 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.97 118.51 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.014 0.435 . . . . 1.0600000000000001 110.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 9.8 mmm180 -92.72 -155.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.906 -0.588 . . . . 2.3599999999999999 109.99 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.96 -54.08 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.60999999999999999 110.986 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.53 -34.4 1.09 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.431 -0.89 . . . . 0.20999999999999999 112.48 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 29.1 tptt -97.77 158.94 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.933 0.397 . . . . 1.72 110.496 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 152.76 38.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.168 -0.678 . . . . 0.91000000000000003 109.168 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.02 140.35 38.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.034 0.445 . . . . 0.34000000000000002 111.213 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -130.4 130.19 44.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 1.1000000000000001 109.717 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -174.49 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.136 0.493 . . . . 1.0800000000000001 111.361 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.54 103.04 4.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.27000000000000002 109.791 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -102.88 -173.22 2.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.96999999999999997 110.11 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.7 150.06 37.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.73 -0.47 . . . . 0.39000000000000001 109.73 178.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -108.61 28.5 8.33 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.428 -0.509 . . . . 1.8700000000000001 110.966 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -103.11 81.78 2.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.54000000000000004 109.919 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HZ1' ' CD ' ' A' ' 101' ' ' GLU . 16.5 ttmt 57.86 49.4 12.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.984 -0.553 . . . . 1.45 110.948 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.23 -23.73 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.762 -0.654 . . . . 0.28000000000000003 111.802 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.98 -4.43 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.207 0.527 . . . . 0.27000000000000002 110.626 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.54 98.19 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.10000000000000001 112.642 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.64 -34.28 77.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.119 0.485 . . . . 1.4099999999999999 110.847 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -80.47 -19.25 46.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.143 -0.48 . . . . 1.5 111.001 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 m -91.73 -45.45 8.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.17999999999999999 110.468 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.04 -99.86 0.14 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.391 -0.684 . . . . 0.16 111.391 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.07 135.29 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.152 -0.684 . . . . 0.28999999999999998 109.152 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -113.86 -63.13 1.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.972 -0.291 . . . . 0.65000000000000002 111.105 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -151.8 -76.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.649 -0.25 . . . . 0.84999999999999998 110.561 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.25 148.6 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.644 0.259 . . . . 0.71999999999999997 110.528 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.24 -31.01 72.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.482 . . . . 0.83999999999999997 111.654 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.95 -32.49 72.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.53000000000000003 110.628 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.99 -19.76 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.083 0.468 . . . . 1.8 110.407 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.497 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 66.9 t -74.34 -43.74 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.731 -0.668 . . . . 1.03 109.57 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.05 99.25 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.435 -0.802 . . . . 1.8700000000000001 111.138 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 34' ' ' TYR . 14.6 mt-30 -84.13 -65.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.5 109.975 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 t -97.16 130.64 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.192 -0.458 . . . . 1.1200000000000001 110.183 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.37 -5.66 59.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.132 -0.485 . . . . 1.47 110.668 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -96.39 116.13 28.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.523 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.44 146.4 9.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.925 -0.58 . . . . 0.17000000000000001 109.624 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -102.0 154.38 19.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.32000000000000001 111.126 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.78 -31.4 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.20000000000000001 109.485 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.2 91.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.069 -0.969 . . . . 0.70999999999999996 109.218 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.05 -28.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.465 -0.334 . . . . 0.28000000000000003 111.826 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -34.43 77.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.876 0.37 . . . . 0.63 111.158 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -106.52 10.9 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 3.0800000000000001 111.031 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.36 28.62 71.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.876 -0.678 . . . . 0.47999999999999998 112.468 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.33 110.83 14.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.571 0.224 . . . . 2.2799999999999998 110.44 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.81 133.81 52.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.999 -0.546 . . . . 1.02 110.444 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 116.33 32.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.023 0.439 . . . . 0.84999999999999998 109.951 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -87.53 -179.52 6.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.87 -0.605 . . . . 2.2400000000000002 110.105 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -57.57 -32.95 67.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 1.47 111.271 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -87.57 7.88 27.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.182 -0.463 . . . . 0.67000000000000004 111.29 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.81 -48.77 3.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.81999999999999995 110.081 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.93 -31.92 73.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.999 -0.546 . . . . 0.48999999999999999 110.212 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -28.14 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.28999999999999998 110.348 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -92.46 -8.43 44.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.235 0.541 . . . . 1.4099999999999999 110.965 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.65 -58.83 2.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.27000000000000002 110.97 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -89.69 -34.88 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.396 -0.365 . . . . 0.98999999999999999 110.833 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.09 30.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.524 -0.846 . . . . 0.35999999999999999 112.283 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -134.23 136.4 43.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.005 -0.369 . . . . 0.85999999999999999 110.005 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.74 -12.93 57.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.64000000000000001 110.748 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.16 102.66 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.54000000000000004 110.396 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.48 -23.65 66.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.89 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.4 88.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.864 -0.607 . . . . 0.53000000000000003 110.734 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.45 -34.93 79.45 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.854 0.359 . . . . 0.33000000000000002 110.234 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.3 -51.68 69.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.392 -0.596 . . . . 0.28999999999999998 109.392 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 54.0 t -64.63 -32.55 74.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.457 -0.792 . . . . 0.17000000000000001 110.374 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -57.63 -51.98 67.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.931 -0.577 . . . . 1.6299999999999999 110.838 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -63.59 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.549 . . . . 0.34999999999999998 111.177 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.8 mt -66.98 -24.69 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.107 0.48 . . . . 1.02 111.48 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -80.21 -33.26 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.735 0.303 . . . . 0.29999999999999999 111.582 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.425 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.2 t -97.83 -22.65 16.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.789 0.663 . . . . 1.1000000000000001 112.789 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HG2' HG23 ' A' ' 91' ' ' THR . 14.3 mmmm -115.22 -2.97 12.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.579 -0.448 . . . . 0.73999999999999999 111.761 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.42 -176.69 21.32 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.517 -0.849 . . . . 0.52000000000000002 112.291 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -108.15 107.84 18.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 1.3200000000000001 110.409 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.61 142.14 24.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.431 -0.804 . . . . 0.23000000000000001 110.186 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 99.82 0.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.239 0.542 . . . . 0.88 110.596 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.61 -179.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.747 -0.66 . . . . 0.51000000000000001 111.691 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 m -122.02 146.97 46.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.49 -0.777 . . . . 0.68999999999999995 109.554 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -130.01 -169.55 2.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.645 -0.252 . . . . 0.81999999999999995 110.794 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 77.98 2.68 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.162 0.913 . . . . 2.1000000000000001 111.648 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.482 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 37.7 tt0 -101.14 98.44 8.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.095 0.474 . . . . 1.5900000000000001 110.566 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 118.77 2.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.551 -0.75 . . . . 1.24 110.021 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -134.94 36.83 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.221 0.534 . . . . 0.97999999999999998 110.167 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.07 13.35 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.682 -0.69 . . . . 0.42999999999999999 110.348 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -82.99 81.56 8.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.762 -0.654 . . . . 0.27000000000000002 111.03 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -114.81 159.39 20.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.733 . . . . 1.53 109.465 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.56 147.36 49.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.498 -0.319 . . . . 1.55 111.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 63.42 16.55 9.63 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.634 -0.712 . . . . 0.98999999999999999 111.765 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.5 tpp -63.34 -34.06 76.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.948 0.404 . . . . 1.6699999999999999 110.819 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -59.21 -45.85 90.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.046 -0.524 . . . . 1.02 110.167 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -70.47 -34.99 73.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 1.8799999999999999 110.881 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.64 -38.6 88.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.127 -0.488 . . . . 0.59999999999999998 111.241 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.3 tt -87.88 -31.03 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.971 0.415 . . . . 1.1799999999999999 110.482 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.4 72.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.389 -0.369 . . . . 0.16 111.148 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 t -63.83 -20.22 65.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.26000000000000001 110.74 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.19 -43.67 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.933 0.397 . . . . 1.25 110.384 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.15 -19.87 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.40999999999999998 111.572 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.7 69.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.922 0.342 . . . . 0.45000000000000001 111.922 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -107.86 19.69 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 1.23 110.246 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -123.6 -40.31 2.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.93000000000000005 110.35 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 19.9 m -114.4 106.9 14.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.031 -0.532 . . . . 0.60999999999999999 110.16 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 m -126.35 163.79 27.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.27000000000000002 111.024 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 168' ' ' LYS . 23.5 p-10 -130.97 141.98 43.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.588 . . . . 0.38 110.19 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.57 44.58 1.76 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.742 2.295 . . . . 0.59999999999999998 112.854 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -116.94 -165.91 1.11 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.278 -0.419 . . . . 1.1699999999999999 110.165 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 t -66.16 -19.88 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.361 . . . . 0.73999999999999999 111.769 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -84.0 71.59 10.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.608 0.242 . . . . 1.73 110.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -58.03 144.76 74.87 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 2.0600000000000001 111.177 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.14 117.23 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.491 2.127 . . . . 0.63 112.69 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.45 ' HH ' ' HG2' ' A' ' 221' ' ' GLU . 0.1 OUTLIER -170.15 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 1.8999999999999999 110.026 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.31 124.3 28.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.38 110.791 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 135' ' ' ILE . 49.6 t -62.18 -35.24 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.35999999999999999 110.869 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.6 mm -56.5 -29.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 111.662 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.33 -32.3 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.54000000000000004 111.444 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 132' ' ' VAL . 10.0 tp -93.56 -30.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.729 -0.388 . . . . 1.71 110.23 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 26.0 tt0 -64.97 -35.75 82.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.183 0.516 . . . . 1.1299999999999999 109.877 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -59.21 -31.49 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.388 -0.824 . . . . 1.02 110.875 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -83.79 -32.37 25.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.28000000000000003 110.72 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -45.88 70.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.56999999999999995 111.727 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 45.2 pttt -80.15 -9.84 59.73 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.806 -0.358 . . . . 0.25 110.903 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 137' ' ' ARG . 35.0 t70 -75.79 -46.41 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.48999999999999999 109.655 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 143' ' ' HIS . 18.1 tt -84.71 -19.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.594 -0.73 . . . . 0.47999999999999998 110.23 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 142' ' ' ILE . 60.5 m-70 72.68 90.7 0.09 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.379 -0.828 . . . . 0.41999999999999998 111.488 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -75.72 95.79 3.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.863 -1.062 . . . . 1.04 110.239 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -155.36 74.69 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.902 -0.59 . . . . 0.71999999999999997 109.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.8 67.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.69999999999999996 110.776 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 149' ' ' ASN . 16.3 mtpt 55.0 79.27 0.15 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.698 -0.683 . . . . 0.46000000000000002 111.244 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.64 17.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 1.3799999999999999 111.999 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 147' ' ' LYS . 4.5 t-20 -68.8 -62.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.211 -0.449 . . . . 0.64000000000000001 109.824 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.52 138.55 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.746 -0.661 . . . . 0.91000000000000003 109.847 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -163.42 -158.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.668 -0.493 . . . . 1.6000000000000001 109.668 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.91 95.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.535 0.334 . . . . 0.44 111.853 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 53.72 42.99 31.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.752 -0.658 . . . . 0.83999999999999997 110.553 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 60.72 66.95 0.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.163 -0.926 . . . . 0.90000000000000002 111.46 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.602 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 0.4 OUTLIER 55.9 31.03 17.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.151 -0.931 . . . . 0.87 113.13 178.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.02 63.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.179 0.514 . . . . 0.34999999999999998 110.613 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -29.66 42.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.363 0.601 . . . . 1.28 110.237 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.602 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.4 mp0 -68.54 -41.75 79.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.97999999999999998 111.379 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.26 -30.29 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 1.48 111.48 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.69 -39.66 86.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.021 0.439 . . . . 0.44 110.704 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.16 -5.5 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 1.49 111.033 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.58 -70.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 1.8200000000000001 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.494 HD11 ' H ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -70.88 -11.08 60.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.28 -0.418 . . . . 2.4199999999999999 111.397 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -61.55 -34.64 75.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.164 0.507 . . . . 1.6000000000000001 110.255 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -87.79 23.7 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.759 -0.655 . . . . 0.59999999999999998 110.815 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -138.73 -52.98 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.937 -0.574 . . . . 1.0700000000000001 110.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.1 ttm -139.7 151.16 45.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.019 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 123' ' ' ASN . 11.5 ptpt -71.59 131.91 43.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 1.3999999999999999 110.467 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 121' ' ' CYS . 0.2 OUTLIER -140.6 -162.05 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.76000000000000001 110.344 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 169' ' ' ILE . 0.6 OUTLIER 70.8 110.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.927 0.767 . . . . 2.4700000000000002 112.019 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.85 102.46 3.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 2.5699999999999998 109.773 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.53 133.92 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.25 111.081 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.46 89.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.28999999999999998 110.221 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 173.92 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.904 0.383 . . . . 1.3500000000000001 111.136 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -83.49 143.64 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 2.1000000000000001 110.533 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.8 mp -126.55 161.94 26.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.208 -0.451 . . . . 1.0800000000000001 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.519 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 15.8 ptt180 -127.09 154.93 44.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.2 -0.454 . . . . 0.34999999999999998 110.156 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 63.2 t80 -120.98 131.26 54.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.439 -0.346 . . . . 0.34999999999999998 110.217 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.91 133.36 66.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.463 0.173 . . . . 0.73999999999999999 111.358 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 178' ' ' PHE . 1.0 OUTLIER -171.37 161.1 5.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.688 -0.233 . . . . 0.33000000000000002 110.518 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.22 155.77 66.7 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.23 . . . . 0.17000000000000001 112.476 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.05 -33.94 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.995 -0.548 . . . . 0.80000000000000004 111.749 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -48.79 -48.81 40.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.221 -0.445 . . . . 2.4900000000000002 111.725 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -95.77 -28.15 14.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.857 0.36 . . . . 0.53000000000000003 110.946 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.11 -32.06 81.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.012 -0.613 . . . . 0.27000000000000002 112.779 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.5 71.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.73 0.3 . . . . 1.55 111.405 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.11 -46.47 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.94999999999999996 111.189 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -17.53 39.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.68000000000000005 111.175 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -57.24 -44.59 83.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.5600000000000001 110.588 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.72 17.12 5.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.46000000000000002 111.485 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -129.08 -39.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 1.1100000000000001 111.662 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.62 -42.57 24.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 1.2 111.758 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 30.0 mtpp -62.63 -48.0 87.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.743 0.646 . . . . 1.46 112.743 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.2 Cg_endo -59.47 -8.61 7.26 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.583 2.189 . . . . 0.059999999999999998 113.837 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.37 -14.83 60.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.34999999999999998 110.121 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.6 mm 59.56 32.88 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.835 0.826 . . . . 0.20000000000000001 110.273 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -125.89 23.01 7.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.656 -0.702 . . . . 0.91000000000000003 110.322 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.5 m -103.26 134.63 43.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.17999999999999999 110.439 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -84.68 147.93 5.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.279 -0.419 . . . . 1.6399999999999999 109.979 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 63.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 1.5900000000000001 111.42 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 m -140.22 21.53 2.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.277 -0.638 . . . . 1.51 109.277 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.53 140.77 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.648 -0.706 . . . . 1.78 111.263 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.42 105.2 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.42 -0.585 . . . . 0.65000000000000002 109.42 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' A' ' 248' ' ' ASP . 0.2 OUTLIER -86.61 102.04 13.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.022 -0.536 . . . . 1.73 110.723 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -169.11 -150.06 6.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.983 -0.627 . . . . 0.63 111.826 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.09 -31.31 72.45 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.028 0.442 . . . . 1.8899999999999999 110.604 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.411 ' NE2' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -117.45 109.42 16.75 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.759 . . . . 1.29 108.952 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.3 99.78 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.074 -0.512 . . . . 1.1100000000000001 110.599 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.2 tt0 -100.98 109.41 21.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.34999999999999998 109.614 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 210' ' ' ILE . 66.3 mt -117.26 134.83 59.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.306 -0.407 . . . . 1.21 110.576 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.61 105.9 18.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.23999999999999999 109.925 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 8.4 t -130.78 96.58 4.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.35999999999999999 110.368 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 132.87 11.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.306 -0.628 . . . . 1.1699999999999999 109.306 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -122.88 171.16 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.517 -0.31 . . . . 0.39000000000000001 110.28 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.59 171.0 3.15 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.005 0.522 . . . . 0.56000000000000005 111.091 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.33 -163.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.394 2.062 . . . . 0.81000000000000005 113.105 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 82.81 -95.68 1.83 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.507 -0.854 . . . . 0.40999999999999998 111.092 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.8 m -80.77 17.94 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.537 . . . . 0.67000000000000004 110.445 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 217' ' ' GLY . 15.7 p90 -68.84 -23.1 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.592 . . . . 0.28999999999999998 111.599 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.1 -45.48 63.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.026 0.441 . . . . 1.6200000000000001 110.201 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG2' ' HH ' ' A' ' 130' ' ' TYR . 15.9 mp0 -62.49 -20.7 64.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.418 -0.81 . . . . 1.96 112.356 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.4 tt -98.57 -43.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.454 -0.499 . . . . 1.24 111.11 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.07 -32.76 74.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.74 0.274 . . . . 0.37 111.74 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.46 -25.06 61.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.428 -0.351 . . . . 0.97999999999999998 111.553 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.3 pp -101.27 -28.79 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.005 0.431 . . . . 0.51000000000000001 110.109 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.4 mm -64.51 -33.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.23999999999999999 111.0 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 11.4 ptmt -60.48 -26.25 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.84 0.682 . . . . 1.9399999999999999 112.84 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -111.45 -20.57 12.17 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.48 -0.488 . . . . 0.94999999999999996 112.094 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.25 -46.67 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.39000000000000001 111.55 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -113.42 -56.14 2.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.173 0.434 . . . . 0.77000000000000002 112.173 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 49.4 mtmt -64.69 -7.7 11.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.89000000000000001 111.825 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.33 16.66 32.01 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.975 -0.631 . . . . 0.28000000000000003 111.648 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -128.51 -56.12 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.643 0.258 . . . . 1.4399999999999999 111.527 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -123.02 -139.21 5.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.326 -0.94 . . . . 0.57999999999999996 113.369 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 73.3 m -121.51 141.62 50.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.54000000000000004 111.431 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 150.21 29.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.398 -0.819 . . . . 0.29999999999999999 109.997 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.95 161.57 39.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 0.26000000000000001 109.916 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.17 153.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.317 . . . . 1.1299999999999999 110.647 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.8 tp -102.5 112.32 25.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.44 109.861 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -88.23 2.3 52.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.347 0.594 . . . . 1.6100000000000001 110.687 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.8 69.62 4.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.961 -0.563 . . . . 1.0800000000000001 110.388 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -94.34 -1.74 53.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 0.88 110.35 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -84.24 -68.71 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.578 -0.737 . . . . 2.3700000000000001 110.2 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.82 151.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.802 -0.636 . . . . 0.70999999999999996 109.755 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -96.87 98.27 9.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.984 0.421 . . . . 1.0600000000000001 110.409 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -115.81 157.49 24.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.6899999999999999 110.269 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -170.39 -179.2 41.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.644 -0.789 . . . . 0.23000000000000001 112.233 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 204' ' ' TYR . 8.1 t70 -94.21 88.5 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 0.51000000000000001 110.078 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 7.52 41.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 1.78 110.959 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 80.39 7.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.326 0.584 . . . . 2.0699999999999998 110.663 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -25.52 66.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 1.26 110.408 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.31 -0.852 . . . . 1.6799999999999999 109.897 179.575 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.775 -0.53 . . . . 0.75 111.775 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.3 m80 59.46 54.42 4.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.047 0.451 . . . . 1.3100000000000001 111.594 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -122.87 168.58 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 2.0299999999999998 110.192 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -68.45 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.47999999999999998 110.792 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.64 146.45 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 1.6899999999999999 109.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -164.69 153.53 12.79 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 123.35 0.406 . . . . 0.77000000000000002 110.168 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -109.71 89.9 8.28 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.48999999999999999 109.839 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.63 156.44 10.48 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.759 2.306 . . . . 0.96999999999999997 113.105 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.428 HG22 ' OH ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -127.73 139.07 52.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.93999999999999995 109.783 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -161.49 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.233 -0.187 . . . . 1.3400000000000001 111.115 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -124.55 -59.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.993 0.425 . . . . 1.9099999999999999 110.351 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.407 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 5.0 mt -128.51 102.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.95999999999999996 109.73 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -134.16 127.21 31.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.154 -0.475 . . . . 1.8 110.802 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.98 -10.02 59.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.361 0.601 . . . . 0.65000000000000002 110.437 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.3 -15.47 50.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.89000000000000001 111.275 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -125.72 40.36 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.17000000000000001 111.679 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.12 147.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.97 0.414 . . . . 0.23000000000000001 110.636 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.82 144.46 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.14999999999999999 110.536 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.32 126.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 0.27000000000000002 110.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.63 115.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.666 -0.697 . . . . 0.41999999999999998 109.58 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -119.27 132.83 55.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.311 -0.404 . . . . 1.29 111.432 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.7 ttp -87.58 132.31 34.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.938 -0.574 . . . . 1.1699999999999999 110.201 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 118.57 37.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.315 -0.402 . . . . 1.0700000000000001 110.618 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 32.9 mmt180 -120.57 -177.5 3.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.39000000000000001 110.323 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.14 81.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.366 0.506 . . . . 0.32000000000000001 112.366 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.3 29.72 2.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.391 -0.909 . . . . 0.38 112.339 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 31.3 tptt -150.35 148.82 29.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.59 -0.522 . . . . 1.6899999999999999 109.59 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.41 30.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.527 -0.546 . . . . 1.1399999999999999 109.527 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -134.29 144.55 48.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.38 110.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -142.94 137.3 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.32 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.85 167.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.682 -0.488 . . . . 0.38 109.682 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 110.61 20.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.81000000000000005 111.824 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -108.74 164.6 12.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.914 -0.585 . . . . 0.19 109.943 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.428 ' OH ' HG22 ' A' ' 9' ' ' THR . 0.1 OUTLIER -66.94 138.05 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.639 -0.255 . . . . 0.25 110.361 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -0.68 23.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 1.26 111.442 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.41 71.38 1.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.63 111.162 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.66 66.07 1.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.356 0.662 . . . . 2.4199999999999999 111.368 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -69.49 -30.25 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.96999999999999997 110.876 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -87.31 5.62 3.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.514 0.673 . . . . 0.39000000000000001 110.327 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.562 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -60.15 -33.6 80.52 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.458 -0.792 . . . . 0.28999999999999998 112.523 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -63.81 -34.81 78.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.266 0.555 . . . . 1.3100000000000001 110.211 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -81.09 -25.38 37.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 1.1000000000000001 110.064 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 m -75.84 -42.5 49.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.666 . . . . 1.21 110.649 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.82 -108.79 0.21 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.869 -0.681 . . . . 0.32000000000000001 112.103 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 t -115.5 122.17 68.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.839 0.352 . . . . 0.52000000000000002 110.297 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' HG3' ' HA3' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -150.31 -170.63 3.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.264 -0.426 . . . . 0.63 111.291 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -71.3 172.12 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 1.1599999999999999 112.647 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' OD2' HD21 ' A' ' 49' ' ' LEU . 17.2 t70 -75.72 160.78 29.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.069 -0.969 . . . . 0.25 110.513 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.535 ' H ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.71 -19.83 60.09 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.78 0.289 . . . . 0.37 111.78 -179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.69 -38.4 64.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.172 0.511 . . . . 0.27000000000000002 109.974 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.57 -32.78 62.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.47 -0.786 . . . . 1.21 111.049 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.96 -17.13 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.312 . . . . 1.05 111.413 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.79 111.15 13.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 1.47 110.168 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 12' ' ' ILE . 11.5 mm-40 -85.29 -78.65 0.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.938 -0.574 . . . . 0.91000000000000003 110.449 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -75.4 117.97 17.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.948 -0.569 . . . . 1.72 110.783 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -86.86 31.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.813 -0.63 . . . . 0.82999999999999996 111.167 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 m -125.67 140.83 52.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.67 -0.493 . . . . 0.79000000000000004 109.67 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.11 142.36 31.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 1.05 110.29 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.3 161.21 16.49 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.013 0.375 . . . . 0.35999999999999999 112.013 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.483 ' CG2' ' HB1' ' A' ' 68' ' ' ALA . 61.1 t -123.96 -55.07 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.792 -0.64 . . . . 0.39000000000000001 109.329 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.08 101.89 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 1.8400000000000001 109.662 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.33 -37.19 79.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.67000000000000004 111.827 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.16 6.45 6.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.37 0.507 . . . . 0.55000000000000004 112.37 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -135.15 -5.37 2.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.849 0.357 . . . . 1.4399999999999999 110.848 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.97 61.63 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.893 -0.67 . . . . 0.35999999999999999 111.819 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.39 113.1 24.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.03 0.443 . . . . 0.66000000000000003 110.929 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.46 128.87 76.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.649 -0.705 . . . . 0.55000000000000004 109.245 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.483 ' HB1' ' CG2' ' A' ' 60' ' ' VAL . . . -84.67 117.63 23.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 111.267 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.87 -174.52 4.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.16 -0.473 . . . . 1.4299999999999999 110.017 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -55.76 -33.04 63.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.46 0.541 . . . . 2.75 112.46 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -82.13 -7.59 59.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.814 0.34 . . . . 1.8100000000000001 111.792 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.38 -49.51 3.55 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.805 -0.358 . . . . 1.78 111.217 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.44 -29.28 68.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.929 0.395 . . . . 0.27000000000000002 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.99 -25.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.898 -0.592 . . . . 1.3999999999999999 110.463 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -97.33 -26.59 14.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.31 111.001 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.77 -39.46 30.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.122 -0.49 . . . . 0.52000000000000002 112.093 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.54 -16.49 13.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.004 -0.278 . . . . 1.4099999999999999 111.45 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.37 79.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.48999999999999999 112.29 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.42 136.97 47.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.568 0.223 . . . . 1.45 110.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -90.55 -23.47 20.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.401 0.619 . . . . 0.58999999999999997 109.899 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.83 103.44 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.81999999999999995 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.87 -31.28 71.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.162 0.506 . . . . 0.40000000000000002 109.951 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -61.02 -29.06 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.59999999999999998 110.282 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.81 -39.33 24.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.805 -0.442 . . . . 0.34000000000000002 109.805 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.12 -50.19 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.23999999999999999 109.441 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.7 t -61.53 -38.72 88.44 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.20999999999999999 110.61 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.73 -41.96 96.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 3.3500000000000001 110.292 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -65.49 -40.67 93.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.78000000000000003 110.786 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.485 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 70.9 mt -71.19 -21.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.47999999999999998 110.907 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -45.88 10.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.451 -0.341 . . . . 0.98999999999999999 111.575 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -83.0 -21.35 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.362 0.505 . . . . 1.8899999999999999 112.362 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.65 31.89 4.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 2.2799999999999998 110.723 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 89' ' ' ILE . . . -128.34 179.76 16.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.498 -0.858 . . . . 0.14999999999999999 112.442 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.85 93.31 5.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.703 0.287 . . . . 0.81000000000000005 110.644 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 p -98.3 134.76 35.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.83999999999999997 109.909 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.62 75.62 2.01 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.206 0.527 . . . . 0.98999999999999999 112.261 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.24 -175.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.68999999999999995 110.437 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.0 t -131.44 103.75 6.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.20000000000000001 111.162 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -121.54 95.76 4.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.214 0.53 . . . . 1.01 110.384 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -163.68 125.59 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.511 -0.768 . . . . 2.46 109.505 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.26 136.87 53.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.555 0.576 . . . . 0.46999999999999997 112.555 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 2.5 mmp_? -136.19 86.7 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.53000000000000003 109.969 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -80.13 115.23 19.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 2.3399999999999999 110.388 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 -177.12 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.114 -0.494 . . . . 0.87 110.039 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.1 125.94 43.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.135 -0.32 . . . . 0.77000000000000002 110.135 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -128.95 171.42 12.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.351 -0.386 . . . . 0.45000000000000001 110.57 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.94 -80.49 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.692 0.282 . . . . 1.1200000000000001 110.597 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -80.85 156.04 26.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.333 -0.394 . . . . 1.76 110.803 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 95.7 mmm -55.84 -43.33 76.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.583 0.586 . . . . 1.0800000000000001 112.583 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -74.98 -14.33 60.61 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.462 -0.495 . . . . 1.0800000000000001 111.437 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -98.09 0.23 45.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.966 0.413 . . . . 2.4900000000000002 110.074 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -61.97 -39.63 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.583 -0.735 . . . . 1.5900000000000001 110.975 -179.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 tt -112.08 -18.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.916 0.389 . . . . 2.4100000000000001 110.468 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.7 89.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.23999999999999999 111.175 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -70.21 -24.7 63.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 110.615 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 120' ' ' LYS . 1.3 mp -73.03 -41.95 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.413 . . . . 0.45000000000000001 110.464 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 -30.38 8.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.366 -0.379 . . . . 0.32000000000000001 111.689 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.48 -44.72 69.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.284 0.564 . . . . 0.35999999999999999 110.273 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.02 54.32 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.377 -0.971 . . . . 0.91000000000000003 108.377 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -154.06 -43.9 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.695 . . . . 0.58999999999999997 111.045 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 49.0 m -123.34 128.65 50.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.975 0.417 . . . . 0.42999999999999999 111.778 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.86 171.83 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.516 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.52 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 6.1 t-20 -147.49 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 119.46 -0.305 . . . . 0.64000000000000001 111.425 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 4.1 Cg_endo -87.46 136.15 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.961 1.774 . . . . 0.35999999999999999 111.918 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.77 20.15 3.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.295 0.569 . . . . 0.81999999999999995 110.634 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.57 -61.19 1.64 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.628 -0.714 . . . . 1.1499999999999999 111.025 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' H ' HG22 ' A' ' 126' ' ' THR . 6.5 ttmt -160.64 123.52 3.31 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.136 0.493 . . . . 2.3399999999999999 111.273 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.511 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . 1.7 tpp180 -171.34 -55.8 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.67 . . . . 2.1899999999999999 110.77 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 128' ' ' ARG . 86.9 Cg_endo -77.62 76.83 4.11 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.69 1.593 . . . . 0.41999999999999998 111.695 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -158.17 -57.41 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.557 . . . . 1.1399999999999999 110.351 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -91.82 108.14 19.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.875 -0.602 . . . . 0.44 111.234 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.18 -16.64 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.421 0.629 . . . . 0.41999999999999998 110.583 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 23.1 mm -71.97 -28.79 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.746 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.04 -47.51 86.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.64000000000000001 110.76 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.9 tt -72.09 -28.3 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.979 -0.378 . . . . 0.25 109.979 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -43.93 97.53 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.939 -0.573 . . . . 1.21 109.694 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 133' ' ' ILE . 19.5 mmm180 -63.01 -31.34 72.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.988 -0.551 . . . . 2.3700000000000001 110.917 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 142' ' ' ILE . . . -77.12 -48.03 18.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.27000000000000002 110.6 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.622 ' SD ' ' HG ' ' A' ' 163' ' ' LEU . 60.6 mmm -76.12 -3.38 35.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 3.1299999999999999 111.225 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -81.04 -41.38 22.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.34 -0.615 . . . . 2.98 109.34 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.85 -50.79 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.56000000000000005 110.355 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.503 HG21 ' O ' ' A' ' 138' ' ' ALA . 18.6 tt -86.06 52.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 122.632 1.206 . . . . 0.48999999999999999 109.093 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -110.84 -5.63 14.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.595 -1.184 . . . . 0.31 110.53 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.73 115.34 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.507 0.558 . . . . 1.3300000000000001 112.507 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 63.9 m 56.11 39.96 30.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.475 -0.784 . . . . 1.1699999999999999 112.796 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.36 -66.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 110.34 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -96.6 -55.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.098 0.475 . . . . 2.3100000000000001 109.799 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.5 25.44 14.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.523 -0.762 . . . . 0.88 111.063 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 57.12 38.08 28.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.721 -0.672 . . . . 0.66000000000000003 110.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -89.68 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 1.6899999999999999 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -149.28 161.44 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.448 . . . . 0.93999999999999995 111.264 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -106.02 -34.04 7.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 1.6499999999999999 110.862 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -88.96 -50.47 6.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 1.0800000000000001 111.418 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -69.14 -14.97 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 1.0 111.559 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.1 mt-30 -112.43 7.48 19.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.629 -0.259 . . . . 0.44 110.912 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.63 72.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.347 . . . . 0.33000000000000002 111.133 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.65 -35.67 80.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.51 . . . . 1.79 111.227 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.95 -46.93 85.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 0.60999999999999999 111.116 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 155' ' ' GLN . 59.3 t -67.04 -48.57 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.34999999999999998 112.112 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -61.23 -35.16 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 1.1399999999999999 111.729 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.39 -32.55 54.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.737 0.303 . . . . 2.9199999999999999 110.592 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.87 -37.96 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.84999999999999998 110.098 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.622 ' HG ' ' SD ' ' A' ' 139' ' ' MET . 0.6 OUTLIER -64.07 -36.92 85.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 1.98 110.036 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 167' ' ' MET . 31.0 tttm -69.31 -12.53 61.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.444 -0.798 . . . . 1.74 111.396 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.3 -32.05 55.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.51 . . . . 0.57999999999999996 109.693 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -89.26 -44.45 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 1.8600000000000001 111.097 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 38.4 mtm -128.75 139.04 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 3.21 110.655 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -89.15 85.83 6.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.538 -0.541 . . . . 1.21 109.538 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 167' ' ' MET . 0.1 OUTLIER -96.81 -170.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 1.27 112.138 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 171' ' ' ARG . 6.4 tp10 -92.81 178.96 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 0.40000000000000002 110.957 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 170' ' ' GLU . 9.2 ptp85 -107.63 -168.82 1.43 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.097 -0.501 . . . . 0.97999999999999998 110.058 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.57 154.1 40.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.44 111.77 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.454 ' CD2' ' HA ' ' A' ' 215' ' ' ASP . 17.3 p80 -90.0 164.25 14.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 0.28000000000000003 111.379 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 39.8 mtt -106.27 -167.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.596 . . . . 2.2000000000000002 110.184 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 175' ' ' ARG . 4.6 mpt_? -124.43 128.24 48.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.478 -0.328 . . . . 1.9299999999999999 110.353 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -128.61 145.12 51.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.616 -0.513 . . . . 0.28999999999999998 109.616 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 18.8 ptt85 -126.18 147.91 49.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.783 0.325 . . . . 0.40000000000000002 110.629 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.04 143.46 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.891 -0.595 . . . . 0.56000000000000005 110.244 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.7 tt -133.4 117.72 28.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.449 0.642 . . . . 0.28000000000000003 110.508 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.416 HD21 HD22 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -149.79 156.44 38.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.385 -0.825 . . . . 0.14000000000000001 109.936 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.72 166.06 14.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 0.14000000000000001 112.546 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.5 t -50.44 -39.89 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.922 -0.581 . . . . 0.23000000000000001 111.962 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -51.33 -53.68 33.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.324 -0.398 . . . . 0.28000000000000003 111.46 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -29.9 31.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.138 -0.483 . . . . 2.0800000000000001 110.883 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.37 94.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.639 -0.71 . . . . 0.28999999999999998 113.084 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.64 -35.9 71.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.891 0.377 . . . . 1.97 111.351 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -76.6 -44.6 33.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.235 -0.439 . . . . 1.1100000000000001 111.814 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.416 HD22 HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -72.2 -32.33 66.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.772 0.32 . . . . 1.01 111.669 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -59.68 -50.55 73.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 1.28 111.435 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -80.34 18.28 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.44 112.119 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -124.29 -49.44 1.81 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.855 -0.338 . . . . 1.8100000000000001 111.648 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.1 -36.58 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.188 0.44 . . . . 2.5 112.188 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 26.5 mtpp -61.39 -52.45 70.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.558 0.577 . . . . 1.3300000000000001 112.558 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.1 Cg_endo -66.09 -14.01 42.46 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.028 1.819 . . . . 0.35999999999999999 112.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 1.0900000000000001 110.312 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mt 62.62 38.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.559 -0.746 . . . . 0.44 111.043 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -120.84 14.23 11.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 1.6899999999999999 110.465 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.86 149.46 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.978 -0.555 . . . . 0.31 111.02 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.5 mt -101.25 155.61 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.685 . . . . 0.46999999999999997 109.744 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.93 64.19 0.5 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.931 0.396 . . . . 1.6399999999999999 111.1 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.426 ' HA ' ' HA3' ' A' ' 247' ' ' GLY . 10.4 m -149.4 31.01 0.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 1.51 110.302 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -81.74 146.88 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.736 -0.665 . . . . 1.5 111.161 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -118.9 133.49 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.834 -0.802 . . . . 1.22 108.834 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.31 111.34 19.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.156 0.503 . . . . 1.0700000000000001 111.395 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -166.93 -131.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.255 -0.738 . . . . 0.14000000000000001 111.255 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.64 -28.32 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.619 0.723 . . . . 0.71999999999999997 109.301 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -119.31 142.87 47.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.811 -1.086 . . . . 1.3200000000000001 109.614 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.28 89.66 5.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.684 -0.487 . . . . 0.16 109.684 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.15 98.41 8.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.398 -0.593 . . . . 0.55000000000000004 109.398 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.9 mm -112.59 134.89 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.44 110.827 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.35 112.57 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.33000000000000002 109.981 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.98 94.41 3.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.943 0.401 . . . . 0.60999999999999999 110.83 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.02 95.83 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.084 -0.507 . . . . 1.0600000000000001 109.845 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.496 HG12 ' H ' ' A' ' 215' ' ' ASP . 9.8 tt -94.23 179.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 1.78 110.061 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.496 ' H ' HG12 ' A' ' 214' ' ' ILE . 4.4 m-20 -67.0 152.85 95.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 111.896 0.332 . . . . 1.0800000000000001 111.896 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.88 166.57 11.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.751 2.301 . . . . 0.26000000000000001 112.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 91.11 -75.98 1.53 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.363 -1.095 . . . . 0.34000000000000002 110.363 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -28.41 64.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.258 0.551 . . . . 0.42999999999999999 109.642 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.88 -26.12 68.19 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.521 -0.763 . . . . 0.34000000000000002 110.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -17.66 64.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.845 0.355 . . . . 1.47 111.383 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -84.17 -50.37 7.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.906 0.384 . . . . 0.69999999999999996 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.695 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 15.1 tt -72.87 -28.05 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.78000000000000003 111.395 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.457 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 4.0 t70 -55.35 -33.02 63.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.863 0.363 . . . . 1.1499999999999999 111.143 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.76 -32.69 67.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.885 -0.598 . . . . 0.46000000000000002 111.733 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 3.0 pp -92.78 -32.99 14.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.545 -0.462 . . . . 1.51 109.862 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 26.9 mm -55.64 -43.37 72.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.279 -0.419 . . . . 1.1699999999999999 111.474 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 12.7 ptpt -61.95 -17.68 57.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.173 0.805 . . . . 0.62 113.173 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -119.92 -16.83 8.61 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.874 -0.516 . . . . 0.72999999999999998 111.515 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 3.1 tp10 -79.95 -39.28 30.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.449 . . . . 1.25 111.15 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 t -136.47 -36.23 0.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.284 0.475 . . . . 1.6699999999999999 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 23.9 tptp -55.96 -46.49 78.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 111.054 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.07 28.22 13.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.65000000000000002 111.958 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -132.85 -46.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 2.54 110.839 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -130.44 -153.4 7.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.034 -0.603 . . . . 0.31 111.976 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.5 m -124.18 156.66 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.626 0.251 . . . . 0.65000000000000002 110.518 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.67 165.65 18.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.714 0.292 . . . . 1.7 111.043 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -151.64 152.85 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.6100000000000001 110.051 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.9 141.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.056 0.455 . . . . 0.20999999999999999 111.181 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.77 75.91 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.253 -0.43 . . . . 1.05 110.44 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -138.98 4.47 2.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.461 -0.336 . . . . 1.0700000000000001 111.41 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -43.1 83.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.56999999999999995 111.266 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 55.77 42.31 29.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.997 -0.547 . . . . 1.24 111.515 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.73 -50.44 7.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.105 0.479 . . . . 1.3899999999999999 110.471 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.13 167.35 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.582 -0.736 . . . . 0.44 109.317 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -77.62 92.54 4.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.918 0.389 . . . . 2.1600000000000001 109.998 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -75.75 143.08 42.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.823 -0.626 . . . . 1.48 110.646 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 201' ' ' SER . . . 101.24 139.82 10.92 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.001 -0.618 . . . . 0.75 113.062 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.93 113.77 8.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 1.3300000000000001 109.928 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 18.81 18.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 1.45 110.679 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -90.16 95.34 10.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.948 -0.569 . . . . 0.90000000000000002 110.17 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.53 3.95 29.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.982 -0.554 . . . . 1.02 110.138 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.386 -0.816 . . . . 1.6200000000000001 109.928 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 111.618 -0.593 . . . . 1.24 111.618 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -122.53 111.2 16.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.034 0.417 . . . . 1.26 110.691 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.6 ttp -155.57 140.76 17.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.82999999999999996 109.998 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.29 145.68 51.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.115 -0.493 . . . . 0.66000000000000003 110.476 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 tp -73.45 104.37 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.92000000000000004 110.995 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.51 110.285 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 82.81 16.93 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.195 -0.457 . . . . 0.91000000000000003 110.294 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' C ' ' HG1' ' A' ' 9' ' ' THR . 62.8 Cg_endo -73.81 -18.33 22.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.519 2.146 . . . . 0.85999999999999999 112.473 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.448 ' HG1' ' C ' ' A' ' 8' ' ' PRO . 24.6 p 46.78 49.14 14.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.857 -0.61 . . . . 1.28 111.464 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -80.33 161.36 25.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.807 -0.633 . . . . 1.76 109.894 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -58.53 -40.11 82.02 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.974 0.416 . . . . 0.67000000000000004 110.405 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mt -119.95 95.32 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 1.6200000000000001 109.632 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -159.27 137.99 10.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.832 -0.622 . . . . 2.8700000000000001 110.21 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.81 37.03 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.52000000000000002 111.006 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.8 p -106.67 -28.58 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.32000000000000001 110.633 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 12.6 m120 -126.26 50.41 1.9 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.78000000000000003 110.26 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 m -92.6 155.33 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.20999999999999999 111.073 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.62 134.03 55.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 0.12 109.688 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.55 127.12 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 0.12 110.889 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 2.7 p -140.59 118.98 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 0.93000000000000005 109.648 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -123.56 132.9 54.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.243 0.544 . . . . 1.1399999999999999 112.047 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.53 159.56 18.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.835 -0.62 . . . . 1.1100000000000001 110.063 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -121.06 115.85 23.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.582 -0.281 . . . . 1.8899999999999999 110.637 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 16.2 mmm180 -99.39 55.39 0.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.731 0.301 . . . . 2.3599999999999999 110.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.24 34.28 20.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.586 -0.734 . . . . 0.45000000000000001 111.778 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.78 -62.92 0.42 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.331 -0.708 . . . . 0.33000000000000002 111.331 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -74.35 145.73 43.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.69 -0.485 . . . . 1.77 109.69 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 28' ' ' ARG . 5.2 mmt180 -109.82 140.26 43.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.271 -0.27 . . . . 0.83999999999999997 110.271 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -134.34 118.61 17.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.361 -0.381 . . . . 1.24 110.158 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -135.87 146.21 47.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.757 0.313 . . . . 1.0900000000000001 110.333 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -132.24 179.26 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.778 -0.646 . . . . 0.14999999999999999 110.26 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.2 106.9 9.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.105 0.479 . . . . 0.12 110.659 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 m -103.58 171.09 7.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.696 -0.683 . . . . 1.1899999999999999 109.416 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' ASN . 11.2 t80 -88.26 154.58 20.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.873 0.368 . . . . 1.05 110.485 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -78.34 31.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 1.52 110.832 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 34' ' ' TYR . 12.9 t30 -85.92 43.34 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.057 -0.519 . . . . 2.4100000000000001 110.56 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt 61.1 46.76 7.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.636 -0.711 . . . . 0.46000000000000002 110.84 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.02 -23.94 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.008 -0.542 . . . . 0.93000000000000005 111.364 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.46 -31.38 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.477 -0.329 . . . . 0.94999999999999996 110.503 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.36 -18.1 74.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.118 -0.563 . . . . 0.29999999999999999 112.571 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.459 ' CE2' ' HB2' ' A' ' 49' ' ' LEU . 78.0 t90 -68.76 -47.15 66.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.268 0.556 . . . . 0.66000000000000003 110.04 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -93.6 17.66 11.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.485 -0.78 . . . . 1.24 110.364 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -158.61 60.1 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.31 110.557 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.96 -149.9 18.62 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.527 -0.844 . . . . 0.20999999999999999 112.636 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.61 122.86 70.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.513 -0.551 . . . . 0.26000000000000001 109.513 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 13.4 mm-40 -136.18 -86.07 0.35 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.237 -0.185 . . . . 0.34000000000000002 111.397 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HD2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -153.74 -144.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.506 -0.553 . . . . 1.04 109.506 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.55 167.53 10.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.926 -0.398 . . . . 0.56000000000000005 109.926 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 41' ' ' TRP . 16.6 tp -104.05 6.79 36.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.457 0.54 . . . . 0.62 112.457 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.77 -44.42 7.09 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.421 -0.512 . . . . 1.21 110.486 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.91 -27.94 61.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.436 -0.802 . . . . 0.69999999999999996 111.048 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.85 -13.01 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.25 110.533 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.99 107.64 18.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.036 -0.529 . . . . 1.0800000000000001 110.055 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -65.71 -44.33 86.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.642 . . . . 0.35999999999999999 111.316 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 t -142.89 136.12 28.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.058 0.456 . . . . 0.45000000000000001 110.145 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -96.68 25.91 4.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.014 -0.539 . . . . 1.3400000000000001 110.851 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -96.68 88.74 4.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.127 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.02 141.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.104 -0.498 . . . . 0.51000000000000001 109.924 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -90.91 162.42 14.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.28999999999999998 111.797 -178.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.6 t -111.92 -46.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.14999999999999999 109.56 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -154.15 120.11 5.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.11 -0.95 . . . . 0.29999999999999999 108.989 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.03 -27.58 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.067 0.395 . . . . 0.32000000000000001 112.067 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -38.39 87.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.062 0.458 . . . . 0.46999999999999997 110.941 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -99.35 -5.35 29.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 2.0800000000000001 110.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.23 52.23 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.914 -0.66 . . . . 0.34999999999999998 111.881 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -105.81 123.19 47.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.973 0.416 . . . . 1.0700000000000001 110.886 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 59' ' ' PHE . 35.2 t -114.97 130.76 68.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.75 -0.659 . . . . 0.34999999999999998 109.994 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.25 110.82 19.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.95999999999999996 110.459 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -84.8 -171.7 3.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.922 -0.581 . . . . 2.1600000000000001 109.803 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -56.7 -38.92 72.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.179 0.437 . . . . 1.7 112.179 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 8.5 pm0 -81.85 -1.34 47.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.34000000000000002 111.5 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -47.79 4.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.69999999999999996 110.963 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.9 -34.28 77.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.611 -0.268 . . . . 0.27000000000000002 110.966 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.08 -24.84 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.076 0.465 . . . . 2.2200000000000002 110.574 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 m -93.22 -32.53 14.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.205 -0.452 . . . . 0.28999999999999998 110.851 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.31 -54.32 7.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.5 111.716 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.44 -36.02 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.2 -0.455 . . . . 2.9300000000000002 110.948 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.87 -25.04 25.24 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.832 -0.907 . . . . 0.44 110.832 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.92 124.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.279 -0.46 . . . . 1.4199999999999999 110.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -23.8 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.172 0.51 . . . . 1.02 109.876 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.98 104.24 2.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.406 -0.815 . . . . 1.3100000000000001 110.093 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -59.86 -31.92 70.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.69999999999999996 111.643 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -38.72 92.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 1.48 110.211 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.05 -40.06 94.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.115 -0.493 . . . . 1.1299999999999999 109.712 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.98 -50.3 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.60999999999999999 109.555 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.8 m -59.66 -34.85 73.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.262 -0.881 . . . . 0.20000000000000001 110.751 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.84 -44.42 96.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.75 110.922 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -63.26 -40.46 97.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.89000000000000001 110.378 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.1 mt -69.7 -34.31 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.66 . . . . 0.64000000000000001 110.866 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.41 -21.23 49.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.365 . . . . 1.23 111.732 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -97.16 -53.59 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.334 0.494 . . . . 1.78 112.334 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -102.32 20.96 15.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 1.4099999999999999 111.373 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.27 165.41 12.8 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.677 -0.773 . . . . 0.28999999999999998 112.173 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.2 tt0 -87.58 102.69 14.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.014 -0.365 . . . . 1.8899999999999999 110.014 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 p -106.29 126.02 61.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 1.01 110.449 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -79.68 88.4 5.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.925 -0.579 . . . . 3.0899999999999999 111.139 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.49 -125.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 1.1599999999999999 110.744 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 m -157.47 -174.88 5.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.225 -0.657 . . . . 1.0700000000000001 109.225 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 100' ' ' LYS . 19.9 p-10 -79.7 -76.48 0.21 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.632 -0.136 . . . . 0.81000000000000005 110.632 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 51.7 mttm 51.97 33.0 10.9 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.007 0.523 . . . . 1.0900000000000001 111.622 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.466 ' CD ' ' HG2' ' A' ' 153' ' ' LYS . 1.2 mm-40 -86.76 173.81 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.48 -0.782 . . . . 1.5800000000000001 111.438 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -160.67 -56.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 1.1200000000000001 110.62 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -162.71 104.58 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 1.26 110.051 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -142.0 140.61 32.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.414 . . . . 0.81000000000000005 110.305 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.21 119.27 38.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 1.23 109.56 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 109' ' ' MET . 0.6 OUTLIER -147.5 141.72 26.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.211 -0.45 . . . . 0.54000000000000004 110.316 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -70.96 -36.36 72.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 1.8799999999999999 110.187 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -84.94 10.49 11.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.834 -0.621 . . . . 1.5 110.912 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -61.07 -35.76 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.26000000000000001 111.287 -179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.66 -40.9 96.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.54000000000000004 111.038 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -25.43 28.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 1.3 110.969 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.65 -58.49 8.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.949 -0.568 . . . . 0.46999999999999997 111.097 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tp -71.31 -24.0 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.154 0.502 . . . . 0.13 110.608 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.22 89.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.676 . . . . 0.26000000000000001 111.797 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 t -65.34 -17.79 64.8 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.648 0.24 . . . . 0.5 111.648 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.2 mp -88.89 -51.22 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.782 0.325 . . . . 2.3700000000000001 110.57 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.87 -31.85 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.148 0.425 . . . . 0.56000000000000005 112.148 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.94 -4.43 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.644 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -102.87 -41.92 6.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.035 0.445 . . . . 1.48 110.493 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -75.52 -11.49 60.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.877 -0.602 . . . . 1.1299999999999999 112.072 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.82 108.22 19.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.868 0.366 . . . . 0.28999999999999998 110.095 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 m -100.23 144.39 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 0.32000000000000001 111.172 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.427 ' ND2' ' HG2' ' A' ' 125' ' ' GLU . 66.6 t30 -145.2 125.02 7.05 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.525 . . . . 0.46999999999999997 109.932 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.3 77.23 3.9 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.607 2.205 . . . . 0.25 112.663 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.427 ' HG2' ' ND2' ' A' ' 123' ' ' ASN . 1.0 OUTLIER -144.84 -157.68 0.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.153 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.6 m -71.33 -45.2 63.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.024 0.44 . . . . 2.2000000000000002 110.511 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -68.12 148.09 51.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.716 -0.675 . . . . 3.1600000000000001 110.575 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -116.46 152.92 48.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.263 -0.426 . . . . 1.49 110.647 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.37 178.73 2.4 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.591 2.194 . . . . 0.23000000000000001 111.512 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.8 t80 68.65 12.3 8.63 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.735 0.779 . . . . 0.88 109.664 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.9 m -107.35 106.12 16.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.373 -0.83 . . . . 0.51000000000000001 109.672 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -55.6 -38.52 50.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.018 -0.537 . . . . 0.55000000000000004 111.337 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -55.41 -30.02 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.679 -0.691 . . . . 1.1399999999999999 111.965 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.3 tp -57.06 -52.08 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 1.1499999999999999 111.535 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.58 -31.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 121.022 -0.271 . . . . 1.3200000000000001 111.039 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.12 -45.93 91.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.03 0.443 . . . . 1.6699999999999999 110.831 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -26.13 64.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 0.58999999999999997 110.727 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.05 -50.73 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.23000000000000001 111.42 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -65.03 -29.78 70.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 1.1299999999999999 110.816 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -76.54 -12.76 60.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 1.0900000000000001 111.168 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -85.3 -28.37 25.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.34999999999999998 109.561 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.5 mt -89.56 -60.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.251 -0.886 . . . . 0.26000000000000001 110.95 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 58.05 67.25 0.98 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.889 -0.596 . . . . 0.23999999999999999 110.201 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.69 120.15 31.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 1.3 110.737 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 m -86.11 153.41 22.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.57999999999999996 110.406 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 t -110.31 -80.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.64 0.257 . . . . 0.67000000000000004 110.723 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.62 160.0 30.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.763 0.316 . . . . 1.27 110.39 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 2.25 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 0.80000000000000004 111.138 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.5 -23.89 61.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.55000000000000004 111.344 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . 45.6 mttm 63.02 36.01 12.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.143 0.497 . . . . 2.54 110.995 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.9 132.35 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.39000000000000001 111.951 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.9 m 52.71 84.18 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.251 0.621 . . . . 0.66000000000000003 112.52 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.466 ' HG2' ' CD ' ' A' ' 101' ' ' GLU . 7.9 mmtp 52.47 38.24 24.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 1.8 111.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.668 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 6.1 tt0 58.85 59.62 2.77 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.049 -0.523 . . . . 1.21 110.703 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.668 ' HG2' ' O ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 46.32 42.09 9.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.207 1.003 . . . . 1.1499999999999999 112.07 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.66 72.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.96999999999999997 110.67 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -67.38 -31.11 71.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 1.6899999999999999 110.698 179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -71.67 -29.11 64.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.923 -0.399 . . . . 0.52000000000000002 109.923 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.54 -37.56 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.862 -0.792 . . . . 0.17999999999999999 108.862 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.2 -40.7 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.184 -0.916 . . . . 0.96999999999999997 109.567 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.1 mmtp -66.95 -39.32 87.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 1.6599999999999999 110.11 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -58.29 -40.76 82.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.737 -0.665 . . . . 2.0499999999999998 110.529 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.65 -46.65 86.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.29999999999999999 110.108 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -62.45 -36.65 83.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 1.1799999999999999 111.414 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 47.9 mm-40 -62.65 -35.53 79.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.411 -0.358 . . . . 0.44 111.431 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -92.25 -41.52 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.31 -0.405 . . . . 1.01 111.089 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.69 106.55 8.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.182 -0.463 . . . . 1.6799999999999999 109.868 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 170' ' ' GLU . 31.6 tttm -75.1 101.74 4.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 1.9399999999999999 110.977 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.77 131.49 48.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.766 -0.652 . . . . 1.2 110.729 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 168' ' ' LYS . 0.6 OUTLIER -82.38 71.71 9.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.131 0.491 . . . . 0.84999999999999998 111.302 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 135.37 35.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 109.7 178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.6 134.57 13.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.763 0.316 . . . . 0.34000000000000002 110.865 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -121.03 136.57 54.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.493 -0.558 . . . . 1.3500000000000001 109.493 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.72 172.34 12.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.58 -0.282 . . . . 1.5 110.569 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.44 133.65 55.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.482 . . . . 0.81999999999999995 110.282 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.44 141.38 48.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.237 -0.438 . . . . 0.33000000000000002 110.274 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.59 139.66 46.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.128 0.489 . . . . 1.3300000000000001 110.962 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 90.4 t80 -113.93 143.28 44.97 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.161 -0.681 . . . . 0.27000000000000002 109.161 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.6 131.56 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.427 0.528 . . . . 0.46000000000000002 112.427 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.433 HD21 ' HD2' ' A' ' 181' ' ' PRO . 7.0 mt -160.61 139.57 7.74 Favored Pre-proline 0 C--N 1.333 -0.112 0 CA-C-N 115.625 -0.716 . . . . 2.1099999999999999 109.649 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.433 ' HD2' HD21 ' A' ' 180' ' ' LEU . 21.3 Cg_endo -62.09 156.03 52.4 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.571 2.181 . . . . 0.20999999999999999 111.674 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.0 t -49.73 -37.05 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.744 0.418 . . . . 0.19 111.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -46.78 -47.08 20.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 1.27 111.451 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.31 -28.59 12.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.33000000000000002 110.588 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.87 64.89 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.009 -0.541 . . . . 0.19 113.233 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -27.73 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.656 0.243 . . . . 1.4099999999999999 111.656 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -76.18 -46.58 27.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.577 0.227 . . . . 1.6499999999999999 111.184 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -25.11 59.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.514 -0.312 . . . . 2.04 111.155 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -59.33 -34.21 72.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 1.4199999999999999 110.919 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.45 6.78 25.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.56 . . . . 1.5 112.187 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 26.6 mtpt -135.38 -28.1 1.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.067 0.766 . . . . 1.75 113.067 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 -56.96 3.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.97 0.414 . . . . 1.8100000000000001 111.349 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 27.1 mtpp -61.1 -52.65 70.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.47 0.915 . . . . 0.28000000000000003 113.47 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 56.3 Cg_endo -68.29 -5.89 16.08 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.191 1.927 . . . . 0.38 114.047 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 191' ' ' LYS . 2.0 mm? -102.52 1.73 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.771 -0.371 . . . . 0.25 110.377 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mt 53.19 45.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.693 0.759 . . . . 0.38 111.23 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -116.91 24.24 11.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 0.37 110.028 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.57 156.72 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.723 -0.671 . . . . 0.28999999999999998 111.341 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.53 145.34 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.95999999999999996 109.072 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 65.99 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.375 0.509 . . . . 0.54000000000000004 112.375 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 m -145.54 36.1 1.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.406 -0.815 . . . . 0.72999999999999998 108.858 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.3 pt-20 -89.87 166.75 13.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.738 -0.665 . . . . 0.55000000000000004 112.25 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.14 118.16 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 1.52 109.6 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.22 45.29 1.25 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.34000000000000002 111.032 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -102.71 -139.58 10.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.725 -0.75 . . . . 0.23000000000000001 112.288 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -78.87 -27.67 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.468 . . . . 1.3400000000000001 110.228 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -120.85 109.53 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.677 -0.692 . . . . 1.51 109.165 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.8 tp -69.83 92.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.89 . . . . 1.99 111.298 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.0 tt0 -94.48 117.46 30.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.028 -0.73 . . . . 0.44 109.028 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 210' ' ' ILE . 8.4 mt -128.18 147.43 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.777 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.33 115.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.507 -0.553 . . . . 0.26000000000000001 109.507 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.4 m -121.4 57.75 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.793 0.33 . . . . 1.4399999999999999 111.722 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.98 127.59 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.715 -0.476 . . . . 0.55000000000000004 109.715 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.71 -51.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.319 -0.4 . . . . 1.47 111.22 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 2.9 p30 -155.54 166.34 16.46 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.725 -0.216 . . . . 1.2 110.639 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 86.2 Cg_endo -80.34 -159.24 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.35 2.034 . . . . 0.58999999999999997 112.754 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.68 -94.14 1.29 Allowed Glycine 0 C--O 1.238 0.392 0 C-N-CA 120.871 -0.681 . . . . 0.35999999999999999 111.621 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.26 -17.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.65000000000000002 110.109 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -55.54 -35.27 65.5 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.314 -0.857 . . . . 0.52000000000000002 110.481 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -25.06 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.6299999999999999 111.563 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -86.06 -45.48 11.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 2.7200000000000002 110.276 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.551 ' O ' HG12 ' A' ' 226' ' ' ILE . 16.3 tt -69.02 -26.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 1.8999999999999999 110.686 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -31.75 72.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.249 -0.432 . . . . 0.23999999999999999 110.196 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.55 -22.96 64.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.678 -0.692 . . . . 1.1699999999999999 110.05 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.8 mt -96.02 -46.61 6.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.525 -0.761 . . . . 0.89000000000000001 109.592 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.5 mm -55.76 -37.96 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.894 -0.594 . . . . 1.1699999999999999 112.326 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -52.64 -31.56 37.47 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.353 0.501 . . . . 1.6399999999999999 112.353 -179.105 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -112.33 -23.93 10.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.82999999999999996 110.711 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 226' ' ' ILE . 1.5 tp10 -62.47 -51.23 68.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.69999999999999996 111.606 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.1 -28.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.432 0.53 . . . . 0.88 112.432 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 32.8 mttt -58.98 -43.88 91.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 1.23 110.97 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.45 39.49 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.646 -0.788 . . . . 0.28000000000000003 112.845 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -151.07 -18.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.888 0.344 . . . . 1.1000000000000001 111.5 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -147.52 -158.17 7.76 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.907 . . . . 0.28000000000000003 112.491 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.5 m -119.11 141.89 48.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.786 0.327 . . . . 0.40999999999999998 110.547 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.32 143.05 51.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 1.0700000000000001 110.639 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 238' ' ' VAL . 2.9 tt0 -134.07 171.17 14.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.638 -0.504 . . . . 1.6699999999999999 109.638 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.47 ' H ' ' HG2' ' A' ' 237' ' ' GLU . 27.6 m -86.08 149.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.795 0.331 . . . . 1.01 110.429 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.0 tp -114.7 96.61 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.769 -0.456 . . . . 1.1699999999999999 109.769 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -88.11 17.24 5.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.3400000000000001 111.453 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.51 97.46 5.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 1.0900000000000001 110.683 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -111.41 -4.6 14.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 2.0299999999999998 110.44 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -77.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.714 -0.675 . . . . 0.81000000000000005 111.923 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.87 149.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.387 -0.369 . . . . 1.0800000000000001 110.891 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.98 116.82 32.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.67000000000000004 110.515 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -123.84 150.29 44.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 1.22 110.087 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.26 -152.54 6.51 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.561 -0.828 . . . . 0.55000000000000004 112.636 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -79.93 43.21 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.769 0.795 . . . . 0.65000000000000002 110.43 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -90.49 12.45 18.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.273 -0.876 . . . . 1.1100000000000001 110.734 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -129.4 90.57 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.68 -0.691 . . . . 0.92000000000000004 109.581 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -76.77 -49.56 15.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.504 . . . . 1.5800000000000001 110.161 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.745 -0.645 . . . . 1.1799999999999999 109.544 179.517 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.063 -0.415 . . . . 1.5700000000000001 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -102.35 164.95 11.39 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.114 -0.328 . . . . 0.34000000000000002 110.114 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.59 143.94 33.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.813 -0.44 . . . . 0.68999999999999995 109.813 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -116.69 162.21 18.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 2.02 110.529 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mt -75.82 86.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.449 0.642 . . . . 1.1599999999999999 109.869 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.42 ' C ' ' HD3' ' A' ' 8' ' ' PRO . 16.1 t80 -167.64 -176.81 3.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.364 -0.976 . . . . 2.5 108.364 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 m -123.9 72.92 54.44 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.789 0.328 . . . . 0.81999999999999995 110.187 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 6' ' ' PHE . 7.2 Cg_exo -73.27 134.47 21.02 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.203 . . . . 1.05 112.136 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.27 69.22 10.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.092 -0.504 . . . . 0.69999999999999996 110.5 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 7.0 t-20 -105.99 -175.41 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.954 -0.566 . . . . 0.71999999999999997 109.643 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -77.75 -85.29 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.626 0.25 . . . . 2.7200000000000002 110.926 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mt -91.38 92.41 3.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.302 0.572 . . . . 1.02 110.764 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 68.2 mmt-85 -143.53 133.11 23.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.26 15.45 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.45 -0.341 . . . . 2.46 111.483 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 p -101.56 -3.11 29.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.434 -0.348 . . . . 0.93000000000000005 111.475 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 37.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.18 0.514 . . . . 1.8999999999999999 110.431 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 54' ' ' GLN . 33.9 m -95.53 150.61 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.65000000000000002 111.597 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.9 151.91 25.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.933 -0.576 . . . . 0.47999999999999998 109.582 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 126.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.781 0.324 . . . . 1.0700000000000001 111.013 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.66 116.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.825 -0.805 . . . . 0.37 108.825 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.1 ttp180 -114.89 123.24 48.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.276 -0.42 . . . . 2.1200000000000001 111.705 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.447 ' HA ' ' CA ' ' A' ' 93' ' ' GLY . 51.6 ttp -88.61 131.45 34.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.98999999999999999 110.595 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -101.87 126.32 48.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.469 . . . . 1.77 110.165 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 16.9 mmm180 -122.11 -164.62 1.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.329 -0.249 . . . . 0.69999999999999996 110.329 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.32 -53.88 14.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.16 111.175 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.1 27.58 3.14 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.517 -0.849 . . . . 0.53000000000000003 112.685 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 162.66 41.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.337 . . . . 2.0499999999999998 110.47 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 141.3 23.23 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.329 -0.619 . . . . 1.5700000000000001 109.329 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -136.05 144.44 45.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.556 -0.293 . . . . 0.34000000000000002 110.333 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 1.2 pt-20 -145.6 144.45 30.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.682 0.277 . . . . 1.6799999999999999 110.682 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.3 mt -140.13 144.67 27.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.45000000000000001 109.994 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.77 122.99 28.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.47999999999999998 110.523 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.44 -170.44 2.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.26000000000000001 110.924 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.94 -176.19 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.453 -0.339 . . . . 1.05 110.987 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -76.67 -140.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.431 -0.35 . . . . 2.21 111.858 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -60.54 -6.8 1.78 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.426 0.898 . . . . 0.81999999999999995 113.426 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.97 -2.96 58.84 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.008 -0.433 . . . . 1.51 111.387 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.15 -33.01 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.268 . . . . 0.28999999999999998 111.499 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.05 70.23 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.119 0.961 . . . . 0.38 110.431 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.31 46.96 77.85 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.807 -1.088 . . . . 0.27000000000000002 112.596 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER 55.8 57.74 4.98 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 110.012 -0.366 . . . . 1.05 110.012 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 44.58 60.6 2.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.923 0.889 . . . . 1.6799999999999999 112.458 -179.256 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.2 m 69.01 13.67 8.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.51 -0.768 . . . . 0.26000000000000001 112.666 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.29 -128.04 6.18 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.291 -0.724 . . . . 0.26000000000000001 111.291 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.39 105.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.905 -0.406 . . . . 0.5 109.905 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -74.04 159.61 32.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.691 -0.686 . . . . 1.3400000000000001 110.752 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -61.95 1.85 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.966 -0.561 . . . . 2.0499999999999998 109.495 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.45 153.67 17.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.257 -0.883 . . . . 0.70999999999999996 108.966 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.03 -27.32 62.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.562 0.22 . . . . 1.03 111.334 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.40999999999999998 111.797 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -87.37 0.15 55.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.8700000000000001 111.791 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.32 -5.54 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.564 0.697 . . . . 0.72999999999999998 110.027 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.24 133.48 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.438 -0.801 . . . . 1.53 109.961 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HG3' HG12 ' A' ' 17' ' ' VAL . 29.0 mm-40 -85.77 -48.88 8.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.099 0.476 . . . . 0.33000000000000002 110.709 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.1 t -119.25 166.68 12.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.891 -0.595 . . . . 1.1299999999999999 109.727 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -121.24 32.54 5.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.272 0.558 . . . . 0.70999999999999996 110.061 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.01 126.36 50.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.79 . . . . 0.55000000000000004 109.447 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -108.86 137.65 39.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.873 0.368 . . . . 0.20000000000000001 110.367 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.95 158.27 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.372 . . . . 0.70999999999999996 111.645 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.18 -56.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.44 109.186 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -137.72 101.13 4.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.255 -0.884 . . . . 0.32000000000000001 109.56 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.71 -30.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.75 110.917 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -70.12 -12.32 61.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.987 0.422 . . . . 0.39000000000000001 111.181 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -121.37 4.71 10.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 1.4099999999999999 110.846 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.82 38.46 94.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.739 -0.743 . . . . 0.40000000000000002 111.351 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -101.77 120.81 40.95 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.14 0.495 . . . . 1.22 111.644 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.9 140.55 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.19 109.919 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.11 127.01 40.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.289 0.566 . . . . 0.83999999999999997 110.834 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -88.86 -178.06 5.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.426 -0.806 . . . . 1.95 109.661 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.67 68.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.102 0.477 . . . . 1.8999999999999999 110.735 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -80.03 -5.31 55.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 2.1899999999999999 111.116 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.27 -46.09 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.334 -0.394 . . . . 0.46999999999999997 111.125 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.82 -28.01 69.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.22 111.149 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.2 tt -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.105 0.478 . . . . 0.33000000000000002 110.596 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -35.75 17.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.54000000000000004 110.841 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.55 -52.66 12.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.701 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -89.65 -66.98 0.87 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.988 0.423 . . . . 1.01 110.927 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.72 -50.82 0.47 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.172 -0.771 . . . . 0.31 111.172 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 148.21 25.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.919 -0.4 . . . . 0.93000000000000005 109.919 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.25 3.82 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 1.23 110.664 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.58 122.92 36.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.207 -0.451 . . . . 1.45 109.962 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -60.33 -27.48 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.527 0.566 . . . . 2.1699999999999999 112.527 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.013 0.435 . . . . 0.80000000000000004 110.605 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.0 -23.16 23.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.1200000000000001 110.275 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -79.54 -55.07 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.28000000000000003 109.975 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 11.7 p -63.98 -24.87 67.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.21 110.721 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 83' ' ' THR . 40.7 ttmt -54.25 -41.75 69.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.645 . . . . 1.5 111.037 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -84.6 -38.19 20.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 1.5600000000000001 110.72 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.47 -34.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.52000000000000002 111.981 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -25.02 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.069 0.766 . . . . 1.0900000000000001 113.069 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.61 -20.74 11.59 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.362 -0.535 . . . . 1.1299999999999999 112.399 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -111.0 12.4 22.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.923 0.392 . . . . 1.3200000000000001 110.57 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 22' ' ' MET . . . -129.11 175.7 18.74 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.663 -0.78 . . . . 0.27000000000000002 112.773 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -91.83 92.84 8.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.991 0.424 . . . . 1.3999999999999999 110.602 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 p -91.66 140.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.869 -0.605 . . . . 0.35999999999999999 109.691 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -69.34 84.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.75 110.837 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.62 36.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.568 -0.742 . . . . 0.55000000000000004 111.544 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 69.37 -1.34 2.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 111.429 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.67 102.38 15.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.364 -0.606 . . . . 0.96999999999999997 109.364 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -153.8 93.46 1.66 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.339 0.59 . . . . 0.58999999999999997 110.761 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -85.56 16.55 3.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.615 -0.72 . . . . 1.1799999999999999 110.579 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -118.8 105.29 11.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.391 -0.822 . . . . 2.48 110.411 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -167.56 140.7 3.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 1.46 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.423 HG21 ' H ' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -71.93 174.65 6.7 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.982 -0.554 . . . . 1.0800000000000001 110.858 179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.423 ' H ' HG21 ' A' ' 104' ' ' THR . 70.2 mt-30 -58.78 132.78 54.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.125 0.488 . . . . 0.78000000000000003 111.558 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 107' ' ' GLU . 0.7 OUTLIER -162.54 -171.44 2.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.541 -0.754 . . . . 1.51 109.167 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.411 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 9.6 tp10 -66.66 163.67 18.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.678 -0.489 . . . . 0.93000000000000005 109.678 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -57.89 100.31 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.671 0.272 . . . . 1.0900000000000001 111.125 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -28.8 66.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.142 0.496 . . . . 1.4399999999999999 110.177 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.94 -43.16 93.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.719 -0.673 . . . . 1.47 110.038 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -68.08 -33.43 74.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.332 -0.395 . . . . 0.84999999999999998 110.396 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 115' ' ' THR . 6.0 t70 -59.61 -48.43 81.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 1.1699999999999999 111.066 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.7 -30.51 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.778 0.323 . . . . 0.20999999999999999 110.923 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 117' ' ' VAL . . . -65.32 -35.32 80.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.534 -0.303 . . . . 0.16 111.138 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 112' ' ' ASP . 2.7 t -71.29 -16.39 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.386 . . . . 1.9099999999999999 110.801 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mm -86.83 -43.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.28000000000000003 109.923 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 114' ' ' ALA . 14.2 p -78.69 -16.35 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.96999999999999997 110.941 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.27 81.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.476 -0.329 . . . . 0.25 111.274 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -79.76 -15.14 58.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 0.56000000000000005 110.494 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -84.01 -26.14 29.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.027 -0.533 . . . . 1.6399999999999999 110.821 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.9 p -91.62 96.52 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.132 0.491 . . . . 0.17999999999999999 110.215 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.98 146.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.053 -0.521 . . . . 1.99 111.036 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -150.9 125.0 4.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.187 -0.671 . . . . 1.6899999999999999 109.187 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.35 61.14 4.16 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.751 2.301 . . . . 0.46000000000000002 113.143 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -132.21 -166.28 1.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.33000000000000002 110.629 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.8 t -75.44 -25.42 57.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.742 0.275 . . . . 0.98999999999999999 111.742 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HB2' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -86.27 101.95 13.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 3.1600000000000001 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -81.71 147.29 58.55 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.067 -0.515 . . . . 2.02 110.016 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 57.76 3.08 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.76 2.306 . . . . 0.19 113.139 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -117.07 17.64 14.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.246 0.546 . . . . 0.70999999999999996 110.727 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.2 m -136.01 118.98 16.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.961 -0.563 . . . . 0.79000000000000004 110.093 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.39 -35.27 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.403 . . . . 0.5 110.943 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.8 mm -54.42 -33.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.40999999999999998 111.809 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.5 mt -57.04 -41.94 79.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.272 -0.422 . . . . 0.81999999999999995 111.557 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.1 tp -96.27 -25.79 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.719 0.295 . . . . 0.23000000000000001 110.604 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.09 -45.36 91.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.753 0.311 . . . . 0.40000000000000002 110.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -61.24 -26.5 67.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.93999999999999995 110.856 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.63 19.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.284 -0.416 . . . . 0.33000000000000002 110.218 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.42 -32.41 73.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 2.0299999999999998 110.454 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -69.66 -32.55 71.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 2.0 109.987 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.44 -48.11 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.729 -0.669 . . . . 0.62 109.896 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 50.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.779 -0.646 . . . . 0.67000000000000004 109.728 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -86.16 2.37 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 1.1299999999999999 111.757 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -107.46 121.42 44.58 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.751 -0.38 . . . . 1.4199999999999999 110.038 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 m -51.1 132.65 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.856 0.723 . . . . 0.53000000000000003 111.978 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.93 68.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.995 -0.548 . . . . 1.8999999999999999 110.156 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 61.52 80.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.606 -0.725 . . . . 1.8100000000000001 111.446 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -3.33 16.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.245 0.545 . . . . 1.04 111.153 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -77.82 -15.96 58.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.432 0.635 . . . . 0.32000000000000001 109.56 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -94.65 159.47 15.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.289 -0.869 . . . . 0.77000000000000002 109.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t -71.57 133.49 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.887 0.375 . . . . 0.81999999999999995 110.289 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -26.37 68.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 1.1699999999999999 110.811 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -82.65 -12.31 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 1.8 110.677 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -91.07 -34.75 14.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 2.2000000000000002 110.512 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.423 ' O ' HG23 ' A' ' 159' ' ' VAL . 14.4 mt-30 -110.07 17.13 21.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 2.02 111.564 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.79 72.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.027 0.442 . . . . 0.23999999999999999 111.383 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.34 -46.88 81.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.635 . . . . 1.6200000000000001 110.791 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -59.5 -38.57 81.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.467 . . . . 0.25 111.129 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 155' ' ' GLN . 96.2 t -67.69 -49.72 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.95999999999999996 111.701 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.6 -34.31 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.644 0.239 . . . . 0.39000000000000001 111.644 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -72.43 -40.54 67.02 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.271 -0.27 . . . . 2.3100000000000001 110.271 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -59.04 -40.01 83.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.144 0.497 . . . . 1.23 110.087 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 53.3 tp -70.24 -41.22 73.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.598 -0.728 . . . . 1.5 110.313 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 167' ' ' MET . 59.8 tttm -58.14 -33.8 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.019 -0.537 . . . . 1.6200000000000001 111.568 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.99 -30.56 71.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.765 0.317 . . . . 1.8600000000000001 111.185 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -94.98 -41.86 8.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.37 110.411 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -133.56 119.89 20.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.089 -0.505 . . . . 1.3600000000000001 109.656 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -90.53 109.01 20.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.08 0.467 . . . . 2.71 111.182 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.28 143.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.573 -0.74 . . . . 1.04 110.919 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.87 -178.36 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.711 -0.222 . . . . 0.72999999999999998 110.934 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.88 21.13 12.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.603 0.565 . . . . 2.5899999999999999 112.106 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.94 33.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.999 0.428 . . . . 0.26000000000000001 111.695 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -115.54 136.55 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.089 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 1.7 tpt -89.82 -85.34 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.507 0.558 . . . . 1.9299999999999999 112.507 -178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -140.31 145.71 37.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.026 0.441 . . . . 1.02 111.826 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.38 150.64 50.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.28999999999999998 108.821 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.464 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 23.1 ptt180 -121.72 153.6 38.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.062 0.458 . . . . 0.28000000000000003 110.962 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 31.4 t80 -117.64 128.21 54.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.27000000000000002 109.876 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.52 128.51 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 1.8600000000000001 111.065 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.518 HD23 ' CE2' ' A' ' 178' ' ' PHE . 0.6 OUTLIER -173.18 160.29 3.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.393 -0.595 . . . . 0.93999999999999995 109.393 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.13 147.64 73.49 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.129 1.886 . . . . 0.23000000000000001 111.536 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 72.9 t -61.62 -22.07 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.908 0.385 . . . . 0.44 110.708 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -52.7 -42.55 64.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.1499999999999999 110.541 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.5 -32.78 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.54000000000000004 109.817 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.96 -20.41 64.52 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.614 -0.721 . . . . 0.13 113.347 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.63 -26.54 61.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.95 0.405 . . . . 1.78 111.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -76.68 -57.45 3.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 1.28 110.989 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -19.57 65.17 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.256 0.465 . . . . 2.0 112.256 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -54.19 -51.6 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.441 . . . . 1.46 111.442 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.88 21.68 4.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.387 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -122.7 0.02 9.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 3.0800000000000001 109.978 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.27 -54.17 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 1.9399999999999999 111.807 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.1 mtpp -53.92 -53.27 59.94 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.813 0.671 . . . . 1.28 112.813 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.8 Cg_endo -65.36 -14.15 43.49 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.219 1.946 . . . . 0.40999999999999998 112.889 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.4 -18.75 40.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.407 -0.36 . . . . 0.81999999999999995 110.442 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 31.4 mt 57.46 75.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.761 -0.654 . . . . 1.54 111.721 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.7 27.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.798 -0.637 . . . . 0.83999999999999997 109.838 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.91 -173.46 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.306 -0.861 . . . . 0.96999999999999997 109.927 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.67 137.66 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.342 -0.614 . . . . 1.46 109.342 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.06 71.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.511 0.507 . . . . 2.0899999999999999 111.185 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 34.39 0.46 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.497 -0.774 . . . . 0.93000000000000005 109.135 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.27 168.45 14.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.889 -0.596 . . . . 1.8700000000000001 111.774 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -126.1 127.32 45.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.611 -0.722 . . . . 1.1299999999999999 109.724 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -115.76 130.15 56.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.599 -0.273 . . . . 1.21 110.5 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 165.97 -114.66 0.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.74 -0.743 . . . . 1.27 112.277 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -40.16 31.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.661 0.743 . . . . 1.3100000000000001 109.092 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -117.41 157.6 25.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.93 -1.032 . . . . 1.79 108.757 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.93 95.03 5.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.101 0.477 . . . . 1.1499999999999999 110.351 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 28.4 tt0 -92.85 107.83 19.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.58999999999999997 109.819 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.47 128.47 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.379 -0.373 . . . . 0.33000000000000002 111.129 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.7 t -90.97 98.02 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.317 -0.623 . . . . 0.91000000000000003 109.317 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 37.3 t -113.51 114.18 26.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.088 -0.506 . . . . 0.31 111.33 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.84 134.46 1.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.248 -0.649 . . . . 1.1899999999999999 109.248 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.5 tt -131.79 171.82 17.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.496 -0.32 . . . . 0.46999999999999997 110.217 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 42.1 m-20 -55.72 148.98 33.56 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.009 -0.541 . . . . 1.75 111.407 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.83 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.078 2.519 . . . . 0.83999999999999997 113.081 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.36 -90.13 0.92 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.879 -0.888 . . . . 0.10000000000000001 110.879 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.7 m -73.34 -4.5 33.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 1.98 110.214 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 79.1 t80 -55.59 -38.78 69.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.23000000000000001 111.265 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 8.1 tpt180 -65.64 -31.2 72.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.565 0.222 . . . . 1.3999999999999999 111.16 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.49 -35.97 78.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.41999999999999998 110.741 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.598 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 3.6 tp -84.95 -27.48 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 1.71 109.879 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.452 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 26.1 t70 -64.44 -29.13 70.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.34999999999999998 110.688 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 220' ' ' ARG . 12.9 mm-40 -53.42 -33.32 53.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.72 -0.673 . . . . 0.47999999999999998 112.007 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -97.47 -33.43 11.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.948 -0.39 . . . . 0.28000000000000003 109.948 178.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 222' ' ' ILE . 31.4 mm -55.96 -37.75 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.20999999999999999 111.78 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 231' ' ' LYS . 8.0 ptpt -62.22 -23.67 66.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.891 0.7 . . . . 1.22 112.891 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -112.47 -28.36 7.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.531 -0.468 . . . . 1.23 111.132 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -41.28 74.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.009 -0.541 . . . . 0.87 111.843 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.28 -47.06 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.501 0.556 . . . . 0.34000000000000002 112.501 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 25.7 ttmt -53.35 -45.96 69.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.938 0.399 . . . . 0.25 111.088 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.28 48.23 2.9 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.806 -0.712 . . . . 0.22 112.017 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.82 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.727 0.299 . . . . 2.0800000000000001 110.902 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.25 -146.99 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.17000000000000001 112.379 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.0 m -108.84 131.24 55.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.82999999999999996 110.858 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -111.82 149.94 31.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.835 -0.432 . . . . 0.31 109.835 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -142.52 -178.84 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.311 -0.404 . . . . 0.26000000000000001 110.01 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.72 149.93 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.975 0.417 . . . . 0.20999999999999999 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.31 58.57 1.71 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.448 0.642 . . . . 0.28999999999999998 109.313 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -114.86 56.92 0.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.22 110.729 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 244' ' ' VAL . 2.1 pt? -73.68 -31.35 63.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.34000000000000002 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 53.33 34.78 18.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.942 0.719 . . . . 0.84999999999999998 112.942 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 241' ' ' LEU . 17.4 t0 -122.65 -73.98 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.838 0.352 . . . . 1.8700000000000001 111.103 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.48 ' O ' HD13 ' A' ' 241' ' ' LEU . 7.7 p -132.47 135.08 58.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.353 -0.385 . . . . 0.66000000000000003 110.411 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -84.2 102.73 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.838 0.351 . . . . 1.52 110.082 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -102.81 138.33 39.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.972 -0.558 . . . . 1.99 110.174 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -161.37 169.83 37.0 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.064 -0.814 . . . . 0.62 111.064 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.63 101.28 7.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.464 0.632 . . . . 1.45 111.609 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -118.01 22.21 12.37 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.686 -0.857 . . . . 1.29 108.686 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -125.07 94.94 4.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.97 -1.014 . . . . 1.6299999999999999 110.032 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -40.91 97.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.43 . . . . 2.6299999999999999 111.285 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.46 -0.781 . . . . 2.3199999999999998 110.518 -179.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 111.896 -0.482 . . . . 0.44 111.896 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -149.14 161.95 40.94 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.341 -0.244 . . . . 0.35999999999999999 110.341 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -72.57 141.74 48.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.245 -0.434 . . . . 1.1299999999999999 109.943 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -141.18 144.64 34.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.553 -0.294 . . . . 1.01 110.506 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.9 -73.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.449 -0.341 . . . . 0.37 110.666 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -66.98 125.15 25.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.742 -0.466 . . . . 1.4099999999999999 109.742 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.14 77.25 61.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.364 -0.38 . . . . 0.87 111.774 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.28 143.65 25.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.427 2.085 . . . . 0.32000000000000001 112.104 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 88.28 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.47999999999999998 111.006 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.45 158.66 15.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.09 -0.505 . . . . 0.84999999999999998 110.193 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -71.08 -50.45 33.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.88 111.174 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.16 94.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.19 109.839 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -166.64 160.14 14.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.0 110.338 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.13 7.19 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.23000000000000001 111.539 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 p -96.99 -0.06 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.38 110.712 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -141.98 38.11 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.612 . . . . 0.22 109.506 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.72 150.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.19 111.799 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.54 137.06 54.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.365 -0.834 . . . . 0.23999999999999999 109.877 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -76.09 122.78 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.377 . . . . 0.39000000000000001 110.989 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -151.57 129.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.17999999999999999 110.498 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 148.0 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 1.1200000000000001 111.152 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 17.6 ttt -110.67 134.3 52.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.61 . . . . 0.28999999999999998 110.847 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -96.68 103.77 15.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.634 -0.506 . . . . 1.5600000000000001 109.634 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 10.9 mmm180 -84.07 -179.82 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.548 -0.296 . . . . 1.8100000000000001 110.62 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.6 69.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.514 . . . . 0.47999999999999998 111.918 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.11 -39.44 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.92 . . . . 0.59999999999999998 113.28 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tttt -113.91 -174.94 2.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.781 0.324 . . . . 1.8700000000000001 110.826 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 5.6 mmt180 -137.03 154.8 50.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.442 -0.948 . . . . 1.0700000000000001 108.442 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -133.48 102.75 5.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.178 -0.304 . . . . 0.32000000000000001 110.178 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' HA ' ' A' ' 61' ' ' ASN . 2.6 mt-10 -106.05 127.0 52.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.37 110.773 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -135.06 -172.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.11 110.798 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.6 110.23 3.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.391 . . . . 1.01 110.886 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 53' ' ' LEU . 62.5 m -100.18 -175.47 2.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 0.16 109.779 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' CZ ' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -72.18 167.45 20.29 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.91 0.386 . . . . 0.34999999999999998 111.338 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -99.69 7.77 44.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.088 0.47 . . . . 1.3500000000000001 111.079 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -87.61 84.94 7.04 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.874 -0.331 . . . . 0.23000000000000001 110.379 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm 58.06 57.18 4.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.733 -0.667 . . . . 1.02 110.778 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.1 p -74.65 61.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.794 1.283 . . . . 1.49 110.74 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.56 9.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.471 -1.24 . . . . 0.67000000000000004 109.308 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -45.12 90.74 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.595 -0.729 . . . . 0.25 112.395 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -74.75 -25.6 59.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.73999999999999999 111.095 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 90' ' ' LEU . 19.0 ttt180 -69.58 -31.9 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.578 0.704 . . . . 0.56999999999999995 109.351 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 20.0 m -109.33 17.06 21.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.442 -0.799 . . . . 0.38 110.649 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.05 -116.65 0.78 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.967 -0.635 . . . . 0.51000000000000001 111.965 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.86 126.13 16.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.962 -0.385 . . . . 1.1599999999999999 109.962 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -90.99 -59.45 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.182 -0.303 . . . . 2.4700000000000002 110.182 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -162.77 -58.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.95999999999999996 110.583 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 3.1 p30 -166.52 -175.53 3.22 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.146 -0.687 . . . . 0.98999999999999999 109.146 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.5 33.86 4.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.453 0.644 . . . . 0.96999999999999997 110.07 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -120.86 -43.97 2.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.542 -0.754 . . . . 1.8799999999999999 109.314 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -87.0 -31.66 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.345 -0.843 . . . . 1.1100000000000001 108.829 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG22 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 t -63.25 -37.25 78.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.901 -1.045 . . . . 0.51000000000000001 110.035 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 HD21 ' SG ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -83.47 80.22 9.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.373 -0.83 . . . . 0.78000000000000003 109.243 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.6 -62.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.288 -0.869 . . . . 0.41999999999999998 111.039 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -78.66 91.98 4.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.67 -0.696 . . . . 0.20000000000000001 111.277 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -84.22 60.46 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.415 0.626 . . . . 0.84999999999999998 110.555 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.3 t -152.91 82.81 1.21 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.241 -0.891 . . . . 0.75 109.136 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.64 138.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.781 -0.645 . . . . 0.28999999999999998 110.636 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -101.14 145.88 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.41999999999999998 109.945 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 97.5 t -73.35 -40.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.033 -0.728 . . . . 0.56999999999999995 109.033 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.426 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 2.1 t-20 -176.38 127.34 0.2 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.054 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.07 -37.93 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.734 -0.666 . . . . 1.1499999999999999 111.772 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.4 m -83.44 43.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.93000000000000005 111.122 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -47.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 2.6800000000000002 110.046 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.14 -2.8 47.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.755 -0.736 . . . . 0.46999999999999997 112.269 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.3 121.95 22.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.69 0.281 . . . . 1.05 110.803 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.8 t -105.86 134.41 47.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.958 -0.386 . . . . 1.1000000000000001 109.958 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.1 98.32 10.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.158 0.504 . . . . 1.01 110.589 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -81.17 178.9 8.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.045 -0.724 . . . . 3.0899999999999999 109.045 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -51.63 -35.8 43.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.685 0.278 . . . . 1.27 111.537 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.51 -30.01 70.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 2.0899999999999999 111.805 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.67 -51.21 6.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 2.1800000000000002 111.829 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 80' ' ' ASP . 2.2 pp -60.12 -32.55 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.22 111.881 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -69.26 -16.39 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.202 0.525 . . . . 1.55 110.363 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.6 m -105.89 -39.15 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.79000000000000004 111.142 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.94 -41.06 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.387 . . . . 0.42999999999999999 111.07 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -96.63 -57.39 2.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.24 109.823 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.29 -31.93 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.902 -0.666 . . . . 0.53000000000000003 112.142 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.02 145.35 45.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.55 0.215 . . . . 1.6599999999999999 110.531 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 7.8 p-10 -92.8 11.68 26.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.059 0.456 . . . . 0.69999999999999996 110.917 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 85' ' ' ILE . 13.5 t0 -82.1 117.72 22.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.44 109.781 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.07 -31.14 70.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 1.1100000000000001 111.535 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' HB ' ' OD1' ' A' ' 81' ' ' ASP . 23.2 m -63.83 -46.97 82.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 0.81999999999999995 110.559 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 13.3 tp10 -67.8 -33.04 74.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.47999999999999998 110.949 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 81' ' ' ASP . 41.6 mm -65.38 -57.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.34000000000000002 111.05 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.64 -28.48 68.51 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.083 0.401 . . . . 0.81000000000000005 112.083 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' THR . 28.0 mtpt -55.34 -53.56 54.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.925 0.393 . . . . 1.3700000000000001 111.14 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -63.9 -40.01 95.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.74 -0.664 . . . . 0.97999999999999998 111.729 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.3 mt -69.81 -28.35 36.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.29 0.567 . . . . 0.98999999999999999 111.078 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.517 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -79.8 -32.12 40.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.291 -0.413 . . . . 1.22 111.771 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 87' ' ' LYS . 11.4 t -99.06 -29.48 12.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.133 0.79 . . . . 1.01 113.133 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -119.44 12.04 12.31 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.073 -0.392 . . . . 2.3700000000000001 111.801 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.84 -177.33 18.39 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.583 -0.818 . . . . 0.44 111.551 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.49 106.62 18.66 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.119 -0.326 . . . . 1.8 110.119 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG13 HG11 ' A' ' 97' ' ' VAL . 2.1 p -117.66 148.64 20.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.622 -0.717 . . . . 0.40999999999999998 110.173 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -70.8 77.09 0.62 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.078 0.466 . . . . 0.40999999999999998 111.64 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.465 HG22 HE22 ' A' ' 108' ' ' GLN . 15.6 m -82.57 157.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 1.27 110.438 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 p -125.99 -70.6 0.73 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.446 -0.343 . . . . 1.6499999999999999 110.938 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.21 146.31 1.87 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.061 -0.348 . . . . 2.4199999999999999 110.061 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 145.85 18.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 1.78 110.126 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.16 20.55 6.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.541 . . . . 1.26 110.914 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 102' ' ' ARG . 3.8 mmp_? -73.66 172.25 11.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.413 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -128.84 84.86 2.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.666 0.617 . . . . 2.8799999999999999 112.666 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.0 m -159.05 -83.68 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.652 -0.249 . . . . 1.0 110.73 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.45 ' H ' ' HA ' ' A' ' 43' ' ' SER . 21.2 tm0? -130.87 141.86 50.34 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.5 -0.556 . . . . 0.56000000000000005 109.5 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mt -141.63 149.36 40.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.772 -0.195 . . . . 1.45 110.478 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -99.76 -10.64 21.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.196 0.522 . . . . 0.64000000000000001 110.515 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.465 HE22 HG22 ' A' ' 97' ' ' VAL . 20.5 mp0 -86.27 87.63 7.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.781 -0.645 . . . . 2.1699999999999999 110.507 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.0 mtt -76.21 20.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.214 0.53 . . . . 0.40999999999999998 111.964 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 108' ' ' GLN . 12.7 m-85 -130.52 5.45 4.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.11 -0.7 . . . . 1.5800000000000001 109.11 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.65 -16.79 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.189 -0.914 . . . . 0.33000000000000002 110.391 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.75 -47.26 87.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.951 -0.568 . . . . 0.17000000000000001 111.653 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.6 mm -71.16 -43.65 74.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.305 0.574 . . . . 0.37 109.944 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.91 88.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.14 -0.937 . . . . 0.22 112.42 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 t -63.95 -22.29 66.86 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.913 0.338 . . . . 2.0499999999999998 111.913 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.71 -40.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.942 0.401 . . . . 0.35999999999999999 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 p -82.99 -13.92 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.257 -0.429 . . . . 0.28999999999999998 111.983 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.449 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . . . -88.78 -47.38 8.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.548 . . . . 0.23999999999999999 110.261 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.547 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 7.4 t70 -60.57 -43.22 97.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.055 -0.975 . . . . 0.22 111.743 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 216' ' ' PRO . 17.9 mtmt -90.01 16.68 7.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.099 0.778 . . . . 1.5 113.099 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' A' ' 169' ' ' ILE . 91.5 m -131.76 108.9 9.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.937 -0.394 . . . . 0.28999999999999998 109.937 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.85 172.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.073 0.463 . . . . 1.02 111.817 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.53 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 9.5 t-20 -174.14 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 114.986 -1.006 . . . . 0.59999999999999998 109.657 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 83.2 Cg_endo -90.25 121.53 0.9 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.87 1.713 . . . . 0.81000000000000005 111.912 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 1.6 pm0 -74.01 -20.64 60.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.038 0.447 . . . . 1.6799999999999999 110.428 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 t -79.03 -6.5 56.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.913 -0.585 . . . . 1.01 110.691 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -143.97 82.14 1.7 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.96 157.08 91.1 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.51000000000000001 110.331 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.86 54.72 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.921 2.414 . . . . 0.31 113.259 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.01 25.12 4.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.53000000000000003 111.027 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.1 m -151.99 110.22 3.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.3400000000000001 110.19 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.47 -34.42 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.03 -0.532 . . . . 0.37 111.095 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mm -60.41 -29.3 44.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.32000000000000001 112.031 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -58.85 -33.58 70.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.62 111.879 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 118' ' ' ALA . 2.6 tp -102.99 -15.27 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 121.036 -0.266 . . . . 1.1399999999999999 111.349 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -36.26 70.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.167 0.508 . . . . 0.40000000000000002 110.143 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -60.08 -32.91 71.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.456 -0.793 . . . . 1.5700000000000001 110.983 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.21 -39.93 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.38 110.825 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 6.2 ttt -63.1 -41.39 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.379 0.609 . . . . 1.1000000000000001 110.079 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -71.29 -23.52 61.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.448 -0.796 . . . . 1.79 110.755 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.18 -43.79 27.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.108 -0.496 . . . . 0.33000000000000002 112.176 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.45 -34.25 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.687 0.255 . . . . 0.32000000000000001 111.687 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 m80 59.96 32.17 21.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.122 0.264 . . . . 0.45000000000000001 111.366 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -134.13 133.99 41.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.889 0.376 . . . . 1.0800000000000001 110.669 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 m -155.36 170.28 22.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.687 -0.688 . . . . 0.52000000000000002 109.194 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.48 -84.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.949 -0.3 . . . . 0.22 110.351 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -143.95 104.48 4.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 1.05 110.373 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -12.08 60.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.19 111.629 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.94 5.68 50.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.22 110.925 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 151' ' ' SER . 12.0 mmmm -116.1 -159.88 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.29 -0.414 . . . . 1.6499999999999999 110.528 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 150' ' ' LYS . 3.0 m -75.41 81.66 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.364 0.602 . . . . 0.63 109.925 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.72 -25.44 18.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.71999999999999997 113.514 -178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -13.06 33.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.65 -0.656 . . . . 1.3799999999999999 111.757 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -84.69 -25.1 28.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.318 0.58 . . . . 0.5 109.592 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.94 29.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.564 -0.744 . . . . 0.17999999999999999 110.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.1 -18.36 63.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.27000000000000002 112.241 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.36 -46.38 16.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.113 0.482 . . . . 0.45000000000000001 109.873 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -62.49 -46.0 90.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 0.54000000000000004 111.023 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.37 -38.39 48.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.722 -0.672 . . . . 0.22 111.506 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.2 -34.34 66.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 2.1099999999999999 111.138 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -82.87 -9.92 59.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.135 -0.484 . . . . 1.9399999999999999 111.412 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -55.09 6.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.34000000000000002 110.127 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.41 -24.0 66.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.268 -0.424 . . . . 1.0900000000000001 110.623 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -61.57 -26.03 67.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 1.8400000000000001 110.153 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -80.59 -7.01 59.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.48999999999999999 110.845 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -107.62 -48.15 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.46000000000000002 110.281 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 mmm -145.85 148.11 32.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 1.27 110.414 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -90.95 99.9 12.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.273 -0.421 . . . . 2.48 110.005 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' A' ' 121' ' ' CYS . 0.2 OUTLIER -100.18 149.32 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.037 -0.529 . . . . 0.31 110.718 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.86 140.88 39.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.161 0.505 . . . . 1.9099999999999999 110.641 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -139.42 61.43 1.55 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.82 -0.627 . . . . 0.64000000000000001 110.268 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 113.2 3.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 0.28000000000000003 110.753 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -170.93 153.44 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.468 -0.567 . . . . 0.87 109.468 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 5.1 ttt -139.64 -140.89 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.985 -0.376 . . . . 2.2799999999999998 109.985 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -137.69 120.83 16.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.024 -0.361 . . . . 0.62 110.024 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.8 mp -120.43 157.91 28.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.99 0.424 . . . . 0.45000000000000001 110.875 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -179.47 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.553 -0.749 . . . . 0.54000000000000004 109.862 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 1.9 p90 -141.66 139.63 33.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.721 0.296 . . . . 0.89000000000000001 110.328 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -108.68 122.17 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.198 -0.456 . . . . 0.46999999999999997 110.943 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.8 149.83 9.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.609 -0.723 . . . . 1.8999999999999999 109.814 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.11 160.57 37.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.917 2.411 . . . . 0.12 112.789 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.36 -34.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 1.3999999999999999 111.121 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -55.2 -45.93 75.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 1.1299999999999999 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -85.57 -30.25 23.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.384 -0.371 . . . . 1.45 110.57 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.04 -22.05 77.1 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.41999999999999998 113.066 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -61.15 -28.23 68.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.0 0.429 . . . . 1.97 110.88 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 4.55 51.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.262 -0.426 . . . . 1.9099999999999999 110.733 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.4 tp -111.82 -41.05 4.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 1.8799999999999999 110.987 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -55.77 -44.37 77.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.6200000000000001 111.19 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -80.61 6.24 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.178 0.436 . . . . 0.46000000000000002 112.178 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -123.06 -2.76 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.292 -0.255 . . . . 1.48 111.127 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.3 -48.69 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.645 -0.252 . . . . 1.0 111.48 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 60.3 tttt -59.8 -50.28 87.47 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.367 0.506 . . . . 1.71 112.367 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 48.6 Cg_endo -68.0 -2.65 9.14 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.174 1.916 . . . . 0.20999999999999999 112.913 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.25 3.02 55.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 110.053 -0.351 . . . . 1.48 110.053 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.409 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 16.9 mt 52.72 72.22 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.178 -0.919 . . . . 0.17999999999999999 110.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 0.1 OUTLIER -152.8 19.37 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.608 -0.723 . . . . 0.39000000000000001 109.932 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.442 HG13 ' SG ' ' A' ' 212' ' ' CYS . 33.2 m -108.95 145.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.499 . . . . 0.28000000000000003 111.013 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.4 mt -97.02 159.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.679 . . . . 0.34999999999999998 109.397 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.07 59.77 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.262 0.553 . . . . 1.3200000000000001 111.613 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -155.99 74.62 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.28 -0.637 . . . . 0.45000000000000001 109.28 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' A' ' 193' ' ' LYS . 7.2 pt-20 -123.52 155.01 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.48 . . . . 1.45 111.045 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.41 129.64 46.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.836 -0.62 . . . . 0.31 109.937 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.7 109.24 11.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.93 0.395 . . . . 1.77 110.117 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -168.77 -96.33 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.041 -0.599 . . . . 0.32000000000000001 111.649 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -89.01 -10.88 45.91 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.122 -0.696 . . . . 0.68999999999999995 109.122 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.19 -176.89 5.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.009 -0.996 . . . . 0.29999999999999999 109.621 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.9 tp -130.02 76.87 1.75 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.581 -0.526 . . . . 0.47999999999999998 109.581 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.69 108.58 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.792 -0.64 . . . . 0.93000000000000005 110.715 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 55.3 mt -123.13 137.39 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.34999999999999998 110.611 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.9 t -91.53 123.75 43.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.28999999999999998 110.065 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.442 ' SG ' HG13 ' A' ' 198' ' ' VAL . 57.4 m -137.21 102.34 4.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.244 -0.435 . . . . 0.89000000000000001 110.468 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.434 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -159.66 136.96 9.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.388 -0.597 . . . . 0.28000000000000003 109.388 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.565 HG13 ' H ' ' A' ' 215' ' ' ASP . 5.6 tp -134.86 179.36 4.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.525 -0.307 . . . . 0.42999999999999999 110.354 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.565 ' H ' HG13 ' A' ' 214' ' ' ILE . 16.8 m-20 -60.43 164.22 7.31 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 122.978 0.511 . . . . 0.83999999999999997 110.861 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 215' ' ' ASP . 10.2 Cg_endo -52.65 170.38 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.853 2.368 . . . . 0.089999999999999997 112.923 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 80.48 -80.44 1.65 Allowed Glycine 0 C--O 1.237 0.315 0 N-CA-C 110.43 -1.068 . . . . 0.11 110.43 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.24 -22.44 63.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.34000000000000002 109.107 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -59.5 -32.26 70.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.298 -0.865 . . . . 0.35999999999999999 110.767 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 220' ' ' ARG . 11.4 mmt180 -85.93 -15.79 40.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.46000000000000002 110.161 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 0.7 OUTLIER -79.69 -48.75 13.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.55000000000000004 109.134 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 tt -66.66 -34.65 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 1.1000000000000001 109.775 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 227' ' ' LYS . 1.8 t70 -59.98 -36.58 77.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.907 -0.588 . . . . 0.44 110.919 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 9.8 mm-40 -47.13 -41.14 16.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.664 -0.698 . . . . 0.90000000000000002 111.934 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -34.09 10.2 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.793 -0.363 . . . . 0.60999999999999999 111.266 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 8.9 mm -56.28 -39.11 58.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 5.8 ptmt -64.74 -11.65 38.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.976 0.732 . . . . 1.3100000000000001 112.976 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -25.74 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.552 -0.459 . . . . 2.4100000000000001 112.005 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.14 -47.83 26.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.64000000000000001 111.362 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -116.38 -38.8 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.845 -0.342 . . . . 0.35999999999999999 111.59 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -66.09 -25.05 66.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 1.97 110.24 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.95 25.35 28.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.015 -0.612 . . . . 0.41999999999999998 111.718 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -139.84 -55.18 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.583 -0.525 . . . . 0.89000000000000001 109.583 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.41 -145.53 9.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.314 -0.714 . . . . 0.28999999999999998 111.314 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.41 133.25 46.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 117.031 0.416 . . . . 1.48 110.018 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -89.55 149.65 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.953 -0.388 . . . . 1.78 109.953 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -155.56 154.61 31.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.83999999999999997 110.179 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -72.57 158.6 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.596 0.236 . . . . 0.27000000000000002 110.406 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.63 52.28 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.458 0.647 . . . . 1.3600000000000001 111.015 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -115.52 75.54 0.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.521 -0.918 . . . . 0.90000000000000002 108.521 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.96 -73.64 0.53 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.462 -0.79 . . . . 1.0900000000000001 110.785 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.44 41.96 25.37 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.756 0.66 . . . . 1.8899999999999999 110.056 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.75 -46.56 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.467 -0.788 . . . . 0.84999999999999998 110.875 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.37 143.84 39.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.358 -0.383 . . . . 0.55000000000000004 110.499 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.02 117.76 8.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.641 -0.708 . . . . 0.63 111.084 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.73 151.88 28.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.965 -0.561 . . . . 1.01 110.929 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.98 76.6 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.593 -0.813 . . . . 0.17999999999999999 113.357 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -147.48 110.84 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.046 -0.353 . . . . 0.68000000000000005 110.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.41 -8.84 13.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.395 -0.366 . . . . 1.54 111.206 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 252' ' ' GLU . 55.6 tptt -75.51 98.0 3.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 1.22 110.836 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.57 -28.69 61.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.87 110.734 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.456 ' HB2' ' HE3' ' A' ' 250' ' ' LYS . 26.0 mt-10 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.449 -0.786 . . . . 2.1099999999999999 110.277 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.906 -0.477 . . . . 1.3600000000000001 111.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -148.49 133.81 18.47 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.919 -0.4 . . . . 2.2200000000000002 109.919 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 mmt -70.54 120.43 16.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.849 -0.426 . . . . 1.3799999999999999 109.849 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -109.89 120.25 41.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.013 0.435 . . . . 1.45 111.057 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -95.08 -14.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.695 0.76 . . . . 1.24 109.33 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -142.04 144.41 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.988 -1.005 . . . . 0.90000000000000002 109.032 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.26 85.9 37.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.631 0.234 . . . . 1.9399999999999999 111.631 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 -32.78 87.6 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.36 2.04 . . . . 0.41999999999999998 111.998 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m 56.36 70.76 0.61 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.961 -0.563 . . . . 0.67000000000000004 111.336 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -90.86 -76.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.93000000000000005 110.752 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -161.37 -80.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.81 0.338 . . . . 0.72999999999999998 110.822 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.18 47.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.132 0.491 . . . . 2.0099999999999998 111.728 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -121.07 151.69 39.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.001 -0.545 . . . . 2.0499999999999998 110.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.71 45.45 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.217 0.532 . . . . 1.8999999999999999 111.608 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -99.51 -33.75 10.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.092 0.472 . . . . 1.3 111.063 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.54 72.33 1.42 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.219 -0.66 . . . . 0.72999999999999998 109.219 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.12 149.01 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.669 -0.696 . . . . 1.1499999999999999 111.331 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.66 123.0 49.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.68999999999999995 109.412 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.43 120.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.114 0.483 . . . . 1.4199999999999999 111.077 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.21 116.89 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.739 . . . . 0.88 109.525 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -126.83 132.95 50.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.229 0.538 . . . . 0.92000000000000004 112.032 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 66.6 ttp -111.48 119.45 38.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.176 -0.676 . . . . 1.1100000000000001 109.176 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 124.23 50.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.782 0.325 . . . . 1.79 110.828 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -109.86 -164.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.533 . . . . 3.2599999999999998 110.055 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.61 72.89 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.3 0.375 . . . . 1.75 111.596 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.08 7.77 4.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.399 -0.905 . . . . 0.92000000000000004 112.952 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -123.13 145.26 48.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 2.5600000000000001 111.261 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -129.72 132.15 46.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.067 -0.716 . . . . 1.03 109.067 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.79 144.81 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.478 0.18 . . . . 0.32000000000000001 110.871 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 44.8 tt0 -156.8 143.11 18.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.986 -0.376 . . . . 1.21 109.986 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.07 -173.21 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.85999999999999999 110.737 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.82 119.78 26.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.58999999999999997 110.915 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' SG ' HD22 ' A' ' 90' ' ' LEU . 29.5 m -116.76 157.78 24.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 0.39000000000000001 110.641 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.531 ' HD1' ' NE2' ' A' ' 54' ' ' GLN . 1.3 t80 -74.15 145.13 44.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.829 0.347 . . . . 1.0900000000000001 110.226 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 8.97 4.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.312 -0.404 . . . . 1.3999999999999999 111.599 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.55 88.34 7.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.305 -0.247 . . . . 1.52 110.797 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.5 44.35 24.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.508 -0.769 . . . . 1.03 112.091 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.89 149.24 8.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 1.03 110.188 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 39' ' ' VAL . 3.9 t 68.81 23.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.41 0.624 . . . . 0.20000000000000001 110.459 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.57 62.35 6.45 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.898 -0.592 . . . . 0.17000000000000001 113.292 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 11.47 5.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.361 0.264 . . . . 0.76000000000000001 111.155 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 22.36 13.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.243 -0.435 . . . . 0.47999999999999998 110.356 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -135.99 -51.35 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.823 -0.626 . . . . 1.1299999999999999 111.11 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.06 -112.9 0.86 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.549 -0.834 . . . . 0.32000000000000001 112.327 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.4 t -129.9 127.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.556 0.217 . . . . 0.28000000000000003 110.71 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.7 -69.03 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.072 -0.714 . . . . 1.5700000000000001 109.072 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 179.92 6.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.442 -0.799 . . . . 1.3400000000000001 108.968 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.41 138.79 58.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.81 0.338 . . . . 0.52000000000000002 111.284 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 52' ' ' VAL . 6.0 mp -68.23 -24.45 64.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.981 -0.554 . . . . 0.63 110.229 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.26 -27.28 68.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.373 0.606 . . . . 1.1399999999999999 109.946 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 17.65 19.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 1.48 111.161 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.3 p -125.12 -9.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.347 . . . . 0.28000000000000003 111.087 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' HE22 ' A' ' 82' ' ' GLN . 1.9 mm? -96.24 110.07 22.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.333 -0.394 . . . . 0.52000000000000002 110.35 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' NE2' ' HD1' ' A' ' 34' ' ' TYR . 17.1 mt-30 -70.52 -35.81 73.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 2.3799999999999999 110.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -122.11 164.37 17.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.748 -0.66 . . . . 1.0800000000000001 110.458 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -125.19 18.05 8.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.947 -0.569 . . . . 1.1599999999999999 109.629 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -116.39 118.49 32.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.462 -0.79 . . . . 1.51 110.164 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.95 143.14 14.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.239 -0.437 . . . . 0.95999999999999996 110.227 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -83.97 157.5 21.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.629 0.252 . . . . 0.28000000000000003 111.087 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 68' ' ' ALA . 83.3 t -117.8 -49.48 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.482 0.658 . . . . 1.28 109.539 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -144.15 111.37 5.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.815 . . . . 0.71999999999999997 108.955 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.5 -37.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.006 0.373 . . . . 0.45000000000000001 112.006 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -31.17 72.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.933 0.397 . . . . 0.78000000000000003 111.142 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -100.96 -1.85 33.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 1.3700000000000001 111.242 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.84 48.13 83.42 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.96 -0.638 . . . . 0.38 112.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -106.6 123.65 48.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.794 0.331 . . . . 0.68999999999999995 111.231 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.76 139.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.736 -0.666 . . . . 0.089999999999999997 109.537 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 60' ' ' VAL . . . -90.93 128.13 36.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.17000000000000001 111.653 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -91.33 -172.33 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.362 -0.607 . . . . 1.24 109.362 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -63.27 -30.74 71.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.758 0.314 . . . . 0.48999999999999999 111.004 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 74' ' ' ILE . 2.1 pm0 -79.62 -24.82 41.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 1.1899999999999999 110.973 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.19 -51.95 15.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.424 -0.353 . . . . 1.8100000000000001 110.288 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.43 -32.78 74.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.34000000000000002 110.935 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -66.8 -23.53 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.961 0.41 . . . . 1.02 110.237 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -100.93 -5.81 25.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.70999999999999996 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.18 -40.27 7.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.53000000000000003 110.763 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.97 -34.51 6.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.48999999999999999 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.01 -10.02 29.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.032 -0.604 . . . . 0.31 111.926 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 147.09 44.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.476 0.179 . . . . 0.94999999999999996 110.523 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -96.69 -8.91 30.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.809 0.338 . . . . 0.85999999999999999 111.02 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.525 ' O ' HG12 ' A' ' 85' ' ' ILE . 56.0 t0 -73.84 110.78 8.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.168 -0.469 . . . . 0.98999999999999999 110.099 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.518 HE22 ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -62.07 -27.86 69.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.851 -0.613 . . . . 0.71999999999999997 110.882 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -34.39 77.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.76000000000000001 110.538 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.96 -29.27 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 81' ' ' ASP . 39.7 mm -67.28 -46.32 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.02 -0.733 . . . . 0.39000000000000001 109.02 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 p -71.1 -24.08 62.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.742 -0.663 . . . . 1.03 110.349 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -59.9 -41.83 92.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.215 0.531 . . . . 1.6399999999999999 109.718 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.04 -49.67 55.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.411 -0.813 . . . . 0.45000000000000001 110.726 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.76 -35.12 65.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 1.1299999999999999 112.245 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.43 HD22 ' SG ' ' A' ' 33' ' ' CYS . 3.7 mm? -82.77 -11.31 58.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.247 0.832 . . . . 1.01 113.247 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -122.98 -10.1 8.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.151 -0.62 . . . . 0.19 112.389 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -121.94 -5.26 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.733 0.302 . . . . 0.22 110.827 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.8 -169.33 19.26 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.547 -0.835 . . . . 0.19 113.067 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.29 107.44 18.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.702 -0.481 . . . . 1.52 109.702 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 p -106.28 138.52 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.34000000000000002 110.456 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.26 89.39 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 1.22 111.021 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.545 HG22 ' H ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -131.17 -87.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.45 . . . . 1.0600000000000001 111.033 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.545 ' H ' HG22 ' A' ' 97' ' ' VAL . 61.8 m -156.86 -166.42 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.371 -0.603 . . . . 0.85999999999999999 109.371 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.07 120.34 11.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.877 0.37 . . . . 0.66000000000000003 111.027 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -163.98 172.42 13.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.07 -0.715 . . . . 1.0900000000000001 109.07 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.83 164.8 22.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.937 0.399 . . . . 2.1699999999999999 110.675 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -88.93 -175.46 4.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.692 -0.686 . . . . 0.44 109.442 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -165.52 147.58 7.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.291 . . . . 0.23000000000000001 110.781 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -80.87 155.05 26.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.108 -0.496 . . . . 0.27000000000000002 109.883 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' THR . 44.8 tt0 175.3 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.391 0.432 . . . . 1.2 110.415 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 109' ' ' MET . 1.9 mt -176.32 176.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.837 -0.431 . . . . 0.69999999999999996 109.837 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.51 136.74 39.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.2 -0.454 . . . . 1.1499999999999999 109.881 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 69.13 1.9 3.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.691 0.62 . . . . 0.91000000000000003 111.121 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 8.5 ptt? -63.72 -23.99 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.204 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 51.4 p90 -62.81 -28.71 70.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.93999999999999995 110.919 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.06 -35.51 23.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.015 0.436 . . . . 2.1400000000000001 110.096 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 115' ' ' THR . 20.0 t70 -62.77 -51.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.6 . . . . 1.24 110.512 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.97 -33.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.078 -0.51 . . . . 1.3899999999999999 110.576 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 110' ' ' PHE . . . -59.96 -43.3 95.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.32000000000000001 111.661 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 112' ' ' ASP . 6.5 t -72.47 -11.76 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.33000000000000002 111.486 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 112' ' ' ASP . 47.5 mm -95.59 -37.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.181 0.515 . . . . 0.81999999999999995 110.259 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.36 -22.91 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.005 -0.543 . . . . 0.75 111.364 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.25 80.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 0.25 111.462 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.57 ' CG ' ' HG ' ' A' ' 218' ' ' CYS . 42.3 t0 -68.35 -21.67 64.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.517 0.675 . . . . 2.0099999999999998 111.107 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -119.31 26.33 9.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.66000000000000003 110.482 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 31.7 t -87.39 101.31 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.02 -0.537 . . . . 2.9399999999999999 111.039 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.21 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.367 -0.379 . . . . 2.3399999999999999 110.283 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 125' ' ' GLU . 28.5 t-20 -154.1 137.13 10.14 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 1.2 109.809 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.39 65.19 3.65 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.922 2.415 . . . . 1.0800000000000001 112.626 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 126' ' ' THR . 3.8 tt0 -146.89 -175.06 4.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.56999999999999995 109.104 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.482 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 10.1 t -81.44 -11.91 59.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.105 0.478 . . . . 1.25 109.829 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.48 80.48 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.40000000000000002 110.153 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -89.71 150.54 44.26 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.156 -0.474 . . . . 2.1400000000000001 110.331 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.86 106.76 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.496 2.797 . . . . 0.28000000000000003 112.47 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -149.98 -65.89 0.21 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.035 -0.53 . . . . 0.84999999999999998 110.487 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.99 143.01 33.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.191 -0.458 . . . . 1.0700000000000001 111.208 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.31 -29.39 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.144 0.497 . . . . 0.14999999999999999 110.762 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -55.61 -32.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.28999999999999998 111.334 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.94 -47.7 82.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 1.02 111.873 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -33.73 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 1.54 110.844 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -65.04 -37.76 88.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.044 0.449 . . . . 1.0800000000000001 110.633 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -28.78 70.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 2.2200000000000002 110.926 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.85 23.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.33000000000000002 110.65 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 11.6 tpt -65.89 -42.95 89.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.981 -0.554 . . . . 1.27 111.043 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -72.31 -26.6 62.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.577 -0.283 . . . . 1.9399999999999999 110.658 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.13 -49.77 68.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.60999999999999999 110.735 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.1 tt -76.46 -51.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 1.1299999999999999 110.989 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 41.16 51.53 3.43 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.686 0.616 . . . . 1.02 111.7 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -114.01 94.59 4.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 0.94999999999999996 111.406 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 139.29 30.79 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.629 . . . . 1.1899999999999999 109.887 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.66 83.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.792 0.33 . . . . 1.3200000000000001 110.533 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 60.75 54.45 3.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.743 -0.662 . . . . 1.76 111.405 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -15.43 63.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.77000000000000002 111.818 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -101.48 15.95 27.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 1.27 111.007 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -119.23 -125.2 0.28 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.39 -0.368 . . . . 1.01 110.907 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.77 79.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 1.71 111.023 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -21.94 60.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.922 -0.581 . . . . 0.73999999999999999 112.52 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -90.89 9.7 29.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.369 . . . . 1.54 111.168 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -128.98 -44.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 1.3600000000000001 110.154 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -71.56 -6.02 37.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.814 -0.63 . . . . 1.6200000000000001 111.22 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -36.82 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.48999999999999999 110.8 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.91 -39.21 76.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.1200000000000001 110.693 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 12.2 mp0 -64.99 -46.17 82.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.049 -0.523 . . . . 0.81999999999999995 111.147 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.26 -44.18 80.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 111.971 0.36 . . . . 0.52000000000000002 111.971 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.16 -29.59 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.874 0.324 . . . . 0.92000000000000004 111.874 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -97.21 -12.84 22.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.591 0.234 . . . . 1.22 111.188 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 3.9 tp-100 -68.15 -43.61 77.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.662 -0.496 . . . . 0.32000000000000001 109.662 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.36 -32.12 73.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.38 109.903 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -67.93 -21.89 65.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.555 -0.748 . . . . 1.5800000000000001 110.391 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.6 -32.85 60.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.42999999999999999 110.271 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -52.82 7.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.82 -0.807 . . . . 2.02 108.82 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mtp -131.59 112.45 12.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.944 -0.761 . . . . 1.4399999999999999 108.944 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -73.52 81.23 1.46 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 1.5800000000000001 111.75 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.6 pt -94.68 143.97 10.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.562 -0.744 . . . . 1.1499999999999999 109.76 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.15 155.42 46.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.934 0.397 . . . . 1.3500000000000001 111.068 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.07 103.93 15.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 1.6599999999999999 110.409 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -117.26 -156.31 0.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.65 -0.705 . . . . 1.03 110.287 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 67.11 80.7 0.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.688 0.617 . . . . 1.3799999999999999 111.274 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.405 ' HE2' ' HB2' ' A' ' 240' ' ' ASN . 19.5 ptm -70.72 167.06 19.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.832 -0.622 . . . . 1.1100000000000001 111.33 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HA ' ' HG ' ' A' ' 213' ' ' LEU . 25.3 mtp180 -84.08 147.99 27.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 1.3700000000000001 111.153 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -129.45 175.64 8.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.32000000000000001 110.567 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.86 167.38 21.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.98999999999999999 109.826 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.3 t80 -123.67 143.08 50.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.636 -0.256 . . . . 0.35999999999999999 110.691 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.6 pt -133.28 115.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.025 0.44 . . . . 0.27000000000000002 110.548 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 180' ' ' LEU . 2.3 pt? -155.84 155.63 29.63 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.028 -0.533 . . . . 0.22 110.238 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.95 161.44 33.07 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.994 2.463 . . . . 0.23000000000000001 113.27 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.8 t -57.65 -35.53 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.607 -0.724 . . . . 0.55000000000000004 111.89 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.31 -39.78 61.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.42999999999999999 111.998 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 49.6 mm-40 -104.46 -17.74 14.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.988 0.423 . . . . 0.46000000000000002 110.529 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.31 -34.6 88.78 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.171 -0.538 . . . . 0.29999999999999999 112.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 30.6 ttpt -71.62 -7.55 48.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.928 0.394 . . . . 1.4299999999999999 111.098 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -84.15 -58.26 2.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.679 0.276 . . . . 1.23 110.704 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -25.66 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 1.1100000000000001 111.21 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.52 -37.21 85.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.837 0.351 . . . . 1.8300000000000001 110.723 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 13.7 mm-40 -90.99 11.23 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.396 -0.366 . . . . 0.76000000000000001 110.684 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -121.1 -49.24 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.09 -36.73 35.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.109 0.781 . . . . 1.0600000000000001 113.109 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 24.8 mtpp -60.93 -50.98 82.54 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 112.228 0.455 . . . . 0.40000000000000002 112.228 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 21.3 Cg_endo -61.43 -19.58 64.93 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.147 1.898 . . . . 0.26000000000000001 112.609 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.95 -13.02 58.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.349 . . . . 1.1200000000000001 110.141 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.1 mt 55.22 59.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.49 -0.777 . . . . 0.56000000000000005 110.371 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 21.37 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.33 -0.85 . . . . 0.68000000000000005 109.783 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.81 149.51 23.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 1.2 110.416 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.66 149.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.374 -0.602 . . . . 1.0800000000000001 109.374 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -73.45 70.01 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 1.3600000000000001 111.005 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.0 m -151.85 37.03 0.56 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.743 -0.662 . . . . 1.1599999999999999 109.397 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.1 pt-20 -88.08 175.25 7.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.596 . . . . 1.6399999999999999 111.798 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.96 146.81 52.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.40000000000000002 109.341 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.35 25.88 9.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.431 0.16 . . . . 1.45 111.431 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.21 -141.88 7.85 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.786 -0.721 . . . . 0.68000000000000005 112.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -74.42 -17.51 60.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.179 0.514 . . . . 2.0 110.642 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 121.38 34.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.699 -0.682 . . . . 1.6899999999999999 109.61 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.71 85.8 6.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.127 0.489 . . . . 0.70999999999999996 110.369 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 25.4 tt0 -76.72 93.61 3.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.817 -0.629 . . . . 1.71 110.048 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.2 127.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.652 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.51 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.855 0.359 . . . . 1.05 110.361 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.8 p -124.51 104.68 8.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.34999999999999998 110.898 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.401 ' HG ' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -164.35 127.37 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.313 -0.625 . . . . 0.35999999999999999 109.313 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.03 -163.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.634 -0.257 . . . . 0.29999999999999999 111.546 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -49.05 148.96 3.66 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.529 -0.76 . . . . 0.77000000000000002 112.388 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.86 -50.09 14.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.134 2.556 . . . . 0.68000000000000005 113.071 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.08 -57.3 8.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.46999999999999997 112.657 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.57 ' HG ' ' CG ' ' A' ' 119' ' ' ASP . 51.4 m -55.88 -36.6 67.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.239 0.459 . . . . 1.0900000000000001 112.239 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.93 -39.75 90.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.096 -0.642 . . . . 0.87 110.609 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -70.89 -8.14 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 2.4100000000000001 110.647 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.46 -22.67 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.755 -0.657 . . . . 1.25 110.571 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 226' ' ' ILE . 7.6 tp -108.69 -29.11 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.453 -0.34 . . . . 1.29 111.459 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 33.9 t70 -61.37 -21.09 63.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.873 0.368 . . . . 0.76000000000000001 111.104 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -26.32 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.85999999999999999 111.114 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 228' ' ' LYS . 0.7 OUTLIER -114.02 -25.53 8.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.575 -0.284 . . . . 0.94999999999999996 110.571 178.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.5 mm -66.51 -33.24 62.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.666 0.27 . . . . 1.46 110.979 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.96 -35.88 77.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.391 . . . . 1.5600000000000001 110.782 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.55 11.21 39.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.239 0.543 . . . . 1.3600000000000001 110.011 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -102.21 -65.77 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.93000000000000005 110.45 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -121.57 -30.1 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 0.75 111.803 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -61.12 -33.05 72.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.161 0.505 . . . . 1.8799999999999999 110.704 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.36 22.82 37.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.71999999999999997 110.974 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -118.66 -57.43 2.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.882 0.372 . . . . 1.9099999999999999 110.4 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.08 -136.08 5.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 0.40000000000000002 112.806 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.7 m -132.59 148.85 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.42999999999999999 110.621 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.68 160.29 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.913 0.387 . . . . 1.01 111.078 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -144.97 157.34 44.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.2 -0.667 . . . . 0.40999999999999998 109.2 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.11 148.34 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.33000000000000002 110.919 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 31.1 tp -97.11 62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.299 0.571 . . . . 1.8100000000000001 109.818 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.405 ' HB2' ' HE2' ' A' ' 174' ' ' MET . 56.3 t30 -119.29 90.38 3.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.806 -0.634 . . . . 1.5 110.191 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.415 HD13 ' H ' ' A' ' 243' ' ' ASP . 0.9 OUTLIER -161.58 127.52 3.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.801 -0.636 . . . . 1.9299999999999999 109.8 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -136.55 60.87 1.65 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.417 0.627 . . . . 1.3400000000000001 110.347 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.415 ' H ' HD13 ' A' ' 241' ' ' LEU . 11.5 t70 -113.55 -67.92 0.96 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.299 -0.864 . . . . 2.1600000000000001 109.322 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 245' ' ' GLU . 4.9 p -117.62 170.53 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.374 -0.83 . . . . 2.4500000000000002 108.77 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.403 ' H ' HG21 ' A' ' 244' ' ' VAL . 43.9 mt-10 -75.81 125.58 29.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.795 0.331 . . . . 2.5899999999999999 110.766 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.28 142.39 46.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.286 -0.415 . . . . 3.4100000000000001 110.39 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.78 142.53 7.19 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.607 -0.806 . . . . 0.89000000000000001 111.93 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -139.66 144.42 37.61 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.714 -0.286 . . . . 0.5 110.802 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.48 3.42 32.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.374 -0.376 . . . . 1.23 110.788 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -74.69 101.43 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.48 . . . . 0.60999999999999999 110.401 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.0 -38.17 19.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.824 -0.625 . . . . 0.71999999999999997 111.076 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.39 -0.814 . . . . 1.1799999999999999 110.899 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.972 -0.451 . . . . 0.79000000000000004 111.972 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -104.96 129.82 53.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.989 -0.375 . . . . 1.04 109.989 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 ttt -164.01 134.73 4.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.236 -0.438 . . . . 2.2599999999999998 110.192 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -79.53 108.14 12.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.042 0.449 . . . . 0.79000000000000004 110.587 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.4 HD11 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -109.16 -179.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.73 -0.668 . . . . 1.27 109.637 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -144.9 120.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.755 0.312 . . . . 2.8100000000000001 110.544 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.422 ' CG2' ' HB ' ' A' ' 15' ' ' THR . 91.3 m -68.1 113.99 18.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.656 -0.702 . . . . 0.70999999999999996 112.592 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -89.24 147.54 5.37 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.958 2.439 . . . . 0.45000000000000001 111.439 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -103.26 136.11 43.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.742 0.306 . . . . 0.23999999999999999 111.231 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t30 65.09 18.4 11.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.624 -0.716 . . . . 0.46000000000000002 112.383 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.89 -3.0 52.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.068 -0.345 . . . . 1.4099999999999999 110.068 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mt 55.1 68.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.568 -0.742 . . . . 1.29 110.922 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -136.37 166.86 22.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.729 -0.669 . . . . 0.34999999999999998 109.5 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -75.78 53.52 0.74 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.977 0.418 . . . . 0.72999999999999998 110.634 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 9.6 p -123.41 -44.83 2.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.991 -0.549 . . . . 1.3799999999999999 111.554 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -112.05 23.51 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 2.6600000000000001 110.593 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -74.41 137.42 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.58999999999999997 112.256 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -91.78 140.26 29.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.614 -0.721 . . . . 0.78000000000000003 110.205 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.07 130.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.186 0.517 . . . . 0.55000000000000004 111.872 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 5.7 p -150.13 126.4 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.574 -0.739 . . . . 0.93999999999999995 109.024 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -132.86 141.7 48.55 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.655 0.613 . . . . 2.4900000000000002 112.655 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttp -113.65 108.71 17.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.166 -0.925 . . . . 0.25 108.806 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -86.94 99.34 11.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.4399999999999999 111.248 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -96.13 167.01 11.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 1.3600000000000001 109.926 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.16 73.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.362 -0.381 . . . . 0.5 111.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.87 -50.78 6.22 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.95 -0.643 . . . . 0.59999999999999998 112.521 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -161.81 147.43 13.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.777 -0.453 . . . . 1.3700000000000001 109.777 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.39 143.87 25.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.671 -0.492 . . . . 1.71 109.671 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.34 132.36 42.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.538 -0.301 . . . . 0.35999999999999999 111.024 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' OE2' ' HD2' ' A' ' 21' ' ' ARG . 22.8 tt0 -124.4 134.87 52.99 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.459 -0.571 . . . . 1.48 109.459 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.37 145.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.404 . . . . 0.38 111.151 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 18' ' ' ALA . . . -106.37 112.77 25.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.479 -0.563 . . . . 1.3400000000000001 109.479 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.1 168.05 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 1.3300000000000001 111.835 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 22.3 t80 -73.26 117.68 15.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.762 -0.654 . . . . 1.8400000000000001 109.854 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HZ1' ' CG ' ' A' ' 243' ' ' ASP . 27.8 ttpt -79.83 82.39 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.398 0.618 . . . . 2.6899999999999999 111.707 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.67 75.5 0.78 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.098 -0.955 . . . . 0.83999999999999997 108.452 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.69 36.19 2.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.956 -1.02 . . . . 1.6399999999999999 109.837 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.18 -40.55 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.493 -0.776 . . . . 0.39000000000000001 110.908 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.58 2.27 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.8899999999999999 110.605 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -27.32 74.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.217 -0.753 . . . . 0.31 111.217 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -72.17 -20.91 61.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.173 0.511 . . . . 0.63 109.974 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -103.06 0.72 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.575 . . . . 0.93000000000000005 110.511 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -129.6 10.73 5.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.298 0.571 . . . . 1.0 110.381 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.68 -138.23 5.24 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.794 -0.922 . . . . 0.64000000000000001 110.794 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.6 121.43 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.825 0.313 . . . . 0.32000000000000001 110.208 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -128.36 -83.85 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.652 -0.249 . . . . 1.1799999999999999 111.501 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.57 172.51 12.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.363 -0.38 . . . . 0.73999999999999999 110.094 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.72 143.77 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.137 -0.32 . . . . 0.28999999999999998 110.137 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.91 -24.88 67.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 1.29 111.24 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -57.83 -37.17 73.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.943 0.401 . . . . 0.38 110.772 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -83.77 -19.61 34.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.972 -0.558 . . . . 2.04 110.798 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.07 -25.47 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 1.1499999999999999 110.938 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 55' ' ' THR . 2.4 mm? -74.76 99.83 3.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.40000000000000002 110.921 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 34' ' ' TYR . 29.2 mt-30 -77.34 -24.48 50.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 1.3400000000000001 110.671 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' HD13 ' A' ' 53' ' ' LEU . 12.6 t -130.63 152.01 50.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 1.1399999999999999 109.808 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -112.53 7.87 19.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.071 0.462 . . . . 0.46999999999999997 110.4 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -110.23 145.59 37.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.016 -0.538 . . . . 0.81000000000000005 109.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 p -112.04 139.8 34.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 0.19 110.934 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -78.01 151.47 33.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 1.1100000000000001 111.547 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.48 -59.34 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.499 -0.319 . . . . 0.70999999999999996 111.636 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -123.68 126.67 46.99 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.456 -0.152 . . . . 0.63 110.825 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.17 -26.36 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 111.957 0.355 . . . . 1.5900000000000001 111.957 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.7 m -72.02 -47.06 54.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.192 0.52 . . . . 1.6200000000000001 110.207 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.47 -22.27 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 2.3100000000000001 110.2 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 44.58 36.6 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 0.46000000000000002 111.374 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -108.02 124.1 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.083 0.468 . . . . 1.6100000000000001 111.068 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.01 145.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.471 -0.786 . . . . 0.58999999999999997 109.606 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.51 126.76 42.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.93000000000000005 110.838 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -97.21 -171.53 2.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.653 -0.703 . . . . 2.04 110.112 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -51.28 -40.21 58.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.699 0.629 . . . . 1.54 112.699 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -62.15 -26.7 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.692 0.627 . . . . 0.46999999999999997 112.692 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -94.17 -44.71 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.682 -0.407 . . . . 0.25 111.751 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.31 -34.69 75.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.929 -0.309 . . . . 0.97999999999999998 111.827 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 74' ' ' ILE . 8.5 tt -67.11 -25.67 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 1.5800000000000001 110.736 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 m -94.58 -43.03 8.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.16 111.387 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.09 -46.43 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.16 112.088 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -94.07 -29.75 15.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 1.21 110.689 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 16.19 54.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.466 -0.874 . . . . 0.80000000000000004 112.184 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.5 m -145.94 124.56 12.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.19 -0.3 . . . . 2.1299999999999999 110.19 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.29 60.68 5.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.433 0.635 . . . . 1.1599999999999999 110.41 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.45 ' OD2' ' HB ' ' A' ' 83' ' ' THR . 19.6 t70 -151.97 111.84 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.728 -0.669 . . . . 2.4100000000000001 109.986 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -68.33 -24.66 64.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.511 . . . . 1.6799999999999999 111.218 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.45 ' HB ' ' OD2' ' A' ' 81' ' ' ASP . 11.6 m -66.82 -45.76 77.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.53 -0.305 . . . . 1.02 110.228 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -58.89 -46.54 87.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.67000000000000004 110.402 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.96 -48.23 87.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.553 -0.749 . . . . 0.40999999999999998 110.596 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.2 -34.6 75.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.19 110.895 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -62.01 -42.21 98.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 0.47999999999999998 110.14 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.55 -40.37 84.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.40000000000000002 110.002 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 20' ' ' VAL . 76.3 mt -68.87 -30.89 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.617 -0.719 . . . . 0.40999999999999998 111.004 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -18.79 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.398 -0.365 . . . . 1.02 111.69 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -105.7 -15.47 14.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.59 -0.444 . . . . 1.03 112.075 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -142.05 36.48 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 3.0 111.164 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.47 165.83 24.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.529 -0.843 . . . . 0.40000000000000002 112.587 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 80.1 mt-10 -82.01 93.49 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 1.52 110.246 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.01 137.24 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.338 -0.392 . . . . 0.28000000000000003 110.227 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -73.31 76.05 1.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.202 0.525 . . . . 0.80000000000000004 111.77 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 m -110.48 -9.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 1.1200000000000001 111.298 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.0 m -147.16 159.35 43.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.604 0.24 . . . . 0.42999999999999999 110.508 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.8 -176.24 3.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 1.3500000000000001 110.155 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 -154.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.425 0.453 . . . . 2.7799999999999998 110.492 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 54.28 38.75 29.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.219 0.533 . . . . 1.5800000000000001 111.655 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -107.34 -90.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 1.3799999999999999 110.218 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -159.17 136.28 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.645 0.259 . . . . 1.23 110.405 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -151.81 108.76 3.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.251 -0.432 . . . . 1.51 110.416 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -118.99 93.5 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.072 0.463 . . . . 2.0299999999999998 110.202 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 mt -140.7 171.77 13.64 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.718 -0.674 . . . . 0.34000000000000002 109.797 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.76 -48.84 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.744 0.652 . . . . 1.29 111.381 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -121.87 76.45 1.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 1.24 110.251 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.75 -40.93 80.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.372 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.656 -0.702 . . . . 0.59999999999999998 111.622 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -88.68 -39.2 14.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.84 0.352 . . . . 0.40999999999999998 110.937 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.5 -40.93 93.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 1.47 110.973 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 tt -76.14 -16.15 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.148 0.499 . . . . 0.58999999999999997 110.802 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.27 -38.7 13.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 0.22 111.071 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.9 t -66.25 -19.88 65.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.744 0.307 . . . . 0.37 111.686 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.0 tp -88.35 -6.56 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.021 0.439 . . . . 0.5 110.823 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 120' ' ' LYS . 4.9 p -124.26 -8.11 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.815 0.341 . . . . 0.22 111.365 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.35 -51.81 66.89 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.327 0.492 . . . . 0.62 112.327 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -84.75 -11.86 54.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 2.2200000000000002 110.79 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 117' ' ' VAL . 13.1 mptt -82.97 -9.88 59.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.01 -0.541 . . . . 1.6100000000000001 110.721 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 6.6 t -155.28 83.78 1.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.248 0.547 . . . . 0.63 109.556 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.11 175.91 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.774 -0.648 . . . . 1.74 112.092 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 123' ' ' ASN . 0.2 OUTLIER -101.66 158.45 31.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.575 -0.739 . . . . 1.1599999999999999 110.625 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.72 -69.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.603 2.202 . . . . 1.1599999999999999 111.573 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -133.88 82.32 1.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.462 0.649 . . . . 1.1299999999999999 110.652 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.1 m -147.85 -53.65 0.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.432 -0.804 . . . . 1.9099999999999999 109.216 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG3' ' H ' ' A' ' 128' ' ' ARG . 3.2 tppt? -152.82 -155.76 0.64 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.439 -0.948 . . . . 1.8600000000000001 108.439 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 18.3 mtt180 -135.29 162.66 56.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 110.485 -0.191 . . . . 1.76 110.485 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.94 -178.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.271 2.647 . . . . 0.64000000000000001 113.415 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 62.63 26.07 15.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.5 -0.773 . . . . 1.73 110.198 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 m -131.08 94.17 3.53 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.768 -0.651 . . . . 0.84999999999999998 110.493 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -69.39 -38.23 76.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.964 -0.562 . . . . 0.59999999999999998 110.934 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.9 mm -52.82 -34.58 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.783 -0.644 . . . . 0.34000000000000002 112.32 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -50.07 72.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.563 0.221 . . . . 1.24 111.561 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.1 tp -77.31 -30.66 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.71999999999999997 110.613 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.37 -44.73 86.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.52000000000000002 110.3 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -34.52 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 1.51 110.4 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.73 -48.58 53.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.178 -0.464 . . . . 0.28000000000000003 110.708 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 44.0 ttp -65.76 -36.71 84.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 2.4199999999999999 110.847 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -65.19 -26.4 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 2.3500000000000001 110.781 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.25 -38.15 51.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.182 -0.463 . . . . 0.55000000000000004 110.897 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 144' ' ' TYR . 8.6 mt -77.51 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.645 . . . . 0.47999999999999998 111.422 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.3 t60 75.06 -24.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.865 0.728 . . . . 1.6499999999999999 111.674 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 142' ' ' ILE . 29.8 t80 -70.86 135.06 47.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.165 -0.309 . . . . 1.3500000000000001 110.165 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 170.38 10.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.426 -0.352 . . . . 0.59999999999999998 110.665 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.21 48.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.33000000000000002 110.536 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 52.41 30.23 7.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.88 111.341 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 148' ' ' THR . 14.6 t 42.33 73.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.341 1.056 . . . . 1.1499999999999999 112.497 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p30 51.37 18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.705 1.202 . . . . 0.64000000000000001 114.114 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.05 140.47 48.43 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.97 -0.456 . . . . 1.78 111.046 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.4 m 62.57 38.96 11.98 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.66000000000000003 110.915 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -63.93 -33.82 76.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.775 -0.648 . . . . 1.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.94 4.07 31.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.855 0.359 . . . . 1.75 110.95 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -105.16 -54.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.28000000000000003 110.834 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -94.91 16.75 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 0.69999999999999996 111.935 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -57.69 -42.8 84.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.894 0.378 . . . . 0.29999999999999999 111.133 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.37 3.16 32.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.76000000000000001 111.881 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -111.46 -48.64 3.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 1.1499999999999999 110.798 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.427 ' O ' HD11 ' A' ' 163' ' ' LEU . 58.5 t -64.65 -39.21 84.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 0.27000000000000002 110.863 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.5 tt -68.22 -9.86 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.189 -0.46 . . . . 0.27000000000000002 111.356 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -102.67 -35.46 8.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.822 -0.436 . . . . 2.0499999999999998 109.822 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -57.37 -56.61 19.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.342 -0.845 . . . . 1.01 111.778 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.566 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -72.41 -21.76 61.21 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.68 -0.408 . . . . 0.57999999999999996 111.218 -178.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.02 -31.24 67.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.94999999999999996 110.008 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.05 -32.91 73.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.653 -0.703 . . . . 1.03 109.87 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.43 -44.65 14.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.701 -0.681 . . . . 2.3700000000000001 110.427 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.0 tpp -145.99 126.32 13.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.36 -0.382 . . . . 1.8100000000000001 110.655 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -80.69 122.5 27.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.815 -0.439 . . . . 1.77 109.815 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 123' ' ' ASN . 0.2 OUTLIER -122.57 172.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.40999999999999998 111.673 -178.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -95.88 -101.4 0.17 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.906 -0.588 . . . . 0.17999999999999999 110.098 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -175.93 167.33 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.101 -0.333 . . . . 0.56000000000000005 110.101 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.47 160.99 21.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.26000000000000001 110.514 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.489 ' CD2' ' HB3' ' A' ' 216' ' ' PRO . 42.3 m-70 -130.6 159.95 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.466 -0.568 . . . . 0.42999999999999999 109.466 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 60.2 mtm -96.5 -179.02 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 3.1600000000000001 111.226 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 242' ' ' LYS . 18.9 mtm180 -76.42 133.0 39.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.802 -0.635 . . . . 0.85999999999999999 110.466 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt -105.39 147.02 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.024 -0.535 . . . . 1.77 110.896 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.585 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 17.1 ptt180 -128.82 141.9 51.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.245 -0.65 . . . . 0.68000000000000005 109.245 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.8 128.27 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.799 0.333 . . . . 0.26000000000000001 110.754 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 30.8 pt -102.02 137.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 1.1200000000000001 110.763 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.7 123.48 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.83999999999999997 109.591 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.26 142.77 45.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.552 2.168 . . . . 0.22 112.032 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.7 t -45.56 -37.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.153 0.581 . . . . 0.34999999999999998 112.176 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -48.5 -40.61 27.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.912 -0.586 . . . . 0.45000000000000001 112.151 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -117.93 7.23 12.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.01 0.433 . . . . 0.48999999999999999 110.526 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.502 ' O ' HD21 ' A' ' 188' ' ' LEU . . . -66.57 -31.21 77.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.32000000000000001 112.777 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 82.1 tttt -63.74 -29.02 70.28 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.69 -0.3 . . . . 2.1400000000000001 111.28 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.76 -47.52 84.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.58999999999999997 111.601 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.502 HD21 ' O ' ' A' ' 185' ' ' GLY . 0.1 OUTLIER -85.77 -22.04 27.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.857 0.36 . . . . 0.65000000000000002 110.607 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -60.1 -52.15 66.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.941 -0.572 . . . . 1.72 110.971 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 11.3 pt-20 -89.27 22.25 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.90000000000000002 111.253 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.455 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -121.38 -47.08 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.511 -0.313 . . . . 0.92000000000000004 111.172 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.01 -39.14 21.66 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.493 0.553 . . . . 1.3200000000000001 112.493 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 53.2 mttm -59.89 -49.92 89.05 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.815 0.672 . . . . 1.9199999999999999 112.815 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.0 Cg_endo -60.18 -19.77 58.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.135 1.89 . . . . 0.29999999999999999 113.044 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 86.3 mt -79.09 -14.43 59.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.607 -0.269 . . . . 0.25 110.438 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.7 mm 56.22 41.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.801 0.81 . . . . 0.26000000000000001 110.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -124.91 28.81 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.343 -0.844 . . . . 0.67000000000000004 109.949 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.6 m -119.13 156.07 21.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.335 -0.848 . . . . 0.17999999999999999 110.43 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.68 147.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.531 -0.544 . . . . 1.54 109.531 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.82 76.3 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 1.23 110.945 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.0 m -155.56 26.3 0.39 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 0.20000000000000001 109.521 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 2.7 mp0 -80.37 162.61 24.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 1.79 111.641 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -109.16 143.26 38.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.903 -0.777 . . . . 1.6000000000000001 108.903 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.75 37.94 3.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 1.22 110.69 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -99.74 -97.67 2.18 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.705 -0.759 . . . . 0.66000000000000003 112.078 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -95.73 -22.32 17.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.158 0.504 . . . . 2.25 110.916 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.49 160.79 37.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.75 109.999 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.15 80.11 2.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.042 0.449 . . . . 1.1899999999999999 110.101 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.585 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 47.2 tt0 -76.62 96.78 4.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.44 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 37.9 mm -96.95 139.55 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.866 0.365 . . . . 1.1399999999999999 111.152 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.76 116.57 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.39000000000000001 110.323 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.2 p -139.28 96.13 3.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.351 . . . . 0.97999999999999998 110.676 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.44 136.66 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.495 -0.557 . . . . 0.84999999999999998 109.495 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.16 -45.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.601 0.238 . . . . 0.94999999999999996 111.191 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -168.92 158.16 7.66 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.564 -0.289 . . . . 0.90000000000000002 110.235 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.489 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 18.8 Cg_endo -62.54 -16.71 54.03 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.816 2.344 . . . . 0.72999999999999998 113.197 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -71.06 -60.05 4.71 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.004 -0.617 . . . . 0.33000000000000002 112.388 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 222' ' ' ILE . 2.2 m -79.0 -8.71 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.973 0.415 . . . . 0.34999999999999998 110.847 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.19 -29.4 68.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.34000000000000002 111.873 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -60.54 -50.61 72.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 0.52000000000000002 111.065 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -77.86 2.27 17.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 1.24 111.608 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.542 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 28.2 mm -101.76 -55.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.878 0.371 . . . . 2.0099999999999998 110.382 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.81 -26.08 67.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.35999999999999999 111.813 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.5 -26.35 65.21 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.195 -0.457 . . . . 1.1000000000000001 111.795 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.0 pp -106.65 -34.01 7.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.33000000000000002 110.126 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.0 mm -55.78 -35.3 39.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.077 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 18.1 ptpt -53.32 -37.17 62.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.582 -0.735 . . . . 2.4300000000000002 112.426 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -19.69 13.7 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.594 -0.443 . . . . 3.1200000000000001 112.15 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.5 -41.07 48.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.213 0.449 . . . . 1.3799999999999999 112.213 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.1 t -142.22 -32.52 0.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.257 0.836 . . . . 0.59999999999999998 113.257 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 37.5 ttmt -57.75 -47.57 82.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.781 0.324 . . . . 1.73 111.462 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.03 10.72 71.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.965 -0.636 . . . . 0.23000000000000001 112.404 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -112.32 -59.86 1.94 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.52000000000000002 110.188 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -106.46 -119.15 4.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.29999999999999999 111.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 7.9 m -143.67 150.69 39.09 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 122.703 -0.292 . . . . 0.47999999999999998 110.574 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.83 142.98 40.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 2.1099999999999999 111.045 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.84 -173.78 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.988 -0.551 . . . . 1.04 109.718 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.93 153.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.418 . . . . 0.28999999999999998 111.772 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.83 96.1 6.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 1.21 109.724 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.41 -23.46 61.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.71999999999999997 111.089 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.99 114.9 16.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.102 -0.499 . . . . 0.94999999999999996 110.408 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.479 ' HA ' ' NH2' ' A' ' 175' ' ' ARG . 54.2 mtmt -132.22 24.74 4.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.815 -0.63 . . . . 3.7999999999999998 110.409 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.504 ' CG ' ' HZ1' ' A' ' 35' ' ' LYS . 3.3 m-20 -111.14 -70.06 0.83 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.705 . . . . 0.65000000000000002 110.092 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.45 149.08 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.249 -0.648 . . . . 0.28999999999999998 109.249 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.39 121.8 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 1.79 111.205 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -126.83 178.46 5.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.552 -0.749 . . . . 2.0600000000000001 109.213 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.15 -161.97 9.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.409 -1.377 . . . . 0.56999999999999995 113.866 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 202' ' ' GLU . 12.6 p-10 -76.86 21.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.499 0.72 . . . . 0.17999999999999999 112.495 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -80.02 -8.61 59.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.104 0.478 . . . . 1.0 110.355 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -90.55 68.98 6.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.897 -0.592 . . . . 0.46000000000000002 109.959 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -71.16 -43.81 66.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.985 -0.552 . . . . 0.95999999999999996 109.787 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.664 -0.684 . . . . 1.54 110.192 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.208 -0.757 . . . . 0.85999999999999999 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.26 -35.69 73.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.765 0.283 . . . . 2.8500000000000001 110.763 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' MET . 1.4 ptp -117.29 133.55 55.85 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.996 0.427 . . . . 0.55000000000000004 110.734 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.4 m -132.26 163.3 28.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 1.1200000000000001 109.56 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tt -98.82 119.75 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.159 0.504 . . . . 0.40999999999999998 110.921 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -143.42 -62.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.01 110.319 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.6 m -155.13 104.51 2.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 0.37 111.544 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -88.43 126.31 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.583 2.189 . . . . 0.44 111.704 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 t -113.65 132.03 55.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.37 110.795 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -171.55 -59.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.93000000000000005 109.566 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB3' ' H ' ' A' ' 12' ' ' ILE . 17.7 mm-40 -128.08 -157.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.662 -0.699 . . . . 3.2200000000000002 111.031 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.458 ' H ' ' HB3' ' A' ' 11' ' ' GLN . 18.2 mm -69.42 100.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.118 0.485 . . . . 1.52 111.099 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -136.25 134.56 38.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.631 -0.713 . . . . 1.8400000000000001 109.744 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.6 mt -66.18 -4.76 8.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.167 0.432 . . . . 1.75 112.167 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -20.34 52.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.124 0.488 . . . . 0.63 111.069 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -114.36 71.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.48999999999999999 110.278 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.5 m -123.13 121.79 63.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.42999999999999999 111.762 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.76 116.16 31.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.619 . . . . 0.46000000000000002 109.327 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.56 109.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.104 0.478 . . . . 1.1299999999999999 111.685 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 p -105.92 129.44 59.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.541 -0.911 . . . . 0.47999999999999998 108.541 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -125.72 125.4 42.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.372 -0.531 . . . . 0.68000000000000005 112.095 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.27 116.18 28.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 1.0700000000000001 109.603 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 128.54 54.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 1.96 110.622 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -113.67 -156.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.617 -0.72 . . . . 1.6000000000000001 109.501 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.86 -60.33 2.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.39000000000000001 110.878 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.18 32.43 3.96 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.959 -0.639 . . . . 0.33000000000000002 111.713 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.02 142.42 31.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 2.3199999999999998 109.726 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.12 125.66 10.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.509 -0.314 . . . . 2.2200000000000002 110.572 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -144.35 132.02 21.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.333 -0.394 . . . . 0.37 110.727 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.91 138.17 43.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.444 . . . . 0.68000000000000005 110.424 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.448 HG23 ' H ' ' A' ' 32' ' ' ALA . 1.1 mt -136.76 172.22 15.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.781 0.324 . . . . 1.97 110.656 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' H ' HG23 ' A' ' 31' ' ' ILE . . . -124.84 107.91 11.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.107 -0.497 . . . . 0.28999999999999998 109.993 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 m -98.55 -161.84 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.23999999999999999 110.077 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.57 -173.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.443 0.164 . . . . 1.03 110.624 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -74.47 -133.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.943 0.401 . . . . 1.6699999999999999 111.499 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 14.6 m120 -64.69 6.21 0.24 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.091 0.774 . . . . 0.68000000000000005 113.091 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 -15.0 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.222 -0.299 . . . . 1.51 110.913 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.23 -27.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.328 0.492 . . . . 0.33000000000000002 112.328 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.83 101.43 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.223 0.535 . . . . 1.01 111.091 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.44 45.69 75.21 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.291 -0.868 . . . . 0.28000000000000003 112.574 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 56.24 51.78 11.18 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.85999999999999999 110.34 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 63.32 33.09 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 2.3300000000000001 110.461 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.3 m 61.81 32.51 18.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.753 -0.658 . . . . 0.27000000000000002 110.989 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.09 -76.53 0.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.272 -0.731 . . . . 0.32000000000000001 111.272 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -166.61 136.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.72999999999999998 110.261 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.67 -87.11 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.153 -0.476 . . . . 2.1400000000000001 110.791 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 20.2 ptmt -163.88 -48.97 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.771 0.286 . . . . 1.6799999999999999 111.771 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.51 127.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.905 -0.405 . . . . 2.04 109.905 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.06 -24.35 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.225 -0.443 . . . . 1.5 111.669 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.63 -41.88 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.02 0.438 . . . . 1.98 110.587 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -78.31 -30.31 48.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 1.8700000000000001 110.169 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.28 -33.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.94999999999999996 110.143 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.28 84.88 6.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.184 -0.462 . . . . 0.34000000000000002 110.458 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.0 -61.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.747 -0.661 . . . . 0.90000000000000002 110.973 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.23 120.24 22.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.953 0.406 . . . . 0.13 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -99.03 5.96 46.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.322 -0.399 . . . . 1.0900000000000001 110.683 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.25 114.75 28.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.895 -0.593 . . . . 0.57999999999999996 110.072 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 31' ' ' ILE . 3.7 p -89.12 136.82 22.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.88 110.507 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -95.21 149.22 21.56 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.11 -0.33 . . . . 0.46999999999999997 110.11 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.17 -45.39 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.458 0.647 . . . . 1.1200000000000001 109.745 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -155.46 107.86 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.485 -0.78 . . . . 2.6000000000000001 109.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.59 -28.98 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.59 . . . . 0.59999999999999998 112.095 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.6 m -73.42 -16.7 61.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.876 0.369 . . . . 1.3700000000000001 111.299 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -13.82 14.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.814 0.34 . . . . 1.1200000000000001 110.45 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.77 75.78 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.31 111.751 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -87.24 112.04 21.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.981 0.419 . . . . 1.8 110.964 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 t -98.0 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.93999999999999995 109.621 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.93 115.11 27.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.864 -0.421 . . . . 1.03 109.864 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.088 -0.506 . . . . 1.6000000000000001 109.747 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -59.4 -30.23 68.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.098 0.475 . . . . 1.5 110.436 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.99 -19.68 54.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.623 -0.717 . . . . 2.3199999999999998 110.899 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.57 -47.58 8.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.51000000000000001 110.966 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 2.3 pp -67.02 -31.77 72.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.259 -0.428 . . . . 0.20000000000000001 111.399 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.46 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.708 0.289 . . . . 1.25 111.384 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -91.38 -9.42 44.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.728 0.299 . . . . 1.23 111.663 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.42 -43.15 5.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.20000000000000001 111.417 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -92.09 -37.5 12.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.49 -0.323 . . . . 0.31 110.75 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.03 -17.95 29.11 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.14999999999999999 112.128 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -116.53 142.22 47.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.917 -0.401 . . . . 0.91000000000000003 109.917 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.65 2.38 48.64 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.98 0.419 . . . . 0.32000000000000001 111.053 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.54 109.0 20.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.543 -0.54 . . . . 1.29 109.543 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -33.17 75.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 0.79000000000000004 111.764 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.32 78.62 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.933 0.397 . . . . 1.3999999999999999 111.114 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -36.9 83.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.746 -0.661 . . . . 1.9399999999999999 110.487 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.8 mt -72.0 -41.56 68.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 1.02 110.328 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.28 -37.79 78.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.871 -0.604 . . . . 0.14999999999999999 110.011 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -61.43 -42.6 99.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.415 -0.811 . . . . 1.8999999999999999 110.409 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.68 -49.17 64.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.923 -0.58 . . . . 1.27 110.775 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.7 mt -57.88 -34.43 48.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.041 -0.527 . . . . 1.1899999999999999 111.413 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -41.34 87.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.42 0.526 . . . . 1.01 112.42 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -96.84 -11.7 24.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.001 0.741 . . . . 1.1200000000000001 113.001 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -106.6 -31.28 8.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.173 0.434 . . . . 1.1399999999999999 112.173 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.56 -173.65 29.58 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.479 -0.867 . . . . 0.45000000000000001 113.136 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -91.74 107.26 19.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.397 . . . . 1.8799999999999999 110.978 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.02 134.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.803 -0.814 . . . . 0.73999999999999999 108.803 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 96.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 1.48 111.491 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 99' ' ' ASP . 15.4 m -122.98 -17.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 1.4299999999999999 110.245 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 m 63.63 23.37 13.53 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.724 -0.671 . . . . 1.46 110.939 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 97' ' ' VAL . 5.6 t70 -122.67 -50.47 1.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.48 -0.782 . . . . 0.91000000000000003 110.747 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HZ2' ' CG ' ' A' ' 99' ' ' ASP . 35.2 mmtm -119.05 42.51 2.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.909 0.385 . . . . 1.25 111.129 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -70.05 138.8 52.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 1.6200000000000001 110.238 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.42 174.16 6.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.348 -0.387 . . . . 2.7799999999999998 110.093 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -61.43 130.8 47.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.56000000000000005 111.058 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.33 179.66 7.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.757 -0.656 . . . . 0.84999999999999998 109.749 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -79.85 107.87 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.317 0.579 . . . . 0.90000000000000002 110.612 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -84.55 93.45 8.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 2.04 110.502 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -128.99 -148.28 0.37 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.697 -0.683 . . . . 2.5600000000000001 110.686 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -56.41 -22.32 30.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.423 -0.353 . . . . 1.51 111.691 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 ttt -50.52 -47.53 57.43 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.046 -0.525 . . . . 1.46 111.862 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -77.44 -28.7 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 1.1399999999999999 110.991 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -41.83 85.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.104 0.478 . . . . 1.6000000000000001 110.218 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.42 -49.09 78.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.41999999999999998 111.652 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -69.72 -35.4 65.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.844 -0.342 . . . . 0.51000000000000001 111.712 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.16 111.73 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 112' ' ' ASP . 6.6 t -72.66 -16.9 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.26000000000000001 111.447 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 112' ' ' ASP . 36.3 mm -83.01 -46.06 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 0.23999999999999999 110.415 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -70.99 -37.19 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.23999999999999999 110.634 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.664 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . . . -68.31 -19.61 64.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.131 0.491 . . . . 0.32000000000000001 110.709 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.73 -7.24 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.639 -0.709 . . . . 0.84999999999999998 110.262 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 0.77 10.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.264 0.468 . . . . 1.3100000000000001 112.264 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.664 ' SG ' ' HA ' ' A' ' 118' ' ' ALA . 31.6 p -120.8 142.53 49.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.95 -0.3 . . . . 0.23000000000000001 110.874 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -100.19 165.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.849 -0.426 . . . . 0.91000000000000003 109.849 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -140.94 156.75 68.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 110.005 -0.369 . . . . 0.42999999999999999 110.005 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 126' ' ' THR . 97.5 Cg_endo -80.71 -156.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.456 2.104 . . . . 0.51000000000000001 111.827 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.2 104.87 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.619 . . . . 1.26 110.885 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 124' ' ' PRO . 2.1 t -144.53 -47.84 0.26 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.712 -0.677 . . . . 1.1100000000000001 110.297 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.52 -63.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 1.51 109.972 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' A' ' 130' ' ' TYR . 62.7 mtt-85 -150.82 146.04 18.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.728 -0.471 . . . . 1.4199999999999999 109.728 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.97 11.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.96 2.44 . . . . 0.58999999999999997 112.508 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 128' ' ' ARG . 6.0 t80 -152.34 89.89 1.46 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.155 -0.683 . . . . 1.6499999999999999 109.155 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 133' ' ' ILE . 10.4 m -152.69 131.89 12.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.457 . . . . 0.70999999999999996 110.535 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -69.07 -29.09 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.631 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.407 ' H ' HG22 ' A' ' 131' ' ' THR . 48.6 mm -51.79 -33.4 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.324 0.49 . . . . 0.32000000000000001 112.324 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -56.79 -51.38 69.16 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.969 0.414 . . . . 0.91000000000000003 110.823 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.4 -33.85 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.093 -0.503 . . . . 2.5899999999999999 110.285 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.25 -47.09 82.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.74 110.534 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -37.19 86.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.976 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 -42.88 66.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.23999999999999999 111.586 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.569 ' O ' ' HB3' ' A' ' 143' ' ' HIS . 20.4 ptt? -67.45 -31.09 71.02 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.878 0.325 . . . . 0.93999999999999995 111.878 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -82.86 -17.73 42.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.401 . . . . 0.80000000000000004 110.105 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.67 -49.57 11.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.219 -0.66 . . . . 0.92000000000000004 109.219 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.7 mm -117.1 88.08 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.58999999999999997 110.651 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.569 ' HB3' ' O ' ' A' ' 139' ' ' MET . 24.8 p80 -132.78 15.56 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.541 . . . . 1.53 110.202 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.34 164.44 17.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.604 -0.726 . . . . 0.87 109.614 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -69.56 113.97 7.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.191 -0.3 . . . . 1.6000000000000001 110.191 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.68 -49.32 81.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.998 -0.546 . . . . 0.34000000000000002 110.253 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.504 ' HB3' ' OD1' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -143.63 119.61 10.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 1.71 109.732 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -18.69 59.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.57999999999999996 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 24.1 p-10 -84.63 -16.38 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.34000000000000002 110.837 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -104.58 132.27 51.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 1.3300000000000001 110.112 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.9 m -84.12 168.86 15.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.352 -0.385 . . . . 1.02 110.775 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -57.72 -36.58 72.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.51000000000000001 111.708 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -79.48 5.58 12.49 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 2.1299999999999999 112.098 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -111.15 -56.35 2.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.801 0.334 . . . . 0.65000000000000002 111.116 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.413 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.4 pt20 -99.25 27.92 4.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.479 -0.328 . . . . 0.71999999999999997 111.55 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.13 -48.68 70.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.23000000000000001 112.092 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.79 -30.84 64.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.352 -0.385 . . . . 0.28000000000000003 111.022 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.001 -0.28 . . . . 1.6499999999999999 110.437 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 155' ' ' GLN . 52.4 t -63.33 -52.9 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.371 -0.377 . . . . 1.3300000000000001 110.595 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.9 -32.24 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.345 -0.389 . . . . 0.57999999999999996 110.984 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -70.54 -35.11 72.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 2.29 110.244 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -35.46 80.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.93999999999999995 110.221 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.18 -37.6 81.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.344 0.592 . . . . 0.38 109.514 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -69.79 -33.32 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.163 -0.926 . . . . 2.1899999999999999 111.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 -27.56 64.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.885 0.374 . . . . 1.28 110.752 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -81.12 -47.21 13.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.704 -0.48 . . . . 1.8799999999999999 109.704 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.3 tpt -134.13 99.39 4.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.403 -0.591 . . . . 1.9199999999999999 109.403 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 113.06 5.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 1.29 111.151 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.472 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -91.31 160.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.453 -0.794 . . . . 1.45 110.521 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . 8.8 tp10 -101.53 155.33 18.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.732 -0.47 . . . . 0.83999999999999997 109.732 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -56.27 148.32 18.84 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.969 0.414 . . . . 2.1099999999999999 111.525 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.64 152.6 45.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.821 -0.627 . . . . 0.37 111.409 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.67 130.29 43.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.41999999999999998 111.018 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -87.34 179.94 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.34999999999999998 110.592 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.97 137.81 49.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 1.3799999999999999 110.451 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 32.2 mt -118.26 149.67 40.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.614 -0.513 . . . . 1.6299999999999999 109.614 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.432 ' HG2' ' HG2' ' A' ' 209' ' ' GLU . 16.1 ttp180 -110.67 136.78 49.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.386 -0.37 . . . . 1.4099999999999999 110.27 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 52.6 m-85 -99.65 137.94 37.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.28000000000000003 110.381 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -126.31 128.05 71.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.29999999999999999 110.581 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -167.63 155.51 8.35 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 1.1100000000000001 110.614 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.97 160.02 35.64 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.853 2.369 . . . . 0.29999999999999999 112.732 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.5 t -57.94 -37.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.251 -0.431 . . . . 0.28999999999999998 111.315 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -51.4 -38.77 55.16 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.65000000000000002 111.748 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 0.7 OUTLIER -102.05 -26.79 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.68999999999999995 111.282 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.51 -34.24 87.7 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 116.054 -0.521 . . . . 0.17000000000000001 113.61 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -61.69 -25.88 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.723 -0.281 . . . . 2.0600000000000001 111.596 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.511 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 13.4 mptt -62.35 -41.85 98.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.978 0.418 . . . . 1.3999999999999999 110.874 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 1.1 pp -87.75 -30.32 20.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.433 -0.348 . . . . 0.34000000000000002 111.133 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.33 -31.96 71.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 1.0700000000000001 111.675 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -86.62 -7.57 58.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.616 0.599 . . . . 1.71 112.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.511 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 26.1 mtmt -122.7 -29.89 3.95 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.129 0.788 . . . . 1.53 113.129 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -87.18 -32.82 19.62 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.164 0.431 . . . . 1.5 112.164 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 2.1 mtpt -72.55 -43.45 9.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.142 0.793 . . . . 1.76 113.142 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 11.0 Cg_endo -54.31 -34.63 80.96 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 122.415 2.077 . . . . 0.54000000000000004 113.642 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -92.73 13.75 19.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.772 -0.371 . . . . 0.90000000000000002 111.462 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 18.6 pt 33.22 56.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.435 1.094 . . . . 1.05 113.897 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -109.98 16.71 21.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 1.0700000000000001 109.773 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.41 152.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.376 -0.829 . . . . 0.65000000000000002 110.769 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 4.6 mp -84.89 144.8 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.347 -0.612 . . . . 1.4199999999999999 109.347 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -72.43 74.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.405 0.621 . . . . 2.46 111.029 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 m -157.07 27.04 0.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.296 -0.865 . . . . 1.6799999999999999 109.146 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 137.98 34.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.768 -0.651 . . . . 1.27 111.342 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.04 117.34 33.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.457 -0.571 . . . . 0.57999999999999996 109.457 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.426 ' H ' ' HB3' ' A' ' 248' ' ' ASP . 78.2 m-85 -98.62 59.2 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.983 0.42 . . . . 0.81000000000000005 111.342 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -109.24 -127.74 5.52 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.417 -0.896 . . . . 0.34999999999999998 111.684 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.06 -28.6 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 1.5700000000000001 109.458 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -118.62 117.97 30.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.805 -1.089 . . . . 1.23 108.405 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mp -80.42 79.09 7.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.126 0.489 . . . . 0.96999999999999997 111.093 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 6.0 tt0 -86.25 106.23 17.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.561 -0.745 . . . . 1.8100000000000001 109.201 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 8.0 mt -120.62 146.9 24.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.939 -0.573 . . . . 0.54000000000000004 111.089 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER -104.22 122.27 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.804 -0.443 . . . . 1.3600000000000001 109.804 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.544 ' O ' HD21 ' A' ' 213' ' ' LEU . 12.8 t -144.39 79.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.643 -0.423 . . . . 0.16 111.717 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 212' ' ' CYS . 0.6 OUTLIER -140.39 116.08 10.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.41999999999999998 109.622 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.3 tt -94.12 172.76 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 1.3500000000000001 111.432 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.452 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -58.01 168.89 1.02 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.612 0.765 . . . . 0.57999999999999996 111.513 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 41.3 Cg_endo -66.68 -172.66 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.271 1.981 . . . . 0.70999999999999996 112.875 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.03 -75.04 1.94 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.656 -0.783 . . . . 0.27000000000000002 111.435 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.96 -1.91 55.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.063 0.459 . . . . 1.1100000000000001 110.581 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.07 -26.78 67.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.548 . . . . 0.27000000000000002 111.449 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -80.2 -32.66 38.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.412 . . . . 2.3999999999999999 110.526 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -72.51 -36.12 68.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.41999999999999998 110.594 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 13.3 tt -79.32 -26.16 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.40999999999999998 110.849 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.85 -32.22 70.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.325 -0.398 . . . . 0.75 110.88 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.63 -35.47 68.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.0800000000000001 111.778 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.9 pp -95.02 -37.3 11.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.773 -0.371 . . . . 0.69999999999999996 110.889 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 33.5 mm -58.22 -39.87 75.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.718 0.294 . . . . 1.1499999999999999 111.308 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -63.98 -20.15 65.67 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.798 0.666 . . . . 1.52 112.798 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -118.96 5.06 11.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.745 -0.382 . . . . 2.25 111.841 -179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 1.0 OUTLIER -108.38 -73.39 0.69 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.846 0.355 . . . . 1.0 111.207 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -100.81 -34.95 9.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.077 0.399 . . . . 0.56000000000000005 112.077 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 61.4 tttm -77.54 -23.88 50.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.52 110.598 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.48 -8.44 62.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.25 112.044 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -113.46 -7.01 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 2.04 111.292 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -157.99 179.19 33.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.168 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 t -91.91 162.94 14.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.784 -0.45 . . . . 0.46999999999999997 109.784 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.51 144.83 44.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.797 0.332 . . . . 1.1299999999999999 110.912 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -140.63 176.49 8.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.885 -0.598 . . . . 1.8500000000000001 109.987 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.39 145.3 11.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.044 0.45 . . . . 0.71999999999999997 111.17 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.3 tp -72.01 -5.79 37.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.368 0.604 . . . . 1.5600000000000001 110.522 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.78 -6.12 47.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.694 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 91.73 3.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.043 -0.526 . . . . 2.0600000000000001 110.198 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.489 ' HZ3' ' CD ' ' A' ' 246' ' ' GLU . 23.2 mmmt -102.7 44.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.624 . . . . 1.5600000000000001 110.604 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.92 18.97 12.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.305 -0.407 . . . . 1.6000000000000001 111.195 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 245' ' ' GLU . 3.9 p -151.52 177.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.484 -0.561 . . . . 1.0600000000000001 109.484 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.465 ' H ' HG22 ' A' ' 244' ' ' VAL . 57.1 mm-40 -57.78 146.7 30.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.324 0.39 . . . . 2.0499999999999998 110.887 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.489 ' CD ' ' HZ3' ' A' ' 242' ' ' LYS . 27.2 tt0 -151.79 120.13 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.429 -0.351 . . . . 1.0800000000000001 110.752 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 75.72 96.21 0.15 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.117 -0.563 . . . . 0.38 112.777 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 204' ' ' TYR . 44.8 t0 -123.11 84.99 2.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.294 0.569 . . . . 0.75 110.119 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 12.32 37.16 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.16 -0.682 . . . . 0.89000000000000001 109.16 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -85.66 91.52 8.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.946 -1.025 . . . . 0.47999999999999998 109.186 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.33 -20.85 39.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 2.8500000000000001 111.646 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 119.073 -0.489 . . . . 0.96999999999999997 110.487 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.93 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -155.24 171.15 20.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.881 -0.785 . . . . 0.64 108.881 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -78.9 -56.65 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.578 0.227 . . . . 1.61 111.518 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.26 90.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 0.38 111.099 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.2 mmt-85 -148.1 149.77 32.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.474 -0.33 . . . . 1.56 110.213 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.69 -6.32 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.984 0.421 . . . . 1.12 111.371 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -11.14 45.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.57 110.716 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -119.15 25.57 10.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.012 -0.54 . . . . 0.2 111.354 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 30.7 m -90.63 151.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.167 0.508 . . . . 0.21 111.843 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.88 139.15 42.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.323 -0.853 . . . . 0.15 109.342 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 46.0 t -80.13 120.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.906 0.384 . . . . 0.51 111.306 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 31' ' ' ILE . 2.4 p -149.75 131.08 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 0.15 109.572 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.7 ptt180 -148.67 148.58 30.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.835 0.35 . . . . 0.4 111.767 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 40.4 ttp -108.1 129.85 55.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.128 -0.487 . . . . 0.22 110.095 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.06 114.16 25.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.062 -0.517 . . . . 1.38 110.148 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.6 175.37 6.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 1.3 109.541 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.67 92.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.704 0.288 . . . . 0.4 111.002 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.68 42.95 1.28 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.68 -0.772 . . . . 0.16 112.911 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -173.61 162.24 4.11 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.79 0.295 . . . . 1.93 110.769 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 39.4 mmt180 -126.57 147.58 49.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 1.57 109.576 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -139.9 94.14 2.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.982 -0.377 . . . . 0.23 109.982 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 16.7 mt-10 -104.46 129.6 52.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.539 -0.3 . . . . 1.25 110.343 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 HG13 ' A' ' 20' ' ' VAL . 29.9 pt -131.48 -179.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.12 111.12 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -139.6 114.38 9.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.11 111.015 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.63 179.45 3.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 0.08 110.344 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.572 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.69 139.82 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.25 110.77 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.75 -5.08 52.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.2 112.241 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.43 78.2 4.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.573 0.225 . . . . 0.3 110.861 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 tttp 50.97 60.43 3.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.656 -0.702 . . . . 1.56 110.389 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.4 p -57.15 -32.92 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.412 -0.813 . . . . 0.32 112.529 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -83.47 5.02 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.182 0.515 . . . . 0.16 111.409 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.352 0 CA-C-N 116.056 -0.52 . . . . 0.23 113.607 -179.015 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.225 0.536 . . . . 0.44 110.114 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -175.49 -177.54 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.304 -0.862 . . . . 0.51 108.675 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.96 30.05 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 2.03 110.773 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -120.63 -54.78 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 1.32 110.502 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.55 -17.29 63.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 1.2 110.644 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.84 -18.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.47 0.652 . . . . 0.46 109.728 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.78 99.48 12.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.23 109.733 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -68.36 -48.92 63.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.25 111.159 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -127.0 151.1 49.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.549 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -106.56 16.55 24.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.338 0.59 . . . . 0.51 109.715 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.6 127.39 53.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.731 . . . . 0.47 110.204 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -108.41 138.41 35.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.067 0.46 . . . . 0.06 110.444 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -95.69 130.49 42.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.266 -0.424 . . . . 0.29 110.538 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 10.3 t -86.13 -17.98 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.347 0.594 . . . . 0.17 109.752 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -177.94 105.13 0.05 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.201 -0.909 . . . . 0.72 109.717 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.52 -19.94 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.428 0.529 . . . . 0.1 112.428 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -36.66 73.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.975 0.417 . . . . 1.14 110.812 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -91.25 -36.53 13.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.63 110.223 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.04 38.87 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.885 -0.674 . . . . 0.36 111.801 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.47 104.49 16.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.72 0.295 . . . . 2.02 110.553 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.0 t -92.85 116.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.548 -0.538 . . . . 0.39 109.548 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -82.7 124.44 30.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.111 0.482 . . . . 0.18 111.52 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.569 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 6.8 ptpp? -87.85 -175.64 5.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.62 109.294 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HG3' ' OE2' ' A' ' 71' ' ' GLU . 11.7 pttm -60.61 -27.15 67.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 8.3 mp0 -78.86 -32.43 46.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.222 0.534 . . . . 1.47 110.245 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 51.0 m-20 -68.72 -50.09 53.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.26 110.74 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.89 -29.27 70.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.956 -0.298 . . . . 0.13 111.205 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -71.26 -22.97 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.089 0.471 . . . . 0.91 109.969 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 m -95.33 -44.98 7.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.045 0.45 . . . . 0.4 110.917 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.26 58.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 0.28 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.72 -51.59 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.078 -0.341 . . . . 1.23 110.078 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.21 16.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.722 -0.751 . . . . 0.28 112.054 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 81' ' ' ASP . 5.2 m -125.09 137.85 54.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.163 -0.31 . . . . 0.89 110.163 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.15 -11.54 57.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.503 -0.317 . . . . 0.41 111.525 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -85.42 117.82 24.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.68 110.705 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.96 -31.08 68.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.18 111.256 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.36 -47.63 75.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.625 0.25 . . . . 0.54 111.471 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.12 -51.07 71.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.998 0.428 . . . . 1.7 110.788 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mt -61.0 -51.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.648 -0.706 . . . . 0.18 111.169 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 99.9 m -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.18 111.152 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -62.22 -42.08 98.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.491 -0.322 . . . . 0.67 110.432 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.69 -43.33 89.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.21 110.134 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 86.1 mt -62.85 -32.57 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.305 0.574 . . . . 0.15 110.82 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HG22 ' A' ' 38' ' ' VAL . 1.3 mm? -74.95 -32.05 61.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.818 -0.628 . . . . 0.12 112.61 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 92' ' ' LYS . 15.1 t -100.57 -13.54 18.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.789 0.662 . . . . 0.22 112.789 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 91' ' ' THR . 32.7 mmmt -129.27 25.38 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.375 -0.203 . . . . 0.96 111.015 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -132.72 -175.98 14.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.032 -1.08 . . . . 0.15 113.64 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -83.4 76.52 9.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.234 0.54 . . . . 1.74 109.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.99 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.624 -0.717 . . . . 0.69 110.91 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.9 mm-40 -72.78 105.72 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.738 -0.467 . . . . 0.59 109.738 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.45 111.077 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.879 0.371 . . . . 1.27 110.667 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -129.22 98.97 5.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.47 110.449 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -67.62 147.24 52.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 1.92 109.81 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 31.5 m 58.78 61.65 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.523 0.678 . . . . 1.58 110.625 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -4.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 1.01 111.138 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -95.15 -30.64 13.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.86 109.816 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 145' ' ' SER . 1.4 m -66.3 123.75 20.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.94 110.93 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.04 42.02 3.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.905 0.882 . . . . 0.42 112.229 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -67.69 111.28 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.72 -0.673 . . . . 1.26 110.761 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -82.73 101.88 11.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 1.12 110.046 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.7 p -58.6 -76.9 0.04 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.75 -0.659 . . . . 1.2 112.358 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -82.35 62.27 5.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.93 0.395 . . . . 1.54 111.296 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -166.07 -48.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.459 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -108.8 22.38 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.52 110.964 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.59 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 0.12 111.938 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 4.1 mm? -74.51 -34.84 63.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.552 -0.295 . . . . 0.7 111.033 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 4.8 mp0 -65.6 -48.86 70.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.17 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.76 -48.27 81.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.2 111.951 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.78 -28.66 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.761 0.315 . . . . 0.3 111.594 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.0 mmtp -80.74 -33.81 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.66 110.359 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.7 -39.19 93.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 2.05 110.199 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.97 -46.89 73.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.162 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -62.04 -30.23 70.83 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.8 -0.636 . . . . 0.86 111.429 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -53.76 -44.57 70.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.57 110.409 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 -69.81 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.4 110.15 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 62.2 ttp -102.37 123.93 47.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.007 -0.542 . . . . 0.27 111.079 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.99 99.52 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.02 -0.536 . . . . 0.48 110.401 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.34 -0.846 . . . . 0.93 110.895 179.711 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.628 0.252 . . . . 1.22 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -128.42 134.67 48.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.441 -0.345 . . . . 2.41 111.172 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 211' ' ' VAL . 2.7 mp -129.49 145.76 51.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 0.31 110.108 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.609 ' HB3' HG22 ' A' ' 211' ' ' VAL . 9.8 ptm180 -126.72 132.12 51.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.384 -0.371 . . . . 0.24 110.413 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 22.0 m-85 -92.95 140.37 29.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 0.39 110.533 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.3 mt -120.85 118.37 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.527 -0.306 . . . . 0.2 111.309 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -152.12 156.43 33.91 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.95 -0.568 . . . . 0.11 109.906 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.31 172.4 12.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.66 2.24 . . . . 0.14 112.516 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.8 -44.95 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.387 -0.37 . . . . 0.15 111.652 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -52.92 -55.84 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.981 -0.554 . . . . 0.81 111.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.55 -27.24 61.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.424 -0.353 . . . . 0.2 111.403 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.57 -34.78 90.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.216 -0.516 . . . . 0.17 111.893 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -77.75 52.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.36 0.6 . . . . 0.65 109.813 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -152.59 -46.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.258 -0.883 . . . . 1.58 109.477 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -86.53 -26.21 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.4 110.693 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 12.0 ttpt -67.31 -21.73 65.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.47 . . . . 0.67 110.603 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.9 OUTLIER -100.19 8.76 43.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.481 . . . . 0.86 110.921 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -124.85 -45.49 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.568 -0.287 . . . . 0.34 111.08 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.4 mt -78.29 -35.39 47.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.715 0.265 . . . . 0.29 111.715 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 23.7 mmtt -62.4 -52.71 64.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.271 0.471 . . . . 0.66 112.271 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.7 Cg_endo -58.98 -24.6 74.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.153 1.902 . . . . 0.23 113.073 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.55 -22.05 54.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.17 110.765 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.3 mm 59.3 66.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.518 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -134.19 15.11 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.765 -0.652 . . . . 0.84 109.91 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.14 163.69 2.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.328 0.585 . . . . 0.35 112.07 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.546 HD12 HG12 ' A' ' 211' ' ' VAL . 66.5 mt -106.85 160.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.31 109.378 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.41 64.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 2.24 111.095 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 t -161.65 90.36 0.78 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.34 -0.615 . . . . 0.8 109.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 43.9 mt-10 -136.79 163.86 29.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 1.32 110.423 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 209' ' ' GLU . 12.1 t0 -119.18 131.47 55.85 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.939 -0.763 . . . . 0.25 108.939 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.45 31.56 6.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.55 111.29 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -96.11 -115.76 3.11 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.832 -0.699 . . . . 0.36 112.275 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -91.63 -22.6 20.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.62 110.148 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.46 123.15 40.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 1.48 109.345 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.94 77.89 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.032 0.444 . . . . 0.33 110.932 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 29.7 mt-10 -75.45 118.65 18.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.052 -0.522 . . . . 1.04 109.884 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 34.1 mt -122.84 126.81 74.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.877 0.37 . . . . 0.48 110.847 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 177' ' ' ARG . 39.4 t -94.09 104.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.11 109.731 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.6 t -130.91 115.56 16.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.15 -0.477 . . . . 0.21 110.121 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -164.7 125.3 2.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.918 -0.583 . . . . 0.42 109.428 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.462 HG12 ' H ' ' A' ' 215' ' ' ASP . 3.3 tt -104.84 -170.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.566 -0.288 . . . . 0.51 110.319 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' H ' HG12 ' A' ' 214' ' ' ILE . 37.4 m-20 -62.27 141.14 96.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.512 0.196 . . . . 1.3 110.572 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.77 -26.73 83.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.051 2.5 . . . . 0.47 113.362 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.71 78.85 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.761 -0.733 . . . . 0.58 111.945 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 62.6 m -110.68 25.44 11.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.76 110.558 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -60.11 -32.42 70.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.53 111.277 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -18.52 59.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.74 110.893 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.5 -24.68 24.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.4 111.096 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.6 tp -96.13 -42.43 12.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.691 -0.404 . . . . 0.91 111.459 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 18.5 t70 -67.17 -22.4 65.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.881 0.326 . . . . 0.33 111.881 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.27 -28.28 64.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.65 0.262 . . . . 1.14 111.352 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.9 OUTLIER -105.38 -37.35 6.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.609 -0.269 . . . . 0.29 110.365 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 223' ' ' ASP . 44.6 mm -59.09 -34.31 52.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.31 111.27 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 16.6 ptpt -53.91 -31.5 50.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.707 0.632 . . . . 1.4 112.707 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -113.52 -25.29 8.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 1.77 112.063 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -41.97 74.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.174 0.435 . . . . 0.73 112.174 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.0 t -135.8 -37.48 0.74 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.373 -0.531 . . . . 0.14 112.376 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 42.0 mtpt -59.67 -41.52 90.82 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 0.51 110.731 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.41 38.03 3.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.13 111.535 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -151.97 -53.36 0.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.645 0.26 . . . . 0.39 110.649 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -114.97 -168.16 15.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.074 -0.584 . . . . 0.13 111.995 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.9 m -101.81 144.5 30.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.956 -0.387 . . . . 0.36 109.956 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.32 119.19 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.28 110.612 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -113.22 151.68 30.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.731 -0.668 . . . . 0.39 109.904 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.79 145.1 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.639 0.256 . . . . 0.16 110.705 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 0.35 109.497 179.385 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.781 0.324 . . . . 0.52 110.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.22 177.09 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.448 -0.575 . . . . 0.59 109.448 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.88 -77.04 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.713 0.292 . . . . 1.44 111.01 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.12 76.05 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.338 0.59 . . . . 1.48 110.603 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -147.91 159.21 44.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.43 -0.805 . . . . 1.48 109.258 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.53 42.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.47 110.337 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 p -110.82 -66.01 1.12 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.001 -0.545 . . . . 0.19 110.427 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -92.34 60.18 3.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.48 0.657 . . . . 1.06 109.464 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.421 HG12 ' OE1' ' A' ' 54' ' ' GLN . 17.0 m -100.08 148.44 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.453 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -113.6 114.6 26.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.831 -0.622 . . . . 0.2 109.904 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.46 121.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.37 110.838 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.9 p -133.43 122.3 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.966 -0.561 . . . . 0.25 110.316 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -110.36 128.4 55.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.518 . . . . 0.37 110.733 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.8 ttp -89.35 141.75 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.16 110.963 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.89 122.35 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.02 110.316 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -125.22 32.62 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.846 -0.161 . . . . 0.71 110.988 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.14 70.84 0.49 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.757 0.661 . . . . 0.44 111.805 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 -35.62 4.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.876 -0.678 . . . . 0.49 111.654 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -106.07 148.48 27.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.154 -0.684 . . . . 1.47 109.154 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.21 153.62 51.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.636 0.255 . . . . 1.8 110.434 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -144.82 116.6 8.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.274 -0.639 . . . . 0.44 109.274 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 59' ' ' PHE . 3.3 pm0 -112.0 132.94 54.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.16 111.661 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 89' ' ' ILE . 6.2 mt -128.94 145.75 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.571 -0.74 . . . . 0.7 109.905 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.85 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.503 -0.317 . . . . 0.08 110.263 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.03 171.17 7.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.365 -0.379 . . . . 0.09 110.347 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.23 119.68 13.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.2 109.908 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -75.32 69.61 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.42 111.135 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.03 64.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.63 109.321 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.51 50.96 13.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.808 -0.633 . . . . 0.97 110.326 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.86 10.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.359 -0.837 . . . . 0.43 112.901 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.6 12.39 7.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.734 0.778 . . . . 0.27 109.463 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42 113.055 -178.92 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.035 -0.728 . . . . 1.07 109.035 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 50' ' ' ASP . 9.5 t0 -65.61 124.01 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.75 110.483 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 tp -70.48 -17.31 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.6 111.951 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -59.84 -35.86 75.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.07 0.462 . . . . 1.67 110.503 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.83 -33.41 21.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 1.49 110.465 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.62 -38.39 82.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.884 -0.598 . . . . 0.3 111.246 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.83 84.05 6.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.051 -0.351 . . . . 0.16 110.051 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.421 ' OE1' HG12 ' A' ' 17' ' ' VAL . 37.4 mt-30 -66.26 -77.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.3 111.098 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -74.96 129.21 37.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.21 110.23 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -93.82 12.28 26.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.368 0.604 . . . . 0.57 110.034 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.495 -0.775 . . . . 0.18 109.962 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.5 p -116.65 146.3 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.692 -0.485 . . . . 0.3 109.692 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 19.0 m-85 -104.94 140.16 38.58 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.885 -0.413 . . . . 0.56 109.885 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 2.4 t -92.58 -16.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.24 110.339 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -178.97 95.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.536 -0.757 . . . . 0.28 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.67 -27.45 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.432 . . . . 0.33 111.53 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 m -68.35 -20.63 64.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.785 0.326 . . . . 0.47 111.461 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.71 3.95 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 1.53 110.419 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 28.14 73.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.14 112.109 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.08 102.43 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.6 110.711 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 128.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.029 -0.532 . . . . 0.25 110.516 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.24 116.62 32.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.3 110.15 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -87.09 178.89 6.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.985 -0.552 . . . . 2.16 110.253 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -23.93 67.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.258 -0.177 . . . . 0.37 111.438 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -87.22 0.94 54.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.782 0.325 . . . . 0.43 110.593 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.5 -42.22 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.25 -0.432 . . . . 1.21 110.738 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.5 -28.19 68.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.784 0.326 . . . . 0.24 110.765 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -68.85 -28.7 40.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.199 0.523 . . . . 0.86 110.067 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.74 20.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.932 -0.576 . . . . 0.7 110.296 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 -56.76 9.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.793 -0.64 . . . . 0.53 111.736 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -102.86 -55.15 2.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.652 0.263 . . . . 0.96 111.003 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.85 -32.28 1.58 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.671 . . . . 0.18 111.954 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.41 133.38 33.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.608 0.242 . . . . 0.78 110.758 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.08 2.86 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.973 0.416 . . . . 0.68 110.595 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 85' ' ' ILE . 6.8 t70 -91.39 126.43 36.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.934 -0.575 . . . . 1.14 110.234 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.29 -27.3 63.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.569 . . . . 1.08 111.13 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -62.66 -49.1 76.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.359 -0.382 . . . . 0.71 110.409 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.02 -43.25 99.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.54 110.899 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 81' ' ' ASP . 50.1 mm -60.61 -49.29 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.26 110.114 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.8 t -64.7 -34.3 77.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.11 110.949 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -61.31 -43.99 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 110.403 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -68.85 -38.64 79.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.77 110.472 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 31' ' ' ILE . 73.5 mt -67.34 -33.44 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.31 110.799 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.91 -12.11 59.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.75 112.504 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 92' ' ' LYS . 14.6 t -116.1 -21.37 9.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 0.81 112.046 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HG2' HG23 ' A' ' 91' ' ' THR . 33.0 mmmt -124.8 25.91 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.025 0.44 . . . . 0.62 110.249 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.6 176.63 19.08 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.669 -0.777 . . . . 0.41 112.322 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -85.31 82.81 8.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 2.48 111.365 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.18 124.93 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.119 -0.492 . . . . 1.03 110.268 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 18' ' ' ALA . 3.4 pt20 -75.79 109.29 9.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.172 0.511 . . . . 0.66 110.011 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.254 0.55 . . . . 0.2 111.095 -179.747 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.19 110.108 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -78.18 56.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.337 -0.847 . . . . 0.8 110.909 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.05 169.57 17.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.973 -0.558 . . . . 2.59 110.694 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.03 107.08 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.29 110.059 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.3 69.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.004 0.431 . . . . 0.5 109.973 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 61.72 85.27 0.12 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.406 -0.815 . . . . 0.83 110.383 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.1 m -80.42 44.79 0.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.859 -0.609 . . . . 0.41 111.354 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.46 -21.11 28.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.907 -0.588 . . . . 0.33 109.79 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 80.9 1.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.448 -0.796 . . . . 0.37 109.58 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -86.14 16.33 4.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.45 112.039 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 131.82 51.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.553 -0.294 . . . . 0.43 111.424 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 58.24 48.56 12.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.715 -0.675 . . . . 1.63 111.299 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 59.41 53.11 5.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.537 -0.756 . . . . 0.76 111.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.1 30.29 19.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.306 -0.861 . . . . 0.23 112.071 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.58 85.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.21 110.521 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 157' ' ' LEU . 4.0 mm? -71.55 -7.85 50.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.713 -0.676 . . . . 0.3 111.234 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -99.56 -47.04 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.537 -0.542 . . . . 0.94 109.537 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.38 111.426 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.62 -15.14 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.053 0.454 . . . . 0.58 111.457 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -109.06 0.04 19.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.319 0.581 . . . . 1.33 110.355 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -84.55 -54.26 4.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.617 -0.719 . . . . 0.63 109.787 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -69.25 -18.9 63.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.18 110.435 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.536 ' N ' HD13 ' A' ' 163' ' ' LEU . 46.6 tttm -69.35 -22.01 63.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.72 110.11 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -81.66 -12.82 58.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.835 -0.62 . . . . 0.63 110.391 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.82 -39.65 5.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.178 -0.465 . . . . 0.21 110.731 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.3 tpp -141.79 143.98 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.45 110.722 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -96.4 119.59 35.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.281 -0.418 . . . . 0.24 110.282 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.285 -0.416 . . . . 0.62 110.78 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 40.5 mtm . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.012 -0.366 . . . . 1.29 110.012 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -102.02 131.54 48.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.369 -0.604 . . . . 1.48 109.369 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.476 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.7 mp -116.5 157.22 25.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.203 0.525 . . . . 0.41 111.325 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.595 ' HB2' ' OE2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -127.77 160.58 31.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.143 -0.935 . . . . 1.05 108.9 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -129.3 128.61 43.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.695 0.283 . . . . 0.53 110.463 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 121.69 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.466 0.651 . . . . 0.88 111.386 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -150.1 157.31 37.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.421 -0.808 . . . . 0.11 109.902 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.21 163.85 11.47 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.688 2.259 . . . . 0.09 112.501 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 208' ' ' LEU . 40.5 t -55.23 -39.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.256 -0.429 . . . . 0.25 112.05 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -57.95 -60.79 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.726 0.298 . . . . 0.53 111.638 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.87 -19.46 61.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 1.44 111.509 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.86 72.87 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.943 -0.646 . . . . 0.15 111.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -61.82 -32.65 72.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.614 0.245 . . . . 1.62 110.712 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -55.75 -43.97 77.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.014 -0.539 . . . . 0.75 111.668 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 -35.27 12.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.416 -0.356 . . . . 0.41 111.63 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.77 -34.25 75.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.688 0.28 . . . . 1.55 111.171 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -95.88 20.73 9.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.807 0.299 . . . . 1.23 111.807 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -146.35 -45.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.447 0.536 . . . . 1.31 112.447 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -75.89 -39.71 55.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.662 0.268 . . . . 0.42 111.494 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 5.2 mtpt -58.6 -52.79 72.19 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.191 -0.459 . . . . 1.02 112.002 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 34.1 Cg_endo -65.12 -12.5 35.03 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.056 1.837 . . . . 0.09 112.961 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.8 mt -88.64 -7.52 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.359 . . . . 0.2 110.304 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 6.8 mm 59.64 40.26 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.519 -0.764 . . . . 0.4 110.815 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -112.21 19.96 17.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.63 109.947 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.433 HG21 ' HE3' ' A' ' 193' ' ' LYS . 14.7 m -110.68 139.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.813 -0.631 . . . . 0.33 111.053 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.93 164.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.812 -0.631 . . . . 1.15 110.039 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -71.14 56.29 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 1.67 111.092 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.2 m -156.17 88.21 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.907 -0.775 . . . . 0.77 108.907 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -134.94 140.03 45.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.533 -0.758 . . . . 0.78 110.396 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.37 137.41 53.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.629 -0.508 . . . . 0.48 109.629 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.29 30.38 7.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 1.28 111.501 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -79.72 -140.28 2.16 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.729 -0.748 . . . . 0.63 112.847 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.63 -20.96 66.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.93 0.395 . . . . 1.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -136.09 143.2 44.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.923 -0.399 . . . . 1.26 109.923 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 182' ' ' VAL . 2.5 mm? -81.99 85.53 6.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.33 110.75 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.595 ' OE2' ' HB2' ' A' ' 177' ' ' ARG . 10.3 tp10 -90.28 106.21 18.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.137 -0.69 . . . . 1.34 109.137 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.79 134.62 58.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.957 0.408 . . . . 0.17 111.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 177' ' ' ARG . 86.5 t -84.53 108.01 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.15 110.21 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.0 m -126.59 90.35 3.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.135 -0.484 . . . . 0.22 110.406 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -155.78 132.01 10.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.28 109.837 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.82 173.21 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.521 -0.309 . . . . 1.06 110.276 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 4.1 m-20 -69.51 169.35 12.54 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.456 -0.338 . . . . 1.22 110.417 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.49 -161.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.642 2.228 . . . . 0.36 112.794 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.62 -98.52 1.55 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.26 111.718 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 68.9 m -75.98 0.88 16.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.64 111.563 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 44.3 t80 -61.46 -32.3 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.033 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -9.1 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 1.31 111.701 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -92.7 -32.69 14.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.794 0.331 . . . . 1.1 110.567 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 226' ' ' ILE . 4.8 tp -94.51 -31.37 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.384 0.513 . . . . 1.38 112.384 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.499 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -60.24 -28.12 67.77 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.33 -0.231 . . . . 0.95 111.42 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -56.43 -35.37 67.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.81 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.2 pp -95.81 -24.89 16.26 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.41 110.492 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -61.59 -38.1 79.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.367 -0.379 . . . . 0.42 110.693 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 223' ' ' ASP . 13.7 ptpt -64.31 -16.48 62.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.656 0.613 . . . . 0.16 112.656 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.57 -23.47 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.613 -0.435 . . . . 0.55 111.838 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -81.93 -43.23 18.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.588 0.588 . . . . 0.92 112.588 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -128.18 -38.87 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.364 -0.535 . . . . 0.31 111.914 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 14.7 tttt -63.76 -28.06 69.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.941 0.401 . . . . 2.08 110.563 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -102.13 16.98 55.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.912 -0.661 . . . . 0.25 112.123 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.7 -36.09 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.339 . . . . 0.39 111.044 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.51 -156.04 6.65 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.515 -0.85 . . . . 0.14 112.725 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 m -101.98 137.7 39.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.875 0.369 . . . . 0.17 110.425 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.13 149.11 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.2 111.013 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.35 161.04 39.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.678 . . . . 0.33 109.168 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.2 m -99.04 148.45 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.762 0.315 . . . . 0.18 111.066 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 109.576 -0.527 . . . . 0.47 109.576 179.406 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.912 0.387 . . . . 0.25 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.88 -89.57 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.34 110.293 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -137.51 -88.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.675 -0.491 . . . . 0.33 109.675 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.01 107.64 23.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.316 -0.624 . . . . 0.81 109.316 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -158.31 152.44 24.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.1 -0.5 . . . . 1.11 110.373 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -78.77 49.06 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.48 110.968 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.3 p -129.04 -45.61 1.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.128 0.49 . . . . 0.25 110.606 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -106.69 39.54 1.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.18 109.672 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 m -94.38 135.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.22 111.581 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.06 116.08 31.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.966 -0.561 . . . . 0.11 109.844 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.6 114.73 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.845 -0.616 . . . . 0.16 111.387 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.796 HG22 HG22 ' A' ' 89' ' ' ILE . 7.7 p -107.82 136.29 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.19 108.986 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HD3' ' CD ' ' A' ' 30' ' ' GLU . 12.4 ttp180 -142.18 140.98 32.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.089 0.471 . . . . 1.33 111.939 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 tpt -135.55 119.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.82 108.877 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -122.62 114.95 21.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.902 0.382 . . . . 1.14 111.734 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -112.42 -164.41 0.91 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.708 -0.849 . . . . 0.89 108.708 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.36 6.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.702 0.287 . . . . 0.41 111.375 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.74 4.77 24.4 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.357 -0.925 . . . . 1.09 113.229 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -126.76 119.02 25.86 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.488 -0.419 . . . . 0.19 110.34 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -140.98 122.54 15.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.295 -0.411 . . . . 1.8 110.478 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -149.96 146.87 27.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.285 0.365 . . . . 0.39 110.923 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' CD ' ' HD3' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -143.9 136.77 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.9 110.714 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -139.98 -173.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.885 0.374 . . . . 0.11 110.59 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -136.46 116.65 13.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.05 110.185 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.8 p -112.67 -158.35 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.334 -0.394 . . . . 0.13 111.172 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -169.1 0.8 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.85 110.673 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -74.43 -157.88 0.06 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.894 0.378 . . . . 0.47 111.295 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -56.71 -19.95 19.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.109 0.781 . . . . 0.52 113.109 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -63.55 -19.03 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.27 111.203 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.05 -24.92 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.1 0.476 . . . . 0.18 110.767 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.2 -13.29 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.323 -0.398 . . . . 0.29 110.403 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.934 -0.575 . . . . 0.27 112.416 179.804 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.52 0.2 . . . . 1.15 110.98 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 m-20 -52.88 114.26 1.37 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.258 -0.428 . . . . 1.44 111.303 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.54 -28.28 68.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 1.36 111.662 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.05 -36.76 82.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.265 0.555 . . . . 0.95 110.403 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.67 -30.21 56.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.49 109.951 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 48' ' ' ASP . 21.9 t -75.48 -27.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.24 110.847 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.09 84.85 7.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.172 0.51 . . . . 0.2 111.148 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -57.34 -64.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.378 -0.828 . . . . 0.18 110.528 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 m -91.23 80.47 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.004 -0.544 . . . . 0.35 109.968 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -80.06 63.79 4.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.63 0.728 . . . . 1.1 110.942 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -148.35 96.04 2.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.796 -1.093 . . . . 0.22 108.074 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.1 p -78.82 146.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.664 -0.698 . . . . 0.13 112.194 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -116.23 147.35 41.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.57 -0.741 . . . . 0.32 109.263 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 18.5 t -84.43 -33.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.568 0.699 . . . . 0.11 109.387 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -166.05 104.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.127 -0.942 . . . . 1.03 109.889 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.71 -27.73 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.39 111.609 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 m -60.84 -45.99 92.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.735 0.302 . . . . 0.43 111.062 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -27.0 25.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.75 110.615 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.72 29.79 8.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.805 -0.712 . . . . 0.1 111.469 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -83.33 109.36 17.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 1.56 110.431 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.63 133.11 36.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.37 109.726 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -110.06 105.17 14.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.029 0.442 . . . . 0.1 110.856 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 34.2 pttt -85.86 -175.81 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.384 -0.599 . . . . 1.68 109.384 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 pttp -58.81 -23.48 60.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.643 0.259 . . . . 0.95 111.419 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.26 -22.03 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.501 -0.318 . . . . 2.07 111.316 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 21.8 m-20 -86.41 -52.28 5.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.39 -0.368 . . . . 0.33 110.748 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.63 -28.84 70.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.21 111.599 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -68.15 -26.55 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.797 0.332 . . . . 0.32 111.018 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 p -102.66 -25.08 13.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 1.04 111.327 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.61 -41.76 16.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.22 111.445 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -97.36 -41.43 8.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 0.42 110.324 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.72 -29.14 5.72 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.758 -0.734 . . . . 0.26 112.345 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.96 145.81 43.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.696 0.284 . . . . 0.22 110.782 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.39 3.01 53.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.242 0.544 . . . . 0.73 110.336 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 85' ' ' ILE . 26.6 t0 -74.25 108.78 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 1.45 110.551 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -60.46 -30.58 69.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.19 110.978 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -60.65 -40.77 93.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.278 -0.419 . . . . 0.61 111.097 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -71.34 -38.78 71.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.65 110.881 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 81' ' ' ASP . 30.0 mm -60.24 -55.11 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.21 110.936 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 7.4 p -67.74 -34.66 77.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.09 111.397 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' THR . 33.3 ttpt -58.82 -45.17 90.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.605 0.241 . . . . 0.21 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -60.62 -45.8 92.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.54 110.868 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.796 HG22 HG22 ' A' ' 20' ' ' VAL . 22.5 mt -72.43 -25.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 0.16 111.439 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.43 -40.52 23.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.053 0.39 . . . . 0.23 112.053 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -91.18 -21.16 21.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.07 0.767 . . . . 0.3 113.07 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -110.99 -24.68 10.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.632 -0.427 . . . . 0.67 111.296 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.77 -166.07 31.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.757 . . . . 0.15 111.931 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -120.97 131.59 54.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.168 0.509 . . . . 2.06 111.278 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 97' ' ' VAL . 14.7 p -118.28 160.36 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.49 109.05 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -73.27 85.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.238 0.542 . . . . 0.26 111.044 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 95' ' ' VAL . 3.8 m . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.2 111.306 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.27 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.6 p80 40.82 50.65 3.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.085 0.954 . . . . 0.25 112.68 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.46 111.85 21.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 1.84 110.397 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -77.92 45.45 0.52 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.233 0.539 . . . . 0.32 111.135 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.6 -24.49 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.53 110.553 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -82.38 22.6 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.58 111.162 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.73 14.5 5.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.349 0.595 . . . . 0.72 110.326 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -79.31 -46.3 17.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.49 110.408 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -154.74 -161.81 1.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.94 109.7 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.4 m -55.98 118.07 4.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.99 111.152 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -23.93 65.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.67 111.392 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.79 1.05 28.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.901 0.382 . . . . 1.1 110.654 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -115.59 -45.53 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.78 110.423 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.0 pt20 -94.06 19.46 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.18 111.579 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.78 72.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.282 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.1 mm? -68.43 -18.36 64.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.28 111.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -92.4 -36.97 12.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.85 0.357 . . . . 2.49 110.63 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 155' ' ' GLN . 24.7 t -64.79 -43.18 96.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.874 -0.603 . . . . 0.16 111.017 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.6 tt -61.36 -32.55 53.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.133 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 41.1 mttp -67.29 -48.62 67.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.711 0.291 . . . . 1.33 110.364 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -39.72 89.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.719 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -42.99 99.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 1.42 110.443 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -65.75 -20.72 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.283 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 161' ' ' LYS . 32.4 mt-10 -72.72 -32.54 65.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.694 0.283 . . . . 0.69 110.822 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -82.21 -44.09 16.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.065 0.46 . . . . 0.87 110.137 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 21.2 ptp -144.45 134.38 23.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.872 -0.604 . . . . 1.44 109.737 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.45 120.91 19.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.202 0.525 . . . . 0.87 111.493 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.525 -0.761 . . . . 0.95 109.641 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 C--O 1.227 -0.095 0 N-CA-C 110.193 -0.299 . . . . 1.41 110.193 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -119.48 144.09 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 1.73 110.491 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.69 154.74 41.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.76 110.976 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 177' ' ' ARG . 9.4 ptm180 -124.44 152.61 43.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.11 109.426 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 95.6 m-85 -116.09 124.64 50.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.854 0.359 . . . . 0.13 110.611 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.48 HG12 ' OE2' ' A' ' 209' ' ' GLU . 4.4 mt -102.07 114.5 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.3 111.47 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.3 OUTLIER -159.11 150.15 16.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 0.6 110.262 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.93 165.47 27.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.79 2.327 . . . . 0.26 112.064 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.95 -30.44 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.762 0.315 . . . . 0.15 110.928 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.11 -50.03 62.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.47 110.497 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -91.94 -21.95 20.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.74 110.272 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.16 -30.23 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.483 -0.781 . . . . 0.17 113.635 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -68.21 -16.44 63.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.072 0.436 . . . . 0.87 111.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.99 -15.65 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 1.32 109.665 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.38 -45.08 5.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.267 -0.878 . . . . 2.04 110.537 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 208' ' ' LEU . 29.2 tttm -57.69 -53.49 57.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 0.72 111.093 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.66 31.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.088 -0.505 . . . . 0.6 111.12 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -144.16 -51.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.839 0.311 . . . . 1.27 111.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.97 -37.58 22.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.176 0.435 . . . . 0.6 112.176 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 6.1 mtpt -60.25 -48.54 93.85 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.234 0.457 . . . . 0.3 112.234 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.4 Cg_endo -60.0 -13.89 25.37 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.063 1.842 . . . . 0.16 113.043 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 66.9 mt -85.48 -2.58 58.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.472 -0.195 . . . . 0.37 110.472 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 39.2 pt 41.78 40.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.543 1.137 . . . . 0.65 113.736 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 195' ' ' LEU . 78.9 mttt -123.32 24.41 8.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 1.03 109.665 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.27 169.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 0.41 110.353 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 211' ' ' VAL . 88.6 mt -110.94 144.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.021 -0.536 . . . . 0.65 110.118 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -70.57 70.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.48 0.488 . . . . 0.66 111.334 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.1 m -157.39 38.72 0.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.29 109.287 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.5 145.07 29.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 1.14 111.608 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -117.62 123.69 46.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.12 110.089 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.61 159.78 18.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.284 -0.416 . . . . 0.47 110.193 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 139.34 -116.61 1.25 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.045 -0.598 . . . . 0.2 111.912 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.25 -18.05 37.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.518 0.675 . . . . 1.24 109.554 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.05 177.21 7.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.114 -0.948 . . . . 0.14 109.5 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 189' ' ' LYS . 2.8 tp -138.37 77.51 1.63 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.404 . . . . 0.69 110.61 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 15.9 mt-10 -82.93 99.73 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.174 -0.467 . . . . 0.16 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 28.7 mt -102.88 132.91 48.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.76 109.74 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.642 HG11 HD12 ' A' ' 239' ' ' LEU . 61.3 t -99.06 122.41 50.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.892 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.9 t -147.39 120.24 8.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.3 110.128 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.07 125.08 1.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.305 -0.628 . . . . 0.23 109.305 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.3 tt -117.1 157.61 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.6 109.922 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.08 150.59 10.39 Favored Pre-proline 0 C--O 1.236 0.344 0 O-C-N 123.295 0.372 . . . . 0.62 111.536 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.1 158.35 3.41 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.654 2.903 . . . . 1.05 113.569 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.15 -82.87 0.41 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.631 -0.988 . . . . 0.37 110.631 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.1 m -72.92 -16.32 61.56 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.31 -0.626 . . . . 0.83 109.31 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 40.3 t80 -63.41 -42.71 98.76 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.564 -0.744 . . . . 1.35 110.762 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 223' ' ' ASP . 17.9 tpt180 -62.2 -27.33 68.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.151 0.5 . . . . 0.34 110.874 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.37 -34.92 70.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.181 -0.463 . . . . 2.19 111.358 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.635 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.3 tt -96.24 -29.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.529 -0.305 . . . . 1.78 111.76 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -62.52 -23.83 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 0.92 110.746 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.12 -25.63 65.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.867 -0.606 . . . . 1.26 111.4 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.0 OUTLIER -106.4 -32.55 8.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.928 -0.309 . . . . 0.47 110.872 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 222' ' ' ILE . 47.2 mm -58.26 -35.28 52.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.954 0.407 . . . . 0.29 110.705 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 16.4 ptmt -54.32 -34.29 60.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.458 -0.792 . . . . 1.56 112.609 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -106.09 -24.29 12.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.689 0.281 . . . . 0.55 111.344 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.12 -59.67 3.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.068 -0.514 . . . . 0.34 111.848 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -125.52 -24.26 3.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.294 0.479 . . . . 0.2 112.294 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 75.6 tttt -66.94 -28.79 68.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.52 110.66 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.83 -14.28 37.53 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.883 -0.675 . . . . 0.68 112.25 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -84.99 -22.31 29.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.381 . . . . 0.64 110.69 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -147.15 -168.98 14.27 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.536 -0.84 . . . . 0.1 112.342 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 m -96.77 131.73 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.891 -0.411 . . . . 0.25 109.891 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.31 142.66 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.004 0.43 . . . . 0.33 111.323 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -144.0 155.14 43.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.09 -0.504 . . . . 0.86 109.937 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -81.28 152.2 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 0.15 110.748 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.642 HD12 HG11 ' A' ' 211' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.944 -0.391 . . . . 1.06 109.944 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 16' ' ' ASN . 81.2 p . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 113.433 0.901 . . . . 0.37 113.433 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.83 -77.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.52 110.195 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.5 -98.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.051 -0.522 . . . . 0.36 109.632 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.7 mt -87.15 89.26 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.25 0.548 . . . . 0.36 109.886 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -143.47 134.83 26.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.599 -0.728 . . . . 1.32 109.754 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.78 61.09 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.86 111.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -9.74 3.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 1.06 110.87 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.56 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 t-20 -153.59 63.88 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.191 -1.04 . . . . 1.1 108.191 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 3.5 m -106.31 128.04 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.012 -0.995 . . . . 0.21 111.542 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.16 113.08 18.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.806 . . . . 0.19 109.626 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.15 117.24 19.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.18 110.872 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 89' ' ' ILE . 1.3 p -125.28 128.84 73.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.82 -0.807 . . . . 0.37 108.82 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 30' ' ' GLU . 30.5 ttt180 -137.01 131.48 32.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.595 0.591 . . . . 1.25 112.595 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.464 ' HB2' HG23 ' A' ' 89' ' ' ILE . 19.2 ttt -83.77 140.7 31.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.674 . . . . 0.34 109.556 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.55 99.18 6.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.42 111.036 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -111.6 -179.69 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 0.82 110.331 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.09 -54.47 45.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.477 0.486 . . . . 0.09 112.072 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.94 28.73 3.64 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.23 111.845 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -148.17 146.84 28.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.775 0.321 . . . . 1.05 110.359 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.82 142.54 20.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.228 -0.656 . . . . 1.13 109.228 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 24.6 m-85 -145.85 129.32 16.92 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.376 0.423 . . . . 0.65 110.497 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.594 ' OE1' ' HD2' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -119.95 137.57 53.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.873 0.368 . . . . 0.34 110.711 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.89 -171.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.69 110.455 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -141.51 133.97 28.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.13 111.954 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.36 158.66 19.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.064 -0.516 . . . . 0.38 110.755 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -82.41 120.79 25.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.704 0.631 . . . . 0.38 112.704 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 84.3 mttt 44.38 39.32 3.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.131 1.16 . . . . 0.76 114.131 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.92 18.85 4.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.405 0.52 . . . . 1.71 112.405 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -73.01 1.16 9.44 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.002 0.43 . . . . 0.46 111.424 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.81 -19.58 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.365 0.603 . . . . 0.27 110.241 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.05 3.33 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.435 0.636 . . . . 0.18 109.87 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-N 115.241 -0.89 . . . . 0.1 113.204 -179.467 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.43 108.503 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.47 140.27 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.352 0.596 . . . . 0.64 111.016 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.629 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -85.44 4.52 35.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.803 -0.635 . . . . 0.31 110.632 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.44 -24.29 42.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.597 -0.729 . . . . 0.67 110.645 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -108.42 -30.52 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.41 111.05 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -68.65 -24.82 29.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.484 -0.326 . . . . 0.6 111.299 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.47 116.25 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.676 -0.49 . . . . 0.58 109.676 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -88.12 -43.22 11.82 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.86 111.015 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -119.86 118.11 29.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.08 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -81.38 4.62 20.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.219 0.533 . . . . 0.63 110.272 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.459 ' H ' HG22 ' A' ' 55' ' ' THR . 4.3 m -115.62 134.59 54.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.13 150.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 110.087 -0.338 . . . . 0.24 110.087 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.43 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 70.7 m-85 -103.66 139.64 38.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.648 0.261 . . . . 0.42 110.551 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 2.1 t -87.05 -16.43 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.475 -0.565 . . . . 0.41 109.475 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 66.9 t30 175.76 97.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.284 -0.871 . . . . 0.46 109.854 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.52 -25.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.2 110.827 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -21.08 66.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.23 111.193 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -119.11 0.48 11.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.79 111.016 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.88 29.79 62.51 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.594 -0.812 . . . . 0.31 112.072 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -83.88 101.85 11.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.634 0.254 . . . . 1.36 110.666 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.3 130.88 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.368 -0.378 . . . . 0.25 110.273 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 60' ' ' VAL . . . -99.73 114.78 28.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.16 0.505 . . . . 0.19 110.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.585 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 24.4 pttt -73.82 177.17 5.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 1.5 109.529 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -61.27 -28.53 69.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.09 110.2 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 74' ' ' ILE . 47.7 tt0 -76.35 -27.97 56.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.866 -0.606 . . . . 1.07 110.189 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 7.7 m-20 -72.88 -51.9 16.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.52 110.251 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.94 -33.71 76.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.14 111.198 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -69.61 -23.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.234 0.54 . . . . 0.13 109.954 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -95.65 -21.82 17.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.42 110.715 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.78 -53.09 4.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.399 -0.364 . . . . 0.36 111.706 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -90.17 -34.2 15.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.931 0.396 . . . . 0.36 110.239 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.08 -14.66 44.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.729 -0.748 . . . . 0.46 112.548 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p -115.61 141.8 47.58 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.778 -0.248 . . . . 1.15 110.989 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.12 -10.77 51.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.159 -0.682 . . . . 0.58 109.159 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.43 120.78 25.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.096 -0.956 . . . . 1.03 109.898 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.98 -22.56 61.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.947 -0.57 . . . . 0.43 112.419 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -58.93 -49.67 76.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.274 -0.17 . . . . 0.13 111.091 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.37 -43.36 99.01 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.047 0.451 . . . . 0.82 111.008 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.48 -52.32 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 0.16 110.769 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.81 -35.56 76.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.15 110.778 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -62.34 -46.58 88.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.379 . . . . 0.43 110.366 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.65 110.764 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 22' ' ' MET . 77.9 mt -69.18 -28.31 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 0.17 109.967 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -38.09 36.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.718 -0.674 . . . . 0.27 111.922 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 92' ' ' LYS . 12.1 t -93.36 -10.11 36.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.544 0.572 . . . . 0.17 112.544 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' A' ' 91' ' ' THR . 34.6 mmtm -137.55 35.35 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.023 -0.423 . . . . 0.78 111.206 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.18 -147.37 4.53 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.581 -0.819 . . . . 0.19 112.237 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -136.06 128.79 30.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.649 -0.501 . . . . 1.16 109.649 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -139.99 142.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.559 -0.292 . . . . 0.35 110.892 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.61 84.29 1.57 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.201 0.524 . . . . 0.38 109.883 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 95' ' ' VAL . 5.5 m . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.44 0.638 . . . . 0.58 112.584 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 122.896 1.331 . . . . 0.69 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -85.04 16.47 3.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.703 -1.135 . . . . 0.53 110.842 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.19 151.7 35.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.681 -0.691 . . . . 1.53 110.109 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.2 m -64.18 116.72 6.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.62 110.708 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.2 t -103.32 -51.08 9.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.35 110.872 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -136.35 -171.72 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.81 110.614 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.46 -34.15 76.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 0.25 110.11 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.57 101.29 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.437 -0.802 . . . . 0.7 109.674 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -85.25 71.21 10.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 0.98 109.477 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 m -133.2 129.0 37.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.883 -0.599 . . . . 0.38 111.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -7.41 46.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.25 110.958 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.03 9.55 6.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.783 -0.644 . . . . 0.24 110.611 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -162.31 -58.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.31 110.049 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -87.33 41.27 0.97 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.976 -0.556 . . . . 0.23 110.362 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.68 -32.65 71.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 0.19 111.663 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.5 mm? -81.01 -2.7 49.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.355 -0.384 . . . . 1.48 111.378 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -111.11 -44.7 3.54 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.963 -0.295 . . . . 2.27 111.091 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -58.48 -42.82 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.39 110.969 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.07 -28.38 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.17 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 16.4 mttp -68.57 -42.78 77.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.853 0.359 . . . . 1.29 110.392 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -35.82 61.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.53 110.659 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.78 -35.15 79.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.21 110.069 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 167' ' ' MET . 2.1 ttpm? -60.28 -20.8 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.112 -0.949 . . . . 1.39 111.662 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -70.72 -20.38 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 1.06 111.191 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -115.11 -47.05 2.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.869 0.366 . . . . 0.9 110.652 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 13.5 tpt -117.59 122.74 44.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 0.25 110.914 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -93.79 110.34 21.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.098 -0.501 . . . . 0.79 110.157 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 0.18 111.083 -179.572 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 120.804 0.335 . . . . 1.39 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -114.39 140.04 48.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 2.39 110.085 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.51 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 1.7 mt -127.98 150.95 49.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.039 0.447 . . . . 0.71 110.657 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -129.51 174.31 9.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.351 -0.84 . . . . 0.48 109.231 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HE2' ' HG ' ' A' ' 212' ' ' CYS . 3.6 p90 -133.58 145.58 50.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.153 -0.314 . . . . 0.49 110.153 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.25 106.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.42 111.439 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -147.06 157.23 46.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.055 -0.52 . . . . 0.13 110.943 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.31 178.44 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.808 2.339 . . . . 0.14 113.123 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.39 -45.81 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.627 0.603 . . . . 0.4 112.627 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.91 -45.9 85.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.083 0.468 . . . . 1.26 111.607 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.61 -39.74 67.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.7 110.68 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -62.69 -38.33 96.26 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.68 -0.691 . . . . 0.16 113.104 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.08 -34.28 68.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.776 0.287 . . . . 0.58 111.776 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 31.7 mmmt -71.91 -33.32 68.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.566 0.21 . . . . 1.38 111.566 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -85.36 -26.3 26.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.47 109.99 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 80.5 tttt -60.94 -31.55 71.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.22 110.62 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.42 12.68 28.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 3.15 111.197 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 9.2 mtmt -126.5 -58.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.222 0.453 . . . . 0.8 112.222 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.3 -42.01 26.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.641 . . . . 0.16 112.729 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 189' ' ' LYS . 1.6 mtpt -58.16 -50.95 85.22 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.07 0.767 . . . . 0.44 113.07 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 20.5 Cg_endo -60.91 -14.76 34.39 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.456 2.104 . . . . 0.21 113.404 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' A' ' 197' ' ' LYS . 72.4 mt -82.19 -11.51 58.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.37 110.15 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mm 56.64 35.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.569 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -109.64 18.16 20.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 1.87 110.042 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 212' ' ' CYS . 2.9 m -113.6 137.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.259 -0.882 . . . . 0.34 110.384 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.63 148.28 5.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.954 -0.566 . . . . 0.79 109.52 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.7 75.13 0.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.749 0.785 . . . . 0.94 111.559 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.2 m -149.83 33.62 0.68 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.146 -1.057 . . . . 0.46 108.146 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.4 pt-20 -79.72 129.96 34.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.768 -1.106 . . . . 0.8 111.792 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -97.13 105.73 17.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.361 -0.977 . . . . 0.3 108.361 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.44 131.31 45.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.8 110.434 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 163.57 -104.77 0.24 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.848 -0.691 . . . . 0.56 112.127 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.4 -17.27 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.4 0.619 . . . . 1.8 110.016 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -140.67 176.91 8.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.231 -0.895 . . . . 0.47 109.35 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.4 tp -128.27 84.73 2.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.372 -0.603 . . . . 0.46 109.372 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 19.3 tt0 -96.56 109.39 21.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.603 -0.726 . . . . 1.24 110.815 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 5.9 mt -130.97 152.04 36.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.739 0.304 . . . . 0.26 110.314 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.4 t -98.7 117.59 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.09 109.808 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.556 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 21.0 p -122.92 56.02 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.26 111.411 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -126.56 125.29 41.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.034 0.445 . . . . 0.12 111.05 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 pt -114.8 -159.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.412 -0.813 . . . . 0.32 109.751 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.65 162.3 60.95 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 110.127 -0.323 . . . . 0.33 110.127 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.92 -177.42 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.67 2.247 . . . . 0.2 113.157 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.69 1.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.066 -0.814 . . . . 0.15 111.066 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.14 -24.22 65.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.297 0.57 . . . . 1.03 110.039 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.13 -32.35 73.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.32 109.947 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -23.51 63.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.87 110.497 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.4 -38.79 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 1.48 110.72 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.634 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.6 tt -85.11 -24.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.84 111.356 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.12 -30.23 61.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.84 0.352 . . . . 0.65 110.957 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -56.14 -33.07 64.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.714 -0.675 . . . . 1.58 111.447 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.85 -23.99 14.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.769 -0.372 . . . . 0.46 110.927 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 222' ' ' ILE . 46.3 mm -64.51 -37.92 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.36 110.508 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -62.87 -29.19 70.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.32 111.388 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 225' ' ' LEU . 60.1 pttt -105.54 11.29 32.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.619 . . . . 0.74 110.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -96.83 -126.55 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.022 -1.103 . . . . 0.51 108.022 178.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.406 HG21 ' CD2' ' A' ' 178' ' ' PHE . 9.5 t -65.2 -27.91 69.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.868 0.365 . . . . 0.45 110.999 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.27 -12.13 61.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.62 111.083 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -108.37 18.37 33.05 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.964 -0.636 . . . . 0.12 112.591 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -149.13 -44.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.62 0.247 . . . . 0.8 111.042 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -105.74 -171.56 23.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.682 -0.771 . . . . 0.33 112.191 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -107.9 143.32 36.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.724 0.297 . . . . 0.54 110.217 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.48 165.7 13.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 0.92 110.902 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -154.13 151.94 29.84 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.52 -0.918 . . . . 2.09 108.52 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.11 155.07 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.232 0.539 . . . . 0.57 111.576 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 239' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.91 108.279 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.247 0.546 . . . . 0.48 110.839 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -87.7 155.05 20.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.46 110.464 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -63.33 -39.45 94.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.2 112.256 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 54' ' ' GLN . 17.5 mt -145.7 82.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.628 0.252 . . . . 0.49 111.237 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -164.18 172.83 13.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 1.45 110.771 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.61 48.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.52 112.27 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.99 3.18 3.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.215 0.531 . . . . 0.35 110.66 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.77 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.704 -0.85 . . . . 0.35 108.704 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 22.8 m -100.46 150.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.981 -1.009 . . . . 0.37 112.527 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.37 111.77 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.378 -0.971 . . . . 0.31 108.378 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.41 110.89 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.78 111.991 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -103.54 135.93 38.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 0.32 109.005 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.93 127.92 47.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.81 111.996 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HB2' HG23 ' A' ' 89' ' ' ILE . 57.8 ttp -101.16 115.39 30.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.312 -0.625 . . . . 0.28 109.312 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 115.86 24.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.433 . . . . 0.87 110.604 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 25.4 mmm-85 -123.93 163.72 20.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.989 -0.551 . . . . 0.9 110.365 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.84 76.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.47 110.872 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.83 -57.7 4.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.799 . . . . 0.38 112.242 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -159.47 152.17 21.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.13 -0.322 . . . . 0.85 110.13 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 2.2 ptt180 -91.41 149.03 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.564 -0.532 . . . . 1.88 109.564 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -129.46 120.29 25.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.415 -0.357 . . . . 0.48 110.654 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 4.8 mt-10 -116.82 123.9 48.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.52 110.9 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mt -128.29 146.82 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.067 -0.346 . . . . 0.27 110.067 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -102.9 103.22 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 0.14 110.303 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 p -100.96 -162.44 0.94 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.12 -0.491 . . . . 0.5 110.749 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.719 ' HB2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.69 -174.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.049 0.452 . . . . 0.52 111.17 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -75.01 -139.83 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.567 -0.742 . . . . 1.15 110.491 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.48 -10.79 37.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.947 0.403 . . . . 0.24 111.546 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -62.85 -30.85 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.42 111.16 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.8 -23.99 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.029 0.442 . . . . 0.2 111.067 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.95 -30.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.439 0.638 . . . . 0.2 110.2 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 CA-C-N 115.606 -0.724 . . . . 0.46 112.126 179.665 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 pttt . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.68 0.276 . . . . 0.81 110.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.2 140.04 56.32 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.004 -0.544 . . . . 1.21 110.493 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -80.9 -18.02 48.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.115 0.783 . . . . 0.44 113.115 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.8 t70 -67.3 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.555 -0.535 . . . . 1.4 109.555 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.56 -19.83 62.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.191 0.519 . . . . 1.02 110.001 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 34' ' ' TYR . 69.2 t -78.83 -23.47 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.32 109.287 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.65 92.62 4.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.255 -0.884 . . . . 1.3 110.432 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' HG23 ' A' ' 12' ' ' ILE . 33.7 mm-40 -60.36 -44.47 95.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 1.3 109.939 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.4 p -115.05 121.57 43.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.753 -0.658 . . . . 1.14 109.992 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -87.76 23.26 2.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.309 0.576 . . . . 0.49 110.204 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.8 157.78 27.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.401 -0.818 . . . . 0.32 109.5 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.3 p -130.16 135.32 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.22 111.128 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . 61.8 m-85 -91.03 138.62 31.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.415 -0.357 . . . . 0.64 110.422 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' A' ' 68' ' ' ALA . 2.1 t -94.93 -33.32 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.571 . . . . 0.55 110.037 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -164.68 93.48 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.62 109.539 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 p -66.09 -20.47 27.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.41 111.509 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.07 -4.53 55.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.5 110.85 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -126.95 -16.03 5.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.897 -0.592 . . . . 1.21 110.588 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.95 17.78 57.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.927 -0.654 . . . . 0.32 111.496 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.58 113.08 22.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.846 0.355 . . . . 0.81 110.563 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.61 141.26 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.52 109.969 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 60' ' ' VAL . . . -101.54 126.21 48.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.653 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 71' ' ' GLU . 10.9 ptpt -98.97 -171.7 2.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.661 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -59.73 -30.08 68.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.24 111.353 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.596 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 6.4 tt0 -80.67 -1.11 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.119 0.485 . . . . 1.39 110.768 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.56 -52.4 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.455 -0.339 . . . . 1.58 110.979 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -31.61 71.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.32 111.611 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -29.95 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.54 110.919 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -98.65 -29.31 13.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.971 0.415 . . . . 0.76 111.074 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.58 45.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.507 . . . . 0.22 111.43 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -105.24 -41.54 5.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.487 -0.324 . . . . 0.41 110.79 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.96 -23.83 5.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.176 -1.011 . . . . 0.22 112.221 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -97.98 133.95 41.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.68 0.276 . . . . 0.46 110.682 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.16 10.93 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.307 0.575 . . . . 0.57 110.429 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -106.86 128.31 54.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.79 -0.641 . . . . 0.65 109.69 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -69.98 -19.24 63.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.62 -0.264 . . . . 0.32 111.289 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 49' ' ' LEU . 7.9 m -60.54 -45.85 92.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.365 -0.38 . . . . 0.43 111.002 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -71.13 -23.36 62.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 1.42 111.309 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mm -77.81 -52.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.379 . . . . 0.24 110.158 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.95 -41.75 99.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.92 -0.582 . . . . 0.36 111.131 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 83' ' ' THR . 8.0 tttt -58.65 -31.84 68.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.92 110.91 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 91' ' ' THR . 1.6 tt0 -76.09 -46.36 29.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.909 -0.587 . . . . 0.72 110.332 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 20' ' ' VAL . 72.2 mt -65.82 -31.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.29 111.211 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -8.21 59.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 0.35 111.449 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -102.31 -28.44 12.26 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.778 -0.369 . . . . 0.24 111.554 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -144.05 43.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.234 0.54 . . . . 1.22 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.18 172.78 20.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.651 -0.785 . . . . 0.29 112.117 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.38 89.92 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.862 0.363 . . . . 1.39 110.539 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 p -104.77 149.29 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.3 110.248 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.07 98.13 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.19 0.519 . . . . 1.78 111.048 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.29 110.598 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 122.209 1.004 . . . . 1.85 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.58 37.37 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.93 111.201 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -82.91 110.63 18.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.926 -0.579 . . . . 0.73 110.162 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.4 m -73.08 116.82 14.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.061 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.8 -43.4 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.52 110.558 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -132.04 152.57 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.88 110.226 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.25 1.44 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 0.66 110.808 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.39 -37.48 85.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.91 110.341 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt 50.99 57.38 6.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.56 -0.746 . . . . 0.71 110.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 15.8 m -118.91 118.31 31.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.119 -0.491 . . . . 0.51 110.954 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -52.53 -61.64 2.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.2 0.815 . . . . 0.63 113.2 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 5.21 3.29 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.962 0.727 . . . . 0.47 112.962 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -109.76 -44.55 3.81 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.816 -0.354 . . . . 0.86 110.583 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.21 10.73 36.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.806 0.336 . . . . 0.47 110.548 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.05 83.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.604 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -67.29 -21.6 65.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 1.61 111.257 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.28 -49.54 9.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.88 109.835 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.33 -40.14 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.535 . . . . 0.15 111.148 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.23 -8.17 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.201 0.524 . . . . 0.27 111.765 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -113.0 -37.16 4.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.503 -0.555 . . . . 0.4 109.503 178.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.39 -45.83 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.725 . . . . 1.39 110.338 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.43 -29.62 69.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.956 -0.565 . . . . 0.34 110.358 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.91 -20.98 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.9 110.414 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.04 -10.75 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 2.45 110.595 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -108.04 -26.31 10.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.957 -0.565 . . . . 1.08 110.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.9 ttp -150.03 125.85 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.885 -0.598 . . . . 2.64 110.042 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -72.19 121.45 19.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 1.86 110.538 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.34 110.475 -179.72 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.721 0.296 . . . . 0.98 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.07 140.21 35.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 1.31 111.275 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 211' ' ' VAL . 1.1 mp -124.56 146.13 49.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.38 110.347 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 22.0 ptt85 -113.54 139.74 48.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.824 -0.625 . . . . 0.25 110.451 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 48.7 t80 -105.94 125.87 51.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.289 -0.414 . . . . 0.7 110.253 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 pt -114.09 135.59 53.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.672 0.272 . . . . 0.52 111.407 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -178.53 163.03 1.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.19 109.568 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.27 165.76 31.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.151 1.901 . . . . 0.21 112.151 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 t -63.96 -21.93 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.342 -0.39 . . . . 0.09 111.574 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -47.89 -60.78 2.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.146 -0.479 . . . . 0.45 111.784 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -93.82 -20.84 19.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.917 0.389 . . . . 0.37 109.985 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.23 93.68 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.793 -0.639 . . . . 0.07 113.485 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -60.33 -33.98 73.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.835 0.317 . . . . 0.34 110.943 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.03 -48.56 78.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.951 -0.568 . . . . 0.86 111.602 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -21.95 47.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.991 -0.284 . . . . 0.17 111.184 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -60.67 -47.82 84.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.58 110.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.59 16.64 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.78 111.222 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.42 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 31.4 mttm -119.93 -50.53 2.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.758 0.313 . . . . 1.53 111.346 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.49 -39.79 27.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.603 0.594 . . . . 0.6 112.603 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 12.2 mtpp -61.66 -52.98 65.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.791 0.663 . . . . 0.44 112.791 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.7 Cg_endo -65.51 -19.8 60.69 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.99 1.793 . . . . 0.25 112.974 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 195' ' ' LEU . 16.9 mt -86.53 -2.24 58.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.66 -0.245 . . . . 0.5 110.797 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.5 mt 54.44 59.52 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.422 0.63 . . . . 0.46 111.399 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.414 ' CE ' ' HB3' ' A' ' 195' ' ' LEU . 14.9 mtmt -139.55 35.83 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.516 0.674 . . . . 1.53 109.673 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.69 167.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.37 109.964 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.1 mt -119.99 150.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 0.69 109.315 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -73.04 71.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.353 0.597 . . . . 2.54 111.701 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 m -151.71 35.71 0.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.3 -1.0 . . . . 0.61 108.3 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.0 mt-10 -94.84 152.65 18.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.919 -1.037 . . . . 1.59 111.585 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -105.99 148.49 27.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.63 109.206 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -138.22 94.92 2.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.873 0.368 . . . . 1.3 110.56 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -162.96 -108.45 0.22 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.156 -0.778 . . . . 0.28 111.156 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -25.46 19.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.694 0.759 . . . . 1.58 108.981 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -119.78 165.18 14.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.717 -1.129 . . . . 0.72 109.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.63 78.17 1.77 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.798 0.333 . . . . 0.72 110.599 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 33.8 tt0 -75.12 107.44 7.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.873 -0.788 . . . . 0.49 108.873 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 202' ' ' GLU . 74.2 mt -121.19 135.82 60.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.027 0.441 . . . . 0.43 111.941 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 176' ' ' LEU . 45.3 t -100.98 107.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.16 -0.682 . . . . 0.3 109.16 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.17 26.66 9.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.241 0.46 . . . . 0.95 112.241 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.402 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.4 OUTLIER -105.24 121.08 43.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.849 0.356 . . . . 0.66 110.481 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.38 -165.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.7 111.231 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.608 ' OD2' ' HD2' ' A' ' 216' ' ' PRO . 0.1 OUTLIER -64.86 160.38 55.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.791 -0.641 . . . . 1.13 111.111 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.608 ' HD2' ' OD2' ' A' ' 215' ' ' ASP . 59.7 Cg_endo -70.52 -154.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.817 2.344 . . . . 0.3 113.05 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.62 -91.42 0.77 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.403 -0.679 . . . . 0.16 111.403 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.91 -0.38 21.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.24 110.732 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.507 ' HA ' HG22 ' A' ' 222' ' ' ILE . 2.5 p90 -62.42 -24.65 67.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.11 110.557 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -68.44 -29.81 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.354 0.597 . . . . 0.82 110.003 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.11 -34.29 38.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.325 -0.852 . . . . 1.51 110.988 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.571 ' O ' HG12 ' A' ' 226' ' ' ILE . 5.2 tt -77.58 -32.65 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.13 110.559 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.38 -28.34 65.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 0.12 111.05 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -54.28 -40.72 68.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.805 -0.634 . . . . 1.31 111.174 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 229' ' ' GLU . 0.9 OUTLIER -94.34 -38.43 10.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.553 -0.294 . . . . 0.15 110.541 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 222' ' ' ILE . 48.5 mm -54.08 -37.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.33 111.384 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 7.1 ptpp? -59.79 -23.33 63.2 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.789 0.663 . . . . 1.4 112.789 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.13 -25.15 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.443 . . . . 0.41 111.507 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -72.99 -44.15 61.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.944 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -135.06 -42.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.355 0.502 . . . . 0.2 112.355 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 24.8 mtpt -60.08 -25.75 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.801 0.297 . . . . 0.53 111.801 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -100.28 12.8 60.22 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.907 -0.663 . . . . 0.4 112.984 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -101.2 -15.0 17.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.39 110.574 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.4 -131.55 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.862 -0.685 . . . . 0.24 112.14 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 m -129.31 141.61 51.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 0.66 110.726 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.6 pt? -116.65 158.62 23.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.646 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.76 164.88 28.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.038 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.41 154.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.963 0.411 . . . . 0.58 111.267 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.61 110.572 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.668 0.618 . . . . 1.26 112.668 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.28 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 1.58 110.779 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -123.41 -81.01 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.535 -0.542 . . . . 2.1 109.535 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.44 98.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.445 -0.576 . . . . 0.89 109.445 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -141.82 145.1 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.863 -0.608 . . . . 0.52 110.331 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.01 13.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.244 -0.435 . . . . 0.57 111.709 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 p -96.02 -6.03 39.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.897 0.38 . . . . 1.0 111.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -151.02 52.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.154 0.502 . . . . 1.18 110.087 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.77 132.43 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.925 -0.58 . . . . 0.24 110.846 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.25 123.17 36.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.741 -0.466 . . . . 0.11 109.741 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 t -81.6 114.82 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.332 0.587 . . . . 0.17 111.147 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.757 HG13 HG13 ' A' ' 31' ' ' ILE . 1.3 p -125.0 133.04 70.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.939 -0.763 . . . . 0.17 108.939 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.402 HH12 ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -141.31 147.18 37.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.13 111.726 -178.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HD3' ' A' ' 24' ' ' ARG . 43.1 ttp -120.7 117.48 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.15 110.187 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -99.5 114.7 27.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.291 -0.413 . . . . 0.72 109.932 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HD3' ' SD ' ' A' ' 22' ' ' MET . 14.7 mmm-85 -100.55 -172.73 2.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.266 -0.425 . . . . 0.34 109.883 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.46 -24.24 46.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.844 0.313 . . . . 0.66 111.844 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.17 -58.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.418 -0.896 . . . . 1.09 113.135 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -123.26 175.91 6.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.079 0.466 . . . . 1.58 110.934 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.13 142.76 48.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 0.98 108.979 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -130.94 119.21 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.787 0.327 . . . . 0.86 111.147 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 130.8 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 1.11 109.915 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.757 HG13 HG13 ' A' ' 20' ' ' VAL . 7.2 pt -135.71 172.27 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.84 0.352 . . . . 0.26 110.661 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 122.31 22.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.262 -0.426 . . . . 0.21 110.387 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 m -118.63 -163.35 0.95 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 1.37 110.848 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 t80 -72.94 -171.15 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.3 110.715 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -71.59 -157.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.279 -0.419 . . . . 0.59 111.828 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -48.67 -22.64 0.82 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.303 0.853 . . . . 1.3 113.303 -178.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -60.69 -18.81 56.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.28 -22.81 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 111.842 0.312 . . . . 0.15 111.842 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.564 ' HB ' HG11 ' A' ' 97' ' ' VAL . 4.0 p -76.02 -10.83 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.016 0.436 . . . . 0.31 110.838 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 C-N-CA 120.986 -0.626 . . . . 0.1 112.073 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 6.8 ptmt . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 111.582 0.216 . . . . 1.26 111.582 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 5.5 t70 -169.32 123.15 0.79 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.629 -0.508 . . . . 0.93 109.629 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.83 -35.57 76.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.197 0.443 . . . . 0.2 112.197 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.11 -39.52 89.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.523 . . . . 0.75 110.375 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -91.57 16.93 9.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.682 -0.69 . . . . 0.82 110.603 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.1 -38.03 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 0.35 110.132 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 81.42 6.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.144 -0.48 . . . . 0.93 110.708 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 34' ' ' TYR . 39.2 mt-30 -61.66 -71.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.26 110.473 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -85.71 86.53 7.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.078 0.466 . . . . 0.41 109.987 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.72 66.6 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 1.4 110.381 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.0 m -154.76 131.42 10.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.21 -0.905 . . . . 0.39 108.782 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.9 p -103.49 136.08 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.283 0.564 . . . . 0.3 110.977 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -106.45 135.59 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.951 -0.568 . . . . 0.42 110.006 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 17.9 t -89.79 -30.88 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.464 0.65 . . . . 0.18 110.207 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -151.66 103.42 2.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.716 -0.675 . . . . 0.51 110.313 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.65 -23.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.847 0.356 . . . . 0.16 111.465 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -35.62 44.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.037 0.446 . . . . 0.21 110.856 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -89.11 -40.68 12.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.045 -0.525 . . . . 0.48 110.909 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.17 33.57 2.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.899 -0.667 . . . . 0.17 111.504 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.54 106.5 18.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.55 110.764 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.31 129.52 47.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.736 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.07 112.43 24.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.148 0.499 . . . . 0.22 110.759 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -82.35 -176.06 6.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.885 -0.598 . . . . 0.89 109.614 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -60.33 -34.34 73.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.597 0.221 . . . . 1.12 111.597 -178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.9 pm0 -72.86 -13.47 61.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.98 111.447 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.47 -48.52 5.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.839 -0.344 . . . . 0.44 110.574 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.58 -31.27 71.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.695 0.283 . . . . 0.27 111.081 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -23.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.27 0.557 . . . . 0.17 110.314 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.565 . . . . 0.27 110.535 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.82 -50.27 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.32 111.287 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CG ' HG13 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -90.78 -49.56 6.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.379 . . . . 0.55 110.47 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.42 6.03 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.262 -0.735 . . . . 0.28 111.262 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.35 143.36 27.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.279 -0.461 . . . . 0.98 110.407 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.75 -5.19 48.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 0.85 110.846 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -91.55 123.99 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.8 -0.444 . . . . 1.12 109.8 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -64.52 -22.87 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.51 112.019 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -73.21 -32.61 64.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.38 . . . . 0.28 110.958 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -67.56 -36.93 81.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.221 -0.445 . . . . 0.24 111.125 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 77' ' ' PHE . 1.9 mp -66.57 -49.28 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.65 110.209 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.1 m -66.11 -26.07 67.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.19 111.523 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -57.14 -44.91 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.57 111.033 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.62 -40.83 61.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.417 -0.356 . . . . 0.39 110.98 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.497 HG22 HG22 ' A' ' 20' ' ' VAL . 63.3 mt -61.01 -36.55 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.883 0.373 . . . . 0.12 111.728 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.777 0.658 . . . . 0.11 112.777 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -105.8 -26.71 11.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.325 0.861 . . . . 0.19 113.325 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 91' ' ' THR . 31.3 mmmt -108.06 3.17 23.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.45 111.113 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.04 178.42 16.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.737 -0.744 . . . . 0.24 111.873 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.402 ' CD ' HH12 ' A' ' 21' ' ' ARG . 0.7 OUTLIER -95.54 122.52 38.37 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.958 -0.386 . . . . 0.24 109.958 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 HG13 ' A' ' 97' ' ' VAL . 3.3 p -119.18 137.21 53.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.022 -0.535 . . . . 0.22 109.973 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -77.23 84.0 3.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.084 0.468 . . . . 0.36 111.151 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.26 110.473 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.441 ' CG1' ' HG3' ' A' ' 166' ' ' LYS . 6.3 mt . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.836 0.35 . . . . 0.22 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t60 51.34 47.53 24.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.435 -0.802 . . . . 1.03 110.368 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.85 119.47 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.604 -0.726 . . . . 0.56 110.322 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 97.47 11.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.001 -0.545 . . . . 1.57 111.295 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.78 -169.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.76 -0.654 . . . . 1.52 109.708 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 66.6 mmtt -78.4 89.37 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.621 -0.511 . . . . 1.21 109.621 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -41.85 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.67 112.845 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.16 -12.84 62.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 2.43 111.968 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' GLN . 95.0 mttt -121.36 9.82 10.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.99 111.215 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -87.51 3.78 46.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.89 110.715 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -37.93 87.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.35 111.525 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -155.79 -26.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.915 0.339 . . . . 0.19 111.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 150' ' ' LYS . 43.3 tt0 -68.43 -60.46 2.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.69 110.778 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 159' ' ' VAL . 0.7 OUTLIER -94.33 14.29 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 1.81 111.155 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.07 111.548 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.75 -21.55 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.353 -0.385 . . . . 0.5 111.075 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.55 -39.14 20.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.311 -0.404 . . . . 1.04 110.451 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 155' ' ' GLN . 61.8 t -62.81 -49.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.083 -0.508 . . . . 0.14 111.083 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.7 tp -64.78 -33.56 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.16 110.536 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 1.6 mmmt -69.25 -43.01 74.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 1.48 110.174 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -61.26 -36.06 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.42 110.474 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.6 tp -69.06 -40.4 78.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.906 -0.588 . . . . 0.16 110.558 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -70.93 -11.11 60.78 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.881 -0.599 . . . . 1.02 111.177 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 36.3 mm-40 -73.48 -27.92 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.049 0.452 . . . . 0.98 110.074 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HG3' ' CG1' ' A' ' 142' ' ' ILE . 16.2 mmtt -93.14 -39.01 11.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.16 111.323 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 52.9 mtt -130.32 136.64 49.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.974 0.416 . . . . 0.35 110.896 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -79.77 81.61 6.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 1.61 110.421 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.4 pt . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.64 111.691 -179.733 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.266 -0.272 . . . . 1.34 110.266 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 213' ' ' LEU . 90.3 mtt180 -115.88 143.62 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 1.01 110.994 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.51 172.15 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.144 -0.48 . . . . 0.26 110.522 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.685 ' HB3' HG22 ' A' ' 211' ' ' VAL . 8.6 ptm180 -141.35 140.17 33.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.58 110.388 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.663 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 9.1 p90 -94.72 150.21 20.45 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.531 -0.468 . . . . 0.27 110.077 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.401 ' C ' HD13 ' A' ' 180' ' ' LEU . 8.4 tt -129.84 118.54 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.545 . . . . 0.46 111.214 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 179' ' ' ILE . 0.0 OUTLIER -152.22 156.87 34.02 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.746 -0.661 . . . . 0.29 110.245 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.22 173.09 10.04 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.397 2.064 . . . . 0.18 112.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.42 -42.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.298 0.481 . . . . 0.44 112.298 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.17 -38.71 87.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.751 0.31 . . . . 0.38 111.571 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.18 -34.81 28.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.043 0.449 . . . . 1.45 110.542 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.15 -29.75 71.97 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.13 112.569 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -65.97 -13.47 59.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.3 . . . . 0.69 111.513 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.92 -18.52 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.706 0.289 . . . . 0.92 110.89 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 178' ' ' PHE . 0.5 OUTLIER -122.98 -17.85 6.6 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.788 0.292 . . . . 1.05 111.788 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 85.4 tttt -55.57 -52.3 64.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.93 110.872 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -98.74 27.58 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.18 111.744 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -137.77 -40.95 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.857 0.317 . . . . 1.46 111.857 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 1.6 tm? -90.97 -40.94 11.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.845 0.355 . . . . 0.94 110.6 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpp -60.29 -48.37 94.2 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.566 . . . . 0.7 112.527 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.1 Cg_endo -58.53 -12.82 15.05 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.529 2.153 . . . . 0.16 113.464 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 192' ' ' LEU . 12.6 mt -76.93 -9.84 58.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.006 -0.368 . . . . 0.45 110.006 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.7 mt 59.3 31.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.517 -0.765 . . . . 0.38 111.14 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -113.51 30.44 7.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.105 -0.498 . . . . 0.56 109.793 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.16 155.43 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.555 -0.748 . . . . 0.38 111.072 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 1.4 mp -103.41 147.76 9.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.434 -0.803 . . . . 0.21 109.453 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -70.39 67.46 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.146 0.498 . . . . 1.15 111.781 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.1 m -156.33 33.4 0.33 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.42 -0.585 . . . . 0.25 109.42 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.1 OUTLIER -90.9 160.96 15.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.4 -0.818 . . . . 1.04 110.77 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.41 141.47 52.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.229 -0.656 . . . . 0.38 109.229 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -116.11 31.42 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.389 . . . . 0.65 110.933 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.81 -125.11 2.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.713 -0.755 . . . . 0.45 112.536 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.89 -31.61 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.195 0.521 . . . . 1.97 109.893 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -110.43 111.81 23.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.664 -0.865 . . . . 0.3 108.664 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.13 73.91 4.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.022 0.439 . . . . 0.49 111.121 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 42.5 mt-10 -83.47 111.6 19.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 1.23 110.523 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.663 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 22.5 mt -125.3 142.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.526 . . . . 0.37 110.908 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 177' ' ' ARG . 94.0 t -98.39 123.9 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.855 -0.794 . . . . 0.22 108.855 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.401 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 13.2 p -137.1 52.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.54 112.0 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 175' ' ' ARG . 4.1 mm? -122.25 114.74 21.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.19 -0.3 . . . . 0.56 110.19 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 215' ' ' ASP . 0.6 OUTLIER -104.99 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.381 -0.372 . . . . 0.72 110.339 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 214' ' ' ILE . 2.8 m-20 -80.5 164.27 52.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 1.24 110.624 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.75 -178.04 2.51 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.16 1.907 . . . . 0.35 112.176 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.2 -79.99 1.43 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.517 -0.849 . . . . 0.24 111.567 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -16.73 64.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.084 0.469 . . . . 0.4 110.878 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 1.3 p90 -62.41 -20.61 64.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.15 110.932 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 220' ' ' ARG . 6.3 tpt180 -65.43 -21.98 66.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.18 0.514 . . . . 0.23 110.303 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -76.29 -33.15 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.546 -0.752 . . . . 1.46 110.878 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 9.3 tt -95.15 -26.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 1.06 110.836 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -34.95 71.55 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.061 -0.518 . . . . 0.19 111.527 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -29.37 70.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.74 111.834 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -97.9 -30.89 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.518 -0.473 . . . . 0.44 111.825 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 222' ' ' ILE . 19.8 mm -57.33 -40.42 73.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 0.21 111.152 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.0 ptpp? -69.23 -8.39 45.42 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.28 0.845 . . . . 0.91 113.28 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -124.7 -31.1 3.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.563 -0.455 . . . . 0.26 111.842 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -54.21 7.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.296 0.48 . . . . 1.1 112.296 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.0 t -108.02 -42.86 4.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.733 0.642 . . . . 0.13 112.733 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 79.4 tttt -61.42 -34.69 75.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 1.98 111.234 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.12 10.41 73.66 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.473 -0.87 . . . . 0.62 112.684 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -140.69 20.32 2.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 1.53 111.141 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 173.67 -145.71 8.4 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.582 -0.818 . . . . 0.37 112.357 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.4 m -138.62 147.31 42.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.374 -0.232 . . . . 0.43 110.374 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 1.1 pt? -121.5 135.45 55.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.849 0.357 . . . . 0.43 110.333 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -129.1 173.28 10.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 1.15 110.422 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -79.4 164.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.56 -0.291 . . . . 0.12 110.696 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 175' ' ' ARG . 1.2 pt? . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 1.31 110.179 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.741 0.305 . . . . 0.61 110.651 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.759 -0.459 . . . . 0.75 109.759 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -71.73 -40.34 69.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 0.73 109.464 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -129.4 98.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.674 -0.861 . . . . 0.95 108.674 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -144.97 135.77 24.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.408 -0.36 . . . . 1.78 110.868 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 17' ' ' VAL . 98.5 mt -66.16 -16.61 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 1.34 112.02 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -89.65 -2.97 58.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.756 0.313 . . . . 0.62 111.382 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -114.75 14.61 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.58 110.544 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' LEU . 23.2 m -86.93 151.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.008 -0.542 . . . . 0.28 111.39 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.72 53.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.653 -0.703 . . . . 0.25 109.626 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.59 117.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.959 0.409 . . . . 0.59 111.139 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 89' ' ' ILE . 1.5 p -138.59 125.43 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.932 -0.576 . . . . 0.18 110.291 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 143.38 50.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.042 0.448 . . . . 2.38 111.598 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.402 ' HB2' HG23 ' A' ' 89' ' ' ILE . 11.3 ttt -109.15 129.12 55.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.607 -0.724 . . . . 0.24 110.047 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -100.09 116.62 32.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.662 0.267 . . . . 1.04 110.746 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -112.0 41.18 2.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 2.46 110.165 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 63.35 90.42 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.522 -0.763 . . . . 0.6 111.061 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.52 -48.29 3.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 0.29 112.017 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -98.63 108.56 21.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.052 0.453 . . . . 1.32 110.659 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.512 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.39 143.95 48.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 1.89 109.979 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.546 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 97.0 m-85 -132.59 150.01 52.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.55 110.441 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -138.87 154.06 48.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.662 0.268 . . . . 1.26 110.594 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.431 HD12 HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -137.55 169.66 18.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.892 -0.594 . . . . 0.51 110.153 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.46 21.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.369 . . . . 0.21 111.384 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -121.54 165.61 15.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.917 -0.583 . . . . 0.5 110.333 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -75.0 129.7 38.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.067 0.46 . . . . 0.31 111.373 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 37' ' ' LYS . 67.8 tttt -67.85 147.51 52.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.636 -0.711 . . . . 1.17 111.057 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.14 -21.47 0.25 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.86 0.864 . . . . 0.7 111.816 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 35' ' ' LYS . 28.7 mmtm -94.91 -45.08 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.051 0.453 . . . . 0.62 110.467 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 p -68.67 -18.27 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.955 -0.566 . . . . 0.33 111.864 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 97' ' ' VAL . 7.6 p -67.71 -16.37 20.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.171 0.51 . . . . 0.41 110.641 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-N 115.762 -0.654 . . . . 0.13 112.701 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 109.953 -0.388 . . . . 0.48 109.953 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -52.29 117.88 3.14 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.469 0.481 . . . . 1.28 110.19 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.26 -4.03 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.603 0.594 . . . . 0.58 112.603 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.94 -35.47 8.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.074 0.464 . . . . 1.56 109.838 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.65 -36.45 73.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 1.83 109.734 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.06 -24.25 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.17 110.779 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.33 87.14 6.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.12 110.008 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -64.11 -53.53 48.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.2 111.286 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -128.53 107.44 9.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.142 -0.481 . . . . 1.43 110.895 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.8 71.1 5.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.512 0.673 . . . . 0.79 110.277 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.4 m -153.15 130.66 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.303 -0.862 . . . . 0.33 109.329 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 29' ' ' PHE . 7.2 p -107.25 140.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.25 110.606 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 149.94 24.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.482 . . . . 0.41 111.568 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.4 t -112.76 -40.43 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.66 -0.7 . . . . 0.54 109.584 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -154.55 116.41 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 1.2 109.038 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.36 -25.18 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.949 0.352 . . . . 0.55 111.949 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -49.41 77.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.58 111.515 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -101.36 10.89 40.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.85 111.251 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.02 56.45 25.12 Favored Glycine 0 C--O 1.229 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.37 112.931 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -102.34 114.46 28.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.668 0.271 . . . . 0.65 110.328 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.9 t -112.43 131.66 63.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.28 109.676 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -84.71 120.3 26.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.977 0.417 . . . . 0.19 111.384 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 3.1 tppt? -78.27 171.82 14.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.851 -0.796 . . . . 2.02 108.851 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 19.2 pttp -59.9 -18.29 43.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 1.66 111.284 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -87.1 -7.24 58.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.52 111.644 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -114.87 -44.44 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 1.95 111.563 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 69' ' ' LYS . 2.7 pp -61.83 -23.22 66.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.879 0.371 . . . . 0.27 110.96 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 73' ' ' LEU . 16.6 tt -66.92 -35.99 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.363 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -8.86 51.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.41 111.152 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.67 -14.77 19.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.218 -0.446 . . . . 0.34 111.044 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -121.32 -43.41 2.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.48 111.008 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.61 -14.25 7.68 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.632 -0.587 . . . . 0.08 111.632 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 81' ' ' ASP . 6.0 m -151.48 150.71 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.407 -0.59 . . . . 0.19 109.407 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.38 -4.77 59.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.683 0.277 . . . . 0.22 111.148 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 79' ' ' THR . 15.1 t70 -59.48 109.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.495 . . . . 1.15 110.469 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.03 -38.96 93.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 1.26 111.532 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -43.77 98.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.71 111.793 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -62.3 -45.69 92.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.622 0.248 . . . . 0.83 111.536 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -64.18 -48.17 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.26 109.982 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 43.2 t -61.95 -42.65 99.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.32 110.471 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -56.75 -47.23 80.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.98 111.214 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -46.6 88.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.812 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG22 HG22 ' A' ' 20' ' ' VAL . 90.4 mt -65.12 -32.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.961 -0.563 . . . . 0.29 110.512 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -81.46 -4.51 56.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.23 111.428 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.413 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 88.3 m -105.35 -46.98 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.082 -0.247 . . . . 0.37 111.374 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' THR . 7.8 mmmm -122.53 40.06 3.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.137 0.494 . . . . 2.72 110.817 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.75 21.66 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.664 -0.698 . . . . 0.15 111.521 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.77 94.09 8.09 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.921 -0.4 . . . . 2.32 109.921 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 HG13 ' A' ' 97' ' ' VAL . 3.5 p -102.69 143.26 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.3 111.308 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.04 89.18 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.867 -0.606 . . . . 1.02 110.911 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 39' ' ' VAL . 10.5 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.095 -0.502 . . . . 0.39 110.759 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.808 -0.441 . . . . 0.34 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 46.09 58.43 4.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.666 -0.697 . . . . 1.37 111.923 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -124.1 143.04 50.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.52 110.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 m -129.67 158.98 37.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.176 -0.676 . . . . 0.33 109.176 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 t -76.67 -55.12 11.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.776 0.322 . . . . 0.43 110.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 149' ' ' ASN . 0.5 OUTLIER -159.35 135.04 8.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.98 110.27 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -8.16 55.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.985 0.421 . . . . 0.18 111.346 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 147' ' ' LYS . 9.7 m120 -85.14 -2.17 57.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.201 0.524 . . . . 0.52 110.343 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -114.35 145.7 41.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.599 -0.728 . . . . 0.44 109.229 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 86.5 p -76.0 169.45 18.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.934 0.397 . . . . 0.24 110.716 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -36.07 74.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.81 111.536 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.65 -11.94 58.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 1.35 111.451 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.01 -11.44 44.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.382 -0.372 . . . . 1.1 111.767 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 151' ' ' SER . 19.0 pt20 -137.88 13.89 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.38 110.763 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.42 68.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.14 111.475 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.72 -23.56 64.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.62 111.054 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -99.19 -42.65 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.425 -0.352 . . . . 1.77 111.011 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 155' ' ' GLN . 89.1 t -57.5 -36.03 52.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.21 111.352 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.6 tt -73.79 -10.23 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.173 0.511 . . . . 0.86 110.749 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -109.06 -9.2 15.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 1.26 109.964 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -53.69 38.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.12 110.542 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -71.02 -16.61 62.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.48 -0.327 . . . . 0.17 110.63 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -23.35 65.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.013 -0.539 . . . . 0.3 109.846 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -76.46 -29.14 56.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.345 -0.613 . . . . 0.38 109.345 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.59 -54.29 5.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.237 -0.892 . . . . 0.91 109.446 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.3 mmt -125.36 109.13 12.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.83 109.349 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -77.19 108.67 10.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.093 0.473 . . . . 0.94 111.213 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.769 -0.651 . . . . 0.28 110.334 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.533 0.206 . . . . 0.65 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -117.33 130.66 56.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.566 0.222 . . . . 1.1 110.525 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.16 153.82 39.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.45 -0.341 . . . . 0.43 111.311 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 237' ' ' GLU . 5.7 ptm180 -119.63 169.83 9.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.723 -0.671 . . . . 1.14 109.305 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.419 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 2.9 p90 -138.69 138.26 37.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.963 0.411 . . . . 0.74 110.792 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.31 118.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 0.22 109.718 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.938 HD12 ' HD2' ' A' ' 181' ' ' PRO . 43.6 tp -156.4 126.57 3.34 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.685 -0.234 . . . . 0.26 110.59 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.938 ' HD2' HD12 ' A' ' 180' ' ' LEU . 14.9 Cg_endo -58.48 156.36 31.7 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.963 2.442 . . . . 0.28 112.549 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.43 -40.24 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.817 0.673 . . . . 0.17 112.817 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.46 -42.98 61.96 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.386 0.513 . . . . 0.5 112.386 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HB3' HD21 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -99.08 -26.6 14.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.267 -0.424 . . . . 0.41 110.986 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.08 -29.68 71.64 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.104 -0.498 . . . . 0.28 113.113 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 74.4 tttt -62.13 -23.13 66.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.775 0.288 . . . . 0.53 111.366 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -68.55 -36.72 79.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.35 110.658 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -89.87 -27.05 20.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.949 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -54.83 -52.51 62.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 1.01 111.791 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 190' ' ' GLU . 5.4 pt-20 -86.46 24.54 1.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.147 0.425 . . . . 1.76 112.147 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.39 -41.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.807 -0.357 . . . . 0.71 111.593 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 226' ' ' ILE . 31.6 mt -85.98 -47.56 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.974 0.361 . . . . 0.41 111.974 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 22.7 mtpp -59.89 -51.78 78.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.648 0.61 . . . . 0.53 112.648 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.6 Cg_endo -61.59 -20.06 67.27 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.383 2.055 . . . . 0.41 113.24 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.5 8.01 33.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.543 0.211 . . . . 0.56 110.742 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.8 pt 35.97 60.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.255 1.022 . . . . 0.41 113.67 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -136.51 26.62 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.634 0.731 . . . . 0.96 109.65 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.77 151.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 114.844 -1.071 . . . . 0.24 109.831 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.452 HD13 HG12 ' A' ' 211' ' ' VAL . 3.5 mp -93.37 149.03 4.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.115 -0.493 . . . . 0.16 110.573 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 67.88 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.314 0.578 . . . . 1.8 111.562 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -149.66 38.75 0.77 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.302 -0.629 . . . . 0.56 109.302 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 210' ' ' ILE . 18.9 mt-10 -86.92 172.34 10.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.104 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.5 118.62 4.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.784 -0.821 . . . . 0.99 108.784 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.22 114.9 28.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.661 0.267 . . . . 1.1 110.925 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -163.05 -104.67 0.19 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.884 -0.674 . . . . 0.36 111.541 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -16.37 32.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.539 0.685 . . . . 1.91 109.367 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.47 HE21 ' HB2' ' A' ' 209' ' ' GLU . 2.8 pm0 -142.22 172.68 12.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.109 -0.95 . . . . 1.11 108.749 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.28 84.4 2.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.682 -0.488 . . . . 0.19 109.682 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB2' HE21 ' A' ' 207' ' ' GLN . 2.9 tp10 -85.99 112.82 21.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.622 -0.717 . . . . 0.93 109.758 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 202' ' ' GLU . 51.0 mt -132.16 146.02 33.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.614 0.245 . . . . 0.39 110.574 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 199' ' ' ILE . 59.0 t -100.03 113.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.43 109.691 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 20.3 t -132.73 97.64 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.19 110.699 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.9 106.25 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 0.37 109.875 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 215' ' ' ASP . 8.1 tp -90.72 168.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.367 -0.379 . . . . 0.55 110.685 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.418 ' H ' HG13 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -68.03 164.4 41.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.443 -0.344 . . . . 1.18 110.449 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.58 170.73 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.996 2.464 . . . . 0.33 113.392 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 92.24 -87.28 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.773 -0.931 . . . . 0.38 110.773 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.71 -1.92 27.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 1.09 110.861 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.48 -33.46 69.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.542 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -81.15 -16.76 52.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.133 0.492 . . . . 1.0 110.78 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.5 -44.33 24.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.72 109.521 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 226' ' ' ILE . 11.6 tt -78.07 -38.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.672 -0.695 . . . . 0.3 110.3 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 0.6 OUTLIER -60.49 -28.71 68.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.997 0.427 . . . . 0.31 110.413 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.593 ' O ' ' HE2' ' A' ' 228' ' ' LYS . 14.5 tp10 -51.02 -46.12 61.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.283 -0.871 . . . . 1.95 111.008 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -90.7 -29.28 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.395 -0.366 . . . . 0.17 111.277 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 222' ' ' ILE . 32.2 mm -58.23 -38.89 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.915 0.339 . . . . 0.24 111.915 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.9 ptpt -64.6 -10.15 24.32 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.147 0.795 . . . . 1.08 113.147 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.593 ' HE2' ' O ' ' A' ' 224' ' ' GLU . 5.7 pttt -124.72 -32.78 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.655 -0.418 . . . . 1.25 111.132 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -47.17 73.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 1.43 111.997 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 188' ' ' LEU . 4.0 t -130.11 -41.55 1.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.129 0.418 . . . . 0.16 112.129 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 0.3 OUTLIER -67.3 -21.7 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.951 0.405 . . . . 1.78 110.805 -179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.73 14.41 64.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.889 -0.672 . . . . 0.45 111.978 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -135.51 -45.82 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.82 110.835 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -109.22 -154.97 16.15 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.799 -0.715 . . . . 0.53 112.225 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -120.94 152.81 38.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.275 -0.269 . . . . 0.16 110.275 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.0 pt? -95.44 150.0 20.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.99 110.496 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 177' ' ' ARG . 9.6 tp10 -150.24 160.03 43.99 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.341 -0.614 . . . . 0.88 109.341 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.17 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.88 0.372 . . . . 0.25 111.013 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.238 0.457 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.609 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.646 -0.501 . . . . 0.69 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -172.03 168.73 5.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -91.27 -57.84 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 0.8 109.889 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.1 mt -129.69 105.16 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 0.35 110.024 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -177.71 149.1 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.141 -0.688 . . . . 1.18 109.141 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.45 61.09 0.66 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.124 0.487 . . . . 0.23 112.04 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -42.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 0.35 109.327 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -105.1 37.14 2.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.4 109.941 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 15.7 m -102.47 155.66 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.16 111.589 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . . . -118.46 125.45 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.503 -0.771 . . . . 0.26 109.29 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.27 133.58 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.448 . . . . 0.57 111.676 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 4.1 p -133.78 129.9 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.66 -0.7 . . . . 0.24 109.504 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.22 140.42 52.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 1.86 111.906 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 59.0 ttp -123.26 125.71 45.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.24 109.691 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -100.04 118.8 37.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.656 0.265 . . . . 0.92 110.757 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -113.21 -159.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.77 110.791 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.56 -73.73 0.07 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.152 -0.477 . . . . 0.37 111.684 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.27 29.78 5.62 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.468 -0.872 . . . . 0.15 112.335 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 11.3 tppt? -156.03 146.56 21.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.238 -0.282 . . . . 0.46 110.238 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' MET . 12.2 ptt-85 -141.0 93.16 2.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.046 0.45 . . . . 2.38 110.308 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 96.0 m-85 -76.93 152.41 35.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 1.33 111.671 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 15.0 pt-20 -146.86 133.02 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.15 109.583 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -132.11 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.97 0.414 . . . . 0.4 110.957 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -137.18 110.77 8.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.14 110.516 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.4 m -106.89 -175.81 2.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.909 -0.587 . . . . 0.59 110.559 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' HA ' HE21 ' A' ' 54' ' ' GLN . 3.0 t80 -66.69 122.77 18.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.006 0.431 . . . . 0.31 110.544 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 32.1 ttpt -60.29 124.83 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.745 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.0 t30 66.28 3.73 2.88 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.832 -1.076 . . . . 0.84 113.414 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 44.2 tptt -107.51 -33.79 7.23 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.673 -0.642 . . . . 1.1 110.242 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.57 -22.05 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.837 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.27 -18.11 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.64 109.86 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.624 0 CA-C-N 115.75 -0.659 . . . . 0.13 112.219 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 19.9 ptmt . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.445 0.165 . . . . 1.32 111.445 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -178.0 126.5 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.238 -0.282 . . . . 0.52 110.238 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 52' ' ' VAL . 48.3 mt -61.6 -29.01 69.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 1.63 112.048 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.21 -35.69 55.42 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.707 -0.397 . . . . 0.92 110.698 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.54 -29.14 41.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 1.22 110.945 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.5 p -72.17 -12.57 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.052 0.453 . . . . 0.27 110.792 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.63 HD21 ' SG ' ' A' ' 86' ' ' CYS . 2.1 mm? -94.19 97.53 10.33 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.566 -0.531 . . . . 0.58 109.566 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 34' ' ' TYR . 73.2 mt-30 -66.03 -39.55 90.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.42 110.83 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 t -117.3 136.63 52.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.798 0.332 . . . . 0.42 110.539 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -100.32 16.06 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 0.69 110.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 m -110.28 112.28 24.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.713 -0.676 . . . . 0.66 110.024 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 31' ' ' ILE . 7.2 p -92.12 139.22 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.2 110.221 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.42 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 11.7 m-85 -100.89 160.71 14.14 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.023 -0.362 . . . . 0.44 110.023 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.94 -61.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.063 0.459 . . . . 0.46 110.834 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.13 92.42 3.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.43 110.41 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -65.68 -24.69 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.174 0.511 . . . . 0.37 110.43 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -29.56 67.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.7 -0.682 . . . . 0.99 111.387 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.12 -34.58 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 1.43 110.74 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.88 41.35 2.31 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.261 -0.736 . . . . 0.48 111.261 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -105.19 121.07 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.785 0.326 . . . . 1.21 111.179 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.03 141.55 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.37 109.93 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.78 104.09 13.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.132 0.491 . . . . 0.23 109.84 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -82.29 -174.9 5.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.27 110.842 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -34.17 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.762 0.652 . . . . 0.91 112.762 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 pm0 -80.84 -4.07 53.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.822 0.344 . . . . 0.92 111.302 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.65 -52.23 3.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 0.18 110.502 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.331 . . . . 0.24 111.706 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.02 -22.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.17 110.949 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -103.06 -32.47 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.62 111.46 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.31 -36.63 46.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.31 111.5 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.68 -51.5 2.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 2.09 110.109 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.93 -37.75 2.41 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.48 111.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.35 147.4 26.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.623 0.249 . . . . 1.42 110.38 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -100.3 -7.56 24.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.448 -0.342 . . . . 1.1 111.628 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.18 126.24 38.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.722 0.296 . . . . 1.21 110.719 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -27.47 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 0.43 111.815 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -63.58 -39.92 95.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.878 0.371 . . . . 0.58 110.468 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.37 -40.66 85.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.25 110.747 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.99 -48.19 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.885 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 53' ' ' LEU . 36.8 t -65.12 -29.61 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.725 . . . . 0.2 111.39 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -58.67 -49.53 77.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.397 . . . . 0.34 110.827 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -68.95 -37.42 78.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.798 -0.637 . . . . 1.45 110.551 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 31' ' ' ILE . 97.4 mt -69.22 -31.02 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.497 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.66 -18.86 56.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.976 0.361 . . . . 0.37 111.976 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 t -108.31 -34.78 6.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.652 -0.419 . . . . 0.42 112.066 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -101.51 7.12 42.52 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.917 0.389 . . . . 0.67 110.564 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.22 175.34 17.34 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.523 -0.846 . . . . 0.1 112.778 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -102.14 119.04 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.935 -0.394 . . . . 1.34 109.935 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.65 146.63 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.704 -0.68 . . . . 0.29 110.252 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.69 101.62 1.07 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.62 110.122 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.989 -0.55 . . . . 0.42 111.358 -179.091 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.8 mt . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.465 -0.198 . . . . 0.54 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 58.5 49.94 9.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.177 -0.465 . . . . 1.11 110.601 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.28 87.26 6.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.136 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -81.92 121.91 27.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.728 -0.669 . . . . 0.52 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.6 -76.01 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.416 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.631 -0.507 . . . . 0.63 109.631 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 123.1 15.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.279 0.362 . . . . 0.51 110.671 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.38 46.35 5.55 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.134 0.896 . . . . 0.16 112.406 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.477 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -59.09 -53.96 52.41 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.108 -0.701 . . . . 0.63 109.108 178.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 155' ' ' GLN . 2.7 p -103.31 179.95 4.12 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.668 -0.697 . . . . 0.22 109.439 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 150.02 49.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.753 0.279 . . . . 0.7 111.753 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tttm 64.11 46.44 3.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.791 -0.641 . . . . 0.28 111.774 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.4 ' HG3' ' NE2' ' A' ' 155' ' ' GLN . 7.8 tp60 59.23 71.39 0.59 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.658 -0.701 . . . . 0.33 111.369 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 151' ' ' SER . 1.9 pm0 44.36 39.26 2.98 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.871 0.868 . . . . 0.07 112.782 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.84 -35.77 75.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.11 112.02 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 4.1 mm? -67.2 -27.54 67.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.878 0.371 . . . . 0.26 110.765 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.477 ' OE1' ' HB3' ' A' ' 150' ' ' LYS . 3.5 mp0 -82.42 -44.81 15.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 163' ' ' LEU . 98.9 t -61.79 -43.52 97.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.17 111.238 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.9 tt -66.61 -10.77 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.284 -0.416 . . . . 0.31 112.063 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -115.17 -10.54 12.14 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.173 -0.329 . . . . 1.18 110.883 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -87.18 -36.96 17.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.395 . . . . 0.71 111.547 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -74.89 -13.67 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.18 110.91 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.542 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.4 tmmt? -62.83 -25.03 68.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.971 -0.559 . . . . 0.38 110.659 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.34 -24.74 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.005 -0.543 . . . . 0.7 110.666 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -93.48 -48.65 6.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.384 -0.598 . . . . 1.48 109.384 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 19.7 mmt -127.34 104.89 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.098 -0.705 . . . . 1.59 109.098 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -87.96 127.81 35.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.03 0.443 . . . . 1.08 111.232 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.612 -0.722 . . . . 0.22 110.399 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.685 0.278 . . . . 1.75 110.66 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.94 130.92 41.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.263 -0.426 . . . . 1.01 110.73 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 213' ' ' LEU . 16.9 tp -116.91 130.84 56.96 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.53 -0.544 . . . . 1.25 109.53 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -126.28 164.13 21.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.88 0.371 . . . . 0.65 110.236 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 94.5 m-85 -122.51 145.04 48.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.635 -0.505 . . . . 0.35 109.635 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -127.69 114.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.501 0.667 . . . . 0.31 111.526 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -147.45 158.96 42.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.31 109.626 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.66 173.92 6.12 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.333 2.022 . . . . 0.16 112.417 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' VAL . 3.3 t -54.01 -31.4 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.4 112.009 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -53.54 -59.5 4.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.974 0.416 . . . . 0.28 110.579 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -77.31 -24.43 50.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.74 110.264 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 189' ' ' LYS . . . -59.92 -35.64 87.6 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.865 -0.607 . . . . 0.21 112.239 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -77.73 2.72 16.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.7 0.285 . . . . 0.92 110.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 190' ' ' GLU . 69.9 mmtt -104.09 -48.43 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.581 -0.281 . . . . 1.34 111.412 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.417 ' CD2' ' HA2' ' A' ' 185' ' ' GLY . 1.3 pt? -79.44 -26.22 41.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.67 111.549 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 17.5 ttpt -66.38 -26.53 67.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 0.65 111.307 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 187' ' ' LYS . 0.4 OUTLIER -95.47 1.36 53.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.457 -0.338 . . . . 0.57 111.465 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.467 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 27.8 mttp -122.97 -43.07 2.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.362 0.504 . . . . 0.86 112.362 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.16 -44.3 47.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.192 0.442 . . . . 0.25 112.192 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.5 mtpt -58.95 -51.36 82.41 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.841 0.682 . . . . 0.22 112.841 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.1 Cg_endo -61.91 -9.1 13.21 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.307 2.005 . . . . 0.19 113.513 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 73.8 mt -81.69 -6.97 59.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.14 110.477 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.2 mm 52.36 53.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.695 -0.684 . . . . 0.19 111.036 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -146.62 27.03 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.717 -0.674 . . . . 1.03 110.181 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.68 147.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.993 -0.549 . . . . 0.11 111.073 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 214' ' ' ILE . 4.2 mp -101.41 144.62 12.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.19 109.926 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -68.78 80.55 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.289 0.566 . . . . 2.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.6 t -160.21 17.3 0.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.92 109.376 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.3 mp0 -75.29 134.03 41.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.22 110.547 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -100.71 136.73 40.12 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.837 -0.619 . . . . 0.79 109.673 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 144.24 44.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.712 0.291 . . . . 0.83 110.348 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 152.69 -121.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.719 -0.753 . . . . 0.22 111.58 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -82.01 -24.33 35.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.194 0.521 . . . . 0.45 110.074 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -124.82 158.7 32.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.472 -0.786 . . . . 1.75 109.543 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.68 91.7 3.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.041 -0.355 . . . . 0.4 110.041 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 45.6 mt-10 -94.6 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.301 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.9 mt -119.01 142.38 34.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.715 -0.221 . . . . 0.28 110.863 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.74 134.63 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.963 -0.384 . . . . 0.34 109.963 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 14.6 t -119.55 -32.75 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.744 0.646 . . . . 1.33 112.744 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -74.56 121.56 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.825 0.345 . . . . 0.75 111.477 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.613 ' HB ' HD11 ' A' ' 199' ' ' ILE . 4.0 tt -125.47 -54.63 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.676 . . . . 0.57 111.185 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 219' ' ' PHE . 0.4 OUTLIER -140.09 161.3 56.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.877 -0.416 . . . . 0.26 109.877 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 219' ' ' PHE . 97.8 Cg_endo -77.52 -173.37 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.437 2.092 . . . . 0.27 113.117 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.01 -88.39 0.77 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.91 -0.586 . . . . 0.39 112.439 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.62 -18.69 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.659 0.384 . . . . 1.21 111.173 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 2.3 p90 -63.69 -25.22 68.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.84 110.597 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 220' ' ' ARG . 2.1 tpp180 -76.72 -32.11 57.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.62 110.139 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.46 -43.21 70.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.492 . . . . 1.12 110.64 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 6.3 tt -73.71 -23.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.054 0.455 . . . . 0.19 110.789 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.7 -29.58 68.2 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.16 111.486 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.6 -30.32 65.21 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.585 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.4 pp -105.0 -35.32 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.997 -0.281 . . . . 0.29 111.317 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.42 HG12 HG12 ' A' ' 222' ' ' ILE . 24.9 mm -55.23 -36.39 39.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 120.788 0.327 . . . . 0.21 111.721 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -62.38 -17.22 58.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.669 0.618 . . . . 0.72 112.669 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.68 -23.98 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.62 111.07 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HG3' ' HD3' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -68.2 -47.54 67.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 1.92 111.713 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.4 t -129.98 -32.45 1.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.674 -0.41 . . . . 0.21 111.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 76.8 tttt -66.56 -30.42 70.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.181 0.515 . . . . 0.3 110.132 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -97.7 23.77 34.53 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.73 -0.668 . . . . 0.22 111.696 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -133.9 -36.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.24 110.31 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.38 -176.89 16.93 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.848 -0.691 . . . . 0.28 111.753 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.3 t -87.36 159.76 18.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 0.46 110.333 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 153.65 25.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.198 -0.455 . . . . 0.41 110.947 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.16 143.29 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.781 -0.645 . . . . 1.89 109.705 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.09 124.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.523 . . . . 0.28 111.367 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 109.299 -0.63 . . . . 0.44 109.299 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 121.052 0.453 . . . . 0.87 111.087 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 27.3 t-20 -144.2 149.12 35.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.549 . . . . 1.46 109.831 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -54.96 40.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.742 0.306 . . . . 0.4 111.701 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mt -91.17 63.54 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.104 0.478 . . . . 0.7 111.242 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 2.4 mmp_? -136.43 148.98 48.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 1.39 110.479 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.45 -0.92 56.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.49 110.333 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -77.62 -41.34 38.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.263 0.554 . . . . 0.44 110.456 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -108.48 78.52 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.818 -0.628 . . . . 0.59 109.936 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.46 HG12 ' OE1' ' A' ' 54' ' ' GLN . 19.2 m -120.54 140.81 43.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.017 -0.538 . . . . 0.17 111.128 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -110.64 116.3 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.087 -0.708 . . . . 0.18 109.087 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.64 110.52 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 0.2 111.591 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 89' ' ' ILE . 3.6 p -102.13 137.79 28.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.997 -1.112 . . . . 0.12 107.997 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 136.82 49.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.326 0.584 . . . . 0.33 112.453 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 36.7 ttp -121.38 120.62 35.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.032 -0.986 . . . . 0.28 109.488 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.28 129.96 55.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.909 -0.404 . . . . 0.89 109.909 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -108.7 35.92 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.409 -0.36 . . . . 0.63 110.771 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.19 63.75 1.81 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.648 0.737 . . . . 0.32 109.942 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.94 -70.43 0.48 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.211 -1.155 . . . . 0.2 110.211 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -87.23 135.82 33.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 1.17 109.217 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -128.23 151.63 49.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.4 111.322 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -141.08 126.23 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.3 110.347 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 132.34 56.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.11 -0.495 . . . . 0.19 110.08 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.43 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -129.52 149.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.84 110.688 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.23 115.98 31.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.2 110.909 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.1 p -149.08 141.01 23.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.58 109.983 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -114.58 -84.42 0.61 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.227 -0.189 . . . . 0.65 111.091 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 65.16 -179.94 0.19 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.808 0.692 . . . . 1.02 111.559 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.62 78.16 9.9 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.279 -1.008 . . . . 1.79 108.279 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt 67.88 78.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.372 -0.831 . . . . 0.9 109.422 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.42 -26.56 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.489 -0.778 . . . . 0.38 111.782 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.48 -28.83 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.46 110.687 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.15 111.814 179.559 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 109.979 -0.378 . . . . 0.47 109.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 164.51 4.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.023 0.439 . . . . 1.22 111.932 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.718 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -84.22 -8.74 58.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.566 . . . . 0.15 111.311 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -27.33 66.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.311 -0.404 . . . . 0.85 110.808 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -104.18 16.85 25.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.47 111.813 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' LEU . 3.0 p -108.3 -27.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.465 -0.494 . . . . 0.22 110.991 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 53' ' ' LEU . 1.2 mm? -80.35 91.36 5.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.397 -0.365 . . . . 0.24 110.766 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' OE1' HG12 ' A' ' 17' ' ' VAL . 69.2 mt-30 -69.31 -31.06 69.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.47 0.652 . . . . 0.3 109.717 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -140.82 126.5 19.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.239 -0.891 . . . . 0.43 109.264 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -86.77 42.74 1.03 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.28 110.629 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.7 113.76 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.833 -0.621 . . . . 0.45 110.267 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.4 p -91.5 138.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.741 -0.466 . . . . 0.37 109.741 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.02 150.18 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.306 -0.406 . . . . 0.19 111.116 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.42 -47.38 7.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.27 109.429 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -130.57 103.28 6.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 0.33 109.349 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.0 -28.09 23.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 113.044 0.757 . . . . 0.22 113.044 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 p -82.12 -27.57 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.525 -0.47 . . . . 0.64 111.81 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -100.54 -2.04 34.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.97 111.093 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.55 45.29 78.7 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.21 113.1 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.33 112.3 25.06 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.921 -0.399 . . . . 0.65 109.921 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.09 144.38 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 0.46 110.752 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.663 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.98 109.56 20.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.635 -0.506 . . . . 0.31 109.635 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.631 ' HB3' ' OE2' ' A' ' 71' ' ' GLU . 7.5 mtpt -78.88 176.62 9.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.886 -0.597 . . . . 1.28 110.878 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.77 -32.11 67.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 1.09 112.176 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.631 ' OE2' ' HB3' ' A' ' 69' ' ' LYS . 1.7 pm0 -93.25 4.0 54.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.756 0.312 . . . . 1.02 111.166 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -105.69 -46.49 4.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 2.16 110.206 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 1.5 pp -63.77 -33.56 75.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.048 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 tt -68.54 -21.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.231 0.538 . . . . 0.65 110.432 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -99.38 1.09 44.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.66 110.635 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.93 -51.35 2.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.49 110.931 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.61 -15.35 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 1.51 110.864 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.03 -25.35 20.31 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.749 -0.738 . . . . 0.25 112.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 138.26 31.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.68 0.276 . . . . 0.31 110.805 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.9 -5.52 55.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.424 0.631 . . . . 0.64 109.6 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.37 117.01 28.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.162 -0.926 . . . . 0.43 110.511 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -68.75 -22.17 64.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.81 111.062 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -47.0 77.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.19 111.064 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -56.43 -39.63 73.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.224 0.535 . . . . 1.34 110.382 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 89' ' ' ILE . 66.9 mt -70.22 -48.2 62.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.683 -0.69 . . . . 0.14 110.106 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 31' ' ' ILE . 51.6 t -58.61 -40.24 82.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 0.12 110.243 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 91' ' ' THR . 5.3 tttp -58.64 -47.19 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 1.05 109.88 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.05 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 1.67 110.937 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 20' ' ' VAL . 69.0 mt -67.54 -29.9 47.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.046 0.45 . . . . 0.3 110.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -35.19 35.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.031 -0.531 . . . . 0.2 111.976 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 87' ' ' LYS . 6.9 t -96.38 -18.05 20.2 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.998 0.74 . . . . 0.26 112.998 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -124.42 17.35 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.32 111.283 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.91 178.44 18.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.59 -0.814 . . . . 0.23 112.459 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.09 112.23 24.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 2.68 110.615 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 97' ' ' VAL . 11.0 p -103.21 155.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.46 109.756 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -71.34 99.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.026 0.441 . . . . 0.62 110.487 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 95' ' ' VAL . 17.6 m . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.4 110.481 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 122.053 0.93 . . . . 0.74 110.06 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -122.33 -2.25 9.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.536 -0.756 . . . . 0.97 110.734 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -78.65 124.24 27.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.319 -0.4 . . . . 1.65 111.029 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.4 m 55.39 34.47 22.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.574 -0.739 . . . . 0.55 112.261 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.92 -53.3 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.58 110.679 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 152' ' ' THR . 45.9 tttt -134.7 14.41 3.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 1.19 110.208 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 116.94 10.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.681 -0.69 . . . . 0.5 110.84 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 67.8 66.16 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.097 0.559 . . . . 0.54 110.797 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -164.48 159.46 19.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.154 -0.684 . . . . 0.36 109.154 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.52 154.38 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 1.28 110.297 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -57.67 -49.55 76.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.857 0.688 . . . . 0.81 112.857 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -82.22 -16.07 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.628 0.251 . . . . 1.23 111.673 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.76 -59.19 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.24 111.826 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.8 mp0 -105.2 23.29 13.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.528 -0.305 . . . . 0.32 111.552 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.976 0.362 . . . . 0.21 111.976 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.8 mm? -78.45 -16.75 57.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.269 -0.423 . . . . 0.57 111.908 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.21 -42.38 10.45 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.906 -0.317 . . . . 0.78 110.988 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 155' ' ' GLN . 86.3 t -59.12 -39.05 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.402 -0.363 . . . . 0.24 111.273 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.61 -19.74 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.336 -0.393 . . . . 0.55 111.283 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -99.34 -16.94 18.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 1.23 110.595 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -62.55 1.46 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.73 111.035 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -71.71 -17.7 62.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.3 111.467 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.454 ' N ' HD13 ' A' ' 163' ' ' LEU . 6.4 tmtt? -70.26 -34.28 72.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.888 0.375 . . . . 1.16 110.628 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -77.76 -34.47 52.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 1.76 110.579 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -35.95 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.3 0.572 . . . . 0.75 109.972 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 tpt -124.24 91.16 3.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.703 -0.851 . . . . 0.24 108.703 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.42 101.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.391 0.615 . . . . 1.34 111.674 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.1 pt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.129 -0.941 . . . . 0.28 109.775 178.895 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 53.5 mtt . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.633 0.254 . . . . 1.0 110.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 54.7 mtt180 -135.13 117.51 15.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 1.19 111.116 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.479 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 13.7 mt -108.22 152.51 24.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.867 -0.606 . . . . 2.2 110.213 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.401 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 19.7 ptt180 -140.82 159.97 41.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.222 -0.445 . . . . 0.35 110.176 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 0.8 OUTLIER -134.17 132.82 40.26 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.181 -0.674 . . . . 0.09 109.181 178.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.2 tt -126.73 123.16 62.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.114 0.483 . . . . 0.1 111.476 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.9 OUTLIER -159.76 156.01 23.69 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 0.23 110.028 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.87 143.36 30.45 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.861 2.374 . . . . 0.09 112.428 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.82 -31.54 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.45 112.427 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -54.89 -46.45 74.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.583 0.23 . . . . 1.38 111.534 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.25 -30.79 17.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.92 109.841 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.39 -29.78 72.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.467 -0.788 . . . . 0.18 113.08 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -59.34 -26.41 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 0.49 111.087 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -44.52 73.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.81 110.523 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 3.0 pp -76.76 -22.91 53.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.26 110.053 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 71.3 tttt -63.0 -35.34 79.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.92 110.189 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -101.07 18.31 20.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.783 -0.644 . . . . 1.65 110.981 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -131.28 -52.79 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.064 0.394 . . . . 0.7 112.064 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 212' ' ' CYS . 1.1 tm? -86.35 -44.18 12.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.17 111.722 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpt -57.13 -48.42 97.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.809 0.67 . . . . 0.21 112.809 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.9 Cg_endo -59.04 -16.64 33.87 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.298 1.998 . . . . 0.26 113.282 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 56.0 mt -74.2 -15.82 61.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 0.36 110.162 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 16.7 mt 56.45 60.63 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.645 -0.707 . . . . 0.75 111.586 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -135.3 10.06 3.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.691 -0.686 . . . . 1.49 109.737 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.2 167.48 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.582 -0.735 . . . . 0.34 111.672 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.72 148.48 10.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.42 -0.809 . . . . 0.29 108.945 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.12 57.99 0.36 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.263 0.554 . . . . 1.19 111.711 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -146.35 55.84 1.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.39 109.275 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.1 pt-20 -106.13 167.7 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.45 111.516 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.9 t70 -131.51 123.53 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.78 31.49 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.91 110.802 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.09 -102.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.596 -0.811 . . . . 0.32 112.067 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -95.78 -31.09 13.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.439 0.638 . . . . 0.34 109.577 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.18 136.96 54.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.384 -0.825 . . . . 0.58 109.44 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 203' ' ' ASP . 36.1 tp -88.82 99.65 12.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.077 0.465 . . . . 0.15 110.265 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 50.2 tt0 -109.38 114.78 28.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.2 109.712 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 178' ' ' PHE . 21.3 mt -127.39 141.13 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 0.12 110.891 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.8 125.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.089 -0.708 . . . . 0.2 109.089 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 192' ' ' LEU . 50.8 t -139.83 99.97 3.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.578 0.227 . . . . 0.25 111.454 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.479 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER 177.73 121.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.966 -0.753 . . . . 0.46 108.966 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -116.0 -40.41 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 111.832 0.308 . . . . 1.53 111.832 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.45 143.69 36.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.879 0.326 . . . . 0.69 111.879 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.68 -30.16 35.03 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.875 2.383 . . . . 0.27 112.077 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.5 -23.37 75.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.915 -0.66 . . . . 0.39 111.761 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.7 6.75 44.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.215 0.531 . . . . 1.43 110.572 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.34 -47.68 81.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.716 -0.674 . . . . 0.97 110.526 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -66.17 -23.68 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.627 . . . . 2.03 111.087 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.54 -42.82 28.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.778 -0.646 . . . . 2.19 111.507 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 0.6 OUTLIER -82.1 -33.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.07 0.396 . . . . 1.3 112.07 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.79 -24.49 67.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.881 0.372 . . . . 0.47 111.045 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 12.9 mm-40 -61.76 -31.41 71.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 0.5 111.408 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.7 OUTLIER -102.6 -36.79 8.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.117 -0.233 . . . . 0.29 110.82 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.8 mm -53.88 -34.35 25.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.61 -0.268 . . . . 0.15 111.72 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.2 ptpt -55.99 -32.06 63.58 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.126 0.417 . . . . 1.36 112.126 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -108.72 -27.15 9.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.007 0.432 . . . . 0.56 110.881 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.57 . . . . 0.62 112.091 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -149.73 -30.89 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.008 0.744 . . . . 0.17 113.008 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 33.3 ttmt -58.9 -37.56 76.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.95 0.341 . . . . 2.23 111.84 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.25 18.6 51.13 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.678 -0.772 . . . . 0.19 112.629 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -129.99 -47.84 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.62 110.501 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -119.65 -158.01 10.48 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.209 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.3 m -108.09 138.64 44.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.346 . . . . 0.31 110.532 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 150.09 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 1.37 109.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.43 167.77 23.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.053 0.454 . . . . 1.19 110.764 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.13 150.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.6 109.742 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 239' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.046 0.451 . . . . 0.4 110.503 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.53 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -153.71 156.83 38.54 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.259 -0.645 . . . . 0.2 109.259 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.1 -19.23 28.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.083 0.401 . . . . 0.83 112.083 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.32 70.94 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.299 0.571 . . . . 1.13 110.803 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -146.35 149.49 33.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.749 -0.66 . . . . 0.85 109.998 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 17' ' ' VAL . 86.1 mt -67.13 -9.32 38.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.443 0.535 . . . . 0.48 112.443 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -90.86 2.67 55.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 0.33 111.48 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -135.35 32.43 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.213 0.53 . . . . 1.12 110.532 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 14' ' ' LEU . 27.2 m -84.32 152.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.69 -0.686 . . . . 0.31 111.514 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.43 140.76 48.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.843 -0.617 . . . . 0.19 110.053 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.48 117.7 32.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.204 0.526 . . . . 0.41 110.948 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -147.62 117.47 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.25 109.993 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 149.29 50.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.26 111.11 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 55.9 ttp -122.14 139.37 53.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.336 -0.847 . . . . 0.36 110.472 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -116.11 120.99 40.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.714 -0.476 . . . . 0.29 109.714 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -122.37 89.47 3.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.549 -0.296 . . . . 0.68 110.52 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.15 46.75 23.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.693 -0.685 . . . . 0.58 111.734 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.91 -48.78 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.448 -0.882 . . . . 0.47 112.815 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -69.38 129.22 39.14 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.199 -0.297 . . . . 0.45 110.199 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -119.11 143.64 47.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.763 0.316 . . . . 0.77 111.336 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -132.87 142.42 48.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.3 109.82 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 24.9 tt0 -146.54 133.02 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.62 -0.511 . . . . 1.75 109.62 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -136.49 130.38 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.326 -0.397 . . . . 0.44 110.01 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 113.09 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.15 111.686 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 31.2 m -107.55 175.91 5.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.786 -0.643 . . . . 0.17 110.219 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CD1' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.77 150.42 37.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.098 0.475 . . . . 0.32 111.084 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -87.5 -7.85 57.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.457 0.539 . . . . 1.53 112.457 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -78.63 78.33 5.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.55 111.76 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 52.27 63.24 2.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.89 -0.596 . . . . 1.71 111.852 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 7.9 p -70.45 -24.2 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.954 -0.566 . . . . 0.54 110.714 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.14 -5.35 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 111.276 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.391 0 C-N-CA 121.239 -0.505 . . . . 0.18 112.852 -179.723 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.753 0.311 . . . . 1.75 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -167.69 160.43 12.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.974 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tp -109.92 -14.63 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.43 110.886 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.28 -40.54 6.71 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.611 -0.514 . . . . 0.23 109.611 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.48 -24.91 61.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.913 -0.585 . . . . 1.88 110.345 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' TYR . 12.0 p -70.88 -26.55 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.415 -0.587 . . . . 0.32 109.415 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.55 97.71 7.96 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.89 110.189 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -67.23 -37.03 82.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.22 108.904 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 t -157.52 126.09 5.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.773 -1.103 . . . . 0.44 108.98 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 10.5 p80 -77.7 67.17 3.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.556 0.693 . . . . 0.47 110.556 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -138.59 111.84 8.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.292 -0.867 . . . . 0.91 110.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.4 p -100.68 135.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.19 110.103 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -91.66 163.84 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.92 0.39 . . . . 2.09 111.238 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.44 -49.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.019 -0.734 . . . . 0.98 109.019 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -142.46 103.63 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.722 . . . . 0.27 109.173 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.9 -26.9 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.19 -0.459 . . . . 0.39 112.132 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 m -72.42 -36.06 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.9 0.381 . . . . 0.27 110.971 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.68 5.85 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.193 -0.458 . . . . 0.27 110.845 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.0 44.19 96.4 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.207 -0.52 . . . . 0.14 112.79 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -112.63 121.96 46.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.863 0.363 . . . . 0.94 110.736 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.78 170.4 7.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.98 -0.554 . . . . 1.29 109.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.714 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -115.45 120.96 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.082 0.467 . . . . 0.37 111.049 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -87.74 -178.28 6.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.078 -0.712 . . . . 1.26 109.078 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' OE1' ' A' ' 71' ' ' GLU . 3.1 pttp -56.56 -39.39 73.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.842 0.353 . . . . 1.61 111.333 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' OE1' ' HG3' ' A' ' 70' ' ' LYS . 7.1 pm0 -75.75 -11.25 59.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 1.79 111.847 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -98.03 -48.69 5.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.655 -0.248 . . . . 0.98 110.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.72 -32.81 73.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.737 -0.211 . . . . 0.33 111.514 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 79' ' ' THR . 6.9 tt -64.51 -26.78 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.085 0.469 . . . . 0.45 110.455 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 m -95.55 -10.46 29.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 1.06 110.276 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.22 -54.69 4.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.736 -0.666 . . . . 0.36 111.252 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -100.72 -37.87 8.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.58 111.33 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.66 -18.17 8.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.293 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.73 141.57 30.58 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.165 -0.309 . . . . 0.36 110.165 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -14.26 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.27 111.09 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' OD1' HG22 ' A' ' 83' ' ' THR . 17.0 t0 -90.09 125.14 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.59 110.178 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.95 -21.76 54.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.07 -0.514 . . . . 0.68 112.171 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.419 HG22 ' OD1' ' A' ' 81' ' ' ASP . 2.5 t -68.0 -31.51 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.224 -0.591 . . . . 1.49 110.034 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 74.3 mm-40 -70.22 -36.78 74.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.092 -0.707 . . . . 1.08 109.092 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 89' ' ' ILE . 32.6 mm -64.34 -45.73 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.206 -0.906 . . . . 0.28 109.172 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.49 -42.3 91.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.38 110.575 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.86 -38.32 90.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 1.86 110.189 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 7.5 mm100 -64.28 -39.95 94.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.05 109.76 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.65 HG22 HG22 ' A' ' 20' ' ' VAL . 45.1 mt -67.66 -26.75 36.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.38 110.391 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.411 HD22 HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.75 -27.4 31.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.29 111.731 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.36 -30.86 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.62 0.6 . . . . 0.52 112.62 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -111.45 -3.73 15.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.029 0.442 . . . . 0.7 110.939 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.5 178.77 22.61 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.673 -0.775 . . . . 0.3 112.516 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.2 112.02 24.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.41 . . . . 1.31 110.573 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 20' ' ' VAL . 7.3 p -101.03 148.09 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.605 -0.725 . . . . 0.36 110.219 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -62.36 100.17 0.17 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.386 0.612 . . . . 0.49 111.058 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.77 111.142 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 7.0 tp . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.234 -0.284 . . . . 0.32 110.234 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 35.5 t60 50.57 57.91 6.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.932 -0.576 . . . . 1.03 110.914 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CD2' ' HG2' ' A' ' 162' ' ' GLN . 44.0 t80 -97.16 136.34 37.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.731 . . . . 1.42 110.059 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.9 124.05 22.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.721 0.296 . . . . 0.36 110.305 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.25 39.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.195 0.522 . . . . 0.29 111.012 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 55.02 83.96 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 1.01 111.989 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -14.51 62.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.982 -0.554 . . . . 0.59 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -102.0 14.88 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.514 0.673 . . . . 0.57 109.188 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 151' ' ' SER . 61.6 mttp -147.65 -149.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.584 -0.734 . . . . 0.62 109.832 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 154' ' ' GLN . 4.1 t -152.99 175.94 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.918 -0.401 . . . . 0.18 109.918 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -65.8 -36.18 82.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.52 111.941 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -76.73 -9.46 58.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.419 -0.355 . . . . 0.38 111.487 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -74.97 -47.57 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.58 110.113 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -161.77 73.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.81 110.987 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -75.26 -24.74 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.48 110.745 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.18 -51.16 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.607 . . . . 0.64 110.878 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.84 -35.27 79.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.41 110.625 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.6 -52.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.22 110.981 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.2 tp -66.01 -31.98 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.349 -0.387 . . . . 0.19 111.125 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -72.41 -31.66 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.6 110.479 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.512 ' HG2' ' CD2' ' A' ' 144' ' ' TYR . 7.4 tp-100 -68.93 -37.78 79.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.76 109.928 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.59 -40.61 97.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.25 109.994 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -66.29 -21.27 66.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.366 -0.834 . . . . 0.45 111.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -71.08 -28.6 64.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.829 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.491 ' HG3' ' HB ' ' A' ' 142' ' ' ILE . 7.1 mmtt -93.09 -41.62 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.42 110.036 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.9 mmm -130.53 99.53 5.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 1.82 109.498 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.35 93.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.165 0.507 . . . . 0.77 110.973 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.49 -0.777 . . . . 0.18 109.859 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 109.518 -0.549 . . . . 0.73 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.99 126.93 22.28 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.921 0.391 . . . . 0.87 110.74 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.48 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 5.7 mp -113.16 144.59 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.199 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 16.0 ptt180 -123.67 138.66 54.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.926 -0.579 . . . . 0.13 110.125 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 71.9 m-85 -106.3 124.58 49.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.035 -0.357 . . . . 0.1 110.035 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.18 112.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.32 111.291 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.416 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -153.83 152.81 27.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.829 -0.623 . . . . 0.21 110.137 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.98 153.36 74.03 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.124 1.883 . . . . 0.14 111.06 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.74 -30.96 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.77 111.329 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.99 -41.94 62.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 1.32 110.584 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -97.56 -31.9 12.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.59 110.781 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.33 -31.05 68.89 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.86 -0.609 . . . . 0.3 112.597 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -64.36 -16.27 61.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.56 0.219 . . . . 2.34 111.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -82.89 -44.5 15.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.72 111.004 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 -23.29 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 0.49 111.311 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -54.54 -55.32 30.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.48 111.325 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -82.89 29.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.366 -0.379 . . . . 0.53 111.629 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -134.8 -48.9 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.5 110.45 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.4 mt -78.83 -39.83 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.58 111.705 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 39.7 mtpt -64.68 -50.51 64.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.529 0.566 . . . . 1.39 112.529 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.7 Cg_endo -62.28 -15.79 46.96 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.978 1.786 . . . . 0.15 112.879 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.44 2.96 49.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.549 -0.296 . . . . 0.3 110.223 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 23.7 pt 41.2 41.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.252 1.021 . . . . 0.13 112.746 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.483 ' HG2' HD12 ' A' ' 222' ' ' ILE . 12.2 mptt -117.8 18.76 14.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.548 0.69 . . . . 1.4 109.798 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 212' ' ' CYS . 22.6 m -111.82 164.06 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.27 -0.877 . . . . 0.33 110.565 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.91 138.48 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.793 -0.817 . . . . 0.25 108.793 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.49 70.96 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.422 0.629 . . . . 1.75 111.374 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.5 m -144.73 28.15 1.3 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.742 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 9.1 pt-20 -85.73 168.78 14.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 1.9 110.62 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -131.34 126.83 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.19 110.681 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.54 79.14 4.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 1.55 110.915 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -125.7 2.68 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.247 -0.741 . . . . 0.33 111.247 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.83 -36.55 17.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.453 0.645 . . . . 2.76 109.726 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -113.35 114.64 26.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.146 -0.933 . . . . 2.24 108.99 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.51 80.72 4.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.141 0.496 . . . . 0.55 110.38 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 28.0 tt0 -80.19 105.68 11.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.66 110.115 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.12 138.27 37.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.36 110.473 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.19 113.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.2 109.826 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.748 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.6 p -138.81 105.5 5.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.028 0.442 . . . . 0.18 111.168 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -148.86 144.96 27.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.275 -0.639 . . . . 0.61 109.275 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.1 tt -137.26 163.17 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.588 -0.278 . . . . 0.38 110.45 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 165.7 4.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.828 0.451 . . . . 0.74 110.808 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.53 -172.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.457 2.105 . . . . 0.23 112.855 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 81.12 -92.6 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.699 -0.762 . . . . 0.21 111.537 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.19 -12.36 50.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 1.44 110.957 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.485 ' HA ' HG22 ' A' ' 222' ' ' ILE . 79.7 t80 -58.2 -30.68 66.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.396 . . . . 0.15 110.617 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -69.4 -18.63 63.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 1.5 110.732 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -90.3 -35.24 15.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.469 -0.332 . . . . 1.11 111.24 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 5.3 tt -82.35 -34.88 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.552 0.215 . . . . 0.14 111.266 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.64 -25.74 66.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.183 0.516 . . . . 0.8 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.21 -32.35 66.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.421 -0.808 . . . . 0.64 111.45 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.48 -36.13 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.784 -0.367 . . . . 0.75 110.433 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.1 mm -53.86 -41.09 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 116.556 -0.293 . . . . 0.37 111.367 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.8 ptpt -55.94 -31.1 62.63 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.887 -0.597 . . . . 0.3 112.603 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.546 ' HE3' ' C ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.63 2.62 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.852 0.316 . . . . 2.25 111.852 -178.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 6.5 tp10 -94.25 -56.39 2.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.36 . . . . 0.89 110.865 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t -126.66 -21.85 4.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.083 -0.508 . . . . 0.19 111.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.514 ' HD2' HD22 ' A' ' 236' ' ' LEU . 26.2 tptp -61.88 -50.51 71.92 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.842 -0.429 . . . . 0.35 109.842 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.74 34.65 4.52 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.17 111.77 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -129.9 -30.4 2.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.747 0.308 . . . . 1.77 110.538 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -151.3 -151.37 5.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.712 -0.756 . . . . 0.35 112.368 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.2 m -110.81 145.85 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.125 -0.324 . . . . 0.33 110.125 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 231' ' ' LYS . 1.2 pt? -114.58 145.37 42.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 0.57 110.659 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.61 170.63 15.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.497 -0.774 . . . . 1.16 109.173 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.17 153.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.404 -0.591 . . . . 0.21 109.404 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.16 109.921 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.52 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -153.62 -171.77 4.01 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.845 -0.428 . . . . 0.63 109.845 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -84.62 -85.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.911 0.386 . . . . 1.18 111.021 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.461 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 mp -93.74 83.49 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.195 0.522 . . . . 0.54 110.721 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.4 mmt85 -141.55 148.59 39.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.81 109.972 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' HA ' HG13 ' A' ' 17' ' ' VAL . 6.4 mp -75.41 -9.75 58.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.066 0.46 . . . . 1.32 111.258 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.29 9.11 30.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 0.59 111.336 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -145.03 37.65 1.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.55 109.743 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 14' ' ' LEU . 30.6 m -88.84 -168.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.32 -0.855 . . . . 0.25 111.916 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.29 152.94 36.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.553 -0.748 . . . . 0.28 109.496 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.07 119.4 47.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.864 0.364 . . . . 0.15 110.749 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -155.47 110.32 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.19 109.784 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -128.61 142.16 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.61 111.665 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 37.7 ttp -112.73 129.57 56.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.48 110.033 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 124.76 47.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 1.46 110.028 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -104.19 -166.49 1.25 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.688 -0.687 . . . . 0.76 110.3 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.23 90.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.427 -0.351 . . . . 0.7 111.037 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.06 46.17 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.594 -0.813 . . . . 0.23 112.442 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -172.82 156.83 3.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.977 -0.379 . . . . 1.59 109.977 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 145.13 48.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.61 109.779 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -134.23 138.61 45.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.378 -0.373 . . . . 0.5 110.639 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 34.6 tt0 -144.19 142.53 30.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.58 0.229 . . . . 1.28 110.664 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.93 -164.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.559 . . . . 0.1 110.107 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.4 153.35 51.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.391 -0.225 . . . . 0.32 110.391 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 42.5 m -133.39 127.3 33.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.852 0.358 . . . . 0.23 111.297 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 2.1 t80 -62.89 122.28 15.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.41 112.375 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 55.72 17.49 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.066 -0.97 . . . . 1.06 112.81 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.19 23.35 13.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.0 0.429 . . . . 0.85 110.35 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -74.52 -1.13 20.01 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.246 0.462 . . . . 1.06 112.246 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.98 -23.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.53 . . . . 0.14 110.423 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.15 -7.46 9.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.82 -0.627 . . . . 0.14 109.798 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.331 0 CA-C-N 115.62 -0.718 . . . . 0.21 111.95 179.538 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tptp . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.682 0.277 . . . . 0.55 111.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.71 127.55 28.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.444 -0.798 . . . . 0.47 110.941 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.45 -10.17 59.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.023 -0.535 . . . . 0.62 111.088 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -105.15 -9.7 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 0.67 111.072 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -102.08 -39.34 7.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 1.27 110.21 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 6.6 p -72.94 -20.13 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.25 111.077 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.17 102.79 14.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.393 -0.367 . . . . 0.1 110.391 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 12' ' ' ILE . 57.6 mt-30 -82.89 -73.54 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.165 -0.471 . . . . 0.36 110.428 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 m -67.2 106.48 2.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.81 -0.632 . . . . 0.08 110.3 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -87.97 49.63 1.84 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.461 0.648 . . . . 0.41 110.427 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 p -161.11 141.97 11.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.064 -0.971 . . . . 0.12 108.872 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.8 p -109.98 145.47 16.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.262 -0.273 . . . . 0.1 110.262 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -89.67 160.66 16.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.634 0.254 . . . . 0.09 111.057 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 84.9 t -123.35 -50.98 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.34 109.945 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 65.8 m-20 -129.23 112.46 13.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.61 109.427 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 7.3 p -79.63 -34.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.83 0.348 . . . . 0.33 111.42 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -78.18 -28.1 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 1.08 110.926 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -94.35 -6.85 43.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.167 -0.469 . . . . 1.01 110.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.03 53.92 36.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.017 -0.611 . . . . 0.6 112.045 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 12.2 mm100 -121.96 121.39 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.37 111.015 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.0 t -110.68 146.0 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.493 -0.776 . . . . 0.27 109.632 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -100.99 121.94 42.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.23 110.27 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 -171.87 2.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.068 -0.716 . . . . 0.67 109.068 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -56.86 -39.68 74.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.835 0.309 . . . . 0.68 111.835 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -72.74 -16.74 61.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.624 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.86 -53.48 4.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.061 0.457 . . . . 0.12 110.654 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.99 -23.81 66.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.1 111.754 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -64.16 -30.37 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.863 0.363 . . . . 0.54 110.64 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -97.2 -23.27 16.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.841 0.353 . . . . 0.26 110.599 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.13 -47.72 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.36 110.974 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 -59.03 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.53 110.401 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.72 -37.43 1.03 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.544 -0.836 . . . . 0.16 112.506 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.56 135.1 44.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.452 0.168 . . . . 0.31 111.054 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.402 ' HB3' HG13 ' A' ' 74' ' ' ILE . 6.5 p-10 -84.77 43.63 1.0 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 0.53 111.02 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.7 130.89 46.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.193 -0.458 . . . . 0.23 110.128 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -64.74 -27.26 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 1.01 111.368 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.571 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 1.1 m -65.65 -35.7 81.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.189 0.518 . . . . 0.23 111.074 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.86 -24.94 60.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.098 -0.501 . . . . 1.34 110.567 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' HG13 ' A' ' 89' ' ' ILE . 29.6 mm -84.17 -51.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.13 110.822 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 30.0 p -60.63 -37.12 80.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.21 111.917 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -64.08 -30.12 71.21 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.898 0.38 . . . . 1.69 110.613 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -77.9 -38.99 44.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.931 -0.396 . . . . 1.88 109.931 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 20' ' ' VAL . 56.5 mt -67.1 -25.3 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.24 110.5 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 20' ' ' VAL . 1.5 mm? -81.55 -35.65 30.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.747 -0.66 . . . . 0.18 112.061 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 -20.56 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.733 0.642 . . . . 0.29 112.733 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' MET . 5.2 mmtm -127.78 23.09 6.25 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.879 -0.329 . . . . 0.47 111.632 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.14 -176.02 14.22 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.228 -0.987 . . . . 0.13 113.501 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 mm-40 -101.88 105.07 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.287 -0.457 . . . . 1.62 109.924 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.05 146.0 15.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.444 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -66.69 97.96 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.381 . . . . 1.14 110.221 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 121.058 0.456 . . . . 1.17 110.908 -179.748 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.88 0.371 . . . . 0.22 110.134 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 60.74 28.12 17.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.348 -0.842 . . . . 0.89 112.01 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -124.19 129.37 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.74 -0.467 . . . . 0.45 109.74 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.73 141.13 37.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.0 -0.545 . . . . 0.21 110.826 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.75 -63.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.346 -0.388 . . . . 0.18 110.564 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -151.32 129.09 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.131 -0.322 . . . . 1.46 110.131 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 145.82 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 0.54 111.65 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.8 t30 66.39 9.87 6.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.24 112.196 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -84.66 140.35 31.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.249 -0.648 . . . . 0.65 109.249 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.3 m -59.02 132.68 54.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.96 -0.385 . . . . 0.4 109.96 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -45.13 73.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.541 0.571 . . . . 0.74 112.541 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -64.07 -25.18 67.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.389 0.514 . . . . 2.29 112.389 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.52 -25.72 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.871 0.323 . . . . 2.17 111.871 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 25.6 pt20 -109.32 12.81 24.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.922 0.391 . . . . 0.37 111.114 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.16 87.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.25 111.142 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.0 mm? -67.3 -31.5 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.41 110.645 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -76.04 -36.22 59.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.399 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 155' ' ' GLN . 94.5 t -65.12 -48.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.19 110.758 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.22 -33.78 64.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.826 0.346 . . . . 0.22 110.711 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.4 mtmt -67.86 -46.29 72.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.326 . . . . 1.22 110.121 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -65.86 -36.32 83.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.7 110.72 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.19 -42.85 99.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.35 110.317 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 167' ' ' MET . 1.4 tmmt? -60.57 -28.72 68.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.492 -0.777 . . . . 0.5 111.306 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.3 mm-40 -70.47 -25.62 63.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.474 . . . . 1.36 110.887 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -99.9 -39.1 8.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 0.71 111.052 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 36.2 ttm -135.25 129.16 33.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.843 -0.428 . . . . 1.44 109.843 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -80.97 97.79 7.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.95 0.405 . . . . 0.73 111.182 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.546 . . . . 0.3 110.299 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.222 -0.659 . . . . 2.04 109.222 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 83.7 mtm180 -133.59 129.58 37.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.968 0.413 . . . . 0.99 111.181 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 6.0 mt -116.65 151.59 35.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 1.14 109.915 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 211' ' ' VAL . 6.8 ptm180 -134.69 135.21 41.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.322 -0.399 . . . . 0.26 110.446 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 49.1 m-85 -102.17 128.04 48.84 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.991 -0.374 . . . . 0.28 109.991 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.59 123.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 0.38 111.196 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -150.46 160.61 32.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.562 -0.744 . . . . 0.13 110.052 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.03 165.64 11.95 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.779 2.319 . . . . 0.13 112.567 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.24 -41.42 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.399 -0.364 . . . . 0.4 111.76 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -59.3 -47.49 85.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.9 111.078 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.58 53.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 0.63 111.581 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.3 71.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.177 -0.535 . . . . 0.2 113.13 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -71.44 -8.17 52.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.828 0.307 . . . . 0.49 111.828 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -87.66 -6.04 58.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.64 0.257 . . . . 0.85 111.066 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -26.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.675 -0.238 . . . . 0.4 111.342 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -56.78 16.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.838 0.351 . . . . 1.46 111.235 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.64 10.5 3.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -118.14 -41.68 2.86 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.684 0.253 . . . . 0.67 111.684 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.33 -38.46 18.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.981 0.363 . . . . 0.4 111.981 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 11.0 mtpt -59.52 -47.54 97.6 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.597 0.591 . . . . 0.36 112.597 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.9 Cg_endo -64.6 -8.95 18.79 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.468 2.112 . . . . 0.2 113.474 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.1 mt -90.46 -5.15 56.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.858 0.361 . . . . 0.09 110.203 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.2 mm 58.09 54.18 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.666 0.746 . . . . 0.11 110.309 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 222' ' ' ILE . 70.3 mmtt -125.97 16.99 7.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.454 -0.794 . . . . 0.16 110.556 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.95 142.37 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.608 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.94 159.03 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.527 -0.761 . . . . 0.47 109.547 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -70.77 53.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.25 0.463 . . . . 1.87 112.25 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.7 m -167.18 100.58 0.52 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.496 0.719 . . . . 0.73 109.797 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -128.05 145.78 50.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.26 111.361 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 209' ' ' GLU . 12.2 t70 -106.27 119.3 38.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.874 -0.417 . . . . 0.25 109.874 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.16 101.39 6.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.74 109.909 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -156.98 -109.4 0.29 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.954 -0.641 . . . . 0.26 111.741 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -88.69 -13.35 39.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.631 0.729 . . . . 1.39 109.037 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -138.58 -177.32 4.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.612 -1.176 . . . . 0.85 108.536 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 40.9 tp -134.1 117.22 16.36 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.813 -0.439 . . . . 0.33 109.813 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 48.3 tt0 -128.77 117.6 21.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.053 -0.522 . . . . 0.34 109.632 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.79 141.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.825 0.345 . . . . 1.53 111.125 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 177' ' ' ARG . 58.7 t -92.46 111.23 24.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.471 -0.566 . . . . 0.23 109.471 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 60.29 0.71 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.992 0.425 . . . . 0.45 111.706 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -138.59 113.94 9.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.79 -78.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.13 111.567 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -138.92 160.83 61.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.521 -0.309 . . . . 0.21 110.766 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.53 176.19 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.55 2.166 . . . . 0.23 111.712 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.24 -75.4 1.77 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.499 -0.858 . . . . 0.15 111.883 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -5.25 32.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.69 0.281 . . . . 1.96 110.843 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 7.7 p90 -59.71 -23.53 63.24 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.19 110.991 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.445 ' HA ' ' OD1' ' A' ' 223' ' ' ASP . 1.2 tpm_? -60.32 -27.89 67.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.875 0.369 . . . . 2.32 110.884 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -50.23 65.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.3 110.499 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 8.3 tt -81.33 -34.9 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 1.02 111.854 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 219' ' ' PHE . 0.0 OUTLIER -64.34 -28.07 69.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.722 0.296 . . . . 1.71 111.299 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -66.49 -36.13 81.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.69 110.382 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -90.89 -39.71 12.15 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.678 -0.409 . . . . 0.12 110.92 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.3 mm -55.7 -36.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.463 -0.335 . . . . 0.3 111.604 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 7.9 ptpt -56.49 -23.72 41.31 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.739 0.644 . . . . 0.64 112.739 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.5 pttm -121.26 -19.19 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.798 0.296 . . . . 0.9 111.798 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -78.64 -32.27 47.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.29 112.34 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -143.26 -33.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.446 -0.502 . . . . 0.16 111.364 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 44.3 tttm -66.12 -18.66 65.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.177 0.513 . . . . 0.26 110.529 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.82 15.47 28.85 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.12 111.512 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -128.49 -35.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.725 0.297 . . . . 0.39 110.73 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.95 -150.29 6.55 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.91 -0.662 . . . . 0.18 112.742 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.2 m -116.71 145.84 43.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.318 . . . . 0.82 110.812 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.5 pt? -106.4 137.45 44.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.943 0.401 . . . . 0.15 110.688 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -129.31 163.75 25.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.66 110.444 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.14 169.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.371 -0.377 . . . . 0.39 110.797 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.877 0.37 . . . . 1.32 111.138 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 16' ' ' ASN . 7.9 p . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.642 0.258 . . . . 0.42 110.729 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -131.58 -82.63 0.51 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.615 0.245 . . . . 1.15 110.683 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -129.34 -122.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.601 -0.272 . . . . 1.23 110.598 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.95 94.42 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.23 110.636 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 13' ' ' ARG . 10.3 mmt85 -134.4 -171.47 2.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.686 -0.688 . . . . 1.51 109.759 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.54 12.65 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.275 0.559 . . . . 1.37 110.379 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.65 -32.75 7.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 0.66 111.833 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 9' ' ' THR . 26.0 p-10 -97.63 18.62 15.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 1.1 111.443 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.1 m -85.8 157.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.599 0.714 . . . . 0.34 112.786 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.11 140.05 53.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.625 -1.17 . . . . 0.42 108.96 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -89.08 98.57 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.49 111.311 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.777 HG22 HG22 ' A' ' 89' ' ' ILE . 2.3 p -103.36 120.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.847 -0.615 . . . . 0.24 109.696 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -122.75 132.56 54.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.28 112.146 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 39.0 ttp -107.01 122.66 46.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.17 110.337 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -97.63 123.62 41.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 1.19 109.99 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -107.39 -154.9 0.53 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.449 -0.341 . . . . 0.36 110.096 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.43 -59.55 2.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.84 0.311 . . . . 0.59 111.84 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.84 21.56 5.88 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.638 -0.791 . . . . 0.56 112.634 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -155.86 161.01 40.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.692 -0.484 . . . . 0.8 109.692 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 142.83 28.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.341 -0.615 . . . . 0.36 109.341 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.89 141.26 47.3 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.343 0.402 . . . . 0.22 110.523 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' CD1' ' A' ' 59' ' ' PHE . 14.1 pt-20 -139.68 149.22 43.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.052 -0.351 . . . . 0.21 110.052 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.3 pt -136.75 -176.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.771 -0.65 . . . . 0.3 110.591 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.36 109.88 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.308 0.575 . . . . 0.19 111.282 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 11.3 p -117.77 -179.63 3.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.698 -0.853 . . . . 0.31 108.698 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -70.32 143.12 52.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.479 -0.489 . . . . 0.36 110.212 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -85.4 -41.87 15.05 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.383 0.512 . . . . 0.86 112.383 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -64.63 127.45 31.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.642 -0.254 . . . . 1.6 111.643 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.5 pttp 43.64 37.34 1.5 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.31 1.044 . . . . 1.59 113.021 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.7 p -64.47 -21.73 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.52 0.676 . . . . 0.4 111.178 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 -4.2 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.56 110.802 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.4 112.693 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.78 0.324 . . . . 1.77 111.194 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.06 149.02 48.42 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.99 110.94 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.76 -20.97 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.39 111.392 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -30.24 71.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 1.01 110.473 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.26 -24.46 24.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.99 109.823 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 34' ' ' TYR . 49.2 t -69.29 -41.18 80.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.537 -0.756 . . . . 0.11 110.121 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD11 HE21 ' A' ' 82' ' ' GLN . 0.7 OUTLIER -75.8 92.28 3.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.426 -0.806 . . . . 0.3 109.899 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -74.64 -61.52 1.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.28 111.834 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.84 108.02 19.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.894 0.378 . . . . 0.27 110.944 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' HA ' HD11 ' A' ' 53' ' ' LEU . 1.9 p-80 -83.4 69.32 9.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.224 0.535 . . . . 0.93 111.438 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -154.4 105.06 2.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.822 -0.626 . . . . 0.22 110.13 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 68' ' ' ALA . 10.9 p -94.7 141.55 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.394 -0.595 . . . . 0.27 109.394 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.669 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -93.73 157.76 16.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.064 0.459 . . . . 0.24 111.678 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.7 t -106.29 -56.47 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.47 -0.937 . . . . 0.26 108.47 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -150.02 116.79 5.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.54 109.406 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.97 -17.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.044 -0.525 . . . . 0.22 111.252 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.9 t -64.81 -26.26 68.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 1.35 110.689 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -122.64 -0.91 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.431 . . . . 0.93 110.987 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.96 37.48 64.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.936 -0.649 . . . . 0.37 112.039 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -86.37 118.73 26.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 1.56 110.772 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.79 144.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.59 109.732 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.693 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -107.29 133.06 52.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.15 0.5 . . . . 0.23 110.631 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 7.3 mtmt -107.64 -171.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.736 -0.666 . . . . 1.25 109.884 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.54 68.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.683 0.277 . . . . 0.3 111.263 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 69' ' ' LYS . 5.0 pm0 -80.32 -5.67 56.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.529 -0.305 . . . . 0.46 111.482 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.33 -44.15 4.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.84 -0.344 . . . . 0.43 110.966 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.35 -26.91 68.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.93 0.395 . . . . 0.18 110.454 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -27.83 33.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 116.077 -0.511 . . . . 0.28 109.908 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -17.66 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.448 0.642 . . . . 0.19 109.63 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.28 -59.19 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.748 . . . . 0.32 110.664 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -95.19 -52.0 4.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.284 -0.417 . . . . 0.25 110.464 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.06 -26.68 2.71 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.472 -0.651 . . . . 0.2 111.472 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.36 143.49 28.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.564 -0.318 . . . . 0.22 110.617 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.85 10.08 32.57 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 1.44 110.817 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.5 120.25 36.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.602 -0.726 . . . . 0.76 110.454 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.457 HE21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.18 -29.78 71.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.23 111.091 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -60.11 -37.87 81.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.21 110.795 179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.92 -24.9 62.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.65 110.637 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.6 mm -79.49 -49.05 20.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.13 109.47 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 25.7 p -67.51 -29.33 68.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.706 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 83' ' ' THR . 18.5 ttpt -66.07 -16.59 64.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.211 0.529 . . . . 0.47 110.419 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.89 -52.59 4.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.67 109.692 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.777 HG22 HG22 ' A' ' 20' ' ' VAL . 19.6 mt -61.44 -35.31 65.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.748 -0.66 . . . . 0.34 112.365 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 2.1 mm? -73.95 2.37 8.78 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.422 0.897 . . . . 0.27 113.422 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.3 t -145.4 -32.92 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.611 -0.436 . . . . 0.93 112.135 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' HG2' HG23 ' A' ' 91' ' ' THR . 40.6 mmtm -96.03 10.21 38.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.001 -0.37 . . . . 1.32 110.001 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.92 -173.79 13.31 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.784 -0.722 . . . . 0.34 112.093 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -95.6 101.73 13.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.842 0.353 . . . . 2.19 110.398 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 p -100.35 133.35 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.992 -0.549 . . . . 0.39 109.688 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -74.19 84.71 1.86 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.272 0.558 . . . . 1.55 110.326 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 1.11 111.455 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.403 HD13 ' HG2' ' A' ' 162' ' ' GLN . 10.3 mt . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.848 -0.427 . . . . 0.28 109.848 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 63.72 32.67 13.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.544 -0.753 . . . . 1.07 111.162 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -100.12 104.04 15.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.87 -0.604 . . . . 0.64 109.781 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 m -74.13 134.79 42.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.43 110.529 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.32 75.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.04 -0.527 . . . . 0.45 110.397 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.66 -168.82 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.189 -0.914 . . . . 1.15 110.985 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.0 t -125.92 15.96 7.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.739 0.781 . . . . 0.5 109.573 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -100.06 -0.26 39.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.161 -0.927 . . . . 1.0 111.078 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.79 20.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.157 0.503 . . . . 0.61 110.004 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 1.5 m -77.21 51.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.22 112.279 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -28.53 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.23 111.902 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 11.88 35.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.068 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 2.0 tp-100 -113.5 -49.25 2.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 1.06 110.524 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mt-30 -105.94 34.05 3.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 0.6 111.204 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.42 -35.97 77.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.942 -0.572 . . . . 0.15 110.845 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.91 -25.04 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.015 -0.539 . . . . 1.43 111.068 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -79.58 -42.42 25.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.828 -0.434 . . . . 0.58 109.828 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.489 ' O ' HD12 ' A' ' 163' ' ' LEU . 21.8 t -64.53 -41.72 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.934 -0.575 . . . . 0.16 111.002 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -26.08 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.457 . . . . 0.45 111.598 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -93.69 -21.67 19.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.12 0.486 . . . . 0.41 110.134 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HG2' HD13 ' A' ' 142' ' ' ILE . 20.7 tt0 -67.46 -53.0 32.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.64 -0.709 . . . . 0.52 111.533 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -79.59 -10.79 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.678 -0.409 . . . . 0.23 110.942 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.444 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.7 ttpt -65.05 -26.57 68.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.79 110.035 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.09 -8.3 58.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 2.07 110.612 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -110.56 -35.23 6.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.189 -0.46 . . . . 0.5 110.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.49 130.7 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.237 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.13 82.29 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.361 0.601 . . . . 1.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.9 pt . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.523 -0.762 . . . . 0.78 111.585 -179.522 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.713 -0.477 . . . . 0.42 109.713 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 mtm180 -92.74 135.73 33.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.035 -0.358 . . . . 0.51 110.035 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.1 150.26 43.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.012 0.434 . . . . 0.24 111.081 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -120.88 -176.15 3.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.89 109.371 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.1 p90 -150.16 127.91 11.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.777 -0.453 . . . . 0.39 109.777 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.8 126.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.56 111.26 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 2.6 pt? -167.34 147.24 4.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.38 -0.827 . . . . 1.16 109.472 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.44 162.3 34.41 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.858 2.372 . . . . 0.27 112.914 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.6 -35.44 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.39 111.44 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -47.86 -47.51 31.58 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.795 -0.638 . . . . 0.65 111.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.24 -26.42 14.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.7 0.286 . . . . 0.74 110.973 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.86 -33.19 77.33 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.2 113.041 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -64.04 -14.29 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.088 0.403 . . . . 2.3 112.088 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -44.81 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.559 0.219 . . . . 0.77 111.252 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.7 pp -86.12 -20.69 28.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.23 110.483 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.91 -41.95 62.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.421 -0.809 . . . . 1.46 111.969 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.467 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -103.94 15.49 28.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.235 0.457 . . . . 1.16 112.235 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -124.22 -30.49 3.44 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.452 -0.499 . . . . 2.42 111.692 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.19 -42.83 9.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.593 0.235 . . . . 0.26 111.468 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 13.5 mtpt -58.05 -47.35 99.03 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.051 0.76 . . . . 0.28 113.051 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.3 Cg_endo -60.72 -16.26 42.53 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.199 1.933 . . . . 0.16 113.401 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.76 -21.0 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.336 -0.246 . . . . 0.14 110.336 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 78.86 -10.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.466 -0.788 . . . . 0.17 111.526 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -86.74 54.36 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.248 0.547 . . . . 0.98 110.771 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.85 138.41 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.258 -0.883 . . . . 0.23 109.613 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.6 142.26 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.658 -0.497 . . . . 0.94 109.658 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -68.76 81.94 0.29 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.133 0.492 . . . . 1.99 110.465 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 68.8 m -157.53 31.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.333 -0.849 . . . . 0.17 109.745 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.1 mp0 -79.96 154.41 28.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.36 110.66 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -108.58 111.86 23.91 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.159 -0.682 . . . . 0.57 109.159 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.39 80.43 3.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.217 0.532 . . . . 1.22 110.356 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -148.36 -130.56 1.96 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.685 -0.689 . . . . 0.36 112.197 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -78.84 -26.76 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.478 . . . . 0.75 110.601 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.67 145.19 49.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.91 -0.774 . . . . 1.38 108.91 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 28.1 tp -105.03 85.9 2.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.936 0.398 . . . . 0.38 110.972 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 5.0 tt0 -93.11 118.69 31.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.97 109.748 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 19.8 mt -128.68 159.13 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.569 -0.287 . . . . 0.11 111.026 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 177' ' ' ARG . 19.9 t -116.6 121.13 66.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.656 -0.498 . . . . 0.21 109.656 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.436 ' SG ' ' HE2' ' A' ' 178' ' ' PHE . 4.6 p -118.51 -30.52 5.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.113 0.412 . . . . 0.58 112.113 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 213' ' ' LEU . 2.3 mm? -68.62 108.47 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.692 0.282 . . . . 0.45 111.013 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.6 tt -110.28 -54.87 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.564 0.579 . . . . 0.38 112.564 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.56 162.2 54.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.04 0.385 . . . . 0.33 112.04 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.33 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.013 2.475 . . . . 0.31 111.334 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 65.35 -81.15 0.08 OUTLIER Glycine 0 C--N 1.339 0.703 0 O-C-N 123.463 0.477 . . . . 0.18 111.963 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 2.1 p -75.6 17.97 0.26 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.179 0.592 . . . . 0.67 111.117 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 217' ' ' GLY . 8.6 p90 -87.76 -16.94 32.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.4 109.859 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -69.28 -48.11 62.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 1.46 110.549 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.57 -31.02 71.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 1.36 110.758 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 46.1 mm -82.8 -42.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.491 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.79 -37.07 68.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.55 111.05 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -56.1 -35.21 66.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 1.28 111.758 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.7 pp -94.41 -33.05 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.475 -0.49 . . . . 1.43 110.834 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.4 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-N 116.395 -0.366 . . . . 0.42 111.418 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 13.7 ptpt -63.53 -22.11 66.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.127 0.417 . . . . 0.91 112.127 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.45 8.65 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 0.38 111.167 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -108.96 -83.52 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.126 -0.488 . . . . 1.33 110.697 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.1 t -84.38 -30.01 25.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.305 -0.407 . . . . 0.22 111.184 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 24.3 tptm -64.64 -30.89 71.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.992 0.425 . . . . 0.71 111.05 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.19 12.56 66.69 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.528 -0.844 . . . . 0.37 112.235 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -123.79 -46.85 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.919 0.39 . . . . 0.76 110.593 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -125.55 -162.25 11.25 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.773 -0.727 . . . . 0.24 112.562 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.94 132.23 56.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.21 -0.292 . . . . 1.03 110.21 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 3.1 pp -80.04 157.29 26.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.057 0.456 . . . . 1.51 111.097 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.71 153.39 38.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.597 -0.729 . . . . 0.85 109.485 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.77 156.96 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.237 -0.282 . . . . 0.29 110.237 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.014 0.435 . . . . 0.42 110.695 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.397 0.618 . . . . 0.98 112.567 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -69.79 157.67 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.884 -0.598 . . . . 1.84 110.042 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 1.76 111.594 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.99 81.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.75 111.251 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -153.7 143.67 22.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 1.28 109.981 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' VAL . 82.0 mt -67.25 -13.15 61.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 1.3 111.147 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -87.35 4.11 44.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.4 110.849 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -139.29 35.91 2.08 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.463 0.649 . . . . 0.38 110.321 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 14' ' ' LEU . 20.3 m -106.41 156.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.18 111.633 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . . . -108.85 137.67 46.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.23 109.958 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 t -78.98 108.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.932 0.396 . . . . 0.44 110.722 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -121.11 129.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.922 -0.581 . . . . 0.16 109.925 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -145.0 144.11 30.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.953 0.406 . . . . 1.06 111.34 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 89' ' ' ILE . 23.2 ttt -127.93 127.29 43.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.671 -0.695 . . . . 0.22 109.819 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.97 118.51 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.014 0.435 . . . . 0.86 110.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 9.8 mmm180 -92.72 -155.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.906 -0.588 . . . . 1.69 109.99 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.96 -54.08 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.51 110.986 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.53 -34.4 1.09 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.431 -0.89 . . . . 0.17 112.48 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 29.1 tptt -97.77 158.94 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.933 0.397 . . . . 1.07 110.496 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 152.76 38.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.168 -0.678 . . . . 0.77 109.168 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.02 140.35 38.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.034 0.445 . . . . 0.26 111.213 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -130.4 130.19 44.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 1.1 109.717 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -174.49 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.136 0.493 . . . . 0.25 111.361 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.54 103.04 4.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.16 109.791 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -102.88 -173.22 2.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.15 110.11 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.7 150.06 37.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.73 -0.47 . . . . 0.26 109.73 178.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 52.8 pttt -108.61 28.5 8.33 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.428 -0.509 . . . . 1.32 110.966 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -103.11 81.78 2.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.54 109.919 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt 57.86 49.4 12.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.984 -0.553 . . . . 0.58 110.948 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.23 -23.73 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.762 -0.654 . . . . 0.22 111.802 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.98 -4.43 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.207 0.527 . . . . 0.17 110.626 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.1 112.642 -179.466 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 110.561 -0.162 . . . . 0.7 110.561 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.25 148.6 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.644 0.259 . . . . 0.72 110.528 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.24 -31.01 72.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.482 . . . . 0.56 111.654 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.95 -32.49 72.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.53 110.628 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.99 -19.76 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.083 0.468 . . . . 1.8 110.407 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 66.9 t -74.34 -43.74 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.731 -0.668 . . . . 0.15 109.57 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.05 99.25 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.435 -0.802 . . . . 1.45 111.138 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 34' ' ' TYR . 14.6 mt-30 -84.13 -65.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.5 109.975 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 t -97.16 130.64 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.183 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.37 -5.66 59.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.132 -0.485 . . . . 1.23 110.668 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -96.39 116.13 28.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.138 -0.483 . . . . 0.79 110.523 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.7 p -100.44 146.4 9.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.925 -0.58 . . . . 0.15 109.624 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -102.0 154.38 19.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.27 111.126 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.2 t -103.78 -31.4 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.18 109.485 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.2 91.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.069 -0.969 . . . . 0.49 109.218 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.05 -28.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.465 -0.334 . . . . 0.21 111.826 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -34.43 77.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.876 0.37 . . . . 0.6 111.158 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -106.52 10.9 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 2.39 111.031 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.36 28.62 71.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.876 -0.678 . . . . 0.4 112.468 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.33 110.83 14.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.571 0.224 . . . . 1.57 110.44 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.81 133.81 52.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.999 -0.546 . . . . 0.21 110.444 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.55 116.33 32.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.023 0.439 . . . . 0.11 109.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -87.53 -179.52 6.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.87 -0.605 . . . . 1.56 110.105 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -57.57 -32.95 67.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.67 111.271 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -87.57 7.88 27.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.182 -0.463 . . . . 0.67 111.29 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.81 -48.77 3.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.82 110.081 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.93 -31.92 73.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.999 -0.546 . . . . 0.31 110.212 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -28.14 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.23 110.348 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -92.46 -8.43 44.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.235 0.541 . . . . 0.71 110.965 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.65 -58.83 2.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.18 110.97 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -89.69 -34.88 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.396 -0.365 . . . . 0.83 110.833 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.09 30.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.524 -0.846 . . . . 0.3 112.283 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 81' ' ' ASP . 1.5 m -134.23 136.4 43.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.005 -0.369 . . . . 0.7 110.005 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.74 -12.93 57.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.64 110.748 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 79' ' ' THR . 28.9 t70 -69.16 102.66 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.54 110.396 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.48 -23.65 66.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.89 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.4 88.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.734 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.45 -34.93 79.45 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.854 0.359 . . . . 0.33 110.234 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.3 -51.68 69.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.392 -0.596 . . . . 0.24 109.392 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 54.0 t -64.63 -32.55 74.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.457 -0.792 . . . . 0.14 110.374 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -57.63 -51.98 67.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.931 -0.577 . . . . 1.2 110.838 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -63.59 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.549 . . . . 0.3 111.177 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 20' ' ' VAL . 63.8 mt -66.98 -24.69 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.107 0.48 . . . . 0.15 111.48 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -80.21 -33.26 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.735 0.303 . . . . 0.3 111.582 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.2 t -97.83 -22.65 16.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.789 0.663 . . . . 0.37 112.789 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 91' ' ' THR . 14.3 mmmm -115.22 -2.97 12.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.579 -0.448 . . . . 0.65 111.761 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.42 -176.69 21.32 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.517 -0.849 . . . . 0.52 112.291 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -108.15 107.84 18.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 1.32 110.409 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 20' ' ' VAL . 3.6 p -111.61 142.14 24.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.431 -0.804 . . . . 0.22 110.186 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 99.82 0.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.239 0.542 . . . . 0.82 110.596 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.747 -0.66 . . . . 0.51 111.691 -178.906 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 143' ' ' HIS . 18.1 tt . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.864 0.364 . . . . 0.35 110.23 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 142' ' ' ILE . 60.5 m-70 72.68 90.7 0.09 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.379 -0.828 . . . . 0.31 111.488 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -75.72 95.79 3.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.863 -1.062 . . . . 0.85 110.239 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -155.36 74.69 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.902 -0.59 . . . . 0.65 109.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.8 67.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.54 110.776 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 149' ' ' ASN . 16.3 mtpt 55.0 79.27 0.15 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.698 -0.683 . . . . 0.33 111.244 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.64 17.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.83 111.999 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 147' ' ' LYS . 4.5 t-20 -68.8 -62.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.211 -0.449 . . . . 0.35 109.824 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.52 138.55 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.746 -0.661 . . . . 0.91 109.847 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -163.42 -158.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.668 -0.493 . . . . 0.99 109.668 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.91 95.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.535 0.334 . . . . 0.38 111.853 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 53.72 42.99 31.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.752 -0.658 . . . . 0.45 110.553 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 60.72 66.95 0.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.163 -0.926 . . . . 0.78 111.46 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.627 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 0.4 OUTLIER 55.9 31.03 17.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.151 -0.931 . . . . 0.76 113.13 178.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.02 63.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.179 0.514 . . . . 0.35 110.613 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -29.66 42.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.363 0.601 . . . . 0.63 110.237 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.627 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.4 mp0 -68.54 -41.75 79.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.98 111.379 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.26 -30.29 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 0.98 111.48 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.69 -39.66 86.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.021 0.439 . . . . 0.39 110.704 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.16 -5.5 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.81 111.033 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.58 -70.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 1.44 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -70.88 -11.08 60.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.28 -0.418 . . . . 1.46 111.397 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -61.55 -34.64 75.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.164 0.507 . . . . 1.16 110.255 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -87.79 23.7 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.759 -0.655 . . . . 0.6 110.815 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -138.73 -52.98 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.937 -0.574 . . . . 0.79 110.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.1 ttm -139.7 151.16 45.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.12 -0.491 . . . . 0.97 110.019 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -71.59 131.91 43.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 1.09 110.467 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.492 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.58 110.344 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.904 0.383 . . . . 1.16 111.136 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -83.49 143.64 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 1.81 110.533 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.8 mp -126.55 161.94 26.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.208 -0.451 . . . . 0.72 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 15.8 ptt180 -127.09 154.93 44.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.2 -0.454 . . . . 0.32 110.156 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 63.2 t80 -120.98 131.26 54.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.439 -0.346 . . . . 0.21 110.217 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.91 133.36 66.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.463 0.173 . . . . 0.45 111.358 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 178' ' ' PHE . 1.0 OUTLIER -171.37 161.1 5.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.688 -0.233 . . . . 0.15 110.518 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.22 155.77 66.7 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.23 . . . . 0.17 112.476 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.05 -33.94 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.995 -0.548 . . . . 0.67 111.749 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -48.79 -48.81 40.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.221 -0.445 . . . . 1.69 111.725 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -95.77 -28.15 14.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.857 0.36 . . . . 0.53 110.946 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.11 -32.06 81.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.012 -0.613 . . . . 0.23 112.779 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.5 71.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.73 0.3 . . . . 0.83 111.405 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.11 -46.47 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.25 111.189 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -17.53 39.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.41 111.175 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -57.24 -44.59 83.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.14 110.588 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.72 17.12 5.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.46 111.485 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -129.08 -39.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.31 111.662 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.62 -42.57 24.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.3 111.758 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 30.0 mtpp -62.63 -48.0 87.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.743 0.646 . . . . 0.68 112.743 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.2 Cg_endo -59.47 -8.61 7.26 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.583 2.189 . . . . 0.04 113.837 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.37 -14.83 60.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.21 110.121 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.6 mm 59.56 32.88 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.835 0.826 . . . . 0.16 110.273 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.434 ' HD3' HD12 ' A' ' 222' ' ' ILE . 28.4 mttp -125.89 23.01 7.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.656 -0.702 . . . . 0.5 110.322 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.5 m -103.26 134.63 43.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.14 110.439 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -84.68 147.93 5.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.279 -0.419 . . . . 0.91 109.979 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 63.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 1.59 111.42 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 m -140.22 21.53 2.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.277 -0.638 . . . . 1.05 109.277 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.475 ' HG2' HG23 ' A' ' 210' ' ' ILE . 46.3 mt-10 -71.53 140.77 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.648 -0.706 . . . . 1.06 111.263 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.42 105.2 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.42 -0.585 . . . . 0.65 109.42 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.61 102.04 13.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.022 -0.536 . . . . 1.73 110.723 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -169.11 -150.06 6.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.983 -0.627 . . . . 0.63 111.826 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.09 -31.31 72.45 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.028 0.442 . . . . 1.88 110.604 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -117.45 109.42 16.75 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.759 . . . . 1.13 108.952 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.3 99.78 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.599 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.2 tt0 -100.98 109.41 21.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.35 109.614 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.475 HG23 ' HG2' ' A' ' 202' ' ' GLU . 66.3 mt -117.26 134.83 59.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.306 -0.407 . . . . 0.24 110.576 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.61 105.9 18.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.23 109.925 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 8.4 t -130.78 96.58 4.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.368 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 132.87 11.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.306 -0.628 . . . . 0.33 109.306 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -122.88 171.16 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.517 -0.31 . . . . 0.34 110.28 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.59 171.0 3.15 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.005 0.522 . . . . 0.56 111.091 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.33 -163.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.394 2.062 . . . . 0.37 113.105 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 82.81 -95.68 1.83 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.507 -0.854 . . . . 0.33 111.092 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.8 m -80.77 17.94 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.537 . . . . 0.45 110.445 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.84 -23.1 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.592 . . . . 0.25 111.599 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.1 -45.48 63.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.026 0.441 . . . . 1.42 110.201 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -62.49 -20.7 64.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.418 -0.81 . . . . 1.96 112.356 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.623 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.4 tt -98.57 -43.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.454 -0.499 . . . . 0.47 111.11 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.07 -32.76 74.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.74 0.274 . . . . 0.37 111.74 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.46 -25.06 61.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.428 -0.351 . . . . 0.98 111.553 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.3 pp -101.27 -28.79 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.005 0.431 . . . . 0.44 110.109 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.4 mm -64.51 -33.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.2 111.0 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 11.4 ptmt -60.48 -26.25 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.84 0.682 . . . . 1.19 112.84 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -111.45 -20.57 12.17 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.48 -0.488 . . . . 0.69 112.094 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.25 -46.67 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.39 111.55 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.442 ' OG1' HG23 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -113.42 -56.14 2.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.173 0.434 . . . . 0.48 112.173 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 49.4 mtmt -64.69 -7.7 11.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.25 111.825 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.33 16.66 32.01 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.975 -0.631 . . . . 0.28 111.648 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -128.51 -56.12 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.643 0.258 . . . . 0.64 111.527 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -123.02 -139.21 5.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.326 -0.94 . . . . 0.46 113.369 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 73.3 m -121.51 141.62 50.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.35 111.431 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -110.84 150.21 29.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.997 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.95 161.57 39.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 0.26 109.916 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.17 153.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.317 . . . . 0.37 110.647 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.8 tp . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.37 109.861 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' OH ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.783 -0.451 . . . . 0.72 109.783 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -161.49 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.233 -0.187 . . . . 1.19 111.115 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -124.55 -59.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.993 0.425 . . . . 1.69 110.351 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 5.0 mt -128.51 102.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.75 109.73 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -134.16 127.21 31.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.154 -0.475 . . . . 1.42 110.802 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.98 -10.02 59.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.361 0.601 . . . . 0.56 110.437 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.3 -15.47 50.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.64 111.275 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -125.72 40.36 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.16 111.679 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.12 147.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.97 0.414 . . . . 0.16 110.636 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.82 144.46 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.13 110.536 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.32 126.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 0.21 110.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -148.63 115.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.666 -0.697 . . . . 0.2 109.58 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -119.27 132.83 55.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.311 -0.404 . . . . 0.94 111.432 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.7 ttp -87.58 132.31 34.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.938 -0.574 . . . . 0.43 110.201 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 118.57 37.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.618 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 32.9 mmt180 -120.57 -177.5 3.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.33 110.323 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.14 81.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.366 0.506 . . . . 0.32 112.366 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.3 29.72 2.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.391 -0.909 . . . . 0.29 112.339 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 31.3 tptt -150.35 148.82 29.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.59 -0.522 . . . . 0.89 109.59 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.41 30.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.527 -0.546 . . . . 0.99 109.527 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -134.29 144.55 48.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -142.94 137.3 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.32 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.85 167.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.682 -0.488 . . . . 0.3 109.682 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 110.61 20.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.12 111.824 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -108.74 164.6 12.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.914 -0.585 . . . . 0.18 109.943 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.433 ' OH ' HG22 ' A' ' 9' ' ' THR . 0.1 OUTLIER -66.94 138.05 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.639 -0.255 . . . . 0.18 110.361 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -0.68 23.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 1.01 111.442 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.41 71.38 1.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.5 111.162 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.66 66.07 1.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.356 0.662 . . . . 1.8 111.368 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -69.49 -30.25 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.14 110.876 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -87.31 5.62 3.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.514 0.673 . . . . 0.27 110.327 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.458 -0.792 . . . . 0.29 112.523 -179.53 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.394 0.616 . . . . 0.55 112.647 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 49' ' ' LEU . 17.2 t70 -75.72 160.78 29.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.069 -0.969 . . . . 0.25 110.513 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.681 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.71 -19.83 60.09 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.78 0.289 . . . . 0.31 111.78 -179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.69 -38.4 64.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.172 0.511 . . . . 0.27 109.974 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.57 -32.78 62.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.47 -0.786 . . . . 0.73 111.049 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 49' ' ' LEU . 3.0 p -79.96 -17.13 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.312 . . . . 0.22 111.413 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.79 111.15 13.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 1.02 110.168 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 12' ' ' ILE . 11.5 mm-40 -85.29 -78.65 0.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.938 -0.574 . . . . 0.91 110.449 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -75.4 117.97 17.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.948 -0.569 . . . . 1.5 110.783 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -86.86 31.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.813 -0.63 . . . . 0.63 111.167 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 m -125.67 140.83 52.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.67 -0.493 . . . . 0.22 109.67 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.3 p -117.11 142.36 31.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.27 110.29 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.3 161.21 16.49 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.013 0.375 . . . . 0.29 112.013 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 61.1 t -123.96 -55.07 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.792 -0.64 . . . . 0.29 109.329 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.08 101.89 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 1.84 109.662 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.33 -37.19 79.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.51 111.827 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.16 6.45 6.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.37 0.507 . . . . 0.45 112.37 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -135.15 -5.37 2.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.849 0.357 . . . . 0.55 110.848 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.97 61.63 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.893 -0.67 . . . . 0.19 111.819 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.39 113.1 24.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.03 0.443 . . . . 0.66 110.929 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.46 128.87 76.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.649 -0.705 . . . . 0.4 109.245 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -84.67 117.63 23.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.909 0.385 . . . . 0.31 111.267 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.87 -174.52 4.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.16 -0.473 . . . . 0.68 110.017 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -55.76 -33.04 63.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.46 0.541 . . . . 1.84 112.46 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -82.13 -7.59 59.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.814 0.34 . . . . 1.81 111.792 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.38 -49.51 3.55 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.805 -0.358 . . . . 1.78 111.217 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.44 -29.28 68.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.929 0.395 . . . . 0.27 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.99 -25.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.898 -0.592 . . . . 0.55 110.463 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -97.33 -26.59 14.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.3 111.001 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.77 -39.46 30.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.122 -0.49 . . . . 0.48 112.093 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.54 -16.49 13.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.004 -0.278 . . . . 1.13 111.45 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.37 79.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.49 112.29 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.42 136.97 47.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.568 0.223 . . . . 0.6 110.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -90.55 -23.47 20.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.401 0.619 . . . . 0.59 109.899 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.83 103.44 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.82 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.87 -31.28 71.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.162 0.506 . . . . 0.33 109.951 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -61.02 -29.06 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.29 110.282 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.81 -39.33 24.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.805 -0.442 . . . . 0.34 109.805 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.12 -50.19 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.2 109.441 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.7 t -61.53 -38.72 88.44 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.19 110.61 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.73 -41.96 96.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 2.86 110.292 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -65.49 -40.67 93.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.71 110.786 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 70.9 mt -71.19 -21.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.33 110.907 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -45.88 10.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.451 -0.341 . . . . 0.99 111.575 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -83.0 -21.35 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.362 0.505 . . . . 1.13 112.362 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.65 31.89 4.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 1.41 110.723 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 89' ' ' ILE . . . -128.34 179.76 16.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.498 -0.858 . . . . 0.15 112.442 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.85 93.31 5.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.703 0.287 . . . . 0.81 110.644 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 97' ' ' VAL . 2.8 p -98.3 134.76 35.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.24 109.909 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 11.5 pt20 -74.62 75.62 2.01 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.206 0.527 . . . . 0.81 112.261 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 95' ' ' VAL . 14.6 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.437 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 122.632 1.206 . . . . 0.49 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -110.84 -5.63 14.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.595 -1.184 . . . . 0.31 110.53 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.73 115.34 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.507 0.558 . . . . 1.03 112.507 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 63.9 m 56.11 39.96 30.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.475 -0.784 . . . . 0.58 112.796 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.36 -66.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.4 110.34 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -96.6 -55.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.098 0.475 . . . . 1.75 109.799 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.5 25.44 14.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.523 -0.762 . . . . 0.21 111.063 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 57.12 38.08 28.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.721 -0.672 . . . . 0.58 110.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -89.68 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.86 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -149.28 161.44 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.448 . . . . 0.65 111.264 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -106.02 -34.04 7.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 1.05 110.862 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -88.96 -50.47 6.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 0.58 111.418 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -69.14 -14.97 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.79 111.559 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.1 mt-30 -112.43 7.48 19.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.629 -0.259 . . . . 0.44 110.912 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.63 72.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.347 . . . . 0.26 111.133 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 160' ' ' ILE . 2.3 mm? -66.65 -35.67 80.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.51 . . . . 1.32 111.227 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.95 -46.93 85.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 0.61 111.116 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 155' ' ' GLN . 59.3 t -67.04 -48.57 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.21 112.112 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 157' ' ' LEU . 10.1 tp -61.23 -35.16 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.41 111.729 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.39 -32.55 54.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.737 0.303 . . . . 1.99 110.592 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.87 -37.96 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.75 110.098 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.07 -36.92 85.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 1.15 110.036 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 167' ' ' MET . 31.0 tttm -69.31 -12.53 61.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.444 -0.798 . . . . 1.18 111.396 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.3 -32.05 55.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.51 . . . . 0.58 109.693 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -89.26 -44.45 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 1.12 111.097 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 38.4 mtm -128.75 139.04 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 2.6 110.655 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -89.15 85.83 6.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.538 -0.541 . . . . 0.56 109.538 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 167' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.47 112.138 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 39.8 mtt . . . . . 0 C--O 1.234 0.272 0 N-CA-C 110.184 -0.302 . . . . 1.48 110.184 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 175' ' ' ARG . 4.6 mpt_? -124.43 128.24 48.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.478 -0.328 . . . . 1.39 110.353 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -128.61 145.12 51.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.616 -0.513 . . . . 0.26 109.616 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 211' ' ' VAL . 18.8 ptt85 -126.18 147.91 49.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.783 0.325 . . . . 0.3 110.629 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.04 143.46 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.891 -0.595 . . . . 0.45 110.244 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.7 tt -133.4 117.72 28.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.449 0.642 . . . . 0.17 110.508 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -149.79 156.44 38.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.385 -0.825 . . . . 0.09 109.936 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.72 166.06 14.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 0.1 112.546 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.5 t -50.44 -39.89 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.922 -0.581 . . . . 0.2 111.962 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -51.33 -53.68 33.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.324 -0.398 . . . . 0.28 111.46 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.423 ' HG3' ' HE3' ' A' ' 233' ' ' LYS . 0.5 OUTLIER -82.17 -29.9 31.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.138 -0.483 . . . . 2.08 110.883 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.37 94.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.639 -0.71 . . . . 0.25 113.084 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.64 -35.9 71.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.891 0.377 . . . . 1.17 111.351 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -76.6 -44.6 33.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.235 -0.439 . . . . 0.71 111.814 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.54 HD22 HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -72.2 -32.33 66.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.772 0.32 . . . . 0.47 111.669 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -59.68 -50.55 73.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.36 111.435 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -80.34 18.28 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.44 112.119 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -124.29 -49.44 1.81 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.855 -0.338 . . . . 1.31 111.648 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.1 -36.58 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.188 0.44 . . . . 1.86 112.188 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 26.5 mtpp -61.39 -52.45 70.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.558 0.577 . . . . 0.59 112.558 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.1 Cg_endo -66.09 -14.01 42.46 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.028 1.819 . . . . 0.31 112.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.31 110.312 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mt 62.62 38.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.559 -0.746 . . . . 0.44 111.043 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -120.84 14.23 11.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.93 110.465 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.86 149.46 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.978 -0.555 . . . . 0.26 111.02 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.5 mt -101.25 155.61 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.685 . . . . 0.41 109.744 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.93 64.19 0.5 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.931 0.396 . . . . 1.64 111.1 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 211' ' ' VAL . 10.4 m -149.4 31.01 0.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 1.09 110.302 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -81.74 146.88 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.736 -0.665 . . . . 0.79 111.161 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -118.9 133.49 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.834 -0.802 . . . . 1.22 108.834 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.31 111.34 19.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.8 111.395 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -166.93 -131.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.255 -0.738 . . . . 0.14 111.255 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.64 -28.32 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.619 0.723 . . . . 0.65 109.301 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -119.31 142.87 47.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.811 -1.086 . . . . 1.32 109.614 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.28 89.66 5.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.684 -0.487 . . . . 0.13 109.684 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.15 98.41 8.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.398 -0.593 . . . . 0.55 109.398 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 188' ' ' LEU . 21.9 mm -112.59 134.89 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.37 110.827 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 201' ' ' SER . 2.5 t -105.35 112.57 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.28 109.981 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.98 94.41 3.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.943 0.401 . . . . 0.61 110.83 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.02 95.83 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.084 -0.507 . . . . 0.28 109.845 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 215' ' ' ASP . 9.8 tt -94.23 179.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 1.14 110.061 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.526 ' H ' HG12 ' A' ' 214' ' ' ILE . 4.4 m-20 -67.0 152.85 95.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 111.896 0.332 . . . . 1.08 111.896 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.88 166.57 11.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.751 2.301 . . . . 0.19 112.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 91.11 -75.98 1.53 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.363 -1.095 . . . . 0.34 110.363 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -28.41 64.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.258 0.551 . . . . 0.24 109.642 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.88 -26.12 68.19 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.521 -0.763 . . . . 0.29 110.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -17.66 64.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.845 0.355 . . . . 1.14 111.383 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -84.17 -50.37 7.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.906 0.384 . . . . 0.7 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 15.1 tt -72.87 -28.05 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.395 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.465 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 4.0 t70 -55.35 -33.02 63.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.863 0.363 . . . . 1.01 111.143 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.76 -32.69 67.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.885 -0.598 . . . . 0.46 111.733 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 3.0 pp -92.78 -32.99 14.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.545 -0.462 . . . . 0.72 109.862 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 26.9 mm -55.64 -43.37 72.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.279 -0.419 . . . . 0.93 111.474 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 12.7 ptpt -61.95 -17.68 57.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.173 0.805 . . . . 0.53 113.173 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -119.92 -16.83 8.61 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.874 -0.516 . . . . 0.73 111.515 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 3.1 tp10 -79.95 -39.28 30.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.449 . . . . 1.25 111.15 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 t -136.47 -36.23 0.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.284 0.475 . . . . 1.38 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 23.9 tptp -55.96 -46.49 78.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.889 0.376 . . . . 0.85 111.054 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.07 28.22 13.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.65 111.958 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.423 ' HE3' ' HG3' ' A' ' 184' ' ' GLU . 27.2 mmmt -132.85 -46.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 1.68 110.839 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -130.44 -153.4 7.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.034 -0.603 . . . . 0.31 111.976 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.5 m -124.18 156.66 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.626 0.251 . . . . 0.58 110.518 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.67 165.65 18.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.714 0.292 . . . . 0.97 111.043 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -151.64 152.85 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.051 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.9 141.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.056 0.455 . . . . 0.18 111.181 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.253 -0.43 . . . . 0.31 110.44 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.366 0.603 . . . . 1.07 111.464 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -80.33 161.36 25.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.807 -0.633 . . . . 1.1 109.894 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -58.53 -40.11 82.02 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.974 0.416 . . . . 0.62 110.405 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mt -119.95 95.32 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 1.13 109.632 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -159.27 137.99 10.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.832 -0.622 . . . . 2.26 110.21 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.81 37.03 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.4 111.006 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.8 p -106.67 -28.58 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.32 110.633 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 12.6 m120 -126.26 50.41 1.9 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.64 110.26 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 54' ' ' GLN . 2.3 m -92.6 155.33 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.15 111.073 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.62 134.03 55.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 0.1 109.688 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.55 127.12 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 0.1 110.889 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 89' ' ' ILE . 2.7 p -140.59 118.98 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 0.1 109.648 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -123.56 132.9 54.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.243 0.544 . . . . 0.81 112.047 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.615 ' HB2' HG23 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -111.53 159.56 18.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.835 -0.62 . . . . 0.26 110.063 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -121.06 115.85 23.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.582 -0.281 . . . . 1.39 110.637 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 16.2 mmm180 -99.39 55.39 0.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.731 0.301 . . . . 1.87 110.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.24 34.28 20.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.586 -0.734 . . . . 0.34 111.778 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.78 -62.92 0.42 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.331 -0.708 . . . . 0.33 111.331 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -74.35 145.73 43.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.69 -0.485 . . . . 1.04 109.69 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 28' ' ' ARG . 5.2 mmt180 -109.82 140.26 43.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.271 -0.27 . . . . 0.75 110.271 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -134.34 118.61 17.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.361 -0.381 . . . . 0.88 110.158 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -135.87 146.21 47.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.757 0.313 . . . . 1.09 110.333 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 pt -132.24 179.26 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.778 -0.646 . . . . 0.09 110.26 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.2 106.9 9.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.105 0.479 . . . . 0.1 110.659 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 m -103.58 171.09 7.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.696 -0.683 . . . . 0.11 109.416 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 11.2 t80 -88.26 154.58 20.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.873 0.368 . . . . 0.86 110.485 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -78.34 31.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.79 110.832 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -85.92 43.34 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.057 -0.519 . . . . 1.8 110.56 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt 61.1 46.76 7.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.636 -0.711 . . . . 0.34 110.84 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.02 -23.94 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.008 -0.542 . . . . 0.34 111.364 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 97' ' ' VAL . 7.8 p -68.46 -31.38 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.477 -0.329 . . . . 0.83 110.503 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 121.118 -0.563 . . . . 0.28 112.571 -179.589 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 109.506 -0.553 . . . . 0.42 109.506 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.55 167.53 10.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.926 -0.398 . . . . 0.39 109.926 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 49' ' ' LEU . 16.6 tp -104.05 6.79 36.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.457 0.54 . . . . 0.53 112.457 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.77 -44.42 7.09 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.421 -0.512 . . . . 1.21 110.486 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.91 -27.94 61.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.436 -0.802 . . . . 0.7 111.048 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.85 -13.01 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.21 110.533 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -87.99 107.64 18.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.036 -0.529 . . . . 0.35 110.055 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.425 ' HG3' HG12 ' A' ' 17' ' ' VAL . 33.5 mm-40 -65.71 -44.33 86.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.642 . . . . 0.36 111.316 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 t -142.89 136.12 28.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.058 0.456 . . . . 0.35 110.145 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -96.68 25.91 4.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.014 -0.539 . . . . 1.03 110.851 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -96.68 88.74 4.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 0.29 110.127 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.3 p -82.02 141.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.104 -0.498 . . . . 0.3 109.924 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -90.91 162.42 14.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.22 111.797 -178.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 98.6 t -111.92 -46.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.15 109.56 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -154.15 120.11 5.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.11 -0.95 . . . . 0.22 108.989 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.03 -27.58 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.067 0.395 . . . . 0.32 112.067 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -38.39 87.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.062 0.458 . . . . 0.38 110.941 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -99.35 -5.35 29.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 1.25 110.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.23 52.23 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.914 -0.66 . . . . 0.27 111.881 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -105.81 123.19 47.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.973 0.416 . . . . 0.74 110.886 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' PHE . 35.2 t -114.97 130.76 68.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.75 -0.659 . . . . 0.34 109.994 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -85.25 110.82 19.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.12 110.459 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -84.8 -171.7 3.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.922 -0.581 . . . . 1.42 109.803 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -56.7 -38.92 72.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.179 0.437 . . . . 0.9 112.179 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -81.85 -1.34 47.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.34 111.5 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -101.6 -47.79 4.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.7 110.963 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.9 -34.28 77.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.611 -0.268 . . . . 0.18 110.966 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.08 -24.84 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.076 0.465 . . . . 1.23 110.574 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 m -93.22 -32.53 14.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.205 -0.452 . . . . 0.29 110.851 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.31 -54.32 7.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.19 111.716 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.44 -36.02 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.2 -0.455 . . . . 2.36 110.948 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.87 -25.04 25.24 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.832 -0.907 . . . . 0.34 110.832 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.92 124.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.279 -0.46 . . . . 1.19 110.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -23.8 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.172 0.51 . . . . 1.0 109.876 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.98 104.24 2.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.406 -0.815 . . . . 1.31 110.093 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -59.86 -31.92 70.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.5 111.643 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -38.72 92.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.69 110.211 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.05 -40.06 94.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.115 -0.493 . . . . 1.13 109.712 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.98 -50.3 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.53 109.555 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.8 m -59.66 -34.85 73.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.262 -0.881 . . . . 0.19 110.751 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.84 -44.42 96.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.54 110.922 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -63.26 -40.46 97.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.78 110.378 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 20' ' ' VAL . 52.1 mt -69.7 -34.31 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.66 . . . . 0.18 110.866 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.41 -21.23 49.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.365 . . . . 0.73 111.732 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -97.16 -53.59 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.334 0.494 . . . . 0.94 112.334 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -102.32 20.96 15.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.91 111.373 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.27 165.41 12.8 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.677 -0.773 . . . . 0.21 112.173 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.2 tt0 -87.58 102.69 14.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.014 -0.365 . . . . 1.89 110.014 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 p -106.29 126.02 61.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.15 110.449 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -79.68 88.4 5.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.925 -0.579 . . . . 2.37 111.139 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.628 HG21 ' HB ' ' A' ' 39' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.81 110.744 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.519 0.2 . . . . 0.2 110.95 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 58.05 67.25 0.98 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.889 -0.596 . . . . 0.13 110.201 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.69 120.15 31.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.64 110.737 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 m -86.11 153.41 22.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.58 110.406 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' A' ' 155' ' ' GLN . 11.1 t -110.31 -80.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.64 0.257 . . . . 0.31 110.723 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.62 160.0 30.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.763 0.316 . . . . 0.49 110.39 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 2.25 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 0.7 111.138 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.5 -23.89 61.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.45 111.344 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . 45.6 mttm 63.02 36.01 12.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.143 0.497 . . . . 1.92 110.995 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.9 132.35 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.21 111.951 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.9 m 52.71 84.18 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.251 0.621 . . . . 0.19 112.52 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp 52.47 38.24 24.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 1.25 111.58 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.67 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 6.1 tt0 58.85 59.62 2.77 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.049 -0.523 . . . . 1.03 110.703 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 46.32 42.09 9.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.207 1.003 . . . . 1.15 112.07 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.66 72.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.09 110.67 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -67.38 -31.11 71.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 1.11 110.698 179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -71.67 -29.11 64.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.923 -0.399 . . . . 0.52 109.923 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.54 -37.56 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.862 -0.792 . . . . 0.14 108.862 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.2 -40.7 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.184 -0.916 . . . . 0.16 109.567 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.1 mmtp -66.95 -39.32 87.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 1.32 110.11 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -58.29 -40.76 82.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.737 -0.665 . . . . 1.61 110.529 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.65 -46.65 86.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.26 110.108 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -62.45 -36.65 83.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.73 111.414 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 47.9 mm-40 -62.65 -35.53 79.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.411 -0.358 . . . . 0.44 111.431 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -92.25 -41.52 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.31 -0.405 . . . . 0.73 111.089 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.69 106.55 8.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.182 -0.463 . . . . 1.05 109.868 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -75.1 101.74 4.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.92 110.977 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.766 -0.652 . . . . 0.38 110.729 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.78 110.569 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.44 133.65 55.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.482 . . . . 0.5 110.282 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.44 141.38 48.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.237 -0.438 . . . . 0.23 110.274 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.59 139.66 46.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.128 0.489 . . . . 1.2 110.962 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 90.4 t80 -113.93 143.28 44.97 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.161 -0.681 . . . . 0.25 109.161 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.6 131.56 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.427 0.528 . . . . 0.37 112.427 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 180' ' ' LEU . 7.0 mt -160.61 139.57 7.74 Favored Pre-proline 0 C--N 1.333 -0.112 0 CA-C-N 115.625 -0.716 . . . . 1.49 109.649 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 180' ' ' LEU . 21.3 Cg_endo -62.09 156.03 52.4 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.571 2.181 . . . . 0.17 111.674 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.0 t -49.73 -37.05 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.744 0.418 . . . . 0.17 111.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -46.78 -47.08 20.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.84 111.451 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.31 -28.59 12.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.33 110.588 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.87 64.89 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.009 -0.541 . . . . 0.18 113.233 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -27.73 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.656 0.243 . . . . 0.8 111.656 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -76.18 -46.58 27.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.577 0.227 . . . . 0.8 111.184 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -25.11 59.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.514 -0.312 . . . . 1.59 111.155 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -59.33 -34.21 72.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.98 110.919 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.45 6.78 25.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.56 . . . . 1.5 112.187 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 26.6 mtpt -135.38 -28.1 1.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 197' ' ' LYS . 80.1 mt -80.73 -56.96 3.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.97 0.414 . . . . 1.15 111.349 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 27.1 mtpp -61.1 -52.65 70.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.47 0.915 . . . . 0.24 113.47 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 56.3 Cg_endo -68.29 -5.89 16.08 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.191 1.927 . . . . 0.32 114.047 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 191' ' ' LYS . 2.0 mm? -102.52 1.73 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.771 -0.371 . . . . 0.21 110.377 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mt 53.19 45.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.693 0.759 . . . . 0.35 111.23 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' HD2' HD23 ' A' ' 192' ' ' LEU . 6.1 ptpp? -116.91 24.24 11.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 0.24 110.028 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.57 156.72 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.723 -0.671 . . . . 0.25 111.341 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.53 145.34 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.4 109.072 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 65.99 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.375 0.509 . . . . 0.32 112.375 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 m -145.54 36.1 1.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.406 -0.815 . . . . 0.25 108.858 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.3 pt-20 -89.87 166.75 13.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.738 -0.665 . . . . 0.55 112.25 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.14 118.16 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 1.52 109.6 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.22 45.29 1.25 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.34 111.032 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -102.71 -139.58 10.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.725 -0.75 . . . . 0.2 112.288 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -78.87 -27.67 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.468 . . . . 1.14 110.228 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -120.85 109.53 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.677 -0.692 . . . . 1.13 109.165 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.8 tp -69.83 92.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.89 . . . . 1.55 111.298 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.0 tt0 -94.48 117.46 30.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.028 -0.73 . . . . 0.44 109.028 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 202' ' ' GLU . 8.4 mt -128.18 147.43 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.842 0.353 . . . . 0.18 110.777 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.33 115.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.507 -0.553 . . . . 0.26 109.507 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.4 m -121.4 57.75 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.793 0.33 . . . . 1.04 111.722 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.98 127.59 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.715 -0.476 . . . . 0.41 109.715 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.71 -51.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.319 -0.4 . . . . 0.77 111.22 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 2.9 p30 -155.54 166.34 16.46 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.725 -0.216 . . . . 1.2 110.639 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 86.2 Cg_endo -80.34 -159.24 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.35 2.034 . . . . 0.44 112.754 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.68 -94.14 1.29 Allowed Glycine 0 C--O 1.238 0.392 0 C-N-CA 120.871 -0.681 . . . . 0.34 111.621 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.26 -17.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.65 110.109 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 222' ' ' ILE . 23.9 t80 -55.54 -35.27 65.5 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.314 -0.857 . . . . 0.45 110.481 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -25.06 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.35 111.563 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -86.06 -45.48 11.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 2.72 110.276 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 226' ' ' ILE . 16.3 tt -69.02 -26.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 1.26 110.686 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -31.75 72.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.249 -0.432 . . . . 0.2 110.196 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.55 -22.96 64.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.678 -0.692 . . . . 1.15 110.05 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.8 mt -96.02 -46.61 6.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.525 -0.761 . . . . 0.74 109.592 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.5 mm -55.76 -37.96 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.894 -0.594 . . . . 0.43 112.326 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -52.64 -31.56 37.47 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.353 0.501 . . . . 1.32 112.353 -179.105 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -112.33 -23.93 10.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.58 110.711 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 226' ' ' ILE . 1.5 tp10 -62.47 -51.23 68.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.64 111.606 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.1 -28.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.432 0.53 . . . . 0.63 112.432 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 32.8 mttt -58.98 -43.88 91.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.69 110.97 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.45 39.49 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.646 -0.788 . . . . 0.28 112.845 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -151.07 -18.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.888 0.344 . . . . 0.49 111.5 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -147.52 -158.17 7.76 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.907 . . . . 0.13 112.491 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.5 m -119.11 141.89 48.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.786 0.327 . . . . 0.21 110.547 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.32 143.05 51.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.29 110.639 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 238' ' ' VAL . 2.9 tt0 -134.07 171.17 14.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.441 ' H ' ' HG2' ' A' ' 237' ' ' GLU . 27.6 m -86.08 149.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.795 0.331 . . . . 0.27 110.429 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 109.769 -0.456 . . . . 0.39 109.769 179.652 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.7 110.5 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.426 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 7.0 t-20 -105.99 -175.41 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.954 -0.566 . . . . 0.52 109.643 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -77.75 -85.29 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.626 0.25 . . . . 2.05 110.926 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mt -91.38 92.41 3.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.302 0.572 . . . . 0.27 110.764 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 68.2 mmt-85 -143.53 133.11 23.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.495 -0.775 . . . . 0.64 109.766 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.26 15.45 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.45 -0.341 . . . . 1.71 111.483 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 p -101.56 -3.11 29.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.434 -0.348 . . . . 0.61 111.475 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 37.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.18 0.514 . . . . 1.62 110.431 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 54' ' ' GLN . 33.9 m -95.53 150.61 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.44 111.597 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.9 151.91 25.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.933 -0.576 . . . . 0.48 109.582 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 126.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.781 0.324 . . . . 0.89 111.013 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -125.66 116.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.825 -0.805 . . . . 0.3 108.825 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.1 ttp180 -114.89 123.24 48.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.705 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.466 ' HB2' HG23 ' A' ' 89' ' ' ILE . 51.6 ttp -88.61 131.45 34.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.25 110.595 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -101.87 126.32 48.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.165 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 16.9 mmm180 -122.11 -164.62 1.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.329 -0.249 . . . . 0.64 110.329 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.32 -53.88 14.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.12 111.175 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.1 27.58 3.14 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.517 -0.849 . . . . 0.53 112.685 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 162.66 41.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.337 . . . . 1.12 110.47 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 141.3 23.23 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.329 -0.619 . . . . 1.09 109.329 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -136.05 144.44 45.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.333 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 1.2 pt-20 -145.6 144.45 30.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.682 0.277 . . . . 1.68 110.682 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.3 mt -140.13 144.67 27.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.33 109.994 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.77 122.99 28.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.17 110.523 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -124.44 -170.44 2.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.15 110.924 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.94 -176.19 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.453 -0.339 . . . . 0.94 110.987 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -76.67 -140.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.431 -0.35 . . . . 1.46 111.858 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -60.54 -6.8 1.78 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.426 0.898 . . . . 0.74 113.426 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.97 -2.96 58.84 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.008 -0.433 . . . . 0.98 111.387 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG21 ' SG ' ' A' ' 33' ' ' CYS . 8.8 p -74.15 -33.01 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.268 . . . . 0.23 111.499 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.05 70.23 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.119 0.961 . . . . 0.28 110.431 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.738 0 CA-C-N 114.807 -1.088 . . . . 0.19 112.596 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.495 -0.557 . . . . 1.41 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.45 153.67 17.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.257 -0.883 . . . . 0.71 108.966 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.03 -27.32 62.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.562 0.22 . . . . 0.29 111.334 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.41 111.797 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -87.37 0.15 55.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.52 111.791 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.32 -5.54 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.564 0.697 . . . . 0.5 110.027 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.24 133.48 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.438 -0.801 . . . . 1.32 109.961 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' HG3' HG12 ' A' ' 17' ' ' VAL . 29.0 mm-40 -85.77 -48.88 8.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.099 0.476 . . . . 0.28 110.709 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.1 t -119.25 166.68 12.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.891 -0.595 . . . . 0.8 109.727 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -121.24 32.54 5.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.272 0.558 . . . . 0.71 110.061 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.01 126.36 50.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.79 . . . . 0.28 109.447 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.6 p -108.86 137.65 39.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.873 0.368 . . . . 0.13 110.367 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HE2' ' H ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -82.95 158.27 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.372 . . . . 0.47 111.645 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.5 t -121.18 -56.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.36 109.186 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -137.72 101.13 4.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.255 -0.884 . . . . 0.32 109.56 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' H ' ' HE2' ' A' ' 59' ' ' PHE . 14.0 p -67.71 -30.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.59 110.917 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -70.12 -12.32 61.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.987 0.422 . . . . 0.33 111.181 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -121.37 4.71 10.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 1.06 110.846 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.82 38.46 94.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.739 -0.743 . . . . 0.4 111.351 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -101.77 120.81 40.95 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.14 0.495 . . . . 0.9 111.644 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.9 140.55 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.18 109.919 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.581 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -95.11 127.01 40.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.289 0.566 . . . . 0.06 110.834 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -88.86 -178.06 5.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.426 -0.806 . . . . 1.33 109.661 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.54 -28.67 68.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.102 0.477 . . . . 1.45 110.735 179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -80.03 -5.31 55.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.54 111.116 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.27 -46.09 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.334 -0.394 . . . . 0.47 111.125 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.82 -28.01 69.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.14 111.149 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 80' ' ' ASP . 10.2 tt -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.105 0.478 . . . . 0.2 110.596 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -35.75 17.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.841 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.55 -52.66 12.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.701 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -89.65 -66.98 0.87 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.988 0.423 . . . . 0.81 110.927 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.72 -50.82 0.47 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.172 -0.771 . . . . 0.24 111.172 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 148.21 25.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.919 -0.4 . . . . 0.71 109.919 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 74' ' ' ILE . 6.9 p-10 -93.25 3.82 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 1.23 110.664 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.58 122.92 36.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.207 -0.451 . . . . 1.45 109.962 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -60.33 -27.48 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.527 0.566 . . . . 1.88 112.527 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.52 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.013 0.435 . . . . 0.55 110.605 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.0 -23.16 23.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.12 110.275 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -79.54 -55.07 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.28 109.975 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 11.7 p -63.98 -24.87 67.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.24 110.721 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' THR . 40.7 ttmt -54.25 -41.75 69.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.645 . . . . 0.95 111.037 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -84.6 -38.19 20.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 1.36 110.72 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.567 HG22 HG22 ' A' ' 20' ' ' VAL . 65.5 mt -62.47 -34.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.18 111.981 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -25.02 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.069 0.766 . . . . 0.26 113.069 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.61 -20.74 11.59 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.362 -0.535 . . . . 0.63 112.399 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -111.0 12.4 22.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.923 0.392 . . . . 0.96 110.57 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 22' ' ' MET . . . -129.11 175.7 18.74 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.663 -0.78 . . . . 0.27 112.773 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -91.83 92.84 8.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.991 0.424 . . . . 1.4 110.602 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -91.66 140.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.869 -0.605 . . . . 0.27 109.691 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -69.34 84.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.62 110.837 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 95' ' ' VAL . 15.4 m . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.568 -0.742 . . . . 0.35 111.544 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 121.265 0.555 . . . . 0.56 109.728 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -86.16 2.37 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.99 111.757 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -107.46 121.42 44.58 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.751 -0.38 . . . . 1.39 110.038 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 m -51.1 132.65 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.856 0.723 . . . . 0.53 111.978 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.93 68.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.995 -0.548 . . . . 0.98 110.156 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 61.52 80.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.606 -0.725 . . . . 1.04 111.446 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -3.33 16.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.245 0.545 . . . . 0.79 111.153 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -77.82 -15.96 58.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.432 0.635 . . . . 0.27 109.56 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -94.65 159.47 15.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.289 -0.869 . . . . 0.57 109.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t -71.57 133.49 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.887 0.375 . . . . 0.46 110.289 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -26.37 68.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.51 110.811 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -82.65 -12.31 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.91 110.677 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -91.07 -34.75 14.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 1.63 110.512 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 159' ' ' VAL . 14.4 mt-30 -110.07 17.13 21.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 1.29 111.564 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.79 72.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.027 0.442 . . . . 0.17 111.383 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 2.9 mm? -64.34 -46.88 81.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.635 . . . . 0.78 110.791 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -59.5 -38.57 81.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.467 . . . . 0.25 111.129 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 155' ' ' GLN . 96.2 t -67.69 -49.72 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.17 111.701 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.6 -34.31 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.644 0.239 . . . . 0.28 111.644 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 29.5 mmtt -72.43 -40.54 67.02 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.271 -0.27 . . . . 1.79 110.271 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -59.04 -40.01 83.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.144 0.497 . . . . 0.99 110.087 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 53.3 tp -70.24 -41.22 73.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.598 -0.728 . . . . 0.76 110.313 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 167' ' ' MET . 59.8 tttm -58.14 -33.8 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.019 -0.537 . . . . 1.29 111.568 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.99 -30.56 71.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.765 0.317 . . . . 1.86 111.185 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -94.98 -41.86 8.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.18 110.411 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -133.56 119.89 20.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.089 -0.505 . . . . 0.79 109.656 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -90.53 109.01 20.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.08 0.467 . . . . 1.95 111.182 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.573 -0.74 . . . . 0.35 110.919 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 112.507 0.558 . . . . 0.97 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 175' ' ' ARG . 11.7 mtp180 -140.31 145.71 37.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.026 0.441 . . . . 0.67 111.826 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.573 ' HB2' HD23 ' A' ' 213' ' ' LEU . 5.9 mp -129.38 150.64 50.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.18 108.821 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 23.1 ptt180 -121.72 153.6 38.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.062 0.458 . . . . 0.18 110.962 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 31.4 t80 -117.64 128.21 54.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.22 109.876 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.52 128.51 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.85 111.065 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.549 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.6 OUTLIER -173.18 160.29 3.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.393 -0.595 . . . . 0.13 109.393 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.13 147.64 73.49 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.129 1.886 . . . . 0.2 111.536 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 72.9 t -61.62 -22.07 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.908 0.385 . . . . 0.35 110.708 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -52.7 -42.55 64.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.75 110.541 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.5 -32.78 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.54 109.817 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.96 -20.41 64.52 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.614 -0.721 . . . . 0.11 113.347 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.63 -26.54 61.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.95 0.405 . . . . 0.8 111.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 191' ' ' LYS . 50.9 mttt -76.68 -57.45 3.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.8 110.989 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -19.57 65.17 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.256 0.465 . . . . 1.55 112.256 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -54.19 -51.6 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.441 . . . . 0.79 111.442 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.88 21.68 4.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.387 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 187' ' ' LYS . 21.4 mtpp -122.7 0.02 9.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 2.29 109.978 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.27 -54.17 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 1.39 111.807 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.1 mtpp -53.92 -53.27 59.94 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.813 0.671 . . . . 0.63 112.813 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.8 Cg_endo -65.36 -14.15 43.49 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.219 1.946 . . . . 0.4 112.889 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.4 -18.75 40.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.407 -0.36 . . . . 0.67 110.442 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 31.4 mt 57.46 75.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.761 -0.654 . . . . 0.67 111.721 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.7 27.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.798 -0.637 . . . . 0.69 109.838 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.91 -173.46 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.306 -0.861 . . . . 0.89 109.927 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.67 137.66 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.342 -0.614 . . . . 0.89 109.342 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.06 71.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.511 0.507 . . . . 2.09 111.185 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 34.39 0.46 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.497 -0.774 . . . . 0.6 109.135 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.27 168.45 14.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.889 -0.596 . . . . 1.26 111.774 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -126.1 127.32 45.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.611 -0.722 . . . . 1.13 109.724 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -115.76 130.15 56.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.599 -0.273 . . . . 0.97 110.5 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 165.97 -114.66 0.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.74 -0.743 . . . . 0.74 112.277 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -40.16 31.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.661 0.743 . . . . 1.13 109.092 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -117.41 157.6 25.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.93 -1.032 . . . . 1.19 108.757 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.93 95.03 5.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.101 0.477 . . . . 0.31 110.351 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 28.4 tt0 -92.85 107.83 19.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.819 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.47 128.47 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.379 -0.373 . . . . 0.3 111.129 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.7 t -90.97 98.02 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.317 -0.623 . . . . 0.21 109.317 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 37.3 t -113.51 114.18 26.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.088 -0.506 . . . . 0.24 111.33 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -169.84 134.46 1.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.248 -0.649 . . . . 0.38 109.248 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.5 tt -131.79 171.82 17.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.496 -0.32 . . . . 0.35 110.217 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 42.1 m-20 -55.72 148.98 33.56 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.009 -0.541 . . . . 1.75 111.407 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.83 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.078 2.519 . . . . 0.41 113.081 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.36 -90.13 0.92 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.879 -0.888 . . . . 0.1 110.879 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.7 m -73.34 -4.5 33.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 1.27 110.214 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 79.1 t80 -55.59 -38.78 69.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.23 111.265 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 8.1 tpt180 -65.64 -31.2 72.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.565 0.222 . . . . 1.2 111.16 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.49 -35.97 78.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.42 110.741 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.604 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 3.6 tp -84.95 -27.48 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 1.11 109.879 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 26.1 t70 -64.44 -29.13 70.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.35 110.688 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 220' ' ' ARG . 12.9 mm-40 -53.42 -33.32 53.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.72 -0.673 . . . . 0.48 112.007 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -97.47 -33.43 11.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.948 -0.39 . . . . 0.17 109.948 178.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 222' ' ' ILE . 31.4 mm -55.96 -37.75 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.13 111.78 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.478 ' HA ' ' CB ' ' A' ' 231' ' ' LYS . 8.0 ptpt -62.22 -23.67 66.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.891 0.7 . . . . 0.42 112.891 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -112.47 -28.36 7.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.531 -0.468 . . . . 0.67 111.132 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -41.28 74.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.009 -0.541 . . . . 0.87 111.843 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.28 -47.06 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.501 0.556 . . . . 0.21 112.501 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 25.7 ttmt -53.35 -45.96 69.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.938 0.399 . . . . 0.23 111.088 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.28 48.23 2.9 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.806 -0.712 . . . . 0.22 112.017 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.82 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.727 0.299 . . . . 1.2 110.902 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.25 -146.99 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.12 112.379 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.0 m -108.84 131.24 55.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.17 110.858 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.4 pt? -111.82 149.94 31.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.835 -0.432 . . . . 0.21 109.835 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -142.52 -178.84 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.01 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.72 149.93 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.975 0.417 . . . . 0.16 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.448 0.642 . . . . 0.22 109.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.005 0.431 . . . . 0.44 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.45 158.66 15.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.09 -0.505 . . . . 0.51 110.193 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -71.08 -50.45 33.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.88 111.174 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.16 94.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.13 109.839 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -166.64 160.14 14.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 1.54 110.338 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.13 7.19 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.17 111.539 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 p -96.99 -0.06 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.27 110.712 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -141.98 38.11 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.612 . . . . 0.22 109.506 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.72 150.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.16 111.799 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.54 137.06 54.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.365 -0.834 . . . . 0.14 109.877 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -76.09 122.78 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.377 . . . . 0.35 110.989 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 31' ' ' ILE . 1.2 p -151.57 129.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.17 110.498 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 148.0 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.95 111.152 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 17.6 ttt -110.67 134.3 52.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.61 . . . . 0.23 110.847 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -96.68 103.77 15.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.634 -0.506 . . . . 0.73 109.634 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 10.9 mmm180 -84.07 -179.82 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.548 -0.296 . . . . 1.42 110.62 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.6 69.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.514 . . . . 0.42 111.918 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.11 -39.44 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.92 . . . . 0.54 113.28 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tttt -113.91 -174.94 2.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.781 0.324 . . . . 1.05 110.826 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 5.6 mmt180 -137.03 154.8 50.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.442 -0.948 . . . . 0.86 108.442 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -133.48 102.75 5.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.178 -0.304 . . . . 0.27 110.178 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 61' ' ' ASN . 2.6 mt-10 -106.05 127.0 52.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.37 110.773 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 20' ' ' VAL . 5.0 pt -135.06 -172.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.1 110.798 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.6 110.23 3.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.391 . . . . 0.09 110.886 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' HD23 ' A' ' 53' ' ' LEU . 62.5 m -100.18 -175.47 2.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 0.12 109.779 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -72.18 167.45 20.29 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.91 0.386 . . . . 0.22 111.338 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -99.69 7.77 44.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.088 0.47 . . . . 1.11 111.079 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -87.61 84.94 7.04 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.874 -0.331 . . . . 0.23 110.379 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm 58.06 57.18 4.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.733 -0.667 . . . . 0.43 110.778 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.1 p -74.65 61.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.794 1.283 . . . . 1.49 110.74 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.56 9.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.471 -1.24 . . . . 0.24 109.308 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-N 115.595 -0.729 . . . . 0.18 112.395 -179.038 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.34 110.583 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 3.1 p30 -166.52 -175.53 3.22 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.146 -0.687 . . . . 0.99 109.146 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.724 ' HB2' HG23 ' A' ' 83' ' ' THR . 1.2 mm? -131.5 33.86 4.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.453 0.644 . . . . 0.97 110.07 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -120.86 -43.97 2.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.542 -0.754 . . . . 1.88 109.314 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -87.0 -31.66 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.345 -0.843 . . . . 0.96 108.829 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.452 HG13 ' CE1' ' A' ' 34' ' ' TYR . 22.2 t -63.25 -37.25 78.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.901 -1.045 . . . . 0.44 110.035 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD23 ' SG ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -83.47 80.22 9.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.373 -0.83 . . . . 0.59 109.243 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.6 -62.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.288 -0.869 . . . . 0.42 111.039 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -78.66 91.98 4.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.67 -0.696 . . . . 0.17 111.277 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -84.22 60.46 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.415 0.626 . . . . 0.72 110.555 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.3 t -152.91 82.81 1.21 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.241 -0.891 . . . . 0.58 109.136 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.2 p -67.64 138.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.781 -0.645 . . . . 0.11 110.636 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -101.14 145.88 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.33 109.945 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 97.5 t -73.35 -40.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.033 -0.728 . . . . 0.5 109.033 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 2.1 t-20 -176.38 127.34 0.2 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.054 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.07 -37.93 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.772 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.4 m -83.44 43.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.93 111.122 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -47.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 2.28 110.046 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.14 -2.8 47.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.755 -0.736 . . . . 0.47 112.269 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.3 121.95 22.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.69 0.281 . . . . 1.01 110.803 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.8 t -105.86 134.41 47.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.958 -0.386 . . . . 0.27 109.958 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.1 98.32 10.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.158 0.504 . . . . 0.41 110.589 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -81.17 178.9 8.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.045 -0.724 . . . . 2.36 109.045 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -51.63 -35.8 43.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.685 0.278 . . . . 0.42 111.537 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.51 -30.01 70.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 2.09 111.805 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.67 -51.21 6.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 2.18 111.829 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 80' ' ' ASP . 2.2 pp -60.12 -32.55 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.19 111.881 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.39 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.202 0.525 . . . . 0.83 110.363 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.6 m -105.89 -39.15 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.79 111.142 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.94 -41.06 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.387 . . . . 0.33 111.07 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -96.63 -57.39 2.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.99 109.823 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.29 -31.93 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.902 -0.666 . . . . 0.53 112.142 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.02 145.35 45.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.55 0.215 . . . . 0.76 110.531 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 7.8 p-10 -92.8 11.68 26.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.059 0.456 . . . . 0.7 110.917 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.589 ' O ' HG12 ' A' ' 85' ' ' ILE . 13.5 t0 -82.1 117.72 22.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.44 109.781 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.07 -31.14 70.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.8 111.535 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.724 HG23 ' HB2' ' A' ' 49' ' ' LEU . 23.2 m -63.83 -46.97 82.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 0.14 110.559 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.8 -33.04 74.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.48 110.949 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 81' ' ' ASP . 41.6 mm -65.38 -57.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.28 111.05 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.64 -28.48 68.51 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.083 0.401 . . . . 0.19 112.083 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' THR . 28.0 mtpt -55.34 -53.56 54.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.925 0.393 . . . . 0.82 111.14 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -63.9 -40.01 95.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.74 -0.664 . . . . 0.81 111.729 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 20' ' ' VAL . 42.3 mt -69.81 -28.35 36.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.29 0.567 . . . . 0.18 111.078 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -32.12 40.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.291 -0.413 . . . . 0.26 111.771 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 87' ' ' LYS . 11.4 t -99.06 -29.48 12.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.133 0.79 . . . . 0.21 113.133 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -119.44 12.04 12.31 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.073 -0.392 . . . . 1.65 111.801 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.84 -177.33 18.39 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.583 -0.818 . . . . 0.26 111.551 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.49 106.62 18.66 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.119 -0.326 . . . . 1.8 110.119 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 97' ' ' VAL . 2.1 p -117.66 148.64 20.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.173 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -70.8 77.09 0.62 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.078 0.466 . . . . 0.41 111.64 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 95' ' ' VAL . 15.6 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 1.12 110.438 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 144' ' ' TYR . 16.2 tt . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 111.687 0.255 . . . . 0.23 111.687 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 m80 59.96 32.17 21.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.122 0.264 . . . . 0.36 111.366 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.452 ' H ' HG23 ' A' ' 142' ' ' ILE . 49.1 t80 -134.13 133.99 41.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.889 0.376 . . . . 0.68 110.669 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 m -155.36 170.28 22.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.687 -0.688 . . . . 0.52 109.194 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.48 -84.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.949 -0.3 . . . . 0.13 110.351 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -143.95 104.48 4.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.45 110.373 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -12.08 60.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.18 111.629 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.94 5.68 50.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.22 110.925 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -116.1 -159.88 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.29 -0.414 . . . . 0.99 110.528 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -75.41 81.66 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.364 0.602 . . . . 0.61 109.925 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 153' ' ' LYS . 0.9 OUTLIER -53.72 -25.44 18.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.5 113.514 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.619 ' HD2' HG23 ' A' ' 152' ' ' THR . 0.0 OUTLIER -91.12 -13.06 33.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.65 -0.656 . . . . 0.69 111.757 -179.148 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -84.69 -25.1 28.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.318 0.58 . . . . 0.5 109.592 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.94 29.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.564 -0.744 . . . . 0.15 110.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.1 -18.36 63.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.22 112.241 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.36 -46.38 16.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.113 0.482 . . . . 0.43 109.873 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -62.49 -46.0 90.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 0.54 111.023 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.37 -38.39 48.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.722 -0.672 . . . . 0.22 111.506 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.2 -34.34 66.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.138 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -82.87 -9.92 59.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.135 -0.484 . . . . 1.27 111.412 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -55.09 6.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.3 110.127 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.41 -24.0 66.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.29 110.623 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -61.57 -26.03 67.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.9 110.153 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -80.59 -7.01 59.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.49 110.845 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -107.62 -48.15 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.35 110.281 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 mmm -145.85 148.11 32.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 1.06 110.414 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -90.95 99.9 12.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.273 -0.421 . . . . 1.6 110.005 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 116.037 -0.529 . . . . 0.24 110.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 5.1 ttt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.985 -0.376 . . . . 1.48 109.985 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -137.69 120.83 16.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.024 -0.361 . . . . 0.58 110.024 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.462 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.8 mp -120.43 157.91 28.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.99 0.424 . . . . 0.39 110.875 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.415 ' HB3' HG22 ' A' ' 211' ' ' VAL . 0.1 OUTLIER -135.79 -179.47 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.553 -0.749 . . . . 0.36 109.862 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 1.9 p90 -141.66 139.63 33.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.721 0.296 . . . . 0.7 110.328 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -108.68 122.17 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.198 -0.456 . . . . 0.42 110.943 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.8 149.83 9.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.609 -0.723 . . . . 1.12 109.814 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.11 160.57 37.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.917 2.411 . . . . 0.12 112.789 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.36 -34.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 0.55 111.121 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -55.2 -45.93 75.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.82 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -85.57 -30.25 23.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.384 -0.371 . . . . 1.45 110.57 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.04 -22.05 77.1 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.42 113.066 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -61.15 -28.23 68.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.0 0.429 . . . . 1.12 110.88 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 4.55 51.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.262 -0.426 . . . . 1.44 110.733 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.4 tp -111.82 -41.05 4.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.94 110.987 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.442 ' HB2' HD21 ' A' ' 208' ' ' LEU . 27.4 ttpp -55.77 -44.37 77.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.98 111.19 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -80.61 6.24 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.178 0.436 . . . . 0.46 112.178 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -123.06 -2.76 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.292 -0.255 . . . . 0.97 111.127 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 192' ' ' LEU . 0.3 OUTLIER -127.3 -48.69 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.645 -0.252 . . . . 0.76 111.48 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 60.3 tttt -59.8 -50.28 87.47 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.367 0.506 . . . . 1.02 112.367 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 48.6 Cg_endo -68.0 -2.65 9.14 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.174 1.916 . . . . 0.16 112.913 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.25 3.02 55.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 110.053 -0.351 . . . . 0.58 110.053 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 16.9 mt 52.72 72.22 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.178 -0.919 . . . . 0.15 110.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 0.1 OUTLIER -152.8 19.37 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.608 -0.723 . . . . 0.34 109.932 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' SG ' ' A' ' 212' ' ' CYS . 33.2 m -108.95 145.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.499 . . . . 0.21 111.013 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.448 HD12 HG12 ' A' ' 211' ' ' VAL . 13.4 mt -97.02 159.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.679 . . . . 0.28 109.397 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.07 59.77 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.262 0.553 . . . . 1.32 111.613 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -155.99 74.62 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.28 -0.637 . . . . 0.45 109.28 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -123.52 155.01 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.48 . . . . 1.04 111.045 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.41 129.64 46.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.836 -0.62 . . . . 0.31 109.937 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.7 109.24 11.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.93 0.395 . . . . 1.17 110.117 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -168.77 -96.33 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.041 -0.599 . . . . 0.32 111.649 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -89.01 -10.88 45.91 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.122 -0.696 . . . . 0.56 109.122 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.19 -176.89 5.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.009 -0.996 . . . . 0.24 109.621 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 189' ' ' LYS . 21.9 tp -130.02 76.87 1.75 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.581 -0.526 . . . . 0.39 109.581 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.69 108.58 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.792 -0.64 . . . . 0.58 110.715 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 55.3 mt -123.13 137.39 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.19 110.611 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.448 HG12 HD12 ' A' ' 199' ' ' ILE . 85.9 t -91.53 123.75 43.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.25 110.065 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.459 ' SG ' HG12 ' A' ' 198' ' ' VAL . 57.4 m -137.21 102.34 4.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.244 -0.435 . . . . 0.41 110.468 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.462 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -159.66 136.96 9.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.388 -0.597 . . . . 0.25 109.388 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 215' ' ' ASP . 5.6 tp -134.86 179.36 4.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.525 -0.307 . . . . 0.29 110.354 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.56 ' H ' HG13 ' A' ' 214' ' ' ILE . 16.8 m-20 -60.43 164.22 7.31 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 122.978 0.511 . . . . 0.84 110.861 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 215' ' ' ASP . 10.2 Cg_endo -52.65 170.38 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.853 2.368 . . . . 0.07 112.923 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.48 -80.44 1.65 Allowed Glycine 0 C--O 1.237 0.315 0 N-CA-C 110.43 -1.068 . . . . 0.11 110.43 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.24 -22.44 63.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.34 109.107 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -59.5 -32.26 70.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.298 -0.865 . . . . 0.31 110.767 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 220' ' ' ARG . 11.4 mmt180 -85.93 -15.79 40.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.37 110.161 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 0.7 OUTLIER -79.69 -48.75 13.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.38 109.134 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 tt -66.66 -34.65 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.22 109.775 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.445 ' O ' ' HD2' ' A' ' 227' ' ' LYS . 1.8 t70 -59.98 -36.58 77.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.907 -0.588 . . . . 0.44 110.919 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 9.8 mm-40 -47.13 -41.14 16.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.664 -0.698 . . . . 0.9 111.934 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -34.09 10.2 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.793 -0.363 . . . . 0.46 111.266 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 8.9 mm -56.28 -39.11 58.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.222 0.453 . . . . 0.19 112.222 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 5.8 ptmt -64.74 -11.65 38.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.976 0.732 . . . . 0.38 112.976 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -25.74 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.552 -0.459 . . . . 1.85 112.005 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.14 -47.83 26.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.64 111.362 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -116.38 -38.8 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.845 -0.342 . . . . 0.31 111.59 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -66.09 -25.05 66.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 1.32 110.24 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.95 25.35 28.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.015 -0.612 . . . . 0.4 111.718 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -139.84 -55.18 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.583 -0.525 . . . . 0.59 109.583 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.41 -145.53 9.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.314 -0.714 . . . . 0.2 111.314 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.41 133.25 46.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 117.031 0.416 . . . . 0.81 110.018 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -89.55 149.65 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.953 -0.388 . . . . 1.18 109.953 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 177' ' ' ARG . 6.6 tp10 -155.56 154.61 31.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.84 110.179 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -72.57 158.6 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.596 0.236 . . . . 0.23 110.406 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.2 tp . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.458 0.647 . . . . 1.05 111.015 -179.418 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.241 0.543 . . . . 0.51 111.336 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -90.86 -76.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.86 110.752 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -161.37 -80.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.81 0.338 . . . . 0.72 110.822 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 54' ' ' GLN . 1.2 pp -89.18 47.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.132 0.491 . . . . 1.51 111.728 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -121.07 151.69 39.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.71 45.45 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.217 0.532 . . . . 1.13 111.608 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -99.51 -33.75 10.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.092 0.472 . . . . 1.06 111.063 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.54 72.33 1.42 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.219 -0.66 . . . . 0.73 109.219 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.12 149.01 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.669 -0.696 . . . . 0.95 111.331 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.66 123.0 49.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.51 109.412 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.43 120.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.114 0.483 . . . . 0.78 111.077 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -139.21 116.89 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.739 . . . . 0.24 109.525 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -126.83 132.95 50.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.229 0.538 . . . . 0.77 112.032 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 66.6 ttp -111.48 119.45 38.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.176 -0.676 . . . . 0.26 109.176 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 124.23 50.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.782 0.325 . . . . 1.17 110.828 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -109.86 -164.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.533 . . . . 2.79 110.055 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.61 72.89 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.3 0.375 . . . . 1.75 111.596 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.08 7.77 4.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.399 -0.905 . . . . 0.46 112.952 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -123.13 145.26 48.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 1.74 111.261 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -129.72 132.15 46.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.067 -0.716 . . . . 0.79 109.067 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.79 144.81 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.478 0.18 . . . . 0.32 110.871 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 44.8 tt0 -156.8 143.11 18.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.986 -0.376 . . . . 0.7 109.986 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 53' ' ' LEU . 2.0 pt -142.07 -173.21 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.737 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.82 119.78 26.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.915 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 90' ' ' LEU . 29.5 m -116.76 157.78 24.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 0.37 110.641 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HD1' ' NE2' ' A' ' 54' ' ' GLN . 1.3 t80 -74.15 145.13 44.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.829 0.347 . . . . 1.02 110.226 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 8.97 4.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.312 -0.404 . . . . 1.13 111.599 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.55 88.34 7.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.305 -0.247 . . . . 1.13 110.797 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.5 44.35 24.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.508 -0.769 . . . . 0.7 112.091 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.89 149.24 8.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 0.33 110.188 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 90' ' ' LEU . 3.9 t 68.81 23.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.41 0.624 . . . . 0.14 110.459 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.404 0 CA-C-N 115.898 -0.592 . . . . 0.17 113.292 178.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.968 -0.753 . . . . 0.64 108.968 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.41 138.79 58.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.81 0.338 . . . . 0.52 111.284 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 52' ' ' VAL . 6.0 mp -68.23 -24.45 64.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.981 -0.554 . . . . 0.52 110.229 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.26 -27.28 68.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.373 0.606 . . . . 1.14 109.946 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 17.65 19.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 1.48 111.161 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.3 p -125.12 -9.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.347 . . . . 0.24 111.087 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 31' ' ' ILE . 1.9 mm? -96.24 110.07 22.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.333 -0.394 . . . . 0.39 110.35 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.532 ' NE2' ' HD1' ' A' ' 34' ' ' TYR . 17.1 mt-30 -70.52 -35.81 73.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 2.38 110.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -122.11 164.37 17.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.748 -0.66 . . . . 0.85 110.458 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -125.19 18.05 8.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.947 -0.569 . . . . 0.83 109.629 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -116.39 118.49 32.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.462 -0.79 . . . . 0.58 110.164 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 68' ' ' ALA . 8.0 p -100.95 143.14 14.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.239 -0.437 . . . . 0.31 110.227 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -83.97 157.5 21.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.629 0.252 . . . . 0.22 111.087 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 83.3 t -117.8 -49.48 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.482 0.658 . . . . 0.4 109.539 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -144.15 111.37 5.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.815 . . . . 0.72 108.955 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.5 -37.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.006 0.373 . . . . 0.36 112.006 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -31.17 72.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.933 0.397 . . . . 0.51 111.142 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -100.96 -1.85 33.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.91 111.242 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.84 48.13 83.42 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.96 -0.638 . . . . 0.38 112.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -106.6 123.65 48.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.794 0.331 . . . . 0.58 111.231 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.76 139.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.736 -0.666 . . . . 0.08 109.537 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.93 128.13 36.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.12 111.653 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -91.33 -172.33 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.362 -0.607 . . . . 0.4 109.362 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -63.27 -30.74 71.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.758 0.314 . . . . 0.31 111.004 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.1 pm0 -79.62 -24.82 41.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 1.19 110.973 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.19 -51.95 15.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.424 -0.353 . . . . 1.81 110.288 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.43 -32.78 74.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.25 110.935 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -66.8 -23.53 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.961 0.41 . . . . 0.72 110.237 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -100.93 -5.81 25.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.65 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.18 -40.27 7.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.33 110.763 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.97 -34.51 6.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.38 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.01 -10.02 29.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.032 -0.604 . . . . 0.31 111.926 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 147.09 44.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.476 0.179 . . . . 0.93 110.523 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -96.69 -8.91 30.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.809 0.338 . . . . 0.86 111.02 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 85' ' ' ILE . 56.0 t0 -73.84 110.78 8.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.168 -0.469 . . . . 0.99 110.099 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -62.07 -27.86 69.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.851 -0.613 . . . . 0.64 110.882 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -34.39 77.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.66 110.538 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.96 -29.27 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 81' ' ' ASP . 39.7 mm -67.28 -46.32 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 p -71.1 -24.08 62.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.27 110.349 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -59.9 -41.83 92.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.215 0.531 . . . . 0.76 109.718 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.04 -49.67 55.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.411 -0.813 . . . . 0.35 110.726 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG22 HG22 ' A' ' 20' ' ' VAL . 33.2 mt -61.76 -35.12 65.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.25 112.245 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 33' ' ' CYS . 3.7 mm? -82.77 -11.31 58.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.247 0.832 . . . . 0.08 113.247 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -122.98 -10.1 8.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.151 -0.62 . . . . 0.14 112.389 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -121.94 -5.26 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.733 0.302 . . . . 0.16 110.827 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.8 -169.33 19.26 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.547 -0.835 . . . . 0.14 113.067 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.29 107.44 18.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.702 -0.481 . . . . 0.99 109.702 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 97' ' ' VAL . 2.2 p -106.28 138.52 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.2 110.456 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.26 89.39 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 1.22 111.021 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.45 . . . . 1.06 111.033 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.1 tt . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 119.841 -0.123 . . . . 0.31 110.989 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 41.16 51.53 3.43 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.686 0.616 . . . . 0.83 111.7 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -114.01 94.59 4.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 0.82 111.406 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 139.29 30.79 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.629 . . . . 0.51 109.887 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.66 83.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.792 0.33 . . . . 0.47 110.533 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 60.75 54.45 3.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.743 -0.662 . . . . 1.09 111.405 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -15.43 63.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.6 111.818 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -101.48 15.95 27.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 1.27 111.007 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -119.23 -125.2 0.28 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.907 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.77 79.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.84 111.023 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -21.94 60.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.922 -0.581 . . . . 0.58 112.52 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 9.7 29.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.369 . . . . 1.19 111.168 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -128.98 -44.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 1.36 110.154 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -71.56 -6.02 37.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.814 -0.63 . . . . 1.26 111.22 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -36.82 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.38 110.8 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.91 -39.21 76.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.9 110.693 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 12.2 mp0 -64.99 -46.17 82.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.049 -0.523 . . . . 0.82 111.147 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.26 -44.18 80.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 111.971 0.36 . . . . 0.45 111.971 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.16 -29.59 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.874 0.324 . . . . 0.79 111.874 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -97.21 -12.84 22.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.591 0.234 . . . . 0.95 111.188 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 3.9 tp-100 -68.15 -43.61 77.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.662 -0.496 . . . . 0.32 109.662 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.36 -32.12 73.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.27 109.903 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -67.93 -21.89 65.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.555 -0.748 . . . . 0.97 110.391 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.6 -32.85 60.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.43 110.271 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -52.82 7.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.82 -0.807 . . . . 1.42 108.82 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mtp -131.59 112.45 12.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.944 -0.761 . . . . 1.04 108.944 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -73.52 81.23 1.46 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 1.23 111.75 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.562 -0.744 . . . . 0.26 109.76 178.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.943 0.401 . . . . 0.74 111.33 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.441 ' HA ' ' HG ' ' A' ' 213' ' ' LEU . 25.3 mtp180 -84.08 147.99 27.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 1.24 111.153 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -129.45 175.64 8.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.32 110.567 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.86 167.38 21.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.83 109.826 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.3 t80 -123.67 143.08 50.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.636 -0.256 . . . . 0.26 110.691 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.6 pt -133.28 115.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.025 0.44 . . . . 0.27 110.548 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 184' ' ' GLU . 2.3 pt? -155.84 155.63 29.63 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.028 -0.533 . . . . 0.11 110.238 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.95 161.44 33.07 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.994 2.463 . . . . 0.17 113.27 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' HD23 ' A' ' 208' ' ' LEU . 27.8 t -57.65 -35.53 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.607 -0.724 . . . . 0.45 111.89 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.31 -39.78 61.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.34 111.998 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 49.6 mm-40 -104.46 -17.74 14.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.988 0.423 . . . . 0.46 110.529 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.31 -34.6 88.78 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.171 -0.538 . . . . 0.24 112.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 30.6 ttpt -71.62 -7.55 48.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.928 0.394 . . . . 0.68 111.098 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -84.15 -58.26 2.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.679 0.276 . . . . 0.62 110.704 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -25.66 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.8 111.21 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.52 -37.21 85.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.837 0.351 . . . . 1.08 110.723 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 13.7 mm-40 -90.99 11.23 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.396 -0.366 . . . . 0.76 110.684 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -121.1 -49.24 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.806 0.299 . . . . 0.64 111.806 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.09 -36.73 35.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.109 0.781 . . . . 0.3 113.109 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 24.8 mtpp -60.93 -50.98 82.54 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 112.228 0.455 . . . . 0.22 112.228 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 21.3 Cg_endo -61.43 -19.58 64.93 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.147 1.898 . . . . 0.23 112.609 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.95 -13.02 58.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.349 . . . . 0.24 110.141 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.1 mt 55.22 59.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.49 -0.777 . . . . 0.46 110.371 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 21.37 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.33 -0.85 . . . . 0.39 109.783 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 212' ' ' CYS . 19.5 m -120.81 149.51 23.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.34 110.416 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.66 149.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.374 -0.602 . . . . 0.25 109.374 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -73.45 70.01 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 1.36 111.005 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.0 m -151.85 37.03 0.56 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.743 -0.662 . . . . 0.81 109.397 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.1 pt-20 -88.08 175.25 7.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.798 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' ' 208' ' ' LEU . 23.3 t70 -132.96 146.81 52.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.4 109.341 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.35 25.88 9.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.431 0.16 . . . . 0.97 111.431 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.21 -141.88 7.85 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.786 -0.721 . . . . 0.68 112.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -74.42 -17.51 60.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.179 0.514 . . . . 1.78 110.642 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 121.38 34.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.699 -0.682 . . . . 1.55 109.61 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 182' ' ' VAL . 4.1 mm? -80.71 85.8 6.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.127 0.489 . . . . 0.54 110.369 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 25.4 tt0 -76.72 93.61 3.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.817 -0.629 . . . . 1.04 110.048 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.2 127.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.514 . . . . 0.32 110.652 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.51 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.855 0.359 . . . . 0.22 110.361 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.8 p -124.51 104.68 8.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.29 110.898 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -164.35 127.37 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.313 -0.625 . . . . 0.21 109.313 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.03 -163.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.634 -0.257 . . . . 0.23 111.546 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -49.05 148.96 3.66 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.529 -0.76 . . . . 0.77 112.388 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.86 -50.09 14.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.134 2.556 . . . . 0.41 113.071 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.08 -57.3 8.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.47 112.657 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 51.4 m -55.88 -36.6 67.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.239 0.459 . . . . 0.48 112.239 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.93 -39.75 90.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.096 -0.642 . . . . 0.74 110.609 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -70.89 -8.14 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 1.7 110.647 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.46 -22.67 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.755 -0.657 . . . . 1.25 110.571 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 226' ' ' ILE . 7.6 tp -108.69 -29.11 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.459 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 33.9 t70 -61.37 -21.09 63.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.873 0.368 . . . . 0.76 111.104 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -26.32 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.86 111.114 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 228' ' ' LYS . 0.7 OUTLIER -114.02 -25.53 8.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.575 -0.284 . . . . 0.77 110.571 178.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.5 mm -66.51 -33.24 62.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.666 0.27 . . . . 0.79 110.979 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.96 -35.88 77.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.391 . . . . 0.98 110.782 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.55 11.21 39.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.239 0.543 . . . . 0.86 110.011 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -102.21 -65.77 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.45 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -121.57 -30.1 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 0.7 111.803 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -61.12 -33.05 72.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.161 0.505 . . . . 1.0 110.704 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.36 22.82 37.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.71 110.974 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -118.66 -57.43 2.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.882 0.372 . . . . 1.39 110.4 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.08 -136.08 5.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 0.4 112.806 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.7 m -132.59 148.85 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.39 110.621 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.68 160.29 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.913 0.387 . . . . 0.53 111.078 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -144.97 157.34 44.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.2 -0.667 . . . . 0.41 109.2 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.11 148.34 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.3 110.919 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.299 0.571 . . . . 1.07 109.818 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.22 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t30 65.09 18.4 11.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.624 -0.716 . . . . 0.46 112.383 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.89 -3.0 52.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.068 -0.345 . . . . 1.09 110.068 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mt 55.1 68.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.568 -0.742 . . . . 0.36 110.922 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -136.37 166.86 22.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.729 -0.669 . . . . 0.26 109.5 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -75.78 53.52 0.74 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.977 0.418 . . . . 0.67 110.634 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -123.41 -44.83 2.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.991 -0.549 . . . . 0.71 111.554 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -112.05 23.51 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 1.9 110.593 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m -74.41 137.42 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.49 112.256 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -91.78 140.26 29.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.614 -0.721 . . . . 0.6 110.205 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.07 130.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.186 0.517 . . . . 0.45 111.872 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 89' ' ' ILE . 5.7 p -150.13 126.4 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.574 -0.739 . . . . 0.18 109.024 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -132.86 141.7 48.55 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.655 0.613 . . . . 1.73 112.655 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttp -113.65 108.71 17.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.166 -0.925 . . . . 0.21 108.806 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -86.94 99.34 11.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.11 111.248 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -96.13 167.01 11.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.89 109.926 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.16 73.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.362 -0.381 . . . . 0.5 111.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.87 -50.78 6.22 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.95 -0.643 . . . . 0.6 112.521 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -161.81 147.43 13.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.777 -0.453 . . . . 0.48 109.777 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -92.39 143.87 25.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.671 -0.492 . . . . 1.32 109.671 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.34 132.36 42.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.538 -0.301 . . . . 0.32 111.024 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 21' ' ' ARG . 22.8 tt0 -124.4 134.87 52.99 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.459 -0.571 . . . . 1.48 109.459 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.37 145.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.404 . . . . 0.34 111.151 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.777 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -106.37 112.77 25.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.479 -0.563 . . . . 0.32 109.479 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.1 168.05 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 0.88 111.835 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.475 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 22.3 t80 -73.26 117.68 15.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.762 -0.654 . . . . 1.1 109.854 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 27.8 ttpt -79.83 82.39 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.398 0.618 . . . . 1.98 111.707 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.67 75.5 0.78 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.098 -0.955 . . . . 0.65 108.452 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.69 36.19 2.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.956 -1.02 . . . . 1.08 109.837 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.18 -40.55 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.493 -0.776 . . . . 0.35 110.908 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.58 2.27 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.33 110.605 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 111.217 -0.753 . . . . 0.27 111.217 179.623 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 110.094 -0.336 . . . . 0.43 110.094 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.72 143.77 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.137 -0.32 . . . . 0.29 110.137 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.91 -24.88 67.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.24 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -57.83 -37.17 73.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.943 0.401 . . . . 0.38 110.772 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -83.77 -19.61 34.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.972 -0.558 . . . . 1.46 110.798 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.07 -25.47 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.36 110.938 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 55' ' ' THR . 2.4 mm? -74.76 99.83 3.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.4 110.921 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 34' ' ' TYR . 29.2 mt-30 -77.34 -24.48 50.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.671 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.443 ' O ' HD12 ' A' ' 53' ' ' LEU . 12.6 t -130.63 152.01 50.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.46 109.808 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -112.53 7.87 19.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.071 0.462 . . . . 0.39 110.4 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -110.23 145.59 37.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.016 -0.538 . . . . 0.18 109.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 68' ' ' ALA . 11.6 p -112.04 139.8 34.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 0.15 110.934 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -78.01 151.47 33.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.89 111.547 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 54.9 t -129.48 -59.34 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.499 -0.319 . . . . 0.61 111.636 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -123.68 126.67 46.99 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.456 -0.152 . . . . 0.63 110.825 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.17 -26.36 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 111.957 0.355 . . . . 0.95 111.957 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.7 m -72.02 -47.06 54.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.192 0.52 . . . . 0.77 110.207 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.47 -22.27 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.44 110.2 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 44.58 36.6 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 0.46 111.374 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -108.02 124.1 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.083 0.468 . . . . 1.16 111.068 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.01 145.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.471 -0.786 . . . . 0.43 109.606 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 72' ' ' ASP . . . -97.51 126.76 42.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.18 110.838 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -97.21 -171.53 2.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.653 -0.703 . . . . 1.11 110.112 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -51.28 -40.21 58.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.699 0.629 . . . . 1.07 112.699 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -62.15 -26.7 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.692 0.627 . . . . 0.47 112.692 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 17.2 t70 -94.17 -44.71 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.682 -0.407 . . . . 0.25 111.751 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.31 -34.69 75.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.929 -0.309 . . . . 0.26 111.827 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.11 -25.67 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.8 110.736 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 m -94.58 -43.03 8.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.16 111.387 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.09 -46.43 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.16 112.088 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -94.07 -29.75 15.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.94 110.689 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 16.19 54.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.466 -0.874 . . . . 0.8 112.184 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.5 m -145.94 124.56 12.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.19 -0.3 . . . . 1.51 110.19 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.29 60.68 5.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.433 0.635 . . . . 1.16 110.41 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.457 ' OD2' ' HB ' ' A' ' 83' ' ' THR . 19.6 t70 -151.97 111.84 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.728 -0.669 . . . . 2.41 109.986 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -68.33 -24.66 64.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.511 . . . . 1.51 111.218 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.457 ' HB ' ' OD2' ' A' ' 81' ' ' ASP . 11.6 m -66.82 -45.76 77.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.58 110.228 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -58.89 -46.54 87.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.67 110.402 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.96 -48.23 87.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.553 -0.749 . . . . 0.35 110.596 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.2 -34.6 75.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.16 110.895 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -62.01 -42.21 98.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 0.33 110.14 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.55 -40.37 84.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.28 110.002 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.558 HG22 HG22 ' A' ' 20' ' ' VAL . 76.3 mt -68.87 -30.89 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.617 -0.719 . . . . 0.12 111.004 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -18.79 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.398 -0.365 . . . . 0.16 111.69 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -105.7 -15.47 14.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.59 -0.444 . . . . 0.2 112.075 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -142.05 36.48 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 2.1 111.164 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.47 165.83 24.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.529 -0.843 . . . . 0.4 112.587 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 80.1 mt-10 -82.01 93.49 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 1.41 110.246 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.01 137.24 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.338 -0.392 . . . . 0.22 110.227 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -73.31 76.05 1.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.202 0.525 . . . . 0.58 111.77 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.36 111.298 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 144' ' ' TYR . 8.6 mt . . . . . 0 C--O 1.232 0.178 0 N-CA-C 111.422 0.156 . . . . 0.4 111.422 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.3 t60 75.06 -24.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.865 0.728 . . . . 1.31 111.674 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 142' ' ' ILE . 29.8 t80 -70.86 135.06 47.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.165 -0.309 . . . . 1.3 110.165 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 170.38 10.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.426 -0.352 . . . . 0.18 110.665 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.408 HG13 HG21 ' A' ' 159' ' ' VAL . 2.8 t -87.21 48.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.25 110.536 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 52.41 30.23 7.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.33 111.341 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 148' ' ' THR . 14.6 t 42.33 73.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.341 1.056 . . . . 0.74 112.497 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p30 51.37 18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.705 1.202 . . . . 0.55 114.114 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.05 140.47 48.43 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.97 -0.456 . . . . 1.43 111.046 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.4 m 62.57 38.96 11.98 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.13 110.915 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -63.93 -33.82 76.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.775 -0.648 . . . . 0.72 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.94 4.07 31.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.855 0.359 . . . . 0.87 110.95 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -105.16 -54.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.26 110.834 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' A' ' 159' ' ' VAL . 6.7 mp0 -94.91 16.75 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 0.6 111.935 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -57.69 -42.8 84.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.894 0.378 . . . . 0.3 111.133 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.37 3.16 32.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.66 111.881 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -111.46 -48.64 3.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 1.15 110.798 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 155' ' ' GLN . 58.5 t -64.65 -39.21 84.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 0.08 110.863 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 164' ' ' LYS . 7.5 tt -68.22 -9.86 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.189 -0.46 . . . . 0.27 111.356 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -102.67 -35.46 8.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.822 -0.436 . . . . 1.27 109.822 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -57.37 -56.61 19.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.342 -0.845 . . . . 0.7 111.778 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -72.41 -21.76 61.21 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.68 -0.408 . . . . 0.39 111.218 -178.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.574 ' N ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.02 -31.24 67.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.68 110.008 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.05 -32.91 73.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.653 -0.703 . . . . 1.03 109.87 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.43 -44.65 14.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.701 -0.681 . . . . 1.65 110.427 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.0 tpp -145.99 126.32 13.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.36 -0.382 . . . . 1.45 110.655 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -80.69 122.5 27.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.815 -0.439 . . . . 1.56 109.815 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.36 111.673 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 60.2 mtm . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 120.847 0.356 . . . . 2.37 111.226 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -76.42 133.0 39.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.802 -0.635 . . . . 0.67 110.466 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt -105.39 147.02 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.024 -0.535 . . . . 1.08 110.896 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 17.1 ptt180 -128.82 141.9 51.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.245 -0.65 . . . . 0.62 109.245 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.8 128.27 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.799 0.333 . . . . 0.22 110.754 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 30.8 pt -102.02 137.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 0.7 110.763 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.755 HD23 ' HD2' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -146.7 123.48 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.28 109.591 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.755 ' HD2' HD23 ' A' ' 180' ' ' LEU . 10.0 Cg_endo -52.26 142.77 45.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.552 2.168 . . . . 0.16 112.032 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.7 t -45.56 -37.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.153 0.581 . . . . 0.27 112.176 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -48.5 -40.61 27.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.912 -0.586 . . . . 0.41 112.151 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -117.93 7.23 12.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.01 0.433 . . . . 0.49 110.526 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.509 ' O ' HD23 ' A' ' 188' ' ' LEU . . . -66.57 -31.21 77.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.25 112.777 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 82.1 tttt -63.74 -29.02 70.28 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.69 -0.3 . . . . 1.48 111.28 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.76 -47.52 84.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.601 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -85.77 -22.04 27.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.857 0.36 . . . . 0.43 110.607 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -60.1 -52.15 66.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.971 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 11.3 pt-20 -89.27 22.25 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.9 111.253 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -121.38 -47.08 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.511 -0.313 . . . . 0.59 111.172 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 188' ' ' LEU . 8.5 mt -83.01 -39.14 21.66 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 53.2 mttm -59.89 -49.92 89.05 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.815 0.672 . . . . 1.16 112.815 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.0 Cg_endo -60.18 -19.77 58.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.135 1.89 . . . . 0.3 113.044 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 86.3 mt -79.09 -14.43 59.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.607 -0.269 . . . . 0.2 110.438 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.7 mm 56.22 41.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.801 0.81 . . . . 0.23 110.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -124.91 28.81 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.343 -0.844 . . . . 0.42 109.949 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.6 m -119.13 156.07 21.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.335 -0.848 . . . . 0.12 110.43 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.68 147.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.531 -0.544 . . . . 0.86 109.531 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.82 76.3 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 1.23 110.945 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.0 m -155.56 26.3 0.39 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 0.19 109.521 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 2.7 mp0 -80.37 162.61 24.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 1.79 111.641 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -109.16 143.26 38.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.903 -0.777 . . . . 1.6 108.903 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.75 37.94 3.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.6 110.69 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -99.74 -97.67 2.18 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.705 -0.759 . . . . 0.66 112.078 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -95.73 -22.32 17.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.158 0.504 . . . . 2.25 110.916 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.49 160.79 37.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.7 109.999 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.7 mm? -100.15 80.11 2.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.042 0.449 . . . . 0.39 110.101 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 47.2 tt0 -76.62 96.78 4.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.44 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 37.9 mm -96.95 139.55 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.866 0.365 . . . . 0.3 111.152 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.76 116.57 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.32 110.323 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.2 p -139.28 96.13 3.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.351 . . . . 0.71 110.676 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -164.44 136.66 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.495 -0.557 . . . . 0.76 109.495 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.16 -45.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.601 0.238 . . . . 0.82 111.191 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -168.92 158.16 7.66 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.564 -0.289 . . . . 0.9 110.235 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.54 -16.71 54.03 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.816 2.344 . . . . 0.57 113.197 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -71.06 -60.05 4.71 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.004 -0.617 . . . . 0.26 112.388 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.456 ' O ' HG12 ' A' ' 222' ' ' ILE . 2.2 m -79.0 -8.71 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.973 0.415 . . . . 0.34 110.847 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.19 -29.4 68.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.29 111.873 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -60.54 -50.61 72.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 0.48 111.065 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -77.86 2.27 17.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 1.24 111.608 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 28.2 mm -101.76 -55.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.878 0.371 . . . . 1.16 110.382 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 35.4 t70 -60.81 -26.08 67.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.36 111.813 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.5 -26.35 65.21 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.195 -0.457 . . . . 1.1 111.795 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.0 pp -106.65 -34.01 7.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.26 110.126 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.0 mm -55.78 -35.3 39.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.003 -0.544 . . . . 0.2 111.077 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 18.1 ptpt -53.32 -37.17 62.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.582 -0.735 . . . . 2.0 112.426 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -19.69 13.7 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.594 -0.443 . . . . 2.79 112.15 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.5 -41.07 48.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.213 0.449 . . . . 1.18 112.213 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.513 ' HB ' HD13 ' A' ' 188' ' ' LEU . 5.1 t -142.22 -32.52 0.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.257 0.836 . . . . 0.18 113.257 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 37.5 ttmt -57.75 -47.57 82.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.781 0.324 . . . . 0.82 111.462 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.03 10.72 71.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.965 -0.636 . . . . 0.23 112.404 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -112.32 -59.86 1.94 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.51 110.188 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -106.46 -119.15 4.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.21 111.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 7.9 m -143.67 150.69 39.09 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 122.703 -0.292 . . . . 0.48 110.574 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.7 pt? -109.83 142.98 40.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 1.5 111.045 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.84 -173.78 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.988 -0.551 . . . . 1.04 109.718 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.93 153.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.418 . . . . 0.24 111.772 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.9 109.724 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.004 0.431 . . . . 0.37 110.795 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -171.55 -59.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.93 109.566 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -128.08 -157.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.662 -0.699 . . . . 2.37 111.031 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -69.42 100.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.118 0.485 . . . . 0.67 111.099 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -136.25 134.56 38.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.631 -0.713 . . . . 1.53 109.744 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.6 mt -66.18 -4.76 8.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.167 0.432 . . . . 1.05 112.167 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -20.34 52.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.124 0.488 . . . . 0.37 111.069 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 48.6 m-80 -114.36 71.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.47 110.278 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.5 m -123.13 121.79 63.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.23 111.762 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.76 116.16 31.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.619 . . . . 0.36 109.327 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.56 109.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.104 0.478 . . . . 0.45 111.685 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 89' ' ' ILE . 6.6 p -105.92 129.44 59.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.541 -0.911 . . . . 0.37 108.541 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -125.72 125.4 42.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.372 -0.531 . . . . 0.61 112.095 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 89' ' ' ILE . 34.7 ttp -114.27 116.18 28.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.25 109.603 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 128.54 54.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 1.0 110.622 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -113.67 -156.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.617 -0.72 . . . . 1.24 109.501 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.86 -60.33 2.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.35 110.878 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.18 32.43 3.96 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.959 -0.639 . . . . 0.21 111.713 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.02 142.42 31.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.49 109.726 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.12 125.66 10.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.509 -0.314 . . . . 1.77 110.572 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -144.35 132.02 21.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.333 -0.394 . . . . 0.31 110.727 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.91 138.17 43.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.444 . . . . 0.68 110.424 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.708 HD11 HD12 ' A' ' 89' ' ' ILE . 1.1 mt -136.76 172.22 15.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.781 0.324 . . . . 1.15 110.656 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' H ' HG22 ' A' ' 31' ' ' ILE . . . -124.84 107.91 11.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.107 -0.497 . . . . 0.21 109.993 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 m -98.55 -161.84 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.2 110.077 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.57 -173.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.443 0.164 . . . . 1.03 110.624 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 23.1 tptt -74.47 -133.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.943 0.401 . . . . 0.86 111.499 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.69 6.21 0.24 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.091 0.774 . . . . 0.61 113.091 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 -15.0 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.222 -0.299 . . . . 0.81 110.913 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.23 -27.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.328 0.492 . . . . 0.26 112.328 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.83 101.43 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.223 0.535 . . . . 0.21 111.091 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.358 0 CA-C-N 115.291 -0.868 . . . . 0.24 112.574 179.609 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 111.771 0.286 . . . . 1.68 111.771 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.51 127.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.905 -0.405 . . . . 2.04 109.905 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.06 -24.35 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.225 -0.443 . . . . 0.65 111.669 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.63 -41.88 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.02 0.438 . . . . 1.98 110.587 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -78.31 -30.31 48.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 1.74 110.169 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.28 -33.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.2 110.143 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -88.28 84.88 6.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.184 -0.462 . . . . 0.2 110.458 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.0 -61.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.747 -0.661 . . . . 0.73 110.973 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.23 120.24 22.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.953 0.406 . . . . 0.13 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -99.03 5.96 46.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.322 -0.399 . . . . 0.69 110.683 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.25 114.75 28.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.895 -0.593 . . . . 0.28 110.072 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 68' ' ' ALA . 3.7 p -89.12 136.82 22.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.14 110.507 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -95.21 149.22 21.56 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.11 -0.33 . . . . 0.33 110.11 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.17 -45.39 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.458 0.647 . . . . 0.26 109.745 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -155.46 107.86 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.485 -0.78 . . . . 1.91 109.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.59 -28.98 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.59 . . . . 0.51 112.095 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.6 m -73.42 -16.7 61.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.876 0.369 . . . . 0.88 111.299 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -13.82 14.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.814 0.34 . . . . 0.64 110.45 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.77 75.78 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.15 111.751 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -87.24 112.04 21.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.981 0.419 . . . . 1.15 110.964 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 t -98.0 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.1 109.621 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.93 115.11 27.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.864 -0.421 . . . . 0.12 109.864 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.088 -0.506 . . . . 0.94 109.747 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -59.4 -30.23 68.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.098 0.475 . . . . 0.95 110.436 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.99 -19.68 54.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.623 -0.717 . . . . 2.32 110.899 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.57 -47.58 8.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.966 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 2.3 pp -67.02 -31.77 72.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.259 -0.428 . . . . 0.11 111.399 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.46 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.708 0.289 . . . . 0.74 111.384 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -91.38 -9.42 44.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.728 0.299 . . . . 0.9 111.663 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.42 -43.15 5.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.14 111.417 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -92.09 -37.5 12.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.49 -0.323 . . . . 0.27 110.75 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.03 -17.95 29.11 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.11 112.128 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 81' ' ' ASP . 3.7 m -116.53 142.22 47.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.917 -0.401 . . . . 0.21 109.917 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.65 2.38 48.64 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.98 0.419 . . . . 0.32 111.053 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 79' ' ' THR . 13.1 t70 -92.54 109.0 20.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.543 -0.54 . . . . 1.29 109.543 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -33.17 75.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 0.6 111.764 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.32 78.62 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.933 0.397 . . . . 0.45 111.114 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -36.9 83.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.746 -0.661 . . . . 1.94 110.487 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.8 mt -72.0 -41.56 68.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.16 110.328 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.28 -37.79 78.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.871 -0.604 . . . . 0.15 110.011 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -61.43 -42.6 99.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.415 -0.811 . . . . 1.08 110.409 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.68 -49.17 64.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.923 -0.58 . . . . 1.04 110.775 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.708 HD12 HD11 ' A' ' 31' ' ' ILE . 54.7 mt -57.88 -34.43 48.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.041 -0.527 . . . . 0.39 111.413 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -41.34 87.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.42 0.526 . . . . 0.26 112.42 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -96.84 -11.7 24.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.001 0.741 . . . . 0.51 113.001 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -106.6 -31.28 8.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.173 0.434 . . . . 0.97 112.173 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.56 -173.65 29.58 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.479 -0.867 . . . . 0.22 113.136 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -91.74 107.26 19.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.397 . . . . 1.88 110.978 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.02 134.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.803 -0.814 . . . . 0.58 108.803 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 96.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 1.48 111.491 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 0.82 110.245 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.7 mm . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.728 0.299 . . . . 0.59 110.651 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -132.78 15.56 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.541 . . . . 1.23 110.202 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.34 164.44 17.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.604 -0.726 . . . . 0.87 109.614 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -69.56 113.97 7.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.191 -0.3 . . . . 1.26 110.191 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.68 -49.32 81.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.998 -0.546 . . . . 0.28 110.253 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HB3' ' OD1' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -143.63 119.61 10.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.8 109.732 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -18.69 59.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.28 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 24.1 p-10 -84.63 -16.38 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.34 110.837 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -104.58 132.27 51.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.48 110.112 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.9 m -84.12 168.86 15.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.352 -0.385 . . . . 0.36 110.775 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -57.72 -36.58 72.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.48 111.708 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -79.48 5.58 12.49 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 1.39 112.098 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -111.15 -56.35 2.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.801 0.334 . . . . 0.41 111.116 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 159' ' ' VAL . 8.4 pt20 -99.25 27.92 4.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.479 -0.328 . . . . 0.6 111.55 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.13 -48.68 70.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.18 112.092 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.79 -30.84 64.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.352 -0.385 . . . . 0.28 111.022 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.001 -0.28 . . . . 1.65 110.437 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 155' ' ' GLN . 52.4 t -63.33 -52.9 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.371 -0.377 . . . . 0.46 110.595 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.9 -32.24 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.345 -0.389 . . . . 0.47 110.984 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -70.54 -35.11 72.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 1.54 110.244 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -65.52 -35.46 80.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.221 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.18 -37.6 81.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.344 0.592 . . . . 0.35 109.514 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -69.79 -33.32 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.163 -0.926 . . . . 1.52 111.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 -27.56 64.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.885 0.374 . . . . 1.28 110.752 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -81.12 -47.21 13.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.3 tpt -134.13 99.39 4.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.403 -0.591 . . . . 1.08 109.403 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 113.06 5.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.74 111.151 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.453 -0.794 . . . . 0.48 110.521 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 18.1 ptt? . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.756 0.312 . . . . 0.35 110.592 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.97 137.81 49.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 1.04 110.451 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 32.2 mt -118.26 149.67 40.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.614 -0.513 . . . . 1.02 109.614 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 209' ' ' GLU . 16.1 ttp180 -110.67 136.78 49.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.386 -0.37 . . . . 1.12 110.27 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 52.6 m-85 -99.65 137.94 37.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.22 110.381 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -126.31 128.05 71.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.19 110.581 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -167.63 155.51 8.35 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.14 110.614 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.97 160.02 35.64 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.853 2.369 . . . . 0.22 112.732 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.5 t -57.94 -37.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.251 -0.431 . . . . 0.23 111.315 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -51.4 -38.77 55.16 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.65 111.748 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 0.7 OUTLIER -102.05 -26.79 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.69 111.282 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.51 -34.24 87.7 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 116.054 -0.521 . . . . 0.17 113.61 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -61.69 -25.88 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.723 -0.281 . . . . 1.19 111.596 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.526 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 13.4 mptt -62.35 -41.85 98.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.978 0.418 . . . . 0.78 110.874 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 1.1 pp -87.75 -30.32 20.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.433 -0.348 . . . . 0.3 111.133 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.33 -31.96 71.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.88 111.675 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -86.62 -7.57 58.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.616 0.599 . . . . 1.71 112.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 26.1 mtmt -122.7 -29.89 3.95 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.129 0.788 . . . . 1.16 113.129 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -87.18 -32.82 19.62 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.164 0.431 . . . . 0.63 112.164 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 2.1 mtpt -72.55 -43.45 9.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.142 0.793 . . . . 1.13 113.142 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 11.0 Cg_endo -54.31 -34.63 80.96 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 122.415 2.077 . . . . 0.54 113.642 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -92.73 13.75 19.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.772 -0.371 . . . . 0.61 111.462 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 18.6 pt 33.22 56.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.435 1.094 . . . . 0.87 113.897 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -109.98 16.71 21.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.95 109.773 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.41 152.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.376 -0.829 . . . . 0.6 110.769 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 4.6 mp -84.89 144.8 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.347 -0.612 . . . . 0.59 109.347 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -72.43 74.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.405 0.621 . . . . 2.46 111.029 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 m -157.07 27.04 0.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.296 -0.865 . . . . 1.45 109.146 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.2 OUTLIER -82.23 137.98 34.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.768 -0.651 . . . . 1.27 111.342 -178.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.04 117.34 33.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.457 -0.571 . . . . 0.58 109.457 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -98.62 59.2 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.983 0.42 . . . . 0.66 111.342 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -109.24 -127.74 5.52 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.417 -0.896 . . . . 0.35 111.684 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.06 -28.6 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 1.3 109.458 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -118.62 117.97 30.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.805 -1.089 . . . . 1.23 108.405 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mp -80.42 79.09 7.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.126 0.489 . . . . 0.29 111.093 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 6.0 tt0 -86.25 106.23 17.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.561 -0.745 . . . . 0.98 109.201 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 202' ' ' GLU . 8.0 mt -120.62 146.9 24.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.939 -0.573 . . . . 0.34 111.089 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER -104.22 122.27 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.804 -0.443 . . . . 0.68 109.804 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.563 ' O ' HD22 ' A' ' 213' ' ' LEU . 12.8 t -144.39 79.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.643 -0.423 . . . . 0.16 111.717 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 212' ' ' CYS . 0.6 OUTLIER -140.39 116.08 10.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 215' ' ' ASP . 11.3 tt -94.12 172.76 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 0.68 111.432 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -58.01 168.89 1.02 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.612 0.765 . . . . 0.58 111.513 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 41.3 Cg_endo -66.68 -172.66 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.271 1.981 . . . . 0.37 112.875 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.03 -75.04 1.94 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.656 -0.783 . . . . 0.23 111.435 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.96 -1.91 55.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.063 0.459 . . . . 1.11 110.581 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.07 -26.78 67.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.548 . . . . 0.25 111.449 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -80.2 -32.66 38.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.412 . . . . 1.82 110.526 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -72.51 -36.12 68.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.42 110.594 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 13.3 tt -79.32 -26.16 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.37 110.849 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.85 -32.22 70.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.325 -0.398 . . . . 0.75 110.88 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.63 -35.47 68.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.08 111.778 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.9 pp -95.02 -37.3 11.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.773 -0.371 . . . . 0.57 110.889 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 33.5 mm -58.22 -39.87 75.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.718 0.294 . . . . 0.36 111.308 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -63.98 -20.15 65.67 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.798 0.666 . . . . 1.09 112.798 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.96 5.06 11.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.745 -0.382 . . . . 1.73 111.841 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 1.0 OUTLIER -108.38 -73.39 0.69 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.846 0.355 . . . . 0.96 111.207 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -100.81 -34.95 9.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.077 0.399 . . . . 0.32 112.077 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 61.4 tttm -77.54 -23.88 50.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.02 110.598 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.48 -8.44 62.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.25 112.044 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -113.46 -7.01 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.41 111.292 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -157.99 179.19 33.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.168 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 t -91.91 162.94 14.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.784 -0.45 . . . . 0.33 109.784 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.51 144.83 44.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.797 0.332 . . . . 0.86 110.912 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -140.63 176.49 8.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.885 -0.598 . . . . 1.85 109.987 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.39 145.3 11.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.044 0.45 . . . . 0.57 111.17 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.3 tp . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.368 0.604 . . . . 1.56 110.522 179.633 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.962 0 N-CA-C 111.83 -0.508 . . . . 0.57 111.83 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.3 p80 42.35 44.51 3.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.746 0.818 . . . . 0.8 112.281 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.7 tpp -137.97 -61.11 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.08 110.044 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.0 t -100.05 141.9 32.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.34 109.629 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 pt -89.27 -31.63 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.976 -0.29 . . . . 0.83 111.151 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -73.93 100.48 3.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.932 0.396 . . . . 0.74 110.702 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.17 81.09 32.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.52 110.292 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.09 141.98 19.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.848 2.366 . . . . 0.45 112.449 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.01 133.84 35.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.863 0.364 . . . . 0.93 110.981 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -155.24 171.15 20.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.881 -0.785 . . . . 0.64 108.881 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -78.9 -56.65 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.578 0.227 . . . . 1.61 111.518 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.26 90.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 0.38 111.099 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.2 mmt-85 -148.1 149.77 32.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.474 -0.33 . . . . 1.56 110.213 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.69 -6.32 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.984 0.421 . . . . 1.12 111.371 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -11.14 45.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.57 110.716 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -119.15 25.57 10.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.012 -0.54 . . . . 0.2 111.354 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 30.7 m -90.63 151.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.167 0.508 . . . . 0.21 111.843 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.88 139.15 42.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.323 -0.853 . . . . 0.15 109.342 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 46.0 t -80.13 120.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.906 0.384 . . . . 0.51 111.306 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 31' ' ' ILE . 2.4 p -149.75 131.08 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 0.15 109.572 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.7 ptt180 -148.67 148.58 30.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.835 0.35 . . . . 0.4 111.767 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 40.4 ttp -108.1 129.85 55.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.128 -0.487 . . . . 0.22 110.095 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.06 114.16 25.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.062 -0.517 . . . . 1.38 110.148 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.6 175.37 6.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 1.3 109.541 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.67 92.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.704 0.288 . . . . 0.4 111.002 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.68 42.95 1.28 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.68 -0.772 . . . . 0.16 112.911 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -173.61 162.24 4.11 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.79 0.295 . . . . 1.93 110.769 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 39.4 mmt180 -126.57 147.58 49.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 1.57 109.576 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -139.9 94.14 2.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.982 -0.377 . . . . 0.23 109.982 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 16.7 mt-10 -104.46 129.6 52.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.539 -0.3 . . . . 1.25 110.343 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 HG13 ' A' ' 20' ' ' VAL . 29.9 pt -131.48 -179.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.12 111.12 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -139.6 114.38 9.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.11 111.015 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.63 179.45 3.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 0.08 110.344 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.572 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.69 139.82 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.25 110.77 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.75 -5.08 52.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.2 112.241 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.43 78.2 4.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.573 0.225 . . . . 0.3 110.861 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 tttp 50.97 60.43 3.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.656 -0.702 . . . . 1.56 110.389 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.4 p -57.15 -32.92 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.412 -0.813 . . . . 0.32 112.529 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -83.47 5.02 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.182 0.515 . . . . 0.16 111.409 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.12 -31.84 80.31 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 116.056 -0.52 . . . . 0.23 113.607 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.475 ' CH2' ' HG3' ' A' ' 87' ' ' LYS . 47.5 p-90 -63.88 -25.04 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.869 0.335 . . . . 0.24 111.78 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 42' ' ' ARG . 1.9 tpt180 -80.75 -2.36 46.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.718 0.294 . . . . 0.47 111.401 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -131.57 1.56 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.623 -0.262 . . . . 1.13 111.072 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 40.03 42.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.879 -0.677 . . . . 0.34 112.623 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.61 13.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.44 110.349 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 41' ' ' TRP . 0.8 OUTLIER -93.24 179.99 5.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 1.31 110.855 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -116.26 -19.83 10.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.225 0.536 . . . . 0.44 110.114 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -175.49 -177.54 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.304 -0.862 . . . . 0.51 108.675 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.96 30.05 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 2.03 110.773 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -120.63 -54.78 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 1.32 110.502 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.55 -17.29 63.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 1.2 110.644 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.84 -18.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.47 0.652 . . . . 0.46 109.728 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.78 99.48 12.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.23 109.733 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -68.36 -48.92 63.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.25 111.159 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -127.0 151.1 49.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.549 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -106.56 16.55 24.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.338 0.59 . . . . 0.51 109.715 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.6 127.39 53.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.731 . . . . 0.47 110.204 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -108.41 138.41 35.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.067 0.46 . . . . 0.06 110.444 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -95.69 130.49 42.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.266 -0.424 . . . . 0.29 110.538 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 10.3 t -86.13 -17.98 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.347 0.594 . . . . 0.17 109.752 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -177.94 105.13 0.05 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.201 -0.909 . . . . 0.72 109.717 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.52 -19.94 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.428 0.529 . . . . 0.1 112.428 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -36.66 73.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.975 0.417 . . . . 1.14 110.812 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -91.25 -36.53 13.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.63 110.223 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.04 38.87 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.885 -0.674 . . . . 0.36 111.801 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.47 104.49 16.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.72 0.295 . . . . 2.02 110.553 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.0 t -92.85 116.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.548 -0.538 . . . . 0.39 109.548 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -82.7 124.44 30.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.111 0.482 . . . . 0.18 111.52 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.569 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 6.8 ptpp? -87.85 -175.64 5.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.62 109.294 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HG3' ' OE2' ' A' ' 71' ' ' GLU . 11.7 pttm -60.61 -27.15 67.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 8.3 mp0 -78.86 -32.43 46.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.222 0.534 . . . . 1.47 110.245 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 51.0 m-20 -68.72 -50.09 53.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.26 110.74 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.89 -29.27 70.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.956 -0.298 . . . . 0.13 111.205 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -71.26 -22.97 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.089 0.471 . . . . 0.91 109.969 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 m -95.33 -44.98 7.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.045 0.45 . . . . 0.4 110.917 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.26 58.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 0.28 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.72 -51.59 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.078 -0.341 . . . . 1.23 110.078 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.21 16.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.722 -0.751 . . . . 0.28 112.054 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 81' ' ' ASP . 5.2 m -125.09 137.85 54.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.163 -0.31 . . . . 0.89 110.163 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.15 -11.54 57.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.503 -0.317 . . . . 0.41 111.525 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -85.42 117.82 24.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.68 110.705 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.96 -31.08 68.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.18 111.256 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.36 -47.63 75.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.625 0.25 . . . . 0.54 111.471 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.12 -51.07 71.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.998 0.428 . . . . 1.7 110.788 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mt -61.0 -51.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.648 -0.706 . . . . 0.18 111.169 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 99.9 m -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.18 111.152 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 27.4 ttpp -62.22 -42.08 98.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.491 -0.322 . . . . 0.67 110.432 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.69 -43.33 89.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.21 110.134 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 86.1 mt -62.85 -32.57 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.305 0.574 . . . . 0.15 110.82 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HG22 ' A' ' 38' ' ' VAL . 1.3 mm? -74.95 -32.05 61.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.818 -0.628 . . . . 0.12 112.61 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 92' ' ' LYS . 15.1 t -100.57 -13.54 18.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.789 0.662 . . . . 0.22 112.789 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 91' ' ' THR . 32.7 mmmt -129.27 25.38 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.375 -0.203 . . . . 0.96 111.015 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -132.72 -175.98 14.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.032 -1.08 . . . . 0.15 113.64 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -83.4 76.52 9.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.234 0.54 . . . . 1.74 109.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.99 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.624 -0.717 . . . . 0.69 110.91 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.9 mm-40 -72.78 105.72 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.738 -0.467 . . . . 0.59 109.738 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.19 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.45 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.652 ' HB3' ' O ' ' A' ' 101' ' ' GLU . 1.3 m -79.79 115.28 19.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.82 110.809 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -94.71 -25.75 16.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.269 -0.423 . . . . 1.35 111.055 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -128.24 -72.85 0.6 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.412 -0.358 . . . . 1.58 110.469 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.652 ' O ' ' HB3' ' A' ' 98' ' ' SER . 56.0 mm-40 -75.94 127.18 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.154 -0.475 . . . . 1.39 110.085 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.75 62.29 7.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.171 -0.468 . . . . 1.83 110.842 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -146.39 -179.78 6.99 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.33 -0.618 . . . . 0.26 109.33 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.56 -142.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.164 0.29 . . . . 0.4 110.606 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 76.19 1.95 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.166 0.508 . . . . 0.96 110.333 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 107' ' ' GLU . 4.7 tp -165.01 -172.06 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.446 -0.797 . . . . 0.63 109.301 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 19.0 mm-40 58.74 28.0 16.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.425 0.453 . . . . 0.82 111.81 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 63.54 25.96 14.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.212 -0.449 . . . . 1.69 111.507 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.6 tpt -65.43 -22.53 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 1.69 111.206 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -70.93 -25.0 62.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.884 0.373 . . . . 0.35 110.476 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -80.66 -17.52 50.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.8 110.305 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.55 -57.27 12.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.895 -0.593 . . . . 0.78 110.217 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.58 -29.16 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.53 110.145 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -65.66 -30.34 71.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.786 -0.643 . . . . 0.18 110.567 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -71.47 -38.0 71.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.96 110.07 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.73 -39.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.739 -0.664 . . . . 1.14 111.248 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 114' ' ' ALA . 9.2 p -77.46 -22.58 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.412 -0.358 . . . . 0.25 111.438 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -56.28 23.96 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.807 0.299 . . . . 0.57 111.807 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 2.7 m-20 -66.94 -16.75 64.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 2.28 111.624 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' A' ' 215' ' ' ASP . 3.9 ttmm -84.26 -8.64 58.98 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.3 m -132.65 156.26 47.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.927 0.394 . . . . 0.61 111.129 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 60.8 t -111.57 128.2 68.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.76 -0.459 . . . . 1.54 109.76 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -93.53 149.67 37.61 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.396 -0.366 . . . . 0.52 110.591 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.27 172.1 14.74 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.182 1.921 . . . . 0.19 111.138 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 126' ' ' THR . 1.7 pt-20 -49.94 116.44 1.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.929 0.395 . . . . 1.11 111.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 1.6 t 176.23 -26.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.44 -0.8 . . . . 0.34 109.822 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm 175.83 -176.67 0.11 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.802 -0.814 . . . . 1.15 108.802 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 128' ' ' ARG . 19.7 mtt180 -91.55 155.41 43.96 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.528 -0.175 . . . . 0.45 110.528 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.8 -7.5 7.66 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.212 2.608 . . . . 0.35 113.75 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.13 -14.87 61.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.79 110.382 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -74.91 81.3 2.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.15 110.906 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.52 -38.32 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.13 110.932 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.3 mm -57.69 -34.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.44 111.53 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.41 -44.48 94.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.447 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.2 tt -81.24 -30.92 11.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.902 -0.319 . . . . 0.21 111.173 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -66.6 -37.29 84.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.353 -0.385 . . . . 0.59 110.638 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 3.4 mmm180 -61.53 -31.12 71.12 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.15 111.59 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.23 -31.46 16.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.047 0.451 . . . . 0.27 110.726 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 3.0 tpt -65.13 -51.92 58.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.524 -0.762 . . . . 0.95 111.289 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -78.13 -5.15 50.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.2 111.676 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -80.23 -45.9 17.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.901 0.382 . . . . 0.42 110.488 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.54 -49.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.27 110.667 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -129.22 98.97 5.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.47 110.449 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -67.62 147.24 52.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 1.92 109.81 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 31.5 m 58.78 61.65 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.523 0.678 . . . . 1.58 110.625 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -4.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 1.01 111.138 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -95.15 -30.64 13.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.86 109.816 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 145' ' ' SER . 1.4 m -66.3 123.75 20.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.94 110.93 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.04 42.02 3.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.905 0.882 . . . . 0.42 112.229 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -67.69 111.28 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.72 -0.673 . . . . 1.26 110.761 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -82.73 101.88 11.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 1.12 110.046 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.7 p -58.6 -76.9 0.04 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.75 -0.659 . . . . 1.2 112.358 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -82.35 62.27 5.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.93 0.395 . . . . 1.54 111.296 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -166.07 -48.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.459 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -108.8 22.38 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.52 110.964 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.59 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 0.12 111.938 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 4.1 mm? -74.51 -34.84 63.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.552 -0.295 . . . . 0.7 111.033 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 4.8 mp0 -65.6 -48.86 70.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.17 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.76 -48.27 81.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.2 111.951 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.78 -28.66 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.761 0.315 . . . . 0.3 111.594 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.0 mmtp -80.74 -33.81 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.66 110.359 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.7 -39.19 93.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 2.05 110.199 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.97 -46.89 73.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.162 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -62.04 -30.23 70.83 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.8 -0.636 . . . . 0.86 111.429 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -53.76 -44.57 70.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.57 110.409 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 -69.81 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.4 110.15 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 62.2 ttp -102.37 123.93 47.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.007 -0.542 . . . . 0.27 111.079 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.99 99.52 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.02 -0.536 . . . . 0.48 110.401 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 pt -74.8 157.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.34 -0.846 . . . . 0.93 110.895 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 122' ' ' VAL . 8.6 mm-40 -98.53 101.79 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.234 -0.439 . . . . 1.18 110.311 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 63.76 -169.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.707 -0.679 . . . . 1.62 111.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -161.12 -162.0 0.87 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.3 109.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.491 ' HE1' ' O ' ' A' ' 213' ' ' LEU . 64.9 t60 -78.44 113.89 16.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 1.89 110.79 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.839 -0.619 . . . . 1.22 110.903 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -128.42 134.67 48.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.441 -0.345 . . . . 2.41 111.172 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 211' ' ' VAL . 2.7 mp -129.49 145.76 51.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 0.31 110.108 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.609 ' HB3' HG22 ' A' ' 211' ' ' VAL . 9.8 ptm180 -126.72 132.12 51.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.384 -0.371 . . . . 0.24 110.413 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 22.0 m-85 -92.95 140.37 29.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 0.39 110.533 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.3 mt -120.85 118.37 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.527 -0.306 . . . . 0.2 111.309 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -152.12 156.43 33.91 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.95 -0.568 . . . . 0.11 109.906 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.31 172.4 12.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.66 2.24 . . . . 0.14 112.516 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.8 -44.95 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.387 -0.37 . . . . 0.15 111.652 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -52.92 -55.84 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.981 -0.554 . . . . 0.81 111.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.55 -27.24 61.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.424 -0.353 . . . . 0.2 111.403 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.57 -34.78 90.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.216 -0.516 . . . . 0.17 111.893 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -77.75 52.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.36 0.6 . . . . 0.65 109.813 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -152.59 -46.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.258 -0.883 . . . . 1.58 109.477 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -86.53 -26.21 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.4 110.693 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 12.0 ttpt -67.31 -21.73 65.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.47 . . . . 0.67 110.603 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.9 OUTLIER -100.19 8.76 43.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.481 . . . . 0.86 110.921 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -124.85 -45.49 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.568 -0.287 . . . . 0.34 111.08 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.4 mt -78.29 -35.39 47.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.715 0.265 . . . . 0.29 111.715 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 23.7 mmtt -62.4 -52.71 64.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.271 0.471 . . . . 0.66 112.271 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.7 Cg_endo -58.98 -24.6 74.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.153 1.902 . . . . 0.23 113.073 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.55 -22.05 54.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.17 110.765 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.3 mm 59.3 66.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.518 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -134.19 15.11 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.765 -0.652 . . . . 0.84 109.91 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.14 163.69 2.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.328 0.585 . . . . 0.35 112.07 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.546 HD12 HG12 ' A' ' 211' ' ' VAL . 66.5 mt -106.85 160.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.31 109.378 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.41 64.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 2.24 111.095 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 246' ' ' GLU . 2.3 t -161.65 90.36 0.78 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.34 -0.615 . . . . 0.8 109.34 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 43.9 mt-10 -136.79 163.86 29.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 1.32 110.423 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 209' ' ' GLU . 12.1 t0 -119.18 131.47 55.85 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.939 -0.763 . . . . 0.25 108.939 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.45 31.56 6.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.55 111.29 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -96.11 -115.76 3.11 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.832 -0.699 . . . . 0.36 112.275 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -91.63 -22.6 20.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.62 110.148 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.46 123.15 40.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 1.48 109.345 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.94 77.89 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.032 0.444 . . . . 0.33 110.932 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 29.7 mt-10 -75.45 118.65 18.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.052 -0.522 . . . . 1.04 109.884 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 34.1 mt -122.84 126.81 74.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.877 0.37 . . . . 0.48 110.847 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 177' ' ' ARG . 39.4 t -94.09 104.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.11 109.731 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.6 t -130.91 115.56 16.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.15 -0.477 . . . . 0.21 110.121 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.491 ' O ' ' HE1' ' A' ' 173' ' ' HIS . 0.2 OUTLIER -164.7 125.3 2.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.918 -0.583 . . . . 0.42 109.428 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.462 HG12 ' H ' ' A' ' 215' ' ' ASP . 3.3 tt -104.84 -170.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.566 -0.288 . . . . 0.51 110.319 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 119' ' ' ASP . 37.4 m-20 -62.27 141.14 96.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.512 0.196 . . . . 1.3 110.572 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.77 -26.73 83.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.051 2.5 . . . . 0.47 113.362 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.71 78.85 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.761 -0.733 . . . . 0.58 111.945 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 62.6 m -110.68 25.44 11.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.76 110.558 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -60.11 -32.42 70.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.53 111.277 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -18.52 59.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.74 110.893 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.5 -24.68 24.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.4 111.096 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.6 tp -96.13 -42.43 12.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.691 -0.404 . . . . 0.91 111.459 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 18.5 t70 -67.17 -22.4 65.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.881 0.326 . . . . 0.33 111.881 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.27 -28.28 64.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.65 0.262 . . . . 1.14 111.352 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.9 OUTLIER -105.38 -37.35 6.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.609 -0.269 . . . . 0.29 110.365 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 223' ' ' ASP . 44.6 mm -59.09 -34.31 52.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.31 111.27 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 16.6 ptpt -53.91 -31.5 50.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.707 0.632 . . . . 1.4 112.707 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -113.52 -25.29 8.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 1.77 112.063 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -41.97 74.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.174 0.435 . . . . 0.73 112.174 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.0 t -135.8 -37.48 0.74 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.373 -0.531 . . . . 0.14 112.376 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 42.0 mtpt -59.67 -41.52 90.82 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 0.51 110.731 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.41 38.03 3.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.13 111.535 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -151.97 -53.36 0.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.645 0.26 . . . . 0.39 110.649 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -114.97 -168.16 15.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.074 -0.584 . . . . 0.13 111.995 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.9 m -101.81 144.5 30.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.956 -0.387 . . . . 0.36 109.956 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.32 119.19 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.28 110.612 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -113.22 151.68 30.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.731 -0.668 . . . . 0.39 109.904 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.79 145.1 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.639 0.256 . . . . 0.16 110.705 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.6 tp -107.21 98.64 8.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 0.35 109.497 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -117.25 -7.83 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.328 -0.396 . . . . 0.52 111.546 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.16 109.2 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 1.03 111.06 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -103.29 8.66 38.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.801 -0.636 . . . . 0.82 110.729 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.75 10.93 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.509 0.671 . . . . 1.54 110.227 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.6 p -123.19 172.38 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.85 109.306 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 244' ' ' VAL . 3.9 tp10 -67.58 115.07 6.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.999 0.428 . . . . 1.64 110.267 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.453 ' HB3' ' OG ' ' A' ' 201' ' ' SER . 40.5 mt-10 -75.29 -38.78 60.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.044 -0.525 . . . . 1.33 111.141 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 150.34 -123.36 1.54 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.131 -0.787 . . . . 0.33 111.131 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.83 132.21 54.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.759 0.314 . . . . 1.67 110.388 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -114.3 -0.35 13.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.284 0.564 . . . . 0.69 110.256 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.22 146.62 15.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 1.98 109.825 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -85.36 -6.78 59.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.996 0.427 . . . . 0.71 110.292 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.356 -0.831 . . . . 2.14 110.593 179.783 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.596 -0.602 . . . . 0.32 111.596 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -118.99 150.83 39.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.828 0.347 . . . . 1.19 110.831 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -104.06 133.05 49.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.096 -0.502 . . . . 0.61 110.049 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -61.24 2.65 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.263 0.352 . . . . 1.34 110.855 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' ' 6' ' ' PHE . 1.1 mp -104.73 -85.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.861 -0.422 . . . . 0.72 109.861 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.407 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 69.6 m-85 -126.02 -66.26 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.261 0.553 . . . . 0.44 109.598 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.85 81.22 9.22 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.853 -0.612 . . . . 0.21 109.961 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.5 160.68 28.57 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.987 2.458 . . . . 0.47 112.214 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.16 149.35 30.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.224 -0.444 . . . . 0.52 110.479 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.22 177.09 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.448 -0.575 . . . . 0.59 109.448 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.88 -77.04 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.713 0.292 . . . . 1.44 111.01 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.12 76.05 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.338 0.59 . . . . 1.48 110.603 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -147.91 159.21 44.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.43 -0.805 . . . . 1.48 109.258 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.53 42.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.47 110.337 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 p -110.82 -66.01 1.12 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.001 -0.545 . . . . 0.19 110.427 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -92.34 60.18 3.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.48 0.657 . . . . 1.06 109.464 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.421 HG12 ' OE1' ' A' ' 54' ' ' GLN . 17.0 m -100.08 148.44 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.453 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -113.6 114.6 26.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.831 -0.622 . . . . 0.2 109.904 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.46 121.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.37 110.838 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.9 p -133.43 122.3 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.966 -0.561 . . . . 0.25 110.316 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -110.36 128.4 55.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.518 . . . . 0.37 110.733 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.8 ttp -89.35 141.75 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.16 110.963 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.89 122.35 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.02 110.316 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -125.22 32.62 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.846 -0.161 . . . . 0.71 110.988 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.14 70.84 0.49 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.757 0.661 . . . . 0.44 111.805 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 -35.62 4.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.876 -0.678 . . . . 0.49 111.654 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -106.07 148.48 27.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.154 -0.684 . . . . 1.47 109.154 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.21 153.62 51.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.636 0.255 . . . . 1.8 110.434 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -144.82 116.6 8.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.274 -0.639 . . . . 0.44 109.274 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 59' ' ' PHE . 3.3 pm0 -112.0 132.94 54.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.16 111.661 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 89' ' ' ILE . 6.2 mt -128.94 145.75 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.571 -0.74 . . . . 0.7 109.905 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.85 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.503 -0.317 . . . . 0.08 110.263 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.03 171.17 7.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.365 -0.379 . . . . 0.09 110.347 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.23 119.68 13.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.2 109.908 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -75.32 69.61 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.42 111.135 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.03 64.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.63 109.321 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.51 50.96 13.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.808 -0.633 . . . . 0.97 110.326 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.86 10.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.359 -0.837 . . . . 0.43 112.901 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.6 12.39 7.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.734 0.778 . . . . 0.27 109.463 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.18 -49.06 7.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42 113.055 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -69.27 -0.41 6.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.017 0.437 . . . . 1.77 111.278 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.542 ' NH1' ' HB3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -96.09 1.13 52.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.203 0.525 . . . . 2.66 109.71 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 m -141.77 -37.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.454 -0.794 . . . . 1.11 110.14 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' HA3' ' OE1' ' A' ' 154' ' ' GLN . . . -150.75 -115.78 0.72 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.255 -0.738 . . . . 0.28 111.255 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.36 137.99 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.087 0.443 . . . . 0.54 110.992 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 4.6 pt-20 -109.57 -73.05 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.377 -0.374 . . . . 1.05 110.025 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 20.4 ptmt -170.71 -172.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.035 -0.728 . . . . 1.07 109.035 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 50' ' ' ASP . 9.5 t0 -65.61 124.01 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.75 110.483 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 tp -70.48 -17.31 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.6 111.951 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -59.84 -35.86 75.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.07 0.462 . . . . 1.67 110.503 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.83 -33.41 21.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 1.49 110.465 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.62 -38.39 82.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.884 -0.598 . . . . 0.3 111.246 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.83 84.05 6.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.051 -0.351 . . . . 0.16 110.051 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' OE1' HG12 ' A' ' 17' ' ' VAL . 37.4 mt-30 -66.26 -77.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.3 111.098 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -74.96 129.21 37.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.21 110.23 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -93.82 12.28 26.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.368 0.604 . . . . 0.57 110.034 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.495 -0.775 . . . . 0.18 109.962 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.5 p -116.65 146.3 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.692 -0.485 . . . . 0.3 109.692 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 19.0 m-85 -104.94 140.16 38.58 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.885 -0.413 . . . . 0.56 109.885 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 2.4 t -92.58 -16.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.24 110.339 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -178.97 95.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.536 -0.757 . . . . 0.28 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.67 -27.45 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.432 . . . . 0.33 111.53 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 m -68.35 -20.63 64.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.785 0.326 . . . . 0.47 111.461 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.71 3.95 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 1.53 110.419 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 28.14 73.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.14 112.109 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.08 102.43 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.6 110.711 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 128.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.029 -0.532 . . . . 0.25 110.516 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.24 116.62 32.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.3 110.15 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -87.09 178.89 6.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.985 -0.552 . . . . 2.16 110.253 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -23.93 67.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.258 -0.177 . . . . 0.37 111.438 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -87.22 0.94 54.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.782 0.325 . . . . 0.43 110.593 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.5 -42.22 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.25 -0.432 . . . . 1.21 110.738 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.5 -28.19 68.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.784 0.326 . . . . 0.24 110.765 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -68.85 -28.7 40.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.199 0.523 . . . . 0.86 110.067 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.74 20.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.932 -0.576 . . . . 0.7 110.296 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 -56.76 9.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.793 -0.64 . . . . 0.53 111.736 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -102.86 -55.15 2.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.652 0.263 . . . . 0.96 111.003 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.85 -32.28 1.58 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.671 . . . . 0.18 111.954 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.41 133.38 33.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.608 0.242 . . . . 0.78 110.758 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.08 2.86 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.973 0.416 . . . . 0.68 110.595 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 85' ' ' ILE . 6.8 t70 -91.39 126.43 36.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.934 -0.575 . . . . 1.14 110.234 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.29 -27.3 63.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.569 . . . . 1.08 111.13 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -62.66 -49.1 76.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.359 -0.382 . . . . 0.71 110.409 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.02 -43.25 99.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.54 110.899 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 81' ' ' ASP . 50.1 mm -60.61 -49.29 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.26 110.114 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.8 t -64.7 -34.3 77.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.11 110.949 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -61.31 -43.99 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 110.403 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -68.85 -38.64 79.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.77 110.472 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 31' ' ' ILE . 73.5 mt -67.34 -33.44 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.31 110.799 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.91 -12.11 59.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.75 112.504 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 92' ' ' LYS . 14.6 t -116.1 -21.37 9.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 0.81 112.046 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HG2' HG23 ' A' ' 91' ' ' THR . 33.0 mmmt -124.8 25.91 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.025 0.44 . . . . 0.62 110.249 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.6 176.63 19.08 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.669 -0.777 . . . . 0.41 112.322 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -85.31 82.81 8.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 2.48 111.365 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.18 124.93 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.119 -0.492 . . . . 1.03 110.268 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 18' ' ' ALA . 3.4 pt20 -75.79 109.29 9.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.172 0.511 . . . . 0.66 110.011 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.27 128.62 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.254 0.55 . . . . 0.2 111.095 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.64 150.75 52.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.674 . . . . 0.57 110.029 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.3 t70 -91.36 -154.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.518 -0.31 . . . . 0.6 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 7.0 mmmm 74.4 52.54 0.09 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.235 0.614 . . . . 1.21 110.597 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.82 110.29 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.095 -0.957 . . . . 1.87 110.564 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.05 175.73 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.451 -0.574 . . . . 1.95 109.451 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.1 m80 72.38 50.89 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.21 0.604 . . . . 2.0 110.44 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 175.79 10.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.389 -0.823 . . . . 0.61 111.313 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.76 154.34 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.922 -0.399 . . . . 0.66 109.922 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 106' ' ' LEU . 3.6 mm? -92.78 74.79 4.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.352 0.596 . . . . 0.73 111.237 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -115.03 -173.2 2.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.608 -0.724 . . . . 1.28 109.775 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -79.74 61.3 3.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.528 -0.545 . . . . 1.47 109.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 113' ' ' ILE . 73.2 mmm -52.92 -50.18 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.87 111.65 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -63.89 -22.71 67.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.274 -0.421 . . . . 0.45 111.992 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.78 -44.85 12.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 1.7 110.307 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -45.12 88.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.214 -0.448 . . . . 0.83 110.82 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 109' ' ' MET . 44.5 pt -64.85 -29.87 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.875 0.369 . . . . 0.36 110.288 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 135' ' ' ILE . . . -65.26 -35.07 79.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.357 0.599 . . . . 0.21 109.807 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -67.02 -38.36 85.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.5 -0.773 . . . . 1.22 110.262 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.431 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 1.3 mp -69.46 -51.55 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.163 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.6 -30.27 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 111.811 0.3 . . . . 0.15 111.811 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.37 69.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.24 110.648 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.42 23.78 1.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.497 . . . . 0.94 110.695 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -129.52 6.18 5.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.25 109.737 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.08 162.59 35.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.421 -0.809 . . . . 0.41 109.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -132.69 125.85 53.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.087 0.47 . . . . 0.49 110.918 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -103.66 155.17 37.29 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.7 -0.682 . . . . 0.22 109.989 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.84 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.421 2.08 . . . . 0.55 111.666 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 126' ' ' THR . 1.7 pm0 -63.57 124.32 21.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 1.37 110.881 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 6.0 t 177.83 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.36 110.444 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -161.21 -77.4 0.05 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.687 0.279 . . . . 1.3 110.38 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -161.07 158.18 23.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.065 -0.717 . . . . 0.95 109.065 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.57 -32.71 95.09 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.263 1.976 . . . . 0.2 111.597 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.3 90.02 3.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.08 -0.711 . . . . 0.76 109.08 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 134' ' ' LEU . 24.0 m -114.0 109.98 19.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.26 111.595 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.23 -31.83 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.438 0.637 . . . . 0.1 109.375 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.8 mm -66.3 -24.86 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.365 -0.834 . . . . 0.16 111.032 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.437 ' H ' HG22 ' A' ' 131' ' ' THR . 26.7 tp -62.12 -55.48 28.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 0.4 110.043 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.45 HG23 ' HB1' ' A' ' 114' ' ' ALA . 1.8 tp -71.56 -31.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.22 110.061 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 11.6 tt0 -59.49 -44.89 92.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 1.2 110.063 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.88 68.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 1.28 110.936 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.6 18.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.393 -0.367 . . . . 0.3 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 39.0 tpp -65.52 -36.21 83.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.359 0.599 . . . . 0.95 109.769 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 1.3 tmtp? -65.93 -32.65 74.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 2.05 109.425 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.57 -65.74 0.86 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.221 -0.9 . . . . 0.57 110.407 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.63 63.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.494 0.664 . . . . 0.19 110.108 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -78.18 56.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.337 -0.847 . . . . 0.8 110.909 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.05 169.57 17.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.973 -0.558 . . . . 2.59 110.694 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.03 107.08 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.29 110.059 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.3 69.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.004 0.431 . . . . 0.5 109.973 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 61.72 85.27 0.12 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.406 -0.815 . . . . 0.83 110.383 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.1 m -80.42 44.79 0.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.859 -0.609 . . . . 0.41 111.354 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.46 -21.11 28.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.907 -0.588 . . . . 0.33 109.79 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 80.9 1.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.448 -0.796 . . . . 0.37 109.58 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -86.14 16.33 4.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.45 112.039 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 131.82 51.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.553 -0.294 . . . . 0.43 111.424 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 58.24 48.56 12.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.715 -0.675 . . . . 1.63 111.299 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.429 ' OE1' ' HA3' ' A' ' 44' ' ' GLY . 24.1 tt0 59.41 53.11 5.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.537 -0.756 . . . . 0.76 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.1 30.29 19.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.306 -0.861 . . . . 0.23 112.071 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.58 85.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.21 110.521 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 157' ' ' LEU . 4.0 mm? -71.55 -7.85 50.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.713 -0.676 . . . . 0.3 111.234 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -99.56 -47.04 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.537 -0.542 . . . . 0.94 109.537 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.38 111.426 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.62 -15.14 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.053 0.454 . . . . 0.58 111.457 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -109.06 0.04 19.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.319 0.581 . . . . 1.33 110.355 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -84.55 -54.26 4.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.617 -0.719 . . . . 0.63 109.787 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -69.25 -18.9 63.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.18 110.435 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.536 ' N ' HD13 ' A' ' 163' ' ' LEU . 46.6 tttm -69.35 -22.01 63.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.72 110.11 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -81.66 -12.82 58.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.835 -0.62 . . . . 0.63 110.391 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.82 -39.65 5.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.178 -0.465 . . . . 0.21 110.731 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.3 tpp -141.79 143.98 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.45 110.722 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -96.4 119.59 35.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.281 -0.418 . . . . 0.24 110.282 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -130.97 170.05 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.285 -0.416 . . . . 0.62 110.78 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.429 ' HB3' HG23 ' A' ' 122' ' ' VAL . 9.6 tp10 -96.68 141.73 29.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.727 -0.842 . . . . 2.06 108.727 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 24.37 0.29 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.417 . . . . 2.58 111.604 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.27 120.25 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.73 110.267 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 154.11 32.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.324 . . . . 0.35 110.876 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 40.5 mtm -138.88 177.46 7.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.419 . . . . 1.29 110.012 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -102.02 131.54 48.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.369 -0.604 . . . . 1.48 109.369 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.476 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.7 mp -116.5 157.22 25.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.203 0.525 . . . . 0.41 111.325 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.595 ' HB2' ' OE2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -127.77 160.58 31.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.143 -0.935 . . . . 1.05 108.9 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -129.3 128.61 43.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.695 0.283 . . . . 0.53 110.463 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 121.69 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.466 0.651 . . . . 0.88 111.386 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -150.1 157.31 37.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.421 -0.808 . . . . 0.11 109.902 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.21 163.85 11.47 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.688 2.259 . . . . 0.09 112.501 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 208' ' ' LEU . 40.5 t -55.23 -39.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.256 -0.429 . . . . 0.25 112.05 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -57.95 -60.79 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.726 0.298 . . . . 0.53 111.638 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.87 -19.46 61.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 1.44 111.509 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.86 72.87 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.943 -0.646 . . . . 0.15 111.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -61.82 -32.65 72.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.614 0.245 . . . . 1.62 110.712 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -55.75 -43.97 77.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.014 -0.539 . . . . 0.75 111.668 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 -35.27 12.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.416 -0.356 . . . . 0.41 111.63 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.77 -34.25 75.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.688 0.28 . . . . 1.55 111.171 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -95.88 20.73 9.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.807 0.299 . . . . 1.23 111.807 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -146.35 -45.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.447 0.536 . . . . 1.31 112.447 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -75.89 -39.71 55.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.662 0.268 . . . . 0.42 111.494 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 5.2 mtpt -58.6 -52.79 72.19 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.191 -0.459 . . . . 1.02 112.002 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 34.1 Cg_endo -65.12 -12.5 35.03 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.056 1.837 . . . . 0.09 112.961 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.8 mt -88.64 -7.52 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.359 . . . . 0.2 110.304 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 6.8 mm 59.64 40.26 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.519 -0.764 . . . . 0.4 110.815 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -112.21 19.96 17.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.63 109.947 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.433 HG21 ' HE3' ' A' ' 193' ' ' LYS . 14.7 m -110.68 139.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.813 -0.631 . . . . 0.33 111.053 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.93 164.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.812 -0.631 . . . . 1.15 110.039 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -71.14 56.29 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 1.67 111.092 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.2 m -156.17 88.21 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.907 -0.775 . . . . 0.77 108.907 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -134.94 140.03 45.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.533 -0.758 . . . . 0.78 110.396 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.37 137.41 53.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.629 -0.508 . . . . 0.48 109.629 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.29 30.38 7.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 1.28 111.501 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -79.72 -140.28 2.16 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.729 -0.748 . . . . 0.63 112.847 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.63 -20.96 66.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.93 0.395 . . . . 1.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -136.09 143.2 44.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.923 -0.399 . . . . 1.26 109.923 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 182' ' ' VAL . 2.5 mm? -81.99 85.53 6.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.33 110.75 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.595 ' OE2' ' HB2' ' A' ' 177' ' ' ARG . 10.3 tp10 -90.28 106.21 18.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.137 -0.69 . . . . 1.34 109.137 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.79 134.62 58.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.957 0.408 . . . . 0.17 111.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 177' ' ' ARG . 86.5 t -84.53 108.01 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.15 110.21 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.0 m -126.59 90.35 3.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.135 -0.484 . . . . 0.22 110.406 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -155.78 132.01 10.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.28 109.837 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.82 173.21 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.521 -0.309 . . . . 1.06 110.276 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 4.1 m-20 -69.51 169.35 12.54 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.456 -0.338 . . . . 1.22 110.417 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 27.4 Cg_exo -63.49 -161.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.642 2.228 . . . . 0.36 112.794 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.62 -98.52 1.55 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.26 111.718 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 68.9 m -75.98 0.88 16.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.64 111.563 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 44.3 t80 -61.46 -32.3 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.033 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -9.1 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 1.31 111.701 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -92.7 -32.69 14.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.794 0.331 . . . . 1.1 110.567 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 226' ' ' ILE . 4.8 tp -94.51 -31.37 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.384 0.513 . . . . 1.38 112.384 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.499 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -60.24 -28.12 67.77 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.33 -0.231 . . . . 0.95 111.42 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -56.43 -35.37 67.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.81 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.2 pp -95.81 -24.89 16.26 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.41 110.492 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -61.59 -38.1 79.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.367 -0.379 . . . . 0.42 110.693 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 223' ' ' ASP . 13.7 ptpt -64.31 -16.48 62.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.656 0.613 . . . . 0.16 112.656 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.57 -23.47 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.613 -0.435 . . . . 0.55 111.838 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -81.93 -43.23 18.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.588 0.588 . . . . 0.92 112.588 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -128.18 -38.87 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.364 -0.535 . . . . 0.31 111.914 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 14.7 tttt -63.76 -28.06 69.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.941 0.401 . . . . 2.08 110.563 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -102.13 16.98 55.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.912 -0.661 . . . . 0.25 112.123 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.7 -36.09 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.339 . . . . 0.39 111.044 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.51 -156.04 6.65 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.515 -0.85 . . . . 0.14 112.725 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 m -101.98 137.7 39.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.875 0.369 . . . . 0.17 110.425 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.13 149.11 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.2 111.013 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.35 161.04 39.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.678 . . . . 0.33 109.168 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.2 m -99.04 148.45 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.762 0.315 . . . . 0.18 111.066 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -87.26 94.12 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.576 -0.527 . . . . 0.47 109.576 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.81 9.59 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.693 -0.685 . . . . 0.69 110.304 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 85.07 6.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.59 110.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -108.13 -6.98 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.9 110.502 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.0 -76.24 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.15 -0.477 . . . . 0.49 110.468 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -98.49 161.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.927 -0.578 . . . . 0.46 110.077 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -80.4 155.77 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.885 -0.413 . . . . 0.78 109.885 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -130.43 140.51 50.56 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.502 -0.317 . . . . 1.24 110.191 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 151.79 127.34 1.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.558 -0.829 . . . . 0.57 112.235 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -111.0 68.56 0.66 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.666 0.746 . . . . 1.24 109.134 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -76.43 -8.12 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.136 -0.938 . . . . 0.55 111.441 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -83.38 70.78 10.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.101 0.476 . . . . 0.84 110.68 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -79.27 -12.63 59.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.069 -0.514 . . . . 0.93 110.21 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 115.803 -0.635 . . . . 2.04 110.068 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.521 -0.632 . . . . 0.81 111.521 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -145.06 148.2 33.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.805 -0.443 . . . . 0.51 109.805 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 mtt -116.28 98.72 6.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.153 0.501 . . . . 1.02 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.78 90.58 4.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.66 110.829 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.2 mt -61.66 -54.89 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.45 110.915 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -130.22 149.26 52.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.668 . . . . 0.25 109.828 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.9 m -152.44 88.88 3.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.735 0.302 . . . . 0.21 111.399 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.41 126.47 14.26 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.214 1.943 . . . . 0.16 111.101 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -108.54 94.22 4.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.912 0.387 . . . . 0.25 110.887 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.88 -89.57 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.34 110.293 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -137.51 -88.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.675 -0.491 . . . . 0.33 109.675 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.01 107.64 23.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.316 -0.624 . . . . 0.81 109.316 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -158.31 152.44 24.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.1 -0.5 . . . . 1.11 110.373 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -78.77 49.06 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.48 110.968 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.3 p -129.04 -45.61 1.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.128 0.49 . . . . 0.25 110.606 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -106.69 39.54 1.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.18 109.672 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 m -94.38 135.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.22 111.581 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.06 116.08 31.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.966 -0.561 . . . . 0.11 109.844 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.6 114.73 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.845 -0.616 . . . . 0.16 111.387 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.796 HG22 HG22 ' A' ' 89' ' ' ILE . 7.7 p -107.82 136.29 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.19 108.986 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HD3' ' CD ' ' A' ' 30' ' ' GLU . 12.4 ttp180 -142.18 140.98 32.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.089 0.471 . . . . 1.33 111.939 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 tpt -135.55 119.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.82 108.877 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -122.62 114.95 21.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.902 0.382 . . . . 1.14 111.734 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -112.42 -164.41 0.91 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.708 -0.849 . . . . 0.89 108.708 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.36 6.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.702 0.287 . . . . 0.41 111.375 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.74 4.77 24.4 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.357 -0.925 . . . . 1.09 113.229 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -126.76 119.02 25.86 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.488 -0.419 . . . . 0.19 110.34 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -140.98 122.54 15.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.295 -0.411 . . . . 1.8 110.478 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -149.96 146.87 27.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.285 0.365 . . . . 0.39 110.923 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' CD ' ' HD3' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -143.9 136.77 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.9 110.714 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -139.98 -173.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.885 0.374 . . . . 0.11 110.59 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -136.46 116.65 13.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.05 110.185 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.8 p -112.67 -158.35 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.334 -0.394 . . . . 0.13 111.172 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -169.1 0.8 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.85 110.673 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -74.43 -157.88 0.06 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.894 0.378 . . . . 0.47 111.295 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' HB3' ' H ' ' A' ' 98' ' ' SER . 28.3 p-10 -56.71 -19.95 19.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.109 0.781 . . . . 0.52 113.109 -178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -63.55 -19.03 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.27 111.203 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.05 -24.92 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.1 0.476 . . . . 0.18 110.767 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.2 -13.29 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.323 -0.398 . . . . 0.29 110.403 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.72 68.68 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.934 -0.575 . . . . 0.27 112.416 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -72.18 -35.56 69.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.875 0.369 . . . . 0.9 110.762 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.28 2.42 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.91 0.386 . . . . 1.01 111.168 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -134.47 28.58 3.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.3 0.572 . . . . 0.48 109.842 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.62 -130.92 3.19 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.378 -0.828 . . . . 0.26 111.232 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -138.56 122.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.75 110.709 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.58 -163.36 0.85 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.474 -0.565 . . . . 0.7 109.474 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -96.89 -164.13 1.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.52 0.2 . . . . 1.15 110.98 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 m-20 -52.88 114.26 1.37 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.258 -0.428 . . . . 1.44 111.303 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.54 -28.28 68.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 1.36 111.662 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.05 -36.76 82.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.265 0.555 . . . . 0.95 110.403 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.67 -30.21 56.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.49 109.951 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 48' ' ' ASP . 21.9 t -75.48 -27.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.24 110.847 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.09 84.85 7.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.172 0.51 . . . . 0.2 111.148 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -57.34 -64.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.378 -0.828 . . . . 0.18 110.528 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 m -91.23 80.47 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.004 -0.544 . . . . 0.35 109.968 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -80.06 63.79 4.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.63 0.728 . . . . 1.1 110.942 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -148.35 96.04 2.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.796 -1.093 . . . . 0.22 108.074 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.1 p -78.82 146.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.664 -0.698 . . . . 0.13 112.194 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -116.23 147.35 41.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.57 -0.741 . . . . 0.32 109.263 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 18.5 t -84.43 -33.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.568 0.699 . . . . 0.11 109.387 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -166.05 104.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.127 -0.942 . . . . 1.03 109.889 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.71 -27.73 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.39 111.609 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 m -60.84 -45.99 92.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.735 0.302 . . . . 0.43 111.062 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -27.0 25.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.75 110.615 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.72 29.79 8.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.805 -0.712 . . . . 0.1 111.469 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -83.33 109.36 17.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 1.56 110.431 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.63 133.11 36.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.37 109.726 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -110.06 105.17 14.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.029 0.442 . . . . 0.1 110.856 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 34.2 pttt -85.86 -175.81 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.384 -0.599 . . . . 1.68 109.384 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 pttp -58.81 -23.48 60.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.643 0.259 . . . . 0.95 111.419 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.26 -22.03 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.501 -0.318 . . . . 2.07 111.316 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 21.8 m-20 -86.41 -52.28 5.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.39 -0.368 . . . . 0.33 110.748 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.63 -28.84 70.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.21 111.599 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -68.15 -26.55 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.797 0.332 . . . . 0.32 111.018 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 p -102.66 -25.08 13.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 1.04 111.327 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.61 -41.76 16.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.22 111.445 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -97.36 -41.43 8.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 0.42 110.324 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.72 -29.14 5.72 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.758 -0.734 . . . . 0.26 112.345 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.96 145.81 43.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.696 0.284 . . . . 0.22 110.782 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.39 3.01 53.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.242 0.544 . . . . 0.73 110.336 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 85' ' ' ILE . 26.6 t0 -74.25 108.78 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 1.45 110.551 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -60.46 -30.58 69.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.19 110.978 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -60.65 -40.77 93.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.278 -0.419 . . . . 0.61 111.097 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -71.34 -38.78 71.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.65 110.881 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 81' ' ' ASP . 30.0 mm -60.24 -55.11 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.21 110.936 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 7.4 p -67.74 -34.66 77.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.09 111.397 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' THR . 33.3 ttpt -58.82 -45.17 90.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.605 0.241 . . . . 0.21 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -60.62 -45.8 92.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.54 110.868 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.796 HG22 HG22 ' A' ' 20' ' ' VAL . 22.5 mt -72.43 -25.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 0.16 111.439 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.43 -40.52 23.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.053 0.39 . . . . 0.23 112.053 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -91.18 -21.16 21.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.07 0.767 . . . . 0.3 113.07 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -110.99 -24.68 10.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.632 -0.427 . . . . 0.67 111.296 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.77 -166.07 31.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.757 . . . . 0.15 111.931 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -120.97 131.59 54.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.168 0.509 . . . . 2.06 111.278 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 97' ' ' VAL . 14.7 p -118.28 160.36 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.49 109.05 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -73.27 85.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.238 0.542 . . . . 0.26 111.044 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 95' ' ' VAL . 3.8 m -95.4 150.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.2 111.306 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -117.32 178.13 4.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.824 -0.625 . . . . 1.74 110.118 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.45 -177.13 6.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.57 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -90.29 151.23 21.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.334 -0.247 . . . . 0.81 110.334 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.29 171.35 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.52 110.755 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -80.74 114.9 19.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.112 -0.494 . . . . 0.79 110.873 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.4 t60 56.73 75.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 0.66 111.433 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -72.46 -62.08 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.254 -0.43 . . . . 0.66 110.777 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -168.32 132.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.864 -0.607 . . . . 1.74 110.222 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.05 54.29 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.056 0.455 . . . . 1.68 110.407 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 109' ' ' MET . 3.4 mm-40 -91.35 174.08 7.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.015 -0.539 . . . . 1.93 111.142 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -76.84 29.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.523 . . . . 0.33 111.49 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.41 ' H ' ' C ' ' A' ' 107' ' ' GLU . 23.6 ptt? -61.41 -33.4 73.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.43 110.889 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -74.08 -20.46 60.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.324 . . . . 0.41 110.587 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -47.03 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 0.85 110.025 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -48.55 81.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.77 -0.65 . . . . 1.02 110.301 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 mm -83.65 52.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.78 0.8 . . . . 0.23 109.573 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.41 -31.97 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.17 110.825 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.1 t -60.2 -24.29 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.42 111.562 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.57 -46.49 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 0.47 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.49 -27.22 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.26 110.582 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.72 71.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.152 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.1 OUTLIER -67.59 -40.27 84.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.127 -0.488 . . . . 1.49 110.915 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -86.52 -3.64 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.87 111.223 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 2.8 t -86.04 84.46 7.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.61 175.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.904 -0.589 . . . . 0.31 112.5 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 25.6 t-20 176.97 -55.15 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.23 109.656 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 84.0 Cg_endo -77.97 166.85 24.47 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.929 1.752 . . . . 0.3 112.104 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.92 -22.0 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 1.12 111.588 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.436 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 7.4 t -75.2 -172.81 1.81 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.594 -0.275 . . . . 0.54 110.601 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.31 105.08 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 3.92 110.281 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.573 ' H ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -90.6 -50.37 0.34 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.683 -0.689 . . . . 1.58 112.173 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.573 ' HD2' ' H ' ' A' ' 128' ' ' ARG . 20.0 Cg_endo -58.58 168.98 3.52 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.292 1.995 . . . . 0.3 113.035 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.8 t80 74.47 -20.32 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.698 0.799 . . . . 0.88 111.751 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -80.12 76.18 6.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.207 0.527 . . . . 0.34 111.218 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.24 -27.98 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.755 -0.657 . . . . 0.42 110.76 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.25 -27.37 39.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.518 -0.765 . . . . 0.42 111.51 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.91 -54.26 33.58 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.919 0.39 . . . . 0.22 110.512 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 tp -71.0 -28.49 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.37 110.66 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 1.35 110.193 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -65.44 -46.59 79.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 1.91 110.656 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.45 81.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.39 111.489 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 44.9 ttp -58.36 -47.32 84.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 2.65 111.606 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -77.67 -24.25 49.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.818 -0.353 . . . . 0.22 111.054 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.88 -37.44 73.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.018 0.437 . . . . 0.31 110.422 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.43 -24.29 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.835 -0.431 . . . . 0.27 109.835 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.6 p80 40.82 50.65 3.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.085 0.954 . . . . 0.25 112.68 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.46 111.85 21.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 1.84 110.397 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -77.92 45.45 0.52 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.233 0.539 . . . . 0.32 111.135 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.6 -24.49 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.53 110.553 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -82.38 22.6 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.58 111.162 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.73 14.5 5.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.349 0.595 . . . . 0.72 110.326 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -79.31 -46.3 17.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.49 110.408 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -154.74 -161.81 1.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.94 109.7 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.4 m -55.98 118.07 4.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.99 111.152 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -23.93 65.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.67 111.392 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.79 1.05 28.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.901 0.382 . . . . 1.1 110.654 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -115.59 -45.53 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.78 110.423 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.0 pt20 -94.06 19.46 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.18 111.579 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.78 72.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.282 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.1 mm? -68.43 -18.36 64.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.28 111.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -92.4 -36.97 12.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.85 0.357 . . . . 2.49 110.63 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 155' ' ' GLN . 24.7 t -64.79 -43.18 96.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.874 -0.603 . . . . 0.16 111.017 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.6 tt -61.36 -32.55 53.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.133 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 41.1 mttp -67.29 -48.62 67.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.711 0.291 . . . . 1.33 110.364 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -39.72 89.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.719 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -42.99 99.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 1.42 110.443 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -65.75 -20.72 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.283 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 161' ' ' LYS . 32.4 mt-10 -72.72 -32.54 65.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.694 0.283 . . . . 0.69 110.822 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -82.21 -44.09 16.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.065 0.46 . . . . 0.87 110.137 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 21.2 ptp -144.45 134.38 23.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.872 -0.604 . . . . 1.44 109.737 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.45 120.91 19.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.202 0.525 . . . . 0.87 111.493 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 pp -122.83 174.59 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.525 -0.761 . . . . 0.95 109.641 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.26 118.84 31.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.24 0.543 . . . . 1.19 110.575 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 11.8 14.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.691 -0.686 . . . . 0.54 111.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.04 133.29 49.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.041 -0.527 . . . . 1.13 111.369 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.2 148.85 10.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 1.72 110.013 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -159.1 -177.14 6.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.193 -0.299 . . . . 1.41 110.193 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -119.48 144.09 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 1.73 110.491 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.69 154.74 41.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.76 110.976 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 177' ' ' ARG . 9.4 ptm180 -124.44 152.61 43.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.11 109.426 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 95.6 m-85 -116.09 124.64 50.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.854 0.359 . . . . 0.13 110.611 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.48 HG12 ' OE2' ' A' ' 209' ' ' GLU . 4.4 mt -102.07 114.5 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.3 111.47 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.3 OUTLIER -159.11 150.15 16.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 0.6 110.262 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.93 165.47 27.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.79 2.327 . . . . 0.26 112.064 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.95 -30.44 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.762 0.315 . . . . 0.15 110.928 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.11 -50.03 62.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.47 110.497 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -91.94 -21.95 20.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.74 110.272 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.16 -30.23 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.483 -0.781 . . . . 0.17 113.635 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -68.21 -16.44 63.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.072 0.436 . . . . 0.87 111.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.99 -15.65 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 1.32 109.665 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.38 -45.08 5.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.267 -0.878 . . . . 2.04 110.537 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 208' ' ' LEU . 29.2 tttm -57.69 -53.49 57.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 0.72 111.093 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.66 31.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.088 -0.505 . . . . 0.6 111.12 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -144.16 -51.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.839 0.311 . . . . 1.27 111.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.97 -37.58 22.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.176 0.435 . . . . 0.6 112.176 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 6.1 mtpt -60.25 -48.54 93.85 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.234 0.457 . . . . 0.3 112.234 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.4 Cg_endo -60.0 -13.89 25.37 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.063 1.842 . . . . 0.16 113.043 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 66.9 mt -85.48 -2.58 58.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.472 -0.195 . . . . 0.37 110.472 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 39.2 pt 41.78 40.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.543 1.137 . . . . 0.65 113.736 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 195' ' ' LEU . 78.9 mttt -123.32 24.41 8.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 1.03 109.665 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.27 169.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 0.41 110.353 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 211' ' ' VAL . 88.6 mt -110.94 144.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.021 -0.536 . . . . 0.65 110.118 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -70.57 70.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.48 0.488 . . . . 0.66 111.334 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.1 m -157.39 38.72 0.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.29 109.287 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.5 145.07 29.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 1.14 111.608 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -117.62 123.69 46.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.12 110.089 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.61 159.78 18.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.284 -0.416 . . . . 0.47 110.193 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 139.34 -116.61 1.25 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.045 -0.598 . . . . 0.2 111.912 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.25 -18.05 37.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.518 0.675 . . . . 1.24 109.554 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.05 177.21 7.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.114 -0.948 . . . . 0.14 109.5 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 189' ' ' LYS . 2.8 tp -138.37 77.51 1.63 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.404 . . . . 0.69 110.61 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 15.9 mt-10 -82.93 99.73 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.174 -0.467 . . . . 0.16 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 28.7 mt -102.88 132.91 48.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.76 109.74 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.642 HG11 HD12 ' A' ' 239' ' ' LEU . 61.3 t -99.06 122.41 50.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.892 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.9 t -147.39 120.24 8.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.3 110.128 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.07 125.08 1.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.305 -0.628 . . . . 0.23 109.305 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.3 tt -117.1 157.61 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.6 109.922 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.08 150.59 10.39 Favored Pre-proline 0 C--O 1.236 0.344 0 O-C-N 123.295 0.372 . . . . 0.62 111.536 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 10.2 Cg_endo -51.1 158.35 3.41 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.654 2.903 . . . . 1.05 113.569 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 103.15 -82.87 0.41 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.631 -0.988 . . . . 0.37 110.631 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.1 m -72.92 -16.32 61.56 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.31 -0.626 . . . . 0.83 109.31 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 40.3 t80 -63.41 -42.71 98.76 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.564 -0.744 . . . . 1.35 110.762 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 223' ' ' ASP . 17.9 tpt180 -62.2 -27.33 68.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.151 0.5 . . . . 0.34 110.874 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.37 -34.92 70.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.181 -0.463 . . . . 2.19 111.358 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.635 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.3 tt -96.24 -29.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.529 -0.305 . . . . 1.78 111.76 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -62.52 -23.83 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 0.92 110.746 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.12 -25.63 65.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.867 -0.606 . . . . 1.26 111.4 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.0 OUTLIER -106.4 -32.55 8.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.928 -0.309 . . . . 0.47 110.872 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 222' ' ' ILE . 47.2 mm -58.26 -35.28 52.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.954 0.407 . . . . 0.29 110.705 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 16.4 ptmt -54.32 -34.29 60.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.458 -0.792 . . . . 1.56 112.609 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -106.09 -24.29 12.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.689 0.281 . . . . 0.55 111.344 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.12 -59.67 3.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.068 -0.514 . . . . 0.34 111.848 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -125.52 -24.26 3.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.294 0.479 . . . . 0.2 112.294 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 75.6 tttt -66.94 -28.79 68.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.52 110.66 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.83 -14.28 37.53 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.883 -0.675 . . . . 0.68 112.25 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -84.99 -22.31 29.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.381 . . . . 0.64 110.69 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -147.15 -168.98 14.27 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.536 -0.84 . . . . 0.1 112.342 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 m -96.77 131.73 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.891 -0.411 . . . . 0.25 109.891 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.31 142.66 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.004 0.43 . . . . 0.33 111.323 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -144.0 155.14 43.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.09 -0.504 . . . . 0.86 109.937 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -81.28 152.2 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 0.15 110.748 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.642 HD12 HG11 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -107.52 92.73 4.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.944 -0.391 . . . . 1.06 109.944 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -119.57 13.18 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.564 0.697 . . . . 1.0 109.704 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.8 100.65 11.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.416 -0.811 . . . . 0.24 109.801 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.1 34.77 4.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.973 -0.558 . . . . 0.74 110.323 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.2 -67.11 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.381 -0.372 . . . . 1.39 111.42 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.01 158.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.37 110.438 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -72.13 121.93 20.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.788 -0.449 . . . . 1.14 109.788 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -130.63 147.87 52.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.477 -0.329 . . . . 0.86 110.519 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 110.26 92.61 2.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.89 -0.671 . . . . 0.43 112.333 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.2 137.2 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.261 -0.274 . . . . 1.13 110.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.49 29.37 1.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.977 -0.556 . . . . 1.22 109.639 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -143.64 112.44 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 1.76 110.455 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.58 16.13 16.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.259 0.552 . . . . 0.56 110.551 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.327 -0.844 . . . . 1.96 109.554 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 111.529 -0.629 . . . . 0.55 111.529 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -129.66 125.4 35.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.803 0.335 . . . . 0.26 110.534 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -109.0 120.87 43.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 0.68 110.241 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.93 123.41 49.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.325 -0.398 . . . . 0.23 110.376 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt -81.04 -11.1 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.27 111.084 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -102.69 134.27 46.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.5 109.47 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 HG23 ' A' ' 9' ' ' THR . 0.2 OUTLIER -149.39 85.68 5.73 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.123 -0.231 . . . . 0.72 111.51 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.61 -47.39 4.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.725 2.284 . . . . 0.34 111.072 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 16' ' ' ASN . 81.2 p 48.15 35.43 5.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.156 -0.929 . . . . 0.37 113.433 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.83 -77.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.52 110.195 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.5 -98.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.051 -0.522 . . . . 0.36 109.632 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.7 mt -87.15 89.26 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.25 0.548 . . . . 0.36 109.886 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -143.47 134.83 26.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.599 -0.728 . . . . 1.32 109.754 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.78 61.09 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.86 111.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -9.74 3.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 1.06 110.87 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 t-20 -153.59 63.88 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.191 -1.04 . . . . 1.1 108.191 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 3.5 m -106.31 128.04 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.012 -0.995 . . . . 0.21 111.542 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.16 113.08 18.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.806 . . . . 0.19 109.626 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.15 117.24 19.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.18 110.872 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 89' ' ' ILE . 1.3 p -125.28 128.84 73.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.82 -0.807 . . . . 0.37 108.82 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 30' ' ' GLU . 30.5 ttt180 -137.01 131.48 32.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.595 0.591 . . . . 1.25 112.595 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.464 ' HB2' HG23 ' A' ' 89' ' ' ILE . 19.2 ttt -83.77 140.7 31.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.674 . . . . 0.34 109.556 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.55 99.18 6.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.42 111.036 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -111.6 -179.69 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 0.82 110.331 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.09 -54.47 45.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.477 0.486 . . . . 0.09 112.072 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.94 28.73 3.64 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.23 111.845 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -148.17 146.84 28.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.775 0.321 . . . . 1.05 110.359 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.82 142.54 20.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.228 -0.656 . . . . 1.13 109.228 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 24.6 m-85 -145.85 129.32 16.92 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.376 0.423 . . . . 0.65 110.497 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.594 ' OE1' ' HD2' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -119.95 137.57 53.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.873 0.368 . . . . 0.34 110.711 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.89 -171.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.69 110.455 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -141.51 133.97 28.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.13 111.954 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.36 158.66 19.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.064 -0.516 . . . . 0.38 110.755 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -82.41 120.79 25.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.704 0.631 . . . . 0.38 112.704 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 84.3 mttt 44.38 39.32 3.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.131 1.16 . . . . 0.76 114.131 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.92 18.85 4.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.405 0.52 . . . . 1.71 112.405 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -73.01 1.16 9.44 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.002 0.43 . . . . 0.46 111.424 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.81 -19.58 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.365 0.603 . . . . 0.27 110.241 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.05 3.33 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.435 0.636 . . . . 0.18 109.87 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.1 -55.56 23.48 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.241 -0.89 . . . . 0.1 113.204 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -70.23 -6.14 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.241 0.52 . . . . 0.29 112.118 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -2.72 58.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.888 0.375 . . . . 0.5 110.04 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 m -144.35 -16.0 0.57 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.109 0.411 . . . . 0.65 112.109 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.13 44.03 1.95 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.984 -0.627 . . . . 0.23 111.892 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG13 ' HB2' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -139.27 29.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.395 . . . . 0.53 110.16 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -80.68 169.82 17.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 1.96 112.257 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -157.39 -168.55 2.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.086 -0.961 . . . . 0.43 108.503 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.47 140.27 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.352 0.596 . . . . 0.64 111.016 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.629 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -85.44 4.52 35.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.803 -0.635 . . . . 0.31 110.632 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.44 -24.29 42.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.597 -0.729 . . . . 0.67 110.645 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -108.42 -30.52 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.41 111.05 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -68.65 -24.82 29.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.484 -0.326 . . . . 0.6 111.299 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.47 116.25 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.676 -0.49 . . . . 0.58 109.676 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -88.12 -43.22 11.82 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.86 111.015 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -119.86 118.11 29.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.08 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -81.38 4.62 20.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.219 0.533 . . . . 0.63 110.272 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.459 ' H ' HG22 ' A' ' 55' ' ' THR . 4.3 m -115.62 134.59 54.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.13 150.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 110.087 -0.338 . . . . 0.24 110.087 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.43 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 70.7 m-85 -103.66 139.64 38.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.648 0.261 . . . . 0.42 110.551 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 2.1 t -87.05 -16.43 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.475 -0.565 . . . . 0.41 109.475 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 66.9 t30 175.76 97.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.284 -0.871 . . . . 0.46 109.854 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.52 -25.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.2 110.827 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -21.08 66.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.23 111.193 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -119.11 0.48 11.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.79 111.016 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.88 29.79 62.51 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.594 -0.812 . . . . 0.31 112.072 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -83.88 101.85 11.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.634 0.254 . . . . 1.36 110.666 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.3 130.88 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.368 -0.378 . . . . 0.25 110.273 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 60' ' ' VAL . . . -99.73 114.78 28.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.16 0.505 . . . . 0.19 110.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.585 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 24.4 pttt -73.82 177.17 5.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 1.5 109.529 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -61.27 -28.53 69.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.09 110.2 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 74' ' ' ILE . 47.7 tt0 -76.35 -27.97 56.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.866 -0.606 . . . . 1.07 110.189 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 7.7 m-20 -72.88 -51.9 16.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.52 110.251 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.94 -33.71 76.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.14 111.198 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -69.61 -23.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.234 0.54 . . . . 0.13 109.954 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -95.65 -21.82 17.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.42 110.715 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.78 -53.09 4.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.399 -0.364 . . . . 0.36 111.706 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -90.17 -34.2 15.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.931 0.396 . . . . 0.36 110.239 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.08 -14.66 44.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.729 -0.748 . . . . 0.46 112.548 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p -115.61 141.8 47.58 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.778 -0.248 . . . . 1.15 110.989 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.12 -10.77 51.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.159 -0.682 . . . . 0.58 109.159 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.43 120.78 25.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.096 -0.956 . . . . 1.03 109.898 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.98 -22.56 61.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.947 -0.57 . . . . 0.43 112.419 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -58.93 -49.67 76.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.274 -0.17 . . . . 0.13 111.091 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.37 -43.36 99.01 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.047 0.451 . . . . 0.82 111.008 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.48 -52.32 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 0.16 110.769 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.81 -35.56 76.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.15 110.778 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -62.34 -46.58 88.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.379 . . . . 0.43 110.366 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.65 110.764 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 22' ' ' MET . 77.9 mt -69.18 -28.31 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 0.17 109.967 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -38.09 36.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.718 -0.674 . . . . 0.27 111.922 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 92' ' ' LYS . 12.1 t -93.36 -10.11 36.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.544 0.572 . . . . 0.17 112.544 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' A' ' 91' ' ' THR . 34.6 mmtm -137.55 35.35 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.023 -0.423 . . . . 0.78 111.206 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.18 -147.37 4.53 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.581 -0.819 . . . . 0.19 112.237 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -136.06 128.79 30.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.649 -0.501 . . . . 1.16 109.649 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -139.99 142.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.559 -0.292 . . . . 0.35 110.892 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.61 84.29 1.57 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.201 0.524 . . . . 0.38 109.883 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 95' ' ' VAL . 5.5 m -100.95 167.04 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.44 0.638 . . . . 0.58 112.584 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.4 m -156.0 156.9 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.851 -1.068 . . . . 1.14 108.219 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.78 149.85 43.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.996 0.426 . . . . 1.31 110.708 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.5 -179.76 4.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.29 111.567 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.89 132.93 33.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 1.22 110.299 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.63 121.01 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.685 0.615 . . . . 0.89 111.078 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.474 ' HB2' HG13 ' A' ' 45' ' ' VAL . 30.6 m80 -140.95 -175.79 4.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.684 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -108.07 154.59 21.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.011 0.434 . . . . 0.48 109.942 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.58 -33.79 0.86 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.707 -0.679 . . . . 0.28 110.377 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt 56.57 38.13 29.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.644 -0.707 . . . . 0.5 111.182 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -138.15 104.37 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.65 110.464 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 57.2 54.08 7.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.154 0.502 . . . . 0.59 110.007 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.3 ttt -54.61 -36.61 64.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.445 -0.798 . . . . 1.88 111.883 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -64.08 -40.55 96.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 1.43 110.16 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -69.28 -39.66 78.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 1.45 110.078 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.429 ' HA ' ' NH2' ' A' ' 111' ' ' ARG . 0.3 OUTLIER -58.73 -56.96 15.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.561 -0.745 . . . . 0.42 111.255 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 113' ' ' ILE . 7.5 tp -65.63 -28.66 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.32 111.612 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.64 66.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.22 110.779 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.1 m -71.83 -32.42 67.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.104 0.478 . . . . 1.17 110.699 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.16 -29.65 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.54 . . . . 0.22 111.106 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.02 -20.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.396 -0.366 . . . . 0.12 111.0 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.28 -56.65 14.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.542 -0.299 . . . . 0.19 111.762 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.83 -29.52 70.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.54 111.327 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HG3' ' OD2' ' A' ' 215' ' ' ASP . 64.5 tttp -70.65 -30.29 66.87 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.859 -0.609 . . . . 0.45 111.195 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 55.1 m -93.55 89.99 6.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.264 0.554 . . . . 0.26 110.453 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.03 118.21 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.375 0.607 . . . . 1.0 111.632 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -135.42 61.45 44.28 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.31 109.913 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 90.3 Cg_endo -79.99 36.03 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.656 2.238 . . . . 0.4 113.306 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -84.64 -54.79 4.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.486 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 t -132.48 0.16 3.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.378 0.609 . . . . 0.96 110.394 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 2.0 tpmt? -143.98 164.62 30.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 0.86 109.792 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.422 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -95.32 141.57 23.41 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.111 -0.7 . . . . 0.33 109.111 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.09 -20.17 44.6 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.85 2.367 . . . . 0.38 113.024 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.54 40.8 0.6 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.018 0.437 . . . . 1.15 110.981 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -125.83 84.76 2.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.375 0.607 . . . . 0.39 109.888 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.14 -25.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.178 -0.919 . . . . 0.25 112.3 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.9 mm -50.01 -51.06 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.245 0.831 . . . . 0.5 113.245 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.396 0.517 . . . . 0.42 112.396 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 tp -79.99 -26.56 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.891 0.376 . . . . 0.15 111.045 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.72 -46.23 83.16 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.148 -0.478 . . . . 1.06 110.034 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.73 -44.04 93.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 1.07 110.307 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -63.78 -41.65 97.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 0.18 110.742 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -63.22 -38.52 91.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.58 110.35 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -31.46 69.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.112 -0.494 . . . . 0.76 110.462 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.18 -53.42 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.735 -0.468 . . . . 1.22 109.735 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 138' ' ' ALA . 10.4 tp -88.75 50.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 122.896 1.331 . . . . 0.69 109.544 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -85.04 16.47 3.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.703 -1.135 . . . . 0.53 110.842 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.19 151.7 35.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.681 -0.691 . . . . 1.53 110.109 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.2 m -64.18 116.72 6.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.62 110.708 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.2 t -103.32 -51.08 9.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.35 110.872 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -136.35 -171.72 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.81 110.614 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.46 -34.15 76.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 0.25 110.11 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.57 101.29 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.437 -0.802 . . . . 0.7 109.674 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -85.25 71.21 10.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 0.98 109.477 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 m -133.2 129.0 37.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.883 -0.599 . . . . 0.38 111.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -7.41 46.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.25 110.958 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.03 9.55 6.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.783 -0.644 . . . . 0.24 110.611 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -162.31 -58.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.31 110.049 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -87.33 41.27 0.97 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.976 -0.556 . . . . 0.23 110.362 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.68 -32.65 71.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 0.19 111.663 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.5 mm? -81.01 -2.7 49.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.355 -0.384 . . . . 1.48 111.378 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -111.11 -44.7 3.54 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.963 -0.295 . . . . 2.27 111.091 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -58.48 -42.82 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.39 110.969 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.07 -28.38 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.17 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 16.4 mttp -68.57 -42.78 77.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.853 0.359 . . . . 1.29 110.392 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -35.82 61.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.53 110.659 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.78 -35.15 79.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.21 110.069 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 167' ' ' MET . 2.1 ttpm? -60.28 -20.8 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.112 -0.949 . . . . 1.39 111.662 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -70.72 -20.38 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 1.06 111.191 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -115.11 -47.05 2.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.869 0.366 . . . . 0.9 110.652 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 13.5 tpt -117.59 122.74 44.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 0.25 110.914 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -93.79 110.34 21.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.098 -0.501 . . . . 0.79 110.157 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp -125.87 157.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 0.18 111.083 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 158.54 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.182 -0.463 . . . . 2.59 110.148 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.88 32.65 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.748 0.309 . . . . 0.47 111.546 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.96 118.65 10.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.991 0.424 . . . . 0.44 111.726 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -165.35 134.61 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.28 109.718 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.01 -173.09 2.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 1.39 110.744 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -114.39 140.04 48.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 2.39 110.085 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.51 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 1.7 mt -127.98 150.95 49.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.039 0.447 . . . . 0.71 110.657 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -129.51 174.31 9.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.351 -0.84 . . . . 0.48 109.231 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HE2' ' HG ' ' A' ' 212' ' ' CYS . 3.6 p90 -133.58 145.58 50.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.153 -0.314 . . . . 0.49 110.153 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.25 106.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.42 111.439 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -147.06 157.23 46.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.055 -0.52 . . . . 0.13 110.943 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.31 178.44 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.808 2.339 . . . . 0.14 113.123 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.39 -45.81 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.627 0.603 . . . . 0.4 112.627 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.91 -45.9 85.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.083 0.468 . . . . 1.26 111.607 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.61 -39.74 67.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.7 110.68 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -62.69 -38.33 96.26 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.68 -0.691 . . . . 0.16 113.104 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.08 -34.28 68.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.776 0.287 . . . . 0.58 111.776 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 31.7 mmmt -71.91 -33.32 68.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.566 0.21 . . . . 1.38 111.566 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -85.36 -26.3 26.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.47 109.99 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 80.5 tttt -60.94 -31.55 71.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.22 110.62 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.42 12.68 28.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 3.15 111.197 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 9.2 mtmt -126.5 -58.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.222 0.453 . . . . 0.8 112.222 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.3 -42.01 26.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.641 . . . . 0.16 112.729 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 189' ' ' LYS . 1.6 mtpt -58.16 -50.95 85.22 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.07 0.767 . . . . 0.44 113.07 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 20.5 Cg_endo -60.91 -14.76 34.39 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.456 2.104 . . . . 0.21 113.404 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' A' ' 197' ' ' LYS . 72.4 mt -82.19 -11.51 58.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.37 110.15 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mm 56.64 35.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.569 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -109.64 18.16 20.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 1.87 110.042 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 212' ' ' CYS . 2.9 m -113.6 137.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.259 -0.882 . . . . 0.34 110.384 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.63 148.28 5.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.954 -0.566 . . . . 0.79 109.52 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.7 75.13 0.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.749 0.785 . . . . 0.94 111.559 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.2 m -149.83 33.62 0.68 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.146 -1.057 . . . . 0.46 108.146 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.4 pt-20 -79.72 129.96 34.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.768 -1.106 . . . . 0.8 111.792 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -97.13 105.73 17.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.361 -0.977 . . . . 0.3 108.361 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.44 131.31 45.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.8 110.434 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 163.57 -104.77 0.24 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.848 -0.691 . . . . 0.56 112.127 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.4 -17.27 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.4 0.619 . . . . 1.8 110.016 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -140.67 176.91 8.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.231 -0.895 . . . . 0.47 109.35 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.4 tp -128.27 84.73 2.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.372 -0.603 . . . . 0.46 109.372 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 19.3 tt0 -96.56 109.39 21.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.603 -0.726 . . . . 1.24 110.815 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 5.9 mt -130.97 152.04 36.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.739 0.304 . . . . 0.26 110.314 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.4 t -98.7 117.59 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.09 109.808 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.556 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 21.0 p -122.92 56.02 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.26 111.411 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -126.56 125.29 41.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.034 0.445 . . . . 0.12 111.05 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 pt -114.8 -159.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.412 -0.813 . . . . 0.32 109.751 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.447 ' OD2' ' HG3' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -80.65 162.3 60.95 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 110.127 -0.323 . . . . 0.33 110.127 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.92 -177.42 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.67 2.247 . . . . 0.2 113.157 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.69 1.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.066 -0.814 . . . . 0.15 111.066 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.14 -24.22 65.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.297 0.57 . . . . 1.03 110.039 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.13 -32.35 73.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.32 109.947 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -23.51 63.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.87 110.497 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.4 -38.79 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 1.48 110.72 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.634 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.6 tt -85.11 -24.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.84 111.356 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.12 -30.23 61.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.84 0.352 . . . . 0.65 110.957 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -56.14 -33.07 64.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.714 -0.675 . . . . 1.58 111.447 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.85 -23.99 14.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.769 -0.372 . . . . 0.46 110.927 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 222' ' ' ILE . 46.3 mm -64.51 -37.92 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.36 110.508 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -62.87 -29.19 70.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.32 111.388 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 225' ' ' LEU . 60.1 pttt -105.54 11.29 32.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.619 . . . . 0.74 110.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -96.83 -126.55 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.022 -1.103 . . . . 0.51 108.022 178.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.406 HG21 ' CD2' ' A' ' 178' ' ' PHE . 9.5 t -65.2 -27.91 69.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.868 0.365 . . . . 0.45 110.999 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.27 -12.13 61.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.62 111.083 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -108.37 18.37 33.05 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.964 -0.636 . . . . 0.12 112.591 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -149.13 -44.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.62 0.247 . . . . 0.8 111.042 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -105.74 -171.56 23.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.682 -0.771 . . . . 0.33 112.191 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -107.9 143.32 36.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.724 0.297 . . . . 0.54 110.217 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.48 165.7 13.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 0.92 110.902 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -154.13 151.94 29.84 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.52 -0.918 . . . . 2.09 108.52 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.11 155.07 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.232 0.539 . . . . 0.57 111.576 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 239' ' ' LEU . 0.4 OUTLIER -97.47 77.41 2.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.91 108.279 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -70.96 -26.33 63.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.673 . . . . 1.29 111.243 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 241' ' ' LEU . 1.2 mm? -52.37 132.76 34.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.82 111.093 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -132.62 -1.14 3.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.086 0.469 . . . . 1.32 110.034 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.87 -66.12 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.397 -0.819 . . . . 1.45 110.964 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.86 150.43 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.311 -0.404 . . . . 0.67 110.275 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.07 110.41 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.397 -0.365 . . . . 1.78 110.022 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -114.94 152.4 32.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 2.1 110.961 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -166.44 171.46 41.43 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.941 -0.863 . . . . 0.18 110.941 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.79 90.34 5.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.215 0.531 . . . . 1.21 110.289 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -86.18 -9.96 55.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.81 110.316 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.5 tptp 57.42 62.4 2.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.457 -0.792 . . . . 0.72 110.599 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -63.11 -48.27 79.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.843 -0.617 . . . . 0.97 110.658 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.693 -0.67 . . . . 2.97 110.406 179.629 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.706 -0.558 . . . . 0.48 111.706 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -111.21 105.42 14.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.964 0.382 . . . . 1.25 110.185 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 tpp -153.4 166.03 33.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.15 -0.477 . . . . 0.96 109.999 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -78.3 87.65 4.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.064 0.459 . . . . 0.7 110.295 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mt -101.57 122.94 54.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.77 109.796 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.542 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.0 t80 -71.22 143.68 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.071 -0.344 . . . . 0.81 110.071 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -101.51 98.2 8.94 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.229 -0.441 . . . . 0.56 111.471 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 87.0 Cg_endo -88.99 1.7 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.472 2.115 . . . . 0.54 111.646 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m 62.28 75.33 0.41 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.277 -0.874 . . . . 0.48 110.839 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -87.7 155.05 20.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.46 110.464 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -63.33 -39.45 94.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.2 112.256 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 54' ' ' GLN . 17.5 mt -145.7 82.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.628 0.252 . . . . 0.49 111.237 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -164.18 172.83 13.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 1.45 110.771 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.61 48.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.52 112.27 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -132.99 3.18 3.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.215 0.531 . . . . 0.35 110.66 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.77 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.704 -0.85 . . . . 0.35 108.704 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 22.8 m -100.46 150.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.981 -1.009 . . . . 0.37 112.527 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.37 111.77 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.378 -0.971 . . . . 0.31 108.378 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.41 110.89 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.78 111.991 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -103.54 135.93 38.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 0.32 109.005 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.93 127.92 47.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.81 111.996 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.421 ' HB2' HG23 ' A' ' 89' ' ' ILE . 57.8 ttp -101.16 115.39 30.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.312 -0.625 . . . . 0.28 109.312 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 115.86 24.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.433 . . . . 0.87 110.604 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 25.4 mmm-85 -123.93 163.72 20.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.989 -0.551 . . . . 0.9 110.365 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.84 76.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.47 110.872 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.83 -57.7 4.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.799 . . . . 0.38 112.242 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -159.47 152.17 21.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.13 -0.322 . . . . 0.85 110.13 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 2.2 ptt180 -91.41 149.03 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.564 -0.532 . . . . 1.88 109.564 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -129.46 120.29 25.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.415 -0.357 . . . . 0.48 110.654 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 4.8 mt-10 -116.82 123.9 48.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.52 110.9 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mt -128.29 146.82 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.067 -0.346 . . . . 0.27 110.067 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -102.9 103.22 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 0.14 110.303 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 p -100.96 -162.44 0.94 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.12 -0.491 . . . . 0.5 110.749 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.719 ' HB2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.69 -174.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.049 0.452 . . . . 0.52 111.17 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -75.01 -139.83 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.567 -0.742 . . . . 1.15 110.491 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.48 -10.79 37.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.947 0.403 . . . . 0.24 111.546 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -62.85 -30.85 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.42 111.16 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.8 -23.99 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.029 0.442 . . . . 0.2 111.067 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.95 -30.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.439 0.638 . . . . 0.2 110.2 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.68 18.42 50.17 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.606 -0.724 . . . . 0.46 112.126 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 40.3 t90 -80.13 -54.33 5.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.82 0.343 . . . . 0.51 110.813 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -97.98 -13.7 20.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.285 0.564 . . . . 1.42 110.233 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.4 m -101.61 14.66 31.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 0.54 110.218 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.33 -146.4 5.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.561 -0.745 . . . . 0.29 111.655 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.73 112.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.731 0.3 . . . . 0.43 110.59 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 41' ' ' TRP . 28.7 mm-40 -130.14 -159.09 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.485 -0.325 . . . . 0.46 110.251 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -112.68 -159.07 0.67 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.586 -0.279 . . . . 0.81 110.719 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.2 140.04 56.32 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.004 -0.544 . . . . 1.21 110.493 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -80.9 -18.02 48.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.115 0.783 . . . . 0.44 113.115 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.8 t70 -67.3 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.555 -0.535 . . . . 1.4 109.555 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.56 -19.83 62.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.191 0.519 . . . . 1.02 110.001 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 34' ' ' TYR . 69.2 t -78.83 -23.47 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.32 109.287 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.65 92.62 4.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.255 -0.884 . . . . 1.3 110.432 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' HG23 ' A' ' 12' ' ' ILE . 33.7 mm-40 -60.36 -44.47 95.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 1.3 109.939 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.4 p -115.05 121.57 43.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.753 -0.658 . . . . 1.14 109.992 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -87.76 23.26 2.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.309 0.576 . . . . 0.49 110.204 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.8 157.78 27.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.401 -0.818 . . . . 0.32 109.5 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.3 p -130.16 135.32 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.22 111.128 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . 61.8 m-85 -91.03 138.62 31.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.415 -0.357 . . . . 0.64 110.422 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' A' ' 68' ' ' ALA . 2.1 t -94.93 -33.32 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.571 . . . . 0.55 110.037 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -164.68 93.48 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.62 109.539 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 p -66.09 -20.47 27.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.41 111.509 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.07 -4.53 55.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.5 110.85 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -126.95 -16.03 5.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.897 -0.592 . . . . 1.21 110.588 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.95 17.78 57.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.927 -0.654 . . . . 0.32 111.496 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.58 113.08 22.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.846 0.355 . . . . 0.81 110.563 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.61 141.26 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.52 109.969 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 60' ' ' VAL . . . -101.54 126.21 48.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.653 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 71' ' ' GLU . 10.9 ptpt -98.97 -171.7 2.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.661 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -59.73 -30.08 68.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.24 111.353 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.596 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 6.4 tt0 -80.67 -1.11 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.119 0.485 . . . . 1.39 110.768 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.56 -52.4 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.455 -0.339 . . . . 1.58 110.979 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -31.61 71.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.32 111.611 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -29.95 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.54 110.919 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -98.65 -29.31 13.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.971 0.415 . . . . 0.76 111.074 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.58 45.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.507 . . . . 0.22 111.43 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -105.24 -41.54 5.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.487 -0.324 . . . . 0.41 110.79 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.96 -23.83 5.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.176 -1.011 . . . . 0.22 112.221 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -97.98 133.95 41.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.68 0.276 . . . . 0.46 110.682 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.16 10.93 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.307 0.575 . . . . 0.57 110.429 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -106.86 128.31 54.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.79 -0.641 . . . . 0.65 109.69 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -69.98 -19.24 63.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.62 -0.264 . . . . 0.32 111.289 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 49' ' ' LEU . 7.9 m -60.54 -45.85 92.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.365 -0.38 . . . . 0.43 111.002 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -71.13 -23.36 62.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 1.42 111.309 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mm -77.81 -52.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.379 . . . . 0.24 110.158 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.95 -41.75 99.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.92 -0.582 . . . . 0.36 111.131 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 83' ' ' THR . 8.0 tttt -58.65 -31.84 68.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.92 110.91 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 91' ' ' THR . 1.6 tt0 -76.09 -46.36 29.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.909 -0.587 . . . . 0.72 110.332 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 20' ' ' VAL . 72.2 mt -65.82 -31.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.29 111.211 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -8.21 59.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 0.35 111.449 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -102.31 -28.44 12.26 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.778 -0.369 . . . . 0.24 111.554 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -144.05 43.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.234 0.54 . . . . 1.22 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.18 172.78 20.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.651 -0.785 . . . . 0.29 112.117 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.38 89.92 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.862 0.363 . . . . 1.39 110.539 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 p -104.77 149.29 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.3 110.248 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.07 98.13 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.19 0.519 . . . . 1.78 111.048 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.86 172.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.29 110.598 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -122.24 -86.62 0.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.874 -0.417 . . . . 0.87 109.874 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.26 149.78 48.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.927 -0.397 . . . . 1.63 109.927 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 26.36 0.38 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.954 0.406 . . . . 1.17 110.257 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -70.2 124.35 23.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.902 -0.59 . . . . 1.01 111.732 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -121.97 -56.61 1.83 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.31 109.657 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 26.7 m-70 60.61 98.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.906 0.754 . . . . 0.41 112.537 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.5 m -147.76 105.93 3.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.781 -0.645 . . . . 0.3 109.599 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -119.04 145.82 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.41 111.438 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 109' ' ' MET . 1.5 mt -165.01 136.45 4.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.492 -0.776 . . . . 0.45 109.489 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 108' ' ' GLN . 0.4 OUTLIER -74.94 152.84 38.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.261 -0.274 . . . . 1.44 110.261 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 82.6 mt-30 75.1 -11.24 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.053 0.845 . . . . 0.31 111.397 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -60.62 -34.26 73.99 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.988 0.423 . . . . 0.35 110.961 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -64.88 -22.87 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.38 111.338 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.6 -26.92 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 1.74 109.963 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.6 -53.09 12.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.59 109.989 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.84 -30.37 49.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.869 -0.605 . . . . 0.34 110.642 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.14 110.678 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.8 m -71.17 -39.05 72.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 1.12 110.923 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.68 -41.04 77.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.792 -0.64 . . . . 1.91 111.255 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.95 -16.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.091 -0.504 . . . . 0.21 112.19 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.98 82.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.83 0.348 . . . . 0.15 111.629 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -17.93 26.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.256 0.55 . . . . 0.26 110.37 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -81.72 -46.89 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.842 -0.617 . . . . 0.77 111.109 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.7 m -87.72 87.01 7.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.166 0.507 . . . . 0.21 110.555 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -100.08 -177.98 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.54 -0.755 . . . . 0.35 110.759 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -141.67 155.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.046 -0.353 . . . . 0.91 110.046 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.92 57.28 5.67 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.993 2.462 . . . . 0.54 113.209 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -131.81 -174.17 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.364 -0.606 . . . . 0.78 109.364 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 t -66.76 -31.74 72.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.46 110.552 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -106.57 83.25 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.709 -0.478 . . . . 0.99 109.709 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HB2' ' HD3' ' A' ' 129' ' ' PRO . 18.9 mtp180 -72.97 -55.72 3.82 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.915 -0.584 . . . . 0.49 111.254 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 128' ' ' ARG . 74.4 Cg_endo -76.13 118.46 4.98 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.271 1.314 . . . . 0.22 111.572 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -88.04 -179.63 6.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.905 0.383 . . . . 0.4 110.972 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -101.72 158.79 15.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.289 -0.414 . . . . 0.46 110.633 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.4 -36.08 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.21 109.991 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mm -64.93 -36.78 78.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.342 -0.845 . . . . 0.39 111.279 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 134' ' ' LEU . 14.9 mt -64.18 -51.48 63.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.571 -0.286 . . . . 0.57 110.988 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.18 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.829 -0.348 . . . . 0.39 110.147 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.09 -40.16 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.463 . . . . 1.47 109.87 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -32.9 71.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.683 -0.69 . . . . 0.66 110.518 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.78 -36.89 21.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.294 -0.412 . . . . 0.28 110.634 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -66.32 -45.45 80.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.71 110.96 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -72.01 -15.67 62.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 1.08 110.568 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.45 -33.61 54.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 0.52 109.737 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.5 52.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.209 1.004 . . . . 1.85 110.102 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.58 37.37 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.93 111.201 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -82.91 110.63 18.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.926 -0.579 . . . . 0.73 110.162 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.4 m -73.08 116.82 14.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.061 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.8 -43.4 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.52 110.558 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -132.04 152.57 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.88 110.226 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.25 1.44 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 0.66 110.808 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' HIS . 27.3 t-20 -66.39 -37.48 85.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.91 110.341 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt 50.99 57.38 6.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.56 -0.746 . . . . 0.71 110.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 15.8 m -118.91 118.31 31.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.119 -0.491 . . . . 0.51 110.954 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -52.53 -61.64 2.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.2 0.815 . . . . 0.63 113.2 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 5.21 3.29 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.962 0.727 . . . . 0.47 112.962 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -109.76 -44.55 3.81 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.816 -0.354 . . . . 0.86 110.583 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.21 10.73 36.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.806 0.336 . . . . 0.47 110.548 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.05 83.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.604 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -67.29 -21.6 65.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 1.61 111.257 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.28 -49.54 9.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.88 109.835 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.33 -40.14 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.535 . . . . 0.15 111.148 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.23 -8.17 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.201 0.524 . . . . 0.27 111.765 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -113.0 -37.16 4.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.503 -0.555 . . . . 0.4 109.503 178.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.39 -45.83 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.725 . . . . 1.39 110.338 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.43 -29.62 69.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.956 -0.565 . . . . 0.34 110.358 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.91 -20.98 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.9 110.414 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.04 -10.75 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 2.45 110.595 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -108.04 -26.31 10.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.957 -0.565 . . . . 1.08 110.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.9 ttp -150.03 125.85 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.885 -0.598 . . . . 2.64 110.042 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -72.19 121.45 19.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 1.86 110.538 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.3 pt -131.51 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.34 110.475 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -104.97 172.51 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.635 -0.505 . . . . 1.04 109.635 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -79.51 166.26 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 2.15 111.155 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.9 175.84 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.08 111.442 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -96.69 148.72 22.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.596 . . . . 1.1 110.151 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.6 mmm -97.45 172.49 7.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.98 110.928 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.07 140.21 35.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 1.31 111.275 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 211' ' ' VAL . 1.1 mp -124.56 146.13 49.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.38 110.347 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 22.0 ptt85 -113.54 139.74 48.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.824 -0.625 . . . . 0.25 110.451 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 48.7 t80 -105.94 125.87 51.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.289 -0.414 . . . . 0.7 110.253 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 pt -114.09 135.59 53.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.672 0.272 . . . . 0.52 111.407 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -178.53 163.03 1.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.19 109.568 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.27 165.76 31.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.151 1.901 . . . . 0.21 112.151 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 t -63.96 -21.93 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.342 -0.39 . . . . 0.09 111.574 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -47.89 -60.78 2.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.146 -0.479 . . . . 0.45 111.784 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -93.82 -20.84 19.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.917 0.389 . . . . 0.37 109.985 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.23 93.68 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.793 -0.639 . . . . 0.07 113.485 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -60.33 -33.98 73.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.835 0.317 . . . . 0.34 110.943 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.03 -48.56 78.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.951 -0.568 . . . . 0.86 111.602 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -21.95 47.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.991 -0.284 . . . . 0.17 111.184 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -60.67 -47.82 84.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.58 110.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.59 16.64 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.78 111.222 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.42 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 31.4 mttm -119.93 -50.53 2.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.758 0.313 . . . . 1.53 111.346 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.49 -39.79 27.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.603 0.594 . . . . 0.6 112.603 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 12.2 mtpp -61.66 -52.98 65.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.791 0.663 . . . . 0.44 112.791 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.7 Cg_endo -65.51 -19.8 60.69 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.99 1.793 . . . . 0.25 112.974 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 195' ' ' LEU . 16.9 mt -86.53 -2.24 58.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.66 -0.245 . . . . 0.5 110.797 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.5 mt 54.44 59.52 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.422 0.63 . . . . 0.46 111.399 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.414 ' CE ' ' HB3' ' A' ' 195' ' ' LEU . 14.9 mtmt -139.55 35.83 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.516 0.674 . . . . 1.53 109.673 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.69 167.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.37 109.964 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.1 mt -119.99 150.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 0.69 109.315 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -73.04 71.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.353 0.597 . . . . 2.54 111.701 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 m -151.71 35.71 0.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.3 -1.0 . . . . 0.61 108.3 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.0 mt-10 -94.84 152.65 18.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.919 -1.037 . . . . 1.59 111.585 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -105.99 148.49 27.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.63 109.206 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -138.22 94.92 2.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.873 0.368 . . . . 1.3 110.56 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -162.96 -108.45 0.22 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.156 -0.778 . . . . 0.28 111.156 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -25.46 19.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.694 0.759 . . . . 1.58 108.981 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -119.78 165.18 14.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.717 -1.129 . . . . 0.72 109.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.63 78.17 1.77 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.798 0.333 . . . . 0.72 110.599 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 33.8 tt0 -75.12 107.44 7.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.873 -0.788 . . . . 0.49 108.873 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 202' ' ' GLU . 74.2 mt -121.19 135.82 60.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.027 0.441 . . . . 0.43 111.941 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 176' ' ' LEU . 45.3 t -100.98 107.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.16 -0.682 . . . . 0.3 109.16 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.17 26.66 9.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.241 0.46 . . . . 0.95 112.241 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.402 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.4 OUTLIER -105.24 121.08 43.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.849 0.356 . . . . 0.66 110.481 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.38 -165.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.7 111.231 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.608 ' OD2' ' HD2' ' A' ' 216' ' ' PRO . 0.1 OUTLIER -64.86 160.38 55.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.791 -0.641 . . . . 1.13 111.111 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.608 ' HD2' ' OD2' ' A' ' 215' ' ' ASP . 59.7 Cg_endo -70.52 -154.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.817 2.344 . . . . 0.3 113.05 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.62 -91.42 0.77 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.403 -0.679 . . . . 0.16 111.403 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.91 -0.38 21.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.24 110.732 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.507 ' HA ' HG22 ' A' ' 222' ' ' ILE . 2.5 p90 -62.42 -24.65 67.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.11 110.557 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -68.44 -29.81 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.354 0.597 . . . . 0.82 110.003 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.11 -34.29 38.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.325 -0.852 . . . . 1.51 110.988 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.571 ' O ' HG12 ' A' ' 226' ' ' ILE . 5.2 tt -77.58 -32.65 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.13 110.559 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.38 -28.34 65.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 0.12 111.05 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -54.28 -40.72 68.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.805 -0.634 . . . . 1.31 111.174 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 229' ' ' GLU . 0.9 OUTLIER -94.34 -38.43 10.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.553 -0.294 . . . . 0.15 110.541 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 222' ' ' ILE . 48.5 mm -54.08 -37.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.33 111.384 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 7.1 ptpp? -59.79 -23.33 63.2 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.789 0.663 . . . . 1.4 112.789 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.13 -25.15 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.443 . . . . 0.41 111.507 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -72.99 -44.15 61.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.944 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -135.06 -42.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.355 0.502 . . . . 0.2 112.355 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 24.8 mtpt -60.08 -25.75 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.801 0.297 . . . . 0.53 111.801 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -100.28 12.8 60.22 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.907 -0.663 . . . . 0.4 112.984 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -101.2 -15.0 17.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.39 110.574 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.4 -131.55 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.862 -0.685 . . . . 0.24 112.14 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 m -129.31 141.61 51.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 0.66 110.726 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.6 pt? -116.65 158.62 23.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.646 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.76 164.88 28.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.038 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.41 154.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.963 0.411 . . . . 0.58 111.267 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.15 100.05 10.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.61 110.572 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -86.42 67.18 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.607 0.717 . . . . 1.45 110.419 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.4 mt -142.56 92.04 2.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.579 -0.737 . . . . 0.78 109.886 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.54 ' H ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -118.77 16.02 13.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.226 -0.897 . . . . 1.09 109.33 -179.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.27 -62.73 1.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.132 -0.94 . . . . 0.83 110.599 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.59 141.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.633 . . . . 0.38 109.993 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -102.47 112.47 25.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.987 0.422 . . . . 1.4 110.457 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.12 153.07 33.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.651 -0.704 . . . . 0.74 110.207 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -128.08 -153.8 8.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.665 -0.778 . . . . 0.31 112.193 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.66 53.05 2.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.6 110.783 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 249' ' ' GLU . 3.0 pt-20 -92.51 17.72 9.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.53 111.008 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' A' ' 252' ' ' GLU . 6.5 tptp -148.21 133.37 18.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.78 109.585 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -98.83 -27.07 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 1.13 111.174 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 250' ' ' LYS . 2.7 pm0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.705 -0.665 . . . . 1.31 109.985 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.013 -0.435 . . . . 0.6 112.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -111.42 145.93 38.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.761 0.281 . . . . 0.86 110.435 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 mmt -95.86 144.88 25.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.331 -0.395 . . . . 1.91 110.58 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 m -156.04 166.46 33.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.697 -0.483 . . . . 1.22 109.697 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -83.17 74.06 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.32 0.581 . . . . 0.89 110.076 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.35 147.8 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.89 -0.595 . . . . 1.56 109.725 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -122.09 84.94 45.85 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.577 0.227 . . . . 0.38 110.517 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HB2' ' OD1' ' A' ' 10' ' ' ASN . 36.7 Cg_endo -66.03 -36.47 29.87 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.53 2.153 . . . . 1.55 112.312 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 37.85 49.16 1.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.895 0.878 . . . . 1.26 112.668 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' A' ' 8' ' ' PRO . 16.6 m120 -68.28 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 1.58 110.779 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -123.41 -81.01 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.535 -0.542 . . . . 2.1 109.535 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.44 98.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.445 -0.576 . . . . 0.89 109.445 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -141.82 145.1 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.863 -0.608 . . . . 0.52 110.331 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.01 13.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.244 -0.435 . . . . 0.57 111.709 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 p -96.02 -6.03 39.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.897 0.38 . . . . 1.0 111.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -151.02 52.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.154 0.502 . . . . 1.18 110.087 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.77 132.43 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.925 -0.58 . . . . 0.24 110.846 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.25 123.17 36.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.741 -0.466 . . . . 0.11 109.741 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 t -81.6 114.82 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.332 0.587 . . . . 0.17 111.147 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.757 HG13 HG13 ' A' ' 31' ' ' ILE . 1.3 p -125.0 133.04 70.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.939 -0.763 . . . . 0.17 108.939 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.402 HH12 ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -141.31 147.18 37.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.13 111.726 -178.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HD3' ' A' ' 24' ' ' ARG . 43.1 ttp -120.7 117.48 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.15 110.187 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -99.5 114.7 27.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.291 -0.413 . . . . 0.72 109.932 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HD3' ' SD ' ' A' ' 22' ' ' MET . 14.7 mmm-85 -100.55 -172.73 2.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.266 -0.425 . . . . 0.34 109.883 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.46 -24.24 46.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.844 0.313 . . . . 0.66 111.844 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.17 -58.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.418 -0.896 . . . . 1.09 113.135 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -123.26 175.91 6.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.079 0.466 . . . . 1.58 110.934 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.13 142.76 48.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 0.98 108.979 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -130.94 119.21 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.787 0.327 . . . . 0.86 111.147 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 130.8 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 1.11 109.915 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.757 HG13 HG13 ' A' ' 20' ' ' VAL . 7.2 pt -135.71 172.27 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.84 0.352 . . . . 0.26 110.661 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 122.31 22.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.262 -0.426 . . . . 0.21 110.387 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 m -118.63 -163.35 0.95 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 1.37 110.848 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 t80 -72.94 -171.15 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.3 110.715 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -71.59 -157.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.279 -0.419 . . . . 0.59 111.828 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -48.67 -22.64 0.82 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.303 0.853 . . . . 1.3 113.303 -178.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -60.69 -18.81 56.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.28 -22.81 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 111.842 0.312 . . . . 0.15 111.842 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.564 ' HB ' HG11 ' A' ' 97' ' ' VAL . 4.0 p -76.02 -10.83 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.016 0.436 . . . . 0.31 110.838 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.86 -25.69 69.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.986 -0.626 . . . . 0.1 112.073 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -61.65 -45.87 92.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.647 0.26 . . . . 2.03 111.386 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.96 17.48 9.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.55 110.949 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m -118.43 -37.01 3.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.57 110.627 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.03 -107.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.615 -0.594 . . . . 0.15 111.615 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.22 123.67 68.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.221 -0.288 . . . . 0.63 110.221 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.93 176.73 6.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 1.46 110.885 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 6.8 ptmt -69.77 -64.12 0.94 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 1.26 111.582 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 5.5 t70 -169.32 123.15 0.79 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.629 -0.508 . . . . 0.93 109.629 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.83 -35.57 76.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.197 0.443 . . . . 0.2 112.197 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.11 -39.52 89.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.523 . . . . 0.75 110.375 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -91.57 16.93 9.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.682 -0.69 . . . . 0.82 110.603 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.1 -38.03 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 0.35 110.132 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 81.42 6.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.144 -0.48 . . . . 0.93 110.708 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 34' ' ' TYR . 39.2 mt-30 -61.66 -71.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.26 110.473 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -85.71 86.53 7.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.078 0.466 . . . . 0.41 109.987 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.72 66.6 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 1.4 110.381 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.0 m -154.76 131.42 10.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.21 -0.905 . . . . 0.39 108.782 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.9 p -103.49 136.08 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.283 0.564 . . . . 0.3 110.977 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -106.45 135.59 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.951 -0.568 . . . . 0.42 110.006 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 17.9 t -89.79 -30.88 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.464 0.65 . . . . 0.18 110.207 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -151.66 103.42 2.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.716 -0.675 . . . . 0.51 110.313 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.65 -23.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.847 0.356 . . . . 0.16 111.465 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -35.62 44.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.037 0.446 . . . . 0.21 110.856 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -89.11 -40.68 12.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.045 -0.525 . . . . 0.48 110.909 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.17 33.57 2.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.899 -0.667 . . . . 0.17 111.504 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.54 106.5 18.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.55 110.764 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.31 129.52 47.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.736 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.07 112.43 24.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.148 0.499 . . . . 0.22 110.759 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -82.35 -176.06 6.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.885 -0.598 . . . . 0.89 109.614 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -60.33 -34.34 73.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.597 0.221 . . . . 1.12 111.597 -178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.9 pm0 -72.86 -13.47 61.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.98 111.447 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.47 -48.52 5.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.839 -0.344 . . . . 0.44 110.574 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.58 -31.27 71.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.695 0.283 . . . . 0.27 111.081 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -23.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.27 0.557 . . . . 0.17 110.314 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.565 . . . . 0.27 110.535 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.82 -50.27 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.32 111.287 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CG ' HG13 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -90.78 -49.56 6.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.379 . . . . 0.55 110.47 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.42 6.03 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.262 -0.735 . . . . 0.28 111.262 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.35 143.36 27.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.279 -0.461 . . . . 0.98 110.407 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.75 -5.19 48.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 0.85 110.846 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -91.55 123.99 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.8 -0.444 . . . . 1.12 109.8 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -64.52 -22.87 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.51 112.019 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -73.21 -32.61 64.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.38 . . . . 0.28 110.958 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -67.56 -36.93 81.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.221 -0.445 . . . . 0.24 111.125 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 77' ' ' PHE . 1.9 mp -66.57 -49.28 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.65 110.209 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.1 m -66.11 -26.07 67.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.19 111.523 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -57.14 -44.91 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.57 111.033 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.62 -40.83 61.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.417 -0.356 . . . . 0.39 110.98 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.497 HG22 HG22 ' A' ' 20' ' ' VAL . 63.3 mt -61.01 -36.55 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.883 0.373 . . . . 0.12 111.728 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.777 0.658 . . . . 0.11 112.777 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -105.8 -26.71 11.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.325 0.861 . . . . 0.19 113.325 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 91' ' ' THR . 31.3 mmmt -108.06 3.17 23.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.45 111.113 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.04 178.42 16.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.737 -0.744 . . . . 0.24 111.873 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.402 ' CD ' HH12 ' A' ' 21' ' ' ARG . 0.7 OUTLIER -95.54 122.52 38.37 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.958 -0.386 . . . . 0.24 109.958 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 HG13 ' A' ' 97' ' ' VAL . 3.3 p -119.18 137.21 53.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.022 -0.535 . . . . 0.22 109.973 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -77.23 84.0 3.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.084 0.468 . . . . 0.36 111.151 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m -135.04 175.66 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.26 110.473 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -124.78 84.36 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.33 110.754 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.4 142.1 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.604 -0.271 . . . . 0.38 111.036 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.35 111.9 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.438 -0.347 . . . . 0.43 110.338 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.05 132.36 20.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.98 110.642 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -138.65 127.48 23.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 2.51 110.007 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -125.67 114.92 19.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.54 0.21 . . . . 0.93 110.503 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 t -102.29 106.05 16.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.356 0.598 . . . . 1.23 111.111 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' HG2' ' HG3' ' A' ' 107' ' ' GLU . 1.6 tt0 -175.27 141.66 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 1.6 109.582 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 mp -99.61 -77.82 0.52 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.361 -0.237 . . . . 0.95 110.361 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 105' ' ' GLN . 10.7 mt-10 52.89 30.66 9.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.003 0.521 . . . . 1.81 112.24 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 60.92 28.08 17.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.35 -0.386 . . . . 0.86 111.408 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.8 ttm -60.73 -19.7 59.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.772 0.32 . . . . 1.64 111.295 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -58.63 -41.22 85.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.74 110.153 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -80.48 -28.9 37.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.86 110.022 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.91 -53.88 53.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.27 110.103 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.1 mt -67.52 -35.06 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.932 -0.576 . . . . 0.22 110.102 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -60.68 -35.96 77.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.637 -0.71 . . . . 0.19 111.474 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -64.22 -31.31 72.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 1.46 111.17 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -78.96 -50.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.233 -0.44 . . . . 0.34 111.319 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 114' ' ' ALA . 8.0 p -65.87 -26.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.085 0.402 . . . . 0.31 112.085 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 122' ' ' VAL . . . -58.78 -37.51 76.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.694 0.257 . . . . 0.44 111.694 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.05 -34.63 15.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.892 0.377 . . . . 1.64 110.937 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.08 -37.62 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.29 111.352 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 88.0 m -139.28 94.92 2.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.334 0.588 . . . . 0.74 110.693 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 118' ' ' ALA . 22.2 m -92.88 164.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.602 -0.726 . . . . 1.1 111.396 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -155.96 132.41 6.01 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.661 -0.699 . . . . 0.89 109.877 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -90.42 27.33 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.01 2.473 . . . . 1.33 112.084 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -100.86 16.04 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 1.47 110.745 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -138.14 -65.56 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.115 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.519 ' H ' HG23 ' A' ' 126' ' ' THR . 12.7 tptm -148.76 -77.64 0.15 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.761 -0.375 . . . . 0.96 111.47 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -158.19 152.19 19.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.523 0.201 . . . . 1.4 111.103 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.74 42.46 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.075 2.517 . . . . 0.84 113.126 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -148.26 30.18 0.86 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.007 0.432 . . . . 1.04 110.234 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.45 ' O ' HD23 ' A' ' 134' ' ' LEU . 20.6 m -151.59 117.82 5.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.634 -0.257 . . . . 0.33 111.624 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.01 -27.91 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.138 0.494 . . . . 0.27 111.174 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -56.47 -25.74 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.17 111.613 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -62.59 -42.56 99.64 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.759 0.314 . . . . 0.34 110.524 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.428 ' N ' ' HG ' ' A' ' 134' ' ' LEU . 6.4 tp -83.76 -29.03 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.759 0.314 . . . . 1.73 110.771 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.55 -34.4 77.0 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.074 -0.713 . . . . 0.93 109.074 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.15 -44.79 92.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.339 -0.846 . . . . 0.79 109.937 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.77 73.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.884 -0.598 . . . . 0.16 110.863 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -58.96 -47.12 86.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.713 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -4.41 51.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.17 -0.468 . . . . 0.65 111.032 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -34.55 23.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.63 109.556 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.441 ' CG1' ' HG3' ' A' ' 166' ' ' LYS . 6.3 mt -93.75 -53.26 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.441 -0.8 . . . . 0.22 110.507 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t60 51.34 47.53 24.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.435 -0.802 . . . . 1.03 110.368 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.85 119.47 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.604 -0.726 . . . . 0.56 110.322 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 97.47 11.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.001 -0.545 . . . . 1.57 111.295 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.78 -169.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.76 -0.654 . . . . 1.52 109.708 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 66.6 mmtt -78.4 89.37 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.621 -0.511 . . . . 1.21 109.621 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -41.85 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.67 112.845 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.16 -12.84 62.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 2.43 111.968 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' GLN . 95.0 mttt -121.36 9.82 10.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.99 111.215 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -87.51 3.78 46.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.89 110.715 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -37.93 87.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.35 111.525 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -155.79 -26.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.915 0.339 . . . . 0.19 111.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 150' ' ' LYS . 43.3 tt0 -68.43 -60.46 2.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.69 110.778 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 159' ' ' VAL . 0.7 OUTLIER -94.33 14.29 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 1.81 111.155 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.07 111.548 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.75 -21.55 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.353 -0.385 . . . . 0.5 111.075 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.55 -39.14 20.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.311 -0.404 . . . . 1.04 110.451 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 155' ' ' GLN . 61.8 t -62.81 -49.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.083 -0.508 . . . . 0.14 111.083 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.7 tp -64.78 -33.56 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.16 110.536 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 1.6 mmmt -69.25 -43.01 74.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 1.48 110.174 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -61.26 -36.06 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.42 110.474 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.6 tp -69.06 -40.4 78.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.906 -0.588 . . . . 0.16 110.558 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -70.93 -11.11 60.78 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.881 -0.599 . . . . 1.02 111.177 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 36.3 mm-40 -73.48 -27.92 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.049 0.452 . . . . 0.98 110.074 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HG3' ' CG1' ' A' ' 142' ' ' ILE . 16.2 mmtt -93.14 -39.01 11.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.16 111.323 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 52.9 mtt -130.32 136.64 49.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.974 0.416 . . . . 0.35 110.896 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -79.77 81.61 6.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 1.61 110.421 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.4 pt -100.21 124.82 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.64 111.691 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -177.72 130.76 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.523 -0.762 . . . . 1.16 109.172 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.89 92.39 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.435 . . . . 1.87 112.13 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.11 137.79 38.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.916 -0.772 . . . . 0.43 108.916 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -142.13 139.42 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.726 0.298 . . . . 1.01 111.234 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.1 mtp -111.28 178.73 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.305 -0.407 . . . . 1.34 110.266 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 213' ' ' LEU . 90.3 mtt180 -115.88 143.62 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 1.01 110.994 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.51 172.15 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.144 -0.48 . . . . 0.26 110.522 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.685 ' HB3' HG22 ' A' ' 211' ' ' VAL . 8.6 ptm180 -141.35 140.17 33.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.58 110.388 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.663 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 9.1 p90 -94.72 150.21 20.45 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.531 -0.468 . . . . 0.27 110.077 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.401 ' C ' HD13 ' A' ' 180' ' ' LEU . 8.4 tt -129.84 118.54 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.545 . . . . 0.46 111.214 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 179' ' ' ILE . 0.0 OUTLIER -152.22 156.87 34.02 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.746 -0.661 . . . . 0.29 110.245 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.22 173.09 10.04 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.397 2.064 . . . . 0.18 112.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.42 -42.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.298 0.481 . . . . 0.44 112.298 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.17 -38.71 87.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.751 0.31 . . . . 0.38 111.571 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.18 -34.81 28.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.043 0.449 . . . . 1.45 110.542 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.15 -29.75 71.97 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.13 112.569 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -65.97 -13.47 59.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.3 . . . . 0.69 111.513 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.92 -18.52 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.706 0.289 . . . . 0.92 110.89 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 178' ' ' PHE . 0.5 OUTLIER -122.98 -17.85 6.6 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.788 0.292 . . . . 1.05 111.788 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 85.4 tttt -55.57 -52.3 64.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.93 110.872 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -98.74 27.58 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.18 111.744 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -137.77 -40.95 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.857 0.317 . . . . 1.46 111.857 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 1.6 tm? -90.97 -40.94 11.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.845 0.355 . . . . 0.94 110.6 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpp -60.29 -48.37 94.2 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.566 . . . . 0.7 112.527 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.1 Cg_endo -58.53 -12.82 15.05 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.529 2.153 . . . . 0.16 113.464 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 192' ' ' LEU . 12.6 mt -76.93 -9.84 58.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.006 -0.368 . . . . 0.45 110.006 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.7 mt 59.3 31.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.517 -0.765 . . . . 0.38 111.14 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -113.51 30.44 7.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.105 -0.498 . . . . 0.56 109.793 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.16 155.43 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.555 -0.748 . . . . 0.38 111.072 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 1.4 mp -103.41 147.76 9.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.434 -0.803 . . . . 0.21 109.453 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -70.39 67.46 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.146 0.498 . . . . 1.15 111.781 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.1 m -156.33 33.4 0.33 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.42 -0.585 . . . . 0.25 109.42 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.1 OUTLIER -90.9 160.96 15.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.4 -0.818 . . . . 1.04 110.77 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.41 141.47 52.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.229 -0.656 . . . . 0.38 109.229 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -116.11 31.42 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.389 . . . . 0.65 110.933 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.81 -125.11 2.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.713 -0.755 . . . . 0.45 112.536 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.89 -31.61 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.195 0.521 . . . . 1.97 109.893 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -110.43 111.81 23.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.664 -0.865 . . . . 0.3 108.664 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.13 73.91 4.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.022 0.439 . . . . 0.49 111.121 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 42.5 mt-10 -83.47 111.6 19.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 1.23 110.523 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.663 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 22.5 mt -125.3 142.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.526 . . . . 0.37 110.908 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 177' ' ' ARG . 94.0 t -98.39 123.9 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.855 -0.794 . . . . 0.22 108.855 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.401 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 13.2 p -137.1 52.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.54 112.0 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 175' ' ' ARG . 4.1 mm? -122.25 114.74 21.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.19 -0.3 . . . . 0.56 110.19 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 215' ' ' ASP . 0.6 OUTLIER -104.99 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.381 -0.372 . . . . 0.72 110.339 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 214' ' ' ILE . 2.8 m-20 -80.5 164.27 52.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 1.24 110.624 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.75 -178.04 2.51 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.16 1.907 . . . . 0.35 112.176 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.2 -79.99 1.43 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.517 -0.849 . . . . 0.24 111.567 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -16.73 64.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.084 0.469 . . . . 0.4 110.878 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 1.3 p90 -62.41 -20.61 64.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.15 110.932 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 220' ' ' ARG . 6.3 tpt180 -65.43 -21.98 66.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.18 0.514 . . . . 0.23 110.303 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -76.29 -33.15 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.546 -0.752 . . . . 1.46 110.878 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 9.3 tt -95.15 -26.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 1.06 110.836 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -34.95 71.55 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.061 -0.518 . . . . 0.19 111.527 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -29.37 70.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.74 111.834 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -97.9 -30.89 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.518 -0.473 . . . . 0.44 111.825 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 222' ' ' ILE . 19.8 mm -57.33 -40.42 73.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 0.21 111.152 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.0 ptpp? -69.23 -8.39 45.42 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.28 0.845 . . . . 0.91 113.28 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -124.7 -31.1 3.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.563 -0.455 . . . . 0.26 111.842 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -54.21 7.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.296 0.48 . . . . 1.1 112.296 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.0 t -108.02 -42.86 4.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.733 0.642 . . . . 0.13 112.733 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 79.4 tttt -61.42 -34.69 75.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 1.98 111.234 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.12 10.41 73.66 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.473 -0.87 . . . . 0.62 112.684 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -140.69 20.32 2.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 1.53 111.141 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 173.67 -145.71 8.4 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.582 -0.818 . . . . 0.37 112.357 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.4 m -138.62 147.31 42.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.374 -0.232 . . . . 0.43 110.374 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 1.1 pt? -121.5 135.45 55.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.849 0.357 . . . . 0.43 110.333 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -129.1 173.28 10.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 1.15 110.422 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -79.4 164.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.56 -0.291 . . . . 0.12 110.696 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 175' ' ' ARG . 1.2 pt? -88.75 14.17 10.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 1.31 110.179 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -82.47 69.4 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.555 -0.748 . . . . 0.57 110.284 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.421 ' HB3' ' OE1' ' A' ' 246' ' ' GLU . 34.3 tp -115.75 -78.79 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.63 -0.714 . . . . 0.65 110.327 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 51.16 36.56 16.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.041 0.537 . . . . 2.81 111.564 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.38 -9.1 13.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.474 0.654 . . . . 1.43 110.376 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.2 p -157.88 174.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.544 -0.91 . . . . 0.46 108.544 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 244' ' ' VAL . 1.5 mp0 -55.96 98.63 0.03 OUTLIER 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.267 0.556 . . . . 2.53 111.173 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.421 ' OE1' ' HB3' ' A' ' 241' ' ' LEU . 3.0 tt0 -88.76 75.84 8.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.484 -0.78 . . . . 1.91 111.132 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 128.69 126.76 2.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.388 -0.91 . . . . 0.69 112.721 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 250' ' ' LYS . 37.3 t0 -139.66 99.9 3.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -96.41 17.75 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 1.78 111.336 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 0.9 OUTLIER -82.27 81.1 8.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.317 0.58 . . . . 1.2 110.209 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -74.34 -25.95 59.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 1.23 109.64 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.189 -0.914 . . . . 1.53 109.939 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.964 0 N-CA-C 112.311 -0.316 . . . . 0.65 112.311 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -85.37 160.03 19.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 1.35 111.148 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -116.31 154.5 30.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.139 -0.482 . . . . 0.5 110.042 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -130.42 170.44 14.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.332 . . . . 0.73 110.851 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mt -76.17 -59.64 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.846 -0.427 . . . . 0.7 109.846 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -83.56 159.57 21.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.676 -0.693 . . . . 1.36 110.171 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -140.78 89.63 10.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.881 0.372 . . . . 0.37 110.452 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.86 155.38 34.45 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.059 2.506 . . . . 0.47 112.575 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.28 123.29 49.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.61 110.651 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.759 -0.459 . . . . 0.75 109.759 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -71.73 -40.34 69.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 0.73 109.464 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -129.4 98.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.674 -0.861 . . . . 0.95 108.674 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -144.97 135.77 24.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.408 -0.36 . . . . 1.78 110.868 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 17' ' ' VAL . 98.5 mt -66.16 -16.61 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 1.34 112.02 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -89.65 -2.97 58.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.756 0.313 . . . . 0.62 111.382 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -114.75 14.61 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.58 110.544 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' LEU . 23.2 m -86.93 151.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.008 -0.542 . . . . 0.28 111.39 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.72 53.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.653 -0.703 . . . . 0.25 109.626 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.59 117.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.959 0.409 . . . . 0.59 111.139 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 89' ' ' ILE . 1.5 p -138.59 125.43 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.932 -0.576 . . . . 0.18 110.291 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 143.38 50.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.042 0.448 . . . . 2.38 111.598 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.402 ' HB2' HG23 ' A' ' 89' ' ' ILE . 11.3 ttt -109.15 129.12 55.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.607 -0.724 . . . . 0.24 110.047 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -100.09 116.62 32.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.662 0.267 . . . . 1.04 110.746 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -112.0 41.18 2.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 2.46 110.165 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 63.35 90.42 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.522 -0.763 . . . . 0.6 111.061 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.52 -48.29 3.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 0.29 112.017 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -98.63 108.56 21.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.052 0.453 . . . . 1.32 110.659 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.39 143.95 48.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 1.89 109.979 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.546 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 97.0 m-85 -132.59 150.01 52.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.55 110.441 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -138.87 154.06 48.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.662 0.268 . . . . 1.26 110.594 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.431 HD12 HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -137.55 169.66 18.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.892 -0.594 . . . . 0.51 110.153 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.46 21.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.369 . . . . 0.21 111.384 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -121.54 165.61 15.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.917 -0.583 . . . . 0.5 110.333 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -75.0 129.7 38.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.067 0.46 . . . . 0.31 111.373 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 37' ' ' LYS . 67.8 tttt -67.85 147.51 52.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.636 -0.711 . . . . 1.17 111.057 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.14 -21.47 0.25 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.86 0.864 . . . . 0.7 111.816 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 35' ' ' LYS . 28.7 mmtm -94.91 -45.08 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.051 0.453 . . . . 0.62 110.467 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 p -68.67 -18.27 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.955 -0.566 . . . . 0.33 111.864 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 97' ' ' VAL . 7.6 p -67.71 -16.37 20.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.171 0.51 . . . . 0.41 110.641 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.19 -35.17 90.46 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.762 -0.654 . . . . 0.13 112.701 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -65.71 -17.47 64.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.975 0.417 . . . . 0.37 111.53 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 91' ' ' THR . 10.0 mmp_? -108.42 4.86 24.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.524 -0.307 . . . . 0.37 110.751 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -131.21 13.35 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.333 . . . . 0.86 111.548 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.89 36.48 86.72 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.66 112.763 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.55 61.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.951 0.405 . . . . 0.37 110.148 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -68.98 156.48 38.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.122 -0.49 . . . . 1.79 110.72 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -155.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.21 -0.45 . . . . 0.48 109.953 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -52.29 117.88 3.14 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.469 0.481 . . . . 1.28 110.19 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.26 -4.03 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.603 0.594 . . . . 0.58 112.603 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.94 -35.47 8.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.074 0.464 . . . . 1.56 109.838 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.65 -36.45 73.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 1.83 109.734 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.06 -24.25 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.17 110.779 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.33 87.14 6.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.12 110.008 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -64.11 -53.53 48.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.2 111.286 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -128.53 107.44 9.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.142 -0.481 . . . . 1.43 110.895 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.8 71.1 5.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.512 0.673 . . . . 0.79 110.277 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.4 m -153.15 130.66 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.303 -0.862 . . . . 0.33 109.329 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 29' ' ' PHE . 7.2 p -107.25 140.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.25 110.606 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 149.94 24.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.482 . . . . 0.41 111.568 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.4 t -112.76 -40.43 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.66 -0.7 . . . . 0.54 109.584 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -154.55 116.41 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 1.2 109.038 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.36 -25.18 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.949 0.352 . . . . 0.55 111.949 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -49.41 77.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.58 111.515 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -101.36 10.89 40.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.85 111.251 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.02 56.45 25.12 Favored Glycine 0 C--O 1.229 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.37 112.931 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -102.34 114.46 28.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.668 0.271 . . . . 0.65 110.328 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.9 t -112.43 131.66 63.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.28 109.676 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -84.71 120.3 26.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.977 0.417 . . . . 0.19 111.384 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 3.1 tppt? -78.27 171.82 14.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.851 -0.796 . . . . 2.02 108.851 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 19.2 pttp -59.9 -18.29 43.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 1.66 111.284 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -87.1 -7.24 58.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.52 111.644 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -114.87 -44.44 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 1.95 111.563 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 69' ' ' LYS . 2.7 pp -61.83 -23.22 66.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.879 0.371 . . . . 0.27 110.96 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 73' ' ' LEU . 16.6 tt -66.92 -35.99 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.363 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -8.86 51.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.41 111.152 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.67 -14.77 19.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.218 -0.446 . . . . 0.34 111.044 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -121.32 -43.41 2.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.48 111.008 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.61 -14.25 7.68 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.632 -0.587 . . . . 0.08 111.632 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 81' ' ' ASP . 6.0 m -151.48 150.71 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.407 -0.59 . . . . 0.19 109.407 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.38 -4.77 59.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.683 0.277 . . . . 0.22 111.148 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 79' ' ' THR . 15.1 t70 -59.48 109.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.495 . . . . 1.15 110.469 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.03 -38.96 93.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 1.26 111.532 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -43.77 98.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.71 111.793 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -62.3 -45.69 92.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.622 0.248 . . . . 0.83 111.536 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -64.18 -48.17 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.26 109.982 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 43.2 t -61.95 -42.65 99.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.32 110.471 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -56.75 -47.23 80.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.98 111.214 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -46.6 88.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.812 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG22 HG22 ' A' ' 20' ' ' VAL . 90.4 mt -65.12 -32.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.961 -0.563 . . . . 0.29 110.512 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -81.46 -4.51 56.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.23 111.428 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.591 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 88.3 m -105.35 -46.98 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.082 -0.247 . . . . 0.37 111.374 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' THR . 7.8 mmmm -122.53 40.06 3.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.137 0.494 . . . . 2.72 110.817 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.75 21.66 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.664 -0.698 . . . . 0.15 111.521 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.77 94.09 8.09 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.921 -0.4 . . . . 2.32 109.921 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 HG13 ' A' ' 97' ' ' VAL . 3.5 p -102.69 143.26 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.3 111.308 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.04 89.18 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.867 -0.606 . . . . 1.02 110.911 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 39' ' ' VAL . 10.5 m -98.26 139.73 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.095 -0.502 . . . . 0.39 110.759 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.8 -58.82 2.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 0.08 110.345 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.82 164.37 23.19 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.441 -0.577 . . . . 0.36 109.441 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.65 ' HA ' ' NZ ' ' A' ' 100' ' ' LYS . 2.0 tpmp? -139.71 49.38 1.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.434 . . . . 0.28 111.486 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 9.0 tp10 -102.16 118.25 36.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.126 -0.488 . . . . 2.77 110.057 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -175.27 149.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 1.53 109.717 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -138.57 134.07 33.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.48 110.681 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -147.73 124.1 10.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.916 -0.584 . . . . 0.52 110.263 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -124.96 116.42 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.012 0.434 . . . . 1.5 110.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.8 tp -130.57 151.95 50.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.99 -0.55 . . . . 0.43 109.717 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.85 138.05 44.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.91 110.801 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 60.18 21.75 11.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.921 -0.581 . . . . 2.01 111.444 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -31.5 71.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.51 111.006 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -68.51 -30.28 69.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 0.96 110.627 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.4 110.262 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.29 -35.56 73.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.76 110.897 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.441 HD12 HD12 ' A' ' 116' ' ' ILE . 7.4 tp -94.25 -22.96 5.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.959 -0.564 . . . . 0.16 110.62 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -63.39 -34.35 77.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.28 111.609 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -65.1 -14.51 60.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 1.51 111.468 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.441 HD12 HD12 ' A' ' 113' ' ' ILE . 48.3 mt -94.11 -45.0 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.34 110.513 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 114' ' ' ALA . 14.9 p -70.77 -30.48 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.368 -0.378 . . . . 0.47 111.543 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.49 -12.51 60.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.997 0.427 . . . . 0.6 111.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -102.94 -42.02 5.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 1.02 109.858 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.4 -26.1 64.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.442 -0.799 . . . . 2.11 111.489 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.554 ' SG ' ' HG2' ' A' ' 171' ' ' ARG . 2.0 m -122.95 148.53 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.5 -0.318 . . . . 0.45 110.364 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 216' ' ' PRO . 3.2 m -120.01 148.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.082 0.467 . . . . 0.2 111.41 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 124' ' ' PRO . 0.8 OUTLIER -83.56 156.77 65.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.356 -0.838 . . . . 0.7 109.776 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.443 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 62.6 Cg_endo -73.26 -157.07 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.526 2.151 . . . . 0.24 112.333 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 5.0 pt-20 -71.14 80.13 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.464 0.65 . . . . 1.86 111.191 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 t -163.47 -38.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.22 110.589 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.72 152.88 30.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.05 -0.352 . . . . 1.05 110.05 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.34 152.59 43.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.464 -0.334 . . . . 1.02 110.127 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.24 108.55 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.565 2.177 . . . . 0.95 112.315 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -127.22 -61.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.803 -0.635 . . . . 1.21 110.404 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.7 p -123.96 176.72 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.42 110.366 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.4 t -63.58 -21.32 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.331 0.586 . . . . 0.49 110.719 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.9 mm -57.89 -25.88 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.464 -0.789 . . . . 0.61 111.676 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.0 tp -51.97 -41.81 62.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.373 -0.376 . . . . 0.69 111.568 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -99.98 -28.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.452 -0.34 . . . . 0.33 110.822 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.844 0.354 . . . . 1.02 110.365 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -63.61 -23.81 67.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.73 111.103 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.24 -38.53 13.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.27 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 53.9 tpp -65.67 -47.92 73.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.545 . . . . 2.04 110.992 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -77.1 -8.23 57.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.37 111.147 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 137' ' ' ARG . 22.3 t0 -76.26 -56.13 4.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.61 110.085 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.0 tt -73.99 -42.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 0.34 109.808 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 46.09 58.43 4.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.666 -0.697 . . . . 1.37 111.923 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -124.1 143.04 50.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.52 110.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 m -129.67 158.98 37.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.176 -0.676 . . . . 0.33 109.176 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 t -76.67 -55.12 11.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.776 0.322 . . . . 0.43 110.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 149' ' ' ASN . 0.5 OUTLIER -159.35 135.04 8.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.98 110.27 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -8.16 55.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.985 0.421 . . . . 0.18 111.346 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 147' ' ' LYS . 9.7 m120 -85.14 -2.17 57.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.201 0.524 . . . . 0.52 110.343 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -114.35 145.7 41.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.599 -0.728 . . . . 0.44 109.229 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 86.5 p -76.0 169.45 18.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.934 0.397 . . . . 0.24 110.716 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -36.07 74.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.81 111.536 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.65 -11.94 58.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 1.35 111.451 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.01 -11.44 44.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.382 -0.372 . . . . 1.1 111.767 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 151' ' ' SER . 19.0 pt20 -137.88 13.89 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.38 110.763 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.42 68.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.14 111.475 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.72 -23.56 64.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.62 111.054 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -99.19 -42.65 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.425 -0.352 . . . . 1.77 111.011 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 155' ' ' GLN . 89.1 t -57.5 -36.03 52.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.21 111.352 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.6 tt -73.79 -10.23 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.173 0.511 . . . . 0.86 110.749 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -109.06 -9.2 15.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 1.26 109.964 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -53.69 38.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.12 110.542 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -71.02 -16.61 62.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.48 -0.327 . . . . 0.17 110.63 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -23.35 65.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.013 -0.539 . . . . 0.3 109.846 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -76.46 -29.14 56.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.345 -0.613 . . . . 0.38 109.345 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.59 -54.29 5.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.237 -0.892 . . . . 0.91 109.446 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.3 mmt -125.36 109.13 12.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.83 109.349 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -77.19 108.67 10.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.093 0.473 . . . . 0.94 111.213 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -101.22 153.64 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.769 -0.651 . . . . 0.28 110.334 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.68 154.09 20.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 3.28 110.67 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HG2' ' SG ' ' A' ' 121' ' ' CYS . 11.5 mtm180 -135.24 -7.68 2.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.729 -0.669 . . . . 2.23 111.233 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.33 140.93 58.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.916 0.339 . . . . 0.36 111.916 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 216' ' ' PRO . 2.7 t-80 -148.19 120.67 8.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.079 -0.509 . . . . 0.25 110.57 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 22.5 mmt -111.86 -174.94 2.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.65 110.667 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -117.33 130.66 56.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.566 0.222 . . . . 1.1 110.525 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.16 153.82 39.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.45 -0.341 . . . . 0.43 111.311 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 237' ' ' GLU . 5.7 ptm180 -119.63 169.83 9.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.723 -0.671 . . . . 1.14 109.305 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.419 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 2.9 p90 -138.69 138.26 37.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.963 0.411 . . . . 0.74 110.792 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.31 118.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 0.22 109.718 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.938 HD12 ' HD2' ' A' ' 181' ' ' PRO . 43.6 tp -156.4 126.57 3.34 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.685 -0.234 . . . . 0.26 110.59 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.938 ' HD2' HD12 ' A' ' 180' ' ' LEU . 14.9 Cg_endo -58.48 156.36 31.7 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.963 2.442 . . . . 0.28 112.549 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.43 -40.24 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.817 0.673 . . . . 0.17 112.817 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.46 -42.98 61.96 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.386 0.513 . . . . 0.5 112.386 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HB3' HD21 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -99.08 -26.6 14.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.267 -0.424 . . . . 0.41 110.986 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.08 -29.68 71.64 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.104 -0.498 . . . . 0.28 113.113 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 74.4 tttt -62.13 -23.13 66.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.775 0.288 . . . . 0.53 111.366 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -68.55 -36.72 79.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.35 110.658 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -89.87 -27.05 20.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.949 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -54.83 -52.51 62.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 1.01 111.791 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 190' ' ' GLU . 5.4 pt-20 -86.46 24.54 1.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.147 0.425 . . . . 1.76 112.147 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.39 -41.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.807 -0.357 . . . . 0.71 111.593 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 226' ' ' ILE . 31.6 mt -85.98 -47.56 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.974 0.361 . . . . 0.41 111.974 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 22.7 mtpp -59.89 -51.78 78.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.648 0.61 . . . . 0.53 112.648 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.6 Cg_endo -61.59 -20.06 67.27 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.383 2.055 . . . . 0.41 113.24 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.5 8.01 33.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.543 0.211 . . . . 0.56 110.742 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.8 pt 35.97 60.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.255 1.022 . . . . 0.41 113.67 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -136.51 26.62 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.634 0.731 . . . . 0.96 109.65 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.77 151.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 114.844 -1.071 . . . . 0.24 109.831 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.452 HD13 HG12 ' A' ' 211' ' ' VAL . 3.5 mp -93.37 149.03 4.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.115 -0.493 . . . . 0.16 110.573 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 67.88 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.314 0.578 . . . . 1.8 111.562 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 247' ' ' GLY . 18.9 m -149.66 38.75 0.77 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.302 -0.629 . . . . 0.56 109.302 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 210' ' ' ILE . 18.9 mt-10 -86.92 172.34 10.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.104 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.5 118.62 4.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.784 -0.821 . . . . 0.99 108.784 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.22 114.9 28.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.661 0.267 . . . . 1.1 110.925 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -163.05 -104.67 0.19 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.884 -0.674 . . . . 0.36 111.541 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -16.37 32.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.539 0.685 . . . . 1.91 109.367 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.47 HE21 ' HB2' ' A' ' 209' ' ' GLU . 2.8 pm0 -142.22 172.68 12.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.109 -0.95 . . . . 1.11 108.749 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.28 84.4 2.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.682 -0.488 . . . . 0.19 109.682 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB2' HE21 ' A' ' 207' ' ' GLN . 2.9 tp10 -85.99 112.82 21.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.622 -0.717 . . . . 0.93 109.758 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 202' ' ' GLU . 51.0 mt -132.16 146.02 33.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.614 0.245 . . . . 0.39 110.574 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 199' ' ' ILE . 59.0 t -100.03 113.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.43 109.691 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 20.3 t -132.73 97.64 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.19 110.699 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.9 106.25 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 0.37 109.875 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 215' ' ' ASP . 8.1 tp -90.72 168.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.367 -0.379 . . . . 0.55 110.685 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.418 ' H ' HG13 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -68.03 164.4 41.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.443 -0.344 . . . . 1.18 110.449 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.432 ' HB3' HG13 ' A' ' 122' ' ' VAL . 78.7 Cg_exo -50.58 170.73 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.996 2.464 . . . . 0.33 113.392 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 92.24 -87.28 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.773 -0.931 . . . . 0.38 110.773 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.71 -1.92 27.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 1.09 110.861 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.408 ' CE1' HG11 ' A' ' 122' ' ' VAL . 3.5 p90 -58.48 -33.46 69.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.542 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -81.15 -16.76 52.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.133 0.492 . . . . 1.0 110.78 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.5 -44.33 24.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.72 109.521 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 226' ' ' ILE . 11.6 tt -78.07 -38.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.672 -0.695 . . . . 0.3 110.3 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 0.6 OUTLIER -60.49 -28.71 68.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.997 0.427 . . . . 0.31 110.413 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.593 ' O ' ' HE2' ' A' ' 228' ' ' LYS . 14.5 tp10 -51.02 -46.12 61.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.283 -0.871 . . . . 1.95 111.008 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -90.7 -29.28 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.395 -0.366 . . . . 0.17 111.277 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 222' ' ' ILE . 32.2 mm -58.23 -38.89 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.915 0.339 . . . . 0.24 111.915 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.9 ptpt -64.6 -10.15 24.32 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.147 0.795 . . . . 1.08 113.147 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.593 ' HE2' ' O ' ' A' ' 224' ' ' GLU . 5.7 pttt -124.72 -32.78 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.655 -0.418 . . . . 1.25 111.132 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -47.17 73.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 1.43 111.997 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 188' ' ' LEU . 4.0 t -130.11 -41.55 1.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.129 0.418 . . . . 0.16 112.129 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 0.3 OUTLIER -67.3 -21.7 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.951 0.405 . . . . 1.78 110.805 -179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.73 14.41 64.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.889 -0.672 . . . . 0.45 111.978 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -135.51 -45.82 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.82 110.835 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -109.22 -154.97 16.15 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.799 -0.715 . . . . 0.53 112.225 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -120.94 152.81 38.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.275 -0.269 . . . . 0.16 110.275 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.0 pt? -95.44 150.0 20.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.99 110.496 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 177' ' ' ARG . 9.6 tp10 -150.24 160.03 43.99 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.341 -0.614 . . . . 0.88 109.341 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.17 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.88 0.372 . . . . 0.25 111.013 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.29 103.49 9.26 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -172.03 26.67 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.974 0.361 . . . . 0.28 111.974 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.552 ' HB2' ' CD ' ' A' ' 246' ' ' GLU . 3.4 mm? -68.0 124.84 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.071 0.462 . . . . 0.57 110.652 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -100.53 -8.46 23.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.76 111.131 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -72.52 -73.34 0.2 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.696 -0.483 . . . . 0.86 109.696 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.84 156.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.625 -0.716 . . . . 0.52 109.388 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.01 130.2 38.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 2.12 111.158 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.552 ' CD ' ' HB2' ' A' ' 241' ' ' LEU . 33.5 mt-10 -96.3 143.48 27.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.75 -0.659 . . . . 0.69 110.019 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 201' ' ' SER . . . 112.71 102.0 2.56 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.48 -0.867 . . . . 0.3 113.42 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -142.05 114.2 8.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.273 -0.64 . . . . 1.1 109.273 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 28.68 8.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 0.78 111.044 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -97.38 108.53 21.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.094 -0.503 . . . . 0.79 110.428 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -81.33 -22.88 38.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.97 110.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.288 -0.863 . . . . 0.94 110.043 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.549 -0.62 . . . . 0.72 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -134.58 84.78 2.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.304 . . . . 0.45 110.27 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 30.6 tpp 60.75 48.61 6.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 0.71 110.959 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.72 91.86 8.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.559 -0.746 . . . . 0.37 109.851 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.5 -50.15 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.001 -0.545 . . . . 0.8 111.006 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -114.25 99.84 7.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.308 -0.406 . . . . 2.93 110.599 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.83 94.11 27.56 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.43 110.503 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.52 175.55 3.81 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.223 2.616 . . . . 0.35 112.61 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t -88.46 153.62 21.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.53 . . . . 0.69 109.646 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -172.03 168.73 5.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -91.27 -57.84 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 0.8 109.889 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.1 mt -129.69 105.16 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 0.35 110.024 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -177.71 149.1 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.141 -0.688 . . . . 1.18 109.141 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.45 61.09 0.66 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.124 0.487 . . . . 0.23 112.04 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -42.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 0.35 109.327 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -105.1 37.14 2.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.4 109.941 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 15.7 m -102.47 155.66 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.16 111.589 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . . . -118.46 125.45 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.503 -0.771 . . . . 0.26 109.29 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.27 133.58 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.448 . . . . 0.57 111.676 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 4.1 p -133.78 129.9 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.66 -0.7 . . . . 0.24 109.504 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.22 140.42 52.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 1.86 111.906 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 59.0 ttp -123.26 125.71 45.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.24 109.691 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -100.04 118.8 37.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.656 0.265 . . . . 0.92 110.757 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -113.21 -159.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.77 110.791 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.56 -73.73 0.07 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.152 -0.477 . . . . 0.37 111.684 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.27 29.78 5.62 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.468 -0.872 . . . . 0.15 112.335 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 11.3 tppt? -156.03 146.56 21.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.238 -0.282 . . . . 0.46 110.238 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' MET . 12.2 ptt-85 -141.0 93.16 2.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.046 0.45 . . . . 2.38 110.308 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 96.0 m-85 -76.93 152.41 35.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 1.33 111.671 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 15.0 pt-20 -146.86 133.02 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.15 109.583 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -132.11 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.97 0.414 . . . . 0.4 110.957 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -137.18 110.77 8.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.14 110.516 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.4 m -106.89 -175.81 2.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.909 -0.587 . . . . 0.59 110.559 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' HA ' HE21 ' A' ' 54' ' ' GLN . 3.0 t80 -66.69 122.77 18.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.006 0.431 . . . . 0.31 110.544 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 32.1 ttpt -60.29 124.83 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.745 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 98' ' ' SER . 46.0 t30 66.28 3.73 2.88 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.832 -1.076 . . . . 0.84 113.414 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 44.2 tptt -107.51 -33.79 7.23 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.673 -0.642 . . . . 1.1 110.242 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.57 -22.05 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.837 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.27 -18.11 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.64 109.86 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.11 93.47 Favored Glycine 0 C--O 1.222 -0.624 0 CA-C-N 115.75 -0.659 . . . . 0.13 112.219 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -65.8 -18.53 65.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.318 0.58 . . . . 0.35 110.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -90.31 -43.32 10.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.997 -0.547 . . . . 0.92 111.817 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.09 -16.72 29.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.533 0.568 . . . . 0.49 112.533 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.42 -107.23 0.2 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.672 -0.775 . . . . 0.66 112.449 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.12 137.71 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.164 -0.31 . . . . 0.94 110.164 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -103.45 -87.33 0.43 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.903 -0.406 . . . . 0.59 109.903 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 19.9 ptmt -159.8 -43.95 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.324 -0.235 . . . . 1.32 111.445 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -178.0 126.5 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.238 -0.282 . . . . 0.52 110.238 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 52' ' ' VAL . 48.3 mt -61.6 -29.01 69.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 1.63 112.048 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.21 -35.69 55.42 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.707 -0.397 . . . . 0.92 110.698 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.54 -29.14 41.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 1.22 110.945 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.5 p -72.17 -12.57 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.052 0.453 . . . . 0.27 110.792 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.63 HD21 ' SG ' ' A' ' 86' ' ' CYS . 2.1 mm? -94.19 97.53 10.33 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.566 -0.531 . . . . 0.58 109.566 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 34' ' ' TYR . 73.2 mt-30 -66.03 -39.55 90.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.42 110.83 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 t -117.3 136.63 52.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.798 0.332 . . . . 0.42 110.539 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -100.32 16.06 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 0.69 110.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 m -110.28 112.28 24.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.713 -0.676 . . . . 0.66 110.024 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 31' ' ' ILE . 7.2 p -92.12 139.22 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.2 110.221 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.42 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 11.7 m-85 -100.89 160.71 14.14 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.023 -0.362 . . . . 0.44 110.023 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.94 -61.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.063 0.459 . . . . 0.46 110.834 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.13 92.42 3.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.43 110.41 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -65.68 -24.69 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.174 0.511 . . . . 0.37 110.43 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -29.56 67.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.7 -0.682 . . . . 0.99 111.387 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.12 -34.58 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 1.43 110.74 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.88 41.35 2.31 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.261 -0.736 . . . . 0.48 111.261 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -105.19 121.07 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.785 0.326 . . . . 1.21 111.179 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.03 141.55 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.37 109.93 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.78 104.09 13.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.132 0.491 . . . . 0.23 109.84 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -82.29 -174.9 5.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.27 110.842 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -34.17 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.762 0.652 . . . . 0.91 112.762 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 pm0 -80.84 -4.07 53.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.822 0.344 . . . . 0.92 111.302 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.65 -52.23 3.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 0.18 110.502 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.331 . . . . 0.24 111.706 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.02 -22.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.17 110.949 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -103.06 -32.47 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.62 111.46 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.31 -36.63 46.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.31 111.5 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.68 -51.5 2.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 2.09 110.109 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.93 -37.75 2.41 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.48 111.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.35 147.4 26.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.623 0.249 . . . . 1.42 110.38 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -100.3 -7.56 24.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.448 -0.342 . . . . 1.1 111.628 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.18 126.24 38.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.722 0.296 . . . . 1.21 110.719 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -27.47 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 0.43 111.815 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -63.58 -39.92 95.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.878 0.371 . . . . 0.58 110.468 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.37 -40.66 85.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.25 110.747 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.99 -48.19 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.885 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 53' ' ' LEU . 36.8 t -65.12 -29.61 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.725 . . . . 0.2 111.39 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -58.67 -49.53 77.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.397 . . . . 0.34 110.827 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -68.95 -37.42 78.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.798 -0.637 . . . . 1.45 110.551 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 31' ' ' ILE . 97.4 mt -69.22 -31.02 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.497 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.66 -18.86 56.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.976 0.361 . . . . 0.37 111.976 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 t -108.31 -34.78 6.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.652 -0.419 . . . . 0.42 112.066 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -101.51 7.12 42.52 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.917 0.389 . . . . 0.67 110.564 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.22 175.34 17.34 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.523 -0.846 . . . . 0.1 112.778 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -102.14 119.04 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.935 -0.394 . . . . 1.34 109.935 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.65 146.63 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.704 -0.68 . . . . 0.29 110.252 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.69 101.62 1.07 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.62 110.122 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 m -106.9 163.59 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.989 -0.55 . . . . 0.42 111.358 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' A' ' 115' ' ' THR . 10.6 t -143.23 -68.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.946 -0.57 . . . . 0.23 109.635 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 30.3 t0 -179.07 157.03 0.82 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.533 0.52 . . . . 0.2 109.862 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 8.2 tptp -167.44 171.66 10.28 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 123.321 0.388 . . . . 1.76 110.854 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.1 mp0 -52.32 117.77 3.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.705 -0.68 . . . . 0.62 112.293 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HB3' HD11 ' A' ' 116' ' ' ILE . 5.2 ppt_? -73.97 125.03 27.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.818 -0.628 . . . . 1.11 111.073 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -149.48 -40.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.411 -0.359 . . . . 1.56 111.219 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -151.97 -171.47 3.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.707 -0.224 . . . . 0.53 110.478 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.15 148.71 52.75 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.6 -0.519 . . . . 0.65 109.6 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -97.38 -71.31 0.69 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.433 -0.349 . . . . 0.3 111.244 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.74 -62.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.835 0.35 . . . . 1.79 110.634 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.06 79.14 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 1.05 110.769 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.3 ptp -62.34 -32.9 73.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.24 111.267 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.41 -3.22 32.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.148 0.499 . . . . 0.57 110.654 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -135.85 34.1 2.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.984 -0.746 . . . . 0.59 108.984 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.39 -49.41 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.999 -1.001 . . . . 1.32 110.325 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.1 mt -79.67 -23.07 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.485 0.659 . . . . 0.19 110.194 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.03 2.28 9.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.393 -0.821 . . . . 0.34 112.938 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 98' ' ' SER . 68.6 p -85.43 -53.44 5.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.808 0.337 . . . . 0.15 111.055 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 102' ' ' ARG . 16.0 mt -58.38 -42.73 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.876 -0.602 . . . . 0.44 111.604 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.97 -25.68 32.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.081 -0.509 . . . . 0.21 111.081 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.7 81.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.913 0.387 . . . . 0.35 110.792 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.519 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.3 OUTLIER -84.36 -14.43 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.315 0.579 . . . . 0.57 110.139 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 -26.51 21.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 1.51 110.857 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.8 50.45 2.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 0.28 111.644 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.86 154.47 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.412 -0.358 . . . . 0.27 110.389 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -52.67 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.498 -0.319 . . . . 0.35 111.744 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -92.94 163.19 2.65 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.262 1.974 . . . . 0.27 113.065 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.76 -28.7 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.67 111.436 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 t -71.3 -16.05 62.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.67 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -161.85 87.44 0.66 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.916 -0.772 . . . . 0.7 108.916 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.459 ' CB ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -56.37 -60.81 8.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.91 -0.586 . . . . 0.73 111.418 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 56.8 Cg_endo -90.12 135.4 2.27 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.122 1.881 . . . . 0.42 112.503 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -89.28 162.07 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.967 -0.56 . . . . 0.43 110.242 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.78 140.36 45.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.154 -0.475 . . . . 0.76 109.759 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 t -51.53 -32.24 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.228 -0.442 . . . . 0.12 112.18 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.4 mm -61.2 -32.95 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.559 -0.291 . . . . 0.11 111.72 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.41 -51.11 64.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.51 111.371 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -33.77 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.16 110.914 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -55.07 -48.03 74.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.125 0.488 . . . . 0.44 110.367 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -59.91 -47.01 87.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.264 -0.88 . . . . 1.33 111.202 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.8 -38.3 88.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.12 111.655 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.4 ttp -67.7 -46.26 72.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 0.27 110.594 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -66.31 -32.0 73.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.885 -0.598 . . . . 1.51 110.251 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.18 -46.7 75.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.592 -0.731 . . . . 0.34 111.235 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.8 mt -82.95 -53.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.354 -0.384 . . . . 0.54 110.465 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 58.5 49.94 9.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.177 -0.465 . . . . 1.11 110.601 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.28 87.26 6.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.136 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -81.92 121.91 27.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.728 -0.669 . . . . 0.52 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.6 -76.01 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.416 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.631 -0.507 . . . . 0.63 109.631 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 123.1 15.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.279 0.362 . . . . 0.51 110.671 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.38 46.35 5.55 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.134 0.896 . . . . 0.16 112.406 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.477 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -59.09 -53.96 52.41 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.108 -0.701 . . . . 0.63 109.108 178.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 155' ' ' GLN . 2.7 p -103.31 179.95 4.12 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.668 -0.697 . . . . 0.22 109.439 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 150.02 49.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.753 0.279 . . . . 0.7 111.753 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tttm 64.11 46.44 3.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.791 -0.641 . . . . 0.28 111.774 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.4 ' HG3' ' NE2' ' A' ' 155' ' ' GLN . 7.8 tp60 59.23 71.39 0.59 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.658 -0.701 . . . . 0.33 111.369 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 151' ' ' SER . 1.9 pm0 44.36 39.26 2.98 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.871 0.868 . . . . 0.07 112.782 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.84 -35.77 75.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.11 112.02 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 4.1 mm? -67.2 -27.54 67.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.878 0.371 . . . . 0.26 110.765 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.477 ' OE1' ' HB3' ' A' ' 150' ' ' LYS . 3.5 mp0 -82.42 -44.81 15.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 163' ' ' LEU . 98.9 t -61.79 -43.52 97.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.17 111.238 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.9 tt -66.61 -10.77 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.284 -0.416 . . . . 0.31 112.063 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -115.17 -10.54 12.14 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.173 -0.329 . . . . 1.18 110.883 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -87.18 -36.96 17.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.395 . . . . 0.71 111.547 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -74.89 -13.67 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.18 110.91 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.542 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.4 tmmt? -62.83 -25.03 68.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.971 -0.559 . . . . 0.38 110.659 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.34 -24.74 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.005 -0.543 . . . . 0.7 110.666 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -93.48 -48.65 6.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.384 -0.598 . . . . 1.48 109.384 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 19.7 mmt -127.34 104.89 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.098 -0.705 . . . . 1.59 109.098 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -87.96 127.81 35.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.03 0.443 . . . . 1.08 111.232 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -70.15 154.31 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.612 -0.722 . . . . 0.22 110.399 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -145.53 88.5 1.85 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.898 0.38 . . . . 1.1 110.57 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.72 114.93 0.28 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.072 -0.513 . . . . 0.69 110.336 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 131.82 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.24 110.922 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -127.11 95.89 4.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.695 0.76 . . . . 1.27 109.94 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.4 ttm -88.08 170.38 11.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.223 -0.899 . . . . 1.75 110.66 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.94 130.92 41.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.263 -0.426 . . . . 1.01 110.73 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 213' ' ' LEU . 16.9 tp -116.91 130.84 56.96 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.53 -0.544 . . . . 1.25 109.53 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -126.28 164.13 21.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.88 0.371 . . . . 0.65 110.236 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 94.5 m-85 -122.51 145.04 48.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.635 -0.505 . . . . 0.35 109.635 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -127.69 114.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.501 0.667 . . . . 0.31 111.526 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -147.45 158.96 42.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.31 109.626 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.66 173.92 6.12 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.333 2.022 . . . . 0.16 112.417 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' VAL . 3.3 t -54.01 -31.4 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.4 112.009 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -53.54 -59.5 4.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.974 0.416 . . . . 0.28 110.579 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -77.31 -24.43 50.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.74 110.264 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 189' ' ' LYS . . . -59.92 -35.64 87.6 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.865 -0.607 . . . . 0.21 112.239 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -77.73 2.72 16.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.7 0.285 . . . . 0.92 110.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 190' ' ' GLU . 69.9 mmtt -104.09 -48.43 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.581 -0.281 . . . . 1.34 111.412 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.417 ' CD2' ' HA2' ' A' ' 185' ' ' GLY . 1.3 pt? -79.44 -26.22 41.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.67 111.549 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 17.5 ttpt -66.38 -26.53 67.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 0.65 111.307 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 187' ' ' LYS . 0.4 OUTLIER -95.47 1.36 53.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.457 -0.338 . . . . 0.57 111.465 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.467 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 27.8 mttp -122.97 -43.07 2.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.362 0.504 . . . . 0.86 112.362 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.16 -44.3 47.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.192 0.442 . . . . 0.25 112.192 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.5 mtpt -58.95 -51.36 82.41 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.841 0.682 . . . . 0.22 112.841 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.1 Cg_endo -61.91 -9.1 13.21 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.307 2.005 . . . . 0.19 113.513 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 73.8 mt -81.69 -6.97 59.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.14 110.477 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.2 mm 52.36 53.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.695 -0.684 . . . . 0.19 111.036 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -146.62 27.03 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.717 -0.674 . . . . 1.03 110.181 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.68 147.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.993 -0.549 . . . . 0.11 111.073 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 214' ' ' ILE . 4.2 mp -101.41 144.62 12.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.19 109.926 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -68.78 80.55 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.289 0.566 . . . . 2.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.6 t -160.21 17.3 0.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.92 109.376 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.3 mp0 -75.29 134.03 41.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.22 110.547 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -100.71 136.73 40.12 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.837 -0.619 . . . . 0.79 109.673 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 144.24 44.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.712 0.291 . . . . 0.83 110.348 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 152.69 -121.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.719 -0.753 . . . . 0.22 111.58 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -82.01 -24.33 35.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.194 0.521 . . . . 0.45 110.074 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -124.82 158.7 32.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.472 -0.786 . . . . 1.75 109.543 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.68 91.7 3.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.041 -0.355 . . . . 0.4 110.041 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 45.6 mt-10 -94.6 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.301 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.9 mt -119.01 142.38 34.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.715 -0.221 . . . . 0.28 110.863 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.74 134.63 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.963 -0.384 . . . . 0.34 109.963 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 14.6 t -119.55 -32.75 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.744 0.646 . . . . 1.33 112.744 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -74.56 121.56 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.825 0.345 . . . . 0.75 111.477 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.613 ' HB ' HD11 ' A' ' 199' ' ' ILE . 4.0 tt -125.47 -54.63 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.676 . . . . 0.57 111.185 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 219' ' ' PHE . 0.4 OUTLIER -140.09 161.3 56.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.877 -0.416 . . . . 0.26 109.877 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 219' ' ' PHE . 97.8 Cg_endo -77.52 -173.37 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.437 2.092 . . . . 0.27 113.117 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 75.01 -88.39 0.77 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.91 -0.586 . . . . 0.39 112.439 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.62 -18.69 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.659 0.384 . . . . 1.21 111.173 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 2.3 p90 -63.69 -25.22 68.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.84 110.597 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 220' ' ' ARG . 2.1 tpp180 -76.72 -32.11 57.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.62 110.139 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.46 -43.21 70.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.492 . . . . 1.12 110.64 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 6.3 tt -73.71 -23.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.054 0.455 . . . . 0.19 110.789 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.7 -29.58 68.2 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.16 111.486 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.6 -30.32 65.21 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.585 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.4 pp -105.0 -35.32 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.997 -0.281 . . . . 0.29 111.317 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.42 HG12 HG12 ' A' ' 222' ' ' ILE . 24.9 mm -55.23 -36.39 39.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 120.788 0.327 . . . . 0.21 111.721 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -62.38 -17.22 58.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.669 0.618 . . . . 0.72 112.669 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.68 -23.98 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.62 111.07 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HG3' ' HD3' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -68.2 -47.54 67.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 1.92 111.713 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.4 t -129.98 -32.45 1.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.674 -0.41 . . . . 0.21 111.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 76.8 tttt -66.56 -30.42 70.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.181 0.515 . . . . 0.3 110.132 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -97.7 23.77 34.53 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.73 -0.668 . . . . 0.22 111.696 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -133.9 -36.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.24 110.31 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.38 -176.89 16.93 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.848 -0.691 . . . . 0.28 111.753 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.3 t -87.36 159.76 18.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 0.46 110.333 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 153.65 25.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.198 -0.455 . . . . 0.41 110.947 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.16 143.29 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.781 -0.645 . . . . 1.89 109.705 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.09 124.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.523 . . . . 0.28 111.367 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.75 74.07 3.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.299 -0.63 . . . . 0.44 109.299 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -84.03 -2.02 55.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.615 -0.721 . . . . 1.33 112.458 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -43.68 98.34 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.89 110.224 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 52.4 pttt 40.79 34.35 0.26 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.182 0.993 . . . . 0.71 112.881 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -117.25 -68.98 0.88 Allowed 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.406 -0.59 . . . . 0.9 109.406 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.16 128.57 49.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.59 -0.893 . . . . 0.19 108.59 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -129.39 98.29 4.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.064 0.459 . . . . 1.44 111.324 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -147.75 169.22 20.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.279 -0.638 . . . . 2.98 109.279 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -149.51 -155.42 6.76 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.85 -0.69 . . . . 0.64 111.502 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -86.98 91.23 8.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.101 0.477 . . . . 1.13 110.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 18.51 14.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.73 . . . . 0.74 110.061 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 86.46 4.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.844 -0.616 . . . . 1.06 109.677 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -98.57 -20.89 16.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.413 . . . . 0.74 110.783 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.47 -0.776 . . . . 2.44 109.873 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.997 0 N-CA-C 112.078 -0.409 . . . . 0.53 112.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -157.5 133.44 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 1.05 110.344 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -110.77 61.87 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.278 0.561 . . . . 0.7 110.234 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -94.64 27.96 2.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.37 110.929 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 pt -132.56 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.3 110.372 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t80 -83.86 162.62 20.49 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.544 -0.539 . . . . 1.37 109.544 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 87.66 13.34 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.768 0.318 . . . . 0.26 111.219 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.5 Cg_exo -78.04 157.76 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.781 2.321 . . . . 0.38 111.022 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -107.37 103.23 12.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.052 0.453 . . . . 0.87 111.087 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 27.3 t-20 -144.2 149.12 35.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.549 . . . . 1.46 109.831 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -54.96 40.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.742 0.306 . . . . 0.4 111.701 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mt -91.17 63.54 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.104 0.478 . . . . 0.7 111.242 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 2.4 mmp_? -136.43 148.98 48.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 1.39 110.479 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.45 -0.92 56.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.49 110.333 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.401 HG21 ' HD2' ' A' ' 8' ' ' PRO . 1.3 p -77.62 -41.34 38.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.263 0.554 . . . . 0.44 110.456 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -108.48 78.52 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.818 -0.628 . . . . 0.59 109.936 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.46 HG12 ' OE1' ' A' ' 54' ' ' GLN . 19.2 m -120.54 140.81 43.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.017 -0.538 . . . . 0.17 111.128 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -110.64 116.3 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.087 -0.708 . . . . 0.18 109.087 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.64 110.52 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 0.2 111.591 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 89' ' ' ILE . 3.6 p -102.13 137.79 28.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.997 -1.112 . . . . 0.12 107.997 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 136.82 49.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.326 0.584 . . . . 0.33 112.453 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 36.7 ttp -121.38 120.62 35.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.032 -0.986 . . . . 0.28 109.488 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.28 129.96 55.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.909 -0.404 . . . . 0.89 109.909 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -108.7 35.92 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.409 -0.36 . . . . 0.63 110.771 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.19 63.75 1.81 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.648 0.737 . . . . 0.32 109.942 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.94 -70.43 0.48 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.211 -1.155 . . . . 0.2 110.211 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -87.23 135.82 33.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 1.17 109.217 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -128.23 151.63 49.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.4 111.322 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -141.08 126.23 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.3 110.347 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 132.34 56.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.11 -0.495 . . . . 0.19 110.08 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -129.52 149.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.84 110.688 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.23 115.98 31.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.2 110.909 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.1 p -149.08 141.01 23.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.58 109.983 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -114.58 -84.42 0.61 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.227 -0.189 . . . . 0.65 111.091 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 65.16 -179.94 0.19 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.808 0.692 . . . . 1.02 111.559 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.62 78.16 9.9 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.279 -1.008 . . . . 1.79 108.279 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt 67.88 78.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.372 -0.831 . . . . 0.9 109.422 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.42 -26.56 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.489 -0.778 . . . . 0.38 111.782 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.48 -28.83 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.46 110.687 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.43 -32.45 84.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.15 111.814 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -64.87 -29.87 70.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.74 110.092 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -65.63 -33.46 75.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 1.34 110.156 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m -87.24 -21.94 25.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.094 0.473 . . . . 0.6 109.999 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.15 27.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.068 -0.587 . . . . 0.43 112.288 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 t -105.52 76.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.882 0.373 . . . . 0.59 110.113 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' OE1' ' HG2' ' A' ' 47' ' ' LYS . 2.3 mm-40 -172.61 172.15 4.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.4 109.904 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HG2' ' OE1' ' A' ' 46' ' ' GLU . 17.1 ptmt -83.55 -168.29 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.979 -0.378 . . . . 0.47 109.979 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 164.51 4.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.023 0.439 . . . . 1.22 111.932 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.718 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -84.22 -8.74 58.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.566 . . . . 0.15 111.311 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -27.33 66.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.311 -0.404 . . . . 0.85 110.808 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -104.18 16.85 25.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.47 111.813 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' LEU . 3.0 p -108.3 -27.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.465 -0.494 . . . . 0.22 110.991 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 53' ' ' LEU . 1.2 mm? -80.35 91.36 5.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.397 -0.365 . . . . 0.24 110.766 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' OE1' HG12 ' A' ' 17' ' ' VAL . 69.2 mt-30 -69.31 -31.06 69.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.47 0.652 . . . . 0.3 109.717 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -140.82 126.5 19.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.239 -0.891 . . . . 0.43 109.264 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -86.77 42.74 1.03 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.28 110.629 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.7 113.76 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.833 -0.621 . . . . 0.45 110.267 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.4 p -91.5 138.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.741 -0.466 . . . . 0.37 109.741 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.02 150.18 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.306 -0.406 . . . . 0.19 111.116 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.42 -47.38 7.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.27 109.429 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -130.57 103.28 6.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 0.33 109.349 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.0 -28.09 23.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 113.044 0.757 . . . . 0.22 113.044 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 p -82.12 -27.57 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.525 -0.47 . . . . 0.64 111.81 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -100.54 -2.04 34.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.97 111.093 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.55 45.29 78.7 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.21 113.1 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.33 112.3 25.06 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.921 -0.399 . . . . 0.65 109.921 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.09 144.38 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 0.46 110.752 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.663 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.98 109.56 20.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.635 -0.506 . . . . 0.31 109.635 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.631 ' HB3' ' OE2' ' A' ' 71' ' ' GLU . 7.5 mtpt -78.88 176.62 9.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.886 -0.597 . . . . 1.28 110.878 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.77 -32.11 67.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 1.09 112.176 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.631 ' OE2' ' HB3' ' A' ' 69' ' ' LYS . 1.7 pm0 -93.25 4.0 54.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.756 0.312 . . . . 1.02 111.166 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -105.69 -46.49 4.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 2.16 110.206 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 1.5 pp -63.77 -33.56 75.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.048 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 tt -68.54 -21.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.231 0.538 . . . . 0.65 110.432 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -99.38 1.09 44.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.66 110.635 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.93 -51.35 2.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.49 110.931 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.61 -15.35 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 1.51 110.864 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.03 -25.35 20.31 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.749 -0.738 . . . . 0.25 112.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 138.26 31.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.68 0.276 . . . . 0.31 110.805 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.9 -5.52 55.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.424 0.631 . . . . 0.64 109.6 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.37 117.01 28.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.162 -0.926 . . . . 0.43 110.511 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -68.75 -22.17 64.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.81 111.062 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -47.0 77.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.19 111.064 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -56.43 -39.63 73.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.224 0.535 . . . . 1.34 110.382 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 89' ' ' ILE . 66.9 mt -70.22 -48.2 62.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.683 -0.69 . . . . 0.14 110.106 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 31' ' ' ILE . 51.6 t -58.61 -40.24 82.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 0.12 110.243 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 91' ' ' THR . 5.3 tttp -58.64 -47.19 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 1.05 109.88 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.05 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 1.67 110.937 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 20' ' ' VAL . 69.0 mt -67.54 -29.9 47.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.046 0.45 . . . . 0.3 110.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -35.19 35.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.031 -0.531 . . . . 0.2 111.976 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 87' ' ' LYS . 6.9 t -96.38 -18.05 20.2 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.998 0.74 . . . . 0.26 112.998 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -124.42 17.35 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.32 111.283 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.91 178.44 18.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.59 -0.814 . . . . 0.23 112.459 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.09 112.23 24.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 2.68 110.615 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 97' ' ' VAL . 11.0 p -103.21 155.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.46 109.756 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -71.34 99.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.026 0.441 . . . . 0.62 110.487 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 95' ' ' VAL . 17.6 m -108.61 167.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.4 110.481 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 m -146.11 -74.55 0.22 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.243 -0.435 . . . . 0.93 110.064 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.8 169.38 10.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.875 -0.417 . . . . 0.52 109.875 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -164.56 165.96 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.797 -0.445 . . . . 0.82 109.797 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -71.35 154.39 41.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.305 0.574 . . . . 1.14 111.277 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -113.42 91.52 3.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.821 -0.627 . . . . 2.58 110.183 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -133.17 128.29 35.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.071 -0.513 . . . . 1.07 110.396 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.03 145.93 50.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.896 -0.593 . . . . 1.16 110.018 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.32 148.53 31.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.889 0.376 . . . . 0.53 110.395 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.79 105.26 9.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.79 110.429 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -158.32 175.81 13.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.18 109.829 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -89.28 30.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.518 0.199 . . . . 0.81 111.376 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.2 ptp -60.19 -32.13 70.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.691 0.282 . . . . 0.16 110.884 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.28 -34.89 66.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.08 110.287 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.38 -30.88 63.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.79 110.214 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.538 ' O ' HG22 ' A' ' 115' ' ' THR . 16.5 t70 -61.75 -50.97 70.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.947 -0.569 . . . . 1.53 110.595 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 tp -73.86 -27.43 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.24 110.367 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -65.56 -42.96 91.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.13 111.187 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 112' ' ' ASP . 2.0 t -65.35 -22.28 66.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.22 110.779 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 112' ' ' ASP . 44.0 mm -83.06 -55.72 6.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.046 -0.525 . . . . 0.25 110.271 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 114' ' ' ALA . 9.9 p -62.09 -31.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.36 0.504 . . . . 0.21 112.36 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.91 -15.3 62.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.13 111.714 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.52 -16.03 17.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.173 -0.467 . . . . 1.46 110.787 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -3.18 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.637 0.606 . . . . 0.99 112.637 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.9 p -129.23 154.57 46.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.066 0.46 . . . . 0.14 111.125 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.76 146.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.751 -0.659 . . . . 1.08 110.3 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.27 153.76 38.78 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.819 -0.437 . . . . 1.82 109.819 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.31 -159.94 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.529 2.152 . . . . 0.78 112.289 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 4.7 pt-20 -65.7 91.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 0.76 111.23 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.0 t -170.69 -42.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.726 -0.67 . . . . 0.54 110.19 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -177.08 119.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.534 -0.543 . . . . 0.52 109.534 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -77.66 149.17 77.52 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.557 -0.292 . . . . 1.39 110.899 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.512 ' HA ' HD22 ' A' ' 134' ' ' LEU . 18.6 Cg_endo -60.53 134.4 54.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.742 2.294 . . . . 0.28 112.425 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -157.41 -46.19 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.95 109.988 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.0 p -126.56 169.24 13.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.69 110.713 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.99 -25.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.486 . . . . 0.24 110.66 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.01 -24.16 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.512 -0.767 . . . . 0.46 111.311 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 129' ' ' PRO . 7.9 tp -53.57 -57.41 10.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.436 . . . . 0.34 111.193 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -30.79 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 0.36 110.907 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -60.59 -39.41 87.97 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.314 -0.403 . . . . 0.83 110.96 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -58.99 -36.67 75.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.206 -0.452 . . . . 0.84 111.258 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.14 -36.3 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.503 -0.317 . . . . 0.19 111.271 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 12.3 ttt -63.4 -40.97 98.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.249 -0.432 . . . . 0.39 111.293 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -71.23 -25.54 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.91 110.883 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.33 -47.94 58.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.499 . . . . 0.42 109.935 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.65 73.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.053 0.93 . . . . 0.74 110.06 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -122.33 -2.25 9.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.536 -0.756 . . . . 0.97 110.734 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -78.65 124.24 27.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.319 -0.4 . . . . 1.65 111.029 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.4 m 55.39 34.47 22.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.574 -0.739 . . . . 0.55 112.261 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.92 -53.3 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.58 110.679 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 152' ' ' THR . 45.9 tttt -134.7 14.41 3.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 1.19 110.208 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 116.94 10.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.681 -0.69 . . . . 0.5 110.84 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 67.8 66.16 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.097 0.559 . . . . 0.54 110.797 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -164.48 159.46 19.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.154 -0.684 . . . . 0.36 109.154 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.52 154.38 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 1.28 110.297 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -57.67 -49.55 76.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.857 0.688 . . . . 0.81 112.857 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -82.22 -16.07 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.628 0.251 . . . . 1.23 111.673 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.76 -59.19 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.24 111.826 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.8 mp0 -105.2 23.29 13.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.528 -0.305 . . . . 0.32 111.552 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.976 0.362 . . . . 0.21 111.976 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.8 mm? -78.45 -16.75 57.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.269 -0.423 . . . . 0.57 111.908 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.21 -42.38 10.45 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.906 -0.317 . . . . 0.78 110.988 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 155' ' ' GLN . 86.3 t -59.12 -39.05 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.402 -0.363 . . . . 0.24 111.273 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.61 -19.74 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.336 -0.393 . . . . 0.55 111.283 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -99.34 -16.94 18.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 1.23 110.595 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -62.55 1.46 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.73 111.035 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -71.71 -17.7 62.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.3 111.467 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.454 ' N ' HD13 ' A' ' 163' ' ' LEU . 6.4 tmtt? -70.26 -34.28 72.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.888 0.375 . . . . 1.16 110.628 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -77.76 -34.47 52.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 1.76 110.579 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -35.95 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.3 0.572 . . . . 0.75 109.972 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 tpt -124.24 91.16 3.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.703 -0.851 . . . . 0.24 108.703 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.42 101.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.391 0.615 . . . . 1.34 111.674 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.89 142.62 20.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.129 -0.941 . . . . 0.28 109.775 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -98.54 107.42 19.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.563 -0.289 . . . . 2.33 110.574 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -82.07 70.28 8.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.927 0.394 . . . . 2.39 110.066 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -138.91 162.23 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.148 -0.478 . . . . 0.27 110.561 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -109.43 123.79 49.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.2 -0.455 . . . . 1.4 109.967 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 53.5 mtt -82.51 153.56 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.655 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 54.7 mtt180 -135.13 117.51 15.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 1.19 111.116 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.479 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 13.7 mt -108.22 152.51 24.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.867 -0.606 . . . . 2.2 110.213 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.401 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 19.7 ptt180 -140.82 159.97 41.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.222 -0.445 . . . . 0.35 110.176 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 0.8 OUTLIER -134.17 132.82 40.26 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.181 -0.674 . . . . 0.09 109.181 178.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.2 tt -126.73 123.16 62.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.114 0.483 . . . . 0.1 111.476 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.9 OUTLIER -159.76 156.01 23.69 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 0.23 110.028 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.87 143.36 30.45 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.861 2.374 . . . . 0.09 112.428 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.82 -31.54 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.45 112.427 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -54.89 -46.45 74.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.583 0.23 . . . . 1.38 111.534 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.25 -30.79 17.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.92 109.841 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.39 -29.78 72.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.467 -0.788 . . . . 0.18 113.08 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -59.34 -26.41 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 0.49 111.087 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -44.52 73.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.81 110.523 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 3.0 pp -76.76 -22.91 53.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.26 110.053 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 71.3 tttt -63.0 -35.34 79.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.92 110.189 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -101.07 18.31 20.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.783 -0.644 . . . . 1.65 110.981 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -131.28 -52.79 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.064 0.394 . . . . 0.7 112.064 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 212' ' ' CYS . 1.1 tm? -86.35 -44.18 12.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.17 111.722 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpt -57.13 -48.42 97.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.809 0.67 . . . . 0.21 112.809 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.9 Cg_endo -59.04 -16.64 33.87 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.298 1.998 . . . . 0.26 113.282 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 56.0 mt -74.2 -15.82 61.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 0.36 110.162 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 16.7 mt 56.45 60.63 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.645 -0.707 . . . . 0.75 111.586 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -135.3 10.06 3.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.691 -0.686 . . . . 1.49 109.737 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.2 167.48 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.582 -0.735 . . . . 0.34 111.672 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.72 148.48 10.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.42 -0.809 . . . . 0.29 108.945 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.12 57.99 0.36 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.263 0.554 . . . . 1.19 111.711 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -146.35 55.84 1.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.39 109.275 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.1 pt-20 -106.13 167.7 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.45 111.516 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.9 t70 -131.51 123.53 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.78 31.49 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.91 110.802 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.09 -102.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.596 -0.811 . . . . 0.32 112.067 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -95.78 -31.09 13.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.439 0.638 . . . . 0.34 109.577 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.18 136.96 54.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.384 -0.825 . . . . 0.58 109.44 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 203' ' ' ASP . 36.1 tp -88.82 99.65 12.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.077 0.465 . . . . 0.15 110.265 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 50.2 tt0 -109.38 114.78 28.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.2 109.712 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 178' ' ' PHE . 21.3 mt -127.39 141.13 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 0.12 110.891 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.8 125.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.089 -0.708 . . . . 0.2 109.089 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 192' ' ' LEU . 50.8 t -139.83 99.97 3.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.578 0.227 . . . . 0.25 111.454 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.479 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER 177.73 121.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.966 -0.753 . . . . 0.46 108.966 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -116.0 -40.41 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 111.832 0.308 . . . . 1.53 111.832 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.45 143.69 36.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.879 0.326 . . . . 0.69 111.879 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.68 -30.16 35.03 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.875 2.383 . . . . 0.27 112.077 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.5 -23.37 75.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.915 -0.66 . . . . 0.39 111.761 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.7 6.75 44.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.215 0.531 . . . . 1.43 110.572 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.34 -47.68 81.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.716 -0.674 . . . . 0.97 110.526 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -66.17 -23.68 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.627 . . . . 2.03 111.087 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.54 -42.82 28.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.778 -0.646 . . . . 2.19 111.507 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 0.6 OUTLIER -82.1 -33.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.07 0.396 . . . . 1.3 112.07 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.79 -24.49 67.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.881 0.372 . . . . 0.47 111.045 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 12.9 mm-40 -61.76 -31.41 71.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 0.5 111.408 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.7 OUTLIER -102.6 -36.79 8.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.117 -0.233 . . . . 0.29 110.82 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.8 mm -53.88 -34.35 25.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.61 -0.268 . . . . 0.15 111.72 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.2 ptpt -55.99 -32.06 63.58 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.126 0.417 . . . . 1.36 112.126 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -108.72 -27.15 9.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.007 0.432 . . . . 0.56 110.881 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.57 . . . . 0.62 112.091 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -149.73 -30.89 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.008 0.744 . . . . 0.17 113.008 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 33.3 ttmt -58.9 -37.56 76.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.95 0.341 . . . . 2.23 111.84 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.25 18.6 51.13 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.678 -0.772 . . . . 0.19 112.629 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -129.99 -47.84 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.62 110.501 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -119.65 -158.01 10.48 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.209 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.3 m -108.09 138.64 44.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.346 . . . . 0.31 110.532 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 150.09 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 1.37 109.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.43 167.77 23.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.053 0.454 . . . . 1.19 110.764 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.13 150.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.6 109.742 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.497 HD12 ' HE3' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -78.53 88.68 4.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.046 0.451 . . . . 0.4 110.503 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -120.42 158.3 27.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.52 109.881 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.7 tp 64.41 80.85 0.22 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.605 0.566 . . . . 0.47 110.979 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.497 ' HE3' HD12 ' A' ' 239' ' ' LEU . 7.8 mptt -86.49 32.24 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.882 -0.599 . . . . 0.36 110.943 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -101.4 -38.96 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.262 0.553 . . . . 0.71 109.864 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.41 160.13 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.54 -0.755 . . . . 0.59 109.082 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -56.02 127.15 29.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 1.39 110.664 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -71.28 -77.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 1.54 111.086 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.28 175.94 21.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.671 -0.776 . . . . 0.68 111.851 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -101.21 92.61 5.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.931 0.396 . . . . 0.58 110.157 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -5.06 59.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.05 111.173 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.23 107.74 19.4 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.643 -0.503 . . . . 0.98 109.643 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -96.54 5.46 50.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.101 0.476 . . . . 0.57 110.308 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 115.707 -0.678 . . . . 1.23 110.031 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 111.909 -0.477 . . . . 0.89 111.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -132.82 154.6 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 1.57 110.157 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -147.18 151.16 36.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.718 0.294 . . . . 0.59 110.239 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -156.7 119.48 4.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.425 -0.352 . . . . 0.42 110.226 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.95 -54.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.14 -0.482 . . . . 0.26 110.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -99.81 152.87 19.63 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -139.77 94.47 9.14 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.934 0.397 . . . . 0.83 111.226 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.52 145.88 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.936 2.424 . . . . 0.29 112.526 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 m -78.78 124.32 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.86 -0.609 . . . . 0.53 110.809 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -153.71 156.83 38.54 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.259 -0.645 . . . . 0.2 109.259 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.1 -19.23 28.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.083 0.401 . . . . 0.83 112.083 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.32 70.94 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.299 0.571 . . . . 1.13 110.803 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -146.35 149.49 33.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.749 -0.66 . . . . 0.85 109.998 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 17' ' ' VAL . 86.1 mt -67.13 -9.32 38.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.443 0.535 . . . . 0.48 112.443 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -90.86 2.67 55.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 0.33 111.48 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -135.35 32.43 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.213 0.53 . . . . 1.12 110.532 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 14' ' ' LEU . 27.2 m -84.32 152.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.69 -0.686 . . . . 0.31 111.514 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.43 140.76 48.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.843 -0.617 . . . . 0.19 110.053 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.48 117.7 32.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.204 0.526 . . . . 0.41 110.948 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -147.62 117.47 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.25 109.993 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 149.29 50.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.26 111.11 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 55.9 ttp -122.14 139.37 53.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.336 -0.847 . . . . 0.36 110.472 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -116.11 120.99 40.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.714 -0.476 . . . . 0.29 109.714 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -122.37 89.47 3.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.549 -0.296 . . . . 0.68 110.52 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.15 46.75 23.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.693 -0.685 . . . . 0.58 111.734 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.91 -48.78 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.448 -0.882 . . . . 0.47 112.815 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -69.38 129.22 39.14 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.199 -0.297 . . . . 0.45 110.199 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -119.11 143.64 47.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.763 0.316 . . . . 0.77 111.336 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -132.87 142.42 48.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.3 109.82 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 24.9 tt0 -146.54 133.02 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.62 -0.511 . . . . 1.75 109.62 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -136.49 130.38 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.326 -0.397 . . . . 0.44 110.01 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 113.09 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.15 111.686 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 31.2 m -107.55 175.91 5.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.786 -0.643 . . . . 0.17 110.219 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CD1' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.77 150.42 37.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.098 0.475 . . . . 0.32 111.084 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -87.5 -7.85 57.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.457 0.539 . . . . 1.53 112.457 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -78.63 78.33 5.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.55 111.76 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 52.27 63.24 2.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.89 -0.596 . . . . 1.71 111.852 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 7.9 p -70.45 -24.2 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.954 -0.566 . . . . 0.54 110.714 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.14 -5.35 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 111.276 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.22 -28.41 58.77 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.239 -0.505 . . . . 0.18 112.852 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.464 ' HE1' ' HB ' ' A' ' 91' ' ' THR . 21.8 t-105 -65.07 -33.84 77.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 1.42 111.101 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -75.9 -41.41 52.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 1.14 110.771 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.67 -39.54 61.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.304 -0.407 . . . . 0.61 111.273 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.52 -98.3 0.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.293 -0.956 . . . . 0.45 112.974 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG12 ' OE1' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -125.89 163.84 26.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.739 0.304 . . . . 0.94 110.822 -179.079 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' OE1' HG12 ' A' ' 45' ' ' VAL . 1.1 pm0 -89.76 161.65 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.436 -0.579 . . . . 1.39 109.436 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -34.5 16.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.875 -0.33 . . . . 1.75 110.449 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -167.69 160.43 12.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.974 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tp -109.92 -14.63 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.43 110.886 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.28 -40.54 6.71 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.611 -0.514 . . . . 0.23 109.611 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.48 -24.91 61.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.913 -0.585 . . . . 1.88 110.345 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' TYR . 12.0 p -70.88 -26.55 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.415 -0.587 . . . . 0.32 109.415 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.55 97.71 7.96 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.89 110.189 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -67.23 -37.03 82.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.22 108.904 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 t -157.52 126.09 5.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.773 -1.103 . . . . 0.44 108.98 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 10.5 p80 -77.7 67.17 3.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.556 0.693 . . . . 0.47 110.556 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -138.59 111.84 8.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.292 -0.867 . . . . 0.91 110.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.4 p -100.68 135.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.19 110.103 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -91.66 163.84 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.92 0.39 . . . . 2.09 111.238 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.44 -49.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.019 -0.734 . . . . 0.98 109.019 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -142.46 103.63 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.722 . . . . 0.27 109.173 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.9 -26.9 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.19 -0.459 . . . . 0.39 112.132 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 m -72.42 -36.06 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.9 0.381 . . . . 0.27 110.971 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.68 5.85 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.193 -0.458 . . . . 0.27 110.845 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.0 44.19 96.4 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.207 -0.52 . . . . 0.14 112.79 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -112.63 121.96 46.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.863 0.363 . . . . 0.94 110.736 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.78 170.4 7.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.98 -0.554 . . . . 1.29 109.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.714 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -115.45 120.96 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.082 0.467 . . . . 0.37 111.049 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -87.74 -178.28 6.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.078 -0.712 . . . . 1.26 109.078 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' OE1' ' A' ' 71' ' ' GLU . 3.1 pttp -56.56 -39.39 73.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.842 0.353 . . . . 1.61 111.333 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' OE1' ' HG3' ' A' ' 70' ' ' LYS . 7.1 pm0 -75.75 -11.25 59.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 1.79 111.847 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -98.03 -48.69 5.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.655 -0.248 . . . . 0.98 110.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.72 -32.81 73.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.737 -0.211 . . . . 0.33 111.514 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 79' ' ' THR . 6.9 tt -64.51 -26.78 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.085 0.469 . . . . 0.45 110.455 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 m -95.55 -10.46 29.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 1.06 110.276 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.22 -54.69 4.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.736 -0.666 . . . . 0.36 111.252 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -100.72 -37.87 8.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.58 111.33 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.66 -18.17 8.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.293 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.73 141.57 30.58 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.165 -0.309 . . . . 0.36 110.165 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -14.26 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.27 111.09 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' OD1' HG22 ' A' ' 83' ' ' THR . 17.0 t0 -90.09 125.14 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.59 110.178 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.95 -21.76 54.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.07 -0.514 . . . . 0.68 112.171 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.419 HG22 ' OD1' ' A' ' 81' ' ' ASP . 2.5 t -68.0 -31.51 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.224 -0.591 . . . . 1.49 110.034 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 74.3 mm-40 -70.22 -36.78 74.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.092 -0.707 . . . . 1.08 109.092 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 89' ' ' ILE . 32.6 mm -64.34 -45.73 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.206 -0.906 . . . . 0.28 109.172 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.49 -42.3 91.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.38 110.575 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.86 -38.32 90.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 1.86 110.189 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 7.5 mm100 -64.28 -39.95 94.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.05 109.76 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.65 HG22 HG22 ' A' ' 20' ' ' VAL . 45.1 mt -67.66 -26.75 36.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.38 110.391 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.411 HD22 HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.75 -27.4 31.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.29 111.731 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.464 ' HB ' ' HE1' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -101.36 -30.86 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.62 0.6 . . . . 0.52 112.62 -177.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -111.45 -3.73 15.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.029 0.442 . . . . 0.7 110.939 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.5 178.77 22.61 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.673 -0.775 . . . . 0.3 112.516 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.2 112.02 24.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.41 . . . . 1.31 110.573 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 20' ' ' VAL . 7.3 p -101.03 148.09 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.605 -0.725 . . . . 0.36 110.219 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -62.36 100.17 0.17 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.386 0.612 . . . . 0.49 111.058 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.56 88.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.77 111.142 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 m -91.92 27.31 2.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 0.65 110.002 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -118.56 122.8 43.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 1.85 109.767 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.6 148.72 52.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.325 . . . . 0.33 110.569 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -135.04 160.48 38.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.586 -0.279 . . . . 0.67 110.314 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -112.56 155.53 24.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.251 -0.432 . . . . 1.01 110.551 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -146.35 140.71 26.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.939 -0.393 . . . . 0.55 109.939 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.76 -60.81 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.763 0.283 . . . . 0.53 111.763 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -97.36 101.74 13.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 1.23 111.461 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.8 mt -95.88 -28.61 14.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.55 110.115 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 17.9 mt-10 -58.88 -24.96 62.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.312 -0.858 . . . . 0.96 112.874 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -41.05 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.683 -0.407 . . . . 1.4 111.187 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -48.48 80.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 1.39 111.172 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -87.08 1.3 53.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.46 -0.336 . . . . 0.33 111.779 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 27.9 ttp180 -84.14 -31.26 25.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.654 -0.499 . . . . 0.76 109.654 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.63 -48.88 75.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.5 110.069 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 116' ' ' ILE . 4.4 tp -68.0 -27.46 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.238 0.542 . . . . 0.86 110.051 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.15 -33.7 75.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.28 110.877 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.04 -23.37 65.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.029 0.443 . . . . 0.38 110.424 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 113' ' ' ILE . 29.4 mt -83.41 -41.94 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.19 110.534 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.87 -19.62 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.29 111.357 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.02 69.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.52 110.926 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.99 10.85 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 1.08 109.958 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . 0.4 OUTLIER -122.3 -49.49 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.927 -0.579 . . . . 0.97 111.154 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.476 ' HB2' HG21 ' A' ' 169' ' ' ILE . 26.5 p -92.65 109.45 20.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.015 0.436 . . . . 0.97 111.227 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.34 162.35 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.272 -0.422 . . . . 0.7 110.564 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.5 147.54 3.82 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.44 109.965 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.87 64.39 4.96 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.711 2.274 . . . . 0.48 112.209 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.44 -171.82 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.783 -0.644 . . . . 1.34 110.434 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.0 t -76.99 -12.58 59.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.245 0.545 . . . . 0.58 110.184 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -118.61 131.5 56.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.745 -0.662 . . . . 0.51 109.36 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 128' ' ' ARG . 1.0 OUTLIER -95.16 153.72 39.68 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.43 -0.35 . . . . 1.22 110.489 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.29 48.48 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.994 2.462 . . . . 0.36 112.493 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -95.03 -7.99 38.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.58 110.269 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 154.12 36.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.206 -0.452 . . . . 0.89 110.531 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 132' ' ' VAL . 2.5 t -60.06 -18.09 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.116 -0.493 . . . . 0.18 111.339 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.1 mm -54.08 -31.18 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.118 -0.492 . . . . 0.3 111.593 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.95 -52.34 64.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.32 111.17 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -81.37 -30.35 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.344 -0.389 . . . . 0.24 110.87 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.87 -46.93 87.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.825 0.345 . . . . 1.51 110.219 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -61.38 -39.93 92.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 1.17 111.148 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.94 70.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.359 -0.382 . . . . 0.31 111.281 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -42.78 91.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 2.31 110.878 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -67.09 -30.86 71.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 1.47 110.878 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -71.2 -45.74 62.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.8 111.106 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 7.0 tp -73.01 -42.57 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.792 -0.363 . . . . 0.32 110.234 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 35.5 t60 50.57 57.91 6.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.932 -0.576 . . . . 1.03 110.914 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CD2' ' HG2' ' A' ' 162' ' ' GLN . 44.0 t80 -97.16 136.34 37.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.731 . . . . 1.42 110.059 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.9 124.05 22.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.721 0.296 . . . . 0.36 110.305 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.25 39.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.195 0.522 . . . . 0.29 111.012 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 55.02 83.96 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 1.01 111.989 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -14.51 62.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.982 -0.554 . . . . 0.59 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -102.0 14.88 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.514 0.673 . . . . 0.57 109.188 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 151' ' ' SER . 61.6 mttp -147.65 -149.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.584 -0.734 . . . . 0.62 109.832 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 154' ' ' GLN . 4.1 t -152.99 175.94 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.918 -0.401 . . . . 0.18 109.918 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -65.8 -36.18 82.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.52 111.941 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -76.73 -9.46 58.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.419 -0.355 . . . . 0.38 111.487 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -74.97 -47.57 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.58 110.113 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -161.77 73.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.81 110.987 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -75.26 -24.74 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.48 110.745 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.18 -51.16 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.607 . . . . 0.64 110.878 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.84 -35.27 79.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.41 110.625 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.6 -52.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.22 110.981 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.2 tp -66.01 -31.98 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.349 -0.387 . . . . 0.19 111.125 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -72.41 -31.66 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.6 110.479 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.512 ' HG2' ' CD2' ' A' ' 144' ' ' TYR . 7.4 tp-100 -68.93 -37.78 79.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.76 109.928 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.59 -40.61 97.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.25 109.994 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -66.29 -21.27 66.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.366 -0.834 . . . . 0.45 111.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -71.08 -28.6 64.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.829 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.491 ' HG3' ' HB ' ' A' ' 142' ' ' ILE . 7.1 mmtt -93.09 -41.62 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.42 110.036 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.9 mmm -130.53 99.53 5.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 1.82 109.498 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.35 93.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.165 0.507 . . . . 0.77 110.973 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -89.33 164.67 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.49 -0.777 . . . . 0.18 109.859 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -172.11 -144.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.021 -0.363 . . . . 0.52 110.021 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 69.85 55.06 0.35 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.333 0.653 . . . . 0.78 111.942 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.51 155.63 40.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.36 109.856 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -119.28 149.06 42.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 1.15 111.986 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 63.1 mtt -124.84 -118.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.73 109.518 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.99 126.93 22.28 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.921 0.391 . . . . 0.87 110.74 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.48 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 5.7 mp -113.16 144.59 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.199 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 16.0 ptt180 -123.67 138.66 54.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.926 -0.579 . . . . 0.13 110.125 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 71.9 m-85 -106.3 124.58 49.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.035 -0.357 . . . . 0.1 110.035 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.18 112.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.32 111.291 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.416 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -153.83 152.81 27.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.829 -0.623 . . . . 0.21 110.137 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.98 153.36 74.03 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.124 1.883 . . . . 0.14 111.06 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.74 -30.96 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.77 111.329 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.99 -41.94 62.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 1.32 110.584 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -97.56 -31.9 12.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.59 110.781 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.33 -31.05 68.89 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.86 -0.609 . . . . 0.3 112.597 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -64.36 -16.27 61.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.56 0.219 . . . . 2.34 111.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -82.89 -44.5 15.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.72 111.004 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 -23.29 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 0.49 111.311 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -54.54 -55.32 30.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.48 111.325 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -82.89 29.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.366 -0.379 . . . . 0.53 111.629 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -134.8 -48.9 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.5 110.45 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.4 mt -78.83 -39.83 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.58 111.705 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 39.7 mtpt -64.68 -50.51 64.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.529 0.566 . . . . 1.39 112.529 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.7 Cg_endo -62.28 -15.79 46.96 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.978 1.786 . . . . 0.15 112.879 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.44 2.96 49.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.549 -0.296 . . . . 0.3 110.223 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 23.7 pt 41.2 41.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.252 1.021 . . . . 0.13 112.746 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.483 ' HG2' HD12 ' A' ' 222' ' ' ILE . 12.2 mptt -117.8 18.76 14.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.548 0.69 . . . . 1.4 109.798 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 212' ' ' CYS . 22.6 m -111.82 164.06 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.27 -0.877 . . . . 0.33 110.565 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.91 138.48 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.793 -0.817 . . . . 0.25 108.793 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.49 70.96 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.422 0.629 . . . . 1.75 111.374 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.5 m -144.73 28.15 1.3 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.742 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 9.1 pt-20 -85.73 168.78 14.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 1.9 110.62 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -131.34 126.83 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.19 110.681 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.54 79.14 4.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 1.55 110.915 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -125.7 2.68 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.247 -0.741 . . . . 0.33 111.247 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.83 -36.55 17.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.453 0.645 . . . . 2.76 109.726 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -113.35 114.64 26.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.146 -0.933 . . . . 2.24 108.99 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.51 80.72 4.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.141 0.496 . . . . 0.55 110.38 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 28.0 tt0 -80.19 105.68 11.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.66 110.115 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.12 138.27 37.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.36 110.473 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.19 113.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.2 109.826 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.748 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.6 p -138.81 105.5 5.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.028 0.442 . . . . 0.18 111.168 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -148.86 144.96 27.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.275 -0.639 . . . . 0.61 109.275 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.1 tt -137.26 163.17 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.588 -0.278 . . . . 0.38 110.45 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 165.7 4.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.828 0.451 . . . . 0.74 110.808 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.53 -172.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.457 2.105 . . . . 0.23 112.855 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 81.12 -92.6 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.699 -0.762 . . . . 0.21 111.537 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.19 -12.36 50.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 1.44 110.957 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.485 ' HA ' HG22 ' A' ' 222' ' ' ILE . 79.7 t80 -58.2 -30.68 66.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.396 . . . . 0.15 110.617 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -69.4 -18.63 63.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 1.5 110.732 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -90.3 -35.24 15.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.469 -0.332 . . . . 1.11 111.24 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 5.3 tt -82.35 -34.88 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.552 0.215 . . . . 0.14 111.266 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.64 -25.74 66.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.183 0.516 . . . . 0.8 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.21 -32.35 66.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.421 -0.808 . . . . 0.64 111.45 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.48 -36.13 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.784 -0.367 . . . . 0.75 110.433 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.1 mm -53.86 -41.09 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 116.556 -0.293 . . . . 0.37 111.367 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.8 ptpt -55.94 -31.1 62.63 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.887 -0.597 . . . . 0.3 112.603 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.546 ' HE3' ' C ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.63 2.62 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.852 0.316 . . . . 2.25 111.852 -178.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 6.5 tp10 -94.25 -56.39 2.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.36 . . . . 0.89 110.865 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t -126.66 -21.85 4.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.083 -0.508 . . . . 0.19 111.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.514 ' HD2' HD22 ' A' ' 236' ' ' LEU . 26.2 tptp -61.88 -50.51 71.92 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.842 -0.429 . . . . 0.35 109.842 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.74 34.65 4.52 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.17 111.77 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -129.9 -30.4 2.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.747 0.308 . . . . 1.77 110.538 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -151.3 -151.37 5.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.712 -0.756 . . . . 0.35 112.368 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.2 m -110.81 145.85 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.125 -0.324 . . . . 0.33 110.125 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 231' ' ' LYS . 1.2 pt? -114.58 145.37 42.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 0.57 110.659 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.61 170.63 15.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.497 -0.774 . . . . 1.16 109.173 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.17 153.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.404 -0.591 . . . . 0.21 109.404 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.5 tp -78.67 70.64 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.16 109.921 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.421 ' OD1' ' HE2' ' A' ' 242' ' ' LYS . 66.6 t30 -103.69 47.77 0.87 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.679 -0.691 . . . . 1.36 110.426 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.45 -71.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.45 110.65 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' HE2' ' OD1' ' A' ' 240' ' ' ASN . 0.0 OUTLIER 61.82 27.77 16.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.89 110.713 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.54 -51.83 2.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.571 . . . . 0.64 110.272 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.726 HG22 ' H ' ' A' ' 246' ' ' GLU . 6.4 p -138.12 134.94 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.37 109.559 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -111.11 21.5 16.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 0.71 110.524 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.726 ' H ' HG22 ' A' ' 244' ' ' VAL . 36.1 tt0 -95.66 119.03 33.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.877 -0.601 . . . . 1.39 110.739 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.33 160.69 20.59 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.28 111.4 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -79.96 89.94 5.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.187 0.518 . . . . 0.69 110.846 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -106.45 14.38 27.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.716 -0.674 . . . . 0.45 110.269 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -125.45 89.58 3.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.859 -0.609 . . . . 0.4 110.693 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -71.21 -35.28 71.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.079 0.466 . . . . 0.64 110.646 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.698 -0.668 . . . . 1.93 109.901 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.542 -0.623 . . . . 0.55 111.542 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.76 110.264 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -59.84 116.61 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.835 -0.62 . . . . 2.58 110.792 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -130.22 117.71 20.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.096 -0.502 . . . . 0.43 110.13 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.69 -56.06 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.9 110.91 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -91.33 93.05 8.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.398 . . . . 2.35 110.636 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 87.43 55.87 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.43 110.691 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' HG21 ' A' ' 15' ' ' THR . 58.3 Cg_endo -72.72 151.75 52.26 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.559 2.173 . . . . 0.32 112.557 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -103.24 124.44 48.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.52 110.615 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -153.62 -171.77 4.01 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.845 -0.428 . . . . 0.63 109.845 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -84.62 -85.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.911 0.386 . . . . 1.18 111.021 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.461 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 mp -93.74 83.49 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.195 0.522 . . . . 0.54 110.721 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.4 mmt85 -141.55 148.59 39.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.81 109.972 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' HA ' HG13 ' A' ' 17' ' ' VAL . 6.4 mp -75.41 -9.75 58.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.066 0.46 . . . . 1.32 111.258 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.428 HG21 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -90.29 9.11 30.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 0.59 111.336 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -145.03 37.65 1.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.55 109.743 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 14' ' ' LEU . 30.6 m -88.84 -168.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.32 -0.855 . . . . 0.25 111.916 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.29 152.94 36.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.553 -0.748 . . . . 0.28 109.496 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.07 119.4 47.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.864 0.364 . . . . 0.15 110.749 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -155.47 110.32 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.19 109.784 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -128.61 142.16 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.61 111.665 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 37.7 ttp -112.73 129.57 56.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.48 110.033 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 124.76 47.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 1.46 110.028 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -104.19 -166.49 1.25 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.688 -0.687 . . . . 0.76 110.3 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.23 90.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.427 -0.351 . . . . 0.7 111.037 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.06 46.17 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.594 -0.813 . . . . 0.23 112.442 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -172.82 156.83 3.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.977 -0.379 . . . . 1.59 109.977 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 145.13 48.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.61 109.779 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -134.23 138.61 45.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.378 -0.373 . . . . 0.5 110.639 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 34.6 tt0 -144.19 142.53 30.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.58 0.229 . . . . 1.28 110.664 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.93 -164.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.559 . . . . 0.1 110.107 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.4 153.35 51.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.391 -0.225 . . . . 0.32 110.391 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 42.5 m -133.39 127.3 33.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.852 0.358 . . . . 0.23 111.297 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 2.1 t80 -62.89 122.28 15.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.41 112.375 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 55.72 17.49 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.066 -0.97 . . . . 1.06 112.81 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.19 23.35 13.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.0 0.429 . . . . 0.85 110.35 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -74.52 -1.13 20.01 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.246 0.462 . . . . 1.06 112.246 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.98 -23.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.53 . . . . 0.14 110.423 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.15 -7.46 9.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.82 -0.627 . . . . 0.14 109.798 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' OG ' ' A' ' 43' ' ' SER . . . -62.48 -27.78 70.12 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.62 -0.718 . . . . 0.21 111.95 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -73.73 2.13 8.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.57 111.001 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -130.41 23.99 5.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.982 -0.747 . . . . 0.43 108.982 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' OG ' ' HA2' ' A' ' 40' ' ' GLY . 1.5 p -148.96 15.75 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.24 110.702 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.96 23.76 77.53 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.133 -0.556 . . . . 0.19 113.901 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.36 78.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.093 0.446 . . . . 0.25 110.474 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.46 136.21 55.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.044 -0.354 . . . . 1.27 110.044 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -125.28 159.49 31.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.584 -0.28 . . . . 0.55 111.097 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.71 127.55 28.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.444 -0.798 . . . . 0.47 110.941 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.45 -10.17 59.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.023 -0.535 . . . . 0.62 111.088 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -105.15 -9.7 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 0.67 111.072 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -102.08 -39.34 7.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 1.27 110.21 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 6.6 p -72.94 -20.13 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.25 111.077 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.17 102.79 14.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.393 -0.367 . . . . 0.1 110.391 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 12' ' ' ILE . 57.6 mt-30 -82.89 -73.54 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.165 -0.471 . . . . 0.36 110.428 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 m -67.2 106.48 2.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.81 -0.632 . . . . 0.08 110.3 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -87.97 49.63 1.84 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.461 0.648 . . . . 0.41 110.427 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 p -161.11 141.97 11.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.064 -0.971 . . . . 0.12 108.872 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.8 p -109.98 145.47 16.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.262 -0.273 . . . . 0.1 110.262 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -89.67 160.66 16.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.634 0.254 . . . . 0.09 111.057 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 84.9 t -123.35 -50.98 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.34 109.945 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 65.8 m-20 -129.23 112.46 13.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.61 109.427 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 7.3 p -79.63 -34.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.83 0.348 . . . . 0.33 111.42 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -78.18 -28.1 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 1.08 110.926 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -94.35 -6.85 43.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.167 -0.469 . . . . 1.01 110.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.03 53.92 36.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.017 -0.611 . . . . 0.6 112.045 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 12.2 mm100 -121.96 121.39 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.37 111.015 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.0 t -110.68 146.0 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.493 -0.776 . . . . 0.27 109.632 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -100.99 121.94 42.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.23 110.27 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 -171.87 2.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.068 -0.716 . . . . 0.67 109.068 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -56.86 -39.68 74.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.835 0.309 . . . . 0.68 111.835 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -72.74 -16.74 61.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.624 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.86 -53.48 4.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.061 0.457 . . . . 0.12 110.654 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.99 -23.81 66.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.1 111.754 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -64.16 -30.37 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.863 0.363 . . . . 0.54 110.64 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -97.2 -23.27 16.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.841 0.353 . . . . 0.26 110.599 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.13 -47.72 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.36 110.974 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 -59.03 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.53 110.401 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.72 -37.43 1.03 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.544 -0.836 . . . . 0.16 112.506 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.56 135.1 44.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.452 0.168 . . . . 0.31 111.054 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' HB3' HG13 ' A' ' 74' ' ' ILE . 6.5 p-10 -84.77 43.63 1.0 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 0.53 111.02 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.7 130.89 46.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.193 -0.458 . . . . 0.23 110.128 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -64.74 -27.26 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 1.01 111.368 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.571 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 1.1 m -65.65 -35.7 81.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.189 0.518 . . . . 0.23 111.074 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.86 -24.94 60.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.098 -0.501 . . . . 1.34 110.567 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' HG13 ' A' ' 89' ' ' ILE . 29.6 mm -84.17 -51.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.13 110.822 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 30.0 p -60.63 -37.12 80.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.21 111.917 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -64.08 -30.12 71.21 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.898 0.38 . . . . 1.69 110.613 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -77.9 -38.99 44.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.931 -0.396 . . . . 1.88 109.931 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 20' ' ' VAL . 56.5 mt -67.1 -25.3 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.24 110.5 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 20' ' ' VAL . 1.5 mm? -81.55 -35.65 30.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.747 -0.66 . . . . 0.18 112.061 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 -20.56 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.733 0.642 . . . . 0.29 112.733 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' MET . 5.2 mmtm -127.78 23.09 6.25 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.879 -0.329 . . . . 0.47 111.632 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.14 -176.02 14.22 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.228 -0.987 . . . . 0.13 113.501 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 mm-40 -101.88 105.07 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.287 -0.457 . . . . 1.62 109.924 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.05 146.0 15.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.444 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -66.69 97.96 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.381 . . . . 1.14 110.221 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.03 131.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.058 0.456 . . . . 1.17 110.908 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.6 m -157.15 126.1 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.55 -0.75 . . . . 0.29 109.054 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.93 93.81 1.02 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 2.6 110.458 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -101.74 -45.88 5.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.63 111.496 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -127.63 161.3 29.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.136 0.493 . . . . 0.62 110.877 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -137.18 136.36 38.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.587 -0.733 . . . . 1.34 110.078 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 104' ' ' THR . 7.5 t-80 -161.11 -158.17 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.482 -0.562 . . . . 0.63 109.482 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.502 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 4.3 m -137.65 128.1 26.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.44 109.385 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' OE1' ' HG2' ' A' ' 108' ' ' GLN . 0.4 OUTLIER -65.03 149.2 50.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.83 0.348 . . . . 0.19 111.203 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.4 tp -97.01 -48.1 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.2 -0.454 . . . . 1.4 110.928 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.497 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 4.9 mm-40 -71.83 -88.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.365 -0.38 . . . . 1.74 111.457 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.497 ' OE1' ' HB2' ' A' ' 107' ' ' GLU . 2.1 pm0 -88.14 61.49 6.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 1.06 110.278 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.3 ttp -52.91 -40.03 63.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.539 -0.755 . . . . 1.3 111.762 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -67.16 -31.9 72.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.778 -0.646 . . . . 0.27 111.481 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -77.51 -31.65 53.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.588 -0.278 . . . . 0.72 111.13 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.1 t70 -57.36 -46.63 83.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.942 0.401 . . . . 0.59 109.966 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -75.24 -32.64 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.28 109.949 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.26 93.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.17 111.364 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -78.54 3.94 14.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.765 0.283 . . . . 0.25 111.765 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 112' ' ' ASP . 52.7 mt -112.92 -11.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.688 0.756 . . . . 0.53 109.76 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 -20.48 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.564 . . . . 0.33 111.594 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.27 81.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.762 0.315 . . . . 0.44 111.449 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -71.08 -35.83 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.703 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -68.97 -32.71 72.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.62 110.939 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 28.5 m -84.79 81.56 8.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.22 110.568 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -74.63 142.93 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.594 . . . . 0.22 111.57 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -133.75 99.2 14.18 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.711 -0.677 . . . . 0.26 109.98 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.72 25.1 0.69 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.653 2.235 . . . . 0.5 112.586 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.35 -48.95 6.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.558 -0.292 . . . . 0.76 110.758 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 t -170.78 -33.16 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.893 -0.323 . . . . 0.36 111.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -95.17 108.34 20.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.034 0.445 . . . . 1.81 110.221 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.42 154.2 93.45 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 1.09 111.21 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.62 53.81 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.315 2.677 . . . . 0.73 112.97 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.22 16.43 3.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.858 -0.61 . . . . 0.24 109.692 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 m -122.86 108.66 13.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.48 111.318 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -30.79 44.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.859 -0.609 . . . . 0.3 110.737 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.02 -27.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.612 . . . . 0.24 111.35 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.52 -45.3 89.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.26 111.156 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -33.76 8.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.559 -0.292 . . . . 0.07 110.475 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.4 -39.66 88.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 1.0 110.983 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -37.34 85.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.555 . . . . 1.21 110.404 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.49 -39.29 28.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.09 -0.505 . . . . 0.09 111.262 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 31.9 ttp -61.23 -36.35 79.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 0.23 110.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.58 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 1.41 110.575 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.78 -39.57 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.216 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 142' ' ' ILE . 8.1 mt -58.04 -53.03 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.966 -0.561 . . . . 0.22 110.134 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 60.74 28.12 17.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.348 -0.842 . . . . 0.89 112.01 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -124.19 129.37 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.74 -0.467 . . . . 0.45 109.74 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.73 141.13 37.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.0 -0.545 . . . . 0.21 110.826 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.75 -63.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.346 -0.388 . . . . 0.18 110.564 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -151.32 129.09 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.131 -0.322 . . . . 1.46 110.131 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 145.82 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 0.54 111.65 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.8 t30 66.39 9.87 6.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.24 112.196 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -84.66 140.35 31.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.249 -0.648 . . . . 0.65 109.249 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.49 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 2.3 m -59.02 132.68 54.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.96 -0.385 . . . . 0.4 109.96 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -45.13 73.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.541 0.571 . . . . 0.74 112.541 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -64.07 -25.18 67.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.389 0.514 . . . . 2.29 112.389 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.52 -25.72 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.871 0.323 . . . . 2.17 111.871 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 25.6 pt20 -109.32 12.81 24.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.922 0.391 . . . . 0.37 111.114 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.68 ' HA ' HD11 ' A' ' 113' ' ' ILE . . . -60.71 -39.16 87.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.25 111.142 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.0 mm? -67.3 -31.5 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.41 110.645 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -76.04 -36.22 59.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.399 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 155' ' ' GLN . 94.5 t -65.12 -48.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.19 110.758 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.22 -33.78 64.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.826 0.346 . . . . 0.22 110.711 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.4 mtmt -67.86 -46.29 72.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.326 . . . . 1.22 110.121 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -65.86 -36.32 83.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.7 110.72 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.19 -42.85 99.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.35 110.317 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 167' ' ' MET . 1.4 tmmt? -60.57 -28.72 68.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.492 -0.777 . . . . 0.5 111.306 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.3 mm-40 -70.47 -25.62 63.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.474 . . . . 1.36 110.887 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -99.9 -39.1 8.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 0.71 111.052 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 36.2 ttm -135.25 129.16 33.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.843 -0.428 . . . . 1.44 109.843 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -80.97 97.79 7.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.95 0.405 . . . . 0.73 111.182 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -101.22 166.11 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.546 . . . . 0.3 110.299 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.42 93.53 7.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.996 0.427 . . . . 0.52 110.751 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -102.66 13.36 34.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 1.28 110.143 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.87 98.87 9.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.51 110.569 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.532 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 2.0 p-80 -91.67 142.47 27.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.971 -0.559 . . . . 0.22 110.772 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.23 167.23 11.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.222 -0.659 . . . . 2.04 109.222 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 83.7 mtm180 -133.59 129.58 37.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.968 0.413 . . . . 0.99 111.181 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 6.0 mt -116.65 151.59 35.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 1.14 109.915 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 211' ' ' VAL . 6.8 ptm180 -134.69 135.21 41.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.322 -0.399 . . . . 0.26 110.446 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 49.1 m-85 -102.17 128.04 48.84 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.991 -0.374 . . . . 0.28 109.991 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.59 123.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 0.38 111.196 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -150.46 160.61 32.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.562 -0.744 . . . . 0.13 110.052 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.03 165.64 11.95 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.779 2.319 . . . . 0.13 112.567 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.24 -41.42 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.399 -0.364 . . . . 0.4 111.76 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -59.3 -47.49 85.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.9 111.078 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.58 53.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 0.63 111.581 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.3 71.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.177 -0.535 . . . . 0.2 113.13 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -71.44 -8.17 52.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.828 0.307 . . . . 0.49 111.828 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -87.66 -6.04 58.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.64 0.257 . . . . 0.85 111.066 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -26.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.675 -0.238 . . . . 0.4 111.342 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -56.78 16.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.838 0.351 . . . . 1.46 111.235 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.64 10.5 3.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -118.14 -41.68 2.86 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.684 0.253 . . . . 0.67 111.684 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.33 -38.46 18.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.981 0.363 . . . . 0.4 111.981 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 11.0 mtpt -59.52 -47.54 97.6 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.597 0.591 . . . . 0.36 112.597 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.9 Cg_endo -64.6 -8.95 18.79 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.468 2.112 . . . . 0.2 113.474 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.1 mt -90.46 -5.15 56.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.858 0.361 . . . . 0.09 110.203 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.2 mm 58.09 54.18 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.666 0.746 . . . . 0.11 110.309 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 222' ' ' ILE . 70.3 mmtt -125.97 16.99 7.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.454 -0.794 . . . . 0.16 110.556 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.95 142.37 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.608 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.94 159.03 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.527 -0.761 . . . . 0.47 109.547 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -70.77 53.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.25 0.463 . . . . 1.87 112.25 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.7 m -167.18 100.58 0.52 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.496 0.719 . . . . 0.73 109.797 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -128.05 145.78 50.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.26 111.361 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 209' ' ' GLU . 12.2 t70 -106.27 119.3 38.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.874 -0.417 . . . . 0.25 109.874 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.16 101.39 6.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.74 109.909 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -156.98 -109.4 0.29 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.954 -0.641 . . . . 0.26 111.741 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -88.69 -13.35 39.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.631 0.729 . . . . 1.39 109.037 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -138.58 -177.32 4.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.612 -1.176 . . . . 0.85 108.536 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 40.9 tp -134.1 117.22 16.36 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.813 -0.439 . . . . 0.33 109.813 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 48.3 tt0 -128.77 117.6 21.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.053 -0.522 . . . . 0.34 109.632 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.79 141.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.825 0.345 . . . . 1.53 111.125 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 177' ' ' ARG . 58.7 t -92.46 111.23 24.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.471 -0.566 . . . . 0.23 109.471 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 60.29 0.71 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.992 0.425 . . . . 0.45 111.706 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -138.59 113.94 9.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.79 -78.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.13 111.567 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -138.92 160.83 61.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.521 -0.309 . . . . 0.21 110.766 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 173' ' ' HIS . 70.2 Cg_endo -74.53 176.19 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.55 2.166 . . . . 0.23 111.712 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 77.24 -75.4 1.77 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.499 -0.858 . . . . 0.15 111.883 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -5.25 32.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.69 0.281 . . . . 1.96 110.843 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 7.7 p90 -59.71 -23.53 63.24 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.19 110.991 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.445 ' HA ' ' OD1' ' A' ' 223' ' ' ASP . 1.2 tpm_? -60.32 -27.89 67.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.875 0.369 . . . . 2.32 110.884 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -50.23 65.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.3 110.499 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 8.3 tt -81.33 -34.9 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 1.02 111.854 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 219' ' ' PHE . 0.0 OUTLIER -64.34 -28.07 69.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.722 0.296 . . . . 1.71 111.299 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -66.49 -36.13 81.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.69 110.382 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -90.89 -39.71 12.15 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.678 -0.409 . . . . 0.12 110.92 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.3 mm -55.7 -36.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.463 -0.335 . . . . 0.3 111.604 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 7.9 ptpt -56.49 -23.72 41.31 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.739 0.644 . . . . 0.64 112.739 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.5 pttm -121.26 -19.19 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.798 0.296 . . . . 0.9 111.798 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -78.64 -32.27 47.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.29 112.34 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -143.26 -33.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.446 -0.502 . . . . 0.16 111.364 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 44.3 tttm -66.12 -18.66 65.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.177 0.513 . . . . 0.26 110.529 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.82 15.47 28.85 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.12 111.512 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -128.49 -35.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.725 0.297 . . . . 0.39 110.73 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.95 -150.29 6.55 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.91 -0.662 . . . . 0.18 112.742 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.2 m -116.71 145.84 43.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.318 . . . . 0.82 110.812 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.5 pt? -106.4 137.45 44.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.943 0.401 . . . . 0.15 110.688 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -129.31 163.75 25.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.66 110.444 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.14 169.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.371 -0.377 . . . . 0.39 110.797 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.72 12.3 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.877 0.37 . . . . 1.32 111.138 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -79.0 70.42 5.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 1.19 110.272 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 241' ' ' LEU . 1.3 mm? -113.39 81.95 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.703 -0.68 . . . . 1.25 110.26 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.06 -19.59 17.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.709 -0.678 . . . . 0.34 109.735 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.57 -60.41 2.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.113 -0.949 . . . . 1.19 110.627 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.17 150.97 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.318 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -80.67 146.46 31.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.083 -0.34 . . . . 1.0 110.083 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -157.97 112.15 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.992 -0.373 . . . . 1.33 109.992 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 149.77 127.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.799 -0.637 . . . . 0.19 111.845 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -114.29 145.26 41.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.84 -0.43 . . . . 0.7 109.84 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 -7.17 37.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.79 -0.448 . . . . 0.81 109.79 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER 56.77 53.46 8.26 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.988 -1.005 . . . . 0.98 111.272 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -71.78 -23.11 61.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.235 0.54 . . . . 0.97 109.807 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.4 -0.809 . . . . 1.42 109.718 179.102 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 111.549 -0.62 . . . . 0.35 111.549 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -69.24 127.54 33.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.902 -0.407 . . . . 0.31 109.902 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.5 mmt -53.49 -53.47 51.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.756 0.312 . . . . 1.29 110.464 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -96.13 106.44 18.62 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.515 -0.55 . . . . 1.11 109.515 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 tp -152.6 120.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.378 0.608 . . . . 0.43 110.667 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -84.66 110.44 18.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 0.91 110.24 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -144.0 108.31 5.0 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.943 -0.571 . . . . 0.22 110.327 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 7' ' ' THR . 19.3 Cg_endo -61.73 109.76 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.594 2.196 . . . . 0.67 112.1 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 16' ' ' ASN . 7.9 p -114.46 105.65 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.13 -0.486 . . . . 0.42 110.729 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -131.58 -82.63 0.51 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.615 0.245 . . . . 1.15 110.683 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -129.34 -122.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.601 -0.272 . . . . 1.23 110.598 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.95 94.42 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.23 110.636 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 13' ' ' ARG . 10.3 mmt85 -134.4 -171.47 2.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.686 -0.688 . . . . 1.51 109.759 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.54 12.65 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.275 0.559 . . . . 1.37 110.379 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.65 -32.75 7.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 0.66 111.833 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 9' ' ' THR . 26.0 p-10 -97.63 18.62 15.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 1.1 111.443 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.1 m -85.8 157.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.599 0.714 . . . . 0.34 112.786 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.11 140.05 53.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.625 -1.17 . . . . 0.42 108.96 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -89.08 98.57 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.49 111.311 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.777 HG22 HG22 ' A' ' 89' ' ' ILE . 2.3 p -103.36 120.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.847 -0.615 . . . . 0.24 109.696 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -122.75 132.56 54.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.28 112.146 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 39.0 ttp -107.01 122.66 46.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.17 110.337 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -97.63 123.62 41.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 1.19 109.99 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -107.39 -154.9 0.53 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.449 -0.341 . . . . 0.36 110.096 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.43 -59.55 2.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.84 0.311 . . . . 0.59 111.84 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.84 21.56 5.88 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.638 -0.791 . . . . 0.56 112.634 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -155.86 161.01 40.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.692 -0.484 . . . . 0.8 109.692 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 142.83 28.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.341 -0.615 . . . . 0.36 109.341 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.89 141.26 47.3 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.343 0.402 . . . . 0.22 110.523 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' CD1' ' A' ' 59' ' ' PHE . 14.1 pt-20 -139.68 149.22 43.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.052 -0.351 . . . . 0.21 110.052 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.3 pt -136.75 -176.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.771 -0.65 . . . . 0.3 110.591 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.36 109.88 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.308 0.575 . . . . 0.19 111.282 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 11.3 p -117.77 -179.63 3.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.698 -0.853 . . . . 0.31 108.698 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -70.32 143.12 52.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.479 -0.489 . . . . 0.36 110.212 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -85.4 -41.87 15.05 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.383 0.512 . . . . 0.86 112.383 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -64.63 127.45 31.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.642 -0.254 . . . . 1.6 111.643 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.5 pttp 43.64 37.34 1.5 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.31 1.044 . . . . 1.59 113.021 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.7 p -64.47 -21.73 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.52 0.676 . . . . 0.4 111.178 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 -4.2 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.56 110.802 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 -24.05 71.21 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.4 112.693 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.518 ' NE1' ' HB3' ' A' ' 90' ' ' LEU . 1.3 p-90 -75.22 -33.11 61.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.394 . . . . 0.25 110.049 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' NH2' ' HA ' ' A' ' 91' ' ' THR . 10.7 tpp85 -72.12 -22.21 61.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.17 0.509 . . . . 1.25 110.272 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -101.86 -6.11 23.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.81 110.905 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.18 44.88 90.13 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.035 -0.53 . . . . 0.25 112.711 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 t -119.44 -18.56 5.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.969 0.414 . . . . 0.66 110.659 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -91.38 -170.35 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 1.78 112.059 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -170.83 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.475 -0.784 . . . . 1.77 111.194 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.06 149.02 48.42 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.99 110.94 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.76 -20.97 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.39 111.392 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -30.24 71.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 1.01 110.473 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.26 -24.46 24.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.99 109.823 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 34' ' ' TYR . 49.2 t -69.29 -41.18 80.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.537 -0.756 . . . . 0.11 110.121 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD11 HE21 ' A' ' 82' ' ' GLN . 0.7 OUTLIER -75.8 92.28 3.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.426 -0.806 . . . . 0.3 109.899 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -74.64 -61.52 1.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.28 111.834 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.84 108.02 19.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.894 0.378 . . . . 0.27 110.944 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' HA ' HD11 ' A' ' 53' ' ' LEU . 1.9 p-80 -83.4 69.32 9.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.224 0.535 . . . . 0.93 111.438 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -154.4 105.06 2.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.822 -0.626 . . . . 0.22 110.13 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 68' ' ' ALA . 10.9 p -94.7 141.55 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.394 -0.595 . . . . 0.27 109.394 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.669 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -93.73 157.76 16.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.064 0.459 . . . . 0.24 111.678 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.7 t -106.29 -56.47 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.47 -0.937 . . . . 0.26 108.47 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -150.02 116.79 5.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.54 109.406 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.97 -17.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.044 -0.525 . . . . 0.22 111.252 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.9 t -64.81 -26.26 68.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 1.35 110.689 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -122.64 -0.91 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.431 . . . . 0.93 110.987 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.96 37.48 64.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.936 -0.649 . . . . 0.37 112.039 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -86.37 118.73 26.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 1.56 110.772 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.79 144.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.59 109.732 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.693 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -107.29 133.06 52.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.15 0.5 . . . . 0.23 110.631 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 7.3 mtmt -107.64 -171.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.736 -0.666 . . . . 1.25 109.884 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.54 68.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.683 0.277 . . . . 0.3 111.263 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 69' ' ' LYS . 5.0 pm0 -80.32 -5.67 56.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.529 -0.305 . . . . 0.46 111.482 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.33 -44.15 4.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.84 -0.344 . . . . 0.43 110.966 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.35 -26.91 68.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.93 0.395 . . . . 0.18 110.454 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -27.83 33.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 116.077 -0.511 . . . . 0.28 109.908 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -17.66 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.448 0.642 . . . . 0.19 109.63 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.28 -59.19 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.748 . . . . 0.32 110.664 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -95.19 -52.0 4.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.284 -0.417 . . . . 0.25 110.464 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.06 -26.68 2.71 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.472 -0.651 . . . . 0.2 111.472 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.36 143.49 28.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.564 -0.318 . . . . 0.22 110.617 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.85 10.08 32.57 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 1.44 110.817 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.5 120.25 36.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.602 -0.726 . . . . 0.76 110.454 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.457 HE21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.18 -29.78 71.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.23 111.091 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -60.11 -37.87 81.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.21 110.795 179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.92 -24.9 62.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.65 110.637 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.6 mm -79.49 -49.05 20.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.13 109.47 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 25.7 p -67.51 -29.33 68.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.706 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 83' ' ' THR . 18.5 ttpt -66.07 -16.59 64.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.211 0.529 . . . . 0.47 110.419 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.89 -52.59 4.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.67 109.692 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.777 HG22 HG22 ' A' ' 20' ' ' VAL . 19.6 mt -61.44 -35.31 65.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.748 -0.66 . . . . 0.34 112.365 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.518 ' HB3' ' NE1' ' A' ' 41' ' ' TRP . 2.1 mm? -73.95 2.37 8.78 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.422 0.897 . . . . 0.27 113.422 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.576 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 3.3 t -145.4 -32.92 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.611 -0.436 . . . . 0.93 112.135 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' HG2' HG23 ' A' ' 91' ' ' THR . 40.6 mmtm -96.03 10.21 38.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.001 -0.37 . . . . 1.32 110.001 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.92 -173.79 13.31 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.784 -0.722 . . . . 0.34 112.093 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -95.6 101.73 13.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.842 0.353 . . . . 2.19 110.398 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 p -100.35 133.35 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.992 -0.549 . . . . 0.39 109.688 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -74.19 84.71 1.86 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.272 0.558 . . . . 1.55 110.326 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.03 162.97 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 1.11 111.455 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.7 m -140.7 153.02 45.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.595 -0.73 . . . . 1.35 109.459 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -74.69 95.02 2.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 1.22 110.518 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -159.01 131.63 6.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 1.91 110.802 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 162.38 27.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.31 110.272 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.82 160.3 25.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.771 -0.455 . . . . 2.33 109.771 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -108.16 147.51 31.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.76 0.314 . . . . 0.75 110.605 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.33 137.26 52.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.048 -0.524 . . . . 0.44 110.998 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.51 118.63 37.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.981 -0.377 . . . . 2.48 109.981 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -141.23 150.24 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.387 -0.369 . . . . 0.6 110.339 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.91 -29.14 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.291 0.567 . . . . 1.97 110.097 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 16.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.714 -0.675 . . . . 1.26 111.192 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.1 ttm -60.84 -34.37 74.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.546 -0.297 . . . . 1.27 110.91 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -58.45 -49.57 76.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.51 110.506 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -71.72 -34.13 69.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.882 -0.599 . . . . 1.8 110.298 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -56.58 -49.58 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.903 -0.59 . . . . 0.3 110.746 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.35 -39.88 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.22 110.441 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' A' ' 135' ' ' ILE . . . -65.32 -40.81 94.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.752 . . . . 0.14 112.756 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.1 t -70.58 -15.48 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.212 0.449 . . . . 0.31 112.212 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.85 -33.88 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.87 110.766 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.2 p -86.81 -13.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.411 -0.358 . . . . 0.63 111.047 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.56 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.46 111.984 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -13.74 62.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 1.72 111.3 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -15.82 57.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 1.27 111.108 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.6 p -119.55 140.66 50.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.111 0.482 . . . . 0.29 111.091 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.63 161.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.248 -0.433 . . . . 0.2 109.957 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . 2.0 p30 -149.91 165.09 18.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.515 -0.55 . . . . 0.15 109.515 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 123' ' ' ASN . 43.0 Cg_endo -67.81 -164.66 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.678 2.252 . . . . 0.12 112.778 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.59 59.21 2.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.85 111.488 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t -129.41 -23.11 2.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.816 0.341 . . . . 0.2 110.623 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 1.8 tppt? -154.57 159.04 40.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.53 109.73 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 142.71 36.45 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.725 -0.472 . . . . 1.23 109.725 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.92 -8.32 19.47 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.577 2.185 . . . . 0.25 112.106 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.12 9.27 36.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.935 -0.575 . . . . 0.29 110.663 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 m -82.95 89.07 6.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.411 0.624 . . . . 0.24 110.303 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.22 -33.12 59.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.305 -0.862 . . . . 0.13 111.401 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.06 -31.8 46.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.068 -0.514 . . . . 0.18 111.774 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.86 -54.42 42.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.18 110.872 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.466 HG23 ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -69.75 -29.38 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.4 110.535 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -57.6 -44.31 85.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.436 -0.347 . . . . 0.25 110.775 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -60.13 -39.22 85.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 1.93 111.157 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.78 -39.95 56.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.332 -0.394 . . . . 0.11 111.054 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -50.25 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.27 111.322 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.52 -17.63 64.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.531 -0.304 . . . . 1.07 111.607 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.98 -33.42 61.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.403 HD13 ' HG2' ' A' ' 162' ' ' GLN . 10.3 mt -82.05 -40.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.671 -0.695 . . . . 0.28 109.848 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 63.72 32.67 13.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.544 -0.753 . . . . 1.07 111.162 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -100.12 104.04 15.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.87 -0.604 . . . . 0.64 109.781 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 m -74.13 134.79 42.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.43 110.529 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.32 75.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.04 -0.527 . . . . 0.45 110.397 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.66 -168.82 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.189 -0.914 . . . . 1.15 110.985 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.0 t -125.92 15.96 7.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.739 0.781 . . . . 0.5 109.573 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -100.06 -0.26 39.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.161 -0.927 . . . . 1.0 111.078 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.79 20.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.157 0.503 . . . . 0.61 110.004 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 1.5 m -77.21 51.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.22 112.279 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -28.53 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.23 111.902 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 11.88 35.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.068 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 2.0 tp-100 -113.5 -49.25 2.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 1.06 110.524 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mt-30 -105.94 34.05 3.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 0.6 111.204 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.42 -35.97 77.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.942 -0.572 . . . . 0.15 110.845 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.91 -25.04 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.015 -0.539 . . . . 1.43 111.068 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -79.58 -42.42 25.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.828 -0.434 . . . . 0.58 109.828 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.489 ' O ' HD12 ' A' ' 163' ' ' LEU . 21.8 t -64.53 -41.72 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.934 -0.575 . . . . 0.16 111.002 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -26.08 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.457 . . . . 0.45 111.598 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -93.69 -21.67 19.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.12 0.486 . . . . 0.41 110.134 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HG2' HD13 ' A' ' 142' ' ' ILE . 20.7 tt0 -67.46 -53.0 32.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.64 -0.709 . . . . 0.52 111.533 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -79.59 -10.79 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.678 -0.409 . . . . 0.23 110.942 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.444 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.7 ttpt -65.05 -26.57 68.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.79 110.035 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.09 -8.3 58.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 2.07 110.612 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -110.56 -35.23 6.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.189 -0.46 . . . . 0.5 110.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.49 130.7 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.237 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.13 82.29 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.361 0.601 . . . . 1.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.9 pt -94.94 175.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.523 -0.762 . . . . 0.78 111.585 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -127.23 171.41 11.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.69 110.058 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 171' ' ' ARG . 34.2 ttt180 -162.87 75.88 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.153 0.501 . . . . 1.0 109.926 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.97 98.67 10.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.926 -0.579 . . . . 0.13 110.639 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -162.02 134.16 5.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.28 110.925 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -120.77 170.62 9.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.747 -0.66 . . . . 0.42 109.713 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 mtm180 -92.74 135.73 33.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.035 -0.358 . . . . 0.51 110.035 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.1 150.26 43.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.012 0.434 . . . . 0.24 111.081 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -120.88 -176.15 3.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.89 109.371 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.1 p90 -150.16 127.91 11.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.777 -0.453 . . . . 0.39 109.777 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.8 126.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.56 111.26 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 2.6 pt? -167.34 147.24 4.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.38 -0.827 . . . . 1.16 109.472 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.44 162.3 34.41 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.858 2.372 . . . . 0.27 112.914 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.6 -35.44 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.39 111.44 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -47.86 -47.51 31.58 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.795 -0.638 . . . . 0.65 111.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.24 -26.42 14.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.7 0.286 . . . . 0.74 110.973 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.86 -33.19 77.33 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.2 113.041 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -64.04 -14.29 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.088 0.403 . . . . 2.3 112.088 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -44.81 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.559 0.219 . . . . 0.77 111.252 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.7 pp -86.12 -20.69 28.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.23 110.483 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.91 -41.95 62.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.421 -0.809 . . . . 1.46 111.969 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.467 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -103.94 15.49 28.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.235 0.457 . . . . 1.16 112.235 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -124.22 -30.49 3.44 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.452 -0.499 . . . . 2.42 111.692 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.19 -42.83 9.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.593 0.235 . . . . 0.26 111.468 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 13.5 mtpt -58.05 -47.35 99.03 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.051 0.76 . . . . 0.28 113.051 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.3 Cg_endo -60.72 -16.26 42.53 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.199 1.933 . . . . 0.16 113.401 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.76 -21.0 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.336 -0.246 . . . . 0.14 110.336 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 78.86 -10.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.466 -0.788 . . . . 0.17 111.526 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -86.74 54.36 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.248 0.547 . . . . 0.98 110.771 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.85 138.41 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.258 -0.883 . . . . 0.23 109.613 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.6 142.26 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.658 -0.497 . . . . 0.94 109.658 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -68.76 81.94 0.29 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.133 0.492 . . . . 1.99 110.465 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.446 ' HA ' ' HA3' ' A' ' 247' ' ' GLY . 68.8 m -157.53 31.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.333 -0.849 . . . . 0.17 109.745 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.1 mp0 -79.96 154.41 28.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.36 110.66 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -108.58 111.86 23.91 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.159 -0.682 . . . . 0.57 109.159 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.39 80.43 3.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.217 0.532 . . . . 1.22 110.356 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -148.36 -130.56 1.96 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.685 -0.689 . . . . 0.36 112.197 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -78.84 -26.76 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.478 . . . . 0.75 110.601 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.67 145.19 49.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.91 -0.774 . . . . 1.38 108.91 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 28.1 tp -105.03 85.9 2.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.936 0.398 . . . . 0.38 110.972 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 5.0 tt0 -93.11 118.69 31.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.97 109.748 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 19.8 mt -128.68 159.13 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.569 -0.287 . . . . 0.11 111.026 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 177' ' ' ARG . 19.9 t -116.6 121.13 66.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.656 -0.498 . . . . 0.21 109.656 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.436 ' SG ' ' HE2' ' A' ' 178' ' ' PHE . 4.6 p -118.51 -30.52 5.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.113 0.412 . . . . 0.58 112.113 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 213' ' ' LEU . 2.3 mm? -68.62 108.47 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.692 0.282 . . . . 0.45 111.013 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.6 tt -110.28 -54.87 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.564 0.579 . . . . 0.38 112.564 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.56 162.2 54.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.04 0.385 . . . . 0.33 112.04 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.33 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.013 2.475 . . . . 0.31 111.334 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 65.35 -81.15 0.08 OUTLIER Glycine 0 C--N 1.339 0.703 0 O-C-N 123.463 0.477 . . . . 0.18 111.963 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 2.1 p -75.6 17.97 0.26 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.179 0.592 . . . . 0.67 111.117 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 217' ' ' GLY . 8.6 p90 -87.76 -16.94 32.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.4 109.859 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -69.28 -48.11 62.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 1.46 110.549 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.57 -31.02 71.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 1.36 110.758 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 46.1 mm -82.8 -42.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.491 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.79 -37.07 68.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.55 111.05 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -56.1 -35.21 66.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 1.28 111.758 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.7 pp -94.41 -33.05 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.475 -0.49 . . . . 1.43 110.834 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.4 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-N 116.395 -0.366 . . . . 0.42 111.418 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 13.7 ptpt -63.53 -22.11 66.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.127 0.417 . . . . 0.91 112.127 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.45 8.65 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 0.38 111.167 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -108.96 -83.52 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.126 -0.488 . . . . 1.33 110.697 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.1 t -84.38 -30.01 25.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.305 -0.407 . . . . 0.22 111.184 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 24.3 tptm -64.64 -30.89 71.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.992 0.425 . . . . 0.71 111.05 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.19 12.56 66.69 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.528 -0.844 . . . . 0.37 112.235 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -123.79 -46.85 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.919 0.39 . . . . 0.76 110.593 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -125.55 -162.25 11.25 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.773 -0.727 . . . . 0.24 112.562 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.94 132.23 56.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.21 -0.292 . . . . 1.03 110.21 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 3.1 pp -80.04 157.29 26.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.057 0.456 . . . . 1.51 111.097 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.71 153.39 38.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.597 -0.729 . . . . 0.85 109.485 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.77 156.96 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.237 -0.282 . . . . 0.29 110.237 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.0 77.29 10.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.014 0.435 . . . . 0.42 110.695 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.62 -2.51 58.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.814 -0.63 . . . . 1.19 110.184 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 241' ' ' LEU . 3.3 mm? -79.75 78.64 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 1.36 110.194 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -116.84 17.19 15.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.731 -0.668 . . . . 0.95 110.379 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -107.99 -58.27 2.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 2.11 110.856 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.5 149.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.989 -0.551 . . . . 0.28 110.089 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.58 144.0 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.784 0.326 . . . . 1.53 110.303 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -147.16 156.56 43.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.221 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 201' ' ' SER . . . 106.36 110.08 3.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.757 -0.735 . . . . 0.51 111.637 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -122.74 125.3 45.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.45 111.217 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.76 7.12 9.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.888 -0.596 . . . . 0.95 109.725 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.12 107.52 17.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 1.07 110.497 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -72.06 -32.53 67.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.109 0.48 . . . . 0.92 110.035 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.436 -0.802 . . . . 1.4 109.758 -179.879 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.642 -0.583 . . . . 0.18 111.642 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -72.38 -53.3 12.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.74 0.305 . . . . 1.13 110.205 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 mtt 60.72 30.36 19.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.607 -0.724 . . . . 1.3 111.347 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.48 -6.25 52.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.837 -0.619 . . . . 0.66 110.968 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mt 57.7 62.59 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.497 0.665 . . . . 0.43 110.036 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -99.08 27.14 5.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.732 -0.667 . . . . 0.27 110.881 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -104.72 96.18 10.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.431 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.78 -12.47 20.02 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.513 2.142 . . . . 0.92 112.411 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t 49.66 24.44 1.19 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.341 1.056 . . . . 0.98 112.567 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -69.79 157.67 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.884 -0.598 . . . . 1.84 110.042 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 1.76 111.594 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.99 81.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.75 111.251 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -153.7 143.67 22.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 1.28 109.981 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' VAL . 82.0 mt -67.25 -13.15 61.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 1.3 111.147 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -87.35 4.11 44.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.4 110.849 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -139.29 35.91 2.08 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.463 0.649 . . . . 0.38 110.321 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 14' ' ' LEU . 20.3 m -106.41 156.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.18 111.633 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . . . -108.85 137.67 46.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.23 109.958 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 t -78.98 108.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.932 0.396 . . . . 0.44 110.722 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -121.11 129.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.922 -0.581 . . . . 0.16 109.925 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -145.0 144.11 30.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.953 0.406 . . . . 1.06 111.34 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 89' ' ' ILE . 23.2 ttt -127.93 127.29 43.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.671 -0.695 . . . . 0.22 109.819 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.97 118.51 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.014 0.435 . . . . 0.86 110.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 9.8 mmm180 -92.72 -155.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.906 -0.588 . . . . 1.69 109.99 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.96 -54.08 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.51 110.986 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.53 -34.4 1.09 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.431 -0.89 . . . . 0.17 112.48 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 29.1 tptt -97.77 158.94 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.933 0.397 . . . . 1.07 110.496 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 152.76 38.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.168 -0.678 . . . . 0.77 109.168 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.02 140.35 38.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.034 0.445 . . . . 0.26 111.213 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -130.4 130.19 44.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 1.1 109.717 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -174.49 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.136 0.493 . . . . 0.25 111.361 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.54 103.04 4.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.16 109.791 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -102.88 -173.22 2.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.15 110.11 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.7 150.06 37.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.73 -0.47 . . . . 0.26 109.73 178.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 52.8 pttt -108.61 28.5 8.33 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.428 -0.509 . . . . 1.32 110.966 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -103.11 81.78 2.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.54 109.919 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt 57.86 49.4 12.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.984 -0.553 . . . . 0.58 110.948 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.23 -23.73 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.762 -0.654 . . . . 0.22 111.802 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.98 -4.43 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.207 0.527 . . . . 0.17 110.626 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.54 98.19 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.1 112.642 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.64 -34.28 77.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.119 0.485 . . . . 1.18 110.847 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -80.47 -19.25 46.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.143 -0.48 . . . . 1.29 111.001 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 m -91.73 -45.45 8.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.15 110.468 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.04 -99.86 0.14 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.391 -0.684 . . . . 0.14 111.391 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.07 135.29 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.152 -0.684 . . . . 0.29 109.152 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -113.86 -63.13 1.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.972 -0.291 . . . . 0.65 111.105 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -151.8 -76.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.649 -0.25 . . . . 0.7 110.561 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.25 148.6 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.644 0.259 . . . . 0.72 110.528 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.24 -31.01 72.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.482 . . . . 0.56 111.654 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.95 -32.49 72.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.53 110.628 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.99 -19.76 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.083 0.468 . . . . 1.8 110.407 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 66.9 t -74.34 -43.74 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.731 -0.668 . . . . 0.15 109.57 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.05 99.25 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.435 -0.802 . . . . 1.45 111.138 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 34' ' ' TYR . 14.6 mt-30 -84.13 -65.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.5 109.975 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 t -97.16 130.64 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.183 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.37 -5.66 59.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.132 -0.485 . . . . 1.23 110.668 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -96.39 116.13 28.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.138 -0.483 . . . . 0.79 110.523 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.7 p -100.44 146.4 9.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.925 -0.58 . . . . 0.15 109.624 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -102.0 154.38 19.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.27 111.126 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.2 t -103.78 -31.4 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.18 109.485 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.2 91.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.069 -0.969 . . . . 0.49 109.218 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.05 -28.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.465 -0.334 . . . . 0.21 111.826 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -34.43 77.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.876 0.37 . . . . 0.6 111.158 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -106.52 10.9 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 2.39 111.031 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.36 28.62 71.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.876 -0.678 . . . . 0.4 112.468 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.33 110.83 14.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.571 0.224 . . . . 1.57 110.44 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.81 133.81 52.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.999 -0.546 . . . . 0.21 110.444 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.55 116.33 32.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.023 0.439 . . . . 0.11 109.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -87.53 -179.52 6.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.87 -0.605 . . . . 1.56 110.105 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -57.57 -32.95 67.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.67 111.271 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -87.57 7.88 27.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.182 -0.463 . . . . 0.67 111.29 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.81 -48.77 3.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.82 110.081 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.93 -31.92 73.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.999 -0.546 . . . . 0.31 110.212 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -28.14 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.23 110.348 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -92.46 -8.43 44.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.235 0.541 . . . . 0.71 110.965 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.65 -58.83 2.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.18 110.97 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -89.69 -34.88 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.396 -0.365 . . . . 0.83 110.833 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.09 30.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.524 -0.846 . . . . 0.3 112.283 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 81' ' ' ASP . 1.5 m -134.23 136.4 43.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.005 -0.369 . . . . 0.7 110.005 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.74 -12.93 57.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.64 110.748 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 79' ' ' THR . 28.9 t70 -69.16 102.66 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.54 110.396 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.48 -23.65 66.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.89 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.4 88.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.734 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.45 -34.93 79.45 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.854 0.359 . . . . 0.33 110.234 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.3 -51.68 69.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.392 -0.596 . . . . 0.24 109.392 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 54.0 t -64.63 -32.55 74.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.457 -0.792 . . . . 0.14 110.374 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -57.63 -51.98 67.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.931 -0.577 . . . . 1.2 110.838 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -63.59 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.549 . . . . 0.3 111.177 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 20' ' ' VAL . 63.8 mt -66.98 -24.69 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.107 0.48 . . . . 0.15 111.48 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -80.21 -33.26 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.735 0.303 . . . . 0.3 111.582 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.2 t -97.83 -22.65 16.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.789 0.663 . . . . 0.37 112.789 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 91' ' ' THR . 14.3 mmmm -115.22 -2.97 12.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.579 -0.448 . . . . 0.65 111.761 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.42 -176.69 21.32 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.517 -0.849 . . . . 0.52 112.291 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -108.15 107.84 18.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 1.32 110.409 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 20' ' ' VAL . 3.6 p -111.61 142.14 24.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.431 -0.804 . . . . 0.22 110.186 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 99.82 0.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.239 0.542 . . . . 0.82 110.596 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.61 -179.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.747 -0.66 . . . . 0.51 111.691 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 m -122.02 146.97 46.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.49 -0.777 . . . . 0.26 109.554 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -130.01 -169.55 2.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.645 -0.252 . . . . 0.82 110.794 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 77.98 2.68 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.162 0.913 . . . . 1.29 111.648 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -101.14 98.44 8.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.095 0.474 . . . . 1.59 110.566 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 118.77 2.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.551 -0.75 . . . . 1.02 110.021 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -134.94 36.83 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.221 0.534 . . . . 0.82 110.167 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.07 13.35 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.682 -0.69 . . . . 0.29 110.348 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -82.99 81.56 8.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.762 -0.654 . . . . 0.27 111.03 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -114.81 159.39 20.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.733 . . . . 0.78 109.465 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.56 147.36 49.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.498 -0.319 . . . . 1.55 111.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 63.42 16.55 9.63 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.634 -0.712 . . . . 0.78 111.765 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.5 tpp -63.34 -34.06 76.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.948 0.404 . . . . 0.76 110.819 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -59.21 -45.85 90.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.046 -0.524 . . . . 0.81 110.167 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -70.47 -34.99 73.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 1.29 110.881 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.64 -38.6 88.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.127 -0.488 . . . . 0.6 111.241 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.3 tt -87.88 -31.03 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.971 0.415 . . . . 0.4 110.482 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -64.4 -31.4 72.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.389 -0.369 . . . . 0.13 111.148 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 t -63.83 -20.22 65.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.14 110.74 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.19 -43.67 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.933 0.397 . . . . 0.42 110.384 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 114' ' ' ALA . 4.3 p -72.15 -19.87 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.3 111.572 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.7 69.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.922 0.342 . . . . 0.35 111.922 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -107.86 19.69 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 1.23 110.246 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -123.6 -40.31 2.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.69 110.35 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 19.9 m -114.4 106.9 14.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.031 -0.532 . . . . 0.56 110.16 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG11 ' HA2' ' A' ' 217' ' ' GLY . 6.3 m -126.35 163.79 27.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.23 111.024 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 168' ' ' LYS . 23.5 p-10 -130.97 141.98 43.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.588 . . . . 0.38 110.19 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.57 44.58 1.76 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.742 2.295 . . . . 0.6 112.854 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -116.94 -165.91 1.11 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.278 -0.419 . . . . 1.17 110.165 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 t -66.16 -19.88 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.361 . . . . 0.4 111.769 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -84.0 71.59 10.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.608 0.242 . . . . 1.2 110.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -58.03 144.76 74.87 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 1.79 111.177 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.14 117.23 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.491 2.127 . . . . 0.49 112.69 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.403 ' OH ' ' HG2' ' A' ' 221' ' ' GLU . 0.1 OUTLIER -170.15 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 1.15 110.026 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.31 124.3 28.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.32 110.791 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 135' ' ' ILE . 49.6 t -62.18 -35.24 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.869 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.6 mm -56.5 -29.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.942 -0.572 . . . . 0.31 111.662 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.33 -32.3 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.45 111.444 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 132' ' ' VAL . 10.0 tp -93.56 -30.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.729 -0.388 . . . . 1.02 110.23 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 26.0 tt0 -64.97 -35.75 82.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.183 0.516 . . . . 1.13 109.877 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -59.21 -31.49 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.388 -0.824 . . . . 0.75 110.875 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -83.79 -32.37 25.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.24 110.72 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.4 ' CE ' ' HA ' ' A' ' 139' ' ' MET . 0.7 OUTLIER -68.58 -45.88 70.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.41 111.727 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 45.2 pttt -80.15 -9.84 59.73 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.806 -0.358 . . . . 0.19 110.903 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' ARG . 35.0 t70 -75.79 -46.41 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.49 109.655 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 143' ' ' HIS . 18.1 tt -84.71 -19.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.594 -0.73 . . . . 0.35 110.23 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 142' ' ' ILE . 60.5 m-70 72.68 90.7 0.09 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.379 -0.828 . . . . 0.31 111.488 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -75.72 95.79 3.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.863 -1.062 . . . . 0.85 110.239 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -155.36 74.69 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.902 -0.59 . . . . 0.65 109.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.8 67.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.54 110.776 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 149' ' ' ASN . 16.3 mtpt 55.0 79.27 0.15 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.698 -0.683 . . . . 0.33 111.244 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.64 17.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.83 111.999 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 147' ' ' LYS . 4.5 t-20 -68.8 -62.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.211 -0.449 . . . . 0.35 109.824 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.52 138.55 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.746 -0.661 . . . . 0.91 109.847 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -163.42 -158.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.668 -0.493 . . . . 0.99 109.668 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.91 95.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.535 0.334 . . . . 0.38 111.853 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 53.72 42.99 31.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.752 -0.658 . . . . 0.45 110.553 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 60.72 66.95 0.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.163 -0.926 . . . . 0.78 111.46 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.627 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 0.4 OUTLIER 55.9 31.03 17.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.151 -0.931 . . . . 0.76 113.13 178.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.02 63.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.179 0.514 . . . . 0.35 110.613 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -29.66 42.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.363 0.601 . . . . 0.63 110.237 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.627 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.4 mp0 -68.54 -41.75 79.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.98 111.379 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.26 -30.29 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 0.98 111.48 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.69 -39.66 86.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.021 0.439 . . . . 0.39 110.704 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.16 -5.5 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.81 111.033 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.58 -70.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 1.44 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -70.88 -11.08 60.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.28 -0.418 . . . . 1.46 111.397 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -61.55 -34.64 75.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.164 0.507 . . . . 1.16 110.255 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -87.79 23.7 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.759 -0.655 . . . . 0.6 110.815 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -138.73 -52.98 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.937 -0.574 . . . . 0.79 110.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.1 ttm -139.7 151.16 45.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.12 -0.491 . . . . 0.97 110.019 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 123' ' ' ASN . 11.5 ptpt -71.59 131.91 43.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 1.09 110.467 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.492 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -140.6 -162.05 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.58 110.344 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.8 110.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.927 0.767 . . . . 2.47 112.019 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.85 102.46 3.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 1.97 109.773 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.53 133.92 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.2 111.081 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.46 89.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.21 110.221 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 173.92 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.904 0.383 . . . . 1.16 111.136 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -83.49 143.64 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 1.81 110.533 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.8 mp -126.55 161.94 26.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.208 -0.451 . . . . 0.72 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 15.8 ptt180 -127.09 154.93 44.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.2 -0.454 . . . . 0.32 110.156 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 63.2 t80 -120.98 131.26 54.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.439 -0.346 . . . . 0.21 110.217 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.91 133.36 66.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.463 0.173 . . . . 0.45 111.358 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 178' ' ' PHE . 1.0 OUTLIER -171.37 161.1 5.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.688 -0.233 . . . . 0.15 110.518 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.22 155.77 66.7 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.23 . . . . 0.17 112.476 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.05 -33.94 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.995 -0.548 . . . . 0.67 111.749 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -48.79 -48.81 40.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.221 -0.445 . . . . 1.69 111.725 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -95.77 -28.15 14.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.857 0.36 . . . . 0.53 110.946 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.11 -32.06 81.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.012 -0.613 . . . . 0.23 112.779 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.5 71.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.73 0.3 . . . . 0.83 111.405 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.11 -46.47 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.25 111.189 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -17.53 39.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.41 111.175 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -57.24 -44.59 83.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.14 110.588 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.72 17.12 5.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.46 111.485 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -129.08 -39.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.31 111.662 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.62 -42.57 24.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.3 111.758 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 30.0 mtpp -62.63 -48.0 87.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.743 0.646 . . . . 0.68 112.743 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.2 Cg_endo -59.47 -8.61 7.26 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.583 2.189 . . . . 0.04 113.837 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.37 -14.83 60.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.21 110.121 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.6 mm 59.56 32.88 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.835 0.826 . . . . 0.16 110.273 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.434 ' HD3' HD12 ' A' ' 222' ' ' ILE . 28.4 mttp -125.89 23.01 7.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.656 -0.702 . . . . 0.5 110.322 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.5 m -103.26 134.63 43.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.14 110.439 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -84.68 147.93 5.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.279 -0.419 . . . . 0.91 109.979 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 63.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 1.59 111.42 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 m -140.22 21.53 2.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.277 -0.638 . . . . 1.05 109.277 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.475 ' HG2' HG23 ' A' ' 210' ' ' ILE . 46.3 mt-10 -71.53 140.77 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.648 -0.706 . . . . 1.06 111.263 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.42 105.2 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.42 -0.585 . . . . 0.65 109.42 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.479 ' H ' ' HB3' ' A' ' 248' ' ' ASP . 0.2 OUTLIER -86.61 102.04 13.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.022 -0.536 . . . . 1.73 110.723 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -169.11 -150.06 6.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.983 -0.627 . . . . 0.63 111.826 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.09 -31.31 72.45 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.028 0.442 . . . . 1.88 110.604 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -117.45 109.42 16.75 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.759 . . . . 1.13 108.952 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.3 99.78 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.599 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.2 tt0 -100.98 109.41 21.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.35 109.614 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.475 HG23 ' HG2' ' A' ' 202' ' ' GLU . 66.3 mt -117.26 134.83 59.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.306 -0.407 . . . . 0.24 110.576 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.61 105.9 18.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.23 109.925 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 8.4 t -130.78 96.58 4.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.368 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 132.87 11.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.306 -0.628 . . . . 0.33 109.306 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -122.88 171.16 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.517 -0.31 . . . . 0.34 110.28 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.59 171.0 3.15 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.005 0.522 . . . . 0.56 111.091 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.33 -163.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.394 2.062 . . . . 0.37 113.105 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.434 ' HA2' HG11 ' A' ' 122' ' ' VAL . . . 82.81 -95.68 1.83 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.507 -0.854 . . . . 0.33 111.092 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.8 m -80.77 17.94 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.537 . . . . 0.45 110.445 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.84 -23.1 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.592 . . . . 0.25 111.599 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.1 -45.48 63.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.026 0.441 . . . . 1.42 110.201 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 15.9 mp0 -62.49 -20.7 64.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.418 -0.81 . . . . 1.96 112.356 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.623 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.4 tt -98.57 -43.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.454 -0.499 . . . . 0.47 111.11 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.07 -32.76 74.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.74 0.274 . . . . 0.37 111.74 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.46 -25.06 61.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.428 -0.351 . . . . 0.98 111.553 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.3 pp -101.27 -28.79 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.005 0.431 . . . . 0.44 110.109 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.4 mm -64.51 -33.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.2 111.0 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 11.4 ptmt -60.48 -26.25 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.84 0.682 . . . . 1.19 112.84 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -111.45 -20.57 12.17 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.48 -0.488 . . . . 0.69 112.094 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.25 -46.67 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.39 111.55 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.442 ' OG1' HG23 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -113.42 -56.14 2.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.173 0.434 . . . . 0.48 112.173 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 49.4 mtmt -64.69 -7.7 11.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.25 111.825 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.33 16.66 32.01 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.975 -0.631 . . . . 0.28 111.648 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -128.51 -56.12 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.643 0.258 . . . . 0.64 111.527 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -123.02 -139.21 5.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.326 -0.94 . . . . 0.46 113.369 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 73.3 m -121.51 141.62 50.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.35 111.431 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -110.84 150.21 29.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.997 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.95 161.57 39.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 0.26 109.916 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.17 153.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.317 . . . . 0.37 110.647 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 241' ' ' LEU . 23.8 tp -102.5 112.32 25.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.37 109.861 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -88.23 2.3 52.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.347 0.594 . . . . 1.53 110.687 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 239' ' ' LEU . 4.2 mm? -77.8 69.62 4.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.388 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -94.34 -1.74 53.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 0.69 110.35 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -84.24 -68.71 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.578 -0.737 . . . . 2.37 110.2 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.82 151.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.802 -0.636 . . . . 0.58 109.755 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -96.87 98.27 9.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.984 0.421 . . . . 1.06 110.409 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -115.81 157.49 24.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.69 110.269 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -170.39 -179.2 41.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.644 -0.789 . . . . 0.23 112.233 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 204' ' ' TYR . 8.1 t70 -94.21 88.5 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 0.51 110.078 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 7.52 41.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 1.78 110.959 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 80.39 7.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.326 0.584 . . . . 1.33 110.663 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -25.52 66.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 1.06 110.408 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.31 -0.852 . . . . 1.6 109.897 179.575 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.775 -0.53 . . . . 0.51 111.775 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.3 m80 59.46 54.42 4.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.047 0.451 . . . . 1.04 111.594 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -122.87 168.58 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 1.55 110.192 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -68.45 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.33 110.792 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.64 146.45 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.94 109.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.2 t80 -164.69 153.53 12.79 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 123.35 0.406 . . . . 0.65 110.168 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.422 HG23 ' HB ' ' A' ' 15' ' ' THR . 3.0 m -109.71 89.9 8.28 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.49 109.839 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 90.1 Cg_endo -85.63 156.44 10.48 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.759 2.306 . . . . 0.8 113.105 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' OH ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -127.73 139.07 52.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.72 109.783 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -161.49 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.233 -0.187 . . . . 1.19 111.115 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -124.55 -59.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.993 0.425 . . . . 1.69 110.351 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 5.0 mt -128.51 102.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.75 109.73 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -134.16 127.21 31.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.154 -0.475 . . . . 1.42 110.802 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.98 -10.02 59.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.361 0.601 . . . . 0.56 110.437 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -83.3 -15.47 50.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.64 111.275 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -125.72 40.36 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.16 111.679 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.12 147.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.97 0.414 . . . . 0.16 110.636 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.82 144.46 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.13 110.536 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.32 126.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 0.21 110.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -148.63 115.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.666 -0.697 . . . . 0.2 109.58 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -119.27 132.83 55.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.311 -0.404 . . . . 0.94 111.432 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.7 ttp -87.58 132.31 34.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.938 -0.574 . . . . 0.43 110.201 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 118.57 37.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.618 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 32.9 mmt180 -120.57 -177.5 3.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.33 110.323 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.14 81.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.366 0.506 . . . . 0.32 112.366 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.3 29.72 2.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.391 -0.909 . . . . 0.29 112.339 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 31.3 tptt -150.35 148.82 29.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.59 -0.522 . . . . 0.89 109.59 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.41 30.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.527 -0.546 . . . . 0.99 109.527 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -134.29 144.55 48.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -142.94 137.3 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.32 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.85 167.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.682 -0.488 . . . . 0.3 109.682 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 110.61 20.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.12 111.824 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -108.74 164.6 12.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.914 -0.585 . . . . 0.18 109.943 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.433 ' OH ' HG22 ' A' ' 9' ' ' THR . 0.1 OUTLIER -66.94 138.05 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.639 -0.255 . . . . 0.18 110.361 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -0.68 23.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 1.01 111.442 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.41 71.38 1.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.5 111.162 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.66 66.07 1.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.356 0.662 . . . . 1.8 111.368 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -69.49 -30.25 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.14 110.876 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -87.31 5.62 3.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.514 0.673 . . . . 0.27 110.327 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.587 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -60.15 -33.6 80.52 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.458 -0.792 . . . . 0.29 112.523 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -63.81 -34.81 78.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.266 0.555 . . . . 0.9 110.211 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -81.09 -25.38 37.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.85 110.064 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 m -75.84 -42.5 49.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.666 . . . . 0.53 110.649 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.82 -108.79 0.21 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.869 -0.681 . . . . 0.31 112.103 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 t -115.5 122.17 68.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.839 0.352 . . . . 0.43 110.297 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' HG3' ' HA3' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -150.31 -170.63 3.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.264 -0.426 . . . . 0.51 111.291 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -71.3 172.12 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 0.55 112.647 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 49' ' ' LEU . 17.2 t70 -75.72 160.78 29.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.069 -0.969 . . . . 0.25 110.513 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.681 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.71 -19.83 60.09 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.78 0.289 . . . . 0.31 111.78 -179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.69 -38.4 64.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.172 0.511 . . . . 0.27 109.974 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.57 -32.78 62.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.47 -0.786 . . . . 0.73 111.049 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 49' ' ' LEU . 3.0 p -79.96 -17.13 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.312 . . . . 0.22 111.413 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.79 111.15 13.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 1.02 110.168 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 12' ' ' ILE . 11.5 mm-40 -85.29 -78.65 0.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.938 -0.574 . . . . 0.91 110.449 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -75.4 117.97 17.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.948 -0.569 . . . . 1.5 110.783 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -86.86 31.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.813 -0.63 . . . . 0.63 111.167 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 m -125.67 140.83 52.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.67 -0.493 . . . . 0.22 109.67 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.3 p -117.11 142.36 31.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.27 110.29 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.3 161.21 16.49 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.013 0.375 . . . . 0.29 112.013 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 61.1 t -123.96 -55.07 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.792 -0.64 . . . . 0.29 109.329 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.08 101.89 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 1.84 109.662 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.33 -37.19 79.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.51 111.827 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.16 6.45 6.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.37 0.507 . . . . 0.45 112.37 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -135.15 -5.37 2.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.849 0.357 . . . . 0.55 110.848 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.97 61.63 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.893 -0.67 . . . . 0.19 111.819 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.39 113.1 24.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.03 0.443 . . . . 0.66 110.929 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.46 128.87 76.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.649 -0.705 . . . . 0.4 109.245 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -84.67 117.63 23.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.909 0.385 . . . . 0.31 111.267 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.87 -174.52 4.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.16 -0.473 . . . . 0.68 110.017 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -55.76 -33.04 63.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.46 0.541 . . . . 1.84 112.46 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -82.13 -7.59 59.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.814 0.34 . . . . 1.81 111.792 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.38 -49.51 3.55 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.805 -0.358 . . . . 1.78 111.217 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.44 -29.28 68.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.929 0.395 . . . . 0.27 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.99 -25.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.898 -0.592 . . . . 0.55 110.463 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -97.33 -26.59 14.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.3 111.001 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.77 -39.46 30.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.122 -0.49 . . . . 0.48 112.093 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.54 -16.49 13.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.004 -0.278 . . . . 1.13 111.45 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.37 79.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.49 112.29 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.42 136.97 47.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.568 0.223 . . . . 0.6 110.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -90.55 -23.47 20.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.401 0.619 . . . . 0.59 109.899 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.83 103.44 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.82 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.87 -31.28 71.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.162 0.506 . . . . 0.33 109.951 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -61.02 -29.06 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.29 110.282 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.81 -39.33 24.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.805 -0.442 . . . . 0.34 109.805 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.12 -50.19 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.2 109.441 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.7 t -61.53 -38.72 88.44 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.19 110.61 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.73 -41.96 96.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 2.86 110.292 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -65.49 -40.67 93.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.71 110.786 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 70.9 mt -71.19 -21.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.33 110.907 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -45.88 10.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.451 -0.341 . . . . 0.99 111.575 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -83.0 -21.35 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.362 0.505 . . . . 1.13 112.362 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.65 31.89 4.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 1.41 110.723 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 89' ' ' ILE . . . -128.34 179.76 16.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.498 -0.858 . . . . 0.15 112.442 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.85 93.31 5.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.703 0.287 . . . . 0.81 110.644 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 97' ' ' VAL . 2.8 p -98.3 134.76 35.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.24 109.909 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 11.5 pt20 -74.62 75.62 2.01 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.206 0.527 . . . . 0.81 112.261 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 95' ' ' VAL . 14.6 m -141.24 -175.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.437 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.0 t -131.44 103.75 6.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.2 111.162 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -121.54 95.76 4.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.214 0.53 . . . . 1.01 110.384 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -163.68 125.59 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.511 -0.768 . . . . 1.65 109.505 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.26 136.87 53.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.555 0.576 . . . . 0.47 112.555 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 102' ' ' ARG . 2.5 mmp_? -136.19 86.7 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.48 109.969 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -80.13 115.23 19.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 1.34 110.388 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 -177.12 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.114 -0.494 . . . . 0.31 110.039 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.1 125.94 43.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.135 -0.32 . . . . 0.65 110.135 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -128.95 171.42 12.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.351 -0.386 . . . . 0.38 110.57 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.94 -80.49 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.692 0.282 . . . . 1.11 110.597 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -80.85 156.04 26.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.333 -0.394 . . . . 1.49 110.803 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 95.7 mmm -55.84 -43.33 76.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.583 0.586 . . . . 1.05 112.583 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -74.98 -14.33 60.61 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.462 -0.495 . . . . 0.8 111.437 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 37.9 ttt180 -98.09 0.23 45.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.966 0.413 . . . . 1.92 110.074 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.423 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -61.97 -39.63 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.583 -0.735 . . . . 1.59 110.975 -179.338 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 tt -112.08 -18.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.916 0.389 . . . . 1.78 110.468 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 111' ' ' ARG . . . -60.48 -46.7 89.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.21 111.175 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 116' ' ' ILE . 14.7 t -70.21 -24.7 63.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.63 110.615 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 120' ' ' LYS . 1.3 mp -73.03 -41.95 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.413 . . . . 0.4 110.464 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 -30.38 8.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.366 -0.379 . . . . 0.25 111.689 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.48 -44.72 69.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.284 0.564 . . . . 0.36 110.273 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.02 54.32 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.377 -0.971 . . . . 0.91 108.377 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -154.06 -43.9 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.695 . . . . 0.39 111.045 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 49.0 m -123.34 128.65 50.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.975 0.417 . . . . 0.36 111.778 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.86 171.83 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.516 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.531 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 6.1 t-20 -147.49 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 119.46 -0.305 . . . . 0.52 111.425 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 4.1 Cg_endo -87.46 136.15 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.961 1.774 . . . . 0.28 111.918 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.77 20.15 3.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.295 0.569 . . . . 0.82 110.634 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.57 -61.19 1.64 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.628 -0.714 . . . . 0.33 111.025 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.471 ' H ' HG23 ' A' ' 126' ' ' THR . 6.5 ttmt -160.64 123.52 3.31 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.136 0.493 . . . . 1.41 111.273 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . 1.7 tpp180 -171.34 -55.8 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.67 . . . . 1.86 110.77 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 128' ' ' ARG . 86.9 Cg_endo -77.62 76.83 4.11 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.69 1.593 . . . . 0.35 111.695 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -158.17 -57.41 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.557 . . . . 0.85 110.351 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -91.82 108.14 19.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.875 -0.602 . . . . 0.36 111.234 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.18 -16.64 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.421 0.629 . . . . 0.37 110.583 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.662 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 23.1 mm -71.97 -28.79 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.942 -0.572 . . . . 0.41 110.746 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.04 -47.51 86.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.52 110.76 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.9 tt -72.09 -28.3 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.979 -0.378 . . . . 0.2 109.979 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -43.93 97.53 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.939 -0.573 . . . . 1.21 109.694 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 133' ' ' ILE . 19.5 mmm180 -63.01 -31.34 72.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.988 -0.551 . . . . 1.87 110.917 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -77.12 -48.03 18.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.21 110.6 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.628 ' SD ' ' HG ' ' A' ' 163' ' ' LEU . 60.6 mmm -76.12 -3.38 35.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 2.27 111.225 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -81.04 -41.38 22.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.34 -0.615 . . . . 2.18 109.34 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.85 -50.79 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.56 110.355 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 138' ' ' ALA . 18.6 tt -86.06 52.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 122.632 1.206 . . . . 0.49 109.093 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -110.84 -5.63 14.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.595 -1.184 . . . . 0.31 110.53 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.73 115.34 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.507 0.558 . . . . 1.03 112.507 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 63.9 m 56.11 39.96 30.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.475 -0.784 . . . . 0.58 112.796 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.36 -66.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.4 110.34 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -96.6 -55.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.098 0.475 . . . . 1.75 109.799 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.5 25.44 14.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.523 -0.762 . . . . 0.21 111.063 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 57.12 38.08 28.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.721 -0.672 . . . . 0.58 110.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -89.68 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.86 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -149.28 161.44 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.448 . . . . 0.65 111.264 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -106.02 -34.04 7.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 1.05 110.862 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -88.96 -50.47 6.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 0.58 111.418 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -69.14 -14.97 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.79 111.559 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.1 mt-30 -112.43 7.48 19.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.629 -0.259 . . . . 0.44 110.912 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.63 72.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.347 . . . . 0.26 111.133 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 160' ' ' ILE . 2.3 mm? -66.65 -35.67 80.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.51 . . . . 1.32 111.227 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.95 -46.93 85.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 0.61 111.116 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 155' ' ' GLN . 59.3 t -67.04 -48.57 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.21 112.112 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 157' ' ' LEU . 10.1 tp -61.23 -35.16 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.41 111.729 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.39 -32.55 54.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.737 0.303 . . . . 1.99 110.592 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.87 -37.96 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.75 110.098 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.628 ' HG ' ' SD ' ' A' ' 139' ' ' MET . 0.6 OUTLIER -64.07 -36.92 85.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 1.15 110.036 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 167' ' ' MET . 31.0 tttm -69.31 -12.53 61.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.444 -0.798 . . . . 1.18 111.396 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.3 -32.05 55.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.51 . . . . 0.58 109.693 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -89.26 -44.45 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 1.12 111.097 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 38.4 mtm -128.75 139.04 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 2.6 110.655 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -89.15 85.83 6.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.538 -0.541 . . . . 0.56 109.538 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 121' ' ' CYS . 0.1 OUTLIER -96.81 -170.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.47 112.138 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 171' ' ' ARG . 6.4 tp10 -92.81 178.96 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 0.4 110.957 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 170' ' ' GLU . 9.2 ptp85 -107.63 -168.82 1.43 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.097 -0.501 . . . . 0.84 110.058 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.57 154.1 40.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.41 111.77 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.454 ' CD2' ' HA ' ' A' ' 215' ' ' ASP . 17.3 p80 -90.0 164.25 14.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 0.23 111.379 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 39.8 mtt -106.27 -167.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.596 . . . . 1.48 110.184 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 175' ' ' ARG . 4.6 mpt_? -124.43 128.24 48.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.478 -0.328 . . . . 1.39 110.353 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -128.61 145.12 51.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.616 -0.513 . . . . 0.26 109.616 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 211' ' ' VAL . 18.8 ptt85 -126.18 147.91 49.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.783 0.325 . . . . 0.3 110.629 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.04 143.46 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.891 -0.595 . . . . 0.45 110.244 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.7 tt -133.4 117.72 28.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.449 0.642 . . . . 0.17 110.508 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -149.79 156.44 38.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.385 -0.825 . . . . 0.09 109.936 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.72 166.06 14.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 0.1 112.546 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.5 t -50.44 -39.89 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.922 -0.581 . . . . 0.2 111.962 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -51.33 -53.68 33.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.324 -0.398 . . . . 0.28 111.46 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.423 ' HG3' ' HE3' ' A' ' 233' ' ' LYS . 0.5 OUTLIER -82.17 -29.9 31.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.138 -0.483 . . . . 2.08 110.883 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.37 94.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.639 -0.71 . . . . 0.25 113.084 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.64 -35.9 71.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.891 0.377 . . . . 1.17 111.351 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -76.6 -44.6 33.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.235 -0.439 . . . . 0.71 111.814 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.54 HD22 HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -72.2 -32.33 66.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.772 0.32 . . . . 0.47 111.669 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -59.68 -50.55 73.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.36 111.435 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -80.34 18.28 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.44 112.119 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -124.29 -49.44 1.81 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.855 -0.338 . . . . 1.31 111.648 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.1 -36.58 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.188 0.44 . . . . 1.86 112.188 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 26.5 mtpp -61.39 -52.45 70.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.558 0.577 . . . . 0.59 112.558 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.1 Cg_endo -66.09 -14.01 42.46 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.028 1.819 . . . . 0.31 112.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.31 110.312 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mt 62.62 38.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.559 -0.746 . . . . 0.44 111.043 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -120.84 14.23 11.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.93 110.465 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.86 149.46 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.978 -0.555 . . . . 0.26 111.02 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.5 mt -101.25 155.61 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.685 . . . . 0.41 109.744 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.93 64.19 0.5 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.931 0.396 . . . . 1.64 111.1 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 211' ' ' VAL . 10.4 m -149.4 31.01 0.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 1.09 110.302 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -81.74 146.88 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.736 -0.665 . . . . 0.79 111.161 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -118.9 133.49 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.834 -0.802 . . . . 1.22 108.834 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.31 111.34 19.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.8 111.395 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -166.93 -131.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.255 -0.738 . . . . 0.14 111.255 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.64 -28.32 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.619 0.723 . . . . 0.65 109.301 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -119.31 142.87 47.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.811 -1.086 . . . . 1.32 109.614 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.28 89.66 5.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.684 -0.487 . . . . 0.13 109.684 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.15 98.41 8.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.398 -0.593 . . . . 0.55 109.398 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 188' ' ' LEU . 21.9 mm -112.59 134.89 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.37 110.827 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 201' ' ' SER . 2.5 t -105.35 112.57 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.28 109.981 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.98 94.41 3.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.943 0.401 . . . . 0.61 110.83 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.02 95.83 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.084 -0.507 . . . . 0.28 109.845 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 215' ' ' ASP . 9.8 tt -94.23 179.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 1.14 110.061 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.526 ' H ' HG12 ' A' ' 214' ' ' ILE . 4.4 m-20 -67.0 152.85 95.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 111.896 0.332 . . . . 1.08 111.896 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.88 166.57 11.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.751 2.301 . . . . 0.19 112.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 91.11 -75.98 1.53 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.363 -1.095 . . . . 0.34 110.363 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -28.41 64.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.258 0.551 . . . . 0.24 109.642 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.88 -26.12 68.19 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.521 -0.763 . . . . 0.29 110.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -17.66 64.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.845 0.355 . . . . 1.14 111.383 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -84.17 -50.37 7.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.906 0.384 . . . . 0.7 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 15.1 tt -72.87 -28.05 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.395 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.465 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 4.0 t70 -55.35 -33.02 63.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.863 0.363 . . . . 1.01 111.143 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.76 -32.69 67.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.885 -0.598 . . . . 0.46 111.733 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 3.0 pp -92.78 -32.99 14.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.545 -0.462 . . . . 0.72 109.862 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 26.9 mm -55.64 -43.37 72.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.279 -0.419 . . . . 0.93 111.474 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 12.7 ptpt -61.95 -17.68 57.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.173 0.805 . . . . 0.53 113.173 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -119.92 -16.83 8.61 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.874 -0.516 . . . . 0.73 111.515 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 3.1 tp10 -79.95 -39.28 30.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.449 . . . . 1.25 111.15 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 t -136.47 -36.23 0.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.284 0.475 . . . . 1.38 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 23.9 tptp -55.96 -46.49 78.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.889 0.376 . . . . 0.85 111.054 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.07 28.22 13.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.65 111.958 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.423 ' HE3' ' HG3' ' A' ' 184' ' ' GLU . 27.2 mmmt -132.85 -46.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 1.68 110.839 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -130.44 -153.4 7.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.034 -0.603 . . . . 0.31 111.976 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.5 m -124.18 156.66 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.626 0.251 . . . . 0.58 110.518 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.67 165.65 18.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.714 0.292 . . . . 0.97 111.043 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -151.64 152.85 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.051 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.9 141.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.056 0.455 . . . . 0.18 111.181 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.77 75.91 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.253 -0.43 . . . . 0.31 110.44 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -138.98 4.47 2.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.461 -0.336 . . . . 0.81 111.41 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -43.1 83.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.46 111.266 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 55.77 42.31 29.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.997 -0.547 . . . . 1.07 111.515 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.73 -50.44 7.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.105 0.479 . . . . 1.39 110.471 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.13 167.35 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.582 -0.736 . . . . 0.38 109.317 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -77.62 92.54 4.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.918 0.389 . . . . 2.16 109.998 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -75.75 143.08 42.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.823 -0.626 . . . . 0.88 110.646 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 201' ' ' SER . . . 101.24 139.82 10.92 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.001 -0.618 . . . . 0.57 113.062 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.93 113.77 8.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 1.33 109.928 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 18.81 18.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 1.45 110.679 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -90.16 95.34 10.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.948 -0.569 . . . . 0.72 110.17 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.53 3.95 29.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.982 -0.554 . . . . 1.02 110.138 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.386 -0.816 . . . . 1.62 109.928 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 111.618 -0.593 . . . . 0.99 111.618 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -122.53 111.2 16.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.034 0.417 . . . . 1.04 110.691 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.6 ttp -155.57 140.76 17.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.5 109.998 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.29 145.68 51.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.115 -0.493 . . . . 0.46 110.476 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 tp -73.45 104.37 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.76 110.995 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.27 110.285 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 82.81 16.93 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.195 -0.457 . . . . 0.91 110.294 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.81 -18.33 22.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.519 2.146 . . . . 0.47 112.473 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p 46.78 49.14 14.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.857 -0.61 . . . . 1.07 111.464 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -80.33 161.36 25.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.807 -0.633 . . . . 1.1 109.894 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -58.53 -40.11 82.02 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.974 0.416 . . . . 0.62 110.405 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mt -119.95 95.32 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 1.13 109.632 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -159.27 137.99 10.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.832 -0.622 . . . . 2.26 110.21 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.81 37.03 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.4 111.006 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.8 p -106.67 -28.58 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.32 110.633 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 12.6 m120 -126.26 50.41 1.9 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.64 110.26 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 54' ' ' GLN . 2.3 m -92.6 155.33 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.15 111.073 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.62 134.03 55.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 0.1 109.688 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.55 127.12 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 0.1 110.889 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 89' ' ' ILE . 2.7 p -140.59 118.98 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 0.1 109.648 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -123.56 132.9 54.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.243 0.544 . . . . 0.81 112.047 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.615 ' HB2' HG23 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -111.53 159.56 18.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.835 -0.62 . . . . 0.26 110.063 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -121.06 115.85 23.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.582 -0.281 . . . . 1.39 110.637 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 16.2 mmm180 -99.39 55.39 0.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.731 0.301 . . . . 1.87 110.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.24 34.28 20.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.586 -0.734 . . . . 0.34 111.778 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.78 -62.92 0.42 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.331 -0.708 . . . . 0.33 111.331 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -74.35 145.73 43.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.69 -0.485 . . . . 1.04 109.69 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 28' ' ' ARG . 5.2 mmt180 -109.82 140.26 43.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.271 -0.27 . . . . 0.75 110.271 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -134.34 118.61 17.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.361 -0.381 . . . . 0.88 110.158 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -135.87 146.21 47.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.757 0.313 . . . . 1.09 110.333 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 pt -132.24 179.26 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.778 -0.646 . . . . 0.09 110.26 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.2 106.9 9.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.105 0.479 . . . . 0.1 110.659 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 m -103.58 171.09 7.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.696 -0.683 . . . . 0.11 109.416 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 11.2 t80 -88.26 154.58 20.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.873 0.368 . . . . 0.86 110.485 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -78.34 31.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.79 110.832 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -85.92 43.34 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.057 -0.519 . . . . 1.8 110.56 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt 61.1 46.76 7.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.636 -0.711 . . . . 0.34 110.84 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.02 -23.94 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.008 -0.542 . . . . 0.34 111.364 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 97' ' ' VAL . 7.8 p -68.46 -31.38 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.477 -0.329 . . . . 0.83 110.503 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.36 -18.1 74.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.118 -0.563 . . . . 0.28 112.571 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CE2' ' HB2' ' A' ' 49' ' ' LEU . 78.0 t90 -68.76 -47.15 66.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.268 0.556 . . . . 0.6 110.04 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HG3' ' H ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -93.6 17.66 11.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.485 -0.78 . . . . 0.93 110.364 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -158.61 60.1 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.31 110.557 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.96 -149.9 18.62 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.527 -0.844 . . . . 0.13 112.636 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.61 122.86 70.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.513 -0.551 . . . . 0.26 109.513 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.602 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 13.4 mm-40 -136.18 -86.07 0.35 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.237 -0.185 . . . . 0.18 111.397 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.602 ' HD2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -153.74 -144.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.506 -0.553 . . . . 0.42 109.506 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.55 167.53 10.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.926 -0.398 . . . . 0.39 109.926 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 41' ' ' TRP . 16.6 tp -104.05 6.79 36.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.457 0.54 . . . . 0.53 112.457 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.77 -44.42 7.09 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.421 -0.512 . . . . 1.21 110.486 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.91 -27.94 61.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.436 -0.802 . . . . 0.7 111.048 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.85 -13.01 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.21 110.533 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -87.99 107.64 18.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.036 -0.529 . . . . 0.35 110.055 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.425 ' HG3' HG12 ' A' ' 17' ' ' VAL . 33.5 mm-40 -65.71 -44.33 86.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.642 . . . . 0.36 111.316 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 t -142.89 136.12 28.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.058 0.456 . . . . 0.35 110.145 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -96.68 25.91 4.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.014 -0.539 . . . . 1.03 110.851 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -96.68 88.74 4.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 0.29 110.127 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.3 p -82.02 141.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.104 -0.498 . . . . 0.3 109.924 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -90.91 162.42 14.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.22 111.797 -178.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 98.6 t -111.92 -46.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.15 109.56 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -154.15 120.11 5.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.11 -0.95 . . . . 0.22 108.989 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.03 -27.58 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.067 0.395 . . . . 0.32 112.067 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -38.39 87.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.062 0.458 . . . . 0.38 110.941 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -99.35 -5.35 29.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 1.25 110.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.23 52.23 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.914 -0.66 . . . . 0.27 111.881 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -105.81 123.19 47.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.973 0.416 . . . . 0.74 110.886 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' PHE . 35.2 t -114.97 130.76 68.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.75 -0.659 . . . . 0.34 109.994 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -85.25 110.82 19.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.12 110.459 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -84.8 -171.7 3.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.922 -0.581 . . . . 1.42 109.803 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -56.7 -38.92 72.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.179 0.437 . . . . 0.9 112.179 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -81.85 -1.34 47.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.34 111.5 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -101.6 -47.79 4.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.7 110.963 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.9 -34.28 77.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.611 -0.268 . . . . 0.18 110.966 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.08 -24.84 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.076 0.465 . . . . 1.23 110.574 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 m -93.22 -32.53 14.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.205 -0.452 . . . . 0.29 110.851 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.31 -54.32 7.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.19 111.716 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.44 -36.02 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.2 -0.455 . . . . 2.36 110.948 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.87 -25.04 25.24 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.832 -0.907 . . . . 0.34 110.832 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.92 124.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.279 -0.46 . . . . 1.19 110.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -23.8 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.172 0.51 . . . . 1.0 109.876 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.98 104.24 2.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.406 -0.815 . . . . 1.31 110.093 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -59.86 -31.92 70.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.5 111.643 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -38.72 92.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.69 110.211 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.05 -40.06 94.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.115 -0.493 . . . . 1.13 109.712 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.98 -50.3 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.53 109.555 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.8 m -59.66 -34.85 73.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.262 -0.881 . . . . 0.19 110.751 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.84 -44.42 96.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.54 110.922 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -63.26 -40.46 97.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.78 110.378 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 20' ' ' VAL . 52.1 mt -69.7 -34.31 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.66 . . . . 0.18 110.866 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.41 -21.23 49.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.365 . . . . 0.73 111.732 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -97.16 -53.59 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.334 0.494 . . . . 0.94 112.334 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -102.32 20.96 15.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.91 111.373 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.27 165.41 12.8 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.677 -0.773 . . . . 0.21 112.173 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.2 tt0 -87.58 102.69 14.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.014 -0.365 . . . . 1.89 110.014 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 p -106.29 126.02 61.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.15 110.449 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -79.68 88.4 5.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.925 -0.579 . . . . 2.37 111.139 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.628 HG21 ' HB ' ' A' ' 39' ' ' VAL . 1.0 OUTLIER -135.49 -125.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.81 110.744 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 m -157.47 -174.88 5.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.225 -0.657 . . . . 0.52 109.225 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 100' ' ' LYS . 19.9 p-10 -79.7 -76.48 0.21 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.632 -0.136 . . . . 0.81 110.632 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 51.7 mttm 51.97 33.0 10.9 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.007 0.523 . . . . 0.68 111.622 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' CD ' ' HG2' ' A' ' 153' ' ' LYS . 1.2 mm-40 -86.76 173.81 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.48 -0.782 . . . . 1.58 111.438 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 102' ' ' ARG . 8.3 ttm180 -160.67 -56.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.84 110.62 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -162.71 104.58 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.81 110.051 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -142.0 140.61 32.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.414 . . . . 0.59 110.305 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -111.21 119.27 38.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 0.92 109.56 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' MET . 0.6 OUTLIER -147.5 141.72 26.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.211 -0.45 . . . . 0.39 110.316 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -70.96 -36.36 72.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 1.88 110.187 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -84.94 10.49 11.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.834 -0.621 . . . . 1.28 110.912 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -61.07 -35.76 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.22 111.287 -179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.66 -40.9 96.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.48 111.038 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 111' ' ' ARG . 0.9 OUTLIER -84.49 -25.43 28.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.88 110.969 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 115' ' ' THR . 17.0 t70 -59.65 -58.49 8.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.949 -0.568 . . . . 0.47 111.097 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tp -71.31 -24.0 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.154 0.502 . . . . 0.12 110.608 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.22 89.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.676 . . . . 0.21 111.797 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 HD12 ' A' ' 116' ' ' ILE . 2.4 t -65.34 -17.79 64.8 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.648 0.24 . . . . 0.25 111.648 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.487 HD12 HG23 ' A' ' 115' ' ' THR . 1.2 mp -88.89 -51.22 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.782 0.325 . . . . 1.89 110.57 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.87 -31.85 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.148 0.425 . . . . 0.5 112.148 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.94 -4.43 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.23 111.644 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 130' ' ' TYR . 26.8 t70 -102.87 -41.92 6.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.035 0.445 . . . . 1.48 110.493 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -75.52 -11.49 60.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.877 -0.602 . . . . 0.57 112.072 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.82 108.22 19.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.868 0.366 . . . . 0.29 110.095 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 m -100.23 144.39 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 0.26 111.172 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.421 ' ND2' ' HG2' ' A' ' 125' ' ' GLU . 66.6 t30 -145.2 125.02 7.05 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.525 . . . . 0.47 109.932 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.3 77.23 3.9 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.607 2.205 . . . . 0.23 112.663 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HG2' ' ND2' ' A' ' 123' ' ' ASN . 1.0 OUTLIER -144.84 -157.68 0.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.153 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.6 m -71.33 -45.2 63.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.024 0.44 . . . . 1.45 110.511 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -68.12 148.09 51.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.716 -0.675 . . . . 2.38 110.575 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -116.46 152.92 48.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.263 -0.426 . . . . 1.12 110.647 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.37 178.73 2.4 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.591 2.194 . . . . 0.16 111.512 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.445 ' H ' ' HA ' ' A' ' 119' ' ' ASP . 31.8 t80 68.65 12.3 8.63 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.735 0.779 . . . . 0.84 109.664 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.9 m -107.35 106.12 16.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.373 -0.83 . . . . 0.38 109.672 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -55.6 -38.52 50.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.018 -0.537 . . . . 0.31 111.337 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -55.41 -30.02 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.679 -0.691 . . . . 0.28 111.965 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.3 tp -57.06 -52.08 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.42 111.535 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.58 -31.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 121.022 -0.271 . . . . 0.68 111.039 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.12 -45.93 91.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.03 0.443 . . . . 0.93 110.831 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -26.13 64.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 0.45 110.727 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.05 -50.73 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.22 111.42 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -65.03 -29.78 70.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.92 110.816 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -76.54 -12.76 60.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.83 111.168 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -85.3 -28.37 25.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.35 109.561 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.5 mt -89.56 -60.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.251 -0.886 . . . . 0.2 110.95 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 58.05 67.25 0.98 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.889 -0.596 . . . . 0.13 110.201 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.69 120.15 31.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.64 110.737 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 m -86.11 153.41 22.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.58 110.406 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' A' ' 155' ' ' GLN . 11.1 t -110.31 -80.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.64 0.257 . . . . 0.31 110.723 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.62 160.0 30.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.763 0.316 . . . . 0.49 110.39 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 2.25 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 0.7 111.138 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.5 -23.89 61.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.45 111.344 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . 45.6 mttm 63.02 36.01 12.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.143 0.497 . . . . 1.92 110.995 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.9 132.35 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.21 111.951 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.9 m 52.71 84.18 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.251 0.621 . . . . 0.19 112.52 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.485 ' HG2' ' CD ' ' A' ' 101' ' ' GLU . 7.9 mmtp 52.47 38.24 24.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 1.25 111.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.67 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 6.1 tt0 58.85 59.62 2.77 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.049 -0.523 . . . . 1.03 110.703 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 46.32 42.09 9.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.207 1.003 . . . . 1.15 112.07 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.66 72.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.09 110.67 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -67.38 -31.11 71.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 1.11 110.698 179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -71.67 -29.11 64.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.923 -0.399 . . . . 0.52 109.923 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.54 -37.56 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.862 -0.792 . . . . 0.14 108.862 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.2 -40.7 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.184 -0.916 . . . . 0.16 109.567 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.1 mmtp -66.95 -39.32 87.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 1.32 110.11 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -58.29 -40.76 82.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.737 -0.665 . . . . 1.61 110.529 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.65 -46.65 86.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.26 110.108 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -62.45 -36.65 83.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.73 111.414 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 47.9 mm-40 -62.65 -35.53 79.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.411 -0.358 . . . . 0.44 111.431 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -92.25 -41.52 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.31 -0.405 . . . . 0.73 111.089 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.69 106.55 8.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.182 -0.463 . . . . 1.05 109.868 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -75.1 101.74 4.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.92 110.977 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.77 131.49 48.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.766 -0.652 . . . . 0.38 110.729 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 71.71 9.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.131 0.491 . . . . 0.6 111.302 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 135.37 35.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.862 -0.608 . . . . 0.99 109.7 178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.6 134.57 13.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.763 0.316 . . . . 0.34 110.865 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -121.03 136.57 54.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.493 -0.558 . . . . 1.06 109.493 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.72 172.34 12.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.58 -0.282 . . . . 0.78 110.569 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.44 133.65 55.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.482 . . . . 0.5 110.282 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.44 141.38 48.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.237 -0.438 . . . . 0.23 110.274 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.59 139.66 46.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.128 0.489 . . . . 1.2 110.962 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 90.4 t80 -113.93 143.28 44.97 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.161 -0.681 . . . . 0.25 109.161 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.6 131.56 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.427 0.528 . . . . 0.37 112.427 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 180' ' ' LEU . 7.0 mt -160.61 139.57 7.74 Favored Pre-proline 0 C--N 1.333 -0.112 0 CA-C-N 115.625 -0.716 . . . . 1.49 109.649 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 180' ' ' LEU . 21.3 Cg_endo -62.09 156.03 52.4 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.571 2.181 . . . . 0.17 111.674 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.0 t -49.73 -37.05 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.744 0.418 . . . . 0.17 111.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -46.78 -47.08 20.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.84 111.451 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.31 -28.59 12.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.33 110.588 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.87 64.89 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.009 -0.541 . . . . 0.18 113.233 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -27.73 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.656 0.243 . . . . 0.8 111.656 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -76.18 -46.58 27.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.577 0.227 . . . . 0.8 111.184 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -25.11 59.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.514 -0.312 . . . . 1.59 111.155 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -59.33 -34.21 72.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.98 110.919 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.45 6.78 25.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.56 . . . . 1.5 112.187 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 26.6 mtpt -135.38 -28.1 1.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 197' ' ' LYS . 80.1 mt -80.73 -56.96 3.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.97 0.414 . . . . 1.15 111.349 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 27.1 mtpp -61.1 -52.65 70.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.47 0.915 . . . . 0.24 113.47 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 56.3 Cg_endo -68.29 -5.89 16.08 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.191 1.927 . . . . 0.32 114.047 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 191' ' ' LYS . 2.0 mm? -102.52 1.73 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.771 -0.371 . . . . 0.21 110.377 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mt 53.19 45.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.693 0.759 . . . . 0.35 111.23 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' HD2' HD23 ' A' ' 192' ' ' LEU . 6.1 ptpp? -116.91 24.24 11.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 0.24 110.028 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.57 156.72 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.723 -0.671 . . . . 0.25 111.341 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.53 145.34 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.4 109.072 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 65.99 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.375 0.509 . . . . 0.32 112.375 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 m -145.54 36.1 1.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.406 -0.815 . . . . 0.25 108.858 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.3 pt-20 -89.87 166.75 13.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.738 -0.665 . . . . 0.55 112.25 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.14 118.16 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 1.52 109.6 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.22 45.29 1.25 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.34 111.032 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -102.71 -139.58 10.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.725 -0.75 . . . . 0.2 112.288 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -78.87 -27.67 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.468 . . . . 1.14 110.228 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -120.85 109.53 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.677 -0.692 . . . . 1.13 109.165 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.8 tp -69.83 92.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.89 . . . . 1.55 111.298 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.0 tt0 -94.48 117.46 30.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.028 -0.73 . . . . 0.44 109.028 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 202' ' ' GLU . 8.4 mt -128.18 147.43 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.842 0.353 . . . . 0.18 110.777 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.33 115.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.507 -0.553 . . . . 0.26 109.507 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.4 m -121.4 57.75 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.793 0.33 . . . . 1.04 111.722 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.98 127.59 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.715 -0.476 . . . . 0.41 109.715 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.71 -51.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.319 -0.4 . . . . 0.77 111.22 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 2.9 p30 -155.54 166.34 16.46 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.725 -0.216 . . . . 1.2 110.639 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 86.2 Cg_endo -80.34 -159.24 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.35 2.034 . . . . 0.44 112.754 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.68 -94.14 1.29 Allowed Glycine 0 C--O 1.238 0.392 0 C-N-CA 120.871 -0.681 . . . . 0.34 111.621 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.26 -17.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.65 110.109 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 222' ' ' ILE . 23.9 t80 -55.54 -35.27 65.5 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.314 -0.857 . . . . 0.45 110.481 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -25.06 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.35 111.563 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -86.06 -45.48 11.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 2.72 110.276 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 226' ' ' ILE . 16.3 tt -69.02 -26.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 1.26 110.686 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -31.75 72.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.249 -0.432 . . . . 0.2 110.196 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.55 -22.96 64.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.678 -0.692 . . . . 1.15 110.05 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.8 mt -96.02 -46.61 6.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.525 -0.761 . . . . 0.74 109.592 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.5 mm -55.76 -37.96 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.894 -0.594 . . . . 0.43 112.326 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -52.64 -31.56 37.47 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.353 0.501 . . . . 1.32 112.353 -179.105 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -112.33 -23.93 10.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.58 110.711 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 226' ' ' ILE . 1.5 tp10 -62.47 -51.23 68.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.64 111.606 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.1 -28.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.432 0.53 . . . . 0.63 112.432 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 32.8 mttt -58.98 -43.88 91.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.69 110.97 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.45 39.49 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.646 -0.788 . . . . 0.28 112.845 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -151.07 -18.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.888 0.344 . . . . 0.49 111.5 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -147.52 -158.17 7.76 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.907 . . . . 0.13 112.491 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.5 m -119.11 141.89 48.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.786 0.327 . . . . 0.21 110.547 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.32 143.05 51.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.29 110.639 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 238' ' ' VAL . 2.9 tt0 -134.07 171.17 14.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.441 ' H ' ' HG2' ' A' ' 237' ' ' GLU . 27.6 m -86.08 149.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.795 0.331 . . . . 0.27 110.429 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.0 tp -114.7 96.61 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.769 -0.456 . . . . 0.39 109.769 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -88.11 17.24 5.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.13 111.453 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 241' ' ' LEU . 3.7 mm? -78.51 97.46 5.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.683 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -111.41 -4.6 14.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 1.21 110.44 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -77.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.714 -0.675 . . . . 0.81 111.923 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.87 149.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.387 -0.369 . . . . 0.27 110.891 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.98 116.82 32.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.67 110.515 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -123.84 150.29 44.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 1.22 110.087 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.26 -152.54 6.51 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.561 -0.828 . . . . 0.39 112.636 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -79.93 43.21 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.769 0.795 . . . . 0.65 110.43 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -90.49 12.45 18.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.273 -0.876 . . . . 0.78 110.734 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -129.4 90.57 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.68 -0.691 . . . . 0.74 109.581 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -76.77 -49.56 15.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.504 . . . . 1.29 110.161 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.745 -0.645 . . . . 1.18 109.544 179.517 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.063 -0.415 . . . . 0.88 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -102.35 164.95 11.39 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.114 -0.328 . . . . 0.2 110.114 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.59 143.94 33.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.813 -0.44 . . . . 0.54 109.813 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -116.69 162.21 18.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 1.34 110.529 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mt -75.82 86.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.449 0.642 . . . . 1.01 109.869 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 8' ' ' PRO . 16.1 t80 -167.64 -176.81 3.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.364 -0.976 . . . . 2.03 108.364 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 m -123.9 72.92 54.44 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.789 0.328 . . . . 0.72 110.187 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 6' ' ' PHE . 7.2 Cg_exo -73.27 134.47 21.02 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.203 . . . . 0.75 112.136 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.27 69.22 10.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.092 -0.504 . . . . 0.7 110.5 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.426 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 7.0 t-20 -105.99 -175.41 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.954 -0.566 . . . . 0.52 109.643 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -77.75 -85.29 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.626 0.25 . . . . 2.05 110.926 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mt -91.38 92.41 3.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.302 0.572 . . . . 0.27 110.764 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 68.2 mmt-85 -143.53 133.11 23.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.495 -0.775 . . . . 0.64 109.766 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.26 15.45 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.45 -0.341 . . . . 1.71 111.483 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 p -101.56 -3.11 29.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.434 -0.348 . . . . 0.61 111.475 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 37.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.18 0.514 . . . . 1.62 110.431 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 54' ' ' GLN . 33.9 m -95.53 150.61 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.44 111.597 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.9 151.91 25.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.933 -0.576 . . . . 0.48 109.582 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 126.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.781 0.324 . . . . 0.89 111.013 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -125.66 116.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.825 -0.805 . . . . 0.3 108.825 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.1 ttp180 -114.89 123.24 48.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.705 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.466 ' HB2' HG23 ' A' ' 89' ' ' ILE . 51.6 ttp -88.61 131.45 34.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.25 110.595 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -101.87 126.32 48.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.165 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 16.9 mmm180 -122.11 -164.62 1.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.329 -0.249 . . . . 0.64 110.329 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.32 -53.88 14.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.12 111.175 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.1 27.58 3.14 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.517 -0.849 . . . . 0.53 112.685 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 162.66 41.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.337 . . . . 1.12 110.47 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 141.3 23.23 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.329 -0.619 . . . . 1.09 109.329 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -136.05 144.44 45.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.333 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 1.2 pt-20 -145.6 144.45 30.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.682 0.277 . . . . 1.68 110.682 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.3 mt -140.13 144.67 27.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.33 109.994 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.77 122.99 28.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.17 110.523 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -124.44 -170.44 2.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.15 110.924 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.94 -176.19 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.453 -0.339 . . . . 0.94 110.987 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -76.67 -140.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.431 -0.35 . . . . 1.46 111.858 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -60.54 -6.8 1.78 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.426 0.898 . . . . 0.74 113.426 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.97 -2.96 58.84 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.008 -0.433 . . . . 0.98 111.387 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG21 ' SG ' ' A' ' 33' ' ' CYS . 8.8 p -74.15 -33.01 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.268 . . . . 0.23 111.499 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.05 70.23 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.119 0.961 . . . . 0.28 110.431 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.31 46.96 77.85 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.807 -1.088 . . . . 0.19 112.596 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.584 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER 55.8 57.74 4.98 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 110.012 -0.366 . . . . 0.77 110.012 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 44.58 60.6 2.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.923 0.889 . . . . 0.95 112.458 -179.256 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.2 m 69.01 13.67 8.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.51 -0.768 . . . . 0.22 112.666 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.29 -128.04 6.18 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.291 -0.724 . . . . 0.15 111.291 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.39 105.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.905 -0.406 . . . . 0.37 109.905 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -74.04 159.61 32.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.691 -0.686 . . . . 1.34 110.752 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -61.95 1.85 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.966 -0.561 . . . . 1.41 109.495 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.45 153.67 17.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.257 -0.883 . . . . 0.71 108.966 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.03 -27.32 62.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.562 0.22 . . . . 0.29 111.334 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.41 111.797 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -87.37 0.15 55.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.52 111.791 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.32 -5.54 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.564 0.697 . . . . 0.5 110.027 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.24 133.48 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.438 -0.801 . . . . 1.32 109.961 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' HG3' HG12 ' A' ' 17' ' ' VAL . 29.0 mm-40 -85.77 -48.88 8.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.099 0.476 . . . . 0.28 110.709 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.1 t -119.25 166.68 12.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.891 -0.595 . . . . 0.8 109.727 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -121.24 32.54 5.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.272 0.558 . . . . 0.71 110.061 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.01 126.36 50.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.79 . . . . 0.28 109.447 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.6 p -108.86 137.65 39.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.873 0.368 . . . . 0.13 110.367 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HE2' ' H ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -82.95 158.27 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.372 . . . . 0.47 111.645 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.5 t -121.18 -56.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.36 109.186 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -137.72 101.13 4.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.255 -0.884 . . . . 0.32 109.56 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' H ' ' HE2' ' A' ' 59' ' ' PHE . 14.0 p -67.71 -30.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.59 110.917 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -70.12 -12.32 61.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.987 0.422 . . . . 0.33 111.181 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -121.37 4.71 10.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 1.06 110.846 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.82 38.46 94.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.739 -0.743 . . . . 0.4 111.351 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -101.77 120.81 40.95 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.14 0.495 . . . . 0.9 111.644 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.9 140.55 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.18 109.919 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.581 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -95.11 127.01 40.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.289 0.566 . . . . 0.06 110.834 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -88.86 -178.06 5.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.426 -0.806 . . . . 1.33 109.661 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.54 -28.67 68.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.102 0.477 . . . . 1.45 110.735 179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -80.03 -5.31 55.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.54 111.116 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.27 -46.09 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.334 -0.394 . . . . 0.47 111.125 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.82 -28.01 69.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.14 111.149 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 80' ' ' ASP . 10.2 tt -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.105 0.478 . . . . 0.2 110.596 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -35.75 17.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.841 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.55 -52.66 12.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.701 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -89.65 -66.98 0.87 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.988 0.423 . . . . 0.81 110.927 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.72 -50.82 0.47 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.172 -0.771 . . . . 0.24 111.172 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 148.21 25.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.919 -0.4 . . . . 0.71 109.919 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 74' ' ' ILE . 6.9 p-10 -93.25 3.82 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 1.23 110.664 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.58 122.92 36.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.207 -0.451 . . . . 1.45 109.962 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -60.33 -27.48 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.527 0.566 . . . . 1.88 112.527 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.52 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.013 0.435 . . . . 0.55 110.605 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.0 -23.16 23.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.12 110.275 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -79.54 -55.07 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.28 109.975 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 11.7 p -63.98 -24.87 67.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.24 110.721 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' THR . 40.7 ttmt -54.25 -41.75 69.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.645 . . . . 0.95 111.037 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -84.6 -38.19 20.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 1.36 110.72 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.567 HG22 HG22 ' A' ' 20' ' ' VAL . 65.5 mt -62.47 -34.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.18 111.981 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -25.02 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.069 0.766 . . . . 0.26 113.069 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.61 -20.74 11.59 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.362 -0.535 . . . . 0.63 112.399 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -111.0 12.4 22.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.923 0.392 . . . . 0.96 110.57 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 22' ' ' MET . . . -129.11 175.7 18.74 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.663 -0.78 . . . . 0.27 112.773 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -91.83 92.84 8.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.991 0.424 . . . . 1.4 110.602 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -91.66 140.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.869 -0.605 . . . . 0.27 109.691 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -69.34 84.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.62 110.837 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 95' ' ' VAL . 15.4 m -90.62 36.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.568 -0.742 . . . . 0.35 111.544 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 69.37 -1.34 2.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.913 -0.585 . . . . 0.58 111.429 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.67 102.38 15.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.364 -0.606 . . . . 0.97 109.364 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -153.8 93.46 1.66 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.339 0.59 . . . . 0.31 110.761 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -85.56 16.55 3.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.615 -0.72 . . . . 1.18 110.579 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -118.8 105.29 11.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.391 -0.822 . . . . 2.04 110.411 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -167.56 140.7 3.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 1.09 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.93 174.65 6.7 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.982 -0.554 . . . . 0.73 110.858 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -58.78 132.78 54.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.125 0.488 . . . . 0.68 111.558 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 107' ' ' GLU . 0.7 OUTLIER -162.54 -171.44 2.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.541 -0.754 . . . . 1.19 109.167 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.415 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 9.6 tp10 -66.66 163.67 18.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.678 -0.489 . . . . 0.9 109.678 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -57.89 100.31 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.671 0.272 . . . . 0.98 111.125 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -28.8 66.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.142 0.496 . . . . 1.17 110.177 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.94 -43.16 93.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.719 -0.673 . . . . 1.24 110.038 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -68.08 -33.43 74.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.332 -0.395 . . . . 0.71 110.396 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 115' ' ' THR . 6.0 t70 -59.61 -48.43 81.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 1.17 111.066 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.7 -30.51 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.778 0.323 . . . . 0.17 110.923 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -65.32 -35.32 80.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.534 -0.303 . . . . 0.15 111.138 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 112' ' ' ASP . 2.7 t -71.29 -16.39 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.386 . . . . 1.18 110.801 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mm -86.83 -43.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.24 109.923 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG13 HG12 ' A' ' 135' ' ' ILE . 14.2 p -78.69 -16.35 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.09 110.941 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.27 81.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.476 -0.329 . . . . 0.19 111.274 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -79.76 -15.14 58.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 0.56 110.494 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -84.01 -26.14 29.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.027 -0.533 . . . . 0.68 110.821 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.9 p -91.62 96.52 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.132 0.491 . . . . 0.18 110.215 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.98 146.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.053 -0.521 . . . . 0.98 111.036 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -150.9 125.0 4.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.187 -0.671 . . . . 1.14 109.187 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.35 61.14 4.16 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.751 2.301 . . . . 0.42 113.143 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' OE1' ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -132.21 -166.28 1.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.33 110.629 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.8 t -75.44 -25.42 57.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.742 0.275 . . . . 0.77 111.742 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' HB2' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -86.27 101.95 13.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 2.18 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -81.71 147.29 58.55 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.067 -0.515 . . . . 1.66 110.016 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 57.76 3.08 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.76 2.306 . . . . 0.19 113.139 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -117.07 17.64 14.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.246 0.546 . . . . 0.71 110.727 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.2 m -136.01 118.98 16.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.961 -0.563 . . . . 0.77 110.093 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.39 -35.27 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.403 . . . . 0.43 110.943 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.8 mm -54.42 -33.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.32 111.809 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.5 mt -57.04 -41.94 79.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.272 -0.422 . . . . 0.69 111.557 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 117' ' ' VAL . 9.1 tp -96.27 -25.79 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.719 0.295 . . . . 0.19 110.604 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.09 -45.36 91.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.753 0.311 . . . . 0.4 110.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -61.24 -26.5 67.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.8 110.856 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.63 19.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.284 -0.416 . . . . 0.26 110.218 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.42 -32.41 73.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 1.31 110.454 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -69.66 -32.55 71.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 1.35 109.987 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.44 -48.11 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.729 -0.669 . . . . 0.62 109.896 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 50.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.779 -0.646 . . . . 0.56 109.728 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -86.16 2.37 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.99 111.757 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -107.46 121.42 44.58 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.751 -0.38 . . . . 1.39 110.038 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 m -51.1 132.65 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.856 0.723 . . . . 0.53 111.978 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.93 68.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.995 -0.548 . . . . 0.98 110.156 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 61.52 80.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.606 -0.725 . . . . 1.04 111.446 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -3.33 16.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.245 0.545 . . . . 0.79 111.153 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -77.82 -15.96 58.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.432 0.635 . . . . 0.27 109.56 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -94.65 159.47 15.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.289 -0.869 . . . . 0.57 109.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t -71.57 133.49 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.887 0.375 . . . . 0.46 110.289 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -26.37 68.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.51 110.811 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -82.65 -12.31 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.91 110.677 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -91.07 -34.75 14.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 1.63 110.512 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 159' ' ' VAL . 14.4 mt-30 -110.07 17.13 21.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 1.29 111.564 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.79 72.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.027 0.442 . . . . 0.17 111.383 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 2.9 mm? -64.34 -46.88 81.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.635 . . . . 0.78 110.791 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -59.5 -38.57 81.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.467 . . . . 0.25 111.129 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 155' ' ' GLN . 96.2 t -67.69 -49.72 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.17 111.701 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.6 -34.31 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.644 0.239 . . . . 0.28 111.644 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 29.5 mmtt -72.43 -40.54 67.02 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.271 -0.27 . . . . 1.79 110.271 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -59.04 -40.01 83.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.144 0.497 . . . . 0.99 110.087 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 53.3 tp -70.24 -41.22 73.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.598 -0.728 . . . . 0.76 110.313 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 167' ' ' MET . 59.8 tttm -58.14 -33.8 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.019 -0.537 . . . . 1.29 111.568 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.99 -30.56 71.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.765 0.317 . . . . 1.86 111.185 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -94.98 -41.86 8.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.18 110.411 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -133.56 119.89 20.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.089 -0.505 . . . . 0.79 109.656 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -90.53 109.01 20.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.08 0.467 . . . . 1.95 111.182 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -99.28 143.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.573 -0.74 . . . . 0.35 110.919 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.87 -178.36 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.711 -0.222 . . . . 0.73 110.934 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.88 21.13 12.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.603 0.565 . . . . 1.82 112.106 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.94 33.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.999 0.428 . . . . 0.23 111.695 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -115.54 136.55 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 1.15 110.089 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 1.7 tpt -89.82 -85.34 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.507 0.558 . . . . 0.97 112.507 -178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 175' ' ' ARG . 11.7 mtp180 -140.31 145.71 37.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.026 0.441 . . . . 0.67 111.826 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.573 ' HB2' HD23 ' A' ' 213' ' ' LEU . 5.9 mp -129.38 150.64 50.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.18 108.821 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 23.1 ptt180 -121.72 153.6 38.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.062 0.458 . . . . 0.18 110.962 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 31.4 t80 -117.64 128.21 54.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.22 109.876 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.52 128.51 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.85 111.065 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.549 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.6 OUTLIER -173.18 160.29 3.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.393 -0.595 . . . . 0.13 109.393 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.13 147.64 73.49 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.129 1.886 . . . . 0.2 111.536 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 72.9 t -61.62 -22.07 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.908 0.385 . . . . 0.35 110.708 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -52.7 -42.55 64.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.75 110.541 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.5 -32.78 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.54 109.817 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.96 -20.41 64.52 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.614 -0.721 . . . . 0.11 113.347 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.63 -26.54 61.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.95 0.405 . . . . 0.8 111.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 191' ' ' LYS . 50.9 mttt -76.68 -57.45 3.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.8 110.989 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -19.57 65.17 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.256 0.465 . . . . 1.55 112.256 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -54.19 -51.6 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.441 . . . . 0.79 111.442 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.88 21.68 4.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.387 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 187' ' ' LYS . 21.4 mtpp -122.7 0.02 9.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 2.29 109.978 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.27 -54.17 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 1.39 111.807 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.1 mtpp -53.92 -53.27 59.94 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.813 0.671 . . . . 0.63 112.813 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.8 Cg_endo -65.36 -14.15 43.49 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.219 1.946 . . . . 0.4 112.889 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.4 -18.75 40.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.407 -0.36 . . . . 0.67 110.442 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 31.4 mt 57.46 75.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.761 -0.654 . . . . 0.67 111.721 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.7 27.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.798 -0.637 . . . . 0.69 109.838 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.91 -173.46 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.306 -0.861 . . . . 0.89 109.927 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.67 137.66 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.342 -0.614 . . . . 0.89 109.342 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.06 71.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.511 0.507 . . . . 2.09 111.185 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 34.39 0.46 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.497 -0.774 . . . . 0.6 109.135 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.27 168.45 14.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.889 -0.596 . . . . 1.26 111.774 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -126.1 127.32 45.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.611 -0.722 . . . . 1.13 109.724 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -115.76 130.15 56.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.599 -0.273 . . . . 0.97 110.5 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 165.97 -114.66 0.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.74 -0.743 . . . . 0.74 112.277 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -40.16 31.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.661 0.743 . . . . 1.13 109.092 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -117.41 157.6 25.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.93 -1.032 . . . . 1.19 108.757 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.93 95.03 5.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.101 0.477 . . . . 0.31 110.351 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 28.4 tt0 -92.85 107.83 19.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.819 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.47 128.47 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.379 -0.373 . . . . 0.3 111.129 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.7 t -90.97 98.02 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.317 -0.623 . . . . 0.21 109.317 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 37.3 t -113.51 114.18 26.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.088 -0.506 . . . . 0.24 111.33 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -169.84 134.46 1.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.248 -0.649 . . . . 0.38 109.248 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.5 tt -131.79 171.82 17.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.496 -0.32 . . . . 0.35 110.217 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 42.1 m-20 -55.72 148.98 33.56 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.009 -0.541 . . . . 1.75 111.407 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.83 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.078 2.519 . . . . 0.41 113.081 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.36 -90.13 0.92 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.879 -0.888 . . . . 0.1 110.879 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.7 m -73.34 -4.5 33.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 1.27 110.214 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 79.1 t80 -55.59 -38.78 69.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.23 111.265 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 8.1 tpt180 -65.64 -31.2 72.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.565 0.222 . . . . 1.2 111.16 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.49 -35.97 78.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.42 110.741 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.604 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 3.6 tp -84.95 -27.48 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 1.11 109.879 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 26.1 t70 -64.44 -29.13 70.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.35 110.688 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 220' ' ' ARG . 12.9 mm-40 -53.42 -33.32 53.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.72 -0.673 . . . . 0.48 112.007 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -97.47 -33.43 11.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.948 -0.39 . . . . 0.17 109.948 178.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 222' ' ' ILE . 31.4 mm -55.96 -37.75 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.13 111.78 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.478 ' HA ' ' CB ' ' A' ' 231' ' ' LYS . 8.0 ptpt -62.22 -23.67 66.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.891 0.7 . . . . 0.42 112.891 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -112.47 -28.36 7.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.531 -0.468 . . . . 0.67 111.132 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -41.28 74.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.009 -0.541 . . . . 0.87 111.843 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.28 -47.06 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.501 0.556 . . . . 0.21 112.501 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 25.7 ttmt -53.35 -45.96 69.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.938 0.399 . . . . 0.23 111.088 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.28 48.23 2.9 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.806 -0.712 . . . . 0.22 112.017 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.82 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.727 0.299 . . . . 1.2 110.902 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.25 -146.99 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.12 112.379 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.0 m -108.84 131.24 55.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.17 110.858 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.4 pt? -111.82 149.94 31.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.835 -0.432 . . . . 0.21 109.835 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -142.52 -178.84 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.01 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.72 149.93 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.975 0.417 . . . . 0.16 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.31 58.57 1.71 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.448 0.642 . . . . 0.22 109.313 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -114.86 56.92 0.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.15 110.729 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 241' ' ' LEU . 2.1 pt? -73.68 -31.35 63.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.29 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 53.33 34.78 18.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.942 0.719 . . . . 0.64 112.942 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.488 ' H ' ' HG ' ' A' ' 241' ' ' LEU . 17.4 t0 -122.65 -73.98 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.838 0.352 . . . . 1.87 111.103 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.49 ' O ' HD11 ' A' ' 241' ' ' LEU . 7.7 p -132.47 135.08 58.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.353 -0.385 . . . . 0.46 110.411 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -84.2 102.73 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.838 0.351 . . . . 0.64 110.082 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -102.81 138.33 39.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.972 -0.558 . . . . 1.99 110.174 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -161.37 169.83 37.0 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.064 -0.814 . . . . 0.47 111.064 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.63 101.28 7.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.464 0.632 . . . . 1.45 111.609 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -118.01 22.21 12.37 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.686 -0.857 . . . . 1.29 108.686 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -125.07 94.94 4.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.97 -1.014 . . . . 1.39 110.032 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -40.91 97.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.43 . . . . 2.07 111.285 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.46 -0.781 . . . . 2.32 110.518 -179.626 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 111.896 -0.482 . . . . 0.34 111.896 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -149.14 161.95 40.94 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.341 -0.244 . . . . 0.33 110.341 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -72.57 141.74 48.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.245 -0.434 . . . . 0.45 109.943 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -141.18 144.64 34.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.553 -0.294 . . . . 0.59 110.506 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.9 -73.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.449 -0.341 . . . . 0.33 110.666 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -66.98 125.15 25.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.742 -0.466 . . . . 1.07 109.742 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.14 77.25 61.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.364 -0.38 . . . . 0.71 111.774 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.28 143.65 25.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.427 2.085 . . . . 0.24 112.104 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 88.28 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.006 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.45 158.66 15.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.09 -0.505 . . . . 0.51 110.193 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -71.08 -50.45 33.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.88 111.174 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.16 94.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.13 109.839 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -166.64 160.14 14.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 1.54 110.338 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.13 7.19 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.17 111.539 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 p -96.99 -0.06 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.27 110.712 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -141.98 38.11 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.612 . . . . 0.22 109.506 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.72 150.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.16 111.799 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.54 137.06 54.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.365 -0.834 . . . . 0.14 109.877 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -76.09 122.78 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.377 . . . . 0.35 110.989 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 31' ' ' ILE . 1.2 p -151.57 129.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.17 110.498 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 148.0 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.95 111.152 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 17.6 ttt -110.67 134.3 52.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.61 . . . . 0.23 110.847 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -96.68 103.77 15.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.634 -0.506 . . . . 0.73 109.634 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 10.9 mmm180 -84.07 -179.82 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.548 -0.296 . . . . 1.42 110.62 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.6 69.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.514 . . . . 0.42 111.918 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.11 -39.44 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.92 . . . . 0.54 113.28 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tttt -113.91 -174.94 2.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.781 0.324 . . . . 1.05 110.826 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 5.6 mmt180 -137.03 154.8 50.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.442 -0.948 . . . . 0.86 108.442 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -133.48 102.75 5.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.178 -0.304 . . . . 0.27 110.178 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 61' ' ' ASN . 2.6 mt-10 -106.05 127.0 52.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.37 110.773 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 20' ' ' VAL . 5.0 pt -135.06 -172.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.1 110.798 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.6 110.23 3.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.391 . . . . 0.09 110.886 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' HD23 ' A' ' 53' ' ' LEU . 62.5 m -100.18 -175.47 2.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 0.12 109.779 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -72.18 167.45 20.29 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.91 0.386 . . . . 0.22 111.338 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -99.69 7.77 44.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.088 0.47 . . . . 1.11 111.079 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -87.61 84.94 7.04 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.874 -0.331 . . . . 0.23 110.379 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm 58.06 57.18 4.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.733 -0.667 . . . . 0.43 110.778 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.1 p -74.65 61.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.794 1.283 . . . . 1.49 110.74 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.56 9.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.471 -1.24 . . . . 0.24 109.308 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -45.12 90.74 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.595 -0.729 . . . . 0.18 112.395 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -74.75 -25.6 59.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.63 111.095 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 90' ' ' LEU . 19.0 ttt180 -69.58 -31.9 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.578 0.704 . . . . 0.49 109.351 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' A' ' 105' ' ' GLN . 20.0 m -109.33 17.06 21.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.442 -0.799 . . . . 0.3 110.649 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.05 -116.65 0.78 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.967 -0.635 . . . . 0.47 111.965 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.86 126.13 16.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.962 -0.385 . . . . 0.99 109.962 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 1.1 pt-20 -90.99 -59.45 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.182 -0.303 . . . . 2.47 110.182 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -162.77 -58.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.34 110.583 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 3.1 p30 -166.52 -175.53 3.22 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.146 -0.687 . . . . 0.99 109.146 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.724 ' HB2' HG23 ' A' ' 83' ' ' THR . 1.2 mm? -131.5 33.86 4.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.453 0.644 . . . . 0.97 110.07 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -120.86 -43.97 2.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.542 -0.754 . . . . 1.88 109.314 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -87.0 -31.66 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.345 -0.843 . . . . 0.96 108.829 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.452 HG13 ' CE1' ' A' ' 34' ' ' TYR . 22.2 t -63.25 -37.25 78.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.901 -1.045 . . . . 0.44 110.035 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD23 ' SG ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -83.47 80.22 9.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.373 -0.83 . . . . 0.59 109.243 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.6 -62.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.288 -0.869 . . . . 0.42 111.039 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -78.66 91.98 4.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.67 -0.696 . . . . 0.17 111.277 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -84.22 60.46 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.415 0.626 . . . . 0.72 110.555 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.3 t -152.91 82.81 1.21 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.241 -0.891 . . . . 0.58 109.136 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.2 p -67.64 138.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.781 -0.645 . . . . 0.11 110.636 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -101.14 145.88 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.33 109.945 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 97.5 t -73.35 -40.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.033 -0.728 . . . . 0.5 109.033 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 2.1 t-20 -176.38 127.34 0.2 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.054 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.07 -37.93 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.772 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.4 m -83.44 43.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.93 111.122 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -47.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 2.28 110.046 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.14 -2.8 47.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.755 -0.736 . . . . 0.47 112.269 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.3 121.95 22.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.69 0.281 . . . . 1.01 110.803 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.8 t -105.86 134.41 47.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.958 -0.386 . . . . 0.27 109.958 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.1 98.32 10.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.158 0.504 . . . . 0.41 110.589 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -81.17 178.9 8.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.045 -0.724 . . . . 2.36 109.045 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -51.63 -35.8 43.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.685 0.278 . . . . 0.42 111.537 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.51 -30.01 70.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 2.09 111.805 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.67 -51.21 6.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 2.18 111.829 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 80' ' ' ASP . 2.2 pp -60.12 -32.55 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.19 111.881 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.39 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.202 0.525 . . . . 0.83 110.363 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.6 m -105.89 -39.15 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.79 111.142 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.94 -41.06 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.387 . . . . 0.33 111.07 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -96.63 -57.39 2.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.99 109.823 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.29 -31.93 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.902 -0.666 . . . . 0.53 112.142 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.02 145.35 45.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.55 0.215 . . . . 0.76 110.531 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 7.8 p-10 -92.8 11.68 26.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.059 0.456 . . . . 0.7 110.917 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.589 ' O ' HG12 ' A' ' 85' ' ' ILE . 13.5 t0 -82.1 117.72 22.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.44 109.781 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.07 -31.14 70.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.8 111.535 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.724 HG23 ' HB2' ' A' ' 49' ' ' LEU . 23.2 m -63.83 -46.97 82.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 0.14 110.559 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.8 -33.04 74.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.48 110.949 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 81' ' ' ASP . 41.6 mm -65.38 -57.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.28 111.05 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.64 -28.48 68.51 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.083 0.401 . . . . 0.19 112.083 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' THR . 28.0 mtpt -55.34 -53.56 54.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.925 0.393 . . . . 0.82 111.14 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -63.9 -40.01 95.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.74 -0.664 . . . . 0.81 111.729 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 20' ' ' VAL . 42.3 mt -69.81 -28.35 36.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.29 0.567 . . . . 0.18 111.078 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.518 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -79.8 -32.12 40.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.291 -0.413 . . . . 0.26 111.771 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 87' ' ' LYS . 11.4 t -99.06 -29.48 12.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.133 0.79 . . . . 0.21 113.133 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -119.44 12.04 12.31 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.073 -0.392 . . . . 1.65 111.801 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.84 -177.33 18.39 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.583 -0.818 . . . . 0.26 111.551 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.49 106.62 18.66 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.119 -0.326 . . . . 1.8 110.119 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 97' ' ' VAL . 2.1 p -117.66 148.64 20.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.173 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -70.8 77.09 0.62 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.078 0.466 . . . . 0.41 111.64 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 95' ' ' VAL . 15.6 m -82.57 157.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 1.12 110.438 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 p -125.99 -70.6 0.73 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.446 -0.343 . . . . 1.15 110.938 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.21 146.31 1.87 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.061 -0.348 . . . . 2.42 110.061 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HD3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -157.89 145.85 18.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 1.1 110.126 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.16 20.55 6.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.541 . . . . 1.26 110.914 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 102' ' ' ARG . 3.8 mmp_? -73.66 172.25 11.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.54 110.413 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -128.84 84.86 2.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.666 0.617 . . . . 2.18 112.666 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.0 m -159.05 -83.68 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.652 -0.249 . . . . 0.66 110.73 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.516 ' H ' ' HA ' ' A' ' 43' ' ' SER . 21.2 tm0? -130.87 141.86 50.34 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.5 -0.556 . . . . 0.43 109.5 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mt -141.63 149.36 40.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.772 -0.195 . . . . 0.62 110.478 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -99.76 -10.64 21.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.196 0.522 . . . . 0.58 110.515 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.27 87.63 7.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.781 -0.645 . . . . 1.72 110.507 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.0 mtt -76.21 20.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.214 0.53 . . . . 0.37 111.964 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -130.52 5.45 4.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.11 -0.7 . . . . 1.24 109.11 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.65 -16.79 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.189 -0.914 . . . . 0.29 110.391 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.75 -47.26 87.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.951 -0.568 . . . . 0.14 111.653 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.6 mm -71.16 -43.65 74.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.305 0.574 . . . . 0.27 109.944 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.91 88.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.14 -0.937 . . . . 0.19 112.42 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 t -63.95 -22.29 66.86 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.913 0.338 . . . . 1.18 111.913 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.71 -40.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.942 0.401 . . . . 0.25 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 163' ' ' LEU . 1.2 p -82.99 -13.92 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.257 -0.429 . . . . 0.23 111.983 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' A' ' 135' ' ' ILE . . . -88.78 -47.38 8.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.548 . . . . 0.11 110.261 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.561 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 7.4 t70 -60.57 -43.22 97.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.055 -0.975 . . . . 0.21 111.743 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 216' ' ' PRO . 17.9 mtmt -90.01 16.68 7.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.099 0.778 . . . . 0.83 113.099 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.454 ' SG ' HD13 ' A' ' 169' ' ' ILE . 91.5 m -131.76 108.9 9.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.937 -0.394 . . . . 0.23 109.937 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.85 172.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.073 0.463 . . . . 0.28 111.817 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 9.5 t-20 -174.14 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 114.986 -1.006 . . . . 0.54 109.657 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 83.2 Cg_endo -90.25 121.53 0.9 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.87 1.713 . . . . 0.81 111.912 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 1.6 pm0 -74.01 -20.64 60.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.038 0.447 . . . . 1.68 110.428 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 t -79.03 -6.5 56.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.913 -0.585 . . . . 1.01 110.691 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -143.97 82.14 1.7 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.644 -0.502 . . . . 0.35 109.644 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HB2' ' CD2' ' A' ' 130' ' ' TYR . 91.0 mtt180 -70.96 157.08 91.1 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.42 110.331 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.86 54.72 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.921 2.414 . . . . 0.31 113.259 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -96.01 25.12 4.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.53 111.027 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.1 m -151.99 110.22 3.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.67 110.19 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.47 -34.42 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.03 -0.532 . . . . 0.35 111.095 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mm -60.41 -29.3 44.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.25 112.031 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -58.85 -33.58 70.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.43 111.879 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.479 HG21 ' HB2' ' A' ' 118' ' ' ALA . 2.6 tp -102.99 -15.27 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 121.036 -0.266 . . . . 0.19 111.349 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -36.26 70.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.167 0.508 . . . . 0.4 110.143 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -60.08 -32.91 71.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.456 -0.793 . . . . 1.03 110.983 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.21 -39.93 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.3 110.825 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 6.2 ttt -63.1 -41.39 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.379 0.609 . . . . 0.32 110.079 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -71.29 -23.52 61.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.448 -0.796 . . . . 1.39 110.755 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.18 -43.79 27.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.108 -0.496 . . . . 0.33 112.176 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 144' ' ' TYR . 16.2 tt -66.45 -34.25 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.687 0.255 . . . . 0.23 111.687 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 m80 59.96 32.17 21.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.122 0.264 . . . . 0.36 111.366 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.452 ' H ' HG23 ' A' ' 142' ' ' ILE . 49.1 t80 -134.13 133.99 41.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.889 0.376 . . . . 0.68 110.669 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 m -155.36 170.28 22.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.687 -0.688 . . . . 0.52 109.194 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.48 -84.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.949 -0.3 . . . . 0.13 110.351 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -143.95 104.48 4.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.45 110.373 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -12.08 60.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.18 111.629 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.94 5.68 50.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.22 110.925 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -116.1 -159.88 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.29 -0.414 . . . . 0.99 110.528 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -75.41 81.66 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.364 0.602 . . . . 0.61 109.925 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 153' ' ' LYS . 0.9 OUTLIER -53.72 -25.44 18.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.5 113.514 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.619 ' HD2' HG23 ' A' ' 152' ' ' THR . 0.0 OUTLIER -91.12 -13.06 33.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.65 -0.656 . . . . 0.69 111.757 -179.148 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -84.69 -25.1 28.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.318 0.58 . . . . 0.5 109.592 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.94 29.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.564 -0.744 . . . . 0.15 110.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.1 -18.36 63.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.22 112.241 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.36 -46.38 16.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.113 0.482 . . . . 0.43 109.873 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -62.49 -46.0 90.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 0.54 111.023 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.37 -38.39 48.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.722 -0.672 . . . . 0.22 111.506 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.2 -34.34 66.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.138 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -82.87 -9.92 59.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.135 -0.484 . . . . 1.27 111.412 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -55.09 6.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.3 110.127 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.4 ' HB2' HG21 ' A' ' 117' ' ' VAL . 55.3 tp -66.41 -24.0 66.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.29 110.623 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -61.57 -26.03 67.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.9 110.153 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -80.59 -7.01 59.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.49 110.845 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -107.62 -48.15 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.35 110.281 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 mmm -145.85 148.11 32.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 1.06 110.414 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -90.95 99.9 12.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.273 -0.421 . . . . 1.6 110.005 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.454 HD13 ' SG ' ' A' ' 121' ' ' CYS . 0.2 OUTLIER -100.18 149.32 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.037 -0.529 . . . . 0.24 110.718 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.86 140.88 39.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.161 0.505 . . . . 1.72 110.641 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -139.42 61.43 1.55 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.82 -0.627 . . . . 0.51 110.268 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 113.2 3.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 0.25 110.753 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -170.93 153.44 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.468 -0.567 . . . . 0.59 109.468 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 5.1 ttt -139.64 -140.89 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.985 -0.376 . . . . 1.48 109.985 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -137.69 120.83 16.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.024 -0.361 . . . . 0.58 110.024 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.462 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.8 mp -120.43 157.91 28.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.99 0.424 . . . . 0.39 110.875 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' HB3' HG22 ' A' ' 211' ' ' VAL . 0.1 OUTLIER -135.79 -179.47 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.553 -0.749 . . . . 0.36 109.862 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 1.9 p90 -141.66 139.63 33.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.721 0.296 . . . . 0.7 110.328 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -108.68 122.17 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.198 -0.456 . . . . 0.42 110.943 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.8 149.83 9.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.609 -0.723 . . . . 1.12 109.814 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.11 160.57 37.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.917 2.411 . . . . 0.12 112.789 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.36 -34.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 0.55 111.121 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -55.2 -45.93 75.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.82 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -85.57 -30.25 23.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.384 -0.371 . . . . 1.45 110.57 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.04 -22.05 77.1 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.42 113.066 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -61.15 -28.23 68.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.0 0.429 . . . . 1.12 110.88 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 4.55 51.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.262 -0.426 . . . . 1.44 110.733 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.4 tp -111.82 -41.05 4.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.94 110.987 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.442 ' HB2' HD21 ' A' ' 208' ' ' LEU . 27.4 ttpp -55.77 -44.37 77.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.98 111.19 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -80.61 6.24 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.178 0.436 . . . . 0.46 112.178 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -123.06 -2.76 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.292 -0.255 . . . . 0.97 111.127 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 192' ' ' LEU . 0.3 OUTLIER -127.3 -48.69 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.645 -0.252 . . . . 0.76 111.48 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 60.3 tttt -59.8 -50.28 87.47 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.367 0.506 . . . . 1.02 112.367 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 48.6 Cg_endo -68.0 -2.65 9.14 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.174 1.916 . . . . 0.16 112.913 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.25 3.02 55.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 110.053 -0.351 . . . . 0.58 110.053 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 16.9 mt 52.72 72.22 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.178 -0.919 . . . . 0.15 110.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 0.1 OUTLIER -152.8 19.37 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.608 -0.723 . . . . 0.34 109.932 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' SG ' ' A' ' 212' ' ' CYS . 33.2 m -108.95 145.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.499 . . . . 0.21 111.013 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.448 HD12 HG12 ' A' ' 211' ' ' VAL . 13.4 mt -97.02 159.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.679 . . . . 0.28 109.397 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.07 59.77 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.262 0.553 . . . . 1.32 111.613 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -155.99 74.62 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.28 -0.637 . . . . 0.45 109.28 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -123.52 155.01 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.48 . . . . 1.04 111.045 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.41 129.64 46.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.836 -0.62 . . . . 0.31 109.937 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.7 109.24 11.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.93 0.395 . . . . 1.17 110.117 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -168.77 -96.33 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.041 -0.599 . . . . 0.32 111.649 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -89.01 -10.88 45.91 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.122 -0.696 . . . . 0.56 109.122 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.19 -176.89 5.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.009 -0.996 . . . . 0.24 109.621 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 189' ' ' LYS . 21.9 tp -130.02 76.87 1.75 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.581 -0.526 . . . . 0.39 109.581 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.69 108.58 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.792 -0.64 . . . . 0.58 110.715 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 55.3 mt -123.13 137.39 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.19 110.611 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.448 HG12 HD12 ' A' ' 199' ' ' ILE . 85.9 t -91.53 123.75 43.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.25 110.065 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.459 ' SG ' HG12 ' A' ' 198' ' ' VAL . 57.4 m -137.21 102.34 4.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.244 -0.435 . . . . 0.41 110.468 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.462 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -159.66 136.96 9.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.388 -0.597 . . . . 0.25 109.388 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 215' ' ' ASP . 5.6 tp -134.86 179.36 4.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.525 -0.307 . . . . 0.29 110.354 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.56 ' H ' HG13 ' A' ' 214' ' ' ILE . 16.8 m-20 -60.43 164.22 7.31 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 122.978 0.511 . . . . 0.84 110.861 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 215' ' ' ASP . 10.2 Cg_endo -52.65 170.38 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.853 2.368 . . . . 0.07 112.923 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 80.48 -80.44 1.65 Allowed Glycine 0 C--O 1.237 0.315 0 N-CA-C 110.43 -1.068 . . . . 0.11 110.43 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.24 -22.44 63.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.34 109.107 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -59.5 -32.26 70.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.298 -0.865 . . . . 0.31 110.767 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 220' ' ' ARG . 11.4 mmt180 -85.93 -15.79 40.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.37 110.161 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 0.7 OUTLIER -79.69 -48.75 13.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.38 109.134 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 tt -66.66 -34.65 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.22 109.775 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.445 ' O ' ' HD2' ' A' ' 227' ' ' LYS . 1.8 t70 -59.98 -36.58 77.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.907 -0.588 . . . . 0.44 110.919 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 9.8 mm-40 -47.13 -41.14 16.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.664 -0.698 . . . . 0.9 111.934 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -34.09 10.2 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.793 -0.363 . . . . 0.46 111.266 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 8.9 mm -56.28 -39.11 58.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.222 0.453 . . . . 0.19 112.222 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 5.8 ptmt -64.74 -11.65 38.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.976 0.732 . . . . 0.38 112.976 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -25.74 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.552 -0.459 . . . . 1.85 112.005 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.14 -47.83 26.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.64 111.362 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -116.38 -38.8 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.845 -0.342 . . . . 0.31 111.59 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -66.09 -25.05 66.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 1.32 110.24 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.95 25.35 28.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.015 -0.612 . . . . 0.4 111.718 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -139.84 -55.18 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.583 -0.525 . . . . 0.59 109.583 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.41 -145.53 9.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.314 -0.714 . . . . 0.2 111.314 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.41 133.25 46.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 117.031 0.416 . . . . 0.81 110.018 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -89.55 149.65 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.953 -0.388 . . . . 1.18 109.953 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 177' ' ' ARG . 6.6 tp10 -155.56 154.61 31.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.84 110.179 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -72.57 158.6 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.596 0.236 . . . . 0.23 110.406 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.63 52.28 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.458 0.647 . . . . 1.05 111.015 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -115.52 75.54 0.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.521 -0.918 . . . . 0.75 108.521 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.96 -73.64 0.53 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.462 -0.79 . . . . 0.22 110.785 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.44 41.96 25.37 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.756 0.66 . . . . 1.07 110.056 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.75 -46.56 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.467 -0.788 . . . . 0.85 110.875 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.37 143.84 39.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.358 -0.383 . . . . 0.21 110.499 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.02 117.76 8.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.641 -0.708 . . . . 0.63 111.084 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.73 151.88 28.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.965 -0.561 . . . . 1.01 110.929 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.98 76.6 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.593 -0.813 . . . . 0.14 113.357 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -147.48 110.84 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.046 -0.353 . . . . 0.68 110.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.41 -8.84 13.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.395 -0.366 . . . . 1.54 111.206 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.464 ' HE3' ' HB2' ' A' ' 252' ' ' GLU . 55.6 tptt -75.51 98.0 3.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 1.03 110.836 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.57 -28.69 61.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.69 110.734 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.464 ' HB2' ' HE3' ' A' ' 250' ' ' LYS . 26.0 mt-10 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.449 -0.786 . . . . 1.44 110.277 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.906 -0.477 . . . . 0.7 111.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -148.49 133.81 18.47 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.919 -0.4 . . . . 1.71 109.919 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 mmt -70.54 120.43 16.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.849 -0.426 . . . . 1.26 109.849 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -109.89 120.25 41.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.013 0.435 . . . . 0.74 111.057 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -95.08 -14.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.695 0.76 . . . . 1.08 109.33 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -142.04 144.41 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.988 -1.005 . . . . 0.73 109.032 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.26 85.9 37.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.631 0.234 . . . . 1.04 111.631 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 -32.78 87.6 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.36 2.04 . . . . 0.42 111.998 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m 56.36 70.76 0.61 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.961 -0.563 . . . . 0.51 111.336 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -90.86 -76.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.86 110.752 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -161.37 -80.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.81 0.338 . . . . 0.72 110.822 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 54' ' ' GLN . 1.2 pp -89.18 47.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.132 0.491 . . . . 1.51 111.728 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -121.07 151.69 39.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.71 45.45 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.217 0.532 . . . . 1.13 111.608 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -99.51 -33.75 10.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.092 0.472 . . . . 1.06 111.063 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.54 72.33 1.42 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.219 -0.66 . . . . 0.73 109.219 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.12 149.01 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.669 -0.696 . . . . 0.95 111.331 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.66 123.0 49.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.51 109.412 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.43 120.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.114 0.483 . . . . 0.78 111.077 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -139.21 116.89 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.739 . . . . 0.24 109.525 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -126.83 132.95 50.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.229 0.538 . . . . 0.77 112.032 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 66.6 ttp -111.48 119.45 38.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.176 -0.676 . . . . 0.26 109.176 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 124.23 50.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.782 0.325 . . . . 1.17 110.828 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -109.86 -164.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.533 . . . . 2.79 110.055 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.61 72.89 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.3 0.375 . . . . 1.75 111.596 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.08 7.77 4.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.399 -0.905 . . . . 0.46 112.952 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -123.13 145.26 48.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 1.74 111.261 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -129.72 132.15 46.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.067 -0.716 . . . . 0.79 109.067 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.79 144.81 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.478 0.18 . . . . 0.32 110.871 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 44.8 tt0 -156.8 143.11 18.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.986 -0.376 . . . . 0.7 109.986 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 53' ' ' LEU . 2.0 pt -142.07 -173.21 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.737 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.82 119.78 26.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.915 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 90' ' ' LEU . 29.5 m -116.76 157.78 24.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 0.37 110.641 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HD1' ' NE2' ' A' ' 54' ' ' GLN . 1.3 t80 -74.15 145.13 44.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.829 0.347 . . . . 1.02 110.226 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 8.97 4.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.312 -0.404 . . . . 1.13 111.599 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.55 88.34 7.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.305 -0.247 . . . . 1.13 110.797 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.5 44.35 24.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.508 -0.769 . . . . 0.7 112.091 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.89 149.24 8.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 0.33 110.188 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 90' ' ' LEU . 3.9 t 68.81 23.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.41 0.624 . . . . 0.14 110.459 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.57 62.35 6.45 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.898 -0.592 . . . . 0.17 113.292 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 11.47 5.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.361 0.264 . . . . 0.61 111.155 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 22.36 13.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.356 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -135.99 -51.35 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.823 -0.626 . . . . 0.44 111.11 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.06 -112.9 0.86 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.549 -0.834 . . . . 0.23 112.327 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.4 t -129.9 127.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.556 0.217 . . . . 0.22 110.71 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.7 -69.03 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.072 -0.714 . . . . 1.57 109.072 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 179.92 6.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.442 -0.799 . . . . 0.64 108.968 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.41 138.79 58.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.81 0.338 . . . . 0.52 111.284 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 52' ' ' VAL . 6.0 mp -68.23 -24.45 64.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.981 -0.554 . . . . 0.52 110.229 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.26 -27.28 68.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.373 0.606 . . . . 1.14 109.946 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 17.65 19.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 1.48 111.161 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.3 p -125.12 -9.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.347 . . . . 0.24 111.087 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 31' ' ' ILE . 1.9 mm? -96.24 110.07 22.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.333 -0.394 . . . . 0.39 110.35 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.532 ' NE2' ' HD1' ' A' ' 34' ' ' TYR . 17.1 mt-30 -70.52 -35.81 73.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 2.38 110.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -122.11 164.37 17.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.748 -0.66 . . . . 0.85 110.458 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -125.19 18.05 8.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.947 -0.569 . . . . 0.83 109.629 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -116.39 118.49 32.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.462 -0.79 . . . . 0.58 110.164 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 68' ' ' ALA . 8.0 p -100.95 143.14 14.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.239 -0.437 . . . . 0.31 110.227 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -83.97 157.5 21.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.629 0.252 . . . . 0.22 111.087 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 83.3 t -117.8 -49.48 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.482 0.658 . . . . 0.4 109.539 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -144.15 111.37 5.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.815 . . . . 0.72 108.955 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.5 -37.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.006 0.373 . . . . 0.36 112.006 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -31.17 72.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.933 0.397 . . . . 0.51 111.142 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -100.96 -1.85 33.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.91 111.242 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.84 48.13 83.42 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.96 -0.638 . . . . 0.38 112.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -106.6 123.65 48.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.794 0.331 . . . . 0.58 111.231 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.76 139.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.736 -0.666 . . . . 0.08 109.537 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.93 128.13 36.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.12 111.653 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -91.33 -172.33 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.362 -0.607 . . . . 0.4 109.362 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -63.27 -30.74 71.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.758 0.314 . . . . 0.31 111.004 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.1 pm0 -79.62 -24.82 41.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 1.19 110.973 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.19 -51.95 15.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.424 -0.353 . . . . 1.81 110.288 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.43 -32.78 74.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.25 110.935 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -66.8 -23.53 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.961 0.41 . . . . 0.72 110.237 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -100.93 -5.81 25.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.65 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.18 -40.27 7.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.33 110.763 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.97 -34.51 6.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.38 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.01 -10.02 29.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.032 -0.604 . . . . 0.31 111.926 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 147.09 44.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.476 0.179 . . . . 0.93 110.523 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -96.69 -8.91 30.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.809 0.338 . . . . 0.86 111.02 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 85' ' ' ILE . 56.0 t0 -73.84 110.78 8.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.168 -0.469 . . . . 0.99 110.099 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -62.07 -27.86 69.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.851 -0.613 . . . . 0.64 110.882 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -34.39 77.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.66 110.538 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.96 -29.27 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 81' ' ' ASP . 39.7 mm -67.28 -46.32 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 p -71.1 -24.08 62.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.27 110.349 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -59.9 -41.83 92.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.215 0.531 . . . . 0.76 109.718 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.04 -49.67 55.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.411 -0.813 . . . . 0.35 110.726 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG22 HG22 ' A' ' 20' ' ' VAL . 33.2 mt -61.76 -35.12 65.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.25 112.245 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 33' ' ' CYS . 3.7 mm? -82.77 -11.31 58.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.247 0.832 . . . . 0.08 113.247 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -122.98 -10.1 8.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.151 -0.62 . . . . 0.14 112.389 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -121.94 -5.26 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.733 0.302 . . . . 0.16 110.827 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.8 -169.33 19.26 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.547 -0.835 . . . . 0.14 113.067 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.29 107.44 18.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.702 -0.481 . . . . 0.99 109.702 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 97' ' ' VAL . 2.2 p -106.28 138.52 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.2 110.456 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.26 89.39 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 1.22 111.021 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.539 HG23 ' H ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -131.17 -87.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.45 . . . . 1.06 111.033 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.539 ' H ' HG23 ' A' ' 97' ' ' VAL . 61.8 m -156.86 -166.42 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.371 -0.603 . . . . 0.67 109.371 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.07 120.34 11.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.877 0.37 . . . . 0.66 111.027 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -163.98 172.42 13.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.07 -0.715 . . . . 0.38 109.07 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.83 164.8 22.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.937 0.399 . . . . 2.17 110.675 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -88.93 -175.46 4.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.692 -0.686 . . . . 0.3 109.442 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -165.52 147.58 7.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.291 . . . . 0.19 110.781 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -80.87 155.05 26.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.108 -0.496 . . . . 0.22 109.883 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' THR . 44.8 tt0 175.3 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.391 0.432 . . . . 1.15 110.415 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' O ' ' HG2' ' A' ' 109' ' ' MET . 1.9 mt -176.32 176.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.837 -0.431 . . . . 0.57 109.837 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.51 136.74 39.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.2 -0.454 . . . . 1.15 109.881 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 69.13 1.9 3.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.691 0.62 . . . . 0.85 111.121 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 8.5 ptt? -63.72 -23.99 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.99 -0.55 . . . . 1.21 111.204 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.81 -28.71 70.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.74 110.919 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.06 -35.51 23.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.015 0.436 . . . . 1.83 110.096 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 115' ' ' THR . 20.0 t70 -62.77 -51.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.6 . . . . 1.24 110.512 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.97 -33.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.078 -0.51 . . . . 0.55 110.576 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.3 95.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.32 111.661 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 112' ' ' ASP . 6.5 t -72.47 -11.76 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.24 111.486 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 112' ' ' ASP . 47.5 mm -95.59 -37.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.181 0.515 . . . . 0.72 110.259 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.36 -22.91 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.005 -0.543 . . . . 0.66 111.364 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.25 80.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 0.25 111.462 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -68.35 -21.67 64.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.517 0.675 . . . . 2.01 111.107 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -119.31 26.33 9.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.44 110.482 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 31.7 t -87.39 101.31 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.02 -0.537 . . . . 1.96 111.039 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.21 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.367 -0.379 . . . . 1.72 110.283 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 125' ' ' GLU . 28.5 t-20 -154.1 137.13 10.14 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 1.01 109.809 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.39 65.19 3.65 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.922 2.415 . . . . 0.64 112.626 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 3.8 tt0 -146.89 -175.06 4.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.57 109.104 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.466 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 10.1 t -81.44 -11.91 59.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.105 0.478 . . . . 0.55 109.829 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.412 ' HB2' ' OE1' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -79.48 80.48 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.153 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -89.71 150.54 44.26 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.156 -0.474 . . . . 1.6 110.331 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.86 106.76 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.496 2.797 . . . . 0.28 112.47 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -149.98 -65.89 0.21 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.035 -0.53 . . . . 0.69 110.487 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.99 143.01 33.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.191 -0.458 . . . . 0.75 111.208 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.31 -29.39 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.144 0.497 . . . . 0.13 110.762 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -55.61 -32.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.26 111.334 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.94 -47.7 82.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.15 111.873 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -33.73 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 1.13 110.844 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -65.04 -37.76 88.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.044 0.449 . . . . 0.73 110.633 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -28.78 70.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 1.87 110.926 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.85 23.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.28 110.65 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 11.6 tpt -65.89 -42.95 89.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.47 111.043 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -72.31 -26.6 62.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.577 -0.283 . . . . 1.13 110.658 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.13 -49.77 68.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.61 110.735 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.1 tt -76.46 -51.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.31 110.989 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 41.16 51.53 3.43 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.686 0.616 . . . . 0.83 111.7 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -114.01 94.59 4.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 0.82 111.406 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 139.29 30.79 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.629 . . . . 0.51 109.887 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.66 83.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.792 0.33 . . . . 0.47 110.533 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 60.75 54.45 3.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.743 -0.662 . . . . 1.09 111.405 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -15.43 63.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.6 111.818 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -101.48 15.95 27.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 1.27 111.007 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -119.23 -125.2 0.28 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.907 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.77 79.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.84 111.023 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -21.94 60.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.922 -0.581 . . . . 0.58 112.52 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 9.7 29.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.369 . . . . 1.19 111.168 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -128.98 -44.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 1.36 110.154 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -71.56 -6.02 37.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.814 -0.63 . . . . 1.26 111.22 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -36.82 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.38 110.8 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.91 -39.21 76.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.9 110.693 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 12.2 mp0 -64.99 -46.17 82.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.049 -0.523 . . . . 0.82 111.147 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.26 -44.18 80.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 111.971 0.36 . . . . 0.45 111.971 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.16 -29.59 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.874 0.324 . . . . 0.79 111.874 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -97.21 -12.84 22.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.591 0.234 . . . . 0.95 111.188 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 3.9 tp-100 -68.15 -43.61 77.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.662 -0.496 . . . . 0.32 109.662 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.36 -32.12 73.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.27 109.903 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -67.93 -21.89 65.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.555 -0.748 . . . . 0.97 110.391 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.6 -32.85 60.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.43 110.271 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -52.82 7.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.82 -0.807 . . . . 1.42 108.82 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mtp -131.59 112.45 12.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.944 -0.761 . . . . 1.04 108.944 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -73.52 81.23 1.46 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 1.23 111.75 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.6 pt -94.68 143.97 10.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.562 -0.744 . . . . 0.26 109.76 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.15 155.42 46.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.934 0.397 . . . . 0.99 111.068 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.07 103.93 15.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 1.32 110.409 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -117.26 -156.31 0.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.65 -0.705 . . . . 0.88 110.287 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 t60 67.11 80.7 0.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.688 0.617 . . . . 1.22 111.274 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 19.5 ptm -70.72 167.06 19.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.832 -0.622 . . . . 0.74 111.33 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.441 ' HA ' ' HG ' ' A' ' 213' ' ' LEU . 25.3 mtp180 -84.08 147.99 27.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 1.24 111.153 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -129.45 175.64 8.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.32 110.567 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.86 167.38 21.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.83 109.826 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.3 t80 -123.67 143.08 50.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.636 -0.256 . . . . 0.26 110.691 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.6 pt -133.28 115.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.025 0.44 . . . . 0.27 110.548 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 184' ' ' GLU . 2.3 pt? -155.84 155.63 29.63 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.028 -0.533 . . . . 0.11 110.238 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.95 161.44 33.07 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.994 2.463 . . . . 0.17 113.27 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' HD23 ' A' ' 208' ' ' LEU . 27.8 t -57.65 -35.53 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.607 -0.724 . . . . 0.45 111.89 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.31 -39.78 61.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.34 111.998 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 49.6 mm-40 -104.46 -17.74 14.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.988 0.423 . . . . 0.46 110.529 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.31 -34.6 88.78 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.171 -0.538 . . . . 0.24 112.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 30.6 ttpt -71.62 -7.55 48.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.928 0.394 . . . . 0.68 111.098 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -84.15 -58.26 2.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.679 0.276 . . . . 0.62 110.704 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -25.66 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.8 111.21 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.52 -37.21 85.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.837 0.351 . . . . 1.08 110.723 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 13.7 mm-40 -90.99 11.23 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.396 -0.366 . . . . 0.76 110.684 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -121.1 -49.24 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.806 0.299 . . . . 0.64 111.806 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.09 -36.73 35.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.109 0.781 . . . . 0.3 113.109 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 24.8 mtpp -60.93 -50.98 82.54 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 112.228 0.455 . . . . 0.22 112.228 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 21.3 Cg_endo -61.43 -19.58 64.93 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.147 1.898 . . . . 0.23 112.609 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.95 -13.02 58.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.349 . . . . 0.24 110.141 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.1 mt 55.22 59.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.49 -0.777 . . . . 0.46 110.371 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 21.37 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.33 -0.85 . . . . 0.39 109.783 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 212' ' ' CYS . 19.5 m -120.81 149.51 23.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.34 110.416 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.66 149.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.374 -0.602 . . . . 0.25 109.374 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -73.45 70.01 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 1.36 111.005 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.0 m -151.85 37.03 0.56 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.743 -0.662 . . . . 0.81 109.397 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.1 pt-20 -88.08 175.25 7.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.798 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' ' 208' ' ' LEU . 23.3 t70 -132.96 146.81 52.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.4 109.341 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.35 25.88 9.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.431 0.16 . . . . 0.97 111.431 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.21 -141.88 7.85 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.786 -0.721 . . . . 0.68 112.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -74.42 -17.51 60.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.179 0.514 . . . . 1.78 110.642 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 121.38 34.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.699 -0.682 . . . . 1.55 109.61 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 182' ' ' VAL . 4.1 mm? -80.71 85.8 6.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.127 0.489 . . . . 0.54 110.369 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 25.4 tt0 -76.72 93.61 3.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.817 -0.629 . . . . 1.04 110.048 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.2 127.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.514 . . . . 0.32 110.652 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.51 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.855 0.359 . . . . 0.22 110.361 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.8 p -124.51 104.68 8.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.29 110.898 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -164.35 127.37 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.313 -0.625 . . . . 0.21 109.313 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.03 -163.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.634 -0.257 . . . . 0.23 111.546 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -49.05 148.96 3.66 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.529 -0.76 . . . . 0.77 112.388 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.86 -50.09 14.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.134 2.556 . . . . 0.41 113.071 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.08 -57.3 8.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.47 112.657 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 51.4 m -55.88 -36.6 67.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.239 0.459 . . . . 0.48 112.239 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.93 -39.75 90.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.096 -0.642 . . . . 0.74 110.609 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -70.89 -8.14 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 1.7 110.647 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.46 -22.67 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.755 -0.657 . . . . 1.25 110.571 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 226' ' ' ILE . 7.6 tp -108.69 -29.11 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.459 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 33.9 t70 -61.37 -21.09 63.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.873 0.368 . . . . 0.76 111.104 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -26.32 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.86 111.114 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 228' ' ' LYS . 0.7 OUTLIER -114.02 -25.53 8.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.575 -0.284 . . . . 0.77 110.571 178.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.5 mm -66.51 -33.24 62.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.666 0.27 . . . . 0.79 110.979 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.96 -35.88 77.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.391 . . . . 0.98 110.782 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.55 11.21 39.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.239 0.543 . . . . 0.86 110.011 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -102.21 -65.77 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.45 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -121.57 -30.1 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 0.7 111.803 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -61.12 -33.05 72.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.161 0.505 . . . . 1.0 110.704 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.36 22.82 37.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.71 110.974 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -118.66 -57.43 2.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.882 0.372 . . . . 1.39 110.4 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.08 -136.08 5.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 0.4 112.806 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.7 m -132.59 148.85 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.39 110.621 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.68 160.29 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.913 0.387 . . . . 0.53 111.078 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -144.97 157.34 44.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.2 -0.667 . . . . 0.41 109.2 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.11 148.34 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.3 110.919 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 31.1 tp -97.11 62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.299 0.571 . . . . 1.07 109.818 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -119.29 90.38 3.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.806 -0.634 . . . . 1.46 110.191 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 243' ' ' ASP . 0.9 OUTLIER -161.58 127.52 3.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.801 -0.636 . . . . 1.61 109.8 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -136.55 60.87 1.65 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.417 0.627 . . . . 1.24 110.347 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.437 ' H ' HD13 ' A' ' 241' ' ' LEU . 11.5 t70 -113.55 -67.92 0.96 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.299 -0.864 . . . . 2.16 109.322 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.9 p -117.62 170.53 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.374 -0.83 . . . . 1.99 108.77 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 244' ' ' VAL . 43.9 mt-10 -75.81 125.58 29.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.795 0.331 . . . . 2.59 110.766 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.28 142.39 46.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.286 -0.415 . . . . 2.44 110.39 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.78 142.53 7.19 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.607 -0.806 . . . . 0.65 111.93 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -139.66 144.42 37.61 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.714 -0.286 . . . . 0.5 110.802 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.48 3.42 32.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.374 -0.376 . . . . 1.23 110.788 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -74.69 101.43 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.48 . . . . 0.52 110.401 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.0 -38.17 19.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.824 -0.625 . . . . 0.51 111.076 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.39 -0.814 . . . . 1.18 110.899 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.972 -0.451 . . . . 0.69 111.972 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -104.96 129.82 53.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.989 -0.375 . . . . 0.77 109.989 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 ttt -164.01 134.73 4.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.236 -0.438 . . . . 1.32 110.192 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -79.53 108.14 12.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.042 0.449 . . . . 0.55 110.587 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -109.16 -179.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.63 109.637 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -144.9 120.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.755 0.312 . . . . 2.4 110.544 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.9 HG23 ' HB ' ' A' ' 15' ' ' THR . 91.3 m -68.1 113.99 18.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.656 -0.702 . . . . 0.41 112.592 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -89.24 147.54 5.37 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.958 2.439 . . . . 0.45 111.439 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -103.26 136.11 43.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.742 0.306 . . . . 0.22 111.231 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t30 65.09 18.4 11.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.624 -0.716 . . . . 0.46 112.383 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.89 -3.0 52.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.068 -0.345 . . . . 1.09 110.068 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mt 55.1 68.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.568 -0.742 . . . . 0.36 110.922 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -136.37 166.86 22.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.729 -0.669 . . . . 0.26 109.5 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -75.78 53.52 0.74 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.977 0.418 . . . . 0.67 110.634 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.9 ' HB ' HG23 ' A' ' 7' ' ' THR . 9.6 p -123.41 -44.83 2.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.991 -0.549 . . . . 0.71 111.554 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -112.05 23.51 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 1.9 110.593 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m -74.41 137.42 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.49 112.256 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -91.78 140.26 29.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.614 -0.721 . . . . 0.6 110.205 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.07 130.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.186 0.517 . . . . 0.45 111.872 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 89' ' ' ILE . 5.7 p -150.13 126.4 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.574 -0.739 . . . . 0.18 109.024 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -132.86 141.7 48.55 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.655 0.613 . . . . 1.73 112.655 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttp -113.65 108.71 17.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.166 -0.925 . . . . 0.21 108.806 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -86.94 99.34 11.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.11 111.248 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -96.13 167.01 11.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.89 109.926 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.16 73.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.362 -0.381 . . . . 0.5 111.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.87 -50.78 6.22 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.95 -0.643 . . . . 0.6 112.521 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -161.81 147.43 13.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.777 -0.453 . . . . 0.48 109.777 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -92.39 143.87 25.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.671 -0.492 . . . . 1.32 109.671 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.34 132.36 42.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.538 -0.301 . . . . 0.32 111.024 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 21' ' ' ARG . 22.8 tt0 -124.4 134.87 52.99 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.459 -0.571 . . . . 1.48 109.459 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.37 145.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.404 . . . . 0.34 111.151 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.777 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -106.37 112.77 25.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.479 -0.563 . . . . 0.32 109.479 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.1 168.05 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 0.88 111.835 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 22.3 t80 -73.26 117.68 15.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.762 -0.654 . . . . 1.1 109.854 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 27.8 ttpt -79.83 82.39 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.398 0.618 . . . . 1.98 111.707 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.67 75.5 0.78 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.098 -0.955 . . . . 0.65 108.452 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.69 36.19 2.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.956 -1.02 . . . . 1.08 109.837 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.18 -40.55 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.493 -0.776 . . . . 0.35 110.908 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.58 2.27 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.33 110.605 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -27.32 74.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.217 -0.753 . . . . 0.27 111.217 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -72.17 -20.91 61.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.173 0.511 . . . . 0.56 109.974 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -103.06 0.72 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.575 . . . . 0.8 110.511 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -129.6 10.73 5.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.298 0.571 . . . . 1.0 110.381 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.68 -138.23 5.24 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.794 -0.922 . . . . 0.37 110.794 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.6 121.43 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.825 0.313 . . . . 0.3 110.208 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -128.36 -83.85 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.652 -0.249 . . . . 1.18 111.501 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.57 172.51 12.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.363 -0.38 . . . . 0.43 110.094 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.72 143.77 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.137 -0.32 . . . . 0.29 110.137 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.91 -24.88 67.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.24 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -57.83 -37.17 73.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.943 0.401 . . . . 0.38 110.772 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -83.77 -19.61 34.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.972 -0.558 . . . . 1.46 110.798 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.07 -25.47 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.36 110.938 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 55' ' ' THR . 2.4 mm? -74.76 99.83 3.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.4 110.921 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 34' ' ' TYR . 29.2 mt-30 -77.34 -24.48 50.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.671 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.443 ' O ' HD12 ' A' ' 53' ' ' LEU . 12.6 t -130.63 152.01 50.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.46 109.808 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -112.53 7.87 19.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.071 0.462 . . . . 0.39 110.4 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -110.23 145.59 37.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.016 -0.538 . . . . 0.18 109.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 68' ' ' ALA . 11.6 p -112.04 139.8 34.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 0.15 110.934 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -78.01 151.47 33.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.89 111.547 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 54.9 t -129.48 -59.34 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.499 -0.319 . . . . 0.61 111.636 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -123.68 126.67 46.99 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.456 -0.152 . . . . 0.63 110.825 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.17 -26.36 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 111.957 0.355 . . . . 0.95 111.957 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.7 m -72.02 -47.06 54.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.192 0.52 . . . . 0.77 110.207 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.47 -22.27 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.44 110.2 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 44.58 36.6 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 0.46 111.374 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -108.02 124.1 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.083 0.468 . . . . 1.16 111.068 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.01 145.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.471 -0.786 . . . . 0.43 109.606 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 72' ' ' ASP . . . -97.51 126.76 42.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.18 110.838 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -97.21 -171.53 2.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.653 -0.703 . . . . 1.11 110.112 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -51.28 -40.21 58.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.699 0.629 . . . . 1.07 112.699 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -62.15 -26.7 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.692 0.627 . . . . 0.47 112.692 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 17.2 t70 -94.17 -44.71 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.682 -0.407 . . . . 0.25 111.751 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.31 -34.69 75.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.929 -0.309 . . . . 0.26 111.827 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.11 -25.67 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.8 110.736 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 m -94.58 -43.03 8.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.16 111.387 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.09 -46.43 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.16 112.088 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -94.07 -29.75 15.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.94 110.689 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 16.19 54.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.466 -0.874 . . . . 0.8 112.184 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.5 m -145.94 124.56 12.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.19 -0.3 . . . . 1.51 110.19 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.29 60.68 5.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.433 0.635 . . . . 1.16 110.41 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.457 ' OD2' ' HB ' ' A' ' 83' ' ' THR . 19.6 t70 -151.97 111.84 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.728 -0.669 . . . . 2.41 109.986 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -68.33 -24.66 64.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.511 . . . . 1.51 111.218 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.457 ' HB ' ' OD2' ' A' ' 81' ' ' ASP . 11.6 m -66.82 -45.76 77.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.58 110.228 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -58.89 -46.54 87.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.67 110.402 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.96 -48.23 87.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.553 -0.749 . . . . 0.35 110.596 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.2 -34.6 75.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.16 110.895 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -62.01 -42.21 98.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 0.33 110.14 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.55 -40.37 84.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.28 110.002 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.558 HG22 HG22 ' A' ' 20' ' ' VAL . 76.3 mt -68.87 -30.89 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.617 -0.719 . . . . 0.12 111.004 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -18.79 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.398 -0.365 . . . . 0.16 111.69 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -105.7 -15.47 14.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.59 -0.444 . . . . 0.2 112.075 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -142.05 36.48 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 2.1 111.164 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.47 165.83 24.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.529 -0.843 . . . . 0.4 112.587 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 80.1 mt-10 -82.01 93.49 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 1.41 110.246 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.01 137.24 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.338 -0.392 . . . . 0.22 110.227 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -73.31 76.05 1.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.202 0.525 . . . . 0.58 111.77 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 m -110.48 -9.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.36 111.298 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.0 m -147.16 159.35 43.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.604 0.24 . . . . 0.43 110.508 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.8 -176.24 3.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 1.35 110.155 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 -154.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.425 0.453 . . . . 2.16 110.492 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 54.28 38.75 29.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.219 0.533 . . . . 1.58 111.655 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -107.34 -90.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 1.38 110.218 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -159.17 136.28 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.645 0.259 . . . . 1.23 110.405 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -151.81 108.76 3.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.251 -0.432 . . . . 0.82 110.416 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -118.99 93.5 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.072 0.463 . . . . 1.67 110.202 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 mt -140.7 171.77 13.64 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.718 -0.674 . . . . 0.25 109.797 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.76 -48.84 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.744 0.652 . . . . 1.29 111.381 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -121.87 76.45 1.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.96 110.251 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.75 -40.93 80.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.72 110.372 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.656 -0.702 . . . . 0.41 111.622 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -88.68 -39.2 14.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.84 0.352 . . . . 0.31 110.937 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.5 -40.93 93.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 1.47 110.973 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 tt -76.14 -16.15 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.148 0.499 . . . . 0.42 110.802 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.27 -38.7 13.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 0.21 111.071 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.9 t -66.25 -19.88 65.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.744 0.307 . . . . 0.22 111.686 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.0 tp -88.35 -6.56 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.021 0.439 . . . . 0.41 110.823 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 120' ' ' LYS . 4.9 p -124.26 -8.11 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.815 0.341 . . . . 0.19 111.365 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.35 -51.81 66.89 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.327 0.492 . . . . 0.62 112.327 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -84.75 -11.86 54.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 2.22 110.79 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 117' ' ' VAL . 13.1 mptt -82.97 -9.88 59.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.01 -0.541 . . . . 0.91 110.721 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 6.6 t -155.28 83.78 1.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.248 0.547 . . . . 0.54 109.556 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.11 175.91 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.774 -0.648 . . . . 1.12 112.092 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.51 ' C ' HD22 ' A' ' 123' ' ' ASN . 0.2 OUTLIER -101.66 158.45 31.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.575 -0.739 . . . . 1.16 110.625 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.72 -69.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.603 2.202 . . . . 1.14 111.573 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -133.88 82.32 1.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.462 0.649 . . . . 0.79 110.652 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.1 m -147.85 -53.65 0.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.432 -0.804 . . . . 1.39 109.216 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 128' ' ' ARG . 3.2 tppt? -152.82 -155.76 0.64 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.439 -0.948 . . . . 1.09 108.439 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 18.3 mtt180 -135.29 162.66 56.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 110.485 -0.191 . . . . 1.5 110.485 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.94 -178.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.271 2.647 . . . . 0.45 113.415 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 62.63 26.07 15.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.5 -0.773 . . . . 1.37 110.198 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 HD23 ' A' ' 134' ' ' LEU . 6.0 m -131.08 94.17 3.53 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.768 -0.651 . . . . 0.39 110.493 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -69.39 -38.23 76.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.964 -0.562 . . . . 0.5 110.934 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.9 mm -52.82 -34.58 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.783 -0.644 . . . . 0.31 112.32 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 131' ' ' THR . 1.0 OUTLIER -62.95 -50.07 72.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.563 0.221 . . . . 0.96 111.561 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.1 tp -77.31 -30.66 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.58 110.613 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.37 -44.73 86.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.4 110.3 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -34.52 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 1.27 110.4 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.73 -48.58 53.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.178 -0.464 . . . . 0.18 110.708 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 44.0 ttp -65.76 -36.71 84.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 1.73 110.847 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -65.19 -26.4 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 1.82 110.781 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.25 -38.15 51.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.182 -0.463 . . . . 0.55 110.897 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 144' ' ' TYR . 8.6 mt -77.51 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.645 . . . . 0.4 111.422 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.3 t60 75.06 -24.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.865 0.728 . . . . 1.31 111.674 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 142' ' ' ILE . 29.8 t80 -70.86 135.06 47.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.165 -0.309 . . . . 1.3 110.165 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 170.38 10.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.426 -0.352 . . . . 0.18 110.665 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.408 HG13 HG21 ' A' ' 159' ' ' VAL . 2.8 t -87.21 48.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.25 110.536 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 52.41 30.23 7.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.33 111.341 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 148' ' ' THR . 14.6 t 42.33 73.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.341 1.056 . . . . 0.74 112.497 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p30 51.37 18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.705 1.202 . . . . 0.55 114.114 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.05 140.47 48.43 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.97 -0.456 . . . . 1.43 111.046 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.4 m 62.57 38.96 11.98 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.13 110.915 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -63.93 -33.82 76.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.775 -0.648 . . . . 0.72 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.94 4.07 31.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.855 0.359 . . . . 0.87 110.95 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -105.16 -54.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.26 110.834 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' A' ' 159' ' ' VAL . 6.7 mp0 -94.91 16.75 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 0.6 111.935 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -57.69 -42.8 84.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.894 0.378 . . . . 0.3 111.133 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.37 3.16 32.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.66 111.881 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -111.46 -48.64 3.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 1.15 110.798 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 155' ' ' GLN . 58.5 t -64.65 -39.21 84.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 0.08 110.863 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 164' ' ' LYS . 7.5 tt -68.22 -9.86 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.189 -0.46 . . . . 0.27 111.356 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -102.67 -35.46 8.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.822 -0.436 . . . . 1.27 109.822 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -57.37 -56.61 19.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.342 -0.845 . . . . 0.7 111.778 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -72.41 -21.76 61.21 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.68 -0.408 . . . . 0.39 111.218 -178.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.574 ' N ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.02 -31.24 67.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.68 110.008 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.05 -32.91 73.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.653 -0.703 . . . . 1.03 109.87 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.43 -44.65 14.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.701 -0.681 . . . . 1.65 110.427 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.0 tpp -145.99 126.32 13.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.36 -0.382 . . . . 1.45 110.655 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -80.69 122.5 27.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.815 -0.439 . . . . 1.56 109.815 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -122.57 172.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.36 111.673 -178.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -95.88 -101.4 0.17 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.906 -0.588 . . . . 0.18 110.098 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -175.93 167.33 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.101 -0.333 . . . . 0.41 110.101 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.47 160.99 21.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.26 110.514 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.502 ' CD2' ' HB3' ' A' ' 216' ' ' PRO . 42.3 m-70 -130.6 159.95 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.466 -0.568 . . . . 0.33 109.466 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 60.2 mtm -96.5 -179.02 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 2.37 111.226 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.491 ' NH2' ' HA ' ' A' ' 242' ' ' LYS . 18.9 mtm180 -76.42 133.0 39.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.802 -0.635 . . . . 0.67 110.466 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt -105.39 147.02 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.024 -0.535 . . . . 1.08 110.896 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 17.1 ptt180 -128.82 141.9 51.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.245 -0.65 . . . . 0.62 109.245 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.8 128.27 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.799 0.333 . . . . 0.22 110.754 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 30.8 pt -102.02 137.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 0.7 110.763 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.755 HD23 ' HD2' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -146.7 123.48 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.28 109.591 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.755 ' HD2' HD23 ' A' ' 180' ' ' LEU . 10.0 Cg_endo -52.26 142.77 45.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.552 2.168 . . . . 0.16 112.032 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.7 t -45.56 -37.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.153 0.581 . . . . 0.27 112.176 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -48.5 -40.61 27.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.912 -0.586 . . . . 0.41 112.151 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -117.93 7.23 12.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.01 0.433 . . . . 0.49 110.526 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.509 ' O ' HD23 ' A' ' 188' ' ' LEU . . . -66.57 -31.21 77.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.25 112.777 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 82.1 tttt -63.74 -29.02 70.28 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.69 -0.3 . . . . 1.48 111.28 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.76 -47.52 84.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.601 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -85.77 -22.04 27.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.857 0.36 . . . . 0.43 110.607 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -60.1 -52.15 66.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.971 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 11.3 pt-20 -89.27 22.25 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.9 111.253 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -121.38 -47.08 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.511 -0.313 . . . . 0.59 111.172 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 188' ' ' LEU . 8.5 mt -83.01 -39.14 21.66 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 53.2 mttm -59.89 -49.92 89.05 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.815 0.672 . . . . 1.16 112.815 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.0 Cg_endo -60.18 -19.77 58.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.135 1.89 . . . . 0.3 113.044 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 86.3 mt -79.09 -14.43 59.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.607 -0.269 . . . . 0.2 110.438 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.7 mm 56.22 41.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.801 0.81 . . . . 0.23 110.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -124.91 28.81 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.343 -0.844 . . . . 0.42 109.949 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.6 m -119.13 156.07 21.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.335 -0.848 . . . . 0.12 110.43 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.68 147.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.531 -0.544 . . . . 0.86 109.531 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.82 76.3 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 1.23 110.945 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.0 m -155.56 26.3 0.39 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 0.19 109.521 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 2.7 mp0 -80.37 162.61 24.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 1.79 111.641 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -109.16 143.26 38.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.903 -0.777 . . . . 1.6 108.903 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.75 37.94 3.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.6 110.69 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -99.74 -97.67 2.18 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.705 -0.759 . . . . 0.66 112.078 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -95.73 -22.32 17.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.158 0.504 . . . . 2.25 110.916 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.49 160.79 37.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.7 109.999 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.7 mm? -100.15 80.11 2.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.042 0.449 . . . . 0.39 110.101 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 47.2 tt0 -76.62 96.78 4.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.44 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 37.9 mm -96.95 139.55 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.866 0.365 . . . . 0.3 111.152 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.76 116.57 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.32 110.323 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.2 p -139.28 96.13 3.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.351 . . . . 0.71 110.676 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -164.44 136.66 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.495 -0.557 . . . . 0.76 109.495 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.16 -45.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.601 0.238 . . . . 0.82 111.191 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -168.92 158.16 7.66 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.564 -0.289 . . . . 0.9 110.235 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.502 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 18.8 Cg_endo -62.54 -16.71 54.03 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.816 2.344 . . . . 0.57 113.197 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -71.06 -60.05 4.71 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.004 -0.617 . . . . 0.26 112.388 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.456 ' O ' HG12 ' A' ' 222' ' ' ILE . 2.2 m -79.0 -8.71 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.973 0.415 . . . . 0.34 110.847 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.19 -29.4 68.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.29 111.873 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -60.54 -50.61 72.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 0.48 111.065 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -77.86 2.27 17.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 1.24 111.608 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 28.2 mm -101.76 -55.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.878 0.371 . . . . 1.16 110.382 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 35.4 t70 -60.81 -26.08 67.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.36 111.813 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.5 -26.35 65.21 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.195 -0.457 . . . . 1.1 111.795 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.0 pp -106.65 -34.01 7.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.26 110.126 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.0 mm -55.78 -35.3 39.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.003 -0.544 . . . . 0.2 111.077 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 18.1 ptpt -53.32 -37.17 62.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.582 -0.735 . . . . 2.0 112.426 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -19.69 13.7 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.594 -0.443 . . . . 2.79 112.15 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.5 -41.07 48.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.213 0.449 . . . . 1.18 112.213 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.513 ' HB ' HD13 ' A' ' 188' ' ' LEU . 5.1 t -142.22 -32.52 0.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.257 0.836 . . . . 0.18 113.257 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 37.5 ttmt -57.75 -47.57 82.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.781 0.324 . . . . 0.82 111.462 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.03 10.72 71.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.965 -0.636 . . . . 0.23 112.404 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -112.32 -59.86 1.94 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.51 110.188 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -106.46 -119.15 4.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.21 111.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 7.9 m -143.67 150.69 39.09 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 122.703 -0.292 . . . . 0.48 110.574 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.7 pt? -109.83 142.98 40.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 1.5 111.045 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.84 -173.78 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.988 -0.551 . . . . 1.04 109.718 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.93 153.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.418 . . . . 0.24 111.772 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.83 96.1 6.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.9 109.724 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.41 -23.46 61.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.72 111.089 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.99 114.9 16.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.102 -0.499 . . . . 0.48 110.408 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.491 ' HA ' ' NH2' ' A' ' 175' ' ' ARG . 54.2 mtmt -132.22 24.74 4.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.815 -0.63 . . . . 3.29 110.409 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 -70.06 0.83 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.705 . . . . 0.64 110.092 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.45 149.08 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.249 -0.648 . . . . 0.19 109.249 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.39 121.8 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 1.79 111.205 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -126.83 178.46 5.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.552 -0.749 . . . . 1.37 109.213 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.15 -161.97 9.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.409 -1.377 . . . . 0.43 113.866 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.86 21.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.499 0.72 . . . . 0.18 112.495 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -80.02 -8.61 59.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.104 0.478 . . . . 1.0 110.355 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -90.55 68.98 6.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.897 -0.592 . . . . 0.46 109.959 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -71.16 -43.81 66.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.985 -0.552 . . . . 0.96 109.787 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.664 -0.684 . . . . 1.54 110.192 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.208 -0.757 . . . . 0.57 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.26 -35.69 73.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.765 0.283 . . . . 2.3 110.763 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 3' ' ' MET . 1.4 ptp -117.29 133.55 55.85 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.996 0.427 . . . . 0.51 110.734 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.4 m -132.26 163.3 28.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.27 109.56 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tt -98.82 119.75 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.159 0.504 . . . . 0.31 110.921 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -143.42 -62.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 0.7 110.319 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.475 HG23 ' HB ' ' A' ' 15' ' ' THR . 95.6 m -155.13 104.51 2.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 0.37 111.544 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -88.43 126.31 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.583 2.189 . . . . 0.32 111.704 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 t -113.65 132.03 55.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.37 110.795 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -171.55 -59.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.93 109.566 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -128.08 -157.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.662 -0.699 . . . . 2.37 111.031 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -69.42 100.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.118 0.485 . . . . 0.67 111.099 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -136.25 134.56 38.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.631 -0.713 . . . . 1.53 109.744 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.6 mt -66.18 -4.76 8.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.167 0.432 . . . . 1.05 112.167 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.475 ' HB ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -78.08 -20.34 52.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.124 0.488 . . . . 0.37 111.069 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 48.6 m-80 -114.36 71.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.47 110.278 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.5 m -123.13 121.79 63.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.23 111.762 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.76 116.16 31.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.619 . . . . 0.36 109.327 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.56 109.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.104 0.478 . . . . 0.45 111.685 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 89' ' ' ILE . 6.6 p -105.92 129.44 59.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.541 -0.911 . . . . 0.37 108.541 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -125.72 125.4 42.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.372 -0.531 . . . . 0.61 112.095 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 89' ' ' ILE . 34.7 ttp -114.27 116.18 28.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.25 109.603 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 128.54 54.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 1.0 110.622 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -113.67 -156.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.617 -0.72 . . . . 1.24 109.501 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.86 -60.33 2.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.35 110.878 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.18 32.43 3.96 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.959 -0.639 . . . . 0.21 111.713 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.02 142.42 31.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.49 109.726 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.12 125.66 10.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.509 -0.314 . . . . 1.77 110.572 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -144.35 132.02 21.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.333 -0.394 . . . . 0.31 110.727 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.91 138.17 43.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.444 . . . . 0.68 110.424 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.708 HD11 HD12 ' A' ' 89' ' ' ILE . 1.1 mt -136.76 172.22 15.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.781 0.324 . . . . 1.15 110.656 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' H ' HG22 ' A' ' 31' ' ' ILE . . . -124.84 107.91 11.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.107 -0.497 . . . . 0.21 109.993 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 m -98.55 -161.84 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.2 110.077 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.57 -173.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.443 0.164 . . . . 1.03 110.624 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 23.1 tptt -74.47 -133.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.943 0.401 . . . . 0.86 111.499 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 14.6 m120 -64.69 6.21 0.24 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.091 0.774 . . . . 0.61 113.091 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 -15.0 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.222 -0.299 . . . . 0.81 110.913 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.23 -27.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.328 0.492 . . . . 0.26 112.328 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.83 101.43 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.223 0.535 . . . . 0.21 111.091 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.44 45.69 75.21 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.291 -0.868 . . . . 0.24 112.574 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 56.24 51.78 11.18 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.74 110.34 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 63.32 33.09 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 1.91 110.461 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.3 m 61.81 32.51 18.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.753 -0.658 . . . . 0.27 110.989 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.09 -76.53 0.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.272 -0.731 . . . . 0.32 111.272 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -166.61 136.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.64 110.261 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.67 -87.11 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.153 -0.476 . . . . 2.14 110.791 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 20.2 ptmt -163.88 -48.97 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.771 0.286 . . . . 1.68 111.771 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.51 127.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.905 -0.405 . . . . 2.04 109.905 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.06 -24.35 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.225 -0.443 . . . . 0.65 111.669 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.63 -41.88 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.02 0.438 . . . . 1.98 110.587 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -78.31 -30.31 48.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 1.74 110.169 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.28 -33.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.2 110.143 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -88.28 84.88 6.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.184 -0.462 . . . . 0.2 110.458 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.0 -61.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.747 -0.661 . . . . 0.73 110.973 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.23 120.24 22.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.953 0.406 . . . . 0.13 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -99.03 5.96 46.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.322 -0.399 . . . . 0.69 110.683 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.25 114.75 28.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.895 -0.593 . . . . 0.28 110.072 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 68' ' ' ALA . 3.7 p -89.12 136.82 22.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.14 110.507 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -95.21 149.22 21.56 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.11 -0.33 . . . . 0.33 110.11 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.17 -45.39 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.458 0.647 . . . . 0.26 109.745 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -155.46 107.86 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.485 -0.78 . . . . 1.91 109.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.59 -28.98 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.59 . . . . 0.51 112.095 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.6 m -73.42 -16.7 61.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.876 0.369 . . . . 0.88 111.299 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -13.82 14.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.814 0.34 . . . . 0.64 110.45 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.77 75.78 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.15 111.751 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -87.24 112.04 21.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.981 0.419 . . . . 1.15 110.964 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 t -98.0 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.1 109.621 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.93 115.11 27.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.864 -0.421 . . . . 0.12 109.864 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.088 -0.506 . . . . 0.94 109.747 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -59.4 -30.23 68.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.098 0.475 . . . . 0.95 110.436 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.99 -19.68 54.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.623 -0.717 . . . . 2.32 110.899 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.57 -47.58 8.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.966 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 2.3 pp -67.02 -31.77 72.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.259 -0.428 . . . . 0.11 111.399 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.46 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.708 0.289 . . . . 0.74 111.384 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -91.38 -9.42 44.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.728 0.299 . . . . 0.9 111.663 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.42 -43.15 5.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.14 111.417 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -92.09 -37.5 12.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.49 -0.323 . . . . 0.27 110.75 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.03 -17.95 29.11 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.11 112.128 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 81' ' ' ASP . 3.7 m -116.53 142.22 47.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.917 -0.401 . . . . 0.21 109.917 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.65 2.38 48.64 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.98 0.419 . . . . 0.32 111.053 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 79' ' ' THR . 13.1 t70 -92.54 109.0 20.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.543 -0.54 . . . . 1.29 109.543 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -33.17 75.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 0.6 111.764 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.32 78.62 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.933 0.397 . . . . 0.45 111.114 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -36.9 83.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.746 -0.661 . . . . 1.94 110.487 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.8 mt -72.0 -41.56 68.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.16 110.328 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.28 -37.79 78.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.871 -0.604 . . . . 0.15 110.011 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -61.43 -42.6 99.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.415 -0.811 . . . . 1.08 110.409 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.68 -49.17 64.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.923 -0.58 . . . . 1.04 110.775 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.708 HD12 HD11 ' A' ' 31' ' ' ILE . 54.7 mt -57.88 -34.43 48.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.041 -0.527 . . . . 0.39 111.413 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -41.34 87.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.42 0.526 . . . . 0.26 112.42 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -96.84 -11.7 24.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.001 0.741 . . . . 0.51 113.001 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -106.6 -31.28 8.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.173 0.434 . . . . 0.97 112.173 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.56 -173.65 29.58 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.479 -0.867 . . . . 0.22 113.136 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -91.74 107.26 19.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.397 . . . . 1.88 110.978 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.02 134.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.803 -0.814 . . . . 0.58 108.803 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 96.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 1.48 111.491 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG23 ' H ' ' A' ' 99' ' ' ASP . 15.4 m -122.98 -17.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 0.82 110.245 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 m 63.63 23.37 13.53 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.724 -0.671 . . . . 1.46 110.939 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.592 ' H ' HG23 ' A' ' 97' ' ' VAL . 5.6 t70 -122.67 -50.47 1.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.48 -0.782 . . . . 0.73 110.747 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 99' ' ' ASP . 35.2 mmtm -119.05 42.51 2.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.909 0.385 . . . . 1.18 111.129 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -70.05 138.8 52.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 1.62 110.238 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.42 174.16 6.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.348 -0.387 . . . . 1.83 110.093 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -61.43 130.8 47.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.46 111.058 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.44 HG21 ' HE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -145.33 179.66 7.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.757 -0.656 . . . . 0.63 109.749 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -79.85 107.87 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.317 0.579 . . . . 0.82 110.612 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -84.55 93.45 8.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 1.2 110.502 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -128.99 -148.28 0.37 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.697 -0.683 . . . . 2.56 110.686 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -56.41 -22.32 30.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.423 -0.353 . . . . 1.51 111.691 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 ttt -50.52 -47.53 57.43 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.046 -0.525 . . . . 1.2 111.862 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -77.44 -28.7 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.93 110.991 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -41.83 85.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.104 0.478 . . . . 1.34 110.218 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.56 ' O ' HG12 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.42 -49.09 78.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.42 111.652 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -69.72 -35.4 65.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.844 -0.342 . . . . 0.41 111.712 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.15 111.73 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 112' ' ' ASP . 6.6 t -72.66 -16.9 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.26 111.447 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 112' ' ' ASP . 36.3 mm -83.01 -46.06 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 0.24 110.415 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -70.99 -37.19 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.21 110.634 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.674 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . . . -68.31 -19.61 64.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.131 0.491 . . . . 0.32 110.709 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.73 -7.24 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.639 -0.709 . . . . 0.85 110.262 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 0.77 10.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.264 0.468 . . . . 0.69 112.264 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.674 ' SG ' ' HA ' ' A' ' 118' ' ' ALA . 31.6 p -120.8 142.53 49.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.95 -0.3 . . . . 0.23 110.874 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -100.19 165.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.849 -0.426 . . . . 0.65 109.849 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -140.94 156.75 68.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 110.005 -0.369 . . . . 0.28 110.005 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 126' ' ' THR . 97.5 Cg_endo -80.71 -156.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.456 2.104 . . . . 0.4 111.827 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.2 104.87 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.619 . . . . 1.26 110.885 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 124' ' ' PRO . 2.1 t -144.53 -47.84 0.26 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.712 -0.677 . . . . 0.26 110.297 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.52 -63.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.78 109.972 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -150.82 146.04 18.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.728 -0.471 . . . . 1.26 109.728 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.97 11.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.96 2.44 . . . . 0.59 112.508 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -152.34 89.89 1.46 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.155 -0.683 . . . . 1.51 109.155 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 133' ' ' ILE . 10.4 m -152.69 131.89 12.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.457 . . . . 0.54 110.535 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -69.07 -29.09 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.631 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.455 ' H ' HG22 ' A' ' 131' ' ' THR . 48.6 mm -51.79 -33.4 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.324 0.49 . . . . 0.28 112.324 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 134' ' ' LEU . 2.7 mm? -56.79 -51.38 69.16 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.969 0.414 . . . . 0.57 110.823 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.4 -33.85 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.093 -0.503 . . . . 1.96 110.285 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 139' ' ' MET . 1.0 OUTLIER -57.25 -47.09 82.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.74 110.534 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -37.19 86.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.92 110.976 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 -42.88 66.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.24 111.586 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.576 ' O ' ' HB3' ' A' ' 143' ' ' HIS . 20.4 ptt? -67.45 -31.09 71.02 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.878 0.325 . . . . 0.4 111.878 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -82.86 -17.73 42.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.401 . . . . 0.45 110.105 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.67 -49.57 11.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.219 -0.66 . . . . 0.92 109.219 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.7 mm -117.1 88.08 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.59 110.651 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 139' ' ' MET . 24.8 p80 -132.78 15.56 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.541 . . . . 1.23 110.202 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.34 164.44 17.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.604 -0.726 . . . . 0.87 109.614 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -69.56 113.97 7.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.191 -0.3 . . . . 1.26 110.191 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.68 -49.32 81.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.998 -0.546 . . . . 0.28 110.253 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HB3' ' OD1' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -143.63 119.61 10.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.8 109.732 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -18.69 59.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.28 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 24.1 p-10 -84.63 -16.38 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.34 110.837 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -104.58 132.27 51.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.48 110.112 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.9 m -84.12 168.86 15.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.352 -0.385 . . . . 0.36 110.775 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -57.72 -36.58 72.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.48 111.708 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -79.48 5.58 12.49 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 1.39 112.098 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -111.15 -56.35 2.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.801 0.334 . . . . 0.41 111.116 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 159' ' ' VAL . 8.4 pt20 -99.25 27.92 4.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.479 -0.328 . . . . 0.6 111.55 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.13 -48.68 70.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.18 112.092 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.79 -30.84 64.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.352 -0.385 . . . . 0.28 111.022 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.001 -0.28 . . . . 1.65 110.437 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 155' ' ' GLN . 52.4 t -63.33 -52.9 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.371 -0.377 . . . . 0.46 110.595 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.9 -32.24 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.345 -0.389 . . . . 0.47 110.984 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -70.54 -35.11 72.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 1.54 110.244 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -65.52 -35.46 80.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.221 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.18 -37.6 81.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.344 0.592 . . . . 0.35 109.514 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -69.79 -33.32 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.163 -0.926 . . . . 1.52 111.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 -27.56 64.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.885 0.374 . . . . 1.28 110.752 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -81.12 -47.21 13.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.3 tpt -134.13 99.39 4.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.403 -0.591 . . . . 1.08 109.403 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 113.06 5.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.74 111.151 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -91.31 160.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.453 -0.794 . . . . 0.48 110.521 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . 8.8 tp10 -101.53 155.33 18.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.732 -0.47 . . . . 0.84 109.732 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -56.27 148.32 18.84 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.969 0.414 . . . . 1.62 111.525 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.64 152.6 45.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.821 -0.627 . . . . 0.37 111.409 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.448 ' CE1' HD12 ' A' ' 213' ' ' LEU . 4.1 t-160 -63.67 130.29 43.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.35 111.018 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -87.34 179.94 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.35 110.592 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.97 137.81 49.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 1.04 110.451 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 32.2 mt -118.26 149.67 40.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.614 -0.513 . . . . 1.02 109.614 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 209' ' ' GLU . 16.1 ttp180 -110.67 136.78 49.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.386 -0.37 . . . . 1.12 110.27 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 52.6 m-85 -99.65 137.94 37.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.22 110.381 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -126.31 128.05 71.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.19 110.581 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -167.63 155.51 8.35 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.14 110.614 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.97 160.02 35.64 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.853 2.369 . . . . 0.22 112.732 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.5 t -57.94 -37.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.251 -0.431 . . . . 0.23 111.315 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -51.4 -38.77 55.16 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.65 111.748 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 0.7 OUTLIER -102.05 -26.79 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.69 111.282 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.51 -34.24 87.7 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 116.054 -0.521 . . . . 0.17 113.61 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -61.69 -25.88 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.723 -0.281 . . . . 1.19 111.596 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.526 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 13.4 mptt -62.35 -41.85 98.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.978 0.418 . . . . 0.78 110.874 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 1.1 pp -87.75 -30.32 20.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.433 -0.348 . . . . 0.3 111.133 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.33 -31.96 71.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.88 111.675 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -86.62 -7.57 58.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.616 0.599 . . . . 1.71 112.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 26.1 mtmt -122.7 -29.89 3.95 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.129 0.788 . . . . 1.16 113.129 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -87.18 -32.82 19.62 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.164 0.431 . . . . 0.63 112.164 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 2.1 mtpt -72.55 -43.45 9.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.142 0.793 . . . . 1.13 113.142 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 11.0 Cg_endo -54.31 -34.63 80.96 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 122.415 2.077 . . . . 0.54 113.642 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -92.73 13.75 19.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.772 -0.371 . . . . 0.61 111.462 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 18.6 pt 33.22 56.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.435 1.094 . . . . 0.87 113.897 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -109.98 16.71 21.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.95 109.773 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.41 152.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.376 -0.829 . . . . 0.6 110.769 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 4.6 mp -84.89 144.8 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.347 -0.612 . . . . 0.59 109.347 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -72.43 74.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.405 0.621 . . . . 2.46 111.029 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 m -157.07 27.04 0.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.296 -0.865 . . . . 1.45 109.146 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.2 OUTLIER -82.23 137.98 34.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.768 -0.651 . . . . 1.27 111.342 -178.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.04 117.34 33.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.457 -0.571 . . . . 0.58 109.457 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.439 ' H ' ' HB3' ' A' ' 248' ' ' ASP . 78.2 m-85 -98.62 59.2 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.983 0.42 . . . . 0.66 111.342 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -109.24 -127.74 5.52 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.417 -0.896 . . . . 0.35 111.684 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.06 -28.6 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 1.3 109.458 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -118.62 117.97 30.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.805 -1.089 . . . . 1.23 108.405 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mp -80.42 79.09 7.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.126 0.489 . . . . 0.29 111.093 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 6.0 tt0 -86.25 106.23 17.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.561 -0.745 . . . . 0.98 109.201 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 202' ' ' GLU . 8.0 mt -120.62 146.9 24.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.939 -0.573 . . . . 0.34 111.089 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER -104.22 122.27 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.804 -0.443 . . . . 0.68 109.804 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.563 ' O ' HD22 ' A' ' 213' ' ' LEU . 12.8 t -144.39 79.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.643 -0.423 . . . . 0.16 111.717 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 212' ' ' CYS . 0.6 OUTLIER -140.39 116.08 10.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 215' ' ' ASP . 11.3 tt -94.12 172.76 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 0.68 111.432 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -58.01 168.89 1.02 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.612 0.765 . . . . 0.58 111.513 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 41.3 Cg_endo -66.68 -172.66 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.271 1.981 . . . . 0.37 112.875 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.03 -75.04 1.94 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.656 -0.783 . . . . 0.23 111.435 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.96 -1.91 55.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.063 0.459 . . . . 1.11 110.581 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.07 -26.78 67.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.548 . . . . 0.25 111.449 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -80.2 -32.66 38.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.412 . . . . 1.82 110.526 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -72.51 -36.12 68.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.42 110.594 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 13.3 tt -79.32 -26.16 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.37 110.849 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.85 -32.22 70.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.325 -0.398 . . . . 0.75 110.88 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.63 -35.47 68.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.08 111.778 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.9 pp -95.02 -37.3 11.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.773 -0.371 . . . . 0.57 110.889 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 33.5 mm -58.22 -39.87 75.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.718 0.294 . . . . 0.36 111.308 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -63.98 -20.15 65.67 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.798 0.666 . . . . 1.09 112.798 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.96 5.06 11.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.745 -0.382 . . . . 1.73 111.841 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 1.0 OUTLIER -108.38 -73.39 0.69 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.846 0.355 . . . . 0.96 111.207 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -100.81 -34.95 9.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.077 0.399 . . . . 0.32 112.077 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 61.4 tttm -77.54 -23.88 50.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.02 110.598 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.48 -8.44 62.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.25 112.044 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -113.46 -7.01 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.41 111.292 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -157.99 179.19 33.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.168 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 t -91.91 162.94 14.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.784 -0.45 . . . . 0.33 109.784 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.51 144.83 44.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.797 0.332 . . . . 0.86 110.912 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -140.63 176.49 8.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.885 -0.598 . . . . 1.85 109.987 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.39 145.3 11.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.044 0.45 . . . . 0.57 111.17 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.3 tp -72.01 -5.79 37.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.368 0.604 . . . . 1.56 110.522 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.78 -6.12 47.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.621 -0.718 . . . . 1.39 110.694 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 91.73 3.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.043 -0.526 . . . . 1.76 110.198 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -102.7 44.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.624 . . . . 1.25 110.604 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.92 18.97 12.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.305 -0.407 . . . . 1.6 111.195 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 245' ' ' GLU . 3.9 p -151.52 177.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.484 -0.561 . . . . 0.89 109.484 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.613 ' H ' HG22 ' A' ' 244' ' ' VAL . 57.1 mm-40 -57.78 146.7 30.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.324 0.39 . . . . 1.25 110.887 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -151.79 120.13 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.429 -0.351 . . . . 1.08 110.752 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 75.72 96.21 0.15 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.117 -0.563 . . . . 0.32 112.777 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 204' ' ' TYR . 44.8 t0 -123.11 84.99 2.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.294 0.569 . . . . 0.75 110.119 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 12.32 37.16 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.16 -0.682 . . . . 0.89 109.16 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -85.66 91.52 8.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.946 -1.025 . . . . 0.45 109.186 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.33 -20.85 39.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 2.31 111.646 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 119.073 -0.489 . . . . 0.97 110.487 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.93 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -155.24 171.15 20.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.881 -0.785 . . . . 0.64 108.881 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -78.9 -56.65 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.578 0.227 . . . . 1.61 111.518 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.26 90.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 0.38 111.099 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.2 mmt-85 -148.1 149.77 32.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.474 -0.33 . . . . 1.56 110.213 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.69 -6.32 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.984 0.421 . . . . 1.12 111.371 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -11.14 45.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.57 110.716 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -119.15 25.57 10.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.012 -0.54 . . . . 0.2 111.354 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 30.7 m -90.63 151.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.167 0.508 . . . . 0.21 111.843 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.88 139.15 42.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.323 -0.853 . . . . 0.15 109.342 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 46.0 t -80.13 120.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.906 0.384 . . . . 0.51 111.306 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 31' ' ' ILE . 2.4 p -149.75 131.08 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 0.15 109.572 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.7 ptt180 -148.67 148.58 30.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.835 0.35 . . . . 0.4 111.767 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 40.4 ttp -108.1 129.85 55.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.128 -0.487 . . . . 0.22 110.095 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.06 114.16 25.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.062 -0.517 . . . . 1.38 110.148 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.6 175.37 6.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 1.3 109.541 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.67 92.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.704 0.288 . . . . 0.4 111.002 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.68 42.95 1.28 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.68 -0.772 . . . . 0.16 112.911 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -173.61 162.24 4.11 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.79 0.295 . . . . 1.93 110.769 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 39.4 mmt180 -126.57 147.58 49.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 1.57 109.576 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -139.9 94.14 2.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.982 -0.377 . . . . 0.23 109.982 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 16.7 mt-10 -104.46 129.6 52.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.539 -0.3 . . . . 1.25 110.343 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 HG13 ' A' ' 20' ' ' VAL . 29.9 pt -131.48 -179.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.12 111.12 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -139.6 114.38 9.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.11 111.015 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.63 179.45 3.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 0.08 110.344 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.572 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.69 139.82 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.25 110.77 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.75 -5.08 52.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.2 112.241 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.43 78.2 4.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.573 0.225 . . . . 0.3 110.861 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 tttp 50.97 60.43 3.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.656 -0.702 . . . . 1.56 110.389 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.4 p -57.15 -32.92 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.412 -0.813 . . . . 0.32 112.529 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -83.47 5.02 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.182 0.515 . . . . 0.16 111.409 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.352 0 CA-C-N 116.056 -0.52 . . . . 0.23 113.607 -179.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.225 0.536 . . . . 0.44 110.114 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -175.49 -177.54 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.304 -0.862 . . . . 0.51 108.675 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.96 30.05 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 2.03 110.773 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -120.63 -54.78 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 1.32 110.502 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.55 -17.29 63.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 1.2 110.644 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.84 -18.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.47 0.652 . . . . 0.46 109.728 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.78 99.48 12.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.23 109.733 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -68.36 -48.92 63.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.25 111.159 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -127.0 151.1 49.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.549 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -106.56 16.55 24.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.338 0.59 . . . . 0.51 109.715 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.6 127.39 53.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.731 . . . . 0.47 110.204 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -108.41 138.41 35.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.067 0.46 . . . . 0.06 110.444 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -95.69 130.49 42.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.266 -0.424 . . . . 0.29 110.538 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 10.3 t -86.13 -17.98 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.347 0.594 . . . . 0.17 109.752 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -177.94 105.13 0.05 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.201 -0.909 . . . . 0.72 109.717 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.52 -19.94 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.428 0.529 . . . . 0.1 112.428 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -36.66 73.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.975 0.417 . . . . 1.14 110.812 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -91.25 -36.53 13.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.63 110.223 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.04 38.87 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.885 -0.674 . . . . 0.36 111.801 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.47 104.49 16.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.72 0.295 . . . . 2.02 110.553 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.0 t -92.85 116.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.548 -0.538 . . . . 0.39 109.548 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -82.7 124.44 30.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.111 0.482 . . . . 0.18 111.52 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.569 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 6.8 ptpp? -87.85 -175.64 5.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.62 109.294 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HG3' ' OE2' ' A' ' 71' ' ' GLU . 11.7 pttm -60.61 -27.15 67.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 8.3 mp0 -78.86 -32.43 46.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.222 0.534 . . . . 1.47 110.245 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 51.0 m-20 -68.72 -50.09 53.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.26 110.74 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.89 -29.27 70.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.956 -0.298 . . . . 0.13 111.205 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -71.26 -22.97 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.089 0.471 . . . . 0.91 109.969 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 m -95.33 -44.98 7.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.045 0.45 . . . . 0.4 110.917 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.26 58.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 0.28 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.72 -51.59 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.078 -0.341 . . . . 1.23 110.078 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.21 16.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.722 -0.751 . . . . 0.28 112.054 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 81' ' ' ASP . 5.2 m -125.09 137.85 54.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.163 -0.31 . . . . 0.89 110.163 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.15 -11.54 57.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.503 -0.317 . . . . 0.41 111.525 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -85.42 117.82 24.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.68 110.705 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.96 -31.08 68.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.18 111.256 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.36 -47.63 75.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.625 0.25 . . . . 0.54 111.471 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.12 -51.07 71.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.998 0.428 . . . . 1.7 110.788 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mt -61.0 -51.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.648 -0.706 . . . . 0.18 111.169 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 99.9 m -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.18 111.152 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -62.22 -42.08 98.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.491 -0.322 . . . . 0.67 110.432 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.69 -43.33 89.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.21 110.134 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 86.1 mt -62.85 -32.57 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.305 0.574 . . . . 0.15 110.82 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HG22 ' A' ' 38' ' ' VAL . 1.3 mm? -74.95 -32.05 61.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.818 -0.628 . . . . 0.12 112.61 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 92' ' ' LYS . 15.1 t -100.57 -13.54 18.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.789 0.662 . . . . 0.22 112.789 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 91' ' ' THR . 32.7 mmmt -129.27 25.38 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.375 -0.203 . . . . 0.96 111.015 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -132.72 -175.98 14.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.032 -1.08 . . . . 0.15 113.64 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -83.4 76.52 9.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.234 0.54 . . . . 1.74 109.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.99 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.624 -0.717 . . . . 0.69 110.91 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.9 mm-40 -72.78 105.72 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.738 -0.467 . . . . 0.59 109.738 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.45 111.077 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.879 0.371 . . . . 1.27 110.667 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -129.22 98.97 5.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.47 110.449 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -67.62 147.24 52.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 1.92 109.81 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 31.5 m 58.78 61.65 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.523 0.678 . . . . 1.58 110.625 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -4.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 1.01 111.138 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -95.15 -30.64 13.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.86 109.816 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 145' ' ' SER . 1.4 m -66.3 123.75 20.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.94 110.93 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.04 42.02 3.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.905 0.882 . . . . 0.42 112.229 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -67.69 111.28 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.72 -0.673 . . . . 1.26 110.761 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -82.73 101.88 11.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 1.12 110.046 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.7 p -58.6 -76.9 0.04 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.75 -0.659 . . . . 1.2 112.358 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -82.35 62.27 5.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.93 0.395 . . . . 1.54 111.296 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -166.07 -48.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.459 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -108.8 22.38 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.52 110.964 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.59 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 0.12 111.938 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 4.1 mm? -74.51 -34.84 63.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.552 -0.295 . . . . 0.7 111.033 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 4.8 mp0 -65.6 -48.86 70.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.17 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.76 -48.27 81.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.2 111.951 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.78 -28.66 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.761 0.315 . . . . 0.3 111.594 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.0 mmtp -80.74 -33.81 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.66 110.359 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.7 -39.19 93.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 2.05 110.199 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.97 -46.89 73.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.162 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -62.04 -30.23 70.83 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.8 -0.636 . . . . 0.86 111.429 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -53.76 -44.57 70.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.57 110.409 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 -69.81 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.4 110.15 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 62.2 ttp -102.37 123.93 47.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.007 -0.542 . . . . 0.27 111.079 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.99 99.52 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.02 -0.536 . . . . 0.48 110.401 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.34 -0.846 . . . . 0.93 110.895 179.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.628 0.252 . . . . 1.22 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -128.42 134.67 48.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.441 -0.345 . . . . 2.41 111.172 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 211' ' ' VAL . 2.7 mp -129.49 145.76 51.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 0.31 110.108 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.609 ' HB3' HG22 ' A' ' 211' ' ' VAL . 9.8 ptm180 -126.72 132.12 51.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.384 -0.371 . . . . 0.24 110.413 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 22.0 m-85 -92.95 140.37 29.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 0.39 110.533 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.3 mt -120.85 118.37 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.527 -0.306 . . . . 0.2 111.309 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -152.12 156.43 33.91 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.95 -0.568 . . . . 0.11 109.906 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.31 172.4 12.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.66 2.24 . . . . 0.14 112.516 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.8 -44.95 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.387 -0.37 . . . . 0.15 111.652 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -52.92 -55.84 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.981 -0.554 . . . . 0.81 111.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.55 -27.24 61.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.424 -0.353 . . . . 0.2 111.403 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.57 -34.78 90.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.216 -0.516 . . . . 0.17 111.893 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -77.75 52.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.36 0.6 . . . . 0.65 109.813 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -152.59 -46.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.258 -0.883 . . . . 1.58 109.477 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -86.53 -26.21 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.4 110.693 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 12.0 ttpt -67.31 -21.73 65.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.47 . . . . 0.67 110.603 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.9 OUTLIER -100.19 8.76 43.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.481 . . . . 0.86 110.921 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -124.85 -45.49 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.568 -0.287 . . . . 0.34 111.08 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.4 mt -78.29 -35.39 47.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.715 0.265 . . . . 0.29 111.715 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 23.7 mmtt -62.4 -52.71 64.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.271 0.471 . . . . 0.66 112.271 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.7 Cg_endo -58.98 -24.6 74.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.153 1.902 . . . . 0.23 113.073 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.55 -22.05 54.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.17 110.765 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.3 mm 59.3 66.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.518 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -134.19 15.11 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.765 -0.652 . . . . 0.84 109.91 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.14 163.69 2.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.328 0.585 . . . . 0.35 112.07 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.546 HD12 HG12 ' A' ' 211' ' ' VAL . 66.5 mt -106.85 160.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.31 109.378 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.41 64.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 2.24 111.095 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 t -161.65 90.36 0.78 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.34 -0.615 . . . . 0.8 109.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 43.9 mt-10 -136.79 163.86 29.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 1.32 110.423 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 209' ' ' GLU . 12.1 t0 -119.18 131.47 55.85 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.939 -0.763 . . . . 0.25 108.939 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.45 31.56 6.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.55 111.29 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -96.11 -115.76 3.11 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.832 -0.699 . . . . 0.36 112.275 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -91.63 -22.6 20.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.62 110.148 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.46 123.15 40.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 1.48 109.345 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.94 77.89 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.032 0.444 . . . . 0.33 110.932 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 29.7 mt-10 -75.45 118.65 18.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.052 -0.522 . . . . 1.04 109.884 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 34.1 mt -122.84 126.81 74.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.877 0.37 . . . . 0.48 110.847 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 177' ' ' ARG . 39.4 t -94.09 104.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.11 109.731 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.6 t -130.91 115.56 16.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.15 -0.477 . . . . 0.21 110.121 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -164.7 125.3 2.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.918 -0.583 . . . . 0.42 109.428 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.462 HG12 ' H ' ' A' ' 215' ' ' ASP . 3.3 tt -104.84 -170.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.566 -0.288 . . . . 0.51 110.319 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' H ' HG12 ' A' ' 214' ' ' ILE . 37.4 m-20 -62.27 141.14 96.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.512 0.196 . . . . 1.3 110.572 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.77 -26.73 83.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.051 2.5 . . . . 0.47 113.362 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.71 78.85 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.761 -0.733 . . . . 0.58 111.945 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 62.6 m -110.68 25.44 11.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.76 110.558 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -60.11 -32.42 70.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.53 111.277 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -18.52 59.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.74 110.893 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.5 -24.68 24.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.4 111.096 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.6 tp -96.13 -42.43 12.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.691 -0.404 . . . . 0.91 111.459 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 18.5 t70 -67.17 -22.4 65.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.881 0.326 . . . . 0.33 111.881 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.27 -28.28 64.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.65 0.262 . . . . 1.14 111.352 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.9 OUTLIER -105.38 -37.35 6.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.609 -0.269 . . . . 0.29 110.365 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 223' ' ' ASP . 44.6 mm -59.09 -34.31 52.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.31 111.27 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 16.6 ptpt -53.91 -31.5 50.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.707 0.632 . . . . 1.4 112.707 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -113.52 -25.29 8.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 1.77 112.063 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -41.97 74.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.174 0.435 . . . . 0.73 112.174 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.0 t -135.8 -37.48 0.74 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.373 -0.531 . . . . 0.14 112.376 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 42.0 mtpt -59.67 -41.52 90.82 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 0.51 110.731 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.41 38.03 3.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.13 111.535 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -151.97 -53.36 0.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.645 0.26 . . . . 0.39 110.649 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -114.97 -168.16 15.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.074 -0.584 . . . . 0.13 111.995 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.9 m -101.81 144.5 30.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.956 -0.387 . . . . 0.36 109.956 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.32 119.19 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.28 110.612 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -113.22 151.68 30.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.731 -0.668 . . . . 0.39 109.904 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.79 145.1 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.639 0.256 . . . . 0.16 110.705 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 0.35 109.497 179.385 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.781 0.324 . . . . 0.52 110.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.22 177.09 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.448 -0.575 . . . . 0.59 109.448 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.88 -77.04 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.713 0.292 . . . . 1.44 111.01 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.12 76.05 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.338 0.59 . . . . 1.48 110.603 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -147.91 159.21 44.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.43 -0.805 . . . . 1.48 109.258 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.53 42.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.47 110.337 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 p -110.82 -66.01 1.12 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.001 -0.545 . . . . 0.19 110.427 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -92.34 60.18 3.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.48 0.657 . . . . 1.06 109.464 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.421 HG12 ' OE1' ' A' ' 54' ' ' GLN . 17.0 m -100.08 148.44 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.453 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -113.6 114.6 26.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.831 -0.622 . . . . 0.2 109.904 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.46 121.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.37 110.838 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.9 p -133.43 122.3 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.966 -0.561 . . . . 0.25 110.316 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -110.36 128.4 55.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.518 . . . . 0.37 110.733 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.8 ttp -89.35 141.75 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.16 110.963 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.89 122.35 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.02 110.316 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -125.22 32.62 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.846 -0.161 . . . . 0.71 110.988 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.14 70.84 0.49 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.757 0.661 . . . . 0.44 111.805 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 -35.62 4.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.876 -0.678 . . . . 0.49 111.654 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -106.07 148.48 27.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.154 -0.684 . . . . 1.47 109.154 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.21 153.62 51.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.636 0.255 . . . . 1.8 110.434 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -144.82 116.6 8.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.274 -0.639 . . . . 0.44 109.274 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 59' ' ' PHE . 3.3 pm0 -112.0 132.94 54.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.16 111.661 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 89' ' ' ILE . 6.2 mt -128.94 145.75 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.571 -0.74 . . . . 0.7 109.905 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.85 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.503 -0.317 . . . . 0.08 110.263 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.03 171.17 7.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.365 -0.379 . . . . 0.09 110.347 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.23 119.68 13.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.2 109.908 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -75.32 69.61 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.42 111.135 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.03 64.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.63 109.321 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.51 50.96 13.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.808 -0.633 . . . . 0.97 110.326 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.86 10.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.359 -0.837 . . . . 0.43 112.901 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.6 12.39 7.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.734 0.778 . . . . 0.27 109.463 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42 113.055 -178.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.035 -0.728 . . . . 1.07 109.035 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 50' ' ' ASP . 9.5 t0 -65.61 124.01 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.75 110.483 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 tp -70.48 -17.31 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.6 111.951 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -59.84 -35.86 75.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.07 0.462 . . . . 1.67 110.503 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.83 -33.41 21.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 1.49 110.465 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.62 -38.39 82.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.884 -0.598 . . . . 0.3 111.246 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.83 84.05 6.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.051 -0.351 . . . . 0.16 110.051 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.421 ' OE1' HG12 ' A' ' 17' ' ' VAL . 37.4 mt-30 -66.26 -77.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.3 111.098 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -74.96 129.21 37.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.21 110.23 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -93.82 12.28 26.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.368 0.604 . . . . 0.57 110.034 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.495 -0.775 . . . . 0.18 109.962 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.5 p -116.65 146.3 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.692 -0.485 . . . . 0.3 109.692 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 19.0 m-85 -104.94 140.16 38.58 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.885 -0.413 . . . . 0.56 109.885 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 2.4 t -92.58 -16.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.24 110.339 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -178.97 95.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.536 -0.757 . . . . 0.28 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.67 -27.45 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.432 . . . . 0.33 111.53 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 m -68.35 -20.63 64.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.785 0.326 . . . . 0.47 111.461 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.71 3.95 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 1.53 110.419 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 28.14 73.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.14 112.109 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.08 102.43 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.6 110.711 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 128.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.029 -0.532 . . . . 0.25 110.516 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.24 116.62 32.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.3 110.15 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -87.09 178.89 6.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.985 -0.552 . . . . 2.16 110.253 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -23.93 67.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.258 -0.177 . . . . 0.37 111.438 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -87.22 0.94 54.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.782 0.325 . . . . 0.43 110.593 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.5 -42.22 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.25 -0.432 . . . . 1.21 110.738 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.5 -28.19 68.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.784 0.326 . . . . 0.24 110.765 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -68.85 -28.7 40.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.199 0.523 . . . . 0.86 110.067 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.74 20.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.932 -0.576 . . . . 0.7 110.296 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 -56.76 9.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.793 -0.64 . . . . 0.53 111.736 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -102.86 -55.15 2.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.652 0.263 . . . . 0.96 111.003 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.85 -32.28 1.58 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.671 . . . . 0.18 111.954 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.41 133.38 33.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.608 0.242 . . . . 0.78 110.758 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.08 2.86 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.973 0.416 . . . . 0.68 110.595 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 85' ' ' ILE . 6.8 t70 -91.39 126.43 36.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.934 -0.575 . . . . 1.14 110.234 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.29 -27.3 63.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.569 . . . . 1.08 111.13 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -62.66 -49.1 76.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.359 -0.382 . . . . 0.71 110.409 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.02 -43.25 99.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.54 110.899 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 81' ' ' ASP . 50.1 mm -60.61 -49.29 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.26 110.114 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.8 t -64.7 -34.3 77.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.11 110.949 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -61.31 -43.99 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 110.403 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -68.85 -38.64 79.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.77 110.472 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 31' ' ' ILE . 73.5 mt -67.34 -33.44 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.31 110.799 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.91 -12.11 59.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.75 112.504 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 92' ' ' LYS . 14.6 t -116.1 -21.37 9.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 0.81 112.046 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HG2' HG23 ' A' ' 91' ' ' THR . 33.0 mmmt -124.8 25.91 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.025 0.44 . . . . 0.62 110.249 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.6 176.63 19.08 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.669 -0.777 . . . . 0.41 112.322 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -85.31 82.81 8.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 2.48 111.365 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.18 124.93 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.119 -0.492 . . . . 1.03 110.268 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 18' ' ' ALA . 3.4 pt20 -75.79 109.29 9.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.172 0.511 . . . . 0.66 110.011 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.254 0.55 . . . . 0.2 111.095 -179.747 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.494 0.664 . . . . 0.19 110.108 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -78.18 56.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.337 -0.847 . . . . 0.8 110.909 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.05 169.57 17.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.973 -0.558 . . . . 2.59 110.694 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.03 107.08 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.29 110.059 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.3 69.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.004 0.431 . . . . 0.5 109.973 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 61.72 85.27 0.12 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.406 -0.815 . . . . 0.83 110.383 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.1 m -80.42 44.79 0.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.859 -0.609 . . . . 0.41 111.354 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.46 -21.11 28.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.907 -0.588 . . . . 0.33 109.79 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 80.9 1.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.448 -0.796 . . . . 0.37 109.58 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -86.14 16.33 4.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.45 112.039 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 131.82 51.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.553 -0.294 . . . . 0.43 111.424 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 58.24 48.56 12.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.715 -0.675 . . . . 1.63 111.299 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 59.41 53.11 5.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.537 -0.756 . . . . 0.76 111.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.1 30.29 19.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.306 -0.861 . . . . 0.23 112.071 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.58 85.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.21 110.521 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 157' ' ' LEU . 4.0 mm? -71.55 -7.85 50.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.713 -0.676 . . . . 0.3 111.234 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -99.56 -47.04 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.537 -0.542 . . . . 0.94 109.537 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.38 111.426 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.62 -15.14 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.053 0.454 . . . . 0.58 111.457 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -109.06 0.04 19.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.319 0.581 . . . . 1.33 110.355 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -84.55 -54.26 4.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.617 -0.719 . . . . 0.63 109.787 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -69.25 -18.9 63.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.18 110.435 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.536 ' N ' HD13 ' A' ' 163' ' ' LEU . 46.6 tttm -69.35 -22.01 63.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.72 110.11 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -81.66 -12.82 58.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.835 -0.62 . . . . 0.63 110.391 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.82 -39.65 5.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.178 -0.465 . . . . 0.21 110.731 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.3 tpp -141.79 143.98 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.45 110.722 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -96.4 119.59 35.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.281 -0.418 . . . . 0.24 110.282 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.285 -0.416 . . . . 0.62 110.78 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 40.5 mtm . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.012 -0.366 . . . . 1.29 110.012 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -102.02 131.54 48.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.369 -0.604 . . . . 1.48 109.369 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.476 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.7 mp -116.5 157.22 25.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.203 0.525 . . . . 0.41 111.325 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.595 ' HB2' ' OE2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -127.77 160.58 31.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.143 -0.935 . . . . 1.05 108.9 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -129.3 128.61 43.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.695 0.283 . . . . 0.53 110.463 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 121.69 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.466 0.651 . . . . 0.88 111.386 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -150.1 157.31 37.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.421 -0.808 . . . . 0.11 109.902 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.21 163.85 11.47 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.688 2.259 . . . . 0.09 112.501 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 208' ' ' LEU . 40.5 t -55.23 -39.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.256 -0.429 . . . . 0.25 112.05 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -57.95 -60.79 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.726 0.298 . . . . 0.53 111.638 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.87 -19.46 61.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 1.44 111.509 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.86 72.87 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.943 -0.646 . . . . 0.15 111.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -61.82 -32.65 72.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.614 0.245 . . . . 1.62 110.712 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -55.75 -43.97 77.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.014 -0.539 . . . . 0.75 111.668 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 -35.27 12.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.416 -0.356 . . . . 0.41 111.63 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.77 -34.25 75.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.688 0.28 . . . . 1.55 111.171 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -95.88 20.73 9.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.807 0.299 . . . . 1.23 111.807 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -146.35 -45.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.447 0.536 . . . . 1.31 112.447 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -75.89 -39.71 55.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.662 0.268 . . . . 0.42 111.494 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 5.2 mtpt -58.6 -52.79 72.19 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.191 -0.459 . . . . 1.02 112.002 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 34.1 Cg_endo -65.12 -12.5 35.03 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.056 1.837 . . . . 0.09 112.961 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.8 mt -88.64 -7.52 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.359 . . . . 0.2 110.304 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 6.8 mm 59.64 40.26 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.519 -0.764 . . . . 0.4 110.815 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -112.21 19.96 17.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.63 109.947 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.433 HG21 ' HE3' ' A' ' 193' ' ' LYS . 14.7 m -110.68 139.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.813 -0.631 . . . . 0.33 111.053 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.93 164.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.812 -0.631 . . . . 1.15 110.039 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -71.14 56.29 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 1.67 111.092 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.2 m -156.17 88.21 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.907 -0.775 . . . . 0.77 108.907 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -134.94 140.03 45.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.533 -0.758 . . . . 0.78 110.396 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.37 137.41 53.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.629 -0.508 . . . . 0.48 109.629 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.29 30.38 7.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 1.28 111.501 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -79.72 -140.28 2.16 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.729 -0.748 . . . . 0.63 112.847 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.63 -20.96 66.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.93 0.395 . . . . 1.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -136.09 143.2 44.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.923 -0.399 . . . . 1.26 109.923 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 182' ' ' VAL . 2.5 mm? -81.99 85.53 6.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.33 110.75 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.595 ' OE2' ' HB2' ' A' ' 177' ' ' ARG . 10.3 tp10 -90.28 106.21 18.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.137 -0.69 . . . . 1.34 109.137 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.79 134.62 58.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.957 0.408 . . . . 0.17 111.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 177' ' ' ARG . 86.5 t -84.53 108.01 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.15 110.21 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.0 m -126.59 90.35 3.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.135 -0.484 . . . . 0.22 110.406 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -155.78 132.01 10.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.28 109.837 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.82 173.21 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.521 -0.309 . . . . 1.06 110.276 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 4.1 m-20 -69.51 169.35 12.54 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.456 -0.338 . . . . 1.22 110.417 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.49 -161.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.642 2.228 . . . . 0.36 112.794 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.62 -98.52 1.55 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.26 111.718 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 68.9 m -75.98 0.88 16.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.64 111.563 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 44.3 t80 -61.46 -32.3 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.033 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -9.1 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 1.31 111.701 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -92.7 -32.69 14.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.794 0.331 . . . . 1.1 110.567 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 226' ' ' ILE . 4.8 tp -94.51 -31.37 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.384 0.513 . . . . 1.38 112.384 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.499 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -60.24 -28.12 67.77 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.33 -0.231 . . . . 0.95 111.42 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -56.43 -35.37 67.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.81 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.2 pp -95.81 -24.89 16.26 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.41 110.492 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -61.59 -38.1 79.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.367 -0.379 . . . . 0.42 110.693 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 223' ' ' ASP . 13.7 ptpt -64.31 -16.48 62.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.656 0.613 . . . . 0.16 112.656 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.57 -23.47 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.613 -0.435 . . . . 0.55 111.838 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -81.93 -43.23 18.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.588 0.588 . . . . 0.92 112.588 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -128.18 -38.87 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.364 -0.535 . . . . 0.31 111.914 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 14.7 tttt -63.76 -28.06 69.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.941 0.401 . . . . 2.08 110.563 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -102.13 16.98 55.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.912 -0.661 . . . . 0.25 112.123 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.7 -36.09 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.339 . . . . 0.39 111.044 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.51 -156.04 6.65 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.515 -0.85 . . . . 0.14 112.725 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 m -101.98 137.7 39.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.875 0.369 . . . . 0.17 110.425 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.13 149.11 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.2 111.013 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.35 161.04 39.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.678 . . . . 0.33 109.168 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.2 m -99.04 148.45 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.762 0.315 . . . . 0.18 111.066 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 109.576 -0.527 . . . . 0.47 109.576 179.406 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.912 0.387 . . . . 0.25 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.88 -89.57 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.34 110.293 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -137.51 -88.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.675 -0.491 . . . . 0.33 109.675 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.01 107.64 23.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.316 -0.624 . . . . 0.81 109.316 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -158.31 152.44 24.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.1 -0.5 . . . . 1.11 110.373 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -78.77 49.06 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.48 110.968 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.3 p -129.04 -45.61 1.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.128 0.49 . . . . 0.25 110.606 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -106.69 39.54 1.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.18 109.672 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 m -94.38 135.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.22 111.581 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.06 116.08 31.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.966 -0.561 . . . . 0.11 109.844 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.6 114.73 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.845 -0.616 . . . . 0.16 111.387 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.796 HG22 HG22 ' A' ' 89' ' ' ILE . 7.7 p -107.82 136.29 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.19 108.986 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HD3' ' CD ' ' A' ' 30' ' ' GLU . 12.4 ttp180 -142.18 140.98 32.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.089 0.471 . . . . 1.33 111.939 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 tpt -135.55 119.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.82 108.877 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -122.62 114.95 21.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.902 0.382 . . . . 1.14 111.734 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -112.42 -164.41 0.91 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.708 -0.849 . . . . 0.89 108.708 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.36 6.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.702 0.287 . . . . 0.41 111.375 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.74 4.77 24.4 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.357 -0.925 . . . . 1.09 113.229 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -126.76 119.02 25.86 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.488 -0.419 . . . . 0.19 110.34 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -140.98 122.54 15.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.295 -0.411 . . . . 1.8 110.478 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -149.96 146.87 27.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.285 0.365 . . . . 0.39 110.923 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' CD ' ' HD3' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -143.9 136.77 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.9 110.714 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -139.98 -173.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.885 0.374 . . . . 0.11 110.59 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -136.46 116.65 13.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.05 110.185 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.8 p -112.67 -158.35 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.334 -0.394 . . . . 0.13 111.172 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -169.1 0.8 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.85 110.673 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -74.43 -157.88 0.06 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.894 0.378 . . . . 0.47 111.295 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -56.71 -19.95 19.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.109 0.781 . . . . 0.52 113.109 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -63.55 -19.03 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.27 111.203 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.05 -24.92 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.1 0.476 . . . . 0.18 110.767 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.2 -13.29 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.323 -0.398 . . . . 0.29 110.403 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.934 -0.575 . . . . 0.27 112.416 179.804 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.52 0.2 . . . . 1.15 110.98 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 m-20 -52.88 114.26 1.37 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.258 -0.428 . . . . 1.44 111.303 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.54 -28.28 68.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 1.36 111.662 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.05 -36.76 82.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.265 0.555 . . . . 0.95 110.403 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.67 -30.21 56.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.49 109.951 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 48' ' ' ASP . 21.9 t -75.48 -27.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.24 110.847 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.09 84.85 7.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.172 0.51 . . . . 0.2 111.148 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -57.34 -64.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.378 -0.828 . . . . 0.18 110.528 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 m -91.23 80.47 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.004 -0.544 . . . . 0.35 109.968 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -80.06 63.79 4.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.63 0.728 . . . . 1.1 110.942 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -148.35 96.04 2.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.796 -1.093 . . . . 0.22 108.074 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.1 p -78.82 146.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.664 -0.698 . . . . 0.13 112.194 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -116.23 147.35 41.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.57 -0.741 . . . . 0.32 109.263 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 18.5 t -84.43 -33.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.568 0.699 . . . . 0.11 109.387 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -166.05 104.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.127 -0.942 . . . . 1.03 109.889 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.71 -27.73 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.39 111.609 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 m -60.84 -45.99 92.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.735 0.302 . . . . 0.43 111.062 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -27.0 25.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.75 110.615 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.72 29.79 8.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.805 -0.712 . . . . 0.1 111.469 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -83.33 109.36 17.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 1.56 110.431 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.63 133.11 36.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.37 109.726 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -110.06 105.17 14.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.029 0.442 . . . . 0.1 110.856 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 34.2 pttt -85.86 -175.81 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.384 -0.599 . . . . 1.68 109.384 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 pttp -58.81 -23.48 60.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.643 0.259 . . . . 0.95 111.419 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.26 -22.03 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.501 -0.318 . . . . 2.07 111.316 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 21.8 m-20 -86.41 -52.28 5.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.39 -0.368 . . . . 0.33 110.748 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.63 -28.84 70.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.21 111.599 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -68.15 -26.55 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.797 0.332 . . . . 0.32 111.018 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 p -102.66 -25.08 13.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 1.04 111.327 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.61 -41.76 16.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.22 111.445 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -97.36 -41.43 8.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 0.42 110.324 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.72 -29.14 5.72 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.758 -0.734 . . . . 0.26 112.345 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.96 145.81 43.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.696 0.284 . . . . 0.22 110.782 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.39 3.01 53.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.242 0.544 . . . . 0.73 110.336 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 85' ' ' ILE . 26.6 t0 -74.25 108.78 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 1.45 110.551 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -60.46 -30.58 69.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.19 110.978 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -60.65 -40.77 93.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.278 -0.419 . . . . 0.61 111.097 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -71.34 -38.78 71.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.65 110.881 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 81' ' ' ASP . 30.0 mm -60.24 -55.11 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.21 110.936 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 7.4 p -67.74 -34.66 77.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.09 111.397 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' THR . 33.3 ttpt -58.82 -45.17 90.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.605 0.241 . . . . 0.21 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -60.62 -45.8 92.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.54 110.868 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.796 HG22 HG22 ' A' ' 20' ' ' VAL . 22.5 mt -72.43 -25.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 0.16 111.439 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.43 -40.52 23.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.053 0.39 . . . . 0.23 112.053 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -91.18 -21.16 21.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.07 0.767 . . . . 0.3 113.07 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -110.99 -24.68 10.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.632 -0.427 . . . . 0.67 111.296 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.77 -166.07 31.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.757 . . . . 0.15 111.931 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -120.97 131.59 54.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.168 0.509 . . . . 2.06 111.278 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 97' ' ' VAL . 14.7 p -118.28 160.36 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.49 109.05 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -73.27 85.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.238 0.542 . . . . 0.26 111.044 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 95' ' ' VAL . 3.8 m . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.2 111.306 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.27 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.6 p80 40.82 50.65 3.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.085 0.954 . . . . 0.25 112.68 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.46 111.85 21.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 1.84 110.397 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -77.92 45.45 0.52 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.233 0.539 . . . . 0.32 111.135 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.6 -24.49 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.53 110.553 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -82.38 22.6 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.58 111.162 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.73 14.5 5.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.349 0.595 . . . . 0.72 110.326 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -79.31 -46.3 17.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.49 110.408 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -154.74 -161.81 1.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.94 109.7 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.4 m -55.98 118.07 4.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.99 111.152 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -23.93 65.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.67 111.392 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.79 1.05 28.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.901 0.382 . . . . 1.1 110.654 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -115.59 -45.53 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.78 110.423 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.0 pt20 -94.06 19.46 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.18 111.579 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.78 72.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.282 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.1 mm? -68.43 -18.36 64.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.28 111.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -92.4 -36.97 12.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.85 0.357 . . . . 2.49 110.63 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 155' ' ' GLN . 24.7 t -64.79 -43.18 96.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.874 -0.603 . . . . 0.16 111.017 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.6 tt -61.36 -32.55 53.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.133 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 41.1 mttp -67.29 -48.62 67.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.711 0.291 . . . . 1.33 110.364 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -39.72 89.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.719 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -42.99 99.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 1.42 110.443 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -65.75 -20.72 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.283 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 161' ' ' LYS . 32.4 mt-10 -72.72 -32.54 65.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.694 0.283 . . . . 0.69 110.822 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -82.21 -44.09 16.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.065 0.46 . . . . 0.87 110.137 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 21.2 ptp -144.45 134.38 23.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.872 -0.604 . . . . 1.44 109.737 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.45 120.91 19.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.202 0.525 . . . . 0.87 111.493 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.525 -0.761 . . . . 0.95 109.641 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 C--O 1.227 -0.095 0 N-CA-C 110.193 -0.299 . . . . 1.41 110.193 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -119.48 144.09 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 1.73 110.491 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.69 154.74 41.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.76 110.976 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 177' ' ' ARG . 9.4 ptm180 -124.44 152.61 43.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.11 109.426 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 95.6 m-85 -116.09 124.64 50.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.854 0.359 . . . . 0.13 110.611 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.48 HG12 ' OE2' ' A' ' 209' ' ' GLU . 4.4 mt -102.07 114.5 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.3 111.47 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.3 OUTLIER -159.11 150.15 16.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 0.6 110.262 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.93 165.47 27.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.79 2.327 . . . . 0.26 112.064 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.95 -30.44 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.762 0.315 . . . . 0.15 110.928 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.11 -50.03 62.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.47 110.497 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -91.94 -21.95 20.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.74 110.272 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.16 -30.23 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.483 -0.781 . . . . 0.17 113.635 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -68.21 -16.44 63.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.072 0.436 . . . . 0.87 111.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.99 -15.65 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 1.32 109.665 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.38 -45.08 5.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.267 -0.878 . . . . 2.04 110.537 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 208' ' ' LEU . 29.2 tttm -57.69 -53.49 57.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 0.72 111.093 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.66 31.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.088 -0.505 . . . . 0.6 111.12 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -144.16 -51.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.839 0.311 . . . . 1.27 111.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.97 -37.58 22.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.176 0.435 . . . . 0.6 112.176 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 6.1 mtpt -60.25 -48.54 93.85 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.234 0.457 . . . . 0.3 112.234 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.4 Cg_endo -60.0 -13.89 25.37 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.063 1.842 . . . . 0.16 113.043 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 66.9 mt -85.48 -2.58 58.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.472 -0.195 . . . . 0.37 110.472 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 39.2 pt 41.78 40.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.543 1.137 . . . . 0.65 113.736 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 195' ' ' LEU . 78.9 mttt -123.32 24.41 8.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 1.03 109.665 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.27 169.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 0.41 110.353 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 211' ' ' VAL . 88.6 mt -110.94 144.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.021 -0.536 . . . . 0.65 110.118 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -70.57 70.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.48 0.488 . . . . 0.66 111.334 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.1 m -157.39 38.72 0.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.29 109.287 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.5 145.07 29.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 1.14 111.608 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -117.62 123.69 46.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.12 110.089 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.61 159.78 18.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.284 -0.416 . . . . 0.47 110.193 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 139.34 -116.61 1.25 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.045 -0.598 . . . . 0.2 111.912 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.25 -18.05 37.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.518 0.675 . . . . 1.24 109.554 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.05 177.21 7.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.114 -0.948 . . . . 0.14 109.5 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 189' ' ' LYS . 2.8 tp -138.37 77.51 1.63 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.404 . . . . 0.69 110.61 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 15.9 mt-10 -82.93 99.73 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.174 -0.467 . . . . 0.16 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 28.7 mt -102.88 132.91 48.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.76 109.74 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.642 HG11 HD12 ' A' ' 239' ' ' LEU . 61.3 t -99.06 122.41 50.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.892 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.9 t -147.39 120.24 8.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.3 110.128 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.07 125.08 1.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.305 -0.628 . . . . 0.23 109.305 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.3 tt -117.1 157.61 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.6 109.922 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.08 150.59 10.39 Favored Pre-proline 0 C--O 1.236 0.344 0 O-C-N 123.295 0.372 . . . . 0.62 111.536 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.1 158.35 3.41 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.654 2.903 . . . . 1.05 113.569 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.15 -82.87 0.41 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.631 -0.988 . . . . 0.37 110.631 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.1 m -72.92 -16.32 61.56 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.31 -0.626 . . . . 0.83 109.31 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 40.3 t80 -63.41 -42.71 98.76 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.564 -0.744 . . . . 1.35 110.762 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 223' ' ' ASP . 17.9 tpt180 -62.2 -27.33 68.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.151 0.5 . . . . 0.34 110.874 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.37 -34.92 70.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.181 -0.463 . . . . 2.19 111.358 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.635 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.3 tt -96.24 -29.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.529 -0.305 . . . . 1.78 111.76 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -62.52 -23.83 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 0.92 110.746 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.12 -25.63 65.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.867 -0.606 . . . . 1.26 111.4 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.0 OUTLIER -106.4 -32.55 8.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.928 -0.309 . . . . 0.47 110.872 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 222' ' ' ILE . 47.2 mm -58.26 -35.28 52.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.954 0.407 . . . . 0.29 110.705 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 16.4 ptmt -54.32 -34.29 60.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.458 -0.792 . . . . 1.56 112.609 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -106.09 -24.29 12.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.689 0.281 . . . . 0.55 111.344 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.12 -59.67 3.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.068 -0.514 . . . . 0.34 111.848 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -125.52 -24.26 3.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.294 0.479 . . . . 0.2 112.294 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 75.6 tttt -66.94 -28.79 68.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.52 110.66 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.83 -14.28 37.53 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.883 -0.675 . . . . 0.68 112.25 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -84.99 -22.31 29.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.381 . . . . 0.64 110.69 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -147.15 -168.98 14.27 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.536 -0.84 . . . . 0.1 112.342 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 m -96.77 131.73 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.891 -0.411 . . . . 0.25 109.891 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.31 142.66 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.004 0.43 . . . . 0.33 111.323 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -144.0 155.14 43.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.09 -0.504 . . . . 0.86 109.937 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -81.28 152.2 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 0.15 110.748 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.642 HD12 HG11 ' A' ' 211' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.944 -0.391 . . . . 1.06 109.944 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 16' ' ' ASN . 81.2 p . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 113.433 0.901 . . . . 0.37 113.433 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.83 -77.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.52 110.195 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.5 -98.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.051 -0.522 . . . . 0.36 109.632 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.7 mt -87.15 89.26 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.25 0.548 . . . . 0.36 109.886 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -143.47 134.83 26.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.599 -0.728 . . . . 1.32 109.754 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.78 61.09 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.86 111.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -9.74 3.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 1.06 110.87 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.56 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 t-20 -153.59 63.88 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.191 -1.04 . . . . 1.1 108.191 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 3.5 m -106.31 128.04 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.012 -0.995 . . . . 0.21 111.542 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.16 113.08 18.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.806 . . . . 0.19 109.626 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.15 117.24 19.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.18 110.872 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 89' ' ' ILE . 1.3 p -125.28 128.84 73.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.82 -0.807 . . . . 0.37 108.82 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 30' ' ' GLU . 30.5 ttt180 -137.01 131.48 32.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.595 0.591 . . . . 1.25 112.595 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.464 ' HB2' HG23 ' A' ' 89' ' ' ILE . 19.2 ttt -83.77 140.7 31.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.674 . . . . 0.34 109.556 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.55 99.18 6.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.42 111.036 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -111.6 -179.69 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 0.82 110.331 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.09 -54.47 45.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.477 0.486 . . . . 0.09 112.072 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.94 28.73 3.64 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.23 111.845 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -148.17 146.84 28.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.775 0.321 . . . . 1.05 110.359 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.82 142.54 20.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.228 -0.656 . . . . 1.13 109.228 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 24.6 m-85 -145.85 129.32 16.92 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.376 0.423 . . . . 0.65 110.497 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.594 ' OE1' ' HD2' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -119.95 137.57 53.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.873 0.368 . . . . 0.34 110.711 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.89 -171.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.69 110.455 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -141.51 133.97 28.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.13 111.954 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.36 158.66 19.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.064 -0.516 . . . . 0.38 110.755 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -82.41 120.79 25.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.704 0.631 . . . . 0.38 112.704 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 84.3 mttt 44.38 39.32 3.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.131 1.16 . . . . 0.76 114.131 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.92 18.85 4.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.405 0.52 . . . . 1.71 112.405 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -73.01 1.16 9.44 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.002 0.43 . . . . 0.46 111.424 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.81 -19.58 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.365 0.603 . . . . 0.27 110.241 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.05 3.33 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.435 0.636 . . . . 0.18 109.87 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-N 115.241 -0.89 . . . . 0.1 113.204 -179.467 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.43 108.503 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.47 140.27 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.352 0.596 . . . . 0.64 111.016 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.629 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -85.44 4.52 35.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.803 -0.635 . . . . 0.31 110.632 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.44 -24.29 42.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.597 -0.729 . . . . 0.67 110.645 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -108.42 -30.52 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.41 111.05 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -68.65 -24.82 29.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.484 -0.326 . . . . 0.6 111.299 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.47 116.25 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.676 -0.49 . . . . 0.58 109.676 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -88.12 -43.22 11.82 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.86 111.015 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -119.86 118.11 29.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.08 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -81.38 4.62 20.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.219 0.533 . . . . 0.63 110.272 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.459 ' H ' HG22 ' A' ' 55' ' ' THR . 4.3 m -115.62 134.59 54.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.13 150.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 110.087 -0.338 . . . . 0.24 110.087 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.43 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 70.7 m-85 -103.66 139.64 38.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.648 0.261 . . . . 0.42 110.551 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 2.1 t -87.05 -16.43 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.475 -0.565 . . . . 0.41 109.475 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 3.2 t-20 175.76 97.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.284 -0.871 . . . . 0.46 109.854 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.52 -25.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.2 110.827 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -21.08 66.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.23 111.193 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -119.11 0.48 11.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.79 111.016 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.88 29.79 62.51 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.594 -0.812 . . . . 0.31 112.072 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -83.88 101.85 11.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.634 0.254 . . . . 1.36 110.666 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.3 130.88 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.368 -0.378 . . . . 0.25 110.273 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 60' ' ' VAL . . . -99.73 114.78 28.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.16 0.505 . . . . 0.19 110.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.585 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 24.4 pttt -73.82 177.17 5.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 1.5 109.529 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -61.27 -28.53 69.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.09 110.2 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 74' ' ' ILE . 47.7 tt0 -76.35 -27.97 56.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.866 -0.606 . . . . 1.07 110.189 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 7.7 m-20 -72.88 -51.9 16.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.52 110.251 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.94 -33.71 76.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.14 111.198 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -69.61 -23.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.234 0.54 . . . . 0.13 109.954 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -95.65 -21.82 17.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.42 110.715 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.78 -53.09 4.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.399 -0.364 . . . . 0.36 111.706 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -90.17 -34.2 15.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.931 0.396 . . . . 0.36 110.239 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.08 -14.66 44.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.729 -0.748 . . . . 0.46 112.548 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p -115.61 141.8 47.58 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.778 -0.248 . . . . 1.15 110.989 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.12 -10.77 51.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.159 -0.682 . . . . 0.58 109.159 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.43 120.78 25.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.096 -0.956 . . . . 1.03 109.898 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.98 -22.56 61.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.947 -0.57 . . . . 0.43 112.419 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -58.93 -49.67 76.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.274 -0.17 . . . . 0.13 111.091 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.37 -43.36 99.01 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.047 0.451 . . . . 0.82 111.008 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.48 -52.32 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 0.16 110.769 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.81 -35.56 76.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.15 110.778 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -62.34 -46.58 88.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.379 . . . . 0.43 110.366 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.65 110.764 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 22' ' ' MET . 77.9 mt -69.18 -28.31 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 0.17 109.967 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -38.09 36.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.718 -0.674 . . . . 0.27 111.922 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 92' ' ' LYS . 12.1 t -93.36 -10.11 36.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.544 0.572 . . . . 0.17 112.544 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' A' ' 91' ' ' THR . 34.6 mmtm -137.55 35.35 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.023 -0.423 . . . . 0.78 111.206 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.18 -147.37 4.53 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.581 -0.819 . . . . 0.19 112.237 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -136.06 128.79 30.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.649 -0.501 . . . . 1.16 109.649 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -139.99 142.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.559 -0.292 . . . . 0.35 110.892 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.61 84.29 1.57 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.201 0.524 . . . . 0.38 109.883 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 95' ' ' VAL . 5.5 m . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.44 0.638 . . . . 0.58 112.584 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 122.896 1.331 . . . . 0.69 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -85.04 16.47 3.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.703 -1.135 . . . . 0.53 110.842 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.19 151.7 35.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.681 -0.691 . . . . 1.53 110.109 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.2 m -64.18 116.72 6.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.62 110.708 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.2 t -103.32 -51.08 9.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.35 110.872 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -136.35 -171.72 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.81 110.614 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.46 -34.15 76.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 0.25 110.11 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.57 101.29 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.437 -0.802 . . . . 0.7 109.674 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -85.25 71.21 10.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 0.98 109.477 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 m -133.2 129.0 37.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.883 -0.599 . . . . 0.38 111.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -7.41 46.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.25 110.958 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.03 9.55 6.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.783 -0.644 . . . . 0.24 110.611 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -162.31 -58.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.31 110.049 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -87.33 41.27 0.97 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.976 -0.556 . . . . 0.23 110.362 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.68 -32.65 71.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 0.19 111.663 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.5 mm? -81.01 -2.7 49.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.355 -0.384 . . . . 1.48 111.378 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -111.11 -44.7 3.54 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.963 -0.295 . . . . 2.27 111.091 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -58.48 -42.82 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.39 110.969 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.07 -28.38 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.17 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 16.4 mttp -68.57 -42.78 77.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.853 0.359 . . . . 1.29 110.392 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -35.82 61.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.53 110.659 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.78 -35.15 79.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.21 110.069 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 167' ' ' MET . 2.1 ttpm? -60.28 -20.8 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.112 -0.949 . . . . 1.39 111.662 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -70.72 -20.38 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 1.06 111.191 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -115.11 -47.05 2.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.869 0.366 . . . . 0.9 110.652 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 13.5 tpt -117.59 122.74 44.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 0.25 110.914 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -93.79 110.34 21.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.098 -0.501 . . . . 0.79 110.157 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 0.18 111.083 -179.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 120.804 0.335 . . . . 1.39 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -114.39 140.04 48.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 2.39 110.085 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.51 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 1.7 mt -127.98 150.95 49.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.039 0.447 . . . . 0.71 110.657 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -129.51 174.31 9.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.351 -0.84 . . . . 0.48 109.231 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HE2' ' HG ' ' A' ' 212' ' ' CYS . 3.6 p90 -133.58 145.58 50.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.153 -0.314 . . . . 0.49 110.153 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.25 106.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.42 111.439 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -147.06 157.23 46.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.055 -0.52 . . . . 0.13 110.943 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.31 178.44 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.808 2.339 . . . . 0.14 113.123 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.39 -45.81 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.627 0.603 . . . . 0.4 112.627 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.91 -45.9 85.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.083 0.468 . . . . 1.26 111.607 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.61 -39.74 67.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.7 110.68 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -62.69 -38.33 96.26 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.68 -0.691 . . . . 0.16 113.104 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.08 -34.28 68.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.776 0.287 . . . . 0.58 111.776 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 31.7 mmmt -71.91 -33.32 68.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.566 0.21 . . . . 1.38 111.566 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -85.36 -26.3 26.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.47 109.99 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 80.5 tttt -60.94 -31.55 71.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.22 110.62 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.42 12.68 28.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 3.15 111.197 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 9.2 mtmt -126.5 -58.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.222 0.453 . . . . 0.8 112.222 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.3 -42.01 26.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.641 . . . . 0.16 112.729 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 189' ' ' LYS . 1.6 mtpt -58.16 -50.95 85.22 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.07 0.767 . . . . 0.44 113.07 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 20.5 Cg_endo -60.91 -14.76 34.39 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.456 2.104 . . . . 0.21 113.404 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' A' ' 197' ' ' LYS . 72.4 mt -82.19 -11.51 58.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.37 110.15 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mm 56.64 35.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.569 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -109.64 18.16 20.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 1.87 110.042 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 212' ' ' CYS . 2.9 m -113.6 137.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.259 -0.882 . . . . 0.34 110.384 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.63 148.28 5.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.954 -0.566 . . . . 0.79 109.52 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.7 75.13 0.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.749 0.785 . . . . 0.94 111.559 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.2 m -149.83 33.62 0.68 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.146 -1.057 . . . . 0.46 108.146 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.4 pt-20 -79.72 129.96 34.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.768 -1.106 . . . . 0.8 111.792 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -97.13 105.73 17.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.361 -0.977 . . . . 0.3 108.361 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.44 131.31 45.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.8 110.434 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 163.57 -104.77 0.24 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.848 -0.691 . . . . 0.56 112.127 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.4 -17.27 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.4 0.619 . . . . 1.8 110.016 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -140.67 176.91 8.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.231 -0.895 . . . . 0.47 109.35 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.4 tp -128.27 84.73 2.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.372 -0.603 . . . . 0.46 109.372 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 19.3 tt0 -96.56 109.39 21.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.603 -0.726 . . . . 1.24 110.815 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 5.9 mt -130.97 152.04 36.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.739 0.304 . . . . 0.26 110.314 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.4 t -98.7 117.59 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.09 109.808 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.556 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 21.0 p -122.92 56.02 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.26 111.411 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -126.56 125.29 41.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.034 0.445 . . . . 0.12 111.05 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 pt -114.8 -159.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.412 -0.813 . . . . 0.32 109.751 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.65 162.3 60.95 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 110.127 -0.323 . . . . 0.33 110.127 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.92 -177.42 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.67 2.247 . . . . 0.2 113.157 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.69 1.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.066 -0.814 . . . . 0.15 111.066 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.14 -24.22 65.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.297 0.57 . . . . 1.03 110.039 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.13 -32.35 73.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.32 109.947 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -23.51 63.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.87 110.497 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.4 -38.79 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 1.48 110.72 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.634 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.6 tt -85.11 -24.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.84 111.356 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.12 -30.23 61.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.84 0.352 . . . . 0.65 110.957 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -56.14 -33.07 64.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.714 -0.675 . . . . 1.58 111.447 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.85 -23.99 14.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.769 -0.372 . . . . 0.46 110.927 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 222' ' ' ILE . 46.3 mm -64.51 -37.92 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.36 110.508 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -62.87 -29.19 70.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.32 111.388 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 225' ' ' LEU . 60.1 pttt -105.54 11.29 32.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.619 . . . . 0.74 110.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -96.83 -126.55 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.022 -1.103 . . . . 0.51 108.022 178.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.406 HG21 ' CD2' ' A' ' 178' ' ' PHE . 9.5 t -65.2 -27.91 69.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.868 0.365 . . . . 0.45 110.999 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.27 -12.13 61.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.62 111.083 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -108.37 18.37 33.05 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.964 -0.636 . . . . 0.12 112.591 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -149.13 -44.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.62 0.247 . . . . 0.8 111.042 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -105.74 -171.56 23.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.682 -0.771 . . . . 0.33 112.191 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -107.9 143.32 36.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.724 0.297 . . . . 0.54 110.217 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.48 165.7 13.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 0.92 110.902 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -154.13 151.94 29.84 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.52 -0.918 . . . . 2.09 108.52 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.11 155.07 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.232 0.539 . . . . 0.57 111.576 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 239' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.91 108.279 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.247 0.546 . . . . 0.48 110.839 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -87.7 155.05 20.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.46 110.464 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -63.33 -39.45 94.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.2 112.256 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 54' ' ' GLN . 17.5 mt -145.7 82.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.628 0.252 . . . . 0.49 111.237 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -164.18 172.83 13.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 1.45 110.771 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.61 48.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.52 112.27 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.99 3.18 3.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.215 0.531 . . . . 0.35 110.66 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.77 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.704 -0.85 . . . . 0.35 108.704 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 22.8 m -100.46 150.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.981 -1.009 . . . . 0.37 112.527 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.37 111.77 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.378 -0.971 . . . . 0.31 108.378 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.41 110.89 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.78 111.991 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -103.54 135.93 38.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 0.32 109.005 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.93 127.92 47.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.81 111.996 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HB2' HG23 ' A' ' 89' ' ' ILE . 57.8 ttp -101.16 115.39 30.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.312 -0.625 . . . . 0.28 109.312 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 115.86 24.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.433 . . . . 0.87 110.604 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 25.4 mmm-85 -123.93 163.72 20.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.989 -0.551 . . . . 0.9 110.365 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.84 76.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.47 110.872 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.83 -57.7 4.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.799 . . . . 0.38 112.242 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -159.47 152.17 21.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.13 -0.322 . . . . 0.85 110.13 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 2.2 ptt180 -91.41 149.03 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.564 -0.532 . . . . 1.88 109.564 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -129.46 120.29 25.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.415 -0.357 . . . . 0.48 110.654 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 4.8 mt-10 -116.82 123.9 48.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.52 110.9 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mt -128.29 146.82 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.067 -0.346 . . . . 0.27 110.067 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -102.9 103.22 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 0.14 110.303 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 p -100.96 -162.44 0.94 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.12 -0.491 . . . . 0.5 110.749 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.719 ' HB2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.69 -174.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.049 0.452 . . . . 0.52 111.17 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -75.01 -139.83 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.567 -0.742 . . . . 1.15 110.491 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.48 -10.79 37.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.947 0.403 . . . . 0.24 111.546 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -62.85 -30.85 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.42 111.16 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.8 -23.99 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.029 0.442 . . . . 0.2 111.067 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.95 -30.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.439 0.638 . . . . 0.2 110.2 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 CA-C-N 115.606 -0.724 . . . . 0.46 112.126 179.665 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 pttt . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.68 0.276 . . . . 0.81 110.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.2 140.04 56.32 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.004 -0.544 . . . . 1.21 110.493 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -80.9 -18.02 48.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.115 0.783 . . . . 0.44 113.115 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.8 t70 -67.3 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.555 -0.535 . . . . 1.4 109.555 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.56 -19.83 62.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.191 0.519 . . . . 1.02 110.001 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 34' ' ' TYR . 69.2 t -78.83 -23.47 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.32 109.287 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.65 92.62 4.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.255 -0.884 . . . . 1.3 110.432 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' HG23 ' A' ' 12' ' ' ILE . 33.7 mm-40 -60.36 -44.47 95.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 1.3 109.939 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.4 p -115.05 121.57 43.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.753 -0.658 . . . . 1.14 109.992 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -87.76 23.26 2.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.309 0.576 . . . . 0.49 110.204 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.8 157.78 27.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.401 -0.818 . . . . 0.32 109.5 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.3 p -130.16 135.32 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.22 111.128 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . 61.8 m-85 -91.03 138.62 31.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.415 -0.357 . . . . 0.64 110.422 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' A' ' 68' ' ' ALA . 2.1 t -94.93 -33.32 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.571 . . . . 0.55 110.037 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -164.68 93.48 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.62 109.539 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 p -66.09 -20.47 27.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.41 111.509 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.07 -4.53 55.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.5 110.85 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -126.95 -16.03 5.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.897 -0.592 . . . . 1.21 110.588 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.95 17.78 57.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.927 -0.654 . . . . 0.32 111.496 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.58 113.08 22.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.846 0.355 . . . . 0.81 110.563 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.61 141.26 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.52 109.969 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 60' ' ' VAL . . . -101.54 126.21 48.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.653 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 71' ' ' GLU . 10.9 ptpt -98.97 -171.7 2.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.661 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -59.73 -30.08 68.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.24 111.353 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.596 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 6.4 tt0 -80.67 -1.11 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.119 0.485 . . . . 1.39 110.768 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.56 -52.4 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.455 -0.339 . . . . 1.58 110.979 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -31.61 71.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.32 111.611 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -29.95 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.54 110.919 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -98.65 -29.31 13.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.971 0.415 . . . . 0.76 111.074 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.58 45.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.507 . . . . 0.22 111.43 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -105.24 -41.54 5.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.487 -0.324 . . . . 0.41 110.79 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.96 -23.83 5.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.176 -1.011 . . . . 0.22 112.221 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -97.98 133.95 41.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.68 0.276 . . . . 0.46 110.682 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.16 10.93 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.307 0.575 . . . . 0.57 110.429 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -106.86 128.31 54.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.79 -0.641 . . . . 0.65 109.69 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -69.98 -19.24 63.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.62 -0.264 . . . . 0.32 111.289 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 49' ' ' LEU . 7.9 m -60.54 -45.85 92.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.365 -0.38 . . . . 0.43 111.002 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -71.13 -23.36 62.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 1.42 111.309 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mm -77.81 -52.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.379 . . . . 0.24 110.158 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.95 -41.75 99.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.92 -0.582 . . . . 0.36 111.131 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 83' ' ' THR . 8.0 tttt -58.65 -31.84 68.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.92 110.91 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 91' ' ' THR . 1.6 tt0 -76.09 -46.36 29.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.909 -0.587 . . . . 0.72 110.332 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 20' ' ' VAL . 72.2 mt -65.82 -31.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.29 111.211 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -8.21 59.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 0.35 111.449 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -102.31 -28.44 12.26 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.778 -0.369 . . . . 0.24 111.554 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -144.05 43.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.234 0.54 . . . . 1.22 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.18 172.78 20.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.651 -0.785 . . . . 0.29 112.117 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.38 89.92 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.862 0.363 . . . . 1.39 110.539 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 p -104.77 149.29 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.3 110.248 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.07 98.13 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.19 0.519 . . . . 1.78 111.048 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.29 110.598 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 122.209 1.004 . . . . 1.85 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.58 37.37 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.93 111.201 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -82.91 110.63 18.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.926 -0.579 . . . . 0.73 110.162 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.4 m -73.08 116.82 14.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.061 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.8 -43.4 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.52 110.558 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -132.04 152.57 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.88 110.226 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.25 1.44 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 0.66 110.808 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.39 -37.48 85.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.91 110.341 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt 50.99 57.38 6.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.56 -0.746 . . . . 0.71 110.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 15.8 m -118.91 118.31 31.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.119 -0.491 . . . . 0.51 110.954 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -52.53 -61.64 2.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.2 0.815 . . . . 0.63 113.2 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 5.21 3.29 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.962 0.727 . . . . 0.47 112.962 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -109.76 -44.55 3.81 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.816 -0.354 . . . . 0.86 110.583 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.21 10.73 36.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.806 0.336 . . . . 0.47 110.548 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.05 83.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.604 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -67.29 -21.6 65.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 1.61 111.257 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.28 -49.54 9.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.88 109.835 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.33 -40.14 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.535 . . . . 0.15 111.148 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.23 -8.17 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.201 0.524 . . . . 0.27 111.765 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -113.0 -37.16 4.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.503 -0.555 . . . . 0.4 109.503 178.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.39 -45.83 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.725 . . . . 1.39 110.338 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.43 -29.62 69.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.956 -0.565 . . . . 0.34 110.358 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.91 -20.98 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.9 110.414 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.04 -10.75 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 2.45 110.595 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -108.04 -26.31 10.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.957 -0.565 . . . . 1.08 110.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.9 ttp -150.03 125.85 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.885 -0.598 . . . . 2.64 110.042 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -72.19 121.45 19.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 1.86 110.538 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.34 110.475 -179.72 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.721 0.296 . . . . 0.98 110.928 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.07 140.21 35.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 1.31 111.275 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 211' ' ' VAL . 1.1 mp -124.56 146.13 49.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.38 110.347 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 22.0 ptt85 -113.54 139.74 48.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.824 -0.625 . . . . 0.25 110.451 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 48.7 t80 -105.94 125.87 51.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.289 -0.414 . . . . 0.7 110.253 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 pt -114.09 135.59 53.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.672 0.272 . . . . 0.52 111.407 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -178.53 163.03 1.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.19 109.568 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.27 165.76 31.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.151 1.901 . . . . 0.21 112.151 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 t -63.96 -21.93 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.342 -0.39 . . . . 0.09 111.574 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -47.89 -60.78 2.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.146 -0.479 . . . . 0.45 111.784 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -93.82 -20.84 19.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.917 0.389 . . . . 0.37 109.985 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.23 93.68 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.793 -0.639 . . . . 0.07 113.485 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -60.33 -33.98 73.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.835 0.317 . . . . 0.34 110.943 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.03 -48.56 78.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.951 -0.568 . . . . 0.86 111.602 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -21.95 47.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.991 -0.284 . . . . 0.17 111.184 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -60.67 -47.82 84.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.58 110.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.59 16.64 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.78 111.222 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.42 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 31.4 mttm -119.93 -50.53 2.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.758 0.313 . . . . 1.53 111.346 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.49 -39.79 27.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.603 0.594 . . . . 0.6 112.603 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 12.2 mtpp -61.66 -52.98 65.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.791 0.663 . . . . 0.44 112.791 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.7 Cg_endo -65.51 -19.8 60.69 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.99 1.793 . . . . 0.25 112.974 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 195' ' ' LEU . 16.9 mt -86.53 -2.24 58.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.66 -0.245 . . . . 0.5 110.797 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.5 mt 54.44 59.52 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.422 0.63 . . . . 0.46 111.399 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.414 ' CE ' ' HB3' ' A' ' 195' ' ' LEU . 14.9 mtmt -139.55 35.83 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.516 0.674 . . . . 1.53 109.673 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.69 167.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.37 109.964 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.1 mt -119.99 150.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 0.69 109.315 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -73.04 71.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.353 0.597 . . . . 2.54 111.701 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 m -151.71 35.71 0.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.3 -1.0 . . . . 0.61 108.3 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.0 mt-10 -94.84 152.65 18.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.919 -1.037 . . . . 1.59 111.585 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -105.99 148.49 27.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.63 109.206 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -138.22 94.92 2.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.873 0.368 . . . . 1.3 110.56 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -162.96 -108.45 0.22 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.156 -0.778 . . . . 0.28 111.156 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -25.46 19.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.694 0.759 . . . . 1.58 108.981 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -119.78 165.18 14.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.717 -1.129 . . . . 0.72 109.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.63 78.17 1.77 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.798 0.333 . . . . 0.72 110.599 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 33.8 tt0 -75.12 107.44 7.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.873 -0.788 . . . . 0.49 108.873 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 202' ' ' GLU . 74.2 mt -121.19 135.82 60.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.027 0.441 . . . . 0.43 111.941 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 176' ' ' LEU . 45.3 t -100.98 107.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.16 -0.682 . . . . 0.3 109.16 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.17 26.66 9.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.241 0.46 . . . . 0.95 112.241 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.402 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.4 OUTLIER -105.24 121.08 43.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.849 0.356 . . . . 0.66 110.481 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.38 -165.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.7 111.231 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.608 ' OD2' ' HD2' ' A' ' 216' ' ' PRO . 0.1 OUTLIER -64.86 160.38 55.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.791 -0.641 . . . . 1.13 111.111 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.608 ' HD2' ' OD2' ' A' ' 215' ' ' ASP . 59.7 Cg_endo -70.52 -154.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.817 2.344 . . . . 0.3 113.05 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.62 -91.42 0.77 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.403 -0.679 . . . . 0.16 111.403 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.91 -0.38 21.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.24 110.732 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.507 ' HA ' HG22 ' A' ' 222' ' ' ILE . 2.5 p90 -62.42 -24.65 67.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.11 110.557 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -68.44 -29.81 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.354 0.597 . . . . 0.82 110.003 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.11 -34.29 38.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.325 -0.852 . . . . 1.51 110.988 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.571 ' O ' HG12 ' A' ' 226' ' ' ILE . 5.2 tt -77.58 -32.65 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.13 110.559 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.38 -28.34 65.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 0.12 111.05 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -54.28 -40.72 68.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.805 -0.634 . . . . 1.31 111.174 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 229' ' ' GLU . 0.9 OUTLIER -94.34 -38.43 10.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.553 -0.294 . . . . 0.15 110.541 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 222' ' ' ILE . 48.5 mm -54.08 -37.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.33 111.384 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 7.1 ptpp? -59.79 -23.33 63.2 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.789 0.663 . . . . 1.4 112.789 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.13 -25.15 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.443 . . . . 0.41 111.507 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -72.99 -44.15 61.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.944 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -135.06 -42.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.355 0.502 . . . . 0.2 112.355 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 24.8 mtpt -60.08 -25.75 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.801 0.297 . . . . 0.53 111.801 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -100.28 12.8 60.22 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.907 -0.663 . . . . 0.4 112.984 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -101.2 -15.0 17.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.39 110.574 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.4 -131.55 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.862 -0.685 . . . . 0.24 112.14 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 m -129.31 141.61 51.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 0.66 110.726 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.6 pt? -116.65 158.62 23.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.646 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.76 164.88 28.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.038 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.41 154.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.963 0.411 . . . . 0.58 111.267 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.61 110.572 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.668 0.618 . . . . 1.26 112.668 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.28 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 1.58 110.779 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -123.41 -81.01 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.535 -0.542 . . . . 2.1 109.535 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.44 98.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.445 -0.576 . . . . 0.89 109.445 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -141.82 145.1 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.863 -0.608 . . . . 0.52 110.331 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.01 13.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.244 -0.435 . . . . 0.57 111.709 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 p -96.02 -6.03 39.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.897 0.38 . . . . 1.0 111.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -151.02 52.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.154 0.502 . . . . 1.18 110.087 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.77 132.43 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.925 -0.58 . . . . 0.24 110.846 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.25 123.17 36.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.741 -0.466 . . . . 0.11 109.741 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 t -81.6 114.82 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.332 0.587 . . . . 0.17 111.147 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.757 HG13 HG13 ' A' ' 31' ' ' ILE . 1.3 p -125.0 133.04 70.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.939 -0.763 . . . . 0.17 108.939 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.402 HH12 ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -141.31 147.18 37.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.13 111.726 -178.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HD3' ' A' ' 24' ' ' ARG . 43.1 ttp -120.7 117.48 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.15 110.187 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -99.5 114.7 27.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.291 -0.413 . . . . 0.72 109.932 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HD3' ' SD ' ' A' ' 22' ' ' MET . 14.7 mmm-85 -100.55 -172.73 2.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.266 -0.425 . . . . 0.34 109.883 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.46 -24.24 46.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.844 0.313 . . . . 0.66 111.844 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.17 -58.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.418 -0.896 . . . . 1.09 113.135 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -123.26 175.91 6.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.079 0.466 . . . . 1.58 110.934 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.13 142.76 48.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 0.98 108.979 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -130.94 119.21 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.787 0.327 . . . . 0.86 111.147 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 130.8 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 1.11 109.915 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.757 HG13 HG13 ' A' ' 20' ' ' VAL . 7.2 pt -135.71 172.27 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.84 0.352 . . . . 0.26 110.661 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 122.31 22.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.262 -0.426 . . . . 0.21 110.387 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 m -118.63 -163.35 0.95 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 1.37 110.848 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 t80 -72.94 -171.15 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.3 110.715 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -71.59 -157.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.279 -0.419 . . . . 0.59 111.828 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -48.67 -22.64 0.82 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.303 0.853 . . . . 1.3 113.303 -178.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -60.69 -18.81 56.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.28 -22.81 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 111.842 0.312 . . . . 0.15 111.842 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.564 ' HB ' HG11 ' A' ' 97' ' ' VAL . 4.0 p -76.02 -10.83 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.016 0.436 . . . . 0.31 110.838 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 C-N-CA 120.986 -0.626 . . . . 0.1 112.073 179.699 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 6.8 ptmt . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 111.582 0.216 . . . . 1.26 111.582 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 5.5 t70 -169.32 123.15 0.79 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.629 -0.508 . . . . 0.93 109.629 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.83 -35.57 76.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.197 0.443 . . . . 0.2 112.197 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.11 -39.52 89.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.523 . . . . 0.75 110.375 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -91.57 16.93 9.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.682 -0.69 . . . . 0.82 110.603 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.1 -38.03 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 0.35 110.132 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 81.42 6.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.144 -0.48 . . . . 0.93 110.708 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 34' ' ' TYR . 39.2 mt-30 -61.66 -71.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.26 110.473 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -85.71 86.53 7.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.078 0.466 . . . . 0.41 109.987 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.72 66.6 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 1.4 110.381 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.0 m -154.76 131.42 10.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.21 -0.905 . . . . 0.39 108.782 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.9 p -103.49 136.08 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.283 0.564 . . . . 0.3 110.977 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -106.45 135.59 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.951 -0.568 . . . . 0.42 110.006 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 17.9 t -89.79 -30.88 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.464 0.65 . . . . 0.18 110.207 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -151.66 103.42 2.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.716 -0.675 . . . . 0.51 110.313 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.65 -23.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.847 0.356 . . . . 0.16 111.465 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -35.62 44.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.037 0.446 . . . . 0.21 110.856 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -89.11 -40.68 12.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.045 -0.525 . . . . 0.48 110.909 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.17 33.57 2.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.899 -0.667 . . . . 0.17 111.504 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.54 106.5 18.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.55 110.764 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.31 129.52 47.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.736 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.07 112.43 24.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.148 0.499 . . . . 0.22 110.759 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -82.35 -176.06 6.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.885 -0.598 . . . . 0.89 109.614 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -60.33 -34.34 73.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.597 0.221 . . . . 1.12 111.597 -178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.9 pm0 -72.86 -13.47 61.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.98 111.447 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.47 -48.52 5.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.839 -0.344 . . . . 0.44 110.574 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.58 -31.27 71.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.695 0.283 . . . . 0.27 111.081 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -23.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.27 0.557 . . . . 0.17 110.314 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.565 . . . . 0.27 110.535 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.82 -50.27 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.32 111.287 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CG ' HG13 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -90.78 -49.56 6.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.379 . . . . 0.55 110.47 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.42 6.03 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.262 -0.735 . . . . 0.28 111.262 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.35 143.36 27.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.279 -0.461 . . . . 0.98 110.407 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.75 -5.19 48.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 0.85 110.846 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -91.55 123.99 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.8 -0.444 . . . . 1.12 109.8 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.87 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.51 112.019 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -73.21 -32.61 64.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.38 . . . . 0.28 110.958 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -67.56 -36.93 81.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.221 -0.445 . . . . 0.24 111.125 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 77' ' ' PHE . 1.9 mp -66.57 -49.28 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.65 110.209 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.1 m -66.11 -26.07 67.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.19 111.523 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -57.14 -44.91 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.57 111.033 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.62 -40.83 61.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.417 -0.356 . . . . 0.39 110.98 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.497 HG22 HG22 ' A' ' 20' ' ' VAL . 63.3 mt -61.01 -36.55 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.883 0.373 . . . . 0.12 111.728 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.777 0.658 . . . . 0.11 112.777 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -105.8 -26.71 11.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.325 0.861 . . . . 0.19 113.325 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 91' ' ' THR . 31.3 mmmt -108.06 3.17 23.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.45 111.113 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.04 178.42 16.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.737 -0.744 . . . . 0.24 111.873 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.402 ' CD ' HH12 ' A' ' 21' ' ' ARG . 0.7 OUTLIER -95.54 122.52 38.37 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.958 -0.386 . . . . 0.24 109.958 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 HG13 ' A' ' 97' ' ' VAL . 3.3 p -119.18 137.21 53.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.022 -0.535 . . . . 0.22 109.973 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -77.23 84.0 3.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.084 0.468 . . . . 0.36 111.151 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.26 110.473 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.441 ' CG1' ' HG3' ' A' ' 166' ' ' LYS . 6.3 mt . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.836 0.35 . . . . 0.22 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t60 51.34 47.53 24.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.435 -0.802 . . . . 1.03 110.368 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.85 119.47 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.604 -0.726 . . . . 0.56 110.322 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 97.47 11.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.001 -0.545 . . . . 1.57 111.295 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.78 -169.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.76 -0.654 . . . . 1.52 109.708 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 66.6 mmtt -78.4 89.37 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.621 -0.511 . . . . 1.21 109.621 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -41.85 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.67 112.845 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.16 -12.84 62.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 2.43 111.968 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' GLN . 95.0 mttt -121.36 9.82 10.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.99 111.215 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -87.51 3.78 46.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.89 110.715 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -37.93 87.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.35 111.525 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -155.79 -26.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.915 0.339 . . . . 0.19 111.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 150' ' ' LYS . 43.3 tt0 -68.43 -60.46 2.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.69 110.778 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 159' ' ' VAL . 0.7 OUTLIER -94.33 14.29 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 1.81 111.155 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.07 111.548 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.75 -21.55 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.353 -0.385 . . . . 0.5 111.075 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.55 -39.14 20.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.311 -0.404 . . . . 1.04 110.451 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 155' ' ' GLN . 61.8 t -62.81 -49.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.083 -0.508 . . . . 0.14 111.083 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.7 tp -64.78 -33.56 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.16 110.536 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 1.6 mmmt -69.25 -43.01 74.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 1.48 110.174 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -61.26 -36.06 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.42 110.474 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.6 tp -69.06 -40.4 78.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.906 -0.588 . . . . 0.16 110.558 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -70.93 -11.11 60.78 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.881 -0.599 . . . . 1.02 111.177 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 36.3 mm-40 -73.48 -27.92 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.049 0.452 . . . . 0.98 110.074 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HG3' ' CG1' ' A' ' 142' ' ' ILE . 16.2 mmtt -93.14 -39.01 11.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.16 111.323 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 52.9 mtt -130.32 136.64 49.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.974 0.416 . . . . 0.35 110.896 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -79.77 81.61 6.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 1.61 110.421 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.4 pt . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.64 111.691 -179.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.266 -0.272 . . . . 1.34 110.266 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 213' ' ' LEU . 90.3 mtt180 -115.88 143.62 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 1.01 110.994 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.51 172.15 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.144 -0.48 . . . . 0.26 110.522 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.685 ' HB3' HG22 ' A' ' 211' ' ' VAL . 8.6 ptm180 -141.35 140.17 33.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.58 110.388 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.663 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 9.1 p90 -94.72 150.21 20.45 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.531 -0.468 . . . . 0.27 110.077 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.401 ' C ' HD13 ' A' ' 180' ' ' LEU . 8.4 tt -129.84 118.54 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.545 . . . . 0.46 111.214 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 179' ' ' ILE . 0.0 OUTLIER -152.22 156.87 34.02 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.746 -0.661 . . . . 0.29 110.245 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.22 173.09 10.04 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.397 2.064 . . . . 0.18 112.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.42 -42.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.298 0.481 . . . . 0.44 112.298 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.17 -38.71 87.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.751 0.31 . . . . 0.38 111.571 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.18 -34.81 28.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.043 0.449 . . . . 1.45 110.542 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.15 -29.75 71.97 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.13 112.569 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -65.97 -13.47 59.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.3 . . . . 0.69 111.513 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.92 -18.52 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.706 0.289 . . . . 0.92 110.89 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 178' ' ' PHE . 0.5 OUTLIER -122.98 -17.85 6.6 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.788 0.292 . . . . 1.05 111.788 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 85.4 tttt -55.57 -52.3 64.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.93 110.872 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -98.74 27.58 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.18 111.744 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -137.77 -40.95 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.857 0.317 . . . . 1.46 111.857 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 1.6 tm? -90.97 -40.94 11.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.845 0.355 . . . . 0.94 110.6 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpp -60.29 -48.37 94.2 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.566 . . . . 0.7 112.527 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.1 Cg_endo -58.53 -12.82 15.05 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.529 2.153 . . . . 0.16 113.464 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 192' ' ' LEU . 12.6 mt -76.93 -9.84 58.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.006 -0.368 . . . . 0.45 110.006 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.7 mt 59.3 31.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.517 -0.765 . . . . 0.38 111.14 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -113.51 30.44 7.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.105 -0.498 . . . . 0.56 109.793 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.16 155.43 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.555 -0.748 . . . . 0.38 111.072 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 1.4 mp -103.41 147.76 9.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.434 -0.803 . . . . 0.21 109.453 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -70.39 67.46 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.146 0.498 . . . . 1.15 111.781 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.1 m -156.33 33.4 0.33 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.42 -0.585 . . . . 0.25 109.42 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.1 OUTLIER -90.9 160.96 15.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.4 -0.818 . . . . 1.04 110.77 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.41 141.47 52.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.229 -0.656 . . . . 0.38 109.229 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -116.11 31.42 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.389 . . . . 0.65 110.933 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.81 -125.11 2.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.713 -0.755 . . . . 0.45 112.536 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.89 -31.61 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.195 0.521 . . . . 1.97 109.893 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -110.43 111.81 23.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.664 -0.865 . . . . 0.3 108.664 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.13 73.91 4.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.022 0.439 . . . . 0.49 111.121 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 42.5 mt-10 -83.47 111.6 19.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 1.23 110.523 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.663 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 22.5 mt -125.3 142.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.526 . . . . 0.37 110.908 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 177' ' ' ARG . 94.0 t -98.39 123.9 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.855 -0.794 . . . . 0.22 108.855 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.401 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 13.2 p -137.1 52.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.54 112.0 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 175' ' ' ARG . 4.1 mm? -122.25 114.74 21.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.19 -0.3 . . . . 0.56 110.19 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 215' ' ' ASP . 0.6 OUTLIER -104.99 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.381 -0.372 . . . . 0.72 110.339 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 214' ' ' ILE . 2.8 m-20 -80.5 164.27 52.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 1.24 110.624 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.75 -178.04 2.51 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.16 1.907 . . . . 0.35 112.176 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.2 -79.99 1.43 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.517 -0.849 . . . . 0.24 111.567 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -16.73 64.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.084 0.469 . . . . 0.4 110.878 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 1.3 p90 -62.41 -20.61 64.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.15 110.932 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 220' ' ' ARG . 6.3 tpt180 -65.43 -21.98 66.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.18 0.514 . . . . 0.23 110.303 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -76.29 -33.15 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.546 -0.752 . . . . 1.46 110.878 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 9.3 tt -95.15 -26.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 1.06 110.836 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -34.95 71.55 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.061 -0.518 . . . . 0.19 111.527 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -29.37 70.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.74 111.834 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -97.9 -30.89 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.518 -0.473 . . . . 0.44 111.825 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 222' ' ' ILE . 19.8 mm -57.33 -40.42 73.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 0.21 111.152 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.0 ptpp? -69.23 -8.39 45.42 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.28 0.845 . . . . 0.91 113.28 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -124.7 -31.1 3.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.563 -0.455 . . . . 0.26 111.842 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -54.21 7.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.296 0.48 . . . . 1.1 112.296 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.0 t -108.02 -42.86 4.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.733 0.642 . . . . 0.13 112.733 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 79.4 tttt -61.42 -34.69 75.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 1.98 111.234 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.12 10.41 73.66 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.473 -0.87 . . . . 0.62 112.684 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -140.69 20.32 2.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 1.53 111.141 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 173.67 -145.71 8.4 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.582 -0.818 . . . . 0.37 112.357 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.4 m -138.62 147.31 42.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.374 -0.232 . . . . 0.43 110.374 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 1.1 pt? -121.5 135.45 55.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.849 0.357 . . . . 0.43 110.333 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -129.1 173.28 10.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 1.15 110.422 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -79.4 164.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.56 -0.291 . . . . 0.12 110.696 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 175' ' ' ARG . 1.2 pt? . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 1.31 110.179 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.741 0.305 . . . . 0.61 110.651 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.759 -0.459 . . . . 0.75 109.759 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -71.73 -40.34 69.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 0.73 109.464 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -129.4 98.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.674 -0.861 . . . . 0.95 108.674 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -144.97 135.77 24.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.408 -0.36 . . . . 1.78 110.868 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 17' ' ' VAL . 98.5 mt -66.16 -16.61 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 1.34 112.02 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -89.65 -2.97 58.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.756 0.313 . . . . 0.62 111.382 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -114.75 14.61 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.58 110.544 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' LEU . 23.2 m -86.93 151.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.008 -0.542 . . . . 0.28 111.39 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.72 53.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.653 -0.703 . . . . 0.25 109.626 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.59 117.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.959 0.409 . . . . 0.59 111.139 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 89' ' ' ILE . 1.5 p -138.59 125.43 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.932 -0.576 . . . . 0.18 110.291 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 143.38 50.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.042 0.448 . . . . 2.38 111.598 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.402 ' HB2' HG23 ' A' ' 89' ' ' ILE . 11.3 ttt -109.15 129.12 55.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.607 -0.724 . . . . 0.24 110.047 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -100.09 116.62 32.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.662 0.267 . . . . 1.04 110.746 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -112.0 41.18 2.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 2.46 110.165 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 63.35 90.42 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.522 -0.763 . . . . 0.6 111.061 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.52 -48.29 3.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 0.29 112.017 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -98.63 108.56 21.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.052 0.453 . . . . 1.32 110.659 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.512 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.39 143.95 48.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 1.89 109.979 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.546 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 97.0 m-85 -132.59 150.01 52.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.55 110.441 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -138.87 154.06 48.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.662 0.268 . . . . 1.26 110.594 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.431 HD12 HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -137.55 169.66 18.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.892 -0.594 . . . . 0.51 110.153 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.46 21.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.369 . . . . 0.21 111.384 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -121.54 165.61 15.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.917 -0.583 . . . . 0.5 110.333 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -75.0 129.7 38.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.067 0.46 . . . . 0.31 111.373 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 37' ' ' LYS . 67.8 tttt -67.85 147.51 52.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.636 -0.711 . . . . 1.17 111.057 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.14 -21.47 0.25 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.86 0.864 . . . . 0.7 111.816 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 35' ' ' LYS . 28.7 mmtm -94.91 -45.08 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.051 0.453 . . . . 0.62 110.467 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 p -68.67 -18.27 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.955 -0.566 . . . . 0.33 111.864 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 97' ' ' VAL . 7.6 p -67.71 -16.37 20.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.171 0.51 . . . . 0.41 110.641 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-N 115.762 -0.654 . . . . 0.13 112.701 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 109.953 -0.388 . . . . 0.48 109.953 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -52.29 117.88 3.14 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.469 0.481 . . . . 1.28 110.19 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.26 -4.03 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.603 0.594 . . . . 0.58 112.603 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.94 -35.47 8.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.074 0.464 . . . . 1.56 109.838 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.65 -36.45 73.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 1.83 109.734 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.06 -24.25 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.17 110.779 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.33 87.14 6.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.12 110.008 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -64.11 -53.53 48.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.2 111.286 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -128.53 107.44 9.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.142 -0.481 . . . . 1.43 110.895 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.8 71.1 5.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.512 0.673 . . . . 0.79 110.277 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.4 m -153.15 130.66 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.303 -0.862 . . . . 0.33 109.329 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 29' ' ' PHE . 7.2 p -107.25 140.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.25 110.606 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 149.94 24.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.482 . . . . 0.41 111.568 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.4 t -112.76 -40.43 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.66 -0.7 . . . . 0.54 109.584 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -154.55 116.41 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 1.2 109.038 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.36 -25.18 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.949 0.352 . . . . 0.55 111.949 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -49.41 77.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.58 111.515 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -101.36 10.89 40.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.85 111.251 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.02 56.45 25.12 Favored Glycine 0 C--O 1.229 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.37 112.931 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -102.34 114.46 28.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.668 0.271 . . . . 0.65 110.328 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.9 t -112.43 131.66 63.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.28 109.676 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -84.71 120.3 26.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.977 0.417 . . . . 0.19 111.384 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 3.1 tppt? -78.27 171.82 14.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.851 -0.796 . . . . 2.02 108.851 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 19.2 pttp -59.9 -18.29 43.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 1.66 111.284 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -87.1 -7.24 58.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.52 111.644 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -114.87 -44.44 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 1.95 111.563 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 69' ' ' LYS . 2.7 pp -61.83 -23.22 66.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.879 0.371 . . . . 0.27 110.96 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 73' ' ' LEU . 16.6 tt -66.92 -35.99 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.363 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -8.86 51.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.41 111.152 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.67 -14.77 19.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.218 -0.446 . . . . 0.34 111.044 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -121.32 -43.41 2.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.48 111.008 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.61 -14.25 7.68 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.632 -0.587 . . . . 0.08 111.632 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 81' ' ' ASP . 6.0 m -151.48 150.71 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.407 -0.59 . . . . 0.19 109.407 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.38 -4.77 59.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.683 0.277 . . . . 0.22 111.148 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 79' ' ' THR . 15.1 t70 -59.48 109.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.495 . . . . 1.15 110.469 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.03 -38.96 93.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 1.26 111.532 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -43.77 98.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.71 111.793 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -62.3 -45.69 92.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.622 0.248 . . . . 0.83 111.536 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -64.18 -48.17 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.26 109.982 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 43.2 t -61.95 -42.65 99.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.32 110.471 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -56.75 -47.23 80.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.98 111.214 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -46.6 88.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.812 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG22 HG22 ' A' ' 20' ' ' VAL . 90.4 mt -65.12 -32.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.961 -0.563 . . . . 0.29 110.512 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -81.46 -4.51 56.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.23 111.428 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.413 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 88.3 m -105.35 -46.98 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.082 -0.247 . . . . 0.37 111.374 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' THR . 7.8 mmmm -122.53 40.06 3.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.137 0.494 . . . . 2.72 110.817 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.75 21.66 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.664 -0.698 . . . . 0.15 111.521 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.77 94.09 8.09 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.921 -0.4 . . . . 2.32 109.921 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 HG13 ' A' ' 97' ' ' VAL . 3.5 p -102.69 143.26 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.3 111.308 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.04 89.18 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.867 -0.606 . . . . 1.02 110.911 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 39' ' ' VAL . 10.5 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.095 -0.502 . . . . 0.39 110.759 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.808 -0.441 . . . . 0.34 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 46.09 58.43 4.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.666 -0.697 . . . . 1.37 111.923 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -124.1 143.04 50.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.52 110.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 m -129.67 158.98 37.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.176 -0.676 . . . . 0.33 109.176 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 t -76.67 -55.12 11.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.776 0.322 . . . . 0.43 110.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 149' ' ' ASN . 0.5 OUTLIER -159.35 135.04 8.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.98 110.27 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -8.16 55.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.985 0.421 . . . . 0.18 111.346 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 147' ' ' LYS . 9.7 m120 -85.14 -2.17 57.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.201 0.524 . . . . 0.52 110.343 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -114.35 145.7 41.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.599 -0.728 . . . . 0.44 109.229 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 86.5 p -76.0 169.45 18.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.934 0.397 . . . . 0.24 110.716 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -36.07 74.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.81 111.536 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.65 -11.94 58.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 1.35 111.451 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.01 -11.44 44.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.382 -0.372 . . . . 1.1 111.767 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 151' ' ' SER . 19.0 pt20 -137.88 13.89 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.38 110.763 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.42 68.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.14 111.475 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.72 -23.56 64.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.62 111.054 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -99.19 -42.65 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.425 -0.352 . . . . 1.77 111.011 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 155' ' ' GLN . 89.1 t -57.5 -36.03 52.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.21 111.352 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.6 tt -73.79 -10.23 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.173 0.511 . . . . 0.86 110.749 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -109.06 -9.2 15.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 1.26 109.964 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -53.69 38.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.12 110.542 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -71.02 -16.61 62.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.48 -0.327 . . . . 0.17 110.63 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -23.35 65.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.013 -0.539 . . . . 0.3 109.846 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -76.46 -29.14 56.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.345 -0.613 . . . . 0.38 109.345 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.59 -54.29 5.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.237 -0.892 . . . . 0.91 109.446 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.3 mmt -125.36 109.13 12.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.83 109.349 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -77.19 108.67 10.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.093 0.473 . . . . 0.94 111.213 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.769 -0.651 . . . . 0.28 110.334 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.533 0.206 . . . . 0.65 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -117.33 130.66 56.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.566 0.222 . . . . 1.1 110.525 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.16 153.82 39.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.45 -0.341 . . . . 0.43 111.311 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 237' ' ' GLU . 5.7 ptm180 -119.63 169.83 9.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.723 -0.671 . . . . 1.14 109.305 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.419 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 2.9 p90 -138.69 138.26 37.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.963 0.411 . . . . 0.74 110.792 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.31 118.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 0.22 109.718 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.938 HD12 ' HD2' ' A' ' 181' ' ' PRO . 43.6 tp -156.4 126.57 3.34 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.685 -0.234 . . . . 0.26 110.59 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.938 ' HD2' HD12 ' A' ' 180' ' ' LEU . 14.9 Cg_endo -58.48 156.36 31.7 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.963 2.442 . . . . 0.28 112.549 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.43 -40.24 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.817 0.673 . . . . 0.17 112.817 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.46 -42.98 61.96 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.386 0.513 . . . . 0.5 112.386 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HB3' HD21 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -99.08 -26.6 14.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.267 -0.424 . . . . 0.41 110.986 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.08 -29.68 71.64 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.104 -0.498 . . . . 0.28 113.113 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 74.4 tttt -62.13 -23.13 66.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.775 0.288 . . . . 0.53 111.366 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -68.55 -36.72 79.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.35 110.658 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -89.87 -27.05 20.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.949 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -54.83 -52.51 62.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 1.01 111.791 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 190' ' ' GLU . 5.4 pt-20 -86.46 24.54 1.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.147 0.425 . . . . 1.76 112.147 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.39 -41.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.807 -0.357 . . . . 0.71 111.593 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 226' ' ' ILE . 31.6 mt -85.98 -47.56 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.974 0.361 . . . . 0.41 111.974 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 22.7 mtpp -59.89 -51.78 78.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.648 0.61 . . . . 0.53 112.648 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.6 Cg_endo -61.59 -20.06 67.27 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.383 2.055 . . . . 0.41 113.24 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.5 8.01 33.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.543 0.211 . . . . 0.56 110.742 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.8 pt 35.97 60.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.255 1.022 . . . . 0.41 113.67 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -136.51 26.62 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.634 0.731 . . . . 0.96 109.65 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.77 151.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 114.844 -1.071 . . . . 0.24 109.831 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.452 HD13 HG12 ' A' ' 211' ' ' VAL . 3.5 mp -93.37 149.03 4.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.115 -0.493 . . . . 0.16 110.573 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 67.88 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.314 0.578 . . . . 1.8 111.562 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -149.66 38.75 0.77 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.302 -0.629 . . . . 0.56 109.302 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 210' ' ' ILE . 18.9 mt-10 -86.92 172.34 10.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.104 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.5 118.62 4.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.784 -0.821 . . . . 0.99 108.784 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.22 114.9 28.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.661 0.267 . . . . 1.1 110.925 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -163.05 -104.67 0.19 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.884 -0.674 . . . . 0.36 111.541 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -16.37 32.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.539 0.685 . . . . 1.91 109.367 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.47 HE21 ' HB2' ' A' ' 209' ' ' GLU . 2.8 pm0 -142.22 172.68 12.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.109 -0.95 . . . . 1.11 108.749 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.28 84.4 2.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.682 -0.488 . . . . 0.19 109.682 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB2' HE21 ' A' ' 207' ' ' GLN . 2.9 tp10 -85.99 112.82 21.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.622 -0.717 . . . . 0.93 109.758 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 202' ' ' GLU . 51.0 mt -132.16 146.02 33.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.614 0.245 . . . . 0.39 110.574 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 199' ' ' ILE . 59.0 t -100.03 113.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.43 109.691 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 20.3 t -132.73 97.64 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.19 110.699 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.9 106.25 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 0.37 109.875 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 215' ' ' ASP . 8.1 tp -90.72 168.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.367 -0.379 . . . . 0.55 110.685 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.418 ' H ' HG13 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -68.03 164.4 41.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.443 -0.344 . . . . 1.18 110.449 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.58 170.73 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.996 2.464 . . . . 0.33 113.392 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 92.24 -87.28 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.773 -0.931 . . . . 0.38 110.773 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.71 -1.92 27.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 1.09 110.861 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.48 -33.46 69.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.542 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -81.15 -16.76 52.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.133 0.492 . . . . 1.0 110.78 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.5 -44.33 24.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.72 109.521 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 226' ' ' ILE . 11.6 tt -78.07 -38.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.672 -0.695 . . . . 0.3 110.3 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 0.6 OUTLIER -60.49 -28.71 68.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.997 0.427 . . . . 0.31 110.413 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.593 ' O ' ' HE2' ' A' ' 228' ' ' LYS . 14.5 tp10 -51.02 -46.12 61.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.283 -0.871 . . . . 1.95 111.008 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -90.7 -29.28 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.395 -0.366 . . . . 0.17 111.277 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 222' ' ' ILE . 32.2 mm -58.23 -38.89 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.915 0.339 . . . . 0.24 111.915 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.9 ptpt -64.6 -10.15 24.32 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.147 0.795 . . . . 1.08 113.147 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.593 ' HE2' ' O ' ' A' ' 224' ' ' GLU . 5.7 pttt -124.72 -32.78 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.655 -0.418 . . . . 1.25 111.132 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -47.17 73.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 1.43 111.997 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 188' ' ' LEU . 4.0 t -130.11 -41.55 1.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.129 0.418 . . . . 0.16 112.129 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 0.3 OUTLIER -67.3 -21.7 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.951 0.405 . . . . 1.78 110.805 -179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.73 14.41 64.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.889 -0.672 . . . . 0.45 111.978 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -135.51 -45.82 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.82 110.835 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -109.22 -154.97 16.15 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.799 -0.715 . . . . 0.53 112.225 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -120.94 152.81 38.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.275 -0.269 . . . . 0.16 110.275 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.0 pt? -95.44 150.0 20.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.99 110.496 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 177' ' ' ARG . 9.6 tp10 -150.24 160.03 43.99 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.341 -0.614 . . . . 0.88 109.341 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.17 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.88 0.372 . . . . 0.25 111.013 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.238 0.457 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.609 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.646 -0.501 . . . . 0.69 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -172.03 168.73 5.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -91.27 -57.84 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 0.8 109.889 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.1 mt -129.69 105.16 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 0.35 110.024 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -177.71 149.1 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.141 -0.688 . . . . 1.18 109.141 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.45 61.09 0.66 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.124 0.487 . . . . 0.23 112.04 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -42.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 0.35 109.327 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -105.1 37.14 2.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.4 109.941 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 15.7 m -102.47 155.66 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.16 111.589 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . . . -118.46 125.45 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.503 -0.771 . . . . 0.26 109.29 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.27 133.58 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.448 . . . . 0.57 111.676 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 4.1 p -133.78 129.9 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.66 -0.7 . . . . 0.24 109.504 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.22 140.42 52.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 1.86 111.906 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 59.0 ttp -123.26 125.71 45.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.24 109.691 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -100.04 118.8 37.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.656 0.265 . . . . 0.92 110.757 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -113.21 -159.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.77 110.791 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.56 -73.73 0.07 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.152 -0.477 . . . . 0.37 111.684 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.27 29.78 5.62 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.468 -0.872 . . . . 0.15 112.335 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 11.3 tppt? -156.03 146.56 21.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.238 -0.282 . . . . 0.46 110.238 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' MET . 12.2 ptt-85 -141.0 93.16 2.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.046 0.45 . . . . 2.38 110.308 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 96.0 m-85 -76.93 152.41 35.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 1.33 111.671 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 15.0 pt-20 -146.86 133.02 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.15 109.583 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -132.11 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.97 0.414 . . . . 0.4 110.957 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -137.18 110.77 8.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.14 110.516 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.4 m -106.89 -175.81 2.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.909 -0.587 . . . . 0.59 110.559 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' HA ' HE21 ' A' ' 54' ' ' GLN . 3.0 t80 -66.69 122.77 18.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.006 0.431 . . . . 0.31 110.544 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 32.1 ttpt -60.29 124.83 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.745 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.0 t30 66.28 3.73 2.88 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.832 -1.076 . . . . 0.84 113.414 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 44.2 tptt -107.51 -33.79 7.23 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.673 -0.642 . . . . 1.1 110.242 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.57 -22.05 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.837 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.27 -18.11 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.64 109.86 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.624 0 CA-C-N 115.75 -0.659 . . . . 0.13 112.219 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 19.9 ptmt . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.445 0.165 . . . . 1.32 111.445 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -178.0 126.5 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.238 -0.282 . . . . 0.52 110.238 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 52' ' ' VAL . 48.3 mt -61.6 -29.01 69.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 1.63 112.048 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.21 -35.69 55.42 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.707 -0.397 . . . . 0.92 110.698 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.54 -29.14 41.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 1.22 110.945 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.5 p -72.17 -12.57 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.052 0.453 . . . . 0.27 110.792 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.63 HD21 ' SG ' ' A' ' 86' ' ' CYS . 2.1 mm? -94.19 97.53 10.33 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.566 -0.531 . . . . 0.58 109.566 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 34' ' ' TYR . 73.2 mt-30 -66.03 -39.55 90.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.42 110.83 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 t -117.3 136.63 52.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.798 0.332 . . . . 0.42 110.539 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -100.32 16.06 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 0.69 110.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 m -110.28 112.28 24.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.713 -0.676 . . . . 0.66 110.024 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 31' ' ' ILE . 7.2 p -92.12 139.22 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.2 110.221 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.42 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 11.7 m-85 -100.89 160.71 14.14 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.023 -0.362 . . . . 0.44 110.023 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.94 -61.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.063 0.459 . . . . 0.46 110.834 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.13 92.42 3.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.43 110.41 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -65.68 -24.69 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.174 0.511 . . . . 0.37 110.43 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -29.56 67.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.7 -0.682 . . . . 0.99 111.387 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.12 -34.58 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 1.43 110.74 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.88 41.35 2.31 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.261 -0.736 . . . . 0.48 111.261 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -105.19 121.07 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.785 0.326 . . . . 1.21 111.179 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.03 141.55 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.37 109.93 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.78 104.09 13.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.132 0.491 . . . . 0.23 109.84 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -82.29 -174.9 5.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.27 110.842 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -34.17 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.762 0.652 . . . . 0.91 112.762 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 pm0 -80.84 -4.07 53.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.822 0.344 . . . . 0.92 111.302 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.65 -52.23 3.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 0.18 110.502 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.331 . . . . 0.24 111.706 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.02 -22.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.17 110.949 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -103.06 -32.47 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.62 111.46 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.31 -36.63 46.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.31 111.5 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.68 -51.5 2.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 2.09 110.109 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.93 -37.75 2.41 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.48 111.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.35 147.4 26.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.623 0.249 . . . . 1.42 110.38 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -100.3 -7.56 24.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.448 -0.342 . . . . 1.1 111.628 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.18 126.24 38.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.722 0.296 . . . . 1.21 110.719 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.462 HE22 HG21 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -63.3 -27.47 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 0.43 111.815 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -63.58 -39.92 95.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.878 0.371 . . . . 0.58 110.468 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.37 -40.66 85.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.25 110.747 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.99 -48.19 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.885 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 53' ' ' LEU . 36.8 t -65.12 -29.61 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.725 . . . . 0.2 111.39 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -58.67 -49.53 77.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.397 . . . . 0.34 110.827 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -68.95 -37.42 78.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.798 -0.637 . . . . 1.45 110.551 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 31' ' ' ILE . 97.4 mt -69.22 -31.02 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.497 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.66 -18.86 56.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.976 0.361 . . . . 0.37 111.976 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 t -108.31 -34.78 6.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.652 -0.419 . . . . 0.42 112.066 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -101.51 7.12 42.52 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.917 0.389 . . . . 0.67 110.564 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.22 175.34 17.34 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.523 -0.846 . . . . 0.1 112.778 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -102.14 119.04 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.935 -0.394 . . . . 1.34 109.935 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.65 146.63 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.704 -0.68 . . . . 0.29 110.252 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.69 101.62 1.07 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.62 110.122 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.989 -0.55 . . . . 0.42 111.358 -179.091 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.8 mt . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.465 -0.198 . . . . 0.54 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 58.5 49.94 9.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.177 -0.465 . . . . 1.11 110.601 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.28 87.26 6.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.136 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -81.92 121.91 27.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.728 -0.669 . . . . 0.52 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.6 -76.01 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.416 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.631 -0.507 . . . . 0.63 109.631 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 123.1 15.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.279 0.362 . . . . 0.51 110.671 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.0 p30 43.38 46.35 5.55 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.134 0.896 . . . . 0.16 112.406 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.477 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -59.09 -53.96 52.41 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.108 -0.701 . . . . 0.63 109.108 178.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 155' ' ' GLN . 2.7 p -103.31 179.95 4.12 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.668 -0.697 . . . . 0.22 109.439 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 150.02 49.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.753 0.279 . . . . 0.7 111.753 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tttm 64.11 46.44 3.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.791 -0.641 . . . . 0.28 111.774 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.4 ' HG3' ' NE2' ' A' ' 155' ' ' GLN . 7.8 tp60 59.23 71.39 0.59 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.658 -0.701 . . . . 0.33 111.369 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 151' ' ' SER . 1.9 pm0 44.36 39.26 2.98 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.871 0.868 . . . . 0.07 112.782 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.84 -35.77 75.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.11 112.02 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 4.1 mm? -67.2 -27.54 67.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.878 0.371 . . . . 0.26 110.765 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.477 ' OE1' ' HB3' ' A' ' 150' ' ' LYS . 3.5 mp0 -82.42 -44.81 15.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 163' ' ' LEU . 98.9 t -61.79 -43.52 97.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.17 111.238 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.9 tt -66.61 -10.77 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.284 -0.416 . . . . 0.31 112.063 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -115.17 -10.54 12.14 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.173 -0.329 . . . . 1.18 110.883 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -87.18 -36.96 17.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.395 . . . . 0.71 111.547 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -74.89 -13.67 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.18 110.91 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.542 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.4 tmmt? -62.83 -25.03 68.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.971 -0.559 . . . . 0.38 110.659 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.34 -24.74 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.005 -0.543 . . . . 0.7 110.666 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -93.48 -48.65 6.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.384 -0.598 . . . . 1.48 109.384 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 19.7 mmt -127.34 104.89 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.098 -0.705 . . . . 1.59 109.098 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -87.96 127.81 35.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.03 0.443 . . . . 1.08 111.232 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.612 -0.722 . . . . 0.22 110.399 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.685 0.278 . . . . 1.75 110.66 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.94 130.92 41.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.263 -0.426 . . . . 1.01 110.73 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 213' ' ' LEU . 16.9 tp -116.91 130.84 56.96 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.53 -0.544 . . . . 1.25 109.53 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -126.28 164.13 21.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.88 0.371 . . . . 0.65 110.236 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 94.5 m-85 -122.51 145.04 48.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.635 -0.505 . . . . 0.35 109.635 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -127.69 114.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.501 0.667 . . . . 0.31 111.526 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -147.45 158.96 42.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.31 109.626 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.66 173.92 6.12 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.333 2.022 . . . . 0.16 112.417 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' VAL . 3.3 t -54.01 -31.4 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.4 112.009 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -53.54 -59.5 4.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.974 0.416 . . . . 0.28 110.579 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -77.31 -24.43 50.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.74 110.264 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 189' ' ' LYS . . . -59.92 -35.64 87.6 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.865 -0.607 . . . . 0.21 112.239 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -77.73 2.72 16.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.7 0.285 . . . . 0.92 110.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 190' ' ' GLU . 69.9 mmtt -104.09 -48.43 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.581 -0.281 . . . . 1.34 111.412 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.417 ' CD2' ' HA2' ' A' ' 185' ' ' GLY . 1.3 pt? -79.44 -26.22 41.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.67 111.549 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 17.5 ttpt -66.38 -26.53 67.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 0.65 111.307 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 187' ' ' LYS . 0.4 OUTLIER -95.47 1.36 53.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.457 -0.338 . . . . 0.57 111.465 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.467 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 27.8 mttp -122.97 -43.07 2.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.362 0.504 . . . . 0.86 112.362 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.16 -44.3 47.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.192 0.442 . . . . 0.25 112.192 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.5 mtpt -58.95 -51.36 82.41 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.841 0.682 . . . . 0.22 112.841 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.1 Cg_endo -61.91 -9.1 13.21 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.307 2.005 . . . . 0.19 113.513 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 73.8 mt -81.69 -6.97 59.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.14 110.477 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.2 mm 52.36 53.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.695 -0.684 . . . . 0.19 111.036 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -146.62 27.03 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.717 -0.674 . . . . 1.03 110.181 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.68 147.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.993 -0.549 . . . . 0.11 111.073 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 214' ' ' ILE . 4.2 mp -101.41 144.62 12.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.19 109.926 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -68.78 80.55 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.289 0.566 . . . . 2.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.6 t -160.21 17.3 0.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.92 109.376 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.3 mp0 -75.29 134.03 41.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.22 110.547 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -100.71 136.73 40.12 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.837 -0.619 . . . . 0.79 109.673 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 144.24 44.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.712 0.291 . . . . 0.83 110.348 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 152.69 -121.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.719 -0.753 . . . . 0.22 111.58 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -82.01 -24.33 35.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.194 0.521 . . . . 0.45 110.074 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -124.82 158.7 32.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.472 -0.786 . . . . 1.75 109.543 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.68 91.7 3.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.041 -0.355 . . . . 0.4 110.041 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 45.6 mt-10 -94.6 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.301 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.9 mt -119.01 142.38 34.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.715 -0.221 . . . . 0.28 110.863 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.74 134.63 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.963 -0.384 . . . . 0.34 109.963 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 14.6 t -119.55 -32.75 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.744 0.646 . . . . 1.33 112.744 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -74.56 121.56 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.825 0.345 . . . . 0.75 111.477 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.613 ' HB ' HD11 ' A' ' 199' ' ' ILE . 4.0 tt -125.47 -54.63 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.676 . . . . 0.57 111.185 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 219' ' ' PHE . 0.4 OUTLIER -140.09 161.3 56.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.877 -0.416 . . . . 0.26 109.877 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 219' ' ' PHE . 97.8 Cg_endo -77.52 -173.37 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.437 2.092 . . . . 0.27 113.117 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 75.01 -88.39 0.77 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.91 -0.586 . . . . 0.39 112.439 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.62 -18.69 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.659 0.384 . . . . 1.21 111.173 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 2.3 p90 -63.69 -25.22 68.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.84 110.597 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 220' ' ' ARG . 2.1 tpp180 -76.72 -32.11 57.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.62 110.139 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.46 -43.21 70.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.492 . . . . 1.12 110.64 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 6.3 tt -73.71 -23.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.054 0.455 . . . . 0.19 110.789 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.7 -29.58 68.2 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.16 111.486 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.6 -30.32 65.21 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.585 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.4 pp -105.0 -35.32 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.997 -0.281 . . . . 0.29 111.317 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.42 HG12 HG12 ' A' ' 222' ' ' ILE . 24.9 mm -55.23 -36.39 39.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 120.788 0.327 . . . . 0.21 111.721 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -62.38 -17.22 58.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.669 0.618 . . . . 0.72 112.669 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.68 -23.98 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.62 111.07 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HG3' ' HD3' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -68.2 -47.54 67.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 1.92 111.713 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.4 t -129.98 -32.45 1.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.674 -0.41 . . . . 0.21 111.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 76.8 tttt -66.56 -30.42 70.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.181 0.515 . . . . 0.3 110.132 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -97.7 23.77 34.53 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.73 -0.668 . . . . 0.22 111.696 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -133.9 -36.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.24 110.31 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.38 -176.89 16.93 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.848 -0.691 . . . . 0.28 111.753 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.3 t -87.36 159.76 18.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 0.46 110.333 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 153.65 25.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.198 -0.455 . . . . 0.41 110.947 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.16 143.29 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.781 -0.645 . . . . 1.89 109.705 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.09 124.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.523 . . . . 0.28 111.367 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 109.299 -0.63 . . . . 0.44 109.299 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 121.052 0.453 . . . . 0.87 111.087 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 27.3 t-20 -144.2 149.12 35.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.549 . . . . 1.46 109.831 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -54.96 40.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.742 0.306 . . . . 0.4 111.701 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mt -91.17 63.54 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.104 0.478 . . . . 0.7 111.242 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 2.4 mmp_? -136.43 148.98 48.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 1.39 110.479 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.45 -0.92 56.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.49 110.333 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -77.62 -41.34 38.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.263 0.554 . . . . 0.44 110.456 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -108.48 78.52 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.818 -0.628 . . . . 0.59 109.936 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.46 HG12 ' OE1' ' A' ' 54' ' ' GLN . 19.2 m -120.54 140.81 43.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.017 -0.538 . . . . 0.17 111.128 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -110.64 116.3 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.087 -0.708 . . . . 0.18 109.087 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.64 110.52 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 0.2 111.591 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 89' ' ' ILE . 3.6 p -102.13 137.79 28.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.997 -1.112 . . . . 0.12 107.997 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 136.82 49.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.326 0.584 . . . . 0.33 112.453 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 36.7 ttp -121.38 120.62 35.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.032 -0.986 . . . . 0.28 109.488 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.28 129.96 55.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.909 -0.404 . . . . 0.89 109.909 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -108.7 35.92 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.409 -0.36 . . . . 0.63 110.771 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.19 63.75 1.81 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.648 0.737 . . . . 0.32 109.942 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.94 -70.43 0.48 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.211 -1.155 . . . . 0.2 110.211 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -87.23 135.82 33.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 1.17 109.217 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -128.23 151.63 49.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.4 111.322 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -141.08 126.23 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.3 110.347 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 132.34 56.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.11 -0.495 . . . . 0.19 110.08 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.43 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -129.52 149.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.84 110.688 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.23 115.98 31.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.2 110.909 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.1 p -149.08 141.01 23.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.58 109.983 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -114.58 -84.42 0.61 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.227 -0.189 . . . . 0.65 111.091 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 65.16 -179.94 0.19 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.808 0.692 . . . . 1.02 111.559 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.62 78.16 9.9 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.279 -1.008 . . . . 1.79 108.279 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt 67.88 78.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.372 -0.831 . . . . 0.9 109.422 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.42 -26.56 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.489 -0.778 . . . . 0.38 111.782 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.48 -28.83 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.46 110.687 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.15 111.814 179.559 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 109.979 -0.378 . . . . 0.47 109.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 164.51 4.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.023 0.439 . . . . 1.22 111.932 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.718 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -84.22 -8.74 58.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.566 . . . . 0.15 111.311 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -27.33 66.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.311 -0.404 . . . . 0.85 110.808 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -104.18 16.85 25.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.47 111.813 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' LEU . 3.0 p -108.3 -27.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.465 -0.494 . . . . 0.22 110.991 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 53' ' ' LEU . 1.2 mm? -80.35 91.36 5.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.397 -0.365 . . . . 0.24 110.766 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' OE1' HG12 ' A' ' 17' ' ' VAL . 69.2 mt-30 -69.31 -31.06 69.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.47 0.652 . . . . 0.3 109.717 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -140.82 126.5 19.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.239 -0.891 . . . . 0.43 109.264 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -86.77 42.74 1.03 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.28 110.629 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.7 113.76 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.833 -0.621 . . . . 0.45 110.267 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.4 p -91.5 138.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.741 -0.466 . . . . 0.37 109.741 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.02 150.18 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.306 -0.406 . . . . 0.19 111.116 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.42 -47.38 7.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.27 109.429 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -130.57 103.28 6.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 0.33 109.349 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.0 -28.09 23.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 113.044 0.757 . . . . 0.22 113.044 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 p -82.12 -27.57 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.525 -0.47 . . . . 0.64 111.81 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -100.54 -2.04 34.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.97 111.093 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.55 45.29 78.7 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.21 113.1 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.33 112.3 25.06 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.921 -0.399 . . . . 0.65 109.921 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.09 144.38 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 0.46 110.752 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.663 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.98 109.56 20.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.635 -0.506 . . . . 0.31 109.635 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.631 ' HB3' ' OE2' ' A' ' 71' ' ' GLU . 7.5 mtpt -78.88 176.62 9.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.886 -0.597 . . . . 1.28 110.878 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.77 -32.11 67.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 1.09 112.176 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.631 ' OE2' ' HB3' ' A' ' 69' ' ' LYS . 1.7 pm0 -93.25 4.0 54.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.756 0.312 . . . . 1.02 111.166 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -105.69 -46.49 4.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 2.16 110.206 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 1.5 pp -63.77 -33.56 75.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.048 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 tt -68.54 -21.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.231 0.538 . . . . 0.65 110.432 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -99.38 1.09 44.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.66 110.635 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.93 -51.35 2.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.49 110.931 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.61 -15.35 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 1.51 110.864 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.03 -25.35 20.31 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.749 -0.738 . . . . 0.25 112.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 138.26 31.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.68 0.276 . . . . 0.31 110.805 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.9 -5.52 55.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.424 0.631 . . . . 0.64 109.6 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.37 117.01 28.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.162 -0.926 . . . . 0.43 110.511 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -68.75 -22.17 64.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.81 111.062 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -47.0 77.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.19 111.064 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -56.43 -39.63 73.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.224 0.535 . . . . 1.34 110.382 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 89' ' ' ILE . 66.9 mt -70.22 -48.2 62.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.683 -0.69 . . . . 0.14 110.106 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 31' ' ' ILE . 51.6 t -58.61 -40.24 82.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 0.12 110.243 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 91' ' ' THR . 5.3 tttp -58.64 -47.19 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 1.05 109.88 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.05 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 1.67 110.937 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 20' ' ' VAL . 69.0 mt -67.54 -29.9 47.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.046 0.45 . . . . 0.3 110.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -35.19 35.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.031 -0.531 . . . . 0.2 111.976 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 87' ' ' LYS . 6.9 t -96.38 -18.05 20.2 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.998 0.74 . . . . 0.26 112.998 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -124.42 17.35 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.32 111.283 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.91 178.44 18.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.59 -0.814 . . . . 0.23 112.459 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.09 112.23 24.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 2.68 110.615 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 97' ' ' VAL . 11.0 p -103.21 155.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.46 109.756 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -71.34 99.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.026 0.441 . . . . 0.62 110.487 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 95' ' ' VAL . 17.6 m . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.4 110.481 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 122.053 0.93 . . . . 0.74 110.06 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -122.33 -2.25 9.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.536 -0.756 . . . . 0.97 110.734 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -78.65 124.24 27.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.319 -0.4 . . . . 1.65 111.029 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.4 m 55.39 34.47 22.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.574 -0.739 . . . . 0.55 112.261 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.92 -53.3 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.58 110.679 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 152' ' ' THR . 45.9 tttt -134.7 14.41 3.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 1.19 110.208 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 116.94 10.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.681 -0.69 . . . . 0.5 110.84 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 67.8 66.16 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.097 0.559 . . . . 0.54 110.797 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -164.48 159.46 19.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.154 -0.684 . . . . 0.36 109.154 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.52 154.38 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 1.28 110.297 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -57.67 -49.55 76.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.857 0.688 . . . . 0.81 112.857 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -82.22 -16.07 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.628 0.251 . . . . 1.23 111.673 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.76 -59.19 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.24 111.826 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.8 mp0 -105.2 23.29 13.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.528 -0.305 . . . . 0.32 111.552 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.976 0.362 . . . . 0.21 111.976 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.8 mm? -78.45 -16.75 57.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.269 -0.423 . . . . 0.57 111.908 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.21 -42.38 10.45 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.906 -0.317 . . . . 0.78 110.988 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 155' ' ' GLN . 86.3 t -59.12 -39.05 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.402 -0.363 . . . . 0.24 111.273 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.61 -19.74 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.336 -0.393 . . . . 0.55 111.283 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -99.34 -16.94 18.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 1.23 110.595 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -62.55 1.46 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.73 111.035 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -71.71 -17.7 62.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.3 111.467 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.454 ' N ' HD13 ' A' ' 163' ' ' LEU . 6.4 tmtt? -70.26 -34.28 72.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.888 0.375 . . . . 1.16 110.628 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -77.76 -34.47 52.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 1.76 110.579 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -35.95 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.3 0.572 . . . . 0.75 109.972 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 tpt -124.24 91.16 3.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.703 -0.851 . . . . 0.24 108.703 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.42 101.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.391 0.615 . . . . 1.34 111.674 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.1 pt . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.129 -0.941 . . . . 0.28 109.775 178.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 53.5 mtt . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.633 0.254 . . . . 1.0 110.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 54.7 mtt180 -135.13 117.51 15.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 1.19 111.116 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.479 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 13.7 mt -108.22 152.51 24.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.867 -0.606 . . . . 2.2 110.213 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.401 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 19.7 ptt180 -140.82 159.97 41.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.222 -0.445 . . . . 0.35 110.176 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 0.8 OUTLIER -134.17 132.82 40.26 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.181 -0.674 . . . . 0.09 109.181 178.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.2 tt -126.73 123.16 62.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.114 0.483 . . . . 0.1 111.476 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.9 OUTLIER -159.76 156.01 23.69 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 0.23 110.028 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.87 143.36 30.45 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.861 2.374 . . . . 0.09 112.428 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.82 -31.54 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.45 112.427 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -54.89 -46.45 74.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.583 0.23 . . . . 1.38 111.534 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.25 -30.79 17.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.92 109.841 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.39 -29.78 72.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.467 -0.788 . . . . 0.18 113.08 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -59.34 -26.41 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 0.49 111.087 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -44.52 73.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.81 110.523 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 3.0 pp -76.76 -22.91 53.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.26 110.053 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 71.3 tttt -63.0 -35.34 79.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.92 110.189 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -101.07 18.31 20.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.783 -0.644 . . . . 1.65 110.981 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -131.28 -52.79 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.064 0.394 . . . . 0.7 112.064 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 212' ' ' CYS . 1.1 tm? -86.35 -44.18 12.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.17 111.722 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpt -57.13 -48.42 97.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.809 0.67 . . . . 0.21 112.809 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.9 Cg_endo -59.04 -16.64 33.87 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.298 1.998 . . . . 0.26 113.282 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 56.0 mt -74.2 -15.82 61.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 0.36 110.162 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 16.7 mt 56.45 60.63 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.645 -0.707 . . . . 0.75 111.586 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -135.3 10.06 3.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.691 -0.686 . . . . 1.49 109.737 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.2 167.48 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.582 -0.735 . . . . 0.34 111.672 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.72 148.48 10.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.42 -0.809 . . . . 0.29 108.945 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.12 57.99 0.36 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.263 0.554 . . . . 1.19 111.711 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -146.35 55.84 1.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.39 109.275 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.1 pt-20 -106.13 167.7 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.45 111.516 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.9 t70 -131.51 123.53 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.78 31.49 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.91 110.802 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.09 -102.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.596 -0.811 . . . . 0.32 112.067 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -95.78 -31.09 13.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.439 0.638 . . . . 0.34 109.577 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.18 136.96 54.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.384 -0.825 . . . . 0.58 109.44 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 203' ' ' ASP . 36.1 tp -88.82 99.65 12.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.077 0.465 . . . . 0.15 110.265 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 50.2 tt0 -109.38 114.78 28.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.2 109.712 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 178' ' ' PHE . 21.3 mt -127.39 141.13 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 0.12 110.891 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.8 125.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.089 -0.708 . . . . 0.2 109.089 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 192' ' ' LEU . 50.8 t -139.83 99.97 3.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.578 0.227 . . . . 0.25 111.454 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.479 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER 177.73 121.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.966 -0.753 . . . . 0.46 108.966 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -116.0 -40.41 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 111.832 0.308 . . . . 1.53 111.832 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.45 143.69 36.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.879 0.326 . . . . 0.69 111.879 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.68 -30.16 35.03 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.875 2.383 . . . . 0.27 112.077 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.5 -23.37 75.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.915 -0.66 . . . . 0.39 111.761 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.7 6.75 44.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.215 0.531 . . . . 1.43 110.572 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.34 -47.68 81.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.716 -0.674 . . . . 0.97 110.526 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -66.17 -23.68 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.627 . . . . 2.03 111.087 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.54 -42.82 28.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.778 -0.646 . . . . 2.19 111.507 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 0.6 OUTLIER -82.1 -33.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.07 0.396 . . . . 1.3 112.07 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.79 -24.49 67.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.881 0.372 . . . . 0.47 111.045 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 12.9 mm-40 -61.76 -31.41 71.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 0.5 111.408 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.7 OUTLIER -102.6 -36.79 8.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.117 -0.233 . . . . 0.29 110.82 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.8 mm -53.88 -34.35 25.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.61 -0.268 . . . . 0.15 111.72 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.2 ptpt -55.99 -32.06 63.58 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.126 0.417 . . . . 1.36 112.126 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -108.72 -27.15 9.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.007 0.432 . . . . 0.56 110.881 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.57 . . . . 0.62 112.091 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -149.73 -30.89 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.008 0.744 . . . . 0.17 113.008 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 33.3 ttmt -58.9 -37.56 76.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.95 0.341 . . . . 2.23 111.84 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.25 18.6 51.13 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.678 -0.772 . . . . 0.19 112.629 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -129.99 -47.84 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.62 110.501 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -119.65 -158.01 10.48 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.209 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.3 m -108.09 138.64 44.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.346 . . . . 0.31 110.532 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 150.09 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 1.37 109.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.43 167.77 23.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.053 0.454 . . . . 1.19 110.764 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.13 150.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.6 109.742 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 239' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.046 0.451 . . . . 0.4 110.503 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.53 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -153.71 156.83 38.54 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.259 -0.645 . . . . 0.2 109.259 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.1 -19.23 28.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.083 0.401 . . . . 0.83 112.083 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.32 70.94 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.299 0.571 . . . . 1.13 110.803 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -146.35 149.49 33.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.749 -0.66 . . . . 0.85 109.998 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 17' ' ' VAL . 86.1 mt -67.13 -9.32 38.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.443 0.535 . . . . 0.48 112.443 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -90.86 2.67 55.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 0.33 111.48 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -135.35 32.43 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.213 0.53 . . . . 1.12 110.532 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 14' ' ' LEU . 27.2 m -84.32 152.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.69 -0.686 . . . . 0.31 111.514 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.43 140.76 48.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.843 -0.617 . . . . 0.19 110.053 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.48 117.7 32.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.204 0.526 . . . . 0.41 110.948 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -147.62 117.47 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.25 109.993 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 149.29 50.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.26 111.11 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 55.9 ttp -122.14 139.37 53.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.336 -0.847 . . . . 0.36 110.472 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -116.11 120.99 40.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.714 -0.476 . . . . 0.29 109.714 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -122.37 89.47 3.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.549 -0.296 . . . . 0.68 110.52 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.15 46.75 23.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.693 -0.685 . . . . 0.58 111.734 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.91 -48.78 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.448 -0.882 . . . . 0.47 112.815 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -69.38 129.22 39.14 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.199 -0.297 . . . . 0.45 110.199 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -119.11 143.64 47.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.763 0.316 . . . . 0.77 111.336 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -132.87 142.42 48.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.3 109.82 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 24.9 tt0 -146.54 133.02 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.62 -0.511 . . . . 1.75 109.62 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -136.49 130.38 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.326 -0.397 . . . . 0.44 110.01 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 113.09 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.15 111.686 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 31.2 m -107.55 175.91 5.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.786 -0.643 . . . . 0.17 110.219 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CD1' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.77 150.42 37.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.098 0.475 . . . . 0.32 111.084 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -87.5 -7.85 57.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.457 0.539 . . . . 1.53 112.457 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -78.63 78.33 5.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.55 111.76 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 52.27 63.24 2.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.89 -0.596 . . . . 1.71 111.852 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 7.9 p -70.45 -24.2 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.954 -0.566 . . . . 0.54 110.714 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.14 -5.35 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 111.276 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.391 0 C-N-CA 121.239 -0.505 . . . . 0.18 112.852 -179.723 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.753 0.311 . . . . 1.75 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -167.69 160.43 12.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.974 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tp -109.92 -14.63 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.43 110.886 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.28 -40.54 6.71 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.611 -0.514 . . . . 0.23 109.611 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.48 -24.91 61.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.913 -0.585 . . . . 1.88 110.345 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' TYR . 12.0 p -70.88 -26.55 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.415 -0.587 . . . . 0.32 109.415 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.55 97.71 7.96 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.89 110.189 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -67.23 -37.03 82.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.22 108.904 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 t -157.52 126.09 5.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.773 -1.103 . . . . 0.44 108.98 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 10.5 p80 -77.7 67.17 3.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.556 0.693 . . . . 0.47 110.556 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -138.59 111.84 8.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.292 -0.867 . . . . 0.91 110.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.4 p -100.68 135.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.19 110.103 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -91.66 163.84 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.92 0.39 . . . . 2.09 111.238 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.44 -49.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.019 -0.734 . . . . 0.98 109.019 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -142.46 103.63 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.722 . . . . 0.27 109.173 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.9 -26.9 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.19 -0.459 . . . . 0.39 112.132 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 m -72.42 -36.06 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.9 0.381 . . . . 0.27 110.971 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.68 5.85 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.193 -0.458 . . . . 0.27 110.845 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.0 44.19 96.4 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.207 -0.52 . . . . 0.14 112.79 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -112.63 121.96 46.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.863 0.363 . . . . 0.94 110.736 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.78 170.4 7.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.98 -0.554 . . . . 1.29 109.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.714 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -115.45 120.96 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.082 0.467 . . . . 0.37 111.049 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -87.74 -178.28 6.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.078 -0.712 . . . . 1.26 109.078 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' OE1' ' A' ' 71' ' ' GLU . 3.1 pttp -56.56 -39.39 73.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.842 0.353 . . . . 1.61 111.333 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' OE1' ' HG3' ' A' ' 70' ' ' LYS . 7.1 pm0 -75.75 -11.25 59.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 1.79 111.847 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -98.03 -48.69 5.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.655 -0.248 . . . . 0.98 110.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.72 -32.81 73.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.737 -0.211 . . . . 0.33 111.514 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 79' ' ' THR . 6.9 tt -64.51 -26.78 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.085 0.469 . . . . 0.45 110.455 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 m -95.55 -10.46 29.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 1.06 110.276 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.22 -54.69 4.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.736 -0.666 . . . . 0.36 111.252 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -100.72 -37.87 8.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.58 111.33 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.66 -18.17 8.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.293 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.73 141.57 30.58 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.165 -0.309 . . . . 0.36 110.165 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -14.26 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.27 111.09 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' OD1' HG22 ' A' ' 83' ' ' THR . 17.0 t0 -90.09 125.14 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.59 110.178 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.95 -21.76 54.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.07 -0.514 . . . . 0.68 112.171 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.419 HG22 ' OD1' ' A' ' 81' ' ' ASP . 2.5 t -68.0 -31.51 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.224 -0.591 . . . . 1.49 110.034 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 74.3 mm-40 -70.22 -36.78 74.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.092 -0.707 . . . . 1.08 109.092 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 89' ' ' ILE . 32.6 mm -64.34 -45.73 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.206 -0.906 . . . . 0.28 109.172 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.49 -42.3 91.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.38 110.575 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.86 -38.32 90.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 1.86 110.189 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 7.5 mm100 -64.28 -39.95 94.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.05 109.76 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.65 HG22 HG22 ' A' ' 20' ' ' VAL . 45.1 mt -67.66 -26.75 36.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.38 110.391 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.411 HD22 HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.75 -27.4 31.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.29 111.731 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.36 -30.86 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.62 0.6 . . . . 0.52 112.62 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -111.45 -3.73 15.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.029 0.442 . . . . 0.7 110.939 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.5 178.77 22.61 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.673 -0.775 . . . . 0.3 112.516 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.2 112.02 24.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.41 . . . . 1.31 110.573 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 20' ' ' VAL . 7.3 p -101.03 148.09 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.605 -0.725 . . . . 0.36 110.219 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -62.36 100.17 0.17 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.386 0.612 . . . . 0.49 111.058 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.77 111.142 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 7.0 tp . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.234 -0.284 . . . . 0.32 110.234 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 35.5 t60 50.57 57.91 6.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.932 -0.576 . . . . 1.03 110.914 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CD2' ' HG2' ' A' ' 162' ' ' GLN . 44.0 t80 -97.16 136.34 37.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.731 . . . . 1.42 110.059 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.9 124.05 22.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.721 0.296 . . . . 0.36 110.305 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.25 39.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.195 0.522 . . . . 0.29 111.012 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 55.02 83.96 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 1.01 111.989 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -14.51 62.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.982 -0.554 . . . . 0.59 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -102.0 14.88 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.514 0.673 . . . . 0.57 109.188 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 151' ' ' SER . 61.6 mttp -147.65 -149.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.584 -0.734 . . . . 0.62 109.832 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 154' ' ' GLN . 4.1 t -152.99 175.94 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.918 -0.401 . . . . 0.18 109.918 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -65.8 -36.18 82.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.52 111.941 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -76.73 -9.46 58.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.419 -0.355 . . . . 0.38 111.487 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -74.97 -47.57 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.58 110.113 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -161.77 73.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.81 110.987 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -75.26 -24.74 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.48 110.745 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.18 -51.16 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.607 . . . . 0.64 110.878 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.84 -35.27 79.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.41 110.625 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.6 -52.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.22 110.981 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.2 tp -66.01 -31.98 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.349 -0.387 . . . . 0.19 111.125 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -72.41 -31.66 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.6 110.479 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.512 ' HG2' ' CD2' ' A' ' 144' ' ' TYR . 7.4 tp-100 -68.93 -37.78 79.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.76 109.928 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.59 -40.61 97.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.25 109.994 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -66.29 -21.27 66.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.366 -0.834 . . . . 0.45 111.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -71.08 -28.6 64.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.829 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.491 ' HG3' ' HB ' ' A' ' 142' ' ' ILE . 7.1 mmtt -93.09 -41.62 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.42 110.036 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.9 mmm -130.53 99.53 5.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 1.82 109.498 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.35 93.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.165 0.507 . . . . 0.77 110.973 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.49 -0.777 . . . . 0.18 109.859 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 109.518 -0.549 . . . . 0.73 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.99 126.93 22.28 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.921 0.391 . . . . 0.87 110.74 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.48 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 5.7 mp -113.16 144.59 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.199 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 16.0 ptt180 -123.67 138.66 54.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.926 -0.579 . . . . 0.13 110.125 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 71.9 m-85 -106.3 124.58 49.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.035 -0.357 . . . . 0.1 110.035 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.18 112.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.32 111.291 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.416 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -153.83 152.81 27.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.829 -0.623 . . . . 0.21 110.137 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.98 153.36 74.03 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.124 1.883 . . . . 0.14 111.06 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.74 -30.96 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.77 111.329 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.99 -41.94 62.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 1.32 110.584 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -97.56 -31.9 12.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.59 110.781 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.33 -31.05 68.89 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.86 -0.609 . . . . 0.3 112.597 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -64.36 -16.27 61.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.56 0.219 . . . . 2.34 111.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -82.89 -44.5 15.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.72 111.004 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 -23.29 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 0.49 111.311 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -54.54 -55.32 30.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.48 111.325 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -82.89 29.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.366 -0.379 . . . . 0.53 111.629 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -134.8 -48.9 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.5 110.45 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.4 mt -78.83 -39.83 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.58 111.705 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 39.7 mtpt -64.68 -50.51 64.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.529 0.566 . . . . 1.39 112.529 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.7 Cg_endo -62.28 -15.79 46.96 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.978 1.786 . . . . 0.15 112.879 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.44 2.96 49.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.549 -0.296 . . . . 0.3 110.223 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 23.7 pt 41.2 41.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.252 1.021 . . . . 0.13 112.746 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.483 ' HG2' HD12 ' A' ' 222' ' ' ILE . 12.2 mptt -117.8 18.76 14.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.548 0.69 . . . . 1.4 109.798 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 212' ' ' CYS . 22.6 m -111.82 164.06 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.27 -0.877 . . . . 0.33 110.565 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.91 138.48 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.793 -0.817 . . . . 0.25 108.793 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.49 70.96 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.422 0.629 . . . . 1.75 111.374 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.5 m -144.73 28.15 1.3 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.742 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 9.1 pt-20 -85.73 168.78 14.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 1.9 110.62 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -131.34 126.83 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.19 110.681 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.54 79.14 4.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 1.55 110.915 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -125.7 2.68 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.247 -0.741 . . . . 0.33 111.247 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.83 -36.55 17.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.453 0.645 . . . . 2.76 109.726 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -113.35 114.64 26.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.146 -0.933 . . . . 2.24 108.99 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.51 80.72 4.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.141 0.496 . . . . 0.55 110.38 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 28.0 tt0 -80.19 105.68 11.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.66 110.115 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.12 138.27 37.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.36 110.473 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.19 113.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.2 109.826 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.748 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.6 p -138.81 105.5 5.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.028 0.442 . . . . 0.18 111.168 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -148.86 144.96 27.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.275 -0.639 . . . . 0.61 109.275 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.1 tt -137.26 163.17 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.588 -0.278 . . . . 0.38 110.45 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 165.7 4.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.828 0.451 . . . . 0.74 110.808 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.53 -172.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.457 2.105 . . . . 0.23 112.855 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 81.12 -92.6 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.699 -0.762 . . . . 0.21 111.537 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.19 -12.36 50.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 1.44 110.957 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.485 ' HA ' HG22 ' A' ' 222' ' ' ILE . 79.7 t80 -58.2 -30.68 66.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.396 . . . . 0.15 110.617 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -69.4 -18.63 63.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 1.5 110.732 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -90.3 -35.24 15.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.469 -0.332 . . . . 1.11 111.24 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 5.3 tt -82.35 -34.88 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.552 0.215 . . . . 0.14 111.266 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.64 -25.74 66.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.183 0.516 . . . . 0.8 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.21 -32.35 66.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.421 -0.808 . . . . 0.64 111.45 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.48 -36.13 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.784 -0.367 . . . . 0.75 110.433 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.1 mm -53.86 -41.09 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 116.556 -0.293 . . . . 0.37 111.367 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.8 ptpt -55.94 -31.1 62.63 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.887 -0.597 . . . . 0.3 112.603 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.546 ' HE3' ' C ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.63 2.62 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.852 0.316 . . . . 2.25 111.852 -178.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 6.5 tp10 -94.25 -56.39 2.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.36 . . . . 0.89 110.865 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t -126.66 -21.85 4.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.083 -0.508 . . . . 0.19 111.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.514 ' HD2' HD22 ' A' ' 236' ' ' LEU . 26.2 tptp -61.88 -50.51 71.92 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.842 -0.429 . . . . 0.35 109.842 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.74 34.65 4.52 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.17 111.77 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -129.9 -30.4 2.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.747 0.308 . . . . 1.77 110.538 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -151.3 -151.37 5.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.712 -0.756 . . . . 0.35 112.368 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.2 m -110.81 145.85 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.125 -0.324 . . . . 0.33 110.125 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 231' ' ' LYS . 1.2 pt? -114.58 145.37 42.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 0.57 110.659 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.61 170.63 15.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.497 -0.774 . . . . 1.16 109.173 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.17 153.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.404 -0.591 . . . . 0.21 109.404 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.16 109.921 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.52 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -153.62 -171.77 4.01 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.845 -0.428 . . . . 0.63 109.845 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -84.62 -85.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.911 0.386 . . . . 1.18 111.021 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.461 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 mp -93.74 83.49 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.195 0.522 . . . . 0.54 110.721 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.4 mmt85 -141.55 148.59 39.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.81 109.972 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' HA ' HG13 ' A' ' 17' ' ' VAL . 6.4 mp -75.41 -9.75 58.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.066 0.46 . . . . 1.32 111.258 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.29 9.11 30.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 0.59 111.336 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -145.03 37.65 1.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.55 109.743 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 14' ' ' LEU . 30.6 m -88.84 -168.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.32 -0.855 . . . . 0.25 111.916 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.29 152.94 36.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.553 -0.748 . . . . 0.28 109.496 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.07 119.4 47.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.864 0.364 . . . . 0.15 110.749 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -155.47 110.32 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.19 109.784 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -128.61 142.16 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.61 111.665 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 37.7 ttp -112.73 129.57 56.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.48 110.033 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 124.76 47.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 1.46 110.028 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -104.19 -166.49 1.25 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.688 -0.687 . . . . 0.76 110.3 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.23 90.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.427 -0.351 . . . . 0.7 111.037 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.06 46.17 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.594 -0.813 . . . . 0.23 112.442 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -172.82 156.83 3.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.977 -0.379 . . . . 1.59 109.977 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 145.13 48.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.61 109.779 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -134.23 138.61 45.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.378 -0.373 . . . . 0.5 110.639 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 34.6 tt0 -144.19 142.53 30.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.58 0.229 . . . . 1.28 110.664 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.93 -164.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.559 . . . . 0.1 110.107 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.4 153.35 51.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.391 -0.225 . . . . 0.32 110.391 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 42.5 m -133.39 127.3 33.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.852 0.358 . . . . 0.23 111.297 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 2.1 t80 -62.89 122.28 15.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.41 112.375 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 55.72 17.49 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.066 -0.97 . . . . 1.06 112.81 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 62.19 23.35 13.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.0 0.429 . . . . 0.85 110.35 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -74.52 -1.13 20.01 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.246 0.462 . . . . 1.06 112.246 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.98 -23.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.53 . . . . 0.14 110.423 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.15 -7.46 9.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.82 -0.627 . . . . 0.14 109.798 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.331 0 CA-C-N 115.62 -0.718 . . . . 0.21 111.95 179.538 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tptp . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.682 0.277 . . . . 0.55 111.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.71 127.55 28.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.444 -0.798 . . . . 0.47 110.941 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.45 -10.17 59.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.023 -0.535 . . . . 0.62 111.088 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -105.15 -9.7 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 0.67 111.072 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -102.08 -39.34 7.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 1.27 110.21 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 6.6 p -72.94 -20.13 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.25 111.077 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.17 102.79 14.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.393 -0.367 . . . . 0.1 110.391 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 12' ' ' ILE . 57.6 mt-30 -82.89 -73.54 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.165 -0.471 . . . . 0.36 110.428 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 m -67.2 106.48 2.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.81 -0.632 . . . . 0.08 110.3 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -87.97 49.63 1.84 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.461 0.648 . . . . 0.41 110.427 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 p -161.11 141.97 11.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.064 -0.971 . . . . 0.12 108.872 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.8 p -109.98 145.47 16.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.262 -0.273 . . . . 0.1 110.262 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -89.67 160.66 16.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.634 0.254 . . . . 0.09 111.057 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 84.9 t -123.35 -50.98 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.34 109.945 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 65.8 m-20 -129.23 112.46 13.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.61 109.427 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 7.3 p -79.63 -34.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.83 0.348 . . . . 0.33 111.42 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -78.18 -28.1 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 1.08 110.926 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -94.35 -6.85 43.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.167 -0.469 . . . . 1.01 110.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.03 53.92 36.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.017 -0.611 . . . . 0.6 112.045 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 12.2 mm100 -121.96 121.39 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.37 111.015 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.0 t -110.68 146.0 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.493 -0.776 . . . . 0.27 109.632 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -100.99 121.94 42.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.23 110.27 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 -171.87 2.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.068 -0.716 . . . . 0.67 109.068 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -56.86 -39.68 74.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.835 0.309 . . . . 0.68 111.835 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -72.74 -16.74 61.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.624 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.86 -53.48 4.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.061 0.457 . . . . 0.12 110.654 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.99 -23.81 66.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.1 111.754 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -64.16 -30.37 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.863 0.363 . . . . 0.54 110.64 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -97.2 -23.27 16.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.841 0.353 . . . . 0.26 110.599 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.13 -47.72 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.36 110.974 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 -59.03 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.53 110.401 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.72 -37.43 1.03 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.544 -0.836 . . . . 0.16 112.506 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.56 135.1 44.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.452 0.168 . . . . 0.31 111.054 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.402 ' HB3' HG13 ' A' ' 74' ' ' ILE . 6.5 p-10 -84.77 43.63 1.0 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 0.53 111.02 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.7 130.89 46.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.193 -0.458 . . . . 0.23 110.128 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -64.74 -27.26 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 1.01 111.368 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.571 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 1.1 m -65.65 -35.7 81.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.189 0.518 . . . . 0.23 111.074 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.86 -24.94 60.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.098 -0.501 . . . . 1.34 110.567 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' HG13 ' A' ' 89' ' ' ILE . 29.6 mm -84.17 -51.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.13 110.822 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 30.0 p -60.63 -37.12 80.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.21 111.917 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -64.08 -30.12 71.21 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.898 0.38 . . . . 1.69 110.613 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -77.9 -38.99 44.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.931 -0.396 . . . . 1.88 109.931 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 20' ' ' VAL . 56.5 mt -67.1 -25.3 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.24 110.5 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 20' ' ' VAL . 1.5 mm? -81.55 -35.65 30.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.747 -0.66 . . . . 0.18 112.061 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 -20.56 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.733 0.642 . . . . 0.29 112.733 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' MET . 5.2 mmtm -127.78 23.09 6.25 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.879 -0.329 . . . . 0.47 111.632 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.14 -176.02 14.22 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.228 -0.987 . . . . 0.13 113.501 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 mm-40 -101.88 105.07 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.287 -0.457 . . . . 1.62 109.924 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.05 146.0 15.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.444 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -66.69 97.96 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.381 . . . . 1.14 110.221 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 121.058 0.456 . . . . 1.17 110.908 -179.748 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.88 0.371 . . . . 0.22 110.134 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 60.74 28.12 17.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.348 -0.842 . . . . 0.89 112.01 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -124.19 129.37 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.74 -0.467 . . . . 0.45 109.74 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.73 141.13 37.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.0 -0.545 . . . . 0.21 110.826 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.75 -63.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.346 -0.388 . . . . 0.18 110.564 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -151.32 129.09 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.131 -0.322 . . . . 1.46 110.131 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 145.82 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 0.54 111.65 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.8 t30 66.39 9.87 6.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.24 112.196 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -84.66 140.35 31.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.249 -0.648 . . . . 0.65 109.249 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.3 m -59.02 132.68 54.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.96 -0.385 . . . . 0.4 109.96 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -45.13 73.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.541 0.571 . . . . 0.74 112.541 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -64.07 -25.18 67.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.389 0.514 . . . . 2.29 112.389 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.52 -25.72 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.871 0.323 . . . . 2.17 111.871 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 25.6 pt20 -109.32 12.81 24.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.922 0.391 . . . . 0.37 111.114 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.16 87.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.25 111.142 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.0 mm? -67.3 -31.5 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.41 110.645 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -76.04 -36.22 59.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.399 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 155' ' ' GLN . 94.5 t -65.12 -48.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.19 110.758 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.22 -33.78 64.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.826 0.346 . . . . 0.22 110.711 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.4 mtmt -67.86 -46.29 72.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.326 . . . . 1.22 110.121 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -65.86 -36.32 83.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.7 110.72 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.19 -42.85 99.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.35 110.317 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 167' ' ' MET . 1.4 tmmt? -60.57 -28.72 68.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.492 -0.777 . . . . 0.5 111.306 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.3 mm-40 -70.47 -25.62 63.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.474 . . . . 1.36 110.887 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -99.9 -39.1 8.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 0.71 111.052 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 36.2 ttm -135.25 129.16 33.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.843 -0.428 . . . . 1.44 109.843 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -80.97 97.79 7.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.95 0.405 . . . . 0.73 111.182 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.546 . . . . 0.3 110.299 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.222 -0.659 . . . . 2.04 109.222 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 83.7 mtm180 -133.59 129.58 37.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.968 0.413 . . . . 0.99 111.181 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 6.0 mt -116.65 151.59 35.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 1.14 109.915 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 211' ' ' VAL . 6.8 ptm180 -134.69 135.21 41.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.322 -0.399 . . . . 0.26 110.446 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 49.1 m-85 -102.17 128.04 48.84 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.991 -0.374 . . . . 0.28 109.991 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.59 123.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 0.38 111.196 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -150.46 160.61 32.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.562 -0.744 . . . . 0.13 110.052 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.03 165.64 11.95 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.779 2.319 . . . . 0.13 112.567 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.24 -41.42 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.399 -0.364 . . . . 0.4 111.76 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -59.3 -47.49 85.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.9 111.078 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.58 53.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 0.63 111.581 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.3 71.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.177 -0.535 . . . . 0.2 113.13 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -71.44 -8.17 52.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.828 0.307 . . . . 0.49 111.828 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -87.66 -6.04 58.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.64 0.257 . . . . 0.85 111.066 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -26.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.675 -0.238 . . . . 0.4 111.342 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -56.78 16.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.838 0.351 . . . . 1.46 111.235 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.64 10.5 3.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -118.14 -41.68 2.86 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.684 0.253 . . . . 0.67 111.684 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.33 -38.46 18.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.981 0.363 . . . . 0.4 111.981 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 11.0 mtpt -59.52 -47.54 97.6 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.597 0.591 . . . . 0.36 112.597 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.9 Cg_endo -64.6 -8.95 18.79 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.468 2.112 . . . . 0.2 113.474 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.1 mt -90.46 -5.15 56.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.858 0.361 . . . . 0.09 110.203 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.2 mm 58.09 54.18 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.666 0.746 . . . . 0.11 110.309 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 222' ' ' ILE . 70.3 mmtt -125.97 16.99 7.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.454 -0.794 . . . . 0.16 110.556 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.95 142.37 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.608 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.94 159.03 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.527 -0.761 . . . . 0.47 109.547 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -70.77 53.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.25 0.463 . . . . 1.87 112.25 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.7 m -167.18 100.58 0.52 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.496 0.719 . . . . 0.73 109.797 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -128.05 145.78 50.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.26 111.361 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 209' ' ' GLU . 12.2 t70 -106.27 119.3 38.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.874 -0.417 . . . . 0.25 109.874 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.16 101.39 6.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.74 109.909 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -156.98 -109.4 0.29 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.954 -0.641 . . . . 0.26 111.741 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -88.69 -13.35 39.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.631 0.729 . . . . 1.39 109.037 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 207' ' ' GLN . 0.4 OUTLIER -138.58 -177.32 4.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.612 -1.176 . . . . 0.85 108.536 179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 40.9 tp -134.1 117.22 16.36 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.813 -0.439 . . . . 0.33 109.813 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 48.3 tt0 -128.77 117.6 21.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.053 -0.522 . . . . 0.34 109.632 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.79 141.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.825 0.345 . . . . 1.53 111.125 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 177' ' ' ARG . 58.7 t -92.46 111.23 24.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.471 -0.566 . . . . 0.23 109.471 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 60.29 0.71 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.992 0.425 . . . . 0.45 111.706 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -138.59 113.94 9.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.79 -78.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.13 111.567 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -138.92 160.83 61.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.521 -0.309 . . . . 0.21 110.766 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.53 176.19 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.55 2.166 . . . . 0.23 111.712 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 77.24 -75.4 1.77 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.499 -0.858 . . . . 0.15 111.883 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -5.25 32.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.69 0.281 . . . . 1.96 110.843 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 7.7 p90 -59.71 -23.53 63.24 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.19 110.991 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.445 ' HA ' ' OD1' ' A' ' 223' ' ' ASP . 1.2 tpm_? -60.32 -27.89 67.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.875 0.369 . . . . 2.32 110.884 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -50.23 65.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.3 110.499 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 8.3 tt -81.33 -34.9 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 1.02 111.854 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 219' ' ' PHE . 0.0 OUTLIER -64.34 -28.07 69.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.722 0.296 . . . . 1.71 111.299 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -66.49 -36.13 81.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.69 110.382 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -90.89 -39.71 12.15 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.678 -0.409 . . . . 0.12 110.92 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.3 mm -55.7 -36.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.463 -0.335 . . . . 0.3 111.604 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 7.9 ptpt -56.49 -23.72 41.31 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.739 0.644 . . . . 0.64 112.739 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.5 pttm -121.26 -19.19 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.798 0.296 . . . . 0.9 111.798 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -78.64 -32.27 47.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.29 112.34 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -143.26 -33.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.446 -0.502 . . . . 0.16 111.364 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 44.3 tttm -66.12 -18.66 65.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.177 0.513 . . . . 0.26 110.529 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.82 15.47 28.85 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.12 111.512 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -128.49 -35.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.725 0.297 . . . . 0.39 110.73 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.95 -150.29 6.55 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.91 -0.662 . . . . 0.18 112.742 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.2 m -116.71 145.84 43.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.318 . . . . 0.82 110.812 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.5 pt? -106.4 137.45 44.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.943 0.401 . . . . 0.15 110.688 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -129.31 163.75 25.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.66 110.444 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.14 169.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.371 -0.377 . . . . 0.39 110.797 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.877 0.37 . . . . 1.32 111.138 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 16' ' ' ASN . 7.9 p . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.642 0.258 . . . . 0.42 110.729 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -131.58 -82.63 0.51 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.615 0.245 . . . . 1.15 110.683 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -129.34 -122.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.601 -0.272 . . . . 1.23 110.598 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.95 94.42 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.23 110.636 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 13' ' ' ARG . 10.3 mmt85 -134.4 -171.47 2.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.686 -0.688 . . . . 1.51 109.759 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.54 12.65 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.275 0.559 . . . . 1.37 110.379 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.65 -32.75 7.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 0.66 111.833 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 9' ' ' THR . 26.0 p-10 -97.63 18.62 15.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 1.1 111.443 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.1 m -85.8 157.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.599 0.714 . . . . 0.34 112.786 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.11 140.05 53.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.625 -1.17 . . . . 0.42 108.96 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -89.08 98.57 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.49 111.311 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.777 HG22 HG22 ' A' ' 89' ' ' ILE . 2.3 p -103.36 120.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.847 -0.615 . . . . 0.24 109.696 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -122.75 132.56 54.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.28 112.146 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 39.0 ttp -107.01 122.66 46.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.17 110.337 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -97.63 123.62 41.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 1.19 109.99 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -107.39 -154.9 0.53 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.449 -0.341 . . . . 0.36 110.096 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.43 -59.55 2.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.84 0.311 . . . . 0.59 111.84 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.84 21.56 5.88 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.638 -0.791 . . . . 0.56 112.634 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -155.86 161.01 40.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.692 -0.484 . . . . 0.8 109.692 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 142.83 28.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.341 -0.615 . . . . 0.36 109.341 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.89 141.26 47.3 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.343 0.402 . . . . 0.22 110.523 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' CD1' ' A' ' 59' ' ' PHE . 14.1 pt-20 -139.68 149.22 43.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.052 -0.351 . . . . 0.21 110.052 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.3 pt -136.75 -176.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.771 -0.65 . . . . 0.3 110.591 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.36 109.88 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.308 0.575 . . . . 0.19 111.282 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 11.3 p -117.77 -179.63 3.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.698 -0.853 . . . . 0.31 108.698 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -70.32 143.12 52.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.479 -0.489 . . . . 0.36 110.212 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -85.4 -41.87 15.05 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.383 0.512 . . . . 0.86 112.383 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -64.63 127.45 31.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.642 -0.254 . . . . 1.6 111.643 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.5 pttp 43.64 37.34 1.5 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.31 1.044 . . . . 1.59 113.021 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.7 p -64.47 -21.73 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.52 0.676 . . . . 0.4 111.178 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 -4.2 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.56 110.802 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.4 112.693 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.78 0.324 . . . . 1.77 111.194 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.06 149.02 48.42 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.99 110.94 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.76 -20.97 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.39 111.392 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -30.24 71.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 1.01 110.473 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.26 -24.46 24.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.99 109.823 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 34' ' ' TYR . 49.2 t -69.29 -41.18 80.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.537 -0.756 . . . . 0.11 110.121 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD11 HE21 ' A' ' 82' ' ' GLN . 0.7 OUTLIER -75.8 92.28 3.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.426 -0.806 . . . . 0.3 109.899 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -74.64 -61.52 1.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.28 111.834 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.84 108.02 19.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.894 0.378 . . . . 0.27 110.944 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' HA ' HD11 ' A' ' 53' ' ' LEU . 1.9 p-80 -83.4 69.32 9.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.224 0.535 . . . . 0.93 111.438 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -154.4 105.06 2.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.822 -0.626 . . . . 0.22 110.13 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 68' ' ' ALA . 10.9 p -94.7 141.55 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.394 -0.595 . . . . 0.27 109.394 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.669 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -93.73 157.76 16.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.064 0.459 . . . . 0.24 111.678 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.7 t -106.29 -56.47 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.47 -0.937 . . . . 0.26 108.47 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -150.02 116.79 5.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.54 109.406 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.97 -17.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.044 -0.525 . . . . 0.22 111.252 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.9 t -64.81 -26.26 68.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 1.35 110.689 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -122.64 -0.91 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.431 . . . . 0.93 110.987 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.96 37.48 64.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.936 -0.649 . . . . 0.37 112.039 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -86.37 118.73 26.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 1.56 110.772 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.79 144.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.59 109.732 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.693 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -107.29 133.06 52.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.15 0.5 . . . . 0.23 110.631 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 7.3 mtmt -107.64 -171.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.736 -0.666 . . . . 1.25 109.884 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.54 68.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.683 0.277 . . . . 0.3 111.263 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 69' ' ' LYS . 5.0 pm0 -80.32 -5.67 56.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.529 -0.305 . . . . 0.46 111.482 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.33 -44.15 4.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.84 -0.344 . . . . 0.43 110.966 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.35 -26.91 68.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.93 0.395 . . . . 0.18 110.454 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -27.83 33.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 116.077 -0.511 . . . . 0.28 109.908 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -17.66 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.448 0.642 . . . . 0.19 109.63 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.28 -59.19 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.748 . . . . 0.32 110.664 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -95.19 -52.0 4.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.284 -0.417 . . . . 0.25 110.464 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.06 -26.68 2.71 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.472 -0.651 . . . . 0.2 111.472 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.36 143.49 28.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.564 -0.318 . . . . 0.22 110.617 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.85 10.08 32.57 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 1.44 110.817 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.5 120.25 36.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.602 -0.726 . . . . 0.76 110.454 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.457 HE21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.18 -29.78 71.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.23 111.091 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -60.11 -37.87 81.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.21 110.795 179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.92 -24.9 62.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.65 110.637 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.6 mm -79.49 -49.05 20.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.13 109.47 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 25.7 p -67.51 -29.33 68.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.706 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 83' ' ' THR . 18.5 ttpt -66.07 -16.59 64.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.211 0.529 . . . . 0.47 110.419 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.89 -52.59 4.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.67 109.692 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.777 HG22 HG22 ' A' ' 20' ' ' VAL . 19.6 mt -61.44 -35.31 65.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.748 -0.66 . . . . 0.34 112.365 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 2.1 mm? -73.95 2.37 8.78 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.422 0.897 . . . . 0.27 113.422 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.3 t -145.4 -32.92 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.611 -0.436 . . . . 0.93 112.135 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' HG2' HG23 ' A' ' 91' ' ' THR . 40.6 mmtm -96.03 10.21 38.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.001 -0.37 . . . . 1.32 110.001 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.92 -173.79 13.31 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.784 -0.722 . . . . 0.34 112.093 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -95.6 101.73 13.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.842 0.353 . . . . 2.19 110.398 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 p -100.35 133.35 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.992 -0.549 . . . . 0.39 109.688 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -74.19 84.71 1.86 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.272 0.558 . . . . 1.55 110.326 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 1.11 111.455 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.403 HD13 ' HG2' ' A' ' 162' ' ' GLN . 10.3 mt . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.848 -0.427 . . . . 0.28 109.848 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 63.72 32.67 13.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.544 -0.753 . . . . 1.07 111.162 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -100.12 104.04 15.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.87 -0.604 . . . . 0.64 109.781 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 m -74.13 134.79 42.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.43 110.529 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.32 75.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.04 -0.527 . . . . 0.45 110.397 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.66 -168.82 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.189 -0.914 . . . . 1.15 110.985 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.0 t -125.92 15.96 7.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.739 0.781 . . . . 0.5 109.573 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -100.06 -0.26 39.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.161 -0.927 . . . . 1.0 111.078 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.79 20.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.157 0.503 . . . . 0.61 110.004 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 1.5 m -77.21 51.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.22 112.279 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -28.53 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.23 111.902 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 11.88 35.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.068 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 2.0 tp-100 -113.5 -49.25 2.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 1.06 110.524 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mt-30 -105.94 34.05 3.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 0.6 111.204 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.42 -35.97 77.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.942 -0.572 . . . . 0.15 110.845 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.91 -25.04 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.015 -0.539 . . . . 1.43 111.068 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -79.58 -42.42 25.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.828 -0.434 . . . . 0.58 109.828 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.489 ' O ' HD12 ' A' ' 163' ' ' LEU . 21.8 t -64.53 -41.72 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.934 -0.575 . . . . 0.16 111.002 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -26.08 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.457 . . . . 0.45 111.598 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -93.69 -21.67 19.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.12 0.486 . . . . 0.41 110.134 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HG2' HD13 ' A' ' 142' ' ' ILE . 20.7 tt0 -67.46 -53.0 32.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.64 -0.709 . . . . 0.52 111.533 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -79.59 -10.79 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.678 -0.409 . . . . 0.23 110.942 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.444 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.7 ttpt -65.05 -26.57 68.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.79 110.035 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.09 -8.3 58.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 2.07 110.612 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -110.56 -35.23 6.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.189 -0.46 . . . . 0.5 110.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.49 130.7 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.237 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.13 82.29 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.361 0.601 . . . . 1.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.9 pt . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.523 -0.762 . . . . 0.78 111.585 -179.522 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.713 -0.477 . . . . 0.42 109.713 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 mtm180 -92.74 135.73 33.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.035 -0.358 . . . . 0.51 110.035 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.1 150.26 43.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.012 0.434 . . . . 0.24 111.081 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -120.88 -176.15 3.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.89 109.371 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.1 p90 -150.16 127.91 11.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.777 -0.453 . . . . 0.39 109.777 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.8 126.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.56 111.26 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 2.6 pt? -167.34 147.24 4.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.38 -0.827 . . . . 1.16 109.472 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.44 162.3 34.41 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.858 2.372 . . . . 0.27 112.914 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.6 -35.44 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.39 111.44 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -47.86 -47.51 31.58 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.795 -0.638 . . . . 0.65 111.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.24 -26.42 14.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.7 0.286 . . . . 0.74 110.973 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.86 -33.19 77.33 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.2 113.041 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -64.04 -14.29 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.088 0.403 . . . . 2.3 112.088 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -44.81 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.559 0.219 . . . . 0.77 111.252 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.7 pp -86.12 -20.69 28.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.23 110.483 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.91 -41.95 62.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.421 -0.809 . . . . 1.46 111.969 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.467 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -103.94 15.49 28.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.235 0.457 . . . . 1.16 112.235 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -124.22 -30.49 3.44 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.452 -0.499 . . . . 2.42 111.692 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.19 -42.83 9.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.593 0.235 . . . . 0.26 111.468 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 13.5 mtpt -58.05 -47.35 99.03 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.051 0.76 . . . . 0.28 113.051 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.3 Cg_endo -60.72 -16.26 42.53 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.199 1.933 . . . . 0.16 113.401 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.76 -21.0 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.336 -0.246 . . . . 0.14 110.336 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 78.86 -10.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.466 -0.788 . . . . 0.17 111.526 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -86.74 54.36 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.248 0.547 . . . . 0.98 110.771 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.85 138.41 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.258 -0.883 . . . . 0.23 109.613 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.6 142.26 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.658 -0.497 . . . . 0.94 109.658 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -68.76 81.94 0.29 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.133 0.492 . . . . 1.99 110.465 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 68.8 m -157.53 31.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.333 -0.849 . . . . 0.17 109.745 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.1 mp0 -79.96 154.41 28.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.36 110.66 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -108.58 111.86 23.91 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.159 -0.682 . . . . 0.57 109.159 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.39 80.43 3.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.217 0.532 . . . . 1.22 110.356 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -148.36 -130.56 1.96 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.685 -0.689 . . . . 0.36 112.197 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -78.84 -26.76 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.478 . . . . 0.75 110.601 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.67 145.19 49.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.91 -0.774 . . . . 1.38 108.91 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 28.1 tp -105.03 85.9 2.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.936 0.398 . . . . 0.38 110.972 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 5.0 tt0 -93.11 118.69 31.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.97 109.748 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 19.8 mt -128.68 159.13 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.569 -0.287 . . . . 0.11 111.026 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 177' ' ' ARG . 19.9 t -116.6 121.13 66.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.656 -0.498 . . . . 0.21 109.656 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.436 ' SG ' ' HE2' ' A' ' 178' ' ' PHE . 4.6 p -118.51 -30.52 5.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.113 0.412 . . . . 0.58 112.113 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 213' ' ' LEU . 2.3 mm? -68.62 108.47 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.692 0.282 . . . . 0.45 111.013 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.6 tt -110.28 -54.87 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.564 0.579 . . . . 0.38 112.564 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.56 162.2 54.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.04 0.385 . . . . 0.33 112.04 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.33 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.013 2.475 . . . . 0.31 111.334 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 65.35 -81.15 0.08 OUTLIER Glycine 0 C--N 1.339 0.703 0 O-C-N 123.463 0.477 . . . . 0.18 111.963 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 2.1 p -75.6 17.97 0.26 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.179 0.592 . . . . 0.67 111.117 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 217' ' ' GLY . 8.6 p90 -87.76 -16.94 32.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.4 109.859 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -69.28 -48.11 62.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 1.46 110.549 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.57 -31.02 71.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 1.36 110.758 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 46.1 mm -82.8 -42.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.491 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.79 -37.07 68.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.55 111.05 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -56.1 -35.21 66.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 1.28 111.758 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.7 pp -94.41 -33.05 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.475 -0.49 . . . . 1.43 110.834 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.4 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-N 116.395 -0.366 . . . . 0.42 111.418 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 13.7 ptpt -63.53 -22.11 66.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.127 0.417 . . . . 0.91 112.127 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.45 8.65 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 0.38 111.167 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -108.96 -83.52 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.126 -0.488 . . . . 1.33 110.697 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.1 t -84.38 -30.01 25.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.305 -0.407 . . . . 0.22 111.184 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 24.3 tptm -64.64 -30.89 71.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.992 0.425 . . . . 0.71 111.05 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.19 12.56 66.69 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.528 -0.844 . . . . 0.37 112.235 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -123.79 -46.85 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.919 0.39 . . . . 0.76 110.593 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -125.55 -162.25 11.25 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.773 -0.727 . . . . 0.24 112.562 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.94 132.23 56.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.21 -0.292 . . . . 1.03 110.21 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 3.1 pp -80.04 157.29 26.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.057 0.456 . . . . 1.51 111.097 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.71 153.39 38.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.597 -0.729 . . . . 0.85 109.485 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.77 156.96 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.237 -0.282 . . . . 0.29 110.237 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.014 0.435 . . . . 0.42 110.695 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.397 0.618 . . . . 0.98 112.567 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -69.79 157.67 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.884 -0.598 . . . . 1.84 110.042 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 1.76 111.594 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.99 81.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.75 111.251 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -153.7 143.67 22.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 1.28 109.981 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' VAL . 82.0 mt -67.25 -13.15 61.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 1.3 111.147 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -87.35 4.11 44.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.4 110.849 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -139.29 35.91 2.08 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.463 0.649 . . . . 0.38 110.321 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 14' ' ' LEU . 20.3 m -106.41 156.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.18 111.633 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . . . -108.85 137.67 46.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.23 109.958 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 t -78.98 108.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.932 0.396 . . . . 0.44 110.722 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -121.11 129.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.922 -0.581 . . . . 0.16 109.925 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -145.0 144.11 30.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.953 0.406 . . . . 1.06 111.34 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 89' ' ' ILE . 23.2 ttt -127.93 127.29 43.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.671 -0.695 . . . . 0.22 109.819 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.97 118.51 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.014 0.435 . . . . 0.86 110.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 9.8 mmm180 -92.72 -155.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.906 -0.588 . . . . 1.69 109.99 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.96 -54.08 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.51 110.986 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.53 -34.4 1.09 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.431 -0.89 . . . . 0.17 112.48 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 29.1 tptt -97.77 158.94 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.933 0.397 . . . . 1.07 110.496 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 152.76 38.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.168 -0.678 . . . . 0.77 109.168 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.02 140.35 38.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.034 0.445 . . . . 0.26 111.213 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -130.4 130.19 44.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 1.1 109.717 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -174.49 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.136 0.493 . . . . 0.25 111.361 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.54 103.04 4.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.16 109.791 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -102.88 -173.22 2.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.15 110.11 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.7 150.06 37.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.73 -0.47 . . . . 0.26 109.73 178.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 52.8 pttt -108.61 28.5 8.33 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.428 -0.509 . . . . 1.32 110.966 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -103.11 81.78 2.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.54 109.919 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt 57.86 49.4 12.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.984 -0.553 . . . . 0.58 110.948 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.23 -23.73 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.762 -0.654 . . . . 0.22 111.802 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.98 -4.43 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.207 0.527 . . . . 0.17 110.626 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.1 112.642 -179.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 110.561 -0.162 . . . . 0.7 110.561 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.25 148.6 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.644 0.259 . . . . 0.72 110.528 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.24 -31.01 72.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.482 . . . . 0.56 111.654 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.95 -32.49 72.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.53 110.628 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.99 -19.76 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.083 0.468 . . . . 1.8 110.407 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 66.9 t -74.34 -43.74 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.731 -0.668 . . . . 0.15 109.57 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.05 99.25 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.435 -0.802 . . . . 1.45 111.138 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 34' ' ' TYR . 14.6 mt-30 -84.13 -65.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.5 109.975 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 t -97.16 130.64 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.183 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.37 -5.66 59.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.132 -0.485 . . . . 1.23 110.668 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -96.39 116.13 28.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.138 -0.483 . . . . 0.79 110.523 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.7 p -100.44 146.4 9.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.925 -0.58 . . . . 0.15 109.624 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -102.0 154.38 19.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.27 111.126 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.2 t -103.78 -31.4 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.18 109.485 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.2 91.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.069 -0.969 . . . . 0.49 109.218 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.05 -28.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.465 -0.334 . . . . 0.21 111.826 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -34.43 77.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.876 0.37 . . . . 0.6 111.158 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -106.52 10.9 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 2.39 111.031 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.36 28.62 71.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.876 -0.678 . . . . 0.4 112.468 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.33 110.83 14.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.571 0.224 . . . . 1.57 110.44 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.81 133.81 52.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.999 -0.546 . . . . 0.21 110.444 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.55 116.33 32.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.023 0.439 . . . . 0.11 109.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -87.53 -179.52 6.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.87 -0.605 . . . . 1.56 110.105 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -57.57 -32.95 67.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.67 111.271 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -87.57 7.88 27.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.182 -0.463 . . . . 0.67 111.29 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.81 -48.77 3.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.82 110.081 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.93 -31.92 73.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.999 -0.546 . . . . 0.31 110.212 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -28.14 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.23 110.348 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -92.46 -8.43 44.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.235 0.541 . . . . 0.71 110.965 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.65 -58.83 2.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.18 110.97 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -89.69 -34.88 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.396 -0.365 . . . . 0.83 110.833 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.09 30.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.524 -0.846 . . . . 0.3 112.283 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 81' ' ' ASP . 1.5 m -134.23 136.4 43.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.005 -0.369 . . . . 0.7 110.005 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.74 -12.93 57.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.64 110.748 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 79' ' ' THR . 28.9 t70 -69.16 102.66 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.54 110.396 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.48 -23.65 66.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.89 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.4 88.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.734 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.45 -34.93 79.45 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.854 0.359 . . . . 0.33 110.234 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.3 -51.68 69.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.392 -0.596 . . . . 0.24 109.392 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 54.0 t -64.63 -32.55 74.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.457 -0.792 . . . . 0.14 110.374 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -57.63 -51.98 67.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.931 -0.577 . . . . 1.2 110.838 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -63.59 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.549 . . . . 0.3 111.177 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 20' ' ' VAL . 63.8 mt -66.98 -24.69 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.107 0.48 . . . . 0.15 111.48 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -80.21 -33.26 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.735 0.303 . . . . 0.3 111.582 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.2 t -97.83 -22.65 16.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.789 0.663 . . . . 0.37 112.789 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 91' ' ' THR . 14.3 mmmm -115.22 -2.97 12.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.579 -0.448 . . . . 0.65 111.761 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.42 -176.69 21.32 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.517 -0.849 . . . . 0.52 112.291 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -108.15 107.84 18.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 1.32 110.409 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 20' ' ' VAL . 3.6 p -111.61 142.14 24.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.431 -0.804 . . . . 0.22 110.186 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 99.82 0.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.239 0.542 . . . . 0.82 110.596 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.747 -0.66 . . . . 0.51 111.691 -178.906 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 143' ' ' HIS . 18.1 tt . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.864 0.364 . . . . 0.35 110.23 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 142' ' ' ILE . 60.5 m-70 72.68 90.7 0.09 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.379 -0.828 . . . . 0.31 111.488 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -75.72 95.79 3.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.863 -1.062 . . . . 0.85 110.239 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -155.36 74.69 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.902 -0.59 . . . . 0.65 109.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.8 67.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.54 110.776 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 149' ' ' ASN . 16.3 mtpt 55.0 79.27 0.15 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.698 -0.683 . . . . 0.33 111.244 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.64 17.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.83 111.999 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 147' ' ' LYS . 4.5 t-20 -68.8 -62.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.211 -0.449 . . . . 0.35 109.824 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.52 138.55 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.746 -0.661 . . . . 0.91 109.847 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -163.42 -158.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.668 -0.493 . . . . 0.99 109.668 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.91 95.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.535 0.334 . . . . 0.38 111.853 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 53.72 42.99 31.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.752 -0.658 . . . . 0.45 110.553 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 60.72 66.95 0.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.163 -0.926 . . . . 0.78 111.46 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.627 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 0.4 OUTLIER 55.9 31.03 17.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.151 -0.931 . . . . 0.76 113.13 178.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.02 63.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.179 0.514 . . . . 0.35 110.613 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -29.66 42.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.363 0.601 . . . . 0.63 110.237 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.627 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.4 mp0 -68.54 -41.75 79.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.98 111.379 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.26 -30.29 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 0.98 111.48 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.69 -39.66 86.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.021 0.439 . . . . 0.39 110.704 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.16 -5.5 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.81 111.033 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.58 -70.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 1.44 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -70.88 -11.08 60.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.28 -0.418 . . . . 1.46 111.397 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -61.55 -34.64 75.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.164 0.507 . . . . 1.16 110.255 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -87.79 23.7 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.759 -0.655 . . . . 0.6 110.815 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -138.73 -52.98 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.937 -0.574 . . . . 0.79 110.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.1 ttm -139.7 151.16 45.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.12 -0.491 . . . . 0.97 110.019 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -71.59 131.91 43.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 1.09 110.467 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.492 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.58 110.344 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.904 0.383 . . . . 1.16 111.136 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -83.49 143.64 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 1.81 110.533 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.8 mp -126.55 161.94 26.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.208 -0.451 . . . . 0.72 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 15.8 ptt180 -127.09 154.93 44.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.2 -0.454 . . . . 0.32 110.156 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 63.2 t80 -120.98 131.26 54.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.439 -0.346 . . . . 0.21 110.217 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.91 133.36 66.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.463 0.173 . . . . 0.45 111.358 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 178' ' ' PHE . 1.0 OUTLIER -171.37 161.1 5.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.688 -0.233 . . . . 0.15 110.518 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.22 155.77 66.7 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.23 . . . . 0.17 112.476 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.05 -33.94 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.995 -0.548 . . . . 0.67 111.749 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -48.79 -48.81 40.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.221 -0.445 . . . . 1.69 111.725 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -95.77 -28.15 14.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.857 0.36 . . . . 0.53 110.946 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.11 -32.06 81.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.012 -0.613 . . . . 0.23 112.779 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.5 71.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.73 0.3 . . . . 0.83 111.405 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.11 -46.47 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.25 111.189 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -17.53 39.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.41 111.175 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -57.24 -44.59 83.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.14 110.588 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.72 17.12 5.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.46 111.485 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -129.08 -39.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.31 111.662 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.62 -42.57 24.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.3 111.758 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 30.0 mtpp -62.63 -48.0 87.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.743 0.646 . . . . 0.68 112.743 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.2 Cg_endo -59.47 -8.61 7.26 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.583 2.189 . . . . 0.04 113.837 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.37 -14.83 60.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.21 110.121 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.6 mm 59.56 32.88 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.835 0.826 . . . . 0.16 110.273 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.434 ' HD3' HD12 ' A' ' 222' ' ' ILE . 28.4 mttp -125.89 23.01 7.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.656 -0.702 . . . . 0.5 110.322 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.5 m -103.26 134.63 43.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.14 110.439 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -84.68 147.93 5.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.279 -0.419 . . . . 0.91 109.979 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 63.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 1.59 111.42 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 m -140.22 21.53 2.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.277 -0.638 . . . . 1.05 109.277 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.475 ' HG2' HG23 ' A' ' 210' ' ' ILE . 46.3 mt-10 -71.53 140.77 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.648 -0.706 . . . . 1.06 111.263 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.42 105.2 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.42 -0.585 . . . . 0.65 109.42 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.61 102.04 13.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.022 -0.536 . . . . 1.73 110.723 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -169.11 -150.06 6.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.983 -0.627 . . . . 0.63 111.826 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.09 -31.31 72.45 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.028 0.442 . . . . 1.88 110.604 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -117.45 109.42 16.75 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.759 . . . . 1.13 108.952 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.3 99.78 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.599 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.2 tt0 -100.98 109.41 21.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.35 109.614 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.475 HG23 ' HG2' ' A' ' 202' ' ' GLU . 66.3 mt -117.26 134.83 59.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.306 -0.407 . . . . 0.24 110.576 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.61 105.9 18.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.23 109.925 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 8.4 t -130.78 96.58 4.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.368 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 132.87 11.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.306 -0.628 . . . . 0.33 109.306 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -122.88 171.16 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.517 -0.31 . . . . 0.34 110.28 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.59 171.0 3.15 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.005 0.522 . . . . 0.56 111.091 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.33 -163.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.394 2.062 . . . . 0.37 113.105 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 82.81 -95.68 1.83 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.507 -0.854 . . . . 0.33 111.092 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.8 m -80.77 17.94 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.537 . . . . 0.45 110.445 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.84 -23.1 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.592 . . . . 0.25 111.599 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.1 -45.48 63.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.026 0.441 . . . . 1.42 110.201 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -62.49 -20.7 64.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.418 -0.81 . . . . 1.96 112.356 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.623 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.4 tt -98.57 -43.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.454 -0.499 . . . . 0.47 111.11 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.07 -32.76 74.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.74 0.274 . . . . 0.37 111.74 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.46 -25.06 61.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.428 -0.351 . . . . 0.98 111.553 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.3 pp -101.27 -28.79 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.005 0.431 . . . . 0.44 110.109 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.4 mm -64.51 -33.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.2 111.0 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 11.4 ptmt -60.48 -26.25 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.84 0.682 . . . . 1.19 112.84 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -111.45 -20.57 12.17 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.48 -0.488 . . . . 0.69 112.094 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.25 -46.67 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.39 111.55 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.442 ' OG1' HG23 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -113.42 -56.14 2.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.173 0.434 . . . . 0.48 112.173 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 49.4 mtmt -64.69 -7.7 11.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.25 111.825 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.33 16.66 32.01 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.975 -0.631 . . . . 0.28 111.648 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -128.51 -56.12 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.643 0.258 . . . . 0.64 111.527 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -123.02 -139.21 5.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.326 -0.94 . . . . 0.46 113.369 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 73.3 m -121.51 141.62 50.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.35 111.431 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -110.84 150.21 29.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.997 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.95 161.57 39.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 0.26 109.916 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.17 153.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.317 . . . . 0.37 110.647 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.8 tp . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.37 109.861 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' OH ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.783 -0.451 . . . . 0.72 109.783 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -161.49 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.233 -0.187 . . . . 1.19 111.115 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -124.55 -59.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.993 0.425 . . . . 1.69 110.351 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 5.0 mt -128.51 102.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.75 109.73 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -134.16 127.21 31.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.154 -0.475 . . . . 1.42 110.802 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.98 -10.02 59.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.361 0.601 . . . . 0.56 110.437 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.3 -15.47 50.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.64 111.275 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -125.72 40.36 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.16 111.679 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.12 147.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.97 0.414 . . . . 0.16 110.636 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.82 144.46 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.13 110.536 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.32 126.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 0.21 110.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -148.63 115.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.666 -0.697 . . . . 0.2 109.58 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -119.27 132.83 55.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.311 -0.404 . . . . 0.94 111.432 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.7 ttp -87.58 132.31 34.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.938 -0.574 . . . . 0.43 110.201 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 118.57 37.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.618 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 32.9 mmt180 -120.57 -177.5 3.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.33 110.323 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.14 81.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.366 0.506 . . . . 0.32 112.366 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.3 29.72 2.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.391 -0.909 . . . . 0.29 112.339 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 31.3 tptt -150.35 148.82 29.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.59 -0.522 . . . . 0.89 109.59 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.41 30.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.527 -0.546 . . . . 0.99 109.527 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -134.29 144.55 48.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -142.94 137.3 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.32 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.85 167.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.682 -0.488 . . . . 0.3 109.682 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 110.61 20.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.12 111.824 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -108.74 164.6 12.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.914 -0.585 . . . . 0.18 109.943 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.433 ' OH ' HG22 ' A' ' 9' ' ' THR . 0.1 OUTLIER -66.94 138.05 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.639 -0.255 . . . . 0.18 110.361 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -0.68 23.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 1.01 111.442 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.41 71.38 1.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.5 111.162 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.66 66.07 1.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.356 0.662 . . . . 1.8 111.368 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -69.49 -30.25 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.14 110.876 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -87.31 5.62 3.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.514 0.673 . . . . 0.27 110.327 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.458 -0.792 . . . . 0.29 112.523 -179.53 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.394 0.616 . . . . 0.55 112.647 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 49' ' ' LEU . 17.2 t70 -75.72 160.78 29.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.069 -0.969 . . . . 0.25 110.513 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.681 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.71 -19.83 60.09 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.78 0.289 . . . . 0.31 111.78 -179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.69 -38.4 64.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.172 0.511 . . . . 0.27 109.974 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.57 -32.78 62.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.47 -0.786 . . . . 0.73 111.049 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 49' ' ' LEU . 3.0 p -79.96 -17.13 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.312 . . . . 0.22 111.413 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.79 111.15 13.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 1.02 110.168 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 12' ' ' ILE . 11.5 mm-40 -85.29 -78.65 0.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.938 -0.574 . . . . 0.91 110.449 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -75.4 117.97 17.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.948 -0.569 . . . . 1.5 110.783 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -86.86 31.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.813 -0.63 . . . . 0.63 111.167 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 m -125.67 140.83 52.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.67 -0.493 . . . . 0.22 109.67 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.3 p -117.11 142.36 31.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.27 110.29 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.3 161.21 16.49 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.013 0.375 . . . . 0.29 112.013 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 61.1 t -123.96 -55.07 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.792 -0.64 . . . . 0.29 109.329 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.08 101.89 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 1.84 109.662 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.33 -37.19 79.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.51 111.827 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.16 6.45 6.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.37 0.507 . . . . 0.45 112.37 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -135.15 -5.37 2.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.849 0.357 . . . . 0.55 110.848 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.97 61.63 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.893 -0.67 . . . . 0.19 111.819 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.39 113.1 24.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.03 0.443 . . . . 0.66 110.929 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.46 128.87 76.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.649 -0.705 . . . . 0.4 109.245 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -84.67 117.63 23.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.909 0.385 . . . . 0.31 111.267 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.87 -174.52 4.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.16 -0.473 . . . . 0.68 110.017 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -55.76 -33.04 63.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.46 0.541 . . . . 1.84 112.46 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -82.13 -7.59 59.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.814 0.34 . . . . 1.81 111.792 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.38 -49.51 3.55 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.805 -0.358 . . . . 1.78 111.217 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.44 -29.28 68.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.929 0.395 . . . . 0.27 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.99 -25.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.898 -0.592 . . . . 0.55 110.463 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -97.33 -26.59 14.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.3 111.001 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.77 -39.46 30.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.122 -0.49 . . . . 0.48 112.093 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.54 -16.49 13.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.004 -0.278 . . . . 1.13 111.45 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.37 79.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.49 112.29 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.42 136.97 47.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.568 0.223 . . . . 0.6 110.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -90.55 -23.47 20.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.401 0.619 . . . . 0.59 109.899 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.83 103.44 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.82 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.87 -31.28 71.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.162 0.506 . . . . 0.33 109.951 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -61.02 -29.06 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.29 110.282 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.81 -39.33 24.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.805 -0.442 . . . . 0.34 109.805 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.12 -50.19 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.2 109.441 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.7 t -61.53 -38.72 88.44 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.19 110.61 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.73 -41.96 96.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 2.86 110.292 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -65.49 -40.67 93.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.71 110.786 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 70.9 mt -71.19 -21.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.33 110.907 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -45.88 10.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.451 -0.341 . . . . 0.99 111.575 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -83.0 -21.35 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.362 0.505 . . . . 1.13 112.362 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.65 31.89 4.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 1.41 110.723 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 89' ' ' ILE . . . -128.34 179.76 16.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.498 -0.858 . . . . 0.15 112.442 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.85 93.31 5.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.703 0.287 . . . . 0.81 110.644 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 97' ' ' VAL . 2.8 p -98.3 134.76 35.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.24 109.909 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 11.5 pt20 -74.62 75.62 2.01 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.206 0.527 . . . . 0.81 112.261 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 95' ' ' VAL . 14.6 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.437 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 122.632 1.206 . . . . 0.49 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -110.84 -5.63 14.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.595 -1.184 . . . . 0.31 110.53 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.73 115.34 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.507 0.558 . . . . 1.03 112.507 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 63.9 m 56.11 39.96 30.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.475 -0.784 . . . . 0.58 112.796 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.36 -66.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.4 110.34 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -96.6 -55.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.098 0.475 . . . . 1.75 109.799 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.5 25.44 14.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.523 -0.762 . . . . 0.21 111.063 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 57.12 38.08 28.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.721 -0.672 . . . . 0.58 110.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -89.68 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.86 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -149.28 161.44 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.448 . . . . 0.65 111.264 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -106.02 -34.04 7.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 1.05 110.862 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -88.96 -50.47 6.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 0.58 111.418 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -69.14 -14.97 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.79 111.559 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.1 mt-30 -112.43 7.48 19.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.629 -0.259 . . . . 0.44 110.912 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.63 72.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.347 . . . . 0.26 111.133 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 160' ' ' ILE . 2.3 mm? -66.65 -35.67 80.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.51 . . . . 1.32 111.227 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.95 -46.93 85.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 0.61 111.116 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 155' ' ' GLN . 59.3 t -67.04 -48.57 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.21 112.112 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 157' ' ' LEU . 10.1 tp -61.23 -35.16 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.41 111.729 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.39 -32.55 54.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.737 0.303 . . . . 1.99 110.592 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.87 -37.96 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.75 110.098 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.07 -36.92 85.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 1.15 110.036 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 167' ' ' MET . 31.0 tttm -69.31 -12.53 61.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.444 -0.798 . . . . 1.18 111.396 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.3 -32.05 55.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.51 . . . . 0.58 109.693 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -89.26 -44.45 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 1.12 111.097 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 38.4 mtm -128.75 139.04 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 2.6 110.655 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -89.15 85.83 6.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.538 -0.541 . . . . 0.56 109.538 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 167' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.47 112.138 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 39.8 mtt . . . . . 0 C--O 1.234 0.272 0 N-CA-C 110.184 -0.302 . . . . 1.48 110.184 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 175' ' ' ARG . 4.6 mpt_? -124.43 128.24 48.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.478 -0.328 . . . . 1.39 110.353 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -128.61 145.12 51.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.616 -0.513 . . . . 0.26 109.616 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 211' ' ' VAL . 18.8 ptt85 -126.18 147.91 49.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.783 0.325 . . . . 0.3 110.629 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.04 143.46 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.891 -0.595 . . . . 0.45 110.244 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.7 tt -133.4 117.72 28.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.449 0.642 . . . . 0.17 110.508 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -149.79 156.44 38.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.385 -0.825 . . . . 0.09 109.936 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.72 166.06 14.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 0.1 112.546 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.5 t -50.44 -39.89 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.922 -0.581 . . . . 0.2 111.962 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -51.33 -53.68 33.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.324 -0.398 . . . . 0.28 111.46 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.423 ' HG3' ' HE3' ' A' ' 233' ' ' LYS . 0.5 OUTLIER -82.17 -29.9 31.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.138 -0.483 . . . . 2.08 110.883 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.37 94.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.639 -0.71 . . . . 0.25 113.084 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.64 -35.9 71.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.891 0.377 . . . . 1.17 111.351 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -76.6 -44.6 33.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.235 -0.439 . . . . 0.71 111.814 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.54 HD22 HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -72.2 -32.33 66.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.772 0.32 . . . . 0.47 111.669 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -59.68 -50.55 73.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.36 111.435 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -80.34 18.28 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.44 112.119 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -124.29 -49.44 1.81 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.855 -0.338 . . . . 1.31 111.648 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.1 -36.58 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.188 0.44 . . . . 1.86 112.188 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 26.5 mtpp -61.39 -52.45 70.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.558 0.577 . . . . 0.59 112.558 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.1 Cg_endo -66.09 -14.01 42.46 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.028 1.819 . . . . 0.31 112.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.31 110.312 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mt 62.62 38.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.559 -0.746 . . . . 0.44 111.043 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -120.84 14.23 11.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.93 110.465 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.86 149.46 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.978 -0.555 . . . . 0.26 111.02 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.5 mt -101.25 155.61 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.685 . . . . 0.41 109.744 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.93 64.19 0.5 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.931 0.396 . . . . 1.64 111.1 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 211' ' ' VAL . 10.4 m -149.4 31.01 0.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 1.09 110.302 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -81.74 146.88 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.736 -0.665 . . . . 0.79 111.161 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -118.9 133.49 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.834 -0.802 . . . . 1.22 108.834 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.31 111.34 19.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.8 111.395 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -166.93 -131.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.255 -0.738 . . . . 0.14 111.255 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.64 -28.32 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.619 0.723 . . . . 0.65 109.301 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -119.31 142.87 47.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.811 -1.086 . . . . 1.32 109.614 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.28 89.66 5.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.684 -0.487 . . . . 0.13 109.684 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.15 98.41 8.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.398 -0.593 . . . . 0.55 109.398 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 188' ' ' LEU . 21.9 mm -112.59 134.89 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.37 110.827 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 201' ' ' SER . 2.5 t -105.35 112.57 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.28 109.981 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.98 94.41 3.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.943 0.401 . . . . 0.61 110.83 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.02 95.83 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.084 -0.507 . . . . 0.28 109.845 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 215' ' ' ASP . 9.8 tt -94.23 179.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 1.14 110.061 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.526 ' H ' HG12 ' A' ' 214' ' ' ILE . 4.4 m-20 -67.0 152.85 95.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 111.896 0.332 . . . . 1.08 111.896 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.88 166.57 11.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.751 2.301 . . . . 0.19 112.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 91.11 -75.98 1.53 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.363 -1.095 . . . . 0.34 110.363 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -28.41 64.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.258 0.551 . . . . 0.24 109.642 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.88 -26.12 68.19 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.521 -0.763 . . . . 0.29 110.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -17.66 64.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.845 0.355 . . . . 1.14 111.383 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -84.17 -50.37 7.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.906 0.384 . . . . 0.7 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 15.1 tt -72.87 -28.05 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.395 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.465 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 4.0 t70 -55.35 -33.02 63.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.863 0.363 . . . . 1.01 111.143 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.76 -32.69 67.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.885 -0.598 . . . . 0.46 111.733 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 3.0 pp -92.78 -32.99 14.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.545 -0.462 . . . . 0.72 109.862 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 26.9 mm -55.64 -43.37 72.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.279 -0.419 . . . . 0.93 111.474 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 12.7 ptpt -61.95 -17.68 57.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.173 0.805 . . . . 0.53 113.173 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -119.92 -16.83 8.61 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.874 -0.516 . . . . 0.73 111.515 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 3.1 tp10 -79.95 -39.28 30.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.449 . . . . 1.25 111.15 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 t -136.47 -36.23 0.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.284 0.475 . . . . 1.38 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 23.9 tptp -55.96 -46.49 78.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.889 0.376 . . . . 0.85 111.054 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.07 28.22 13.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.65 111.958 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.423 ' HE3' ' HG3' ' A' ' 184' ' ' GLU . 27.2 mmmt -132.85 -46.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 1.68 110.839 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -130.44 -153.4 7.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.034 -0.603 . . . . 0.31 111.976 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.5 m -124.18 156.66 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.626 0.251 . . . . 0.58 110.518 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.67 165.65 18.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.714 0.292 . . . . 0.97 111.043 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -151.64 152.85 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.051 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.9 141.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.056 0.455 . . . . 0.18 111.181 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.253 -0.43 . . . . 0.31 110.44 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.366 0.603 . . . . 1.07 111.464 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -80.33 161.36 25.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.807 -0.633 . . . . 1.1 109.894 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -58.53 -40.11 82.02 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.974 0.416 . . . . 0.62 110.405 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mt -119.95 95.32 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 1.13 109.632 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -159.27 137.99 10.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.832 -0.622 . . . . 2.26 110.21 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.81 37.03 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.4 111.006 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.8 p -106.67 -28.58 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.32 110.633 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 12.6 m120 -126.26 50.41 1.9 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.64 110.26 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 54' ' ' GLN . 2.3 m -92.6 155.33 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.15 111.073 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.62 134.03 55.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 0.1 109.688 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.55 127.12 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 0.1 110.889 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 89' ' ' ILE . 2.7 p -140.59 118.98 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 0.1 109.648 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -123.56 132.9 54.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.243 0.544 . . . . 0.81 112.047 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.615 ' HB2' HG23 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -111.53 159.56 18.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.835 -0.62 . . . . 0.26 110.063 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -121.06 115.85 23.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.582 -0.281 . . . . 1.39 110.637 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 16.2 mmm180 -99.39 55.39 0.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.731 0.301 . . . . 1.87 110.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.24 34.28 20.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.586 -0.734 . . . . 0.34 111.778 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.78 -62.92 0.42 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.331 -0.708 . . . . 0.33 111.331 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -74.35 145.73 43.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.69 -0.485 . . . . 1.04 109.69 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 28' ' ' ARG . 5.2 mmt180 -109.82 140.26 43.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.271 -0.27 . . . . 0.75 110.271 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -134.34 118.61 17.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.361 -0.381 . . . . 0.88 110.158 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -135.87 146.21 47.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.757 0.313 . . . . 1.09 110.333 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 pt -132.24 179.26 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.778 -0.646 . . . . 0.09 110.26 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.2 106.9 9.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.105 0.479 . . . . 0.1 110.659 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 m -103.58 171.09 7.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.696 -0.683 . . . . 0.11 109.416 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 11.2 t80 -88.26 154.58 20.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.873 0.368 . . . . 0.86 110.485 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -78.34 31.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.79 110.832 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -85.92 43.34 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.057 -0.519 . . . . 1.8 110.56 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt 61.1 46.76 7.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.636 -0.711 . . . . 0.34 110.84 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.02 -23.94 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.008 -0.542 . . . . 0.34 111.364 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 97' ' ' VAL . 7.8 p -68.46 -31.38 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.477 -0.329 . . . . 0.83 110.503 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 121.118 -0.563 . . . . 0.28 112.571 -179.589 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 109.506 -0.553 . . . . 0.42 109.506 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.55 167.53 10.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.926 -0.398 . . . . 0.39 109.926 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 49' ' ' LEU . 16.6 tp -104.05 6.79 36.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.457 0.54 . . . . 0.53 112.457 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.77 -44.42 7.09 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.421 -0.512 . . . . 1.21 110.486 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.91 -27.94 61.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.436 -0.802 . . . . 0.7 111.048 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.85 -13.01 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.21 110.533 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -87.99 107.64 18.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.036 -0.529 . . . . 0.35 110.055 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.425 ' HG3' HG12 ' A' ' 17' ' ' VAL . 33.5 mm-40 -65.71 -44.33 86.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.642 . . . . 0.36 111.316 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 t -142.89 136.12 28.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.058 0.456 . . . . 0.35 110.145 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -96.68 25.91 4.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.014 -0.539 . . . . 1.03 110.851 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -96.68 88.74 4.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 0.29 110.127 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.3 p -82.02 141.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.104 -0.498 . . . . 0.3 109.924 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -90.91 162.42 14.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.22 111.797 -178.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 98.6 t -111.92 -46.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.15 109.56 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -154.15 120.11 5.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.11 -0.95 . . . . 0.22 108.989 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.03 -27.58 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.067 0.395 . . . . 0.32 112.067 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -38.39 87.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.062 0.458 . . . . 0.38 110.941 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -99.35 -5.35 29.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 1.25 110.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.23 52.23 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.914 -0.66 . . . . 0.27 111.881 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -105.81 123.19 47.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.973 0.416 . . . . 0.74 110.886 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' PHE . 35.2 t -114.97 130.76 68.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.75 -0.659 . . . . 0.34 109.994 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -85.25 110.82 19.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.12 110.459 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -84.8 -171.7 3.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.922 -0.581 . . . . 1.42 109.803 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -56.7 -38.92 72.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.179 0.437 . . . . 0.9 112.179 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -81.85 -1.34 47.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.34 111.5 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -101.6 -47.79 4.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.7 110.963 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.9 -34.28 77.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.611 -0.268 . . . . 0.18 110.966 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.08 -24.84 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.076 0.465 . . . . 1.23 110.574 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 m -93.22 -32.53 14.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.205 -0.452 . . . . 0.29 110.851 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.31 -54.32 7.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.19 111.716 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.44 -36.02 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.2 -0.455 . . . . 2.36 110.948 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.87 -25.04 25.24 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.832 -0.907 . . . . 0.34 110.832 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.92 124.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.279 -0.46 . . . . 1.19 110.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -23.8 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.172 0.51 . . . . 1.0 109.876 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.98 104.24 2.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.406 -0.815 . . . . 1.31 110.093 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -59.86 -31.92 70.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.5 111.643 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -38.72 92.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.69 110.211 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.05 -40.06 94.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.115 -0.493 . . . . 1.13 109.712 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.98 -50.3 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.53 109.555 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.8 m -59.66 -34.85 73.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.262 -0.881 . . . . 0.19 110.751 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.84 -44.42 96.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.54 110.922 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -63.26 -40.46 97.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.78 110.378 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 20' ' ' VAL . 52.1 mt -69.7 -34.31 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.66 . . . . 0.18 110.866 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.41 -21.23 49.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.365 . . . . 0.73 111.732 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -97.16 -53.59 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.334 0.494 . . . . 0.94 112.334 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -102.32 20.96 15.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.91 111.373 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.27 165.41 12.8 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.677 -0.773 . . . . 0.21 112.173 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.2 tt0 -87.58 102.69 14.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.014 -0.365 . . . . 1.89 110.014 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 p -106.29 126.02 61.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.15 110.449 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -79.68 88.4 5.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.925 -0.579 . . . . 2.37 111.139 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.628 HG21 ' HB ' ' A' ' 39' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.81 110.744 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.519 0.2 . . . . 0.2 110.95 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 58.05 67.25 0.98 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.889 -0.596 . . . . 0.13 110.201 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.69 120.15 31.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.64 110.737 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 m -86.11 153.41 22.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.58 110.406 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' A' ' 155' ' ' GLN . 11.1 t -110.31 -80.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.64 0.257 . . . . 0.31 110.723 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.62 160.0 30.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.763 0.316 . . . . 0.49 110.39 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 2.25 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 0.7 111.138 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.5 -23.89 61.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.45 111.344 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . 45.6 mttm 63.02 36.01 12.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.143 0.497 . . . . 1.92 110.995 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.9 132.35 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.21 111.951 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.9 m 52.71 84.18 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.251 0.621 . . . . 0.19 112.52 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp 52.47 38.24 24.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 1.25 111.58 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.67 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 6.1 tt0 58.85 59.62 2.77 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.049 -0.523 . . . . 1.03 110.703 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 46.32 42.09 9.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.207 1.003 . . . . 1.15 112.07 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.66 72.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.09 110.67 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -67.38 -31.11 71.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 1.11 110.698 179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -71.67 -29.11 64.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.923 -0.399 . . . . 0.52 109.923 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.54 -37.56 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.862 -0.792 . . . . 0.14 108.862 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.2 -40.7 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.184 -0.916 . . . . 0.16 109.567 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.1 mmtp -66.95 -39.32 87.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 1.32 110.11 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -58.29 -40.76 82.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.737 -0.665 . . . . 1.61 110.529 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.65 -46.65 86.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.26 110.108 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -62.45 -36.65 83.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.73 111.414 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 47.9 mm-40 -62.65 -35.53 79.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.411 -0.358 . . . . 0.44 111.431 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -92.25 -41.52 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.31 -0.405 . . . . 0.73 111.089 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.69 106.55 8.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.182 -0.463 . . . . 1.05 109.868 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -75.1 101.74 4.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.92 110.977 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.766 -0.652 . . . . 0.38 110.729 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.78 110.569 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.44 133.65 55.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.482 . . . . 0.5 110.282 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.44 141.38 48.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.237 -0.438 . . . . 0.23 110.274 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.59 139.66 46.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.128 0.489 . . . . 1.2 110.962 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 90.4 t80 -113.93 143.28 44.97 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.161 -0.681 . . . . 0.25 109.161 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.6 131.56 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.427 0.528 . . . . 0.37 112.427 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 180' ' ' LEU . 7.0 mt -160.61 139.57 7.74 Favored Pre-proline 0 C--N 1.333 -0.112 0 CA-C-N 115.625 -0.716 . . . . 1.49 109.649 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 180' ' ' LEU . 21.3 Cg_endo -62.09 156.03 52.4 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.571 2.181 . . . . 0.17 111.674 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.0 t -49.73 -37.05 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.744 0.418 . . . . 0.17 111.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -46.78 -47.08 20.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.84 111.451 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.31 -28.59 12.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.33 110.588 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.87 64.89 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.009 -0.541 . . . . 0.18 113.233 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -27.73 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.656 0.243 . . . . 0.8 111.656 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -76.18 -46.58 27.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.577 0.227 . . . . 0.8 111.184 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -25.11 59.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.514 -0.312 . . . . 1.59 111.155 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -59.33 -34.21 72.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.98 110.919 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.45 6.78 25.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.56 . . . . 1.5 112.187 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 26.6 mtpt -135.38 -28.1 1.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 197' ' ' LYS . 80.1 mt -80.73 -56.96 3.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.97 0.414 . . . . 1.15 111.349 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 27.1 mtpp -61.1 -52.65 70.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.47 0.915 . . . . 0.24 113.47 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 56.3 Cg_endo -68.29 -5.89 16.08 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.191 1.927 . . . . 0.32 114.047 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 191' ' ' LYS . 2.0 mm? -102.52 1.73 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.771 -0.371 . . . . 0.21 110.377 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mt 53.19 45.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.693 0.759 . . . . 0.35 111.23 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' HD2' HD23 ' A' ' 192' ' ' LEU . 6.1 ptpp? -116.91 24.24 11.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 0.24 110.028 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.57 156.72 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.723 -0.671 . . . . 0.25 111.341 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.53 145.34 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.4 109.072 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 65.99 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.375 0.509 . . . . 0.32 112.375 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 m -145.54 36.1 1.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.406 -0.815 . . . . 0.25 108.858 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.3 pt-20 -89.87 166.75 13.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.738 -0.665 . . . . 0.55 112.25 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.14 118.16 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 1.52 109.6 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.22 45.29 1.25 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.34 111.032 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -102.71 -139.58 10.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.725 -0.75 . . . . 0.2 112.288 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -78.87 -27.67 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.468 . . . . 1.14 110.228 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -120.85 109.53 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.677 -0.692 . . . . 1.13 109.165 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.8 tp -69.83 92.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.89 . . . . 1.55 111.298 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.0 tt0 -94.48 117.46 30.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.028 -0.73 . . . . 0.44 109.028 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 202' ' ' GLU . 8.4 mt -128.18 147.43 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.842 0.353 . . . . 0.18 110.777 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.33 115.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.507 -0.553 . . . . 0.26 109.507 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.4 m -121.4 57.75 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.793 0.33 . . . . 1.04 111.722 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.98 127.59 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.715 -0.476 . . . . 0.41 109.715 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.71 -51.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.319 -0.4 . . . . 0.77 111.22 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 2.9 p30 -155.54 166.34 16.46 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.725 -0.216 . . . . 1.2 110.639 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 86.2 Cg_endo -80.34 -159.24 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.35 2.034 . . . . 0.44 112.754 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.68 -94.14 1.29 Allowed Glycine 0 C--O 1.238 0.392 0 C-N-CA 120.871 -0.681 . . . . 0.34 111.621 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.26 -17.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.65 110.109 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 222' ' ' ILE . 23.9 t80 -55.54 -35.27 65.5 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.314 -0.857 . . . . 0.45 110.481 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -25.06 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.35 111.563 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -86.06 -45.48 11.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 2.72 110.276 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 226' ' ' ILE . 16.3 tt -69.02 -26.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 1.26 110.686 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -31.75 72.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.249 -0.432 . . . . 0.2 110.196 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.55 -22.96 64.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.678 -0.692 . . . . 1.15 110.05 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.8 mt -96.02 -46.61 6.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.525 -0.761 . . . . 0.74 109.592 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.5 mm -55.76 -37.96 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.894 -0.594 . . . . 0.43 112.326 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -52.64 -31.56 37.47 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.353 0.501 . . . . 1.32 112.353 -179.105 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -112.33 -23.93 10.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.58 110.711 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 226' ' ' ILE . 1.5 tp10 -62.47 -51.23 68.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.64 111.606 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.1 -28.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.432 0.53 . . . . 0.63 112.432 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 32.8 mttt -58.98 -43.88 91.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.69 110.97 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.45 39.49 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.646 -0.788 . . . . 0.28 112.845 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -151.07 -18.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.888 0.344 . . . . 0.49 111.5 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -147.52 -158.17 7.76 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.907 . . . . 0.13 112.491 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.5 m -119.11 141.89 48.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.786 0.327 . . . . 0.21 110.547 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.32 143.05 51.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.29 110.639 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 238' ' ' VAL . 2.9 tt0 -134.07 171.17 14.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.441 ' H ' ' HG2' ' A' ' 237' ' ' GLU . 27.6 m -86.08 149.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.795 0.331 . . . . 0.27 110.429 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 109.769 -0.456 . . . . 0.39 109.769 179.652 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.7 110.5 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.426 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 7.0 t-20 -105.99 -175.41 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.954 -0.566 . . . . 0.52 109.643 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -77.75 -85.29 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.626 0.25 . . . . 2.05 110.926 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mt -91.38 92.41 3.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.302 0.572 . . . . 0.27 110.764 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 68.2 mmt-85 -143.53 133.11 23.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.495 -0.775 . . . . 0.64 109.766 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.26 15.45 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.45 -0.341 . . . . 1.71 111.483 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 p -101.56 -3.11 29.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.434 -0.348 . . . . 0.61 111.475 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 37.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.18 0.514 . . . . 1.62 110.431 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 54' ' ' GLN . 33.9 m -95.53 150.61 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.44 111.597 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.9 151.91 25.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.933 -0.576 . . . . 0.48 109.582 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 126.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.781 0.324 . . . . 0.89 111.013 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -125.66 116.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.825 -0.805 . . . . 0.3 108.825 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.1 ttp180 -114.89 123.24 48.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.705 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.466 ' HB2' HG23 ' A' ' 89' ' ' ILE . 51.6 ttp -88.61 131.45 34.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.25 110.595 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -101.87 126.32 48.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.165 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 16.9 mmm180 -122.11 -164.62 1.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.329 -0.249 . . . . 0.64 110.329 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.32 -53.88 14.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.12 111.175 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.1 27.58 3.14 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.517 -0.849 . . . . 0.53 112.685 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 162.66 41.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.337 . . . . 1.12 110.47 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 141.3 23.23 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.329 -0.619 . . . . 1.09 109.329 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -136.05 144.44 45.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.333 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 1.2 pt-20 -145.6 144.45 30.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.682 0.277 . . . . 1.68 110.682 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.3 mt -140.13 144.67 27.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.33 109.994 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.77 122.99 28.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.17 110.523 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -124.44 -170.44 2.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.15 110.924 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.94 -176.19 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.453 -0.339 . . . . 0.94 110.987 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -76.67 -140.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.431 -0.35 . . . . 1.46 111.858 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -60.54 -6.8 1.78 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.426 0.898 . . . . 0.74 113.426 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.97 -2.96 58.84 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.008 -0.433 . . . . 0.98 111.387 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG21 ' SG ' ' A' ' 33' ' ' CYS . 8.8 p -74.15 -33.01 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.268 . . . . 0.23 111.499 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.05 70.23 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.119 0.961 . . . . 0.28 110.431 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.738 0 CA-C-N 114.807 -1.088 . . . . 0.19 112.596 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.495 -0.557 . . . . 1.41 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.45 153.67 17.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.257 -0.883 . . . . 0.71 108.966 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.03 -27.32 62.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.562 0.22 . . . . 0.29 111.334 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.41 111.797 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -87.37 0.15 55.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.52 111.791 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.32 -5.54 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.564 0.697 . . . . 0.5 110.027 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.24 133.48 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.438 -0.801 . . . . 1.32 109.961 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' HG3' HG12 ' A' ' 17' ' ' VAL . 29.0 mm-40 -85.77 -48.88 8.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.099 0.476 . . . . 0.28 110.709 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.1 t -119.25 166.68 12.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.891 -0.595 . . . . 0.8 109.727 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -121.24 32.54 5.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.272 0.558 . . . . 0.71 110.061 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.01 126.36 50.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.79 . . . . 0.28 109.447 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.6 p -108.86 137.65 39.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.873 0.368 . . . . 0.13 110.367 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HE2' ' H ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -82.95 158.27 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.372 . . . . 0.47 111.645 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.5 t -121.18 -56.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.36 109.186 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -137.72 101.13 4.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.255 -0.884 . . . . 0.32 109.56 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' H ' ' HE2' ' A' ' 59' ' ' PHE . 14.0 p -67.71 -30.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.59 110.917 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -70.12 -12.32 61.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.987 0.422 . . . . 0.33 111.181 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -121.37 4.71 10.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 1.06 110.846 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.82 38.46 94.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.739 -0.743 . . . . 0.4 111.351 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -101.77 120.81 40.95 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.14 0.495 . . . . 0.9 111.644 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.9 140.55 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.18 109.919 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.581 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -95.11 127.01 40.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.289 0.566 . . . . 0.06 110.834 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -88.86 -178.06 5.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.426 -0.806 . . . . 1.33 109.661 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.54 -28.67 68.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.102 0.477 . . . . 1.45 110.735 179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -80.03 -5.31 55.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.54 111.116 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.27 -46.09 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.334 -0.394 . . . . 0.47 111.125 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.82 -28.01 69.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.14 111.149 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 80' ' ' ASP . 10.2 tt -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.105 0.478 . . . . 0.2 110.596 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -35.75 17.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.841 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.55 -52.66 12.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.701 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -89.65 -66.98 0.87 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.988 0.423 . . . . 0.81 110.927 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.72 -50.82 0.47 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.172 -0.771 . . . . 0.24 111.172 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 148.21 25.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.919 -0.4 . . . . 0.71 109.919 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 74' ' ' ILE . 6.9 p-10 -93.25 3.82 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 1.23 110.664 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.58 122.92 36.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.207 -0.451 . . . . 1.45 109.962 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -60.33 -27.48 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.527 0.566 . . . . 1.88 112.527 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.52 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.013 0.435 . . . . 0.55 110.605 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.0 -23.16 23.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.12 110.275 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -79.54 -55.07 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.28 109.975 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 11.7 p -63.98 -24.87 67.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.24 110.721 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' THR . 40.7 ttmt -54.25 -41.75 69.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.645 . . . . 0.95 111.037 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -84.6 -38.19 20.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 1.36 110.72 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.567 HG22 HG22 ' A' ' 20' ' ' VAL . 65.5 mt -62.47 -34.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.18 111.981 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -25.02 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.069 0.766 . . . . 0.26 113.069 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.61 -20.74 11.59 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.362 -0.535 . . . . 0.63 112.399 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -111.0 12.4 22.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.923 0.392 . . . . 0.96 110.57 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 22' ' ' MET . . . -129.11 175.7 18.74 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.663 -0.78 . . . . 0.27 112.773 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -91.83 92.84 8.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.991 0.424 . . . . 1.4 110.602 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -91.66 140.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.869 -0.605 . . . . 0.27 109.691 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -69.34 84.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.62 110.837 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 95' ' ' VAL . 15.4 m . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.568 -0.742 . . . . 0.35 111.544 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 121.265 0.555 . . . . 0.56 109.728 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -86.16 2.37 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.99 111.757 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -107.46 121.42 44.58 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.751 -0.38 . . . . 1.39 110.038 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 m -51.1 132.65 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.856 0.723 . . . . 0.53 111.978 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.93 68.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.995 -0.548 . . . . 0.98 110.156 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 61.52 80.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.606 -0.725 . . . . 1.04 111.446 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -3.33 16.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.245 0.545 . . . . 0.79 111.153 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -77.82 -15.96 58.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.432 0.635 . . . . 0.27 109.56 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -94.65 159.47 15.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.289 -0.869 . . . . 0.57 109.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t -71.57 133.49 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.887 0.375 . . . . 0.46 110.289 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -26.37 68.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.51 110.811 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -82.65 -12.31 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.91 110.677 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -91.07 -34.75 14.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 1.63 110.512 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 159' ' ' VAL . 14.4 mt-30 -110.07 17.13 21.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 1.29 111.564 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.79 72.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.027 0.442 . . . . 0.17 111.383 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 2.9 mm? -64.34 -46.88 81.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.635 . . . . 0.78 110.791 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -59.5 -38.57 81.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.467 . . . . 0.25 111.129 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 155' ' ' GLN . 96.2 t -67.69 -49.72 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.17 111.701 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.6 -34.31 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.644 0.239 . . . . 0.28 111.644 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 29.5 mmtt -72.43 -40.54 67.02 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.271 -0.27 . . . . 1.79 110.271 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -59.04 -40.01 83.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.144 0.497 . . . . 0.99 110.087 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 53.3 tp -70.24 -41.22 73.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.598 -0.728 . . . . 0.76 110.313 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 167' ' ' MET . 59.8 tttm -58.14 -33.8 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.019 -0.537 . . . . 1.29 111.568 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.99 -30.56 71.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.765 0.317 . . . . 1.86 111.185 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -94.98 -41.86 8.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.18 110.411 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -133.56 119.89 20.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.089 -0.505 . . . . 0.79 109.656 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -90.53 109.01 20.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.08 0.467 . . . . 1.95 111.182 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.573 -0.74 . . . . 0.35 110.919 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 112.507 0.558 . . . . 0.97 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 175' ' ' ARG . 11.7 mtp180 -140.31 145.71 37.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.026 0.441 . . . . 0.67 111.826 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.573 ' HB2' HD23 ' A' ' 213' ' ' LEU . 5.9 mp -129.38 150.64 50.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.18 108.821 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 23.1 ptt180 -121.72 153.6 38.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.062 0.458 . . . . 0.18 110.962 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 31.4 t80 -117.64 128.21 54.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.22 109.876 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.52 128.51 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.85 111.065 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.549 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.6 OUTLIER -173.18 160.29 3.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.393 -0.595 . . . . 0.13 109.393 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.13 147.64 73.49 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.129 1.886 . . . . 0.2 111.536 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 72.9 t -61.62 -22.07 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.908 0.385 . . . . 0.35 110.708 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -52.7 -42.55 64.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.75 110.541 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.5 -32.78 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.54 109.817 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.96 -20.41 64.52 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.614 -0.721 . . . . 0.11 113.347 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.63 -26.54 61.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.95 0.405 . . . . 0.8 111.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 191' ' ' LYS . 50.9 mttt -76.68 -57.45 3.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.8 110.989 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -19.57 65.17 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.256 0.465 . . . . 1.55 112.256 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -54.19 -51.6 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.441 . . . . 0.79 111.442 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.88 21.68 4.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.387 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 187' ' ' LYS . 21.4 mtpp -122.7 0.02 9.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 2.29 109.978 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.27 -54.17 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 1.39 111.807 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.1 mtpp -53.92 -53.27 59.94 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.813 0.671 . . . . 0.63 112.813 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.8 Cg_endo -65.36 -14.15 43.49 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.219 1.946 . . . . 0.4 112.889 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.4 -18.75 40.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.407 -0.36 . . . . 0.67 110.442 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 31.4 mt 57.46 75.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.761 -0.654 . . . . 0.67 111.721 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.7 27.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.798 -0.637 . . . . 0.69 109.838 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.91 -173.46 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.306 -0.861 . . . . 0.89 109.927 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.67 137.66 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.342 -0.614 . . . . 0.89 109.342 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.06 71.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.511 0.507 . . . . 2.09 111.185 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 34.39 0.46 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.497 -0.774 . . . . 0.6 109.135 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.27 168.45 14.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.889 -0.596 . . . . 1.26 111.774 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -126.1 127.32 45.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.611 -0.722 . . . . 1.13 109.724 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -115.76 130.15 56.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.599 -0.273 . . . . 0.97 110.5 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 165.97 -114.66 0.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.74 -0.743 . . . . 0.74 112.277 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -40.16 31.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.661 0.743 . . . . 1.13 109.092 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -117.41 157.6 25.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.93 -1.032 . . . . 1.19 108.757 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.93 95.03 5.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.101 0.477 . . . . 0.31 110.351 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 28.4 tt0 -92.85 107.83 19.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.819 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.47 128.47 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.379 -0.373 . . . . 0.3 111.129 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.7 t -90.97 98.02 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.317 -0.623 . . . . 0.21 109.317 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 37.3 t -113.51 114.18 26.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.088 -0.506 . . . . 0.24 111.33 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -169.84 134.46 1.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.248 -0.649 . . . . 0.38 109.248 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.5 tt -131.79 171.82 17.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.496 -0.32 . . . . 0.35 110.217 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 42.1 m-20 -55.72 148.98 33.56 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.009 -0.541 . . . . 1.75 111.407 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.83 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.078 2.519 . . . . 0.41 113.081 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.36 -90.13 0.92 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.879 -0.888 . . . . 0.1 110.879 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.7 m -73.34 -4.5 33.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 1.27 110.214 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 79.1 t80 -55.59 -38.78 69.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.23 111.265 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 8.1 tpt180 -65.64 -31.2 72.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.565 0.222 . . . . 1.2 111.16 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.49 -35.97 78.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.42 110.741 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.604 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 3.6 tp -84.95 -27.48 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 1.11 109.879 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 26.1 t70 -64.44 -29.13 70.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.35 110.688 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 220' ' ' ARG . 12.9 mm-40 -53.42 -33.32 53.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.72 -0.673 . . . . 0.48 112.007 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -97.47 -33.43 11.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.948 -0.39 . . . . 0.17 109.948 178.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 222' ' ' ILE . 31.4 mm -55.96 -37.75 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.13 111.78 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.478 ' HA ' ' CB ' ' A' ' 231' ' ' LYS . 8.0 ptpt -62.22 -23.67 66.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.891 0.7 . . . . 0.42 112.891 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -112.47 -28.36 7.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.531 -0.468 . . . . 0.67 111.132 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -41.28 74.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.009 -0.541 . . . . 0.87 111.843 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.28 -47.06 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.501 0.556 . . . . 0.21 112.501 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 25.7 ttmt -53.35 -45.96 69.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.938 0.399 . . . . 0.23 111.088 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.28 48.23 2.9 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.806 -0.712 . . . . 0.22 112.017 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.82 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.727 0.299 . . . . 1.2 110.902 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.25 -146.99 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.12 112.379 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.0 m -108.84 131.24 55.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.17 110.858 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.4 pt? -111.82 149.94 31.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.835 -0.432 . . . . 0.21 109.835 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -142.52 -178.84 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.01 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.72 149.93 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.975 0.417 . . . . 0.16 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.448 0.642 . . . . 0.22 109.313 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.005 0.431 . . . . 0.44 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.45 158.66 15.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.09 -0.505 . . . . 0.51 110.193 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -71.08 -50.45 33.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.88 111.174 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.16 94.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.13 109.839 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -166.64 160.14 14.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 1.54 110.338 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.13 7.19 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.17 111.539 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 p -96.99 -0.06 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.27 110.712 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -141.98 38.11 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.612 . . . . 0.22 109.506 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.72 150.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.16 111.799 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.54 137.06 54.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.365 -0.834 . . . . 0.14 109.877 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -76.09 122.78 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.377 . . . . 0.35 110.989 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 31' ' ' ILE . 1.2 p -151.57 129.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.17 110.498 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 148.0 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.95 111.152 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 17.6 ttt -110.67 134.3 52.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.61 . . . . 0.23 110.847 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -96.68 103.77 15.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.634 -0.506 . . . . 0.73 109.634 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 10.9 mmm180 -84.07 -179.82 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.548 -0.296 . . . . 1.42 110.62 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.6 69.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.514 . . . . 0.42 111.918 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.11 -39.44 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.92 . . . . 0.54 113.28 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tttt -113.91 -174.94 2.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.781 0.324 . . . . 1.05 110.826 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 5.6 mmt180 -137.03 154.8 50.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.442 -0.948 . . . . 0.86 108.442 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -133.48 102.75 5.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.178 -0.304 . . . . 0.27 110.178 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 61' ' ' ASN . 2.6 mt-10 -106.05 127.0 52.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.37 110.773 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 20' ' ' VAL . 5.0 pt -135.06 -172.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.1 110.798 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.6 110.23 3.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.391 . . . . 0.09 110.886 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' HD23 ' A' ' 53' ' ' LEU . 62.5 m -100.18 -175.47 2.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 0.12 109.779 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -72.18 167.45 20.29 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.91 0.386 . . . . 0.22 111.338 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -99.69 7.77 44.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.088 0.47 . . . . 1.11 111.079 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -87.61 84.94 7.04 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.874 -0.331 . . . . 0.23 110.379 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm 58.06 57.18 4.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.733 -0.667 . . . . 0.43 110.778 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.1 p -74.65 61.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.794 1.283 . . . . 1.49 110.74 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.56 9.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.471 -1.24 . . . . 0.24 109.308 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-N 115.595 -0.729 . . . . 0.18 112.395 -179.038 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.34 110.583 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 3.1 p30 -166.52 -175.53 3.22 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.146 -0.687 . . . . 0.99 109.146 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.724 ' HB2' HG23 ' A' ' 83' ' ' THR . 1.2 mm? -131.5 33.86 4.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.453 0.644 . . . . 0.97 110.07 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -120.86 -43.97 2.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.542 -0.754 . . . . 1.88 109.314 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -87.0 -31.66 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.345 -0.843 . . . . 0.96 108.829 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.452 HG13 ' CE1' ' A' ' 34' ' ' TYR . 22.2 t -63.25 -37.25 78.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.901 -1.045 . . . . 0.44 110.035 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD23 ' SG ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -83.47 80.22 9.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.373 -0.83 . . . . 0.59 109.243 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.6 -62.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.288 -0.869 . . . . 0.42 111.039 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -78.66 91.98 4.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.67 -0.696 . . . . 0.17 111.277 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -84.22 60.46 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.415 0.626 . . . . 0.72 110.555 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.3 t -152.91 82.81 1.21 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.241 -0.891 . . . . 0.58 109.136 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.2 p -67.64 138.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.781 -0.645 . . . . 0.11 110.636 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -101.14 145.88 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.33 109.945 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 97.5 t -73.35 -40.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.033 -0.728 . . . . 0.5 109.033 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 2.1 t-20 -176.38 127.34 0.2 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.054 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.07 -37.93 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.772 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.4 m -83.44 43.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.93 111.122 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -47.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 2.28 110.046 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.14 -2.8 47.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.755 -0.736 . . . . 0.47 112.269 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.3 121.95 22.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.69 0.281 . . . . 1.01 110.803 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.8 t -105.86 134.41 47.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.958 -0.386 . . . . 0.27 109.958 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.1 98.32 10.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.158 0.504 . . . . 0.41 110.589 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -81.17 178.9 8.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.045 -0.724 . . . . 2.36 109.045 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -51.63 -35.8 43.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.685 0.278 . . . . 0.42 111.537 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.51 -30.01 70.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 2.09 111.805 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.67 -51.21 6.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 2.18 111.829 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 80' ' ' ASP . 2.2 pp -60.12 -32.55 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.19 111.881 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.39 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.202 0.525 . . . . 0.83 110.363 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.6 m -105.89 -39.15 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.79 111.142 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.94 -41.06 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.387 . . . . 0.33 111.07 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -96.63 -57.39 2.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.99 109.823 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.29 -31.93 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.902 -0.666 . . . . 0.53 112.142 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.02 145.35 45.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.55 0.215 . . . . 0.76 110.531 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 7.8 p-10 -92.8 11.68 26.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.059 0.456 . . . . 0.7 110.917 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.589 ' O ' HG12 ' A' ' 85' ' ' ILE . 13.5 t0 -82.1 117.72 22.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.44 109.781 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.07 -31.14 70.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.8 111.535 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.724 HG23 ' HB2' ' A' ' 49' ' ' LEU . 23.2 m -63.83 -46.97 82.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 0.14 110.559 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.8 -33.04 74.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.48 110.949 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 81' ' ' ASP . 41.6 mm -65.38 -57.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.28 111.05 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.64 -28.48 68.51 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.083 0.401 . . . . 0.19 112.083 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' THR . 28.0 mtpt -55.34 -53.56 54.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.925 0.393 . . . . 0.82 111.14 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -63.9 -40.01 95.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.74 -0.664 . . . . 0.81 111.729 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 20' ' ' VAL . 42.3 mt -69.81 -28.35 36.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.29 0.567 . . . . 0.18 111.078 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -32.12 40.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.291 -0.413 . . . . 0.26 111.771 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 87' ' ' LYS . 11.4 t -99.06 -29.48 12.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.133 0.79 . . . . 0.21 113.133 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -119.44 12.04 12.31 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.073 -0.392 . . . . 1.65 111.801 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.84 -177.33 18.39 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.583 -0.818 . . . . 0.26 111.551 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.49 106.62 18.66 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.119 -0.326 . . . . 1.8 110.119 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 97' ' ' VAL . 2.1 p -117.66 148.64 20.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.173 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -70.8 77.09 0.62 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.078 0.466 . . . . 0.41 111.64 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 95' ' ' VAL . 15.6 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 1.12 110.438 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 144' ' ' TYR . 16.2 tt . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 111.687 0.255 . . . . 0.23 111.687 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 m80 59.96 32.17 21.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.122 0.264 . . . . 0.36 111.366 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.452 ' H ' HG23 ' A' ' 142' ' ' ILE . 49.1 t80 -134.13 133.99 41.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.889 0.376 . . . . 0.68 110.669 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 m -155.36 170.28 22.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.687 -0.688 . . . . 0.52 109.194 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.48 -84.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.949 -0.3 . . . . 0.13 110.351 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -143.95 104.48 4.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.45 110.373 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -12.08 60.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.18 111.629 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.94 5.68 50.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.22 110.925 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -116.1 -159.88 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.29 -0.414 . . . . 0.99 110.528 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -75.41 81.66 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.364 0.602 . . . . 0.61 109.925 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 153' ' ' LYS . 0.9 OUTLIER -53.72 -25.44 18.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.5 113.514 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.619 ' HD2' HG23 ' A' ' 152' ' ' THR . 0.0 OUTLIER -91.12 -13.06 33.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.65 -0.656 . . . . 0.69 111.757 -179.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -84.69 -25.1 28.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.318 0.58 . . . . 0.5 109.592 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.94 29.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.564 -0.744 . . . . 0.15 110.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.1 -18.36 63.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.22 112.241 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.36 -46.38 16.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.113 0.482 . . . . 0.43 109.873 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -62.49 -46.0 90.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 0.54 111.023 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.37 -38.39 48.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.722 -0.672 . . . . 0.22 111.506 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.2 -34.34 66.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.138 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -82.87 -9.92 59.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.135 -0.484 . . . . 1.27 111.412 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -55.09 6.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.3 110.127 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.41 -24.0 66.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.29 110.623 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -61.57 -26.03 67.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.9 110.153 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -80.59 -7.01 59.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.49 110.845 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -107.62 -48.15 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.35 110.281 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 mmm -145.85 148.11 32.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 1.06 110.414 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -90.95 99.9 12.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.273 -0.421 . . . . 1.6 110.005 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 116.037 -0.529 . . . . 0.24 110.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 5.1 ttt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.985 -0.376 . . . . 1.48 109.985 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -137.69 120.83 16.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.024 -0.361 . . . . 0.58 110.024 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.462 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.8 mp -120.43 157.91 28.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.99 0.424 . . . . 0.39 110.875 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.415 ' HB3' HG22 ' A' ' 211' ' ' VAL . 0.1 OUTLIER -135.79 -179.47 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.553 -0.749 . . . . 0.36 109.862 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 1.9 p90 -141.66 139.63 33.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.721 0.296 . . . . 0.7 110.328 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -108.68 122.17 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.198 -0.456 . . . . 0.42 110.943 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.8 149.83 9.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.609 -0.723 . . . . 1.12 109.814 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.11 160.57 37.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.917 2.411 . . . . 0.12 112.789 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.36 -34.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 0.55 111.121 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -55.2 -45.93 75.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.82 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -85.57 -30.25 23.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.384 -0.371 . . . . 1.45 110.57 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.04 -22.05 77.1 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.42 113.066 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -61.15 -28.23 68.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.0 0.429 . . . . 1.12 110.88 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 4.55 51.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.262 -0.426 . . . . 1.44 110.733 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.4 tp -111.82 -41.05 4.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.94 110.987 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.442 ' HB2' HD21 ' A' ' 208' ' ' LEU . 27.4 ttpp -55.77 -44.37 77.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.98 111.19 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -80.61 6.24 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.178 0.436 . . . . 0.46 112.178 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -123.06 -2.76 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.292 -0.255 . . . . 0.97 111.127 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 192' ' ' LEU . 0.3 OUTLIER -127.3 -48.69 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.645 -0.252 . . . . 0.76 111.48 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 60.3 tttt -59.8 -50.28 87.47 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.367 0.506 . . . . 1.02 112.367 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 48.6 Cg_endo -68.0 -2.65 9.14 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.174 1.916 . . . . 0.16 112.913 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.25 3.02 55.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 110.053 -0.351 . . . . 0.58 110.053 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 16.9 mt 52.72 72.22 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.178 -0.919 . . . . 0.15 110.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 0.1 OUTLIER -152.8 19.37 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.608 -0.723 . . . . 0.34 109.932 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' SG ' ' A' ' 212' ' ' CYS . 33.2 m -108.95 145.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.499 . . . . 0.21 111.013 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.448 HD12 HG12 ' A' ' 211' ' ' VAL . 13.4 mt -97.02 159.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.679 . . . . 0.28 109.397 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.07 59.77 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.262 0.553 . . . . 1.32 111.613 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -155.99 74.62 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.28 -0.637 . . . . 0.45 109.28 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -123.52 155.01 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.48 . . . . 1.04 111.045 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.41 129.64 46.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.836 -0.62 . . . . 0.31 109.937 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.7 109.24 11.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.93 0.395 . . . . 1.17 110.117 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -168.77 -96.33 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.041 -0.599 . . . . 0.32 111.649 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -89.01 -10.88 45.91 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.122 -0.696 . . . . 0.56 109.122 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.19 -176.89 5.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.009 -0.996 . . . . 0.24 109.621 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 189' ' ' LYS . 21.9 tp -130.02 76.87 1.75 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.581 -0.526 . . . . 0.39 109.581 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.69 108.58 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.792 -0.64 . . . . 0.58 110.715 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 55.3 mt -123.13 137.39 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.19 110.611 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.448 HG12 HD12 ' A' ' 199' ' ' ILE . 85.9 t -91.53 123.75 43.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.25 110.065 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.459 ' SG ' HG12 ' A' ' 198' ' ' VAL . 57.4 m -137.21 102.34 4.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.244 -0.435 . . . . 0.41 110.468 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.462 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -159.66 136.96 9.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.388 -0.597 . . . . 0.25 109.388 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 215' ' ' ASP . 5.6 tp -134.86 179.36 4.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.525 -0.307 . . . . 0.29 110.354 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.56 ' H ' HG13 ' A' ' 214' ' ' ILE . 16.8 m-20 -60.43 164.22 7.31 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 122.978 0.511 . . . . 0.84 110.861 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 215' ' ' ASP . 10.2 Cg_endo -52.65 170.38 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.853 2.368 . . . . 0.07 112.923 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 80.48 -80.44 1.65 Allowed Glycine 0 C--O 1.237 0.315 0 N-CA-C 110.43 -1.068 . . . . 0.11 110.43 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.24 -22.44 63.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.34 109.107 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -59.5 -32.26 70.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.298 -0.865 . . . . 0.31 110.767 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 220' ' ' ARG . 11.4 mmt180 -85.93 -15.79 40.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.37 110.161 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 0.7 OUTLIER -79.69 -48.75 13.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.38 109.134 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 tt -66.66 -34.65 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.22 109.775 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.445 ' O ' ' HD2' ' A' ' 227' ' ' LYS . 1.8 t70 -59.98 -36.58 77.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.907 -0.588 . . . . 0.44 110.919 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 9.8 mm-40 -47.13 -41.14 16.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.664 -0.698 . . . . 0.9 111.934 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -34.09 10.2 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.793 -0.363 . . . . 0.46 111.266 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 8.9 mm -56.28 -39.11 58.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.222 0.453 . . . . 0.19 112.222 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 5.8 ptmt -64.74 -11.65 38.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.976 0.732 . . . . 0.38 112.976 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -25.74 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.552 -0.459 . . . . 1.85 112.005 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.14 -47.83 26.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.64 111.362 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -116.38 -38.8 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.845 -0.342 . . . . 0.31 111.59 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -66.09 -25.05 66.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 1.32 110.24 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.95 25.35 28.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.015 -0.612 . . . . 0.4 111.718 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -139.84 -55.18 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.583 -0.525 . . . . 0.59 109.583 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.41 -145.53 9.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.314 -0.714 . . . . 0.2 111.314 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.41 133.25 46.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 117.031 0.416 . . . . 0.81 110.018 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -89.55 149.65 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.953 -0.388 . . . . 1.18 109.953 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 177' ' ' ARG . 6.6 tp10 -155.56 154.61 31.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.84 110.179 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -72.57 158.6 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.596 0.236 . . . . 0.23 110.406 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.2 tp . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.458 0.647 . . . . 1.05 111.015 -179.418 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.241 0.543 . . . . 0.51 111.336 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -90.86 -76.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.86 110.752 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -161.37 -80.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.81 0.338 . . . . 0.72 110.822 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 54' ' ' GLN . 1.2 pp -89.18 47.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.132 0.491 . . . . 1.51 111.728 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -121.07 151.69 39.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.71 45.45 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.217 0.532 . . . . 1.13 111.608 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -99.51 -33.75 10.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.092 0.472 . . . . 1.06 111.063 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.54 72.33 1.42 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.219 -0.66 . . . . 0.73 109.219 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.12 149.01 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.669 -0.696 . . . . 0.95 111.331 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.66 123.0 49.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.51 109.412 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.43 120.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.114 0.483 . . . . 0.78 111.077 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -139.21 116.89 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.739 . . . . 0.24 109.525 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -126.83 132.95 50.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.229 0.538 . . . . 0.77 112.032 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 66.6 ttp -111.48 119.45 38.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.176 -0.676 . . . . 0.26 109.176 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 124.23 50.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.782 0.325 . . . . 1.17 110.828 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -109.86 -164.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.533 . . . . 2.79 110.055 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.61 72.89 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.3 0.375 . . . . 1.75 111.596 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.08 7.77 4.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.399 -0.905 . . . . 0.46 112.952 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -123.13 145.26 48.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 1.74 111.261 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -129.72 132.15 46.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.067 -0.716 . . . . 0.79 109.067 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.79 144.81 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.478 0.18 . . . . 0.32 110.871 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 44.8 tt0 -156.8 143.11 18.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.986 -0.376 . . . . 0.7 109.986 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 53' ' ' LEU . 2.0 pt -142.07 -173.21 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.737 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.82 119.78 26.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.915 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 90' ' ' LEU . 29.5 m -116.76 157.78 24.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 0.37 110.641 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HD1' ' NE2' ' A' ' 54' ' ' GLN . 1.3 t80 -74.15 145.13 44.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.829 0.347 . . . . 1.02 110.226 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 8.97 4.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.312 -0.404 . . . . 1.13 111.599 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.55 88.34 7.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.305 -0.247 . . . . 1.13 110.797 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.5 44.35 24.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.508 -0.769 . . . . 0.7 112.091 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.89 149.24 8.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 0.33 110.188 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 90' ' ' LEU . 3.9 t 68.81 23.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.41 0.624 . . . . 0.14 110.459 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.404 0 CA-C-N 115.898 -0.592 . . . . 0.17 113.292 178.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.968 -0.753 . . . . 0.64 108.968 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.41 138.79 58.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.81 0.338 . . . . 0.52 111.284 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 52' ' ' VAL . 6.0 mp -68.23 -24.45 64.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.981 -0.554 . . . . 0.52 110.229 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.26 -27.28 68.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.373 0.606 . . . . 1.14 109.946 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 17.65 19.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 1.48 111.161 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.3 p -125.12 -9.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.347 . . . . 0.24 111.087 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.575 ' HG ' HE22 ' A' ' 82' ' ' GLN . 1.9 mm? -96.24 110.07 22.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.333 -0.394 . . . . 0.39 110.35 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.532 ' NE2' ' HD1' ' A' ' 34' ' ' TYR . 17.1 mt-30 -70.52 -35.81 73.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 2.38 110.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -122.11 164.37 17.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.748 -0.66 . . . . 0.85 110.458 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -125.19 18.05 8.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.947 -0.569 . . . . 0.83 109.629 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -116.39 118.49 32.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.462 -0.79 . . . . 0.58 110.164 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 68' ' ' ALA . 8.0 p -100.95 143.14 14.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.239 -0.437 . . . . 0.31 110.227 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -83.97 157.5 21.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.629 0.252 . . . . 0.22 111.087 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 83.3 t -117.8 -49.48 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.482 0.658 . . . . 0.4 109.539 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -144.15 111.37 5.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.815 . . . . 0.72 108.955 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.5 -37.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.006 0.373 . . . . 0.36 112.006 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -31.17 72.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.933 0.397 . . . . 0.51 111.142 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -100.96 -1.85 33.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.91 111.242 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.84 48.13 83.42 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.96 -0.638 . . . . 0.38 112.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -106.6 123.65 48.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.794 0.331 . . . . 0.58 111.231 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.76 139.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.736 -0.666 . . . . 0.08 109.537 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.93 128.13 36.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.12 111.653 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -91.33 -172.33 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.362 -0.607 . . . . 0.4 109.362 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -63.27 -30.74 71.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.758 0.314 . . . . 0.31 111.004 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.1 pm0 -79.62 -24.82 41.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 1.19 110.973 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.19 -51.95 15.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.424 -0.353 . . . . 1.81 110.288 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.43 -32.78 74.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.25 110.935 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -66.8 -23.53 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.961 0.41 . . . . 0.72 110.237 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -100.93 -5.81 25.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.65 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.18 -40.27 7.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.33 110.763 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.97 -34.51 6.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.38 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.01 -10.02 29.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.032 -0.604 . . . . 0.31 111.926 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 147.09 44.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.476 0.179 . . . . 0.93 110.523 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -96.69 -8.91 30.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.809 0.338 . . . . 0.86 111.02 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 85' ' ' ILE . 56.0 t0 -73.84 110.78 8.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.168 -0.469 . . . . 0.99 110.099 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.575 HE22 ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -62.07 -27.86 69.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.851 -0.613 . . . . 0.64 110.882 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -34.39 77.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.66 110.538 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.96 -29.27 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 81' ' ' ASP . 39.7 mm -67.28 -46.32 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 p -71.1 -24.08 62.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.27 110.349 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -59.9 -41.83 92.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.215 0.531 . . . . 0.76 109.718 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.04 -49.67 55.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.411 -0.813 . . . . 0.35 110.726 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG22 HG22 ' A' ' 20' ' ' VAL . 33.2 mt -61.76 -35.12 65.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.25 112.245 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 33' ' ' CYS . 3.7 mm? -82.77 -11.31 58.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.247 0.832 . . . . 0.08 113.247 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -122.98 -10.1 8.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.151 -0.62 . . . . 0.14 112.389 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -121.94 -5.26 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.733 0.302 . . . . 0.16 110.827 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.8 -169.33 19.26 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.547 -0.835 . . . . 0.14 113.067 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.29 107.44 18.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.702 -0.481 . . . . 0.99 109.702 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 97' ' ' VAL . 2.2 p -106.28 138.52 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.2 110.456 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.26 89.39 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 1.22 111.021 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.45 . . . . 1.06 111.033 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.1 tt . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 119.841 -0.123 . . . . 0.31 110.989 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 41.16 51.53 3.43 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.686 0.616 . . . . 0.83 111.7 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -114.01 94.59 4.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 0.82 111.406 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 139.29 30.79 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.629 . . . . 0.51 109.887 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.66 83.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.792 0.33 . . . . 0.47 110.533 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 60.75 54.45 3.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.743 -0.662 . . . . 1.09 111.405 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -15.43 63.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.6 111.818 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -101.48 15.95 27.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 1.27 111.007 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -119.23 -125.2 0.28 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.907 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.77 79.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.84 111.023 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -21.94 60.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.922 -0.581 . . . . 0.58 112.52 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 9.7 29.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.369 . . . . 1.19 111.168 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -128.98 -44.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 1.36 110.154 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -71.56 -6.02 37.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.814 -0.63 . . . . 1.26 111.22 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -36.82 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.38 110.8 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.91 -39.21 76.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.9 110.693 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 12.2 mp0 -64.99 -46.17 82.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.049 -0.523 . . . . 0.82 111.147 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.26 -44.18 80.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 111.971 0.36 . . . . 0.45 111.971 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.16 -29.59 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.874 0.324 . . . . 0.79 111.874 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -97.21 -12.84 22.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.591 0.234 . . . . 0.95 111.188 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 3.9 tp-100 -68.15 -43.61 77.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.662 -0.496 . . . . 0.32 109.662 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.36 -32.12 73.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.27 109.903 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -67.93 -21.89 65.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.555 -0.748 . . . . 0.97 110.391 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.6 -32.85 60.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.43 110.271 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -52.82 7.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.82 -0.807 . . . . 1.42 108.82 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mtp -131.59 112.45 12.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.944 -0.761 . . . . 1.04 108.944 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -73.52 81.23 1.46 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 1.23 111.75 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.562 -0.744 . . . . 0.26 109.76 178.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.943 0.401 . . . . 0.74 111.33 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.441 ' HA ' ' HG ' ' A' ' 213' ' ' LEU . 25.3 mtp180 -84.08 147.99 27.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 1.24 111.153 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -129.45 175.64 8.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.32 110.567 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.86 167.38 21.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.83 109.826 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.3 t80 -123.67 143.08 50.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.636 -0.256 . . . . 0.26 110.691 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.6 pt -133.28 115.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.025 0.44 . . . . 0.27 110.548 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 184' ' ' GLU . 2.3 pt? -155.84 155.63 29.63 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.028 -0.533 . . . . 0.11 110.238 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.95 161.44 33.07 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.994 2.463 . . . . 0.17 113.27 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' HD23 ' A' ' 208' ' ' LEU . 27.8 t -57.65 -35.53 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.607 -0.724 . . . . 0.45 111.89 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.31 -39.78 61.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.34 111.998 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 49.6 mm-40 -104.46 -17.74 14.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.988 0.423 . . . . 0.46 110.529 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.31 -34.6 88.78 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.171 -0.538 . . . . 0.24 112.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 30.6 ttpt -71.62 -7.55 48.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.928 0.394 . . . . 0.68 111.098 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -84.15 -58.26 2.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.679 0.276 . . . . 0.62 110.704 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -25.66 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.8 111.21 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.52 -37.21 85.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.837 0.351 . . . . 1.08 110.723 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 13.7 mm-40 -90.99 11.23 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.396 -0.366 . . . . 0.76 110.684 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -121.1 -49.24 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.806 0.299 . . . . 0.64 111.806 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.09 -36.73 35.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.109 0.781 . . . . 0.3 113.109 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 24.8 mtpp -60.93 -50.98 82.54 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 112.228 0.455 . . . . 0.22 112.228 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 21.3 Cg_endo -61.43 -19.58 64.93 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.147 1.898 . . . . 0.23 112.609 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.95 -13.02 58.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.349 . . . . 0.24 110.141 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.1 mt 55.22 59.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.49 -0.777 . . . . 0.46 110.371 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 21.37 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.33 -0.85 . . . . 0.39 109.783 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 212' ' ' CYS . 19.5 m -120.81 149.51 23.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.34 110.416 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.66 149.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.374 -0.602 . . . . 0.25 109.374 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -73.45 70.01 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 1.36 111.005 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.0 m -151.85 37.03 0.56 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.743 -0.662 . . . . 0.81 109.397 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.1 pt-20 -88.08 175.25 7.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.798 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' ' 208' ' ' LEU . 23.3 t70 -132.96 146.81 52.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.4 109.341 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.35 25.88 9.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.431 0.16 . . . . 0.97 111.431 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.21 -141.88 7.85 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.786 -0.721 . . . . 0.68 112.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -74.42 -17.51 60.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.179 0.514 . . . . 1.78 110.642 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 121.38 34.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.699 -0.682 . . . . 1.55 109.61 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 182' ' ' VAL . 4.1 mm? -80.71 85.8 6.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.127 0.489 . . . . 0.54 110.369 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 25.4 tt0 -76.72 93.61 3.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.817 -0.629 . . . . 1.04 110.048 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.2 127.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.514 . . . . 0.32 110.652 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.51 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.855 0.359 . . . . 0.22 110.361 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.8 p -124.51 104.68 8.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.29 110.898 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -164.35 127.37 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.313 -0.625 . . . . 0.21 109.313 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.03 -163.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.634 -0.257 . . . . 0.23 111.546 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -49.05 148.96 3.66 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.529 -0.76 . . . . 0.77 112.388 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.86 -50.09 14.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.134 2.556 . . . . 0.41 113.071 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.08 -57.3 8.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.47 112.657 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 51.4 m -55.88 -36.6 67.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.239 0.459 . . . . 0.48 112.239 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.93 -39.75 90.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.096 -0.642 . . . . 0.74 110.609 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -70.89 -8.14 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 1.7 110.647 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.46 -22.67 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.755 -0.657 . . . . 1.25 110.571 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 226' ' ' ILE . 7.6 tp -108.69 -29.11 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.459 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 33.9 t70 -61.37 -21.09 63.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.873 0.368 . . . . 0.76 111.104 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -26.32 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.86 111.114 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 228' ' ' LYS . 0.7 OUTLIER -114.02 -25.53 8.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.575 -0.284 . . . . 0.77 110.571 178.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.5 mm -66.51 -33.24 62.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.666 0.27 . . . . 0.79 110.979 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.96 -35.88 77.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.391 . . . . 0.98 110.782 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.55 11.21 39.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.239 0.543 . . . . 0.86 110.011 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -102.21 -65.77 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.45 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -121.57 -30.1 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 0.7 111.803 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -61.12 -33.05 72.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.161 0.505 . . . . 1.0 110.704 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.36 22.82 37.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.71 110.974 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -118.66 -57.43 2.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.882 0.372 . . . . 1.39 110.4 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.08 -136.08 5.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 0.4 112.806 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.7 m -132.59 148.85 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.39 110.621 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.68 160.29 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.913 0.387 . . . . 0.53 111.078 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -144.97 157.34 44.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.2 -0.667 . . . . 0.41 109.2 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.11 148.34 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.3 110.919 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.299 0.571 . . . . 1.07 109.818 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.22 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t30 65.09 18.4 11.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.624 -0.716 . . . . 0.46 112.383 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.89 -3.0 52.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.068 -0.345 . . . . 1.09 110.068 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mt 55.1 68.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.568 -0.742 . . . . 0.36 110.922 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -136.37 166.86 22.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.729 -0.669 . . . . 0.26 109.5 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -75.78 53.52 0.74 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.977 0.418 . . . . 0.67 110.634 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -123.41 -44.83 2.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.991 -0.549 . . . . 0.71 111.554 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -112.05 23.51 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 1.9 110.593 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m -74.41 137.42 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.49 112.256 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -91.78 140.26 29.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.614 -0.721 . . . . 0.6 110.205 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.07 130.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.186 0.517 . . . . 0.45 111.872 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 89' ' ' ILE . 5.7 p -150.13 126.4 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.574 -0.739 . . . . 0.18 109.024 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -132.86 141.7 48.55 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.655 0.613 . . . . 1.73 112.655 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttp -113.65 108.71 17.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.166 -0.925 . . . . 0.21 108.806 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -86.94 99.34 11.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.11 111.248 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -96.13 167.01 11.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.89 109.926 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.16 73.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.362 -0.381 . . . . 0.5 111.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.87 -50.78 6.22 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.95 -0.643 . . . . 0.6 112.521 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -161.81 147.43 13.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.777 -0.453 . . . . 0.48 109.777 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -92.39 143.87 25.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.671 -0.492 . . . . 1.32 109.671 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.34 132.36 42.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.538 -0.301 . . . . 0.32 111.024 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 21' ' ' ARG . 22.8 tt0 -124.4 134.87 52.99 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.459 -0.571 . . . . 1.48 109.459 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.37 145.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.404 . . . . 0.34 111.151 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.777 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -106.37 112.77 25.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.479 -0.563 . . . . 0.32 109.479 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.1 168.05 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 0.88 111.835 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.475 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 22.3 t80 -73.26 117.68 15.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.762 -0.654 . . . . 1.1 109.854 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 27.8 ttpt -79.83 82.39 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.398 0.618 . . . . 1.98 111.707 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.67 75.5 0.78 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.098 -0.955 . . . . 0.65 108.452 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.69 36.19 2.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.956 -1.02 . . . . 1.08 109.837 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.18 -40.55 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.493 -0.776 . . . . 0.35 110.908 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.58 2.27 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.33 110.605 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 111.217 -0.753 . . . . 0.27 111.217 179.623 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 110.094 -0.336 . . . . 0.43 110.094 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.72 143.77 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.137 -0.32 . . . . 0.29 110.137 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.91 -24.88 67.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.24 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -57.83 -37.17 73.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.943 0.401 . . . . 0.38 110.772 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -83.77 -19.61 34.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.972 -0.558 . . . . 1.46 110.798 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.07 -25.47 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.36 110.938 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 55' ' ' THR . 2.4 mm? -74.76 99.83 3.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.4 110.921 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 34' ' ' TYR . 29.2 mt-30 -77.34 -24.48 50.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.671 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.443 ' O ' HD12 ' A' ' 53' ' ' LEU . 12.6 t -130.63 152.01 50.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.46 109.808 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -112.53 7.87 19.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.071 0.462 . . . . 0.39 110.4 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -110.23 145.59 37.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.016 -0.538 . . . . 0.18 109.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 68' ' ' ALA . 11.6 p -112.04 139.8 34.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 0.15 110.934 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -78.01 151.47 33.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.89 111.547 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 54.9 t -129.48 -59.34 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.499 -0.319 . . . . 0.61 111.636 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -123.68 126.67 46.99 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.456 -0.152 . . . . 0.63 110.825 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.17 -26.36 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 111.957 0.355 . . . . 0.95 111.957 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.7 m -72.02 -47.06 54.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.192 0.52 . . . . 0.77 110.207 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.47 -22.27 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.44 110.2 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 44.58 36.6 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 0.46 111.374 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -108.02 124.1 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.083 0.468 . . . . 1.16 111.068 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.01 145.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.471 -0.786 . . . . 0.43 109.606 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 72' ' ' ASP . . . -97.51 126.76 42.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.18 110.838 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -97.21 -171.53 2.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.653 -0.703 . . . . 1.11 110.112 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -51.28 -40.21 58.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.699 0.629 . . . . 1.07 112.699 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -62.15 -26.7 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.692 0.627 . . . . 0.47 112.692 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 17.2 t70 -94.17 -44.71 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.682 -0.407 . . . . 0.25 111.751 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.31 -34.69 75.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.929 -0.309 . . . . 0.26 111.827 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.11 -25.67 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.8 110.736 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 m -94.58 -43.03 8.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.16 111.387 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.09 -46.43 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.16 112.088 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -94.07 -29.75 15.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.94 110.689 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 16.19 54.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.466 -0.874 . . . . 0.8 112.184 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.5 m -145.94 124.56 12.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.19 -0.3 . . . . 1.51 110.19 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.29 60.68 5.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.433 0.635 . . . . 1.16 110.41 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.457 ' OD2' ' HB ' ' A' ' 83' ' ' THR . 19.6 t70 -151.97 111.84 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.728 -0.669 . . . . 2.41 109.986 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -68.33 -24.66 64.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.511 . . . . 1.51 111.218 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.457 ' HB ' ' OD2' ' A' ' 81' ' ' ASP . 11.6 m -66.82 -45.76 77.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.58 110.228 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -58.89 -46.54 87.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.67 110.402 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.96 -48.23 87.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.553 -0.749 . . . . 0.35 110.596 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.2 -34.6 75.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.16 110.895 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -62.01 -42.21 98.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 0.33 110.14 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.55 -40.37 84.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.28 110.002 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.558 HG22 HG22 ' A' ' 20' ' ' VAL . 76.3 mt -68.87 -30.89 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.617 -0.719 . . . . 0.12 111.004 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -18.79 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.398 -0.365 . . . . 0.16 111.69 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -105.7 -15.47 14.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.59 -0.444 . . . . 0.2 112.075 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -142.05 36.48 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 2.1 111.164 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.47 165.83 24.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.529 -0.843 . . . . 0.4 112.587 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 80.1 mt-10 -82.01 93.49 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 1.41 110.246 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.01 137.24 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.338 -0.392 . . . . 0.22 110.227 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -73.31 76.05 1.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.202 0.525 . . . . 0.58 111.77 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.36 111.298 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 144' ' ' TYR . 8.6 mt . . . . . 0 C--O 1.232 0.178 0 N-CA-C 111.422 0.156 . . . . 0.4 111.422 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.3 t60 75.06 -24.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.865 0.728 . . . . 1.31 111.674 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 142' ' ' ILE . 29.8 t80 -70.86 135.06 47.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.165 -0.309 . . . . 1.3 110.165 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 170.38 10.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.426 -0.352 . . . . 0.18 110.665 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.408 HG13 HG21 ' A' ' 159' ' ' VAL . 2.8 t -87.21 48.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.25 110.536 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 52.41 30.23 7.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.33 111.341 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 148' ' ' THR . 14.6 t 42.33 73.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.341 1.056 . . . . 0.74 112.497 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p30 51.37 18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.705 1.202 . . . . 0.55 114.114 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.05 140.47 48.43 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.97 -0.456 . . . . 1.43 111.046 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.4 m 62.57 38.96 11.98 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.13 110.915 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -63.93 -33.82 76.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.775 -0.648 . . . . 0.72 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.94 4.07 31.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.855 0.359 . . . . 0.87 110.95 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -105.16 -54.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.26 110.834 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' A' ' 159' ' ' VAL . 6.7 mp0 -94.91 16.75 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 0.6 111.935 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -57.69 -42.8 84.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.894 0.378 . . . . 0.3 111.133 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.37 3.16 32.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.66 111.881 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -111.46 -48.64 3.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 1.15 110.798 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 155' ' ' GLN . 58.5 t -64.65 -39.21 84.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 0.08 110.863 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 164' ' ' LYS . 7.5 tt -68.22 -9.86 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.189 -0.46 . . . . 0.27 111.356 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -102.67 -35.46 8.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.822 -0.436 . . . . 1.27 109.822 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -57.37 -56.61 19.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.342 -0.845 . . . . 0.7 111.778 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -72.41 -21.76 61.21 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.68 -0.408 . . . . 0.39 111.218 -178.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.574 ' N ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.02 -31.24 67.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.68 110.008 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.05 -32.91 73.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.653 -0.703 . . . . 1.03 109.87 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.43 -44.65 14.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.701 -0.681 . . . . 1.65 110.427 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.0 tpp -145.99 126.32 13.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.36 -0.382 . . . . 1.45 110.655 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -80.69 122.5 27.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.815 -0.439 . . . . 1.56 109.815 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.36 111.673 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 60.2 mtm . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 120.847 0.356 . . . . 2.37 111.226 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -76.42 133.0 39.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.802 -0.635 . . . . 0.67 110.466 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt -105.39 147.02 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.024 -0.535 . . . . 1.08 110.896 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 17.1 ptt180 -128.82 141.9 51.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.245 -0.65 . . . . 0.62 109.245 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.8 128.27 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.799 0.333 . . . . 0.22 110.754 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 30.8 pt -102.02 137.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 0.7 110.763 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.755 HD23 ' HD2' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -146.7 123.48 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.28 109.591 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.755 ' HD2' HD23 ' A' ' 180' ' ' LEU . 10.0 Cg_endo -52.26 142.77 45.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.552 2.168 . . . . 0.16 112.032 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.7 t -45.56 -37.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.153 0.581 . . . . 0.27 112.176 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -48.5 -40.61 27.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.912 -0.586 . . . . 0.41 112.151 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -117.93 7.23 12.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.01 0.433 . . . . 0.49 110.526 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.509 ' O ' HD23 ' A' ' 188' ' ' LEU . . . -66.57 -31.21 77.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.25 112.777 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 82.1 tttt -63.74 -29.02 70.28 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.69 -0.3 . . . . 1.48 111.28 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.76 -47.52 84.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.601 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -85.77 -22.04 27.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.857 0.36 . . . . 0.43 110.607 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -60.1 -52.15 66.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.971 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 11.3 pt-20 -89.27 22.25 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.9 111.253 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -121.38 -47.08 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.511 -0.313 . . . . 0.59 111.172 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 188' ' ' LEU . 8.5 mt -83.01 -39.14 21.66 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 53.2 mttm -59.89 -49.92 89.05 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.815 0.672 . . . . 1.16 112.815 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.0 Cg_endo -60.18 -19.77 58.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.135 1.89 . . . . 0.3 113.044 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 86.3 mt -79.09 -14.43 59.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.607 -0.269 . . . . 0.2 110.438 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.7 mm 56.22 41.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.801 0.81 . . . . 0.23 110.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -124.91 28.81 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.343 -0.844 . . . . 0.42 109.949 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.6 m -119.13 156.07 21.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.335 -0.848 . . . . 0.12 110.43 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.68 147.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.531 -0.544 . . . . 0.86 109.531 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.82 76.3 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 1.23 110.945 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.0 m -155.56 26.3 0.39 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 0.19 109.521 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 2.7 mp0 -80.37 162.61 24.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 1.79 111.641 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -109.16 143.26 38.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.903 -0.777 . . . . 1.6 108.903 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.75 37.94 3.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.6 110.69 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -99.74 -97.67 2.18 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.705 -0.759 . . . . 0.66 112.078 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -95.73 -22.32 17.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.158 0.504 . . . . 2.25 110.916 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.49 160.79 37.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.7 109.999 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.7 mm? -100.15 80.11 2.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.042 0.449 . . . . 0.39 110.101 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 47.2 tt0 -76.62 96.78 4.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.44 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 37.9 mm -96.95 139.55 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.866 0.365 . . . . 0.3 111.152 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.76 116.57 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.32 110.323 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.2 p -139.28 96.13 3.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.351 . . . . 0.71 110.676 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -164.44 136.66 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.495 -0.557 . . . . 0.76 109.495 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.16 -45.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.601 0.238 . . . . 0.82 111.191 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -168.92 158.16 7.66 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.564 -0.289 . . . . 0.9 110.235 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.54 -16.71 54.03 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.816 2.344 . . . . 0.57 113.197 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -71.06 -60.05 4.71 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.004 -0.617 . . . . 0.26 112.388 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.456 ' O ' HG12 ' A' ' 222' ' ' ILE . 2.2 m -79.0 -8.71 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.973 0.415 . . . . 0.34 110.847 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.19 -29.4 68.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.29 111.873 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -60.54 -50.61 72.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 0.48 111.065 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -77.86 2.27 17.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 1.24 111.608 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 28.2 mm -101.76 -55.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.878 0.371 . . . . 1.16 110.382 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 35.4 t70 -60.81 -26.08 67.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.36 111.813 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.5 -26.35 65.21 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.195 -0.457 . . . . 1.1 111.795 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.0 pp -106.65 -34.01 7.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.26 110.126 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.0 mm -55.78 -35.3 39.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.003 -0.544 . . . . 0.2 111.077 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 18.1 ptpt -53.32 -37.17 62.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.582 -0.735 . . . . 2.0 112.426 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -19.69 13.7 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.594 -0.443 . . . . 2.79 112.15 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.5 -41.07 48.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.213 0.449 . . . . 1.18 112.213 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.513 ' HB ' HD13 ' A' ' 188' ' ' LEU . 5.1 t -142.22 -32.52 0.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.257 0.836 . . . . 0.18 113.257 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 37.5 ttmt -57.75 -47.57 82.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.781 0.324 . . . . 0.82 111.462 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.03 10.72 71.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.965 -0.636 . . . . 0.23 112.404 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -112.32 -59.86 1.94 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.51 110.188 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -106.46 -119.15 4.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.21 111.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 7.9 m -143.67 150.69 39.09 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 122.703 -0.292 . . . . 0.48 110.574 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.7 pt? -109.83 142.98 40.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 1.5 111.045 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.84 -173.78 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.988 -0.551 . . . . 1.04 109.718 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.93 153.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.418 . . . . 0.24 111.772 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.9 109.724 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.004 0.431 . . . . 0.37 110.795 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -171.55 -59.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.93 109.566 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -128.08 -157.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.662 -0.699 . . . . 2.37 111.031 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -69.42 100.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.118 0.485 . . . . 0.67 111.099 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -136.25 134.56 38.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.631 -0.713 . . . . 1.53 109.744 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.6 mt -66.18 -4.76 8.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.167 0.432 . . . . 1.05 112.167 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -20.34 52.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.124 0.488 . . . . 0.37 111.069 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 48.6 m-80 -114.36 71.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.47 110.278 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.5 m -123.13 121.79 63.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.23 111.762 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.76 116.16 31.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.619 . . . . 0.36 109.327 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.56 109.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.104 0.478 . . . . 0.45 111.685 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 89' ' ' ILE . 6.6 p -105.92 129.44 59.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.541 -0.911 . . . . 0.37 108.541 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -125.72 125.4 42.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.372 -0.531 . . . . 0.61 112.095 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 89' ' ' ILE . 34.7 ttp -114.27 116.18 28.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.25 109.603 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 128.54 54.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 1.0 110.622 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -113.67 -156.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.617 -0.72 . . . . 1.24 109.501 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.86 -60.33 2.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.35 110.878 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.18 32.43 3.96 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.959 -0.639 . . . . 0.21 111.713 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.02 142.42 31.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.49 109.726 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.12 125.66 10.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.509 -0.314 . . . . 1.77 110.572 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -144.35 132.02 21.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.333 -0.394 . . . . 0.31 110.727 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.91 138.17 43.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.444 . . . . 0.68 110.424 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.708 HD11 HD12 ' A' ' 89' ' ' ILE . 1.1 mt -136.76 172.22 15.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.781 0.324 . . . . 1.15 110.656 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' H ' HG22 ' A' ' 31' ' ' ILE . . . -124.84 107.91 11.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.107 -0.497 . . . . 0.21 109.993 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 m -98.55 -161.84 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.2 110.077 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.57 -173.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.443 0.164 . . . . 1.03 110.624 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 23.1 tptt -74.47 -133.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.943 0.401 . . . . 0.86 111.499 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.69 6.21 0.24 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.091 0.774 . . . . 0.61 113.091 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 -15.0 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.222 -0.299 . . . . 0.81 110.913 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.23 -27.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.328 0.492 . . . . 0.26 112.328 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.83 101.43 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.223 0.535 . . . . 0.21 111.091 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.358 0 CA-C-N 115.291 -0.868 . . . . 0.24 112.574 179.609 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 111.771 0.286 . . . . 1.68 111.771 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.51 127.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.905 -0.405 . . . . 2.04 109.905 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.06 -24.35 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.225 -0.443 . . . . 0.65 111.669 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.63 -41.88 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.02 0.438 . . . . 1.98 110.587 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -78.31 -30.31 48.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 1.74 110.169 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.28 -33.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.2 110.143 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -88.28 84.88 6.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.184 -0.462 . . . . 0.2 110.458 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.0 -61.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.747 -0.661 . . . . 0.73 110.973 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.23 120.24 22.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.953 0.406 . . . . 0.13 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -99.03 5.96 46.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.322 -0.399 . . . . 0.69 110.683 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.25 114.75 28.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.895 -0.593 . . . . 0.28 110.072 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 68' ' ' ALA . 3.7 p -89.12 136.82 22.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.14 110.507 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -95.21 149.22 21.56 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.11 -0.33 . . . . 0.33 110.11 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.17 -45.39 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.458 0.647 . . . . 0.26 109.745 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -155.46 107.86 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.485 -0.78 . . . . 1.91 109.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.59 -28.98 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.59 . . . . 0.51 112.095 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.6 m -73.42 -16.7 61.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.876 0.369 . . . . 0.88 111.299 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -13.82 14.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.814 0.34 . . . . 0.64 110.45 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.77 75.78 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.15 111.751 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -87.24 112.04 21.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.981 0.419 . . . . 1.15 110.964 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 t -98.0 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.1 109.621 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.93 115.11 27.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.864 -0.421 . . . . 0.12 109.864 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.088 -0.506 . . . . 0.94 109.747 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -59.4 -30.23 68.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.098 0.475 . . . . 0.95 110.436 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.99 -19.68 54.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.623 -0.717 . . . . 2.32 110.899 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.57 -47.58 8.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.966 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 2.3 pp -67.02 -31.77 72.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.259 -0.428 . . . . 0.11 111.399 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.46 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.708 0.289 . . . . 0.74 111.384 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -91.38 -9.42 44.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.728 0.299 . . . . 0.9 111.663 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.42 -43.15 5.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.14 111.417 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -92.09 -37.5 12.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.49 -0.323 . . . . 0.27 110.75 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.03 -17.95 29.11 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.11 112.128 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 81' ' ' ASP . 3.7 m -116.53 142.22 47.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.917 -0.401 . . . . 0.21 109.917 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.65 2.38 48.64 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.98 0.419 . . . . 0.32 111.053 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 79' ' ' THR . 13.1 t70 -92.54 109.0 20.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.543 -0.54 . . . . 1.29 109.543 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -33.17 75.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 0.6 111.764 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.32 78.62 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.933 0.397 . . . . 0.45 111.114 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -36.9 83.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.746 -0.661 . . . . 1.94 110.487 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.8 mt -72.0 -41.56 68.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.16 110.328 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.28 -37.79 78.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.871 -0.604 . . . . 0.15 110.011 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -61.43 -42.6 99.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.415 -0.811 . . . . 1.08 110.409 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.68 -49.17 64.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.923 -0.58 . . . . 1.04 110.775 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.708 HD12 HD11 ' A' ' 31' ' ' ILE . 54.7 mt -57.88 -34.43 48.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.041 -0.527 . . . . 0.39 111.413 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -41.34 87.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.42 0.526 . . . . 0.26 112.42 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -96.84 -11.7 24.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.001 0.741 . . . . 0.51 113.001 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -106.6 -31.28 8.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.173 0.434 . . . . 0.97 112.173 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.56 -173.65 29.58 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.479 -0.867 . . . . 0.22 113.136 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -91.74 107.26 19.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.397 . . . . 1.88 110.978 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.02 134.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.803 -0.814 . . . . 0.58 108.803 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 96.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 1.48 111.491 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 0.82 110.245 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.7 mm . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.728 0.299 . . . . 0.59 110.651 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -132.78 15.56 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.541 . . . . 1.23 110.202 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.34 164.44 17.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.604 -0.726 . . . . 0.87 109.614 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -69.56 113.97 7.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.191 -0.3 . . . . 1.26 110.191 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.68 -49.32 81.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.998 -0.546 . . . . 0.28 110.253 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HB3' ' OD1' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -143.63 119.61 10.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.8 109.732 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -18.69 59.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.28 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 24.1 p-10 -84.63 -16.38 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.34 110.837 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -104.58 132.27 51.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.48 110.112 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.9 m -84.12 168.86 15.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.352 -0.385 . . . . 0.36 110.775 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -57.72 -36.58 72.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.48 111.708 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -79.48 5.58 12.49 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 1.39 112.098 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -111.15 -56.35 2.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.801 0.334 . . . . 0.41 111.116 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 159' ' ' VAL . 8.4 pt20 -99.25 27.92 4.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.479 -0.328 . . . . 0.6 111.55 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.13 -48.68 70.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.18 112.092 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.79 -30.84 64.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.352 -0.385 . . . . 0.28 111.022 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.001 -0.28 . . . . 1.65 110.437 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 155' ' ' GLN . 52.4 t -63.33 -52.9 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.371 -0.377 . . . . 0.46 110.595 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.9 -32.24 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.345 -0.389 . . . . 0.47 110.984 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -70.54 -35.11 72.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 1.54 110.244 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -65.52 -35.46 80.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.221 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.18 -37.6 81.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.344 0.592 . . . . 0.35 109.514 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -69.79 -33.32 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.163 -0.926 . . . . 1.52 111.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 -27.56 64.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.885 0.374 . . . . 1.28 110.752 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -81.12 -47.21 13.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.3 tpt -134.13 99.39 4.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.403 -0.591 . . . . 1.08 109.403 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 113.06 5.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.74 111.151 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.453 -0.794 . . . . 0.48 110.521 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 18.1 ptt? . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.756 0.312 . . . . 0.35 110.592 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.97 137.81 49.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 1.04 110.451 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 32.2 mt -118.26 149.67 40.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.614 -0.513 . . . . 1.02 109.614 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 209' ' ' GLU . 16.1 ttp180 -110.67 136.78 49.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.386 -0.37 . . . . 1.12 110.27 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 52.6 m-85 -99.65 137.94 37.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.22 110.381 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -126.31 128.05 71.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.19 110.581 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -167.63 155.51 8.35 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.14 110.614 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.97 160.02 35.64 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.853 2.369 . . . . 0.22 112.732 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.5 t -57.94 -37.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.251 -0.431 . . . . 0.23 111.315 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -51.4 -38.77 55.16 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.65 111.748 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 0.7 OUTLIER -102.05 -26.79 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.69 111.282 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.51 -34.24 87.7 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 116.054 -0.521 . . . . 0.17 113.61 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -61.69 -25.88 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.723 -0.281 . . . . 1.19 111.596 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.526 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 13.4 mptt -62.35 -41.85 98.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.978 0.418 . . . . 0.78 110.874 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 1.1 pp -87.75 -30.32 20.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.433 -0.348 . . . . 0.3 111.133 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.33 -31.96 71.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.88 111.675 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -86.62 -7.57 58.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.616 0.599 . . . . 1.71 112.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 26.1 mtmt -122.7 -29.89 3.95 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.129 0.788 . . . . 1.16 113.129 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -87.18 -32.82 19.62 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.164 0.431 . . . . 0.63 112.164 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 2.1 mtpt -72.55 -43.45 9.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.142 0.793 . . . . 1.13 113.142 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 11.0 Cg_endo -54.31 -34.63 80.96 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 122.415 2.077 . . . . 0.54 113.642 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -92.73 13.75 19.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.772 -0.371 . . . . 0.61 111.462 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 18.6 pt 33.22 56.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.435 1.094 . . . . 0.87 113.897 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -109.98 16.71 21.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.95 109.773 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.41 152.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.376 -0.829 . . . . 0.6 110.769 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 4.6 mp -84.89 144.8 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.347 -0.612 . . . . 0.59 109.347 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -72.43 74.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.405 0.621 . . . . 2.46 111.029 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 m -157.07 27.04 0.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.296 -0.865 . . . . 1.45 109.146 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.2 OUTLIER -82.23 137.98 34.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.768 -0.651 . . . . 1.27 111.342 -178.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.04 117.34 33.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.457 -0.571 . . . . 0.58 109.457 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -98.62 59.2 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.983 0.42 . . . . 0.66 111.342 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -109.24 -127.74 5.52 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.417 -0.896 . . . . 0.35 111.684 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.06 -28.6 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 1.3 109.458 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -118.62 117.97 30.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.805 -1.089 . . . . 1.23 108.405 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mp -80.42 79.09 7.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.126 0.489 . . . . 0.29 111.093 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 6.0 tt0 -86.25 106.23 17.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.561 -0.745 . . . . 0.98 109.201 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 202' ' ' GLU . 8.0 mt -120.62 146.9 24.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.939 -0.573 . . . . 0.34 111.089 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER -104.22 122.27 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.804 -0.443 . . . . 0.68 109.804 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.563 ' O ' HD22 ' A' ' 213' ' ' LEU . 12.8 t -144.39 79.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.643 -0.423 . . . . 0.16 111.717 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 212' ' ' CYS . 0.6 OUTLIER -140.39 116.08 10.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 215' ' ' ASP . 11.3 tt -94.12 172.76 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 0.68 111.432 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -58.01 168.89 1.02 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.612 0.765 . . . . 0.58 111.513 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 41.3 Cg_endo -66.68 -172.66 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.271 1.981 . . . . 0.37 112.875 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.03 -75.04 1.94 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.656 -0.783 . . . . 0.23 111.435 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.96 -1.91 55.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.063 0.459 . . . . 1.11 110.581 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.07 -26.78 67.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.548 . . . . 0.25 111.449 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -80.2 -32.66 38.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.412 . . . . 1.82 110.526 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -72.51 -36.12 68.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.42 110.594 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 13.3 tt -79.32 -26.16 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.37 110.849 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.85 -32.22 70.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.325 -0.398 . . . . 0.75 110.88 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.63 -35.47 68.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.08 111.778 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.9 pp -95.02 -37.3 11.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.773 -0.371 . . . . 0.57 110.889 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 33.5 mm -58.22 -39.87 75.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.718 0.294 . . . . 0.36 111.308 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -63.98 -20.15 65.67 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.798 0.666 . . . . 1.09 112.798 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.96 5.06 11.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.745 -0.382 . . . . 1.73 111.841 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 1.0 OUTLIER -108.38 -73.39 0.69 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.846 0.355 . . . . 0.96 111.207 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -100.81 -34.95 9.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.077 0.399 . . . . 0.32 112.077 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 61.4 tttm -77.54 -23.88 50.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.02 110.598 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.48 -8.44 62.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.25 112.044 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -113.46 -7.01 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.41 111.292 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -157.99 179.19 33.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.168 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 t -91.91 162.94 14.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.784 -0.45 . . . . 0.33 109.784 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.51 144.83 44.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.797 0.332 . . . . 0.86 110.912 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -140.63 176.49 8.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.885 -0.598 . . . . 1.85 109.987 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.39 145.3 11.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.044 0.45 . . . . 0.57 111.17 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.3 tp . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.368 0.604 . . . . 1.56 110.522 179.633 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.962 0 N-CA-C 111.83 -0.508 . . . . 0.57 111.83 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.3 p80 42.35 44.51 3.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.746 0.818 . . . . 0.8 112.281 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.7 tpp -137.97 -61.11 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.08 110.044 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.0 t -100.05 141.9 32.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.34 109.629 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 pt -89.27 -31.63 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.976 -0.29 . . . . 0.83 111.151 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -73.93 100.48 3.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.932 0.396 . . . . 0.74 110.702 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.17 81.09 32.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.52 110.292 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.09 141.98 19.09 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.848 2.366 . . . . 0.45 112.449 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.01 133.84 35.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.863 0.364 . . . . 0.93 110.981 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -155.24 171.15 20.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.881 -0.785 . . . . 0.64 108.881 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -78.9 -56.65 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.578 0.227 . . . . 1.61 111.518 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.26 90.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 0.38 111.099 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.2 mmt-85 -148.1 149.77 32.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.474 -0.33 . . . . 1.56 110.213 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.69 -6.32 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.984 0.421 . . . . 1.12 111.371 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -11.14 45.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.57 110.716 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -119.15 25.57 10.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.012 -0.54 . . . . 0.2 111.354 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.654 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 30.7 m -90.63 151.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.167 0.508 . . . . 0.21 111.843 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.88 139.15 42.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.323 -0.853 . . . . 0.15 109.342 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 46.0 t -80.13 120.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.906 0.384 . . . . 0.51 111.306 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 31' ' ' ILE . 2.4 p -149.75 131.08 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.572 -0.529 . . . . 0.15 109.572 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.7 ptt180 -148.67 148.58 30.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.835 0.35 . . . . 0.4 111.767 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 40.4 ttp -108.1 129.85 55.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.128 -0.487 . . . . 0.22 110.095 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.06 114.16 25.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.062 -0.517 . . . . 1.38 110.148 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.6 175.37 6.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 1.3 109.541 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.67 92.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.704 0.288 . . . . 0.4 111.002 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.68 42.95 1.28 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.68 -0.772 . . . . 0.16 112.911 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -173.61 162.24 4.11 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.79 0.295 . . . . 1.93 110.769 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 39.4 mmt180 -126.57 147.58 49.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.576 -0.527 . . . . 1.57 109.576 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -139.9 94.14 2.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.982 -0.377 . . . . 0.23 109.982 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 16.7 mt-10 -104.46 129.6 52.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.539 -0.3 . . . . 1.25 110.343 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 HG13 ' A' ' 20' ' ' VAL . 29.9 pt -131.48 -179.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 0.12 111.12 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -139.6 114.38 9.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.11 111.015 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.63 179.45 3.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 0.08 110.344 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.572 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.69 139.82 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.856 0.36 . . . . 0.25 110.77 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.75 -5.08 52.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.2 112.241 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.43 78.2 4.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.573 0.225 . . . . 0.3 110.861 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 tttp 50.97 60.43 3.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.656 -0.702 . . . . 1.56 110.389 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.4 p -57.15 -32.92 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.412 -0.813 . . . . 0.32 112.529 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -83.47 5.02 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.182 0.515 . . . . 0.16 111.409 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.12 -31.84 80.31 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 116.056 -0.52 . . . . 0.23 113.607 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.475 ' CH2' ' HG3' ' A' ' 87' ' ' LYS . 47.5 p-90 -63.88 -25.04 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.869 0.335 . . . . 0.24 111.78 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 42' ' ' ARG . 1.9 tpt180 -80.75 -2.36 46.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.718 0.294 . . . . 0.47 111.401 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -131.57 1.56 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.623 -0.262 . . . . 1.13 111.072 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 40.03 42.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.879 -0.677 . . . . 0.34 112.623 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.61 13.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.44 110.349 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 41' ' ' TRP . 0.8 OUTLIER -93.24 179.99 5.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.639 -0.71 . . . . 1.31 110.855 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -116.26 -19.83 10.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.225 0.536 . . . . 0.44 110.114 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -175.49 -177.54 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.304 -0.862 . . . . 0.51 108.675 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.96 30.05 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 2.03 110.773 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -120.63 -54.78 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 1.32 110.502 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.55 -17.29 63.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 1.2 110.644 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.84 -18.69 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.47 0.652 . . . . 0.46 109.728 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.78 99.48 12.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.23 109.733 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -68.36 -48.92 63.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.25 111.159 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -127.0 151.1 49.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.549 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -106.56 16.55 24.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.338 0.59 . . . . 0.51 109.715 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.6 127.39 53.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.731 . . . . 0.47 110.204 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -108.41 138.41 35.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.067 0.46 . . . . 0.06 110.444 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -95.69 130.49 42.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.266 -0.424 . . . . 0.29 110.538 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 10.3 t -86.13 -17.98 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.347 0.594 . . . . 0.17 109.752 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -177.94 105.13 0.05 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.201 -0.909 . . . . 0.72 109.717 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.52 -19.94 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.428 0.529 . . . . 0.1 112.428 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -36.66 73.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.975 0.417 . . . . 1.14 110.812 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -91.25 -36.53 13.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.63 110.223 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.04 38.87 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.885 -0.674 . . . . 0.36 111.801 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.47 104.49 16.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.72 0.295 . . . . 2.02 110.553 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.0 t -92.85 116.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.548 -0.538 . . . . 0.39 109.548 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -82.7 124.44 30.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.111 0.482 . . . . 0.18 111.52 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.569 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 6.8 ptpp? -87.85 -175.64 5.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.62 109.294 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HG3' ' OE2' ' A' ' 71' ' ' GLU . 11.7 pttm -60.61 -27.15 67.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 8.3 mp0 -78.86 -32.43 46.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.222 0.534 . . . . 1.47 110.245 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 51.0 m-20 -68.72 -50.09 53.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.26 110.74 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.89 -29.27 70.21 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.956 -0.298 . . . . 0.13 111.205 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -71.26 -22.97 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.089 0.471 . . . . 0.91 109.969 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 m -95.33 -44.98 7.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.045 0.45 . . . . 0.4 110.917 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 -49.26 58.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 0.28 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.72 -51.59 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.078 -0.341 . . . . 1.23 110.078 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.02 -3.21 16.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.722 -0.751 . . . . 0.28 112.054 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 81' ' ' ASP . 5.2 m -125.09 137.85 54.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.163 -0.31 . . . . 0.89 110.163 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.15 -11.54 57.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.503 -0.317 . . . . 0.41 111.525 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -85.42 117.82 24.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.68 110.705 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.96 -31.08 68.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.18 111.256 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.36 -47.63 75.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.625 0.25 . . . . 0.54 111.471 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.12 -51.07 71.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.998 0.428 . . . . 1.7 110.788 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mt -61.0 -51.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.648 -0.706 . . . . 0.18 111.169 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 99.9 m -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.18 111.152 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 27.4 ttpp -62.22 -42.08 98.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.491 -0.322 . . . . 0.67 110.432 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.69 -43.33 89.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.21 110.134 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 86.1 mt -62.85 -32.57 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.305 0.574 . . . . 0.15 110.82 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HG22 ' A' ' 38' ' ' VAL . 1.3 mm? -74.95 -32.05 61.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.818 -0.628 . . . . 0.12 112.61 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 92' ' ' LYS . 15.1 t -100.57 -13.54 18.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.789 0.662 . . . . 0.22 112.789 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 91' ' ' THR . 32.7 mmmt -129.27 25.38 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.375 -0.203 . . . . 0.96 111.015 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -132.72 -175.98 14.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.032 -1.08 . . . . 0.15 113.64 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -83.4 76.52 9.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.234 0.54 . . . . 1.74 109.995 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.99 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.624 -0.717 . . . . 0.69 110.91 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.9 mm-40 -72.78 105.72 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.738 -0.467 . . . . 0.59 109.738 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.19 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.325 0.583 . . . . 0.45 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.652 ' HB3' ' O ' ' A' ' 101' ' ' GLU . 1.3 m -79.79 115.28 19.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.82 110.809 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -94.71 -25.75 16.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.269 -0.423 . . . . 1.35 111.055 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -128.24 -72.85 0.6 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.412 -0.358 . . . . 1.58 110.469 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.652 ' O ' ' HB3' ' A' ' 98' ' ' SER . 56.0 mm-40 -75.94 127.18 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.154 -0.475 . . . . 1.39 110.085 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.75 62.29 7.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.171 -0.468 . . . . 1.83 110.842 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -146.39 -179.78 6.99 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.33 -0.618 . . . . 0.26 109.33 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.56 -142.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.164 0.29 . . . . 0.4 110.606 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 76.19 1.95 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.166 0.508 . . . . 0.96 110.333 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 107' ' ' GLU . 4.7 tp -165.01 -172.06 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.446 -0.797 . . . . 0.63 109.301 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 19.0 mm-40 58.74 28.0 16.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.425 0.453 . . . . 0.82 111.81 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 63.54 25.96 14.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.212 -0.449 . . . . 1.69 111.507 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.6 tpt -65.43 -22.53 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 1.69 111.206 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -70.93 -25.0 62.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.884 0.373 . . . . 0.35 110.476 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -80.66 -17.52 50.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.992 -0.549 . . . . 0.8 110.305 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.55 -57.27 12.75 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.895 -0.593 . . . . 0.78 110.217 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.58 -29.16 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.53 110.145 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -65.66 -30.34 71.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.786 -0.643 . . . . 0.18 110.567 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -71.47 -38.0 71.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.96 110.07 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.73 -39.84 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.739 -0.664 . . . . 1.14 111.248 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 114' ' ' ALA . 9.2 p -77.46 -22.58 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.412 -0.358 . . . . 0.25 111.438 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -56.28 23.96 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.807 0.299 . . . . 0.57 111.807 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 2.7 m-20 -66.94 -16.75 64.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 2.28 111.624 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' A' ' 215' ' ' ASP . 3.9 ttmm -84.26 -8.64 58.98 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.3 m -132.65 156.26 47.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.927 0.394 . . . . 0.61 111.129 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 60.8 t -111.57 128.2 68.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.76 -0.459 . . . . 1.54 109.76 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -93.53 149.67 37.61 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.396 -0.366 . . . . 0.52 110.591 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.27 172.1 14.74 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.182 1.921 . . . . 0.19 111.138 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 126' ' ' THR . 1.7 pt-20 -49.94 116.44 1.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.929 0.395 . . . . 1.11 111.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 1.6 t 176.23 -26.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.44 -0.8 . . . . 0.34 109.822 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm 175.83 -176.67 0.11 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.802 -0.814 . . . . 1.15 108.802 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 128' ' ' ARG . 19.7 mtt180 -91.55 155.41 43.96 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 110.528 -0.175 . . . . 0.45 110.528 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.8 -7.5 7.66 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.212 2.608 . . . . 0.35 113.75 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.13 -14.87 61.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.79 110.382 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -74.91 81.3 2.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.15 110.906 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.52 -38.32 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.13 110.932 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.3 mm -57.69 -34.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.44 111.53 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.41 -44.48 94.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.447 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.2 tt -81.24 -30.92 11.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.902 -0.319 . . . . 0.21 111.173 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -66.6 -37.29 84.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.353 -0.385 . . . . 0.59 110.638 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 3.4 mmm180 -61.53 -31.12 71.12 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.15 111.59 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.23 -31.46 16.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.047 0.451 . . . . 0.27 110.726 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 3.0 tpt -65.13 -51.92 58.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.524 -0.762 . . . . 0.95 111.289 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -78.13 -5.15 50.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.2 111.676 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -80.23 -45.9 17.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.901 0.382 . . . . 0.42 110.488 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.54 -49.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.27 110.667 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -129.22 98.97 5.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.47 110.449 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -67.62 147.24 52.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 1.92 109.81 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 31.5 m 58.78 61.65 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.523 0.678 . . . . 1.58 110.625 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -4.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 1.01 111.138 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -95.15 -30.64 13.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.93 -0.577 . . . . 0.86 109.816 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 145' ' ' SER . 1.4 m -66.3 123.75 20.82 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.94 110.93 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.04 42.02 3.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.905 0.882 . . . . 0.42 112.229 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -67.69 111.28 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.72 -0.673 . . . . 1.26 110.761 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -82.73 101.88 11.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 1.12 110.046 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.7 p -58.6 -76.9 0.04 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.75 -0.659 . . . . 1.2 112.358 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -82.35 62.27 5.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.93 0.395 . . . . 1.54 111.296 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -166.07 -48.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.459 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -108.8 22.38 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.52 110.964 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.92 -43.59 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 0.12 111.938 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 4.1 mm? -74.51 -34.84 63.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.552 -0.295 . . . . 0.7 111.033 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 4.8 mp0 -65.6 -48.86 70.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.17 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.76 -48.27 81.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.2 111.951 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.78 -28.66 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.761 0.315 . . . . 0.3 111.594 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.0 mmtp -80.74 -33.81 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.66 110.359 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.7 -39.19 93.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 2.05 110.199 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.97 -46.89 73.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.162 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -62.04 -30.23 70.83 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.8 -0.636 . . . . 0.86 111.429 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -53.76 -44.57 70.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.57 110.409 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 -69.81 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.4 110.15 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 62.2 ttp -102.37 123.93 47.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.007 -0.542 . . . . 0.27 111.079 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.99 99.52 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.02 -0.536 . . . . 0.48 110.401 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 pt -74.8 157.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.34 -0.846 . . . . 0.93 110.895 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 122' ' ' VAL . 8.6 mm-40 -98.53 101.79 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.234 -0.439 . . . . 1.18 110.311 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 63.76 -169.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.707 -0.679 . . . . 1.62 111.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -161.12 -162.0 0.87 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.3 109.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.491 ' HE1' ' O ' ' A' ' 213' ' ' LEU . 64.9 t60 -78.44 113.89 16.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 1.89 110.79 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.839 -0.619 . . . . 1.22 110.903 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -128.42 134.67 48.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.441 -0.345 . . . . 2.41 111.172 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 211' ' ' VAL . 2.7 mp -129.49 145.76 51.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 0.31 110.108 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.609 ' HB3' HG22 ' A' ' 211' ' ' VAL . 9.8 ptm180 -126.72 132.12 51.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.384 -0.371 . . . . 0.24 110.413 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 22.0 m-85 -92.95 140.37 29.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 0.39 110.533 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.3 mt -120.85 118.37 56.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.527 -0.306 . . . . 0.2 111.309 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -152.12 156.43 33.91 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.95 -0.568 . . . . 0.11 109.906 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.31 172.4 12.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.66 2.24 . . . . 0.14 112.516 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.8 -44.95 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.387 -0.37 . . . . 0.15 111.652 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -52.92 -55.84 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.981 -0.554 . . . . 0.81 111.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.55 -27.24 61.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.424 -0.353 . . . . 0.2 111.403 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.57 -34.78 90.87 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.216 -0.516 . . . . 0.17 111.893 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -77.75 52.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.36 0.6 . . . . 0.65 109.813 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -152.59 -46.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.258 -0.883 . . . . 1.58 109.477 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -86.53 -26.21 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.4 110.693 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 12.0 ttpt -67.31 -21.73 65.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.47 . . . . 0.67 110.603 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.9 OUTLIER -100.19 8.76 43.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.481 . . . . 0.86 110.921 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -124.85 -45.49 1.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.568 -0.287 . . . . 0.34 111.08 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.4 mt -78.29 -35.39 47.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.715 0.265 . . . . 0.29 111.715 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 23.7 mmtt -62.4 -52.71 64.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.271 0.471 . . . . 0.66 112.271 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.7 Cg_endo -58.98 -24.6 74.01 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.153 1.902 . . . . 0.23 113.073 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.5 mt -76.55 -22.05 54.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.17 110.765 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.3 mm 59.3 66.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.518 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -134.19 15.11 3.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.765 -0.652 . . . . 0.84 109.91 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 28.5 m -99.14 163.69 2.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.328 0.585 . . . . 0.35 112.07 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.546 HD12 HG12 ' A' ' 211' ' ' VAL . 66.5 mt -106.85 160.43 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.267 -0.879 . . . . 0.31 109.378 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.41 64.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 2.24 111.095 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 246' ' ' GLU . 2.3 t -161.65 90.36 0.78 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.34 -0.615 . . . . 0.8 109.34 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 43.9 mt-10 -136.79 163.86 29.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 1.32 110.423 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 209' ' ' GLU . 12.1 t0 -119.18 131.47 55.85 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.939 -0.763 . . . . 0.25 108.939 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.45 31.56 6.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.55 111.29 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -96.11 -115.76 3.11 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.832 -0.699 . . . . 0.36 112.275 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -91.63 -22.6 20.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.62 110.148 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.46 123.15 40.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 1.48 109.345 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.94 77.89 9.83 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.032 0.444 . . . . 0.33 110.932 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 29.7 mt-10 -75.45 118.65 18.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.052 -0.522 . . . . 1.04 109.884 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 34.1 mt -122.84 126.81 74.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.877 0.37 . . . . 0.48 110.847 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 177' ' ' ARG . 39.4 t -94.09 104.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.11 109.731 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.6 t -130.91 115.56 16.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.15 -0.477 . . . . 0.21 110.121 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.491 ' O ' ' HE1' ' A' ' 173' ' ' HIS . 0.2 OUTLIER -164.7 125.3 2.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.918 -0.583 . . . . 0.42 109.428 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.462 HG12 ' H ' ' A' ' 215' ' ' ASP . 3.3 tt -104.84 -170.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.566 -0.288 . . . . 0.51 110.319 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 119' ' ' ASP . 37.4 m-20 -62.27 141.14 96.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.512 0.196 . . . . 1.3 110.572 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.77 -26.73 83.11 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.051 2.5 . . . . 0.47 113.362 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.71 78.85 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.761 -0.733 . . . . 0.58 111.945 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 62.6 m -110.68 25.44 11.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.76 110.558 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -60.11 -32.42 70.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.53 111.277 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -18.52 59.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.474 -0.33 . . . . 0.74 110.893 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.5 -24.68 24.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.4 111.096 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.6 tp -96.13 -42.43 12.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.691 -0.404 . . . . 0.91 111.459 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 18.5 t70 -67.17 -22.4 65.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.881 0.326 . . . . 0.33 111.881 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.27 -28.28 64.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.65 0.262 . . . . 1.14 111.352 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.9 OUTLIER -105.38 -37.35 6.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.609 -0.269 . . . . 0.29 110.365 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 223' ' ' ASP . 44.6 mm -59.09 -34.31 52.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.31 111.27 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 16.6 ptpt -53.91 -31.5 50.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.707 0.632 . . . . 1.4 112.707 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.4 ' H ' ' HG3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -113.52 -25.29 8.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.063 0.394 . . . . 1.77 112.063 -178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 -41.97 74.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.174 0.435 . . . . 0.73 112.174 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.0 t -135.8 -37.48 0.74 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.373 -0.531 . . . . 0.14 112.376 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 42.0 mtpt -59.67 -41.52 90.82 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 0.51 110.731 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.41 38.03 3.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.13 111.535 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -151.97 -53.36 0.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.645 0.26 . . . . 0.39 110.649 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -114.97 -168.16 15.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.074 -0.584 . . . . 0.13 111.995 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.9 m -101.81 144.5 30.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.956 -0.387 . . . . 0.36 109.956 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.32 119.19 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.28 110.612 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -113.22 151.68 30.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.731 -0.668 . . . . 0.39 109.904 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.79 145.1 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.639 0.256 . . . . 0.16 110.705 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.6 tp -107.21 98.64 8.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 0.35 109.497 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -117.25 -7.83 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.328 -0.396 . . . . 0.52 111.546 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.16 109.2 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 1.03 111.06 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -103.29 8.66 38.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.801 -0.636 . . . . 0.82 110.729 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.75 10.93 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.509 0.671 . . . . 1.54 110.227 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.6 p -123.19 172.38 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.85 109.306 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 244' ' ' VAL . 3.9 tp10 -67.58 115.07 6.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.999 0.428 . . . . 1.64 110.267 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.453 ' HB3' ' OG ' ' A' ' 201' ' ' SER . 40.5 mt-10 -75.29 -38.78 60.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.044 -0.525 . . . . 1.33 111.141 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 150.34 -123.36 1.54 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.131 -0.787 . . . . 0.33 111.131 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.83 132.21 54.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.759 0.314 . . . . 1.67 110.388 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -114.3 -0.35 13.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.284 0.564 . . . . 0.69 110.256 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.22 146.62 15.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 1.98 109.825 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -85.36 -6.78 59.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.996 0.427 . . . . 0.71 110.292 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.356 -0.831 . . . . 2.14 110.593 179.783 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.596 -0.602 . . . . 0.32 111.596 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -118.99 150.83 39.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.828 0.347 . . . . 1.19 110.831 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -104.06 133.05 49.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.096 -0.502 . . . . 0.61 110.049 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -61.24 2.65 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.263 0.352 . . . . 1.34 110.855 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' ' 6' ' ' PHE . 1.1 mp -104.73 -85.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.861 -0.422 . . . . 0.72 109.861 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.407 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 69.6 m-85 -126.02 -66.26 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.261 0.553 . . . . 0.44 109.598 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.85 81.22 9.22 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.853 -0.612 . . . . 0.21 109.961 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.5 160.68 28.57 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.987 2.458 . . . . 0.47 112.214 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.16 149.35 30.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.224 -0.444 . . . . 0.52 110.479 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.22 177.09 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.448 -0.575 . . . . 0.59 109.448 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.88 -77.04 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.713 0.292 . . . . 1.44 111.01 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.12 76.05 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.338 0.59 . . . . 1.48 110.603 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -147.91 159.21 44.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.43 -0.805 . . . . 1.48 109.258 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.53 42.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.47 110.337 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 p -110.82 -66.01 1.12 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.001 -0.545 . . . . 0.19 110.427 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -92.34 60.18 3.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.48 0.657 . . . . 1.06 109.464 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.421 HG12 ' OE1' ' A' ' 54' ' ' GLN . 17.0 m -100.08 148.44 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.453 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -113.6 114.6 26.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.831 -0.622 . . . . 0.2 109.904 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.46 121.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.37 110.838 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 3.9 p -133.43 122.3 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.966 -0.561 . . . . 0.25 110.316 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -110.36 128.4 55.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.518 . . . . 0.37 110.733 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.8 ttp -89.35 141.75 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.16 110.963 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.89 122.35 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 1.02 110.316 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -125.22 32.62 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.846 -0.161 . . . . 0.71 110.988 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 51.14 70.84 0.49 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.757 0.661 . . . . 0.44 111.805 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 -35.62 4.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.876 -0.678 . . . . 0.49 111.654 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -106.07 148.48 27.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.154 -0.684 . . . . 1.47 109.154 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.21 153.62 51.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.636 0.255 . . . . 1.8 110.434 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -144.82 116.6 8.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.274 -0.639 . . . . 0.44 109.274 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 59' ' ' PHE . 3.3 pm0 -112.0 132.94 54.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.16 111.661 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 89' ' ' ILE . 6.2 mt -128.94 145.75 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.571 -0.74 . . . . 0.7 109.905 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.85 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.503 -0.317 . . . . 0.08 110.263 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.03 171.17 7.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.365 -0.379 . . . . 0.09 110.347 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.23 119.68 13.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.2 109.908 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -75.32 69.61 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.42 111.135 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -129.03 64.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.63 109.321 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.51 50.96 13.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.808 -0.633 . . . . 0.97 110.326 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.86 10.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.359 -0.837 . . . . 0.43 112.901 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.6 12.39 7.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.734 0.778 . . . . 0.27 109.463 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.18 -49.06 7.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42 113.055 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -69.27 -0.41 6.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.017 0.437 . . . . 1.77 111.278 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.542 ' NH1' ' HB3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -96.09 1.13 52.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.203 0.525 . . . . 2.66 109.71 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.8 m -141.77 -37.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.454 -0.794 . . . . 1.11 110.14 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' HA3' ' OE1' ' A' ' 154' ' ' GLN . . . -150.75 -115.78 0.72 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.255 -0.738 . . . . 0.28 111.255 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.36 137.99 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.087 0.443 . . . . 0.54 110.992 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 4.6 pt-20 -109.57 -73.05 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.377 -0.374 . . . . 1.05 110.025 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 20.4 ptmt -170.71 -172.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.035 -0.728 . . . . 1.07 109.035 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 50' ' ' ASP . 9.5 t0 -65.61 124.01 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.75 110.483 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 tp -70.48 -17.31 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.6 111.951 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -59.84 -35.86 75.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.07 0.462 . . . . 1.67 110.503 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.83 -33.41 21.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.929 -0.578 . . . . 1.49 110.465 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.62 -38.39 82.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.884 -0.598 . . . . 0.3 111.246 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.83 84.05 6.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.051 -0.351 . . . . 0.16 110.051 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' OE1' HG12 ' A' ' 17' ' ' VAL . 37.4 mt-30 -66.26 -77.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.3 111.098 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 t -74.96 129.21 37.25 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.21 110.23 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -93.82 12.28 26.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.368 0.604 . . . . 0.57 110.034 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.495 -0.775 . . . . 0.18 109.962 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.5 p -116.65 146.3 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.692 -0.485 . . . . 0.3 109.692 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 19.0 m-85 -104.94 140.16 38.58 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.885 -0.413 . . . . 0.56 109.885 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 2.4 t -92.58 -16.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.155 0.502 . . . . 0.24 110.339 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -178.97 95.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.536 -0.757 . . . . 0.28 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.67 -27.45 42.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.432 . . . . 0.33 111.53 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 m -68.35 -20.63 64.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.785 0.326 . . . . 0.47 111.461 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.71 3.95 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 1.53 110.419 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 28.14 73.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.14 112.109 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.08 102.43 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.6 110.711 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 128.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.029 -0.532 . . . . 0.25 110.516 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.24 116.62 32.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.3 110.15 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -87.09 178.89 6.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.985 -0.552 . . . . 2.16 110.253 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -23.93 67.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.258 -0.177 . . . . 0.37 111.438 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -87.22 0.94 54.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.782 0.325 . . . . 0.43 110.593 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.5 -42.22 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.25 -0.432 . . . . 1.21 110.738 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.5 -28.19 68.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.784 0.326 . . . . 0.24 110.765 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -68.85 -28.7 40.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.199 0.523 . . . . 0.86 110.067 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.74 20.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.932 -0.576 . . . . 0.7 110.296 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 -56.76 9.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.793 -0.64 . . . . 0.53 111.736 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -102.86 -55.15 2.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.652 0.263 . . . . 0.96 111.003 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.85 -32.28 1.58 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.892 -0.671 . . . . 0.18 111.954 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.41 133.38 33.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.608 0.242 . . . . 0.78 110.758 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.08 2.86 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.973 0.416 . . . . 0.68 110.595 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 85' ' ' ILE . 6.8 t70 -91.39 126.43 36.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.934 -0.575 . . . . 1.14 110.234 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.29 -27.3 63.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.569 . . . . 1.08 111.13 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -62.66 -49.1 76.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.359 -0.382 . . . . 0.71 110.409 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.02 -43.25 99.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.54 110.899 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 81' ' ' ASP . 50.1 mm -60.61 -49.29 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.26 110.114 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.8 t -64.7 -34.3 77.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.11 110.949 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -61.31 -43.99 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 110.403 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -68.85 -38.64 79.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.77 110.472 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 31' ' ' ILE . 73.5 mt -67.34 -33.44 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.31 110.799 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.91 -12.11 59.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.75 112.504 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 92' ' ' LYS . 14.6 t -116.1 -21.37 9.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 0.81 112.046 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HG2' HG23 ' A' ' 91' ' ' THR . 33.0 mmmt -124.8 25.91 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.025 0.44 . . . . 0.62 110.249 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.6 176.63 19.08 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.669 -0.777 . . . . 0.41 112.322 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -85.31 82.81 8.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 2.48 111.365 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 p -81.18 124.93 39.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.119 -0.492 . . . . 1.03 110.268 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 18' ' ' ALA . 3.4 pt20 -75.79 109.29 9.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.172 0.511 . . . . 0.66 110.011 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.27 128.62 34.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.254 0.55 . . . . 0.2 111.095 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.64 150.75 52.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.718 -0.674 . . . . 0.57 110.029 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.3 t70 -91.36 -154.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.518 -0.31 . . . . 0.6 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 7.0 mmmm 74.4 52.54 0.09 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.235 0.614 . . . . 1.21 110.597 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.82 110.29 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.095 -0.957 . . . . 1.87 110.564 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.05 175.73 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.451 -0.574 . . . . 1.95 109.451 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.1 m80 72.38 50.89 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.21 0.604 . . . . 2.0 110.44 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 175.79 10.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.389 -0.823 . . . . 0.61 111.313 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -125.76 154.34 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.922 -0.399 . . . . 0.66 109.922 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 106' ' ' LEU . 3.6 mm? -92.78 74.79 4.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.352 0.596 . . . . 0.73 111.237 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -115.03 -173.2 2.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.608 -0.724 . . . . 1.28 109.775 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -79.74 61.3 3.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.528 -0.545 . . . . 1.47 109.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 113' ' ' ILE . 73.2 mmm -52.92 -50.18 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.87 111.65 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -63.89 -22.71 67.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.274 -0.421 . . . . 0.45 111.992 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.78 -44.85 12.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 1.7 110.307 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -45.12 88.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.214 -0.448 . . . . 0.83 110.82 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 109' ' ' MET . 44.5 pt -64.85 -29.87 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.875 0.369 . . . . 0.36 110.288 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 135' ' ' ILE . . . -65.26 -35.07 79.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.357 0.599 . . . . 0.21 109.807 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -67.02 -38.36 85.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.5 -0.773 . . . . 1.22 110.262 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.431 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 1.3 mp -69.46 -51.55 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.163 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.6 -30.27 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 111.811 0.3 . . . . 0.15 111.811 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.37 69.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.24 110.648 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.42 23.78 1.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.145 0.497 . . . . 0.94 110.695 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -129.52 6.18 5.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.25 109.737 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.08 162.59 35.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.421 -0.809 . . . . 0.41 109.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -132.69 125.85 53.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.087 0.47 . . . . 0.49 110.918 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -103.66 155.17 37.29 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.7 -0.682 . . . . 0.22 109.989 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.84 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.421 2.08 . . . . 0.55 111.666 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 126' ' ' THR . 1.7 pm0 -63.57 124.32 21.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 1.37 110.881 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 125' ' ' GLU . 6.0 t 177.83 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.36 110.444 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -161.21 -77.4 0.05 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.687 0.279 . . . . 1.3 110.38 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -161.07 158.18 23.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.065 -0.717 . . . . 0.95 109.065 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.57 -32.71 95.09 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.263 1.976 . . . . 0.2 111.597 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.3 90.02 3.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.08 -0.711 . . . . 0.76 109.08 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 134' ' ' LEU . 24.0 m -114.0 109.98 19.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.26 111.595 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.23 -31.83 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.438 0.637 . . . . 0.1 109.375 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.8 mm -66.3 -24.86 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.365 -0.834 . . . . 0.16 111.032 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.437 ' H ' HG22 ' A' ' 131' ' ' THR . 26.7 tp -62.12 -55.48 28.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 0.4 110.043 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.45 HG23 ' HB1' ' A' ' 114' ' ' ALA . 1.8 tp -71.56 -31.76 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.22 110.061 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 11.6 tt0 -59.49 -44.89 92.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 1.2 110.063 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.88 68.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 1.28 110.936 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.6 18.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.393 -0.367 . . . . 0.3 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 39.0 tpp -65.52 -36.21 83.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.359 0.599 . . . . 0.95 109.769 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 1.3 tmtp? -65.93 -32.65 74.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 2.05 109.425 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.57 -65.74 0.86 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.221 -0.9 . . . . 0.57 110.407 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.63 63.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.494 0.664 . . . . 0.19 110.108 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -78.18 56.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.337 -0.847 . . . . 0.8 110.909 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.05 169.57 17.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.973 -0.558 . . . . 2.59 110.694 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.03 107.08 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 0.29 110.059 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.3 69.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.004 0.431 . . . . 0.5 109.973 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 61.72 85.27 0.12 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.406 -0.815 . . . . 0.83 110.383 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.1 m -80.42 44.79 0.72 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.859 -0.609 . . . . 0.41 111.354 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.46 -21.11 28.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.907 -0.588 . . . . 0.33 109.79 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 80.9 1.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.448 -0.796 . . . . 0.37 109.58 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -86.14 16.33 4.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.45 112.039 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.42 131.82 51.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.553 -0.294 . . . . 0.43 111.424 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 58.24 48.56 12.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.715 -0.675 . . . . 1.63 111.299 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.429 ' OE1' ' HA3' ' A' ' 44' ' ' GLY . 24.1 tt0 59.41 53.11 5.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.537 -0.756 . . . . 0.76 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.1 30.29 19.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.306 -0.861 . . . . 0.23 112.071 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.58 85.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.21 110.521 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 157' ' ' LEU . 4.0 mm? -71.55 -7.85 50.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.713 -0.676 . . . . 0.3 111.234 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -99.56 -47.04 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.537 -0.542 . . . . 0.94 109.537 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.08 -42.99 97.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.38 111.426 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.62 -15.14 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.053 0.454 . . . . 0.58 111.457 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -109.06 0.04 19.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.319 0.581 . . . . 1.33 110.355 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -84.55 -54.26 4.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.617 -0.719 . . . . 0.63 109.787 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -69.25 -18.9 63.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.18 110.435 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.536 ' N ' HD13 ' A' ' 163' ' ' LEU . 46.6 tttm -69.35 -22.01 63.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.72 110.11 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -81.66 -12.82 58.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.835 -0.62 . . . . 0.63 110.391 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.82 -39.65 5.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.178 -0.465 . . . . 0.21 110.731 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 51.3 tpp -141.79 143.98 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.45 110.722 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -96.4 119.59 35.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.281 -0.418 . . . . 0.24 110.282 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -130.97 170.05 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.285 -0.416 . . . . 0.62 110.78 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.429 ' HB3' HG23 ' A' ' 122' ' ' VAL . 9.6 tp10 -96.68 141.73 29.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.727 -0.842 . . . . 2.06 108.727 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 24.37 0.29 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.417 . . . . 2.58 111.604 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.27 120.25 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.73 110.267 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 154.11 32.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.324 . . . . 0.35 110.876 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 40.5 mtm -138.88 177.46 7.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.419 . . . . 1.29 110.012 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -102.02 131.54 48.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.369 -0.604 . . . . 1.48 109.369 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.476 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.7 mp -116.5 157.22 25.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.203 0.525 . . . . 0.41 111.325 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.595 ' HB2' ' OE2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -127.77 160.58 31.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.143 -0.935 . . . . 1.05 108.9 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -129.3 128.61 43.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.695 0.283 . . . . 0.53 110.463 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 121.69 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.466 0.651 . . . . 0.88 111.386 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -150.1 157.31 37.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.421 -0.808 . . . . 0.11 109.902 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.21 163.85 11.47 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.688 2.259 . . . . 0.09 112.501 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 208' ' ' LEU . 40.5 t -55.23 -39.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.256 -0.429 . . . . 0.25 112.05 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -57.95 -60.79 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.726 0.298 . . . . 0.53 111.638 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.87 -19.46 61.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 1.44 111.509 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.86 72.87 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.943 -0.646 . . . . 0.15 111.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -61.82 -32.65 72.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.614 0.245 . . . . 1.62 110.712 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -55.75 -43.97 77.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.014 -0.539 . . . . 0.75 111.668 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 -35.27 12.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.416 -0.356 . . . . 0.41 111.63 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.77 -34.25 75.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.688 0.28 . . . . 1.55 111.171 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -95.88 20.73 9.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.807 0.299 . . . . 1.23 111.807 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -146.35 -45.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.447 0.536 . . . . 1.31 112.447 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 mt -75.89 -39.71 55.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.662 0.268 . . . . 0.42 111.494 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 5.2 mtpt -58.6 -52.79 72.19 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.191 -0.459 . . . . 1.02 112.002 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 34.1 Cg_endo -65.12 -12.5 35.03 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.056 1.837 . . . . 0.09 112.961 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.8 mt -88.64 -7.52 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.359 . . . . 0.2 110.304 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 6.8 mm 59.64 40.26 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.519 -0.764 . . . . 0.4 110.815 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -112.21 19.96 17.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.63 109.947 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.433 HG21 ' HE3' ' A' ' 193' ' ' LYS . 14.7 m -110.68 139.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.813 -0.631 . . . . 0.33 111.053 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.93 164.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.812 -0.631 . . . . 1.15 110.039 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -71.14 56.29 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 1.67 111.092 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.2 m -156.17 88.21 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.907 -0.775 . . . . 0.77 108.907 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -134.94 140.03 45.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.533 -0.758 . . . . 0.78 110.396 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.37 137.41 53.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.629 -0.508 . . . . 0.48 109.629 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.29 30.38 7.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 1.28 111.501 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -79.72 -140.28 2.16 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.729 -0.748 . . . . 0.63 112.847 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -65.63 -20.96 66.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.93 0.395 . . . . 1.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -136.09 143.2 44.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.923 -0.399 . . . . 1.26 109.923 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 182' ' ' VAL . 2.5 mm? -81.99 85.53 6.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.001 0.429 . . . . 0.33 110.75 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.595 ' OE2' ' HB2' ' A' ' 177' ' ' ARG . 10.3 tp10 -90.28 106.21 18.33 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.137 -0.69 . . . . 1.34 109.137 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.79 134.62 58.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.957 0.408 . . . . 0.17 111.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 177' ' ' ARG . 86.5 t -84.53 108.01 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.15 110.21 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.0 m -126.59 90.35 3.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.135 -0.484 . . . . 0.22 110.406 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -155.78 132.01 10.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.28 109.837 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.82 173.21 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.521 -0.309 . . . . 1.06 110.276 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 4.1 m-20 -69.51 169.35 12.54 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.456 -0.338 . . . . 1.22 110.417 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 27.4 Cg_exo -63.49 -161.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.642 2.228 . . . . 0.36 112.794 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.62 -98.52 1.55 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.26 111.718 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 68.9 m -75.98 0.88 16.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.64 111.563 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 44.3 t80 -61.46 -32.3 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.033 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -9.1 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 1.31 111.701 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -92.7 -32.69 14.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.794 0.331 . . . . 1.1 110.567 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 226' ' ' ILE . 4.8 tp -94.51 -31.37 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.384 0.513 . . . . 1.38 112.384 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.499 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -60.24 -28.12 67.77 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.33 -0.231 . . . . 0.95 111.42 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -56.43 -35.37 67.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.81 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.2 pp -95.81 -24.89 16.26 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.41 110.492 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.6 mm -61.59 -38.1 79.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.367 -0.379 . . . . 0.42 110.693 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 223' ' ' ASP . 13.7 ptpt -64.31 -16.48 62.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.656 0.613 . . . . 0.16 112.656 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.57 -23.47 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.613 -0.435 . . . . 0.55 111.838 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -81.93 -43.23 18.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.588 0.588 . . . . 0.92 112.588 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -128.18 -38.87 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.364 -0.535 . . . . 0.31 111.914 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 14.7 tttt -63.76 -28.06 69.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.941 0.401 . . . . 2.08 110.563 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -102.13 16.98 55.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.912 -0.661 . . . . 0.25 112.123 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.7 -36.09 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.339 . . . . 0.39 111.044 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.51 -156.04 6.65 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.515 -0.85 . . . . 0.14 112.725 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 m -101.98 137.7 39.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.875 0.369 . . . . 0.17 110.425 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.13 149.11 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.2 111.013 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.35 161.04 39.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.678 . . . . 0.33 109.168 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.2 m -99.04 148.45 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.762 0.315 . . . . 0.18 111.066 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -87.26 94.12 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.576 -0.527 . . . . 0.47 109.576 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.81 9.59 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.693 -0.685 . . . . 0.69 110.304 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 85.07 6.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.59 110.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -108.13 -6.98 16.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.9 110.502 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.0 -76.24 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.15 -0.477 . . . . 0.49 110.468 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -98.49 161.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.927 -0.578 . . . . 0.46 110.077 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -80.4 155.77 26.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.885 -0.413 . . . . 0.78 109.885 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -130.43 140.51 50.56 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.502 -0.317 . . . . 1.24 110.191 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 151.79 127.34 1.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.558 -0.829 . . . . 0.57 112.235 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -111.0 68.56 0.66 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.666 0.746 . . . . 1.24 109.134 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -76.43 -8.12 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.136 -0.938 . . . . 0.55 111.441 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -83.38 70.78 10.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.101 0.476 . . . . 0.84 110.68 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -79.27 -12.63 59.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.069 -0.514 . . . . 0.93 110.21 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 115.803 -0.635 . . . . 2.04 110.068 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.521 -0.632 . . . . 0.81 111.521 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -145.06 148.2 33.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.805 -0.443 . . . . 0.51 109.805 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 mtt -116.28 98.72 6.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.153 0.501 . . . . 1.02 111.113 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.78 90.58 4.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.66 110.829 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.2 mt -61.66 -54.89 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.45 110.915 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -130.22 149.26 52.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.668 . . . . 0.25 109.828 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.9 m -152.44 88.88 3.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.735 0.302 . . . . 0.21 111.399 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.41 126.47 14.26 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.214 1.943 . . . . 0.16 111.101 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -108.54 94.22 4.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.912 0.387 . . . . 0.25 110.887 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.88 -89.57 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.34 110.293 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -137.51 -88.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.675 -0.491 . . . . 0.33 109.675 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.01 107.64 23.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.316 -0.624 . . . . 0.81 109.316 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -158.31 152.44 24.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.1 -0.5 . . . . 1.11 110.373 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -78.77 49.06 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.48 110.968 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.3 p -129.04 -45.61 1.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.128 0.49 . . . . 0.25 110.606 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -106.69 39.54 1.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.18 109.672 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 m -94.38 135.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.683 -0.69 . . . . 0.22 111.581 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.06 116.08 31.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.966 -0.561 . . . . 0.11 109.844 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.6 114.73 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.845 -0.616 . . . . 0.16 111.387 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.796 HG22 HG22 ' A' ' 89' ' ' ILE . 7.7 p -107.82 136.29 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.19 108.986 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HD3' ' CD ' ' A' ' 30' ' ' GLU . 12.4 ttp180 -142.18 140.98 32.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.089 0.471 . . . . 1.33 111.939 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 tpt -135.55 119.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.325 -0.852 . . . . 0.82 108.877 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -122.62 114.95 21.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.902 0.382 . . . . 1.14 111.734 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -112.42 -164.41 0.91 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.708 -0.849 . . . . 0.89 108.708 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.36 6.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.702 0.287 . . . . 0.41 111.375 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.74 4.77 24.4 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.357 -0.925 . . . . 1.09 113.229 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -126.76 119.02 25.86 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.488 -0.419 . . . . 0.19 110.34 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -140.98 122.54 15.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.295 -0.411 . . . . 1.8 110.478 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -149.96 146.87 27.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.285 0.365 . . . . 0.39 110.923 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' CD ' ' HD3' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -143.9 136.77 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.9 110.714 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -139.98 -173.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.885 0.374 . . . . 0.11 110.59 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -136.46 116.65 13.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.05 110.185 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.8 p -112.67 -158.35 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.334 -0.394 . . . . 0.13 111.172 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -169.1 0.8 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.85 110.673 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -74.43 -157.88 0.06 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.894 0.378 . . . . 0.47 111.295 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' HB3' ' H ' ' A' ' 98' ' ' SER . 28.3 p-10 -56.71 -19.95 19.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.109 0.781 . . . . 0.52 113.109 -178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -63.55 -19.03 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.27 111.203 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.05 -24.92 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.1 0.476 . . . . 0.18 110.767 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.2 -13.29 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.323 -0.398 . . . . 0.29 110.403 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.72 68.68 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.934 -0.575 . . . . 0.27 112.416 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -72.18 -35.56 69.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.875 0.369 . . . . 0.9 110.762 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.28 2.42 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.91 0.386 . . . . 1.01 111.168 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -134.47 28.58 3.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.3 0.572 . . . . 0.48 109.842 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.62 -130.92 3.19 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.378 -0.828 . . . . 0.26 111.232 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -138.56 122.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.75 110.709 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.58 -163.36 0.85 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.474 -0.565 . . . . 0.7 109.474 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -96.89 -164.13 1.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.52 0.2 . . . . 1.15 110.98 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 m-20 -52.88 114.26 1.37 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.258 -0.428 . . . . 1.44 111.303 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.54 -28.28 68.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 1.36 111.662 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -62.05 -36.76 82.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.265 0.555 . . . . 0.95 110.403 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.67 -30.21 56.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.49 109.951 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 48' ' ' ASP . 21.9 t -75.48 -27.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.537 -0.756 . . . . 0.24 110.847 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.09 84.85 7.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.172 0.51 . . . . 0.2 111.148 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -57.34 -64.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.378 -0.828 . . . . 0.18 110.528 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 1.6 m -91.23 80.47 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.004 -0.544 . . . . 0.35 109.968 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -80.06 63.79 4.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.63 0.728 . . . . 1.1 110.942 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -148.35 96.04 2.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.796 -1.093 . . . . 0.22 108.074 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.1 p -78.82 146.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.664 -0.698 . . . . 0.13 112.194 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -116.23 147.35 41.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.57 -0.741 . . . . 0.32 109.263 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 18.5 t -84.43 -33.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.568 0.699 . . . . 0.11 109.387 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -166.05 104.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.127 -0.942 . . . . 1.03 109.889 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.71 -27.73 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.39 111.609 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 m -60.84 -45.99 92.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.735 0.302 . . . . 0.43 111.062 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -27.0 25.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.75 110.615 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.72 29.79 8.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.805 -0.712 . . . . 0.1 111.469 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -83.33 109.36 17.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 1.56 110.431 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.63 133.11 36.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.37 109.726 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -110.06 105.17 14.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.029 0.442 . . . . 0.1 110.856 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 34.2 pttt -85.86 -175.81 5.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.384 -0.599 . . . . 1.68 109.384 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 pttp -58.81 -23.48 60.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.643 0.259 . . . . 0.95 111.419 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.26 -22.03 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.501 -0.318 . . . . 2.07 111.316 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 21.8 m-20 -86.41 -52.28 5.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.39 -0.368 . . . . 0.33 110.748 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.63 -28.84 70.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.21 111.599 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -68.15 -26.55 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.797 0.332 . . . . 0.32 111.018 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 p -102.66 -25.08 13.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 1.04 111.327 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.61 -41.76 16.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.22 111.445 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -97.36 -41.43 8.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 0.42 110.324 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.72 -29.14 5.72 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.758 -0.734 . . . . 0.26 112.345 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.96 145.81 43.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.696 0.284 . . . . 0.22 110.782 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.39 3.01 53.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.242 0.544 . . . . 0.73 110.336 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 85' ' ' ILE . 26.6 t0 -74.25 108.78 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 1.45 110.551 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -60.46 -30.58 69.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.19 110.978 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -60.65 -40.77 93.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.278 -0.419 . . . . 0.61 111.097 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -71.34 -38.78 71.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.65 110.881 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 81' ' ' ASP . 30.0 mm -60.24 -55.11 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.21 110.936 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 7.4 p -67.74 -34.66 77.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.361 -0.381 . . . . 0.09 111.397 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' THR . 33.3 ttpt -58.82 -45.17 90.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.605 0.241 . . . . 0.21 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -60.62 -45.8 92.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.54 110.868 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.796 HG22 HG22 ' A' ' 20' ' ' VAL . 22.5 mt -72.43 -25.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 0.16 111.439 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.43 -40.52 23.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.053 0.39 . . . . 0.23 112.053 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -91.18 -21.16 21.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.07 0.767 . . . . 0.3 113.07 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -110.99 -24.68 10.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.632 -0.427 . . . . 0.67 111.296 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.77 -166.07 31.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.757 . . . . 0.15 111.931 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -120.97 131.59 54.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.168 0.509 . . . . 2.06 111.278 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 97' ' ' VAL . 14.7 p -118.28 160.36 18.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.49 109.05 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -73.27 85.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.238 0.542 . . . . 0.26 111.044 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 HG13 ' A' ' 95' ' ' VAL . 3.8 m -95.4 150.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.927 -0.579 . . . . 0.2 111.306 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -117.32 178.13 4.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.824 -0.625 . . . . 1.74 110.118 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.45 -177.13 6.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.57 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -90.29 151.23 21.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.334 -0.247 . . . . 0.81 110.334 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.29 171.35 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.52 110.755 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -80.74 114.9 19.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.112 -0.494 . . . . 0.79 110.873 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.4 t60 56.73 75.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 0.66 111.433 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -72.46 -62.08 1.57 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.254 -0.43 . . . . 0.66 110.777 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -168.32 132.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.864 -0.607 . . . . 1.74 110.222 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.05 54.29 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.056 0.455 . . . . 1.68 110.407 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 109' ' ' MET . 3.4 mm-40 -91.35 174.08 7.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.015 -0.539 . . . . 1.93 111.142 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -76.84 29.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.523 . . . . 0.33 111.49 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.41 ' H ' ' C ' ' A' ' 107' ' ' GLU . 23.6 ptt? -61.41 -33.4 73.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.43 110.889 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -74.08 -20.46 60.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.324 . . . . 0.41 110.587 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -47.03 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 0.85 110.025 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -48.55 81.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.77 -0.65 . . . . 1.02 110.301 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 mm -83.65 52.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.78 0.8 . . . . 0.23 109.573 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.41 -31.97 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.17 110.825 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.1 t -60.2 -24.29 64.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.42 111.562 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 33.4 mt -73.57 -46.49 48.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 0.47 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.49 -27.22 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.26 110.582 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.72 71.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.152 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.1 OUTLIER -67.59 -40.27 84.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.127 -0.488 . . . . 1.49 110.915 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -86.52 -3.64 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.87 111.223 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 2.8 t -86.04 84.46 7.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.61 175.92 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.904 -0.589 . . . . 0.31 112.5 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 25.6 t-20 176.97 -55.15 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.23 109.656 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 84.0 Cg_endo -77.97 166.85 24.47 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.929 1.752 . . . . 0.3 112.104 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.92 -22.0 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 1.12 111.588 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.436 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 7.4 t -75.2 -172.81 1.81 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.594 -0.275 . . . . 0.54 110.601 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.31 105.08 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 3.92 110.281 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.573 ' H ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -90.6 -50.37 0.34 Allowed Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.683 -0.689 . . . . 1.58 112.173 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.573 ' HD2' ' H ' ' A' ' 128' ' ' ARG . 20.0 Cg_endo -58.58 168.98 3.52 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.292 1.995 . . . . 0.3 113.035 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.8 t80 74.47 -20.32 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.698 0.799 . . . . 0.88 111.751 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -80.12 76.18 6.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.207 0.527 . . . . 0.34 111.218 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.24 -27.98 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.755 -0.657 . . . . 0.42 110.76 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.25 -27.37 39.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.518 -0.765 . . . . 0.42 111.51 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.91 -54.26 33.58 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.919 0.39 . . . . 0.22 110.512 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 tp -71.0 -28.49 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.37 110.66 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.04 -38.61 89.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 1.35 110.193 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -65.44 -46.59 79.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 1.91 110.656 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.45 81.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.39 111.489 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 44.9 ttp -58.36 -47.32 84.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 2.65 111.606 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -77.67 -24.25 49.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.818 -0.353 . . . . 0.22 111.054 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.88 -37.44 73.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.018 0.437 . . . . 0.31 110.422 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.43 -24.29 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.835 -0.431 . . . . 0.27 109.835 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.6 p80 40.82 50.65 3.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.085 0.954 . . . . 0.25 112.68 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.46 111.85 21.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.61 . . . . 1.84 110.397 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -77.92 45.45 0.52 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.233 0.539 . . . . 0.32 111.135 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.6 -24.49 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.53 110.553 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -82.38 22.6 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.58 111.162 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.73 14.5 5.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.349 0.595 . . . . 0.72 110.326 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -79.31 -46.3 17.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.843 -0.617 . . . . 0.49 110.408 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -154.74 -161.81 1.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.94 109.7 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.4 m -55.98 118.07 4.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.99 111.152 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -23.93 65.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.67 111.392 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.79 1.05 28.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.901 0.382 . . . . 1.1 110.654 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -115.59 -45.53 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.78 110.423 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.0 pt20 -94.06 19.46 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.18 111.579 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.78 72.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.23 111.282 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.1 mm? -68.43 -18.36 64.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.28 111.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -92.4 -36.97 12.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.85 0.357 . . . . 2.49 110.63 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 155' ' ' GLN . 24.7 t -64.79 -43.18 96.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.874 -0.603 . . . . 0.16 111.017 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.6 tt -61.36 -32.55 53.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.133 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 41.1 mttp -67.29 -48.62 67.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.711 0.291 . . . . 1.33 110.364 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -39.72 89.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.719 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -42.99 99.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 1.42 110.443 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -65.75 -20.72 66.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.283 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 161' ' ' LYS . 32.4 mt-10 -72.72 -32.54 65.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.694 0.283 . . . . 0.69 110.822 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -82.21 -44.09 16.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.065 0.46 . . . . 0.87 110.137 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 21.2 ptp -144.45 134.38 23.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.872 -0.604 . . . . 1.44 109.737 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.45 120.91 19.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.202 0.525 . . . . 0.87 111.493 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 pp -122.83 174.59 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.525 -0.761 . . . . 0.95 109.641 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.26 118.84 31.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.24 0.543 . . . . 1.19 110.575 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 11.8 14.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.691 -0.686 . . . . 0.54 111.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.04 133.29 49.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.041 -0.527 . . . . 1.13 111.369 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.2 148.85 10.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 1.72 110.013 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -159.1 -177.14 6.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.193 -0.299 . . . . 1.41 110.193 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -119.48 144.09 47.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.627 0.251 . . . . 1.73 110.491 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.69 154.74 41.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.76 110.976 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 177' ' ' ARG . 9.4 ptm180 -124.44 152.61 43.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.11 109.426 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 95.6 m-85 -116.09 124.64 50.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.854 0.359 . . . . 0.13 110.611 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.48 HG12 ' OE2' ' A' ' 209' ' ' GLU . 4.4 mt -102.07 114.5 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.3 111.47 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.3 OUTLIER -159.11 150.15 16.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 0.6 110.262 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.93 165.47 27.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.79 2.327 . . . . 0.26 112.064 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.95 -30.44 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.762 0.315 . . . . 0.15 110.928 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.11 -50.03 62.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.47 110.497 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -91.94 -21.95 20.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.74 110.272 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.16 -30.23 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.483 -0.781 . . . . 0.17 113.635 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -68.21 -16.44 63.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.072 0.436 . . . . 0.87 111.344 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.99 -15.65 35.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.172 0.511 . . . . 1.32 109.665 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.38 -45.08 5.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.267 -0.878 . . . . 2.04 110.537 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 208' ' ' LEU . 29.2 tttm -57.69 -53.49 57.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 0.72 111.093 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.66 31.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.088 -0.505 . . . . 0.6 111.12 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -144.16 -51.57 0.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.839 0.311 . . . . 1.27 111.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.97 -37.58 22.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.176 0.435 . . . . 0.6 112.176 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 6.1 mtpt -60.25 -48.54 93.85 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.234 0.457 . . . . 0.3 112.234 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.4 Cg_endo -60.0 -13.89 25.37 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.063 1.842 . . . . 0.16 113.043 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 66.9 mt -85.48 -2.58 58.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.472 -0.195 . . . . 0.37 110.472 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 39.2 pt 41.78 40.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.543 1.137 . . . . 0.65 113.736 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 195' ' ' LEU . 78.9 mttt -123.32 24.41 8.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 1.03 109.665 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.27 169.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 0.41 110.353 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 211' ' ' VAL . 88.6 mt -110.94 144.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.021 -0.536 . . . . 0.65 110.118 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -70.57 70.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.48 0.488 . . . . 0.66 111.334 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.1 m -157.39 38.72 0.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.595 -0.729 . . . . 0.29 109.287 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.5 145.07 29.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 1.14 111.608 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -117.62 123.69 46.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.12 110.089 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.61 159.78 18.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.284 -0.416 . . . . 0.47 110.193 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 139.34 -116.61 1.25 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.045 -0.598 . . . . 0.2 111.912 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.25 -18.05 37.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.518 0.675 . . . . 1.24 109.554 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.05 177.21 7.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.114 -0.948 . . . . 0.14 109.5 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 189' ' ' LYS . 2.8 tp -138.37 77.51 1.63 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.947 0.404 . . . . 0.69 110.61 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 15.9 mt-10 -82.93 99.73 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.174 -0.467 . . . . 0.16 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 28.7 mt -102.88 132.91 48.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.76 109.74 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.642 HG11 HD12 ' A' ' 239' ' ' LEU . 61.3 t -99.06 122.41 50.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.892 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.9 t -147.39 120.24 8.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.274 -0.421 . . . . 0.3 110.128 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.07 125.08 1.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.305 -0.628 . . . . 0.23 109.305 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.3 tt -117.1 157.61 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.922 -0.399 . . . . 0.6 109.922 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.08 150.59 10.39 Favored Pre-proline 0 C--O 1.236 0.344 0 O-C-N 123.295 0.372 . . . . 0.62 111.536 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 10.2 Cg_endo -51.1 158.35 3.41 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.654 2.903 . . . . 1.05 113.569 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 103.15 -82.87 0.41 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.631 -0.988 . . . . 0.37 110.631 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.1 m -72.92 -16.32 61.56 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.31 -0.626 . . . . 0.83 109.31 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 40.3 t80 -63.41 -42.71 98.76 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.564 -0.744 . . . . 1.35 110.762 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 223' ' ' ASP . 17.9 tpt180 -62.2 -27.33 68.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.151 0.5 . . . . 0.34 110.874 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.37 -34.92 70.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.181 -0.463 . . . . 2.19 111.358 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.635 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.3 tt -96.24 -29.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.529 -0.305 . . . . 1.78 111.76 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -62.52 -23.83 67.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 0.92 110.746 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -60.12 -25.63 65.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.867 -0.606 . . . . 1.26 111.4 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.0 OUTLIER -106.4 -32.55 8.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.928 -0.309 . . . . 0.47 110.872 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 222' ' ' ILE . 47.2 mm -58.26 -35.28 52.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.954 0.407 . . . . 0.29 110.705 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 16.4 ptmt -54.32 -34.29 60.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.458 -0.792 . . . . 1.56 112.609 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -106.09 -24.29 12.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.689 0.281 . . . . 0.55 111.344 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.12 -59.67 3.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.068 -0.514 . . . . 0.34 111.848 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.8 t -125.52 -24.26 3.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.294 0.479 . . . . 0.2 112.294 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 75.6 tttt -66.94 -28.79 68.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 0.52 110.66 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.83 -14.28 37.53 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.883 -0.675 . . . . 0.68 112.25 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -84.99 -22.31 29.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.381 . . . . 0.64 110.69 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -147.15 -168.98 14.27 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.536 -0.84 . . . . 0.1 112.342 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 m -96.77 131.73 43.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.891 -0.411 . . . . 0.25 109.891 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.31 142.66 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.004 0.43 . . . . 0.33 111.323 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -144.0 155.14 43.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.09 -0.504 . . . . 0.86 109.937 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -81.28 152.2 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 0.15 110.748 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.642 HD12 HG11 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -107.52 92.73 4.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.944 -0.391 . . . . 1.06 109.944 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -119.57 13.18 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.564 0.697 . . . . 1.0 109.704 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.8 100.65 11.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.416 -0.811 . . . . 0.24 109.801 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.1 34.77 4.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.973 -0.558 . . . . 0.74 110.323 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.2 -67.11 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.381 -0.372 . . . . 1.39 111.42 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.01 158.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.37 110.438 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -72.13 121.93 20.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.788 -0.449 . . . . 1.14 109.788 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -130.63 147.87 52.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.477 -0.329 . . . . 0.86 110.519 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 110.26 92.61 2.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.89 -0.671 . . . . 0.43 112.333 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.2 137.2 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.261 -0.274 . . . . 1.13 110.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.49 29.37 1.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.977 -0.556 . . . . 1.22 109.639 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -143.64 112.44 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.05 -0.523 . . . . 1.76 110.455 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.58 16.13 16.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.259 0.552 . . . . 0.56 110.551 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.327 -0.844 . . . . 1.96 109.554 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 111.529 -0.629 . . . . 0.55 111.529 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -129.66 125.4 35.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.803 0.335 . . . . 0.26 110.534 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -109.0 120.87 43.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 0.68 110.241 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.93 123.41 49.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.325 -0.398 . . . . 0.23 110.376 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 pt -81.04 -11.1 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.27 111.084 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -102.69 134.27 46.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.5 109.47 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 HG23 ' A' ' 9' ' ' THR . 0.2 OUTLIER -149.39 85.68 5.73 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.123 -0.231 . . . . 0.72 111.51 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.61 -47.39 4.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.725 2.284 . . . . 0.34 111.072 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 16' ' ' ASN . 81.2 p 48.15 35.43 5.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.156 -0.929 . . . . 0.37 113.433 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.83 -77.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.52 110.195 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.5 -98.24 0.25 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.051 -0.522 . . . . 0.36 109.632 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.7 mt -87.15 89.26 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.25 0.548 . . . . 0.36 109.886 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -143.47 134.83 26.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.599 -0.728 . . . . 1.32 109.754 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.78 61.09 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.995 0.426 . . . . 0.86 111.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -9.74 3.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 1.06 110.87 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 t-20 -153.59 63.88 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.191 -1.04 . . . . 1.1 108.191 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 3.5 m -106.31 128.04 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.012 -0.995 . . . . 0.21 111.542 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.16 113.08 18.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.806 . . . . 0.19 109.626 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.15 117.24 19.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.18 110.872 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 89' ' ' ILE . 1.3 p -125.28 128.84 73.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.82 -0.807 . . . . 0.37 108.82 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 30' ' ' GLU . 30.5 ttt180 -137.01 131.48 32.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.595 0.591 . . . . 1.25 112.595 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.464 ' HB2' HG23 ' A' ' 89' ' ' ILE . 19.2 ttt -83.77 140.7 31.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.674 . . . . 0.34 109.556 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.55 99.18 6.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.42 111.036 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -111.6 -179.69 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 0.82 110.331 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.09 -54.47 45.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.477 0.486 . . . . 0.09 112.072 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.94 28.73 3.64 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.746 -0.74 . . . . 0.23 111.845 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -148.17 146.84 28.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.775 0.321 . . . . 1.05 110.359 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.82 142.54 20.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.228 -0.656 . . . . 1.13 109.228 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 24.6 m-85 -145.85 129.32 16.92 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.376 0.423 . . . . 0.65 110.497 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.594 ' OE1' ' HD2' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -119.95 137.57 53.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.873 0.368 . . . . 0.34 110.711 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.89 -171.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.69 110.455 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -141.51 133.97 28.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.13 111.954 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.2 m -112.36 158.66 19.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.064 -0.516 . . . . 0.38 110.755 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -82.41 120.79 25.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.704 0.631 . . . . 0.38 112.704 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 84.3 mttt 44.38 39.32 3.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.131 1.16 . . . . 0.76 114.131 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.92 18.85 4.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.405 0.52 . . . . 1.71 112.405 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -73.01 1.16 9.44 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.002 0.43 . . . . 0.46 111.424 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.81 -19.58 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.365 0.603 . . . . 0.27 110.241 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.05 3.33 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.435 0.636 . . . . 0.18 109.87 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.1 -55.56 23.48 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.241 -0.89 . . . . 0.1 113.204 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -70.23 -6.14 32.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.241 0.52 . . . . 0.29 112.118 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -2.72 58.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.888 0.375 . . . . 0.5 110.04 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 m -144.35 -16.0 0.57 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.109 0.411 . . . . 0.65 112.109 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.13 44.03 1.95 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.984 -0.627 . . . . 0.23 111.892 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG13 ' HB2' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -139.27 29.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.395 . . . . 0.53 110.16 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -80.68 169.82 17.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.537 . . . . 1.96 112.257 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -157.39 -168.55 2.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.086 -0.961 . . . . 0.43 108.503 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.47 140.27 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.352 0.596 . . . . 0.64 111.016 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.629 ' HA ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -85.44 4.52 35.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.803 -0.635 . . . . 0.31 110.632 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.44 -24.29 42.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.597 -0.729 . . . . 0.67 110.645 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -108.42 -30.52 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.41 111.05 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -68.65 -24.82 29.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.484 -0.326 . . . . 0.6 111.299 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.47 116.25 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.676 -0.49 . . . . 0.58 109.676 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -88.12 -43.22 11.82 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.86 111.015 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -119.86 118.11 29.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.08 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -81.38 4.62 20.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.219 0.533 . . . . 0.63 110.272 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.459 ' H ' HG22 ' A' ' 55' ' ' THR . 4.3 m -115.62 134.59 54.9 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.13 150.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 110.087 -0.338 . . . . 0.24 110.087 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.43 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 70.7 m-85 -103.66 139.64 38.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.648 0.261 . . . . 0.42 110.551 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 2.1 t -87.05 -16.43 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.475 -0.565 . . . . 0.41 109.475 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 3.2 t-20 175.76 97.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.284 -0.871 . . . . 0.46 109.854 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.52 -25.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.2 110.827 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -21.08 66.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.071 -0.513 . . . . 0.23 111.193 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -119.11 0.48 11.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.79 111.016 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.88 29.79 62.51 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.594 -0.812 . . . . 0.31 112.072 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -83.88 101.85 11.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.634 0.254 . . . . 1.36 110.666 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.3 130.88 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.368 -0.378 . . . . 0.25 110.273 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 60' ' ' VAL . . . -99.73 114.78 28.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.16 0.505 . . . . 0.19 110.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.585 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 24.4 pttt -73.82 177.17 5.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 1.5 109.529 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -61.27 -28.53 69.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.09 110.2 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 74' ' ' ILE . 47.7 tt0 -76.35 -27.97 56.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.866 -0.606 . . . . 1.07 110.189 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' OD2' ' HG2' ' A' ' 69' ' ' LYS . 7.7 m-20 -72.88 -51.9 16.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.133 -0.485 . . . . 0.52 110.251 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.94 -33.71 76.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.14 111.198 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -69.61 -23.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.234 0.54 . . . . 0.13 109.954 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -95.65 -21.82 17.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.42 110.715 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.78 -53.09 4.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.399 -0.364 . . . . 0.36 111.706 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -90.17 -34.2 15.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.931 0.396 . . . . 0.36 110.239 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.08 -14.66 44.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.729 -0.748 . . . . 0.46 112.548 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.8 p -115.61 141.8 47.58 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.778 -0.248 . . . . 1.15 110.989 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.12 -10.77 51.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.159 -0.682 . . . . 0.58 109.159 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.43 120.78 25.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.096 -0.956 . . . . 1.03 109.898 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.98 -22.56 61.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.947 -0.57 . . . . 0.43 112.419 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -58.93 -49.67 76.96 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.274 -0.17 . . . . 0.13 111.091 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -62.37 -43.36 99.01 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.047 0.451 . . . . 0.82 111.008 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -62.48 -52.32 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 0.16 110.769 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.81 -35.56 76.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.15 110.778 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -62.34 -46.58 88.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.379 . . . . 0.43 110.366 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.65 110.764 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 22' ' ' MET . 77.9 mt -69.18 -28.31 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 0.17 109.967 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -38.09 36.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.718 -0.674 . . . . 0.27 111.922 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 92' ' ' LYS . 12.1 t -93.36 -10.11 36.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.544 0.572 . . . . 0.17 112.544 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' A' ' 91' ' ' THR . 34.6 mmtm -137.55 35.35 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.023 -0.423 . . . . 0.78 111.206 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.18 -147.37 4.53 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.581 -0.819 . . . . 0.19 112.237 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -136.06 128.79 30.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.649 -0.501 . . . . 1.16 109.649 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -139.99 142.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.559 -0.292 . . . . 0.35 110.892 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.61 84.29 1.57 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.201 0.524 . . . . 0.38 109.883 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 95' ' ' VAL . 5.5 m -100.95 167.04 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.44 0.638 . . . . 0.58 112.584 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.4 m -156.0 156.9 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.851 -1.068 . . . . 1.14 108.219 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.78 149.85 43.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.996 0.426 . . . . 1.31 110.708 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.5 -179.76 4.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.29 111.567 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.89 132.93 33.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 1.22 110.299 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.63 121.01 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.685 0.615 . . . . 0.89 111.078 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.474 ' HB2' HG13 ' A' ' 45' ' ' VAL . 30.6 m80 -140.95 -175.79 4.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.684 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -108.07 154.59 21.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.011 0.434 . . . . 0.48 109.942 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.58 -33.79 0.86 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.707 -0.679 . . . . 0.28 110.377 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt 56.57 38.13 29.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.644 -0.707 . . . . 0.5 111.182 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -138.15 104.37 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.65 110.464 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 57.2 54.08 7.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.154 0.502 . . . . 0.59 110.007 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.3 ttt -54.61 -36.61 64.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.445 -0.798 . . . . 1.88 111.883 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -64.08 -40.55 96.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 1.43 110.16 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -69.28 -39.66 78.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 1.45 110.078 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.429 ' HA ' ' NH2' ' A' ' 111' ' ' ARG . 0.3 OUTLIER -58.73 -56.96 15.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.561 -0.745 . . . . 0.42 111.255 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 113' ' ' ILE . 7.5 tp -65.63 -28.66 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.32 111.612 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.64 66.2 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.22 110.779 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.1 m -71.83 -32.42 67.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.104 0.478 . . . . 1.17 110.699 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.16 -29.65 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.013 -0.54 . . . . 0.22 111.106 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.02 -20.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.396 -0.366 . . . . 0.12 111.0 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.28 -56.65 14.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.542 -0.299 . . . . 0.19 111.762 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.83 -29.52 70.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.54 111.327 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HG3' ' OD2' ' A' ' 215' ' ' ASP . 64.5 tttp -70.65 -30.29 66.87 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.859 -0.609 . . . . 0.45 111.195 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 55.1 m -93.55 89.99 6.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.264 0.554 . . . . 0.26 110.453 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.03 118.21 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.375 0.607 . . . . 1.0 111.632 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -135.42 61.45 44.28 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.528 -0.76 . . . . 0.31 109.913 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 90.3 Cg_endo -79.99 36.03 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.656 2.238 . . . . 0.4 113.306 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -84.64 -54.79 4.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.486 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 t -132.48 0.16 3.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.378 0.609 . . . . 0.96 110.394 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 2.0 tpmt? -143.98 164.62 30.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 0.86 109.792 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.422 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -95.32 141.57 23.41 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.111 -0.7 . . . . 0.33 109.111 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.09 -20.17 44.6 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.85 2.367 . . . . 0.38 113.024 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.54 40.8 0.6 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.018 0.437 . . . . 1.15 110.981 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.8 m -125.83 84.76 2.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.375 0.607 . . . . 0.39 109.888 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 t -63.14 -25.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.178 -0.919 . . . . 0.25 112.3 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.9 mm -50.01 -51.06 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.245 0.831 . . . . 0.5 113.245 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.396 0.517 . . . . 0.42 112.396 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 tp -79.99 -26.56 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.891 0.376 . . . . 0.15 111.045 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.72 -46.23 83.16 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.148 -0.478 . . . . 1.06 110.034 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.73 -44.04 93.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 1.07 110.307 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -63.78 -41.65 97.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 0.18 110.742 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -63.22 -38.52 91.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.58 110.35 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -31.46 69.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.112 -0.494 . . . . 0.76 110.462 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.18 -53.42 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.735 -0.468 . . . . 1.22 109.735 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 138' ' ' ALA . 10.4 tp -88.75 50.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 122.896 1.331 . . . . 0.69 109.544 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -85.04 16.47 3.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.703 -1.135 . . . . 0.53 110.842 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.19 151.7 35.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.681 -0.691 . . . . 1.53 110.109 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.2 m -64.18 116.72 6.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.62 110.708 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.2 t -103.32 -51.08 9.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.35 110.872 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -136.35 -171.72 2.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.81 110.614 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.46 -34.15 76.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.52 . . . . 0.25 110.11 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -132.57 101.29 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.437 -0.802 . . . . 0.7 109.674 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -85.25 71.21 10.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.477 -0.564 . . . . 0.98 109.477 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 m -133.2 129.0 37.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.883 -0.599 . . . . 0.38 111.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -7.41 46.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.25 110.958 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.03 9.55 6.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.783 -0.644 . . . . 0.24 110.611 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -162.31 -58.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.31 110.049 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -87.33 41.27 0.97 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.976 -0.556 . . . . 0.23 110.362 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.68 -32.65 71.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 0.19 111.663 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.5 mm? -81.01 -2.7 49.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.355 -0.384 . . . . 1.48 111.378 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -111.11 -44.7 3.54 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.963 -0.295 . . . . 2.27 111.091 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -58.48 -42.82 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.39 110.969 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.8 tt -65.07 -28.38 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.17 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 16.4 mttp -68.57 -42.78 77.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.853 0.359 . . . . 1.29 110.392 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -35.82 61.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.53 110.659 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 7.2 tp -65.78 -35.15 79.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.21 110.069 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 167' ' ' MET . 2.1 ttpm? -60.28 -20.8 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.112 -0.949 . . . . 1.39 111.662 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -70.72 -20.38 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 1.06 111.191 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -115.11 -47.05 2.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.869 0.366 . . . . 0.9 110.652 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 13.5 tpt -117.59 122.74 44.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 0.25 110.914 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -93.79 110.34 21.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.098 -0.501 . . . . 0.79 110.157 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp -125.87 157.11 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 0.18 111.083 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 158.54 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.182 -0.463 . . . . 2.59 110.148 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.88 32.65 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.748 0.309 . . . . 0.47 111.546 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.96 118.65 10.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.991 0.424 . . . . 0.44 111.726 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -165.35 134.61 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.28 109.718 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.01 -173.09 2.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 1.39 110.744 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -114.39 140.04 48.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 2.39 110.085 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.51 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 1.7 mt -127.98 150.95 49.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.039 0.447 . . . . 0.71 110.657 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -129.51 174.31 9.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.351 -0.84 . . . . 0.48 109.231 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.556 ' HE2' ' HG ' ' A' ' 212' ' ' CYS . 3.6 p90 -133.58 145.58 50.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.153 -0.314 . . . . 0.49 110.153 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.25 106.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.42 111.439 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -147.06 157.23 46.63 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.055 -0.52 . . . . 0.13 110.943 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.31 178.44 2.55 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.808 2.339 . . . . 0.14 113.123 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.39 -45.81 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.627 0.603 . . . . 0.4 112.627 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.91 -45.9 85.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.083 0.468 . . . . 1.26 111.607 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.61 -39.74 67.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.7 110.68 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -62.69 -38.33 96.26 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.68 -0.691 . . . . 0.16 113.104 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -57.08 -34.28 68.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.776 0.287 . . . . 0.58 111.776 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 31.7 mmmt -71.91 -33.32 68.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.566 0.21 . . . . 1.38 111.566 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -85.36 -26.3 26.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.47 109.99 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 80.5 tttt -60.94 -31.55 71.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.22 110.62 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -95.42 12.68 28.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.996 -0.547 . . . . 3.15 111.197 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 9.2 mtmt -126.5 -58.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.222 0.453 . . . . 0.8 112.222 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.3 -42.01 26.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.641 . . . . 0.16 112.729 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 189' ' ' LYS . 1.6 mtpt -58.16 -50.95 85.22 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.07 0.767 . . . . 0.44 113.07 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 20.5 Cg_endo -60.91 -14.76 34.39 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.456 2.104 . . . . 0.21 113.404 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' A' ' 197' ' ' LYS . 72.4 mt -82.19 -11.51 58.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.37 110.15 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mm 56.64 35.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.569 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -109.64 18.16 20.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.356 0.598 . . . . 1.87 110.042 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 212' ' ' CYS . 2.9 m -113.6 137.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.259 -0.882 . . . . 0.34 110.384 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.6 mp -80.63 148.28 5.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.954 -0.566 . . . . 0.79 109.52 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.7 75.13 0.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.749 0.785 . . . . 0.94 111.559 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.2 m -149.83 33.62 0.68 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.146 -1.057 . . . . 0.46 108.146 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.4 pt-20 -79.72 129.96 34.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.768 -1.106 . . . . 0.8 111.792 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -97.13 105.73 17.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.361 -0.977 . . . . 0.3 108.361 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.44 131.31 45.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.8 110.434 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 163.57 -104.77 0.24 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.848 -0.691 . . . . 0.56 112.127 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.4 -17.27 32.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.4 0.619 . . . . 1.8 110.016 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -140.67 176.91 8.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.231 -0.895 . . . . 0.47 109.35 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.4 tp -128.27 84.73 2.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.372 -0.603 . . . . 0.46 109.372 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 19.3 tt0 -96.56 109.39 21.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.603 -0.726 . . . . 1.24 110.815 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 5.9 mt -130.97 152.04 36.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.739 0.304 . . . . 0.26 110.314 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.4 t -98.7 117.59 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.09 109.808 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.556 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 21.0 p -122.92 56.02 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.26 111.411 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.51 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -126.56 125.29 41.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.034 0.445 . . . . 0.12 111.05 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 pt -114.8 -159.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.412 -0.813 . . . . 0.32 109.751 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.447 ' OD2' ' HG3' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -80.65 162.3 60.95 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 110.127 -0.323 . . . . 0.33 110.127 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.92 -177.42 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.67 2.247 . . . . 0.2 113.157 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.69 1.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.066 -0.814 . . . . 0.15 111.066 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.14 -24.22 65.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.297 0.57 . . . . 1.03 110.039 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.13 -32.35 73.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.32 109.947 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -23.51 63.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.87 110.497 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.4 -38.79 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 1.48 110.72 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.634 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 19.6 tt -85.11 -24.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.84 111.356 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.12 -30.23 61.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.84 0.352 . . . . 0.65 110.957 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -56.14 -33.07 64.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.714 -0.675 . . . . 1.58 111.447 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.85 -23.99 14.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.769 -0.372 . . . . 0.46 110.927 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 222' ' ' ILE . 46.3 mm -64.51 -37.92 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.36 110.508 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -62.87 -29.19 70.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.32 111.388 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 225' ' ' LEU . 60.1 pttt -105.54 11.29 32.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.619 . . . . 0.74 110.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -96.83 -126.55 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.022 -1.103 . . . . 0.51 108.022 178.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.406 HG21 ' CD2' ' A' ' 178' ' ' PHE . 9.5 t -65.2 -27.91 69.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.868 0.365 . . . . 0.45 110.999 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.27 -12.13 61.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.62 111.083 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -108.37 18.37 33.05 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.964 -0.636 . . . . 0.12 112.591 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -149.13 -44.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.62 0.247 . . . . 0.8 111.042 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -105.74 -171.56 23.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.682 -0.771 . . . . 0.33 112.191 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -107.9 143.32 36.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.724 0.297 . . . . 0.54 110.217 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.48 165.7 13.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 0.92 110.902 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -154.13 151.94 29.84 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.52 -0.918 . . . . 2.09 108.52 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.11 155.07 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.232 0.539 . . . . 0.57 111.576 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 239' ' ' LEU . 0.4 OUTLIER -97.47 77.41 2.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.91 108.279 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -70.96 -26.33 63.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.673 . . . . 1.29 111.243 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 241' ' ' LEU . 1.2 mm? -52.37 132.76 34.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.82 111.093 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -132.62 -1.14 3.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.086 0.469 . . . . 1.32 110.034 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.87 -66.12 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.397 -0.819 . . . . 1.45 110.964 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.86 150.43 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.311 -0.404 . . . . 0.67 110.275 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.07 110.41 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.397 -0.365 . . . . 1.78 110.022 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -114.94 152.4 32.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 2.1 110.961 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -166.44 171.46 41.43 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.941 -0.863 . . . . 0.18 110.941 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.79 90.34 5.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.215 0.531 . . . . 1.21 110.289 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -86.18 -9.96 55.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.81 110.316 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.5 tptp 57.42 62.4 2.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.457 -0.792 . . . . 0.72 110.599 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -63.11 -48.27 79.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.843 -0.617 . . . . 0.97 110.658 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.693 -0.67 . . . . 2.97 110.406 179.629 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.706 -0.558 . . . . 0.48 111.706 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -111.21 105.42 14.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.964 0.382 . . . . 1.25 110.185 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 tpp -153.4 166.03 33.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.15 -0.477 . . . . 0.96 109.999 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -78.3 87.65 4.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.064 0.459 . . . . 0.7 110.295 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mt -101.57 122.94 54.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.77 109.796 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.542 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.0 t80 -71.22 143.68 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.071 -0.344 . . . . 0.81 110.071 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -101.51 98.2 8.94 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.229 -0.441 . . . . 0.56 111.471 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 87.0 Cg_endo -88.99 1.7 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.472 2.115 . . . . 0.54 111.646 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m 62.28 75.33 0.41 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.277 -0.874 . . . . 0.48 110.839 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -87.7 155.05 20.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.46 110.464 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -63.33 -39.45 94.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.2 112.256 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 54' ' ' GLN . 17.5 mt -145.7 82.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.628 0.252 . . . . 0.49 111.237 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -164.18 172.83 13.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.633 0.254 . . . . 1.45 110.771 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.61 48.42 0.55 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.52 112.27 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -132.99 3.18 3.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.215 0.531 . . . . 0.35 110.66 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.77 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.704 -0.85 . . . . 0.35 108.704 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 22.8 m -100.46 150.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.981 -1.009 . . . . 0.37 112.527 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.37 111.77 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.378 -0.971 . . . . 0.31 108.378 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.41 110.89 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.78 111.991 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -103.54 135.93 38.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 0.32 109.005 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.93 127.92 47.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.81 111.996 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.421 ' HB2' HG23 ' A' ' 89' ' ' ILE . 57.8 ttp -101.16 115.39 30.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.312 -0.625 . . . . 0.28 109.312 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 115.86 24.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.433 . . . . 0.87 110.604 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 25.4 mmm-85 -123.93 163.72 20.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.989 -0.551 . . . . 0.9 110.365 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.84 76.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.47 110.872 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.83 -57.7 4.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.799 . . . . 0.38 112.242 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -159.47 152.17 21.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.13 -0.322 . . . . 0.85 110.13 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 2.2 ptt180 -91.41 149.03 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.564 -0.532 . . . . 1.88 109.564 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -129.46 120.29 25.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.415 -0.357 . . . . 0.48 110.654 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 4.8 mt-10 -116.82 123.9 48.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.52 110.9 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mt -128.29 146.82 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.067 -0.346 . . . . 0.27 110.067 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.585 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -102.9 103.22 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 0.14 110.303 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 p -100.96 -162.44 0.94 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.12 -0.491 . . . . 0.5 110.749 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.719 ' HB2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.69 -174.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.049 0.452 . . . . 0.52 111.17 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -75.01 -139.83 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.567 -0.742 . . . . 1.15 110.491 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.48 -10.79 37.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.947 0.403 . . . . 0.24 111.546 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -62.85 -30.85 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.42 111.16 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.8 -23.99 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.029 0.442 . . . . 0.2 111.067 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.95 -30.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.439 0.638 . . . . 0.2 110.2 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.68 18.42 50.17 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.606 -0.724 . . . . 0.46 112.126 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 40.3 t90 -80.13 -54.33 5.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.82 0.343 . . . . 0.51 110.813 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -97.98 -13.7 20.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.285 0.564 . . . . 1.42 110.233 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.4 m -101.61 14.66 31.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 0.54 110.218 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.33 -146.4 5.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.561 -0.745 . . . . 0.29 111.655 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.73 112.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.731 0.3 . . . . 0.43 110.59 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 41' ' ' TRP . 28.7 mm-40 -130.14 -159.09 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.485 -0.325 . . . . 0.46 110.251 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -112.68 -159.07 0.67 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.586 -0.279 . . . . 0.81 110.719 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.2 140.04 56.32 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.004 -0.544 . . . . 1.21 110.493 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -80.9 -18.02 48.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.115 0.783 . . . . 0.44 113.115 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 49' ' ' LEU . 5.8 t70 -67.3 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.555 -0.535 . . . . 1.4 109.555 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.56 -19.83 62.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.191 0.519 . . . . 1.02 110.001 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 34' ' ' TYR . 69.2 t -78.83 -23.47 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.32 109.287 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.65 92.62 4.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.255 -0.884 . . . . 1.3 110.432 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' HG23 ' A' ' 12' ' ' ILE . 33.7 mm-40 -60.36 -44.47 95.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 1.3 109.939 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.4 p -115.05 121.57 43.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.753 -0.658 . . . . 1.14 109.992 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -87.76 23.26 2.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.309 0.576 . . . . 0.49 110.204 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.8 157.78 27.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.401 -0.818 . . . . 0.32 109.5 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.3 p -130.16 135.32 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.22 111.128 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . 61.8 m-85 -91.03 138.62 31.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.415 -0.357 . . . . 0.64 110.422 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG23 ' HB2' ' A' ' 68' ' ' ALA . 2.1 t -94.93 -33.32 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.571 . . . . 0.55 110.037 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -164.68 93.48 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.62 109.539 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 p -66.09 -20.47 27.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.351 -0.386 . . . . 0.41 111.509 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.07 -4.53 55.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.5 110.85 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -126.95 -16.03 5.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.897 -0.592 . . . . 1.21 110.588 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.95 17.78 57.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.927 -0.654 . . . . 0.32 111.496 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.58 113.08 22.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.846 0.355 . . . . 0.81 110.563 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.61 141.26 31.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.124 -0.489 . . . . 0.52 109.969 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 60' ' ' VAL . . . -101.54 126.21 48.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.653 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 71' ' ' GLU . 10.9 ptpt -98.97 -171.7 2.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.661 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -59.73 -30.08 68.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.24 111.353 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.596 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 6.4 tt0 -80.67 -1.11 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.119 0.485 . . . . 1.39 110.768 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.56 -52.4 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.455 -0.339 . . . . 1.58 110.979 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -31.61 71.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.32 111.611 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -29.95 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.54 110.919 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -98.65 -29.31 13.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.971 0.415 . . . . 0.76 111.074 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.58 45.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.507 . . . . 0.22 111.43 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -105.24 -41.54 5.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.487 -0.324 . . . . 0.41 110.79 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.96 -23.83 5.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.176 -1.011 . . . . 0.22 112.221 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -97.98 133.95 41.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.68 0.276 . . . . 0.46 110.682 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.16 10.93 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.307 0.575 . . . . 0.57 110.429 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -106.86 128.31 54.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.79 -0.641 . . . . 0.65 109.69 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -69.98 -19.24 63.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.62 -0.264 . . . . 0.32 111.289 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 49' ' ' LEU . 7.9 m -60.54 -45.85 92.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.365 -0.38 . . . . 0.43 111.002 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -71.13 -23.36 62.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 1.42 111.309 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.6 mm -77.81 -52.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.379 . . . . 0.24 110.158 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.95 -41.75 99.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.92 -0.582 . . . . 0.36 111.131 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 83' ' ' THR . 8.0 tttt -58.65 -31.84 68.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.92 110.91 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 91' ' ' THR . 1.6 tt0 -76.09 -46.36 29.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.909 -0.587 . . . . 0.72 110.332 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 20' ' ' VAL . 72.2 mt -65.82 -31.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.684 -0.689 . . . . 0.29 111.211 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -8.21 59.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 0.35 111.449 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 88' ' ' GLN . 0.7 OUTLIER -102.31 -28.44 12.26 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.778 -0.369 . . . . 0.24 111.554 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -144.05 43.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.234 0.54 . . . . 1.22 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.18 172.78 20.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.651 -0.785 . . . . 0.29 112.117 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.38 89.92 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.862 0.363 . . . . 1.39 110.539 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 p -104.77 149.29 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.3 110.248 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.07 98.13 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.19 0.519 . . . . 1.78 111.048 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.86 172.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.29 110.598 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -122.24 -86.62 0.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.874 -0.417 . . . . 0.87 109.874 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.26 149.78 48.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.927 -0.397 . . . . 1.63 109.927 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 26.36 0.38 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.954 0.406 . . . . 1.17 110.257 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -70.2 124.35 23.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.902 -0.59 . . . . 1.01 111.732 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -121.97 -56.61 1.83 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.31 109.657 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 26.7 m-70 60.61 98.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.906 0.754 . . . . 0.41 112.537 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.5 m -147.76 105.93 3.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.781 -0.645 . . . . 0.3 109.599 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -119.04 145.82 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.41 111.438 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 109' ' ' MET . 1.5 mt -165.01 136.45 4.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.492 -0.776 . . . . 0.45 109.489 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 108' ' ' GLN . 0.4 OUTLIER -74.94 152.84 38.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.261 -0.274 . . . . 1.44 110.261 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 82.6 mt-30 75.1 -11.24 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.053 0.845 . . . . 0.31 111.397 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -60.62 -34.26 73.99 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.988 0.423 . . . . 0.35 110.961 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -64.88 -22.87 67.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.38 111.338 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.6 -26.92 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.053 0.454 . . . . 1.74 109.963 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.6 -53.09 12.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.59 109.989 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.84 -30.37 49.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.869 -0.605 . . . . 0.34 110.642 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.14 110.678 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.8 m -71.17 -39.05 72.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 1.12 110.923 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.68 -41.04 77.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.792 -0.64 . . . . 1.91 111.255 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.95 -16.47 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.091 -0.504 . . . . 0.21 112.19 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.98 82.75 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.83 0.348 . . . . 0.15 111.629 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -17.93 26.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.256 0.55 . . . . 0.26 110.37 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -81.72 -46.89 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.842 -0.617 . . . . 0.77 111.109 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.7 m -87.72 87.01 7.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.166 0.507 . . . . 0.21 110.555 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -100.08 -177.98 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.54 -0.755 . . . . 0.35 110.759 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -141.67 155.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.046 -0.353 . . . . 0.91 110.046 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.92 57.28 5.67 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.993 2.462 . . . . 0.54 113.209 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -131.81 -174.17 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.364 -0.606 . . . . 0.78 109.364 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 t -66.76 -31.74 72.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.46 110.552 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -106.57 83.25 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.709 -0.478 . . . . 0.99 109.709 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HB2' ' HD3' ' A' ' 129' ' ' PRO . 18.9 mtp180 -72.97 -55.72 3.82 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.915 -0.584 . . . . 0.49 111.254 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 128' ' ' ARG . 74.4 Cg_endo -76.13 118.46 4.98 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.271 1.314 . . . . 0.22 111.572 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -88.04 -179.63 6.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.905 0.383 . . . . 0.4 110.972 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -101.72 158.79 15.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.289 -0.414 . . . . 0.46 110.633 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.4 -36.08 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.21 109.991 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mm -64.93 -36.78 78.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.342 -0.845 . . . . 0.39 111.279 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 134' ' ' LEU . 14.9 mt -64.18 -51.48 63.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.571 -0.286 . . . . 0.57 110.988 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.18 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.829 -0.348 . . . . 0.39 110.147 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.09 -40.16 94.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.463 . . . . 1.47 109.87 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -32.9 71.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.683 -0.69 . . . . 0.66 110.518 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.78 -36.89 21.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.294 -0.412 . . . . 0.28 110.634 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -66.32 -45.45 80.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.71 110.96 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -72.01 -15.67 62.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 1.08 110.568 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.45 -33.61 54.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 0.52 109.737 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.5 52.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.209 1.004 . . . . 1.85 110.102 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.58 37.37 0.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.93 111.201 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -82.91 110.63 18.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.926 -0.579 . . . . 0.73 110.162 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.4 m -73.08 116.82 14.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.061 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.8 -43.4 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.52 110.558 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -132.04 152.57 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.88 110.226 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.25 1.44 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 0.66 110.808 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' HIS . 27.3 t-20 -66.39 -37.48 85.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.91 110.341 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt 50.99 57.38 6.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.56 -0.746 . . . . 0.71 110.886 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 15.8 m -118.91 118.31 31.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.119 -0.491 . . . . 0.51 110.954 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -52.53 -61.64 2.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.2 0.815 . . . . 0.63 113.2 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 5.21 3.29 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.962 0.727 . . . . 0.47 112.962 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -109.76 -44.55 3.81 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.816 -0.354 . . . . 0.86 110.583 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.21 10.73 36.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.806 0.336 . . . . 0.47 110.548 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.05 83.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.604 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -67.29 -21.6 65.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 1.61 111.257 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.28 -49.54 9.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.88 109.835 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.33 -40.14 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.535 . . . . 0.15 111.148 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.23 -8.17 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.201 0.524 . . . . 0.27 111.765 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -113.0 -37.16 4.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.503 -0.555 . . . . 0.4 109.503 178.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.39 -45.83 78.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.725 . . . . 1.39 110.338 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.43 -29.62 69.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.956 -0.565 . . . . 0.34 110.358 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.91 -20.98 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.9 110.414 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.04 -10.75 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 2.45 110.595 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -108.04 -26.31 10.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.957 -0.565 . . . . 1.08 110.343 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.9 ttp -150.03 125.85 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.885 -0.598 . . . . 2.64 110.042 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -72.19 121.45 19.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 1.86 110.538 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.3 pt -131.51 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.34 110.475 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -104.97 172.51 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.635 -0.505 . . . . 1.04 109.635 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -79.51 166.26 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 2.15 111.155 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.9 175.84 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.08 111.442 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -96.69 148.72 22.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.596 . . . . 1.1 110.151 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.6 mmm -97.45 172.49 7.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.98 110.928 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.07 140.21 35.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 1.31 111.275 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 211' ' ' VAL . 1.1 mp -124.56 146.13 49.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.38 110.347 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 22.0 ptt85 -113.54 139.74 48.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.824 -0.625 . . . . 0.25 110.451 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 48.7 t80 -105.94 125.87 51.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.289 -0.414 . . . . 0.7 110.253 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 pt -114.09 135.59 53.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.672 0.272 . . . . 0.52 111.407 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -178.53 163.03 1.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.19 109.568 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.27 165.76 31.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.151 1.901 . . . . 0.21 112.151 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 t -63.96 -21.93 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.342 -0.39 . . . . 0.09 111.574 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -47.89 -60.78 2.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.146 -0.479 . . . . 0.45 111.784 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -93.82 -20.84 19.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.917 0.389 . . . . 0.37 109.985 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.23 93.68 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.793 -0.639 . . . . 0.07 113.485 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -60.33 -33.98 73.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.835 0.317 . . . . 0.34 110.943 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.03 -48.56 78.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.951 -0.568 . . . . 0.86 111.602 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -21.95 47.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.991 -0.284 . . . . 0.17 111.184 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -60.67 -47.82 84.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.58 110.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.59 16.64 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.78 111.222 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.42 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 31.4 mttm -119.93 -50.53 2.27 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.758 0.313 . . . . 1.53 111.346 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.49 -39.79 27.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.603 0.594 . . . . 0.6 112.603 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 12.2 mtpp -61.66 -52.98 65.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 112.791 0.663 . . . . 0.44 112.791 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.7 Cg_endo -65.51 -19.8 60.69 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.99 1.793 . . . . 0.25 112.974 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 195' ' ' LEU . 16.9 mt -86.53 -2.24 58.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.66 -0.245 . . . . 0.5 110.797 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.5 mt 54.44 59.52 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.422 0.63 . . . . 0.46 111.399 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.414 ' CE ' ' HB3' ' A' ' 195' ' ' LEU . 14.9 mtmt -139.55 35.83 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.516 0.674 . . . . 1.53 109.673 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.69 167.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.37 109.964 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.1 mt -119.99 150.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 0.69 109.315 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -73.04 71.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.353 0.597 . . . . 2.54 111.701 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 m -151.71 35.71 0.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.3 -1.0 . . . . 0.61 108.3 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.0 mt-10 -94.84 152.65 18.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.919 -1.037 . . . . 1.59 111.585 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -105.99 148.49 27.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.206 -0.664 . . . . 0.63 109.206 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -138.22 94.92 2.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.873 0.368 . . . . 1.3 110.56 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -162.96 -108.45 0.22 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.156 -0.778 . . . . 0.28 111.156 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 -25.46 19.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.694 0.759 . . . . 1.58 108.981 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -119.78 165.18 14.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.717 -1.129 . . . . 0.72 109.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.63 78.17 1.77 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.798 0.333 . . . . 0.72 110.599 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 202' ' ' GLU . 33.8 tt0 -75.12 107.44 7.21 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.873 -0.788 . . . . 0.49 108.873 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.419 HG23 ' HG2' ' A' ' 202' ' ' GLU . 74.2 mt -121.19 135.82 60.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.027 0.441 . . . . 0.43 111.941 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 176' ' ' LEU . 45.3 t -100.98 107.01 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.16 -0.682 . . . . 0.3 109.16 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.17 26.66 9.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.241 0.46 . . . . 0.95 112.241 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.402 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.4 OUTLIER -105.24 121.08 43.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.849 0.356 . . . . 0.66 110.481 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.6 pt -108.38 -165.06 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.7 111.231 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.608 ' OD2' ' HD2' ' A' ' 216' ' ' PRO . 0.1 OUTLIER -64.86 160.38 55.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.791 -0.641 . . . . 1.13 111.111 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.608 ' HD2' ' OD2' ' A' ' 215' ' ' ASP . 59.7 Cg_endo -70.52 -154.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.817 2.344 . . . . 0.3 113.05 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 74.62 -91.42 0.77 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.403 -0.679 . . . . 0.16 111.403 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.91 -0.38 21.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.24 110.732 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.507 ' HA ' HG22 ' A' ' 222' ' ' ILE . 2.5 p90 -62.42 -24.65 67.53 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.11 110.557 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -68.44 -29.81 68.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.354 0.597 . . . . 0.82 110.003 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -80.11 -34.29 38.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.325 -0.852 . . . . 1.51 110.988 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.571 ' O ' HG12 ' A' ' 226' ' ' ILE . 5.2 tt -77.58 -32.65 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.13 110.559 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.38 -28.34 65.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.069 -0.514 . . . . 0.12 111.05 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -54.28 -40.72 68.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.805 -0.634 . . . . 1.31 111.174 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 229' ' ' GLU . 0.9 OUTLIER -94.34 -38.43 10.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.553 -0.294 . . . . 0.15 110.541 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 222' ' ' ILE . 48.5 mm -54.08 -37.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.33 111.384 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 7.1 ptpp? -59.79 -23.33 63.2 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.789 0.663 . . . . 1.4 112.789 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.13 -25.15 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.443 . . . . 0.41 111.507 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -72.99 -44.15 61.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.944 -178.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.3 t -135.06 -42.26 0.73 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.355 0.502 . . . . 0.2 112.355 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 24.8 mtpt -60.08 -25.75 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.801 0.297 . . . . 0.53 111.801 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -100.28 12.8 60.22 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.907 -0.663 . . . . 0.4 112.984 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -101.2 -15.0 17.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.39 110.574 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.4 -131.55 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.862 -0.685 . . . . 0.24 112.14 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 m -129.31 141.61 51.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 0.66 110.726 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.6 pt? -116.65 158.62 23.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.646 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.76 164.88 28.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.038 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.41 154.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.963 0.411 . . . . 0.58 111.267 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.15 100.05 10.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.61 110.572 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -86.42 67.18 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.607 0.717 . . . . 1.45 110.419 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.4 mt -142.56 92.04 2.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.579 -0.737 . . . . 0.78 109.886 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.54 ' H ' ' HD3' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -118.77 16.02 13.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.226 -0.897 . . . . 1.09 109.33 -179.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.27 -62.73 1.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.132 -0.94 . . . . 0.83 110.599 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.59 141.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.633 . . . . 0.38 109.993 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -102.47 112.47 25.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.987 0.422 . . . . 1.4 110.457 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.12 153.07 33.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.651 -0.704 . . . . 0.74 110.207 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -128.08 -153.8 8.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.665 -0.778 . . . . 0.31 112.193 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.66 53.05 2.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.6 110.783 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 249' ' ' GLU . 3.0 pt-20 -92.51 17.72 9.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.53 111.008 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' A' ' 252' ' ' GLU . 6.5 tptp -148.21 133.37 18.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.78 109.585 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -98.83 -27.07 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 1.13 111.174 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 250' ' ' LYS . 2.7 pm0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.705 -0.665 . . . . 1.31 109.985 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.013 -0.435 . . . . 0.6 112.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -111.42 145.93 38.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.761 0.281 . . . . 0.86 110.435 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 mmt -95.86 144.88 25.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.331 -0.395 . . . . 1.91 110.58 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 m -156.04 166.46 33.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.697 -0.483 . . . . 1.22 109.697 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -83.17 74.06 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.32 0.581 . . . . 0.89 110.076 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.35 147.8 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.89 -0.595 . . . . 1.56 109.725 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -122.09 84.94 45.85 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.577 0.227 . . . . 0.38 110.517 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HB2' ' OD1' ' A' ' 10' ' ' ASN . 36.7 Cg_endo -66.03 -36.47 29.87 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.53 2.153 . . . . 1.55 112.312 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 37.85 49.16 1.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.895 0.878 . . . . 1.26 112.668 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' A' ' 8' ' ' PRO . 16.6 m120 -68.28 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 1.58 110.779 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -123.41 -81.01 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.535 -0.542 . . . . 2.1 109.535 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.44 98.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.445 -0.576 . . . . 0.89 109.445 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -141.82 145.1 34.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.863 -0.608 . . . . 0.52 110.331 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.01 13.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.244 -0.435 . . . . 0.57 111.709 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 p -96.02 -6.03 39.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.897 0.38 . . . . 1.0 111.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -151.02 52.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.154 0.502 . . . . 1.18 110.087 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.77 132.43 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.925 -0.58 . . . . 0.24 110.846 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.25 123.17 36.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.741 -0.466 . . . . 0.11 109.741 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 t -81.6 114.82 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.332 0.587 . . . . 0.17 111.147 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.757 HG13 HG13 ' A' ' 31' ' ' ILE . 1.3 p -125.0 133.04 70.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.939 -0.763 . . . . 0.17 108.939 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.402 HH12 ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -141.31 147.18 37.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.13 111.726 -178.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HD3' ' A' ' 24' ' ' ARG . 43.1 ttp -120.7 117.48 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.15 110.187 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -99.5 114.7 27.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.291 -0.413 . . . . 0.72 109.932 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HD3' ' SD ' ' A' ' 22' ' ' MET . 14.7 mmm-85 -100.55 -172.73 2.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.266 -0.425 . . . . 0.34 109.883 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.46 -24.24 46.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.844 0.313 . . . . 0.66 111.844 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.17 -58.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.418 -0.896 . . . . 1.09 113.135 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -123.26 175.91 6.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.079 0.466 . . . . 1.58 110.934 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.13 142.76 48.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 0.98 108.979 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -130.94 119.21 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.787 0.327 . . . . 0.86 111.147 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 130.8 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 1.11 109.915 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.757 HG13 HG13 ' A' ' 20' ' ' VAL . 7.2 pt -135.71 172.27 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.84 0.352 . . . . 0.26 110.661 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 122.31 22.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.262 -0.426 . . . . 0.21 110.387 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.8 m -118.63 -163.35 0.95 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 1.37 110.848 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 t80 -72.94 -171.15 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.3 110.715 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -71.59 -157.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.279 -0.419 . . . . 0.59 111.828 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -48.67 -22.64 0.82 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.303 0.853 . . . . 1.3 113.303 -178.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -60.69 -18.81 56.31 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.28 -22.81 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 111.842 0.312 . . . . 0.15 111.842 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.564 ' HB ' HG11 ' A' ' 97' ' ' VAL . 4.0 p -76.02 -10.83 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.016 0.436 . . . . 0.31 110.838 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.86 -25.69 69.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.986 -0.626 . . . . 0.1 112.073 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -61.65 -45.87 92.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.647 0.26 . . . . 2.03 111.386 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.96 17.48 9.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.55 110.949 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m -118.43 -37.01 3.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.554 . . . . 0.57 110.627 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.03 -107.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.615 -0.594 . . . . 0.15 111.615 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.22 123.67 68.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.221 -0.288 . . . . 0.63 110.221 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.93 176.73 6.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 1.46 110.885 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 6.8 ptmt -69.77 -64.12 0.94 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 1.26 111.582 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 5.5 t70 -169.32 123.15 0.79 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.629 -0.508 . . . . 0.93 109.629 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.83 -35.57 76.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.197 0.443 . . . . 0.2 112.197 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.11 -39.52 89.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.197 0.523 . . . . 0.75 110.375 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -91.57 16.93 9.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.682 -0.69 . . . . 0.82 110.603 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.1 -38.03 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 0.35 110.132 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 81.42 6.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.144 -0.48 . . . . 0.93 110.708 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 34' ' ' TYR . 39.2 mt-30 -61.66 -71.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.26 110.473 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -85.71 86.53 7.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.078 0.466 . . . . 0.41 109.987 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.72 66.6 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 1.4 110.381 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.0 m -154.76 131.42 10.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.21 -0.905 . . . . 0.39 108.782 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.9 p -103.49 136.08 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.283 0.564 . . . . 0.3 110.977 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -106.45 135.59 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.951 -0.568 . . . . 0.42 110.006 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 17.9 t -89.79 -30.88 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.464 0.65 . . . . 0.18 110.207 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -151.66 103.42 2.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.716 -0.675 . . . . 0.51 110.313 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.65 -23.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.847 0.356 . . . . 0.16 111.465 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -35.62 44.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.037 0.446 . . . . 0.21 110.856 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -89.11 -40.68 12.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.045 -0.525 . . . . 0.48 110.909 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.17 33.57 2.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.899 -0.667 . . . . 0.17 111.504 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.54 106.5 18.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.55 110.764 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.31 129.52 47.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.736 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.07 112.43 24.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.148 0.499 . . . . 0.22 110.759 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -82.35 -176.06 6.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.885 -0.598 . . . . 0.89 109.614 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -60.33 -34.34 73.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.597 0.221 . . . . 1.12 111.597 -178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.9 pm0 -72.86 -13.47 61.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.98 111.447 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.47 -48.52 5.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.839 -0.344 . . . . 0.44 110.574 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.58 -31.27 71.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.695 0.283 . . . . 0.27 111.081 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -23.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.27 0.557 . . . . 0.17 110.314 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 m -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.565 . . . . 0.27 110.535 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.82 -50.27 17.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.32 111.287 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CG ' HG13 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -90.78 -49.56 6.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.379 . . . . 0.55 110.47 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.42 6.03 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.262 -0.735 . . . . 0.28 111.262 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.35 143.36 27.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.279 -0.461 . . . . 0.98 110.407 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.75 -5.19 48.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 0.85 110.846 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -91.55 123.99 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.8 -0.444 . . . . 1.12 109.8 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.87 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.51 112.019 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -73.21 -32.61 64.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.38 . . . . 0.28 110.958 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -67.56 -36.93 81.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.221 -0.445 . . . . 0.24 111.125 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 77' ' ' PHE . 1.9 mp -66.57 -49.28 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.65 110.209 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.1 m -66.11 -26.07 67.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.19 111.523 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -57.14 -44.91 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.57 111.033 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.62 -40.83 61.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.417 -0.356 . . . . 0.39 110.98 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.497 HG22 HG22 ' A' ' 20' ' ' VAL . 63.3 mt -61.01 -36.55 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.883 0.373 . . . . 0.12 111.728 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -27.14 62.27 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.777 0.658 . . . . 0.11 112.777 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -105.8 -26.71 11.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.325 0.861 . . . . 0.19 113.325 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 91' ' ' THR . 31.3 mmmt -108.06 3.17 23.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.864 0.364 . . . . 0.45 111.113 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.04 178.42 16.49 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.737 -0.744 . . . . 0.24 111.873 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.402 ' CD ' HH12 ' A' ' 21' ' ' ARG . 0.7 OUTLIER -95.54 122.52 38.37 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.958 -0.386 . . . . 0.24 109.958 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 HG13 ' A' ' 97' ' ' VAL . 3.3 p -119.18 137.21 53.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.022 -0.535 . . . . 0.22 109.973 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -77.23 84.0 3.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.084 0.468 . . . . 0.36 111.151 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m -135.04 175.66 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.26 110.473 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -124.78 84.36 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.33 110.754 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.4 142.1 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.604 -0.271 . . . . 0.38 111.036 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.35 111.9 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.438 -0.347 . . . . 0.43 110.338 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.05 132.36 20.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.98 110.642 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -138.65 127.48 23.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 2.51 110.007 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -125.67 114.92 19.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.54 0.21 . . . . 0.93 110.503 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 t -102.29 106.05 16.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.356 0.598 . . . . 1.23 111.111 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' HG2' ' HG3' ' A' ' 107' ' ' GLU . 1.6 tt0 -175.27 141.66 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 1.6 109.582 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 mp -99.61 -77.82 0.52 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.361 -0.237 . . . . 0.95 110.361 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 105' ' ' GLN . 10.7 mt-10 52.89 30.66 9.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.003 0.521 . . . . 1.81 112.24 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 60.92 28.08 17.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.35 -0.386 . . . . 0.86 111.408 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.8 ttm -60.73 -19.7 59.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.772 0.32 . . . . 1.64 111.295 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -58.63 -41.22 85.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.74 110.153 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.2 ttt85 -80.48 -28.9 37.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.86 110.022 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.91 -53.88 53.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.27 110.103 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.1 mt -67.52 -35.06 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.932 -0.576 . . . . 0.22 110.102 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -60.68 -35.96 77.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.637 -0.71 . . . . 0.19 111.474 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -64.22 -31.31 72.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 1.46 111.17 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -78.96 -50.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.233 -0.44 . . . . 0.34 111.319 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 114' ' ' ALA . 8.0 p -65.87 -26.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.085 0.402 . . . . 0.31 112.085 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 122' ' ' VAL . . . -58.78 -37.51 76.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.694 0.257 . . . . 0.44 111.694 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.05 -34.63 15.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.892 0.377 . . . . 1.64 110.937 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -64.08 -37.62 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.29 111.352 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 88.0 m -139.28 94.92 2.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.334 0.588 . . . . 0.74 110.693 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 118' ' ' ALA . 22.2 m -92.88 164.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.602 -0.726 . . . . 1.1 111.396 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -155.96 132.41 6.01 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.661 -0.699 . . . . 0.89 109.877 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -90.42 27.33 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.01 2.473 . . . . 1.33 112.084 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -100.86 16.04 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 1.47 110.745 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -138.14 -65.56 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.115 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.519 ' H ' HG23 ' A' ' 126' ' ' THR . 12.7 tptm -148.76 -77.64 0.15 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.761 -0.375 . . . . 0.96 111.47 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -158.19 152.19 19.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.523 0.201 . . . . 1.4 111.103 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.74 42.46 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.075 2.517 . . . . 0.84 113.126 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -148.26 30.18 0.86 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.007 0.432 . . . . 1.04 110.234 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.45 ' O ' HD23 ' A' ' 134' ' ' LEU . 20.6 m -151.59 117.82 5.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.634 -0.257 . . . . 0.33 111.624 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.01 -27.91 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.138 0.494 . . . . 0.27 111.174 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.3 mm -56.47 -25.74 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.17 111.613 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -62.59 -42.56 99.64 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.759 0.314 . . . . 0.34 110.524 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.428 ' N ' ' HG ' ' A' ' 134' ' ' LEU . 6.4 tp -83.76 -29.03 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 120.759 0.314 . . . . 1.73 110.771 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.55 -34.4 77.0 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.074 -0.713 . . . . 0.93 109.074 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.15 -44.79 92.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.339 -0.846 . . . . 0.79 109.937 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.77 73.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.884 -0.598 . . . . 0.16 110.863 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -58.96 -47.12 86.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.713 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -4.41 51.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.17 -0.468 . . . . 0.65 111.032 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -34.55 23.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.63 109.556 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.441 ' CG1' ' HG3' ' A' ' 166' ' ' LYS . 6.3 mt -93.75 -53.26 8.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.441 -0.8 . . . . 0.22 110.507 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t60 51.34 47.53 24.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.435 -0.802 . . . . 1.03 110.368 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.85 119.47 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.604 -0.726 . . . . 0.56 110.322 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 97.47 11.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.001 -0.545 . . . . 1.57 111.295 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.78 -169.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.76 -0.654 . . . . 1.52 109.708 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 66.6 mmtt -78.4 89.37 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.621 -0.511 . . . . 1.21 109.621 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -41.85 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.67 112.845 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.16 -12.84 62.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 2.43 111.968 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' GLN . 95.0 mttt -121.36 9.82 10.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.99 111.215 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -87.51 3.78 46.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.89 110.715 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -37.93 87.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.35 111.525 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -155.79 -26.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.915 0.339 . . . . 0.19 111.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 150' ' ' LYS . 43.3 tt0 -68.43 -60.46 2.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.69 110.778 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 159' ' ' VAL . 0.7 OUTLIER -94.33 14.29 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 1.81 111.155 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.07 111.548 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.75 -21.55 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.353 -0.385 . . . . 0.5 111.075 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.55 -39.14 20.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.311 -0.404 . . . . 1.04 110.451 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 155' ' ' GLN . 61.8 t -62.81 -49.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.083 -0.508 . . . . 0.14 111.083 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.7 tp -64.78 -33.56 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.16 110.536 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 1.6 mmmt -69.25 -43.01 74.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.355 -0.384 . . . . 1.48 110.174 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -61.26 -36.06 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.42 110.474 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.6 tp -69.06 -40.4 78.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.906 -0.588 . . . . 0.16 110.558 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -70.93 -11.11 60.78 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.881 -0.599 . . . . 1.02 111.177 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 36.3 mm-40 -73.48 -27.92 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.049 0.452 . . . . 0.98 110.074 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HG3' ' CG1' ' A' ' 142' ' ' ILE . 16.2 mmtt -93.14 -39.01 11.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.16 111.323 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 52.9 mtt -130.32 136.64 49.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.974 0.416 . . . . 0.35 110.896 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -79.77 81.61 6.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 1.61 110.421 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.4 pt -100.21 124.82 53.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.64 111.691 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -177.72 130.76 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.523 -0.762 . . . . 1.16 109.172 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.89 92.39 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.435 . . . . 1.87 112.13 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.11 137.79 38.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.916 -0.772 . . . . 0.43 108.916 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -142.13 139.42 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.726 0.298 . . . . 1.01 111.234 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 89.1 mtp -111.28 178.73 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.305 -0.407 . . . . 1.34 110.266 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 213' ' ' LEU . 90.3 mtt180 -115.88 143.62 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 1.01 110.994 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.51 172.15 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.144 -0.48 . . . . 0.26 110.522 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.685 ' HB3' HG22 ' A' ' 211' ' ' VAL . 8.6 ptm180 -141.35 140.17 33.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 1.58 110.388 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.663 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 9.1 p90 -94.72 150.21 20.45 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.531 -0.468 . . . . 0.27 110.077 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.401 ' C ' HD13 ' A' ' 180' ' ' LEU . 8.4 tt -129.84 118.54 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.246 0.545 . . . . 0.46 111.214 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 179' ' ' ILE . 0.0 OUTLIER -152.22 156.87 34.02 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.746 -0.661 . . . . 0.29 110.245 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.22 173.09 10.04 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.397 2.064 . . . . 0.18 112.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.42 -42.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.298 0.481 . . . . 0.44 112.298 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.17 -38.71 87.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.751 0.31 . . . . 0.38 111.571 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.18 -34.81 28.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.043 0.449 . . . . 1.45 110.542 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.15 -29.75 71.97 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.13 112.569 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -65.97 -13.47 59.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.3 . . . . 0.69 111.513 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.92 -18.52 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.706 0.289 . . . . 0.92 110.89 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 178' ' ' PHE . 0.5 OUTLIER -122.98 -17.85 6.6 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.788 0.292 . . . . 1.05 111.788 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 85.4 tttt -55.57 -52.3 64.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 0.93 110.872 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -98.74 27.58 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.18 111.744 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -137.77 -40.95 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.857 0.317 . . . . 1.46 111.857 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 1.6 tm? -90.97 -40.94 11.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.845 0.355 . . . . 0.94 110.6 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpp -60.29 -48.37 94.2 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.566 . . . . 0.7 112.527 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.1 Cg_endo -58.53 -12.82 15.05 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.529 2.153 . . . . 0.16 113.464 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 192' ' ' LEU . 12.6 mt -76.93 -9.84 58.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.006 -0.368 . . . . 0.45 110.006 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.7 mt 59.3 31.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.517 -0.765 . . . . 0.38 111.14 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -113.51 30.44 7.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.105 -0.498 . . . . 0.56 109.793 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.16 155.43 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.555 -0.748 . . . . 0.38 111.072 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 1.4 mp -103.41 147.76 9.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.434 -0.803 . . . . 0.21 109.453 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -70.39 67.46 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.146 0.498 . . . . 1.15 111.781 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.1 m -156.33 33.4 0.33 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.42 -0.585 . . . . 0.25 109.42 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.1 OUTLIER -90.9 160.96 15.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.4 -0.818 . . . . 1.04 110.77 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.41 141.47 52.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.229 -0.656 . . . . 0.38 109.229 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -116.11 31.42 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.389 . . . . 0.65 110.933 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.81 -125.11 2.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.713 -0.755 . . . . 0.45 112.536 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.89 -31.61 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.195 0.521 . . . . 1.97 109.893 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -110.43 111.81 23.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.664 -0.865 . . . . 0.3 108.664 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.13 73.91 4.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.022 0.439 . . . . 0.49 111.121 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 42.5 mt-10 -83.47 111.6 19.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 1.23 110.523 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.663 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 22.5 mt -125.3 142.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.042 -0.526 . . . . 0.37 110.908 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 177' ' ' ARG . 94.0 t -98.39 123.9 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.855 -0.794 . . . . 0.22 108.855 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.401 ' HG ' ' HE2' ' A' ' 178' ' ' PHE . 13.2 p -137.1 52.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.54 112.0 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 175' ' ' ARG . 4.1 mm? -122.25 114.74 21.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.19 -0.3 . . . . 0.56 110.19 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 215' ' ' ASP . 0.6 OUTLIER -104.99 -151.83 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.381 -0.372 . . . . 0.72 110.339 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 214' ' ' ILE . 2.8 m-20 -80.5 164.27 52.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 1.24 110.624 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.75 -178.04 2.51 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.16 1.907 . . . . 0.35 112.176 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.2 -79.99 1.43 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.517 -0.849 . . . . 0.24 111.567 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -16.73 64.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.084 0.469 . . . . 0.4 110.878 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 1.3 p90 -62.41 -20.61 64.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.15 110.932 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 220' ' ' ARG . 6.3 tpt180 -65.43 -21.98 66.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.18 0.514 . . . . 0.23 110.303 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -76.29 -33.15 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.546 -0.752 . . . . 1.46 110.878 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 9.3 tt -95.15 -26.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 1.06 110.836 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -34.95 71.55 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.061 -0.518 . . . . 0.19 111.527 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -29.37 70.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.74 111.834 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -97.9 -30.89 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.518 -0.473 . . . . 0.44 111.825 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 222' ' ' ILE . 19.8 mm -57.33 -40.42 73.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 0.21 111.152 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.0 ptpp? -69.23 -8.39 45.42 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.28 0.845 . . . . 0.91 113.28 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -124.7 -31.1 3.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.563 -0.455 . . . . 0.26 111.842 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -54.21 7.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.296 0.48 . . . . 1.1 112.296 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.0 t -108.02 -42.86 4.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.733 0.642 . . . . 0.13 112.733 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 79.4 tttt -61.42 -34.69 75.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 1.98 111.234 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.12 10.41 73.66 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.473 -0.87 . . . . 0.62 112.684 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -140.69 20.32 2.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.099 0.476 . . . . 1.53 111.141 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 173.67 -145.71 8.4 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.582 -0.818 . . . . 0.37 112.357 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.4 m -138.62 147.31 42.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.374 -0.232 . . . . 0.43 110.374 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 1.1 pt? -121.5 135.45 55.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.849 0.357 . . . . 0.43 110.333 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -129.1 173.28 10.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.977 -0.556 . . . . 1.15 110.422 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -79.4 164.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.56 -0.291 . . . . 0.12 110.696 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 175' ' ' ARG . 1.2 pt? -88.75 14.17 10.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 1.31 110.179 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -82.47 69.4 9.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.555 -0.748 . . . . 0.57 110.284 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.421 ' HB3' ' OE1' ' A' ' 246' ' ' GLU . 34.3 tp -115.75 -78.79 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.63 -0.714 . . . . 0.65 110.327 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 51.16 36.56 16.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.041 0.537 . . . . 2.81 111.564 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.38 -9.1 13.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.474 0.654 . . . . 1.43 110.376 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.2 p -157.88 174.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.544 -0.91 . . . . 0.46 108.544 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 244' ' ' VAL . 1.5 mp0 -55.96 98.63 0.03 OUTLIER 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.267 0.556 . . . . 2.53 111.173 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.421 ' OE1' ' HB3' ' A' ' 241' ' ' LEU . 3.0 tt0 -88.76 75.84 8.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.484 -0.78 . . . . 1.91 111.132 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 128.69 126.76 2.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.388 -0.91 . . . . 0.69 112.721 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 250' ' ' LYS . 37.3 t0 -139.66 99.9 3.83 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -96.41 17.75 15.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 1.78 111.336 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 248' ' ' ASP . 0.9 OUTLIER -82.27 81.1 8.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.317 0.58 . . . . 1.2 110.209 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -74.34 -25.95 59.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 1.23 109.64 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.189 -0.914 . . . . 1.53 109.939 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.964 0 N-CA-C 112.311 -0.316 . . . . 0.65 112.311 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -85.37 160.03 19.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 1.35 111.148 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -116.31 154.5 30.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.139 -0.482 . . . . 0.5 110.042 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -130.42 170.44 14.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.332 . . . . 0.73 110.851 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mt -76.17 -59.64 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.846 -0.427 . . . . 0.7 109.846 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -83.56 159.57 21.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.676 -0.693 . . . . 1.36 110.171 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -140.78 89.63 10.03 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.881 0.372 . . . . 0.37 110.452 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.86 155.38 34.45 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.059 2.506 . . . . 0.47 112.575 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.28 123.29 49.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.863 -0.608 . . . . 0.61 110.651 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.759 -0.459 . . . . 0.75 109.759 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -71.73 -40.34 69.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 0.73 109.464 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -129.4 98.65 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.674 -0.861 . . . . 0.95 108.674 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -144.97 135.77 24.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.408 -0.36 . . . . 1.78 110.868 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 17' ' ' VAL . 98.5 mt -66.16 -16.61 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.492 . . . . 1.34 112.02 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -89.65 -2.97 58.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.756 0.313 . . . . 0.62 111.382 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -114.75 14.61 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.58 110.544 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' LEU . 23.2 m -86.93 151.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.008 -0.542 . . . . 0.28 111.39 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.72 53.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.653 -0.703 . . . . 0.25 109.626 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -75.59 117.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.959 0.409 . . . . 0.59 111.139 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 89' ' ' ILE . 1.5 p -138.59 125.43 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.932 -0.576 . . . . 0.18 110.291 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 143.38 50.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.042 0.448 . . . . 2.38 111.598 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.402 ' HB2' HG23 ' A' ' 89' ' ' ILE . 11.3 ttt -109.15 129.12 55.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.607 -0.724 . . . . 0.24 110.047 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -100.09 116.62 32.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.662 0.267 . . . . 1.04 110.746 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -112.0 41.18 2.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 2.46 110.165 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 63.35 90.42 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.522 -0.763 . . . . 0.6 111.061 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.52 -48.29 3.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 0.29 112.017 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -98.63 108.56 21.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.052 0.453 . . . . 1.32 110.659 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.39 143.95 48.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.06 -0.518 . . . . 1.89 109.979 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.546 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 97.0 m-85 -132.59 150.01 52.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.55 110.441 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -138.87 154.06 48.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.662 0.268 . . . . 1.26 110.594 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.431 HD12 HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -137.55 169.66 18.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.892 -0.594 . . . . 0.51 110.153 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.46 21.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.369 . . . . 0.21 111.384 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -121.54 165.61 15.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.917 -0.583 . . . . 0.5 110.333 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -75.0 129.7 38.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.067 0.46 . . . . 0.31 111.373 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 37' ' ' LYS . 67.8 tttt -67.85 147.51 52.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.636 -0.711 . . . . 1.17 111.057 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.14 -21.47 0.25 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.86 0.864 . . . . 0.7 111.816 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 35' ' ' LYS . 28.7 mmtm -94.91 -45.08 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.051 0.453 . . . . 0.62 110.467 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 p -68.67 -18.27 22.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.955 -0.566 . . . . 0.33 111.864 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 97' ' ' VAL . 7.6 p -67.71 -16.37 20.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.171 0.51 . . . . 0.41 110.641 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.19 -35.17 90.46 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.762 -0.654 . . . . 0.13 112.701 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -65.71 -17.47 64.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.975 0.417 . . . . 0.37 111.53 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 91' ' ' THR . 10.0 mmp_? -108.42 4.86 24.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.524 -0.307 . . . . 0.37 110.751 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -131.21 13.35 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.333 . . . . 0.86 111.548 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.89 36.48 86.72 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.66 112.763 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.55 61.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.951 0.405 . . . . 0.37 110.148 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -68.98 156.48 38.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.122 -0.49 . . . . 1.79 110.72 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -155.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.21 -0.45 . . . . 0.48 109.953 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -52.29 117.88 3.14 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.469 0.481 . . . . 1.28 110.19 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.26 -4.03 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.603 0.594 . . . . 0.58 112.603 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -101.94 -35.47 8.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.074 0.464 . . . . 1.56 109.838 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.65 -36.45 73.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 1.83 109.734 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.06 -24.25 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.17 110.779 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.33 87.14 6.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 0.12 110.008 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -64.11 -53.53 48.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.2 111.286 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -128.53 107.44 9.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.142 -0.481 . . . . 1.43 110.895 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.8 71.1 5.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.512 0.673 . . . . 0.79 110.277 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.4 m -153.15 130.66 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.303 -0.862 . . . . 0.33 109.329 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 29' ' ' PHE . 7.2 p -107.25 140.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.107 0.48 . . . . 0.25 110.606 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 149.94 24.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.482 . . . . 0.41 111.568 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.4 t -112.76 -40.43 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.66 -0.7 . . . . 0.54 109.584 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -154.55 116.41 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 1.2 109.038 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -79.36 -25.18 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.949 0.352 . . . . 0.55 111.949 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -49.41 77.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.58 111.515 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -101.36 10.89 40.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.85 111.251 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.02 56.45 25.12 Favored Glycine 0 C--O 1.229 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.37 112.931 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -102.34 114.46 28.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.668 0.271 . . . . 0.65 110.328 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.9 t -112.43 131.66 63.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.28 109.676 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -84.71 120.3 26.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.977 0.417 . . . . 0.19 111.384 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 3.1 tppt? -78.27 171.82 14.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.851 -0.796 . . . . 2.02 108.851 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 19.2 pttp -59.9 -18.29 43.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 1.66 111.284 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -87.1 -7.24 58.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.406 . . . . 0.52 111.644 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -114.87 -44.44 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 1.95 111.563 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 69' ' ' LYS . 2.7 pp -61.83 -23.22 66.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.879 0.371 . . . . 0.27 110.96 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 73' ' ' LEU . 16.6 tt -66.92 -35.99 76.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.363 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -8.86 51.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.093 0.473 . . . . 0.41 111.152 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.67 -14.77 19.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.218 -0.446 . . . . 0.34 111.044 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -121.32 -43.41 2.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.48 111.008 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.61 -14.25 7.68 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.632 -0.587 . . . . 0.08 111.632 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 81' ' ' ASP . 6.0 m -151.48 150.71 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.407 -0.59 . . . . 0.19 109.407 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.38 -4.77 59.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.683 0.277 . . . . 0.22 111.148 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 79' ' ' THR . 15.1 t70 -59.48 109.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.495 . . . . 1.15 110.469 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.03 -38.96 93.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 1.26 111.532 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -43.77 98.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.71 111.793 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -62.3 -45.69 92.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.622 0.248 . . . . 0.83 111.536 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -64.18 -48.17 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.26 109.982 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 43.2 t -61.95 -42.65 99.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.32 110.471 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -56.75 -47.23 80.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.98 111.214 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -46.6 88.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.812 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG22 HG22 ' A' ' 20' ' ' VAL . 90.4 mt -65.12 -32.79 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.961 -0.563 . . . . 0.29 110.512 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -81.46 -4.51 56.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.23 111.428 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.591 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 88.3 m -105.35 -46.98 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.082 -0.247 . . . . 0.37 111.374 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' THR . 7.8 mmmm -122.53 40.06 3.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.137 0.494 . . . . 2.72 110.817 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.75 21.66 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.664 -0.698 . . . . 0.15 111.521 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.77 94.09 8.09 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.921 -0.4 . . . . 2.32 109.921 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 HG13 ' A' ' 97' ' ' VAL . 3.5 p -102.69 143.26 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.3 111.308 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.04 89.18 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.867 -0.606 . . . . 1.02 110.911 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.647 HG12 HG23 ' A' ' 39' ' ' VAL . 10.5 m -98.26 139.73 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.095 -0.502 . . . . 0.39 110.759 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.8 -58.82 2.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 0.08 110.345 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.82 164.37 23.19 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.441 -0.577 . . . . 0.36 109.441 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.65 ' HA ' ' NZ ' ' A' ' 100' ' ' LYS . 2.0 tpmp? -139.71 49.38 1.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.434 . . . . 0.28 111.486 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 9.0 tp10 -102.16 118.25 36.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.126 -0.488 . . . . 2.77 110.057 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -175.27 149.37 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 1.53 109.717 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -138.57 134.07 33.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.48 110.681 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 m -147.73 124.1 10.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.916 -0.584 . . . . 0.52 110.263 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -124.96 116.42 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.012 0.434 . . . . 1.5 110.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.8 tp -130.57 151.95 50.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.99 -0.55 . . . . 0.43 109.717 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.85 138.05 44.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.91 110.801 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 60.18 21.75 11.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.921 -0.581 . . . . 2.01 111.444 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -31.5 71.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.51 111.006 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -68.51 -30.28 69.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 0.96 110.627 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.4 110.262 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.29 -35.56 73.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.76 110.897 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.441 HD12 HD12 ' A' ' 116' ' ' ILE . 7.4 tp -94.25 -22.96 5.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.959 -0.564 . . . . 0.16 110.62 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -63.39 -34.35 77.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.28 111.609 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -65.1 -14.51 60.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 1.51 111.468 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.441 HD12 HD12 ' A' ' 113' ' ' ILE . 48.3 mt -94.11 -45.0 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.34 110.513 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 114' ' ' ALA . 14.9 p -70.77 -30.48 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.368 -0.378 . . . . 0.47 111.543 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.49 -12.51 60.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.997 0.427 . . . . 0.6 111.151 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -102.94 -42.02 5.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.69 -0.686 . . . . 1.02 109.858 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 0.3 OUTLIER -69.4 -26.1 64.47 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.442 -0.799 . . . . 2.11 111.489 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.554 ' SG ' ' HG2' ' A' ' 171' ' ' ARG . 2.0 m -122.95 148.53 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.5 -0.318 . . . . 0.45 110.364 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 216' ' ' PRO . 3.2 m -120.01 148.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.082 0.467 . . . . 0.2 111.41 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 124' ' ' PRO . 0.8 OUTLIER -83.56 156.77 65.17 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.356 -0.838 . . . . 0.7 109.776 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.443 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 62.6 Cg_endo -73.26 -157.07 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.526 2.151 . . . . 0.24 112.333 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 5.0 pt-20 -71.14 80.13 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.464 0.65 . . . . 1.86 111.191 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 t -163.47 -38.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.68 -0.691 . . . . 0.22 110.589 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.72 152.88 30.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.05 -0.352 . . . . 1.05 110.05 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.34 152.59 43.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.464 -0.334 . . . . 1.02 110.127 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.24 108.55 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.565 2.177 . . . . 0.95 112.315 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -127.22 -61.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.803 -0.635 . . . . 1.21 110.404 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.7 p -123.96 176.72 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.42 110.366 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.4 t -63.58 -21.32 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.331 0.586 . . . . 0.49 110.719 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.9 mm -57.89 -25.88 26.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.464 -0.789 . . . . 0.61 111.676 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.0 tp -51.97 -41.81 62.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.373 -0.376 . . . . 0.69 111.568 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -99.98 -28.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.452 -0.34 . . . . 0.33 110.822 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -63.6 -41.26 98.33 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.844 0.354 . . . . 1.02 110.365 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -63.61 -23.81 67.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.854 -0.612 . . . . 0.73 111.103 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.24 -38.53 13.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.27 110.402 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 53.9 tpp -65.67 -47.92 73.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.545 . . . . 2.04 110.992 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -77.1 -8.23 57.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.37 111.147 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 137' ' ' ARG . 22.3 t0 -76.26 -56.13 4.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.61 110.085 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.0 tt -73.99 -42.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.524 . . . . 0.34 109.808 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 46.09 58.43 4.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.666 -0.697 . . . . 1.37 111.923 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -124.1 143.04 50.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.52 110.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 m -129.67 158.98 37.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.176 -0.676 . . . . 0.33 109.176 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.8 t -76.67 -55.12 11.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.776 0.322 . . . . 0.43 110.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 149' ' ' ASN . 0.5 OUTLIER -159.35 135.04 8.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.98 110.27 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -8.16 55.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.985 0.421 . . . . 0.18 111.346 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 147' ' ' LYS . 9.7 m120 -85.14 -2.17 57.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.201 0.524 . . . . 0.52 110.343 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -114.35 145.7 41.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.599 -0.728 . . . . 0.44 109.229 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 86.5 p -76.0 169.45 18.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.934 0.397 . . . . 0.24 110.716 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -36.07 74.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.81 111.536 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -82.65 -11.94 58.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 1.35 111.451 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.01 -11.44 44.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.382 -0.372 . . . . 1.1 111.767 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 151' ' ' SER . 19.0 pt20 -137.88 13.89 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.298 . . . . 0.38 110.763 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.42 68.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.14 111.475 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.72 -23.56 64.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.62 111.054 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -99.19 -42.65 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.425 -0.352 . . . . 1.77 111.011 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 155' ' ' GLN . 89.1 t -57.5 -36.03 52.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.21 111.352 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 12.6 tt -73.79 -10.23 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.173 0.511 . . . . 0.86 110.749 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -109.06 -9.2 15.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 1.26 109.964 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -53.69 38.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.12 110.542 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -71.02 -16.61 62.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.48 -0.327 . . . . 0.17 110.63 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -23.35 65.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.013 -0.539 . . . . 0.3 109.846 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -76.46 -29.14 56.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.345 -0.613 . . . . 0.38 109.345 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.59 -54.29 5.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.237 -0.892 . . . . 0.91 109.446 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.3 mmt -125.36 109.13 12.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.83 109.349 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -77.19 108.67 10.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.093 0.473 . . . . 0.94 111.213 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -101.22 153.64 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.769 -0.651 . . . . 0.28 110.334 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.68 154.09 20.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 3.28 110.67 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HG2' ' SG ' ' A' ' 121' ' ' CYS . 11.5 mtm180 -135.24 -7.68 2.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.729 -0.669 . . . . 2.23 111.233 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.33 140.93 58.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.916 0.339 . . . . 0.36 111.916 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 216' ' ' PRO . 2.7 t-80 -148.19 120.67 8.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.079 -0.509 . . . . 0.25 110.57 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 22.5 mmt -111.86 -174.94 2.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.65 110.667 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -117.33 130.66 56.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.566 0.222 . . . . 1.1 110.525 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.16 153.82 39.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.45 -0.341 . . . . 0.43 111.311 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 237' ' ' GLU . 5.7 ptm180 -119.63 169.83 9.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.723 -0.671 . . . . 1.14 109.305 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.419 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 2.9 p90 -138.69 138.26 37.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.963 0.411 . . . . 0.74 110.792 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.31 118.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 0.22 109.718 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.938 HD12 ' HD2' ' A' ' 181' ' ' PRO . 43.6 tp -156.4 126.57 3.34 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.685 -0.234 . . . . 0.26 110.59 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.938 ' HD2' HD12 ' A' ' 180' ' ' LEU . 14.9 Cg_endo -58.48 156.36 31.7 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.963 2.442 . . . . 0.28 112.549 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.43 -40.24 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.817 0.673 . . . . 0.17 112.817 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.46 -42.98 61.96 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.386 0.513 . . . . 0.5 112.386 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HB3' HD21 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -99.08 -26.6 14.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.267 -0.424 . . . . 0.41 110.986 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.08 -29.68 71.64 Favored Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.104 -0.498 . . . . 0.28 113.113 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 74.4 tttt -62.13 -23.13 66.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.775 0.288 . . . . 0.53 111.366 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -68.55 -36.72 79.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.881 0.372 . . . . 0.35 110.658 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 2.0 pp -89.87 -27.05 20.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.949 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -54.83 -52.51 62.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 1.01 111.791 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 190' ' ' GLU . 5.4 pt-20 -86.46 24.54 1.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.147 0.425 . . . . 1.76 112.147 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.39 -41.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.807 -0.357 . . . . 0.71 111.593 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 226' ' ' ILE . 31.6 mt -85.98 -47.56 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.974 0.361 . . . . 0.41 111.974 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 22.7 mtpp -59.89 -51.78 78.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.648 0.61 . . . . 0.53 112.648 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.6 Cg_endo -61.59 -20.06 67.27 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.383 2.055 . . . . 0.41 113.24 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.5 8.01 33.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.543 0.211 . . . . 0.56 110.742 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.8 pt 35.97 60.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.255 1.022 . . . . 0.41 113.67 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -136.51 26.62 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.634 0.731 . . . . 0.96 109.65 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.77 151.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 114.844 -1.071 . . . . 0.24 109.831 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.452 HD13 HG12 ' A' ' 211' ' ' VAL . 3.5 mp -93.37 149.03 4.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.115 -0.493 . . . . 0.16 110.573 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 67.88 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.314 0.578 . . . . 1.8 111.562 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 247' ' ' GLY . 18.9 m -149.66 38.75 0.77 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.302 -0.629 . . . . 0.56 109.302 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 210' ' ' ILE . 18.9 mt-10 -86.92 172.34 10.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.104 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.5 118.62 4.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.784 -0.821 . . . . 0.99 108.784 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.22 114.9 28.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.661 0.267 . . . . 1.1 110.925 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -163.05 -104.67 0.19 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.884 -0.674 . . . . 0.36 111.541 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -16.37 32.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.539 0.685 . . . . 1.91 109.367 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.47 HE21 ' HB2' ' A' ' 209' ' ' GLU . 2.8 pm0 -142.22 172.68 12.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.109 -0.95 . . . . 1.11 108.749 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.28 84.4 2.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.682 -0.488 . . . . 0.19 109.682 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB2' HE21 ' A' ' 207' ' ' GLN . 2.9 tp10 -85.99 112.82 21.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.622 -0.717 . . . . 0.93 109.758 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 202' ' ' GLU . 51.0 mt -132.16 146.02 33.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.614 0.245 . . . . 0.39 110.574 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 199' ' ' ILE . 59.0 t -100.03 113.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.691 -0.485 . . . . 0.43 109.691 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 20.3 t -132.73 97.64 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.19 110.699 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.9 106.25 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 0.37 109.875 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 215' ' ' ASP . 8.1 tp -90.72 168.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.367 -0.379 . . . . 0.55 110.685 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.418 ' H ' HG13 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -68.03 164.4 41.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.443 -0.344 . . . . 1.18 110.449 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.432 ' HB3' HG13 ' A' ' 122' ' ' VAL . 78.7 Cg_exo -50.58 170.73 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.996 2.464 . . . . 0.33 113.392 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 92.24 -87.28 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.773 -0.931 . . . . 0.38 110.773 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.71 -1.92 27.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 1.09 110.861 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.408 ' CE1' HG11 ' A' ' 122' ' ' VAL . 3.5 p90 -58.48 -33.46 69.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.542 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -81.15 -16.76 52.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.133 0.492 . . . . 1.0 110.78 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.5 -44.33 24.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.72 109.521 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 226' ' ' ILE . 11.6 tt -78.07 -38.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.672 -0.695 . . . . 0.3 110.3 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 0.6 OUTLIER -60.49 -28.71 68.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.997 0.427 . . . . 0.31 110.413 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.593 ' O ' ' HE2' ' A' ' 228' ' ' LYS . 14.5 tp10 -51.02 -46.12 61.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.283 -0.871 . . . . 1.95 111.008 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -90.7 -29.28 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.395 -0.366 . . . . 0.17 111.277 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 222' ' ' ILE . 32.2 mm -58.23 -38.89 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.915 0.339 . . . . 0.24 111.915 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 8.9 ptpt -64.6 -10.15 24.32 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.147 0.795 . . . . 1.08 113.147 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.593 ' HE2' ' O ' ' A' ' 224' ' ' GLU . 5.7 pttt -124.72 -32.78 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.655 -0.418 . . . . 1.25 111.132 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -47.17 73.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 1.43 111.997 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 188' ' ' LEU . 4.0 t -130.11 -41.55 1.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.129 0.418 . . . . 0.16 112.129 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 0.3 OUTLIER -67.3 -21.7 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.951 0.405 . . . . 1.78 110.805 -179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.73 14.41 64.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.889 -0.672 . . . . 0.45 111.978 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -135.51 -45.82 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.599 0.238 . . . . 0.82 110.835 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -109.22 -154.97 16.15 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.799 -0.715 . . . . 0.53 112.225 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -120.94 152.81 38.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.275 -0.269 . . . . 0.16 110.275 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 236' ' ' LEU . 2.0 pt? -95.44 150.0 20.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.99 110.496 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 177' ' ' ARG . 9.6 tp10 -150.24 160.03 43.99 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.341 -0.614 . . . . 0.88 109.341 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.17 140.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.88 0.372 . . . . 0.25 111.013 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.29 103.49 9.26 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -172.03 26.67 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.974 0.361 . . . . 0.28 111.974 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.552 ' HB2' ' CD ' ' A' ' 246' ' ' GLU . 3.4 mm? -68.0 124.84 24.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.071 0.462 . . . . 0.57 110.652 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -100.53 -8.46 23.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.76 111.131 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -72.52 -73.34 0.2 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.696 -0.483 . . . . 0.86 109.696 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.84 156.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.625 -0.716 . . . . 0.52 109.388 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.01 130.2 38.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 2.12 111.158 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.552 ' CD ' ' HB2' ' A' ' 241' ' ' LEU . 33.5 mt-10 -96.3 143.48 27.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.75 -0.659 . . . . 0.69 110.019 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 201' ' ' SER . . . 112.71 102.0 2.56 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.48 -0.867 . . . . 0.3 113.42 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -142.05 114.2 8.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.273 -0.64 . . . . 1.1 109.273 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 28.68 8.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 0.78 111.044 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -97.38 108.53 21.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.094 -0.503 . . . . 0.79 110.428 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -81.33 -22.88 38.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.97 110.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.288 -0.863 . . . . 0.94 110.043 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.549 -0.62 . . . . 0.72 111.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -134.58 84.78 2.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.304 . . . . 0.45 110.27 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 30.6 tpp 60.75 48.61 6.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 0.71 110.959 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.72 91.86 8.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.559 -0.746 . . . . 0.37 109.851 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.5 -50.15 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.001 -0.545 . . . . 0.8 111.006 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -114.25 99.84 7.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.308 -0.406 . . . . 2.93 110.599 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.83 94.11 27.56 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.862 -0.608 . . . . 0.43 110.503 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.52 175.55 3.81 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.223 2.616 . . . . 0.35 112.61 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t -88.46 153.62 21.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.53 . . . . 0.69 109.646 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -172.03 168.73 5.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -91.27 -57.84 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 0.8 109.889 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.1 mt -129.69 105.16 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 0.35 110.024 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -177.71 149.1 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.141 -0.688 . . . . 1.18 109.141 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.45 61.09 0.66 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.124 0.487 . . . . 0.23 112.04 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -42.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 0.35 109.327 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -105.1 37.14 2.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.4 109.941 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.71 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 15.7 m -102.47 155.66 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.16 111.589 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . . . -118.46 125.45 49.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.503 -0.771 . . . . 0.26 109.29 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.27 133.58 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.448 . . . . 0.57 111.676 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 4.1 p -133.78 129.9 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.66 -0.7 . . . . 0.24 109.504 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.22 140.42 52.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 1.86 111.906 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 59.0 ttp -123.26 125.71 45.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.24 109.691 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -100.04 118.8 37.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.656 0.265 . . . . 0.92 110.757 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -113.21 -159.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.77 110.791 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.56 -73.73 0.07 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.152 -0.477 . . . . 0.37 111.684 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.27 29.78 5.62 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.468 -0.872 . . . . 0.15 112.335 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 29' ' ' PHE . 11.3 tppt? -156.03 146.56 21.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.238 -0.282 . . . . 0.46 110.238 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' MET . 12.2 ptt-85 -141.0 93.16 2.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.046 0.45 . . . . 2.38 110.308 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 96.0 m-85 -76.93 152.41 35.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 1.33 111.671 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 15.0 pt-20 -146.86 133.02 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.15 109.583 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -132.11 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.97 0.414 . . . . 0.4 110.957 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -137.18 110.77 8.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 0.14 110.516 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.4 m -106.89 -175.81 2.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.909 -0.587 . . . . 0.59 110.559 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' HA ' HE21 ' A' ' 54' ' ' GLN . 3.0 t80 -66.69 122.77 18.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.006 0.431 . . . . 0.31 110.544 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 32.1 ttpt -60.29 124.83 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.533 -0.758 . . . . 0.51 112.745 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 98' ' ' SER . 46.0 t30 66.28 3.73 2.88 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.832 -1.076 . . . . 0.84 113.414 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 44.2 tptt -107.51 -33.79 7.23 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.673 -0.642 . . . . 1.1 110.242 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.57 -22.05 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.837 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.27 -18.11 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.64 109.86 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.11 93.47 Favored Glycine 0 C--O 1.222 -0.624 0 CA-C-N 115.75 -0.659 . . . . 0.13 112.219 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -65.8 -18.53 65.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.318 0.58 . . . . 0.35 110.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -90.31 -43.32 10.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.997 -0.547 . . . . 0.92 111.817 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.09 -16.72 29.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.533 0.568 . . . . 0.49 112.533 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.42 -107.23 0.2 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.672 -0.775 . . . . 0.66 112.449 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.12 137.71 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.164 -0.31 . . . . 0.94 110.164 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -103.45 -87.33 0.43 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.903 -0.406 . . . . 0.59 109.903 178.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 19.9 ptmt -159.8 -43.95 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.324 -0.235 . . . . 1.32 111.445 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -178.0 126.5 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.238 -0.282 . . . . 0.52 110.238 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 52' ' ' VAL . 48.3 mt -61.6 -29.01 69.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 1.63 112.048 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.21 -35.69 55.42 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.707 -0.397 . . . . 0.92 110.698 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.54 -29.14 41.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 1.22 110.945 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.5 p -72.17 -12.57 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.052 0.453 . . . . 0.27 110.792 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.63 HD21 ' SG ' ' A' ' 86' ' ' CYS . 2.1 mm? -94.19 97.53 10.33 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.566 -0.531 . . . . 0.58 109.566 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 34' ' ' TYR . 73.2 mt-30 -66.03 -39.55 90.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.42 110.83 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 t -117.3 136.63 52.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.798 0.332 . . . . 0.42 110.539 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -100.32 16.06 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 0.69 110.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 m -110.28 112.28 24.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.713 -0.676 . . . . 0.66 110.024 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 31' ' ' ILE . 7.2 p -92.12 139.22 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.2 110.221 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.42 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 11.7 m-85 -100.89 160.71 14.14 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.023 -0.362 . . . . 0.44 110.023 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.94 -61.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.063 0.459 . . . . 0.46 110.834 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.13 92.42 3.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.43 110.41 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -65.68 -24.69 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.174 0.511 . . . . 0.37 110.43 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -29.56 67.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.7 -0.682 . . . . 0.99 111.387 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.12 -34.58 8.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 1.43 110.74 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.88 41.35 2.31 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.261 -0.736 . . . . 0.48 111.261 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -105.19 121.07 43.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.785 0.326 . . . . 1.21 111.179 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.03 141.55 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.37 109.93 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -104.78 104.09 13.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.132 0.491 . . . . 0.23 109.84 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -82.29 -174.9 5.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.27 110.842 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -34.17 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.762 0.652 . . . . 0.91 112.762 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 pm0 -80.84 -4.07 53.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.822 0.344 . . . . 0.92 111.302 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -101.65 -52.23 3.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 0.18 110.502 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.331 . . . . 0.24 111.706 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.02 -22.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.17 110.949 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -103.06 -32.47 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.62 111.46 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.31 -36.63 46.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.31 111.5 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.68 -51.5 2.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 2.09 110.109 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.93 -37.75 2.41 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.48 111.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.35 147.4 26.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.623 0.249 . . . . 1.42 110.38 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -100.3 -7.56 24.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.448 -0.342 . . . . 1.1 111.628 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.18 126.24 38.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.722 0.296 . . . . 1.21 110.719 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.462 HE22 HG21 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -63.3 -27.47 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 0.43 111.815 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -63.58 -39.92 95.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.878 0.371 . . . . 0.58 110.468 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.37 -40.66 85.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.25 110.747 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mm -63.99 -48.19 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.885 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 53' ' ' LEU . 36.8 t -65.12 -29.61 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.725 . . . . 0.2 111.39 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -58.67 -49.53 77.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.397 . . . . 0.34 110.827 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -68.95 -37.42 78.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.798 -0.637 . . . . 1.45 110.551 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 31' ' ' ILE . 97.4 mt -69.22 -31.02 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.497 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.66 -18.86 56.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.976 0.361 . . . . 0.37 111.976 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 t -108.31 -34.78 6.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.652 -0.419 . . . . 0.42 112.066 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -101.51 7.12 42.52 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.917 0.389 . . . . 0.67 110.564 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.22 175.34 17.34 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.523 -0.846 . . . . 0.1 112.778 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -102.14 119.04 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.935 -0.394 . . . . 1.34 109.935 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 p -119.65 146.63 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.704 -0.68 . . . . 0.29 110.252 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.69 101.62 1.07 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.62 110.122 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 m -106.9 163.59 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.989 -0.55 . . . . 0.42 111.358 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' A' ' 115' ' ' THR . 10.6 t -143.23 -68.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.946 -0.57 . . . . 0.23 109.635 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 30.3 t0 -179.07 157.03 0.82 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.533 0.52 . . . . 0.2 109.862 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 8.2 tptp -167.44 171.66 10.28 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 123.321 0.388 . . . . 1.76 110.854 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.1 mp0 -52.32 117.77 3.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.705 -0.68 . . . . 0.62 112.293 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HB3' HD11 ' A' ' 116' ' ' ILE . 5.2 ppt_? -73.97 125.03 27.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.818 -0.628 . . . . 1.11 111.073 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -149.48 -40.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.411 -0.359 . . . . 1.56 111.219 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -151.97 -171.47 3.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.707 -0.224 . . . . 0.53 110.478 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.402 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 1.0 OUTLIER -131.15 148.71 52.75 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.6 -0.519 . . . . 0.65 109.6 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -97.38 -71.31 0.69 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.433 -0.349 . . . . 0.3 111.244 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.74 -62.71 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.835 0.35 . . . . 1.79 110.634 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.06 79.14 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.819 -0.628 . . . . 1.05 110.769 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.3 ptp -62.34 -32.9 73.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.891 0.377 . . . . 0.24 111.267 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.41 -3.22 32.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.148 0.499 . . . . 0.57 110.654 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -135.85 34.1 2.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.984 -0.746 . . . . 0.59 108.984 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.39 -49.41 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.999 -1.001 . . . . 1.32 110.325 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.1 mt -79.67 -23.07 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.485 0.659 . . . . 0.19 110.194 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.03 2.28 9.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.393 -0.821 . . . . 0.34 112.938 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 98' ' ' SER . 68.6 p -85.43 -53.44 5.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.808 0.337 . . . . 0.15 111.055 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 102' ' ' ARG . 16.0 mt -58.38 -42.73 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.876 -0.602 . . . . 0.44 111.604 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.97 -25.68 32.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.081 -0.509 . . . . 0.21 111.081 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.7 81.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.913 0.387 . . . . 0.35 110.792 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.519 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.3 OUTLIER -84.36 -14.43 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.315 0.579 . . . . 0.57 110.139 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 -26.51 21.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.001 -0.545 . . . . 1.51 110.857 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.8 50.45 2.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 0.28 111.644 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.86 154.47 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.412 -0.358 . . . . 0.27 110.389 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -52.67 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.498 -0.319 . . . . 0.35 111.744 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -92.94 163.19 2.65 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.262 1.974 . . . . 0.27 113.065 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.76 -28.7 19.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.67 111.436 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 t -71.3 -16.05 62.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.67 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -161.85 87.44 0.66 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.916 -0.772 . . . . 0.7 108.916 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.459 ' CB ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -56.37 -60.81 8.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.91 -0.586 . . . . 0.73 111.418 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 128' ' ' ARG . 56.8 Cg_endo -90.12 135.4 2.27 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.122 1.881 . . . . 0.42 112.503 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -89.28 162.07 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.967 -0.56 . . . . 0.43 110.242 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.78 140.36 45.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.154 -0.475 . . . . 0.76 109.759 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 t -51.53 -32.24 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.228 -0.442 . . . . 0.12 112.18 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.4 mm -61.2 -32.95 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.559 -0.291 . . . . 0.11 111.72 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.41 -51.11 64.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.51 111.371 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -33.77 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.16 110.914 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -55.07 -48.03 74.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.125 0.488 . . . . 0.44 110.367 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -59.91 -47.01 87.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.264 -0.88 . . . . 1.33 111.202 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.8 -38.3 88.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.12 111.655 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.4 ttp -67.7 -46.26 72.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 0.27 110.594 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -66.31 -32.0 73.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.885 -0.598 . . . . 1.51 110.251 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -55.18 -46.7 75.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.592 -0.731 . . . . 0.34 111.235 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.8 mt -82.95 -53.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.354 -0.384 . . . . 0.54 110.465 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 58.5 49.94 9.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.177 -0.465 . . . . 1.11 110.601 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.28 87.26 6.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.136 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -81.92 121.91 27.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.728 -0.669 . . . . 0.52 110.593 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.6 -76.01 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.416 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.631 -0.507 . . . . 0.63 109.631 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 123.1 15.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.279 0.362 . . . . 0.51 110.671 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.0 p30 43.38 46.35 5.55 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.134 0.896 . . . . 0.16 112.406 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.477 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -59.09 -53.96 52.41 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.108 -0.701 . . . . 0.63 109.108 178.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 155' ' ' GLN . 2.7 p -103.31 179.95 4.12 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.668 -0.697 . . . . 0.22 109.439 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 150.02 49.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.753 0.279 . . . . 0.7 111.753 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.4 tttm 64.11 46.44 3.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.791 -0.641 . . . . 0.28 111.774 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.4 ' HG3' ' NE2' ' A' ' 155' ' ' GLN . 7.8 tp60 59.23 71.39 0.59 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.658 -0.701 . . . . 0.33 111.369 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 151' ' ' SER . 1.9 pm0 44.36 39.26 2.98 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.871 0.868 . . . . 0.07 112.782 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.84 -35.77 75.45 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.11 112.02 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 4.1 mm? -67.2 -27.54 67.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.878 0.371 . . . . 0.26 110.765 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.477 ' OE1' ' HB3' ' A' ' 150' ' ' LYS . 3.5 mp0 -82.42 -44.81 15.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 163' ' ' LEU . 98.9 t -61.79 -43.52 97.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.17 111.238 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.9 tt -66.61 -10.77 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.284 -0.416 . . . . 0.31 112.063 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -115.17 -10.54 12.14 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.173 -0.329 . . . . 1.18 110.883 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -87.18 -36.96 17.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.332 -0.395 . . . . 0.71 111.547 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -74.89 -13.67 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.18 110.91 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.542 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.4 tmmt? -62.83 -25.03 68.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.971 -0.559 . . . . 0.38 110.659 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.34 -24.74 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.005 -0.543 . . . . 0.7 110.666 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -93.48 -48.65 6.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.384 -0.598 . . . . 1.48 109.384 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 19.7 mmt -127.34 104.89 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.098 -0.705 . . . . 1.59 109.098 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -87.96 127.81 35.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.03 0.443 . . . . 1.08 111.232 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -70.15 154.31 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.612 -0.722 . . . . 0.22 110.399 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -145.53 88.5 1.85 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.898 0.38 . . . . 1.1 110.57 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -172.72 114.93 0.28 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.072 -0.513 . . . . 0.69 110.336 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 131.82 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.24 110.922 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -127.11 95.89 4.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.695 0.76 . . . . 1.27 109.94 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.4 ttm -88.08 170.38 11.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.223 -0.899 . . . . 1.75 110.66 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.94 130.92 41.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.263 -0.426 . . . . 1.01 110.73 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 213' ' ' LEU . 16.9 tp -116.91 130.84 56.96 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.53 -0.544 . . . . 1.25 109.53 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -126.28 164.13 21.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.88 0.371 . . . . 0.65 110.236 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 94.5 m-85 -122.51 145.04 48.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.635 -0.505 . . . . 0.35 109.635 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -127.69 114.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.501 0.667 . . . . 0.31 111.526 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.444 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -147.45 158.96 42.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.31 109.626 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.66 173.92 6.12 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.333 2.022 . . . . 0.16 112.417 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' VAL . 3.3 t -54.01 -31.4 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.4 112.009 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -53.54 -59.5 4.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.974 0.416 . . . . 0.28 110.579 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -77.31 -24.43 50.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.74 110.264 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 189' ' ' LYS . . . -59.92 -35.64 87.6 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.865 -0.607 . . . . 0.21 112.239 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -77.73 2.72 16.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.7 0.285 . . . . 0.92 110.914 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 190' ' ' GLU . 69.9 mmtt -104.09 -48.43 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.581 -0.281 . . . . 1.34 111.412 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.417 ' CD2' ' HA2' ' A' ' 185' ' ' GLY . 1.3 pt? -79.44 -26.22 41.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.67 111.549 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 17.5 ttpt -66.38 -26.53 67.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.849 0.357 . . . . 0.65 111.307 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 187' ' ' LYS . 0.4 OUTLIER -95.47 1.36 53.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.457 -0.338 . . . . 0.57 111.465 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.467 ' HD3' ' HG3' ' A' ' 229' ' ' GLU . 27.8 mttp -122.97 -43.07 2.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.362 0.504 . . . . 0.86 112.362 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.16 -44.3 47.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.192 0.442 . . . . 0.25 112.192 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.5 mtpt -58.95 -51.36 82.41 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.841 0.682 . . . . 0.22 112.841 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 24.1 Cg_endo -61.91 -9.1 13.21 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.307 2.005 . . . . 0.19 113.513 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 73.8 mt -81.69 -6.97 59.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.14 110.477 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 11.2 mm 52.36 53.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.695 -0.684 . . . . 0.19 111.036 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -146.62 27.03 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.717 -0.674 . . . . 1.03 110.181 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.68 147.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.993 -0.549 . . . . 0.11 111.073 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 214' ' ' ILE . 4.2 mp -101.41 144.62 12.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.19 109.926 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -68.78 80.55 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.289 0.566 . . . . 2.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.6 t -160.21 17.3 0.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.92 109.376 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.3 mp0 -75.29 134.03 41.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.22 110.547 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -100.71 136.73 40.12 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.837 -0.619 . . . . 0.79 109.673 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 144.24 44.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.712 0.291 . . . . 0.83 110.348 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 152.69 -121.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.719 -0.753 . . . . 0.22 111.58 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -82.01 -24.33 35.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.194 0.521 . . . . 0.45 110.074 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -124.82 158.7 32.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.472 -0.786 . . . . 1.75 109.543 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.68 91.7 3.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.041 -0.355 . . . . 0.4 110.041 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 45.6 mt-10 -94.6 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.301 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.9 mt -119.01 142.38 34.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.715 -0.221 . . . . 0.28 110.863 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.74 134.63 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.963 -0.384 . . . . 0.34 109.963 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 14.6 t -119.55 -32.75 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.744 0.646 . . . . 1.33 112.744 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -74.56 121.56 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.825 0.345 . . . . 0.75 111.477 -178.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.613 ' HB ' HD11 ' A' ' 199' ' ' ILE . 4.0 tt -125.47 -54.63 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.676 . . . . 0.57 111.185 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 219' ' ' PHE . 0.4 OUTLIER -140.09 161.3 56.44 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.877 -0.416 . . . . 0.26 109.877 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 219' ' ' PHE . 97.8 Cg_endo -77.52 -173.37 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.437 2.092 . . . . 0.27 113.117 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 75.01 -88.39 0.77 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.91 -0.586 . . . . 0.39 112.439 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.62 -18.69 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.659 0.384 . . . . 1.21 111.173 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 215' ' ' ASP . 2.3 p90 -63.69 -25.22 68.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.84 110.597 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 220' ' ' ARG . 2.1 tpp180 -76.72 -32.11 57.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.62 110.139 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.46 -43.21 70.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.119 -0.492 . . . . 1.12 110.64 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 6.3 tt -73.71 -23.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.054 0.455 . . . . 0.19 110.789 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.7 -29.58 68.2 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.16 111.486 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.6 -30.32 65.21 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.585 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.4 pp -105.0 -35.32 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.997 -0.281 . . . . 0.29 111.317 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.42 HG12 HG12 ' A' ' 222' ' ' ILE . 24.9 mm -55.23 -36.39 39.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 120.788 0.327 . . . . 0.21 111.721 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -62.38 -17.22 58.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.669 0.618 . . . . 0.72 112.669 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.68 -23.98 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.62 111.07 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.467 ' HG3' ' HD3' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -68.2 -47.54 67.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.196 -0.456 . . . . 1.92 111.713 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 3.4 t -129.98 -32.45 1.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.674 -0.41 . . . . 0.21 111.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 76.8 tttt -66.56 -30.42 70.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.181 0.515 . . . . 0.3 110.132 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -97.7 23.77 34.53 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.73 -0.668 . . . . 0.22 111.696 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -133.9 -36.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.24 110.31 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -142.38 -176.89 16.93 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.848 -0.691 . . . . 0.28 111.753 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.3 t -87.36 159.76 18.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 0.46 110.333 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 153.65 25.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.198 -0.455 . . . . 0.41 110.947 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.16 143.29 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.781 -0.645 . . . . 1.89 109.705 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.09 124.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.523 . . . . 0.28 111.367 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.75 74.07 3.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.299 -0.63 . . . . 0.44 109.299 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -84.03 -2.02 55.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.615 -0.721 . . . . 1.33 112.458 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -43.68 98.34 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.89 110.224 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 52.4 pttt 40.79 34.35 0.26 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.182 0.993 . . . . 0.71 112.881 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -117.25 -68.98 0.88 Allowed 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.406 -0.59 . . . . 0.9 109.406 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.16 128.57 49.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.59 -0.893 . . . . 0.19 108.59 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -129.39 98.29 4.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.064 0.459 . . . . 1.44 111.324 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -147.75 169.22 20.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.279 -0.638 . . . . 2.98 109.279 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -149.51 -155.42 6.76 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.85 -0.69 . . . . 0.64 111.502 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -86.98 91.23 8.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.101 0.477 . . . . 1.13 110.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 18.51 14.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.73 . . . . 0.74 110.061 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 86.46 4.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.844 -0.616 . . . . 1.06 109.677 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -98.57 -20.89 16.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.29 -0.413 . . . . 0.74 110.783 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.47 -0.776 . . . . 2.44 109.873 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.997 0 N-CA-C 112.078 -0.409 . . . . 0.53 112.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -157.5 133.44 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 1.05 110.344 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -110.77 61.87 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.278 0.561 . . . . 0.7 110.234 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -94.64 27.96 2.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.37 110.929 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 pt -132.56 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.059 -0.519 . . . . 0.3 110.372 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t80 -83.86 162.62 20.49 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.544 -0.539 . . . . 1.37 109.544 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 87.66 13.34 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.768 0.318 . . . . 0.26 111.219 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 4.5 Cg_exo -78.04 157.76 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.781 2.321 . . . . 0.38 111.022 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -107.37 103.23 12.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.052 0.453 . . . . 0.87 111.087 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 27.3 t-20 -144.2 149.12 35.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.549 . . . . 1.46 109.831 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -54.96 40.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.742 0.306 . . . . 0.4 111.701 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mt -91.17 63.54 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.104 0.478 . . . . 0.7 111.242 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 2.4 mmp_? -136.43 148.98 48.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 1.39 110.479 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.45 -0.92 56.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.49 110.333 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.401 HG21 ' HD2' ' A' ' 8' ' ' PRO . 1.3 p -77.62 -41.34 38.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.263 0.554 . . . . 0.44 110.456 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -108.48 78.52 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.818 -0.628 . . . . 0.59 109.936 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.46 HG12 ' OE1' ' A' ' 54' ' ' GLN . 19.2 m -120.54 140.81 43.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.017 -0.538 . . . . 0.17 111.128 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 33' ' ' CYS . . . -110.64 116.3 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.087 -0.708 . . . . 0.18 109.087 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.64 110.52 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 0.2 111.591 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 89' ' ' ILE . 3.6 p -102.13 137.79 28.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.997 -1.112 . . . . 0.12 107.997 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 136.82 49.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.326 0.584 . . . . 0.33 112.453 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.423 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 36.7 ttp -121.38 120.62 35.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.032 -0.986 . . . . 0.28 109.488 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.28 129.96 55.5 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.909 -0.404 . . . . 0.89 109.909 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -108.7 35.92 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.409 -0.36 . . . . 0.63 110.771 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.19 63.75 1.81 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.648 0.737 . . . . 0.32 109.942 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.94 -70.43 0.48 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.211 -1.155 . . . . 0.2 110.211 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -87.23 135.82 33.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 1.17 109.217 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -128.23 151.63 49.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.4 111.322 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -141.08 126.23 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.3 110.347 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 132.34 56.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.11 -0.495 . . . . 0.19 110.08 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -129.52 149.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.677 0.275 . . . . 0.84 110.688 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.23 115.98 31.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.2 110.909 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.1 p -149.08 141.01 23.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.826 -0.625 . . . . 0.58 109.983 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -114.58 -84.42 0.61 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.227 -0.189 . . . . 0.65 111.091 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 65.16 -179.94 0.19 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.808 0.692 . . . . 1.02 111.559 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.62 78.16 9.9 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.279 -1.008 . . . . 1.79 108.279 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt 67.88 78.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.372 -0.831 . . . . 0.9 109.422 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.42 -26.56 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.489 -0.778 . . . . 0.38 111.782 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.48 -28.83 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.46 110.687 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.43 -32.45 84.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.15 111.814 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -64.87 -29.87 70.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.74 110.092 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -65.63 -33.46 75.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 1.34 110.156 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m -87.24 -21.94 25.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.094 0.473 . . . . 0.6 109.999 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.15 27.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.068 -0.587 . . . . 0.43 112.288 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 t -105.52 76.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.882 0.373 . . . . 0.59 110.113 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' OE1' ' HG2' ' A' ' 47' ' ' LYS . 2.3 mm-40 -172.61 172.15 4.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 0.4 109.904 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HG2' ' OE1' ' A' ' 46' ' ' GLU . 17.1 ptmt -83.55 -168.29 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.979 -0.378 . . . . 0.47 109.979 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 164.51 4.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.023 0.439 . . . . 1.22 111.932 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.718 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -84.22 -8.74 58.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.954 -0.566 . . . . 0.15 111.311 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -27.33 66.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.311 -0.404 . . . . 0.85 110.808 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -104.18 16.85 25.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.47 111.813 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' LEU . 3.0 p -108.3 -27.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.465 -0.494 . . . . 0.22 110.991 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 53' ' ' LEU . 1.2 mm? -80.35 91.36 5.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.397 -0.365 . . . . 0.24 110.766 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' OE1' HG12 ' A' ' 17' ' ' VAL . 69.2 mt-30 -69.31 -31.06 69.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.47 0.652 . . . . 0.3 109.717 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 t -140.82 126.5 19.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.239 -0.891 . . . . 0.43 109.264 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -86.77 42.74 1.03 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.28 110.629 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.7 113.76 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.833 -0.621 . . . . 0.45 110.267 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.4 p -91.5 138.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.741 -0.466 . . . . 0.37 109.741 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.02 150.18 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.306 -0.406 . . . . 0.19 111.116 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.42 -47.38 7.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.27 109.429 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -130.57 103.28 6.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 0.33 109.349 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.0 -28.09 23.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 113.044 0.757 . . . . 0.22 113.044 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 p -82.12 -27.57 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.525 -0.47 . . . . 0.64 111.81 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -100.54 -2.04 34.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.97 111.093 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.55 45.29 78.7 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.21 113.1 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.33 112.3 25.06 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.921 -0.399 . . . . 0.65 109.921 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.09 144.38 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 0.46 110.752 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.663 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.98 109.56 20.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.635 -0.506 . . . . 0.31 109.635 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.631 ' HB3' ' OE2' ' A' ' 71' ' ' GLU . 7.5 mtpt -78.88 176.62 9.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.886 -0.597 . . . . 1.28 110.878 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.77 -32.11 67.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 1.09 112.176 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.631 ' OE2' ' HB3' ' A' ' 69' ' ' LYS . 1.7 pm0 -93.25 4.0 54.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.756 0.312 . . . . 1.02 111.166 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -105.69 -46.49 4.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 2.16 110.206 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 1.5 pp -63.77 -33.56 75.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.048 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 tt -68.54 -21.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.231 0.538 . . . . 0.65 110.432 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -99.38 1.09 44.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.66 110.635 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.93 -51.35 2.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.49 110.931 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.61 -15.35 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 1.51 110.864 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.03 -25.35 20.31 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.749 -0.738 . . . . 0.25 112.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 138.26 31.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.68 0.276 . . . . 0.31 110.805 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.9 -5.52 55.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.424 0.631 . . . . 0.64 109.6 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.37 117.01 28.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.162 -0.926 . . . . 0.43 110.511 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -68.75 -22.17 64.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.81 111.062 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -47.0 77.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.19 111.064 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -56.43 -39.63 73.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.224 0.535 . . . . 1.34 110.382 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 89' ' ' ILE . 66.9 mt -70.22 -48.2 62.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.683 -0.69 . . . . 0.14 110.106 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 31' ' ' ILE . 51.6 t -58.61 -40.24 82.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 0.12 110.243 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 91' ' ' THR . 5.3 tttp -58.64 -47.19 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 1.05 109.88 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -64.05 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 1.67 110.937 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.632 HG22 HG22 ' A' ' 20' ' ' VAL . 69.0 mt -67.54 -29.9 47.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.046 0.45 . . . . 0.3 110.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -35.19 35.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.031 -0.531 . . . . 0.2 111.976 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 87' ' ' LYS . 6.9 t -96.38 -18.05 20.2 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.998 0.74 . . . . 0.26 112.998 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -124.42 17.35 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.32 111.283 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.91 178.44 18.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.59 -0.814 . . . . 0.23 112.459 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.09 112.23 24.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 2.68 110.615 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 97' ' ' VAL . 11.0 p -103.21 155.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.46 109.756 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -71.34 99.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.026 0.441 . . . . 0.62 110.487 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 95' ' ' VAL . 17.6 m -108.61 167.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.4 110.481 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 m -146.11 -74.55 0.22 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.243 -0.435 . . . . 0.93 110.064 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.8 169.38 10.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.875 -0.417 . . . . 0.52 109.875 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -164.56 165.96 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.797 -0.445 . . . . 0.82 109.797 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -71.35 154.39 41.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.305 0.574 . . . . 1.14 111.277 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -113.42 91.52 3.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.821 -0.627 . . . . 2.58 110.183 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -133.17 128.29 35.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.071 -0.513 . . . . 1.07 110.396 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.03 145.93 50.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.896 -0.593 . . . . 1.16 110.018 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.32 148.53 31.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.889 0.376 . . . . 0.53 110.395 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.79 105.26 9.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.79 110.429 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -158.32 175.81 13.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.18 109.829 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -89.28 30.77 0.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.518 0.199 . . . . 0.81 111.376 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.2 ptp -60.19 -32.13 70.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.691 0.282 . . . . 0.16 110.884 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.28 -34.89 66.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.08 110.287 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.38 -30.88 63.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.79 110.214 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.538 ' O ' HG22 ' A' ' 115' ' ' THR . 16.5 t70 -61.75 -50.97 70.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.947 -0.569 . . . . 1.53 110.595 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 tp -73.86 -27.43 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.24 110.367 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -65.56 -42.96 91.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.13 111.187 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 112' ' ' ASP . 2.0 t -65.35 -22.28 66.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.22 110.779 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 112' ' ' ASP . 44.0 mm -83.06 -55.72 6.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.046 -0.525 . . . . 0.25 110.271 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 114' ' ' ALA . 9.9 p -62.09 -31.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.36 0.504 . . . . 0.21 112.36 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.91 -15.3 62.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.13 111.714 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.52 -16.03 17.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.173 -0.467 . . . . 1.46 110.787 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -3.18 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.637 0.606 . . . . 0.99 112.637 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.9 p -129.23 154.57 46.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.066 0.46 . . . . 0.14 111.125 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.76 146.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.751 -0.659 . . . . 1.08 110.3 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.27 153.76 38.78 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.819 -0.437 . . . . 1.82 109.819 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.31 -159.94 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.529 2.152 . . . . 0.78 112.289 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 4.7 pt-20 -65.7 91.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 0.76 111.23 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.0 t -170.69 -42.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.726 -0.67 . . . . 0.54 110.19 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -177.08 119.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.534 -0.543 . . . . 0.52 109.534 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -77.66 149.17 77.52 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.557 -0.292 . . . . 1.39 110.899 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.512 ' HA ' HD22 ' A' ' 134' ' ' LEU . 18.6 Cg_endo -60.53 134.4 54.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.742 2.294 . . . . 0.28 112.425 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -157.41 -46.19 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.95 109.988 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.0 p -126.56 169.24 13.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.69 110.713 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.99 -25.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.486 . . . . 0.24 110.66 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.01 -24.16 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.512 -0.767 . . . . 0.46 111.311 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 129' ' ' PRO . 7.9 tp -53.57 -57.41 10.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.436 . . . . 0.34 111.193 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -30.79 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 0.36 110.907 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -60.59 -39.41 87.97 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.314 -0.403 . . . . 0.83 110.96 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -58.99 -36.67 75.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.206 -0.452 . . . . 0.84 111.258 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.14 -36.3 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.503 -0.317 . . . . 0.19 111.271 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 12.3 ttt -63.4 -40.97 98.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.249 -0.432 . . . . 0.39 111.293 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -71.23 -25.54 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.91 110.883 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.33 -47.94 58.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.149 0.499 . . . . 0.42 109.935 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.65 73.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.053 0.93 . . . . 0.74 110.06 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -122.33 -2.25 9.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.536 -0.756 . . . . 0.97 110.734 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -78.65 124.24 27.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.319 -0.4 . . . . 1.65 111.029 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.4 m 55.39 34.47 22.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.574 -0.739 . . . . 0.55 112.261 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.92 -53.3 8.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.58 110.679 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 152' ' ' THR . 45.9 tttt -134.7 14.41 3.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 1.19 110.208 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 116.94 10.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.681 -0.69 . . . . 0.5 110.84 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 67.8 66.16 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.097 0.559 . . . . 0.54 110.797 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -164.48 159.46 19.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.154 -0.684 . . . . 0.36 109.154 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.52 154.38 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 1.28 110.297 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -57.67 -49.55 76.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.857 0.688 . . . . 0.81 112.857 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -82.22 -16.07 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.628 0.251 . . . . 1.23 111.673 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.76 -59.19 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.24 111.826 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.8 mp0 -105.2 23.29 13.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.528 -0.305 . . . . 0.32 111.552 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.976 0.362 . . . . 0.21 111.976 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.8 mm? -78.45 -16.75 57.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.269 -0.423 . . . . 0.57 111.908 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.21 -42.38 10.45 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.906 -0.317 . . . . 0.78 110.988 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 155' ' ' GLN . 86.3 t -59.12 -39.05 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.402 -0.363 . . . . 0.24 111.273 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.61 -19.74 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.336 -0.393 . . . . 0.55 111.283 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -99.34 -16.94 18.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 1.23 110.595 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -62.55 1.46 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.73 111.035 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -71.71 -17.7 62.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.501 . . . . 0.3 111.467 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.454 ' N ' HD13 ' A' ' 163' ' ' LEU . 6.4 tmtt? -70.26 -34.28 72.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.888 0.375 . . . . 1.16 110.628 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -77.76 -34.47 52.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 1.76 110.579 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -35.95 61.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.3 0.572 . . . . 0.75 109.972 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 tpt -124.24 91.16 3.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.703 -0.851 . . . . 0.24 108.703 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.42 101.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.391 0.615 . . . . 1.34 111.674 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.89 142.62 20.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.129 -0.941 . . . . 0.28 109.775 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -98.54 107.42 19.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.563 -0.289 . . . . 2.33 110.574 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -82.07 70.28 8.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.927 0.394 . . . . 2.39 110.066 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -138.91 162.23 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.148 -0.478 . . . . 0.27 110.561 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -109.43 123.79 49.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.2 -0.455 . . . . 1.4 109.967 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 53.5 mtt -82.51 153.56 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.655 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 54.7 mtt180 -135.13 117.51 15.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 1.19 111.116 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.479 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 13.7 mt -108.22 152.51 24.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.867 -0.606 . . . . 2.2 110.213 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.401 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 19.7 ptt180 -140.82 159.97 41.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.222 -0.445 . . . . 0.35 110.176 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 0.8 OUTLIER -134.17 132.82 40.26 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.181 -0.674 . . . . 0.09 109.181 178.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.2 tt -126.73 123.16 62.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.114 0.483 . . . . 0.1 111.476 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.9 OUTLIER -159.76 156.01 23.69 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 0.23 110.028 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.87 143.36 30.45 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.861 2.374 . . . . 0.09 112.428 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.82 -31.54 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.861 -0.609 . . . . 0.45 112.427 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -54.89 -46.45 74.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.583 0.23 . . . . 1.38 111.534 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.25 -30.79 17.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.92 109.841 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.39 -29.78 72.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.467 -0.788 . . . . 0.18 113.08 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -59.34 -26.41 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 0.49 111.087 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -44.52 73.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.81 110.523 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 3.0 pp -76.76 -22.91 53.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.98 0.419 . . . . 0.26 110.053 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 193' ' ' LYS . 71.3 tttt -63.0 -35.34 79.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.839 -0.619 . . . . 0.92 110.189 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -101.07 18.31 20.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.783 -0.644 . . . . 1.65 110.981 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -131.28 -52.79 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.064 0.394 . . . . 0.7 112.064 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 212' ' ' CYS . 1.1 tm? -86.35 -44.18 12.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.17 111.722 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 18.3 mtpt -57.13 -48.42 97.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 112.809 0.67 . . . . 0.21 112.809 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.9 Cg_endo -59.04 -16.64 33.87 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.298 1.998 . . . . 0.26 113.282 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 56.0 mt -74.2 -15.82 61.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 0.36 110.162 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 16.7 mt 56.45 60.63 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.645 -0.707 . . . . 0.75 111.586 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -135.3 10.06 3.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.691 -0.686 . . . . 1.49 109.737 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.2 167.48 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.582 -0.735 . . . . 0.34 111.672 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.72 148.48 10.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.42 -0.809 . . . . 0.29 108.945 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.12 57.99 0.36 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.263 0.554 . . . . 1.19 111.711 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -146.35 55.84 1.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.568 -0.742 . . . . 0.39 109.275 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.1 pt-20 -106.13 167.7 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.45 111.516 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.9 t70 -131.51 123.53 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -114.78 31.49 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.91 110.802 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.09 -102.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.596 -0.811 . . . . 0.32 112.067 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -95.78 -31.09 13.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.439 0.638 . . . . 0.34 109.577 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.18 136.96 54.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.384 -0.825 . . . . 0.58 109.44 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 203' ' ' ASP . 36.1 tp -88.82 99.65 12.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.077 0.465 . . . . 0.15 110.265 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 50.2 tt0 -109.38 114.78 28.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.2 109.712 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 178' ' ' PHE . 21.3 mt -127.39 141.13 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 0.12 110.891 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.8 125.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.089 -0.708 . . . . 0.2 109.089 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 192' ' ' LEU . 50.8 t -139.83 99.97 3.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.578 0.227 . . . . 0.25 111.454 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.479 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER 177.73 121.28 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.966 -0.753 . . . . 0.46 108.966 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -116.0 -40.41 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 111.832 0.308 . . . . 1.53 111.832 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.45 143.69 36.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.879 0.326 . . . . 0.69 111.879 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.68 -30.16 35.03 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.875 2.383 . . . . 0.27 112.077 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.5 -23.37 75.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.915 -0.66 . . . . 0.39 111.761 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.7 6.75 44.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.215 0.531 . . . . 1.43 110.572 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.34 -47.68 81.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.716 -0.674 . . . . 0.97 110.526 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -66.17 -23.68 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.627 . . . . 2.03 111.087 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.54 -42.82 28.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.778 -0.646 . . . . 2.19 111.507 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 0.6 OUTLIER -82.1 -33.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.07 0.396 . . . . 1.3 112.07 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.79 -24.49 67.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.881 0.372 . . . . 0.47 111.045 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 12.9 mm-40 -61.76 -31.41 71.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 0.5 111.408 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.7 OUTLIER -102.6 -36.79 8.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.117 -0.233 . . . . 0.29 110.82 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.8 mm -53.88 -34.35 25.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.61 -0.268 . . . . 0.15 111.72 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.2 ptpt -55.99 -32.06 63.58 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.126 0.417 . . . . 1.36 112.126 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -108.72 -27.15 9.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.007 0.432 . . . . 0.56 110.881 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.947 -0.57 . . . . 0.62 112.091 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -149.73 -30.89 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.008 0.744 . . . . 0.17 113.008 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 33.3 ttmt -58.9 -37.56 76.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.95 0.341 . . . . 2.23 111.84 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.25 18.6 51.13 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.678 -0.772 . . . . 0.19 112.629 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -129.99 -47.84 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.62 110.501 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -119.65 -158.01 10.48 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.209 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.3 m -108.09 138.64 44.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.828 0.346 . . . . 0.31 110.532 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 150.09 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 1.37 109.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.43 167.77 23.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.053 0.454 . . . . 1.19 110.764 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.13 150.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.6 109.742 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.497 HD12 ' HE3' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -78.53 88.68 4.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.046 0.451 . . . . 0.4 110.503 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -120.42 158.3 27.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.862 -0.608 . . . . 0.52 109.881 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.7 tp 64.41 80.85 0.22 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.605 0.566 . . . . 0.47 110.979 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.497 ' HE3' HD12 ' A' ' 239' ' ' LEU . 7.8 mptt -86.49 32.24 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.882 -0.599 . . . . 0.36 110.943 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -101.4 -38.96 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.262 0.553 . . . . 0.71 109.864 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.41 160.13 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.54 -0.755 . . . . 0.59 109.082 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -56.02 127.15 29.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.631 0.253 . . . . 1.39 110.664 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -71.28 -77.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 1.54 111.086 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.28 175.94 21.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.671 -0.776 . . . . 0.68 111.851 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -101.21 92.61 5.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.931 0.396 . . . . 0.58 110.157 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -5.06 59.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.05 111.173 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.23 107.74 19.4 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.643 -0.503 . . . . 0.98 109.643 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -96.54 5.46 50.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.101 0.476 . . . . 0.57 110.308 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 115.707 -0.678 . . . . 1.23 110.031 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 111.909 -0.477 . . . . 0.89 111.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -132.82 154.6 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 1.57 110.157 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -147.18 151.16 36.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.718 0.294 . . . . 0.59 110.239 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -156.7 119.48 4.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.425 -0.352 . . . . 0.42 110.226 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.95 -54.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.14 -0.482 . . . . 0.26 110.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -99.81 152.87 19.63 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -139.77 94.47 9.14 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.934 0.397 . . . . 0.83 111.226 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.52 145.88 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.936 2.424 . . . . 0.29 112.526 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 m -78.78 124.32 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.86 -0.609 . . . . 0.53 110.809 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -153.71 156.83 38.54 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.259 -0.645 . . . . 0.2 109.259 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -87.1 -19.23 28.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.083 0.401 . . . . 0.83 112.083 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.32 70.94 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.299 0.571 . . . . 1.13 110.803 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -146.35 149.49 33.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.749 -0.66 . . . . 0.85 109.998 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 17' ' ' VAL . 86.1 mt -67.13 -9.32 38.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.443 0.535 . . . . 0.48 112.443 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -90.86 2.67 55.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 0.33 111.48 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -135.35 32.43 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.213 0.53 . . . . 1.12 110.532 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 14' ' ' LEU . 27.2 m -84.32 152.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.69 -0.686 . . . . 0.31 111.514 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.43 140.76 48.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.843 -0.617 . . . . 0.19 110.053 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.48 117.7 32.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.204 0.526 . . . . 0.41 110.948 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -147.62 117.47 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.25 109.993 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 149.29 50.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.26 111.11 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 55.9 ttp -122.14 139.37 53.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.336 -0.847 . . . . 0.36 110.472 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -116.11 120.99 40.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.714 -0.476 . . . . 0.29 109.714 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -122.37 89.47 3.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.549 -0.296 . . . . 0.68 110.52 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.15 46.75 23.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.693 -0.685 . . . . 0.58 111.734 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.91 -48.78 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.448 -0.882 . . . . 0.47 112.815 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -69.38 129.22 39.14 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.199 -0.297 . . . . 0.45 110.199 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -119.11 143.64 47.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.763 0.316 . . . . 0.77 111.336 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -132.87 142.42 48.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.829 -0.623 . . . . 0.3 109.82 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 24.9 tt0 -146.54 133.02 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.62 -0.511 . . . . 1.75 109.62 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.0 mt -136.49 130.38 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.326 -0.397 . . . . 0.44 110.01 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 113.09 4.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.15 111.686 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 31.2 m -107.55 175.91 5.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.786 -0.643 . . . . 0.17 110.219 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CD1' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.77 150.42 37.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.098 0.475 . . . . 0.32 111.084 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -87.5 -7.85 57.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.457 0.539 . . . . 1.53 112.457 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -78.63 78.33 5.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.55 111.76 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 52.27 63.24 2.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.89 -0.596 . . . . 1.71 111.852 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 7.9 p -70.45 -24.2 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.954 -0.566 . . . . 0.54 110.714 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.14 -5.35 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 111.276 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.22 -28.41 58.77 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.239 -0.505 . . . . 0.18 112.852 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.464 ' HE1' ' HB ' ' A' ' 91' ' ' THR . 21.8 t-105 -65.07 -33.84 77.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 1.42 111.101 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -75.9 -41.41 52.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 1.14 110.771 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.67 -39.54 61.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.304 -0.407 . . . . 0.61 111.273 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.52 -98.3 0.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.293 -0.956 . . . . 0.45 112.974 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG12 ' OE1' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -125.89 163.84 26.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.739 0.304 . . . . 0.94 110.822 -179.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' OE1' HG12 ' A' ' 45' ' ' VAL . 1.1 pm0 -89.76 161.65 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.436 -0.579 . . . . 1.39 109.436 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -34.5 16.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.875 -0.33 . . . . 1.75 110.449 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -167.69 160.43 12.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.974 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tp -109.92 -14.63 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.43 110.886 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.28 -40.54 6.71 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.611 -0.514 . . . . 0.23 109.611 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.48 -24.91 61.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.913 -0.585 . . . . 1.88 110.345 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.586 HG23 ' CD1' ' A' ' 34' ' ' TYR . 12.0 p -70.88 -26.55 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.415 -0.587 . . . . 0.32 109.415 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.55 97.71 7.96 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.89 110.189 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -67.23 -37.03 82.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.22 108.904 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 t -157.52 126.09 5.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.773 -1.103 . . . . 0.44 108.98 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 82' ' ' GLN . 10.5 p80 -77.7 67.17 3.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.556 0.693 . . . . 0.47 110.556 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.4 p -138.59 111.84 8.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.292 -0.867 . . . . 0.91 110.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 68' ' ' ALA . 5.4 p -100.68 135.08 38.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.19 110.103 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -91.66 163.84 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.92 0.39 . . . . 2.09 111.238 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.44 -49.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.019 -0.734 . . . . 0.98 109.019 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -142.46 103.63 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.722 . . . . 0.27 109.173 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.9 -26.9 23.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.19 -0.459 . . . . 0.39 112.132 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.2 m -72.42 -36.06 68.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.9 0.381 . . . . 0.27 110.971 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.68 5.85 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.193 -0.458 . . . . 0.27 110.845 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.0 44.19 96.4 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.207 -0.52 . . . . 0.14 112.79 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -112.63 121.96 46.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.863 0.363 . . . . 0.94 110.736 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.78 170.4 7.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.98 -0.554 . . . . 1.29 109.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.714 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -115.45 120.96 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.082 0.467 . . . . 0.37 111.049 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -87.74 -178.28 6.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.078 -0.712 . . . . 1.26 109.078 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' OE1' ' A' ' 71' ' ' GLU . 3.1 pttp -56.56 -39.39 73.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.842 0.353 . . . . 1.61 111.333 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' OE1' ' HG3' ' A' ' 70' ' ' LYS . 7.1 pm0 -75.75 -11.25 59.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 1.79 111.847 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -98.03 -48.69 5.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.655 -0.248 . . . . 0.98 110.641 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.72 -32.81 73.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.737 -0.211 . . . . 0.33 111.514 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 79' ' ' THR . 6.9 tt -64.51 -26.78 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.085 0.469 . . . . 0.45 110.455 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 m -95.55 -10.46 29.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 1.06 110.276 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.22 -54.69 4.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.736 -0.666 . . . . 0.36 111.252 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -100.72 -37.87 8.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 0.58 111.33 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.66 -18.17 8.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.293 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -97.73 141.57 30.58 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.165 -0.309 . . . . 0.36 110.165 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -14.26 42.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.27 111.09 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' OD1' HG22 ' A' ' 83' ' ' THR . 17.0 t0 -90.09 125.14 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.59 110.178 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.95 -21.76 54.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.07 -0.514 . . . . 0.68 112.171 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.419 HG22 ' OD1' ' A' ' 81' ' ' ASP . 2.5 t -68.0 -31.51 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.224 -0.591 . . . . 1.49 110.034 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 74.3 mm-40 -70.22 -36.78 74.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.092 -0.707 . . . . 1.08 109.092 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.638 ' O ' HG13 ' A' ' 89' ' ' ILE . 32.6 mm -64.34 -45.73 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.206 -0.906 . . . . 0.28 109.172 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.49 -42.3 91.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.38 110.575 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.86 -38.32 90.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 1.86 110.189 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 7.5 mm100 -64.28 -39.95 94.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.05 109.76 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.65 HG22 HG22 ' A' ' 20' ' ' VAL . 45.1 mt -67.66 -26.75 36.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.38 110.391 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.411 HD22 HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.75 -27.4 31.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.144 -0.48 . . . . 0.29 111.731 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.464 ' HB ' ' HE1' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -101.36 -30.86 11.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.62 0.6 . . . . 0.52 112.62 -177.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -111.45 -3.73 15.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.029 0.442 . . . . 0.7 110.939 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.5 178.77 22.61 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.673 -0.775 . . . . 0.3 112.516 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.2 112.02 24.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.41 . . . . 1.31 110.573 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 20' ' ' VAL . 7.3 p -101.03 148.09 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.605 -0.725 . . . . 0.36 110.219 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -62.36 100.17 0.17 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.386 0.612 . . . . 0.49 111.058 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.56 88.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.77 111.142 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 m -91.92 27.31 2.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 0.65 110.002 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -118.56 122.8 43.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 1.85 109.767 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.6 148.72 52.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.325 . . . . 0.33 110.569 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -135.04 160.48 38.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.586 -0.279 . . . . 0.67 110.314 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -112.56 155.53 24.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.251 -0.432 . . . . 1.01 110.551 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -146.35 140.71 26.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.939 -0.393 . . . . 0.55 109.939 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.76 -60.81 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.763 0.283 . . . . 0.53 111.763 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -97.36 101.74 13.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 1.23 111.461 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.8 mt -95.88 -28.61 14.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.55 110.115 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 17.9 mt-10 -58.88 -24.96 62.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.312 -0.858 . . . . 0.96 112.874 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -41.05 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.683 -0.407 . . . . 1.4 111.187 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -48.48 80.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 1.39 111.172 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -87.08 1.3 53.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.46 -0.336 . . . . 0.33 111.779 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 107' ' ' GLU . 27.9 ttp180 -84.14 -31.26 25.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.654 -0.499 . . . . 0.76 109.654 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.63 -48.88 75.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.5 110.069 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 116' ' ' ILE . 4.4 tp -68.0 -27.46 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.238 0.542 . . . . 0.86 110.051 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.15 -33.7 75.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.28 110.877 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.04 -23.37 65.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.029 0.443 . . . . 0.38 110.424 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 113' ' ' ILE . 29.4 mt -83.41 -41.94 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.19 110.534 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.87 -19.62 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.29 111.357 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.36 -28.02 69.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.52 110.926 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.99 10.85 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 1.08 109.958 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . 0.4 OUTLIER -122.3 -49.49 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.927 -0.579 . . . . 0.97 111.154 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.476 ' HB2' HG21 ' A' ' 169' ' ' ILE . 26.5 p -92.65 109.45 20.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.015 0.436 . . . . 0.97 111.227 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.34 162.35 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.272 -0.422 . . . . 0.7 110.564 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.5 147.54 3.82 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.44 109.965 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.87 64.39 4.96 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.711 2.274 . . . . 0.48 112.209 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.44 -171.82 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.783 -0.644 . . . . 1.34 110.434 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.0 t -76.99 -12.58 59.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.245 0.545 . . . . 0.58 110.184 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -118.61 131.5 56.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.745 -0.662 . . . . 0.51 109.36 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 128' ' ' ARG . 1.0 OUTLIER -95.16 153.72 39.68 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.43 -0.35 . . . . 1.22 110.489 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.29 48.48 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.994 2.462 . . . . 0.36 112.493 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -95.03 -7.99 38.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.115 0.483 . . . . 0.58 110.269 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 154.12 36.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.206 -0.452 . . . . 0.89 110.531 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 132' ' ' VAL . 2.5 t -60.06 -18.09 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.116 -0.493 . . . . 0.18 111.339 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.1 mm -54.08 -31.18 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.118 -0.492 . . . . 0.3 111.593 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.95 -52.34 64.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.32 111.17 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tp -81.37 -30.35 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.344 -0.389 . . . . 0.24 110.87 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.87 -46.93 87.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.825 0.345 . . . . 1.51 110.219 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -61.38 -39.93 92.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 1.17 111.148 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.84 -46.94 70.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.359 -0.382 . . . . 0.31 111.281 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -42.78 91.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 2.31 110.878 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -67.09 -30.86 71.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 1.47 110.878 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -71.2 -45.74 62.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.8 111.106 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 166' ' ' LYS . 7.0 tp -73.01 -42.57 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.792 -0.363 . . . . 0.32 110.234 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 35.5 t60 50.57 57.91 6.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.932 -0.576 . . . . 1.03 110.914 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CD2' ' HG2' ' A' ' 162' ' ' GLN . 44.0 t80 -97.16 136.34 37.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.731 . . . . 1.42 110.059 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.9 124.05 22.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.721 0.296 . . . . 0.36 110.305 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.25 39.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.195 0.522 . . . . 0.29 111.012 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 55.02 83.96 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 1.01 111.989 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -14.51 62.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.982 -0.554 . . . . 0.59 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -102.0 14.88 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.514 0.673 . . . . 0.57 109.188 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 151' ' ' SER . 61.6 mttp -147.65 -149.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.584 -0.734 . . . . 0.62 109.832 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 154' ' ' GLN . 4.1 t -152.99 175.94 12.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.918 -0.401 . . . . 0.18 109.918 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -65.8 -36.18 82.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.52 111.941 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -76.73 -9.46 58.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.419 -0.355 . . . . 0.38 111.487 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -74.97 -47.57 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.58 110.113 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -161.77 73.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.81 110.987 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -75.26 -24.74 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.48 110.745 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.18 -51.16 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.607 . . . . 0.64 110.878 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.84 -35.27 79.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.41 110.625 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.6 -52.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.22 110.981 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.2 tp -66.01 -31.98 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.349 -0.387 . . . . 0.19 111.125 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -72.41 -31.66 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.6 110.479 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.512 ' HG2' ' CD2' ' A' ' 144' ' ' TYR . 7.4 tp-100 -68.93 -37.78 79.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.02 -0.536 . . . . 0.76 109.928 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.59 -40.61 97.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.25 109.994 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -66.29 -21.27 66.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.366 -0.834 . . . . 0.45 111.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -71.08 -28.6 64.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.829 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.491 ' HG3' ' HB ' ' A' ' 142' ' ' ILE . 7.1 mmtt -93.09 -41.62 9.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.42 110.036 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.9 mmm -130.53 99.53 5.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 1.82 109.498 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.35 93.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.165 0.507 . . . . 0.77 110.973 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -89.33 164.67 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.49 -0.777 . . . . 0.18 109.859 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -172.11 -144.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.021 -0.363 . . . . 0.52 110.021 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 69.85 55.06 0.35 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.333 0.653 . . . . 0.78 111.942 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.51 155.63 40.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.36 109.856 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -119.28 149.06 42.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 1.15 111.986 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 63.1 mtt -124.84 -118.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.73 109.518 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.99 126.93 22.28 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.921 0.391 . . . . 0.87 110.74 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.48 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 5.7 mp -113.16 144.59 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.199 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 16.0 ptt180 -123.67 138.66 54.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.926 -0.579 . . . . 0.13 110.125 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 71.9 m-85 -106.3 124.58 49.81 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.035 -0.357 . . . . 0.1 110.035 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.18 112.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.32 111.291 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.416 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -153.83 152.81 27.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.829 -0.623 . . . . 0.21 110.137 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.98 153.36 74.03 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.124 1.883 . . . . 0.14 111.06 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.74 -30.96 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.77 111.329 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.99 -41.94 62.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 1.32 110.584 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -97.56 -31.9 12.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.59 110.781 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.33 -31.05 68.89 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.86 -0.609 . . . . 0.3 112.597 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -64.36 -16.27 61.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.56 0.219 . . . . 2.34 111.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -82.89 -44.5 15.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.72 111.004 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 -23.29 30.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 0.49 111.311 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -54.54 -55.32 30.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.48 111.325 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -82.89 29.62 0.46 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.366 -0.379 . . . . 0.53 111.629 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -134.8 -48.9 0.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.5 110.45 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.4 mt -78.83 -39.83 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.58 111.705 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 39.7 mtpt -64.68 -50.51 64.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.529 0.566 . . . . 1.39 112.529 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.7 Cg_endo -62.28 -15.79 46.96 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.978 1.786 . . . . 0.15 112.879 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.44 2.96 49.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.549 -0.296 . . . . 0.3 110.223 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 23.7 pt 41.2 41.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.252 1.021 . . . . 0.13 112.746 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.483 ' HG2' HD12 ' A' ' 222' ' ' ILE . 12.2 mptt -117.8 18.76 14.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.548 0.69 . . . . 1.4 109.798 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 212' ' ' CYS . 22.6 m -111.82 164.06 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.27 -0.877 . . . . 0.33 110.565 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.91 138.48 34.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.793 -0.817 . . . . 0.25 108.793 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.49 70.96 0.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.422 0.629 . . . . 1.75 111.374 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.5 m -144.73 28.15 1.3 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.742 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 9.1 pt-20 -85.73 168.78 14.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 1.9 110.62 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -131.34 126.83 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.19 110.681 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.54 79.14 4.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 1.55 110.915 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.93 -125.7 2.68 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.247 -0.741 . . . . 0.33 111.247 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.83 -36.55 17.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.453 0.645 . . . . 2.76 109.726 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -113.35 114.64 26.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.146 -0.933 . . . . 2.24 108.99 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 17.9 tp -78.51 80.72 4.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.141 0.496 . . . . 0.55 110.38 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 28.0 tt0 -80.19 105.68 11.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.66 110.115 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.12 138.27 37.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.36 110.473 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.6 t -102.19 113.82 39.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.2 109.826 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.748 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.6 p -138.81 105.5 5.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.028 0.442 . . . . 0.18 111.168 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -148.86 144.96 27.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.275 -0.639 . . . . 0.61 109.275 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.1 tt -137.26 163.17 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.588 -0.278 . . . . 0.38 110.45 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.78 165.7 4.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.828 0.451 . . . . 0.74 110.808 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.53 -172.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.457 2.105 . . . . 0.23 112.855 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 81.12 -92.6 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.699 -0.762 . . . . 0.21 111.537 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.19 -12.36 50.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 1.44 110.957 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.485 ' HA ' HG22 ' A' ' 222' ' ' ILE . 79.7 t80 -58.2 -30.68 66.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.396 . . . . 0.15 110.617 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -69.4 -18.63 63.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 1.5 110.732 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -90.3 -35.24 15.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.469 -0.332 . . . . 1.11 111.24 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 5.3 tt -82.35 -34.88 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.552 0.215 . . . . 0.14 111.266 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.64 -25.74 66.53 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.183 0.516 . . . . 0.8 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.21 -32.35 66.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.421 -0.808 . . . . 0.64 111.45 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.2 pp -99.48 -36.13 9.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.784 -0.367 . . . . 0.75 110.433 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.1 mm -53.86 -41.09 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 116.556 -0.293 . . . . 0.37 111.367 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 17.8 ptpt -55.94 -31.1 62.63 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.887 -0.597 . . . . 0.3 112.603 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.546 ' HE3' ' C ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.63 2.62 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.852 0.316 . . . . 2.25 111.852 -178.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 6.5 tp10 -94.25 -56.39 2.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.36 . . . . 0.89 110.865 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t -126.66 -21.85 4.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.083 -0.508 . . . . 0.19 111.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.514 ' HD2' HD22 ' A' ' 236' ' ' LEU . 26.2 tptp -61.88 -50.51 71.92 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.842 -0.429 . . . . 0.35 109.842 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.74 34.65 4.52 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.84 -0.695 . . . . 0.17 111.77 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -129.9 -30.4 2.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.747 0.308 . . . . 1.77 110.538 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -151.3 -151.37 5.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.712 -0.756 . . . . 0.35 112.368 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.2 m -110.81 145.85 37.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.125 -0.324 . . . . 0.33 110.125 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 231' ' ' LYS . 1.2 pt? -114.58 145.37 42.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 0.57 110.659 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.61 170.63 15.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.497 -0.774 . . . . 1.16 109.173 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.17 153.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.404 -0.591 . . . . 0.21 109.404 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.5 tp -78.67 70.64 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.16 109.921 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.421 ' OD1' ' HE2' ' A' ' 242' ' ' LYS . 66.6 t30 -103.69 47.77 0.87 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.679 -0.691 . . . . 1.36 110.426 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.45 -71.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.45 110.65 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' HE2' ' OD1' ' A' ' 240' ' ' ASN . 0.0 OUTLIER 61.82 27.77 16.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.89 110.713 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.54 -51.83 2.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.945 -0.571 . . . . 0.64 110.272 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.726 HG22 ' H ' ' A' ' 246' ' ' GLU . 6.4 p -138.12 134.94 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.37 109.559 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -111.11 21.5 16.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 0.71 110.524 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.726 ' H ' HG22 ' A' ' 244' ' ' VAL . 36.1 tt0 -95.66 119.03 33.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.877 -0.601 . . . . 1.39 110.739 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.33 160.69 20.59 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.28 111.4 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -79.96 89.94 5.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.187 0.518 . . . . 0.69 110.846 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -106.45 14.38 27.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.716 -0.674 . . . . 0.45 110.269 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -125.45 89.58 3.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.859 -0.609 . . . . 0.4 110.693 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -71.21 -35.28 71.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.079 0.466 . . . . 0.64 110.646 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.698 -0.668 . . . . 1.93 109.901 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.54 0 N-CA-C 111.542 -0.623 . . . . 0.55 111.542 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -140.75 102.41 4.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.722 0.296 . . . . 0.76 110.264 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -59.84 116.61 4.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.835 -0.62 . . . . 2.58 110.792 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -130.22 117.71 20.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.096 -0.502 . . . . 0.43 110.13 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.69 -56.06 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.9 110.91 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -91.33 93.05 8.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.398 . . . . 2.35 110.636 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 87.43 55.87 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.43 110.691 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' HG21 ' A' ' 15' ' ' THR . 58.3 Cg_endo -72.72 151.75 52.26 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.559 2.173 . . . . 0.32 112.557 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -103.24 124.44 48.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.52 110.615 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -153.62 -171.77 4.01 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.845 -0.428 . . . . 0.63 109.845 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -84.62 -85.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.911 0.386 . . . . 1.18 111.021 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.461 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 mp -93.74 83.49 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.195 0.522 . . . . 0.54 110.721 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.4 mmt85 -141.55 148.59 39.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.81 109.972 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' HA ' HG13 ' A' ' 17' ' ' VAL . 6.4 mp -75.41 -9.75 58.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.066 0.46 . . . . 1.32 111.258 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.428 HG21 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -90.29 9.11 30.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 0.59 111.336 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -145.03 37.65 1.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.55 109.743 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 14' ' ' LEU . 30.6 m -88.84 -168.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.32 -0.855 . . . . 0.25 111.916 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.29 152.94 36.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.553 -0.748 . . . . 0.28 109.496 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.07 119.4 47.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.864 0.364 . . . . 0.15 110.749 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -155.47 110.32 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.71 -0.677 . . . . 0.19 109.784 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -128.61 142.16 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.61 111.665 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 37.7 ttp -112.73 129.57 56.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.48 110.033 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 124.76 47.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 1.46 110.028 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -104.19 -166.49 1.25 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.688 -0.687 . . . . 0.76 110.3 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.23 90.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.427 -0.351 . . . . 0.7 111.037 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.06 46.17 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.594 -0.813 . . . . 0.23 112.442 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -172.82 156.83 3.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.977 -0.379 . . . . 1.59 109.977 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.59 145.13 48.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.61 109.779 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -134.23 138.61 45.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.378 -0.373 . . . . 0.5 110.639 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 34.6 tt0 -144.19 142.53 30.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.58 0.229 . . . . 1.28 110.664 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.93 -164.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.559 . . . . 0.1 110.107 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.4 153.35 51.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.391 -0.225 . . . . 0.32 110.391 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 42.5 m -133.39 127.3 33.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.852 0.358 . . . . 0.23 111.297 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 2.1 t80 -62.89 122.28 15.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.41 112.375 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 55.72 17.49 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.066 -0.97 . . . . 1.06 112.81 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 62.19 23.35 13.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.0 0.429 . . . . 0.85 110.35 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -74.52 -1.13 20.01 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.246 0.462 . . . . 1.06 112.246 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.98 -23.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.53 . . . . 0.14 110.423 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.15 -7.46 9.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.82 -0.627 . . . . 0.14 109.798 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' OG ' ' A' ' 43' ' ' SER . . . -62.48 -27.78 70.12 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.62 -0.718 . . . . 0.21 111.95 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -73.73 2.13 8.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.57 111.001 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -130.41 23.99 5.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.982 -0.747 . . . . 0.43 108.982 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' OG ' ' HA2' ' A' ' 40' ' ' GLY . 1.5 p -148.96 15.75 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.24 110.702 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.96 23.76 77.53 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.133 -0.556 . . . . 0.19 113.901 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.36 78.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.093 0.446 . . . . 0.25 110.474 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.46 136.21 55.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.044 -0.354 . . . . 1.27 110.044 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -125.28 159.49 31.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.584 -0.28 . . . . 0.55 111.097 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.71 127.55 28.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.444 -0.798 . . . . 0.47 110.941 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.2 mt -72.45 -10.17 59.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.023 -0.535 . . . . 0.62 111.088 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -105.15 -9.7 17.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 0.67 111.072 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -102.08 -39.34 7.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 1.27 110.21 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 6.6 p -72.94 -20.13 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.25 111.077 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.17 102.79 14.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.393 -0.367 . . . . 0.1 110.391 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 12' ' ' ILE . 57.6 mt-30 -82.89 -73.54 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.165 -0.471 . . . . 0.36 110.428 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.4 m -67.2 106.48 2.03 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.81 -0.632 . . . . 0.08 110.3 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -87.97 49.63 1.84 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.461 0.648 . . . . 0.41 110.427 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 p -161.11 141.97 11.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.064 -0.971 . . . . 0.12 108.872 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.8 p -109.98 145.47 16.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.262 -0.273 . . . . 0.1 110.262 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -89.67 160.66 16.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.634 0.254 . . . . 0.09 111.057 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 84.9 t -123.35 -50.98 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.34 109.945 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 65.8 m-20 -129.23 112.46 13.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.61 109.427 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 7.3 p -79.63 -34.09 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.83 0.348 . . . . 0.33 111.42 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -78.18 -28.1 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 1.08 110.926 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -94.35 -6.85 43.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.167 -0.469 . . . . 1.01 110.99 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.03 53.92 36.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.017 -0.611 . . . . 0.6 112.045 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 12.2 mm100 -121.96 121.39 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.37 111.015 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.0 t -110.68 146.0 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.493 -0.776 . . . . 0.27 109.632 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . . . -100.99 121.94 42.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.057 0.456 . . . . 0.23 110.27 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 -171.87 2.85 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.068 -0.716 . . . . 0.67 109.068 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -56.86 -39.68 74.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.835 0.309 . . . . 0.68 111.835 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -72.74 -16.74 61.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.624 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.86 -53.48 4.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.061 0.457 . . . . 0.12 110.654 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.99 -23.81 66.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.1 111.754 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -64.16 -30.37 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.863 0.363 . . . . 0.54 110.64 179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 m -97.2 -23.27 16.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.841 0.353 . . . . 0.26 110.599 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.13 -47.72 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.36 110.974 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 -59.03 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.53 110.401 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.72 -37.43 1.03 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.544 -0.836 . . . . 0.16 112.506 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.56 135.1 44.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.452 0.168 . . . . 0.31 111.054 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' HB3' HG13 ' A' ' 74' ' ' ILE . 6.5 p-10 -84.77 43.63 1.0 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 0.53 111.02 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.7 130.89 46.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.193 -0.458 . . . . 0.23 110.128 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -64.74 -27.26 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 1.01 111.368 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.571 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 1.1 m -65.65 -35.7 81.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.189 0.518 . . . . 0.23 111.074 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.86 -24.94 60.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.098 -0.501 . . . . 1.34 110.567 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' HG13 ' A' ' 89' ' ' ILE . 29.6 mm -84.17 -51.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.13 110.822 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 30.0 p -60.63 -37.12 80.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.21 111.917 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -64.08 -30.12 71.21 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.898 0.38 . . . . 1.69 110.613 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -77.9 -38.99 44.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.931 -0.396 . . . . 1.88 109.931 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 20' ' ' VAL . 56.5 mt -67.1 -25.3 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.24 110.5 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 20' ' ' VAL . 1.5 mm? -81.55 -35.65 30.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.747 -0.66 . . . . 0.18 112.061 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 -20.56 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.733 0.642 . . . . 0.29 112.733 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' MET . 5.2 mmtm -127.78 23.09 6.25 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.879 -0.329 . . . . 0.47 111.632 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.14 -176.02 14.22 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.228 -0.987 . . . . 0.13 113.501 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 mm-40 -101.88 105.07 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.287 -0.457 . . . . 1.62 109.924 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.05 146.0 15.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.444 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -66.69 97.96 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.381 . . . . 1.14 110.221 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.03 131.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.058 0.456 . . . . 1.17 110.908 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.6 m -157.15 126.1 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.55 -0.75 . . . . 0.29 109.054 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.93 93.81 1.02 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 2.6 110.458 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -101.74 -45.88 5.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.63 111.496 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -127.63 161.3 29.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.136 0.493 . . . . 0.62 110.877 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -137.18 136.36 38.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.587 -0.733 . . . . 1.34 110.078 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 104' ' ' THR . 7.5 t-80 -161.11 -158.17 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.482 -0.562 . . . . 0.63 109.482 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.502 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 4.3 m -137.65 128.1 26.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.44 109.385 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' OE1' ' HG2' ' A' ' 108' ' ' GLN . 0.4 OUTLIER -65.03 149.2 50.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.83 0.348 . . . . 0.19 111.203 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.4 tp -97.01 -48.1 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.2 -0.454 . . . . 1.4 110.928 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.497 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 4.9 mm-40 -71.83 -88.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.365 -0.38 . . . . 1.74 111.457 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.497 ' OE1' ' HB2' ' A' ' 107' ' ' GLU . 2.1 pm0 -88.14 61.49 6.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 1.06 110.278 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.3 ttp -52.91 -40.03 63.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.539 -0.755 . . . . 1.3 111.762 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -67.16 -31.9 72.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.778 -0.646 . . . . 0.27 111.481 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -77.51 -31.65 53.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.588 -0.278 . . . . 0.72 111.13 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.1 t70 -57.36 -46.63 83.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.942 0.401 . . . . 0.59 109.966 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -75.24 -32.64 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.28 109.949 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.26 93.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.17 111.364 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -78.54 3.94 14.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.765 0.283 . . . . 0.25 111.765 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 112' ' ' ASP . 52.7 mt -112.92 -11.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.688 0.756 . . . . 0.53 109.76 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 -20.48 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.958 -0.564 . . . . 0.33 111.594 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.27 81.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.762 0.315 . . . . 0.44 111.449 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -71.08 -35.83 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.703 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -68.97 -32.71 72.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.62 110.939 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 28.5 m -84.79 81.56 8.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.22 110.568 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -74.63 142.93 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.594 . . . . 0.22 111.57 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -133.75 99.2 14.18 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.711 -0.677 . . . . 0.26 109.98 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.72 25.1 0.69 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.653 2.235 . . . . 0.5 112.586 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.35 -48.95 6.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.558 -0.292 . . . . 0.76 110.758 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.2 t -170.78 -33.16 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.893 -0.323 . . . . 0.36 111.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -95.17 108.34 20.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.034 0.445 . . . . 1.81 110.221 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.42 154.2 93.45 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 1.09 111.21 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.62 53.81 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.315 2.677 . . . . 0.73 112.97 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.22 16.43 3.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.858 -0.61 . . . . 0.24 109.692 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 m -122.86 108.66 13.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.48 111.318 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -30.79 44.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.859 -0.609 . . . . 0.3 110.737 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.02 -27.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.612 . . . . 0.24 111.35 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.52 -45.3 89.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.26 111.156 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -33.76 8.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.559 -0.292 . . . . 0.07 110.475 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.4 -39.66 88.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 1.0 110.983 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -37.34 85.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.555 . . . . 1.21 110.404 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.49 -39.29 28.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.09 -0.505 . . . . 0.09 111.262 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 31.9 ttp -61.23 -36.35 79.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 0.23 110.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.58 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 1.41 110.575 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.78 -39.57 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.216 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 142' ' ' ILE . 8.1 mt -58.04 -53.03 51.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.966 -0.561 . . . . 0.22 110.134 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 60.74 28.12 17.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.348 -0.842 . . . . 0.89 112.01 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -124.19 129.37 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.74 -0.467 . . . . 0.45 109.74 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.73 141.13 37.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.0 -0.545 . . . . 0.21 110.826 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.75 -63.8 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.346 -0.388 . . . . 0.18 110.564 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -151.32 129.09 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.131 -0.322 . . . . 1.46 110.131 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 145.82 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 0.54 111.65 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.8 t30 66.39 9.87 6.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.24 112.196 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -84.66 140.35 31.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.249 -0.648 . . . . 0.65 109.249 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.49 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 2.3 m -59.02 132.68 54.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.96 -0.385 . . . . 0.4 109.96 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -45.13 73.56 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.541 0.571 . . . . 0.74 112.541 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -64.07 -25.18 67.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.389 0.514 . . . . 2.29 112.389 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.52 -25.72 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.871 0.323 . . . . 2.17 111.871 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 25.6 pt20 -109.32 12.81 24.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.922 0.391 . . . . 0.37 111.114 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.68 ' HA ' HD11 ' A' ' 113' ' ' ILE . . . -60.71 -39.16 87.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.25 111.142 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 157' ' ' LEU . 3.0 mm? -67.3 -31.5 71.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.41 110.645 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -76.04 -36.22 59.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.399 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 155' ' ' GLN . 94.5 t -65.12 -48.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.19 110.758 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.22 -33.78 64.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.826 0.346 . . . . 0.22 110.711 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.4 mtmt -67.86 -46.29 72.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.326 . . . . 1.22 110.121 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -65.86 -36.32 83.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.7 110.72 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.19 -42.85 99.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.35 110.317 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 167' ' ' MET . 1.4 tmmt? -60.57 -28.72 68.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.492 -0.777 . . . . 0.5 111.306 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 7.3 mm-40 -70.47 -25.62 63.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.474 . . . . 1.36 110.887 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -99.9 -39.1 8.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 0.71 111.052 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 36.2 ttm -135.25 129.16 33.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.843 -0.428 . . . . 1.44 109.843 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -80.97 97.79 7.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.95 0.405 . . . . 0.73 111.182 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -101.22 166.11 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.546 . . . . 0.3 110.299 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.42 93.53 7.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.996 0.427 . . . . 0.52 110.751 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -102.66 13.36 34.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 1.28 110.143 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.87 98.87 9.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.51 110.569 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.532 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 2.0 p-80 -91.67 142.47 27.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.971 -0.559 . . . . 0.22 110.772 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -93.23 167.23 11.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.222 -0.659 . . . . 2.04 109.222 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 213' ' ' LEU . 83.7 mtm180 -133.59 129.58 37.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.968 0.413 . . . . 0.99 111.181 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 6.0 mt -116.65 151.59 35.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 1.14 109.915 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 211' ' ' VAL . 6.8 ptm180 -134.69 135.21 41.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.322 -0.399 . . . . 0.26 110.446 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 49.1 m-85 -102.17 128.04 48.84 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.991 -0.374 . . . . 0.28 109.991 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.59 123.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.521 0.677 . . . . 0.38 111.196 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -150.46 160.61 32.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.562 -0.744 . . . . 0.13 110.052 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.03 165.64 11.95 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.779 2.319 . . . . 0.13 112.567 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.24 -41.42 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.399 -0.364 . . . . 0.4 111.76 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -59.3 -47.49 85.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.9 111.078 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.58 53.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 0.63 111.581 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.3 71.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.177 -0.535 . . . . 0.2 113.13 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -71.44 -8.17 52.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.828 0.307 . . . . 0.49 111.828 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -87.66 -6.04 58.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.64 0.257 . . . . 0.85 111.066 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -26.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.675 -0.238 . . . . 0.4 111.342 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -56.78 16.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.838 0.351 . . . . 1.46 111.235 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.64 10.5 3.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.435 0.531 . . . . 1.0 112.435 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -118.14 -41.68 2.86 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.684 0.253 . . . . 0.67 111.684 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.33 -38.46 18.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.981 0.363 . . . . 0.4 111.981 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 11.0 mtpt -59.52 -47.54 97.6 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.597 0.591 . . . . 0.36 112.597 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.9 Cg_endo -64.6 -8.95 18.79 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.468 2.112 . . . . 0.2 113.474 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.1 mt -90.46 -5.15 56.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.858 0.361 . . . . 0.09 110.203 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.2 mm 58.09 54.18 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.666 0.746 . . . . 0.11 110.309 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 222' ' ' ILE . 70.3 mmtt -125.97 16.99 7.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.454 -0.794 . . . . 0.16 110.556 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.95 142.37 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.608 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.94 159.03 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.527 -0.761 . . . . 0.47 109.547 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -70.77 53.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.25 0.463 . . . . 1.87 112.25 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.7 m -167.18 100.58 0.52 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.496 0.719 . . . . 0.73 109.797 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -128.05 145.78 50.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.917 0.389 . . . . 0.26 111.361 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 209' ' ' GLU . 12.2 t70 -106.27 119.3 38.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.874 -0.417 . . . . 0.25 109.874 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.16 101.39 6.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.74 109.909 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -156.98 -109.4 0.29 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.954 -0.641 . . . . 0.26 111.741 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -88.69 -13.35 39.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.631 0.729 . . . . 1.39 109.037 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 207' ' ' GLN . 0.4 OUTLIER -138.58 -177.32 4.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.612 -1.176 . . . . 0.85 108.536 179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 40.9 tp -134.1 117.22 16.36 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.813 -0.439 . . . . 0.33 109.813 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 48.3 tt0 -128.77 117.6 21.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.053 -0.522 . . . . 0.34 109.632 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.79 141.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.825 0.345 . . . . 1.53 111.125 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 177' ' ' ARG . 58.7 t -92.46 111.23 24.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.471 -0.566 . . . . 0.23 109.471 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 60.29 0.71 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.992 0.425 . . . . 0.45 111.706 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -138.59 113.94 9.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.79 -78.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.468 -0.333 . . . . 0.13 111.567 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -138.92 160.83 61.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.521 -0.309 . . . . 0.21 110.766 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 173' ' ' HIS . 70.2 Cg_endo -74.53 176.19 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.55 2.166 . . . . 0.23 111.712 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 77.24 -75.4 1.77 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.499 -0.858 . . . . 0.15 111.883 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -5.25 32.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.69 0.281 . . . . 1.96 110.843 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 223' ' ' ASP . 7.7 p90 -59.71 -23.53 63.24 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.19 110.991 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.445 ' HA ' ' OD1' ' A' ' 223' ' ' ASP . 1.2 tpm_? -60.32 -27.89 67.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.875 0.369 . . . . 2.32 110.884 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -50.23 65.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.3 110.499 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 8.3 tt -81.33 -34.9 13.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 1.02 111.854 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 219' ' ' PHE . 0.0 OUTLIER -64.34 -28.07 69.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.722 0.296 . . . . 1.71 111.299 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -66.49 -36.13 81.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.69 110.382 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.5 pp -90.89 -39.71 12.15 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.678 -0.409 . . . . 0.12 110.92 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.3 mm -55.7 -36.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.463 -0.335 . . . . 0.3 111.604 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 7.9 ptpt -56.49 -23.72 41.31 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.739 0.644 . . . . 0.64 112.739 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 18.5 pttm -121.26 -19.19 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.798 0.296 . . . . 0.9 111.798 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -78.64 -32.27 47.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.29 112.34 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -143.26 -33.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.446 -0.502 . . . . 0.16 111.364 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 44.3 tttm -66.12 -18.66 65.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.177 0.513 . . . . 0.26 110.529 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.82 15.47 28.85 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.12 111.512 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -128.49 -35.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.725 0.297 . . . . 0.39 110.73 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.95 -150.29 6.55 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.91 -0.662 . . . . 0.18 112.742 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.2 m -116.71 145.84 43.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.318 . . . . 0.82 110.812 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.5 pt? -106.4 137.45 44.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.943 0.401 . . . . 0.15 110.688 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -129.31 163.75 25.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.05 -0.523 . . . . 0.66 110.444 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.14 169.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.371 -0.377 . . . . 0.39 110.797 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.72 12.3 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.877 0.37 . . . . 1.32 111.138 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -79.0 70.42 5.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 1.19 110.272 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 241' ' ' LEU . 1.3 mm? -113.39 81.95 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.703 -0.68 . . . . 1.25 110.26 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.06 -19.59 17.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.709 -0.678 . . . . 0.34 109.735 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.57 -60.41 2.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.113 -0.949 . . . . 1.19 110.627 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.17 150.97 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.318 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -80.67 146.46 31.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.083 -0.34 . . . . 1.0 110.083 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -157.97 112.15 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.992 -0.373 . . . . 1.33 109.992 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 149.77 127.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.799 -0.637 . . . . 0.19 111.845 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -114.29 145.26 41.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.84 -0.43 . . . . 0.7 109.84 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 -7.17 37.2 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.79 -0.448 . . . . 0.81 109.79 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER 56.77 53.46 8.26 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.988 -1.005 . . . . 0.98 111.272 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -71.78 -23.11 61.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.235 0.54 . . . . 0.97 109.807 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.4 -0.809 . . . . 1.42 109.718 179.102 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 111.549 -0.62 . . . . 0.35 111.549 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -69.24 127.54 33.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.902 -0.407 . . . . 0.31 109.902 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.5 mmt -53.49 -53.47 51.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.756 0.312 . . . . 1.29 110.464 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -96.13 106.44 18.62 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.515 -0.55 . . . . 1.11 109.515 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 tp -152.6 120.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.378 0.608 . . . . 0.43 110.667 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -84.66 110.44 18.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 0.91 110.24 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -144.0 108.31 5.0 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.943 -0.571 . . . . 0.22 110.327 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 7' ' ' THR . 19.3 Cg_endo -61.73 109.76 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.594 2.196 . . . . 0.67 112.1 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 16' ' ' ASN . 7.9 p -114.46 105.65 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.13 -0.486 . . . . 0.42 110.729 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -131.58 -82.63 0.51 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.615 0.245 . . . . 1.15 110.683 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -129.34 -122.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.601 -0.272 . . . . 1.23 110.598 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.95 94.42 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.23 110.636 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 13' ' ' ARG . 10.3 mmt85 -134.4 -171.47 2.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.686 -0.688 . . . . 1.51 109.759 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tp -116.54 12.65 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.275 0.559 . . . . 1.37 110.379 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.65 -32.75 7.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 0.66 111.833 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 9' ' ' THR . 26.0 p-10 -97.63 18.62 15.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 1.1 111.443 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.1 m -85.8 157.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.599 0.714 . . . . 0.34 112.786 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.11 140.05 53.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.625 -1.17 . . . . 0.42 108.96 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -89.08 98.57 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.49 111.311 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.777 HG22 HG22 ' A' ' 89' ' ' ILE . 2.3 p -103.36 120.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.847 -0.615 . . . . 0.24 109.696 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -122.75 132.56 54.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.135 0.493 . . . . 0.28 112.146 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 89' ' ' ILE . 39.0 ttp -107.01 122.66 46.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.17 110.337 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -97.63 123.62 41.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 1.19 109.99 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -107.39 -154.9 0.53 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.449 -0.341 . . . . 0.36 110.096 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.43 -59.55 2.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.84 0.311 . . . . 0.59 111.84 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.84 21.56 5.88 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.638 -0.791 . . . . 0.56 112.634 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -155.86 161.01 40.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.692 -0.484 . . . . 0.8 109.692 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 142.83 28.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.341 -0.615 . . . . 0.36 109.341 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.89 141.26 47.3 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.343 0.402 . . . . 0.22 110.523 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' CD1' ' A' ' 59' ' ' PHE . 14.1 pt-20 -139.68 149.22 43.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.052 -0.351 . . . . 0.21 110.052 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.3 pt -136.75 -176.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.771 -0.65 . . . . 0.3 110.591 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.36 109.88 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.308 0.575 . . . . 0.19 111.282 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 11.3 p -117.77 -179.63 3.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.698 -0.853 . . . . 0.31 108.698 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -70.32 143.12 52.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.479 -0.489 . . . . 0.36 110.212 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -85.4 -41.87 15.05 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.383 0.512 . . . . 0.86 112.383 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -64.63 127.45 31.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.642 -0.254 . . . . 1.6 111.643 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.5 pttp 43.64 37.34 1.5 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.31 1.044 . . . . 1.59 113.021 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.7 p -64.47 -21.73 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.52 0.676 . . . . 0.4 111.178 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.57 -4.2 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.56 110.802 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 -24.05 71.21 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.4 112.693 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.518 ' NE1' ' HB3' ' A' ' 90' ' ' LEU . 1.3 p-90 -75.22 -33.11 61.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.394 . . . . 0.25 110.049 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' NH2' ' HA ' ' A' ' 91' ' ' THR . 10.7 tpp85 -72.12 -22.21 61.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.17 0.509 . . . . 1.25 110.272 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -101.86 -6.11 23.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.81 110.905 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.18 44.88 90.13 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.035 -0.53 . . . . 0.25 112.711 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 t -119.44 -18.56 5.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.969 0.414 . . . . 0.66 110.659 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -91.38 -170.35 2.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 1.78 112.059 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -170.83 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.475 -0.784 . . . . 1.77 111.194 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.06 149.02 48.42 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.99 110.94 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.76 -20.97 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.39 111.392 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -30.24 71.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 1.01 110.473 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.26 -24.46 24.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.99 109.823 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 34' ' ' TYR . 49.2 t -69.29 -41.18 80.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.537 -0.756 . . . . 0.11 110.121 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD11 HE21 ' A' ' 82' ' ' GLN . 0.7 OUTLIER -75.8 92.28 3.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.426 -0.806 . . . . 0.3 109.899 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -74.64 -61.52 1.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.28 111.834 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.84 108.02 19.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.894 0.378 . . . . 0.27 110.944 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' HA ' HD11 ' A' ' 53' ' ' LEU . 1.9 p-80 -83.4 69.32 9.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.224 0.535 . . . . 0.93 111.438 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -154.4 105.06 2.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.822 -0.626 . . . . 0.22 110.13 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 68' ' ' ALA . 10.9 p -94.7 141.55 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.394 -0.595 . . . . 0.27 109.394 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.669 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -93.73 157.76 16.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.064 0.459 . . . . 0.24 111.678 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 39.7 t -106.29 -56.47 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.47 -0.937 . . . . 0.26 108.47 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -150.02 116.79 5.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.54 109.406 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.97 -17.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.044 -0.525 . . . . 0.22 111.252 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.9 t -64.81 -26.26 68.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 1.35 110.689 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -122.64 -0.91 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.431 . . . . 0.93 110.987 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.96 37.48 64.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.936 -0.649 . . . . 0.37 112.039 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -86.37 118.73 26.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.312 . . . . 1.56 110.772 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.79 144.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.59 109.732 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.693 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -107.29 133.06 52.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.15 0.5 . . . . 0.23 110.631 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 7.3 mtmt -107.64 -171.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.736 -0.666 . . . . 1.25 109.884 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.54 68.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.683 0.277 . . . . 0.3 111.263 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 69' ' ' LYS . 5.0 pm0 -80.32 -5.67 56.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.529 -0.305 . . . . 0.46 111.482 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.33 -44.15 4.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.84 -0.344 . . . . 0.43 110.966 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.35 -26.91 68.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.93 0.395 . . . . 0.18 110.454 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -27.83 33.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 116.077 -0.511 . . . . 0.28 109.908 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 -17.66 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.448 0.642 . . . . 0.19 109.63 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.28 -59.19 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.748 . . . . 0.32 110.664 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -95.19 -52.0 4.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.284 -0.417 . . . . 0.25 110.464 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.06 -26.68 2.71 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.472 -0.651 . . . . 0.2 111.472 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.36 143.49 28.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.564 -0.318 . . . . 0.22 110.617 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.85 10.08 32.57 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 1.44 110.817 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.5 120.25 36.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.602 -0.726 . . . . 0.76 110.454 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.457 HE21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.18 -29.78 71.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.23 111.091 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -60.11 -37.87 81.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.21 110.795 179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.92 -24.9 62.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.182 0.515 . . . . 0.65 110.637 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.6 mm -79.49 -49.05 20.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.13 109.47 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 25.7 p -67.51 -29.33 68.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.706 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 83' ' ' THR . 18.5 ttpt -66.07 -16.59 64.06 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.211 0.529 . . . . 0.47 110.419 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -91.89 -52.59 4.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.67 109.692 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.777 HG22 HG22 ' A' ' 20' ' ' VAL . 19.6 mt -61.44 -35.31 65.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.748 -0.66 . . . . 0.34 112.365 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.518 ' HB3' ' NE1' ' A' ' 41' ' ' TRP . 2.1 mm? -73.95 2.37 8.78 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.422 0.897 . . . . 0.27 113.422 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.576 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 3.3 t -145.4 -32.92 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.611 -0.436 . . . . 0.93 112.135 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' HG2' HG23 ' A' ' 91' ' ' THR . 40.6 mmtm -96.03 10.21 38.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.001 -0.37 . . . . 1.32 110.001 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.92 -173.79 13.31 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.784 -0.722 . . . . 0.34 112.093 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -95.6 101.73 13.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.842 0.353 . . . . 2.19 110.398 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 p -100.35 133.35 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.992 -0.549 . . . . 0.39 109.688 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -74.19 84.71 1.86 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.272 0.558 . . . . 1.55 110.326 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.03 162.97 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 1.11 111.455 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.7 m -140.7 153.02 45.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.595 -0.73 . . . . 1.35 109.459 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -74.69 95.02 2.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 1.22 110.518 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -159.01 131.63 6.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 1.91 110.802 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 162.38 27.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.31 110.272 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -162.82 160.3 25.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.771 -0.455 . . . . 2.33 109.771 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -108.16 147.51 31.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.76 0.314 . . . . 0.75 110.605 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.33 137.26 52.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.048 -0.524 . . . . 0.44 110.998 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.51 118.63 37.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.981 -0.377 . . . . 2.48 109.981 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -141.23 150.24 42.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.387 -0.369 . . . . 0.6 110.339 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.91 -29.14 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.291 0.567 . . . . 1.97 110.097 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -77.12 16.92 0.5 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.714 -0.675 . . . . 1.26 111.192 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.1 ttm -60.84 -34.37 74.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.546 -0.297 . . . . 1.27 110.91 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -58.45 -49.57 76.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.51 110.506 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -71.72 -34.13 69.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.882 -0.599 . . . . 1.8 110.298 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -56.58 -49.58 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.903 -0.59 . . . . 0.3 110.746 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.35 -39.88 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.22 110.441 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' A' ' 135' ' ' ILE . . . -65.32 -40.81 94.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.752 . . . . 0.14 112.756 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.1 t -70.58 -15.48 62.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.212 0.449 . . . . 0.31 112.212 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.85 -33.88 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.87 110.766 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.2 p -86.81 -13.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.411 -0.358 . . . . 0.63 111.047 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.56 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.46 111.984 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -13.74 62.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 1.72 111.3 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -15.82 57.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 1.27 111.108 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.6 p -119.55 140.66 50.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.111 0.482 . . . . 0.29 111.091 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.63 161.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.248 -0.433 . . . . 0.2 109.957 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . 2.0 p30 -149.91 165.09 18.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.515 -0.55 . . . . 0.15 109.515 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 123' ' ' ASN . 43.0 Cg_endo -67.81 -164.66 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.678 2.252 . . . . 0.12 112.778 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.59 59.21 2.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.85 111.488 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t -129.41 -23.11 2.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.816 0.341 . . . . 0.2 110.623 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 1.8 tppt? -154.57 159.04 40.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.53 109.73 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.04 142.71 36.45 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.725 -0.472 . . . . 1.23 109.725 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.92 -8.32 19.47 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.577 2.185 . . . . 0.25 112.106 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.12 9.27 36.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.935 -0.575 . . . . 0.29 110.663 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 m -82.95 89.07 6.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.411 0.624 . . . . 0.24 110.303 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.4 t -63.22 -33.12 59.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.305 -0.862 . . . . 0.13 111.401 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.06 -31.8 46.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.068 -0.514 . . . . 0.18 111.774 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.86 -54.42 42.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.18 110.872 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.466 HG23 ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -69.75 -29.38 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.4 110.535 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -57.6 -44.31 85.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.436 -0.347 . . . . 0.25 110.775 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -60.13 -39.22 85.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 1.93 111.157 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.78 -39.95 56.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.332 -0.394 . . . . 0.11 111.054 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -50.25 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.27 111.322 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.52 -17.63 64.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.531 -0.304 . . . . 1.07 111.607 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.98 -33.42 61.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.403 HD13 ' HG2' ' A' ' 162' ' ' GLN . 10.3 mt -82.05 -40.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.671 -0.695 . . . . 0.28 109.848 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 63.72 32.67 13.55 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.544 -0.753 . . . . 1.07 111.162 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -100.12 104.04 15.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.87 -0.604 . . . . 0.64 109.781 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 m -74.13 134.79 42.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.43 110.529 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.32 75.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.04 -0.527 . . . . 0.45 110.397 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.66 -168.82 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.189 -0.914 . . . . 1.15 110.985 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.0 t -125.92 15.96 7.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.739 0.781 . . . . 0.5 109.573 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -100.06 -0.26 39.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.161 -0.927 . . . . 1.0 111.078 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.79 20.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.157 0.503 . . . . 0.61 110.004 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 1.5 m -77.21 51.45 0.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.22 112.279 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -28.53 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.23 111.902 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 11.88 35.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.068 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 2.0 tp-100 -113.5 -49.25 2.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.395 -0.366 . . . . 1.06 110.524 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 159' ' ' VAL . 40.5 mt-30 -105.94 34.05 3.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 0.6 111.204 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.42 -35.97 77.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.942 -0.572 . . . . 0.15 110.845 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.91 -25.04 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.015 -0.539 . . . . 1.43 111.068 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -79.58 -42.42 25.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.828 -0.434 . . . . 0.58 109.828 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.489 ' O ' HD12 ' A' ' 163' ' ' LEU . 21.8 t -64.53 -41.72 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.934 -0.575 . . . . 0.16 111.002 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -26.08 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.457 . . . . 0.45 111.598 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -93.69 -21.67 19.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.12 0.486 . . . . 0.41 110.134 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HG2' HD13 ' A' ' 142' ' ' ILE . 20.7 tt0 -67.46 -53.0 32.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.64 -0.709 . . . . 0.52 111.533 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -79.59 -10.79 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.678 -0.409 . . . . 0.23 110.942 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.444 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.7 ttpt -65.05 -26.57 68.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.79 110.035 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.09 -8.3 58.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 2.07 110.612 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -110.56 -35.23 6.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.189 -0.46 . . . . 0.5 110.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.49 130.7 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.237 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.13 82.29 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.361 0.601 . . . . 1.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.9 pt -94.94 175.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.523 -0.762 . . . . 0.78 111.585 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -127.23 171.41 11.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.69 110.058 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 171' ' ' ARG . 34.2 ttt180 -162.87 75.88 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.153 0.501 . . . . 1.0 109.926 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.97 98.67 10.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.926 -0.579 . . . . 0.13 110.639 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -162.02 134.16 5.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.28 110.925 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -120.77 170.62 9.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.747 -0.66 . . . . 0.42 109.713 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 mtm180 -92.74 135.73 33.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.035 -0.358 . . . . 0.51 110.035 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.1 150.26 43.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.012 0.434 . . . . 0.24 111.081 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -120.88 -176.15 3.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.89 109.371 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.1 p90 -150.16 127.91 11.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.777 -0.453 . . . . 0.39 109.777 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.8 126.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.008 -0.542 . . . . 0.56 111.26 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 2.6 pt? -167.34 147.24 4.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.38 -0.827 . . . . 1.16 109.472 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.44 162.3 34.41 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.858 2.372 . . . . 0.27 112.914 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.6 -35.44 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.39 111.44 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -47.86 -47.51 31.58 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.795 -0.638 . . . . 0.65 111.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.24 -26.42 14.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.7 0.286 . . . . 0.74 110.973 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.86 -33.19 77.33 Favored Glycine 0 N--CA 1.454 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.2 113.041 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -64.04 -14.29 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.088 0.403 . . . . 2.3 112.088 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -44.81 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.559 0.219 . . . . 0.77 111.252 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.7 pp -86.12 -20.69 28.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.23 110.483 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.91 -41.95 62.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.421 -0.809 . . . . 1.46 111.969 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.467 ' H ' ' HG2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -103.94 15.49 28.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.235 0.457 . . . . 1.16 112.235 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -124.22 -30.49 3.44 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.452 -0.499 . . . . 2.42 111.692 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.19 -42.83 9.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.593 0.235 . . . . 0.26 111.468 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 13.5 mtpt -58.05 -47.35 99.03 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.051 0.76 . . . . 0.28 113.051 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 22.3 Cg_endo -60.72 -16.26 42.53 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.199 1.933 . . . . 0.16 113.401 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.76 -21.0 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.336 -0.246 . . . . 0.14 110.336 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 78.86 -10.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.466 -0.788 . . . . 0.17 111.526 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -86.74 54.36 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.248 0.547 . . . . 0.98 110.771 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.85 138.41 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.258 -0.883 . . . . 0.23 109.613 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.6 142.26 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.658 -0.497 . . . . 0.94 109.658 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -68.76 81.94 0.29 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.133 0.492 . . . . 1.99 110.465 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.446 ' HA ' ' HA3' ' A' ' 247' ' ' GLY . 68.8 m -157.53 31.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.333 -0.849 . . . . 0.17 109.745 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 1.1 mp0 -79.96 154.41 28.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.101 -0.5 . . . . 0.36 110.66 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -108.58 111.86 23.91 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.159 -0.682 . . . . 0.57 109.159 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.39 80.43 3.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.217 0.532 . . . . 1.22 110.356 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -148.36 -130.56 1.96 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.685 -0.689 . . . . 0.36 112.197 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -78.84 -26.76 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.105 0.478 . . . . 0.75 110.601 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.67 145.19 49.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.91 -0.774 . . . . 1.38 108.91 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 28.1 tp -105.03 85.9 2.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.936 0.398 . . . . 0.38 110.972 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 5.0 tt0 -93.11 118.69 31.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.97 109.748 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 19.8 mt -128.68 159.13 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.569 -0.287 . . . . 0.11 111.026 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 177' ' ' ARG . 19.9 t -116.6 121.13 66.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.656 -0.498 . . . . 0.21 109.656 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.436 ' SG ' ' HE2' ' A' ' 178' ' ' PHE . 4.6 p -118.51 -30.52 5.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.113 0.412 . . . . 0.58 112.113 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 213' ' ' LEU . 2.3 mm? -68.62 108.47 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.692 0.282 . . . . 0.45 111.013 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.6 tt -110.28 -54.87 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.564 0.579 . . . . 0.38 112.564 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.56 162.2 54.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.04 0.385 . . . . 0.33 112.04 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.33 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.013 2.475 . . . . 0.31 111.334 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 219' ' ' PHE . . . 65.35 -81.15 0.08 OUTLIER Glycine 0 C--N 1.339 0.703 0 O-C-N 123.463 0.477 . . . . 0.18 111.963 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 2.1 p -75.6 17.97 0.26 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.179 0.592 . . . . 0.67 111.117 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 217' ' ' GLY . 8.6 p90 -87.76 -16.94 32.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.4 109.859 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -69.28 -48.11 62.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 1.46 110.549 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.57 -31.02 71.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 1.36 110.758 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 46.1 mm -82.8 -42.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.491 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.79 -37.07 68.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.55 111.05 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -56.1 -35.21 66.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 1.28 111.758 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.7 pp -94.41 -33.05 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.475 -0.49 . . . . 1.43 110.834 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.4 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-N 116.395 -0.366 . . . . 0.42 111.418 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 13.7 ptpt -63.53 -22.11 66.71 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.127 0.417 . . . . 0.91 112.127 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.45 8.65 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 0.38 111.167 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -108.96 -83.52 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.126 -0.488 . . . . 1.33 110.697 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.1 t -84.38 -30.01 25.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.305 -0.407 . . . . 0.22 111.184 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 24.3 tptm -64.64 -30.89 71.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.992 0.425 . . . . 0.71 111.05 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.19 12.56 66.69 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.528 -0.844 . . . . 0.37 112.235 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -123.79 -46.85 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.919 0.39 . . . . 0.76 110.593 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 180' ' ' LEU . . . -125.55 -162.25 11.25 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.773 -0.727 . . . . 0.24 112.562 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.94 132.23 56.07 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.21 -0.292 . . . . 1.03 110.21 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 178' ' ' PHE . 3.1 pp -80.04 157.29 26.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.057 0.456 . . . . 1.51 111.097 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.71 153.39 38.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.597 -0.729 . . . . 0.85 109.485 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.9 m -85.77 156.96 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.237 -0.282 . . . . 0.29 110.237 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.0 77.29 10.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.014 0.435 . . . . 0.42 110.695 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.62 -2.51 58.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.814 -0.63 . . . . 1.19 110.184 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 241' ' ' LEU . 3.3 mm? -79.75 78.64 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 1.36 110.194 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -116.84 17.19 15.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.731 -0.668 . . . . 0.95 110.379 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -107.99 -58.27 2.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 2.11 110.856 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.5 149.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.989 -0.551 . . . . 0.28 110.089 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.58 144.0 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.784 0.326 . . . . 1.53 110.303 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -147.16 156.56 43.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.221 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 201' ' ' SER . . . 106.36 110.08 3.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.757 -0.735 . . . . 0.51 111.637 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -122.74 125.3 45.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.45 111.217 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.76 7.12 9.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.888 -0.596 . . . . 0.95 109.725 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.12 107.52 17.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 1.07 110.497 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -72.06 -32.53 67.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.109 0.48 . . . . 0.92 110.035 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.436 -0.802 . . . . 1.4 109.758 -179.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.642 -0.583 . . . . 0.18 111.642 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -72.38 -53.3 12.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.74 0.305 . . . . 1.13 110.205 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 mtt 60.72 30.36 19.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.607 -0.724 . . . . 1.3 111.347 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.48 -6.25 52.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.837 -0.619 . . . . 0.66 110.968 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mt 57.7 62.59 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.497 0.665 . . . . 0.43 110.036 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -99.08 27.14 5.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.732 -0.667 . . . . 0.27 110.881 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -104.72 96.18 10.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.431 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.78 -12.47 20.02 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.513 2.142 . . . . 0.92 112.411 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t 49.66 24.44 1.19 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.341 1.056 . . . . 0.98 112.567 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -69.79 157.67 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.884 -0.598 . . . . 1.84 110.042 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 1.76 111.594 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.99 81.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.75 111.251 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -153.7 143.67 22.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.951 -0.568 . . . . 1.28 109.981 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' VAL . 82.0 mt -67.25 -13.15 61.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 1.3 111.147 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 p -87.35 4.11 44.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.4 110.849 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -139.29 35.91 2.08 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.463 0.649 . . . . 0.38 110.321 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 14' ' ' LEU . 20.3 m -106.41 156.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.18 111.633 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . . . -108.85 137.67 46.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.23 109.958 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 t -78.98 108.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.932 0.396 . . . . 0.44 110.722 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 89' ' ' ILE . 2.4 p -121.11 129.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.922 -0.581 . . . . 0.16 109.925 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -145.0 144.11 30.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.953 0.406 . . . . 1.06 111.34 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 89' ' ' ILE . 23.2 ttt -127.93 127.29 43.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.671 -0.695 . . . . 0.22 109.819 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.97 118.51 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.014 0.435 . . . . 0.86 110.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 9.8 mmm180 -92.72 -155.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.906 -0.588 . . . . 1.69 109.99 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.96 -54.08 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.51 110.986 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.53 -34.4 1.09 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.431 -0.89 . . . . 0.17 112.48 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 29.1 tptt -97.77 158.94 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.933 0.397 . . . . 1.07 110.496 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 152.76 38.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.168 -0.678 . . . . 0.77 109.168 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.02 140.35 38.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.034 0.445 . . . . 0.26 111.213 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -130.4 130.19 44.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 1.1 109.717 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -174.49 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.136 0.493 . . . . 0.25 111.361 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.54 103.04 4.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.16 109.791 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -102.88 -173.22 2.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.15 110.11 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -75.7 150.06 37.96 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.73 -0.47 . . . . 0.26 109.73 178.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 52.8 pttt -108.61 28.5 8.33 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.428 -0.509 . . . . 1.32 110.966 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -103.11 81.78 2.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.54 109.919 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt 57.86 49.4 12.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.984 -0.553 . . . . 0.58 110.948 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.23 -23.73 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.762 -0.654 . . . . 0.22 111.802 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.98 -4.43 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.207 0.527 . . . . 0.17 110.626 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.54 98.19 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.1 112.642 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.64 -34.28 77.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.119 0.485 . . . . 1.18 110.847 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -80.47 -19.25 46.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.143 -0.48 . . . . 1.29 111.001 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 m -91.73 -45.45 8.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.15 110.468 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.04 -99.86 0.14 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.391 -0.684 . . . . 0.14 111.391 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.07 135.29 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.152 -0.684 . . . . 0.29 109.152 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -113.86 -63.13 1.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.972 -0.291 . . . . 0.65 111.105 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -151.8 -76.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.649 -0.25 . . . . 0.7 110.561 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.25 148.6 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.644 0.259 . . . . 0.72 110.528 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.24 -31.01 72.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.141 -0.482 . . . . 0.56 111.654 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.95 -32.49 72.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.53 110.628 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.99 -19.76 60.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.083 0.468 . . . . 1.8 110.407 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 66.9 t -74.34 -43.74 49.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.731 -0.668 . . . . 0.15 109.57 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.05 99.25 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.435 -0.802 . . . . 1.45 111.138 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 34' ' ' TYR . 14.6 mt-30 -84.13 -65.09 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.5 109.975 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.2 t -97.16 130.64 44.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.183 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.37 -5.66 59.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.132 -0.485 . . . . 1.23 110.668 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -96.39 116.13 28.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.138 -0.483 . . . . 0.79 110.523 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.7 p -100.44 146.4 9.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.925 -0.58 . . . . 0.15 109.624 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -102.0 154.38 19.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.27 111.126 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.2 t -103.78 -31.4 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.18 109.485 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.2 91.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.069 -0.969 . . . . 0.49 109.218 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.05 -28.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.465 -0.334 . . . . 0.21 111.826 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -34.43 77.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.876 0.37 . . . . 0.6 111.158 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -106.52 10.9 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 2.39 111.031 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.36 28.62 71.32 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.876 -0.678 . . . . 0.4 112.468 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.33 110.83 14.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.571 0.224 . . . . 1.57 110.44 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.81 133.81 52.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.999 -0.546 . . . . 0.21 110.444 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -101.55 116.33 32.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.023 0.439 . . . . 0.11 109.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -87.53 -179.52 6.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.87 -0.605 . . . . 1.56 110.105 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -57.57 -32.95 67.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.67 111.271 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -87.57 7.88 27.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.182 -0.463 . . . . 0.67 111.29 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.81 -48.77 3.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.82 110.081 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.93 -31.92 73.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.999 -0.546 . . . . 0.31 110.212 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -28.14 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.886 -0.597 . . . . 0.23 110.348 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -92.46 -8.43 44.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.235 0.541 . . . . 0.71 110.965 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.65 -58.83 2.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.18 110.97 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -89.69 -34.88 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.396 -0.365 . . . . 0.83 110.833 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.09 30.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.524 -0.846 . . . . 0.3 112.283 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 81' ' ' ASP . 1.5 m -134.23 136.4 43.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.005 -0.369 . . . . 0.7 110.005 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.74 -12.93 57.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.64 110.748 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 79' ' ' THR . 28.9 t70 -69.16 102.66 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.927 -0.579 . . . . 0.54 110.396 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.48 -23.65 66.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.89 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.4 88.86 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.734 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.45 -34.93 79.45 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.854 0.359 . . . . 0.33 110.234 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -62.3 -51.68 69.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.392 -0.596 . . . . 0.24 109.392 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 54.0 t -64.63 -32.55 74.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.457 -0.792 . . . . 0.14 110.374 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -57.63 -51.98 67.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.931 -0.577 . . . . 1.2 110.838 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -63.59 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.549 . . . . 0.3 111.177 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 20' ' ' VAL . 63.8 mt -66.98 -24.69 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.107 0.48 . . . . 0.15 111.48 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -80.21 -33.26 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.735 0.303 . . . . 0.3 111.582 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.2 t -97.83 -22.65 16.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.789 0.663 . . . . 0.37 112.789 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 91' ' ' THR . 14.3 mmmm -115.22 -2.97 12.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.579 -0.448 . . . . 0.65 111.761 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.42 -176.69 21.32 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.517 -0.849 . . . . 0.52 112.291 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -108.15 107.84 18.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.212 0.529 . . . . 1.32 110.409 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 20' ' ' VAL . 3.6 p -111.61 142.14 24.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.431 -0.804 . . . . 0.22 110.186 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 99.82 0.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.239 0.542 . . . . 0.82 110.596 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.61 -179.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.747 -0.66 . . . . 0.51 111.691 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 m -122.02 146.97 46.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.49 -0.777 . . . . 0.26 109.554 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -130.01 -169.55 2.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.645 -0.252 . . . . 0.82 110.794 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.5 tttm 77.98 2.68 2.87 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.162 0.913 . . . . 1.29 111.648 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -101.14 98.44 8.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.095 0.474 . . . . 1.59 110.566 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 118.77 2.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.551 -0.75 . . . . 1.02 110.021 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -134.94 36.83 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.221 0.534 . . . . 0.82 110.167 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.07 13.35 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.682 -0.69 . . . . 0.29 110.348 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -82.99 81.56 8.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.762 -0.654 . . . . 0.27 111.03 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -114.81 159.39 20.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.733 . . . . 0.78 109.465 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.56 147.36 49.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.498 -0.319 . . . . 1.55 111.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 63.42 16.55 9.63 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.634 -0.712 . . . . 0.78 111.765 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.5 tpp -63.34 -34.06 76.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.948 0.404 . . . . 0.76 110.819 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -59.21 -45.85 90.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.046 -0.524 . . . . 0.81 110.167 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -70.47 -34.99 73.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 1.29 110.881 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.64 -38.6 88.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.127 -0.488 . . . . 0.6 111.241 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.3 tt -87.88 -31.03 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.971 0.415 . . . . 0.4 110.482 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -64.4 -31.4 72.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.389 -0.369 . . . . 0.13 111.148 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 t -63.83 -20.22 65.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.14 110.74 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.19 -43.67 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.933 0.397 . . . . 0.42 110.384 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 114' ' ' ALA . 4.3 p -72.15 -19.87 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.3 111.572 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.7 69.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.922 0.342 . . . . 0.35 111.922 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -107.86 19.69 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 1.23 110.246 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -123.6 -40.31 2.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.69 110.35 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 19.9 m -114.4 106.9 14.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.031 -0.532 . . . . 0.56 110.16 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG11 ' HA2' ' A' ' 217' ' ' GLY . 6.3 m -126.35 163.79 27.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.23 111.024 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 168' ' ' LYS . 23.5 p-10 -130.97 141.98 43.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.588 . . . . 0.38 110.19 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.57 44.58 1.76 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.742 2.295 . . . . 0.6 112.854 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -116.94 -165.91 1.11 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.278 -0.419 . . . . 1.17 110.165 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 t -66.16 -19.88 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.361 . . . . 0.4 111.769 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -84.0 71.59 10.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.608 0.242 . . . . 1.2 110.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -58.03 144.76 74.87 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 1.79 111.177 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.14 117.23 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.491 2.127 . . . . 0.49 112.69 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.403 ' OH ' ' HG2' ' A' ' 221' ' ' GLU . 0.1 OUTLIER -170.15 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 1.15 110.026 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.31 124.3 28.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.954 -0.566 . . . . 0.32 110.791 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 135' ' ' ILE . 49.6 t -62.18 -35.24 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.869 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.6 mm -56.5 -29.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.942 -0.572 . . . . 0.31 111.662 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.33 -32.3 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.45 111.444 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 132' ' ' VAL . 10.0 tp -93.56 -30.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.729 -0.388 . . . . 1.02 110.23 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 26.0 tt0 -64.97 -35.75 82.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.183 0.516 . . . . 1.13 109.877 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -59.21 -31.49 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.388 -0.824 . . . . 0.75 110.875 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -83.79 -32.37 25.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.24 110.72 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.4 ' CE ' ' HA ' ' A' ' 139' ' ' MET . 0.7 OUTLIER -68.58 -45.88 70.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.41 111.727 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 45.2 pttt -80.15 -9.84 59.73 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.806 -0.358 . . . . 0.19 110.903 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' ARG . 35.0 t70 -75.79 -46.41 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.49 109.655 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 143' ' ' HIS . 18.1 tt -84.71 -19.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.594 -0.73 . . . . 0.35 110.23 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 142' ' ' ILE . 60.5 m-70 72.68 90.7 0.09 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.379 -0.828 . . . . 0.31 111.488 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -75.72 95.79 3.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.863 -1.062 . . . . 0.85 110.239 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -155.36 74.69 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.902 -0.59 . . . . 0.65 109.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.8 67.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.194 -0.457 . . . . 0.54 110.776 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 149' ' ' ASN . 16.3 mtpt 55.0 79.27 0.15 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.698 -0.683 . . . . 0.33 111.244 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.64 17.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.83 111.999 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 147' ' ' LYS . 4.5 t-20 -68.8 -62.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.211 -0.449 . . . . 0.35 109.824 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.52 138.55 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.746 -0.661 . . . . 0.91 109.847 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -163.42 -158.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.668 -0.493 . . . . 0.99 109.668 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.91 95.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.535 0.334 . . . . 0.38 111.853 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 53.72 42.99 31.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.752 -0.658 . . . . 0.45 110.553 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.7 tp60 60.72 66.95 0.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.163 -0.926 . . . . 0.78 111.46 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.627 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 0.4 OUTLIER 55.9 31.03 17.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.151 -0.931 . . . . 0.76 113.13 178.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.02 63.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.179 0.514 . . . . 0.35 110.613 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -29.66 42.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.363 0.601 . . . . 0.63 110.237 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.627 ' OE1' ' HA ' ' A' ' 155' ' ' GLN . 6.4 mp0 -68.54 -41.75 79.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.98 111.379 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.26 -30.29 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.528 0.204 . . . . 0.98 111.48 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.69 -39.66 86.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.021 0.439 . . . . 0.39 110.704 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.16 -5.5 59.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.81 111.033 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.58 -70.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 1.44 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -70.88 -11.08 60.75 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.28 -0.418 . . . . 1.46 111.397 -179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -61.55 -34.64 75.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.164 0.507 . . . . 1.16 110.255 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -87.79 23.7 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.759 -0.655 . . . . 0.6 110.815 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -138.73 -52.98 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.937 -0.574 . . . . 0.79 110.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.1 ttm -139.7 151.16 45.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.12 -0.491 . . . . 0.97 110.019 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 123' ' ' ASN . 11.5 ptpt -71.59 131.91 43.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 1.09 110.467 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.492 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -140.6 -162.05 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.052 -0.522 . . . . 0.58 110.344 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.8 110.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.927 0.767 . . . . 2.47 112.019 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.85 102.46 3.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.523 -0.762 . . . . 1.97 109.773 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.53 133.92 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.2 111.081 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.46 89.78 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.21 110.221 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 173.92 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.904 0.383 . . . . 1.16 111.136 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -83.49 143.64 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 1.81 110.533 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.8 mp -126.55 161.94 26.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.208 -0.451 . . . . 0.72 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 15.8 ptt180 -127.09 154.93 44.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.2 -0.454 . . . . 0.32 110.156 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 63.2 t80 -120.98 131.26 54.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.439 -0.346 . . . . 0.21 110.217 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.91 133.36 66.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.463 0.173 . . . . 0.45 111.358 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 178' ' ' PHE . 1.0 OUTLIER -171.37 161.1 5.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.688 -0.233 . . . . 0.15 110.518 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.22 155.77 66.7 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.23 . . . . 0.17 112.476 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.05 -33.94 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.995 -0.548 . . . . 0.67 111.749 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -48.79 -48.81 40.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.221 -0.445 . . . . 1.69 111.725 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -95.77 -28.15 14.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.857 0.36 . . . . 0.53 110.946 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.11 -32.06 81.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.012 -0.613 . . . . 0.23 112.779 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -31.5 71.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.73 0.3 . . . . 0.83 111.405 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.11 -46.47 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.25 111.189 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -17.53 39.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.41 111.175 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -57.24 -44.59 83.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.14 110.588 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.72 17.12 5.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.46 111.485 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -129.08 -39.24 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.31 111.662 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.62 -42.57 24.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.29 -0.414 . . . . 0.3 111.758 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 30.0 mtpp -62.63 -48.0 87.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.743 0.646 . . . . 0.68 112.743 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 18.2 Cg_endo -59.47 -8.61 7.26 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.583 2.189 . . . . 0.04 113.837 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.37 -14.83 60.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.21 110.121 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.6 mm 59.56 32.88 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.835 0.826 . . . . 0.16 110.273 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.434 ' HD3' HD12 ' A' ' 222' ' ' ILE . 28.4 mttp -125.89 23.01 7.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.656 -0.702 . . . . 0.5 110.322 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.5 m -103.26 134.63 43.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.14 110.439 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -84.68 147.93 5.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.279 -0.419 . . . . 0.91 109.979 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 63.35 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 1.59 111.42 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 m -140.22 21.53 2.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.277 -0.638 . . . . 1.05 109.277 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.475 ' HG2' HG23 ' A' ' 210' ' ' ILE . 46.3 mt-10 -71.53 140.77 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.648 -0.706 . . . . 1.06 111.263 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.42 105.2 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.42 -0.585 . . . . 0.65 109.42 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.479 ' H ' ' HB3' ' A' ' 248' ' ' ASP . 0.2 OUTLIER -86.61 102.04 13.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.022 -0.536 . . . . 1.73 110.723 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -169.11 -150.06 6.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.983 -0.627 . . . . 0.63 111.826 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -64.09 -31.31 72.45 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.028 0.442 . . . . 1.88 110.604 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -117.45 109.42 16.75 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.952 -0.759 . . . . 1.13 108.952 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.3 99.78 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.599 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.2 tt0 -100.98 109.41 21.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.35 109.614 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.475 HG23 ' HG2' ' A' ' 202' ' ' GLU . 66.3 mt -117.26 134.83 59.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.306 -0.407 . . . . 0.24 110.576 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.61 105.9 18.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.087 -0.506 . . . . 0.23 109.925 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 8.4 t -130.78 96.58 4.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.368 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 132.87 11.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.306 -0.628 . . . . 0.33 109.306 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.2 tt -122.88 171.16 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.517 -0.31 . . . . 0.34 110.28 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.59 171.0 3.15 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.005 0.522 . . . . 0.56 111.091 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.33 -163.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.394 2.062 . . . . 0.37 113.105 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.434 ' HA2' HG11 ' A' ' 122' ' ' VAL . . . 82.81 -95.68 1.83 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.507 -0.854 . . . . 0.33 111.092 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 8.8 m -80.77 17.94 1.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.537 . . . . 0.45 110.445 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.84 -23.1 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.592 . . . . 0.25 111.599 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.1 -45.48 63.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.026 0.441 . . . . 1.42 110.201 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' HG2' ' OH ' ' A' ' 130' ' ' TYR . 15.9 mp0 -62.49 -20.7 64.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.418 -0.81 . . . . 1.96 112.356 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.623 ' O ' HG12 ' A' ' 226' ' ' ILE . 6.4 tt -98.57 -43.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.454 -0.499 . . . . 0.47 111.11 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.07 -32.76 74.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.74 0.274 . . . . 0.37 111.74 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.46 -25.06 61.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.428 -0.351 . . . . 0.98 111.553 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.3 pp -101.27 -28.79 12.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.005 0.431 . . . . 0.44 110.109 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.4 mm -64.51 -33.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.2 111.0 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 11.4 ptmt -60.48 -26.25 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.84 0.682 . . . . 1.19 112.84 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -111.45 -20.57 12.17 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.48 -0.488 . . . . 0.69 112.094 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.25 -46.67 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.39 111.55 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.442 ' OG1' HG23 ' A' ' 226' ' ' ILE . 0.2 OUTLIER -113.42 -56.14 2.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.173 0.434 . . . . 0.48 112.173 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 49.4 mtmt -64.69 -7.7 11.73 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.25 111.825 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.33 16.66 32.01 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.975 -0.631 . . . . 0.28 111.648 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -128.51 -56.12 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.643 0.258 . . . . 0.64 111.527 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -123.02 -139.21 5.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.326 -0.94 . . . . 0.46 113.369 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 73.3 m -121.51 141.62 50.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.35 111.431 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.9 OUTLIER -110.84 150.21 29.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.398 -0.819 . . . . 0.21 109.997 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.95 161.57 39.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 0.26 109.916 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.17 153.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.317 . . . . 0.37 110.647 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 241' ' ' LEU . 23.8 tp -102.5 112.32 25.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.37 109.861 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -88.23 2.3 52.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.347 0.594 . . . . 1.53 110.687 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 239' ' ' LEU . 4.2 mm? -77.8 69.62 4.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.388 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -94.34 -1.74 53.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 0.69 110.35 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -84.24 -68.71 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.578 -0.737 . . . . 2.37 110.2 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.82 151.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.802 -0.636 . . . . 0.58 109.755 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -96.87 98.27 9.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.984 0.421 . . . . 1.06 110.409 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -115.81 157.49 24.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.69 110.269 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -170.39 -179.2 41.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.644 -0.789 . . . . 0.23 112.233 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 204' ' ' TYR . 8.1 t70 -94.21 88.5 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.862 0.363 . . . . 0.51 110.078 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 7.52 41.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 1.78 110.959 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 80.39 7.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.326 0.584 . . . . 1.33 110.663 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -25.52 66.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 1.06 110.408 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.31 -0.852 . . . . 1.6 109.897 179.575 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.775 -0.53 . . . . 0.51 111.775 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.3 m80 59.46 54.42 4.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.047 0.451 . . . . 1.04 111.594 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -122.87 168.58 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.131 -0.486 . . . . 1.55 110.192 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -68.45 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.33 110.792 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.64 146.45 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.94 109.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.2 t80 -164.69 153.53 12.79 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 123.35 0.406 . . . . 0.65 110.168 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.422 HG23 ' HB ' ' A' ' 15' ' ' THR . 3.0 m -109.71 89.9 8.28 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.49 109.839 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 6' ' ' PHE . 90.1 Cg_endo -85.63 156.44 10.48 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.759 2.306 . . . . 0.8 113.105 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' OH ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -127.73 139.07 52.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.72 109.783 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -161.49 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.233 -0.187 . . . . 1.19 111.115 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -124.55 -59.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.993 0.425 . . . . 1.69 110.351 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 5.0 mt -128.51 102.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.75 109.73 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -134.16 127.21 31.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.154 -0.475 . . . . 1.42 110.802 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.98 -10.02 59.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.361 0.601 . . . . 0.56 110.437 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -83.3 -15.47 50.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.64 111.275 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -125.72 40.36 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.16 111.679 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.12 147.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.97 0.414 . . . . 0.16 110.636 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.82 144.46 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.13 110.536 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.32 126.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 0.21 110.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -148.63 115.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.666 -0.697 . . . . 0.2 109.58 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -119.27 132.83 55.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.311 -0.404 . . . . 0.94 111.432 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.7 ttp -87.58 132.31 34.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.938 -0.574 . . . . 0.43 110.201 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 118.57 37.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.618 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 32.9 mmt180 -120.57 -177.5 3.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.33 110.323 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -47.14 81.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.366 0.506 . . . . 0.32 112.366 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.3 29.72 2.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.391 -0.909 . . . . 0.29 112.339 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 31.3 tptt -150.35 148.82 29.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.59 -0.522 . . . . 0.89 109.59 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 133.41 30.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.527 -0.546 . . . . 0.99 109.527 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -134.29 144.55 48.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -142.94 137.3 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.32 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.85 167.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.682 -0.488 . . . . 0.3 109.682 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 110.61 20.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.055 0.455 . . . . 0.12 111.824 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -108.74 164.6 12.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.914 -0.585 . . . . 0.18 109.943 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.433 ' OH ' HG22 ' A' ' 9' ' ' THR . 0.1 OUTLIER -66.94 138.05 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.639 -0.255 . . . . 0.18 110.361 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -0.68 23.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 1.01 111.442 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.41 71.38 1.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.376 . . . . 0.5 111.162 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 53.66 66.07 1.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.356 0.662 . . . . 1.8 111.368 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -69.49 -30.25 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.14 110.876 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -87.31 5.62 3.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.514 0.673 . . . . 0.27 110.327 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.587 ' HA3' ' HG3' ' A' ' 46' ' ' GLU . . . -60.15 -33.6 80.52 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.458 -0.792 . . . . 0.29 112.523 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -63.81 -34.81 78.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.266 0.555 . . . . 0.9 110.211 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -81.09 -25.38 37.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.85 110.064 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 m -75.84 -42.5 49.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.666 . . . . 0.53 110.649 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.82 -108.79 0.21 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.869 -0.681 . . . . 0.31 112.103 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 t -115.5 122.17 68.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.839 0.352 . . . . 0.43 110.297 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' HG3' ' HA3' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -150.31 -170.63 3.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.264 -0.426 . . . . 0.51 111.291 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -71.3 172.12 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 0.55 112.647 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 49' ' ' LEU . 17.2 t70 -75.72 160.78 29.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.069 -0.969 . . . . 0.25 110.513 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.681 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.71 -19.83 60.09 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.78 0.289 . . . . 0.31 111.78 -179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.69 -38.4 64.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.172 0.511 . . . . 0.27 109.974 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.57 -32.78 62.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.47 -0.786 . . . . 0.73 111.049 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 49' ' ' LEU . 3.0 p -79.96 -17.13 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.312 . . . . 0.22 111.413 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.79 111.15 13.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 1.02 110.168 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 12' ' ' ILE . 11.5 mm-40 -85.29 -78.65 0.25 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.938 -0.574 . . . . 0.91 110.449 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -75.4 117.97 17.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.948 -0.569 . . . . 1.5 110.783 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -86.86 31.55 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.813 -0.63 . . . . 0.63 111.167 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 m -125.67 140.83 52.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.67 -0.493 . . . . 0.22 109.67 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 68' ' ' ALA . 7.3 p -117.11 142.36 31.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.27 110.29 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -89.3 161.21 16.49 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.013 0.375 . . . . 0.29 112.013 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 61.1 t -123.96 -55.07 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.792 -0.64 . . . . 0.29 109.329 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.08 101.89 4.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.835 . . . . 1.84 109.662 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.33 -37.19 79.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.51 111.827 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.16 6.45 6.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.37 0.507 . . . . 0.45 112.37 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -135.15 -5.37 2.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.849 0.357 . . . . 0.55 110.848 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.4 30.97 61.63 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.893 -0.67 . . . . 0.19 111.819 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.39 113.1 24.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.03 0.443 . . . . 0.66 110.929 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.46 128.87 76.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.649 -0.705 . . . . 0.4 109.245 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -84.67 117.63 23.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.909 0.385 . . . . 0.31 111.267 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.87 -174.52 4.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.16 -0.473 . . . . 0.68 110.017 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -55.76 -33.04 63.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.46 0.541 . . . . 1.84 112.46 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -82.13 -7.59 59.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.814 0.34 . . . . 1.81 111.792 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.38 -49.51 3.55 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.805 -0.358 . . . . 1.78 111.217 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.44 -29.28 68.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.929 0.395 . . . . 0.27 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.99 -25.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.898 -0.592 . . . . 0.55 110.463 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -97.33 -26.59 14.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.3 111.001 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.77 -39.46 30.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.122 -0.49 . . . . 0.48 112.093 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.54 -16.49 13.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.004 -0.278 . . . . 1.13 111.45 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.37 79.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 0.49 112.29 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.42 136.97 47.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.568 0.223 . . . . 0.6 110.613 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -90.55 -23.47 20.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.401 0.619 . . . . 0.59 109.899 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.83 103.44 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.82 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.87 -31.28 71.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.162 0.506 . . . . 0.33 109.951 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -61.02 -29.06 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.29 110.282 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -81.81 -39.33 24.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.805 -0.442 . . . . 0.34 109.805 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.12 -50.19 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.2 109.441 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.7 t -61.53 -38.72 88.44 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.19 110.61 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.73 -41.96 96.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 2.86 110.292 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -65.49 -40.67 93.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.71 110.786 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 70.9 mt -71.19 -21.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.33 110.907 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -45.88 10.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.451 -0.341 . . . . 0.99 111.575 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -83.0 -21.35 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.362 0.505 . . . . 1.13 112.362 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.65 31.89 4.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 1.41 110.723 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 89' ' ' ILE . . . -128.34 179.76 16.37 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.498 -0.858 . . . . 0.15 112.442 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.85 93.31 5.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.703 0.287 . . . . 0.81 110.644 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 97' ' ' VAL . 2.8 p -98.3 134.76 35.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.24 109.909 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 11.5 pt20 -74.62 75.62 2.01 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.206 0.527 . . . . 0.81 112.261 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 95' ' ' VAL . 14.6 m -141.24 -175.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.437 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.0 t -131.44 103.75 6.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.2 111.162 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -121.54 95.76 4.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.214 0.53 . . . . 1.01 110.384 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -163.68 125.59 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.511 -0.768 . . . . 1.65 109.505 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.26 136.87 53.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.555 0.576 . . . . 0.47 112.555 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 102' ' ' ARG . 2.5 mmp_? -136.19 86.7 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.48 109.969 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -80.13 115.23 19.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 1.34 110.388 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 -177.12 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.114 -0.494 . . . . 0.31 110.039 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.1 125.94 43.32 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.135 -0.32 . . . . 0.65 110.135 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -128.95 171.42 12.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.351 -0.386 . . . . 0.38 110.57 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.94 -80.49 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.692 0.282 . . . . 1.11 110.597 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -80.85 156.04 26.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.333 -0.394 . . . . 1.49 110.803 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 95.7 mmm -55.84 -43.33 76.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.583 0.586 . . . . 1.05 112.583 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -74.98 -14.33 60.61 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.462 -0.495 . . . . 0.8 111.437 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 37.9 ttt180 -98.09 0.23 45.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.966 0.413 . . . . 1.92 110.074 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.423 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -61.97 -39.63 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.583 -0.735 . . . . 1.59 110.975 -179.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 tt -112.08 -18.3 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.916 0.389 . . . . 1.78 110.468 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 111' ' ' ARG . . . -60.48 -46.7 89.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.21 111.175 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 116' ' ' ILE . 14.7 t -70.21 -24.7 63.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.63 110.615 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 120' ' ' LYS . 1.3 mp -73.03 -41.95 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.413 . . . . 0.4 110.464 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 -30.38 8.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.366 -0.379 . . . . 0.25 111.689 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.48 -44.72 69.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.284 0.564 . . . . 0.36 110.273 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.02 54.32 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.377 -0.971 . . . . 0.91 108.377 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -154.06 -43.9 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.695 . . . . 0.39 111.045 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 49.0 m -123.34 128.65 50.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.975 0.417 . . . . 0.36 111.778 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.86 171.83 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.516 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.531 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 6.1 t-20 -147.49 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 119.46 -0.305 . . . . 0.52 111.425 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 4.1 Cg_endo -87.46 136.15 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.961 1.774 . . . . 0.28 111.918 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.77 20.15 3.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.295 0.569 . . . . 0.82 110.634 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.57 -61.19 1.64 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.628 -0.714 . . . . 0.33 111.025 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.471 ' H ' HG23 ' A' ' 126' ' ' THR . 6.5 ttmt -160.64 123.52 3.31 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.136 0.493 . . . . 1.41 111.273 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . 1.7 tpp180 -171.34 -55.8 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.67 . . . . 1.86 110.77 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 128' ' ' ARG . 86.9 Cg_endo -77.62 76.83 4.11 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.69 1.593 . . . . 0.35 111.695 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -158.17 -57.41 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.557 . . . . 0.85 110.351 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.3 m -91.82 108.14 19.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.875 -0.602 . . . . 0.36 111.234 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.18 -16.64 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.421 0.629 . . . . 0.37 110.583 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.662 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 23.1 mm -71.97 -28.79 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.942 -0.572 . . . . 0.41 110.746 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.4 mp -61.04 -47.51 86.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.52 110.76 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.9 tt -72.09 -28.3 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.979 -0.378 . . . . 0.2 109.979 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -43.93 97.53 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.939 -0.573 . . . . 1.21 109.694 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 133' ' ' ILE . 19.5 mmm180 -63.01 -31.34 72.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.988 -0.551 . . . . 1.87 110.917 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -77.12 -48.03 18.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.21 110.6 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.628 ' SD ' ' HG ' ' A' ' 163' ' ' LEU . 60.6 mmm -76.12 -3.38 35.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 2.27 111.225 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -81.04 -41.38 22.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.34 -0.615 . . . . 2.18 109.34 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.85 -50.79 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.691 -0.686 . . . . 0.56 110.355 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 138' ' ' ALA . 18.6 tt -86.06 52.7 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 122.632 1.206 . . . . 0.49 109.093 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -110.84 -5.63 14.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.595 -1.184 . . . . 0.31 110.53 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.73 115.34 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.507 0.558 . . . . 1.03 112.507 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 63.9 m 56.11 39.96 30.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.475 -0.784 . . . . 0.58 112.796 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.0 t -98.36 -66.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.4 110.34 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -96.6 -55.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.098 0.475 . . . . 1.75 109.799 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.5 25.44 14.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.523 -0.762 . . . . 0.21 111.063 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 57.12 38.08 28.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.721 -0.672 . . . . 0.58 110.788 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -89.68 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 0.86 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -149.28 161.44 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.04 0.448 . . . . 0.65 111.264 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -106.02 -34.04 7.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 1.05 110.862 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -88.96 -50.47 6.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 0.58 111.418 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -69.14 -14.97 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.79 111.559 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.1 mt-30 -112.43 7.48 19.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.629 -0.259 . . . . 0.44 110.912 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.63 72.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.347 . . . . 0.26 111.133 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 160' ' ' ILE . 2.3 mm? -66.65 -35.67 80.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.51 . . . . 1.32 111.227 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.95 -46.93 85.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 0.61 111.116 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 155' ' ' GLN . 59.3 t -67.04 -48.57 78.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.21 112.112 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 157' ' ' LEU . 10.1 tp -61.23 -35.16 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.41 111.729 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.39 -32.55 54.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.737 0.303 . . . . 1.99 110.592 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.87 -37.96 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.937 0.399 . . . . 0.75 110.098 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.628 ' HG ' ' SD ' ' A' ' 139' ' ' MET . 0.6 OUTLIER -64.07 -36.92 85.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.926 -0.579 . . . . 1.15 110.036 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 167' ' ' MET . 31.0 tttm -69.31 -12.53 61.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.444 -0.798 . . . . 1.18 111.396 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.3 -32.05 55.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.51 . . . . 0.58 109.693 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -89.26 -44.45 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.681 -0.69 . . . . 1.12 111.097 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 38.4 mtm -128.75 139.04 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 2.6 110.655 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -89.15 85.83 6.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.538 -0.541 . . . . 0.56 109.538 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 121' ' ' CYS . 0.1 OUTLIER -96.81 -170.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.47 112.138 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 171' ' ' ARG . 6.4 tp10 -92.81 178.96 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 0.4 110.957 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 170' ' ' GLU . 9.2 ptp85 -107.63 -168.82 1.43 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.097 -0.501 . . . . 0.84 110.058 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.57 154.1 40.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.41 111.77 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.454 ' CD2' ' HA ' ' A' ' 215' ' ' ASP . 17.3 p80 -90.0 164.25 14.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 0.23 111.379 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 39.8 mtt -106.27 -167.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.596 . . . . 1.48 110.184 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 175' ' ' ARG . 4.6 mpt_? -124.43 128.24 48.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.478 -0.328 . . . . 1.39 110.353 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -128.61 145.12 51.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.616 -0.513 . . . . 0.26 109.616 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 211' ' ' VAL . 18.8 ptt85 -126.18 147.91 49.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.783 0.325 . . . . 0.3 110.629 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -100.04 143.46 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.891 -0.595 . . . . 0.45 110.244 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.7 tt -133.4 117.72 28.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.449 0.642 . . . . 0.17 110.508 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -149.79 156.44 38.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.385 -0.825 . . . . 0.09 109.936 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.72 166.06 14.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 0.1 112.546 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.5 t -50.44 -39.89 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.922 -0.581 . . . . 0.2 111.962 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -51.33 -53.68 33.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.324 -0.398 . . . . 0.28 111.46 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.423 ' HG3' ' HE3' ' A' ' 233' ' ' LYS . 0.5 OUTLIER -82.17 -29.9 31.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.138 -0.483 . . . . 2.08 110.883 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.37 94.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.639 -0.71 . . . . 0.25 113.084 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.64 -35.9 71.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.891 0.377 . . . . 1.17 111.351 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -76.6 -44.6 33.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.235 -0.439 . . . . 0.71 111.814 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.54 HD22 HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -72.2 -32.33 66.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.772 0.32 . . . . 0.47 111.669 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -59.68 -50.55 73.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.36 111.435 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -80.34 18.28 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.44 112.119 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -124.29 -49.44 1.81 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.855 -0.338 . . . . 1.31 111.648 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.1 -36.58 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.188 0.44 . . . . 1.86 112.188 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 26.5 mtpp -61.39 -52.45 70.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.558 0.577 . . . . 0.59 112.558 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 35.1 Cg_endo -66.09 -14.01 42.46 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.028 1.819 . . . . 0.31 112.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.31 110.312 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 7.7 mt 62.62 38.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.559 -0.746 . . . . 0.44 111.043 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -120.84 14.23 11.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.93 110.465 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.86 149.46 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.978 -0.555 . . . . 0.26 111.02 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.5 mt -101.25 155.61 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.685 . . . . 0.41 109.744 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.93 64.19 0.5 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.931 0.396 . . . . 1.64 111.1 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 211' ' ' VAL . 10.4 m -149.4 31.01 0.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 1.09 110.302 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -81.74 146.88 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.736 -0.665 . . . . 0.79 111.161 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -118.9 133.49 55.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.834 -0.802 . . . . 1.22 108.834 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.31 111.34 19.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.8 111.395 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -166.93 -131.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.255 -0.738 . . . . 0.14 111.255 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.64 -28.32 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.619 0.723 . . . . 0.65 109.301 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 8.6 pm0 -119.31 142.87 47.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.811 -1.086 . . . . 1.32 109.614 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.28 89.66 5.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.684 -0.487 . . . . 0.13 109.684 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.15 98.41 8.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.398 -0.593 . . . . 0.55 109.398 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 188' ' ' LEU . 21.9 mm -112.59 134.89 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.37 110.827 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 201' ' ' SER . 2.5 t -105.35 112.57 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.28 109.981 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.98 94.41 3.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.943 0.401 . . . . 0.61 110.83 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.02 95.83 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.084 -0.507 . . . . 0.28 109.845 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 215' ' ' ASP . 9.8 tt -94.23 179.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 1.14 110.061 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.526 ' H ' HG12 ' A' ' 214' ' ' ILE . 4.4 m-20 -67.0 152.85 95.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 111.896 0.332 . . . . 1.08 111.896 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.88 166.57 11.93 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.751 2.301 . . . . 0.19 112.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 91.11 -75.98 1.53 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.363 -1.095 . . . . 0.34 110.363 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -28.41 64.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.258 0.551 . . . . 0.24 109.642 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.88 -26.12 68.19 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.521 -0.763 . . . . 0.29 110.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -17.66 64.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.845 0.355 . . . . 1.14 111.383 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -84.17 -50.37 7.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.906 0.384 . . . . 0.7 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 15.1 tt -72.87 -28.05 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.395 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.465 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 4.0 t70 -55.35 -33.02 63.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.863 0.363 . . . . 1.01 111.143 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.76 -32.69 67.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.885 -0.598 . . . . 0.46 111.733 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 3.0 pp -92.78 -32.99 14.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.545 -0.462 . . . . 0.72 109.862 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 26.9 mm -55.64 -43.37 72.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.279 -0.419 . . . . 0.93 111.474 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 12.7 ptpt -61.95 -17.68 57.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.173 0.805 . . . . 0.53 113.173 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -119.92 -16.83 8.61 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.874 -0.516 . . . . 0.73 111.515 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 3.1 tp10 -79.95 -39.28 30.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.449 . . . . 1.25 111.15 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.6 t -136.47 -36.23 0.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.284 0.475 . . . . 1.38 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 23.9 tptp -55.96 -46.49 78.56 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.889 0.376 . . . . 0.85 111.054 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.07 28.22 13.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.65 111.958 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.423 ' HE3' ' HG3' ' A' ' 184' ' ' GLU . 27.2 mmmt -132.85 -46.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 1.68 110.839 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -130.44 -153.4 7.7 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.034 -0.603 . . . . 0.31 111.976 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.5 m -124.18 156.66 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.626 0.251 . . . . 0.58 110.518 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.67 165.65 18.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.714 0.292 . . . . 0.97 111.043 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -151.64 152.85 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.051 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.9 141.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.056 0.455 . . . . 0.18 111.181 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.77 75.91 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.253 -0.43 . . . . 0.31 110.44 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -138.98 4.47 2.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.461 -0.336 . . . . 0.81 111.41 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.13 -43.1 83.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.46 111.266 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 55.77 42.31 29.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.997 -0.547 . . . . 1.07 111.515 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.73 -50.44 7.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.105 0.479 . . . . 1.39 110.471 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.13 167.35 23.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.582 -0.736 . . . . 0.38 109.317 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -77.62 92.54 4.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.918 0.389 . . . . 2.16 109.998 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -75.75 143.08 42.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.823 -0.626 . . . . 0.88 110.646 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 201' ' ' SER . . . 101.24 139.82 10.92 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.001 -0.618 . . . . 0.57 113.062 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.93 113.77 8.78 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 1.33 109.928 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 18.81 18.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 1.45 110.679 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -90.16 95.34 10.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.948 -0.569 . . . . 0.72 110.17 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -105.53 3.95 29.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.982 -0.554 . . . . 1.02 110.138 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.386 -0.816 . . . . 1.62 109.928 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 111.618 -0.593 . . . . 0.99 111.618 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -122.53 111.2 16.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.034 0.417 . . . . 1.04 110.691 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.6 ttp -155.57 140.76 17.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.5 109.998 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.29 145.68 51.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.115 -0.493 . . . . 0.46 110.476 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 tp -73.45 104.37 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.76 110.995 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.27 110.285 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 82.81 16.93 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.195 -0.457 . . . . 0.91 110.294 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.81 -18.33 22.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.519 2.146 . . . . 0.47 112.473 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.6 p 46.78 49.14 14.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.857 -0.61 . . . . 1.07 111.464 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -80.33 161.36 25.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.807 -0.633 . . . . 1.1 109.894 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -58.53 -40.11 82.02 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.974 0.416 . . . . 0.62 110.405 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.6 mt -119.95 95.32 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 1.13 109.632 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -159.27 137.99 10.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.832 -0.622 . . . . 2.26 110.21 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.81 37.03 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.4 111.006 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.8 p -106.67 -28.58 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.32 110.633 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 12.6 m120 -126.26 50.41 1.9 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.64 110.26 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 54' ' ' GLN . 2.3 m -92.6 155.33 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.15 111.073 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.62 134.03 55.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 0.1 109.688 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.55 127.12 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 0.1 110.889 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 89' ' ' ILE . 2.7 p -140.59 118.98 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 0.1 109.648 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -123.56 132.9 54.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.243 0.544 . . . . 0.81 112.047 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.615 ' HB2' HG23 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -111.53 159.56 18.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.835 -0.62 . . . . 0.26 110.063 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -121.06 115.85 23.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.582 -0.281 . . . . 1.39 110.637 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 16.2 mmm180 -99.39 55.39 0.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.731 0.301 . . . . 1.87 110.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.24 34.28 20.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.586 -0.734 . . . . 0.34 111.778 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.78 -62.92 0.42 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.331 -0.708 . . . . 0.33 111.331 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -74.35 145.73 43.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.69 -0.485 . . . . 1.04 109.69 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 28' ' ' ARG . 5.2 mmt180 -109.82 140.26 43.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.271 -0.27 . . . . 0.75 110.271 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -134.34 118.61 17.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.361 -0.381 . . . . 0.88 110.158 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -135.87 146.21 47.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.757 0.313 . . . . 1.09 110.333 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 pt -132.24 179.26 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.778 -0.646 . . . . 0.09 110.26 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.2 106.9 9.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.105 0.479 . . . . 0.1 110.659 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 m -103.58 171.09 7.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.696 -0.683 . . . . 0.11 109.416 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 11.2 t80 -88.26 154.58 20.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.873 0.368 . . . . 0.86 110.485 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -78.34 31.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.79 110.832 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -85.92 43.34 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.057 -0.519 . . . . 1.8 110.56 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt 61.1 46.76 7.85 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.636 -0.711 . . . . 0.34 110.84 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.02 -23.94 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.008 -0.542 . . . . 0.34 111.364 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 97' ' ' VAL . 7.8 p -68.46 -31.38 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.477 -0.329 . . . . 0.83 110.503 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.36 -18.1 74.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.118 -0.563 . . . . 0.28 112.571 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CE2' ' HB2' ' A' ' 49' ' ' LEU . 78.0 t90 -68.76 -47.15 66.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.268 0.556 . . . . 0.6 110.04 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HG3' ' H ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -93.6 17.66 11.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.485 -0.78 . . . . 0.93 110.364 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 m -158.61 60.1 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.31 110.557 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.96 -149.9 18.62 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.527 -0.844 . . . . 0.13 112.636 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.61 122.86 70.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.513 -0.551 . . . . 0.26 109.513 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.602 ' HB3' ' HD2' ' A' ' 47' ' ' LYS . 13.4 mm-40 -136.18 -86.07 0.35 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.237 -0.185 . . . . 0.18 111.397 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.602 ' HD2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -153.74 -144.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.506 -0.553 . . . . 0.42 109.506 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.55 167.53 10.75 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.926 -0.398 . . . . 0.39 109.926 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 41' ' ' TRP . 16.6 tp -104.05 6.79 36.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.457 0.54 . . . . 0.53 112.457 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.77 -44.42 7.09 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.421 -0.512 . . . . 1.21 110.486 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.91 -27.94 61.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.436 -0.802 . . . . 0.7 111.048 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.85 -13.01 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.21 110.533 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -87.99 107.64 18.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.036 -0.529 . . . . 0.35 110.055 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.425 ' HG3' HG12 ' A' ' 17' ' ' VAL . 33.5 mm-40 -65.71 -44.33 86.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.642 . . . . 0.36 111.316 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 t -142.89 136.12 28.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.058 0.456 . . . . 0.35 110.145 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -96.68 25.91 4.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.014 -0.539 . . . . 1.03 110.851 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 p -96.68 88.74 4.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 0.29 110.127 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.3 p -82.02 141.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.104 -0.498 . . . . 0.3 109.924 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -90.91 162.42 14.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.22 111.797 -178.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 98.6 t -111.92 -46.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.15 109.56 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -154.15 120.11 5.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.11 -0.95 . . . . 0.22 108.989 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.03 -27.58 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.067 0.395 . . . . 0.32 112.067 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -38.39 87.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.062 0.458 . . . . 0.38 110.941 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -99.35 -5.35 29.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 1.25 110.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.23 52.23 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.914 -0.66 . . . . 0.27 111.881 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -105.81 123.19 47.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.973 0.416 . . . . 0.74 110.886 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' PHE . 35.2 t -114.97 130.76 68.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.75 -0.659 . . . . 0.34 109.994 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -85.25 110.82 19.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.12 110.459 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -84.8 -171.7 3.78 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.922 -0.581 . . . . 1.42 109.803 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -56.7 -38.92 72.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.179 0.437 . . . . 0.9 112.179 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -81.85 -1.34 47.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.399 . . . . 0.34 111.5 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -101.6 -47.79 4.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.558 -0.292 . . . . 0.7 110.963 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.9 -34.28 77.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.611 -0.268 . . . . 0.18 110.966 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.08 -24.84 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.076 0.465 . . . . 1.23 110.574 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.9 m -93.22 -32.53 14.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.205 -0.452 . . . . 0.29 110.851 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.31 -54.32 7.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.19 111.716 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.44 -36.02 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.2 -0.455 . . . . 2.36 110.948 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.87 -25.04 25.24 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.832 -0.907 . . . . 0.34 110.832 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.92 124.95 34.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.279 -0.46 . . . . 1.19 110.594 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -23.8 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.172 0.51 . . . . 1.0 109.876 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.98 104.24 2.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.406 -0.815 . . . . 1.31 110.093 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -59.86 -31.92 70.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.5 111.643 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -38.72 92.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 0.69 110.211 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.05 -40.06 94.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.115 -0.493 . . . . 1.13 109.712 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.98 -50.3 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.53 109.555 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.8 m -59.66 -34.85 73.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.262 -0.881 . . . . 0.19 110.751 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -61.84 -44.42 96.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.54 110.922 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -63.26 -40.46 97.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.78 110.378 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 20' ' ' VAL . 52.1 mt -69.7 -34.31 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.66 . . . . 0.18 110.866 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.41 -21.23 49.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.396 -0.365 . . . . 0.73 111.732 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -97.16 -53.59 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.334 0.494 . . . . 0.94 112.334 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -102.32 20.96 15.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.91 111.373 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.27 165.41 12.8 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.677 -0.773 . . . . 0.21 112.173 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.2 tt0 -87.58 102.69 14.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.014 -0.365 . . . . 1.89 110.014 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 p -106.29 126.02 61.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.15 110.449 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -79.68 88.4 5.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.925 -0.579 . . . . 2.37 111.139 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.628 HG21 ' HB ' ' A' ' 39' ' ' VAL . 1.0 OUTLIER -135.49 -125.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.81 110.744 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 m -157.47 -174.88 5.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.225 -0.657 . . . . 0.52 109.225 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 100' ' ' LYS . 19.9 p-10 -79.7 -76.48 0.21 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.632 -0.136 . . . . 0.81 110.632 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 51.7 mttm 51.97 33.0 10.9 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.007 0.523 . . . . 0.68 111.622 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' CD ' ' HG2' ' A' ' 153' ' ' LYS . 1.2 mm-40 -86.76 173.81 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.48 -0.782 . . . . 1.58 111.438 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 102' ' ' ARG . 8.3 ttm180 -160.67 -56.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.84 110.62 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -162.71 104.58 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.81 110.051 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -142.0 140.61 32.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.414 . . . . 0.59 110.305 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.21 119.27 38.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 0.92 109.56 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' MET . 0.6 OUTLIER -147.5 141.72 26.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.211 -0.45 . . . . 0.39 110.316 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -70.96 -36.36 72.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 1.88 110.187 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -84.94 10.49 11.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.834 -0.621 . . . . 1.28 110.912 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -61.07 -35.76 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.22 111.287 -179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.66 -40.9 96.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.48 111.038 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 111' ' ' ARG . 0.9 OUTLIER -84.49 -25.43 28.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.88 110.969 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 115' ' ' THR . 17.0 t70 -59.65 -58.49 8.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.949 -0.568 . . . . 0.47 111.097 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tp -71.31 -24.0 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.154 0.502 . . . . 0.12 110.608 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.22 89.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.676 . . . . 0.21 111.797 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 HD12 ' A' ' 116' ' ' ILE . 2.4 t -65.34 -17.79 64.8 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.648 0.24 . . . . 0.25 111.648 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.487 HD12 HG23 ' A' ' 115' ' ' THR . 1.2 mp -88.89 -51.22 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.782 0.325 . . . . 1.89 110.57 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.87 -31.85 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.148 0.425 . . . . 0.5 112.148 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.94 -4.43 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.23 111.644 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' HA ' ' H ' ' A' ' 130' ' ' TYR . 26.8 t70 -102.87 -41.92 6.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.035 0.445 . . . . 1.48 110.493 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -75.52 -11.49 60.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.877 -0.602 . . . . 0.57 112.072 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.82 108.22 19.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.868 0.366 . . . . 0.29 110.095 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 m -100.23 144.39 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 0.26 111.172 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.421 ' ND2' ' HG2' ' A' ' 125' ' ' GLU . 66.6 t30 -145.2 125.02 7.05 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.525 . . . . 0.47 109.932 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.3 77.23 3.9 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.607 2.205 . . . . 0.23 112.663 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HG2' ' ND2' ' A' ' 123' ' ' ASN . 1.0 OUTLIER -144.84 -157.68 0.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.153 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.6 m -71.33 -45.2 63.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.024 0.44 . . . . 1.45 110.511 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -68.12 148.09 51.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.716 -0.675 . . . . 2.38 110.575 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -116.46 152.92 48.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.263 -0.426 . . . . 1.12 110.647 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.37 178.73 2.4 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.591 2.194 . . . . 0.16 111.512 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.445 ' H ' ' HA ' ' A' ' 119' ' ' ASP . 31.8 t80 68.65 12.3 8.63 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.735 0.779 . . . . 0.84 109.664 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.9 m -107.35 106.12 16.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.373 -0.83 . . . . 0.38 109.672 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -55.6 -38.52 50.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.018 -0.537 . . . . 0.31 111.337 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -55.41 -30.02 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.679 -0.691 . . . . 0.28 111.965 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.3 tp -57.06 -52.08 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.42 111.535 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.58 -31.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 121.022 -0.271 . . . . 0.68 111.039 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.12 -45.93 91.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.03 0.443 . . . . 0.93 110.831 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -26.13 64.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 0.45 110.727 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.05 -50.73 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.22 111.42 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -65.03 -29.78 70.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.92 110.816 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -76.54 -12.76 60.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.83 111.168 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -85.3 -28.37 25.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.35 109.561 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.5 mt -89.56 -60.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.251 -0.886 . . . . 0.2 110.95 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 58.05 67.25 0.98 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.889 -0.596 . . . . 0.13 110.201 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.69 120.15 31.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.64 110.737 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 m -86.11 153.41 22.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.58 110.406 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' A' ' 155' ' ' GLN . 11.1 t -110.31 -80.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.64 0.257 . . . . 0.31 110.723 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.62 160.0 30.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.763 0.316 . . . . 0.49 110.39 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 2.25 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 0.7 111.138 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.5 -23.89 61.88 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.45 111.344 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 154' ' ' GLN . 45.6 mttm 63.02 36.01 12.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.143 0.497 . . . . 1.92 110.995 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.9 132.35 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.794 -0.639 . . . . 0.21 111.951 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.9 m 52.71 84.18 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.251 0.621 . . . . 0.19 112.52 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.485 ' HG2' ' CD ' ' A' ' 101' ' ' GLU . 7.9 mmtp 52.47 38.24 24.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 1.25 111.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.67 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 6.1 tt0 58.85 59.62 2.77 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.049 -0.523 . . . . 1.03 110.703 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 46.32 42.09 9.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.207 1.003 . . . . 1.15 112.07 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.66 72.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.09 110.67 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -67.38 -31.11 71.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 1.11 110.698 179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -71.67 -29.11 64.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.923 -0.399 . . . . 0.52 109.923 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.54 -37.56 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.862 -0.792 . . . . 0.14 108.862 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.2 -40.7 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.184 -0.916 . . . . 0.16 109.567 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 33.1 mmtp -66.95 -39.32 87.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.523 -0.762 . . . . 1.32 110.11 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -58.29 -40.76 82.82 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.737 -0.665 . . . . 1.61 110.529 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -58.65 -46.65 86.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.26 110.108 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -62.45 -36.65 83.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.73 111.414 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 47.9 mm-40 -62.65 -35.53 79.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.411 -0.358 . . . . 0.44 111.431 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -92.25 -41.52 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.31 -0.405 . . . . 0.73 111.089 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.69 106.55 8.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.182 -0.463 . . . . 1.05 109.868 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -75.1 101.74 4.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.92 110.977 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.77 131.49 48.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.766 -0.652 . . . . 0.38 110.729 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 71.71 9.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.131 0.491 . . . . 0.6 111.302 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 135.37 35.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.862 -0.608 . . . . 0.99 109.7 178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.6 134.57 13.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.763 0.316 . . . . 0.34 110.865 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -121.03 136.57 54.95 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.493 -0.558 . . . . 1.06 109.493 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.72 172.34 12.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.58 -0.282 . . . . 0.78 110.569 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.44 133.65 55.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.482 . . . . 0.5 110.282 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.44 141.38 48.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.237 -0.438 . . . . 0.23 110.274 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.59 139.66 46.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.128 0.489 . . . . 1.2 110.962 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 90.4 t80 -113.93 143.28 44.97 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.161 -0.681 . . . . 0.25 109.161 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.6 131.56 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.427 0.528 . . . . 0.37 112.427 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 180' ' ' LEU . 7.0 mt -160.61 139.57 7.74 Favored Pre-proline 0 C--N 1.333 -0.112 0 CA-C-N 115.625 -0.716 . . . . 1.49 109.649 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 180' ' ' LEU . 21.3 Cg_endo -62.09 156.03 52.4 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.571 2.181 . . . . 0.17 111.674 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.0 t -49.73 -37.05 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.744 0.418 . . . . 0.17 111.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -46.78 -47.08 20.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.84 111.451 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.31 -28.59 12.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.33 110.588 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.87 64.89 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.009 -0.541 . . . . 0.18 113.233 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -27.73 67.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.656 0.243 . . . . 0.8 111.656 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -76.18 -46.58 27.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.577 0.227 . . . . 0.8 111.184 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -25.11 59.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.514 -0.312 . . . . 1.59 111.155 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -59.33 -34.21 72.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.98 110.919 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.45 6.78 25.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.56 . . . . 1.5 112.187 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 195' ' ' LEU . 26.6 mtpt -135.38 -28.1 1.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 197' ' ' LYS . 80.1 mt -80.73 -56.96 3.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.97 0.414 . . . . 1.15 111.349 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 27.1 mtpp -61.1 -52.65 70.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.47 0.915 . . . . 0.24 113.47 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 56.3 Cg_endo -68.29 -5.89 16.08 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.191 1.927 . . . . 0.32 114.047 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 191' ' ' LYS . 2.0 mm? -102.52 1.73 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.771 -0.371 . . . . 0.21 110.377 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mt 53.19 45.13 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.693 0.759 . . . . 0.35 111.23 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' HD2' HD23 ' A' ' 192' ' ' LEU . 6.1 ptpp? -116.91 24.24 11.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 0.24 110.028 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.57 156.72 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.723 -0.671 . . . . 0.25 111.341 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.53 145.34 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.4 109.072 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 65.99 0.41 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.375 0.509 . . . . 0.32 112.375 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 m -145.54 36.1 1.07 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.406 -0.815 . . . . 0.25 108.858 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 11.3 pt-20 -89.87 166.75 13.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.738 -0.665 . . . . 0.55 112.25 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.14 118.16 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 1.52 109.6 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.22 45.29 1.25 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.34 111.032 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -102.71 -139.58 10.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.725 -0.75 . . . . 0.2 112.288 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -78.87 -27.67 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.468 . . . . 1.14 110.228 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -120.85 109.53 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.677 -0.692 . . . . 1.13 109.165 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 34.8 tp -69.83 92.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.89 . . . . 1.55 111.298 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 27.0 tt0 -94.48 117.46 30.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.028 -0.73 . . . . 0.44 109.028 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 202' ' ' GLU . 8.4 mt -128.18 147.43 32.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.842 0.353 . . . . 0.18 110.777 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.33 115.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.507 -0.553 . . . . 0.26 109.507 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.4 m -121.4 57.75 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.793 0.33 . . . . 1.04 111.722 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.98 127.59 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.715 -0.476 . . . . 0.41 109.715 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tt -125.71 -51.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.319 -0.4 . . . . 0.77 111.22 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 2.9 p30 -155.54 166.34 16.46 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.725 -0.216 . . . . 1.2 110.639 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 86.2 Cg_endo -80.34 -159.24 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.35 2.034 . . . . 0.44 112.754 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.68 -94.14 1.29 Allowed Glycine 0 C--O 1.238 0.392 0 C-N-CA 120.871 -0.681 . . . . 0.34 111.621 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.26 -17.67 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.65 110.109 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 222' ' ' ILE . 23.9 t80 -55.54 -35.27 65.5 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.314 -0.857 . . . . 0.45 110.481 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -25.06 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.35 111.563 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -86.06 -45.48 11.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 2.72 110.276 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 226' ' ' ILE . 16.3 tt -69.02 -26.94 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 1.26 110.686 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -31.75 72.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.249 -0.432 . . . . 0.2 110.196 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.55 -22.96 64.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.678 -0.692 . . . . 1.15 110.05 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.8 mt -96.02 -46.61 6.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.525 -0.761 . . . . 0.74 109.592 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.5 mm -55.76 -37.96 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.894 -0.594 . . . . 0.43 112.326 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -52.64 -31.56 37.47 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.353 0.501 . . . . 1.32 112.353 -179.105 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -112.33 -23.93 10.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.58 110.711 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 226' ' ' ILE . 1.5 tp10 -62.47 -51.23 68.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.64 111.606 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.1 -28.29 0.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.432 0.53 . . . . 0.63 112.432 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 227' ' ' LYS . 32.8 mttt -58.98 -43.88 91.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.69 110.97 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.45 39.49 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.646 -0.788 . . . . 0.28 112.845 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -151.07 -18.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.888 0.344 . . . . 0.49 111.5 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -147.52 -158.17 7.76 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.396 -0.907 . . . . 0.13 112.491 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.5 m -119.11 141.89 48.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.786 0.327 . . . . 0.21 110.547 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.32 143.05 51.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.29 110.639 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 238' ' ' VAL . 2.9 tt0 -134.07 171.17 14.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.441 ' H ' ' HG2' ' A' ' 237' ' ' GLU . 27.6 m -86.08 149.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.795 0.331 . . . . 0.27 110.429 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.0 tp -114.7 96.61 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.769 -0.456 . . . . 0.39 109.769 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -88.11 17.24 5.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.13 111.453 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 241' ' ' LEU . 3.7 mm? -78.51 97.46 5.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.683 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -111.41 -4.6 14.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.756 -0.656 . . . . 1.21 110.44 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -77.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.714 -0.675 . . . . 0.81 111.923 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.87 149.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.387 -0.369 . . . . 0.27 110.891 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -98.98 116.82 32.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.67 110.515 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -123.84 150.29 44.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.285 -0.416 . . . . 1.22 110.087 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.26 -152.54 6.51 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.561 -0.828 . . . . 0.39 112.636 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -79.93 43.21 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.769 0.795 . . . . 0.65 110.43 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -90.49 12.45 18.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.273 -0.876 . . . . 0.78 110.734 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -129.4 90.57 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.68 -0.691 . . . . 0.74 109.581 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -76.77 -49.56 15.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.504 . . . . 1.29 110.161 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.745 -0.645 . . . . 1.18 109.544 179.517 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.063 -0.415 . . . . 0.88 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -102.35 164.95 11.39 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.114 -0.328 . . . . 0.2 110.114 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.59 143.94 33.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.813 -0.44 . . . . 0.54 109.813 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -116.69 162.21 18.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 1.34 110.529 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mt -75.82 86.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.449 0.642 . . . . 1.01 109.869 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 8' ' ' PRO . 16.1 t80 -167.64 -176.81 3.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.364 -0.976 . . . . 2.03 108.364 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 m -123.9 72.92 54.44 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.789 0.328 . . . . 0.72 110.187 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 6' ' ' PHE . 7.2 Cg_exo -73.27 134.47 21.02 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.203 . . . . 0.75 112.136 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.27 69.22 10.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.092 -0.504 . . . . 0.7 110.5 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.426 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 7.0 t-20 -105.99 -175.41 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.954 -0.566 . . . . 0.52 109.643 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -77.75 -85.29 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.626 0.25 . . . . 2.05 110.926 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mt -91.38 92.41 3.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.302 0.572 . . . . 0.27 110.764 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 10' ' ' ASN . 68.2 mmt-85 -143.53 133.11 23.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.495 -0.775 . . . . 0.64 109.766 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.26 15.45 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.45 -0.341 . . . . 1.71 111.483 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 p -101.56 -3.11 29.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.434 -0.348 . . . . 0.61 111.475 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 37.38 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.18 0.514 . . . . 1.62 110.431 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 54' ' ' GLN . 33.9 m -95.53 150.61 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.44 111.597 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -107.9 151.91 25.13 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.933 -0.576 . . . . 0.48 109.582 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 126.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.781 0.324 . . . . 0.89 111.013 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 89' ' ' ILE . 3.0 p -125.66 116.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.825 -0.805 . . . . 0.3 108.825 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 19.1 ttp180 -114.89 123.24 48.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.705 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.466 ' HB2' HG23 ' A' ' 89' ' ' ILE . 51.6 ttp -88.61 131.45 34.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.25 110.595 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -101.87 126.32 48.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.165 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 16.9 mmm180 -122.11 -164.62 1.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.329 -0.249 . . . . 0.64 110.329 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.32 -53.88 14.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.12 111.175 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.1 27.58 3.14 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.517 -0.849 . . . . 0.53 112.685 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 162.66 41.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.337 . . . . 1.12 110.47 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 141.3 23.23 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.329 -0.619 . . . . 1.09 109.329 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -136.05 144.44 45.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.333 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE1' ' HD3' ' A' ' 21' ' ' ARG . 1.2 pt-20 -145.6 144.45 30.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.682 0.277 . . . . 1.68 110.682 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.3 mt -140.13 144.67 27.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.91 -0.586 . . . . 0.33 109.994 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.77 122.99 28.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.17 110.523 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -124.44 -170.44 2.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.15 110.924 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.94 -176.19 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.453 -0.339 . . . . 0.94 110.987 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -76.67 -140.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.431 -0.35 . . . . 1.46 111.858 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -60.54 -6.8 1.78 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.426 0.898 . . . . 0.74 113.426 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.97 -2.96 58.84 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.008 -0.433 . . . . 0.98 111.387 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG21 ' SG ' ' A' ' 33' ' ' CYS . 8.8 p -74.15 -33.01 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.268 . . . . 0.23 111.499 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.05 70.23 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.119 0.961 . . . . 0.28 110.431 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.31 46.96 77.85 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.807 -1.088 . . . . 0.19 112.596 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.584 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER 55.8 57.74 4.98 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 110.012 -0.366 . . . . 0.77 110.012 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 44.58 60.6 2.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.923 0.889 . . . . 0.95 112.458 -179.256 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.2 m 69.01 13.67 8.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.51 -0.768 . . . . 0.22 112.666 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.29 -128.04 6.18 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.291 -0.724 . . . . 0.15 111.291 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.39 105.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.905 -0.406 . . . . 0.37 109.905 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -74.04 159.61 32.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.691 -0.686 . . . . 1.34 110.752 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -61.95 1.85 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.966 -0.561 . . . . 1.41 109.495 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.45 153.67 17.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.257 -0.883 . . . . 0.71 108.966 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.03 -27.32 62.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.562 0.22 . . . . 0.29 111.334 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.03 -42.87 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 0.41 111.797 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -87.37 0.15 55.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.52 111.791 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.32 -5.54 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.564 0.697 . . . . 0.5 110.027 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.24 133.48 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.438 -0.801 . . . . 1.32 109.961 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' HG3' HG12 ' A' ' 17' ' ' VAL . 29.0 mm-40 -85.77 -48.88 8.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.099 0.476 . . . . 0.28 110.709 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.1 t -119.25 166.68 12.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.891 -0.595 . . . . 0.8 109.727 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -121.24 32.54 5.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.272 0.558 . . . . 0.71 110.061 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.01 126.36 50.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.79 . . . . 0.28 109.447 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 68' ' ' ALA . 12.6 p -108.86 137.65 39.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.873 0.368 . . . . 0.13 110.367 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HE2' ' H ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -82.95 158.27 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.372 . . . . 0.47 111.645 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 25.5 t -121.18 -56.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.36 109.186 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -137.72 101.13 4.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.255 -0.884 . . . . 0.32 109.56 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' H ' ' HE2' ' A' ' 59' ' ' PHE . 14.0 p -67.71 -30.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.59 110.917 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 m -70.12 -12.32 61.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.987 0.422 . . . . 0.33 111.181 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -121.37 4.71 10.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.126 -0.488 . . . . 1.06 110.846 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.82 38.46 94.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.739 -0.743 . . . . 0.4 111.351 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -101.77 120.81 40.95 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.14 0.495 . . . . 0.9 111.644 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.9 140.55 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.18 109.919 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.581 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -95.11 127.01 40.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.289 0.566 . . . . 0.06 110.834 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -88.86 -178.06 5.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.426 -0.806 . . . . 1.33 109.661 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.54 -28.67 68.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.102 0.477 . . . . 1.45 110.735 179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -80.03 -5.31 55.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.54 111.116 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.27 -46.09 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.334 -0.394 . . . . 0.47 111.125 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.82 -28.01 69.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.14 111.149 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 80' ' ' ASP . 10.2 tt -67.54 -29.19 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.105 0.478 . . . . 0.2 110.596 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -35.75 17.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.841 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.55 -52.66 12.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.25 111.701 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -89.65 -66.98 0.87 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.988 0.423 . . . . 0.81 110.927 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.72 -50.82 0.47 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.172 -0.771 . . . . 0.24 111.172 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 148.21 25.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.919 -0.4 . . . . 0.71 109.919 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 74' ' ' ILE . 6.9 p-10 -93.25 3.82 55.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 1.23 110.664 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.58 122.92 36.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.207 -0.451 . . . . 1.45 109.962 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -60.33 -27.48 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.527 0.566 . . . . 1.88 112.527 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.52 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -64.57 -20.92 66.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.013 0.435 . . . . 0.55 110.605 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.0 -23.16 23.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.12 110.275 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -79.54 -55.07 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.28 109.975 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 83' ' ' THR . 11.7 p -63.98 -24.87 67.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.24 110.721 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' THR . 40.7 ttmt -54.25 -41.75 69.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.645 . . . . 0.95 111.037 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -84.6 -38.19 20.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 1.36 110.72 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.567 HG22 HG22 ' A' ' 20' ' ' VAL . 65.5 mt -62.47 -34.19 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.18 111.981 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -25.02 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.069 0.766 . . . . 0.26 113.069 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.61 -20.74 11.59 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.362 -0.535 . . . . 0.63 112.399 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -111.0 12.4 22.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.923 0.392 . . . . 0.96 110.57 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 22' ' ' MET . . . -129.11 175.7 18.74 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.663 -0.78 . . . . 0.27 112.773 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -91.83 92.84 8.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.991 0.424 . . . . 1.4 110.602 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 97' ' ' VAL . 2.5 p -91.66 140.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.869 -0.605 . . . . 0.27 109.691 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -69.34 84.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.27 0.557 . . . . 0.62 110.837 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 95' ' ' VAL . 15.4 m -90.62 36.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.568 -0.742 . . . . 0.35 111.544 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 69.37 -1.34 2.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.913 -0.585 . . . . 0.58 111.429 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.67 102.38 15.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.364 -0.606 . . . . 0.97 109.364 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -153.8 93.46 1.66 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.339 0.59 . . . . 0.31 110.761 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -85.56 16.55 3.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.615 -0.72 . . . . 1.18 110.579 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -118.8 105.29 11.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.391 -0.822 . . . . 2.04 110.411 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -167.56 140.7 3.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 1.09 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.93 174.65 6.7 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.982 -0.554 . . . . 0.73 110.858 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -58.78 132.78 54.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.125 0.488 . . . . 0.68 111.558 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 107' ' ' GLU . 0.7 OUTLIER -162.54 -171.44 2.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.541 -0.754 . . . . 1.19 109.167 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.415 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 9.6 tp10 -66.66 163.67 18.49 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.678 -0.489 . . . . 0.9 109.678 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -57.89 100.31 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.671 0.272 . . . . 0.98 111.125 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -28.8 66.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.142 0.496 . . . . 1.17 110.177 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.94 -43.16 93.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.719 -0.673 . . . . 1.24 110.038 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -68.08 -33.43 74.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.332 -0.395 . . . . 0.71 110.396 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 115' ' ' THR . 6.0 t70 -59.61 -48.43 81.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 1.17 111.066 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.7 -30.51 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.778 0.323 . . . . 0.17 110.923 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 117' ' ' VAL . . . -65.32 -35.32 80.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.534 -0.303 . . . . 0.15 111.138 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 112' ' ' ASP . 2.7 t -71.29 -16.39 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.386 . . . . 1.18 110.801 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mm -86.83 -43.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.24 109.923 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG13 HG12 ' A' ' 135' ' ' ILE . 14.2 p -78.69 -16.35 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.09 110.941 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.27 81.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.476 -0.329 . . . . 0.19 111.274 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -79.76 -15.14 58.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.17 0.51 . . . . 0.56 110.494 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -84.01 -26.14 29.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.027 -0.533 . . . . 0.68 110.821 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.9 p -91.62 96.52 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.132 0.491 . . . . 0.18 110.215 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.98 146.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.053 -0.521 . . . . 0.98 111.036 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -150.9 125.0 4.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.187 -0.671 . . . . 1.14 109.187 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.35 61.14 4.16 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.751 2.301 . . . . 0.42 113.143 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' OE1' ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -132.21 -166.28 1.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.33 110.629 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.8 t -75.44 -25.42 57.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.742 0.275 . . . . 0.77 111.742 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' HB2' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -86.27 101.95 13.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 2.18 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -81.71 147.29 58.55 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.067 -0.515 . . . . 1.66 110.016 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 57.76 3.08 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.76 2.306 . . . . 0.19 113.139 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -117.07 17.64 14.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.246 0.546 . . . . 0.71 110.727 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.2 m -136.01 118.98 16.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.961 -0.563 . . . . 0.77 110.093 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.39 -35.27 71.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.403 . . . . 0.43 110.943 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.8 mm -54.42 -33.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.32 111.809 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.5 mt -57.04 -41.94 79.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.272 -0.422 . . . . 0.69 111.557 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 117' ' ' VAL . 9.1 tp -96.27 -25.79 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.719 0.295 . . . . 0.19 110.604 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.09 -45.36 91.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.753 0.311 . . . . 0.4 110.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -61.24 -26.5 67.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.8 110.856 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.63 19.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.284 -0.416 . . . . 0.26 110.218 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.42 -32.41 73.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 1.31 110.454 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -69.66 -32.55 71.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 1.35 109.987 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.44 -48.11 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.729 -0.669 . . . . 0.62 109.896 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 50.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.779 -0.646 . . . . 0.56 109.728 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -86.16 2.37 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.99 111.757 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -107.46 121.42 44.58 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.751 -0.38 . . . . 1.39 110.038 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 m -51.1 132.65 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.856 0.723 . . . . 0.53 111.978 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.93 68.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.995 -0.548 . . . . 0.98 110.156 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 61.52 80.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.606 -0.725 . . . . 1.04 111.446 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -3.33 16.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.245 0.545 . . . . 0.79 111.153 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -77.82 -15.96 58.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.432 0.635 . . . . 0.27 109.56 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -94.65 159.47 15.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.289 -0.869 . . . . 0.57 109.947 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.3 t -71.57 133.49 45.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.887 0.375 . . . . 0.46 110.289 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -26.37 68.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.51 110.811 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -82.65 -12.31 57.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.91 110.677 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -91.07 -34.75 14.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 1.63 110.512 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.42 ' O ' HG23 ' A' ' 159' ' ' VAL . 14.4 mt-30 -110.07 17.13 21.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 1.29 111.564 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.79 72.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.027 0.442 . . . . 0.17 111.383 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 161' ' ' LYS . 2.9 mm? -64.34 -46.88 81.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.635 . . . . 0.78 110.791 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -59.5 -38.57 81.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.467 . . . . 0.25 111.129 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 155' ' ' GLN . 96.2 t -67.69 -49.72 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.17 111.701 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.6 -34.31 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.644 0.239 . . . . 0.28 111.644 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 157' ' ' LEU . 29.5 mmtt -72.43 -40.54 67.02 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.271 -0.27 . . . . 1.79 110.271 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -59.04 -40.01 83.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.144 0.497 . . . . 0.99 110.087 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 53.3 tp -70.24 -41.22 73.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.598 -0.728 . . . . 0.76 110.313 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 167' ' ' MET . 59.8 tttm -58.14 -33.8 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.019 -0.537 . . . . 1.29 111.568 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.99 -30.56 71.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.765 0.317 . . . . 1.86 111.185 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -94.98 -41.86 8.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.18 110.411 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -133.56 119.89 20.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.089 -0.505 . . . . 0.79 109.656 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -90.53 109.01 20.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.08 0.467 . . . . 1.95 111.182 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -99.28 143.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.573 -0.74 . . . . 0.35 110.919 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.87 -178.36 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.711 -0.222 . . . . 0.73 110.934 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.88 21.13 12.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.603 0.565 . . . . 1.82 112.106 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.94 33.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.999 0.428 . . . . 0.23 111.695 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -115.54 136.55 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.97 -0.559 . . . . 1.15 110.089 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 1.7 tpt -89.82 -85.34 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.507 0.558 . . . . 0.97 112.507 -178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 175' ' ' ARG . 11.7 mtp180 -140.31 145.71 37.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.026 0.441 . . . . 0.67 111.826 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.573 ' HB2' HD23 ' A' ' 213' ' ' LEU . 5.9 mp -129.38 150.64 50.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.18 108.821 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 23.1 ptt180 -121.72 153.6 38.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.062 0.458 . . . . 0.18 110.962 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 31.4 t80 -117.64 128.21 54.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.22 109.876 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.52 128.51 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.85 111.065 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.549 HD22 ' CE2' ' A' ' 178' ' ' PHE . 0.6 OUTLIER -173.18 160.29 3.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.393 -0.595 . . . . 0.13 109.393 179.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.13 147.64 73.49 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.129 1.886 . . . . 0.2 111.536 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 72.9 t -61.62 -22.07 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.908 0.385 . . . . 0.35 110.708 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -52.7 -42.55 64.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.75 110.541 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -100.5 -32.78 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.54 109.817 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.96 -20.41 64.52 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.614 -0.721 . . . . 0.11 113.347 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.63 -26.54 61.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.95 0.405 . . . . 0.8 111.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 191' ' ' LYS . 50.9 mttt -76.68 -57.45 3.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.8 110.989 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -19.57 65.17 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.256 0.465 . . . . 1.55 112.256 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -54.19 -51.6 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.441 . . . . 0.79 111.442 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.88 21.68 4.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.387 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 187' ' ' LYS . 21.4 mtpp -122.7 0.02 9.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 2.29 109.978 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.27 -54.17 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 1.39 111.807 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 17.1 mtpp -53.92 -53.27 59.94 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.813 0.671 . . . . 0.63 112.813 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 36.8 Cg_endo -65.36 -14.15 43.49 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.219 1.946 . . . . 0.4 112.889 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.4 -18.75 40.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.407 -0.36 . . . . 0.67 110.442 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 31.4 mt 57.46 75.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.761 -0.654 . . . . 0.67 111.721 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.7 27.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.798 -0.637 . . . . 0.69 109.838 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.91 -173.46 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.306 -0.861 . . . . 0.89 109.927 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.67 137.66 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.342 -0.614 . . . . 0.89 109.342 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.06 71.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.511 0.507 . . . . 2.09 111.185 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 34.39 0.46 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.497 -0.774 . . . . 0.6 109.135 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.27 168.45 14.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.889 -0.596 . . . . 1.26 111.774 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -126.1 127.32 45.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.611 -0.722 . . . . 1.13 109.724 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -115.76 130.15 56.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.599 -0.273 . . . . 0.97 110.5 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 165.97 -114.66 0.6 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.74 -0.743 . . . . 0.74 112.277 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -40.16 31.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.661 0.743 . . . . 1.13 109.092 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -117.41 157.6 25.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.93 -1.032 . . . . 1.19 108.757 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.93 95.03 5.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.101 0.477 . . . . 0.31 110.351 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 28.4 tt0 -92.85 107.83 19.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.819 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 70.0 mt -114.47 128.47 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.379 -0.373 . . . . 0.3 111.129 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 39.7 t -90.97 98.02 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.317 -0.623 . . . . 0.21 109.317 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 37.3 t -113.51 114.18 26.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.088 -0.506 . . . . 0.24 111.33 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -169.84 134.46 1.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.248 -0.649 . . . . 0.38 109.248 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.5 tt -131.79 171.82 17.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.496 -0.32 . . . . 0.35 110.217 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 219' ' ' PHE . 42.1 m-20 -55.72 148.98 33.56 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.009 -0.541 . . . . 1.75 111.407 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.83 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.078 2.519 . . . . 0.41 113.081 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.36 -90.13 0.92 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.879 -0.888 . . . . 0.1 110.879 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.7 m -73.34 -4.5 33.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 1.27 110.214 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 79.1 t80 -55.59 -38.78 69.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.23 111.265 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 8.1 tpt180 -65.64 -31.2 72.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.565 0.222 . . . . 1.2 111.16 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.49 -35.97 78.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.42 110.741 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.604 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 3.6 tp -84.95 -27.48 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 1.11 109.879 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 26.1 t70 -64.44 -29.13 70.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.35 110.688 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 220' ' ' ARG . 12.9 mm-40 -53.42 -33.32 53.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.72 -0.673 . . . . 0.48 112.007 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 0.8 OUTLIER -97.47 -33.43 11.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.948 -0.39 . . . . 0.17 109.948 178.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 222' ' ' ILE . 31.4 mm -55.96 -37.75 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.13 111.78 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.478 ' HA ' ' CB ' ' A' ' 231' ' ' LYS . 8.0 ptpt -62.22 -23.67 66.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.891 0.7 . . . . 0.42 112.891 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -112.47 -28.36 7.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.531 -0.468 . . . . 0.67 111.132 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -41.28 74.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.009 -0.541 . . . . 0.87 111.843 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.28 -47.06 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.501 0.556 . . . . 0.21 112.501 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 227' ' ' LYS . 25.7 ttmt -53.35 -45.96 69.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.938 0.399 . . . . 0.23 111.088 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -91.28 48.23 2.9 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.806 -0.712 . . . . 0.22 112.017 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.82 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.727 0.299 . . . . 1.2 110.902 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.25 -146.99 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.12 112.379 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.0 m -108.84 131.24 55.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.17 110.858 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.4 pt? -111.82 149.94 31.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.835 -0.432 . . . . 0.21 109.835 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -142.52 -178.84 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.01 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.72 149.93 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.975 0.417 . . . . 0.16 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.31 58.57 1.71 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.448 0.642 . . . . 0.22 109.313 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -114.86 56.92 0.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.15 110.729 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 241' ' ' LEU . 2.1 pt? -73.68 -31.35 63.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.29 110.036 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 53.33 34.78 18.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.942 0.719 . . . . 0.64 112.942 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.488 ' H ' ' HG ' ' A' ' 241' ' ' LEU . 17.4 t0 -122.65 -73.98 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.838 0.352 . . . . 1.87 111.103 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.49 ' O ' HD11 ' A' ' 241' ' ' LEU . 7.7 p -132.47 135.08 58.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.353 -0.385 . . . . 0.46 110.411 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -84.2 102.73 12.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.838 0.351 . . . . 0.64 110.082 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -102.81 138.33 39.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.972 -0.558 . . . . 1.99 110.174 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -161.37 169.83 37.0 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.064 -0.814 . . . . 0.47 111.064 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.63 101.28 7.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.464 0.632 . . . . 1.45 111.609 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -118.01 22.21 12.37 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.686 -0.857 . . . . 1.29 108.686 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -125.07 94.94 4.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.97 -1.014 . . . . 1.39 110.032 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -40.91 97.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.43 . . . . 2.07 111.285 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.46 -0.781 . . . . 2.32 110.518 -179.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 111.896 -0.482 . . . . 0.34 111.896 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -149.14 161.95 40.94 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.341 -0.244 . . . . 0.33 110.341 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -72.57 141.74 48.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.245 -0.434 . . . . 0.45 109.943 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -141.18 144.64 34.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.553 -0.294 . . . . 0.59 110.506 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.9 -73.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.449 -0.341 . . . . 0.33 110.666 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -66.98 125.15 25.05 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.742 -0.466 . . . . 1.07 109.742 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.14 77.25 61.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.364 -0.38 . . . . 0.71 111.774 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.28 143.65 25.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.427 2.085 . . . . 0.24 112.104 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 88.28 5.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.006 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -99.45 158.66 15.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.09 -0.505 . . . . 0.51 110.193 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -71.08 -50.45 33.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.88 111.174 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.16 94.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.13 109.839 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -166.64 160.14 14.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 1.54 110.338 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.13 7.19 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.17 111.539 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 p -96.99 -0.06 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.27 110.712 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -141.98 38.11 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.612 . . . . 0.22 109.506 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.72 150.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.16 111.799 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.54 137.06 54.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.365 -0.834 . . . . 0.14 109.877 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -76.09 122.78 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.377 . . . . 0.35 110.989 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 31' ' ' ILE . 1.2 p -151.57 129.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.17 110.498 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 148.0 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.95 111.152 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 17.6 ttt -110.67 134.3 52.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.61 . . . . 0.23 110.847 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -96.68 103.77 15.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.634 -0.506 . . . . 0.73 109.634 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 10.9 mmm180 -84.07 -179.82 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.548 -0.296 . . . . 1.42 110.62 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.6 69.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.514 . . . . 0.42 111.918 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.11 -39.44 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.92 . . . . 0.54 113.28 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 24.1 tttt -113.91 -174.94 2.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.781 0.324 . . . . 1.05 110.826 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 5.6 mmt180 -137.03 154.8 50.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.442 -0.948 . . . . 0.86 108.442 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -133.48 102.75 5.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.178 -0.304 . . . . 0.27 110.178 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 61' ' ' ASN . 2.6 mt-10 -106.05 127.0 52.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.344 -0.389 . . . . 0.37 110.773 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 20' ' ' VAL . 5.0 pt -135.06 -172.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.1 110.798 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.6 110.23 3.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.92 0.391 . . . . 0.09 110.886 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' HD23 ' A' ' 53' ' ' LEU . 62.5 m -100.18 -175.47 2.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 0.12 109.779 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -72.18 167.45 20.29 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.91 0.386 . . . . 0.22 111.338 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -99.69 7.77 44.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.088 0.47 . . . . 1.11 111.079 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -87.61 84.94 7.04 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.874 -0.331 . . . . 0.23 110.379 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm 58.06 57.18 4.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.733 -0.667 . . . . 0.43 110.778 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 34' ' ' TYR . 9.1 p -74.65 61.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.794 1.283 . . . . 1.49 110.74 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.56 9.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.471 -1.24 . . . . 0.24 109.308 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -45.12 90.74 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.595 -0.729 . . . . 0.18 112.395 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -74.75 -25.6 59.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.63 111.095 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 90' ' ' LEU . 19.0 ttt180 -69.58 -31.9 70.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.578 0.704 . . . . 0.49 109.351 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' A' ' 105' ' ' GLN . 20.0 m -109.33 17.06 21.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.442 -0.799 . . . . 0.3 110.649 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.05 -116.65 0.78 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.967 -0.635 . . . . 0.47 111.965 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.86 126.13 16.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.962 -0.385 . . . . 0.99 109.962 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 1.1 pt-20 -90.99 -59.45 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.182 -0.303 . . . . 2.47 110.182 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -162.77 -58.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.34 110.583 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 47' ' ' LYS . 3.1 p30 -166.52 -175.53 3.22 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.146 -0.687 . . . . 0.99 109.146 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.724 ' HB2' HG23 ' A' ' 83' ' ' THR . 1.2 mm? -131.5 33.86 4.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.453 0.644 . . . . 0.97 110.07 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -120.86 -43.97 2.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.542 -0.754 . . . . 1.88 109.314 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -87.0 -31.66 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.345 -0.843 . . . . 0.96 108.829 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.452 HG13 ' CE1' ' A' ' 34' ' ' TYR . 22.2 t -63.25 -37.25 78.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.901 -1.045 . . . . 0.44 110.035 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD23 ' SG ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -83.47 80.22 9.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.373 -0.83 . . . . 0.59 109.243 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.6 -62.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.288 -0.869 . . . . 0.42 111.039 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -78.66 91.98 4.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.67 -0.696 . . . . 0.17 111.277 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -84.22 60.46 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.415 0.626 . . . . 0.72 110.555 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.3 t -152.91 82.81 1.21 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.241 -0.891 . . . . 0.58 109.136 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 68' ' ' ALA . 2.2 p -67.64 138.03 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.781 -0.645 . . . . 0.11 110.636 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -101.14 145.88 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.33 109.945 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 97.5 t -73.35 -40.94 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.033 -0.728 . . . . 0.5 109.033 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 2.1 t-20 -176.38 127.34 0.2 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.225 -0.898 . . . . 0.63 110.054 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.07 -37.93 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.772 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.4 m -83.44 43.28 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.952 0.406 . . . . 0.93 111.122 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -47.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 2.28 110.046 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.14 -2.8 47.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.755 -0.736 . . . . 0.47 112.269 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.3 121.95 22.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.69 0.281 . . . . 1.01 110.803 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.8 t -105.86 134.41 47.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.958 -0.386 . . . . 0.27 109.958 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.1 98.32 10.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.158 0.504 . . . . 0.41 110.589 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -81.17 178.9 8.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.045 -0.724 . . . . 2.36 109.045 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -51.63 -35.8 43.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.685 0.278 . . . . 0.42 111.537 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.51 -30.01 70.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 2.09 111.805 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.67 -51.21 6.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 2.18 111.829 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 80' ' ' ASP . 2.2 pp -60.12 -32.55 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.19 111.881 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.39 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.202 0.525 . . . . 0.83 110.363 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.6 m -105.89 -39.15 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.79 111.142 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.94 -41.06 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.387 . . . . 0.33 111.07 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -96.63 -57.39 2.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.99 109.823 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.29 -31.93 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.902 -0.666 . . . . 0.53 112.142 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.02 145.35 45.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.55 0.215 . . . . 0.76 110.531 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 7.8 p-10 -92.8 11.68 26.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.059 0.456 . . . . 0.7 110.917 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.589 ' O ' HG12 ' A' ' 85' ' ' ILE . 13.5 t0 -82.1 117.72 22.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.44 109.781 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -61.07 -31.14 70.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.8 111.535 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.724 HG23 ' HB2' ' A' ' 49' ' ' LEU . 23.2 m -63.83 -46.97 82.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 0.14 110.559 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.8 -33.04 74.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.48 110.949 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 81' ' ' ASP . 41.6 mm -65.38 -57.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.421 . . . . 0.28 111.05 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.6 p -66.64 -28.48 68.51 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.083 0.401 . . . . 0.19 112.083 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' THR . 28.0 mtpt -55.34 -53.56 54.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.925 0.393 . . . . 0.82 111.14 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -63.9 -40.01 95.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.74 -0.664 . . . . 0.81 111.729 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.445 HG22 HG22 ' A' ' 20' ' ' VAL . 42.3 mt -69.81 -28.35 36.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.29 0.567 . . . . 0.18 111.078 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.518 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -79.8 -32.12 40.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.291 -0.413 . . . . 0.26 111.771 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 87' ' ' LYS . 11.4 t -99.06 -29.48 12.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.133 0.79 . . . . 0.21 113.133 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -119.44 12.04 12.31 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.073 -0.392 . . . . 1.65 111.801 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.84 -177.33 18.39 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.583 -0.818 . . . . 0.26 111.551 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.49 106.62 18.66 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.119 -0.326 . . . . 1.8 110.119 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 97' ' ' VAL . 2.1 p -117.66 148.64 20.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.173 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -70.8 77.09 0.62 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.078 0.466 . . . . 0.41 111.64 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.565 HG23 HE22 ' A' ' 108' ' ' GLN . 15.6 m -82.57 157.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 1.12 110.438 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 p -125.99 -70.6 0.73 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.446 -0.343 . . . . 1.15 110.938 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.21 146.31 1.87 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.061 -0.348 . . . . 2.42 110.061 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HD3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -157.89 145.85 18.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 1.1 110.126 179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.16 20.55 6.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.541 . . . . 1.26 110.914 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 102' ' ' ARG . 3.8 mmp_? -73.66 172.25 11.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.54 110.413 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -128.84 84.86 2.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.666 0.617 . . . . 2.18 112.666 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.0 m -159.05 -83.68 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.652 -0.249 . . . . 0.66 110.73 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.516 ' H ' ' HA ' ' A' ' 43' ' ' SER . 21.2 tm0? -130.87 141.86 50.34 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.5 -0.556 . . . . 0.43 109.5 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mt -141.63 149.36 40.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.772 -0.195 . . . . 0.62 110.478 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -99.76 -10.64 21.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.196 0.522 . . . . 0.58 110.515 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.565 HE22 HG23 ' A' ' 97' ' ' VAL . 20.5 mp0 -86.27 87.63 7.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.781 -0.645 . . . . 1.72 110.507 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.0 mtt -76.21 20.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.214 0.53 . . . . 0.37 111.964 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -130.52 5.45 4.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.11 -0.7 . . . . 1.24 109.11 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -139.65 -16.79 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.189 -0.914 . . . . 0.29 110.391 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.75 -47.26 87.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.951 -0.568 . . . . 0.14 111.653 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.6 mm -71.16 -43.65 74.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.305 0.574 . . . . 0.27 109.944 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.91 88.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.14 -0.937 . . . . 0.19 112.42 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 t -63.95 -22.29 66.86 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.913 0.338 . . . . 1.18 111.913 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.71 -40.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.942 0.401 . . . . 0.25 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 163' ' ' LEU . 1.2 p -82.99 -13.92 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.257 -0.429 . . . . 0.23 111.983 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' A' ' 135' ' ' ILE . . . -88.78 -47.38 8.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.548 . . . . 0.11 110.261 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.561 ' O ' ' HA3' ' A' ' 217' ' ' GLY . 7.4 t70 -60.57 -43.22 97.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.055 -0.975 . . . . 0.21 111.743 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 216' ' ' PRO . 17.9 mtmt -90.01 16.68 7.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.099 0.778 . . . . 0.83 113.099 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.454 ' SG ' HD13 ' A' ' 169' ' ' ILE . 91.5 m -131.76 108.9 9.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.937 -0.394 . . . . 0.23 109.937 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.85 172.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.073 0.463 . . . . 0.28 111.817 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . 9.5 t-20 -174.14 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 114.986 -1.006 . . . . 0.54 109.657 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 123' ' ' ASN . 83.2 Cg_endo -90.25 121.53 0.9 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.87 1.713 . . . . 0.81 111.912 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 1.6 pm0 -74.01 -20.64 60.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.038 0.447 . . . . 1.68 110.428 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 t -79.03 -6.5 56.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.913 -0.585 . . . . 1.01 110.691 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -143.97 82.14 1.7 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.644 -0.502 . . . . 0.35 109.644 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HB2' ' CD2' ' A' ' 130' ' ' TYR . 91.0 mtt180 -70.96 157.08 91.1 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.715 -0.675 . . . . 0.42 110.331 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.86 54.72 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.921 2.414 . . . . 0.31 113.259 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -96.01 25.12 4.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.53 111.027 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.1 m -151.99 110.22 3.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.67 110.19 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.47 -34.42 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.03 -0.532 . . . . 0.35 111.095 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.2 mm -60.41 -29.3 44.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.25 112.031 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -58.85 -33.58 70.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.43 111.879 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.479 HG21 ' HB2' ' A' ' 118' ' ' ALA . 2.6 tp -102.99 -15.27 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 121.036 -0.266 . . . . 0.19 111.349 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -36.26 70.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.167 0.508 . . . . 0.4 110.143 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -60.08 -32.91 71.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.456 -0.793 . . . . 1.03 110.983 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.21 -39.93 22.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.3 110.825 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 6.2 ttt -63.1 -41.39 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.379 0.609 . . . . 0.32 110.079 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -71.29 -23.52 61.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.448 -0.796 . . . . 1.39 110.755 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.18 -43.79 27.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.108 -0.496 . . . . 0.33 112.176 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 144' ' ' TYR . 16.2 tt -66.45 -34.25 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.687 0.255 . . . . 0.23 111.687 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 m80 59.96 32.17 21.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.122 0.264 . . . . 0.36 111.366 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.452 ' H ' HG23 ' A' ' 142' ' ' ILE . 49.1 t80 -134.13 133.99 41.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.889 0.376 . . . . 0.68 110.669 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.8 m -155.36 170.28 22.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.687 -0.688 . . . . 0.52 109.194 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.48 -84.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.949 -0.3 . . . . 0.13 110.351 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -143.95 104.48 4.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.45 110.373 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -12.08 60.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.18 111.629 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.94 5.68 50.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.22 110.925 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -116.1 -159.88 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.29 -0.414 . . . . 0.99 110.528 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -75.41 81.66 2.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.364 0.602 . . . . 0.61 109.925 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 153' ' ' LYS . 0.9 OUTLIER -53.72 -25.44 18.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.5 113.514 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.619 ' HD2' HG23 ' A' ' 152' ' ' THR . 0.0 OUTLIER -91.12 -13.06 33.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.65 -0.656 . . . . 0.69 111.757 -179.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -84.69 -25.1 28.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.318 0.58 . . . . 0.5 109.592 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.94 29.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.564 -0.744 . . . . 0.15 110.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.1 -18.36 63.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.22 112.241 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.36 -46.38 16.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.113 0.482 . . . . 0.43 109.873 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -62.49 -46.0 90.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 0.54 111.023 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.37 -38.39 48.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.722 -0.672 . . . . 0.22 111.506 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.2 -34.34 66.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.138 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -82.87 -9.92 59.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.135 -0.484 . . . . 1.27 111.412 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -55.09 6.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.3 110.127 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.4 ' HB2' HG21 ' A' ' 117' ' ' VAL . 55.3 tp -66.41 -24.0 66.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.29 110.623 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -61.57 -26.03 67.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.9 110.153 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -80.59 -7.01 59.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.49 110.845 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -107.62 -48.15 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.35 110.281 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 mmm -145.85 148.11 32.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 1.06 110.414 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -90.95 99.9 12.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.273 -0.421 . . . . 1.6 110.005 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.454 HD13 ' SG ' ' A' ' 121' ' ' CYS . 0.2 OUTLIER -100.18 149.32 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.037 -0.529 . . . . 0.24 110.718 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -77.86 140.88 39.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.161 0.505 . . . . 1.72 110.641 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -139.42 61.43 1.55 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.82 -0.627 . . . . 0.51 110.268 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 113.2 3.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.776 -0.647 . . . . 0.25 110.753 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -170.93 153.44 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.468 -0.567 . . . . 0.59 109.468 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 5.1 ttt -139.64 -140.89 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.985 -0.376 . . . . 1.48 109.985 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -137.69 120.83 16.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.024 -0.361 . . . . 0.58 110.024 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.462 ' H ' ' HB2' ' A' ' 213' ' ' LEU . 4.8 mp -120.43 157.91 28.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.99 0.424 . . . . 0.39 110.875 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' HB3' HG22 ' A' ' 211' ' ' VAL . 0.1 OUTLIER -135.79 -179.47 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.553 -0.749 . . . . 0.36 109.862 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 210' ' ' ILE . 1.9 p90 -141.66 139.63 33.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.721 0.296 . . . . 0.7 110.328 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.2 pt -108.68 122.17 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.198 -0.456 . . . . 0.42 110.943 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.8 149.83 9.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.609 -0.723 . . . . 1.12 109.814 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.11 160.57 37.51 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.917 2.411 . . . . 0.12 112.789 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.36 -34.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 0.55 111.121 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -55.2 -45.93 75.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.82 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -85.57 -30.25 23.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.384 -0.371 . . . . 1.45 110.57 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.04 -22.05 77.1 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.42 113.066 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -61.15 -28.23 68.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.0 0.429 . . . . 1.12 110.88 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.52 4.55 51.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.262 -0.426 . . . . 1.44 110.733 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.4 tp -111.82 -41.05 4.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.385 -0.37 . . . . 0.94 110.987 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.442 ' HB2' HD21 ' A' ' 208' ' ' LEU . 27.4 ttpp -55.77 -44.37 77.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.98 111.19 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -80.61 6.24 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.178 0.436 . . . . 0.46 112.178 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -123.06 -2.76 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.292 -0.255 . . . . 0.97 111.127 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 192' ' ' LEU . 0.3 OUTLIER -127.3 -48.69 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.645 -0.252 . . . . 0.76 111.48 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 60.3 tttt -59.8 -50.28 87.47 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 112.367 0.506 . . . . 1.02 112.367 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 48.6 Cg_endo -68.0 -2.65 9.14 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.174 1.916 . . . . 0.16 112.913 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.25 3.02 55.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 110.053 -0.351 . . . . 0.58 110.053 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 197' ' ' LYS . 16.9 mt 52.72 72.22 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.178 -0.919 . . . . 0.15 110.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 0.1 OUTLIER -152.8 19.37 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.608 -0.723 . . . . 0.34 109.932 179.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.459 HG12 ' SG ' ' A' ' 212' ' ' CYS . 33.2 m -108.95 145.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.499 . . . . 0.21 111.013 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.448 HD12 HG12 ' A' ' 211' ' ' VAL . 13.4 mt -97.02 159.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.679 . . . . 0.28 109.397 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.07 59.77 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.262 0.553 . . . . 1.32 111.613 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -155.99 74.62 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.28 -0.637 . . . . 0.45 109.28 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -123.52 155.01 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.48 . . . . 1.04 111.045 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.41 129.64 46.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.836 -0.62 . . . . 0.31 109.937 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.7 109.24 11.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.93 0.395 . . . . 1.17 110.117 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -168.77 -96.33 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.041 -0.599 . . . . 0.32 111.649 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -89.01 -10.88 45.91 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.122 -0.696 . . . . 0.56 109.122 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.19 -176.89 5.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.009 -0.996 . . . . 0.24 109.621 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 189' ' ' LYS . 21.9 tp -130.02 76.87 1.75 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.581 -0.526 . . . . 0.39 109.581 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -87.69 108.58 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.792 -0.64 . . . . 0.58 110.715 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 178' ' ' PHE . 55.3 mt -123.13 137.39 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.19 110.611 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.448 HG12 HD12 ' A' ' 199' ' ' ILE . 85.9 t -91.53 123.75 43.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.25 110.065 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.459 ' SG ' HG12 ' A' ' 198' ' ' VAL . 57.4 m -137.21 102.34 4.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.244 -0.435 . . . . 0.41 110.468 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.462 ' HB2' ' H ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -159.66 136.96 9.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.388 -0.597 . . . . 0.25 109.388 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 215' ' ' ASP . 5.6 tp -134.86 179.36 4.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.525 -0.307 . . . . 0.29 110.354 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.56 ' H ' HG13 ' A' ' 214' ' ' ILE . 16.8 m-20 -60.43 164.22 7.31 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 122.978 0.511 . . . . 0.84 110.861 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 215' ' ' ASP . 10.2 Cg_endo -52.65 170.38 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.853 2.368 . . . . 0.07 112.923 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . 80.48 -80.44 1.65 Allowed Glycine 0 C--O 1.237 0.315 0 N-CA-C 110.43 -1.068 . . . . 0.11 110.43 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.24 -22.44 63.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.107 -0.701 . . . . 0.34 109.107 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -59.5 -32.26 70.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.298 -0.865 . . . . 0.31 110.767 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 220' ' ' ARG . 11.4 mmt180 -85.93 -15.79 40.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.37 110.161 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 0.7 OUTLIER -79.69 -48.75 13.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.38 109.134 178.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 tt -66.66 -34.65 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.22 109.775 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.445 ' O ' ' HD2' ' A' ' 227' ' ' LYS . 1.8 t70 -59.98 -36.58 77.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.907 -0.588 . . . . 0.44 110.919 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 221' ' ' GLU . 9.8 mm-40 -47.13 -41.14 16.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.664 -0.698 . . . . 0.9 111.934 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -34.09 10.2 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.793 -0.363 . . . . 0.46 111.266 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 8.9 mm -56.28 -39.11 58.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.222 0.453 . . . . 0.19 112.222 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 5.8 ptmt -64.74 -11.65 38.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.976 0.732 . . . . 0.38 112.976 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -25.74 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.552 -0.459 . . . . 1.85 112.005 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.14 -47.83 26.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.64 111.362 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -116.38 -38.8 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.845 -0.342 . . . . 0.31 111.59 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -66.09 -25.05 66.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 1.32 110.24 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.95 25.35 28.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.015 -0.612 . . . . 0.4 111.718 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -139.84 -55.18 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.583 -0.525 . . . . 0.59 109.583 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.41 -145.53 9.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.314 -0.714 . . . . 0.2 111.314 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.41 133.25 46.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 117.031 0.416 . . . . 0.81 110.018 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -89.55 149.65 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.953 -0.388 . . . . 1.18 109.953 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 177' ' ' ARG . 6.6 tp10 -155.56 154.61 31.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.84 110.179 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -72.57 158.6 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.596 0.236 . . . . 0.23 110.406 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.63 52.28 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.458 0.647 . . . . 1.05 111.015 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -115.52 75.54 0.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.521 -0.918 . . . . 0.75 108.521 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.96 -73.64 0.53 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.462 -0.79 . . . . 0.22 110.785 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.44 41.96 25.37 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.756 0.66 . . . . 1.07 110.056 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.75 -46.56 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.467 -0.788 . . . . 0.85 110.875 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.37 143.84 39.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.358 -0.383 . . . . 0.21 110.499 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.02 117.76 8.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.641 -0.708 . . . . 0.63 111.084 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.73 151.88 28.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.965 -0.561 . . . . 1.01 110.929 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.98 76.6 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.593 -0.813 . . . . 0.14 113.357 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -147.48 110.84 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.046 -0.353 . . . . 0.68 110.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.41 -8.84 13.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.395 -0.366 . . . . 1.54 111.206 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.464 ' HE3' ' HB2' ' A' ' 252' ' ' GLU . 55.6 tptt -75.51 98.0 3.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 1.03 110.836 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.57 -28.69 61.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.69 110.734 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.464 ' HB2' ' HE3' ' A' ' 250' ' ' LYS . 26.0 mt-10 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.449 -0.786 . . . . 1.44 110.277 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.906 -0.477 . . . . 0.7 111.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -148.49 133.81 18.47 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.919 -0.4 . . . . 1.71 109.919 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 mmt -70.54 120.43 16.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.849 -0.426 . . . . 1.26 109.849 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -109.89 120.25 41.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.013 0.435 . . . . 0.74 111.057 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -95.08 -14.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.695 0.76 . . . . 1.08 109.33 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -142.04 144.41 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.988 -1.005 . . . . 0.73 109.032 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.26 85.9 37.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.631 0.234 . . . . 1.04 111.631 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.61 -32.78 87.6 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.36 2.04 . . . . 0.42 111.998 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m 56.36 70.76 0.61 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.961 -0.563 . . . . 0.51 111.336 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -90.86 -76.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.86 110.752 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -161.37 -80.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.81 0.338 . . . . 0.72 110.822 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 54' ' ' GLN . 1.2 pp -89.18 47.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.132 0.491 . . . . 1.51 111.728 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -121.07 151.69 39.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.001 -0.545 . . . . 1.44 110.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.71 45.45 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.217 0.532 . . . . 1.13 111.608 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 p -99.51 -33.75 10.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.092 0.472 . . . . 1.06 111.063 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.54 72.33 1.42 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.219 -0.66 . . . . 0.73 109.219 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.12 149.01 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.669 -0.696 . . . . 0.95 111.331 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.66 123.0 49.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.51 109.412 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.43 120.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.114 0.483 . . . . 0.78 111.077 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 89' ' ' ILE . 2.5 p -139.21 116.89 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.739 . . . . 0.24 109.525 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -126.83 132.95 50.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.229 0.538 . . . . 0.77 112.032 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 66.6 ttp -111.48 119.45 38.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.176 -0.676 . . . . 0.26 109.176 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 124.23 50.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.782 0.325 . . . . 1.17 110.828 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -109.86 -164.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.026 -0.533 . . . . 2.79 110.055 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.61 72.89 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.3 0.375 . . . . 1.75 111.596 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.08 7.77 4.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.399 -0.905 . . . . 0.46 112.952 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -123.13 145.26 48.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 1.74 111.261 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -129.72 132.15 46.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.067 -0.716 . . . . 0.79 109.067 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.79 144.81 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.478 0.18 . . . . 0.32 110.871 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 44.8 tt0 -156.8 143.11 18.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.986 -0.376 . . . . 0.7 109.986 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 53' ' ' LEU . 2.0 pt -142.07 -173.21 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.737 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.82 119.78 26.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.915 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 90' ' ' LEU . 29.5 m -116.76 157.78 24.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 0.37 110.641 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HD1' ' NE2' ' A' ' 54' ' ' GLN . 1.3 t80 -74.15 145.13 44.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.829 0.347 . . . . 1.02 110.226 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 8.97 4.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.312 -0.404 . . . . 1.13 111.599 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.55 88.34 7.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.305 -0.247 . . . . 1.13 110.797 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.5 44.35 24.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.508 -0.769 . . . . 0.7 112.091 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.89 149.24 8.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.869 -0.605 . . . . 0.33 110.188 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 90' ' ' LEU . 3.9 t 68.81 23.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.41 0.624 . . . . 0.14 110.459 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.57 62.35 6.45 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.898 -0.592 . . . . 0.17 113.292 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 11.47 5.07 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.361 0.264 . . . . 0.61 111.155 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 22.36 13.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.356 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -135.99 -51.35 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.823 -0.626 . . . . 0.44 111.11 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.06 -112.9 0.86 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.549 -0.834 . . . . 0.23 112.327 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.4 t -129.9 127.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.556 0.217 . . . . 0.22 110.71 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.7 -69.03 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.072 -0.714 . . . . 1.57 109.072 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 179.92 6.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.442 -0.799 . . . . 0.64 108.968 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.41 138.79 58.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.81 0.338 . . . . 0.52 111.284 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 52' ' ' VAL . 6.0 mp -68.23 -24.45 64.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.981 -0.554 . . . . 0.52 110.229 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.26 -27.28 68.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.373 0.606 . . . . 1.14 109.946 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 17.65 19.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 1.48 111.161 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 49' ' ' LEU . 1.3 p -125.12 -9.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.347 . . . . 0.24 111.087 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.575 ' HG ' HE22 ' A' ' 82' ' ' GLN . 1.9 mm? -96.24 110.07 22.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.333 -0.394 . . . . 0.39 110.35 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.532 ' NE2' ' HD1' ' A' ' 34' ' ' TYR . 17.1 mt-30 -70.52 -35.81 73.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.064 -0.516 . . . . 2.38 110.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -122.11 164.37 17.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.748 -0.66 . . . . 0.85 110.458 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -125.19 18.05 8.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.947 -0.569 . . . . 0.83 109.629 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -116.39 118.49 32.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.462 -0.79 . . . . 0.58 110.164 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 68' ' ' ALA . 8.0 p -100.95 143.14 14.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.239 -0.437 . . . . 0.31 110.227 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -83.97 157.5 21.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.629 0.252 . . . . 0.22 111.087 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 83.3 t -117.8 -49.48 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.482 0.658 . . . . 0.4 109.539 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -144.15 111.37 5.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.815 . . . . 0.72 108.955 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.5 -37.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.006 0.373 . . . . 0.36 112.006 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -31.17 72.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.933 0.397 . . . . 0.51 111.142 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -100.96 -1.85 33.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.91 111.242 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.84 48.13 83.42 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.96 -0.638 . . . . 0.38 112.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -106.6 123.65 48.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.794 0.331 . . . . 0.58 111.231 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.76 139.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.736 -0.666 . . . . 0.08 109.537 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -90.93 128.13 36.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.12 111.653 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -91.33 -172.33 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.362 -0.607 . . . . 0.4 109.362 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -63.27 -30.74 71.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.758 0.314 . . . . 0.31 111.004 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.1 pm0 -79.62 -24.82 41.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 1.19 110.973 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.19 -51.95 15.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.424 -0.353 . . . . 1.81 110.288 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.43 -32.78 74.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.25 110.935 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -66.8 -23.53 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.961 0.41 . . . . 0.72 110.237 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -100.93 -5.81 25.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.65 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.18 -40.27 7.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.33 110.763 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.97 -34.51 6.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.38 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.01 -10.02 29.41 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.032 -0.604 . . . . 0.31 111.926 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 147.09 44.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.476 0.179 . . . . 0.93 110.523 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -96.69 -8.91 30.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.809 0.338 . . . . 0.86 111.02 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 85' ' ' ILE . 56.0 t0 -73.84 110.78 8.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.168 -0.469 . . . . 0.99 110.099 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.575 HE22 ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -62.07 -27.86 69.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.851 -0.613 . . . . 0.64 110.882 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -34.39 77.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.66 110.538 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.96 -29.27 32.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 81' ' ' ASP . 39.7 mm -67.28 -46.32 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 p -71.1 -24.08 62.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.27 110.349 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -59.9 -41.83 92.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.215 0.531 . . . . 0.76 109.718 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.04 -49.67 55.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.411 -0.813 . . . . 0.35 110.726 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG22 HG22 ' A' ' 20' ' ' VAL . 33.2 mt -61.76 -35.12 65.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.25 112.245 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 33' ' ' CYS . 3.7 mm? -82.77 -11.31 58.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.247 0.832 . . . . 0.08 113.247 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -122.98 -10.1 8.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.151 -0.62 . . . . 0.14 112.389 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -121.94 -5.26 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.733 0.302 . . . . 0.16 110.827 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.8 -169.33 19.26 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.547 -0.835 . . . . 0.14 113.067 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.29 107.44 18.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.702 -0.481 . . . . 0.99 109.702 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 97' ' ' VAL . 2.2 p -106.28 138.52 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.2 110.456 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.26 89.39 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 1.22 111.021 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.539 HG23 ' H ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -131.17 -87.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.45 . . . . 1.06 111.033 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.539 ' H ' HG23 ' A' ' 97' ' ' VAL . 61.8 m -156.86 -166.42 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.371 -0.603 . . . . 0.67 109.371 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.07 120.34 11.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.877 0.37 . . . . 0.66 111.027 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -163.98 172.42 13.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.07 -0.715 . . . . 0.38 109.07 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.83 164.8 22.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.937 0.399 . . . . 2.17 110.675 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -88.93 -175.46 4.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.692 -0.686 . . . . 0.3 109.442 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -165.52 147.58 7.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.291 . . . . 0.19 110.781 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -80.87 155.05 26.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.108 -0.496 . . . . 0.22 109.883 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' THR . 44.8 tt0 175.3 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.391 0.432 . . . . 1.15 110.415 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' O ' ' HG2' ' A' ' 109' ' ' MET . 1.9 mt -176.32 176.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.837 -0.431 . . . . 0.57 109.837 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.51 136.74 39.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.2 -0.454 . . . . 1.15 109.881 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 69.13 1.9 3.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.691 0.62 . . . . 0.85 111.121 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 8.5 ptt? -63.72 -23.99 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.99 -0.55 . . . . 1.21 111.204 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.81 -28.71 70.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.74 110.919 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.06 -35.51 23.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.015 0.436 . . . . 1.83 110.096 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 115' ' ' THR . 20.0 t70 -62.77 -51.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.6 . . . . 1.24 110.512 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.97 -33.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.078 -0.51 . . . . 0.55 110.576 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.3 95.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.32 111.661 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 112' ' ' ASP . 6.5 t -72.47 -11.76 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.24 111.486 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 112' ' ' ASP . 47.5 mm -95.59 -37.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.181 0.515 . . . . 0.72 110.259 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.36 -22.91 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.005 -0.543 . . . . 0.66 111.364 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.25 80.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 0.25 111.462 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -68.35 -21.67 64.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.517 0.675 . . . . 2.01 111.107 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -119.31 26.33 9.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.44 110.482 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 31.7 t -87.39 101.31 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.02 -0.537 . . . . 1.96 111.039 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.21 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.367 -0.379 . . . . 1.72 110.283 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 125' ' ' GLU . 28.5 t-20 -154.1 137.13 10.14 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 1.01 109.809 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.39 65.19 3.65 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.922 2.415 . . . . 0.64 112.626 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 3.8 tt0 -146.89 -175.06 4.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.57 109.104 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.466 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 10.1 t -81.44 -11.91 59.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.105 0.478 . . . . 0.55 109.829 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.412 ' HB2' ' OE1' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -79.48 80.48 5.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.153 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -89.71 150.54 44.26 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.156 -0.474 . . . . 1.6 110.331 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.86 106.76 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.496 2.797 . . . . 0.28 112.47 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -149.98 -65.89 0.21 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.035 -0.53 . . . . 0.69 110.487 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.99 143.01 33.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.191 -0.458 . . . . 0.75 111.208 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.31 -29.39 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.144 0.497 . . . . 0.13 110.762 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -55.61 -32.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.26 111.334 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.94 -47.7 82.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.15 111.873 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -33.73 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 1.13 110.844 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -65.04 -37.76 88.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.044 0.449 . . . . 0.73 110.633 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -28.78 70.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 1.87 110.926 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.85 23.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.28 110.65 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 11.6 tpt -65.89 -42.95 89.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.47 111.043 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -72.31 -26.6 62.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.577 -0.283 . . . . 1.13 110.658 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.13 -49.77 68.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.095 -0.502 . . . . 0.61 110.735 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.1 tt -76.46 -51.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.204 -0.453 . . . . 0.31 110.989 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 41.16 51.53 3.43 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.686 0.616 . . . . 0.83 111.7 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -114.01 94.59 4.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 0.82 111.406 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 139.29 30.79 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.629 . . . . 0.51 109.887 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.66 83.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.792 0.33 . . . . 0.47 110.533 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 60.75 54.45 3.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.743 -0.662 . . . . 1.09 111.405 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -15.43 63.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.6 111.818 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -101.48 15.95 27.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 1.27 111.007 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -119.23 -125.2 0.28 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.59 110.907 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.77 79.71 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.84 111.023 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -21.94 60.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.922 -0.581 . . . . 0.58 112.52 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 9.7 29.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.369 . . . . 1.19 111.168 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -128.98 -44.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 1.36 110.154 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -71.56 -6.02 37.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.814 -0.63 . . . . 1.26 111.22 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -36.82 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.38 110.8 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.91 -39.21 76.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.9 110.693 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 12.2 mp0 -64.99 -46.17 82.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.049 -0.523 . . . . 0.82 111.147 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.26 -44.18 80.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 111.971 0.36 . . . . 0.45 111.971 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.16 -29.59 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.874 0.324 . . . . 0.79 111.874 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -97.21 -12.84 22.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.591 0.234 . . . . 0.95 111.188 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 3.9 tp-100 -68.15 -43.61 77.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.662 -0.496 . . . . 0.32 109.662 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.36 -32.12 73.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.27 109.903 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -67.93 -21.89 65.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.555 -0.748 . . . . 0.97 110.391 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.6 -32.85 60.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.43 110.271 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -52.82 7.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.82 -0.807 . . . . 1.42 108.82 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mtp -131.59 112.45 12.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.944 -0.761 . . . . 1.04 108.944 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -73.52 81.23 1.46 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 1.23 111.75 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.6 pt -94.68 143.97 10.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.562 -0.744 . . . . 0.26 109.76 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.15 155.42 46.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.934 0.397 . . . . 0.99 111.068 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.07 103.93 15.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 1.32 110.409 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -117.26 -156.31 0.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.65 -0.705 . . . . 0.88 110.287 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 67.11 80.7 0.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.688 0.617 . . . . 1.22 111.274 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 19.5 ptm -70.72 167.06 19.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.832 -0.622 . . . . 0.74 111.33 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.441 ' HA ' ' HG ' ' A' ' 213' ' ' LEU . 25.3 mtp180 -84.08 147.99 27.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 1.24 111.153 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 mp -129.45 175.64 8.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 0.32 110.567 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -136.86 167.38 21.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.015 -0.539 . . . . 0.83 109.826 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 1.3 t80 -123.67 143.08 50.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.636 -0.256 . . . . 0.26 110.691 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.6 pt -133.28 115.34 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.025 0.44 . . . . 0.27 110.548 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 184' ' ' GLU . 2.3 pt? -155.84 155.63 29.63 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.028 -0.533 . . . . 0.11 110.238 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.95 161.44 33.07 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.994 2.463 . . . . 0.17 113.27 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HA ' HD23 ' A' ' 208' ' ' LEU . 27.8 t -57.65 -35.53 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.607 -0.724 . . . . 0.45 111.89 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.31 -39.78 61.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.34 111.998 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 49.6 mm-40 -104.46 -17.74 14.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.988 0.423 . . . . 0.46 110.529 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.31 -34.6 88.78 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.171 -0.538 . . . . 0.24 112.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 30.6 ttpt -71.62 -7.55 48.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.928 0.394 . . . . 0.68 111.098 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -84.15 -58.26 2.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.679 0.276 . . . . 0.62 110.704 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -25.66 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.8 111.21 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.52 -37.21 85.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.837 0.351 . . . . 1.08 110.723 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 13.7 mm-40 -90.99 11.23 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.396 -0.366 . . . . 0.76 110.684 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -121.1 -49.24 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.806 0.299 . . . . 0.64 111.806 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mt -80.09 -36.73 35.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.109 0.781 . . . . 0.3 113.109 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 24.8 mtpp -60.93 -50.98 82.54 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 112.228 0.455 . . . . 0.22 112.228 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 21.3 Cg_endo -61.43 -19.58 64.93 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.147 1.898 . . . . 0.23 112.609 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 48.0 mt -81.95 -13.02 58.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.349 . . . . 0.24 110.141 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 14.1 mt 55.22 59.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.49 -0.777 . . . . 0.46 110.371 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 21.37 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.33 -0.85 . . . . 0.39 109.783 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 212' ' ' CYS . 19.5 m -120.81 149.51 23.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.34 110.416 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.66 149.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.374 -0.602 . . . . 0.25 109.374 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -73.45 70.01 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 1.36 111.005 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.0 m -151.85 37.03 0.56 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.743 -0.662 . . . . 0.81 109.397 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 4.1 pt-20 -88.08 175.25 7.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.798 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.406 ' O ' HD13 ' A' ' 208' ' ' LEU . 23.3 t70 -132.96 146.81 52.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.4 109.341 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.35 25.88 9.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.431 0.16 . . . . 0.97 111.431 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.21 -141.88 7.85 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.786 -0.721 . . . . 0.68 112.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -74.42 -17.51 60.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.179 0.514 . . . . 1.78 110.642 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 121.38 34.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.699 -0.682 . . . . 1.55 109.61 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 182' ' ' VAL . 4.1 mm? -80.71 85.8 6.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.127 0.489 . . . . 0.54 110.369 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 25.4 tt0 -76.72 93.61 3.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.817 -0.629 . . . . 1.04 110.048 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.2 127.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.514 . . . . 0.32 110.652 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.51 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.855 0.359 . . . . 0.22 110.361 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 198' ' ' VAL . 1.8 p -124.51 104.68 8.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 0.29 110.898 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -164.35 127.37 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.313 -0.625 . . . . 0.21 109.313 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.03 -163.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.634 -0.257 . . . . 0.23 111.546 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -49.05 148.96 3.66 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.529 -0.76 . . . . 0.77 112.388 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.86 -50.09 14.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.134 2.556 . . . . 0.41 113.071 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -68.08 -57.3 8.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.47 112.657 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 51.4 m -55.88 -36.6 67.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.239 0.459 . . . . 0.48 112.239 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.93 -39.75 90.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.096 -0.642 . . . . 0.74 110.609 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -70.89 -8.14 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 1.7 110.647 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -95.46 -22.67 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.755 -0.657 . . . . 1.25 110.571 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 226' ' ' ILE . 7.6 tp -108.69 -29.11 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.459 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 33.9 t70 -61.37 -21.09 63.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.873 0.368 . . . . 0.76 111.104 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -26.32 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.86 111.114 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 228' ' ' LYS . 0.7 OUTLIER -114.02 -25.53 8.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.575 -0.284 . . . . 0.77 110.571 178.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 222' ' ' ILE . 44.5 mm -66.51 -33.24 62.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.666 0.27 . . . . 0.79 110.979 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.96 -35.88 77.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.391 . . . . 0.98 110.782 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 225' ' ' LEU . 0.0 OUTLIER -99.55 11.21 39.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.239 0.543 . . . . 0.86 110.011 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -102.21 -65.77 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.84 110.45 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -121.57 -30.1 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 0.7 111.803 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -61.12 -33.05 72.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.161 0.505 . . . . 1.0 110.704 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -96.36 22.82 37.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.974 -0.851 . . . . 0.71 110.974 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -118.66 -57.43 2.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.882 0.372 . . . . 1.39 110.4 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.08 -136.08 5.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 0.4 112.806 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.7 m -132.59 148.85 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.845 0.355 . . . . 0.39 110.621 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.68 160.29 19.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.913 0.387 . . . . 0.53 111.078 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -144.97 157.34 44.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.2 -0.667 . . . . 0.41 109.2 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.11 148.34 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.3 110.919 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 31.1 tp -97.11 62.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.299 0.571 . . . . 1.07 109.818 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -119.29 90.38 3.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.806 -0.634 . . . . 1.46 110.191 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 243' ' ' ASP . 0.9 OUTLIER -161.58 127.52 3.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.801 -0.636 . . . . 1.61 109.8 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -136.55 60.87 1.65 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.417 0.627 . . . . 1.24 110.347 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.437 ' H ' HD13 ' A' ' 241' ' ' LEU . 11.5 t70 -113.55 -67.92 0.96 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.299 -0.864 . . . . 2.16 109.322 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 245' ' ' GLU . 4.9 p -117.62 170.53 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.374 -0.83 . . . . 1.99 108.77 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 244' ' ' VAL . 43.9 mt-10 -75.81 125.58 29.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.795 0.331 . . . . 2.59 110.766 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.28 142.39 46.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.286 -0.415 . . . . 2.44 110.39 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.78 142.53 7.19 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.607 -0.806 . . . . 0.65 111.93 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -139.66 144.42 37.61 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.714 -0.286 . . . . 0.5 110.802 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.48 3.42 32.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.374 -0.376 . . . . 1.23 110.788 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -74.69 101.43 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.48 . . . . 0.52 110.401 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.0 -38.17 19.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.824 -0.625 . . . . 0.51 111.076 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.39 -0.814 . . . . 1.18 110.899 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.972 -0.451 . . . . 0.69 111.972 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -104.96 129.82 53.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.989 -0.375 . . . . 0.77 109.989 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 ttt -164.01 134.73 4.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.236 -0.438 . . . . 1.32 110.192 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -79.53 108.14 12.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.042 0.449 . . . . 0.55 110.587 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -109.16 -179.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.63 109.637 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -144.9 120.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.755 0.312 . . . . 2.4 110.544 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.9 HG23 ' HB ' ' A' ' 15' ' ' THR . 91.3 m -68.1 113.99 18.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.656 -0.702 . . . . 0.41 112.592 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -89.24 147.54 5.37 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.958 2.439 . . . . 0.45 111.439 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -103.26 136.11 43.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.742 0.306 . . . . 0.22 111.231 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t30 65.09 18.4 11.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.624 -0.716 . . . . 0.46 112.383 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -93.89 -3.0 52.56 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.068 -0.345 . . . . 1.09 110.068 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.4 mt 55.1 68.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.568 -0.742 . . . . 0.36 110.922 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -136.37 166.86 22.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.729 -0.669 . . . . 0.26 109.5 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -75.78 53.52 0.74 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.977 0.418 . . . . 0.67 110.634 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.9 ' HB ' HG23 ' A' ' 7' ' ' THR . 9.6 p -123.41 -44.83 2.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.991 -0.549 . . . . 0.71 111.554 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -112.05 23.51 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 1.9 110.593 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m -74.41 137.42 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.49 112.256 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . -91.78 140.26 29.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.614 -0.721 . . . . 0.6 110.205 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.07 130.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.186 0.517 . . . . 0.45 111.872 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 89' ' ' ILE . 5.7 p -150.13 126.4 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.574 -0.739 . . . . 0.18 109.024 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -132.86 141.7 48.55 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.655 0.613 . . . . 1.73 112.655 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttp -113.65 108.71 17.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.166 -0.925 . . . . 0.21 108.806 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -86.94 99.34 11.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.11 111.248 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -96.13 167.01 11.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.834 -0.621 . . . . 0.89 109.926 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.16 73.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.362 -0.381 . . . . 0.5 111.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.87 -50.78 6.22 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.95 -0.643 . . . . 0.6 112.521 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -161.81 147.43 13.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.777 -0.453 . . . . 0.48 109.777 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -92.39 143.87 25.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.671 -0.492 . . . . 1.32 109.671 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.34 132.36 42.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.538 -0.301 . . . . 0.32 111.024 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 21' ' ' ARG . 22.8 tt0 -124.4 134.87 52.99 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.459 -0.571 . . . . 1.48 109.459 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.37 145.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.404 . . . . 0.34 111.151 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.777 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -106.37 112.77 25.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.479 -0.563 . . . . 0.32 109.479 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.1 168.05 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.919 0.39 . . . . 0.88 111.835 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 22.3 t80 -73.26 117.68 15.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.762 -0.654 . . . . 1.1 109.854 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 27.8 ttpt -79.83 82.39 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.398 0.618 . . . . 1.98 111.707 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.67 75.5 0.78 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.098 -0.955 . . . . 0.65 108.452 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.69 36.19 2.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.956 -1.02 . . . . 1.08 109.837 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.18 -40.55 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.493 -0.776 . . . . 0.35 110.908 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 m -84.58 2.27 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.33 110.605 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.04 -27.32 74.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.217 -0.753 . . . . 0.27 111.217 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -72.17 -20.91 61.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.173 0.511 . . . . 0.56 109.974 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -103.06 0.72 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.575 . . . . 0.8 110.511 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -129.6 10.73 5.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.298 0.571 . . . . 1.0 110.381 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.68 -138.23 5.24 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.794 -0.922 . . . . 0.37 110.794 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.6 121.43 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.825 0.313 . . . . 0.3 110.208 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -128.36 -83.85 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.652 -0.249 . . . . 1.18 111.501 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.57 172.51 12.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.363 -0.38 . . . . 0.43 110.094 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.72 143.77 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.137 -0.32 . . . . 0.29 110.137 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.91 -24.88 67.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.24 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -57.83 -37.17 73.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.943 0.401 . . . . 0.38 110.772 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -83.77 -19.61 34.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.972 -0.558 . . . . 1.46 110.798 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.07 -25.47 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.36 110.938 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 55' ' ' THR . 2.4 mm? -74.76 99.83 3.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.4 110.921 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 34' ' ' TYR . 29.2 mt-30 -77.34 -24.48 50.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.671 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.443 ' O ' HD12 ' A' ' 53' ' ' LEU . 12.6 t -130.63 152.01 50.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.46 109.808 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -112.53 7.87 19.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.071 0.462 . . . . 0.39 110.4 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 m -110.23 145.59 37.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.016 -0.538 . . . . 0.18 109.947 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 68' ' ' ALA . 11.6 p -112.04 139.8 34.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 0.15 110.934 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -78.01 151.47 33.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.89 111.547 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 54.9 t -129.48 -59.34 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.499 -0.319 . . . . 0.61 111.636 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -123.68 126.67 46.99 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.456 -0.152 . . . . 0.63 110.825 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.17 -26.36 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 N-CA-C 111.957 0.355 . . . . 0.95 111.957 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.7 m -72.02 -47.06 54.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.192 0.52 . . . . 0.77 110.207 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.47 -22.27 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.894 -0.594 . . . . 1.44 110.2 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.92 44.58 36.6 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 0.46 111.374 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -108.02 124.1 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.083 0.468 . . . . 1.16 111.068 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.01 145.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.471 -0.786 . . . . 0.43 109.606 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 72' ' ' ASP . . . -97.51 126.76 42.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.18 110.838 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -97.21 -171.53 2.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.653 -0.703 . . . . 1.11 110.112 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -51.28 -40.21 58.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.699 0.629 . . . . 1.07 112.699 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -62.15 -26.7 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.692 0.627 . . . . 0.47 112.692 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 17.2 t70 -94.17 -44.71 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.682 -0.407 . . . . 0.25 111.751 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.31 -34.69 75.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.929 -0.309 . . . . 0.26 111.827 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.11 -25.67 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.8 110.736 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 m -94.58 -43.03 8.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.16 111.387 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.09 -46.43 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.16 112.088 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -94.07 -29.75 15.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.843 0.354 . . . . 0.94 110.689 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.9 16.19 54.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.466 -0.874 . . . . 0.8 112.184 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.5 m -145.94 124.56 12.51 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.19 -0.3 . . . . 1.51 110.19 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.29 60.68 5.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.433 0.635 . . . . 1.16 110.41 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.457 ' OD2' ' HB ' ' A' ' 83' ' ' THR . 19.6 t70 -151.97 111.84 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.728 -0.669 . . . . 2.41 109.986 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -68.33 -24.66 64.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.077 -0.511 . . . . 1.51 111.218 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.457 ' HB ' ' OD2' ' A' ' 81' ' ' ASP . 11.6 m -66.82 -45.76 77.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.58 110.228 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -58.89 -46.54 87.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.67 110.402 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.96 -48.23 87.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.553 -0.749 . . . . 0.35 110.596 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.2 -34.6 75.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.16 110.895 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -62.01 -42.21 98.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 0.33 110.14 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -67.55 -40.37 84.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.959 -0.564 . . . . 0.28 110.002 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.558 HG22 HG22 ' A' ' 20' ' ' VAL . 76.3 mt -68.87 -30.89 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.617 -0.719 . . . . 0.12 111.004 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.87 -18.79 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.398 -0.365 . . . . 0.16 111.69 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -105.7 -15.47 14.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.59 -0.444 . . . . 0.2 112.075 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -142.05 36.48 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 2.1 111.164 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.47 165.83 24.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.529 -0.843 . . . . 0.4 112.587 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 80.1 mt-10 -82.01 93.49 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 1.41 110.246 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.01 137.24 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.338 -0.392 . . . . 0.22 110.227 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -73.31 76.05 1.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.202 0.525 . . . . 0.58 111.77 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 m -110.48 -9.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.36 111.298 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.0 m -147.16 159.35 43.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.604 0.24 . . . . 0.43 110.508 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.8 -176.24 3.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.895 -0.593 . . . . 1.35 110.155 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.58 -154.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.425 0.453 . . . . 2.16 110.492 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 54.28 38.75 29.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.219 0.533 . . . . 1.58 111.655 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -107.34 -90.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 1.38 110.218 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -159.17 136.28 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.645 0.259 . . . . 1.23 110.405 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -151.81 108.76 3.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.251 -0.432 . . . . 0.82 110.416 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -118.99 93.5 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.072 0.463 . . . . 1.67 110.202 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 mt -140.7 171.77 13.64 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.718 -0.674 . . . . 0.25 109.797 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.76 -48.84 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.744 0.652 . . . . 1.29 111.381 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -121.87 76.45 1.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.96 110.251 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.75 -40.93 80.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.72 110.372 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.656 -0.702 . . . . 0.41 111.622 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -88.68 -39.2 14.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.84 0.352 . . . . 0.31 110.937 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.5 -40.93 93.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 1.47 110.973 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 tt -76.14 -16.15 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.148 0.499 . . . . 0.42 110.802 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.27 -38.7 13.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 0.21 111.071 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.9 t -66.25 -19.88 65.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.744 0.307 . . . . 0.22 111.686 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.0 tp -88.35 -6.56 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.021 0.439 . . . . 0.41 110.823 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 120' ' ' LYS . 4.9 p -124.26 -8.11 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.815 0.341 . . . . 0.19 111.365 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.35 -51.81 66.89 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.327 0.492 . . . . 0.62 112.327 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -84.75 -11.86 54.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 2.22 110.79 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 117' ' ' VAL . 13.1 mptt -82.97 -9.88 59.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.01 -0.541 . . . . 0.91 110.721 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 6.6 t -155.28 83.78 1.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.248 0.547 . . . . 0.54 109.556 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.11 175.91 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.774 -0.648 . . . . 1.12 112.092 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.51 ' C ' HD22 ' A' ' 123' ' ' ASN . 0.2 OUTLIER -101.66 158.45 31.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.575 -0.739 . . . . 1.16 110.625 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.72 -69.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.603 2.202 . . . . 1.14 111.573 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -133.88 82.32 1.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.462 0.649 . . . . 0.79 110.652 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.1 m -147.85 -53.65 0.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.432 -0.804 . . . . 1.39 109.216 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 128' ' ' ARG . 3.2 tppt? -152.82 -155.76 0.64 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.439 -0.948 . . . . 1.09 108.439 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 18.3 mtt180 -135.29 162.66 56.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 110.485 -0.191 . . . . 1.5 110.485 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.94 -178.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.271 2.647 . . . . 0.45 113.415 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 62.63 26.07 15.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.5 -0.773 . . . . 1.37 110.198 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 HD23 ' A' ' 134' ' ' LEU . 6.0 m -131.08 94.17 3.53 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.768 -0.651 . . . . 0.39 110.493 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -69.39 -38.23 76.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.964 -0.562 . . . . 0.5 110.934 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.9 mm -52.82 -34.58 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.783 -0.644 . . . . 0.31 112.32 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 131' ' ' THR . 1.0 OUTLIER -62.95 -50.07 72.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.563 0.221 . . . . 0.96 111.561 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.1 tp -77.31 -30.66 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.58 110.613 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.37 -44.73 86.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.228 -0.442 . . . . 0.4 110.3 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -34.52 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 1.27 110.4 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.73 -48.58 53.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.178 -0.464 . . . . 0.18 110.708 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 44.0 ttp -65.76 -36.71 84.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 1.73 110.847 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -65.19 -26.4 68.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 1.82 110.781 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.25 -38.15 51.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.182 -0.463 . . . . 0.55 110.897 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 144' ' ' TYR . 8.6 mt -77.51 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.645 . . . . 0.4 111.422 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.3 t60 75.06 -24.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.865 0.728 . . . . 1.31 111.674 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 142' ' ' ILE . 29.8 t80 -70.86 135.06 47.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.165 -0.309 . . . . 1.3 110.165 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 170.38 10.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.426 -0.352 . . . . 0.18 110.665 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.408 HG13 HG21 ' A' ' 159' ' ' VAL . 2.8 t -87.21 48.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.25 110.536 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 52.41 30.23 7.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.33 111.341 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 148' ' ' THR . 14.6 t 42.33 73.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.341 1.056 . . . . 0.74 112.497 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p30 51.37 18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.705 1.202 . . . . 0.55 114.114 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.05 140.47 48.43 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.97 -0.456 . . . . 1.43 111.046 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.4 m 62.57 38.96 11.98 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.13 110.915 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -63.93 -33.82 76.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.775 -0.648 . . . . 0.72 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.94 4.07 31.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.855 0.359 . . . . 0.87 110.95 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -105.16 -54.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.26 110.834 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' A' ' 159' ' ' VAL . 6.7 mp0 -94.91 16.75 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 0.6 111.935 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 152' ' ' THR . . . -57.69 -42.8 84.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.894 0.378 . . . . 0.3 111.133 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.37 3.16 32.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.66 111.881 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -111.46 -48.64 3.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 1.15 110.798 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 155' ' ' GLN . 58.5 t -64.65 -39.21 84.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 0.08 110.863 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 164' ' ' LYS . 7.5 tt -68.22 -9.86 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.189 -0.46 . . . . 0.27 111.356 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -102.67 -35.46 8.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.822 -0.436 . . . . 1.27 109.822 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -57.37 -56.61 19.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.342 -0.845 . . . . 0.7 111.778 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -72.41 -21.76 61.21 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.68 -0.408 . . . . 0.39 111.218 -178.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.574 ' N ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.02 -31.24 67.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.68 110.008 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.05 -32.91 73.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.653 -0.703 . . . . 1.03 109.87 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.43 -44.65 14.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.701 -0.681 . . . . 1.65 110.427 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.0 tpp -145.99 126.32 13.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.36 -0.382 . . . . 1.45 110.655 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -80.69 122.5 27.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.815 -0.439 . . . . 1.56 109.815 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -122.57 172.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.36 111.673 -178.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -95.88 -101.4 0.17 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.906 -0.588 . . . . 0.18 110.098 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -175.93 167.33 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.101 -0.333 . . . . 0.41 110.101 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.47 160.99 21.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.26 110.514 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.502 ' CD2' ' HB3' ' A' ' 216' ' ' PRO . 42.3 m-70 -130.6 159.95 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.466 -0.568 . . . . 0.33 109.466 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 60.2 mtm -96.5 -179.02 4.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.847 0.356 . . . . 2.37 111.226 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.491 ' NH2' ' HA ' ' A' ' 242' ' ' LYS . 18.9 mtm180 -76.42 133.0 39.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.802 -0.635 . . . . 0.67 110.466 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt -105.39 147.02 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.024 -0.535 . . . . 1.08 110.896 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 17.1 ptt180 -128.82 141.9 51.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.245 -0.65 . . . . 0.62 109.245 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.8 128.27 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.799 0.333 . . . . 0.22 110.754 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 30.8 pt -102.02 137.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 0.7 110.763 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.755 HD23 ' HD2' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -146.7 123.48 5.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.28 109.591 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.755 ' HD2' HD23 ' A' ' 180' ' ' LEU . 10.0 Cg_endo -52.26 142.77 45.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.552 2.168 . . . . 0.16 112.032 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 59.7 t -45.56 -37.88 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.153 0.581 . . . . 0.27 112.176 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -48.5 -40.61 27.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.912 -0.586 . . . . 0.41 112.151 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -117.93 7.23 12.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.01 0.433 . . . . 0.49 110.526 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.509 ' O ' HD23 ' A' ' 188' ' ' LEU . . . -66.57 -31.21 77.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.25 112.777 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 82.1 tttt -63.74 -29.02 70.28 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.69 -0.3 . . . . 1.48 111.28 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.76 -47.52 84.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.601 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 230' ' ' THR . 0.1 OUTLIER -85.77 -22.04 27.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.857 0.36 . . . . 0.43 110.607 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -60.1 -52.15 66.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.971 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 11.3 pt-20 -89.27 22.25 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.9 111.253 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -121.38 -47.08 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.511 -0.313 . . . . 0.59 111.172 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 188' ' ' LEU . 8.5 mt -83.01 -39.14 21.66 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 53.2 mttm -59.89 -49.92 89.05 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.815 0.672 . . . . 1.16 112.815 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 19.0 Cg_endo -60.18 -19.77 58.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.135 1.89 . . . . 0.3 113.044 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 191' ' ' LYS . 86.3 mt -79.09 -14.43 59.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.607 -0.269 . . . . 0.2 110.438 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 8.7 mm 56.22 41.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.801 0.81 . . . . 0.23 110.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -124.91 28.81 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.343 -0.844 . . . . 0.42 109.949 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.6 m -119.13 156.07 21.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.335 -0.848 . . . . 0.12 110.43 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.68 147.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.531 -0.544 . . . . 0.86 109.531 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.82 76.3 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 1.23 110.945 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.0 m -155.56 26.3 0.39 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 0.19 109.521 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 209' ' ' GLU . 2.7 mp0 -80.37 162.61 24.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 1.79 111.641 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -109.16 143.26 38.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.903 -0.777 . . . . 1.6 108.903 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.75 37.94 3.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.6 110.69 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -99.74 -97.67 2.18 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.705 -0.759 . . . . 0.66 112.078 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -95.73 -22.32 17.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.158 0.504 . . . . 2.25 110.916 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.49 160.79 37.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.7 109.999 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 208' ' ' LEU . 2.7 mm? -100.15 80.11 2.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.042 0.449 . . . . 0.39 110.101 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 177' ' ' ARG . 47.2 tt0 -76.62 96.78 4.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.44 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 37.9 mm -96.95 139.55 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.866 0.365 . . . . 0.3 111.152 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.76 116.57 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.32 110.323 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.2 p -139.28 96.13 3.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.351 . . . . 0.71 110.676 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -164.44 136.66 4.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.495 -0.557 . . . . 0.76 109.495 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -133.16 -45.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.601 0.238 . . . . 0.82 111.191 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -168.92 158.16 7.66 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.564 -0.289 . . . . 0.9 110.235 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.502 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 18.8 Cg_endo -62.54 -16.71 54.03 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.816 2.344 . . . . 0.57 113.197 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -71.06 -60.05 4.71 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.004 -0.617 . . . . 0.26 112.388 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.456 ' O ' HG12 ' A' ' 222' ' ' ILE . 2.2 m -79.0 -8.71 59.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.973 0.415 . . . . 0.34 110.847 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.19 -29.4 68.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.29 111.873 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -60.54 -50.61 72.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 0.48 111.065 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -77.86 2.27 17.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 1.24 111.608 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 28.2 mm -101.76 -55.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.878 0.371 . . . . 1.16 110.382 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 35.4 t70 -60.81 -26.08 67.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.36 111.813 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.5 -26.35 65.21 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.195 -0.457 . . . . 1.1 111.795 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 2.0 pp -106.65 -34.01 7.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.26 110.126 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 222' ' ' ILE . 41.0 mm -55.78 -35.3 39.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.003 -0.544 . . . . 0.2 111.077 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 18.1 ptpt -53.32 -37.17 62.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.582 -0.735 . . . . 2.0 112.426 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -19.69 13.7 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.594 -0.443 . . . . 2.79 112.15 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.5 -41.07 48.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.213 0.449 . . . . 1.18 112.213 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.513 ' HB ' HD13 ' A' ' 188' ' ' LEU . 5.1 t -142.22 -32.52 0.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.257 0.836 . . . . 0.18 113.257 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 37.5 ttmt -57.75 -47.57 82.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.781 0.324 . . . . 0.82 111.462 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -89.03 10.72 71.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.965 -0.636 . . . . 0.23 112.404 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -112.32 -59.86 1.94 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.51 110.188 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -106.46 -119.15 4.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.21 111.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 7.9 m -143.67 150.69 39.09 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 122.703 -0.292 . . . . 0.48 110.574 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 236' ' ' LEU . 1.7 pt? -109.83 142.98 40.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 1.5 111.045 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.84 -173.78 4.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.988 -0.551 . . . . 1.04 109.718 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.93 153.91 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.977 0.418 . . . . 0.24 111.772 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.83 96.1 6.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.9 109.724 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.41 -23.46 61.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.72 111.089 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.99 114.9 16.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.102 -0.499 . . . . 0.48 110.408 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.491 ' HA ' ' NH2' ' A' ' 175' ' ' ARG . 54.2 mtmt -132.22 24.74 4.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.815 -0.63 . . . . 3.29 110.409 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 -70.06 0.83 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.705 . . . . 0.64 110.092 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.45 149.08 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.249 -0.648 . . . . 0.19 109.249 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.39 121.8 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 1.79 111.205 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -126.83 178.46 5.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.552 -0.749 . . . . 1.37 109.213 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.15 -161.97 9.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.409 -1.377 . . . . 0.43 113.866 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.86 21.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.499 0.72 . . . . 0.18 112.495 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -80.02 -8.61 59.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.104 0.478 . . . . 1.0 110.355 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -90.55 68.98 6.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.897 -0.592 . . . . 0.46 109.959 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -71.16 -43.81 66.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.985 -0.552 . . . . 0.96 109.787 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.664 -0.684 . . . . 1.54 110.192 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.208 -0.757 . . . . 0.57 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.26 -35.69 73.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.765 0.283 . . . . 2.3 110.763 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 3' ' ' MET . 1.4 ptp -117.29 133.55 55.85 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.996 0.427 . . . . 0.51 110.734 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.4 m -132.26 163.3 28.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.27 109.56 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tt -98.82 119.75 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.159 0.504 . . . . 0.31 110.921 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -143.42 -62.22 0.41 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 0.7 110.319 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.475 HG23 ' HB ' ' A' ' 15' ' ' THR . 95.6 m -155.13 104.51 2.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 0.37 111.544 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -88.43 126.31 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.583 2.189 . . . . 0.32 111.704 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 t -113.65 132.03 55.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.37 110.795 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -171.55 -59.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.803 -0.635 . . . . 0.93 109.566 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -128.08 -157.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.662 -0.699 . . . . 2.37 111.031 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -69.42 100.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.118 0.485 . . . . 0.67 111.099 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -136.25 134.56 38.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.631 -0.713 . . . . 1.53 109.744 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.6 mt -66.18 -4.76 8.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.167 0.432 . . . . 1.05 112.167 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.475 ' HB ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -78.08 -20.34 52.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.124 0.488 . . . . 0.37 111.069 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 48.6 m-80 -114.36 71.94 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.47 110.278 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 5.5 m -123.13 121.79 63.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.23 111.762 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.76 116.16 31.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.619 . . . . 0.36 109.327 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.56 109.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.104 0.478 . . . . 0.45 111.685 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 89' ' ' ILE . 6.6 p -105.92 129.44 59.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.541 -0.911 . . . . 0.37 108.541 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -125.72 125.4 42.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.372 -0.531 . . . . 0.61 112.095 -178.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 89' ' ' ILE . 34.7 ttp -114.27 116.18 28.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.25 109.603 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 128.54 54.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 1.0 110.622 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -113.67 -156.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.617 -0.72 . . . . 1.24 109.501 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.86 -60.33 2.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.35 110.878 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.18 32.43 3.96 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.959 -0.639 . . . . 0.21 111.713 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.02 142.42 31.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.49 109.726 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.12 125.66 10.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.509 -0.314 . . . . 1.77 110.572 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -144.35 132.02 21.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.333 -0.394 . . . . 0.31 110.727 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.91 138.17 43.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.444 . . . . 0.68 110.424 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.708 HD11 HD12 ' A' ' 89' ' ' ILE . 1.1 mt -136.76 172.22 15.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.781 0.324 . . . . 1.15 110.656 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' H ' HG22 ' A' ' 31' ' ' ILE . . . -124.84 107.91 11.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.107 -0.497 . . . . 0.21 109.993 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 m -98.55 -161.84 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.2 110.077 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.57 -173.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.443 0.164 . . . . 1.03 110.624 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 23.1 tptt -74.47 -133.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.943 0.401 . . . . 0.86 111.499 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 14.6 m120 -64.69 6.21 0.24 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.091 0.774 . . . . 0.61 113.091 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 -15.0 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.222 -0.299 . . . . 0.81 110.913 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.23 -27.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.328 0.492 . . . . 0.26 112.328 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.83 101.43 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.223 0.535 . . . . 0.21 111.091 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.44 45.69 75.21 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.291 -0.868 . . . . 0.24 112.574 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 56.24 51.78 11.18 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.74 110.34 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 63.32 33.09 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 1.91 110.461 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.3 m 61.81 32.51 18.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.753 -0.658 . . . . 0.27 110.989 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.09 -76.53 0.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.272 -0.731 . . . . 0.32 111.272 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -166.61 136.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.077 0.465 . . . . 0.64 110.261 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -107.67 -87.11 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.153 -0.476 . . . . 2.14 110.791 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 20.2 ptmt -163.88 -48.97 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.771 0.286 . . . . 1.68 111.771 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -169.51 127.06 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.905 -0.405 . . . . 2.04 109.905 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.06 -24.35 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.225 -0.443 . . . . 0.65 111.669 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.63 -41.88 91.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.02 0.438 . . . . 1.98 110.587 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -78.31 -30.31 48.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 1.74 110.169 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.28 -33.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.904 -0.589 . . . . 0.2 110.143 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -88.28 84.88 6.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.184 -0.462 . . . . 0.2 110.458 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.0 -61.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.747 -0.661 . . . . 0.73 110.973 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.23 120.24 22.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.953 0.406 . . . . 0.13 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -99.03 5.96 46.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.322 -0.399 . . . . 0.69 110.683 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.25 114.75 28.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.895 -0.593 . . . . 0.28 110.072 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 68' ' ' ALA . 3.7 p -89.12 136.82 22.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.14 110.507 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -95.21 149.22 21.56 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.11 -0.33 . . . . 0.33 110.11 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.17 -45.39 13.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.458 0.647 . . . . 0.26 109.745 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -155.46 107.86 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.485 -0.78 . . . . 1.91 109.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.59 -28.98 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.59 . . . . 0.51 112.095 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.6 m -73.42 -16.7 61.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.876 0.369 . . . . 0.88 111.299 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -13.82 14.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.814 0.34 . . . . 0.64 110.45 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.77 75.78 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.93 -0.652 . . . . 0.15 111.751 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -87.24 112.04 21.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.981 0.419 . . . . 1.15 110.964 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 t -98.0 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.1 109.621 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -94.93 115.11 27.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.864 -0.421 . . . . 0.12 109.864 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.088 -0.506 . . . . 0.94 109.747 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -59.4 -30.23 68.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.098 0.475 . . . . 0.95 110.436 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.99 -19.68 54.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.623 -0.717 . . . . 2.32 110.899 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.57 -47.58 8.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.966 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 2.3 pp -67.02 -31.77 72.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.259 -0.428 . . . . 0.11 111.399 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.46 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.708 0.289 . . . . 0.74 111.384 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -91.38 -9.42 44.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.728 0.299 . . . . 0.9 111.663 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.42 -43.15 5.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.14 111.417 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -92.09 -37.5 12.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.49 -0.323 . . . . 0.27 110.75 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.03 -17.95 29.11 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.11 112.128 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 81' ' ' ASP . 3.7 m -116.53 142.22 47.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.917 -0.401 . . . . 0.21 109.917 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.65 2.38 48.64 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.98 0.419 . . . . 0.32 111.053 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 79' ' ' THR . 13.1 t70 -92.54 109.0 20.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.543 -0.54 . . . . 1.29 109.543 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -33.17 75.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.27 -0.423 . . . . 0.6 111.764 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.32 78.62 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.933 0.397 . . . . 0.45 111.114 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -36.9 83.34 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.746 -0.661 . . . . 1.94 110.487 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 73' ' ' LEU . 45.8 mt -72.0 -41.56 68.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.16 110.328 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.28 -37.79 78.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.871 -0.604 . . . . 0.15 110.011 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -61.43 -42.6 99.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.415 -0.811 . . . . 1.08 110.409 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.68 -49.17 64.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.923 -0.58 . . . . 1.04 110.775 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.708 HD12 HD11 ' A' ' 31' ' ' ILE . 54.7 mt -57.88 -34.43 48.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.041 -0.527 . . . . 0.39 111.413 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -41.34 87.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.42 0.526 . . . . 0.26 112.42 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -96.84 -11.7 24.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.001 0.741 . . . . 0.51 113.001 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -106.6 -31.28 8.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.173 0.434 . . . . 0.97 112.173 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.56 -173.65 29.58 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.479 -0.867 . . . . 0.22 113.136 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -91.74 107.26 19.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.407 -0.397 . . . . 1.88 110.978 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.02 134.46 26.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.803 -0.814 . . . . 0.58 108.803 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 96.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 1.48 111.491 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG23 ' H ' ' A' ' 99' ' ' ASP . 15.4 m -122.98 -17.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 0.82 110.245 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 m 63.63 23.37 13.53 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.724 -0.671 . . . . 1.46 110.939 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.592 ' H ' HG23 ' A' ' 97' ' ' VAL . 5.6 t70 -122.67 -50.47 1.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.48 -0.782 . . . . 0.73 110.747 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 99' ' ' ASP . 35.2 mmtm -119.05 42.51 2.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.909 0.385 . . . . 1.18 111.129 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -70.05 138.8 52.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 1.62 110.238 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.42 174.16 6.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.348 -0.387 . . . . 1.83 110.093 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -61.43 130.8 47.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.46 111.058 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.44 HG21 ' HE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -145.33 179.66 7.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.757 -0.656 . . . . 0.63 109.749 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -79.85 107.87 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.317 0.579 . . . . 0.82 110.612 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -84.55 93.45 8.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 1.2 110.502 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -128.99 -148.28 0.37 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.697 -0.683 . . . . 2.56 110.686 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -56.41 -22.32 30.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.423 -0.353 . . . . 1.51 111.691 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 ttt -50.52 -47.53 57.43 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.046 -0.525 . . . . 1.2 111.862 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -77.44 -28.7 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.93 110.991 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -41.83 85.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.104 0.478 . . . . 1.34 110.218 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.56 ' O ' HG12 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.42 -49.09 78.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.42 111.652 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -69.72 -35.4 65.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.844 -0.342 . . . . 0.41 111.712 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.15 111.73 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 112' ' ' ASP . 6.6 t -72.66 -16.9 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.81 -0.356 . . . . 0.26 111.447 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 112' ' ' ASP . 36.3 mm -83.01 -46.06 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 0.24 110.415 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -70.99 -37.19 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.21 110.634 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.674 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . . . -68.31 -19.61 64.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.131 0.491 . . . . 0.32 110.709 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.73 -7.24 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.639 -0.709 . . . . 0.85 110.262 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 0.77 10.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.264 0.468 . . . . 0.69 112.264 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.674 ' SG ' ' HA ' ' A' ' 118' ' ' ALA . 31.6 p -120.8 142.53 49.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.95 -0.3 . . . . 0.23 110.874 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 170' ' ' GLU . 0.2 OUTLIER -100.19 165.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.849 -0.426 . . . . 0.65 109.849 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -140.94 156.75 68.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 110.005 -0.369 . . . . 0.28 110.005 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 126' ' ' THR . 97.5 Cg_endo -80.71 -156.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.456 2.104 . . . . 0.4 111.827 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -67.2 104.87 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.619 . . . . 1.26 110.885 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 124' ' ' PRO . 2.1 t -144.53 -47.84 0.26 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.712 -0.677 . . . . 0.26 110.297 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.52 -63.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.78 109.972 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -150.82 146.04 18.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.728 -0.471 . . . . 1.26 109.728 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.97 11.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.96 2.44 . . . . 0.59 112.508 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -152.34 89.89 1.46 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.155 -0.683 . . . . 1.51 109.155 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 133' ' ' ILE . 10.4 m -152.69 131.89 12.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.196 -0.457 . . . . 0.54 110.535 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -69.07 -29.09 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.631 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.455 ' H ' HG22 ' A' ' 131' ' ' THR . 48.6 mm -51.79 -33.4 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.324 0.49 . . . . 0.28 112.324 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 134' ' ' LEU . 2.7 mm? -56.79 -51.38 69.16 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.969 0.414 . . . . 0.57 110.823 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.4 -33.85 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.093 -0.503 . . . . 1.96 110.285 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 139' ' ' MET . 1.0 OUTLIER -57.25 -47.09 82.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.74 110.534 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -37.19 86.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.92 110.976 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 -42.88 66.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.24 111.586 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.576 ' O ' ' HB3' ' A' ' 143' ' ' HIS . 20.4 ptt? -67.45 -31.09 71.02 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.878 0.325 . . . . 0.4 111.878 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -82.86 -17.73 42.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.401 . . . . 0.45 110.105 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.67 -49.57 11.92 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.219 -0.66 . . . . 0.92 109.219 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.7 mm -117.1 88.08 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.59 110.651 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 139' ' ' MET . 24.8 p80 -132.78 15.56 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.237 0.541 . . . . 1.23 110.202 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.34 164.44 17.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.604 -0.726 . . . . 0.87 109.614 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -69.56 113.97 7.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.191 -0.3 . . . . 1.26 110.191 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.68 -49.32 81.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.998 -0.546 . . . . 0.28 110.253 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HB3' ' OD1' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -143.63 119.61 10.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.365 -0.834 . . . . 0.8 109.732 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -18.69 59.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.013 0.435 . . . . 0.28 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 24.1 p-10 -84.63 -16.38 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.34 110.837 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -104.58 132.27 51.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.48 110.112 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.9 m -84.12 168.86 15.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.352 -0.385 . . . . 0.36 110.775 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -57.72 -36.58 72.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.48 111.708 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -79.48 5.58 12.49 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 1.39 112.098 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -111.15 -56.35 2.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.801 0.334 . . . . 0.41 111.116 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 159' ' ' VAL . 8.4 pt20 -99.25 27.92 4.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.479 -0.328 . . . . 0.6 111.55 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.13 -48.68 70.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.18 112.092 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.79 -30.84 64.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.352 -0.385 . . . . 0.28 111.022 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.001 -0.28 . . . . 1.65 110.437 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 155' ' ' GLN . 52.4 t -63.33 -52.9 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.371 -0.377 . . . . 0.46 110.595 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.9 -32.24 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.345 -0.389 . . . . 0.47 110.984 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -70.54 -35.11 72.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 1.54 110.244 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -65.52 -35.46 80.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.221 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -68.18 -37.6 81.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.344 0.592 . . . . 0.35 109.514 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -69.79 -33.32 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.163 -0.926 . . . . 1.52 111.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 -27.56 64.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.885 0.374 . . . . 1.28 110.752 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -81.12 -47.21 13.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.3 tpt -134.13 99.39 4.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.403 -0.591 . . . . 1.08 109.403 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 113.06 5.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.74 111.151 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -91.31 160.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.453 -0.794 . . . . 0.48 110.521 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . 8.8 tp10 -101.53 155.33 18.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.732 -0.47 . . . . 0.84 109.732 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -56.27 148.32 18.84 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.969 0.414 . . . . 1.62 111.525 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.64 152.6 45.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.821 -0.627 . . . . 0.37 111.409 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.448 ' CE1' HD12 ' A' ' 213' ' ' LEU . 4.1 t-160 -63.67 130.29 43.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.35 111.018 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -87.34 179.94 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.35 110.592 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.97 137.81 49.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 1.04 110.451 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 32.2 mt -118.26 149.67 40.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.614 -0.513 . . . . 1.02 109.614 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 209' ' ' GLU . 16.1 ttp180 -110.67 136.78 49.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.386 -0.37 . . . . 1.12 110.27 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 209' ' ' GLU . 52.6 m-85 -99.65 137.94 37.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.22 110.381 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 6.3 tt -126.31 128.05 71.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.19 110.581 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -167.63 155.51 8.35 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.52 . . . . 0.14 110.614 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.97 160.02 35.64 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.853 2.369 . . . . 0.22 112.732 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.5 t -57.94 -37.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.251 -0.431 . . . . 0.23 111.315 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -51.4 -38.77 55.16 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.65 111.748 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 187' ' ' LYS . 0.7 OUTLIER -102.05 -26.79 13.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.757 0.313 . . . . 0.69 111.282 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' A' ' 188' ' ' LEU . . . -61.51 -34.24 87.7 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 116.054 -0.521 . . . . 0.17 113.61 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -61.69 -25.88 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.723 -0.281 . . . . 1.19 111.596 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.526 ' O ' ' HE3' ' A' ' 191' ' ' LYS . 13.4 mptt -62.35 -41.85 98.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.978 0.418 . . . . 0.78 110.874 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 185' ' ' GLY . 1.1 pp -87.75 -30.32 20.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.433 -0.348 . . . . 0.3 111.133 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.33 -31.96 71.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.88 111.675 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -86.62 -7.57 58.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.616 0.599 . . . . 1.71 112.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 187' ' ' LYS . 26.1 mtmt -122.7 -29.89 3.95 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.129 0.788 . . . . 1.16 113.129 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -87.18 -32.82 19.62 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.164 0.431 . . . . 0.63 112.164 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 194' ' ' PRO . 2.1 mtpt -72.55 -43.45 9.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 113.142 0.793 . . . . 1.13 113.142 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 193' ' ' LYS . 11.0 Cg_endo -54.31 -34.63 80.96 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 122.415 2.077 . . . . 0.54 113.642 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -92.73 13.75 19.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.772 -0.371 . . . . 0.61 111.462 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 18.6 pt 33.22 56.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.435 1.094 . . . . 0.87 113.897 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -109.98 16.71 21.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.95 109.773 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.41 152.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.376 -0.829 . . . . 0.6 110.769 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 211' ' ' VAL . 4.6 mp -84.89 144.8 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.347 -0.612 . . . . 0.59 109.347 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -72.43 74.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.405 0.621 . . . . 2.46 111.029 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 m -157.07 27.04 0.31 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.296 -0.865 . . . . 1.45 109.146 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 210' ' ' ILE . 0.2 OUTLIER -82.23 137.98 34.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.768 -0.651 . . . . 1.27 111.342 -178.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.04 117.34 33.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.457 -0.571 . . . . 0.58 109.457 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.439 ' H ' ' HB3' ' A' ' 248' ' ' ASP . 78.2 m-85 -98.62 59.2 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.983 0.42 . . . . 0.66 111.342 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -109.24 -127.74 5.52 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.417 -0.896 . . . . 0.35 111.684 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.06 -28.6 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 1.3 109.458 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -118.62 117.97 30.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.805 -1.089 . . . . 1.23 108.405 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mp -80.42 79.09 7.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.126 0.489 . . . . 0.29 111.093 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 178' ' ' PHE . 6.0 tt0 -86.25 106.23 17.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.561 -0.745 . . . . 0.98 109.201 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 202' ' ' GLU . 8.0 mt -120.62 146.9 24.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.939 -0.573 . . . . 0.34 111.089 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 199' ' ' ILE . 0.3 OUTLIER -104.22 122.27 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.804 -0.443 . . . . 0.68 109.804 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.563 ' O ' HD22 ' A' ' 213' ' ' LEU . 12.8 t -144.39 79.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.643 -0.423 . . . . 0.16 111.717 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 212' ' ' CYS . 0.6 OUTLIER -140.39 116.08 10.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 215' ' ' ASP . 11.3 tt -94.12 172.76 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 0.68 111.432 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' A' ' 216' ' ' PRO . 0.0 OUTLIER -58.01 168.89 1.02 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.612 0.765 . . . . 0.58 111.513 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 215' ' ' ASP . 41.3 Cg_endo -66.68 -172.66 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.271 1.981 . . . . 0.37 112.875 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 78.03 -75.04 1.94 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.656 -0.783 . . . . 0.23 111.435 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.96 -1.91 55.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.063 0.459 . . . . 1.11 110.581 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.07 -26.78 67.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.548 . . . . 0.25 111.449 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -80.2 -32.66 38.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.964 0.412 . . . . 1.82 110.526 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -72.51 -36.12 68.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.42 110.594 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 225' ' ' LEU . 13.3 tt -79.32 -26.16 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 0.37 110.849 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.85 -32.22 70.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.325 -0.398 . . . . 0.75 110.88 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.63 -35.47 68.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.08 111.778 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 222' ' ' ILE . 1.9 pp -95.02 -37.3 11.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.773 -0.371 . . . . 0.57 110.889 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 33.5 mm -58.22 -39.87 75.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.718 0.294 . . . . 0.36 111.308 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 231' ' ' LYS . 0.7 OUTLIER -63.98 -20.15 65.67 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.798 0.666 . . . . 1.09 112.798 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.96 5.06 11.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.745 -0.382 . . . . 1.73 111.841 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 225' ' ' LEU . 1.0 OUTLIER -108.38 -73.39 0.69 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.846 0.355 . . . . 0.96 111.207 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.2 t -100.81 -34.95 9.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.077 0.399 . . . . 0.32 112.077 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 227' ' ' LYS . 61.4 tttm -77.54 -23.88 50.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.02 110.598 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.48 -8.44 62.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.25 112.044 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -113.46 -7.01 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.41 111.292 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -157.99 179.19 33.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.168 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 t -91.91 162.94 14.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.784 -0.45 . . . . 0.33 109.784 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.51 144.83 44.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.797 0.332 . . . . 0.86 110.912 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -140.63 176.49 8.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.885 -0.598 . . . . 1.85 109.987 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.39 145.3 11.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.044 0.45 . . . . 0.57 111.17 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.3 tp -72.01 -5.79 37.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.368 0.604 . . . . 1.56 110.522 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.78 -6.12 47.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.621 -0.718 . . . . 1.39 110.694 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 91.73 3.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.043 -0.526 . . . . 1.76 110.198 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -102.7 44.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.624 . . . . 1.25 110.604 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.92 18.97 12.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.305 -0.407 . . . . 1.6 111.195 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 245' ' ' GLU . 3.9 p -151.52 177.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.484 -0.561 . . . . 0.89 109.484 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.613 ' H ' HG22 ' A' ' 244' ' ' VAL . 57.1 mm-40 -57.78 146.7 30.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.324 0.39 . . . . 1.25 110.887 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -151.79 120.13 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.429 -0.351 . . . . 1.08 110.752 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 75.72 96.21 0.15 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.117 -0.563 . . . . 0.32 112.777 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 204' ' ' TYR . 44.8 t0 -123.11 84.99 2.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.294 0.569 . . . . 0.75 110.119 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 12.32 37.16 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.16 -0.682 . . . . 0.89 109.16 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -85.66 91.52 8.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.946 -1.025 . . . . 0.45 109.186 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.33 -20.85 39.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 2.31 111.646 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 119.073 -0.489 . . . . 0.97 110.487 179.957 . . . . . . . . 0 0 . 1 stop_ save_